Citrus Sinensis ID: 007035
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 621 | 2.2.26 [Sep-21-2011] | |||||||
| Q54BC9 | 915 | Probable serine/threonine | yes | no | 0.323 | 0.219 | 0.463 | 9e-49 | |
| Q09690 | 1087 | Dual specificity protein | yes | no | 0.347 | 0.198 | 0.443 | 1e-47 | |
| P14680 | 807 | Dual specificity protein | yes | no | 0.354 | 0.272 | 0.430 | 4e-46 | |
| Q9V3D5 | 722 | Dual specificity tyrosine | yes | no | 0.344 | 0.296 | 0.422 | 1e-44 | |
| Q8BI55 | 632 | Dual specificity tyrosine | yes | no | 0.331 | 0.325 | 0.438 | 2e-44 | |
| Q9P6P3 | 534 | Serine/threonine-protein | no | no | 0.331 | 0.385 | 0.450 | 7e-44 | |
| Q54QV3 | 1458 | Probable serine/threonine | no | no | 0.333 | 0.141 | 0.452 | 1e-43 | |
| Q9NR20 | 520 | Dual specificity tyrosine | yes | no | 0.331 | 0.396 | 0.438 | 2e-43 | |
| P83102 | 828 | Putative dual specificity | no | no | 0.323 | 0.242 | 0.434 | 6e-43 | |
| A8WJR8 | 815 | Dual specificity tyrosine | N/A | no | 0.367 | 0.279 | 0.416 | 7e-43 |
| >sp|Q54BC9|DYRK2_DICDI Probable serine/threonine-protein kinase dyrk2 OS=Dictyostelium discoideum GN=dyrk2 PE=3 SV=1 | Back alignment and function desciption |
|---|
Score = 195 bits (496), Expect = 9e-49, Method: Compositional matrix adjust.
Identities = 95/205 (46%), Positives = 129/205 (62%), Gaps = 4/205 (1%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKND 471
IA R+ + LG +F +V + D TG V LKI++N K F +Q+L EIK+L+ + ND
Sbjct: 601 IAYRFEIVSILGQGSFCQVVKGYDYKTGEMVALKILRNQKRFHNQALTEIKILEYLKTND 660
Query: 472 PADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCL 531
P I+ L +YFY HL + ELL NLY+F K N G + L ++ Q L
Sbjct: 661 PNSTASIVHLNNYFYFRNHLILTFELLSMNLYDFLKVNHFQG----YNLNLVRRFGAQIL 716
Query: 532 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEV 591
+L +L IIH DLKPENIL+KS + IK+ID GSSCF+ + + Y+QSR YR+PEV
Sbjct: 717 TSLRFLSKRNIIHADLKPENILLKSPTKSGIKLIDFGSSCFENEQIFTYIQSRFYRSPEV 776
Query: 592 IIGLPYDQKIDLWSLGCILAELWTG 616
I+G YD+ ID+WSLGCIL E++TG
Sbjct: 777 ILGTKYDKSIDIWSLGCILVEIFTG 801
|
Dictyostelium discoideum (taxid: 44689) EC: 2EC: .EC: 7EC: .EC: 1EC: 2EC: .EC: 1 |
| >sp|Q09690|POM1_SCHPO Dual specificity protein kinase pom1 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=pom1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 191 bits (486), Expect = 1e-47, Method: Compositional matrix adjust.
Identities = 98/221 (44%), Positives = 142/221 (64%), Gaps = 5/221 (2%)
Query: 397 GFE-ENKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFD 455
GF+ E D ++L IA RY V ++LG +F +V + D TG V LKII+N K F
Sbjct: 679 GFDDERGDYKVVLGDHIAYRYEVVDFLGKGSFGQVLRCIDYETGKLVALKIIRNKKRFHM 738
Query: 456 QSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE 515
Q+L E K+L+ + + DP DE+ +++ D+FY +HL + ELL NLYE K N G
Sbjct: 739 QALVETKILQKIREWDPLDEYCMVQYTDHFYFRDHLCVATELLGKNLYELIKSNGFKG-- 796
Query: 516 AYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTD 575
+ ++ ITRQ ++ L L+ +IHCDLKPENIL+ + ++K+ID GSSCF+ +
Sbjct: 797 --LPIVVIKSITRQLIQCLTLLNEKHVIHCDLKPENILLCHPFKSQVKVIDFGSSCFEGE 854
Query: 576 NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTG 616
+ Y+QSR YR+PEVI+G+ Y ID+WSLGCI+AE++TG
Sbjct: 855 CVYTYIQSRFYRSPEVILGMGYGTPIDVWSLGCIIAEMYTG 895
|
Involved in localization of polarized growth and cytokinesis. May interact with both the actin and microtubule cytoskeleton. Requires tea1 for localization to the cell ends but not to the cell center. Schizosaccharomyces pombe (strain 972 / ATCC 24843) (taxid: 284812) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|P14680|YAK1_YEAST Dual specificity protein kinase YAK1 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) GN=YAK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 186 bits (472), Expect = 4e-46, Method: Compositional matrix adjust.
Identities = 99/230 (43%), Positives = 144/230 (62%), Gaps = 10/230 (4%)
Query: 393 KNRTGFEE-NKDLPIILNTVIA----GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKII 447
K GF+ N D + +N V+ +Y V + LG F +V + Q+L T + +K++
Sbjct: 341 KCNNGFDNINSDYILYVNDVLGVEQNRKYLVLDILGQGTFGQVVKCQNLLTKEILAVKVV 400
Query: 448 KNDKDFFDQSLDEIKLLKLVN-KNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQ 506
K+ ++ QS+ E K+L+L+N K DP ++HH LR+YD F H HL +V ELL NLYE
Sbjct: 401 KSRTEYLTQSITEAKILELLNQKIDPTNKHHFLRMYDSFVHKNHLCLVFELLSNNLYELL 460
Query: 507 KFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566
K N+ G ++ ++ T Q L++L L +IHCDLKPENIL+ + + E+KIID
Sbjct: 461 KQNKFHG----LSIQLIRTFTTQILDSLCVLKESKLIHCDLKPENILLCAPDKPELKIID 516
Query: 567 LGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTG 616
GSSC + + Y+QSR YRAPE+I+G+PY ID+WSLGCI+AEL+ G
Sbjct: 517 FGSSCEEARTVYTYIQSRFYRAPEIILGIPYSTSIDMWSLGCIVAELFLG 566
|
Negative regulator of the cell cycle acting downstream of the cAMP-dependent protein kinase. Part of a glucose-sensing system involved in growth control in response to glucose availability. Phosphorylates POP2. Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (taxid: 559292) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|Q9V3D5|DYRK2_DROME Dual specificity tyrosine-phosphorylation-regulated kinase 2 OS=Drosophila melanogaster GN=smi35A PE=1 SV=1 | Back alignment and function description |
|---|
Score = 181 bits (459), Expect = 1e-44, Method: Compositional matrix adjust.
Identities = 92/218 (42%), Positives = 133/218 (61%), Gaps = 4/218 (1%)
Query: 399 EENKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSL 458
++N + II + IA RY + E +G +F +V +A D T V +KII+N K F +Q++
Sbjct: 181 DDNGNYKIIEHDHIAFRYEILEVIGKGSFGQVIRALDHKTNTHVAIKIIRNKKRFLNQAV 240
Query: 459 DEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYF 518
E+ +L + + D H+++ + DY Y +HL I EL+ NLYE K N +G F
Sbjct: 241 VELNILDELREKDADGSHNVIHMLDYTYFRKHLCITFELMSLNLYELIKKNNYNG----F 296
Query: 519 TLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC 578
++ ++ ++ L L+ IIHCDLKPENIL+K IK+ID GSSC+ +
Sbjct: 297 SMSLIRRFCNSIVKCLRLLYKENIIHCDLKPENILLKQRGSSSIKVIDFGSSCYVDRKIY 356
Query: 579 LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTG 616
Y+QSR YR+PEVI+GL Y ID+WSLGCILAEL+TG
Sbjct: 357 TYIQSRFYRSPEVILGLQYGTAIDMWSLGCILAELYTG 394
|
In vitro; can phosphorylate exogenous substrates on Ser and Thr residues. May have a physiological role in development being involved in cellular growth and differentiation. Drosophila melanogaster (taxid: 7227) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|Q8BI55|DYRK4_MOUSE Dual specificity tyrosine-phosphorylation-regulated kinase 4 OS=Mus musculus GN=Dyrk4 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 181 bits (459), Expect = 2e-44, Method: Compositional matrix adjust.
Identities = 92/210 (43%), Positives = 130/210 (61%), Gaps = 4/210 (1%)
Query: 407 ILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKL 466
+L+ IA RY V E +G +F +V + D V LKII+N K F Q+L E+K+L+
Sbjct: 210 VLHDHIAYRYEVLEMIGKGSFGQVAKCLDHKNNELVALKIIRNKKRFHHQALVELKILEA 269
Query: 467 VNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVI 526
+ + D + H+++ + D+FY HL I ELL NLYE K N G F L ++
Sbjct: 270 LRRKDKDNNHNVVHMKDFFYFRNHLCITFELLGINLYELMKNNSFHG----FNLSIVRRF 325
Query: 527 TRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSY 586
T L+ L L+ IIHCDLKPENI++ + +K+ID GSSC++ + Y+QSR Y
Sbjct: 326 TFSILKCLHMLYVEKIIHCDLKPENIVLYQRGQVTVKVIDFGSSCYEHQKVYTYIQSRFY 385
Query: 587 RAPEVIIGLPYDQKIDLWSLGCILAELWTG 616
R+PEVI+G PY+ ID+WSLGCI+AEL+TG
Sbjct: 386 RSPEVILGHPYNMAIDMWSLGCIMAELYTG 415
|
Possible non-essential role in spermiogenesis. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|Q9P6P3|PPK15_SCHPO Serine/threonine-protein kinase ppk15 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=ppk15 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 179 bits (453), Expect = 7e-44, Method: Compositional matrix adjust.
Identities = 95/211 (45%), Positives = 129/211 (61%), Gaps = 5/211 (2%)
Query: 407 ILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKL 466
+L T +Y + + LG F +V + QDL T V +K+IKN F++Q + E+ +L+L
Sbjct: 121 LLGTDEGRKYLILDTLGHGTFGQVARCQDLKTQQIVAIKVIKNKPAFYNQCVMEVSILEL 180
Query: 467 VN-KNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQV 525
+N K DP D+ H++RLYD F H HL +V ELL NLYE K NQ G L ++
Sbjct: 181 LNNKYDPEDKRHLIRLYDQFMHKNHLCLVFELLSINLYELIKQNQFRG----LHLSLVRS 236
Query: 526 ITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS 585
Q L L IIHCDLKPENIL++ +K+ID GS+C + + Y+QSR
Sbjct: 237 FATQLLSCTSLLKQARIIHCDLKPENILLQDLSSPIVKVIDFGSACHERQTVYTYIQSRF 296
Query: 586 YRAPEVIIGLPYDQKIDLWSLGCILAELWTG 616
YR+PEVI+GL Y+ ID+WSLGCILAEL+ G
Sbjct: 297 YRSPEVILGLHYNCGIDMWSLGCILAELFLG 327
|
Schizosaccharomyces pombe (strain 972 / ATCC 24843) (taxid: 284812) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54QV3|YAKA_DICDI Probable serine/threonine-protein kinase yakA OS=Dictyostelium discoideum GN=yakA PE=1 SV=1 | Back alignment and function description |
|---|
Score = 178 bits (452), Expect = 1e-43, Method: Compositional matrix adjust.
Identities = 96/212 (45%), Positives = 130/212 (61%), Gaps = 5/212 (2%)
Query: 406 IILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLK 465
II N +Y V + LG F +V + ++ T V +KI+KN + +F Q EI+ LK
Sbjct: 195 IITNNESGQKYKVLDSLGQGTFGQVVKCKNCDTDELVAIKILKNKQAYFQQGRLEIQTLK 254
Query: 466 LVN-KNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQ 524
+N ++DP D++HILRL D F H HL IV ELL NL+E K N G + ++
Sbjct: 255 SLNDQHDPEDKNHILRLLDSFIHKMHLCIVFELLSVNLFELIKQNNFRG----LSTNLIK 310
Query: 525 VITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSR 584
V Q L+AL L + IIHCDLKPENIL+++ IKIID GS+C++ L Y+QSR
Sbjct: 311 VFLIQILDALIVLANANIIHCDLKPENILLQNVNSPAIKIIDFGSACYEKSTLYTYIQSR 370
Query: 585 SYRAPEVIIGLPYDQKIDLWSLGCILAELWTG 616
YR+PEV++G Y ID+WSLGCI AEL+ G
Sbjct: 371 HYRSPEVLVGTVYCASIDMWSLGCISAELFLG 402
|
General sensor of environmental conditions, such as heat stress, effecting changes through pkaC. Essential for survival to nitrosoative and oxidative stresses. Required for cell cycle control, not only at the onset but also during development (aggregation process and postaggregative development). Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|Q9NR20|DYRK4_HUMAN Dual specificity tyrosine-phosphorylation-regulated kinase 4 OS=Homo sapiens GN=DYRK4 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 177 bits (450), Expect = 2e-43, Method: Compositional matrix adjust.
Identities = 92/210 (43%), Positives = 129/210 (61%), Gaps = 4/210 (1%)
Query: 407 ILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKL 466
+L+ IA RY V E +G +F +V + D V LKII+N K F Q+L E+K+L+
Sbjct: 95 VLHDHIAYRYEVLETIGKGSFGQVAKCLDHKNNELVALKIIRNKKRFHQQALMELKILEA 154
Query: 467 VNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVI 526
+ K D + ++++ + D+FY H I ELL NLYE K N G F+L ++
Sbjct: 155 LRKKDKDNTYNVVHMKDFFYFRNHFCITFELLGINLYELMKNNNFQG----FSLSIVRRF 210
Query: 527 TRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSY 586
T L+ L+ L IIHCDLKPENI++ + +K+ID GSSC++ + Y+QSR Y
Sbjct: 211 TLSVLKCLQMLSVEKIIHCDLKPENIVLYQKGQASVKVIDFGSSCYEHQKVYTYIQSRFY 270
Query: 587 RAPEVIIGLPYDQKIDLWSLGCILAELWTG 616
R+PEVI+G PYD ID+WSLGCI AEL+TG
Sbjct: 271 RSPEVILGHPYDVAIDMWSLGCITAELYTG 300
|
Possible non-essential role in spermiogenesis. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|P83102|DYRK3_DROME Putative dual specificity tyrosine-phosphorylation-regulated kinase 3 homolog OS=Drosophila melanogaster GN=Dyrk3 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 176 bits (445), Expect = 6e-43, Method: Compositional matrix adjust.
Identities = 89/205 (43%), Positives = 128/205 (62%), Gaps = 4/205 (1%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKND 471
+A RY + + +G +F +V +A D T V LKI++N+K F Q+ +EI++L + ++D
Sbjct: 272 VAYRYEMLKIIGKGSFGQVIKAYDHKTHEHVALKIVRNEKRFHRQAQEEIRILHHLRRHD 331
Query: 472 PADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCL 531
+ +I+ ++DYF H I ELL NLYE K N G F+L ++ L
Sbjct: 332 KYNTMNIIHMFDYFTFRNHTCITFELLSINLYELIKKNGFKG----FSLQLVRKFAHSLL 387
Query: 532 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEV 591
+ L+ L+ IIHCD+KPEN+L+K R IK+ID GSSCF+ + Y+QSR YRAPEV
Sbjct: 388 QCLDALYKNDIIHCDMKPENVLLKQQGRSGIKVIDFGSSCFENQRIYTYIQSRFYRAPEV 447
Query: 592 IIGLPYDQKIDLWSLGCILAELWTG 616
I+G Y + ID+WSLGCILAEL +G
Sbjct: 448 ILGGKYGRAIDMWSLGCILAELLSG 472
|
Drosophila melanogaster (taxid: 7227) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|A8WJR8|MBK2_CAEBR Dual specificity tyrosine-phosphorylation-regulated kinase mbk-2 OS=Caenorhabditis briggsae GN=mbk-2 PE=3 SV=2 | Back alignment and function description |
|---|
Score = 176 bits (445), Expect = 7e-43, Method: Compositional matrix adjust.
Identities = 97/233 (41%), Positives = 135/233 (57%), Gaps = 5/233 (2%)
Query: 389 IIHRKNRTGFE-ENKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKII 447
+I N G++ EN ++++ IA RY V + +G +F +V +A D V LK++
Sbjct: 432 VIGGANNGGYDDENGSYQLVVHDHIAYRYEVLKVIGKGSFGQVIKAFDHKYQQYVALKLV 491
Query: 448 KNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQK 507
+N+K F Q+ +EI++L + + D H+I+ + DYF H I ELL NLYE K
Sbjct: 492 RNEKRFHRQADEEIRILDHLRRQDSDGTHNIIHMLDYFNFRNHKCITFELLSINLYELIK 551
Query: 508 FNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 567
N+ G F+L ++ L L+ L +IHCDLKPEN+L+K R IK+ID
Sbjct: 552 RNKFQG----FSLMLVRKFAYSMLLCLDLLQKNRLIHCDLKPENVLLKQQGRSGIKVIDF 607
Query: 568 GSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620
GSSCF + Y+QSR YRAPEVI+G Y ID+WSLGCILAEL TG L
Sbjct: 608 GSSCFDDQRIYTYIQSRFYRAPEVILGTKYGMPIDMWSLGCILAELLTGYPLL 660
|
Required for oocyte-to-zygote transition in which it phosphorylates oocyte proteins, including mei-1, oma-1, oma-2, mex-5, and mex-6, modifying their activity and/or stability following meiosis. Functions in both spindle positioning and in the posterior localization of cytoplasmic determinants, including pie-1, pos-1, and pgl-1, in early embryos. Caenorhabditis briggsae (taxid: 6238) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 621 | ||||||
| 224101151 | 725 | predicted protein [Populus trichocarpa] | 0.924 | 0.791 | 0.6 | 0.0 | |
| 297736602 | 728 | unnamed protein product [Vitis vinifera] | 0.969 | 0.826 | 0.618 | 0.0 | |
| 356551440 | 710 | PREDICTED: dual specificity tyrosine-pho | 0.950 | 0.830 | 0.568 | 1e-175 | |
| 357492707 | 612 | Dual specificity tyrosine-phosphorylatio | 0.935 | 0.949 | 0.537 | 1e-154 | |
| 255585370 | 609 | ATP binding protein, putative [Ricinus c | 0.450 | 0.459 | 0.826 | 1e-132 | |
| 226506060 | 725 | ATP binding protein [Zea mays] gi|195616 | 0.913 | 0.782 | 0.460 | 1e-131 | |
| 359486399 | 596 | PREDICTED: probable serine/threonine-pro | 0.436 | 0.454 | 0.830 | 1e-130 | |
| 357125722 | 715 | PREDICTED: dual specificity protein kina | 0.900 | 0.781 | 0.455 | 1e-130 | |
| 413952032 | 714 | putative protein kinase superfamily prot | 0.909 | 0.791 | 0.447 | 1e-129 | |
| 357125720 | 726 | PREDICTED: dual specificity protein kina | 0.900 | 0.769 | 0.452 | 1e-129 |
| >gi|224101151|ref|XP_002312161.1| predicted protein [Populus trichocarpa] gi|222851981|gb|EEE89528.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 719 bits (1855), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 387/645 (60%), Positives = 459/645 (71%), Gaps = 71/645 (11%)
Query: 8 DVETVIEFLRKNGFKEAESALKEDMMEKIRDLGSFDYEKFLFPVLPPVKIPASLRQTEVD 67
DVE V++FLRKNG ++AE ALKEDM+E+ +LGSFD+EKFLF VLPPV++PAS+R +V+
Sbjct: 14 DVEAVLDFLRKNGLRDAELALKEDMIERSNELGSFDFEKFLF-VLPPVRVPASVRPLDVE 72
Query: 68 EGGADRSSRSSSASSSDDDEFVSLASSTS--DLCSSEFTNPYGLRSTSHGNSEASSESLS 125
EGG SS+ S DDEFVSL SSTS ++ SSEF+NPYGL STS NSE SS+ LS
Sbjct: 73 EGGGAVERLRSSSGSPSDDEFVSLGSSTSASEVYSSEFSNPYGLHSTSQANSETSSDRLS 132
Query: 126 QFDTARDY---DLQNDFYWHDEKDEGYFMTPSYGGSDFFGCPSEDKFIMTSEADRLFENP 182
QF TARDY D+QND YW+DEK+EG+FM+P + G D+FGCPSEDKF+MTSE + FEN
Sbjct: 133 QFGTARDYPDFDMQNDSYWYDEKEEGHFMSPCFNGPDYFGCPSEDKFVMTSETGKQFENS 192
Query: 183 LAVYDQSEGLHSEASTDYLDKPCLFHIVPLNDDKEVGVTDYYR-FEKTNQPEAGGIKEKL 241
L +YD+SEG ++ + DYLDK CL+++ +N+ E +Y+ F+K NQ E G I
Sbjct: 193 LGLYDKSEG-ETQGNIDYLDKQCLYNVTSVNNKNEAQSMNYHHDFDKKNQLE-GDID--- 247
Query: 242 KDCAAYGCSEPLCKCCAGEGKINNDYGYLSSKEADLIDLQHNVVGDSSTDCDLAPHPGTE 301
+D ++ ++ + G+I+ D Y SSK DL D Q VG+S TD D P
Sbjct: 248 RDGSSAHNAKFFTETGGIYGRISVDCIYTSSKGPDLGDFQLK-VGESPTDYDTVP----- 301
Query: 302 KSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDNSDTRD-GEVNGALHEGKA 360
+H + + ID+ + D G VNG HE A
Sbjct: 302 -------------------------VHMENKNANYYENGIDDFEVGDGGGVNGEAHELAA 336
Query: 361 DAEEHGVATPDLLMFDNLEEECEIFHLRIIHRKNR------------------------- 395
V +LLM+ N E+E E+F+LR+IHRKNR
Sbjct: 337 AIGGEDVNANELLMYYNQEDEYEVFNLRVIHRKNRSCGHGIDPADSTLFSWRSDACAMQV 396
Query: 396 --TGFEENKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDF 453
TGFEENKDLPI+LNTVIAGRYYVTEYLGSAAFSKV QA DLHTG+DVCLKIIKNDKDF
Sbjct: 397 KWTGFEENKDLPIVLNTVIAGRYYVTEYLGSAAFSKVIQAHDLHTGIDVCLKIIKNDKDF 456
Query: 454 FDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESG 513
FDQSLDEIKLLK+VNK DPADE HILRLYDYFYH EHLFIVCELL+ANLYEFQKFNQESG
Sbjct: 457 FDQSLDEIKLLKIVNKLDPADERHILRLYDYFYHQEHLFIVCELLKANLYEFQKFNQESG 516
Query: 514 GEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQ 573
GEAYFTL RLQVITRQCLEALEYLH LGIIHCDLKPEN+LIKSY++CEIK+IDLGSSCF+
Sbjct: 517 GEAYFTLSRLQVITRQCLEALEYLHDLGIIHCDLKPENVLIKSYRKCEIKVIDLGSSCFK 576
Query: 574 TDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEV 618
+DNLCLYVQSRSYRAPEVI+GLPYDQKIDLWSLGCILAEL +GEV
Sbjct: 577 SDNLCLYVQSRSYRAPEVILGLPYDQKIDLWSLGCILAELCSGEV 621
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297736602|emb|CBI25473.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 717 bits (1850), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 387/626 (61%), Positives = 463/626 (73%), Gaps = 24/626 (3%)
Query: 4 VSSSDVETVIEFLRKNGFKEAESALKEDMMEKIRDLGSFDYEKFLFPVLPPV---KIPAS 60
++ SDV+ V+EFLRK G E+ESAL++D+ E+ + SFD+E F+FP++PP +IPAS
Sbjct: 1 MAVSDVDAVLEFLRKYGLSESESALRQDVSER-GGVASFDFESFVFPMVPPPPPVRIPAS 59
Query: 61 LRQTEVDEGGADRSSRSSSASSSDDDEFVSLASSTSDLCSSEFTNPYGLRSTSHGNSEAS 120
R+ E G D SS S D+FVSL SS +D SSEFTNPYG+ S + NS AS
Sbjct: 60 SRRMEEAVGDTDSSSVCS-------DDFVSLGSSATDAYSSEFTNPYGVHSATQANSTAS 112
Query: 121 SESLSQFDTARDY---DLQNDFYWHDEKDEGYFMTPSYGGSDFFGCPSEDKFIMTSEADR 177
S+SL +F TARDY D+QND YW+DEKD+ YF T +GGS+ FGCPSEDKF+MT E D+
Sbjct: 113 SDSLCEFGTARDYSDFDMQNDLYWYDEKDDDYFNTSCFGGSESFGCPSEDKFVMTLEKDK 172
Query: 178 LFENPLAVYDQSEGLHSEASTDYLDKPCLFHIVPLNDDKEVGVTDYYRFEKTNQPEAGGI 237
E+ L + +SEG + +T+YL+KPC+F++ ++ ++ VTDYY + QP+ G
Sbjct: 173 QSESQLTLIHKSEGYPTLPTTNYLEKPCVFNLTSMDGVNDIPVTDYYHLGEHFQPD-GAR 231
Query: 238 KEKLKDCAAYGCSEPLCKCCAG----EGKINNDYGYLSSKEADLIDLQHNVVGDSSTDCD 293
+ + CA Y CS PLCKCCAG G DY ++ E DL Q VVG TDCD
Sbjct: 232 EGDHESCAVYSCSVPLCKCCAGAEGFRGGDPVDYSQMNFAETDLDGSQLKVVGKIPTDCD 291
Query: 294 LAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDNSDTRDGEVNG 353
A KS YS KR S+ D I FK +SDLH + E + DGEV G
Sbjct: 292 SASEYKINKSFDYSI-KRSSANDLIGEFKSTSDLHIENTEPN---GNYGYEVGDDGEVAG 347
Query: 354 ALHEGKADAEEHGVATPD-LLMFDNLEEECEIFHLRIIHRKNRTGFEENKDLPIILNTVI 412
+E +A+ ++ AT D LLM++N E+E E+F+LRIIHRKNRTGFEENKDLPI+LNTV+
Sbjct: 348 ECYEPEANVDDQEGATADELLMYENQEDEYEVFNLRIIHRKNRTGFEENKDLPIVLNTVL 407
Query: 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDP 472
AGRYY+TEYLGSAAFSKV QA DL TG+DVCLKIIKNDKDFFDQSLDEIKLLK VNK+DP
Sbjct: 408 AGRYYITEYLGSAAFSKVVQAHDLQTGMDVCLKIIKNDKDFFDQSLDEIKLLKYVNKHDP 467
Query: 473 ADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLE 532
ADE HILRLYDYFYH EHLFIVCELLRANLYEFQKFNQESGGE YFTL RLQVITRQCLE
Sbjct: 468 ADERHILRLYDYFYHQEHLFIVCELLRANLYEFQKFNQESGGETYFTLKRLQVITRQCLE 527
Query: 533 ALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVI 592
ALEYLH LGIIHCDLKPENILIKSY+RC+IK+IDLGSSCF+TDNL LYVQSRSYRAPEVI
Sbjct: 528 ALEYLHDLGIIHCDLKPENILIKSYRRCDIKVIDLGSSCFRTDNLSLYVQSRSYRAPEVI 587
Query: 593 IGLPYDQKIDLWSLGCILAELWTGEV 618
+GLPYDQ+ID+WSLGCILAEL +GEV
Sbjct: 588 LGLPYDQRIDIWSLGCILAELCSGEV 613
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356551440|ref|XP_003544083.1| PREDICTED: dual specificity tyrosine-phosphorylation-regulated kinase 4-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 620 bits (1600), Expect = e-175, Method: Compositional matrix adjust.
Identities = 356/626 (56%), Positives = 428/626 (68%), Gaps = 36/626 (5%)
Query: 6 SSDVETVIEFLRKNGFKEAESALKEDMMEKIRDLGSFDYEKFLFPVLPPVKIPASLRQTE 65
S+ VE V+EFLRKNG EAESAL++D++E DLG+FDYEKF FP++PP +
Sbjct: 4 SNGVEAVLEFLRKNGLSEAESALRQDIIEN-NDLGNFDYEKFFFPMVPPPPPVRVRSFSR 62
Query: 66 VDEGGADRSSRSSSASSSDDDEFVSLASSTSDLCSSEFTNPYGLRSTSH--GNSEASSES 123
+ E AD + S S DEFVS+ S TS + SSEF NPYG+RS+S +S +SSE
Sbjct: 63 LSELSAD-----GNCSKSSSDEFVSIGSPTSRVSSSEFINPYGIRSSSQTQNDSASSSER 117
Query: 124 LSQFDTARDY---DLQNDFYWHDEKDEGYFMTPSYGGSDFFGCPSEDKFIMTSEADRLFE 180
LSQF TARDY ++QN+ YW++EKD+ YFMTPS+ G DFF C SEDKF+MT+E + +
Sbjct: 118 LSQFGTARDYHDFEMQNEPYWYNEKDDDYFMTPSFEGPDFFACQSEDKFVMTAETENQHD 177
Query: 181 NPL-AVYDQSEGL-HSEASTDYLDKPCLFHIVPLNDDKEVGVTDYYRFEKTNQPEAGGIK 238
N L VY+ E L + ++DK CL++ + D +Y + N E
Sbjct: 178 NSLDLVYNSEEFLLKGNGNGGFMDKACLYNHSSVRDGNATYSKEYCHVDNNNLFEGELEG 237
Query: 239 EKLKDCAAYGCSEPLCKCCAGEGKINND---YGYLSSKEADLIDLQHNVVGDSSTDCDLA 295
+ K A C P CK G G + D +GY + KE I L+ + + +L
Sbjct: 238 KAEKHTVACSCEVPFCKSSPG-GSCSLDPTNFGYPNLKE---IHLKFGDINSFDSTSELT 293
Query: 296 PHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDNSDTRDGEVNGAL 355
+ + + SSK + G DL K +KDL P +D RDG G L
Sbjct: 294 VNQSFDYYTKNDSSKE---------YNGPYDLTIKVNQKDL-PNGLDTYKARDG---GEL 340
Query: 356 HEGKADAE---EHGVATPDLLMFDNLEEECEIFHLRIIHRKNRTGFEENKDLPIILNTVI 412
E D E + T D L+ EEE E+F LRIIHRKNRTGFEENK+LPI+LNTV+
Sbjct: 341 AEECQDPEITADGEDTTDDELLKYTQEEEYEVFDLRIIHRKNRTGFEENKELPIVLNTVL 400
Query: 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDP 472
AGRYYVTEYLGSAAFS+V QA DL TG+DVCLKIIKNDKDFFDQSLDEIKLLKLVNK+DP
Sbjct: 401 AGRYYVTEYLGSAAFSRVVQAHDLQTGIDVCLKIIKNDKDFFDQSLDEIKLLKLVNKHDP 460
Query: 473 ADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLE 532
AD HH LRLYDYFYH EHLFIV ELL+ANLYEFQKF QESGGE YFTL RLQ+ITRQCLE
Sbjct: 461 ADLHHFLRLYDYFYHQEHLFIVTELLQANLYEFQKFKQESGGEEYFTLNRLQLITRQCLE 520
Query: 533 ALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVI 592
AL+YLHSLGI+HCDLKPENILIKSY+RCEIK+IDLGSSCFQTDNLCLYVQSRSYRAPEV+
Sbjct: 521 ALQYLHSLGIVHCDLKPENILIKSYRRCEIKVIDLGSSCFQTDNLCLYVQSRSYRAPEVM 580
Query: 593 IGLPYDQKIDLWSLGCILAELWTGEV 618
+GL YD+KID+WSLGCILAEL +GEV
Sbjct: 581 LGLQYDEKIDIWSLGCILAELCSGEV 606
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357492707|ref|XP_003616642.1| Dual specificity tyrosine-phosphorylation-regulated kinase [Medicago truncatula] gi|355517977|gb|AES99600.1| Dual specificity tyrosine-phosphorylation-regulated kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 553 bits (1425), Expect = e-154, Method: Compositional matrix adjust.
Identities = 342/636 (53%), Positives = 430/636 (67%), Gaps = 55/636 (8%)
Query: 6 SSDVETVIEFLRKNGFKEAESALKEDMMEK-IRDLGSFDYEKFLFPVLPPV---KIPASL 61
S+ VE V EFLRKNG EAESAL++D+++K DL SFDYEKF FP++PP K+ +
Sbjct: 4 SNSVEAVFEFLRKNGLSEAESALRQDIIDKHNNDLASFDYEKFFFPMVPPPPPVKLRSFS 63
Query: 62 RQTEVDEGGADRSSRSSSASSSDDDEFVSLASSTSDLCSS----EFTNPYGLRSTSH--G 115
R +E G + S+S+S SS +++FVS+ASSTS S EF NPYG+ S+S
Sbjct: 64 RPSEFTSGDG-QFSKSNSVSS--EEQFVSIASSTSPSRSRVSSSEFINPYGINSSSQTQN 120
Query: 116 NSEASSESLSQFDTARDY---DLQNDFYWHDEKDEGYFMTPSYG-GSDFFGCPSEDKFIM 171
+SE+SS+ LSQF TARDY D+Q++ YW++E D+ G DFFGC SEDKFI+
Sbjct: 121 DSESSSDRLSQFGTARDYHEFDMQHEPYWYNENDDDDDFMTPDFDGPDFFGCQSEDKFIL 180
Query: 172 TSEADRLFENPLAVYDQSEGLHSEASTDYLDKP---CLFHIVPLNDDKEVGVTDYYRFEK 228
SE + ++ ++ E + E + Y+DK CL + D+ DY
Sbjct: 181 NSETENQQDDSRDLHYNFEEIQLEGNEGYIDKSMEQCLCNHSSGGDENATYSKDYCH--- 237
Query: 229 TNQPEAGGIKEKLKDCAAYGCSEPLCKCCAGEGKINN----DYGYLSSKEADLIDLQHNV 284
G KE + A+ C P CK G G + ++ YL+ KE L +L
Sbjct: 238 ------GAEKEAI----AHNCEVPFCKSSPGSGGSCSEDPMNFSYLNLKEIKL-NLNDFH 286
Query: 285 VGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDNS 344
+ D ++ D P + SS + +K DL + E DL P I++
Sbjct: 287 MKDINS-FDSVPVLTMKHSS--------------DCYKDPYDLTIEVVETDL-PNGIESY 330
Query: 345 DTRDG-EVNGALHEGKADAEEHGVATPDLLMFDNLEEECEIFHLRIIHRKNRTGFEENKD 403
+ RD ++N LH + A+ T D L+ ++E E+F LRI+HRKNRTGFEENK+
Sbjct: 331 EVRDDRDLNEELHVPEVAADGEDNNTDDDLLKYIQDDEYEVFELRIVHRKNRTGFEENKE 390
Query: 404 LPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKL 463
+PI+LN+V+AGRYYVTEYLGSAAFS+V QA DL G+DVCLKIIKNDKDFFDQSLDEIKL
Sbjct: 391 VPIVLNSVMAGRYYVTEYLGSAAFSRVVQAHDLQMGIDVCLKIIKNDKDFFDQSLDEIKL 450
Query: 464 LKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRL 523
LKLVNK+DP D+HHILRLYDYFYH EHLFIV ELLRANLYEFQKFNQESGGEAYFTL RL
Sbjct: 451 LKLVNKHDPGDKHHILRLYDYFYHQEHLFIVTELLRANLYEFQKFNQESGGEAYFTLKRL 510
Query: 524 QVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQS 583
Q+ITRQCLEAL+YLH+LGI+HCDLKPEN+LIKSY++CEIKIIDLGSSCF+TDNLCLYVQS
Sbjct: 511 QLITRQCLEALQYLHNLGIVHCDLKPENVLIKSYKKCEIKIIDLGSSCFKTDNLCLYVQS 570
Query: 584 RSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVC 619
RSYRAPEV++GL YD+KID+WSLGCILAEL +GEVC
Sbjct: 571 RSYRAPEVMLGLQYDEKIDIWSLGCILAELCSGEVC 606
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255585370|ref|XP_002533381.1| ATP binding protein, putative [Ricinus communis] gi|223526774|gb|EEF28999.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 477 bits (1228), Expect = e-132, Method: Compositional matrix adjust.
Identities = 233/282 (82%), Positives = 249/282 (88%), Gaps = 2/282 (0%)
Query: 341 IDNSDTRDGEVNGALHEGKADAEEHG--VATPDLLMFDNLEEECEIFHLRIIHRKNRTGF 398
+ +S + GE N E +A EE V T DLLM D E+E E+F LRIIHRKNRTGF
Sbjct: 221 MKSSKDKIGEANEEADELRATEEEEDGEVNTNDLLMLDAQEDEYEVFDLRIIHRKNRTGF 280
Query: 399 EENKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSL 458
EENKDLPI+LNTVIAGRYYVTEYLGSAAFSKV QA DL+TG+DVCLKIIKNDKDFFDQSL
Sbjct: 281 EENKDLPIVLNTVIAGRYYVTEYLGSAAFSKVVQAHDLYTGIDVCLKIIKNDKDFFDQSL 340
Query: 459 DEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYF 518
DEIKLLKLVNK+DPADE HI+RLYDYFYH EHLFIVCELLRANLYEFQKFNQESGGE YF
Sbjct: 341 DEIKLLKLVNKHDPADERHIIRLYDYFYHQEHLFIVCELLRANLYEFQKFNQESGGEPYF 400
Query: 519 TLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC 578
TL RLQVITRQCLEALEYLH LGIIHCDLKPENILIKSY+RCEIK+IDLGSSCFQ+DNLC
Sbjct: 401 TLSRLQVITRQCLEALEYLHHLGIIHCDLKPENILIKSYRRCEIKVIDLGSSCFQSDNLC 460
Query: 579 LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620
LYVQSRSYRAPEVI+GLPYDQKIDLWSLGCILAEL +GEV
Sbjct: 461 LYVQSRSYRAPEVILGLPYDQKIDLWSLGCILAELCSGEVLF 502
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|226506060|ref|NP_001148168.1| ATP binding protein [Zea mays] gi|195616354|gb|ACG30007.1| ATP binding protein [Zea mays] gi|414879861|tpg|DAA56992.1| TPA: putative protein kinase superfamily protein [Zea mays] | Back alignment and taxonomy information |
|---|
Score = 476 bits (1226), Expect = e-131, Method: Compositional matrix adjust.
Identities = 308/669 (46%), Positives = 377/669 (56%), Gaps = 102/669 (15%)
Query: 4 VSSSDVETVIEFLRKNGFKEAESALKEDMMEKIRDLGSFDYEKFLFPVLPPVKIPASLRQ 63
+++ ++ V+ FL +GF A SAL++D++E+ G ++ L P LPP+++PAS
Sbjct: 1 MAAPGLDKVMAFLTDHGFAGAASALRDDVLERTA-AGDESHDAALDPHLPPLRMPASAGG 59
Query: 64 TEVDEGGADRSSRSSSASSSDDDE------FVSLASSTSDLCSSEFTNPYGLRSTSHGNS 117
G + + AS FVSL S+ S L NPYGL S H S
Sbjct: 60 AGAGAGAGAGAGTPTPASPGSSSGSASSSAFVSLRSTPSGLL-----NPYGLWSPRHSQS 114
Query: 118 EASSESLSQFDTARDYDLQNDFYWHDEKDEGYFMTPSYGGSDFFGCPSEDKFIMTSEADR 177
+ASS + +F TAR YD + F+ ++D Y D
Sbjct: 115 DASSSEM-EFGTARQYDTTDLFF---QEDWLY-------------------------DDH 145
Query: 178 LFENPLAVYDQSEGLHSEASTDYLDKPCLFHIVPLNDDKEVGVTDYYRFEKTNQPEAGGI 237
LF + L D + D D I ++G +R E GG
Sbjct: 146 LFPSKLDDEDDEGKEEDKFVLDAHDGSEQVEI------GKLGAGHNHRHEHI-----GG- 193
Query: 238 KEKLKDCA-AYGCSEPLCKCCAGEGKINN-DYGYLSSKEA----DLIDLQHNVVGDSSTD 291
++ + CA Y CS PLC CC G K + D SS ++D Q ++ D + D
Sbjct: 194 -DRCEGCAEVYICSSPLCGCCGGGLKNDGLDVARSSSSTVYGRYKIMDDQTEILDDCAQD 252
Query: 292 -------------CDLAPHPG----------TEKS----SSYSSSKRGSSIDWIEG--FK 322
C + PG EK SS+ + + D+ E
Sbjct: 253 AFQLKQSRDIMFECGMTRDPGRGYDDSGLSVVEKELQILSSFDTVVNHGTYDFTENGELN 312
Query: 323 GSSDLHFKGAEKDLMP-----------AEIDNSD--TRDGEVNGALHEGKADAEEHGVAT 369
GS D + K + P ++D +D G +N + A E T
Sbjct: 313 GSCDKNLKSSIHKEYPKGHRIQPFPESGDLDEADEFRHVGSLNTDVQHSTALKAEEDAET 372
Query: 370 PDLLMFDNLEEECEIFHLRIIHRKNRTGFEENKDLPIILNTVIAGRYYVTEYLGSAAFSK 429
L + E E+F LRIIHRKNRTGFEENKD PI+LN+V+AGRYY+TEYLGSAAFSK
Sbjct: 373 NIDLALSDFHREYEVFELRIIHRKNRTGFEENKDFPIVLNSVVAGRYYITEYLGSAAFSK 432
Query: 430 VFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489
V QA DL TG+DVCLKIIKNDKDFFDQSLDEIKLLK VNK DP DEHH+LRLYDYFYH E
Sbjct: 433 VVQAHDLRTGMDVCLKIIKNDKDFFDQSLDEIKLLKFVNKYDPLDEHHVLRLYDYFYHQE 492
Query: 490 HLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKP 549
HLFIV ELLRANLYEFQK+NQESGGE YFTL R+QVI RQCLEAL YLH L IIHCDLKP
Sbjct: 493 HLFIVTELLRANLYEFQKYNQESGGEVYFTLPRIQVIARQCLEALVYLHRLRIIHCDLKP 552
Query: 550 ENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCI 609
ENILIKSY RCEIK+IDLGSSCF TDNLCLYVQSRSYRAPEVI+GLPYDQ+ID+WSLGCI
Sbjct: 553 ENILIKSYSRCEIKVIDLGSSCFLTDNLCLYVQSRSYRAPEVILGLPYDQRIDIWSLGCI 612
Query: 610 LAELWTGEV 618
L+EL+TGEV
Sbjct: 613 LSELYTGEV 621
|
Source: Zea mays Species: Zea mays Genus: Zea Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359486399|ref|XP_002272072.2| PREDICTED: probable serine/threonine-protein kinase dyrk2 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 473 bits (1216), Expect = e-130, Method: Compositional matrix adjust.
Identities = 226/272 (83%), Positives = 249/272 (91%), Gaps = 1/272 (0%)
Query: 348 DGEVNGALHEGKADAEEHGVATPD-LLMFDNLEEECEIFHLRIIHRKNRTGFEENKDLPI 406
DGEV G +E +A+ ++ AT D LLM++N E+E E+F+LRIIHRKNRTGFEENKDLPI
Sbjct: 210 DGEVAGECYEPEANVDDQEGATADELLMYENQEDEYEVFNLRIIHRKNRTGFEENKDLPI 269
Query: 407 ILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKL 466
+LNTV+AGRYY+TEYLGSAAFSKV QA DL TG+DVCLKIIKNDKDFFDQSLDEIKLLK
Sbjct: 270 VLNTVLAGRYYITEYLGSAAFSKVVQAHDLQTGMDVCLKIIKNDKDFFDQSLDEIKLLKY 329
Query: 467 VNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVI 526
VNK+DPADE HILRLYDYFYH EHLFIVCELLRANLYEFQKFNQESGGE YFTL RLQVI
Sbjct: 330 VNKHDPADERHILRLYDYFYHQEHLFIVCELLRANLYEFQKFNQESGGETYFTLKRLQVI 389
Query: 527 TRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSY 586
TRQCLEALEYLH LGIIHCDLKPENILIKSY+RC+IK+IDLGSSCF+TDNL LYVQSRSY
Sbjct: 390 TRQCLEALEYLHDLGIIHCDLKPENILIKSYRRCDIKVIDLGSSCFRTDNLSLYVQSRSY 449
Query: 587 RAPEVIIGLPYDQKIDLWSLGCILAELWTGEV 618
RAPEVI+GLPYDQ+ID+WSLGCILAEL +GEV
Sbjct: 450 RAPEVILGLPYDQRIDIWSLGCILAELCSGEV 481
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357125722|ref|XP_003564539.1| PREDICTED: dual specificity protein kinase YAK1-like isoform 2 [Brachypodium distachyon] | Back alignment and taxonomy information |
|---|
Score = 472 bits (1215), Expect = e-130, Method: Compositional matrix adjust.
Identities = 304/667 (45%), Positives = 374/667 (56%), Gaps = 108/667 (16%)
Query: 4 VSSSDVETVIEFLRKNGFKEAESALKEDMMEKIRDLGSFDYEKFLFPVLPPVKIPASLRQ 63
+++ ++ V+ FL ++GF SAL++D++++ D G D L P LPP+++PAS
Sbjct: 1 MAAPGLDEVMAFLTEHGFASTASALRDDVLDRSAD-GESDSTATLGPQLPPLRLPASASG 59
Query: 64 TEVDEGGADRSSRSSSASSSDDDEFVSLASSTSDLCSSEFTNPYGLRSTSHGNSEASSES 123
+ + S+S+S S A + S NPYG+ S H S+ SS
Sbjct: 60 GAGGGVALEAPASPGSSSNSA----SSSAFVSMSSSPSGLLNPYGVWSPPHSQSDGSSSE 115
Query: 124 LSQFDTARDYDLQNDFY---WHDEKDEGYFMTPSYGGSDFFGCPSEDKFIMTSEADRLFE 180
+ +F TAR YD + F+ W + D + P G D EDKF+
Sbjct: 116 M-EFGTARQYDTTDLFFQEGWLYD-DHLFHSKPDDDGRD----KEEDKFVHGGSG----- 164
Query: 181 NPLAVYDQSEGLHSEASTDYLDKPCLFHIVPLNDDKEVGVTDYYRFEKTNQPEAGGIKEK 240
++E L ++ +DD+ R E G E
Sbjct: 165 -------RTEML----------------VLNADDDR--------RHEHAGNNSCEGCAE- 192
Query: 241 LKDCAAYGCSEPLCKCCAGEGK---------------------INNDYGYLSSKEADLID 279
Y CS PLC CC GE K +++ L DL
Sbjct: 193 -----VYTCSSPLCGCCGGELKNEEGLQVVSNSSSVVYGRYKVMDDQTEILDECGLDLFQ 247
Query: 280 LQHNVVGDSSTDCDLAPHPGT-----EKSSSYSSSKRGSSIDWI---------------E 319
L+ +V DS +CDL PG E + + SS D
Sbjct: 248 LKQSV--DSVLECDLPRDPGQGDEHLELNVVEKELQMLSSFDRFIPHVTDNIKLHDSTEN 305
Query: 320 GFKGSSDLHFKGAEKDLMPAEIDNSDTRD-------GEVNGALHEGKA-DAEEHGVATPD 371
+ SSD + L P ++ D D G +N + A AE+ + +
Sbjct: 306 NLESSSDKEYLKESYSLHPFP-ESGDPDDPYEFGDIGPLNTGVKSSTALIAEKEDMESNI 364
Query: 372 LLMFDNLEEECEIFHLRIIHRKNRTGFEENKDLPIILNTVIAGRYYVTEYLGSAAFSKVF 431
L N + E E+F LRI+HRKNRTGFEENKD PI+LN+VIAGRYYVTEYLGSAAFSKV
Sbjct: 365 DLALSNFQREYEVFELRIVHRKNRTGFEENKDFPIVLNSVIAGRYYVTEYLGSAAFSKVV 424
Query: 432 QAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491
QA DL TG+DVCLKIIKNDKDFFDQSLDEIKLLK VNK DP+DEHH+LRLYDYFYH EHL
Sbjct: 425 QAHDLQTGIDVCLKIIKNDKDFFDQSLDEIKLLKFVNKYDPSDEHHVLRLYDYFYHQEHL 484
Query: 492 FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPEN 551
FIV ELLRANLYEFQK+NQE GGE YFTL R+QVI RQCLEAL YLH L I+HCDLKPEN
Sbjct: 485 FIVTELLRANLYEFQKYNQEFGGEVYFTLPRIQVIARQCLEALVYLHHLRIVHCDLKPEN 544
Query: 552 ILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILA 611
ILIKSY+RCEIK+IDLGSSCF TDNLCLYVQSRSYRAPEVI+GLPYDQ+ID+WSLGCILA
Sbjct: 545 ILIKSYRRCEIKVIDLGSSCFLTDNLCLYVQSRSYRAPEVILGLPYDQRIDIWSLGCILA 604
Query: 612 ELWTGEV 618
EL TGEV
Sbjct: 605 ELCTGEV 611
|
Source: Brachypodium distachyon Species: Brachypodium distachyon Genus: Brachypodium Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|413952032|gb|AFW84681.1| putative protein kinase superfamily protein, partial [Zea mays] | Back alignment and taxonomy information |
|---|
Score = 470 bits (1209), Expect = e-129, Method: Compositional matrix adjust.
Identities = 300/670 (44%), Positives = 379/670 (56%), Gaps = 105/670 (15%)
Query: 4 VSSSDVETVIEFLRKNGFKEAESALKEDMMEKIRDLGSFDYEKFLFPVLPPVKIPASLRQ 63
+++ ++ V+ FL +GF A SAL++D++ + G ++ L P LPP+++PA+
Sbjct: 1 MAAPGLDQVMAFLTDHGFAGAASALRDDVLARTA-AGDEGHDAALGPRLPPLRMPAAGTG 59
Query: 64 TEVDEGGADRSSRSSSASSSDDDE--FVSLASSTSDLCSSEFTNPYGLRSTSHGNSEASS 121
+ G + S +SS FVS+ S+ S L NPYGL S H S+ SS
Sbjct: 60 SGSGAGSGTPAPASPGSSSGSASSSAFVSMRSTPSGL-----LNPYGLWSPRHSQSDVSS 114
Query: 122 ESLSQFDTARDYDLQNDFYWHDEKDEGYFMTPSYGGSDFFGCPSEDKFIMTSEADRLFEN 181
+ +F TAR YD + F+ D + + PS + EDKF++ +
Sbjct: 115 SEM-EFGTARQYDTTDLFFQEDWLYDDHLF-PSKLDDEDDEREEEDKFVLDA-------- 164
Query: 182 PLAVYDQSEGLHSEASTDYLDKPCLFHIVPLNDDKEVGVTDYYRFEKTNQPEAGGIKEKL 241
H AS + ++G +R E GG ++
Sbjct: 165 -----------HGGASAQ-------------TEIGKLGAGHNHRHEHI-----GG--DRC 193
Query: 242 KDCA-AYGCSEPLCKCCAGEGKINNDYGYLSSKEADLIDLQHNVV--------------- 285
+ CA Y CS PLC CC G + ND +++ + + ++ ++
Sbjct: 194 EGCAEVYTCSSPLCGCCGG--GLKNDGLHVARSSSSTVYGRYQIMDDRTETMDDCAQDGF 251
Query: 286 -----GDSSTDCDLAPHPG----------TEKSSSYSSSKRGSSID--WIEGFKGSSDL- 327
GD +C + PG EK SS ++ + F + DL
Sbjct: 252 QLKQSGDIMFECGMQRDPGRGDDDSDLSVVEKELQMLSSFDTDAVTNHGVHDFTDNGDLN 311
Query: 328 --------------HFKGAEKDLMPAEIDNSDTRDGEVNGAL-----HEGKADAEEHGVA 368
+ KG P D + + G+L H +AEE
Sbjct: 312 GICDKNPKISIDKEYLKGHRIQPFPEIGDPDEAYEFRNVGSLNADVQHSTALEAEEDAET 371
Query: 369 TPDLLMFDNLEEECEIFHLRIIHRKNRTGFEENKDLPIILNTVIAGRYYVTEYLGSAAFS 428
DL + D E E+F LRIIHRKNRTGFEENKD PI+LN+V+AGRY +TEYLGSAAFS
Sbjct: 372 NIDLALSD-FHREYEVFELRIIHRKNRTGFEENKDFPIVLNSVVAGRYCITEYLGSAAFS 430
Query: 429 KVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488
KV QA DL TG+DVCLKIIKNDKDFFDQSLDEIKLLK VNK DP DEHH+LRLYDYFYH
Sbjct: 431 KVVQAHDLQTGMDVCLKIIKNDKDFFDQSLDEIKLLKFVNKYDPLDEHHVLRLYDYFYHQ 490
Query: 489 EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLK 548
EHLFIV ELLRANLYEFQK+NQESGGE YFTL R+QVI RQCLEAL YLH L IIHCDLK
Sbjct: 491 EHLFIVTELLRANLYEFQKYNQESGGEVYFTLPRIQVIARQCLEALVYLHHLRIIHCDLK 550
Query: 549 PENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGC 608
PENILIKSY RCEIK+IDLGSSCF TDNLCLYVQSRSYRAPEVI+GLPYDQ+ID+WSLGC
Sbjct: 551 PENILIKSYSRCEIKVIDLGSSCFLTDNLCLYVQSRSYRAPEVILGLPYDQRIDIWSLGC 610
Query: 609 ILAELWTGEV 618
I++EL+TGEV
Sbjct: 611 IISELYTGEV 620
|
Source: Zea mays Species: Zea mays Genus: Zea Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357125720|ref|XP_003564538.1| PREDICTED: dual specificity protein kinase YAK1-like isoform 1 [Brachypodium distachyon] | Back alignment and taxonomy information |
|---|
Score = 469 bits (1208), Expect = e-129, Method: Compositional matrix adjust.
Identities = 307/678 (45%), Positives = 374/678 (55%), Gaps = 119/678 (17%)
Query: 4 VSSSDVETVIEFLRKNGFKEAESALKEDMMEKIRDLGSFDYEKFLFPVLPPVKIPASLRQ 63
+++ ++ V+ FL ++GF SAL++D++++ D G D L P LPP+++PAS
Sbjct: 1 MAAPGLDEVMAFLTEHGFASTASALRDDVLDRSAD-GESDSTATLGPQLPPLRLPASASG 59
Query: 64 TEVDEGGADRSSRSSSASSSDDDEFVSLASSTSDLCSSEFTNPYGLRSTSHGNSEASSES 123
+ + S+S+S S A + S NPYG+ S H S+ SS
Sbjct: 60 GAGGGVALEAPASPGSSSNSA----SSSAFVSMSSSPSGLLNPYGVWSPPHSQSDGSSSE 115
Query: 124 LSQFDTARDYDLQNDFY---WHDEKDEGYFMTPSYGGSDFFGCPSEDKFIMTSEADRLFE 180
+ +F TAR YD + F+ W + D + P G D EDKF+
Sbjct: 116 M-EFGTARQYDTTDLFFQEGWLYD-DHLFHSKPDDDGRD----KEEDKFVHGGSG----- 164
Query: 181 NPLAVYDQSEGLHSEASTDYLDKPCLFHIVPLNDDKEVGVTDYYRFEKTNQPEAGGIKEK 240
++E L ++ +DD+ R E G E
Sbjct: 165 -------RTEML----------------VLNADDDR--------RHEHAGNNSCEGCAE- 192
Query: 241 LKDCAAYGCSEPLCKCCAGEGK---------------------INNDYGYLSSKEADLID 279
Y CS PLC CC GE K +++ L DL
Sbjct: 193 -----VYTCSSPLCGCCGGELKNEEGLQVVSNSSSVVYGRYKVMDDQTEILDECGLDLFQ 247
Query: 280 LQHNVVGDSSTDCDLAPHPG----------TEKSSSYSSSKRGSSIDWIEGFKG------ 323
L+ +V DS +CDL PG EK SS D I G
Sbjct: 248 LKQSV--DSVLECDLPRDPGQGDEHLELNVVEKELQMLSSFDSYGDDDIVANPGFIPHVT 305
Query: 324 ---------------SSDLHFKGAEKDLMPAEIDNSDTRD-------GEVNGALHEGKA- 360
SSD + L P ++ D D G +N + A
Sbjct: 306 DNIKLHDSTENNLESSSDKEYLKESYSLHPFP-ESGDPDDPYEFGDIGPLNTGVKSSTAL 364
Query: 361 DAEEHGVATPDLLMFDNLEEECEIFHLRIIHRKNRTGFEENKDLPIILNTVIAGRYYVTE 420
AE+ + + L N + E E+F LRI+HRKNRTGFEENKD PI+LN+VIAGRYYVTE
Sbjct: 365 IAEKEDMESNIDLALSNFQREYEVFELRIVHRKNRTGFEENKDFPIVLNSVIAGRYYVTE 424
Query: 421 YLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILR 480
YLGSAAFSKV QA DL TG+DVCLKIIKNDKDFFDQSLDEIKLLK VNK DP+DEHH+LR
Sbjct: 425 YLGSAAFSKVVQAHDLQTGIDVCLKIIKNDKDFFDQSLDEIKLLKFVNKYDPSDEHHVLR 484
Query: 481 LYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSL 540
LYDYFYH EHLFIV ELLRANLYEFQK+NQE GGE YFTL R+QVI RQCLEAL YLH L
Sbjct: 485 LYDYFYHQEHLFIVTELLRANLYEFQKYNQEFGGEVYFTLPRIQVIARQCLEALVYLHHL 544
Query: 541 GIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQK 600
I+HCDLKPENILIKSY+RCEIK+IDLGSSCF TDNLCLYVQSRSYRAPEVI+GLPYDQ+
Sbjct: 545 RIVHCDLKPENILIKSYRRCEIKVIDLGSSCFLTDNLCLYVQSRSYRAPEVILGLPYDQR 604
Query: 601 IDLWSLGCILAELWTGEV 618
ID+WSLGCILAEL TGEV
Sbjct: 605 IDIWSLGCILAELCTGEV 622
|
Source: Brachypodium distachyon Species: Brachypodium distachyon Genus: Brachypodium Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 621 | ||||||
| TAIR|locus:2047741 | 570 | AT2G40120 [Arabidopsis thalian | 0.412 | 0.449 | 0.820 | 5.2e-149 | |
| TAIR|locus:2206840 | 1169 | AT1G73460 [Arabidopsis thalian | 0.470 | 0.249 | 0.674 | 9.3e-113 | |
| TAIR|locus:2206855 | 1152 | AT1G73450 [Arabidopsis thalian | 0.465 | 0.250 | 0.677 | 3.4e-111 | |
| TAIR|locus:2089774 | 1138 | AT3G17750 [Arabidopsis thalian | 0.386 | 0.210 | 0.783 | 9e-111 | |
| RGD|1306800 | 633 | Dyrk4 "dual-specificity tyrosi | 0.363 | 0.357 | 0.409 | 4.2e-47 | |
| UNIPROTKB|D4A0W8 | 597 | Dyrk4 "Protein Dyrk4" [Rattus | 0.363 | 0.378 | 0.409 | 4.2e-47 | |
| UNIPROTKB|F5H6L9 | 545 | DYRK4 "Dual-specificity tyrosi | 0.352 | 0.401 | 0.419 | 8.6e-47 | |
| UNIPROTKB|Q9NR20 | 520 | DYRK4 "Dual specificity tyrosi | 0.352 | 0.421 | 0.419 | 8.6e-47 | |
| MGI|MGI:1330292 | 632 | Dyrk4 "dual-specificity tyrosi | 0.360 | 0.354 | 0.427 | 1.4e-46 | |
| POMBASE|SPAC2F7.03c | 1087 | pom1 "DYRK family protein kina | 0.347 | 0.198 | 0.438 | 6.3e-46 |
| TAIR|locus:2047741 AT2G40120 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1129 (402.5 bits), Expect = 5.2e-149, Sum P(2) = 5.2e-149
Identities = 210/256 (82%), Positives = 233/256 (91%)
Query: 363 EEHGVATPDLLMFDNLEEECEIFHLRIIHRKNRTGFEENKDLPIILNTVIAGRYYVTEYL 422
++ V ++ + +E+E E+F+LRIIH KNRTGFEENKDLPI++NTVI GRYY+TEY+
Sbjct: 208 DQLNVTDEEVDVVHEVEDEYEVFNLRIIHWKNRTGFEENKDLPIVINTVIGGRYYITEYI 267
Query: 423 GSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLY 482
GSAAFSKV QAQDLH GVDVCLKIIKNDKDFFDQSLDEIKLLK VNK+DPADEHHILRLY
Sbjct: 268 GSAAFSKVVQAQDLHNGVDVCLKIIKNDKDFFDQSLDEIKLLKHVNKHDPADEHHILRLY 327
Query: 483 DYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGI 542
DYFYH EHLFIVCELLRANLYEFQKFNQESGGE YF L RLQVITRQCL+AL +LH LGI
Sbjct: 328 DYFYHQEHLFIVCELLRANLYEFQKFNQESGGEPYFNLSRLQVITRQCLDALVFLHGLGI 387
Query: 543 IHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKID 602
IHCDLKPENILIKSY+RC +KIIDLGSSCF++DNLCLYVQSRSYRAPEVI+GLPYD+KID
Sbjct: 388 IHCDLKPENILIKSYKRCAVKIIDLGSSCFRSDNLCLYVQSRSYRAPEVILGLPYDEKID 447
Query: 603 LWSLGCILAELWTGEV 618
LWSLGCILAEL +GEV
Sbjct: 448 LWSLGCILAELCSGEV 463
|
|
| TAIR|locus:2206840 AT1G73460 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1037 (370.1 bits), Expect = 9.3e-113, Sum P(3) = 9.3e-113
Identities = 199/295 (67%), Positives = 236/295 (80%)
Query: 324 SSDLHFKGAEKDLMPAEIDNSDTRDGEVNGALHEGKADAEEHGVATPDLLMFDNLEEECE 383
SS ++ E+ E D +D+ + E + A D EE + EEE E
Sbjct: 769 SSLSNYACEERKHADKEDDRNDSSEIEDDNAT---ALDDEEAVAVQEQVRQIKAQEEEFE 825
Query: 384 IFHLRIIHRKNRTGFEENKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVC 443
F L+I+HRKNRTGFEE K+ ++LN+VIAGRY+VTEYLGSAAFSK QA DL TG+DVC
Sbjct: 826 TFDLKIVHRKNRTGFEEEKNFNVVLNSVIAGRYHVTEYLGSAAFSKAIQAHDLQTGMDVC 885
Query: 444 LKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLY 503
+KIIKN+KDFFDQSLDEIKLLK VNK+DPAD++H+LRLYDYFY+ EHL IVCELL+ANLY
Sbjct: 886 IKIIKNNKDFFDQSLDEIKLLKYVNKHDPADKYHLLRLYDYFYYREHLLIVCELLKANLY 945
Query: 504 EFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 563
EF KFN+ESGGE YFT+ RLQ IT QCLE+L++LH LG+IHCDLKPENIL+KSY RCEIK
Sbjct: 946 EFHKFNRESGGEVYFTMPRLQSITIQCLESLQFLHGLGLIHCDLKPENILVKSYSRCEIK 1005
Query: 564 IIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEV 618
+IDLGSSCF+TD+LC YVQSRSYRAPEVI+GLPYD+KID+WSLGCILAEL TG V
Sbjct: 1006 VIDLGSSCFETDHLCSYVQSRSYRAPEVILGLPYDKKIDVWSLGCILAELCTGNV 1060
|
|
| TAIR|locus:2206855 AT1G73450 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1045 (372.9 bits), Expect = 3.4e-111, Sum P(2) = 3.4e-111
Identities = 200/295 (67%), Positives = 235/295 (79%)
Query: 324 SSDLHFKGAEKDLMPAEIDNSDTRDGEVNGALHEGKADAEEHGVATPDLLMFDNLEEECE 383
SS ++ E+ E D+S+ DG H D EE + EEE E
Sbjct: 755 SSLSNYARGERKHAEKENDSSEREDG------HATALDDEEAVAVQEQVRQIKAQEEEFE 808
Query: 384 IFHLRIIHRKNRTGFEENKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVC 443
F L+I+HRKNRTGFEE K+ ++LN+VIAGRY+VTEYLGSAAFSK QA DL TG+DVC
Sbjct: 809 TFDLKIVHRKNRTGFEEEKNFNVVLNSVIAGRYHVTEYLGSAAFSKAIQAHDLQTGMDVC 868
Query: 444 LKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLY 503
+KIIKN+KDFFDQSLDEIKLLK VNK+DPAD++H+LRLYDYFY+ EHL IVCELL+ANLY
Sbjct: 869 IKIIKNNKDFFDQSLDEIKLLKYVNKHDPADKYHLLRLYDYFYYREHLLIVCELLKANLY 928
Query: 504 EFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 563
EF KFN+ESGGE YFT+ RLQ IT QCLE+L++LH LG+IHCDLKPENIL+KSY RCEIK
Sbjct: 929 EFHKFNRESGGEVYFTMPRLQSITIQCLESLQFLHGLGLIHCDLKPENILVKSYSRCEIK 988
Query: 564 IIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEV 618
+IDLGSSCF+TD+LC YVQSRSYRAPEVI+GLPYD+KID+WSLGCILAEL TG V
Sbjct: 989 VIDLGSSCFETDHLCSYVQSRSYRAPEVILGLPYDKKIDVWSLGCILAELCTGNV 1043
|
|
| TAIR|locus:2089774 AT3G17750 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1033 (368.7 bits), Expect = 9.0e-111, Sum P(2) = 9.0e-111
Identities = 188/240 (78%), Positives = 219/240 (91%)
Query: 379 EEECEIFHLRIIHRKNRTGFEENKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHT 438
E++ E F+L+I+HRKNRTGFEE+K+ ++LN+VIAGRY+VTE+LGSAAFSK QA DLHT
Sbjct: 790 EQDFETFNLKIVHRKNRTGFEEDKNFHVVLNSVIAGRYHVTEHLGSAAFSKAIQAHDLHT 849
Query: 439 GVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELL 498
G+DVC+KIIKN+KDFFDQSLDEIKLLK VN++DPAD++H+LRLYDYFY EHL IVCELL
Sbjct: 850 GIDVCVKIIKNNKDFFDQSLDEIKLLKYVNQHDPADKYHLLRLYDYFYFREHLLIVCELL 909
Query: 499 RANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQ 558
+ANLYEFQKFN+ESGGE YFT+ RLQ IT QCLEAL +LH LG+IHCDLKPENILIKSY
Sbjct: 910 KANLYEFQKFNRESGGEVYFTMPRLQSITIQCLEALNFLHGLGLIHCDLKPENILIKSYS 969
Query: 559 RCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEV 618
RCEIK+IDLGSSCF+TD+LC YVQSRSYRAPEVI+GLPYD+KID+WSLGCILAEL TG V
Sbjct: 970 RCEIKVIDLGSSCFETDHLCSYVQSRSYRAPEVILGLPYDKKIDIWSLGCILAELCTGNV 1029
|
|
| RGD|1306800 Dyrk4 "dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 4" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 455 (165.2 bits), Expect = 4.2e-47, Sum P(2) = 4.2e-47
Identities = 95/232 (40%), Positives = 143/232 (61%)
Query: 387 LRIIHRK-NRTGFEENKDLPI-ILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCL 444
L ++ K ++T F++ + +L+ IA RY V + +G +F +V + D V L
Sbjct: 189 LNVVPEKFSKTSFDDEHGSYVKVLHDHIAYRYEVLDMIGKGSFGQVAKCLDHKNNELVAL 248
Query: 445 KIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYE 504
KII+N K F Q+L E+K+L+ + + D + H+++ + D+FY HL I ELL NLYE
Sbjct: 249 KIIRNKKRFHHQALVELKILEALRRKDKDNTHNVVHMKDFFYFRNHLCITFELLGINLYE 308
Query: 505 FQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKI 564
K N G F+L ++ T L+ L+ L+ IIHCDLKPENI++ + +K+
Sbjct: 309 LMKNNSFQG----FSLSIVRRFTLSVLKCLQMLYVEKIIHCDLKPENIVLYHRGQVTVKV 364
Query: 565 IDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTG 616
ID GSSC++ + Y+QSR YR+PEVI+G PY+ ID+WSLGCI+AEL+TG
Sbjct: 365 IDFGSSCYEHQKVYTYIQSRFYRSPEVILGHPYNMAIDMWSLGCIMAELYTG 416
|
|
| UNIPROTKB|D4A0W8 Dyrk4 "Protein Dyrk4" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 455 (165.2 bits), Expect = 4.2e-47, Sum P(2) = 4.2e-47
Identities = 95/232 (40%), Positives = 143/232 (61%)
Query: 387 LRIIHRK-NRTGFEENKDLPI-ILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCL 444
L ++ K ++T F++ + +L+ IA RY V + +G +F +V + D V L
Sbjct: 153 LNVVPEKFSKTSFDDEHGSYVKVLHDHIAYRYEVLDMIGKGSFGQVAKCLDHKNNELVAL 212
Query: 445 KIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYE 504
KII+N K F Q+L E+K+L+ + + D + H+++ + D+FY HL I ELL NLYE
Sbjct: 213 KIIRNKKRFHHQALVELKILEALRRKDKDNTHNVVHMKDFFYFRNHLCITFELLGINLYE 272
Query: 505 FQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKI 564
K N G F+L ++ T L+ L+ L+ IIHCDLKPENI++ + +K+
Sbjct: 273 LMKNNSFQG----FSLSIVRRFTLSVLKCLQMLYVEKIIHCDLKPENIVLYHRGQVTVKV 328
Query: 565 IDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTG 616
ID GSSC++ + Y+QSR YR+PEVI+G PY+ ID+WSLGCI+AEL+TG
Sbjct: 329 IDFGSSCYEHQKVYTYIQSRFYRSPEVILGHPYNMAIDMWSLGCIMAELYTG 380
|
|
| UNIPROTKB|F5H6L9 DYRK4 "Dual-specificity tyrosine-phosphorylation-regulated kinase 4" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 448 (162.8 bits), Expect = 8.6e-47, Sum P(2) = 8.6e-47
Identities = 94/224 (41%), Positives = 136/224 (60%)
Query: 394 NRTGFEENKDLPI-ILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD 452
++T F++ + +L+ IA RY V E +G +F +V + D V LKII+N K
Sbjct: 196 SKTSFDDEHGFYLKVLHDHIAYRYEVLETIGKGSFGQVAKCLDHKNNELVALKIIRNKKR 255
Query: 453 FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQES 512
F Q+L E+K+L+ + K D + ++++ + D+FY H I ELL NLYE K N
Sbjct: 256 FHQQALMELKILEALRKKDKDNTYNVVHMKDFFYFRNHFCITFELLGINLYELMKNNNFQ 315
Query: 513 GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF 572
G F+L ++ T L+ L+ L IIHCDLKPENI++ + +K+ID GSSC+
Sbjct: 316 G----FSLSIVRRFTLSVLKCLQMLSVEKIIHCDLKPENIVLYQKGQASVKVIDFGSSCY 371
Query: 573 QTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTG 616
+ + Y+QSR YR+PEVI+G PYD ID+WSLGCI AEL+TG
Sbjct: 372 EHQKVYTYIQSRFYRSPEVILGHPYDVAIDMWSLGCITAELYTG 415
|
|
| UNIPROTKB|Q9NR20 DYRK4 "Dual specificity tyrosine-phosphorylation-regulated kinase 4" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 448 (162.8 bits), Expect = 8.6e-47, Sum P(2) = 8.6e-47
Identities = 94/224 (41%), Positives = 136/224 (60%)
Query: 394 NRTGFEENKDLPI-ILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD 452
++T F++ + +L+ IA RY V E +G +F +V + D V LKII+N K
Sbjct: 81 SKTSFDDEHGFYLKVLHDHIAYRYEVLETIGKGSFGQVAKCLDHKNNELVALKIIRNKKR 140
Query: 453 FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQES 512
F Q+L E+K+L+ + K D + ++++ + D+FY H I ELL NLYE K N
Sbjct: 141 FHQQALMELKILEALRKKDKDNTYNVVHMKDFFYFRNHFCITFELLGINLYELMKNNNFQ 200
Query: 513 GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF 572
G F+L ++ T L+ L+ L IIHCDLKPENI++ + +K+ID GSSC+
Sbjct: 201 G----FSLSIVRRFTLSVLKCLQMLSVEKIIHCDLKPENIVLYQKGQASVKVIDFGSSCY 256
Query: 573 QTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTG 616
+ + Y+QSR YR+PEVI+G PYD ID+WSLGCI AEL+TG
Sbjct: 257 EHQKVYTYIQSRFYRSPEVILGHPYDVAIDMWSLGCITAELYTG 300
|
|
| MGI|MGI:1330292 Dyrk4 "dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 4" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
Score = 456 (165.6 bits), Expect = 1.4e-46, Sum P(2) = 1.4e-46
Identities = 100/234 (42%), Positives = 144/234 (61%)
Query: 387 LRIIHRK-NRTGFE-ENKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCL 444
L ++ K ++T F+ E+ +L+ IA RY V E +G +F +V + D V L
Sbjct: 188 LNVVPEKFSKTSFDDEHGSYMKVLHDHIAYRYEVLEMIGKGSFGQVAKCLDHKNNELVAL 247
Query: 445 KIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYE 504
KII+N K F Q+L E+K+L+ + + D + H+++ + D+FY HL I ELL NLYE
Sbjct: 248 KIIRNKKRFHHQALVELKILEALRRKDKDNNHNVVHMKDFFYFRNHLCITFELLGINLYE 307
Query: 505 FQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEI-- 562
K N G F L ++ T L+ L L+ IIHCDLKPENI++ YQR ++
Sbjct: 308 LMKNNSFHG----FNLSIVRRFTFSILKCLHMLYVEKIIHCDLKPENIVL--YQRGQVTV 361
Query: 563 KIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTG 616
K+ID GSSC++ + Y+QSR YR+PEVI+G PY+ ID+WSLGCI+AEL+TG
Sbjct: 362 KVIDFGSSCYEHQKVYTYIQSRFYRSPEVILGHPYNMAIDMWSLGCIMAELYTG 415
|
|
| POMBASE|SPAC2F7.03c pom1 "DYRK family protein kinase Pom1" [Schizosaccharomyces pombe (taxid:4896)] | Back alignment and assigned GO terms |
|---|
Score = 475 (172.3 bits), Expect = 6.3e-46, Sum P(2) = 6.3e-46
Identities = 97/221 (43%), Positives = 143/221 (64%)
Query: 397 GFEENK-DLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFD 455
GF++ + D ++L IA RY V ++LG +F +V + D TG V LKII+N K F
Sbjct: 679 GFDDERGDYKVVLGDHIAYRYEVVDFLGKGSFGQVLRCIDYETGKLVALKIIRNKKRFHM 738
Query: 456 QSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE 515
Q+L E K+L+ + + DP DE+ +++ D+FY +HL + ELL NLYE K N G
Sbjct: 739 QALVETKILQKIREWDPLDEYCMVQYTDHFYFRDHLCVATELLGKNLYELIKSNGFKG-- 796
Query: 516 AYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTD 575
+ ++ ITRQ ++ L L+ +IHCDLKPENIL+ + ++K+ID GSSCF+ +
Sbjct: 797 --LPIVVIKSITRQLIQCLTLLNEKHVIHCDLKPENILLCHPFKSQVKVIDFGSSCFEGE 854
Query: 576 NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTG 616
+ Y+QSR YR+PEVI+G+ Y ID+WSLGCI+AE++TG
Sbjct: 855 CVYTYIQSRFYRSPEVILGMGYGTPIDVWSLGCIIAEMYTG 895
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | LOW CONFIDENCE prediction! |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | estExt_fgenesh4_pg.C_LG_VIII0583 | hypothetical protein (726 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 621 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-55 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 9e-46 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 5e-45 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-39 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-36 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-35 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 3e-35 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 5e-34 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 4e-33 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-31 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-31 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-30 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-30 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-29 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-29 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 4e-29 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 4e-29 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 5e-29 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 5e-28 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-27 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 4e-27 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 5e-27 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-26 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 7e-26 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-25 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-25 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-25 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 7e-25 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 8e-25 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-24 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 6e-24 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 7e-24 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 8e-24 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-23 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-23 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-23 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 5e-23 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 6e-23 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-22 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-22 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-22 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 5e-22 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 5e-22 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 7e-22 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 8e-22 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-21 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-21 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 4e-21 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 8e-21 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 9e-21 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-20 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 5e-20 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 6e-20 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 7e-20 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 7e-20 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 9e-20 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-19 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-19 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-19 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-19 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-19 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 4e-19 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 9e-19 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-18 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-18 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-18 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 4e-18 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 6e-18 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-17 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-17 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-17 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-17 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-17 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-17 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-17 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 4e-17 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 5e-17 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 5e-17 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 7e-17 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-16 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-16 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-16 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-15 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-15 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-15 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-15 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-15 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-15 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-15 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-15 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 5e-15 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 7e-15 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-14 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-14 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-14 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 7e-14 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 9e-14 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-13 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-13 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-13 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-13 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-13 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-13 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-13 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 4e-13 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 4e-13 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 4e-13 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 6e-13 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 6e-13 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-12 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-12 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 1e-12 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-12 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-12 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-12 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-12 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-12 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-12 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-12 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 3e-12 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 4e-12 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 5e-12 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 7e-12 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-11 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-11 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-11 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-11 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-11 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-11 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-11 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-11 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-11 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-11 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 3e-11 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 3e-11 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 5e-11 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 5e-11 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 5e-11 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 5e-11 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 6e-11 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 6e-11 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 7e-11 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-10 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-10 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-10 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-10 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-10 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-10 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-10 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-10 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-10 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 4e-10 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 4e-10 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 4e-10 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 5e-10 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 5e-10 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 6e-10 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-09 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-09 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-09 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-09 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-09 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-09 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-09 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-09 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-09 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-09 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-09 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-09 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-09 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-09 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-09 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 4e-09 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 4e-09 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 5e-09 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 6e-09 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 6e-09 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-08 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-08 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-08 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-08 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-08 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-08 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-08 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 4e-08 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 4e-08 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 4e-08 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 4e-08 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 4e-08 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 4e-08 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 5e-08 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 6e-08 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 8e-08 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 9e-08 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 9e-08 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-07 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-07 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-07 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-07 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-07 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-07 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-07 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 3e-07 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-07 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-07 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 5e-07 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 6e-07 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 7e-07 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 7e-07 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 9e-07 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 1e-06 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-06 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-06 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-06 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-06 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-06 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-06 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-06 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-06 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-06 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-06 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 3e-06 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 3e-06 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-06 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-06 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 6e-06 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 7e-06 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 9e-06 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 9e-06 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-05 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-05 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-05 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-05 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-05 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-05 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 2e-05 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-05 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-05 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 4e-05 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 4e-05 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 6e-05 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 7e-05 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 9e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-04 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-04 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-04 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-04 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 2e-04 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-04 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-04 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 3e-04 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-04 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 4e-04 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 4e-04 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 5e-04 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 5e-04 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 6e-04 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 6e-04 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 7e-04 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 7e-04 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 0.001 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 0.001 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 0.001 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 0.002 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 0.002 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 0.003 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 187 bits (478), Expect = 3e-55
Identities = 78/208 (37%), Positives = 111/208 (53%), Gaps = 21/208 (10%)
Query: 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD--FFDQSLDEIKLLKLVNKNDPA 473
Y + E LG +F KV+ A+D TG V +K+IK K ++ L EIK+LK +
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLK----- 55
Query: 474 DEH-HILRLYDYFYHLEHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITRQCL 531
H +I+RLYD F + L++V E +L++ K + + RQ L
Sbjct: 56 --HPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRG------RLSEDEARFYLRQIL 107
Query: 532 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL--YVQSRSYRAP 589
ALEYLHS GI+H DLKPENIL+ +K+ D G + L +V + Y AP
Sbjct: 108 SALEYLHSKGIVHRDLKPENILLDE--DGHVKLADFGLARQLDPGEKLTTFVGTPEYMAP 165
Query: 590 EVIIGLPYDQKIDLWSLGCILAELWTGE 617
EV++G Y + +D+WSLG IL EL TG+
Sbjct: 166 EVLLGKGYGKAVDIWSLGVILYELLTGK 193
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 162 bits (412), Expect = 9e-46
Identities = 72/205 (35%), Positives = 107/205 (52%), Gaps = 24/205 (11%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIK---NDKDFFDQSLDEIKLLKLVNKNDPADEH-H 477
LGS +F V++A+ TG V +KI+K + EI++L+ ++ H +
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLS-------HPN 59
Query: 478 ILRLYDYFYHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEY 536
I+RL D F +HL++V E +L+++ + + I Q L LEY
Sbjct: 60 IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGG------PLSEDEAKKIALQILRGLEY 113
Query: 537 LHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN---LCLYVQSRSYRAPEVII 593
LHS GIIH DLKPENIL+ + +KI D G + + L +V + Y APEV++
Sbjct: 114 LHSNGIIHRDLKPENILLD--ENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLL 171
Query: 594 -GLPYDQKIDLWSLGCILAELWTGE 617
G Y K+D+WSLG IL EL TG+
Sbjct: 172 GGNGYGPKVDVWSLGVILYELLTGK 196
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 158 bits (403), Expect = 5e-45
Identities = 76/199 (38%), Positives = 104/199 (52%), Gaps = 19/199 (9%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIK--NDKDFFDQSLDEIKLLKLVNKNDPADEHHIL 479
LG F V+ A+D TG V +KIIK + ++ L EI++LK +N +I+
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNH------PNIV 54
Query: 480 RLYDYFYHLEHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLH 538
+LY F HL++V E +L + K N+ + + I Q LE LEYLH
Sbjct: 55 KLYGVFEDENHLYLVMEYCEGGSLKDLLKENEG-----KLSEDEILRILLQILEGLEYLH 109
Query: 539 SLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF---QTDNLCLYVQSRSYRAPEVIIGL 595
S GIIH DLKPENIL+ S +K+ D G S L V + +Y APEV++G
Sbjct: 110 SNGIIHRDLKPENILLDSDNGK-VKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGK 168
Query: 596 P-YDQKIDLWSLGCILAEL 613
Y +K D+WSLG IL EL
Sbjct: 169 GYYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 1e-39
Identities = 71/209 (33%), Positives = 105/209 (50%), Gaps = 22/209 (10%)
Query: 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD---FFDQSLDEIKLLKLVN-KND 471
Y +G + V++A+D TG V +K IK + +L EIKLLK +N N
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPN- 59
Query: 472 PADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCL 531
I++L D F H L++V E + +LY+ K Q ++ Q L
Sbjct: 60 ------IIKLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQRG-----LPESLIKSYLYQLL 108
Query: 532 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS-CFQTDNLCL--YVQSRSYRA 588
+ L + HS GI+H DLKPEN+LI +K+ D G + F + YV +R YRA
Sbjct: 109 QGLAFCHSHGILHRDLKPENLLIN--TEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRA 166
Query: 589 PEVIIGLP-YDQKIDLWSLGCILAELWTG 616
PE+++G Y +D+WS+GCI AEL +
Sbjct: 167 PELLLGDKGYSTPVDIWSVGCIFAELLSR 195
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 137 bits (348), Expect = 2e-36
Identities = 68/214 (31%), Positives = 102/214 (47%), Gaps = 30/214 (14%)
Query: 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD---FFDQSLDEIKLLKLVNKNDP 472
Y E LG + V++A+D TG V LK I+ D + +L EI LLK +
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELK---- 56
Query: 473 ADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCL 531
H +I++L D + L++V E +L ++ + ++ I Q L
Sbjct: 57 ---HPNIVKLLDVIHTERKLYLVFEYCDMDLKKYLDKRPGP-----LSPNLIKSIMYQLL 108
Query: 532 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG-SSCFQ------TDNLCLYVQSR 584
L Y HS I+H DLKP+NILI +K+ D G + F T V +
Sbjct: 109 RGLAYCHSHRILHRDLKPQNILINR--DGVLKLADFGLARAFGIPLRTYTHE----VVTL 162
Query: 585 SYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGE 617
YRAPE+++G Y +D+WS+GCI AE+ TG+
Sbjct: 163 WYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 3e-35
Identities = 68/202 (33%), Positives = 108/202 (53%), Gaps = 17/202 (8%)
Query: 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIK-NDKDFFDQSLDEIKLLKLVNKNDPADEHHI 478
E +G F +V++A+ TG +V +K+IK K+ ++ ++EI++LK +I
Sbjct: 6 EKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCK------HPNI 59
Query: 479 LRLYDYFYHLEHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYL 537
++ Y + + L+IV E +L + K ++ T ++ + ++ L+ LEYL
Sbjct: 60 VKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQT-----LTESQIAYVCKELLKGLEYL 114
Query: 538 HSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL--YVQSRSYRAPEVIIGL 595
HS GIIH D+K NIL+ S E+K+ID G S +D V + + APEVI G
Sbjct: 115 HSNGIIHRDIKAANILLTS--DGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGK 172
Query: 596 PYDQKIDLWSLGCILAELWTGE 617
PYD K D+WSLG EL G+
Sbjct: 173 PYDYKADIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 3e-35
Identities = 78/221 (35%), Positives = 108/221 (48%), Gaps = 37/221 (16%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD------EIKLLKLVN 468
RY + + +GS A+ V A D TG V +K I N FD +D EIKLL+ +
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISN---VFDDLIDAKRILREIKLLRHLR 57
Query: 469 KNDPADEH-HILRLYDYFYH-----LEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGR 522
H +I+ L D ++IV EL+ +L++ K Q T
Sbjct: 58 -------HENIIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQP------LTDDH 104
Query: 523 LQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG------SSCFQTDN 576
+Q Q L L+YLHS +IH DLKP NIL+ S C++KI D G +
Sbjct: 105 IQYFLYQILRGLKYLHSANVIHRDLKPSNILVNS--NCDLKICDFGLARGVDPDEDEKGF 162
Query: 577 LCLYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTG 616
L YV +R YRAPE+++ Y + ID+WS+GCI AEL T
Sbjct: 163 LTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTR 203
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 130 bits (330), Expect = 5e-34
Identities = 68/211 (32%), Positives = 111/211 (52%), Gaps = 24/211 (11%)
Query: 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQ--SLDEIKLLKLVNKNDPA 473
Y V + LG F V+ A++ TG V +K +K +++ +L E+K L+ +N++
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHP-- 58
Query: 474 DEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEA 533
+I++L + F + L+ V E + NLY+ K + F+ ++ I Q L+
Sbjct: 59 ---NIVKLKEVFRENDELYFVFEYMEGNLYQLMKDRKGK----PFSESVIRSIIYQILQG 111
Query: 534 LEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG------SSCFQTDNLCLYVQSRSYR 587
L ++H G H DLKPEN+L+ + +KI D G S TD YV +R YR
Sbjct: 112 LAHIHKHGFFHRDLKPENLLVSGPEV--VKIADFGLAREIRSRPPYTD----YVSTRWYR 165
Query: 588 APEVIIGLP-YDQKIDLWSLGCILAELWTGE 617
APE+++ Y +D+W+LGCI+AEL+T
Sbjct: 166 APEILLRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 4e-33
Identities = 68/209 (32%), Positives = 106/209 (50%), Gaps = 25/209 (11%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKII----KNDKDFFDQSLDEIKLLKLVNKN 470
RY + +G A VF+A+D TG V LK + +Q+L EIK L+
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGG-IPNQALREIKALQAC--- 56
Query: 471 DPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQ 529
+H ++++L D F H +V E + ++L E + + +++ R
Sbjct: 57 ----QHPYVVKLLDVFPHGSGFVLVMEYMPSDLSEVLRDEERP-----LPEAQVKSYMRM 107
Query: 530 CLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG-SSCFQTDNLCLY---VQSRS 585
L+ + Y+H+ GI+H DLKP N+LI + +KI D G + F + LY V +R
Sbjct: 108 LLKGVAYMHANGIMHRDLKPANLLISA--DGVLKIADFGLARLFSEEEPRLYSHQVATRW 165
Query: 586 YRAPEVIIGLP-YDQKIDLWSLGCILAEL 613
YRAPE++ G YD +DLW++GCI AEL
Sbjct: 166 YRAPELLYGARKYDPGVDLWAVGCIFAEL 194
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 1e-31
Identities = 69/215 (32%), Positives = 101/215 (46%), Gaps = 37/215 (17%)
Query: 420 EYLGSAAFSKVFQAQDLHTGVDVCLK--IIKNDKDFFDQSLD-EIKLLK-LVNKNDPADE 475
E LG +F V+ A D TG + +K + D + ++L+ EI++L L + N
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN----- 60
Query: 476 HHILRLYDYFYHLE--HLFIVCEL-----LRANLYEFQKFNQESGGEAYFTLGRLQVITR 528
I+R Y E L I E L + L +F K E ++ TR
Sbjct: 61 --IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLP-EP---------VIRKYTR 108
Query: 529 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR- 587
Q LE L YLHS GI+H D+K NIL+ S +K+ D G + + ++ + S R
Sbjct: 109 QILEGLAYLHSNGIVHRDIKGANILVDS--DGVVKLADFGCA-KRLGDIETGEGTGSVRG 165
Query: 588 -----APEVIIGLPYDQKIDLWSLGCILAELWTGE 617
APEVI G Y + D+WSLGC + E+ TG+
Sbjct: 166 TPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGK 200
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 69/210 (32%), Positives = 109/210 (51%), Gaps = 23/210 (10%)
Query: 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK--NDKDFFDQS-LDEIKLLKLVNKNDP 472
Y +G A+ V++A+DL+TG V LK ++ ++ S L EI LLK +
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLE---- 56
Query: 473 ADEH-HILRLYD--YFYHLEH---LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVI 526
+ EH +I+RL D + + L +V E + +L + + G ++ +
Sbjct: 57 SFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPE----TIKDL 112
Query: 527 TRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS---CFQTDNLCLYVQS 583
RQ L +++LHS I+H DLKP+NIL+ S + +KI D G + F+ L V +
Sbjct: 113 MRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQ--VKIADFGLARIYSFEM-ALTSVVVT 169
Query: 584 RSYRAPEVIIGLPYDQKIDLWSLGCILAEL 613
YRAPEV++ Y +D+WS+GCI AEL
Sbjct: 170 LWYRAPEVLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 1e-30
Identities = 79/226 (34%), Positives = 116/226 (51%), Gaps = 41/226 (18%)
Query: 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQ-----SLDEIKLLK 465
+ RY + +GS A V A D TG +V +K K + F + + E+ L+K
Sbjct: 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIK--KLSRPFQNVTHAKRAYRELVLMK 70
Query: 466 LVN-KNDPADEHHILRLYDYFY------HLEHLFIVCELLRANLYEFQKFNQESGGEAYF 518
LVN KN I+ L + F + +++V EL+ ANL Q + E
Sbjct: 71 LVNHKN-------IIGLLNVFTPQKSLEEFQDVYLVMELMDANLC--QVIQMDLDHE--- 118
Query: 519 TLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG------SSCF 572
R+ + Q L +++LHS GIIH DLKP NI++KS C +KI+D G +S
Sbjct: 119 ---RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS--DCTLKILDFGLARTAGTSFM 173
Query: 573 QTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEV 618
T YV +R YRAPEVI+G+ Y + +D+WS+GCI+ E+ G V
Sbjct: 174 MTP----YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTV 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 2e-30
Identities = 74/219 (33%), Positives = 114/219 (52%), Gaps = 35/219 (15%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFD-----QSLDEIKLLKLVNK 469
RY +GS A+ +V A D TG V +K K + F ++ E++LLK +
Sbjct: 16 RYQNLSPVGSGAYGQVCSAFDTKTGRKVAIK--KLSRPFQSAIHAKRTYRELRLLKHM-- 71
Query: 470 NDPADEHHILRLYDYFYHLEHL------FIVCELLRANLY---EFQKFNQESGGEAYFTL 520
D +++ L D F L ++V L+ A+L + QK + +
Sbjct: 72 ----DHENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDD--------- 118
Query: 521 GRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLY 580
+Q + Q L L+Y+HS GIIH DLKP NI + CE+KI+D G + D + Y
Sbjct: 119 -HIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNE--DCELKILDFGLARHTDDEMTGY 175
Query: 581 VQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEV 618
V +R YRAPE+++ + Y+Q +D+WS+GCI+AEL TG+
Sbjct: 176 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKT 214
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 1e-29
Identities = 67/212 (31%), Positives = 108/212 (50%), Gaps = 21/212 (9%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK----NDKDFFDQSLDEIKLLKLVNKN 470
+Y + + +G +F KV+ + G LK I ++K+ + +L+E+K+LK +N
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKER-EDALNEVKILKKLN-- 57
Query: 471 DPADEH-HILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITR 528
H +I++ Y+ F L IV E +L + K Q+ G+ F ++
Sbjct: 58 -----HPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIK-KQKKEGK-PFPEEQILDWFV 110
Query: 529 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF--QTDNLCL-YVQSRS 585
Q AL+YLHS I+H D+KP+NI + S +K+ D G S T +L V +
Sbjct: 111 QLCLALKYLHSRKILHRDIKPQNIFLTSNGL--VKLGDFGISKVLSSTVDLAKTVVGTPY 168
Query: 586 YRAPEVIIGLPYDQKIDLWSLGCILAELWTGE 617
Y +PE+ PY+ K D+WSLGC+L EL T +
Sbjct: 169 YLSPELCQNKPYNYKSDIWSLGCVLYELCTLK 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 66/208 (31%), Positives = 107/208 (51%), Gaps = 22/208 (10%)
Query: 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQ--SLDEIKLLKLVNKNDPA 473
Y + +G FS+V +AQ TG +K +K +Q +L EI+ L+ ++
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLS----- 55
Query: 474 DEHHILRLYDYFYHLEH--LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCL 531
+ILRL + + + L +V EL+ NLYE K G + R++ Q L
Sbjct: 56 PHPNILRLIEVLFDRKTGRLALVFELMDMNLYELIK-----GRKRPLPEKRVKSYMYQLL 110
Query: 532 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC--FQTDNLCLYVQSRSYRAP 589
++L+++H GI H D+KPENILIK +K+ D GS + Y+ +R YRAP
Sbjct: 111 KSLDHMHRNGIFHRDIKPENILIKDD---ILKLADFGSCRGIYSKPPYTEYISTRWYRAP 167
Query: 590 EVII--GLPYDQKIDLWSLGCILAELWT 615
E ++ G Y K+D+W++GC+ E+ +
Sbjct: 168 ECLLTDGY-YGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (294), Expect = 4e-29
Identities = 69/218 (31%), Positives = 113/218 (51%), Gaps = 35/218 (16%)
Query: 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK--NDKDFFD-QSLDEIKLLKLVNKNDP 472
Y +G + +V++A++ TG V LK I+ N+K+ F ++ EIKLL+ +
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLR---- 56
Query: 473 ADEH-HILRLYDYFYHLEHLFIVCELLRANLY---EFQKFNQESG----GEAYFTLGRLQ 524
H +I+RL + IV + ++Y E+ + +G E FT +++
Sbjct: 57 ---HPNIVRLKE---------IVTSKGKGSIYMVFEYMDHDL-TGLLDSPEVKFTESQIK 103
Query: 525 VITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSR 584
+Q LE L+YLHS GI+H D+K NILI + +K+ D G + T +R
Sbjct: 104 CYMKQLLEGLQYLHSNGILHRDIKGSNILINN--DGVLKLADFGLARPYTKRNSADYTNR 161
Query: 585 S----YRAPEVIIGLP-YDQKIDLWSLGCILAELWTGE 617
YR PE+++G Y ++D+WS+GCILAEL+ G+
Sbjct: 162 VITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 4e-29
Identities = 65/213 (30%), Positives = 105/213 (49%), Gaps = 23/213 (10%)
Query: 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK---NDKDFFDQSLDEIKLLKLVNKN 470
+Y V +G A+ V + ++ TG V +K K +D+D +L E+K+L+ +
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQL--- 57
Query: 471 DPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQ 529
H +I+ L + F L++V E + L E + + ++ Q
Sbjct: 58 ----RHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDA-----VRSYIWQ 108
Query: 530 CLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG----SSCFQTDNLCLYVQSRS 585
L+A+ Y HS IIH D+KPENIL+ +K+ D G L YV +R
Sbjct: 109 LLQAIAYCHSHNIIHRDIKPENILVSESG--VLKLCDFGFARALRARPASPLTDYVATRW 166
Query: 586 YRAPEVIIG-LPYDQKIDLWSLGCILAELWTGE 617
YRAPE+++G Y + +D+W++GCI+AEL GE
Sbjct: 167 YRAPELLVGDTNYGKPVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 119 bits (297), Expect = 5e-29
Identities = 65/212 (30%), Positives = 99/212 (46%), Gaps = 27/212 (12%)
Query: 418 VTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK----NDKDFFDQSLDEIKLLKLVNKNDPA 473
+ LG +F +V+ A+D V LK++ + ++ L EI++L +N
Sbjct: 4 ILRKLGEGSFGEVYLARDRKL---VALKVLAKKLESKSKEVERFLREIQILASLN----- 55
Query: 474 DEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEA 533
+I++LYD+F L++V E + + ++ G + + I Q L A
Sbjct: 56 HPPNIVKLYDFFQDEGSLYLVMEYVDGG--SLEDLLKKIGRKGPLSESEALFILAQILSA 113
Query: 534 LEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN---------LCLYVQSR 584
LEYLHS GIIH D+KPENIL+ +K+ID G + D V +
Sbjct: 114 LEYLHSKGIIHRDIKPENILL-DRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTP 172
Query: 585 SYRAPEVIIGL---PYDQKIDLWSLGCILAEL 613
Y APEV++GL D+WSLG L EL
Sbjct: 173 GYMAPEVLLGLSLAYASSSSDIWSLGITLYEL 204
|
Length = 384 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 5e-28
Identities = 60/211 (28%), Positives = 98/211 (46%), Gaps = 27/211 (12%)
Query: 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLK-LVNKNDPAD 474
Y E +G A +V++A D TG +V +K ++ K + ++EI ++K + N
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPN---- 76
Query: 475 EHHILRLYDYFYHLEHLFIVCELLRAN-LYEFQKFNQESGGEAYFTLGRLQVITRQCLEA 533
I+ YD + + L++V E + L + N ++ + R+ L+
Sbjct: 77 ---IVDYYDSYLVGDELWVVMEYMDGGSLTDIITQN-----FVRMNEPQIAYVCREVLQG 128
Query: 534 LEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS-------Y 586
LEYLHS +IH D+K +NIL+ +K+ D G F L R+ +
Sbjct: 129 LEYLHSQNVIHRDIKSDNILLSK--DGSVKLADFG---FAA-QLTKEKSKRNSVVGTPYW 182
Query: 587 RAPEVIIGLPYDQKIDLWSLGCILAELWTGE 617
APEVI Y K+D+WSLG + E+ GE
Sbjct: 183 MAPEVIKRKDYGPKVDIWSLGIMCIEMAEGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 1e-27
Identities = 76/221 (34%), Positives = 113/221 (51%), Gaps = 34/221 (15%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD------EIKLLKLVN 468
RY + E +G ++ V A D HTG V +K I D F+ D EIKLL+L+
Sbjct: 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIN---DVFEHVSDATRILREIKLLRLLR 57
Query: 469 KNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITR 528
D + HI+ L + +++V EL+ ++L++ K N + E + Q
Sbjct: 58 HPDIVEIKHIM-LPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHH------QFFLY 110
Query: 529 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG----------SSCFQTDNLC 578
Q L AL+Y+H+ + H DLKP+NIL + C++KI D G ++ F TD
Sbjct: 111 QLLRALKYIHTANVFHRDLKPKNILANA--DCKLKICDFGLARVAFNDTPTAIFWTD--- 165
Query: 579 LYVQSRSYRAPEVIIGL--PYDQKIDLWSLGCILAELWTGE 617
YV +R YRAPE+ Y ID+WS+GCI AE+ TG+
Sbjct: 166 -YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 4e-27
Identities = 71/216 (32%), Positives = 108/216 (50%), Gaps = 21/216 (9%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKN-DKDFFDQ-SLDEIKLLKLVNK 469
+ RY Y+G A+ V A TGV V +K I + F Q +L EIK+L+
Sbjct: 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKH 62
Query: 470 NDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEA-YFTLGRLQVITR 528
+ I+R + ++IV EL+ +LY+ K S YF
Sbjct: 63 ENIIGILDIIRPPSFES-FNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLY-------- 113
Query: 529 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG---SSCFQTDN---LCLYVQ 582
Q L L+Y+HS ++H DLKP N+L+ + C++KI D G + + D+ L YV
Sbjct: 114 QILRGLKYIHSANVLHRDLKPSNLLLNT--NCDLKICDFGLARIADPEHDHTGFLTEYVA 171
Query: 583 SRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGE 617
+R YRAPE+++ Y + ID+WS+GCILAE+ +
Sbjct: 172 TRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 5e-27
Identities = 79/219 (36%), Positives = 114/219 (52%), Gaps = 24/219 (10%)
Query: 407 ILNTV--IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKN---DKDFFDQSLDEI 461
I TV I RY + +G AF V A+D TG +V +K I ++ E+
Sbjct: 1 IFGTVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYREL 60
Query: 462 KLLK-LVNKNDPADEHHILRLYDYFYH-LEHLFIVCELLRANLYEFQKFNQESGGEAYFT 519
KLLK L ++N I+ L D F LE ++ V ELL +L+ + E F
Sbjct: 61 KLLKHLRHEN-------IISLSDIFISPLEDIYFVTELLGTDLH---RLLTSRPLEKQF- 109
Query: 520 LGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL 579
+Q Q L L+Y+HS G++H DLKP NILI + C++KI D G + Q +
Sbjct: 110 ---IQYFLYQILRGLKYVHSAGVVHRDLKPSNILIN--ENCDLKICDFGLARIQDPQMTG 164
Query: 580 YVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGE 617
YV +R YRAPE+++ YD ++D+WS GCI AE+ G+
Sbjct: 165 YVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (271), Expect = 2e-26
Identities = 65/212 (30%), Positives = 97/212 (45%), Gaps = 40/212 (18%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIK----NDKDFFDQSLDEIKLLKLVNKNDPADEHH 477
LG +F KV + TG +K++K + + +L E +L +N H
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRIN--------H 52
Query: 478 --ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE--------AYFTLGRLQVIT 527
I++L+ F E L++V E GGE F+ R +
Sbjct: 53 PFIVKLHYAFQTEEKLYLVLEYA-------------PGGELFSHLSKEGRFSEERARFYA 99
Query: 528 RQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC--FQTDNLCL-YVQSR 584
+ + ALEYLHSLGII+ DLKPENIL+ IK+ D G + + + +
Sbjct: 100 AEIVLALEYLHSLGIIYRDLKPENILLD--ADGHIKLTDFGLAKELSSEGSRTNTFCGTP 157
Query: 585 SYRAPEVIIGLPYDQKIDLWSLGCILAELWTG 616
Y APEV++G Y + +D WSLG +L E+ TG
Sbjct: 158 EYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 7e-26
Identities = 78/217 (35%), Positives = 115/217 (52%), Gaps = 31/217 (14%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQS-----LDEIKLLKLVNK 469
RY + +GS A V A D G++V +K K + F +Q+ E+ LLK VN
Sbjct: 22 RYQQLKPIGSGAQGIVCAAFDTVLGINVAVK--KLSRPFQNQTHAKRAYRELVLLKCVNH 79
Query: 470 NDPADEHHILRLYDYFY------HLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRL 523
+ I+ L + F + +++V EL+ ANL Q + E E R+
Sbjct: 80 KN------IISLLNVFTPQKSLEEFQDVYLVMELMDANL--CQVIHMELDHE------RM 125
Query: 524 QVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL--YV 581
+ Q L +++LHS GIIH DLKP NI++KS C +KI+D G + N + YV
Sbjct: 126 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS--DCTLKILDFGLARTACTNFMMTPYV 183
Query: 582 QSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEV 618
+R YRAPEVI+G+ Y + +D+WS+GCI+ EL G V
Sbjct: 184 VTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSV 220
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 66/217 (30%), Positives = 108/217 (49%), Gaps = 35/217 (16%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFD------QSLDEIKLLKLVN 468
RY E +GS A+ V A D +G V +K I + FD ++L E+K+L+
Sbjct: 6 RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHA---FDVPTLAKRTLRELKILRHFK 62
Query: 469 KNDPADEHHILRLYDYFY----HLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQ 524
++ I+ + D + +++V +L+ ++L+ +Q T ++
Sbjct: 63 HDN------IIAIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQP------LTEEHIR 110
Query: 525 VITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG-------SSCFQTDNL 577
Q L L+Y+HS +IH DLKP N+L+ + CE++I D G S +
Sbjct: 111 YFLYQLLRGLKYIHSANVIHRDLKPSNLLVN--EDCELRIGDFGMARGLSSSPTEHKYFM 168
Query: 578 CLYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAEL 613
YV +R YRAPE+++ LP Y ID+WS+GCI AE+
Sbjct: 169 TEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEM 205
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 68/215 (31%), Positives = 97/215 (45%), Gaps = 44/215 (20%)
Query: 426 AFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHHILRL 481
A+ +VF A+ TG +K+IK K+ DQ L E +L ++++L
Sbjct: 5 AYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSP------YVVKL 58
Query: 482 YDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTL---GRL-----QVITRQCLEA 533
Y F ++L++V E L GG+ L G L ++ + + A
Sbjct: 59 YYSFQGKKNLYLVMEYLP-------------GGDLASLLENVGSLDEDVARIYIAEIVLA 105
Query: 534 LEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS-------- 585
LEYLHS GIIH DLKP+NILI S +K+ D G S + +
Sbjct: 106 LEYLHSNGIIHRDLKPDNILIDSNG--HLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVG 163
Query: 586 ---YRAPEVIIGLPYDQKIDLWSLGCILAELWTGE 617
Y APEVI+G + + +D WSLGCIL E G
Sbjct: 164 TPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGI 198
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 72/210 (34%), Positives = 106/210 (50%), Gaps = 25/210 (11%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK-----NDKDFFDQS-LDEIKLLKLVN 468
RY + LG ++ V++A+D TG V +K IK KD + + L EIKLL+ +
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 469 KNDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVIT 527
H +I+ L D F H ++ +V E + +L + K T ++
Sbjct: 61 -------HPNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDK-----SIVLTPADIKSYM 108
Query: 528 RQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC-FQTDNLCLYVQ--SR 584
L LEYLHS I+H DLKP N+LI S +K+ D G + F + N + Q +R
Sbjct: 109 LMTLRGLEYLHSNWILHRDLKPNNLLIAS--DGVLKLADFGLARSFGSPNRKMTHQVVTR 166
Query: 585 SYRAPEVIIGLP-YDQKIDLWSLGCILAEL 613
YRAPE++ G Y +D+WS+GCI AEL
Sbjct: 167 WYRAPELLFGARHYGVGVDMWSVGCIFAEL 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 7e-25
Identities = 71/219 (32%), Positives = 113/219 (51%), Gaps = 30/219 (13%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHT--GVDVCLKIIKN---DKDFFDQSLDEIKLLKLVNK 469
RY + + LG A+ V A++ T V +K I N K ++L E+KLL+
Sbjct: 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRG 60
Query: 470 NDPADEHHILRLYD----YFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQV 525
+ +I LYD + + L++ EL+ A+L++ + Q +A+F Q
Sbjct: 61 HK-----NITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLT-DAHF-----QS 109
Query: 526 ITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN-------LC 578
Q L L+Y+HS ++H DLKP N+L+ + CE+KI D G + ++N +
Sbjct: 110 FIYQILCGLKYIHSANVLHRDLKPGNLLVNA--DCELKICDFGLARGFSENPGENAGFMT 167
Query: 579 LYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTG 616
YV +R YRAPE+++ Y + ID+WS+GCILAEL
Sbjct: 168 EYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGR 206
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 8e-25
Identities = 65/232 (28%), Positives = 98/232 (42%), Gaps = 53/232 (22%)
Query: 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPA------ 473
+ +G +FS V A++ T + +KI LD+ +L+K K
Sbjct: 7 KIIGEGSFSTVVLAKEKETNKEYAIKI-----------LDKRQLIKE-KKVKYVKIEKEV 54
Query: 474 ---DEHH--ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITR 528
H I++LY F E+L+ V E A E ++ ++ G +
Sbjct: 55 LTRLNGHPGIIKLYYTFQDEENLYFVLEY--APNGELLQYIRKYGS---LDEKCTRFYAA 109
Query: 529 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC---------- 578
+ L ALEYLHS GIIH DLKPENIL+ IKI D G++ N
Sbjct: 110 EILLALEYLHSKGIIHRDLKPENILLDKDMH--IKITDFGTAKVLDPNSSPESNKGDATN 167
Query: 579 -----LYVQSRS--------YRAPEVIIGLPYDQKIDLWSLGCILAELWTGE 617
+ R Y +PE++ P + DLW+LGCI+ ++ TG+
Sbjct: 168 IDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 72/236 (30%), Positives = 107/236 (45%), Gaps = 62/236 (26%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD------EIKLLK 465
I +Y + + LG A+ V++A D T V LK I D F + D EI L+
Sbjct: 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIF---DAFRNATDAQRTFREIMFLQ 61
Query: 466 LVNKNDPADEHHILRLYD----------Y--FYHLE---HLFIVCELLRAN-LYEFQKFN 509
+ + +I++L + Y F ++E H I RAN L + K
Sbjct: 62 ELGDHP-----NIVKLLNVIKAENDKDIYLVFEYMETDLHAVI-----RANILEDVHK-- 109
Query: 510 QESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG- 568
+ I Q L+AL+Y+HS +IH DLKP NIL+ S C +K+ D G
Sbjct: 110 --------------RYIMYQLLKALKYIHSGNVIHRDLKPSNILLNS--DCRVKLADFGL 153
Query: 569 SSCFQTDNLCL-------YVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTG 616
+ YV +R YRAPE+++G Y + +D+WS+GCIL E+ G
Sbjct: 154 ARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLG 209
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 6e-24
Identities = 62/213 (29%), Positives = 91/213 (42%), Gaps = 29/213 (13%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKII---KNDKDFFDQSLDEIKLLKLVNKND 471
Y + + +G AF V++ +L TG V +K I K ++ + EI LLK +
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLK--- 57
Query: 472 PADEHHILRLYDYFYHLEHLFIVCEL-----LRANLYEFQKFNQESGGEAYFTLGRLQVI 526
+I++ + L+I+ E LR + +F F ES Y
Sbjct: 58 ---HPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFP-ESLVAVYV-------- 105
Query: 527 TRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN---LCLYVQS 583
Q L+ L YLH G+IH D+K NIL +K+ D G + D V +
Sbjct: 106 -YQVLQGLAYLHEQGVIHRDIKAANILTTKDG--VVKLADFGVATKLNDVSKDDASVVGT 162
Query: 584 RSYRAPEVIIGLPYDQKIDLWSLGCILAELWTG 616
+ APEVI D+WSLGC + EL TG
Sbjct: 163 PYWMAPEVIEMSGASTASDIWSLGCTVIELLTG 195
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 105 bits (262), Expect = 7e-24
Identities = 67/228 (29%), Positives = 111/228 (48%), Gaps = 30/228 (13%)
Query: 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKN 470
V R+ + LG F KV +A D +KI++N + + EI+ ++ V +
Sbjct: 126 VSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQA 185
Query: 471 DPADEHHILRLYDYFYHLE-HLFIVCELLRANLYEF----QKFNQESGGEAYFTLGRLQV 525
DPAD ++++ YF + H+ IV L ++ F+ + F G
Sbjct: 186 DPADRFPLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQTG---- 241
Query: 526 ITRQCLEALEYLHS-LGIIHCDLKPENILIKSYQR--------------CEIKIIDLGSS 570
AL+Y H+ L ++H DLKPENIL+++ C ++I DLG
Sbjct: 242 ------VALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGC 295
Query: 571 CFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEV 618
C + + V +R YR+PEV++GL + D+WS+GCI+ EL+TG++
Sbjct: 296 CDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKL 343
|
Length = 467 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 8e-24
Identities = 70/213 (32%), Positives = 111/213 (52%), Gaps = 25/213 (11%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK---NDKDFFDQSLDEIKLLKLVNKND 471
RY + +GS A+ V A D TG V +K + + F ++ E++LLK + +
Sbjct: 16 RYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHEN 75
Query: 472 PADEHHILRLYDYFYHLEHL------FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQV 525
++ L D F L ++V + +L + K E E R+Q
Sbjct: 76 ------VIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMK--HEKLSED-----RIQF 122
Query: 526 ITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS 585
+ Q L+ L+Y+H+ GIIH DLKP N+ + + CE+KI+D G + + YV +R
Sbjct: 123 LVYQMLKGLKYIHAAGIIHRDLKPGNLAVN--EDCELKILDFGLARQTDSEMTGYVVTRW 180
Query: 586 YRAPEVIIG-LPYDQKIDLWSLGCILAELWTGE 617
YRAPEVI+ + Y Q +D+WS+GCI+AE+ TG+
Sbjct: 181 YRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 66/215 (30%), Positives = 111/215 (51%), Gaps = 30/215 (13%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK---NDKDFFDQSLDEIKLLKLVNKND 471
RY + +GS A+ V A D TG V +K + + F ++ E+ LLK +
Sbjct: 16 RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQ--- 72
Query: 472 PADEHHILRLYDYF------YHLEHLFIVCELLRANLYEFQ--KFNQESGGEAYFTLGRL 523
+++ L D F + ++V ++ +L + +++ ++
Sbjct: 73 ---HENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSED----------KV 119
Query: 524 QVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQS 583
Q + Q L L+Y+HS GIIH DLKP N+ + + CE+KI+D G + + YV +
Sbjct: 120 QYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVN--EDCELKILDFGLARHADAEMTGYVVT 177
Query: 584 RSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGE 617
R YRAPEVI+ + Y+Q +D+WS+GCI+AE+ TG+
Sbjct: 178 RWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 67/208 (32%), Positives = 106/208 (50%), Gaps = 17/208 (8%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDF-----FDQSLDEIKLLKLVNK 469
RY +GS A+ V A D TG+ V +K K + F ++ E++LLK +
Sbjct: 18 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQSIIHAKRTYRELRLLKHMKH 75
Query: 470 NDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQ 529
+ + +++V L+ A+L K + T +Q + Q
Sbjct: 76 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-------LTDDHVQFLIYQ 128
Query: 530 CLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAP 589
L L+Y+HS IIH DLKP N+ + + CE+KI+D G + D + YV +R YRAP
Sbjct: 129 ILRGLKYIHSADIIHRDLKPSNLAVN--EDCELKILDFGLARHTDDEMTGYVATRWYRAP 186
Query: 590 EVIIG-LPYDQKIDLWSLGCILAELWTG 616
E+++ + Y+Q +D+WS+GCI+AEL TG
Sbjct: 187 EIMLNWMHYNQTVDIWSVGCIMAELLTG 214
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 3e-23
Identities = 67/202 (33%), Positives = 103/202 (50%), Gaps = 23/202 (11%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKII--KNDKDFFDQSLDEIKLLKLVNKNDPADEHHIL 479
LG AF KV++A++ TG K+I K++++ D + EI++L + +I+
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMV-EIEILA------TCNHPYIV 72
Query: 480 RLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS 539
+L FY L+I+ E + + G T ++QVI RQ LEAL+YLHS
Sbjct: 73 KLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRG----LTEPQIQVICRQMLEALQYLHS 128
Query: 540 LGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL---YVQSRSYRAPEVII--- 593
+ IIH DLK N+L+ +IK+ D G S L ++ + + APEV++
Sbjct: 129 MKIIHRDLKAGNVLLT--LDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCET 186
Query: 594 --GLPYDQKIDLWSLGCILAEL 613
PYD K D+WSLG L E+
Sbjct: 187 MKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.8 bits (247), Expect = 5e-23
Identities = 62/215 (28%), Positives = 98/215 (45%), Gaps = 33/215 (15%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLK-----LVNK 469
+ + E +G +F +V++A D T V +K+I +++ DEI+ ++ L
Sbjct: 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVID-----LEEAEDEIEDIQQEIQFLSQC 56
Query: 470 NDPADEHHILRLYDYFYHLEHLFIVCELLR----ANLYEFQKFNQESGGEAYFTLGRLQV 525
P +I + Y F L+I+ E +L + K ++ +
Sbjct: 57 RSP----YITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETY----------IAF 102
Query: 526 ITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC---LYVQ 582
I R+ L LEYLH G IH D+K NIL+ ++K+ D G S T + +V
Sbjct: 103 ILREVLLGLEYLHEEGKIHRDIKAANILLSEEG--DVKLADFGVSGQLTSTMSKRNTFVG 160
Query: 583 SRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGE 617
+ + APEVI YD+K D+WSLG EL GE
Sbjct: 161 TPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGE 195
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 98.2 bits (245), Expect = 6e-23
Identities = 65/216 (30%), Positives = 99/216 (45%), Gaps = 40/216 (18%)
Query: 421 YLGSAAFSKVFQAQDLHTGVDVCLKIIK---NDKDFFDQSLDEIKLLKLVNKNDPADEH- 476
+G F KV+ A +L TG + +K I+ ND + DE+K+L+L+ H
Sbjct: 7 KIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLK-------HP 59
Query: 477 HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGR------LQVITRQC 530
++++ Y H E ++I F ++ E GR ++V T Q
Sbjct: 60 NLVKYYGVEVHREKVYI-----------FMEYCSGGTLEELLEHGRILDEHVIRVYTLQL 108
Query: 531 LEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQ-------S 583
LE L YLHS GI+H D+KP NI + IK+ D G + +N + +
Sbjct: 109 LEGLAYLHSHGIVHRDIKPANIFLDH--NGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGT 166
Query: 584 RSYRAPEVIIGLPYDQK---IDLWSLGCILAELWTG 616
+Y APEVI G D+WSLGC++ E+ TG
Sbjct: 167 PAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATG 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 1e-22
Identities = 64/209 (30%), Positives = 107/209 (51%), Gaps = 29/209 (13%)
Query: 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQS--LDEIKLLK-LVNKNDPADEH 476
E LG ++ V++ ++ TG V LK I D + S + EI L+K L ++N
Sbjct: 6 EKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHEN------ 59
Query: 477 HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEY 536
I+RL+D + L +V E + +L ++ + G ++ T Q L+ + +
Sbjct: 60 -IVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGA---LDPNTVKSFTYQLLKGIAF 115
Query: 537 LHSLGIIHCDLKPENILIKSYQRCEIKIIDLG--------SSCFQTDNLCLYVQSRSYRA 588
H ++H DLKP+N+LI +R E+K+ D G + F + + L+ YRA
Sbjct: 116 CHENRVLHRDLKPQNLLIN--KRGELKLADFGLARAFGIPVNTFSNEVVTLW-----YRA 168
Query: 589 PEVIIG-LPYDQKIDLWSLGCILAELWTG 616
P+V++G Y ID+WS+GCI+AE+ TG
Sbjct: 169 PDVLLGSRTYSTSIDIWSVGCIMAEMITG 197
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 99.4 bits (247), Expect = 1e-22
Identities = 71/221 (32%), Positives = 112/221 (50%), Gaps = 39/221 (17%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSL-------DEIKLLKLV 467
RY +GS A+ V A D V +K K + F QSL E++LLK +
Sbjct: 16 RYQNLTPVGSGAYGSVCSAYDTRLRQKVAVK--KLSRPF--QSLIHARRTYRELRLLKHM 71
Query: 468 NKNDPADEHHILRLYDYFY------HLEHLFIVCELLRA---NLYEFQKFNQESGGEAYF 518
+++ L D F + +++V L+ A N+ + QK + E
Sbjct: 72 K------HENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDE------- 118
Query: 519 TLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC 578
+Q + Q L L+Y+HS GIIH DLKP N+ + + CE++I+D G + D +
Sbjct: 119 ---HVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVN--EDCELRILDFGLARQADDEMT 173
Query: 579 LYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEV 618
YV +R YRAPE+++ + Y+Q +D+WS+GCI+AEL G+
Sbjct: 174 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKA 214
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 97.3 bits (243), Expect = 1e-22
Identities = 67/207 (32%), Positives = 95/207 (45%), Gaps = 29/207 (14%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIK--NDKDFFDQSLDEIKLLKLVNKNDPADEHHIL 479
LG + V++ + TG LK I D++F Q L E+K L+ + +++
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRS------CESPYVV 62
Query: 480 RLYDYFYHLEHLFIVCEL-----LRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEAL 534
+ Y FY + IV E L L + K E L I RQ L+ L
Sbjct: 63 KCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIP-----EPV-----LAYIARQILKGL 112
Query: 535 EYLHS-LGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF--QTDNLCL-YVQSRSYRAPE 590
+YLH+ IIH D+KP N+LI S E+KI D G S T + C +V + +Y +PE
Sbjct: 113 DYLHTKRHIIHRDIKPSNLLINSKG--EVKIADFGISKVLENTLDQCNTFVGTVTYMSPE 170
Query: 591 VIIGLPYDQKIDLWSLGCILAELWTGE 617
I G Y D+WSLG L E G+
Sbjct: 171 RIQGESYSYAADIWSLGLTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 5e-22
Identities = 72/211 (34%), Positives = 109/211 (51%), Gaps = 19/211 (9%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQS-----LDEIKLLKLVNK 469
RY + +GS A V A D +V +K K + F +Q+ E+ L+K VN
Sbjct: 25 RYQNLKPIGSGAQGIVCAAYDAILERNVAIK--KLSRPFQNQTHAKRAYRELVLMKCVNH 82
Query: 470 NDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQ 529
+ ++ + ++IV EL+ ANL Q E E R+ + Q
Sbjct: 83 KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANL--CQVIQMELDHE------RMSYLLYQ 134
Query: 530 CLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL--YVQSRSYR 587
L +++LHS GIIH DLKP NI++KS C +KI+D G + + + YV +R YR
Sbjct: 135 MLCGIKHLHSAGIIHRDLKPSNIVVKS--DCTLKILDFGLARTAGTSFMMTPYVVTRYYR 192
Query: 588 APEVIIGLPYDQKIDLWSLGCILAELWTGEV 618
APEVI+G+ Y + +D+WS+GCI+ E+ G V
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKGGV 223
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 5e-22
Identities = 64/218 (29%), Positives = 112/218 (51%), Gaps = 27/218 (12%)
Query: 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK---NDKDFFDQSLDEIKLLKLVNKNDP 472
Y E +G + KV++A+D +TG V LK + +++ +L EI LL++++++
Sbjct: 3 YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESI- 61
Query: 473 ADEHHILRLYDYFYHLEH---------LFIVCELLRANLYEFQKFNQESGGEAYFTLGRL 523
+I+RL D +EH L++V E L ++L +F N G +
Sbjct: 62 ----YIVRLLD----VEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPA-KTI 112
Query: 524 QVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLY--- 580
+ Q L+ + + H G++H DLKP+N+L+ + +KI DLG + + Y
Sbjct: 113 KSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGL-LKIADLGLGRAFSIPVKSYTHE 171
Query: 581 VQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGE 617
+ + YRAPEV++G Y +D+WS+GCI AE+ +
Sbjct: 172 IVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQ 209
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 95.0 bits (237), Expect = 7e-22
Identities = 60/204 (29%), Positives = 98/204 (48%), Gaps = 18/204 (8%)
Query: 418 VTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHH 477
+ E LG ++ V++A TG V +K++ ++D + EI +LK D +
Sbjct: 7 ILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEII-KEISILK------QCDSPY 59
Query: 478 ILRLYDYFYHLEHLFIVCELLRAN-LYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEY 536
I++ Y ++ L+IV E A + + K ++ E + I Q L+ LEY
Sbjct: 60 IVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEE-----EIAAILYQTLKGLEY 114
Query: 537 LHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL---YVQSRSYRAPEVII 593
LHS IH D+K NIL+ + + K+ D G S TD + + + + APEVI
Sbjct: 115 LHSNKKIHRDIKAGNILLN--EEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQ 172
Query: 594 GLPYDQKIDLWSLGCILAELWTGE 617
+ Y+ K D+WSLG E+ G+
Sbjct: 173 EIGYNNKADIWSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 8e-22
Identities = 64/214 (29%), Positives = 95/214 (44%), Gaps = 25/214 (11%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK----NDKDFFDQSLDEIKLLKLVNKN 470
+ V + LG ++ V++ + L LK + + K+ D +++EI++L VN
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKERED-AVNEIRILASVN-- 57
Query: 471 DPADEHHILRLYDYFYHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITR- 528
+I+ + F L IV E +L + ++ L Q I R
Sbjct: 58 ----HPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKR-----KLIPEQEIWRI 108
Query: 529 --QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQ--SR 584
Q L L+ LH I+H DLK NIL+ +KI DLG S N+ Q +
Sbjct: 109 FIQLLRGLQALHEQKILHRDLKSANILL--VANDLVKIGDLGISKVLKKNM-AKTQIGTP 165
Query: 585 SYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEV 618
Y APEV G PY K D+WSLGC+L E+ T
Sbjct: 166 HYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAP 199
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 96.3 bits (239), Expect = 1e-21
Identities = 69/206 (33%), Positives = 107/206 (51%), Gaps = 19/206 (9%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQS-----LDEIKLLKLVNK 469
RY + +GS A V A D +V +K K + F +Q+ E+ L+K VN
Sbjct: 18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIK--KLSRPFQNQTHAKRAYRELVLMKCVNH 75
Query: 470 NDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQ 529
+ ++ + +++V EL+ ANL Q E E R+ + Q
Sbjct: 76 KNIISLLNVFTPQKSLEEFQDVYLVMELMDANL--CQVIQMELDHE------RMSYLLYQ 127
Query: 530 CLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL--YVQSRSYR 587
L +++LHS GIIH DLKP NI++KS C +KI+D G + + + YV +R YR
Sbjct: 128 MLCGIKHLHSAGIIHRDLKPSNIVVKS--DCTLKILDFGLARTAGTSFMMTPYVVTRYYR 185
Query: 588 APEVIIGLPYDQKIDLWSLGCILAEL 613
APEVI+G+ Y + +D+WS+GCI+ E+
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEM 211
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 3e-21
Identities = 65/214 (30%), Positives = 101/214 (47%), Gaps = 35/214 (16%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFD------QSLDEIKLLKLVNKNDPADE 475
+G AF V+ D G V LK + N F + E+K+L ++
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPN---VFQNLVSCKRVFRELKMLCFFKHDNVLSA 64
Query: 476 HHILR--LYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEA 533
IL+ D F E +++V EL++++L++ Q + ++V Q L
Sbjct: 65 LDILQPPHIDPF---EEIYVVTELMQSDLHKIIVSPQP------LSSDHVKVFLYQILRG 115
Query: 534 LEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG--------SSCFQTDNLCLYVQSRS 585
L+YLHS GI+H D+KP N+L+ S C +KI D G S T V ++
Sbjct: 116 LKYLHSAGILHRDIKPGNLLVNS--NCVLKICDFGLARVEEPDESKHMTQE----VVTQY 169
Query: 586 YRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEV 618
YRAPE+++G Y +D+WS+GCI AEL +
Sbjct: 170 YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRI 203
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 4e-21
Identities = 68/214 (31%), Positives = 107/214 (50%), Gaps = 36/214 (16%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQ-----SLDEIKLLK-LVN 468
+Y E +G + VF+A++ T V LK ++ D D D+ +L EI LLK L +
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD--DEGVPSSALREICLLKELKH 58
Query: 469 KNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITR 528
KN I+RLYD + + L +V E +L +K+ G+ + ++
Sbjct: 59 KN-------IVRLYDVLHSDKKLTLVFEYCDQDL---KKYFDSCNGDIDPEI--VKSFMF 106
Query: 529 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS--------CFQTDNLCLY 580
Q L+ L + HS ++H DLKP+N+LI + E+K+ D G + C+ + + L+
Sbjct: 107 QLLKGLAFCHSHNVLHRDLKPQNLLIN--KNGELKLADFGLARAFGIPVRCYSAEVVTLW 164
Query: 581 VQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAEL 613
YR P+V+ G Y ID+WS GCI AEL
Sbjct: 165 -----YRPPDVLFGAKLYSTSIDMWSAGCIFAEL 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 92.6 bits (231), Expect = 8e-21
Identities = 62/218 (28%), Positives = 97/218 (44%), Gaps = 55/218 (25%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHH 477
LG+ +F +V + +G LKI+ K + L+E ++L+ + H
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIR--------H 60
Query: 478 --ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTL----GRL-----QVI 526
++ LY F +L++V E + GGE F+ GR +
Sbjct: 61 PFLVNLYGSFQDDSNLYLVMEYV-------------PGGE-LFSHLRKSGRFPEPVARFY 106
Query: 527 TRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS- 585
Q + ALEYLHSL I++ DLKPEN+L+ S IKI D G V+ R+
Sbjct: 107 AAQVVLALEYLHSLDIVYRDLKPENLLLDSDG--YIKITDFG--------FAKRVKGRTY 156
Query: 586 -------YRAPEVIIGLPYDQKIDLWSLGCILAELWTG 616
Y APE+I+ Y + +D W+LG ++ E+ G
Sbjct: 157 TLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 9e-21
Identities = 64/208 (30%), Positives = 105/208 (50%), Gaps = 26/208 (12%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD------EIKLLKLVNKNDPADE 475
+G A+ V A++ T V +K I N FD +D EIKLL+ ++ +
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIAN---AFDNRIDAKRTLREIKLLRHLDHENVIAI 69
Query: 476 HHILR--LYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEA 533
I+ + F ++IV EL+ +L++ + +Q + Q Q L
Sbjct: 70 KDIMPPPHREAF---NDVYIVYELMDTDLHQIIRSSQT------LSDDHCQYFLYQLLRG 120
Query: 534 LEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG---SSCFQTDNLCLYVQSRSYRAPE 590
L+Y+HS ++H DLKP N+L+ + C++KI D G ++ + D + YV +R YRAPE
Sbjct: 121 LKYIHSANVLHRDLKPSNLLLNA--NCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPE 178
Query: 591 VIIGLP-YDQKIDLWSLGCILAELWTGE 617
+++ Y ID+WS+GCI AEL +
Sbjct: 179 LLLNCSEYTTAIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 92.0 bits (229), Expect = 2e-20
Identities = 64/233 (27%), Positives = 103/233 (44%), Gaps = 47/233 (20%)
Query: 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLK--IIKNDKDFFD-QSLDEIKLLKLVN-K 469
Y + LG F +V++A+ + TG V LK ++ N+KD F +L EIK+LK +
Sbjct: 8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHP 67
Query: 470 N---------DPADEHHILR--LYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYF 518
N + D+ R +Y +++H +L + L E
Sbjct: 68 NVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-----DL--SGLLENPSVK--------L 112
Query: 519 TLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG---------- 568
T +++ Q LE + YLH I+H D+K NILI + + +KI D G
Sbjct: 113 TESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDN--QGILKIADFGLARPYDGPPP 170
Query: 569 ----SSCFQTDNLCLYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTG 616
T V +R YR PE+++G Y +D+W +GC+ AE++T
Sbjct: 171 NPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTR 223
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 5e-20
Identities = 66/201 (32%), Positives = 99/201 (49%), Gaps = 21/201 (10%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKN-DKDFFDQSLDEIKLLKLVNKNDPADEHHILR 480
LG AF KV++AQ+ TGV K+I ++ + + EI +L D +I++
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILA------SCDHPNIVK 66
Query: 481 LYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSL 540
L D FY+ +L+I+ E + E T +++V+ +Q LEAL YLH
Sbjct: 67 LLDAFYYENNLWILIEFCAGGAVDAVMLELERP----LTEPQIRVVCKQTLEALNYLHEN 122
Query: 541 GIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL---YVQSRSYRAPEVII---- 593
IIH DLK NIL +IK+ D G S T + ++ + + APEV++
Sbjct: 123 KIIHRDLKAGNILFT--LDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETS 180
Query: 594 -GLPYDQKIDLWSLGCILAEL 613
PYD K D+WSLG L E+
Sbjct: 181 KDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 6e-20
Identities = 67/218 (30%), Positives = 97/218 (44%), Gaps = 47/218 (21%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIK-NDKDFFDQSLDEIKLLKLVNKNDPADEHHILR 480
LG AF KV++AQ TG+ KII+ ++ + + EI +L +I+
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILS------ECKHPNIVG 66
Query: 481 LYDYFYHLEHLFIVCELLRANLYEFQKFNQESGG---------EAYFTLGRLQVITRQCL 531
LY+ +++ L+I+ E GG E T +++ + RQ L
Sbjct: 67 LYEAYFYENKLWILIEFC-------------DGGALDSIMLELERGLTEPQIRYVCRQML 113
Query: 532 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS------ 585
EAL +LHS +IH DLK NIL+ ++K+ D G S L Q R
Sbjct: 114 EALNFLHSHKVIHRDLKAGNILLT--LDGDVKLADFGVSAKNKSTL----QKRDTFIGTP 167
Query: 586 -YRAPEVII-----GLPYDQKIDLWSLGCILAELWTGE 617
+ APEV+ PYD K D+WSLG L EL E
Sbjct: 168 YWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQME 205
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 7e-20
Identities = 68/226 (30%), Positives = 106/226 (46%), Gaps = 45/226 (19%)
Query: 418 VTEY-----LGSAAFSKVFQAQDLHTGVDVCLKIIK--NDKDFFD-QSLDEIKLLKLVNK 469
VTE+ +G + V++A+D +G V LK ++ N++D SL EI LL +
Sbjct: 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNL-- 63
Query: 470 NDPADEHH--ILRLYDYFY--HLEHLFIV---CELLRANLYEFQKFNQESGGEAYFTLGR 522
H I+ L + HL+ +F+V CE A+L + F+ +
Sbjct: 64 ------RHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMP--------TPFSESQ 109
Query: 523 LQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQ 582
++ + Q L L+YLH IIH DLK N+L+ + +KI D G L +
Sbjct: 110 VKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLT--DKGCLKIADFG----LARTYGLPAK 163
Query: 583 SRS-------YRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVCL 620
+ YRAPE+++G Y ID+W++GCILAEL + L
Sbjct: 164 PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLL 209
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 90.0 bits (224), Expect = 7e-20
Identities = 63/198 (31%), Positives = 101/198 (51%), Gaps = 24/198 (12%)
Query: 430 VFQAQDLHTGVDVCLKIIKNDKD---FFDQSLDEIK-LLKLVNKNDPADEHHILRLYDYF 485
V++A+D TG V LK +K +K+ F SL EI LLKL + N I+ + +
Sbjct: 21 VYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPN-------IVTVKEVV 73
Query: 486 Y--HLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGII 543
+L+ +++V E + +L + ++ F ++ + Q L + +LH I+
Sbjct: 74 VGSNLDKIYMVMEYVEHDLKSLMETMKQP-----FLQSEVKCLMLQLLSGVAHLHDNWIL 128
Query: 544 HCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQ---SRSYRAPEVIIGLP-YDQ 599
H DLK N+L+ + R +KI D G + L Y Q + YRAPE+++G Y
Sbjct: 129 HRDLKTSNLLLNN--RGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYST 186
Query: 600 KIDLWSLGCILAELWTGE 617
ID+WS+GCI AEL T +
Sbjct: 187 AIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 89.2 bits (222), Expect = 9e-20
Identities = 58/218 (26%), Positives = 90/218 (41%), Gaps = 49/218 (22%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDE-IKLLKLVNKNDPADEHHILR 480
LG F +V + LK +K + E I K + + + I++
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRH-IVETGQQEHIFSEKEILEE--CNHPFIVK 57
Query: 481 LYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTL---GRL-----QVITRQCLE 532
LY F ++++++ E GGE + L G + +
Sbjct: 58 LYRTFKDKKYIYMLMEYCL-------------GGELWTILRDRGLFDEYTARFYIACVVL 104
Query: 533 ALEYLHSLGIIHCDLKPENILIKS--YQRCEIKIIDLGSSCFQTDNLCLYVQSRS----- 585
A EYLH+ GII+ DLKPEN+L+ S Y +K++D G + ++S
Sbjct: 105 AFEYLHNRGIIYRDLKPENLLLDSNGY----VKLVDFGFA--------KKLKSGQKTWTF 152
Query: 586 -----YRAPEVIIGLPYDQKIDLWSLGCILAELWTGEV 618
Y APE+I+ YD +D WSLG +L EL TG
Sbjct: 153 CGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRP 190
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 2e-19
Identities = 57/217 (26%), Positives = 101/217 (46%), Gaps = 36/217 (16%)
Query: 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIK------NDKDFFDQSL-DEIKLLKLVNKNDP 472
+ LG+ AFS +QA+D+ TG + +K + ++++ ++L EI+L+ +N
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLN---- 61
Query: 473 ADEHHILRLYDYFYHLEHLFIVCELLRAN-----LYEFQKFNQESGGEAYFTLGRLQVIT 527
HI+R+ H + E + L ++ F +E+ Y T
Sbjct: 62 --HPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAF-KEAVIINY---------T 109
Query: 528 RQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC-------LY 580
Q L L YLH IIH D+K N+LI S + ++I D G++
Sbjct: 110 EQLLRGLSYLHENQIIHRDVKGANLLIDSTGQ-RLRIADFGAAARLAAKGTGAGEFQGQL 168
Query: 581 VQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGE 617
+ + ++ APEV+ G Y + D+WS+GC++ E+ T +
Sbjct: 169 LGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 2e-19
Identities = 64/214 (29%), Positives = 97/214 (45%), Gaps = 41/214 (19%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFD-----QSLD-EIKLLKLVNKNDPADE 475
LG AF +V+ D+ TG ++ +K + D D + +L+ EI+LLK +
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHE----- 64
Query: 476 HHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGG------EAYFTLGR--LQVIT 527
R+ Y+ C L F ++ GG +AY L + T
Sbjct: 65 ----RIVQYYG--------CLRDDETLSIFMEYM--PGGSVKDQLKAYGALTETVTRKYT 110
Query: 528 RQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS------CFQTDNLCLYV 581
RQ LE +EYLHS I+H D+K NIL S +K+ D G+S C +
Sbjct: 111 RQILEGVEYLHSNMIVHRDIKGANILRDSAG--NVKLGDFGASKRLQTICSSGTGMKSVT 168
Query: 582 QSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT 615
+ + +PEVI G Y +K D+WS+GC + E+ T
Sbjct: 169 GTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 3e-19
Identities = 64/208 (30%), Positives = 105/208 (50%), Gaps = 29/208 (13%)
Query: 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD---FFDQSLDEIKLLKLVNKNDPADEH 476
E +G + V++A++ TG V LK I+ D + ++ EI LLK +N +
Sbjct: 6 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN----- 60
Query: 477 HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEY 536
I++L D + L++V E L +L +F + SG L ++ Q L+ L +
Sbjct: 61 -IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSG----IPLPLIKSYLFQLLQGLAF 115
Query: 537 LHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS--------CFQTDNLCLYVQSRSYRA 588
HS ++H DLKP+N+LI + IK+ D G + + + + L+ YRA
Sbjct: 116 CHSHRVLHRDLKPQNLLINT--EGAIKLADFGLARAFGVPVRTYTHEVVTLW-----YRA 168
Query: 589 PEVIIGLP-YDQKIDLWSLGCILAELWT 615
PE+++G Y +D+WSLGCI AE+ T
Sbjct: 169 PEILLGCKYYSTAVDIWSLGCIFAEMVT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 3e-19
Identities = 68/202 (33%), Positives = 95/202 (47%), Gaps = 18/202 (8%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD--FFDQSLDEIKLLKLVNKNDPADEHHIL 479
LG+ V + TG + +K I+ + + Q L E+ +L N P +I+
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILH--KCNSP----YIV 62
Query: 480 RLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLH 538
Y FY+ + I E + +L + K Q E LG+ I L+ L YLH
Sbjct: 63 GFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPE--RILGK---IAVAVLKGLTYLH 117
Query: 539 S-LGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL-YVQSRSYRAPEVIIGLP 596
IIH D+KP NIL+ S R +IK+ D G S ++L +V + SY APE I G
Sbjct: 118 EKHKIIHRDVKPSNILVNS--RGQIKLCDFGVSGQLVNSLAKTFVGTSSYMAPERIQGND 175
Query: 597 YDQKIDLWSLGCILAELWTGEV 618
Y K D+WSLG L EL TG
Sbjct: 176 YSVKSDIWSLGLSLIELATGRF 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 3e-19
Identities = 68/224 (30%), Positives = 101/224 (45%), Gaps = 49/224 (21%)
Query: 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQS--LDEIKLLKLVNKNDPA 473
Y E +G A+ V++ + + TG V LKII D D S E+ LL + ++ P
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPP 62
Query: 474 DEHHILRLYDYFYHLEHLFIVCE---------LLRANLYEFQKFNQESGGEAYFTLGRLQ 524
+ I + Y + L+I+ E L++A E Y +
Sbjct: 63 N---ITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIA----------EKY-----IS 104
Query: 525 VITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSR 584
VI R+ L AL+Y+H +G+IH D+K NIL+ + +K+ D G + L Q+
Sbjct: 105 VIIREVLVALKYIHKVGVIHRDIKAANILVTNTGN--VKLCDFGVA-------ALLNQNS 155
Query: 585 SYR----------APEVII-GLPYDQKIDLWSLGCILAELWTGE 617
S R APEVI G YD K D+WSLG + E+ TG
Sbjct: 156 SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGN 199
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.8 bits (218), Expect = 4e-19
Identities = 64/204 (31%), Positives = 103/204 (50%), Gaps = 25/204 (12%)
Query: 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQ-----SLDEIKLLKLVNKNDPAD 474
E +G + V++A+D TG V LK I+ + + D+ ++ EI LLK +N P
Sbjct: 5 EKIGEGTYGVVYKARDKLTGEIVALKKIRLETE--DEGVPSTAIREISLLKELN--HP-- 58
Query: 475 EHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEAL 534
+I+RL D + L++V E L +L K +S ++ Q L+ +
Sbjct: 59 --NIVRLLDVVHSENKLYLVFEFLDLDL----KKYMDSSPLTGLDPPLIKSYLYQLLQGI 112
Query: 535 EYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG-SSCFQTDNLCLY---VQSRSYRAPE 590
Y HS ++H DLKP+N+LI +K+ D G + F + Y V + YRAPE
Sbjct: 113 AYCHSHRVLHRDLKPQNLLIDREG--ALKLADFGLARAFGVP-VRTYTHEVVTLWYRAPE 169
Query: 591 VIIGLP-YDQKIDLWSLGCILAEL 613
+++G Y +D+WS+GCI AE+
Sbjct: 170 ILLGSRQYSTPVDIWSIGCIFAEM 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 9e-19
Identities = 61/215 (28%), Positives = 105/215 (48%), Gaps = 29/215 (13%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPAD 474
+Y +G A+ V++A+D H+G V LK ++ + L ++ + L+ + + D
Sbjct: 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFD 60
Query: 475 EHHILRLYDYFYHLEHLFIVCELLRAN-----LYEFQKFNQESGGEAYFT--------LG 521
+I+RL D VC R + F+ +Q+ Y
Sbjct: 61 HPNIVRLMD----------VCATSRTDRETKVTLVFEHVDQDL--RTYLDKVPPPGLPAE 108
Query: 522 RLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL-- 579
++ + RQ L L++LH+ I+H DLKPENIL+ S ++K+ D G + + + L
Sbjct: 109 TIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTS--GGQVKLADFGLARIYSCQMALTP 166
Query: 580 YVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELW 614
V + YRAPEV++ Y +D+WS+GCI AE++
Sbjct: 167 VVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 1e-18
Identities = 42/97 (43%), Positives = 59/97 (60%), Gaps = 8/97 (8%)
Query: 526 ITRQCLEALEYLHSLGIIHCDLKPENILI-KSYQRCEIKIIDLGSSCFQT---DNLCLYV 581
I Q L+A+ + H IH D+KPENILI K Q IK+ D G + T D+ YV
Sbjct: 105 IIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQ---IKLCDFGFARILTGPGDDYTDYV 161
Query: 582 QSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGE 617
+R YRAPE+++G Y +D+W++GC+ AEL TG+
Sbjct: 162 ATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.0 bits (211), Expect = 2e-18
Identities = 64/221 (28%), Positives = 98/221 (44%), Gaps = 46/221 (20%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK-NDKDFFDQSLDEIKLLKLVNKNDPA 473
Y + + +GS + V++A+D+ TG V +K+IK D F+ EI +LK +
Sbjct: 4 DYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPN-- 61
Query: 474 DEHHILRLYDYFYHLEHLFIVCE------------LLRANLYEFQKFNQESGGEAYFTLG 521
I+ + + + L+IV E + R L E Q AY
Sbjct: 62 ----IVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQI--------AY---- 105
Query: 522 RLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC--- 578
+ R+ L+ L YLH G IH D+K NIL+ ++K+ D G S T +
Sbjct: 106 ----VCRETLKGLAYLHETGKIHRDIKGANILLTE--DGDVKLADFGVSAQLTATIAKRK 159
Query: 579 LYVQSRSYRAPEVI---IGLPYDQKIDLWSLG--CI-LAEL 613
++ + + APEV YD K D+W+LG I LAEL
Sbjct: 160 SFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAEL 200
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 2e-18
Identities = 61/214 (28%), Positives = 94/214 (43%), Gaps = 24/214 (11%)
Query: 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPA 473
Y + E +G A + V+ A L V +K I +K D+ E++ + N
Sbjct: 3 YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCN----- 57
Query: 474 DEH-HILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCL 531
H ++++ Y F + L++V L +L + K + GG + + ++ L
Sbjct: 58 --HPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIA---TVLKEVL 112
Query: 532 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS------ 585
+ LEYLHS G IH D+K NIL+ +KI D G S D + R
Sbjct: 113 KGLEYLHSNGQIHRDIKAGNILLGEDG--SVKIADFGVSASLADGGDRTRKVRKTFVGTP 170
Query: 586 -YRAPEVIIGLP-YDQKIDLWSLGCILAELWTGE 617
+ APEV+ + YD K D+WS G EL TG
Sbjct: 171 CWMAPEVMEQVHGYDFKADIWSFGITAIELATGA 204
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.4 bits (212), Expect = 4e-18
Identities = 65/218 (29%), Positives = 112/218 (51%), Gaps = 30/218 (13%)
Query: 421 YLGSAAFSKVFQA--QDLHTGVDVCLKIIKNDKDFFD---QS-LDEIKLLK-LVNKNDPA 473
+G + +V++A ++ G + +K K DK+ + QS EI LL+ L ++N
Sbjct: 7 CIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHEN--- 63
Query: 474 DEHHILRLYDYFYHLEH----LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQ 529
++ L + F LEH ++++ + +L++ KF++++ ++ + Q
Sbjct: 64 ----VVSLVEVF--LEHADKSVYLLFDYAEHDLWQIIKFHRQAKR-VSIPPSMVKSLLWQ 116
Query: 530 CLEALEYLHSLGIIHCDLKPENILIKS--YQRCEIKIIDLG-SSCFQTDNLCLY-----V 581
L + YLHS ++H DLKP NIL+ +R +KI DLG + F L V
Sbjct: 117 ILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVV 176
Query: 582 QSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEV 618
+ YRAPE+++G Y + ID+W++GCI AEL T E
Sbjct: 177 VTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEP 214
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 6e-18
Identities = 70/238 (29%), Positives = 114/238 (47%), Gaps = 24/238 (10%)
Query: 391 HRKNRTGFEEN-KDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKN 449
H N E+ K + +N Y + +G+ +F V++A + T V +K +
Sbjct: 42 HNNNAGEDEDEEKMIDNDINRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQ 101
Query: 450 DKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY------HLEHLF--IVCELLRAN 501
D + ++ L +K L +N I+ L DY+Y + +++F +V E +
Sbjct: 102 DPQYKNRELLIMKNLNHIN---------IIFLKDYYYTECFKKNEKNIFLNVVMEFIPQT 152
Query: 502 LYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCE 561
++++ K + L +L + Q AL Y+HS I H DLKP+N+LI
Sbjct: 153 VHKYMKHYARNNHALPLFLVKL--YSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTH-T 209
Query: 562 IKIIDLGSS--CFQTDNLCLYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTG 616
+K+ D GS+ Y+ SR YRAPE+++G Y IDLWSLGCI+AE+ G
Sbjct: 210 LKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 1e-17
Identities = 64/215 (29%), Positives = 94/215 (43%), Gaps = 32/215 (14%)
Query: 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK----NDKDFFDQSLDEIKLLKLVNK 469
G + + + +G FS V++A L G V LK ++ D L EI LLK
Sbjct: 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLK---- 57
Query: 470 NDPADEHHILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGE-------AYFTLG 521
D ++++ F L IV EL A +L K ++ YF
Sbjct: 58 --QLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFV-- 113
Query: 522 RLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF---QTDNLC 578
Q ALE++HS I+H D+KP N+ I + +K+ DLG F +T
Sbjct: 114 -------QLCSALEHMHSKRIMHRDIKPANVFITA--TGVVKLGDLGLGRFFSSKTTAAH 164
Query: 579 LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAEL 613
V + Y +PE I Y+ K D+WSLGC+L E+
Sbjct: 165 SLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 1e-17
Identities = 62/217 (28%), Positives = 108/217 (49%), Gaps = 34/217 (15%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKII---KNDKDFFDQSLDEIKLLKLVNKND 471
+Y +G ++ V + + TG V +K ++DK ++ EI++LK +
Sbjct: 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQL---- 57
Query: 472 PADEHH--ILRLYDYFYHLEHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITR 528
H ++ L + F + L++V E + L + +K+ +G R++
Sbjct: 58 ----RHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKY--PNG----LDESRVRKYLF 107
Query: 529 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF-------QTDNLCLYV 581
Q L +E+ HS IIH D+KPENIL+ Q +K+ D G + TD YV
Sbjct: 108 QILRGIEFCHSHNIIHRDIKPENILVS--QSGVVKLCDFGFARTLAAPGEVYTD----YV 161
Query: 582 QSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGE 617
+R YRAPE+++G Y + +D+W++GC++ E+ TGE
Sbjct: 162 ATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGE 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 82.2 bits (204), Expect = 2e-17
Identities = 54/210 (25%), Positives = 89/210 (42%), Gaps = 30/210 (14%)
Query: 420 EYLGSAAFSKVFQAQ----DLHTGVDVCLKIIKNDKDFFDQS--LDEIKLLKLVNKNDPA 473
+ LG AF +V++ + V+V +K +K D L E ++++ ++
Sbjct: 5 KKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLD----- 59
Query: 474 DEH-HILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCL 531
H ++++L E L+IV E + +L + + N+ +L L Q
Sbjct: 60 --HPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPK-----LSLSDLLSFALQIA 112
Query: 532 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS----YR 587
+EYL S IH DL N L+ +KI D G S D Y + R R
Sbjct: 113 RGMEYLESKNFIHRDLAARNCLVGE--NLVVKISDFGLSRDLYD--DDYYRKRGGKLPIR 168
Query: 588 --APEVIIGLPYDQKIDLWSLGCILAELWT 615
APE + + K D+WS G +L E++T
Sbjct: 169 WMAPESLKEGKFTSKSDVWSFGVLLWEIFT 198
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 2e-17
Identities = 61/213 (28%), Positives = 103/213 (48%), Gaps = 32/213 (15%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK---NDKDFFDQSLDEIKLLKLVNKND 471
+Y E +G + V++A+D T + LK I+ D+ ++ EI LLK
Sbjct: 3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLK------ 56
Query: 472 PADEHH--ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQ 529
+ H I+RL D + + L++V E L +L K + +S + ++ Q
Sbjct: 57 --EMQHGNIVRLQDVVHSEKRLYLVFEYLDLDL----KKHMDSSPDFAKNPRLIKTYLYQ 110
Query: 530 CLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS--------CFQTDNLCLYV 581
L + Y HS ++H DLKP+N+LI + +K+ D G + F + + L+
Sbjct: 111 ILRGIAYCHSHRVLHRDLKPQNLLIDR-RTNALKLADFGLARAFGIPVRTFTHEVVTLW- 168
Query: 582 QSRSYRAPEVIIG-LPYDQKIDLWSLGCILAEL 613
YRAPE+++G Y +D+WS+GCI AE+
Sbjct: 169 ----YRAPEILLGSRHYSTPVDIWSVGCIFAEM 197
|
Length = 294 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 3e-17
Identities = 68/226 (30%), Positives = 98/226 (43%), Gaps = 53/226 (23%)
Query: 420 EYLGSAAFSKVFQAQDLHTG-------VDVCLKIIKND----KDFFDQSLDEIKLLKLVN 468
E +G + +V+ A ++ TG V++ I KD EI+ LK
Sbjct: 7 ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLK--- 63
Query: 469 KNDPADEHHILRLYDYFYHLEHLFIV----CELLRANLYEFQKF-NQESGGEAYFTLGRL 523
L+HL IV E L F ++ S G T GR
Sbjct: 64 ------------------DLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRF 105
Query: 524 Q-----VITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC 578
+ T Q LE L YLHS GI+H DLK +N+L+ + C KI D G S ++D++
Sbjct: 106 EEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGIC--KISDFGIS-KKSDDIY 162
Query: 579 LYVQSRSYR------APEVI--IGLPYDQKIDLWSLGCILAELWTG 616
Q+ S + APEVI Y K+D+WSLGC++ E++ G
Sbjct: 163 DNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAG 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 81.4 bits (202), Expect = 3e-17
Identities = 54/209 (25%), Positives = 87/209 (41%), Gaps = 27/209 (12%)
Query: 420 EYLGSAAFSKVFQAQ----DLHTGVDVCLKIIKNDKDFFDQS--LDEIKLLKLVNKNDPA 473
+ LG AF +V++ V+V +K +K D L E ++++ ++
Sbjct: 5 KKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLD----- 59
Query: 474 DEH-HILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCL 531
H +I++L E L IV E + +L ++ + N+ +L L Q
Sbjct: 60 --HPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKE----LSLSDLLSFALQIA 113
Query: 532 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS---YR- 587
+EYL S IH DL N L+ +KI D G S D+ Y R
Sbjct: 114 RGMEYLESKNFIHRDLAARNCLVGE--NLVVKISDFGLSRDLYDDD-YYKVKGGKLPIRW 170
Query: 588 -APEVIIGLPYDQKIDLWSLGCILAELWT 615
APE + + K D+WS G +L E++T
Sbjct: 171 MAPESLKEGKFTSKSDVWSFGVLLWEIFT 199
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 3e-17
Identities = 57/210 (27%), Positives = 109/210 (51%), Gaps = 20/210 (9%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKN---DKDFFDQSLDEIKLLKLVNKND 471
++ V +G A+ V + + T V +K K+ +++ + +L E+K+L+ + + +
Sbjct: 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQEN 61
Query: 472 PADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCL 531
I+ L + F L++V E + N+ E + +G +++ Q +
Sbjct: 62 ------IVELKEAFRRRGKLYLVFEYVEKNMLELLE-EMPNGVPP----EKVRSYIYQLI 110
Query: 532 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTD----NLCLYVQSRSYR 587
+A+ + H I+H D+KPEN+LI +K+ D G + ++ N YV +R YR
Sbjct: 111 KAIHWCHKNDIVHRDIKPENLLISHNDV--LKLCDFGFARNLSEGSNANYTEYVATRWYR 168
Query: 588 APEVIIGLPYDQKIDLWSLGCILAELWTGE 617
+PE+++G PY + +D+WS+GCIL EL G+
Sbjct: 169 SPELLLGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 4e-17
Identities = 59/204 (28%), Positives = 101/204 (49%), Gaps = 20/204 (9%)
Query: 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIK---NDKDFFDQSLDEIKLLK-LVNKNDPADE 475
E +G + V++ ++ TG V +K I+ ++ ++ EI LLK L + N
Sbjct: 6 EKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPN----- 60
Query: 476 HHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALE 535
I+ L D L+++ E L +L +K+ Y ++ Q L+ +
Sbjct: 61 --IVCLQDVLMQESRLYLIFEFLSMDL---KKYLDSLPKGQYMDAELVKSYLYQILQGIL 115
Query: 536 YLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLY---VQSRSYRAPEVI 592
+ HS ++H DLKP+N+LI + + IK+ D G + + +Y V + YRAPEV+
Sbjct: 116 FCHSRRVLHRDLKPQNLLIDN--KGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVL 173
Query: 593 IGLP-YDQKIDLWSLGCILAELWT 615
+G P Y +D+WS+G I AE+ T
Sbjct: 174 LGSPRYSTPVDIWSIGTIFAEMAT 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 5e-17
Identities = 63/219 (28%), Positives = 111/219 (50%), Gaps = 24/219 (10%)
Query: 414 GRYYVTEY-----LGSAAFSKVFQAQDLHTGVDVCLKIIK--NDKDFFD-QSLDEIKLLK 465
G+ V ++ +G + +V++A+D TG V LK ++ N+K+ F ++ EIK+L+
Sbjct: 2 GKRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILR 61
Query: 466 LVNKNDPADEHHIL----RLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLG 521
+N + + I+ D+ ++V E + +L ESG +F+
Sbjct: 62 QLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLL----ESG-LVHFSED 116
Query: 522 RLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG-SSCFQTDNLCLY 580
++ +Q LE L Y H +H D+K NIL+ + + +IK+ D G + + ++ Y
Sbjct: 117 HIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNN--KGQIKLADFGLARLYNSEESRPY 174
Query: 581 ---VQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWT 615
V + YR PE+++G Y ID+WS GCIL EL+T
Sbjct: 175 TNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFT 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 5e-17
Identities = 64/210 (30%), Positives = 100/210 (47%), Gaps = 26/210 (12%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKII--KNDKDFFD-QSLDEIKLLKLVNKNDPADEHHI 478
+G F +VF+A+ T V LK + +N+K+ F +L EIK+L+L+ + + I
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 79
Query: 479 LR----LYDYFYHLEHL-FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEA 533
R Y+ + +L F CE A L + FTL ++ + + L
Sbjct: 80 CRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVK--------FTLSEIKKVMKMLLNG 131
Query: 534 LEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG----SSCFQTDNLCLY---VQSRSY 586
L Y+H I+H D+K NILI + +K+ D G S + Y V + Y
Sbjct: 132 LYYIHRNKILHRDMKAANILIT--KDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWY 189
Query: 587 RAPEVIIG-LPYDQKIDLWSLGCILAELWT 615
R PE+++G Y ID+W GCI+AE+WT
Sbjct: 190 RPPELLLGERDYGPPIDMWGAGCIMAEMWT 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 7e-17
Identities = 56/202 (27%), Positives = 93/202 (46%), Gaps = 31/202 (15%)
Query: 426 AFSKVFQAQDLHTGVDVCLKII-KNDKDFFDQSLDEIKLLKLVNKN--DPADEHHILRLY 482
AF V+ A+ TG +K++ K+D + +++ +K + ++ +LY
Sbjct: 8 AFGSVYLAKKRSTGDYFAIKVLKKSDMI----AKNQVTNVKAERAIMMIQGESPYVAKLY 63
Query: 483 DYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQ--------CLEAL 534
F ++L++V E L +GG+ + L + + +
Sbjct: 64 YSFQSKDYLYLVMEYL-------------NGGDCASLIKTLGGLPEDWAKQYIAEVVLGV 110
Query: 535 EYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIG 594
E LH GIIH D+KPEN+LI Q +K+ D G S +N +V + Y APE I+G
Sbjct: 111 EDLHQRGIIHRDIKPENLLID--QTGHLKLTDFGLSRNGLENK-KFVGTPDYLAPETILG 167
Query: 595 LPYDQKIDLWSLGCILAELWTG 616
+ D+ D WSLGC++ E G
Sbjct: 168 VGDDKMSDWWSLGCVIFEFLFG 189
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 1e-16
Identities = 60/228 (26%), Positives = 98/228 (42%), Gaps = 38/228 (16%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLK-IIKNDKDFFDQSLDEIKLLKLVNKN 470
+ RY LG + VF A D V +K I+ D +L EIK+++ +
Sbjct: 3 LGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRL--- 59
Query: 471 DPADEHHILRLYDYF--------------YHLEHLFIVCELLRANLYEFQKFNQESGGEA 516
D +I+++Y+ L ++IV E + +L Q E
Sbjct: 60 ---DHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANV--LEQGPLSEE 114
Query: 517 YFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF---- 572
+ L Q L L+Y+HS ++H DLKP N+ I + +KI D G +
Sbjct: 115 HARL-----FMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLV-LKIGDFGLARIVDPH 168
Query: 573 --QTDNLCLYVQSRSYRAPEVIIGLP--YDQKIDLWSLGCILAELWTG 616
L + ++ YR+P +++ P Y + ID+W+ GCI AE+ TG
Sbjct: 169 YSHKGYLSEGLVTKWYRSPRLLLS-PNNYTKAIDMWAAGCIFAEMLTG 215
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 78.7 bits (195), Expect = 3e-16
Identities = 54/219 (24%), Positives = 85/219 (38%), Gaps = 49/219 (22%)
Query: 422 LGSAAFSKVFQA----QDLHTGVDVCLKIIKND------KDFFDQSLDEIKLLKLVNKND 471
LG AF +V++ T V +K +K ++F L+E ++K +
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEF----LEEASIMKKL---- 58
Query: 472 PADEHHILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQC 530
+I+RL E L+IV E + +L +F + + E TL L + Q
Sbjct: 59 --SHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEK-----LTLKDLLQMALQI 111
Query: 531 LEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSY---- 586
+ +EYL S +H DL N L+ KI D G L + Y
Sbjct: 112 AKGMEYLESKNFVHRDLAARNCLVTENLVV--KISDFG--------LSRDIYEDDYYRKR 161
Query: 587 ---------RAPEVIIGLPYDQKIDLWSLGCILAELWTG 616
APE + + K D+WS G +L E++T
Sbjct: 162 GGGKLPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTL 200
|
Length = 258 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 3e-16
Identities = 63/215 (29%), Positives = 104/215 (48%), Gaps = 28/215 (13%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVD-VCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPA 473
+Y +G A+ KVF+A+DL G V LK ++ L I+ + ++ +
Sbjct: 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 61
Query: 474 DEHHILRLYDYFYHLEHLFIVCELLRAN-----LYEFQKFNQ------ESGGEAYFTLGR 522
+ +++RL+D VC + R + F+ +Q + E
Sbjct: 62 EHPNVVRLFD----------VCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTET 111
Query: 523 LQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS---CFQTDNLCL 579
++ + Q L L++LHS ++H DLKP+NIL+ S +IK+ D G + FQ L
Sbjct: 112 IKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTS--SGQIKLADFGLARIYSFQM-ALTS 168
Query: 580 YVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELW 614
V + YRAPEV++ Y +DLWS+GCI AE++
Sbjct: 169 VVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 1e-15
Identities = 63/239 (26%), Positives = 103/239 (43%), Gaps = 48/239 (20%)
Query: 412 IAGRY-YVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKN---------DKDFFDQ----- 456
I+ RY +LG + KV +A D TG V +K +K D+
Sbjct: 6 ISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHF 65
Query: 457 -SLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE 515
+L E+K++ + +I+ L D + + + +V +++ ++L + +++
Sbjct: 66 TTLRELKIMNEIK------HENIMGLVDVYVEGDFINLVMDIMASDLKKV--VDRK---- 113
Query: 516 AYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG-SSCFQT 574
T +++ I Q L L LH +H DL P NI I S C KI D G + +
Sbjct: 114 IRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGIC--KIADFGLARRYGY 171
Query: 575 DNLC------LYVQSRS----------YRAPEVIIGLP-YDQKIDLWSLGCILAELWTG 616
+Q R YRAPE+++G Y +D+WS+GCI AEL TG
Sbjct: 172 PPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTG 230
|
Length = 335 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 1e-15
Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 29/212 (13%)
Query: 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQS----LDEIKLLKLVNKND 471
+ + +G AF KV Q T +K + K S L+E ++L+ +N
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP- 60
Query: 472 PADEHHILRLYDYFYHLEHLFIVCEL-----LRANLYEFQKFNQESGGEAYFTLGRLQVI 526
++ L+ F E++++V +L LR +L + KF++E +++
Sbjct: 61 -----FLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEE----------QVKFW 105
Query: 527 TRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL--YVQSR 584
+ + ALEYLHS GIIH D+KP+NIL+ ++ + I D + T + +
Sbjct: 106 ICEIVLALEYLHSKGIIHRDIKPDNILLD--EQGHVHITDFNIATKVTPDTLTTSTSGTP 163
Query: 585 SYRAPEVIIGLPYDQKIDLWSLGCILAELWTG 616
Y APEV+ Y +D WSLG E G
Sbjct: 164 GYMAPEVLCRQGYSVAVDWWSLGVTAYECLRG 195
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 1e-15
Identities = 65/216 (30%), Positives = 99/216 (45%), Gaps = 25/216 (11%)
Query: 416 YYVTEYLGSAAFSKVFQAQDLHTGVD-VCLKII----------KNDKD-FFDQSLDEIKL 463
Y V E+LGS AF V++ + + G + + LK I K ++D + E+ +
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61
Query: 464 LK--LVNKNDPADEHHILRLYDYFYHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTL 520
+K L + N I+R Y F + L+IV +L+ A L E +E FT
Sbjct: 62 IKEQLRHPN-------IVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQR--FTE 112
Query: 521 GRLQVITRQCLEALEYLH-SLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL 579
R+ I Q + AL YLH I+H DL P NI++ + I L L
Sbjct: 113 ERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTS 172
Query: 580 YVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT 615
V + Y PE++ PY +K D+W+ GCIL ++ T
Sbjct: 173 VVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCT 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 1e-15
Identities = 63/206 (30%), Positives = 95/206 (46%), Gaps = 25/206 (12%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD----EIKLLKLVNKNDPADEHH 477
LG +F KVF A+ T +K +K D D ++ E ++L L A EH
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSL------AWEHP 56
Query: 478 IL-RLYDYFYHLEHLFIVCELLRAN--LYEFQKFNQESGGEAYFTLGRLQVITRQCLEAL 534
L LY F E+LF V E L ++ Q ++ F L R + + L
Sbjct: 57 FLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHK-------FDLPRATFYAAEIICGL 109
Query: 535 EYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG---SSCFQTDNLCLYVQSRSYRAPEV 591
++LHS GI++ DLK +NIL+ IKI D G + C + + Y APE+
Sbjct: 110 QFLHSKGIVYRDLKLDNILLD--TDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEI 167
Query: 592 IIGLPYDQKIDLWSLGCILAELWTGE 617
++G Y+ +D WS G +L E+ G+
Sbjct: 168 LLGQKYNTSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.3 bits (191), Expect = 2e-15
Identities = 65/233 (27%), Positives = 93/233 (39%), Gaps = 61/233 (26%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLK-----LVNKNDPADEH 476
+G AF +V+ +D TG +K+++ D + ++I ++ L + + P
Sbjct: 9 IGRGAFGEVWLVRDKDTGQVYAMKVLRK-SDMIKR--NQIAHVRAERDILADADSP---- 61
Query: 477 HILRLYDYFYHLEHLFIVCEL-----LRANLYEFQKFNQESGGEAYFTLGRLQVITRQCL 531
I++LY F EHL++V E L L F +E A F I L
Sbjct: 62 WIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEE---TARF------YIAELVL 112
Query: 532 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS--------------CFQTDNL 577
AL+ +H LG IH D+KP+NILI + IK+ D G
Sbjct: 113 -ALDSVHKLGFIHRDIKPDNILIDA--DGHIKLADFGLCKKMNKAKDREYYLNDSHNLLF 169
Query: 578 CLYVQSR------------------SYRAPEVIIGLPYDQKIDLWSLGCILAE 612
V R Y APEV+ G PY + D WSLG IL E
Sbjct: 170 RDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYE 222
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 2e-15
Identities = 63/205 (30%), Positives = 91/205 (44%), Gaps = 29/205 (14%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLK------LVNKNDPADE 475
+G + +VF A+ TG V LK +K K L+E++ + K++
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMK--KSLL-FKLNEVRHVLTERDILTTTKSE---- 61
Query: 476 HHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESG----GEAYFTLGRLQVITRQCL 531
+++L F E+L++ E + +F+ G A F + +
Sbjct: 62 -WLVKLLYAFQDDEYLYLAMEYVPGG--DFRTLLNNLGVLSEDHARFYMAEM-------F 111
Query: 532 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEV 591
EA++ LH LG IH DLKPEN LI IK+ D G S V S Y APEV
Sbjct: 112 EAVDALHELGYIHRDLKPENFLID--ASGHIKLTDFGLSKGIVTYANSVVGSPDYMAPEV 169
Query: 592 IIGLPYDQKIDLWSLGCILAELWTG 616
+ G YD +D WSLGC+L E G
Sbjct: 170 LRGKGYDFTVDYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.0 bits (188), Expect = 2e-15
Identities = 51/219 (23%), Positives = 87/219 (39%), Gaps = 40/219 (18%)
Query: 420 EYLGSAAFSKVFQA---QDLHTGVDVCLKIIKNDKDFFDQS--LDEIKLLKLVNKNDPAD 474
+ LG AF +V++ +V +K +K D ++ L E +++K +
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLG------ 54
Query: 475 EH-HILRLYDYFYHLEHLFIVCELL-RANLYEF---QKFNQESGGEAYFTLGRLQVITRQ 529
H +++RL E L++V E + +L ++ + S ++ +L L Q
Sbjct: 55 -HPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQ 113
Query: 530 CLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR-- 587
+ +EYL S +H DL N L+ KI D G L V Y
Sbjct: 114 IAKGMEYLASKKFVHRDLAARNCLVGEDLVV--KISDFG--------LSRDVYDDDYYRK 163
Query: 588 -----------APEVIIGLPYDQKIDLWSLGCILAELWT 615
APE + + K D+WS G +L E++T
Sbjct: 164 KTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFT 202
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 3e-15
Identities = 61/219 (27%), Positives = 99/219 (45%), Gaps = 40/219 (18%)
Query: 415 RYYVTEY--LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSL-DEIKLLKLVNKND 471
R Y+ + +G + V A D TG V +K + K + L +E+ +++
Sbjct: 18 RSYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMR------ 71
Query: 472 PADEHH--ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEA--YFTLGRLQ--- 524
D H I+ +Y + + L++V E L GG T R+
Sbjct: 72 --DYQHPNIVEMYSSYLVGDELWVVMEFL-------------EGGALTDIVTHTRMNEEQ 116
Query: 525 --VITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC---- 578
+ L+AL +LH+ G+IH D+K ++IL+ S R +K+ D G C Q
Sbjct: 117 IATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGR--VKLSDFG-FCAQVSKEVPRRK 173
Query: 579 LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGE 617
V + + APEVI LPY ++D+WSLG ++ E+ GE
Sbjct: 174 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.4 bits (186), Expect = 5e-15
Identities = 60/234 (25%), Positives = 97/234 (41%), Gaps = 52/234 (22%)
Query: 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDP 472
G + + E +G + KV++A+ TG V +KI+ +D ++ +E +L+
Sbjct: 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILR-----KY 59
Query: 473 ADEHHILRLYDYFYHLEH------LFIVCELLRA----NLYEFQKFNQESGGE---AYFT 519
++ +I Y F L++V EL +L + + + E AY
Sbjct: 60 SNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAY-- 117
Query: 520 LGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL 579
I R+ L L YLH +IH D+K +NIL+ E+K++D G +
Sbjct: 118 ------ILRETLRGLAYLHENKVIHRDIKGQNILLTK--NAEVKLVDFG--------VSA 161
Query: 580 YVQSRSYR-----------APEVII-----GLPYDQKIDLWSLGCILAELWTGE 617
+ S R APEVI YD + D+WSLG EL G+
Sbjct: 162 QLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGK 215
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 7e-15
Identities = 56/204 (27%), Positives = 93/204 (45%), Gaps = 12/204 (5%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPAD 474
+Y V +G +F + Q +++ +K I+ K + + L P
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHP-- 58
Query: 475 EHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEAL 534
+I+ + F HL+IV E QK + G + + LQ + CL +
Sbjct: 59 --NIVAFKESFEADGHLYIVMEYCDGGDL-MQKIKLQRG-KLFPEDTILQWFVQMCL-GV 113
Query: 535 EYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNL---CLYVQSRSYRAPEV 591
+++H ++H D+K +NI + Q ++K+ D GS+ T C YV + Y PE+
Sbjct: 114 QHIHEKRVLHRDIKSKNIFLT--QNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEI 171
Query: 592 IIGLPYDQKIDLWSLGCILAELWT 615
+PY+ K D+WSLGCIL EL T
Sbjct: 172 WENMPYNNKSDIWSLGCILYELCT 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 1e-14
Identities = 59/204 (28%), Positives = 94/204 (46%), Gaps = 15/204 (7%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKND 471
+Y +G AF V + V +K I + KD + +E ++LKL++ +
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60
Query: 472 PADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCL 531
I+ Y+ F + L IV E ++ Q+ L Q L
Sbjct: 61 ------IIEYYENFLEDKALMIVMEYAPGGTLA--EYIQKRCNSLLDEDTILHFFV-QIL 111
Query: 532 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLY--VQSRSYRAP 589
AL ++H+ I+H DLK +NIL+ ++ +KI D G S + Y V + Y +P
Sbjct: 112 LALHHVHTKLILHRDLKTQNILLDKHKMV-VKIGDFGISKILSSKSKAYTVVGTPCYISP 170
Query: 590 EVIIGLPYDQKIDLWSLGCILAEL 613
E+ G PY+QK D+W+LGC+L EL
Sbjct: 171 ELCEGKPYNQKSDIWALGCVLYEL 194
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 2e-14
Identities = 63/216 (29%), Positives = 103/216 (47%), Gaps = 36/216 (16%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSL--DEIKLLKLVNKNDP 472
+Y E +G A V+ A D+ TG +V +K + N + + L +EI +++ NK+
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQM-NLQQQPKKELIINEILVMR-ENKHP- 76
Query: 473 ADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGG-------EAYFTLGRLQV 525
+I+ D + + L++V E L +GG E G++
Sbjct: 77 ----NIVNYLDSYLVGDELWVVMEYL-------------AGGSLTDVVTETCMDEGQIAA 119
Query: 526 ITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQ----TDNLCLYV 581
+ R+CL+ALE+LHS +IH D+K +NIL+ +K+ D G C Q V
Sbjct: 120 VCRECLQALEFLHSNQVIHRDIKSDNILLG--MDGSVKLTDFG-FCAQITPEQSKRSTMV 176
Query: 582 QSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGE 617
+ + APEV+ Y K+D+WSLG + E+ GE
Sbjct: 177 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 3e-14
Identities = 63/207 (30%), Positives = 93/207 (44%), Gaps = 30/207 (14%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKN----DKDFFDQSLDEIKLLKLVNKNDPADEHH 477
+G +F KV Q + T LK I+ + +L E +L VN P
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVN--CP----F 54
Query: 478 ILRLYDYFYHLEHLFIVCELLRAN--LYEFQKFNQESGGEAYFTLGRLQVITRQCLEALE 535
I+ L F E L++V + + Q+ E F L R + T + L ALE
Sbjct: 55 IVPLKFSFQSPEKLYLVLAFINGGELFHHLQR-------EGRFDLSRARFYTAELLCALE 107
Query: 536 YLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG------SSCFQTDNLCLYVQSRSYRAP 589
LH +I+ DLKPENIL+ YQ I + D G +T+ C + Y AP
Sbjct: 108 NLHKFNVIYRDLKPENILL-DYQG-HIALCDFGLCKLNMKDDDKTNTFC---GTPEYLAP 162
Query: 590 EVIIGLPYDQKIDLWSLGCILAELWTG 616
E+++G Y + +D W+LG +L E+ TG
Sbjct: 163 ELLLGHGYTKAVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 7e-14
Identities = 60/211 (28%), Positives = 94/211 (44%), Gaps = 32/211 (15%)
Query: 420 EYLGSAAFSKVFQAQDLHTGVDVCLK---IIKNDKDFFD---QSLDEIKLL-KLVNKNDP 472
E LGS +F V++ +L G +K + + + + Q EI LL KL + N
Sbjct: 6 ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPN-- 63
Query: 473 ADEHHILRLYDYFYHLEHLFIVCELLR----ANLYEFQKFNQESGGEAYFTLGRLQVITR 528
I++ ++L+I EL+ A L +K+ F +++ TR
Sbjct: 64 -----IVQYLGTEREEDNLYIFLELVPGGSLAKLL--KKYGS-------FPEPVIRLYTR 109
Query: 529 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL--YVQSRSY 586
Q L LEYLH +H D+K NIL+ + +K+ D G + + + S +
Sbjct: 110 QILLGLEYLHDRNTVHRDIKGANILVDT--NGVVKLADFGMAKQVVEFSFAKSFKGSPYW 167
Query: 587 RAPEVIIGL-PYDQKIDLWSLGCILAELWTG 616
APEVI Y D+WSLGC + E+ TG
Sbjct: 168 MAPEVIAQQGGYGLAADIWSLGCTVLEMATG 198
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 9e-14
Identities = 58/201 (28%), Positives = 90/201 (44%), Gaps = 17/201 (8%)
Query: 422 LGSAAFSKVFQAQDLHTG-VDVCLKIIKN---DKDFFDQSLDEIKLLKLVNKNDPADEHH 477
LG F +V Q TG + C K+ K + +L+E K+L+ V+
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSS------RF 54
Query: 478 ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYL 537
I+ L F + L +V L+ ++ +N GE F R Q + LE+L
Sbjct: 55 IVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNV---GEPGFPEARAIFYAAQIICGLEHL 111
Query: 538 HSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL--YVQSRSYRAPEVIIGL 595
H I++ DLKPEN+L+ + +I DLG + + + Y APEV+ G
Sbjct: 112 HQRRIVYRDLKPENVLLDDHGNV--RISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGE 169
Query: 596 PYDQKIDLWSLGCILAELWTG 616
YD +D ++LGC L E+ G
Sbjct: 170 VYDFSVDWFALGCTLYEMIAG 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 71.7 bits (175), Expect = 1e-13
Identities = 63/209 (30%), Positives = 98/209 (46%), Gaps = 22/209 (10%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQ-SLDEIKLLK-LVNKNDP 472
+Y E +G A VF A D+ TG +V +K I K + ++EI ++K L N N
Sbjct: 20 KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPN-- 77
Query: 473 ADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLE 532
I+ D F + LF+V E L + E ++ + R+CL+
Sbjct: 78 -----IVNFLDSFLVGDELFVVMEYLAGGSL------TDVVTETCMDEAQIAAVCRECLQ 126
Query: 533 ALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQ----TDNLCLYVQSRSYRA 588
ALE+LH+ +IH D+K +N+L+ +K+ D G C Q V + + A
Sbjct: 127 ALEFLHANQVIHRDIKSDNVLLG--MDGSVKLTDFG-FCAQITPEQSKRSTMVGTPYWMA 183
Query: 589 PEVIIGLPYDQKIDLWSLGCILAELWTGE 617
PEV+ Y K+D+WSLG + E+ GE
Sbjct: 184 PEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 1e-13
Identities = 64/203 (31%), Positives = 93/203 (45%), Gaps = 19/203 (9%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD----EIKLLKLVNKNDPADEHH 477
LG +F KV A+ G +K +K D D ++ E ++L L +N P H
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWEN-PFLTH- 60
Query: 478 ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYL 537
LY F EHLF V E L F Q+ G F L R + + L++L
Sbjct: 61 ---LYCTFQTKEHLFFVMEFLNGGDLMFHI--QDKG---RFDLYRATFYAAEIVCGLQFL 112
Query: 538 HSLGIIHCDLKPENILIKSYQRCEIKIIDLG---SSCFQTDNLCLYVQSRSYRAPEVIIG 594
HS GII+ DLK +N+++ IKI D G + F + + + Y APE++ G
Sbjct: 113 HSKGIIYRDLKLDNVMLDRDGH--IKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQG 170
Query: 595 LPYDQKIDLWSLGCILAELWTGE 617
L Y +D WS G +L E+ G+
Sbjct: 171 LKYTFSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 1e-13
Identities = 59/207 (28%), Positives = 102/207 (49%), Gaps = 19/207 (9%)
Query: 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK--NDKDFFDQSLDEIKLLKLVNKNDPA 473
Y + LG ++ VF+ + T V LK I+ +++ ++ E+ LLK + +
Sbjct: 7 YVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHAN-- 64
Query: 474 DEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEA 533
I+ L+D + L +V E L ++L +++ G ++ +++ Q L
Sbjct: 65 ----IVTLHDIIHTERCLTLVFEYLDSDL---KQYLDNCGN--LMSMHNVKIFMFQLLRG 115
Query: 534 LEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG---SSCFQTDNLCLYVQSRSYRAPE 590
L Y H I+H DLKP+N+LI ++ E+K+ D G + T V + YR P+
Sbjct: 116 LSYCHKRKILHRDLKPQNLLIN--EKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPD 173
Query: 591 VIIG-LPYDQKIDLWSLGCILAELWTG 616
V++G Y ID+W +GCIL E+ TG
Sbjct: 174 VLLGSTEYSTPIDMWGVGCILYEMATG 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 2e-13
Identities = 55/205 (26%), Positives = 92/205 (44%), Gaps = 23/205 (11%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD----EIKLLKLVNKNDPADEHH 477
LG +F KV A+ T +KI+K D D ++ E ++L L P
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLAL-----PGKPPF 62
Query: 478 ILRLYDYFYHLEHLFIVCELLRAN--LYEFQKFNQESGGEAYFTLGRLQVITRQCLEALE 535
+ +L+ F ++ L+ V E + +Y Q+ + A F + + L
Sbjct: 63 LTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAI-------GLF 115
Query: 536 YLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG---SSCFQTDNLCLYVQSRSYRAPEVI 592
+LHS GII+ DLK +N+++ + IKI D G + F + + Y APE+I
Sbjct: 116 FLHSKGIIYRDLKLDNVMLDA--EGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEII 173
Query: 593 IGLPYDQKIDLWSLGCILAELWTGE 617
PY + +D W+ G +L E+ G+
Sbjct: 174 AYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 2e-13
Identities = 62/209 (29%), Positives = 96/209 (45%), Gaps = 31/209 (14%)
Query: 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIK-LLKLVNKNDPADEHHI 478
E +G +F +VF+ D T V +KII +++ DEI+ + + + D ++
Sbjct: 10 EKIGKGSFGEVFKGIDNRTQKVVAIKIID-----LEEAEDEIEDIQQEITVLSQCDSPYV 64
Query: 479 LRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTL-------GRLQVITRQCL 531
+ Y + L+I+ E L GG A L ++ I R+ L
Sbjct: 65 TKYYGSYLKDTKLWIIMEYL-------------GGGSALDLLEPGPLDETQIATILREIL 111
Query: 532 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC---LYVQSRSYRA 588
+ L+YLHS IH D+K N+L+ + E+K+ D G + TD +V + + A
Sbjct: 112 KGLDYLHSEKKIHRDIKAANVLLSEHG--EVKLADFGVAGQLTDTQIKRNTFVGTPFWMA 169
Query: 589 PEVIIGLPYDQKIDLWSLGCILAELWTGE 617
PEVI YD K D+WSLG EL GE
Sbjct: 170 PEVIKQSAYDSKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 2e-13
Identities = 62/215 (28%), Positives = 102/215 (47%), Gaps = 32/215 (14%)
Query: 415 RYYVTEYL--GSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDP 472
R Y+ ++ G + V A + HTG V +K + D Q E+ ++V D
Sbjct: 21 REYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKM----DLRKQQRRELLFNEVVIMRD- 75
Query: 473 ADEHH--ILRLYDYFYHLEHLFIVCELLRA----NLYEFQKFNQESGGEAYFTLGRLQVI 526
HH ++ +Y+ + + L++V E L ++ + N+E ++ +
Sbjct: 76 --YHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEE----------QIATV 123
Query: 527 TRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC----LYVQ 582
L AL YLH+ G+IH D+K ++IL+ S R IK+ D G C Q V
Sbjct: 124 CLSVLRALSYLHNQGVIHRDIKSDSILLTSDGR--IKLSDFGF-CAQVSKEVPKRKSLVG 180
Query: 583 SRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGE 617
+ + APEVI LPY ++D+WSLG ++ E+ GE
Sbjct: 181 TPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGE 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 3e-13
Identities = 57/209 (27%), Positives = 94/209 (44%), Gaps = 31/209 (14%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHH 477
LG +F KV A+ T +K++K D D + ++ E ++L L K H
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGK------HP 56
Query: 478 IL-RLYDYFYHLEHLFIVCELLRAN--LYEFQKFNQESGGEAYFTLGRLQVITRQCLEAL 534
L +L+ F + LF V E + ++ Q+ + A F + + L
Sbjct: 57 FLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVL-------GL 109
Query: 535 EYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS------YRA 588
++LH GII+ DLK +N+L+ S IKI D G + + V + + Y A
Sbjct: 110 QFLHERGIIYRDLKLDNVLLDS--EGHIKIADFGMC---KEGILGGVTTSTFCGTPDYIA 164
Query: 589 PEVIIGLPYDQKIDLWSLGCILAELWTGE 617
PE++ PY +D W+LG +L E+ G+
Sbjct: 165 PEILSYQPYGPAVDWWALGVLLYEMLAGQ 193
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 4e-13
Identities = 63/207 (30%), Positives = 91/207 (43%), Gaps = 27/207 (13%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHH 477
LG +F KV A+ T +K +K D D + ++ E ++L L A EH
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLAL------AWEHP 56
Query: 478 IL-RLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEY 536
L L+ F EHLF V E L F Q SG F R + + + L++
Sbjct: 57 FLTHLFCTFQTKEHLFFVMEYLNGGDLMFHI--QSSG---RFDEARARFYAAEIICGLQF 111
Query: 537 LHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQ------TDNLCLYVQSRSYRAPE 590
LH GII+ DLK +N+L+ IKI D G C + Y APE
Sbjct: 112 LHKKGIIYRDLKLDNVLLDKDGH--IKIADFGMCKENMNGEGKASTFC---GTPDYIAPE 166
Query: 591 VIIGLPYDQKIDLWSLGCILAELWTGE 617
++ G Y++ +D WS G +L E+ G+
Sbjct: 167 ILKGQKYNESVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 4e-13
Identities = 40/99 (40%), Positives = 54/99 (54%), Gaps = 13/99 (13%)
Query: 528 RQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR 587
RQ L+ L YLH+ GIIH D+K NIL+ + + IKI D G S N L ++ R
Sbjct: 113 RQILKGLNYLHNRGIIHRDIKGANILVDN--KGGIKISDFGISKKLEANS-LSTKTNGAR 169
Query: 588 ----------APEVIIGLPYDQKIDLWSLGCILAELWTG 616
APEV+ Y +K D+WSLGC++ E+ TG
Sbjct: 170 PSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTG 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 4e-13
Identities = 64/209 (30%), Positives = 98/209 (46%), Gaps = 31/209 (14%)
Query: 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIK-LLKLVNKNDPADEHHI 478
E +G +F +V++ D T V +KII +++ DEI+ + + + D +I
Sbjct: 10 ERIGKGSFGEVYKGIDNRTKEVVAIKIID-----LEEAEDEIEDIQQEITVLSQCDSPYI 64
Query: 479 LRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTL--GRLQ-----VITRQCL 531
R Y + L+I+ E L GG A L G L+ I R+ L
Sbjct: 65 TRYYGSYLKGTKLWIIMEYL-------------GGGSALDLLKPGPLEETYIATILREIL 111
Query: 532 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC---LYVQSRSYRA 588
+ L+YLHS IH D+K N+L+ ++ ++K+ D G + TD +V + + A
Sbjct: 112 KGLDYLHSERKIHRDIKAANVLLS--EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMA 169
Query: 589 PEVIIGLPYDQKIDLWSLGCILAELWTGE 617
PEVI YD K D+WSLG EL GE
Sbjct: 170 PEVIKQSAYDFKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 69.4 bits (169), Expect = 6e-13
Identities = 58/207 (28%), Positives = 96/207 (46%), Gaps = 18/207 (8%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPAD 474
+Y E +G A V+ A D+ TG +V +K + + + + L+ NKN
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNP--- 76
Query: 475 EHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEAL 534
+I+ D + + L++V E L + E G++ + R+CL+AL
Sbjct: 77 --NIVNYLDSYLVGDELWVVMEYLAGGSL------TDVVTETCMDEGQIAAVCRECLQAL 128
Query: 535 EYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQ----TDNLCLYVQSRSYRAPE 590
++LHS +IH D+K +NIL+ +K+ D G C Q V + + APE
Sbjct: 129 DFLHSNQVIHRDIKSDNILLG--MDGSVKLTDFG-FCAQITPEQSKRSTMVGTPYWMAPE 185
Query: 591 VIIGLPYDQKIDLWSLGCILAELWTGE 617
V+ Y K+D+WSLG + E+ GE
Sbjct: 186 VVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 69.4 bits (169), Expect = 6e-13
Identities = 58/207 (28%), Positives = 96/207 (46%), Gaps = 18/207 (8%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPAD 474
+Y E +G A V+ A D+ TG +V ++ + + + + L+ NKN
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNP--- 77
Query: 475 EHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEAL 534
+I+ D + + L++V E L + E G++ + R+CL+AL
Sbjct: 78 --NIVNYLDSYLVGDELWVVMEYLAGGSL------TDVVTETCMDEGQIAAVCRECLQAL 129
Query: 535 EYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQ----TDNLCLYVQSRSYRAPE 590
E+LHS +IH D+K +NIL+ +K+ D G C Q V + + APE
Sbjct: 130 EFLHSNQVIHRDIKSDNILLG--MDGSVKLTDFG-FCAQITPEQSKRSTMVGTPYWMAPE 186
Query: 591 VIIGLPYDQKIDLWSLGCILAELWTGE 617
V+ Y K+D+WSLG + E+ GE
Sbjct: 187 VVTRKAYGPKVDIWSLGIMAIEMIEGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 1e-12
Identities = 57/210 (27%), Positives = 91/210 (43%), Gaps = 23/210 (10%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPA- 473
RY + + LG +F V+ +D + LK++K + + E+ + V N A
Sbjct: 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLK------EIPVGELNPNETVQANQEAQ 54
Query: 474 -----DEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITR 528
D I++ + F + I+ E + + + G+ TL QV
Sbjct: 55 LLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGK---TLSENQVCEW 111
Query: 529 --QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF---QTDNLCLYVQS 583
Q L + Y+H I+H DLK +NI +K+ +KI D G S D + +
Sbjct: 112 FIQLLLGVHYMHQRRILHRDLKAKNIFLKNNL---LKIGDFGVSRLLMGSCDLATTFTGT 168
Query: 584 RSYRAPEVIIGLPYDQKIDLWSLGCILAEL 613
Y +PE + YD K D+WSLGCIL E+
Sbjct: 169 PYYMSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 1e-12
Identities = 64/217 (29%), Positives = 95/217 (43%), Gaps = 45/217 (20%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSL-DEIKLLK-LVNKNDPADEHHIL 479
LG + V+ A+DL T V + +K I + Q L +EI L L ++N I+
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRN-------IV 68
Query: 480 RLYDYFYHLEHLFIVCE---------LLRANLYEFQKFNQESGGEAYFTLGRLQVITRQC 530
+ I E LLR+ K+ E + T+Q
Sbjct: 69 QYLGSDSENGFFKIFMEQVPGGSLSALLRS------KWGPLKDNEQ-----TIIFYTKQI 117
Query: 531 LEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS--------CFQTDNLCLYVQ 582
LE L+YLH I+H D+K +N+L+ +Y +KI D G+S C +T +
Sbjct: 118 LEGLKYLHDNQIVHRDIKGDNVLVNTYSGV-VKISDFGTSKRLAGINPCTET-----FTG 171
Query: 583 SRSYRAPEVIIGLP--YDQKIDLWSLGCILAELWTGE 617
+ Y APEVI P Y D+WSLGC + E+ TG+
Sbjct: 172 TLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 1e-12
Identities = 38/107 (35%), Positives = 55/107 (51%), Gaps = 23/107 (21%)
Query: 520 LGRLQV--ITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNL 577
LG QV + RQ L A++Y+H GIIH D+K EN+L+ + +I + D G++CF
Sbjct: 257 LGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPE--DICLGDFGAACFARG-- 312
Query: 578 CLYVQSRS------------YRAPEVIIGLPYDQKIDLWSLGCILAE 612
S S APEV+ G PY +D+WS G ++ E
Sbjct: 313 -----SWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 62/217 (28%), Positives = 102/217 (47%), Gaps = 31/217 (14%)
Query: 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKII--KNDKDFFDQSLDEIKLLK-LVNK 469
A Y E LG +++ V++ G V LK+I K ++ ++ E LLK L +
Sbjct: 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHA 63
Query: 470 NDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQ 529
N I+ L+D + E L V E + +L ++ Q GG + + ++ Q
Sbjct: 64 N-------IVLLHDIIHTKETLTFVFEYMHTDLAQY--MIQHPGGLHPYNV---RLFMFQ 111
Query: 530 CLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG--------SSCFQTDNLCLYV 581
L L Y+H I+H DLKP+N+LI E+K+ D G S + ++ + L+
Sbjct: 112 LLRGLAYIHGQHILHRDLKPQNLLISYLG--ELKLADFGLARAKSIPSQTYSSEVVTLW- 168
Query: 582 QSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGE 617
YR P+V++G Y +D+W GCI E+ G+
Sbjct: 169 ----YRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 60/209 (28%), Positives = 103/209 (49%), Gaps = 23/209 (11%)
Query: 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK--NDKDFFDQSLDEIKLLKLVNKNDPA 473
Y E LG ++ VF+ + T V LK I+ +++ ++ E+ LLK
Sbjct: 8 YIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLK-------- 59
Query: 474 DEHH--ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCL 531
D H I+ L+D + + L +V E L +L +++ + G ++ +++ Q L
Sbjct: 60 DLKHANIVTLHDIVHTDKSLTLVFEYLDKDL---KQYMDDCG--NIMSMHNVKIFLYQIL 114
Query: 532 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG---SSCFQTDNLCLYVQSRSYRA 588
L Y H ++H DLKP+N+LI +R E+K+ D G + T V + YR
Sbjct: 115 RGLAYCHRRKVLHRDLKPQNLLIN--ERGELKLADFGLARAKSVPTKTYSNEVVTLWYRP 172
Query: 589 PEVIIGLP-YDQKIDLWSLGCILAELWTG 616
P+V++G Y +ID+W +GCI E+ +G
Sbjct: 173 PDVLLGSSEYSTQIDMWGVGCIFFEMASG 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 2e-12
Identities = 60/221 (27%), Positives = 97/221 (43%), Gaps = 42/221 (19%)
Query: 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK----NDKDFFDQSLDEIKLL-KLVNKN 470
Y V E +G +F V + + G + K I +K+ Q + E+ +L +L + N
Sbjct: 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEK-QQLVSEVNILRELKHPN 60
Query: 471 DPADEHHILRLYDYFYHLEH--LFIVCEL-----LRANLYEFQKFNQESGGEAYFTLGRL 523
I+R YD + L+IV E L + + +K + Y +
Sbjct: 61 -------IVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERK------YIEEEFI 107
Query: 524 QVITRQCLEALEYLHSLG-----IIHCDLKPENILIKSYQRCEI------KIIDLGSSCF 572
I Q L AL H+ ++H DLKP NI + + ++ KI+ SS
Sbjct: 108 WRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFA 167
Query: 573 QTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAEL 613
+T YV + Y +PE + + YD+K D+WSLGC++ EL
Sbjct: 168 KT-----YVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYEL 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 2e-12
Identities = 63/209 (30%), Positives = 89/209 (42%), Gaps = 33/209 (15%)
Query: 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHIL 479
E LG+ +F +V A+ TG +K +K EI +K V H+
Sbjct: 24 ETLGTGSFGRVRIAKHKGTGEYYAIKCLKKR---------EILKMKQVQ--------HVA 66
Query: 480 RLYDYFYHLEHLFIV---CELLRAN-LYEFQKFNQESGGEAYFTL---GRL--QVITRQC 530
+ L H FIV C N +Y +F GGE + L GR V
Sbjct: 67 QEKSILMELSHPFIVNMMCSFQDENRVYFLLEF--VVGGELFTHLRKAGRFPNDVAKFYH 124
Query: 531 LE---ALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR 587
E A EYLHS II+ DLKPEN+L+ + +K+ D G + D + Y
Sbjct: 125 AELVLAFEYLHSKDIIYRDLKPENLLLD--NKGHVKVTDFGFAKKVPDRTFTLCGTPEYL 182
Query: 588 APEVIIGLPYDQKIDLWSLGCILAELWTG 616
APEVI + + +D W++G +L E G
Sbjct: 183 APEVIQSKGHGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 2e-12
Identities = 61/212 (28%), Positives = 99/212 (46%), Gaps = 37/212 (17%)
Query: 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIK-LLKLVNKNDPADEHHI 478
E +G +F +VF+ D T V +KII +++ DEI+ + + + D ++
Sbjct: 10 ERIGKGSFGEVFKGIDNRTQQVVAIKIID-----LEEAEDEIEDIQQEITVLSQCDSPYV 64
Query: 479 LRLYDYFYHLEHLFIVCE---------LLRANLY-EFQKFNQESGGEAYFTLGRLQVITR 528
+ Y + L+I+ E LLRA + EFQ + + +
Sbjct: 65 TKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQ----------------IATMLK 108
Query: 529 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC---LYVQSRS 585
+ L+ L+YLHS IH D+K N+L+ ++ ++K+ D G + TD +V +
Sbjct: 109 EILKGLDYLHSEKKIHRDIKAANVLLS--EQGDVKLADFGVAGQLTDTQIKRNTFVGTPF 166
Query: 586 YRAPEVIIGLPYDQKIDLWSLGCILAELWTGE 617
+ APEVI YD K D+WSLG EL GE
Sbjct: 167 WMAPEVIQQSAYDSKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 42/116 (36%), Positives = 59/116 (50%), Gaps = 13/116 (11%)
Query: 512 SGGEAYFTLG--------RLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 563
+GGE +F L R + + AL YLHS+ I++ DLKPENIL+ S + +
Sbjct: 79 NGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDS--QGHVV 136
Query: 564 IIDLG---SSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTG 616
+ D G Q+D + + Y APEVI PYD +D W LG +L E+ G
Sbjct: 137 LTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 3e-12
Identities = 42/119 (35%), Positives = 62/119 (52%), Gaps = 16/119 (13%)
Query: 512 SGGE--------AYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 563
+GGE +FT ++V + + AL++LH LGII+ D+K ENIL+ S +
Sbjct: 88 NGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDS--EGHVV 145
Query: 564 IIDLG-SSCFQTDNL---CLYVQSRSYRAPEVIIGLP--YDQKIDLWSLGCILAELWTG 616
+ D G S F + + + Y APEVI G +D+ +D WSLG + EL TG
Sbjct: 146 LTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 3e-12
Identities = 41/126 (32%), Positives = 72/126 (57%), Gaps = 9/126 (7%)
Query: 501 NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILI--KSYQ 558
++ +F + ++ + G ++ + Q L+ + YLH+ ++H DLKP NIL+ + +
Sbjct: 88 HIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPE 147
Query: 559 RCEIKIIDLG-SSCFQTD-----NLCLYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILA 611
R +KI D+G + F + +L V + YRAPE+++G Y + ID+W++GCI A
Sbjct: 148 RGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFA 207
Query: 612 ELWTGE 617
EL T E
Sbjct: 208 ELLTSE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 4e-12
Identities = 58/215 (26%), Positives = 102/215 (47%), Gaps = 29/215 (13%)
Query: 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK--NDKDFFDQSLDEIKLLKLVNKN 470
A Y E LG +++ V++ + G V LK+I+ ++ ++ E LLK +
Sbjct: 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHA 63
Query: 471 DPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQC 530
+ I+ L+D + E L +V E + +L ++ ++ GG +++ Q
Sbjct: 64 N------IVLLHDIIHTKETLTLVFEYVHTDLCQY--MDKHPGG---LHPENVKLFLFQL 112
Query: 531 LEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG--------SSCFQTDNLCLYVQ 582
L L Y+H I+H DLKP+N+LI E+K+ D G S + + + L+
Sbjct: 113 LRGLSYIHQRYILHRDLKPQNLLISDTG--ELKLADFGLARAKSVPSHTYSNEVVTLW-- 168
Query: 583 SRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTG 616
YR P+V++G Y +D+W +GCI E+ G
Sbjct: 169 ---YRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 5e-12
Identities = 63/209 (30%), Positives = 94/209 (44%), Gaps = 29/209 (13%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD------EIKLLKLVNKNDPADE 475
LG AF +V+ D+ TG ++ K ++ D + + S + EI+LLK +
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 476 HHILRLYDYFYHLEH-LFIVCELLRANLYEFQKFNQESGGEAY--FTLGRLQVITRQCLE 532
+ LR E L I E + + Q +AY T + TRQ LE
Sbjct: 70 YGCLR-----DRAEKTLTIFMEYMPGGSVKDQL-------KAYGALTESVTRKYTRQILE 117
Query: 533 ALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS------CFQTDNLCLYVQSRSY 586
+ YLHS I+H D+K NIL S +K+ D G+S C + + +
Sbjct: 118 GMSYLHSNMIVHRDIKGANILRDSAG--NVKLGDFGASKRLQTICMSGTGIRSVTGTPYW 175
Query: 587 RAPEVIIGLPYDQKIDLWSLGCILAELWT 615
+PEVI G Y +K D+WSLGC + E+ T
Sbjct: 176 MSPEVISGEGYGRKADVWSLGCTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 7e-12
Identities = 57/210 (27%), Positives = 97/210 (46%), Gaps = 23/210 (10%)
Query: 416 YYVTEYLGSAAFSKVFQA---QDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDP 472
+ + +G +F VF+ D + + K ++ ++++DE ++L +
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKL----- 56
Query: 473 ADEHHILRLYDYFYHLEHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQV--ITRQ 529
D +I+R Y+ F L IV E +L++ K + L QV Q
Sbjct: 57 -DSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGR------PLPEDQVWRFFIQ 109
Query: 530 CLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL---YVQSRSY 586
L L +LHS I+H D+K N+ + +Y +KI DLG + +DN V + Y
Sbjct: 110 ILLGLAHLHSKKILHRDIKSLNLFLDAYD--NVKIGDLGVAKLLSDNTNFANTIVGTPYY 167
Query: 587 RAPEVIIGLPYDQKIDLWSLGCILAELWTG 616
+PE+ PY++K D+W+LG +L E TG
Sbjct: 168 LSPELCEDKPYNEKSDVWALGVVLYECCTG 197
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 57/213 (26%), Positives = 101/213 (47%), Gaps = 28/213 (13%)
Query: 415 RYYVTEY--LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDP 472
R + Y +G + V A++ H+G V +K++ D Q E+ ++V D
Sbjct: 20 RSLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMM----DLRKQQRRELLFNEVVIMRD- 74
Query: 473 ADEHHILRLYDYFYHLEHLFIVCELLRA----NLYEFQKFNQESGGEAYFTLGRLQVITR 528
+++ +Y + E L+++ E L+ ++ + N+E ++ +
Sbjct: 75 YQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQTRLNEE----------QIATVCE 124
Query: 529 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC----LYVQSR 584
L+AL YLHS G+IH D+K ++IL+ R +K+ D G C Q V +
Sbjct: 125 SVLQALCYLHSQGVIHRDIKSDSILLTLDGR--VKLSDFGF-CAQISKDVPKRKSLVGTP 181
Query: 585 SYRAPEVIIGLPYDQKIDLWSLGCILAELWTGE 617
+ APEVI PY ++D+WSLG ++ E+ GE
Sbjct: 182 YWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGE 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 1e-11
Identities = 39/98 (39%), Positives = 60/98 (61%), Gaps = 9/98 (9%)
Query: 529 QCLEALEYLHSLGIIHCDLKPENILI--KSYQRCEIKIIDLG-SSCFQTD-----NLCLY 580
Q L+ + YLH+ ++H DLKP NIL+ + +R +KI D+G + F + +L
Sbjct: 116 QILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPV 175
Query: 581 VQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGE 617
V + YRAPE+++G Y + ID+W++GCI AEL T E
Sbjct: 176 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 58/209 (27%), Positives = 102/209 (48%), Gaps = 23/209 (11%)
Query: 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK--NDKDFFDQSLDEIKLLKLVNKNDPA 473
Y + LG ++ V++ + T V LK I+ +++ ++ E+ LLK
Sbjct: 8 YIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLK-------- 59
Query: 474 DEHH--ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCL 531
D H I+ L+D + + L +V E L +L +++ + G + +++ Q L
Sbjct: 60 DLKHANIVTLHDIIHTEKSLTLVFEYLDKDL---KQYLDDCGN--SINMHNVKLFLFQLL 114
Query: 532 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG---SSCFQTDNLCLYVQSRSYRA 588
L Y H ++H DLKP+N+LI +R E+K+ D G + T V + YR
Sbjct: 115 RGLNYCHRRKVLHRDLKPQNLLIN--ERGELKLADFGLARAKSIPTKTYSNEVVTLWYRP 172
Query: 589 PEVIIG-LPYDQKIDLWSLGCILAELWTG 616
P++++G Y +ID+W +GCI E+ TG
Sbjct: 173 PDILLGSTDYSTQIDMWGVGCIFYEMSTG 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 1e-11
Identities = 65/219 (29%), Positives = 101/219 (46%), Gaps = 50/219 (22%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPAD---EHHI 478
LG + KVFQ + + TG D K F + L + +++ N+ D A E +I
Sbjct: 4 LGKGGYGKVFQVRKV-TGAD-------TGKIFAMKVLKKATIVR--NQKDTAHTKAERNI 53
Query: 479 LRLYDYFYHLEHLFIVCELLRANLYEFQK-------FNQESGGEAYFTLGRLQVITR--- 528
L ++H FIV +L+ Y FQ SGGE + L R +
Sbjct: 54 LE------AVKHPFIV-DLI----YAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTA 102
Query: 529 -----QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG---SSCFQ---TDNL 577
+ ALE+LH GII+ DLKPENIL+ + +K+ D G S + T
Sbjct: 103 CFYLSEISLALEHLHQQGIIYRDLKPENILLDAQG--HVKLTDFGLCKESIHEGTVTHTF 160
Query: 578 CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTG 616
C ++ Y APE+++ + + +D WSLG ++ ++ TG
Sbjct: 161 CGTIE---YMAPEILMRSGHGKAVDWWSLGALMYDMLTG 196
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 40/99 (40%), Positives = 55/99 (55%), Gaps = 7/99 (7%)
Query: 520 LGRLQVITRQCLEALEYLHS-LGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC 578
LG+ I+ L L YL I+H D+KP NIL+ S R EIK+ D G S D++
Sbjct: 101 LGK---ISIAVLRGLTYLREKHKIMHRDVKPSNILVNS--RGEIKLCDFGVSGQLIDSMA 155
Query: 579 -LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTG 616
+V +RSY +PE + G Y + D+WSLG L E+ G
Sbjct: 156 NSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIG 194
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 40/101 (39%), Positives = 56/101 (55%), Gaps = 9/101 (8%)
Query: 523 LQVITRQCLEALEYLHS-LGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYV 581
L I ++ALEYLHS L +IH D+KP N+LI + ++K+ D G S + D++ +
Sbjct: 105 LGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLIN--RNGQVKLCDFGISGYLVDSVAKTI 162
Query: 582 Q--SRSYRAPEVIIG----LPYDQKIDLWSLGCILAELWTG 616
+ Y APE I YD K D+WSLG + EL TG
Sbjct: 163 DAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATG 203
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 51/201 (25%), Positives = 88/201 (43%), Gaps = 13/201 (6%)
Query: 422 LGSAAFSKVFQAQDLHTG-VDVCLKIIKN---DKDFFDQSLDEIKLLKLVNKNDPADEHH 477
LG F +V Q +TG + C K+ K K +L E ++L+ VN
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVN------SPF 54
Query: 478 ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYL 537
I+ L F HL +V L+ ++ +N GE + R+ + Q + +L
Sbjct: 55 IVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNV---GERGLEMERVIHYSAQITCGILHL 111
Query: 538 HSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPY 597
HS+ I++ D+KPEN+L+ C + + L + + Y APE++ PY
Sbjct: 112 HSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEPY 171
Query: 598 DQKIDLWSLGCILAELWTGEV 618
+D +++GC + E+ G
Sbjct: 172 SYPVDWFAMGCSIYEMVAGRT 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 2e-11
Identities = 58/200 (29%), Positives = 92/200 (46%), Gaps = 20/200 (10%)
Query: 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHH 477
E LG V++A L T + +K+I D + Q + E+++L D +
Sbjct: 7 EILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILY------KCDSPY 60
Query: 478 ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYL 537
I+ Y F+ + I E + + + E LGR+ V ++ L YL
Sbjct: 61 IIGFYGAFFVENRISICTEFMDGGSLDVYRKIPEH------VLGRIAVAV---VKGLTYL 111
Query: 538 HSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC-LYVQSRSYRAPEVIIGLP 596
SL I+H D+KP N+L+ + R ++K+ D G S +++ YV + +Y APE I G
Sbjct: 112 WSLKILHRDVKPSNMLVNT--RGQVKLCDFGVSTQLVNSIAKTYVGTNAYMAPERISGEQ 169
Query: 597 YDQKIDLWSLGCILAELWTG 616
Y D+WSLG EL G
Sbjct: 170 YGIHSDVWSLGISFMELALG 189
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 51/152 (33%), Positives = 77/152 (50%), Gaps = 18/152 (11%)
Query: 473 ADEHH--ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQC 530
A+ +H I++L+ F L+++ + LR F + S E FT ++ +
Sbjct: 53 AEVNHPFIVKLHYAFQTEGKLYLILDFLRGG----DLFTRLSK-EVMFTEEDVKFYLAEL 107
Query: 531 LEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN------LCLYVQSR 584
AL++LHSLGII+ DLKPENIL+ + IK+ D G S D+ C V+
Sbjct: 108 ALALDHLHSLGIIYRDLKPENILLD--EEGHIKLTDFGLSKESIDHEKKAYSFCGTVE-- 163
Query: 585 SYRAPEVIIGLPYDQKIDLWSLGCILAELWTG 616
Y APEV+ + Q D WS G ++ E+ TG
Sbjct: 164 -YMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 2e-11
Identities = 62/214 (28%), Positives = 98/214 (45%), Gaps = 39/214 (18%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD------EIKLLK-LVNKNDPAD 474
LG AF +V+ D TG ++ +K ++ D + + S + EI+LLK L+++
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHE----- 64
Query: 475 EHHILRLYDYFYHLEH-----LFIVCELLRANLYEFQKFNQESGGEAYFTLGR--LQVIT 527
R+ Y+ L L I E + + Q ++Y L + T
Sbjct: 65 -----RIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQL-------KSYGALTENVTRKYT 112
Query: 528 RQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS------CFQTDNLCLYV 581
RQ LE + YLHS I+H D+K NIL S +K+ D G+S C +
Sbjct: 113 RQILEGVSYLHSNMIVHRDIKGANILRDSVG--NVKLGDFGASKRLQTICLSGTGMKSVT 170
Query: 582 QSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT 615
+ + +PEVI G Y +K D+WS+GC + E+ T
Sbjct: 171 GTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 3e-11
Identities = 39/107 (36%), Positives = 51/107 (47%), Gaps = 26/107 (24%)
Query: 533 ALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC--------------------- 571
ALEYLH+ GI+H DLKP+N+LI S IK+ D G S
Sbjct: 113 ALEYLHNYGIVHRDLKPDNLLITSMG--HIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170
Query: 572 FQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEV 618
F +C + Y APEVI+ Y + +D W++G IL E G V
Sbjct: 171 FLDKQVC---GTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCV 214
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 3e-11
Identities = 62/217 (28%), Positives = 97/217 (44%), Gaps = 49/217 (22%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLK---LVNKNDPADEHHI 478
+G +F KV A+ K D F+ +K+L+ ++ K + + HI
Sbjct: 3 IGKGSFGKVLLAKH------------KADGKFY-----AVKVLQKKAILKKKE---QKHI 42
Query: 479 LRLYDYFY-HLEHLFIVCELLRANLYEFQK-------FNQESGGEAYFTLGR----LQVI 526
+ + +++H F+V L Y FQ + +GGE +F L R +
Sbjct: 43 MAERNVLLKNVKHPFLVG--LH---YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPR 97
Query: 527 TR----QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG---SSCFQTDNLCL 579
R + AL YLHSL II+ DLKPENIL+ S + + + D G +
Sbjct: 98 ARFYAAEIASALGYLHSLNIIYRDLKPENILLDS--QGHVVLTDFGLCKEGIEHSKTTST 155
Query: 580 YVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTG 616
+ + Y APEV+ PYD+ +D W LG +L E+ G
Sbjct: 156 FCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 5e-11
Identities = 61/211 (28%), Positives = 104/211 (49%), Gaps = 35/211 (16%)
Query: 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD----FFDQSLDEIKLLK-LVNKNDPAD 474
+ LG +++ V++ + TG V LK I+ + + F ++ E LLK L + N
Sbjct: 11 DKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPF--TAIREASLLKDLKHAN---- 64
Query: 475 EHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEAL 534
I+ L+D + + L +V E L +L Q + GG ++ +++ Q L L
Sbjct: 65 ---IVTLHDIIHTKKTLTLVFEYLDTDLK--QYMDDCGGG---LSMHNVRLFLFQLLRGL 116
Query: 535 EYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG--------SSCFQTDNLCLYVQSRSY 586
Y H ++H DLKP+N+LI +R E+K+ D G S + + + L+ Y
Sbjct: 117 AYCHQRRVLHRDLKPQNLLIS--ERGELKLADFGLARAKSVPSKTYSNEVVTLW-----Y 169
Query: 587 RAPEVIIG-LPYDQKIDLWSLGCILAELWTG 616
R P+V++G Y +D+W +GCI E+ TG
Sbjct: 170 RPPDVLLGSTEYSTSLDMWGVGCIFYEMATG 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 5e-11
Identities = 64/213 (30%), Positives = 98/213 (46%), Gaps = 32/213 (15%)
Query: 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK----NDKDFFDQSLDEIKLLKLVNKND 471
+ + + +G FS+V++A L GV V LK ++ D + EI LLK +N +
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63
Query: 472 PADEHHILRLYDYFYHLEHLFIVCELLRAN-----LYEFQKFNQ---ESGGEAYFTLGRL 523
+++ Y F L IV EL A + F+K + E YF
Sbjct: 64 ------VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFV---- 113
Query: 524 QVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF---QTDNLCLY 580
Q ALE++HS ++H D+KP N+ I + +K+ DLG F +T
Sbjct: 114 -----QLCSALEHMHSRRVMHRDIKPANVFITATG--VVKLGDLGLGRFFSSKTTAAHSL 166
Query: 581 VQSRSYRAPEVIIGLPYDQKIDLWSLGCILAEL 613
V + Y +PE I Y+ K D+WSLGC+L E+
Sbjct: 167 VGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 5e-11
Identities = 56/205 (27%), Positives = 91/205 (44%), Gaps = 25/205 (12%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHH 477
LG +F KV A+ +G +K++K D D + ++ E ++L L A H
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSL------ARNHP 56
Query: 478 IL-RLYDYFYHLEHLFIVCELLRAN--LYEFQKFNQESGGEAYFTLGRLQVITRQCLEAL 534
L +LY F + LF V E + ++ QK + F R + + AL
Sbjct: 57 FLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRR-------FDEARARFYAAEITSAL 109
Query: 535 EYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL---YVQSRSYRAPEV 591
+LH GII+ DLK +N+L+ C K+ D G N + + Y APE+
Sbjct: 110 MFLHDKGIIYRDLKLDNVLLDHEGHC--KLADFGMCKEGIFNGKTTSTFCGTPDYIAPEI 167
Query: 592 IIGLPYDQKIDLWSLGCILAELWTG 616
+ + Y +D W++G +L E+ G
Sbjct: 168 LQEMLYGPSVDWWAMGVLLYEMLCG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 5e-11
Identities = 61/206 (29%), Positives = 92/206 (44%), Gaps = 29/206 (14%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKII--KNDKDFFDQSLDEIKLLKLVNKNDPADEHHIL 479
+GS A V++ TG LK+I ++ Q EI++L+ VN P ++
Sbjct: 82 IGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNH--PN----VV 135
Query: 480 RLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS 539
+ +D F H + ++ E + E E L + RQ L + YLH
Sbjct: 136 KCHDMFDHNGEIQVLLEFMDGGSLEGTHIADE---------QFLADVARQILSGIAYLHR 186
Query: 540 LGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF--QTDNLC-LYVQSRSYRAPEVI---- 592
I+H D+KP N+LI S + +KI D G S QT + C V + +Y +PE I
Sbjct: 187 RHIVHRDIKPSNLLINSAKN--VKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDL 244
Query: 593 -IGLPYDQKI-DLWSLGCILAELWTG 616
G YD D+WSLG + E + G
Sbjct: 245 NHGA-YDGYAGDIWSLGVSILEFYLG 269
|
Length = 353 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 6e-11
Identities = 37/93 (39%), Positives = 51/93 (54%), Gaps = 9/93 (9%)
Query: 526 ITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS 585
I L+ L YLHS IH D+K NIL+ + +K+ D GS+ +V +
Sbjct: 120 ICHGALQGLAYLHSHERIHRDIKAGNILLT--EPGTVKLADFGSASL-VSPANSFVGTPY 176
Query: 586 YRAPEVIIGL---PYDQKIDLWSLG--CI-LAE 612
+ APEVI+ + YD K+D+WSLG CI LAE
Sbjct: 177 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 209
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 6e-11
Identities = 62/214 (28%), Positives = 95/214 (44%), Gaps = 43/214 (20%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFD-QSLDEIKLLKLVNKNDPADEHHILR 480
+G +F KV A+ K+D F+ + L + +LK +N E ++L
Sbjct: 3 IGKGSFGKVLLAKR------------KSDGSFYAVKVLQKKTILKKKEQNHIMAERNVL- 49
Query: 481 LYDYFYHLEHLFIVCELLRANLYEFQK-------FNQESGGEAYFTLGRLQVITR----- 528
+L+H F+V L Y FQ + +GGE +F L R +
Sbjct: 50 ----LKNLKHPFLVG--LH---YSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARF 100
Query: 529 ---QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG---SSCFQTDNLCLYVQ 582
+ A+ YLHSL II+ DLKPENIL+ S + + + D G + +
Sbjct: 101 YAAEVASAIGYLHSLNIIYRDLKPENILLDS--QGHVVLTDFGLCKEGVEPEETTSTFCG 158
Query: 583 SRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTG 616
+ Y APEV+ PYD+ +D W LG +L E+ G
Sbjct: 159 TPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 7e-11
Identities = 35/84 (41%), Positives = 48/84 (57%), Gaps = 3/84 (3%)
Query: 531 LEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC-LYVQSRSYRAP 589
L+ L YLHS IIH D+KP NIL+ + ++K+ D G S ++L + + Y AP
Sbjct: 115 LKGLSYLHSRKIIHRDIKPSNILLTR--KGQVKLCDFGVSGELVNSLAGTFTGTSFYMAP 172
Query: 590 EVIIGLPYDQKIDLWSLGCILAEL 613
E I G PY D+WSLG L E+
Sbjct: 173 ERIQGKPYSITSDVWSLGLTLLEV 196
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 60/208 (28%), Positives = 94/208 (45%), Gaps = 27/208 (12%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD------EIKLLKLVNKNDPADE 475
LG AF +V+ D TG ++ +K + D D + S + EI+LLK + +
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69
Query: 476 HHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGR--LQVITRQCLEA 533
+ LR + + L I E + + Q +AY L + TRQ L+
Sbjct: 70 YGCLRDPEE----KKLSIFVEYMPGGSIKDQL-------KAYGALTENVTRRYTRQILQG 118
Query: 534 LEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS------CFQTDNLCLYVQSRSYR 587
+ YLHS I+H D+K NIL S +K+ D G+S C + + +
Sbjct: 119 VSYLHSNMIVHRDIKGANILRDSAG--NVKLGDFGASKRIQTICMSGTGIKSVTGTPYWM 176
Query: 588 APEVIIGLPYDQKIDLWSLGCILAELWT 615
+PEVI G Y +K D+WS+ C + E+ T
Sbjct: 177 SPEVISGEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 36/94 (38%), Positives = 54/94 (57%), Gaps = 4/94 (4%)
Query: 526 ITRQCLEALEYLHS-LGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC-LYVQS 583
I +E L YL++ I+H D+KP NIL+ S R +IK+ D G S +++ +V +
Sbjct: 108 IAVAVVEGLTYLYNVHRIMHRDIKPSNILVNS--RGQIKLCDFGVSGELINSIADTFVGT 165
Query: 584 RSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGE 617
+Y +PE I G Y K D+WSLG + EL G+
Sbjct: 166 STYMSPERIQGGKYTVKSDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 42/116 (36%), Positives = 60/116 (51%), Gaps = 13/116 (11%)
Query: 512 SGGEAYFTLGR----LQVITR----QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 563
+GGE ++ L R L+ R + AL YLHSL I++ DLKPENIL+ S + I
Sbjct: 79 NGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDS--QGHIV 136
Query: 564 IIDLG---SSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTG 616
+ D G + + + Y APEV+ PYD+ +D W LG +L E+ G
Sbjct: 137 LTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 2e-10
Identities = 53/201 (26%), Positives = 88/201 (43%), Gaps = 22/201 (10%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD-EIKLLKLVNKNDPADEHHILR 480
LGS F +V++ + V V +KI+K+D Q E++ LK + H++
Sbjct: 14 LGSGYFGEVWEGLWKNR-VRVAIKILKSDDLLKQQDFQKEVQALKRLR------HKHLIS 66
Query: 481 LYDYFYHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS 539
L+ E ++I+ EL+ +L F + S + L + Q E + YL
Sbjct: 67 LFAVCSVGEPVYIITELMEKGSLLAFLR----SPEGQVLPVASLIDMACQVAEGMAYLEE 122
Query: 540 LGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS-----YRAPEVIIG 594
IH DL NIL+ C K+ D G + +++ Y+ S + APE
Sbjct: 123 QNSIHRDLAARNILVGEDLVC--KVADFGLARLIKEDV--YLSSDKKIPYKWTAPEAASH 178
Query: 595 LPYDQKIDLWSLGCILAELWT 615
+ K D+WS G +L E++T
Sbjct: 179 GTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-10
Identities = 44/157 (28%), Positives = 76/157 (48%), Gaps = 29/157 (18%)
Query: 474 DEHH--ILRLYDYFYHLEHLFIVCELLRA----NLYEFQKFNQESGGEAYFTLGRLQVIT 527
D H ++ +Y+ + + L++V E L ++ + N+E ++ +
Sbjct: 73 DYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEE----------QIAAVC 122
Query: 528 RQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS-- 585
L+AL LH+ G+IH D+K ++IL+ R +K+ D G C Q V R
Sbjct: 123 LAVLKALSVLHAQGVIHRDIKSDSILLTHDGR--VKLSDFGF-CAQVSK---EVPRRKSL 176
Query: 586 -----YRAPEVIIGLPYDQKIDLWSLGCILAELWTGE 617
+ APE+I LPY ++D+WSLG ++ E+ GE
Sbjct: 177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 61/213 (28%), Positives = 97/213 (45%), Gaps = 32/213 (15%)
Query: 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK----NDKDFFDQSLDEIKLLKLVNKND 471
+ + + +G FS+V++A L V LK ++ D + EI LLK +N +
Sbjct: 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63
Query: 472 PADEHHILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITR-- 528
+++ D F L IV EL A +L + K YF + + R
Sbjct: 64 ------VIKYLDSFIEDNELNIVLELADAGDLSQMIK---------YFKKQKRLIPERTV 108
Query: 529 -----QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF---QTDNLCLY 580
Q A+E++HS ++H D+KP N+ I + +K+ DLG F +T
Sbjct: 109 WKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATG--VVKLGDLGLGRFFSSKTTAAHSL 166
Query: 581 VQSRSYRAPEVIIGLPYDQKIDLWSLGCILAEL 613
V + Y +PE I Y+ K D+WSLGC+L E+
Sbjct: 167 VGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 2e-10
Identities = 56/209 (26%), Positives = 94/209 (44%), Gaps = 31/209 (14%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHH 477
LG +F KV A+ T +K++K D D D ++ E ++L L K+
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHP-----F 57
Query: 478 ILRLYDYFYHLEHLFIVCELLRAN--LYEFQKFNQESGGEAYFTLGRLQVITRQCLEALE 535
+ L+ F + LF V E + +++ Q+ + F R + + AL
Sbjct: 58 LTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRK-------FDEPRSRFYAAEVTLALM 110
Query: 536 YLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQ-------TDNLCLYVQSRSYRA 588
+LH G+I+ DLK +NIL+ + C K+ D G C + T C + Y A
Sbjct: 111 FLHRHGVIYRDLKLDNILLDAEGHC--KLADFGM-CKEGILNGVTTTTFC---GTPDYIA 164
Query: 589 PEVIIGLPYDQKIDLWSLGCILAELWTGE 617
PE++ L Y +D W+LG ++ E+ G+
Sbjct: 165 PEILQELEYGPSVDWWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 3e-10
Identities = 33/84 (39%), Positives = 47/84 (55%), Gaps = 2/84 (2%)
Query: 533 ALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVI 592
ALEYLHS I++ DLKPENIL+ IK+ D G + D + Y APEVI
Sbjct: 113 ALEYLHSKEIVYRDLKPENILLDK--EGHIKLTDFGFAKKLRDRTWTLCGTPEYLAPEVI 170
Query: 593 IGLPYDQKIDLWSLGCILAELWTG 616
+++ +D W+LG ++ E+ G
Sbjct: 171 QSKGHNKAVDWWALGILIYEMLVG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 3e-10
Identities = 57/206 (27%), Positives = 96/206 (46%), Gaps = 25/206 (12%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHH 477
LG +F KV A+ T +KI+K D D + ++ E ++L L +K
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDK-----PPF 62
Query: 478 ILRLYDYFYHLEHLFIVCELLRAN--LYEFQKFNQESGGEAYFTLGRLQVITRQCLEALE 535
+ +L+ F ++ L+ V E + +Y Q+ + +A F + V L
Sbjct: 63 LTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISV-------GLF 115
Query: 536 YLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQT--DNLCL--YVQSRSYRAPEV 591
+LH GII+ DLK +N+++ S IKI D G C + D + + + Y APE+
Sbjct: 116 FLHRRGIIYRDLKLDNVMLDS--EGHIKIADFGM-CKEHMVDGVTTRTFCGTPDYIAPEI 172
Query: 592 IIGLPYDQKIDLWSLGCILAELWTGE 617
I PY + +D W+ G +L E+ G+
Sbjct: 173 IAYQPYGKSVDWWAYGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 4e-10
Identities = 56/209 (26%), Positives = 96/209 (45%), Gaps = 29/209 (13%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHH 477
LG +F KV A+ T +KI+K D D + ++ E ++L L
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLAL-----SGKPPF 62
Query: 478 ILRLYDYFYHLEHLFIVCELLRAN--LYEFQKFNQESGGEAYFTLGRLQVITRQCLEALE 535
+ +L+ F ++ L+ V E + +Y+ Q+ + A F + + L
Sbjct: 63 LTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAI-------GLF 115
Query: 536 YLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS------YRAP 589
+LHS GII+ DLK +N+++ S IKI D G +N+ V +++ Y AP
Sbjct: 116 FLHSKGIIYRDLKLDNVMLDS--EGHIKIADFGMC---KENMWDGVTTKTFCGTPDYIAP 170
Query: 590 EVIIGLPYDQKIDLWSLGCILAELWTGEV 618
E+I PY + +D W+ G +L E+ G+
Sbjct: 171 EIIAYQPYGKSVDWWAFGVLLYEMLAGQA 199
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 4e-10
Identities = 34/100 (34%), Positives = 50/100 (50%), Gaps = 14/100 (14%)
Query: 526 ITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS 585
I R L A++YLH IIH D+K ENI I ++ + D G++CF D ++
Sbjct: 187 IERSVLRAIQYLHENRIIHRDIKAENIFIN--HPGDVCLGDFGAACFPVD----INANKY 240
Query: 586 Y--------RAPEVIIGLPYDQKIDLWSLGCILAELWTGE 617
Y APE++ PY +D+WS G +L E+ T
Sbjct: 241 YGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 60.6 bits (148), Expect = 4e-10
Identities = 50/181 (27%), Positives = 82/181 (45%), Gaps = 32/181 (17%)
Query: 445 KIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLR-ANLY 503
KIIK K+F + E + +L+ N + ++LY L+ ++ + ++ +L+
Sbjct: 47 KIIKA-KNF---NAIEPMVHQLMKDNP-----NFIKLYYSVTTLKGHVLIMDYIKDGDLF 97
Query: 504 EFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 563
+ K + ++ I RQ +EAL LH IIH D+K EN+L + I
Sbjct: 98 DLLKKEG------KLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRA-KDRIY 150
Query: 564 IIDLGSSCFQTDNLCLYVQSRS-------YRAPEVIIGLPYDQKIDLWSLGCILAELWTG 616
+ D G LC + + S Y +PE I G YD D W++G + EL TG
Sbjct: 151 LCDYG--------LCKIIGTPSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTG 202
Query: 617 E 617
+
Sbjct: 203 K 203
|
Length = 267 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 5e-10
Identities = 38/98 (38%), Positives = 55/98 (56%), Gaps = 5/98 (5%)
Query: 520 LGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC- 578
LG++ + + L L H I+H D+KP NIL+ S R EIK+ D G S D++
Sbjct: 105 LGKVSIAVLRGLAYLREKHQ--IMHRDVKPSNILVNS--RGEIKLCDFGVSGQLIDSMAN 160
Query: 579 LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTG 616
+V +RSY +PE + G Y + D+WS+G L EL G
Sbjct: 161 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIG 198
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 5e-10
Identities = 53/153 (34%), Positives = 75/153 (49%), Gaps = 24/153 (15%)
Query: 477 HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEY 536
+I++ Y YF +FI EL+ L + K Q G LG++ V ++AL Y
Sbjct: 75 YIVKCYGYFITDSDVFICMELMSTCLDKLLKRIQ--GPIPEDILGKMTVAI---VKALHY 129
Query: 537 L---HSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS-----YRA 588
L H G+IH D+KP NIL+ + +K+ D G S D+ ++RS Y A
Sbjct: 130 LKEKH--GVIHRDVKPSNILLDA--SGNVKLCDFGISGRLVDSK---AKTRSAGCAAYMA 182
Query: 589 PEVIIGLP----YDQKIDLWSLGCILAELWTGE 617
PE I YD + D+WSLG L EL TG+
Sbjct: 183 PERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 6e-10
Identities = 58/221 (26%), Positives = 101/221 (45%), Gaps = 30/221 (13%)
Query: 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDP 472
AG + + E +G+ + +V++ + + TG +K++ +D ++ EI +LK +
Sbjct: 15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYS---- 70
Query: 473 ADEHH--ILRLYDYFY------HLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQ 524
HH I Y F H + L++V E A + + G A +
Sbjct: 71 ---HHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAG--SVTDLVKNTKGNA-LKEDWIA 124
Query: 525 VITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC----LY 580
I R+ L L +LH+ +IH D+K +N+L+ + E+K++D G S Q D +
Sbjct: 125 YICREILRGLAHLHAHKVIHRDIKGQNVLLT--ENAEVKLVDFGVSA-QLDRTVGRRNTF 181
Query: 581 VQSRSYRAPEVII-----GLPYDQKIDLWSLGCILAELWTG 616
+ + + APEVI YD + D+WSLG E+ G
Sbjct: 182 IGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 1e-09
Identities = 45/155 (29%), Positives = 72/155 (46%), Gaps = 13/155 (8%)
Query: 461 IKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTL 520
I+ + L N N P+ ++R+ D +V ++LY + + S +
Sbjct: 106 IEAMLLQNVNHPS----VIRMKDTLVSGAITCMVLPHYSSDLYTY--LTKRSRP---LPI 156
Query: 521 GRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLY 580
+ +I +Q LE L YLH+ IIH D+K ENI I ++ I DLG++ F
Sbjct: 157 DQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVD--QVCIGDLGAAQFPVVAPAFL 214
Query: 581 --VQSRSYRAPEVIIGLPYDQKIDLWSLGCILAEL 613
+ APEV+ Y+ K D+WS G +L E+
Sbjct: 215 GLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEM 249
|
Length = 357 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 1e-09
Identities = 53/204 (25%), Positives = 91/204 (44%), Gaps = 10/204 (4%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPAD 474
RY + + +G +F K++ A+ +K I K + K + L+ K +
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 475 EHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEAL 534
I+ + F LFIV E ++ N++ G F+ ++ Q L
Sbjct: 61 ---IVTFFASFQENGRLFIVMEYCDGGDL-MKRINRQRG--VLFSEDQILSWFVQISLGL 114
Query: 535 EYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLY---VQSRSYRAPEV 591
+++H I+H D+K +NI + K+ D G + D++ L V + Y +PE+
Sbjct: 115 KHIHDRKILHRDIKSQNIFLSKNGMVA-KLGDFGIARQLNDSMELAYTCVGTPYYLSPEI 173
Query: 592 IIGLPYDQKIDLWSLGCILAELWT 615
PY+ K D+WSLGC+L EL T
Sbjct: 174 CQNRPYNNKTDIWSLGCVLYELCT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 1e-09
Identities = 57/207 (27%), Positives = 95/207 (45%), Gaps = 24/207 (11%)
Query: 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPAD 474
Y + + +GS + V++A++LHTG +KIIK + D F EI ++K
Sbjct: 11 YELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVK------ECK 64
Query: 475 EHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQV--ITRQCLE 532
+I+ + + E L+I E Q +G L LQ+ + R+ L+
Sbjct: 65 HCNIVAYFGSYLSREKLWICMEYCGGG--SLQDIYHVTG-----PLSELQIAYVCRETLQ 117
Query: 533 ALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC---LYVQSRSYRAP 589
L YLHS G +H D+K NIL+ ++K+ D G + T + ++ + + AP
Sbjct: 118 GLAYLHSKGKMHRDIKGANILLTDNG--DVKLADFGVAAKITATIAKRKSFIGTPYWMAP 175
Query: 590 EVII---GLPYDQKIDLWSLGCILAEL 613
EV Y+Q D+W++G EL
Sbjct: 176 EVAAVEKNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 60/214 (28%), Positives = 96/214 (44%), Gaps = 40/214 (18%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHH 477
LG F KV ++ TG +KI++ + KD ++ E ++L+ H
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ-------NTRHP 55
Query: 478 ILRLYDY-FYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITR-------- 528
L Y F + L V E AN GGE +F L R +V T
Sbjct: 56 FLTALKYAFQTHDRLCFVMEY--AN-----------GGELFFHLSRERVFTEERARFYGA 102
Query: 529 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQ--TDNLCL--YVQSR 584
+ + ALEYLHS +++ D+K EN+++ + IKI D G C + +D + + +
Sbjct: 103 EIVSALEYLHSRDVVYRDIKLENLMLD--KDGHIKITDFG-LCKEGISDGATMKTFCGTP 159
Query: 585 SYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEV 618
Y APEV+ Y + +D W LG ++ E+ G +
Sbjct: 160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 1e-09
Identities = 54/200 (27%), Positives = 95/200 (47%), Gaps = 23/200 (11%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKII----KNDKDFFDQSLDEIKLLKLVNKNDPADEHH 477
+G +F V+ A+D+ T V +K + K + + + E+K L+ + + +
Sbjct: 33 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIE--- 89
Query: 478 ILRLYDYFYHLEHL-FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEY 536
Y Y EH ++V E + + + +++ E + IT L+ L Y
Sbjct: 90 ----YKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEV-----EIAAITHGALQGLAY 140
Query: 537 LHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGL- 595
LHS +IH D+K NIL+ + ++K+ D GS+ + +V + + APEVI+ +
Sbjct: 141 LHSHNMIHRDIKAGNILLT--EPGQVKLADFGSASIASPANS-FVGTPYWMAPEVILAMD 197
Query: 596 --PYDQKIDLWSLGCILAEL 613
YD K+D+WSLG EL
Sbjct: 198 EGQYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 1e-09
Identities = 52/200 (26%), Positives = 87/200 (43%), Gaps = 13/200 (6%)
Query: 422 LGSAAFSKVFQAQDLHTG-VDVCLKIIKN---DKDFFDQSLDEIKLLKLVNKNDPADEHH 477
LG F +V Q TG + C ++ K + +L+E ++L+ VN
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVN------SQF 61
Query: 478 ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYL 537
++ L + + L +V ++ +F +N + G F R + L LE L
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPG---FEEERALFYAAEILCGLEDL 118
Query: 538 HSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPY 597
H ++ DLKPENIL+ Y I + L + +++ V + Y APEV+ Y
Sbjct: 119 HRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRY 178
Query: 598 DQKIDLWSLGCILAELWTGE 617
D W LGC++ E+ G+
Sbjct: 179 TLSPDYWGLGCLIYEMIEGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 58/214 (27%), Positives = 88/214 (41%), Gaps = 44/214 (20%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHH 477
LG F KV ++ TG +KI+K + KD +L E ++L+ H
Sbjct: 3 LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTR-------HP 55
Query: 478 ILRLYDYFYHLEH-LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITR-------- 528
L Y + L V E +GGE +F L R +V +
Sbjct: 56 FLTALKYSFQTHDRLCFVMEYA-------------NGGELFFHLSRERVFSEDRARFYGA 102
Query: 529 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG------SSCFQTDNLCLYVQ 582
+ + AL YLHS +++ DLK EN+++ + IKI D G S C
Sbjct: 103 EIVSALGYLHSCDVVYRDLKLENLMLD--KDGHIKITDFGLCKEGISDGATMKTFC---G 157
Query: 583 SRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTG 616
+ Y APEV+ Y + +D W LG ++ E+ G
Sbjct: 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 191
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 59.0 bits (142), Expect = 2e-09
Identities = 62/227 (27%), Positives = 101/227 (44%), Gaps = 42/227 (18%)
Query: 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDP 472
AG + + E +G+ + +V++ + + TG +K++ D ++ EI +LK +
Sbjct: 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYS---- 60
Query: 473 ADEHH--ILRLYDYFYHL------EHLFIVCELLRA----NLYEFQKFNQESGGEAYFTL 520
HH I Y F + L++V E A +L + K N TL
Sbjct: 61 ---HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGN---------TL 108
Query: 521 GR--LQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC 578
+ I R+ L L +LH +IH D+K +N+L+ + E+K++D G S Q D
Sbjct: 109 KEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLT--ENAEVKLVDFGVSA-QLDRTV 165
Query: 579 ----LYVQSRSYRAPEVII-----GLPYDQKIDLWSLGCILAELWTG 616
++ + + APEVI YD K DLWSLG E+ G
Sbjct: 166 GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 2e-09
Identities = 44/142 (30%), Positives = 69/142 (48%), Gaps = 24/142 (16%)
Query: 492 FIVCELLRANLYEFQKFNQES-------GGEAYFTLGRLQVITRQCLE--------ALEY 536
FIVC Y F ++ S GG+ ++ L + V + + LE+
Sbjct: 58 FIVCMS-----YAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEH 112
Query: 537 LHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC-FQTDNLCLYVQSRSYRAPEVII-G 594
+H+ +++ DLKP NIL+ + ++I DLG +C F V + Y APEV+ G
Sbjct: 113 MHNRFVVYRDLKPANILLDEHG--HVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKG 170
Query: 595 LPYDQKIDLWSLGCILAELWTG 616
+ YD D +SLGC+L +L G
Sbjct: 171 VAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 37/98 (37%), Positives = 55/98 (56%), Gaps = 5/98 (5%)
Query: 520 LGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC- 578
LG++ + + L L H I+H D+KP NIL+ S R EIK+ D G S D++
Sbjct: 105 LGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNS--RGEIKLCDFGVSGQLIDSMAN 160
Query: 579 LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTG 616
+V +RSY +PE + G Y + D+WS+G L E+ G
Sbjct: 161 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIG 198
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 2e-09
Identities = 38/113 (33%), Positives = 54/113 (47%), Gaps = 4/113 (3%)
Query: 507 KFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566
KF+ + G F R + LE LH I++ DLKPENIL+ Y I+I D
Sbjct: 88 KFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYG--HIRISD 145
Query: 567 LGSSCFQTDNLCL--YVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGE 617
LG + + + V + Y APEV+ Y D W LGC++ E+ G+
Sbjct: 146 LGLAVEIPEGETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 2e-09
Identities = 48/165 (29%), Positives = 76/165 (46%), Gaps = 16/165 (9%)
Query: 455 DQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESG 513
+L+EI +L L+ + I+ Y++F L I E LY K ++ G
Sbjct: 44 RDALNEIVILSLLQHPN------IIAYYNHFMDDNTLLIEMEYANGGTLY--DKIVRQKG 95
Query: 514 GEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQ 573
F + Q + A+ Y+H GI+H D+K NI + + IK+ D G S
Sbjct: 96 --QLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLT--KAGLIKLGDFGISKIL 151
Query: 574 TDNLCL---YVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT 615
+ V + Y +PE+ G+ Y+ K D+W+LGC+L EL T
Sbjct: 152 GSEYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 2e-09
Identities = 56/212 (26%), Positives = 93/212 (43%), Gaps = 43/212 (20%)
Query: 422 LGSAAFSKVFQAQDLHTG-----VDVCLKIIK----NDKDFFDQSLDEIKLL-KLVNKND 471
LGS F V H G +DV +K+I+ ++ DF + E K++ KL + N
Sbjct: 12 LGSGQFGVV------HLGKWRGKIDVAIKMIREGAMSEDDFIE----EAKVMMKLSHPN- 60
Query: 472 PADEHHILRLYDYFYHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQC 530
+++LY +FIV E + L + + + G + L + + C
Sbjct: 61 ------LVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWL----LDMCSDVC 110
Query: 531 LEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR--- 587
EA+EYL S G IH DL N L+ +K+ D G + + D+ Y S+ +
Sbjct: 111 -EAMEYLESNGFIHRDLAARNCLVGE--DNVVKVSDFGLARYVLDDQ--YTSSQGTKFPV 165
Query: 588 ---APEVIIGLPYDQKIDLWSLGCILAELWTG 616
PEV + K D+WS G ++ E+++
Sbjct: 166 KWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSE 197
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 3e-09
Identities = 50/149 (33%), Positives = 75/149 (50%), Gaps = 15/149 (10%)
Query: 478 ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYF---TLGRLQVITRQCLEAL 534
I++ Y + +I EL+ +L +F K+ E ++ LG++ V T ++AL
Sbjct: 65 IVKFYGALFREGDCWICMELMDISLDKFYKYVYEVL-KSVIPEEILGKIAVAT---VKAL 120
Query: 535 EYL-HSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQS--RSYRAPEV 591
YL L IIH D+KP NIL+ + IK+ D G S D++ + R Y APE
Sbjct: 121 NYLKEELKIIHRDVKPSNILLD--RNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPER 178
Query: 592 I---IGLPYDQKIDLWSLGCILAELWTGE 617
I YD + D+WSLG L E+ TG+
Sbjct: 179 IDPSARDGYDVRSDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 58/212 (27%), Positives = 93/212 (43%), Gaps = 36/212 (16%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHH 477
LG F KV ++ +G +KI+K + KD +L E ++LK N P
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLK--NTRHP----F 56
Query: 478 ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITR--------Q 529
+ L F + L V E + +GGE +F L R +V + +
Sbjct: 57 LTSLKYSFQTKDRLCFVMEYV-------------NGGELFFHLSRERVFSEDRTRFYGAE 103
Query: 530 CLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG---SSCFQTDNLCLYVQSRSY 586
+ AL+YLHS I++ DLK EN+++ + IKI D G + + + Y
Sbjct: 104 IVSALDYLHSGKIVYRDLKLENLMLD--KDGHIKITDFGLCKEGITDAATMKTFCGTPEY 161
Query: 587 RAPEVIIGLPYDQKIDLWSLGCILAELWTGEV 618
APEV+ Y + +D W LG ++ E+ G +
Sbjct: 162 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 4e-09
Identities = 40/122 (32%), Positives = 65/122 (53%), Gaps = 22/122 (18%)
Query: 512 SGGEAY--------FTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 563
+GGE + F +Q+ + + + ALE+LH LGII+ D+K ENIL+ S +
Sbjct: 88 NGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDS--NGHVV 145
Query: 564 IIDLG-SSCFQTD------NLCLYVQSRSYRAPEVIIG--LPYDQKIDLWSLGCILAELW 614
+ D G S F D + C ++ Y AP+++ G +D+ +D WS+G ++ EL
Sbjct: 146 LTDFGLSKEFHEDEVERAYSFCGTIE---YMAPDIVRGGDGGHDKAVDWWSMGVLMYELL 202
Query: 615 TG 616
TG
Sbjct: 203 TG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 4e-09
Identities = 61/203 (30%), Positives = 93/203 (45%), Gaps = 19/203 (9%)
Query: 422 LGSAAFSKVFQAQDLHTG-VDVCLKI----IKNDKDFFDQSLDEIKLLKLVNKNDPADEH 476
LG F +V Q TG + C K+ IK K +L+E ++L+ VN
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGE-SMALNEKQILEKVN------SR 60
Query: 477 HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEY 536
++ L + + L +V L+ +F ++ GEA F GR + LE
Sbjct: 61 FVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHM---GEAGFEEGRAVFYAAEICCGLED 117
Query: 537 LHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL--YVQSRSYRAPEVIIG 594
LH I++ DLKPENIL+ + I+I DLG + + + V + Y APEV+
Sbjct: 118 LHQERIVYRDLKPENILLDDHG--HIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKN 175
Query: 595 LPYDQKIDLWSLGCILAELWTGE 617
Y D W+LGC+L E+ G+
Sbjct: 176 ERYTFSPDWWALGCLLYEMIAGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 5e-09
Identities = 59/203 (29%), Positives = 97/203 (47%), Gaps = 29/203 (14%)
Query: 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEH 476
E +G F V Q + +TG V +K IK D + F +++ + KL +KN
Sbjct: 12 EIIGEGEFGAVLQGE--YTGQKVAVKNIKCDVTAQAFLEET---AVMTKLHHKN------ 60
Query: 477 HILRLYDYFYHLEHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALE 535
++RL H L+IV EL+ + NL F + + G A ++ +L + E +E
Sbjct: 61 -LVRLLGVILH-NGLYIVMELMSKGNLVNFLR----TRGRALVSVIQLLQFSLDVAEGME 114
Query: 536 YLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQT---DNLCLYVQSRSYRAPEVI 592
YL S ++H DL NIL+ + K+ D G + + DN L V+ + APE +
Sbjct: 115 YLESKKLVHRDLAARNILVS--EDGVAKVSDFGLARVGSMGVDNSKLPVK---WTAPEAL 169
Query: 593 IGLPYDQKIDLWSLGCILAELWT 615
+ K D+WS G +L E+++
Sbjct: 170 KHKKFSSKSDVWSYGVLLWEVFS 192
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 6e-09
Identities = 54/200 (27%), Positives = 94/200 (47%), Gaps = 23/200 (11%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKII----KNDKDFFDQSLDEIKLLKLVNKNDPADEHH 477
+G +F V+ A + HT V +K + K + + + E+K L+ + + +
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIE--- 85
Query: 478 ILRLYDYFYHLEHL-FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEY 536
Y Y EH ++V E + + + +++ E + IT L+ L Y
Sbjct: 86 ----YKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEV-----EIAAITHGALQGLAY 136
Query: 537 LHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGL- 595
LHS +IH D+K NIL+ + ++K+ D GS+ + +V + + APEVI+ +
Sbjct: 137 LHSHNMIHRDIKAGNILLT--EPGQVKLADFGSASKSSPANS-FVGTPYWMAPEVILAMD 193
Query: 596 --PYDQKIDLWSLGCILAEL 613
YD K+D+WSLG EL
Sbjct: 194 EGQYDGKVDVWSLGITCIEL 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 6e-09
Identities = 53/202 (26%), Positives = 92/202 (45%), Gaps = 19/202 (9%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHIL-R 480
+G +++KV + T +K+IK + D+ +D ++ K V + A H L
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFET--ASNHPFLVG 60
Query: 481 LYDYFYHLEHLFIVCELLRAN--LYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLH 538
L+ F LF V E + ++ Q+ + A F + + AL +LH
Sbjct: 61 LHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISL-------ALNFLH 113
Query: 539 SLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQT----DNLCLYVQSRSYRAPEVIIG 594
GII+ DLK +N+L+ + IK+ D G C + D + + +Y APE++ G
Sbjct: 114 ERGIIYRDLKLDNVLLDA--EGHIKLTDYG-MCKEGIRPGDTTSTFCGTPNYIAPEILRG 170
Query: 595 LPYDQKIDLWSLGCILAELWTG 616
Y +D W+LG ++ E+ G
Sbjct: 171 EDYGFSVDWWALGVLMFEMMAG 192
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 1e-08
Identities = 54/203 (26%), Positives = 87/203 (42%), Gaps = 26/203 (12%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIK----NDKDFFDQSLDEIKLLKLVNKNDPADEHH 477
LG+ F +V+ T V +K +K + + F L E +++K + +
Sbjct: 14 LGAGQFGEVWMGTWNGT-TKVAVKTLKPGTMSPEAF----LQEAQIMKKLRHD------K 62
Query: 478 ILRLYDYFYHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEY 536
+++LY E ++IV E + +L +F K SG L +L + Q E + Y
Sbjct: 63 LVQLYAVCSEEEPIYIVTEYMSKGSLLDFLK----SGEGKKLRLPQLVDMAAQIAEGMAY 118
Query: 537 LHSLGIIHCDLKPENILIKSYQRCEIKIIDLG-SSCFQTDNLCLYVQSR---SYRAPEVI 592
L S IH DL NIL+ C KI D G + + D ++ + APE
Sbjct: 119 LESRNYIHRDLAARNILVGENLVC--KIADFGLARLIEDDEYTAREGAKFPIKWTAPEAA 176
Query: 593 IGLPYDQKIDLWSLGCILAELWT 615
+ K D+WS G +L E+ T
Sbjct: 177 NYGRFTIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.1 bits (136), Expect = 2e-08
Identities = 67/247 (27%), Positives = 92/247 (37%), Gaps = 77/247 (31%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRL 481
LG +VF + TG LK++ DK + + + +K V E IL
Sbjct: 9 LGKGDVGRVFLVRLKGTGKLFALKVL--DK----KEMIKRNKVKRV-----LTEQEILAT 57
Query: 482 YDYFYHLEHLFIVCELLRANLY-EFQK-----FNQE--SGGEAYFTLGRLQVITRQCLE- 532
D H F+ LY FQ + GGE + L Q +CL
Sbjct: 58 LD------HPFLP------TLYASFQTETYLCLVMDYCPGGELFRLL---QRQPGKCLSE 102
Query: 533 ------------ALEYLHSLGIIHCDLKPENILIK------------SYQ-----RCEIK 563
ALEYLH LGI++ DLKPENIL+ S Q K
Sbjct: 103 EVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSK 162
Query: 564 IIDLGSSCFQTDNLCLYV-------QSRS------YRAPEVIIGLPYDQKIDLWSLGCIL 610
+ GS +++ +S S Y APEVI G + +D W+LG +L
Sbjct: 163 ALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILL 222
Query: 611 AELWTGE 617
E+ G
Sbjct: 223 YEMLYGT 229
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 50/200 (25%), Positives = 91/200 (45%), Gaps = 15/200 (7%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRL 481
+G +++KV + T +K++K + D+ +D ++ K V + ++ ++ L
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQ-ASNHPFLVGL 61
Query: 482 YDYFYHLEHLFIVCELLRAN--LYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS 539
+ F LF V E + ++ Q+ + A F + + AL YLH
Sbjct: 62 HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISL-------ALNYLHE 114
Query: 540 LGIIHCDLKPENILIKSYQRCEIKIIDLG---SSCFQTDNLCLYVQSRSYRAPEVIIGLP 596
GII+ DLK +N+L+ S IK+ D G D + + +Y APE++ G
Sbjct: 115 RGIIYRDLKLDNVLLDS--EGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGED 172
Query: 597 YDQKIDLWSLGCILAELWTG 616
Y +D W+LG ++ E+ G
Sbjct: 173 YGFSVDWWALGVLMFEMMAG 192
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 54/209 (25%), Positives = 96/209 (45%), Gaps = 32/209 (15%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQ----SLDEIKLLKLVNKNDPADEHH 477
+G F +V+ + TG +K + + Q +L+E +L LV+ D
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCP---F 58
Query: 478 ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLE----- 532
I+ + F+ + L + +L+ +GG+ ++ L + V + + +
Sbjct: 59 IVCMTYAFHTPDKLCFILDLM-------------NGGDLHYHLSQHGVFSEKEMRFYATE 105
Query: 533 ---ALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC-FQTDNLCLYVQSRSYRA 588
LE++H+ +++ DLKP NIL+ + ++I DLG +C F V + Y A
Sbjct: 106 IILGLEHMHNRFVVYRDLKPANILLDEHG--HVRISDLGLACDFSKKKPHASVGTHGYMA 163
Query: 589 PEVI-IGLPYDQKIDLWSLGCILAELWTG 616
PEV+ G YD D +SLGC+L +L G
Sbjct: 164 PEVLQKGTAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 2e-08
Identities = 31/100 (31%), Positives = 52/100 (52%), Gaps = 11/100 (11%)
Query: 527 TRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS---CFQTDNLCLYVQS 583
T+Q L+ + YLH+ ++H D+K N+++ IK+ID G + + +
Sbjct: 108 TKQILDGVAYLHNNCVVHRDIKGNNVMLMP--NGIIKLIDFGCARRLAWVGLHGTHSNML 165
Query: 584 RSYR------APEVIIGLPYDQKIDLWSLGCILAELWTGE 617
+S APEVI Y +K D+WS+GC + E+ TG+
Sbjct: 166 KSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 3e-08
Identities = 41/121 (33%), Positives = 64/121 (52%), Gaps = 21/121 (17%)
Query: 512 SGGEA--------YFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 563
SGGE F+ ++ + + + ALE+LH LGI++ D+K ENIL+ S +
Sbjct: 88 SGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDS--EGHVV 145
Query: 564 IIDLG-SSCF------QTDNLCLYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWT 615
+ D G S F +T + C ++ Y APE+I G + + +D WSLG ++ EL T
Sbjct: 146 LTDFGLSKEFLSEEKERTYSFCGTIE---YMAPEIIRGKGGHGKAVDWWSLGILIFELLT 202
Query: 616 G 616
G
Sbjct: 203 G 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 3e-08
Identities = 52/190 (27%), Positives = 76/190 (40%), Gaps = 45/190 (23%)
Query: 464 LKLVNKNDPADEH------------------HILRLYDYFYHLEH-LFIVCEL-----LR 499
+KL+ + P +EH +I+ L D LF V E LR
Sbjct: 8 IKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTLR 67
Query: 500 ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILI-KSYQ 558
L G GRL + Q L+AL H+ GI+H DLKP+NI++ ++
Sbjct: 68 EVL-------AADGALPAGETGRLML---QVLDALACAHNQGIVHRDLKPQNIMVSQTGV 117
Query: 559 RCEIKIID-----LGSSCFQTDNLCL-----YVQSRSYRAPEVIIGLPYDQKIDLWSLGC 608
R K++D L D L + + +Y APE + G P DL++ G
Sbjct: 118 RPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGL 177
Query: 609 ILAELWTGEV 618
I E TG+
Sbjct: 178 IFLECLTGQR 187
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 4e-08
Identities = 24/48 (50%), Positives = 32/48 (66%), Gaps = 1/48 (2%)
Query: 523 LQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570
+Q I RQ L AL+ LHS GI+H D+KP+NI+ KIIDLG++
Sbjct: 257 IQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSG-SFKIIDLGAA 303
|
Length = 566 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 4e-08
Identities = 64/266 (24%), Positives = 101/266 (37%), Gaps = 85/266 (31%)
Query: 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLK--LVNKNDPA 473
++ + +G AF +V Q TG +K + + F L +K + L + P
Sbjct: 3 FHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSP- 61
Query: 474 DEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQV----ITR- 528
++ LY F ++L+++ E L GG+ L + +TR
Sbjct: 62 ---WVVSLYYSFQDAQYLYLIMEFL-------------PGGDLMTMLIKYDTFSEDVTRF 105
Query: 529 ---QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC-------------- 571
+C+ A+E +H LG IH D+KP+NILI + IK+ D G S
Sbjct: 106 YMAECVLAIEAVHKLGFIHRDIKPDNILID--RGGHIKLSDFGLSTGFHKQHDSAYYQKL 163
Query: 572 FQ---------------TDNLCLYVQSRS---------------------YRAPEVIIGL 595
Q D++ L + S+ Y APE+ +
Sbjct: 164 LQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQ 223
Query: 596 PYDQKIDLWSLGCILAELWTGEVCLI 621
Y Q+ D WSLG I+ E CLI
Sbjct: 224 GYGQECDWWSLGAIMFE------CLI 243
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 4e-08
Identities = 54/214 (25%), Positives = 95/214 (44%), Gaps = 23/214 (10%)
Query: 418 VTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHH 477
+ E +G + KVF+ + G +KI+ D ++ E +LK + +D +
Sbjct: 22 IIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKAL-----SDHPN 76
Query: 478 ILRLYDYFYHLE-----HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCL 531
+++ Y +Y + L++V EL ++ + K + G + + I + L
Sbjct: 77 VVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPI--IAYILHEAL 134
Query: 532 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC---LYVQSRSYRA 588
L++LH IH D+K NIL+ + +K++D G S T V + + A
Sbjct: 135 MGLQHLHVNKTIHRDVKGNNILLTT--EGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMA 192
Query: 589 PEVI-----IGLPYDQKIDLWSLGCILAELWTGE 617
PEVI + YD + D+WSLG EL G+
Sbjct: 193 PEVIACEQQLDSTYDARCDVWSLGITAIELGDGD 226
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 4e-08
Identities = 54/201 (26%), Positives = 91/201 (45%), Gaps = 25/201 (12%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKII----KNDKDFFDQSLDEIKLL-KLVNKNDPADEH 476
+G +F V+ A+D+ V +K + K + + + E++ L KL + N
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 477 HILRLYDYFYHLEH-LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALE 535
LR + + +E+ L +LL + Q+ + +T L+ L
Sbjct: 83 CYLREHTAWLVMEYCLGSASDLLEVHKKPLQEV-------------EIAAVTHGALQGLA 129
Query: 536 YLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGL 595
YLHS +IH D+K NIL+ + +K+ D GS+ +V + + APEVI+ +
Sbjct: 130 YLHSHNMIHRDVKAGNILLS--EPGLVKLGDFGSASIMAPANX-FVGTPYWMAPEVILAM 186
Query: 596 ---PYDQKIDLWSLGCILAEL 613
YD K+D+WSLG EL
Sbjct: 187 DEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 4e-08
Identities = 60/225 (26%), Positives = 91/225 (40%), Gaps = 49/225 (21%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPAD------- 474
LG AF KVF A+ C ++ D+ L +K LK +++ D
Sbjct: 13 LGEGAFGKVFLAE--------CHNLLPEQ----DKMLVAVKALKEASESARQDFQREAEL 60
Query: 475 -----EHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAY------------ 517
HI+R Y L +V E +R + +F + G +A
Sbjct: 61 LTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHG--DLNRFLRSHGPDAKILAGGEDVAPGQ 118
Query: 518 FTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS--CFQTD 575
TLG++ I Q + YL SL +H DL N L+ Q +KI D G S + TD
Sbjct: 119 LTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVG--QGLVVKIGDFGMSRDIYSTD 176
Query: 576 NLCLYVQSRS-----YRAPEVIIGLPYDQKIDLWSLGCILAELWT 615
V R+ + PE I+ + + D+WS G +L E++T
Sbjct: 177 Y--YRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 4e-08
Identities = 39/117 (33%), Positives = 59/117 (50%), Gaps = 17/117 (14%)
Query: 513 GGEAYFTL----GRLQVITRQCLE-------ALEYLHSLGIIHCDLKPENILIKSYQRCE 561
GG+ Y L G+L + Q +E AL+YLH I+H DLK +N+ +
Sbjct: 84 GGDLYHKLKEQKGKL-LPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNI-- 140
Query: 562 IKIIDLGSSCF---QTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT 615
IK+ DLG + Q D + + Y +PE+ PY+ K D+W+LGC + E+ T
Sbjct: 141 IKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMAT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 5e-08
Identities = 33/94 (35%), Positives = 49/94 (52%), Gaps = 7/94 (7%)
Query: 525 VITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNL----CL- 579
I R+ LEAL YLH GIIH D+K ENI + + + D G++C + C
Sbjct: 189 TIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLG--DFGAACKLDAHPDTPQCYG 246
Query: 580 YVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAEL 613
+ + +PE++ PY K D+WS G +L E+
Sbjct: 247 WSGTLETNSPELLALDPYCAKTDIWSAGLVLFEM 280
|
Length = 392 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 6e-08
Identities = 33/92 (35%), Positives = 46/92 (50%), Gaps = 12/92 (13%)
Query: 532 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN----LCLYVQSRSYR 587
A+ +H +G +H D+KPEN+LI IK+ D GS+ T N L V + Y
Sbjct: 113 LAIHSVHQMGYVHRDIKPENVLIDRTG--HIKLADFGSAARLTANKMVNSKLPVGTPDYI 170
Query: 588 APEVIIGL------PYDQKIDLWSLGCILAEL 613
APEV+ + Y + D WSLG I E+
Sbjct: 171 APEVLTTMNGDGKGTYGVECDWWSLGVIAYEM 202
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 8e-08
Identities = 56/219 (25%), Positives = 94/219 (42%), Gaps = 23/219 (10%)
Query: 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDP 472
+ + E +G + KV++ + G +KI+ D ++ E +L+ + N P
Sbjct: 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSL-PNHP 79
Query: 473 ADEHHILRLYDYFYHLEH-----LFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVI 526
++++ Y FY + L++V EL ++ E K G + I
Sbjct: 80 ----NVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQR--LDEAMISYI 133
Query: 527 TRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC---LYVQS 583
L L++LH+ IIH D+K NIL+ + +K++D G S T V +
Sbjct: 134 LYGALLGLQHLHNNRIIHRDVKGNNILLTT--EGGVKLVDFGVSAQLTSTRLRRNTSVGT 191
Query: 584 RSYRAPEVII-----GLPYDQKIDLWSLGCILAELWTGE 617
+ APEVI YD + D+WSLG EL G+
Sbjct: 192 PFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGD 230
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 9e-08
Identities = 51/207 (24%), Positives = 94/207 (45%), Gaps = 24/207 (11%)
Query: 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPAD 474
+ + + +GS + V++A++++TG +K+IK + + F EI ++K
Sbjct: 11 FELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMK------DCK 64
Query: 475 EHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQV--ITRQCLE 532
+I+ + + + L+I E Q +G L Q+ ++R+ L+
Sbjct: 65 HSNIVAYFGSYLRRDKLWICMEFCGGG--SLQDIYHVTG-----PLSESQIAYVSRETLQ 117
Query: 533 ALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC---LYVQSRSYRAP 589
L YLHS G +H D+K NIL+ +K+ D G S T + ++ + + AP
Sbjct: 118 GLYYLHSKGKMHRDIKGANILLTD--NGHVKLADFGVSAQITATIAKRKSFIGTPYWMAP 175
Query: 590 EVII---GLPYDQKIDLWSLGCILAEL 613
EV Y+Q D+W++G EL
Sbjct: 176 EVAAVERKGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 9e-08
Identities = 57/221 (25%), Positives = 100/221 (45%), Gaps = 36/221 (16%)
Query: 422 LGSAAFSKVFQAQDL-------HTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKND 471
LG F +V A+ L V V +K++K+D KD D + E++++K++ K+
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDL-VSEMEMMKMIGKHK 81
Query: 472 PADEHHILRLYDYFYHLEHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGR-------- 522
+I+ L L+++ E + NL E+ + + G E + + R
Sbjct: 82 -----NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTF 136
Query: 523 --LQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLY 580
L T Q +EYL S IH DL N+L+ + +KI D G + +N+ Y
Sbjct: 137 KDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVT--ENNVMKIADFGLA-RDVNNIDYY 193
Query: 581 VQSRSYR------APEVIIGLPYDQKIDLWSLGCILAELWT 615
++ + R APE + Y + D+WS G ++ E++T
Sbjct: 194 KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 1e-07
Identities = 48/183 (26%), Positives = 85/183 (46%), Gaps = 17/183 (9%)
Query: 445 KIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYE 504
K +K Q +EI L +N + ILR Y + + +LY
Sbjct: 198 KRVKAGSRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKY------DFDLYS 251
Query: 505 FQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKI 564
F +++ + L + + I +Q L A+EY+H +IH D+K ENI + C+ KI
Sbjct: 252 FM-YDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLN----CDGKI 306
Query: 565 I--DLGSSC-FQTDNLCL---YVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEV 618
+ D G++ F+ + +V + + +PE++ G Y + D+WS G IL ++ + +
Sbjct: 307 VLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDF 366
Query: 619 CLI 621
C I
Sbjct: 367 CPI 369
|
Length = 501 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 55/224 (24%), Positives = 90/224 (40%), Gaps = 37/224 (16%)
Query: 422 LGSAAFSKVFQAQDLHTG-----VDVCLKIIK---NDKDFFDQSLDEIKLLKLVNKNDPA 473
LG F KV +A V +K++K + + D L E LLK VN
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDL-LSEFNLLKQVN----- 61
Query: 474 DEHHILRLYDYFYHLEHLFIVCEL-----LRANLYEFQKF---------NQESG-----G 514
H+++LY L ++ E LR+ L E +K N+ S
Sbjct: 62 -HPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120
Query: 515 EAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQT 574
E T+G L Q ++YL + ++H DL N+L+ ++ +I L ++
Sbjct: 121 ERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEE 180
Query: 575 DNLCLYVQSR---SYRAPEVIIGLPYDQKIDLWSLGCILAELWT 615
D+ + R + A E + Y + D+WS G +L E+ T
Sbjct: 181 DSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 2e-07
Identities = 55/201 (27%), Positives = 91/201 (45%), Gaps = 20/201 (9%)
Query: 422 LGSAAFSKVFQAQDLHTG-VDVCLKIIKN---DKDFFDQSLDEIKLLKLVNKNDPADEHH 477
LG F +V Q TG + C K+ K + ++ ++ E ++L V+
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVH------SRF 54
Query: 478 ILRLYDYFYHLEHLFIVCELLRANLYEFQKFN--QESGGEAYFTLGRLQVITRQCLEALE 535
I+ L F L +V ++ + +N +E+ G F R T Q + LE
Sbjct: 55 IVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPG---FPEPRACFYTAQIISGLE 111
Query: 536 YLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL---YVQSRSYRAPEVI 592
+LH II+ DLKPEN+L+ + ++I DLG + D Y + + APE++
Sbjct: 112 HLHQRRIIYRDLKPENVLLDN--DGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELL 169
Query: 593 IGLPYDQKIDLWSLGCILAEL 613
G YD +D ++LG L E+
Sbjct: 170 QGEEYDFSVDYFALGVTLYEM 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 48/198 (24%), Positives = 89/198 (44%), Gaps = 11/198 (5%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRL 481
+G +++KV + +K++K + D+ +D ++ K V + ++ ++ L
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPF-LVGL 61
Query: 482 YDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLG 541
+ F LF+V E + F Q E + ++ C+ AL +LH G
Sbjct: 62 HSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEI----CI-ALNFLHERG 116
Query: 542 IIHCDLKPENILIKSYQRCEIKIIDLG---SSCFQTDNLCLYVQSRSYRAPEVIIGLPYD 598
II+ DLK +N+L+ IK+ D G D + + +Y APE++ G Y
Sbjct: 117 IIYRDLKLDNVLLD--ADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYG 174
Query: 599 QKIDLWSLGCILAELWTG 616
+D W+LG ++ E+ G
Sbjct: 175 FSVDWWALGVLMFEMMAG 192
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 2e-07
Identities = 58/213 (27%), Positives = 99/213 (46%), Gaps = 29/213 (13%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLK---IIKNDKDFFDQSLDEIKLLKLVNKND 471
+Y + +G +F K + G +K I K ++S E+ +L N
Sbjct: 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLS--NMKH 58
Query: 472 PADEHHILRLYDYFYHLEHLFIV---CELLRANLYEFQKFNQESGGEAYFTLGR-LQVIT 527
P +I++ + F +L+IV CE +LY +K N + G F + L
Sbjct: 59 P----NIVQYQESFEENGNLYIVMDYCE--GGDLY--KKINAQRG--VLFPEDQILDWFV 108
Query: 528 RQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG-----SSCFQTDNLCLYVQ 582
+ CL AL+++H I+H D+K +NI + + IK+ D G +S + C +
Sbjct: 109 QICL-ALKHVHDRKILHRDIKSQNIFLT--KDGTIKLGDFGIARVLNSTVELARTC--IG 163
Query: 583 SRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT 615
+ Y +PE+ PY+ K D+W+LGC+L E+ T
Sbjct: 164 TPYYLSPEICENRPYNNKSDIWALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-07
Identities = 57/220 (25%), Positives = 92/220 (41%), Gaps = 51/220 (23%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHH 477
LG F KV ++ TG +KI+K + KD +L E ++L+ N P
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQ--NSRHP----- 55
Query: 478 ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQ-------ESGGEAYFTLGRLQVITR-- 528
L A Y FQ ++ +GGE +F L R +V +
Sbjct: 56 -------------------FLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDR 96
Query: 529 ------QCLEALEYLHS-LGIIHCDLKPENILIKSYQRCEIKIIDLG---SSCFQTDNLC 578
+ + AL+YLHS +++ DLK EN+++ + IKI D G +
Sbjct: 97 ARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLD--KDGHIKITDFGLCKEGIKDGATMK 154
Query: 579 LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEV 618
+ + Y APEV+ Y + +D W LG ++ E+ G +
Sbjct: 155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 3e-07
Identities = 48/201 (23%), Positives = 84/201 (41%), Gaps = 23/201 (11%)
Query: 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLL-KLVNKNDPADEHHI 478
+G F V + G V +K +K+D L E ++ L + N +
Sbjct: 12 ATIGKGEFGDVMLG--DYRGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPN-------L 62
Query: 479 LRLYDYFYHLEHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYL 537
++L L+IV E + + +L ++ + S G A TL + E +EYL
Sbjct: 63 VQLLGVVLQGNPLYIVTEYMAKGSLVDYLR----SRGRAVITLAQQLGFALDVCEGMEYL 118
Query: 538 HSLGIIHCDLKPENILIKSYQRCEIKIIDLG---SSCFQTDNLCLYVQSRSYRAPEVIIG 594
+H DL N+L+ + K+ D G + D+ L V+ + APE +
Sbjct: 119 EEKNFVHRDLAARNVLVS--EDLVAKVSDFGLAKEASQGQDSGKLPVK---WTAPEALRE 173
Query: 595 LPYDQKIDLWSLGCILAELWT 615
+ K D+WS G +L E+++
Sbjct: 174 KKFSTKSDVWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 3e-07
Identities = 39/148 (26%), Positives = 61/148 (41%), Gaps = 23/148 (15%)
Query: 477 HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLE---- 532
+++ L+ Y + +F+V + GG+ + + + I +C++
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQ-------------HAEGGKLWSHISKFLNIPEECVKRWAA 92
Query: 533 ----ALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRA 588
AL+ LH GI+ DL P NIL+ R I++ D+ Y A
Sbjct: 93 EMVVALDALHREGIVCRDLNPNNILLD--DRGHIQLTYFSRWSEVEDSCDGEAVENMYCA 150
Query: 589 PEVIIGLPYDQKIDLWSLGCILAELWTG 616
PEV + D WSLG IL EL TG
Sbjct: 151 PEVGGISEETEACDWWSLGAILFELLTG 178
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 3e-07
Identities = 53/220 (24%), Positives = 87/220 (39%), Gaps = 52/220 (23%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHH 477
LG F KV A+ TG +K +K +D + + E ++ + N E H
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANS-----ERH 61
Query: 478 --ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGG-------EAYFTLGRLQVITR 528
++ L+ F +H+ V E +GG F+ R
Sbjct: 62 PFLVNLFACFQTEDHVCFVMEYA-------------AGGDLMMHIHTDVFSEPRAVFYAA 108
Query: 529 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC---LYVQSRS 585
+ L+YLH I++ DLK +N+L+ + +KI D G LC + R+
Sbjct: 109 CVVLGLQYLHENKIVYRDLKLDNLLLDT--EGFVKIADFG--------LCKEGMGFGDRT 158
Query: 586 --------YRAPEVIIGLPYDQKIDLWSLGCILAELWTGE 617
+ APEV+ Y + +D W LG ++ E+ GE
Sbjct: 159 STFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGE 198
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 3e-07
Identities = 52/199 (26%), Positives = 87/199 (43%), Gaps = 18/199 (9%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRL 481
LG+ F +V+ + V +K +K L+E L+K + + ++RL
Sbjct: 14 LGAGQFGEVWMGY-YNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHD------KLVRL 66
Query: 482 YDYFYHLEHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSL 540
Y E ++I+ E + + +L +F K + GG+ L +L + Q E + Y+
Sbjct: 67 YAVVTKEEPIYIITEYMAKGSLLDFLK--SDEGGK--VLLPKLIDFSAQIAEGMAYIERK 122
Query: 541 GIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSY----RAPEVIIGLP 596
IH DL+ N+L+ C KI D G + DN + + APE I
Sbjct: 123 NYIHRDLRAANVLVSESLMC--KIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGS 180
Query: 597 YDQKIDLWSLGCILAELWT 615
+ K D+WS G +L E+ T
Sbjct: 181 FTIKSDVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 5e-07
Identities = 53/207 (25%), Positives = 82/207 (39%), Gaps = 23/207 (11%)
Query: 420 EYLGSAAFSKVFQA---QDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEH 476
+ LG +F V + + V +K +K+DK +D+ LK D
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDK--LSDIMDD--FLKEAAIMHSLDHE 56
Query: 477 HILRLYDYFYHLEH-LFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEAL 534
+++RLY L H L +V EL +L + + + +F + L Q +
Sbjct: 57 NLIRLYGVV--LTHPLMMVTELAPLGSLLDRLRKDAL----GHFLISTLCDYAVQIANGM 110
Query: 535 EYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR------A 588
YL S IH DL NIL+ S ++KI D G N YV + A
Sbjct: 111 RYLESKRFIHRDLAARNILLAS--DDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCA 168
Query: 589 PEVIIGLPYDQKIDLWSLGCILAELWT 615
PE + + D+W G L E++T
Sbjct: 169 PESLRTRTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 6e-07
Identities = 40/117 (34%), Positives = 60/117 (51%), Gaps = 14/117 (11%)
Query: 512 SGGEAY--------FTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 563
SGGE + F+ R + + + ALE+LH I++ DLKPENIL+ + I
Sbjct: 79 SGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDA--TGHIA 136
Query: 564 IIDLG-SSCFQTDNLC--LYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTG 616
+ D G S TDN + + Y APEV++ Y + +D WSLG ++ E+ G
Sbjct: 137 LCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 7e-07
Identities = 54/214 (25%), Positives = 92/214 (42%), Gaps = 30/214 (14%)
Query: 418 VTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKN--DKDFFDQSLDEIKLLKLVNKNDPADE 475
V + LG + V++ TGV + +K I+ D+ F+Q + E+ +L A
Sbjct: 5 VLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILH------KAVS 58
Query: 476 HHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALE 535
+I+ Y F+ +++ E + A K L+ IT ++ L+
Sbjct: 59 PYIVDFYGAFFIEGAVYMCMEYMDAG--SLDKLYAGGVATEGIPEDVLRRITYAVVKGLK 116
Query: 536 YL-HSLGIIHCDLKPENILIKSYQRCEIKIIDLG------SSCFQTDNLCLYVQSRSYRA 588
+L IIH D+KP N+L+ ++K+ D G +S +T+ C +SY A
Sbjct: 117 FLKEEHNIIHRDVKPTNVLVNG--NGQVKLCDFGVSGNLVASLAKTNIGC-----QSYMA 169
Query: 589 PEVIIG------LPYDQKIDLWSLGCILAELWTG 616
PE I Y + D+WSLG + E+ G
Sbjct: 170 PERIKSGGPNQNPTYTVQSDVWSLGLSILEMALG 203
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 7e-07
Identities = 49/214 (22%), Positives = 90/214 (42%), Gaps = 42/214 (19%)
Query: 422 LGSAAFSKVFQAQDLHTG----VDVCLKIIKNDKD--FFDQSLDEIKLLKLVNKNDPADE 475
LGS AF V++ + G + V +K+++ + + LDE ++ V D
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASV------DH 68
Query: 476 HHILRLYDYFYHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVIT--RQCLE 532
H++RL + ++ +L+ L ++ + +++ +G ++ Q +
Sbjct: 69 PHVVRLLGICLS-SQVQLITQLMPLGCLLDYVRNHKD-------NIGSQYLLNWCVQIAK 120
Query: 533 ALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR----- 587
+ YL ++H DL N+L+K+ Q +KI D G + L V + Y
Sbjct: 121 GMSYLEEKRLVHRDLAARNVLVKTPQ--HVKITDFGLAKL------LDVDEKEYHAEGGK 172
Query: 588 ------APEVIIGLPYDQKIDLWSLGCILAELWT 615
A E I+ Y K D+WS G + EL T
Sbjct: 173 VPIKWMALESILHRIYTHKSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 9e-07
Identities = 48/197 (24%), Positives = 75/197 (38%), Gaps = 63/197 (31%)
Query: 473 ADEHHILRLYDYFYHLEHLFIVCEL-----LRANLYEFQKFNQESGGEAYFTLGRLQVIT 527
AD +++LY F ++L+ V + + + L F ++ L R +
Sbjct: 58 ADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEED--------LARFYIAE 109
Query: 528 RQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG------------------- 568
C A+E +H +G IH D+KP+NILI + IK+ D G
Sbjct: 110 LTC--AIESVHKMGFIHRDIKPDNILID--RDGHIKLTDFGLCTGFRWTHDSKYYQKGDH 165
Query: 569 ---------------SSC---------FQTDNLCL---YVQSRSYRAPEVIIGLPYDQKI 601
C + CL V + +Y APEV++ Y Q
Sbjct: 166 HRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLC 225
Query: 602 DLWSLGCILAELWTGEV 618
D WS+G IL E+ G+
Sbjct: 226 DWWSVGVILYEMLVGQP 242
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 58/252 (23%), Positives = 93/252 (36%), Gaps = 71/252 (28%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRL 481
LG AF +V A + T +K ++ + +K + + AD +++L
Sbjct: 9 LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAE--ADNEWVVKL 66
Query: 482 YDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLE--------A 533
Y F ++L+ V + + GG+ L R++V A
Sbjct: 67 YYSFQDKDNLYFVMDYI-------------PGGDMMSLLIRMEVFPEVLARFYIAELTLA 113
Query: 534 LEYLHSLGIIHCDLKPENILI-----------------------KSYQ------------ 558
+E +H +G IH D+KP+NILI K YQ
Sbjct: 114 IESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEP 173
Query: 559 ----------RCEIKIIDLGSSCFQTDNLCL---YVQSRSYRAPEVIIGLPYDQKIDLWS 605
RC ++ L + CL V + +Y APEV++ Y Q D WS
Sbjct: 174 SDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWS 233
Query: 606 LGCILAELWTGE 617
+G IL E+ G+
Sbjct: 234 VGVILFEMLVGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 1e-06
Identities = 53/200 (26%), Positives = 86/200 (43%), Gaps = 21/200 (10%)
Query: 422 LGSAAFSKVFQAQ-DLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILR 480
LG+ F +V+ A + HT V V K +K + L E ++K +H L
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAV--KTMKPGSMSVEAFLAEANVMK-------TLQHDKLV 64
Query: 481 LYDYFYHLEHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS 539
E ++I+ E + + +L +F K + G + L +L + Q E + ++
Sbjct: 65 KLHAVVTKEPIYIITEFMAKGSLLDFLK--SDEGSKQ--PLPKLIDFSAQIAEGMAFIEQ 120
Query: 540 LGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSY----RAPEVIIGL 595
IH DL+ NIL+ + C KI D G + DN + + APE I
Sbjct: 121 RNYIHRDLRAANILVSASLVC--KIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFG 178
Query: 596 PYDQKIDLWSLGCILAELWT 615
+ K D+WS G +L E+ T
Sbjct: 179 SFTIKSDVWSFGILLMEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 59/254 (23%), Positives = 95/254 (37%), Gaps = 75/254 (29%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRL 481
LG AF +V A+ + T +K ++ + +K + + AD ++RL
Sbjct: 9 LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAE--ADNEWVVRL 66
Query: 482 YDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLE--------A 533
Y F ++L+ V + + GG+ L R+ + A
Sbjct: 67 YYSFQDKDNLYFVMDYI-------------PGGDMMSLLIRMGIFPEDLARFYIAELTCA 113
Query: 534 LEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG------------------------- 568
+E +H +G IH D+KP+NILI + IK+ D G
Sbjct: 114 VESVHKMGFIHRDIKPDNILID--RDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSM 171
Query: 569 ---------SSCFQTDNL-------------CL---YVQSRSYRAPEVIIGLPYDQKIDL 603
++C D L CL V + +Y APEV++ Y Q D
Sbjct: 172 DFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDW 231
Query: 604 WSLGCILAELWTGE 617
WS+G IL E+ G+
Sbjct: 232 WSVGVILYEMLVGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 1e-06
Identities = 34/103 (33%), Positives = 57/103 (55%), Gaps = 23/103 (22%)
Query: 534 LEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF----QTDNLCLYVQSRS---- 585
+EY+HS G++H DLKP+NIL+ + E+ I+D G++ F + D L + V R+
Sbjct: 126 IEYVHSKGVLHRDLKPDNILLGLFG--EVVILDWGAAIFKKLEEEDLLDIDVDERNICYS 183
Query: 586 -------------YRAPEVIIGLPYDQKIDLWSLGCILAELWT 615
Y APE ++G+P + D+++LG IL ++ T
Sbjct: 184 SMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 2e-06
Identities = 31/100 (31%), Positives = 53/100 (53%), Gaps = 12/100 (12%)
Query: 527 TRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLY-----V 581
T + + AL+ +HS+G IH D+KP+N+L+ +K+ D G +C + D + V
Sbjct: 148 TAEVVLALDAIHSMGFIHRDVKPDNMLLDKSG--HLKLADFG-TCMKMDANGMVRCDTAV 204
Query: 582 QSRSYRAPEVIIGL----PYDQKIDLWSLGCILAELWTGE 617
+ Y +PEV+ Y ++ D WS+G L E+ G+
Sbjct: 205 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 244
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 49/177 (27%), Positives = 83/177 (46%), Gaps = 25/177 (14%)
Query: 445 KIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCE-LLRANLY 503
KIIK + D E K+L +N + LY F +L++V E ++ +
Sbjct: 68 KIIKQKQ--VDHVFSERKILNYIN------HPFCVNLYGSFKDESYLYLVLEFVIGGEFF 119
Query: 504 EFQKFNQESGGE-AYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEI 562
F + N+ + F ++ +I EYL SL I++ DLKPEN+L+ + I
Sbjct: 120 TFLRRNKRFPNDVGCFYAAQIVLI-------FEYLQSLNIVYRDLKPENLLLD--KDGFI 170
Query: 563 KIIDLGSSCF---QTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTG 616
K+ D G + +T LC + Y APE+++ + + + D W+LG + E+ G
Sbjct: 171 KMTDFGFAKVVDTRTYTLC---GTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 2e-06
Identities = 53/220 (24%), Positives = 90/220 (40%), Gaps = 36/220 (16%)
Query: 422 LGSAAFSKVFQAQ----DLHTGVDVC----LKIIKNDKDFFDQSLDEIKLLKLVNKNDPA 473
LG AF +V +A+ D LK +KD D + E++++K++ K+
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDL-VSEMEMMKMIGKHK-- 76
Query: 474 DEHHILRLYDYFYHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYF----------TLGR 522
+I+ L L++V E NL +F + + G A T
Sbjct: 77 ---NIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKD 133
Query: 523 LQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQ 582
L Q +E+L S IH DL N+L+ + +KI D G + + + Y +
Sbjct: 134 LVSFAYQVARGMEFLASKKCIHRDLAARNVLVT--EDHVMKIADFGLA--RDIHHIDYYR 189
Query: 583 SRS-------YRAPEVIIGLPYDQKIDLWSLGCILAELWT 615
+ + APE + Y + D+WS G +L E++T
Sbjct: 190 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 33/86 (38%), Positives = 46/86 (53%), Gaps = 4/86 (4%)
Query: 534 LEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF--QTDNLCLYVQSRSYRAPEV 591
LE L I++ DLKPENIL+ R I+I DLG + + + + V + Y APEV
Sbjct: 115 LEDLQRERIVYRDLKPENILLDD--RGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEV 172
Query: 592 IIGLPYDQKIDLWSLGCILAELWTGE 617
I Y D W LGC++ E+ G+
Sbjct: 173 INNEKYTFSPDWWGLGCLIYEMIQGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 36/92 (39%), Positives = 49/92 (53%), Gaps = 7/92 (7%)
Query: 529 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSR---- 584
Q + AL+ +HS ++H DLK NI + IK+ D G S +D++ L V S
Sbjct: 177 QIVLALDEVHSRKMMHRDLKSANIFLMPTGI--IKLGDFGFSKQYSDSVSLDVASSFCGT 234
Query: 585 -SYRAPEVIIGLPYDQKIDLWSLGCILAELWT 615
Y APE+ Y +K D+WSLG IL EL T
Sbjct: 235 PYYLAPELWERKRYSKKADMWSLGVILYELLT 266
|
Length = 478 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.5 bits (120), Expect = 2e-06
Identities = 64/239 (26%), Positives = 104/239 (43%), Gaps = 50/239 (20%)
Query: 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADE 475
Y V + +G+ F +VF + T C K I + ++ +L+ VN
Sbjct: 15 YEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL---KEREKSQLVIEVNVMRELKH 71
Query: 476 HHILRLYDYFYHL--EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQV-----ITR 528
+I+R D F + + L+I+ E A + + Q+ Y G+++ ITR
Sbjct: 72 KNIVRYIDRFLNKANQKLYILMEFCDAG--DLSRNIQK----CYKMFGKIEEHAIVDITR 125
Query: 529 QCLEALEYLHSLG-------IIHCDLKPENILIKS---------------YQRCEIKIID 566
Q L AL Y H+L ++H DLKP+NI + + R KI D
Sbjct: 126 QLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGD 185
Query: 567 LGSSCFQTDNLCLYVQSRS------YRAPEVII--GLPYDQKIDLWSLGCILAELWTGE 617
G S N+ + + S Y +PE+++ YD K D+W+LGCI+ EL +G+
Sbjct: 186 FGLS----KNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240
|
Length = 1021 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 31/100 (31%), Positives = 55/100 (55%), Gaps = 12/100 (12%)
Query: 527 TRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLY-----V 581
T + + AL+ +HS+G+IH D+KP+N+L+ + +K+ D G +C + D + V
Sbjct: 148 TAEVVLALDAIHSMGLIHRDVKPDNMLLDKHG--HLKLADFG-TCMKMDETGMVRCDTAV 204
Query: 582 QSRSYRAPEVIIGLP----YDQKIDLWSLGCILAELWTGE 617
+ Y +PEV+ Y ++ D WS+G L E+ G+
Sbjct: 205 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGD 244
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 3e-06
Identities = 29/91 (31%), Positives = 37/91 (40%), Gaps = 12/91 (13%)
Query: 528 RQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR 587
QCL AL LH L + L+K GS F+T +
Sbjct: 24 LQCLGALRELHRQAKSGNILLTWDGLLKLD----------GSVAFKTPEQSR--PDPYFM 71
Query: 588 APEVIIGLPYDQKIDLWSLGCILAELWTGEV 618
APEVI G Y +K D++SLG L E E+
Sbjct: 72 APEVIQGQSYTEKADIYSLGITLYEALDYEL 102
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 3e-06
Identities = 30/129 (23%), Positives = 53/129 (41%), Gaps = 43/129 (33%)
Query: 529 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG-SSCFQTDNLCLY------- 580
+ + A++ +H LG IH D+KP+N+L+ + + IK+ D G + + + +
Sbjct: 109 ETILAIDSIHKLGYIHRDIKPDNLLLDA--KGHIKLSDFGLCTGLKKSHRTEFYRILSHA 166
Query: 581 ---------------------------------VQSRSYRAPEVIIGLPYDQKIDLWSLG 607
V + Y APEV + Y+++ D WSLG
Sbjct: 167 LPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLG 226
Query: 608 CILAELWTG 616
I+ E+ G
Sbjct: 227 VIMYEMLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 3e-06
Identities = 50/203 (24%), Positives = 90/203 (44%), Gaps = 21/203 (10%)
Query: 422 LGSAAFSKVFQA--QDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHIL 479
LGS F V + + + V +KI+KND + D +L + +LL+ N D +I+
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNN--DPALKD-ELLREANVMQQLDNPYIV 59
Query: 480 RLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS 539
R+ E +V EL A L KF Q++ + T + + Q ++YL
Sbjct: 60 RMIG-ICEAESWMLVMEL--AELGPLNKFLQKN---KHVTEKNITELVHQVSMGMKYLEE 113
Query: 540 LGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS-------YRAPEVI 592
+H DL N+L+ + +I L + +N Y ++++ + APE +
Sbjct: 114 TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADEN---YYKAKTHGKWPVKWYAPECM 170
Query: 593 IGLPYDQKIDLWSLGCILAELWT 615
+ K D+WS G ++ E ++
Sbjct: 171 NYYKFSSKSDVWSFGVLMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 3e-06
Identities = 40/132 (30%), Positives = 60/132 (45%), Gaps = 11/132 (8%)
Query: 489 EHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDL 547
E ++IV E + + +L +F K G Y L +L + Q + + Y+ + IH DL
Sbjct: 73 EPIYIVTEFMGKGSLLDFLK----EGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDL 128
Query: 548 KPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSY----RAPEVIIGLPYDQKIDL 603
+ NIL+ C KI D G + DN Q + APE + + K D+
Sbjct: 129 RAANILVGDNLVC--KIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186
Query: 604 WSLGCILAELWT 615
WS G +L EL T
Sbjct: 187 WSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 6e-06
Identities = 51/207 (24%), Positives = 87/207 (42%), Gaps = 27/207 (13%)
Query: 420 EYLGSAAFSKVF----QAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADE 475
E +G F +VF +A + V C + + D + L E ++LK + +
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLP--PDLKAKFLQEARILKQYSHPN---- 54
Query: 476 HHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALE 535
I+RL + ++IV EL++ +F F + G + L + +E
Sbjct: 55 --IVRLIGVCTQKQPIYIVMELVQGG--DFLTFLRTEG--PRLKVKELIQMVENAAAGME 108
Query: 536 YLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR-------A 588
YL S IH DL N L+ ++ +KI D G S + D + Y + + A
Sbjct: 109 YLESKHCIHRDLAARNCLVT--EKNVLKISDFGMSREEEDGV--YASTGGMKQIPVKWTA 164
Query: 589 PEVIIGLPYDQKIDLWSLGCILAELWT 615
PE + Y + D+WS G +L E ++
Sbjct: 165 PEALNYGRYSSESDVWSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 7e-06
Identities = 45/182 (24%), Positives = 80/182 (43%), Gaps = 22/182 (12%)
Query: 441 DVCLKIIKNDKDFFDQSLDEIK-LLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLR 499
DV +K+IK D+ ++E K ++KL ++ +++LY ++IV E +
Sbjct: 30 DVAIKMIKEGSMSEDEFIEEAKVMMKLSHEK-------LVQLYGVCTKQRPIYIVTEYMS 82
Query: 500 ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQR 559
N F +L + + E + YL S IH DL N L+ Q
Sbjct: 83 NGCL----LNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDD-QG 137
Query: 560 CEIKIIDLGSSCFQTDNLCLYVQSRS------YRAPEVIIGLPYDQKIDLWSLGCILAEL 613
C +K+ D G S + D+ Y S + PEV++ + K D+W+ G ++ E+
Sbjct: 138 C-VKVSDFGLSRYVLDDE--YTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEV 194
Query: 614 WT 615
++
Sbjct: 195 YS 196
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 9e-06
Identities = 56/221 (25%), Positives = 98/221 (44%), Gaps = 36/221 (16%)
Query: 422 LGSAAFSKVFQAQDL-------HTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKND 471
LG F +V A+ + + V V +K++K+D KD D + E++++K++ K+
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDL-VSEMEMMKMIGKHK 78
Query: 472 PADEHHILRLYDYFYHLEHLFIVCELL-RANLYEFQKFNQESGGEAYF----------TL 520
+I+ L L+++ E + NL E+ + + G + F T
Sbjct: 79 -----NIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTF 133
Query: 521 GRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLY 580
L Q +EYL S IH DL N+L+ + +KI D G + N+ Y
Sbjct: 134 KDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVT--EDNVMKIADFGLA-RDVHNIDYY 190
Query: 581 VQSRSYR------APEVIIGLPYDQKIDLWSLGCILAELWT 615
++ + R APE + Y + D+WS G +L E++T
Sbjct: 191 KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 9e-06
Identities = 52/199 (26%), Positives = 87/199 (43%), Gaps = 19/199 (9%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRL 481
LG+ F +V+ + V +K +K + L+E +++K + ++D +++L
Sbjct: 14 LGNGQFGEVWMGT-WNGNTKVAVKTLKPGTMSPESFLEEAQIMKKL-RHD-----KLVQL 66
Query: 482 YDYFYHLEHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSL 540
Y E ++IV E + + +L +F K G L L + Q + Y+ +
Sbjct: 67 YAVVSE-EPIYIVTEYMSKGSLLDFLK----DGEGRALKLPNLVDMAAQVAAGMAYIERM 121
Query: 541 GIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSY----RAPEVIIGLP 596
IH DL+ NIL+ C KI D G + DN Q + APE +
Sbjct: 122 NYIHRDLRSANILVGDGLVC--KIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 179
Query: 597 YDQKIDLWSLGCILAELWT 615
+ K D+WS G +L EL T
Sbjct: 180 FTIKSDVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 1e-05
Identities = 40/149 (26%), Positives = 65/149 (43%), Gaps = 13/149 (8%)
Query: 476 HHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALE 535
H+I+RL + I+ E + K+ ++ GE F+ +L + R ++
Sbjct: 66 HNIIRLEGVVTKFKPAMIITEYMENG--ALDKYLRDHDGE--FSSYQLVGMLRGIAAGMK 121
Query: 536 YLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG-SSCFQTDNLCLYVQSRS-----YRAP 589
YL + +H DL NIL+ S C K+ D G S + D Y S + AP
Sbjct: 122 YLSDMNYVHRDLAARNILVNSNLEC--KVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAP 179
Query: 590 EVIIGLPYDQKIDLWSLGCILAELWT-GE 617
E I + D+WS G ++ E+ + GE
Sbjct: 180 EAIAYRKFTSASDVWSFGIVMWEVMSFGE 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 1e-05
Identities = 55/220 (25%), Positives = 92/220 (41%), Gaps = 34/220 (15%)
Query: 422 LGSAAFSKVFQAQDLHTGVD---------VCLKIIKN---DKDFFDQSLDEIKLLKLVNK 469
LG F +V +A+ G+D V +K++K+ DKD D + E++L+KL+ K
Sbjct: 20 LGEGCFGQVVRAEAY--GIDKSRPDQTVTVAVKMLKDNATDKDLADL-ISEMELMKLIGK 76
Query: 470 NDPADEHHILRLYDYFYHLEHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGR------ 522
+ +I+ L L+++ E + NL EF + + G + F + +
Sbjct: 77 HK-----NIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQL 131
Query: 523 ----LQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC 578
L Q +EYL S IH DL N+L+ +I L D
Sbjct: 132 SFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYK 191
Query: 579 LYVQSR---SYRAPEVIIGLPYDQKIDLWSLGCILAELWT 615
R + APE + Y + D+WS G ++ E++T
Sbjct: 192 KTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 1e-05
Identities = 51/213 (23%), Positives = 88/213 (41%), Gaps = 32/213 (15%)
Query: 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQS---LDEIKLLKLVNKNDPADEH 476
E +G F V++ L +V +K ++ D L E ++LK + P
Sbjct: 1 EKIGKGNFGDVYKGV-LKGNTEVAVKTCRST-LPPDLKRKFLQEAEILK--QYDHP---- 52
Query: 477 HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEA--- 533
+I++L + ++IV EL+ F ++ T+ +L + L+A
Sbjct: 53 NIVKLIGVCVQKQPIYIVMELVPGG--SLLTFLRKKKNR--LTVKKL---LQMSLDAAAG 105
Query: 534 LEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR------ 587
+EYL S IH DL N L+ + +KI D G S + + +Y S +
Sbjct: 106 MEYLESKNCIHRDLAARNCLVG--ENNVLKISDFGMS--REEEGGIYTVSDGLKQIPIKW 161
Query: 588 -APEVIIGLPYDQKIDLWSLGCILAELWTGEVC 619
APE + Y + D+WS G +L E ++
Sbjct: 162 TAPEALNYGRYTSESDVWSYGILLWETFSLGDT 194
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 53/220 (24%), Positives = 90/220 (40%), Gaps = 34/220 (15%)
Query: 422 LGSAAFSKVFQAQDLHTGVD---------VCLKIIKND---KDFFDQSLDEIKLLKLVNK 469
LG F +V A+ + G+D V +K++K+D KD D + E++++K++ K
Sbjct: 26 LGEGCFGQVVMAEAI--GLDKEKPNRVTKVAVKMLKSDATEKDLSDL-ISEMEMMKMIGK 82
Query: 470 NDPADEHHILRLYDYFYHLEHLFIVCELL-RANLYEFQK----------FNQESGGEAYF 518
+ +I+ L L+++ E + NL E+ + +N E
Sbjct: 83 HK-----NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQL 137
Query: 519 TLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC 578
+ L Q +EYL S IH DL N+L+ +I L D
Sbjct: 138 SFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 197
Query: 579 LYVQSR---SYRAPEVIIGLPYDQKIDLWSLGCILAELWT 615
R + APE + Y + D+WS G +L E++T
Sbjct: 198 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 1e-05
Identities = 55/211 (26%), Positives = 89/211 (42%), Gaps = 23/211 (10%)
Query: 422 LGSAAFSKVFQAQ--DLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHIL 479
LG AF KVF A+ +L D L +K KD D + + + N HI+
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTN--LQHEHIV 70
Query: 480 RLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYF----------TLGRLQVITRQ 529
+ Y + L +V E ++ + KF + G +A T ++ I +Q
Sbjct: 71 KFYGVCVEGDPLIMVFEYMKHG--DLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQ 128
Query: 530 CLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS--CFQTDNLCLYVQSR--- 584
+ YL S +H DL N L+ + +KI D G S + TD + +
Sbjct: 129 IAAGMVYLASQHFVHRDLATRNCLVG--ENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 186
Query: 585 SYRAPEVIIGLPYDQKIDLWSLGCILAELWT 615
+ PE I+ + + D+WSLG +L E++T
Sbjct: 187 RWMPPESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 1e-05
Identities = 41/152 (26%), Positives = 69/152 (45%), Gaps = 16/152 (10%)
Query: 474 DEHHILRLYDYFYHLEHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITRQCLE 532
D +I+RL + I+ E + +L +F + N + FT+G+L + R
Sbjct: 63 DHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLREN-----DGKFTVGQLVGMLRGIAS 117
Query: 533 ALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS------Y 586
++YL + +H DL NIL+ S C K+ D G S D+ Y ++ +
Sbjct: 118 GMKYLSEMNYVHRDLAARNILVNSNLVC--KVSDFGLSRRLEDSEATY-TTKGGKIPIRW 174
Query: 587 RAPEVIIGLPYDQKIDLWSLGCILAELWT-GE 617
APE I + D+WS G ++ E+ + GE
Sbjct: 175 TAPEAIAYRKFTSASDVWSFGIVMWEVMSYGE 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 2e-05
Identities = 20/48 (41%), Positives = 32/48 (66%), Gaps = 2/48 (4%)
Query: 523 LQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570
++ + RQ L L LH +GI+H D+KPEN+L+ ++KIID G++
Sbjct: 311 IKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTV--DGQVKIIDFGAA 356
|
Length = 507 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 2e-05
Identities = 33/99 (33%), Positives = 48/99 (48%), Gaps = 21/99 (21%)
Query: 529 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS--- 585
Q L A+ ++HS +IH D+K NIL+ C ++ LG F +Y + S
Sbjct: 151 QVLLAVHHVHSKHMIHRDIKSANILL-----CSNGLVKLGDFGFSK----MYAATVSDDV 201
Query: 586 ---------YRAPEVIIGLPYDQKIDLWSLGCILAELWT 615
Y APE+ PY +K D++SLG +L EL T
Sbjct: 202 GRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLT 240
|
Length = 496 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 52/209 (24%), Positives = 89/209 (42%), Gaps = 28/209 (13%)
Query: 422 LGSAAFSKVFQA----QDLHTGVDVCLKIIKNDKDFFDQS--LDEIKLLKLVNKNDPADE 475
LG F KV +TG V +K + + + +S EI++L+ + D
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTL------DH 65
Query: 476 HHILRL--YDYFYHLEHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITRQCLE 532
+I++ L ++ E L +L ++ + +++ L RL + + Q +
Sbjct: 66 ENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQIN-----LKRLLLFSSQICK 120
Query: 533 ALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF-QTDNLCLYVQSRS-----Y 586
++YL S IH DL NIL++S +KI D G + D YV+ +
Sbjct: 121 GMDYLGSQRYIHRDLAARNILVESEDL--VKISDFGLAKVLPEDKDYYYVKEPGESPIFW 178
Query: 587 RAPEVIIGLPYDQKIDLWSLGCILAELWT 615
APE + + D+WS G L EL+T
Sbjct: 179 YAPECLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 4e-05
Identities = 54/205 (26%), Positives = 92/205 (44%), Gaps = 30/205 (14%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIK----NDKDFFDQSLDEIKLLKLVNKNDPADEHH 477
LG+ F +V++ +T V +K +K + KDF L E +++K + H
Sbjct: 14 LGAGQFGEVWEGLWNNT-TPVAVKTLKPGTMDPKDF----LAEAQIMKKL--------RH 60
Query: 478 --ILRLYDYFYHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEAL 534
+++LY E ++IV EL++ +L E+ Q G A L +L + Q +
Sbjct: 61 PKLIQLYAVCTLEEPIYIVTELMKYGSLLEYL---QGGAGRA-LKLPQLIDMAAQVASGM 116
Query: 535 EYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG-SSCFQTDNLCLYVQSR---SYRAPE 590
YL + IH DL N+L+ C K+ D G + + D ++ + APE
Sbjct: 117 AYLEAQNYIHRDLAARNVLVGENNIC--KVADFGLARVIKEDIYEAREGAKFPIKWTAPE 174
Query: 591 VIIGLPYDQKIDLWSLGCILAELWT 615
+ + K D+WS G +L E+ T
Sbjct: 175 AALYNRFSIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 4e-05
Identities = 39/132 (29%), Positives = 60/132 (45%), Gaps = 11/132 (8%)
Query: 489 EHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDL 547
E ++IV E + + +L +F K E G Y L +L + Q + Y+ + +H DL
Sbjct: 73 EPIYIVTEYMSKGSLLDFLK--GEMG--KYLRLPQLVDMAAQIASGMAYVERMNYVHRDL 128
Query: 548 KPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSY----RAPEVIIGLPYDQKIDL 603
+ NIL+ C K+ D G + DN Q + APE + + K D+
Sbjct: 129 RAANILVGENLVC--KVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186
Query: 604 WSLGCILAELWT 615
WS G +L EL T
Sbjct: 187 WSFGILLTELTT 198
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 6e-05
Identities = 52/207 (25%), Positives = 83/207 (40%), Gaps = 35/207 (16%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIK----NDKDFFDQSLDEIKLL--KLVNKNDPADE 475
LGS F V + V +K I +++DF +++ +KL KLV
Sbjct: 12 LGSGQFG-VVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLV-------- 62
Query: 476 HHILRLYDYFYHLEHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEAL 534
+LY + L+IV E + L + + Q + L + + E +
Sbjct: 63 ----QLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQ-----GKLSKDMLLSMCQDVCEGM 113
Query: 535 EYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSR------SYRA 588
EYL IH DL N L+ S +K+ D G + + D+ Y S +
Sbjct: 114 EYLERNSFIHRDLAARNCLVSS--TGVVKVSDFGMTRYVLDDE--YTSSSGAKFPVKWSP 169
Query: 589 PEVIIGLPYDQKIDLWSLGCILAELWT 615
PEV Y K D+WS G ++ E++T
Sbjct: 170 PEVFNFSKYSSKSDVWSFGVLMWEVFT 196
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 7e-05
Identities = 53/243 (21%), Positives = 97/243 (39%), Gaps = 67/243 (27%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLK--LVNKNDPADEHHIL 479
+G AF +V Q TG +KI++ + + I+ + LV AD ++
Sbjct: 9 IGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVE----ADSLWVV 64
Query: 480 RLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLE------- 532
+++ F +L+++ E L GG+ L + +T + +
Sbjct: 65 KMFYSFQDKLNLYLIMEFL-------------PGGDMMTLLMKKDTLTEEETQFYIAETV 111
Query: 533 -ALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG---------------------SS 570
A++ +H LG IH D+KP+N+L+ S + +K+ D G S
Sbjct: 112 LAIDSIHQLGFIHRDIKPDNLLLDS--KGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPS 169
Query: 571 CFQTDNLCLYVQSRSYR-----------------APEVIIGLPYDQKIDLWSLGCILAEL 613
F N+ ++ +++ APEV + Y++ D WSLG I+ E+
Sbjct: 170 DFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEM 229
Query: 614 WTG 616
G
Sbjct: 230 LIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 9e-05
Identities = 52/222 (23%), Positives = 97/222 (43%), Gaps = 36/222 (16%)
Query: 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKII-------KNDKDFFDQSLDEIKLLK 465
A Y V + +G AF +V + T +K++ ++D FF + D +
Sbjct: 42 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF-- 99
Query: 466 LVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQ 524
A+ +++L+ F +L++V E + +L A F
Sbjct: 100 -------ANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARF------ 146
Query: 525 VITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLY---- 580
T + + AL+ +HS+G IH D+KP+N+L+ + +K+ D G +C + + +
Sbjct: 147 -YTAEVVLALDAIHSMGFIHRDVKPDNMLLD--KSGHLKLADFG-TCMKMNKEGMVRCDT 202
Query: 581 -VQSRSYRAPEVIIGLP----YDQKIDLWSLGCILAELWTGE 617
V + Y +PEV+ Y ++ D WS+G L E+ G+
Sbjct: 203 AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 244
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 1e-04
Identities = 21/38 (55%), Positives = 26/38 (68%), Gaps = 2/38 (5%)
Query: 533 ALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570
AL+YLH GIIH DLKP+N+LI + IK+ D G S
Sbjct: 116 ALDYLHRHGIIHRDLKPDNMLISN--EGHIKLTDFGLS 151
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 1e-04
Identities = 30/92 (32%), Positives = 43/92 (46%), Gaps = 7/92 (7%)
Query: 529 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID--LGSSCFQTDNLCLY-VQSRS 585
Q + YLH G+IH D+ N +I + +KI D L F D CL ++R
Sbjct: 125 QIACGMSYLHKRGVIHKDIAARNCVIDEELQ--VKITDNALSRDLFPMDYHCLGDNENRP 182
Query: 586 YR--APEVIIGLPYDQKIDLWSLGCILAELWT 615
+ A E ++ Y D+WS G +L EL T
Sbjct: 183 VKWMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 1e-04
Identities = 49/220 (22%), Positives = 88/220 (40%), Gaps = 43/220 (19%)
Query: 422 LGSAAFSKVFQ--AQDL---HTGVDVCLKIIKNDKDFFD--QSLDEIKLLKLVNKNDPAD 474
LG +F V++ A+ + V +K + + + + L+E ++K N
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNC----- 68
Query: 475 EHHILRLYDYFYHLEHLFIVCEL-----LRANLYEFQKFNQESGGEAYFTLGRLQVITRQ 529
HH++RL + +V EL L++ L + + + G TL + + +
Sbjct: 69 -HHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAE 127
Query: 530 CLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS--CFQTDNLCLYVQSRSYR 587
+ + YL + +H DL N ++ KI D G + ++TD Y YR
Sbjct: 128 IADGMAYLAAKKFVHRDLAARNCMVAEDLTV--KIGDFGMTRDIYETD----Y-----YR 176
Query: 588 ------------APEVIIGLPYDQKIDLWSLGCILAELWT 615
APE + + K D+WS G +L E+ T
Sbjct: 177 KGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 59/221 (26%), Positives = 93/221 (42%), Gaps = 35/221 (15%)
Query: 420 EYLGSAAFSKVFQAQDLHTGVD-VCLKIIKNDKDF--------FDQS---LDEIK----- 462
E LG AF K+++ G+D L IK KD F Q + E+
Sbjct: 11 EELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIV 70
Query: 463 -LLKLVNKNDPADEHHILRLYDYFYHLE-HLFIVCELLRANLYEFQKFNQESGG-EAYFT 519
LL +V + P + L++Y + H F++ +R+ + + E G ++
Sbjct: 71 CLLGVVTQEQP-----VCMLFEYLNQGDLHEFLI---MRSPHSDVGCSSDEDGTVKSSLD 122
Query: 520 LGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL 579
G I Q +EYL S +H DL NILI ++ +KI DLG S
Sbjct: 123 HGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIG--EQLHVKISDLGLSREIYSADYY 180
Query: 580 YVQSRS-----YRAPEVIIGLPYDQKIDLWSLGCILAELWT 615
VQ +S + PE I+ + D+WS G +L E+++
Sbjct: 181 RVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 2e-04
Identities = 31/155 (20%), Positives = 57/155 (36%), Gaps = 26/155 (16%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRL 481
L ++V+ D LKI + + D+ E+ +L+L+ + + ++
Sbjct: 6 LKGGLTNRVYLLGT--KDEDYVLKINPSREKGADR-EREVAILQLLARKGL----PVPKV 58
Query: 482 YDYFYHLEHLFIVCELLRAN-LYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSL 540
+++ E + L E + +E I Q E L LH L
Sbjct: 59 LASGESDGWSYLLMEWIEGETLDEVSEEEKED-------------IAEQLAELLAKLHQL 105
Query: 541 ---GIIHCDLKPENILIKSYQRCEIKIIDLGSSCF 572
+ H DL P NIL+ + + IID + +
Sbjct: 106 PLLVLCHGDLHPGNILVDDGK--ILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 54/237 (22%), Positives = 95/237 (40%), Gaps = 55/237 (23%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLK--LVNKNDPADEHHIL 479
+G AF +V Q TG +KI++ + + I+ + LV AD ++
Sbjct: 9 IGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVE----ADGAWVV 64
Query: 480 RLYDYFYHLEHLFIVCELLRAN--LYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYL 537
+++ F +L+++ E L + K + S F + + + A++ +
Sbjct: 65 KMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIA-------ETVLAIDAI 117
Query: 538 HSLGIIHCDLKPENILIKSYQRCEIKIIDLG---------------------SSCFQTDN 576
H LG IH D+KP+N+L+ + + +K+ D G S F N
Sbjct: 118 HQLGFIHRDIKPDNLLLDA--KGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQN 175
Query: 577 L---------------CLY--VQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTG 616
+ Y V + Y APEV + Y++ D WSLG I+ E+ G
Sbjct: 176 MNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 2e-04
Identities = 30/105 (28%), Positives = 47/105 (44%), Gaps = 8/105 (7%)
Query: 515 EAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG-SSCFQ 573
+ FT+ +L + R ++YL +G +H DL NIL+ S C K+ D G S +
Sbjct: 100 DGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVC--KVSDFGLSRVLE 157
Query: 574 TDNLCLYVQSRS-----YRAPEVIIGLPYDQKIDLWSLGCILAEL 613
D Y + APE I + D+WS G ++ E+
Sbjct: 158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEV 202
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 3e-04
Identities = 20/43 (46%), Positives = 25/43 (58%), Gaps = 2/43 (4%)
Query: 526 ITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568
I + L LEY+H GI H D+KPENI++ R IID G
Sbjct: 131 IMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRG--YIIDYG 171
|
Length = 294 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 3e-04
Identities = 30/95 (31%), Positives = 45/95 (47%), Gaps = 13/95 (13%)
Query: 530 CL---EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS- 585
CL E + YL S +IH DL N L+ Q +K+ D G + F D+ Y S
Sbjct: 106 CLDVCEGMAYLESSNVIHRDLAARNCLVGENQ--VVKVSDFGMTRFVLDDQ--YTSSTGT 161
Query: 586 -----YRAPEVIIGLPYDQKIDLWSLGCILAELWT 615
+ +PEV Y K D+WS G ++ E+++
Sbjct: 162 KFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFS 196
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 4e-04
Identities = 37/132 (28%), Positives = 59/132 (44%), Gaps = 11/132 (8%)
Query: 489 EHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDL 547
E ++I+ E + +L +F K G + T+ +L + Q E + ++ IH DL
Sbjct: 73 EPIYIITEYMENGSLVDFLK--TPEGIK--LTINKLIDMAAQIAEGMAFIERKNYIHRDL 128
Query: 548 KPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSY----RAPEVIIGLPYDQKIDL 603
+ NIL+ C KI D G + DN + + APE I + K D+
Sbjct: 129 RAANILVSETLCC--KIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 186
Query: 604 WSLGCILAELWT 615
WS G +L E+ T
Sbjct: 187 WSFGILLTEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 4e-04
Identities = 53/225 (23%), Positives = 82/225 (36%), Gaps = 49/225 (21%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPAD------- 474
LG AF KVF + C + + D+ L +K LK ND
Sbjct: 13 LGEGAFGKVFLGE--------CYHLEPEN----DKELVAVKTLKETASNDARKDFEREAE 60
Query: 475 -----EH-HILRLYDYFYHLEHLFIVCE---------LLRANLYEFQKFNQESGGEAYFT 519
+H +I++ Y + +V E LR++ + T
Sbjct: 61 LLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELT 120
Query: 520 LGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS--CFQTDNL 577
L +L I Q + YL S +H DL N L+ +KI D G S + TD
Sbjct: 121 LSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGY--DLVVKIGDFGMSRDVYTTD-- 176
Query: 578 CLYVQSRSYR-------APEVIIGLPYDQKIDLWSLGCILAELWT 615
Y + + PE I+ + + D+WS G +L E++T
Sbjct: 177 --YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 5e-04
Identities = 32/110 (29%), Positives = 48/110 (43%), Gaps = 13/110 (11%)
Query: 514 GEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG--SSC 571
+ TL L + Q +E+L S IH DL NIL+ +KI D G
Sbjct: 166 YKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENN--VVKICDFGLARDI 223
Query: 572 FQTDNLCLYVQSRSYR------APEVIIGLPYDQKIDLWSLGCILAELWT 615
++ + YV+ R APE I Y + D+WS G +L E+++
Sbjct: 224 YKDPD---YVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 5e-04
Identities = 29/95 (30%), Positives = 50/95 (52%), Gaps = 13/95 (13%)
Query: 533 ALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQ--TDNLC---LYVQSRSYR 587
A++ +H LG +H D+KP+N+L+ + I++ D G SC + D + V + Y
Sbjct: 114 AIDSVHQLGYVHRDIKPDNVLLD--KNGHIRLADFG-SCLRLLADGTVQSNVAVGTPDYI 170
Query: 588 APEVIIGLP-----YDQKIDLWSLGCILAELWTGE 617
+PE++ + Y + D WSLG + E+ GE
Sbjct: 171 SPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 41.9 bits (99), Expect = 6e-04
Identities = 59/229 (25%), Positives = 92/229 (40%), Gaps = 47/229 (20%)
Query: 414 GRYYVTEYLGSAAFS-KVFQAQDLHTGVD-VCLKIIKND------KDFFDQSLDEIKLLK 465
G ++ E G FS K F D V +K+++ D +DF L E+K+L
Sbjct: 19 GEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDF----LKEVKILS 74
Query: 466 LVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQV 525
++ DP +I RL L ++ E + + +F Q+ E +
Sbjct: 75 RLS--DP----NIARLLGVCTVDPPLCMIMEYM--ENGDLNQFLQKHVAETSGLACNSKS 126
Query: 526 ITRQCL--------EALEYLHSLGIIHCDLKPENILI-KSYQRCEIKIIDLGSSCFQTDN 576
++ L + YL SL +H DL N L+ K+Y IKI D G S N
Sbjct: 127 LSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYT---IKIADFGMS----RN 179
Query: 577 L--CLYVQSRSYRAP--------EVIIGLPYDQKIDLWSLGCILAELWT 615
L Y + + RAP E ++ + K D+W+ G L E+ T
Sbjct: 180 LYSSDYYRVQG-RAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 6e-04
Identities = 56/211 (26%), Positives = 92/211 (43%), Gaps = 29/211 (13%)
Query: 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHH 477
E LG F +VF+ L V +K K D ++ + L E ++LK D +
Sbjct: 1 ELLGKGNFGEVFKGT-LKDKTPVAVKTCKEDLPQELKIKFLSEARILK------QYDHPN 53
Query: 478 ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEA---L 534
I++L + ++IV EL+ +F F ++ E + + + + L+A +
Sbjct: 54 IVKLIGVCTQRQPIYIVMELVPGG--DFLSFLRKKKDEL-----KTKQLVKFALDAAAGM 106
Query: 535 EYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSR------SYRA 588
YL S IH DL N L+ + +KI D G S + D + Y S + A
Sbjct: 107 AYLESKNCIHRDLAARNCLVG--ENNVLKISDFGMSRQEDDGI--YSSSGLKQIPIKWTA 162
Query: 589 PEVIIGLPYDQKIDLWSLGCILAELWTGEVC 619
PE + Y + D+WS G +L E ++ VC
Sbjct: 163 PEALNYGRYSSESDVWSYGILLWETFSLGVC 193
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 7e-04
Identities = 53/215 (24%), Positives = 89/215 (41%), Gaps = 28/215 (13%)
Query: 421 YLGSAAFSKVFQAQ---DLHTG---VDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPAD 474
+LGS AF +V++ L G + V +K ++ K DQ ++ + LK + +
Sbjct: 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLR--KGATDQ--EKKEFLKEAHLMSNFN 57
Query: 475 EHHILRLYDYFYHLEHLFIVCELLRAN--LYEFQKFNQESGGEAYFTLGRLQVITRQCLE 532
+I++L E +I+ EL+ L + E G TL L I +
Sbjct: 58 HPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAK 117
Query: 533 ALEYLHSLGIIHCDLKPENILI--KSYQRCEI-KIIDLG--SSCFQTDNLCLYVQSRSYR 587
YL + IH DL N L+ K Y + KI D G +++D Y +
Sbjct: 118 GCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSD----YYRKEGEG 173
Query: 588 -------APEVIIGLPYDQKIDLWSLGCILAELWT 615
APE ++ + + D+WS G ++ E+ T
Sbjct: 174 LLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 7e-04
Identities = 31/98 (31%), Positives = 47/98 (47%), Gaps = 13/98 (13%)
Query: 526 ITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS--CFQTDNLCLY-VQ 582
I Q +EYL S +H DL N L+ + +KI D G S + D Y VQ
Sbjct: 129 IAIQIAAGMEYLSSHHFVHRDLAARNCLV--GEGLTVKISDFGLSRDIYSAD---YYRVQ 183
Query: 583 SRS-----YRAPEVIIGLPYDQKIDLWSLGCILAELWT 615
S+S + PE I+ + + D+WS G +L E+++
Sbjct: 184 SKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 0.001
Identities = 30/100 (30%), Positives = 46/100 (46%), Gaps = 8/100 (8%)
Query: 522 RLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYV 581
+L + Q + +EYL S +H DL NIL++S R +KI D G + + Y
Sbjct: 109 KLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENR--VKIGDFGLTKVLPQDKEYYK 166
Query: 582 QSRS------YRAPEVIIGLPYDQKIDLWSLGCILAELWT 615
+ APE + + D+WS G +L EL+T
Sbjct: 167 VREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.001
Identities = 29/95 (30%), Positives = 48/95 (50%), Gaps = 13/95 (13%)
Query: 533 ALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQ-----TDNLCLYVQSRSYR 587
A++ +H L +H D+KP+NIL+ I++ D G SC + T + V + Y
Sbjct: 114 AIDSVHQLHYVHRDIKPDNILMD--MNGHIRLADFG-SCLKLMEDGTVQSSVAVGTPDYI 170
Query: 588 APEVIIGLP-----YDQKIDLWSLGCILAELWTGE 617
+PE++ + Y + D WSLG + E+ GE
Sbjct: 171 SPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.001
Identities = 45/203 (22%), Positives = 79/203 (38%), Gaps = 25/203 (12%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHH--IL 479
LG + +V++ + V +K +K D ++ L E ++K + H ++
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMK--------EIKHPNLV 65
Query: 480 RLYDYFYHLEHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLH 538
+L +I+ E + NL ++ + A L + Q A+EYL
Sbjct: 66 QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLL----YMATQISSAMEYLE 121
Query: 539 SLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSR------SYRAPEVI 592
IH DL N L+ +K+ D G S T + Y + APE +
Sbjct: 122 KKNFIHRDLAARNCLVGENHL--VKVADFGLSRLMTGD--TYTAHAGAKFPIKWTAPESL 177
Query: 593 IGLPYDQKIDLWSLGCILAELWT 615
+ K D+W+ G +L E+ T
Sbjct: 178 AYNKFSIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.002
Identities = 29/93 (31%), Positives = 45/93 (48%), Gaps = 8/93 (8%)
Query: 529 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG-SSCFQTDNLCLYVQSRS-- 585
Q + ++YL S +H DL N+L++S + +KI D G + +TD V+
Sbjct: 117 QICKGMDYLGSRQYVHRDLAARNVLVESEHQ--VKIGDFGLTKAIETDKEYYTVKDDLDS 174
Query: 586 ---YRAPEVIIGLPYDQKIDLWSLGCILAELWT 615
+ APE +I + D+WS G L EL T
Sbjct: 175 PVFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 28/95 (29%), Positives = 47/95 (49%), Gaps = 13/95 (13%)
Query: 533 ALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQ-----TDNLCLYVQSRSYR 587
A+ +H L +H D+KP+N+L+ I++ D G SC + T + V + Y
Sbjct: 114 AIHSIHQLHYVHRDIKPDNVLLD--MNGHIRLADFG-SCLKMNQDGTVQSSVAVGTPDYI 170
Query: 588 APEVIIGL-----PYDQKIDLWSLGCILAELWTGE 617
+PE++ + Y + D WSLG + E+ GE
Sbjct: 171 SPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.003
Identities = 27/95 (28%), Positives = 46/95 (48%), Gaps = 7/95 (7%)
Query: 526 ITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG--SSCFQTDNLCLYVQS 583
I Q +E+L S ++H DL N+L+ + + +KI DLG + D L S
Sbjct: 129 IVTQIAAGMEFLSSHHVVHKDLATRNVLV--FDKLNVKISDLGLFREVYAADYYKLMGNS 186
Query: 584 R---SYRAPEVIIGLPYDQKIDLWSLGCILAELWT 615
+ +PE I+ + D+WS G +L E+++
Sbjct: 187 LLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 621 | |||
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 99.98 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.98 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 99.98 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 99.98 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 99.98 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 99.98 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 99.98 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.98 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 99.98 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 99.98 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 99.98 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 99.98 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 99.98 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.98 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.98 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.98 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.98 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.98 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 99.97 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 99.97 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.97 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 99.97 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.97 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 99.97 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 99.97 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 99.97 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.97 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.97 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.97 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 99.97 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.97 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.97 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.97 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 99.97 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.97 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.97 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.97 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.97 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.97 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 99.97 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.97 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.97 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.97 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 99.97 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.97 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.97 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.97 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.97 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.97 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.97 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.97 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 99.97 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.97 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.97 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.97 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.97 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.97 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.97 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.97 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.97 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.97 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.97 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.97 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.97 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 99.97 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.96 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.96 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.96 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 99.96 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.96 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.96 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.96 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.96 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.96 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.96 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.96 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.96 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.96 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.96 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.96 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.96 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.96 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.96 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.96 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 99.96 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.96 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.96 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.96 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.96 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.96 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.96 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.96 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.96 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.96 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.96 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.96 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.96 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.96 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.96 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.96 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.96 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.96 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.96 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.96 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.96 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.96 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.96 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.96 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.96 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.96 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.96 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.96 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.96 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.96 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.96 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.96 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.96 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.96 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.96 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.96 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.96 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.96 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.96 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.96 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.96 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.96 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.96 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.96 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.96 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.96 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.96 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.96 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.96 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.96 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.96 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.96 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.96 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.96 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.96 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.96 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.96 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.96 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.96 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.96 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.96 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.96 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.96 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.96 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.96 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.96 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.96 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.96 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.96 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 99.96 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.96 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.96 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.95 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.95 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.95 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.95 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.95 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.95 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.95 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.95 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 99.95 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.95 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.95 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.95 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.95 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.95 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.95 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.95 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.95 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.95 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.95 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.95 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.95 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.95 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.95 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.95 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.95 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.95 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.95 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.95 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.95 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.95 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.95 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.95 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.95 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.95 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.95 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.94 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.94 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.94 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.94 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.94 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.94 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.94 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.94 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.94 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.94 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.93 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.93 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.93 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.93 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.93 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.93 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.93 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.92 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.92 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.92 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.92 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.92 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.92 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.91 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.91 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.91 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.91 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.9 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.9 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.9 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.89 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.86 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.84 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.84 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.83 | |
| cd08677 | 118 | C2A_Synaptotagmin-13 C2 domain. Synaptotagmin is a | 99.82 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.81 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.8 | |
| cd08680 | 124 | C2_Kibra C2 domain found in Human protein Kibra. K | 99.78 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.78 | |
| cd08407 | 138 | C2B_Synaptotagmin-13 C2 domain second repeat prese | 99.77 | |
| cd04028 | 146 | C2B_RIM1alpha C2 domain second repeat contained in | 99.76 | |
| cd08392 | 128 | C2A_SLP-3 C2 domain first repeat present in Synapt | 99.76 | |
| cd08406 | 136 | C2B_Synaptotagmin-12 C2 domain second repeat prese | 99.76 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.76 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.75 | |
| cd08381 | 122 | C2B_PI3K_class_II C2 domain second repeat present | 99.75 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.75 | |
| cd08692 | 135 | C2B_Tac2-N C2 domain second repeat found in Tac2-N | 99.74 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.74 | |
| cd08393 | 125 | C2A_SLP-1_2 C2 domain first repeat present in Syna | 99.73 | |
| cd08685 | 119 | C2_RGS-like C2 domain of the Regulator Of G-Protei | 99.72 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.72 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.71 | |
| cd04029 | 125 | C2A_SLP-4_5 C2 domain first repeat present in Syna | 99.7 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.68 | |
| cd08395 | 120 | C2C_Munc13 C2 domain third repeat in Munc13 (mamma | 99.67 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.66 | |
| cd08408 | 138 | C2B_Synaptotagmin-14_16 C2 domain second repeat pr | 99.66 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.65 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.65 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.64 | |
| KOG1028 | 421 | consensus Ca2+-dependent phospholipid-binding prot | 99.63 | |
| cd04020 | 162 | C2B_SLP_1-2-3-4 C2 domain second repeat present in | 99.63 | |
| cd08389 | 124 | C2A_Synaptotagmin-14_16 C2A domain first repeat pr | 99.62 | |
| cd08388 | 128 | C2A_Synaptotagmin-4-11 C2A domain first repeat pre | 99.61 | |
| cd08404 | 136 | C2B_Synaptotagmin-4 C2 domain second repeat presen | 99.6 | |
| cd08384 | 133 | C2B_Rabphilin_Doc2 C2 domain second repeat present | 99.59 | |
| cd04031 | 125 | C2A_RIM1alpha C2 domain first repeat contained in | 99.58 | |
| cd08409 | 137 | C2B_Synaptotagmin-15 C2 domain second repeat prese | 99.58 | |
| cd08410 | 135 | C2B_Synaptotagmin-17 C2 domain second repeat prese | 99.58 | |
| cd08521 | 123 | C2A_SLP C2 domain first repeat present in Synaptot | 99.58 | |
| cd08387 | 124 | C2A_Synaptotagmin-8 C2A domain first repeat presen | 99.57 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.56 | |
| cd04010 | 148 | C2B_RasA3 C2 domain second repeat present in RAS p | 99.55 | |
| cd08402 | 136 | C2B_Synaptotagmin-1 C2 domain second repeat presen | 99.55 | |
| cd04041 | 111 | C2A_fungal C2 domain first repeat; fungal group. C | 99.55 | |
| cd08385 | 124 | C2A_Synaptotagmin-1-5-6-9-10 C2A domain first repe | 99.55 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.54 | |
| cd08405 | 136 | C2B_Synaptotagmin-7 C2 domain second repeat presen | 99.54 | |
| cd08403 | 134 | C2B_Synaptotagmin-3-5-6-9-10 C2 domain second repe | 99.54 | |
| cd04030 | 127 | C2C_KIAA1228 C2 domain third repeat present in unc | 99.54 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.53 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.53 | |
| cd08386 | 125 | C2A_Synaptotagmin-7 C2A domain first repeat presen | 99.52 | |
| cd04009 | 133 | C2B_Munc13-like C2 domain second repeat in Munc13 | 99.52 | |
| KOG1028 | 421 | consensus Ca2+-dependent phospholipid-binding prot | 99.49 | |
| cd04039 | 108 | C2_PSD C2 domain present in Phosphatidylserine dec | 99.49 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.49 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.49 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.48 | |
| cd08682 | 126 | C2_Rab11-FIP_classI C2 domain found in Rab11-famil | 99.48 | |
| cd08688 | 110 | C2_KIAA0528-like C2 domain found in the Human KIAA | 99.48 | |
| cd08401 | 121 | C2A_RasA2_RasA3 C2 domain first repeat present in | 99.46 | |
| cd04032 | 127 | C2_Perforin C2 domain of Perforin. Perforin contai | 99.46 | |
| cd08390 | 123 | C2A_Synaptotagmin-15-17 C2A domain first repeat pr | 99.46 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.46 | |
| cd08690 | 155 | C2_Freud-1 C2 domain found in 5' repressor element | 99.43 | |
| cd08376 | 116 | C2B_MCTP_PRT C2 domain second repeat found in Mult | 99.42 | |
| cd04036 | 119 | C2_cPLA2 C2 domain present in cytosolic PhosphoLip | 99.42 | |
| cd04022 | 127 | C2A_MCTP_PRT_plant C2 domain first repeat found in | 99.42 | |
| cd04035 | 123 | C2A_Rabphilin_Doc2 C2 domain first repeat present | 99.42 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.4 | |
| cd04026 | 131 | C2_PKC_alpha_gamma C2 domain in Protein Kinase C ( | 99.4 | |
| cd04025 | 123 | C2B_RasA1_RasA4 C2 domain second repeat present in | 99.38 | |
| cd08686 | 118 | C2_ABR C2 domain in the Active BCR (Breakpoint clu | 99.38 | |
| cd04042 | 121 | C2A_MCTP_PRT C2 domain first repeat found in Multi | 99.38 | |
| cd08379 | 126 | C2D_MCTP_PRT_plant C2 domain fourth repeat found i | 99.37 | |
| cd04018 | 151 | C2C_Ferlin C2 domain third repeat in Ferlin. Ferli | 99.37 | |
| cd04019 | 150 | C2C_MCTP_PRT_plant C2 domain third repeat found in | 99.35 | |
| cd00276 | 134 | C2B_Synaptotagmin C2 domain second repeat present | 99.35 | |
| cd04033 | 133 | C2_NEDD4_NEDD4L C2 domain present in the Human neu | 99.35 | |
| cd04016 | 121 | C2_Tollip C2 domain present in Toll-interacting pr | 99.35 | |
| cd08375 | 136 | C2_Intersectin C2 domain present in Intersectin. A | 99.34 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.34 | |
| KOG1030 | 168 | consensus Predicted Ca2+-dependent phospholipid-bi | 99.33 | |
| cd04017 | 135 | C2D_Ferlin C2 domain fourth repeat in Ferlin. Ferl | 99.33 | |
| cd08691 | 137 | C2_NEDL1-like C2 domain present in NEDL1 (NEDD4-li | 99.33 | |
| cd04024 | 128 | C2A_Synaptotagmin-like C2 domain first repeat pres | 99.32 | |
| cd08676 | 153 | C2A_Munc13-like C2 domain first repeat in Munc13 ( | 99.31 | |
| cd04011 | 111 | C2B_Ferlin C2 domain second repeat in Ferlin. Ferl | 99.31 | |
| cd04043 | 126 | C2_Munc13_fungal C2 domain in Munc13 (mammalian un | 99.31 | |
| cd04054 | 121 | C2A_Rasal1_RasA4 C2 domain first repeat present in | 99.3 | |
| cd04047 | 110 | C2B_Copine C2 domain second repeat in Copine. Ther | 99.3 | |
| cd08678 | 126 | C2_C21orf25-like C2 domain found in the Human chro | 99.3 | |
| cd04048 | 120 | C2A_Copine C2 domain first repeat in Copine. There | 99.3 | |
| cd08681 | 118 | C2_fungal_Inn1p-like C2 domain found in fungal Ing | 99.3 |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-70 Score=563.24 Aligned_cols=375 Identities=23% Similarity=0.309 Sum_probs=307.8
Q ss_pred cCcCCCccccccccCCCCCccccccceeccccCCCccCCcccccccccccccCCCCccccCCCCcccCcceEEEEecC-C
Q 007035 198 TDYLDKPCLFHIVPLNDDKEVGVTDYYRFEKTNQPEAGGIKEKLKDCAAYGCSEPLCKCCAGEGKINNDYGYLSSKEA-D 276 (621)
Q Consensus 198 ~~~~~k~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~c~~~~g~~~~s~~~l~v~l~e~-~ 276 (621)
.--+|++|+.||||+||+|||++|++.++..|. ..+.|+|.|+|| |
T Consensus 145 ~mNVH~rCv~nVPslCG~DhtE~RGrl~l~~~~---------------------------------~~~~l~v~i~ea~N 191 (683)
T KOG0696|consen 145 DMNVHHRCVENVPSLCGTDHTERRGRLYLEAHI---------------------------------KRDVLTVTIKEAKN 191 (683)
T ss_pred cchHHHHHhhcCCcccCCcchhhcceEEEEEEe---------------------------------cCceEEEEehhhcc
Confidence 336899999999999999999999999977777 345789999999 9
Q ss_pred CccccCcCCCCcceEeecCCCCCCcccceeeccccCCCceeccceeeecccccccccccccccccCCCCCCCCCcccccc
Q 007035 277 LIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDNSDTRDGEVNGALH 356 (621)
Q Consensus 277 L~~~d~~g~sDpyVK~~Llp~~~~~~k~kt~v~k~tlnP~fnE~f~f~~~~~~~~~~k~L~~~V~D~d~~~r~d~iG~v~ 356 (621)
|.|||.||+||||||++|.||.+.++|+||+++|+||||+|||+|+|. +...+.+++|.++||||||.+||+|+|.++
T Consensus 192 LiPMDpNGlSDPYvk~kliPD~~~~sKqKTkTik~~LNP~wNEtftf~--Lkp~DkdrRlsiEvWDWDrTsRNDFMGslS 269 (683)
T KOG0696|consen 192 LIPMDPNGLSDPYVKLKLIPDPKNESKQKTKTIKATLNPVWNETFTFK--LKPSDKDRRLSIEVWDWDRTSRNDFMGSLS 269 (683)
T ss_pred ccccCCCCCCCcceeEEeccCCcchhhhhhhhhhhhcCccccceeEEe--cccccccceeEEEEecccccccccccceec
Confidence 999999999999999999999999999999999999999999999999 888899999999999999999999999999
Q ss_pred cccccccccCCCCccchhccchhhhhhh-heeeeeec-------------cccCCccc----CCCcc--------eeeCe
Q 007035 357 EGKADAEEHGVATPDLLMFDNLEEECEI-FHLRIIHR-------------KNRTGFEE----NKDLP--------IILNT 410 (621)
Q Consensus 357 ~~~a~~~~~~~~~~~ll~~~~l~eE~e~-~~lr~i~~-------------~~r~~~~~----~~~~p--------i~l~~ 410 (621)
+++.++.++++.+ ||+.|.+|+.+ |++.+... +.+.+..+ ....| -....
T Consensus 270 FgisEl~K~p~~G----WyKlLsqeEGEyyNvp~~~~~~e~~~~lr~k~~~~~~~~~~s~p~~~~~~~~~~~~~~~~~d~ 345 (683)
T KOG0696|consen 270 FGISELQKAPVDG----WYKLLSQEEGEYYNVPVPDEDSEDNEELRQKFERARIGPGSSKPEKKTMPTDSKFHNSSKRDR 345 (683)
T ss_pred ccHHHHhhcchhh----HHHHhhhhcCceeccCCCCchhhHHHHHHHHHhhcccCCCcCCCCCCCCCCcccCCCCCcccc
Confidence 9999999999999 88888655544 43332211 11111100 00000 01112
Q ss_pred eecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCe
Q 007035 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (621)
Q Consensus 411 ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~ 490 (621)
+-..+|..+..||+|+||+|.++..+.+.+.+|||+++++....+...+...+.+++-.. ..+.|+++++..+|+..++
T Consensus 346 i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL-~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 346 IKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLAL-PGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred eeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheec-CCCCchHHHHHHHhhhhhh
Confidence 334679999999999999999999999999999999988654433333322233333222 2345799999999999999
Q ss_pred EEEEEeccccchHHH-HHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCC
Q 007035 491 LFIVCELLRANLYEF-QKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (621)
Q Consensus 491 l~LVmEyl~gsLld~-l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGl 569 (621)
+|+||||+.|+-+-+ ++.-.. |.+..+..++.+|+-||-+||++||+.||||.+|||++. .|+|||+|||+
T Consensus 425 LyFVMEyvnGGDLMyhiQQ~Gk------FKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~--eGHiKi~DFGm 496 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQVGK------FKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDS--EGHIKIADFGM 496 (683)
T ss_pred eeeEEEEecCchhhhHHHHhcc------cCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEecc--CCceEeeeccc
Confidence 999999999753332 222221 778888999999999999999999999999999999994 89999999999
Q ss_pred cccc---CCCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 570 SCFQ---TDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 570 s~~~---~~~~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
+... .....+++|||.|+|||++...+|+.++|+||+||+||||+.|++||
T Consensus 497 cKEni~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPF 550 (683)
T KOG0696|consen 497 CKENIFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPF 550 (683)
T ss_pred ccccccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCC
Confidence 8653 33456689999999999999999999999999999999999999998
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-43 Score=383.97 Aligned_cols=220 Identities=54% Similarity=0.874 Sum_probs=210.0
Q ss_pred CcccCCCcceeeCeeecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCC
Q 007035 397 GFEENKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEH 476 (621)
Q Consensus 397 ~~~~~~~~pi~l~~ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hp 476 (621)
......++.++.++.+..+|.|++.||+|+||+|.+|.|..|++.||||++++.+.+..+...|++||..++.....+..
T Consensus 169 ~~~~~~dY~~v~~d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~ 248 (586)
T KOG0667|consen 169 FDDEDGDYQLVVNDHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKY 248 (586)
T ss_pred CCCCCCceeEEecceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCe
Confidence 44567788999999999999999999999999999999999999999999999999999999999999999977667777
Q ss_pred ceEEEeeEeEecCeEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEec
Q 007035 477 HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS 556 (621)
Q Consensus 477 nIvrl~~~f~~~~~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~ 556 (621)
|||+++++|...+|+|||+|.++.+|+++++.++..+ |++..++.++.||+.||.+||+.+|||+||||+||||..
T Consensus 249 n~Vrm~d~F~fr~HlciVfELL~~NLYellK~n~f~G----lsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~ 324 (586)
T KOG0667|consen 249 NIVRMLDYFYFRNHLCIVFELLSTNLYELLKNNKFRG----LSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKD 324 (586)
T ss_pred eEEEeeeccccccceeeeehhhhhhHHHHHHhcCCCC----CCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeecc
Confidence 9999999999999999999999999999999988776 999999999999999999999999999999999999988
Q ss_pred cCCCeEEEEecCCccccCCCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 557 YQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 557 ~~~~~IKL~DFGls~~~~~~~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
..+..|||+|||+|+......+.++++..|+|||++.|.+|+.++||||||||++||++|.++|
T Consensus 325 ~~r~~vKVIDFGSSc~~~q~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLf 388 (586)
T KOG0667|consen 325 PKRSRIKVIDFGSSCFESQRVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLF 388 (586)
T ss_pred CCcCceeEEecccccccCCcceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCcccc
Confidence 7788999999999999999999999999999999999999999999999999999999998887
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=340.50 Aligned_cols=197 Identities=32% Similarity=0.531 Sum_probs=175.4
Q ss_pred ecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecC---chhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEec
Q 007035 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (621)
Q Consensus 412 i~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~---~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~ 488 (621)
..++|.+.+.||+|+|++||+|+++.++..||||.+.+. +...+....|++||+.++ |||||++++++...
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~------H~nIV~l~d~~~~~ 81 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELK------HPNIVRLLDCIEDD 81 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcC------CcceeeEEEEEecC
Confidence 347899999999999999999999999999999998754 345567788999999886 78999999999999
Q ss_pred CeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEecc-CC---CeEE
Q 007035 489 EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSY-QR---CEIK 563 (621)
Q Consensus 489 ~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~-~~---~~IK 563 (621)
+++|+|||||.| +|-+++..... +++..++.++.||+.||++||+++||||||||+||||... .. -.+|
T Consensus 82 ~~i~lVMEyC~gGDLs~yi~~~~~------l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LK 155 (429)
T KOG0595|consen 82 DFIYLVMEYCNGGDLSDYIRRRGR------LPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLK 155 (429)
T ss_pred CeEEEEEEeCCCCCHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEE
Confidence 999999999994 66666665432 8999999999999999999999999999999999999864 22 5689
Q ss_pred EEecCCccccCCC--ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 564 IIDLGSSCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 564 L~DFGls~~~~~~--~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
|+|||+|+..... ..+.+|+|.|||||++...+|+.|+|+||+|+|||+|++|++||
T Consensus 156 IADFGfAR~L~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf 214 (429)
T KOG0595|consen 156 IADFGFARFLQPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPF 214 (429)
T ss_pred ecccchhhhCCchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCc
Confidence 9999999886643 55689999999999999999999999999999999999999998
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=335.46 Aligned_cols=196 Identities=31% Similarity=0.503 Sum_probs=172.6
Q ss_pred ecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc----hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEe
Q 007035 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (621)
Q Consensus 412 i~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~ 487 (621)
-.++|++++.||+|+||+|++++.+.+++.+|+|++++.. ...+...+|..||..+ .||+||+++..|++
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v------~hPFiv~l~ysFQt 96 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKI------KHPFIVKLIYSFQT 96 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhC------CCCcEeeeEEeccc
Confidence 3578999999999999999999999999999999998743 2345667777777764 58899999999999
Q ss_pred cCeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEe
Q 007035 488 LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (621)
Q Consensus 488 ~~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~D 566 (621)
.+++|+|+||+.| .|.-.++... .|++..++.++.+|+.||.|||++|||||||||+|||++ .+|+|+|+|
T Consensus 97 ~~kLylVld~~~GGeLf~hL~~eg------~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd--~~GHi~LtD 168 (357)
T KOG0598|consen 97 EEKLYLVLDYLNGGELFYHLQREG------RFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLD--EQGHIKLTD 168 (357)
T ss_pred CCeEEEEEeccCCccHHHHHHhcC------CcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeec--CCCcEEEec
Confidence 9999999999997 4555544332 299999999999999999999999999999999999999 599999999
Q ss_pred cCCcccc---CCCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 007035 567 LGSSCFQ---TDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCLI 621 (621)
Q Consensus 567 FGls~~~---~~~~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF~ 621 (621)
||++... +.....++||+.|||||++.+.+|+..+|+||||+++|||++|.+||.
T Consensus 169 FgL~k~~~~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~ 226 (357)
T KOG0598|consen 169 FGLCKEDLKDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFY 226 (357)
T ss_pred cccchhcccCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCc
Confidence 9998743 345666899999999999999999999999999999999999999994
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=345.29 Aligned_cols=203 Identities=30% Similarity=0.531 Sum_probs=177.9
Q ss_pred cceeeCeeecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEec----CchhhhhHHHHHHHHHHhcccCCCCCCceE
Q 007035 404 LPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKN----DKDFFDQSLDEIKLLKLVNKNDPADEHHIL 479 (621)
Q Consensus 404 ~pi~l~~ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~----~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIv 479 (621)
+|-.+-+.-..+|...+.||+|||++||.+++..+|+.||+|++.+ .....++..+|++|.+.+ +|||||
T Consensus 8 ip~~i~D~~~~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L------~HpnIV 81 (592)
T KOG0575|consen 8 IPEVIEDPRSKRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSL------KHPNIV 81 (592)
T ss_pred CCCeeecCCcceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhc------CCCcEE
Confidence 3333333333789999999999999999999999999999999986 445567788888888777 478999
Q ss_pred EEeeEeEecCeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccC
Q 007035 480 RLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQ 558 (621)
Q Consensus 480 rl~~~f~~~~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~ 558 (621)
+++++|++.+++|||.|+|.. +|..+++... .+++.+++.+++||+.||.|||+++|+|||||..|++++ .
T Consensus 82 ~f~~~FEDs~nVYivLELC~~~sL~el~Krrk------~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~--~ 153 (592)
T KOG0575|consen 82 QFYHFFEDSNNVYIVLELCHRGSLMELLKRRK------PLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLN--E 153 (592)
T ss_pred eeeeEeecCCceEEEEEecCCccHHHHHHhcC------CCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeec--C
Confidence 999999999999999999985 5555555222 399999999999999999999999999999999999999 4
Q ss_pred CCeEEEEecCCccccC---CCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 559 RCEIKIIDLGSSCFQT---DNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 559 ~~~IKL~DFGls~~~~---~~~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
+.+|||+|||+|.... ....+.+|||.|.|||++.....+..+||||+|||||-||+|++||
T Consensus 154 ~~~VKIgDFGLAt~le~~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPF 218 (592)
T KOG0575|consen 154 NMNVKIGDFGLATQLEYDGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPF 218 (592)
T ss_pred cCcEEecccceeeeecCcccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCc
Confidence 8899999999998765 5577789999999999999999999999999999999999999999
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=335.60 Aligned_cols=201 Identities=33% Similarity=0.513 Sum_probs=175.1
Q ss_pred CeeecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCch--------hhhhHHHHHHHHHHhcccCCCCCCceEE
Q 007035 409 NTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD--------FFDQSLDEIKLLKLVNKNDPADEHHILR 480 (621)
Q Consensus 409 ~~ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~--------~~~~~~~Ei~iL~~l~~~~~~~hpnIvr 480 (621)
...+++.|.+.+.||+|+||.|-+|.++.+|+.||||++++... ......+|++||++++ ||+||+
T Consensus 167 pks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~------HP~IV~ 240 (475)
T KOG0615|consen 167 PKSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLS------HPNIVR 240 (475)
T ss_pred cchhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcC------CCCEEE
Confidence 34477889999999999999999999999999999999986432 2234578999999886 789999
Q ss_pred EeeEeEecCeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEecc-C
Q 007035 481 LYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSY-Q 558 (621)
Q Consensus 481 l~~~f~~~~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~-~ 558 (621)
++++|...+..||||||++| .|.+.+..+.. +.+..-+.+++||+.|+.|||++||+||||||+|||+..+ .
T Consensus 241 ~~d~f~~~ds~YmVlE~v~GGeLfd~vv~nk~------l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e 314 (475)
T KOG0615|consen 241 IKDFFEVPDSSYMVLEYVEGGELFDKVVANKY------LREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAE 314 (475)
T ss_pred EeeeeecCCceEEEEEEecCccHHHHHHhccc------cccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCc
Confidence 99999999999999999985 78888876554 7788889999999999999999999999999999999865 5
Q ss_pred CCeEEEEecCCccccC--CCccccccCCcccCchhhcCCC---CCchhhHHHHHHHHHHHHhCCCCCC
Q 007035 559 RCEIKIIDLGSSCFQT--DNLCLYVQSRSYRAPEVIIGLP---YDQKIDLWSLGCILAELWTGEVCLI 621 (621)
Q Consensus 559 ~~~IKL~DFGls~~~~--~~~~~~~gt~~Y~APEvl~~~~---~s~ksDIWSLGvILyELltG~~PF~ 621 (621)
+..+||+|||+|...+ .-..+.||||.|.|||++.+.. +..++|||||||+||-+++|.+||.
T Consensus 315 ~~llKItDFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS 382 (475)
T KOG0615|consen 315 DCLLKITDFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFS 382 (475)
T ss_pred ceEEEecccchhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcc
Confidence 6899999999998874 3456689999999999998765 3347899999999999999999994
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=316.70 Aligned_cols=195 Identities=28% Similarity=0.497 Sum_probs=176.9
Q ss_pred cCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc----hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEec
Q 007035 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (621)
Q Consensus 413 ~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~ 488 (621)
-++|++++.||.|+||+|.+++++.+|..+|+|++.+.+ .+.+...+|..+|+.+. ||+++++++.|.+.
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~------~PFlv~l~~t~~d~ 116 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVS------HPFLVKLYGTFKDN 116 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhcc------CceeEEEEEeeccC
Confidence 367999999999999999999999999999999998754 34455667777777664 78999999999999
Q ss_pred CeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEec
Q 007035 489 EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 567 (621)
Q Consensus 489 ~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DF 567 (621)
+.++|||||++| .|..++...++ |++..++.++.||+.||+|||+++|++|||||+||||+ ++|.+||+||
T Consensus 117 ~~lymvmeyv~GGElFS~Lrk~~r------F~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD--~~G~iKitDF 188 (355)
T KOG0616|consen 117 SNLYMVMEYVPGGELFSYLRKSGR------FSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLD--QNGHIKITDF 188 (355)
T ss_pred CeEEEEEeccCCccHHHHHHhcCC------CCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeec--cCCcEEEEec
Confidence 999999999986 56666655443 99999999999999999999999999999999999999 5999999999
Q ss_pred CCccccCCCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 007035 568 GSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCLI 621 (621)
Q Consensus 568 Gls~~~~~~~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF~ 621 (621)
|++........+.||||.|+|||++...+|..++|+||||+++|||+.|.+||.
T Consensus 189 GFAK~v~~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~ 242 (355)
T KOG0616|consen 189 GFAKRVSGRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFY 242 (355)
T ss_pred cceEEecCcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCc
Confidence 999999999899999999999999999999999999999999999999999994
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=326.05 Aligned_cols=196 Identities=32% Similarity=0.433 Sum_probs=173.9
Q ss_pred ecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEe--cCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecC
Q 007035 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK--NDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (621)
Q Consensus 412 i~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~--~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~ 489 (621)
...+.+.++.||+|+.|+||+++|+.+++.+|+|.+. .+.....++.+|+++++.++ +||||.+|+.|++..
T Consensus 77 ~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~------spyIV~~ygaF~~~~ 150 (364)
T KOG0581|consen 77 SLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQ------SPYIVGFYGAFYSNG 150 (364)
T ss_pred CHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCC------CCCeeeEeEEEEeCC
Confidence 3456788899999999999999999999999999984 45667788999999998884 679999999999999
Q ss_pred -eEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHH-CCeecccCCCccEEEeccCCCeEEEEe
Q 007035 490 -HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS-LGIIHCDLKPENILIKSYQRCEIKIID 566 (621)
Q Consensus 490 -~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs-~gIvHrDLKP~NILl~~~~~~~IKL~D 566 (621)
.++|+||||++ +|..++...+. +++..+..+++++++||.|||+ ++|+||||||+||||++ .|+|||+|
T Consensus 151 ~~isI~mEYMDgGSLd~~~k~~g~------i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNs--kGeVKicD 222 (364)
T KOG0581|consen 151 EEISICMEYMDGGSLDDILKRVGR------IPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNS--KGEVKICD 222 (364)
T ss_pred ceEEeehhhcCCCCHHHHHhhcCC------CCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeecc--CCCEEecc
Confidence 59999999996 55555554322 8999999999999999999995 89999999999999995 99999999
Q ss_pred cCCccccCCC-ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 007035 567 LGSSCFQTDN-LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCLI 621 (621)
Q Consensus 567 FGls~~~~~~-~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF~ 621 (621)
||.+...... ...++||..|||||.+.+..|+.++||||||++++||++|+.||.
T Consensus 223 FGVS~~lvnS~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~ 278 (364)
T KOG0581|consen 223 FGVSGILVNSIANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYP 278 (364)
T ss_pred ccccHHhhhhhcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCC
Confidence 9998775544 467899999999999999999999999999999999999999984
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=314.83 Aligned_cols=194 Identities=28% Similarity=0.469 Sum_probs=174.5
Q ss_pred CceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecC---chhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCe
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~---~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~ 490 (621)
++|+.+.++|.|+||.||+++++.||+.||||.+... +....-.++|+++|++++ |+|+|.++.+|.....
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLk------H~NLVnLiEVFrrkrk 75 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLK------HENLVNLIEVFRRKRK 75 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcc------cchHHHHHHHHHhcce
Confidence 4688999999999999999999999999999998753 335566788999988875 6789999999999999
Q ss_pred EEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCc
Q 007035 491 LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (621)
Q Consensus 491 l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls 570 (621)
+++|+|||+.++++.+...... ++...++.+++|++.|+.|+|+++++||||||+||||+ ..+.+||+|||+|
T Consensus 76 lhLVFE~~dhTvL~eLe~~p~G-----~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit--~~gvvKLCDFGFA 148 (396)
T KOG0593|consen 76 LHLVFEYCDHTVLHELERYPNG-----VPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILIT--QNGVVKLCDFGFA 148 (396)
T ss_pred eEEEeeecchHHHHHHHhccCC-----CCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEe--cCCcEEeccchhh
Confidence 9999999999999988876543 88999999999999999999999999999999999999 5899999999999
Q ss_pred cccCCC---ccccccCCcccCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 571 CFQTDN---LCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 571 ~~~~~~---~~~~~gt~~Y~APEvl~~-~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
+....+ -+.++.|.+|+|||.+.+ .+|+.++||||+||++.||++|+++|
T Consensus 149 R~L~~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~ 202 (396)
T KOG0593|consen 149 RTLSAPGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLW 202 (396)
T ss_pred HhhcCCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCC
Confidence 876633 344788999999999998 57999999999999999999999986
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=326.01 Aligned_cols=195 Identities=29% Similarity=0.468 Sum_probs=166.1
Q ss_pred ecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchh----hhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEe
Q 007035 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDF----FDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (621)
Q Consensus 412 i~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~----~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~ 487 (621)
-.++|.++..||+|+||.||+|+.+.||..+|+|++++.... ...++.|..+|.. .+.|+||++|..|++
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~------~ds~~vVKLyYsFQD 212 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAE------VDSPWVVKLYYSFQD 212 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhh------cCCCcEEEEEEEecC
Confidence 347899999999999999999999999999999999986433 3445555555554 356799999999999
Q ss_pred cCeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEe
Q 007035 488 LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (621)
Q Consensus 488 ~~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~D 566 (621)
.+++||||||++| .+..++..... |++..++.++.+++.|+..||+.|++||||||+|+||+ ..|+|||+|
T Consensus 213 ~~~LYLiMEylPGGD~mTLL~~~~~------L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD--~~GHiKLSD 284 (550)
T KOG0605|consen 213 KEYLYLIMEYLPGGDMMTLLMRKDT------LTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLID--AKGHIKLSD 284 (550)
T ss_pred CCeeEEEEEecCCccHHHHHHhcCc------CchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeec--CCCCEeecc
Confidence 9999999999996 55566554432 99999999999999999999999999999999999999 599999999
Q ss_pred cCCccccC------------------------C-C-----c--------------------cccccCCcccCchhhcCCC
Q 007035 567 LGSSCFQT------------------------D-N-----L--------------------CLYVQSRSYRAPEVIIGLP 596 (621)
Q Consensus 567 FGls~~~~------------------------~-~-----~--------------------~~~~gt~~Y~APEvl~~~~ 596 (621)
||++.-.. + . . ...+|||.|+|||++.+..
T Consensus 285 FGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kg 364 (550)
T KOG0605|consen 285 FGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKG 364 (550)
T ss_pred ccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCC
Confidence 99872100 0 0 0 1148899999999999999
Q ss_pred CCchhhHHHHHHHHHHHHhCCCCC
Q 007035 597 YDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 597 ~s~ksDIWSLGvILyELltG~~PF 620 (621)
|+..+|+|||||||||||.|-+||
T Consensus 365 Y~~~cDwWSLG~ImyEmLvGyPPF 388 (550)
T KOG0605|consen 365 YGKECDWWSLGCIMYEMLVGYPPF 388 (550)
T ss_pred CCccccHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999999
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=324.55 Aligned_cols=195 Identities=31% Similarity=0.492 Sum_probs=173.0
Q ss_pred cCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCch----hhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEec
Q 007035 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD----FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (621)
Q Consensus 413 ~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~----~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~ 488 (621)
..+|...+.||.|+|++|++|+++.+++.||||++.+... -.+-+..|..+|.+|. .||.|++||..|++.
T Consensus 72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~-----~hPgivkLy~TFQD~ 146 (604)
T KOG0592|consen 72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLS-----GHPGIVKLYFTFQDE 146 (604)
T ss_pred hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhh-----CCCCeEEEEEEeecc
Confidence 3679999999999999999999999999999999876422 2344667888888886 589999999999999
Q ss_pred CeEEEEEeccc-cchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEec
Q 007035 489 EHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 567 (621)
Q Consensus 489 ~~l~LVmEyl~-gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DF 567 (621)
..+|+|+||++ |.|++++..... |++...+.++.||+.||+|||++|||||||||+|||++ ++++++|+||
T Consensus 147 ~sLYFvLe~A~nGdll~~i~K~Gs------fde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd--~dmhikITDF 218 (604)
T KOG0592|consen 147 ESLYFVLEYAPNGDLLDLIKKYGS------FDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLD--KDGHIKITDF 218 (604)
T ss_pred cceEEEEEecCCCcHHHHHHHhCc------chHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEc--CCCcEEEeec
Confidence 99999999998 689998886643 89999999999999999999999999999999999999 5999999999
Q ss_pred CCccccCCC----------------ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 568 GSSCFQTDN----------------LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 568 Gls~~~~~~----------------~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
|.+...... ...++||-.|.+||++.....++.+|||+||||||+|+.|.+||
T Consensus 219 GsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPF 287 (604)
T KOG0592|consen 219 GSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPF 287 (604)
T ss_pred cccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCC
Confidence 987653321 14489999999999999999999999999999999999999999
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=331.84 Aligned_cols=197 Identities=26% Similarity=0.438 Sum_probs=173.8
Q ss_pred eecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc----hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeE
Q 007035 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (621)
Q Consensus 411 ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~ 486 (621)
+--++|.+++.||+|+||+|+++..+.+++.+|||+++++. +..+....|.+|+.... .||++++++.+|+
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~-----~HPFL~~L~~~fQ 439 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELAN-----RHPFLVNLFSCFQ 439 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhc-----cCCeEeecccccc
Confidence 33478999999999999999999999999999999999854 33456677777777775 6999999999999
Q ss_pred ecCeEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEe
Q 007035 487 HLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (621)
Q Consensus 487 ~~~~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~D 566 (621)
..+|+|+||||+.|+.+-.++. ...|++..++.++.+|+.||.|||++|||+||||.+|||++ ..|++||+|
T Consensus 440 T~~~l~fvmey~~Ggdm~~~~~------~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD--~eGh~kiAD 511 (694)
T KOG0694|consen 440 TKEHLFFVMEYVAGGDLMHHIH------TDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLD--TEGHVKIAD 511 (694)
T ss_pred cCCeEEEEEEecCCCcEEEEEe------cccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEc--ccCcEEecc
Confidence 9999999999999875221111 12399999999999999999999999999999999999999 599999999
Q ss_pred cCCcccc---CCCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 567 LGSSCFQ---TDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 567 FGls~~~---~~~~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
||++... +....+++|||.|+|||++.+..|+.++|+|||||+|||||.|+.||
T Consensus 512 FGlcKe~m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF 568 (694)
T KOG0694|consen 512 FGLCKEGMGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPF 568 (694)
T ss_pred cccccccCCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCC
Confidence 9998753 45677899999999999999999999999999999999999999998
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=320.69 Aligned_cols=197 Identities=34% Similarity=0.562 Sum_probs=173.6
Q ss_pred eecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecC---chhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEe
Q 007035 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (621)
Q Consensus 411 ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~---~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~ 487 (621)
.-.+.|+.+++||+|.||.||+|++..+|+.||+|.++.+ ..+.....+|+.||+++. ||||+++.+...+
T Consensus 114 r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~------HpNIikL~eivt~ 187 (560)
T KOG0600|consen 114 RRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLD------HPNIIKLEEIVTS 187 (560)
T ss_pred cchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcC------CCcccceeeEEEe
Confidence 3456799999999999999999999999999999998754 345667789999999885 7899999999987
Q ss_pred c--CeEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEE
Q 007035 488 L--EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKII 565 (621)
Q Consensus 488 ~--~~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~ 565 (621)
. ..+|||+|||+..|..++....- .|++.+++.+++||+.||.|||.+||+|||||.+||||+ .+|.+||+
T Consensus 188 ~~~~siYlVFeYMdhDL~GLl~~p~v-----kft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLid--n~G~LKia 260 (560)
T KOG0600|consen 188 KLSGSIYLVFEYMDHDLSGLLSSPGV-----KFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILID--NNGVLKIA 260 (560)
T ss_pred cCCceEEEEEecccchhhhhhcCCCc-----ccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEc--CCCCEEec
Confidence 7 68999999999998887765432 399999999999999999999999999999999999999 58999999
Q ss_pred ecCCccccCCC----ccccccCCcccCchhhcCCC-CCchhhHHHHHHHHHHHHhCCCCC
Q 007035 566 DLGSSCFQTDN----LCLYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 566 DFGls~~~~~~----~~~~~gt~~Y~APEvl~~~~-~s~ksDIWSLGvILyELltG~~PF 620 (621)
|||+|+..... .+..+-|.+|+|||.++|.. |+.++|+||+||||.||++|++.|
T Consensus 261 DFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~ 320 (560)
T KOG0600|consen 261 DFGLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPIL 320 (560)
T ss_pred cccceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCc
Confidence 99999865432 34456799999999999874 999999999999999999999886
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=324.40 Aligned_cols=198 Identities=34% Similarity=0.541 Sum_probs=172.8
Q ss_pred eecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhh--hhHHHHHHHHHHhcccCCCCCCceEEEeeEeEec
Q 007035 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFF--DQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (621)
Q Consensus 411 ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~--~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~ 488 (621)
.+.+||.++++||.|.||.||+|+.+.+|..||||.+++.-... -.-++|++.|++++ .||||+++.+++.+.
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln-----~hpniikL~Evi~d~ 81 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLN-----PHPNIIKLKEVIRDN 81 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcC-----CCCcchhhHHHhhcc
Confidence 35689999999999999999999999999999999987642211 22366777777765 378999999999998
Q ss_pred C-eEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEec
Q 007035 489 E-HLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 567 (621)
Q Consensus 489 ~-~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DF 567 (621)
+ ++++|||||+.+|+++++.... .|++..++.|+.||++||+|+|++|+.||||||+||||.. ...|||+||
T Consensus 82 ~~~L~fVfE~Md~NLYqLmK~R~r-----~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~--~~~iKiaDF 154 (538)
T KOG0661|consen 82 DRILYFVFEFMDCNLYQLMKDRNR-----LFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISG--NDVIKIADF 154 (538)
T ss_pred CceEeeeHHhhhhhHHHHHhhcCC-----cCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecc--cceeEeccc
Confidence 8 9999999999999999986633 3999999999999999999999999999999999999984 778999999
Q ss_pred CCccccCC--CccccccCCcccCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 568 GSSCFQTD--NLCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 568 Gls~~~~~--~~~~~~gt~~Y~APEvl~~-~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
|+|+.... +-+.++.|.+|+|||+++. .-|+.++||||+|||++|+.+=+++|
T Consensus 155 GLARev~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLF 210 (538)
T KOG0661|consen 155 GLAREVRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLF 210 (538)
T ss_pred ccccccccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccC
Confidence 99987643 4556889999999999865 45899999999999999999999988
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=314.62 Aligned_cols=198 Identities=33% Similarity=0.531 Sum_probs=174.6
Q ss_pred eecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecC----c--hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeE
Q 007035 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND----K--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDY 484 (621)
Q Consensus 411 ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~----~--~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~ 484 (621)
...++|.+.+.||+|+||+|++|++..+++.||+|++.+. . .....+.+|+.+++.+.. ||||++++++
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~-----HpnI~~l~ev 88 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRS-----HPNIIRLLEV 88 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhcc-----CCCEeEEEEE
Confidence 4567899999999999999999999999999999987664 1 234566678888888863 6799999999
Q ss_pred eEecCeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEE
Q 007035 485 FYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 563 (621)
Q Consensus 485 f~~~~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IK 563 (621)
+....++++||||+.+ .|++.+..... +.+..++.+++||+.|++|||++||+||||||+|||++.+. +.+|
T Consensus 89 ~~t~~~~~ivmEy~~gGdL~~~i~~~g~------l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~-~~~K 161 (370)
T KOG0583|consen 89 FATPTKIYIVMEYCSGGDLFDYIVNKGR------LKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNE-GNLK 161 (370)
T ss_pred EecCCeEEEEEEecCCccHHHHHHHcCC------CChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCC-CCEE
Confidence 9999999999999985 88888876322 88899999999999999999999999999999999999632 8999
Q ss_pred EEecCCcccc---CCCccccccCCcccCchhhcCCC-CC-chhhHHHHHHHHHHHHhCCCCC
Q 007035 564 IIDLGSSCFQ---TDNLCLYVQSRSYRAPEVIIGLP-YD-QKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 564 L~DFGls~~~---~~~~~~~~gt~~Y~APEvl~~~~-~s-~ksDIWSLGvILyELltG~~PF 620 (621)
|+|||++... .......+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||
T Consensus 162 l~DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF 223 (370)
T KOG0583|consen 162 LSDFGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPF 223 (370)
T ss_pred EeccccccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCC
Confidence 9999999866 34567789999999999999987 85 7899999999999999999999
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=322.60 Aligned_cols=194 Identities=30% Similarity=0.527 Sum_probs=175.6
Q ss_pred CceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc---hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCe
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~---~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~ 490 (621)
++|.+.+.||+|+||.||+|+.+.+.+.||+|.+.+.. .....+.+|++|++.++ ||||+.++++|+...+
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lk------Hpniv~m~esfEt~~~ 75 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLK------HPNIVEMLESFETSAH 75 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcC------CcchhhHHHhhcccce
Confidence 57899999999999999999999999999999987643 33456777888888775 7899999999999999
Q ss_pred EEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCc
Q 007035 491 LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (621)
Q Consensus 491 l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls 570 (621)
+|+|+||+.|.|..++..+.. ++++.++.++.+++.||.|||+.+|+|||+||.|||+. +.+.+|++|||++
T Consensus 76 ~~vVte~a~g~L~~il~~d~~------lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~--~~~~~KlcdFg~A 147 (808)
T KOG0597|consen 76 LWVVTEYAVGDLFTILEQDGK------LPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLE--KGGTLKLCDFGLA 147 (808)
T ss_pred EEEEehhhhhhHHHHHHhccC------CCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeec--CCCceeechhhhh
Confidence 999999999999988876654 89999999999999999999999999999999999999 5899999999999
Q ss_pred cccCCC---ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 007035 571 CFQTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCLI 621 (621)
Q Consensus 571 ~~~~~~---~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF~ 621 (621)
+....+ .+.+.|||.|||||.+.+.+|+..+|+||||||+|||++|++||.
T Consensus 148 r~m~~~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~ 201 (808)
T KOG0597|consen 148 RAMSTNTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFY 201 (808)
T ss_pred hhcccCceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCch
Confidence 876654 334689999999999999999999999999999999999999994
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=306.41 Aligned_cols=198 Identities=29% Similarity=0.403 Sum_probs=170.8
Q ss_pred cCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEec---CchhhhhHHHHHHHHHHhcccCCCCCCceEEEee-EeEec
Q 007035 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKN---DKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYD-YFYHL 488 (621)
Q Consensus 413 ~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~---~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~-~f~~~ 488 (621)
...|+|+++||.|.||+||++.++.+|..+|+|-++- +....+....|+.+|++|+ ||||+++++ .|...
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~------HpNIVqYy~~~f~~~ 91 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLN------HPNIVQYYAHSFIED 91 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcC------CchHHHHHHHhhhcc
Confidence 3569999999999999999999999999999998864 3344566778888888775 789999999 55555
Q ss_pred Ce-EEEEEeccc-cchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHH--CC--eecccCCCccEEEeccCCCeE
Q 007035 489 EH-LFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS--LG--IIHCDLKPENILIKSYQRCEI 562 (621)
Q Consensus 489 ~~-l~LVmEyl~-gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs--~g--IvHrDLKP~NILl~~~~~~~I 562 (621)
+. ++||||||. |.|-+.++..+. ....+++..+|.++.|++.||..+|. .. |+||||||.||+|+ .+|.+
T Consensus 92 ~evlnivmE~c~~GDLsqmIk~~K~--qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~--~~gvv 167 (375)
T KOG0591|consen 92 NEVLNIVMELCDAGDLSQMIKHFKK--QKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLT--ANGVV 167 (375)
T ss_pred chhhHHHHHhhcccCHHHHHHHHHh--ccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEc--CCCce
Confidence 54 999999998 566666665443 34559999999999999999999998 44 99999999999999 58999
Q ss_pred EEEecCCccccCCC---ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 563 KIIDLGSSCFQTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 563 KL~DFGls~~~~~~---~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
||+|||+++..... ...++|||.||+||.+...+|+.++|||||||++|||+.=++||
T Consensus 168 KLGDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF 228 (375)
T KOG0591|consen 168 KLGDFGLGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPF 228 (375)
T ss_pred eeccchhHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCc
Confidence 99999999876654 34589999999999999999999999999999999999999998
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=294.54 Aligned_cols=194 Identities=35% Similarity=0.526 Sum_probs=172.5
Q ss_pred CceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCch---hhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCe
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD---FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~---~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~ 490 (621)
.+|..+++||+|.||.||+|++..+|+.||||.++..+. .....++|++.|++++ |+||+.++++|.+.+.
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~------h~nIi~LiD~F~~~~~ 75 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELK------HPNIIELIDVFPHKSN 75 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHcc------CcchhhhhhhccCCCc
Confidence 578999999999999999999999999999999986432 3567889999999886 6799999999999999
Q ss_pred EEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCc
Q 007035 491 LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (621)
Q Consensus 491 l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls 570 (621)
+.||+||++.+|...++.... .++...++.++.++++||+|||++.|+||||||.|+||++ +|.+||+|||++
T Consensus 76 l~lVfEfm~tdLe~vIkd~~i-----~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~--~g~lKiADFGLA 148 (318)
T KOG0659|consen 76 LSLVFEFMPTDLEVVIKDKNI-----ILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISS--DGQLKIADFGLA 148 (318)
T ss_pred eEEEEEeccccHHHHhccccc-----ccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcC--CCcEEeecccch
Confidence 999999999999888875543 3889999999999999999999999999999999999995 899999999999
Q ss_pred cccCCCccc---cccCCcccCchhhcCCC-CCchhhHHHHHHHHHHHHhCCCCC
Q 007035 571 CFQTDNLCL---YVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 571 ~~~~~~~~~---~~gt~~Y~APEvl~~~~-~s~ksDIWSLGvILyELltG~~PF 620 (621)
+........ .+-|.+|+|||.+.|.+ |+..+||||.|||+.||+-|.+.|
T Consensus 149 r~f~~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~f 202 (318)
T KOG0659|consen 149 RFFGSPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFF 202 (318)
T ss_pred hccCCCCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCC
Confidence 887654333 36699999999998865 999999999999999999887665
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=302.58 Aligned_cols=196 Identities=29% Similarity=0.456 Sum_probs=174.1
Q ss_pred ecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCch---hhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEe-
Q 007035 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD---FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH- 487 (621)
Q Consensus 412 i~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~---~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~- 487 (621)
-.+.|++++.|+.|.||.||+|+|+.+++.||+|.++.++. +.-..++|+.+|.+++ |||||.+-.+...
T Consensus 74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~------H~NIV~vkEVVvG~ 147 (419)
T KOG0663|consen 74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKAR------HPNIVEVKEVVVGS 147 (419)
T ss_pred cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcC------CCCeeeeEEEEecc
Confidence 34679999999999999999999999999999999986542 4456789999988775 6799999998774
Q ss_pred -cCeEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEe
Q 007035 488 -LEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (621)
Q Consensus 488 -~~~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~D 566 (621)
.+.+|||||||+..|..++..... .|...+++.++.|+++||+|||.+.|+||||||+|+|+. ..|.+||+|
T Consensus 148 ~~d~iy~VMe~~EhDLksl~d~m~q-----~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~--~~G~lKiaD 220 (419)
T KOG0663|consen 148 NMDKIYIVMEYVEHDLKSLMETMKQ-----PFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLS--HKGILKIAD 220 (419)
T ss_pred ccceeeeeHHHHHhhHHHHHHhccC-----CCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeec--cCCcEEecc
Confidence 467999999999999888876552 289999999999999999999999999999999999999 489999999
Q ss_pred cCCccccCCC---ccccccCCcccCchhhcCCC-CCchhhHHHHHHHHHHHHhCCCCC
Q 007035 567 LGSSCFQTDN---LCLYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 567 FGls~~~~~~---~~~~~gt~~Y~APEvl~~~~-~s~ksDIWSLGvILyELltG~~PF 620 (621)
||+|+..+.+ .+..+-|.+|+|||.+.+.+ |+.++||||+|||+.||++++++|
T Consensus 221 FGLAR~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf 278 (419)
T KOG0663|consen 221 FGLAREYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLF 278 (419)
T ss_pred cchhhhhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCC
Confidence 9999988877 44567799999999999876 999999999999999999999987
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=314.28 Aligned_cols=202 Identities=33% Similarity=0.599 Sum_probs=177.5
Q ss_pred cCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEec-CeE
Q 007035 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL-EHL 491 (621)
Q Consensus 413 ~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~-~~l 491 (621)
.++|+++++||+|+||+||+|.+..+++.||||+++...........|+.+++.+++.+...|++|++++++|... .+.
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~ 207 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHM 207 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceE
Confidence 4789999999999999999999999999999999976555556677899999999888777888999999998865 589
Q ss_pred EEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHH-CCeecccCCCccEEEeccC------------
Q 007035 492 FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS-LGIIHCDLKPENILIKSYQ------------ 558 (621)
Q Consensus 492 ~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs-~gIvHrDLKP~NILl~~~~------------ 558 (621)
+||||+++++|++.+.... .+++..++.++.||+.||.|||+ .||+||||||+|||++.+.
T Consensus 208 ~iv~~~~g~~l~~~l~~~~------~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~ 281 (467)
T PTZ00284 208 CIVMPKYGPCLLDWIMKHG------PFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALP 281 (467)
T ss_pred EEEEeccCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccC
Confidence 9999999999988876432 28889999999999999999998 5999999999999998532
Q ss_pred --CCeEEEEecCCccccCCCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 559 --RCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 559 --~~~IKL~DFGls~~~~~~~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
.+.+||+|||.+..........++|+.|+|||++.+..++.++|||||||+||||++|++||
T Consensus 282 ~~~~~vkl~DfG~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf 345 (467)
T PTZ00284 282 PDPCRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLY 345 (467)
T ss_pred CCCceEEECCCCccccCccccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 13599999998876655556678999999999999999999999999999999999999998
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=304.86 Aligned_cols=193 Identities=25% Similarity=0.406 Sum_probs=164.4
Q ss_pred CceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc----hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecC
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~ 489 (621)
++|++++.||+|+||+||+++++.+++.||+|++.... .....+..|+.++..+ +|++|+++++.+.+..
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~------~~~~iv~~~~~~~~~~ 74 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEA------DSLWVVKMFYSFQDKL 74 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhC------CCCCcceEEEEEecCC
Confidence 47999999999999999999999999999999997532 2234455666666655 4789999999999999
Q ss_pred eEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecC
Q 007035 490 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (621)
Q Consensus 490 ~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFG 568 (621)
.+++||||+.+ +|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||
T Consensus 75 ~~~lv~E~~~gg~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~--~~~vkL~DFG 146 (363)
T cd05628 75 NLYLIMEFLPGGDMMTLLMKKD------TLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDS--KGHVKLSDFG 146 (363)
T ss_pred eEEEEEcCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECC--CCCEEEeecc
Confidence 99999999985 6766665432 2889999999999999999999999999999999999984 7889999999
Q ss_pred CccccCCC--------------------------------------ccccccCCcccCchhhcCCCCCchhhHHHHHHHH
Q 007035 569 SSCFQTDN--------------------------------------LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCIL 610 (621)
Q Consensus 569 ls~~~~~~--------------------------------------~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvIL 610 (621)
++...... ....+||+.|+|||++.+..++.++|||||||++
T Consensus 147 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil 226 (363)
T cd05628 147 LCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM 226 (363)
T ss_pred CcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHH
Confidence 87543211 1234789999999999999999999999999999
Q ss_pred HHHHhCCCCC
Q 007035 611 AELWTGEVCL 620 (621)
Q Consensus 611 yELltG~~PF 620 (621)
|||++|+.||
T Consensus 227 ~ell~G~~Pf 236 (363)
T cd05628 227 YEMLIGYPPF 236 (363)
T ss_pred HHHHhCCCCC
Confidence 9999999998
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=299.96 Aligned_cols=194 Identities=34% Similarity=0.584 Sum_probs=167.0
Q ss_pred ceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecC-----
Q 007035 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE----- 489 (621)
Q Consensus 415 rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~----- 489 (621)
.|.-.+.+|+|+||.||+|....+++.||||....++.. .-+|+.+++++ +||||+++..+|....
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~---knrEl~im~~l------~HpNIV~L~~~f~~~~~~d~~ 95 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY---KNRELQIMRKL------DHPNIVRLLYFFSSSTESDEV 95 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc---CcHHHHHHHhc------CCcCeeeEEEEEEecCCCchh
Confidence 588899999999999999999999999999998877653 34678888744 6899999999998542
Q ss_pred eEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCC
Q 007035 490 HLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (621)
Q Consensus 490 ~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGl 569 (621)
++.+||||++.+|++.+...-.. ...++...++.+.+||++||+|||+.||+||||||.|||++. .+|.+||+|||+
T Consensus 96 ~lnlVleymP~tL~~~~r~~~~~--~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~-~tg~LKicDFGS 172 (364)
T KOG0658|consen 96 YLNLVLEYMPETLYRVIRHYTRA--NQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDP-DTGVLKICDFGS 172 (364)
T ss_pred HHHHHHHhchHHHHHHHHHHhhc--CCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcC-CCCeEEeccCCc
Confidence 57789999999999998753221 222788889999999999999999999999999999999997 679999999999
Q ss_pred ccccC--CCccccccCCcccCchhhcCCC-CCchhhHHHHHHHHHHHHhCCCCC
Q 007035 570 SCFQT--DNLCLYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 570 s~~~~--~~~~~~~gt~~Y~APEvl~~~~-~s~ksDIWSLGvILyELltG~~PF 620 (621)
|.... .+...+.-|..|+|||.+.|.. |+.++||||.||++.||+-|+++|
T Consensus 173 AK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plF 226 (364)
T KOG0658|consen 173 AKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLF 226 (364)
T ss_pred ceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCccc
Confidence 98754 3445567799999999999875 999999999999999999999998
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=294.82 Aligned_cols=193 Identities=26% Similarity=0.369 Sum_probs=167.9
Q ss_pred CceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc----hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecC
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~ 489 (621)
++|++.+.||.|+||.||+|.+..+++.||+|++.... ...+.+.+|+.+++.+ .||||+++++++.+..
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l------~hp~iv~~~~~~~~~~ 74 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEV------SHPFIIRLFWTEHDQR 74 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhC------CCCcHhhhHhhhccCC
Confidence 47999999999999999999999999999999987532 2234556677777666 4789999999999999
Q ss_pred eEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecC
Q 007035 490 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (621)
Q Consensus 490 ~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFG 568 (621)
++++||||+.+ +|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||
T Consensus 75 ~~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~--~~~~kl~Dfg 146 (291)
T cd05612 75 FLYMLMEYVPGGELFSYLRNSG------RFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDK--EGHIKLTDFG 146 (291)
T ss_pred eEEEEEeCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECC--CCCEEEEecC
Confidence 99999999985 6777665432 2788899999999999999999999999999999999984 7889999999
Q ss_pred CccccCCCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 569 SSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 569 ls~~~~~~~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
++...........|++.|+|||++.+..++.++|||||||++|+|++|+.||
T Consensus 147 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf 198 (291)
T cd05612 147 FAKKLRDRTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPF 198 (291)
T ss_pred cchhccCCcccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 9877665555667899999999999988999999999999999999999998
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-34 Score=299.20 Aligned_cols=195 Identities=25% Similarity=0.378 Sum_probs=170.2
Q ss_pred cCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc----hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEec
Q 007035 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (621)
Q Consensus 413 ~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~ 488 (621)
.++|++.+.||+|+||.||+|++..+++.||+|++.... ...+.+.+|+.+++.+ .||||+++++++...
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l------~hp~iv~~~~~~~~~ 90 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMEL------SHPFIVNMMCSFQDE 90 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC------CCCCCCcEEEEEEcC
Confidence 467999999999999999999999999999999997532 2334566777777766 478999999999999
Q ss_pred CeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEec
Q 007035 489 EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 567 (621)
Q Consensus 489 ~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DF 567 (621)
+.+++||||+.+ +|.+.+.... .+++..++.++.||+.||.|||+++|+||||||+|||++. ++.+||+||
T Consensus 91 ~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~--~~~~kl~Df 162 (329)
T PTZ00263 91 NRVYFLLEFVVGGELFTHLRKAG------RFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDN--KGHVKVTDF 162 (329)
T ss_pred CEEEEEEcCCCCChHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECC--CCCEEEeec
Confidence 999999999975 6666665432 2788899999999999999999999999999999999984 788999999
Q ss_pred CCccccCCCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 007035 568 GSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCLI 621 (621)
Q Consensus 568 Gls~~~~~~~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF~ 621 (621)
|++...........|++.|+|||++.+..++.++|||||||++|+|++|+.||.
T Consensus 163 g~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~ 216 (329)
T PTZ00263 163 GFAKKVPDRTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFF 216 (329)
T ss_pred cCceEcCCCcceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCC
Confidence 999877666666789999999999999999999999999999999999999983
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=293.91 Aligned_cols=199 Identities=34% Similarity=0.520 Sum_probs=172.7
Q ss_pred cCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCch---hhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecC
Q 007035 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD---FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (621)
Q Consensus 413 ~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~---~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~ 489 (621)
...|..+++||.|+||+||+|+++.+|+.||+|.++.+.. ......+|+.+++.+++.+ ||+++++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~-----~iv~L~dv~~~~~ 84 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHAN-----HIVRLHDVIHTSN 84 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCc-----ceEEEEeeeeecc
Confidence 3457778889999999999999999999999999986544 4566799999999998653 2999999999877
Q ss_pred ------eEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEE
Q 007035 490 ------HLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 563 (621)
Q Consensus 490 ------~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IK 563 (621)
.+++|+||+...|..++....... ..++...++.+++||+.||+|||+++|+||||||.||||++ .|.+|
T Consensus 85 ~~~~~~~l~lvfe~~d~DL~~ymd~~~~~~--~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~--~G~lK 160 (323)
T KOG0594|consen 85 NHRGIGKLYLVFEFLDRDLKKYMDSLPKKP--QGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISS--SGVLK 160 (323)
T ss_pred cccccceEEEEEEeecccHHHHHHhccccc--cCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECC--CCcEe
Confidence 899999999999988887665321 22666889999999999999999999999999999999995 99999
Q ss_pred EEecCCccccCCC---ccccccCCcccCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 564 IIDLGSSCFQTDN---LCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 564 L~DFGls~~~~~~---~~~~~gt~~Y~APEvl~~~-~~s~ksDIWSLGvILyELltG~~PF 620 (621)
|+|||+|+...-+ .+..+.|.+|+|||++.+. .|+...||||+|||++||++++++|
T Consensus 161 laDFGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LF 221 (323)
T KOG0594|consen 161 LADFGLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLF 221 (323)
T ss_pred eeccchHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCC
Confidence 9999999865533 3345779999999999988 5999999999999999999999988
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=303.86 Aligned_cols=192 Identities=27% Similarity=0.395 Sum_probs=163.1
Q ss_pred ceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc----hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCe
Q 007035 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (621)
Q Consensus 415 rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~ 490 (621)
+|+++++||+|+||+||+|++..+++.||+|++.... .....+.+|+.+++.+ +|+||+++++.|...++
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~------~h~~iv~~~~~~~~~~~ 75 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEA------DNEWVVRLYYSFQDKDN 75 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhC------CCCcCCeEEEEEEeCCE
Confidence 6899999999999999999999999999999987532 2334566677777665 47899999999999999
Q ss_pred EEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCC
Q 007035 491 LFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (621)
Q Consensus 491 l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGl 569 (621)
+++||||+.+ +|.+++.... .+++..++.++.||+.||.|||+++|+||||||+|||++. ++.+||+|||+
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~------~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~--~g~~kL~DFGl 147 (382)
T cd05625 76 LYFVMDYIPGGDMMSLLIRMG------IFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDR--DGHIKLTDFGL 147 (382)
T ss_pred EEEEEeCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECC--CCCEEEeECCC
Confidence 9999999985 6666665332 2788899999999999999999999999999999999984 78999999998
Q ss_pred ccccCC--------------------------------------------------CccccccCCcccCchhhcCCCCCc
Q 007035 570 SCFQTD--------------------------------------------------NLCLYVQSRSYRAPEVIIGLPYDQ 599 (621)
Q Consensus 570 s~~~~~--------------------------------------------------~~~~~~gt~~Y~APEvl~~~~~s~ 599 (621)
+..... .....+||+.|+|||++.+..++.
T Consensus 148 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ 227 (382)
T cd05625 148 CTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQ 227 (382)
T ss_pred CccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCC
Confidence 642100 011246899999999999999999
Q ss_pred hhhHHHHHHHHHHHHhCCCCC
Q 007035 600 KIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 600 ksDIWSLGvILyELltG~~PF 620 (621)
++|||||||+||||++|++||
T Consensus 228 ~~DiwSlGvil~elltG~~Pf 248 (382)
T cd05625 228 LCDWWSVGVILYEMLVGQPPF 248 (382)
T ss_pred eeeEEechHHHHHHHhCCCCC
Confidence 999999999999999999998
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=303.54 Aligned_cols=193 Identities=28% Similarity=0.424 Sum_probs=162.8
Q ss_pred CceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc----hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecC
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~ 489 (621)
++|++++.||+|+||+||++++..+++.||||++.+.. .....+.+|+++++.+ +||||++++++|.+..
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l------~hp~iv~~~~~~~~~~ 74 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAES------DSPWVVSLYYSFQDAQ 74 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhC------CCCCcceEEEEEEcCC
Confidence 47999999999999999999999999999999987532 2234456676666654 5789999999999999
Q ss_pred eEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecC
Q 007035 490 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (621)
Q Consensus 490 ~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFG 568 (621)
++|+||||+.+ +|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||
T Consensus 75 ~~~lv~E~~~gg~L~~~l~~~~------~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~--~~~~~kl~DfG 146 (377)
T cd05629 75 YLYLIMEFLPGGDLMTMLIKYD------TFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILID--RGGHIKLSDFG 146 (377)
T ss_pred eeEEEEeCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEC--CCCCEEEeecc
Confidence 99999999974 6766665332 278899999999999999999999999999999999998 47889999999
Q ss_pred CccccCCC--------------------------------------------------ccccccCCcccCchhhcCCCCC
Q 007035 569 SSCFQTDN--------------------------------------------------LCLYVQSRSYRAPEVIIGLPYD 598 (621)
Q Consensus 569 ls~~~~~~--------------------------------------------------~~~~~gt~~Y~APEvl~~~~~s 598 (621)
++...... ....+||+.|+|||++.+..++
T Consensus 147 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 226 (377)
T cd05629 147 LSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYG 226 (377)
T ss_pred cccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCC
Confidence 88521100 0024689999999999998999
Q ss_pred chhhHHHHHHHHHHHHhCCCCC
Q 007035 599 QKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 599 ~ksDIWSLGvILyELltG~~PF 620 (621)
.++|||||||+||||++|++||
T Consensus 227 ~~~DiwSlGvil~elltG~~Pf 248 (377)
T cd05629 227 QECDWWSLGAIMFECLIGWPPF 248 (377)
T ss_pred CceeeEecchhhhhhhcCCCCC
Confidence 9999999999999999999998
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=300.71 Aligned_cols=193 Identities=25% Similarity=0.416 Sum_probs=164.6
Q ss_pred CceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc----hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecC
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~ 489 (621)
++|++++.||+|+||+||+|++..+|+.||||++.... .....+.+|+.+++.++ ||||+++++++.+.+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~------h~~iv~~~~~~~~~~ 74 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEAD------NPWVVKLYYSFQDEN 74 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC------CCCCcceEEEEEcCC
Confidence 47999999999999999999999999999999997532 23344566777777664 789999999999999
Q ss_pred eEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecC
Q 007035 490 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (621)
Q Consensus 490 ~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFG 568 (621)
++++||||+.+ +|.+++.... .+++..++.++.||+.||.|||+++|+||||||+|||++ .++.++|+|||
T Consensus 75 ~~~lv~E~~~~g~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~--~~~~~kl~Dfg 146 (364)
T cd05599 75 YLYLIMEYLPGGDMMTLLMKKD------TFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLD--AKGHIKLSDFG 146 (364)
T ss_pred eEEEEECCCCCcHHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEEC--CCCCEEEeecc
Confidence 99999999975 6666665322 288999999999999999999999999999999999998 48889999999
Q ss_pred CccccCCC-----------------------------------------ccccccCCcccCchhhcCCCCCchhhHHHHH
Q 007035 569 SSCFQTDN-----------------------------------------LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLG 607 (621)
Q Consensus 569 ls~~~~~~-----------------------------------------~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLG 607 (621)
++...... ....+||+.|+|||++.+..++.++||||||
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 226 (364)
T cd05599 147 LCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLG 226 (364)
T ss_pred cceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecch
Confidence 87543211 0123689999999999998999999999999
Q ss_pred HHHHHHHhCCCCC
Q 007035 608 CILAELWTGEVCL 620 (621)
Q Consensus 608 vILyELltG~~PF 620 (621)
|++|+|++|+.||
T Consensus 227 ~il~el~~G~~Pf 239 (364)
T cd05599 227 VIMYEMLVGYPPF 239 (364)
T ss_pred hHHHHhhcCCCCC
Confidence 9999999999998
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=302.51 Aligned_cols=192 Identities=26% Similarity=0.380 Sum_probs=163.3
Q ss_pred ceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc----hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCe
Q 007035 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (621)
Q Consensus 415 rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~ 490 (621)
.|++++.||+|+||+||+|+++.+++.||||++.... .....+.+|+.+++.+ +|+||+++++++.+.++
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l------~h~~iv~l~~~~~~~~~ 75 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEA------DNEWVVKLYYSFQDKDN 75 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhc------CCCCeeeeEEEEecCCE
Confidence 5899999999999999999999999999999997532 2334566777777665 47899999999999999
Q ss_pred EEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCC
Q 007035 491 LFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (621)
Q Consensus 491 l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGl 569 (621)
+++||||+++ +|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+|||+
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~------~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~--~~~~kL~DFGl 147 (381)
T cd05626 76 LYFVMDYIPGGDMMSLLIRME------VFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDL--DGHIKLTDFGL 147 (381)
T ss_pred EEEEEecCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECC--CCCEEEeeCcC
Confidence 9999999975 6666665432 2788899999999999999999999999999999999984 78999999998
Q ss_pred ccccCC--------------------------------------------------CccccccCCcccCchhhcCCCCCc
Q 007035 570 SCFQTD--------------------------------------------------NLCLYVQSRSYRAPEVIIGLPYDQ 599 (621)
Q Consensus 570 s~~~~~--------------------------------------------------~~~~~~gt~~Y~APEvl~~~~~s~ 599 (621)
+..... .....+||+.|+|||++.+..++.
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ 227 (381)
T cd05626 148 CTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQ 227 (381)
T ss_pred CcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCC
Confidence 642110 012346899999999999988999
Q ss_pred hhhHHHHHHHHHHHHhCCCCC
Q 007035 600 KIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 600 ksDIWSLGvILyELltG~~PF 620 (621)
++|||||||++|||++|+.||
T Consensus 228 ~~DiwSlG~il~elltG~~Pf 248 (381)
T cd05626 228 LCDWWSVGVILFEMLVGQPPF 248 (381)
T ss_pred ccceeehhhHHHHHHhCCCCC
Confidence 999999999999999999998
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=296.59 Aligned_cols=193 Identities=30% Similarity=0.438 Sum_probs=167.3
Q ss_pred CceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc----hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecC
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~ 489 (621)
++|++++.||+|+||.||+|++..+++.||||+++... .....+..|+.++..+ .||||+++++++...+
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~------~h~~iv~~~~~~~~~~ 74 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTT------KSEWLVKLLYAFQDDE 74 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhC------CCCCCccEEEEEEcCC
Confidence 47999999999999999999999999999999997542 2234455666666655 4789999999999999
Q ss_pred eEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecC
Q 007035 490 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (621)
Q Consensus 490 ~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFG 568 (621)
+.+|||||+.+ +|.+++.... .+++..++.++.||+.||.|||+++|+||||||+|||++. ++.+||+|||
T Consensus 75 ~~~lv~e~~~g~~L~~~l~~~~------~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~--~~~~kL~Dfg 146 (333)
T cd05600 75 YLYLAMEYVPGGDFRTLLNNLG------VLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDA--SGHIKLTDFG 146 (333)
T ss_pred EEEEEEeCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECC--CCCEEEEeCc
Confidence 99999999975 6766664332 2788999999999999999999999999999999999984 7889999999
Q ss_pred CccccCCCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 569 SSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 569 ls~~~~~~~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
++...........|++.|+|||++.+..++.++|||||||++|+|++|+.||
T Consensus 147 ~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf 198 (333)
T cd05600 147 LSKGIVTYANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPF 198 (333)
T ss_pred CCcccccccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCC
Confidence 9877665555678899999999999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=289.55 Aligned_cols=195 Identities=28% Similarity=0.462 Sum_probs=165.8
Q ss_pred cCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc--hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCe
Q 007035 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (621)
Q Consensus 413 ~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~ 490 (621)
.++|++++.||.|+||+||+|+++.+++.||+|++.... .......+|+.+++.+ .||||+++++++.....
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~~~~~~~~~~~ 77 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGL------KHANIVLLHDIIHTKET 77 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhC------CCCCcCeEEEEEecCCe
Confidence 368999999999999999999999999999999987532 2223456777777766 47899999999999999
Q ss_pred EEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCc
Q 007035 491 LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (621)
Q Consensus 491 l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls 570 (621)
.++||||+.+++.+.+..... .+++..++.++.||+.||.|||+++|+||||||+|||++. ++.+||+|||++
T Consensus 78 ~~lv~e~~~~~l~~~~~~~~~-----~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~--~~~~kl~Dfg~~ 150 (303)
T cd07869 78 LTLVFEYVHTDLCQYMDKHPG-----GLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISD--TGELKLADFGLA 150 (303)
T ss_pred EEEEEECCCcCHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECC--CCCEEECCCCcc
Confidence 999999999999888764322 2788899999999999999999999999999999999984 788999999998
Q ss_pred cccCCC---ccccccCCcccCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 571 CFQTDN---LCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 571 ~~~~~~---~~~~~gt~~Y~APEvl~~~-~~s~ksDIWSLGvILyELltG~~PF 620 (621)
...... .....+++.|+|||++.+. .++.++|||||||++|+|++|+.||
T Consensus 151 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf 204 (303)
T cd07869 151 RAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAF 204 (303)
T ss_pred eeccCCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 653322 2234678999999998764 5788999999999999999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=302.54 Aligned_cols=193 Identities=25% Similarity=0.381 Sum_probs=163.6
Q ss_pred CceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc----hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecC
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~ 489 (621)
.+|++++.||+|+||.||++++..+++.||+|++.... .....+.+|+.+++.+ .|+||+++++.|...+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l------~h~~iv~~~~~~~~~~ 74 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEA------DNEWVVKLYYSFQDKD 74 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhC------CCCCcceEEEEEEcCC
Confidence 36999999999999999999999999999999987532 2234566777777766 4789999999999999
Q ss_pred eEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecC
Q 007035 490 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (621)
Q Consensus 490 ~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFG 568 (621)
++++||||+.+ +|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||
T Consensus 75 ~~~lv~E~~~~g~L~~~i~~~~------~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~--~~~ikL~DFG 146 (376)
T cd05598 75 NLYFVMDYIPGGDMMSLLIRLG------IFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDR--DGHIKLTDFG 146 (376)
T ss_pred EEEEEEeCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECC--CCCEEEEeCC
Confidence 99999999975 6777765432 2788889999999999999999999999999999999984 7889999999
Q ss_pred CccccCC----------------------------------------------CccccccCCcccCchhhcCCCCCchhh
Q 007035 569 SSCFQTD----------------------------------------------NLCLYVQSRSYRAPEVIIGLPYDQKID 602 (621)
Q Consensus 569 ls~~~~~----------------------------------------------~~~~~~gt~~Y~APEvl~~~~~s~ksD 602 (621)
++..... .....+||+.|+|||++.+..++.++|
T Consensus 147 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 226 (376)
T cd05598 147 LCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCD 226 (376)
T ss_pred CCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCccee
Confidence 8632100 011246899999999999999999999
Q ss_pred HHHHHHHHHHHHhCCCCC
Q 007035 603 LWSLGCILAELWTGEVCL 620 (621)
Q Consensus 603 IWSLGvILyELltG~~PF 620 (621)
||||||++|+|++|+.||
T Consensus 227 iwSlGvilyell~G~~Pf 244 (376)
T cd05598 227 WWSVGVILYEMLVGQPPF 244 (376)
T ss_pred eeeccceeeehhhCCCCC
Confidence 999999999999999998
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=286.87 Aligned_cols=194 Identities=29% Similarity=0.476 Sum_probs=165.7
Q ss_pred CceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc--hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeE
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l 491 (621)
++|++.+.||.|+||+||+|++..+++.||+|+++... .......+|+.+++.+ +||||+++++++...+..
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~~~~~~~~~~~~ 78 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNL------KHANIVTLHDIIHTERCL 78 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhC------CCCCEeeEEEEEcCCCeE
Confidence 57999999999999999999999999999999987532 2234566788887766 478999999999999999
Q ss_pred EEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCcc
Q 007035 492 FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 571 (621)
Q Consensus 492 ~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~ 571 (621)
++||||+.++|.+.+..... .+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++.
T Consensus 79 ~lv~e~~~~~l~~~l~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~--~~~~kl~DfG~~~ 151 (288)
T cd07871 79 TLVFEYLDSDLKQYLDNCGN-----LMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINE--KGELKLADFGLAR 151 (288)
T ss_pred EEEEeCCCcCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECC--CCCEEECcCccee
Confidence 99999999988887754322 2788899999999999999999999999999999999984 7889999999986
Q ss_pred ccCCC---ccccccCCcccCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 572 FQTDN---LCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 572 ~~~~~---~~~~~gt~~Y~APEvl~~-~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
..... .....+++.|+|||++.+ ..++.++|||||||++|+|++|++||
T Consensus 152 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf 204 (288)
T cd07871 152 AKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMF 204 (288)
T ss_pred eccCCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCC
Confidence 54322 223467899999999876 46899999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=297.29 Aligned_cols=199 Identities=25% Similarity=0.402 Sum_probs=169.8
Q ss_pred CeeecCceEEEEEeccCCCCceeEEEeCCCC-cEEEEEEEecCc----hhhhhHHHHHHHHHHhcccCCCCCCceEEEee
Q 007035 409 NTVIAGRYYVTEYLGSAAFSKVFQAQDLHTG-VDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYD 483 (621)
Q Consensus 409 ~~ii~~rY~I~~~LG~G~fG~Vyka~d~~tg-~~VAlKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~ 483 (621)
..+..++|++.+.||.|+||.||+|.+..++ ..||+|++.... .....+.+|+.+++.+ .||||+++++
T Consensus 25 ~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l------~hp~Iv~~~~ 98 (340)
T PTZ00426 25 NKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYI------NHPFCVNLYG 98 (340)
T ss_pred CCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC------CCCCCcceEE
Confidence 4445678999999999999999999876655 689999987532 2334556677777766 4789999999
Q ss_pred EeEecCeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeE
Q 007035 484 YFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEI 562 (621)
Q Consensus 484 ~f~~~~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~I 562 (621)
++...+++++||||+.+ +|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++ .++.+
T Consensus 99 ~~~~~~~~~lv~Ey~~~g~L~~~i~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~--~~~~i 170 (340)
T PTZ00426 99 SFKDESYLYLVLEFVIGGEFFTFLRRNK------RFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLD--KDGFI 170 (340)
T ss_pred EEEeCCEEEEEEeCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEEC--CCCCE
Confidence 99999999999999975 6776665432 288899999999999999999999999999999999998 47899
Q ss_pred EEEecCCccccCCCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 007035 563 KIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCLI 621 (621)
Q Consensus 563 KL~DFGls~~~~~~~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF~ 621 (621)
||+|||++...........||+.|+|||++.+..++.++|||||||++|+|++|++||.
T Consensus 171 kL~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~ 229 (340)
T PTZ00426 171 KMTDFGFAKVVDTRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFY 229 (340)
T ss_pred EEecCCCCeecCCCcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCC
Confidence 99999998776655556789999999999999889999999999999999999999983
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=292.89 Aligned_cols=195 Identities=36% Similarity=0.632 Sum_probs=170.2
Q ss_pred ecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEec---CchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEe-
Q 007035 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKN---DKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH- 487 (621)
Q Consensus 412 i~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~---~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~- 487 (621)
+..+|..++.||.|+||.|+.+.++.+|+.||||.+.+ ......+..+|+++|++++ |+||+.+++.+..
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~------HeNIi~l~di~~p~ 93 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLR------HENIIGLLDIFRPP 93 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhc------CCCcceEEeecccc
Confidence 34567778999999999999999999999999998762 3445677888999988885 6789999999876
Q ss_pred ----cCeEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEE
Q 007035 488 ----LEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 563 (621)
Q Consensus 488 ----~~~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IK 563 (621)
-+.+|+|+|+|+..|.+.++..+. ++...++.+++||++||.|+|+.+|+||||||.|+|++ .++.+|
T Consensus 94 ~~~~f~DvYiV~elMetDL~~iik~~~~------L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n--~~c~lK 165 (359)
T KOG0660|consen 94 SRDKFNDVYLVFELMETDLHQIIKSQQD------LTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLN--ADCDLK 165 (359)
T ss_pred cccccceeEEehhHHhhHHHHHHHcCcc------ccHHHHHHHHHHHHHhcchhhcccccccccchhheeec--cCCCEE
Confidence 246999999999888888875543 88899999999999999999999999999999999999 488999
Q ss_pred EEecCCccccC-----CCccccccCCcccCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 564 IIDLGSSCFQT-----DNLCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 564 L~DFGls~~~~-----~~~~~~~gt~~Y~APEvl~~-~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
|+|||+|+... ...+.++.|.+|+|||++.. ..|+.++||||+||||.||++|+++|
T Consensus 166 I~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplF 228 (359)
T KOG0660|consen 166 ICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLF 228 (359)
T ss_pred eccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCC
Confidence 99999998873 33456788999999999865 46999999999999999999999998
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=299.77 Aligned_cols=194 Identities=31% Similarity=0.431 Sum_probs=163.0
Q ss_pred cCceEEEEEeccCCCCceeEEEeCCCCcE-EEEEEEecCc---hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEec
Q 007035 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVD-VCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (621)
Q Consensus 413 ~~rY~I~~~LG~G~fG~Vyka~d~~tg~~-VAlKii~~~~---~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~ 488 (621)
.....+.+.||.|+||+||++.. .|.. ||+|++.... .....+.+|+.++..+ +||||+++++++...
T Consensus 40 ~~~l~~~~~iG~G~~g~V~~~~~--~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l------~HpNIV~f~G~~~~~ 111 (362)
T KOG0192|consen 40 PDELPIEEVLGSGSFGTVYKGKW--RGTDVVAVKIISDPDFDDESRKAFRREASLLSRL------RHPNIVQFYGACTSP 111 (362)
T ss_pred hHHhhhhhhcccCCceeEEEEEe--CCceeEEEEEecchhcChHHHHHHHHHHHHHHhC------CCCCeeeEEEEEcCC
Confidence 34456666799999999999974 5666 9999998632 2245788888888876 478999999999988
Q ss_pred C-eEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCC-eecccCCCccEEEeccCCC-eEEE
Q 007035 489 E-HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLG-IIHCDLKPENILIKSYQRC-EIKI 564 (621)
Q Consensus 489 ~-~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~g-IvHrDLKP~NILl~~~~~~-~IKL 564 (621)
. .++|||||+++ +|.+++... ....+++..+..++.||++||.|||+++ ||||||||+|||++. ++ ++||
T Consensus 112 ~~~~~iVtEy~~~GsL~~~l~~~----~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~--~~~~~KI 185 (362)
T KOG0192|consen 112 PGSLCIVTEYMPGGSLSVLLHKK----RKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDL--KGKTLKI 185 (362)
T ss_pred CCceEEEEEeCCCCcHHHHHhhc----ccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcC--CCCEEEE
Confidence 7 79999999985 666666543 1223999999999999999999999999 999999999999994 65 9999
Q ss_pred EecCCccccCC---CccccccCCcccCchhhc--CCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 565 IDLGSSCFQTD---NLCLYVQSRSYRAPEVII--GLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 565 ~DFGls~~~~~---~~~~~~gt~~Y~APEvl~--~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
+|||+++.... ..+...||+.|||||++. ..+|+.|+||||+|++||||+||+.||
T Consensus 186 ~DFGlsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf 246 (362)
T KOG0192|consen 186 ADFGLSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPF 246 (362)
T ss_pred CCCccceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCC
Confidence 99999976553 334468999999999999 668999999999999999999999998
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-33 Score=284.72 Aligned_cols=194 Identities=28% Similarity=0.539 Sum_probs=167.0
Q ss_pred CceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc---hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCe
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~---~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~ 490 (621)
++|++.+.||+|+||+||+++++.+++.||+|++.... .......+|+.+++.+ .||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l------~h~~iv~~~~~~~~~~~ 74 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTL------KQENIVELKEAFRRRGK 74 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhC------CCccccchhhhEecCCE
Confidence 47999999999999999999999999999999987542 2334566777777766 46899999999999999
Q ss_pred EEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCc
Q 007035 491 LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (621)
Q Consensus 491 l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls 570 (621)
+++||||+++++++.+..... .+++..++.++.||+.||.|||+.+|+||||||+||+++ .++.+||+|||++
T Consensus 75 ~~lv~e~~~~~~l~~~~~~~~-----~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~--~~~~~kl~Dfg~~ 147 (287)
T cd07848 75 LYLVFEYVEKNMLELLEEMPN-----GVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLIS--HNDVLKLCDFGFA 147 (287)
T ss_pred EEEEEecCCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc--CCCcEEEeeccCc
Confidence 999999999988776653321 288899999999999999999999999999999999998 4788999999998
Q ss_pred cccCCC----ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 571 CFQTDN----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 571 ~~~~~~----~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
...... .....+++.|+|||++.+..++.++|||||||++|+|++|++||
T Consensus 148 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf 201 (287)
T cd07848 148 RNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLF 201 (287)
T ss_pred ccccccccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCC
Confidence 764322 22346789999999999988999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=292.38 Aligned_cols=223 Identities=37% Similarity=0.651 Sum_probs=200.8
Q ss_pred ccCCcccCCCcceeeCeeec-CceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccC-
Q 007035 394 NRTGFEENKDLPIILNTVIA-GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKND- 471 (621)
Q Consensus 394 ~r~~~~~~~~~pi~l~~ii~-~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~- 471 (621)
....|.....+|+.++++++ +||.++++||.|-|++||+|.|....+.||+|+.+......+..+.|+++|+.++...
T Consensus 57 ~~~dY~kGGYHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp 136 (590)
T KOG1290|consen 57 DPEDYRKGGYHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDP 136 (590)
T ss_pred ChhhhhcCCCceeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCC
Confidence 44566788899999999999 9999999999999999999999999999999999998888899999999999999765
Q ss_pred -CCCCCceEEEeeEeEec----CeEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHH-CCeecc
Q 007035 472 -PADEHHILRLYDYFYHL----EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS-LGIIHC 545 (621)
Q Consensus 472 -~~~hpnIvrl~~~f~~~----~~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs-~gIvHr 545 (621)
..+..+||+|++.|... .|+|||+|+++.+|+.++++....+ +++..++.|++|||.||.|||. +||+|.
T Consensus 137 ~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvLGdnLLklI~~s~YrG----lpl~~VK~I~~qvL~GLdYLH~ecgIIHT 212 (590)
T KOG1290|consen 137 NDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVLGDNLLKLIKYSNYRG----LPLSCVKEICRQVLTGLDYLHRECGIIHT 212 (590)
T ss_pred CCCCCceeeeeeccceecCCCCcEEEEEehhhhhHHHHHHHHhCCCC----CcHHHHHHHHHHHHHHHHHHHHhcCcccc
Confidence 45556999999999854 6999999999999999999988776 9999999999999999999995 599999
Q ss_pred cCCCccEEEec---------------------------------------------------------------------
Q 007035 546 DLKPENILIKS--------------------------------------------------------------------- 556 (621)
Q Consensus 546 DLKP~NILl~~--------------------------------------------------------------------- 556 (621)
||||+|||+..
T Consensus 213 DlKPENvLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~ 292 (590)
T KOG1290|consen 213 DLKPENVLLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLE 292 (590)
T ss_pred CCCcceeeeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccc
Confidence 99999999830
Q ss_pred -------------------------------------------cC-----------------------------------
Q 007035 557 -------------------------------------------YQ----------------------------------- 558 (621)
Q Consensus 557 -------------------------------------------~~----------------------------------- 558 (621)
..
T Consensus 293 ~~~~~~~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~ 372 (590)
T KOG1290|consen 293 GIEEEPNQESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPG 372 (590)
T ss_pred cccccccccccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCcc
Confidence 00
Q ss_pred -----------------CCeEEEEecCCccccCCCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 559 -----------------RCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 559 -----------------~~~IKL~DFGls~~~~~~~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
+-++||+|||.++......+.-.+|..|+|||++.+..|+..+||||++|++|||+||..+|
T Consensus 373 ~~~~n~~v~p~~~~~~~di~vKIaDlGNACW~~khFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLF 451 (590)
T KOG1290|consen 373 TIASNPLVNPDIPLPECDIRVKIADLGNACWVHKHFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLF 451 (590)
T ss_pred ccccccccCCCCCCCccceeEEEeeccchhhhhhhhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceee
Confidence 01478889998888888877788999999999999999999999999999999999999988
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-33 Score=290.73 Aligned_cols=194 Identities=24% Similarity=0.387 Sum_probs=163.4
Q ss_pred eEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc----hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeE
Q 007035 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (621)
Q Consensus 416 Y~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l 491 (621)
|++++.||+|+||.||+|.+..+++.||||++++.. ...+.+..|++++..++ ...||||+++++++...+++
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~---~l~hp~i~~~~~~~~~~~~~ 77 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETAN---SERHPFLVNLFACFQTEDHV 77 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcc---ccCCCChhceeeEEEcCCEE
Confidence 788999999999999999999999999999997532 23345666666666554 35699999999999999999
Q ss_pred EEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCcc
Q 007035 492 FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 571 (621)
Q Consensus 492 ~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~ 571 (621)
|+||||+.++.+...... ..+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++.
T Consensus 78 ~lv~E~~~~~~L~~~~~~------~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~--~~~~kL~Dfg~~~ 149 (324)
T cd05589 78 CFVMEYAAGGDLMMHIHT------DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDT--EGFVKIADFGLCK 149 (324)
T ss_pred EEEEcCCCCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECC--CCcEEeCcccCCc
Confidence 999999986543333221 12889999999999999999999999999999999999984 7899999999876
Q ss_pred ccC---CCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 572 FQT---DNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 572 ~~~---~~~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
... .......|++.|+|||++.+..++.++|||||||++|+|++|+.||
T Consensus 150 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf 201 (324)
T cd05589 150 EGMGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPF 201 (324)
T ss_pred cCCCCCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCC
Confidence 432 2233457899999999999989999999999999999999999998
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=283.37 Aligned_cols=198 Identities=30% Similarity=0.499 Sum_probs=165.2
Q ss_pred CceEEEEEeccCCCCceeEEEeCC-CCcEEEEEEEecCc---hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEe--
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQDLH-TGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH-- 487 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d~~-tg~~VAlKii~~~~---~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~-- 487 (621)
.+|++++.||+|+||+||+|++.. .++.||+|+++... .......+|+.+++.+.. ..||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~---~~hpniv~~~~~~~~~~ 77 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET---FEHPNVVRLFDVCTVSR 77 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcc---cCCCCcceEEEEEeccc
Confidence 479999999999999999999865 46889999887532 223345667777777653 468999999998862
Q ss_pred ---cCeEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEE
Q 007035 488 ---LEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKI 564 (621)
Q Consensus 488 ---~~~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL 564 (621)
...+++||||+.++|.+++..... ..+++..++.++.||+.||.|||+++|+||||||+|||++. ++.+||
T Consensus 78 ~~~~~~~~lv~e~~~~~l~~~~~~~~~----~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~--~~~~kl 151 (290)
T cd07862 78 TDRETKLTLVFEHVDQDLTTYLDKVPE----PGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTS--SGQIKL 151 (290)
T ss_pred CCCCCcEEEEEccCCCCHHHHHHhCCC----CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcC--CCCEEE
Confidence 456999999999998888764432 22788999999999999999999999999999999999984 788999
Q ss_pred EecCCccccCCC--ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 565 IDLGSSCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 565 ~DFGls~~~~~~--~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
+|||++...... .....+++.|+|||++.+..++.++|||||||++|+|++|++||
T Consensus 152 ~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f 209 (290)
T cd07862 152 ADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLF 209 (290)
T ss_pred ccccceEeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCc
Confidence 999998654432 23456799999999999888999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=288.52 Aligned_cols=193 Identities=27% Similarity=0.409 Sum_probs=162.4
Q ss_pred ceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc----hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCe
Q 007035 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (621)
Q Consensus 415 rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~ 490 (621)
+|++++.||+|+||.||+|++..+++.||+|++.+.. ...+....|.+++..+.+ |++|+++++++...+.
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~-----~~~i~~~~~~~~~~~~ 75 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGK-----PPFLTQLHSCFQTMDR 75 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCC-----CCceeeeEEEEEcCCE
Confidence 4899999999999999999999999999999997532 223455666666666542 4579999999999999
Q ss_pred EEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCC
Q 007035 491 LFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (621)
Q Consensus 491 l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGl 569 (621)
+|+||||+.+ +|.+.+.... .+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||+
T Consensus 76 ~~lv~E~~~~g~L~~~~~~~~------~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~--~~~~kL~Dfg~ 147 (324)
T cd05587 76 LYFVMEYVNGGDLMYHIQQVG------KFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDA--EGHIKIADFGM 147 (324)
T ss_pred EEEEEcCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcC--CCCEEEeecCc
Confidence 9999999985 6665554322 2788899999999999999999999999999999999984 78899999998
Q ss_pred ccccC---CCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 570 SCFQT---DNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 570 s~~~~---~~~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
+.... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||
T Consensus 148 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf 201 (324)
T cd05587 148 CKENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPF 201 (324)
T ss_pred ceecCCCCCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCC
Confidence 76421 2233457899999999999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=296.73 Aligned_cols=193 Identities=24% Similarity=0.406 Sum_probs=163.5
Q ss_pred CceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc----hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecC
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~ 489 (621)
++|++++.||+|+||+||+++++.+++.||+|+++... .....+..|+.++..+ +||+|+++++.+...+
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l------~~~~iv~~~~~~~~~~ 74 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEA------DGAWVVKMFYSFQDKR 74 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC------CCCCEeeEEEEEEcCC
Confidence 46899999999999999999999999999999997532 2334455666666554 5789999999999999
Q ss_pred eEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecC
Q 007035 490 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (621)
Q Consensus 490 ~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFG 568 (621)
++++||||+.+ +|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.++|+|||
T Consensus 75 ~~~lv~E~~~gg~L~~~l~~~~------~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~--~~~vkL~DfG 146 (360)
T cd05627 75 NLYLIMEFLPGGDMMTLLMKKD------TLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDA--KGHVKLSDFG 146 (360)
T ss_pred EEEEEEeCCCCccHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECC--CCCEEEeecc
Confidence 99999999985 6766665332 2888999999999999999999999999999999999984 7899999999
Q ss_pred CccccCCC--------------------------------------ccccccCCcccCchhhcCCCCCchhhHHHHHHHH
Q 007035 569 SSCFQTDN--------------------------------------LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCIL 610 (621)
Q Consensus 569 ls~~~~~~--------------------------------------~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvIL 610 (621)
++...... ....+||+.|+|||++.+..++.++|||||||++
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil 226 (360)
T cd05627 147 LCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM 226 (360)
T ss_pred CCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceecccccee
Confidence 87533210 1124689999999999999999999999999999
Q ss_pred HHHHhCCCCC
Q 007035 611 AELWTGEVCL 620 (621)
Q Consensus 611 yELltG~~PF 620 (621)
|||++|++||
T Consensus 227 yel~tG~~Pf 236 (360)
T cd05627 227 YEMLIGYPPF 236 (360)
T ss_pred eecccCCCCC
Confidence 9999999998
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=295.21 Aligned_cols=194 Identities=30% Similarity=0.471 Sum_probs=166.8
Q ss_pred CceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc----hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecC
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~ 489 (621)
++|++.+.||+|+||+||+|++..+++.||||+++... .....+..|+.++..++ |+||+++++++.+.+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~------~~~i~~~~~~~~~~~ 74 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADAD------SPWIVKLYYSFQDEE 74 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcC------CCCccchhhheecCC
Confidence 47999999999999999999999999999999997532 23345566777776664 789999999999999
Q ss_pred eEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecC
Q 007035 490 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (621)
Q Consensus 490 ~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFG 568 (621)
++++||||+.+ +|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||
T Consensus 75 ~~~lv~e~~~~~~L~~~l~~~~------~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~--~~~~kL~Dfg 146 (350)
T cd05573 75 HLYLVMEYMPGGDLMNLLIRKD------VFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDA--DGHIKLADFG 146 (350)
T ss_pred eEEEEEcCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECC--CCCEEeecCC
Confidence 99999999975 6777665431 2889999999999999999999999999999999999984 7889999999
Q ss_pred CccccCCCc--------------------------------cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhC
Q 007035 569 SSCFQTDNL--------------------------------CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTG 616 (621)
Q Consensus 569 ls~~~~~~~--------------------------------~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG 616 (621)
++....... ....||+.|+|||++.+..++.++|||||||+||+|++|
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g 226 (350)
T cd05573 147 LCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG 226 (350)
T ss_pred CCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccC
Confidence 986543322 235689999999999999999999999999999999999
Q ss_pred CCCCC
Q 007035 617 EVCLI 621 (621)
Q Consensus 617 ~~PF~ 621 (621)
+.||.
T Consensus 227 ~~Pf~ 231 (350)
T cd05573 227 FPPFY 231 (350)
T ss_pred CCCCC
Confidence 99983
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=304.75 Aligned_cols=193 Identities=28% Similarity=0.486 Sum_probs=170.3
Q ss_pred CceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchh-hhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeEE
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDF-FDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLF 492 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~-~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l~ 492 (621)
..|....+||+|+.|.||.|+...+++.||||.+...... .+-+.+|+.+++..+ |+|||++++.|...+.+|
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~------H~NiVnfl~Sylv~deLW 346 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLH------HPNIVNFLDSYLVGDELW 346 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhcc------chHHHHHHHHhcccceeE
Confidence 5688889999999999999999999999999998765433 345678888887775 679999999999999999
Q ss_pred EEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCcc
Q 007035 493 IVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 571 (621)
Q Consensus 493 LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~ 571 (621)
+||||++| +|.+.+.... +++.++..|+++++.||.|||.+||+|||||.+|||++. +|.+||+|||++.
T Consensus 347 VVMEym~ggsLTDvVt~~~-------~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~--~g~vKltDFGFca 417 (550)
T KOG0578|consen 347 VVMEYMEGGSLTDVVTKTR-------MTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTM--DGSVKLTDFGFCA 417 (550)
T ss_pred EEEeecCCCchhhhhhccc-------ccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEecc--CCcEEEeeeeeee
Confidence 99999996 5555554332 889999999999999999999999999999999999995 7889999999987
Q ss_pred ccCC---CccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 007035 572 FQTD---NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCLI 621 (621)
Q Consensus 572 ~~~~---~~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF~ 621 (621)
.... .....+|||.|||||++....|+.++||||||++++||+.|++||+
T Consensus 418 qi~~~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYl 470 (550)
T KOG0578|consen 418 QISEEQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYL 470 (550)
T ss_pred ccccccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCcc
Confidence 6543 3556899999999999999999999999999999999999999997
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=288.22 Aligned_cols=192 Identities=35% Similarity=0.583 Sum_probs=161.7
Q ss_pred ceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecC---chhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEec---
Q 007035 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL--- 488 (621)
Q Consensus 415 rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~---~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~--- 488 (621)
+|++.+.||.|+||.||+|++..+++.||||.+... .....++.+|+++++.+ .||||+++++++...
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l------~hpniv~~~~~~~~~~~~ 74 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLL------RHPDIVEIKHIMLPPSRR 74 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhC------CCCCEeeecceEeccCCC
Confidence 699999999999999999999999999999998642 12234566777777766 478999999988643
Q ss_pred --CeEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEe
Q 007035 489 --EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (621)
Q Consensus 489 --~~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~D 566 (621)
..+++||||++++|.+.+.... .+++..++.++.||+.||.|||+++|+||||||+|||++ .++.+||+|
T Consensus 75 ~~~~~~lv~e~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~--~~~~~kL~D 146 (338)
T cd07859 75 EFKDIYVVFELMESDLHQVIKAND------DLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILAN--ADCKLKICD 146 (338)
T ss_pred CCceEEEEEecCCCCHHHHHHhcc------cCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC--CCCcEEEcc
Confidence 3589999999988888776432 288999999999999999999999999999999999998 478999999
Q ss_pred cCCccccCCC------ccccccCCcccCchhhcC--CCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 567 LGSSCFQTDN------LCLYVQSRSYRAPEVIIG--LPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 567 FGls~~~~~~------~~~~~gt~~Y~APEvl~~--~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
||++...... .....+++.|+|||++.+ ..++.++|||||||++|+|++|++||
T Consensus 147 fg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf 208 (338)
T cd07859 147 FGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLF 208 (338)
T ss_pred CccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCC
Confidence 9998643221 123468999999999876 56899999999999999999999998
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=297.89 Aligned_cols=191 Identities=26% Similarity=0.416 Sum_probs=166.8
Q ss_pred ecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeE
Q 007035 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (621)
Q Consensus 412 i~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l 491 (621)
..++|++++.||+|+||.||++.+..+++.||+|.... ....+|+.+++.++ ||||++++++|....+.
T Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~-----~~~~~E~~il~~l~------HpnIv~~~~~~~~~~~~ 158 (391)
T PHA03212 90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR-----GGTATEAHILRAIN------HPSIIQLKGTFTYNKFT 158 (391)
T ss_pred ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh-----hhhHHHHHHHHhCC------CCCCCCEeEEEEECCee
Confidence 34679999999999999999999999999999997543 34578888888774 78999999999999999
Q ss_pred EEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCcc
Q 007035 492 FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 571 (621)
Q Consensus 492 ~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~ 571 (621)
++|||++.++|+..+.... .+++..++.++.||+.||.|||+++|+||||||+|||++. .+.+||+|||++.
T Consensus 159 ~lv~e~~~~~L~~~l~~~~------~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~--~~~vkL~DFG~a~ 230 (391)
T PHA03212 159 CLILPRYKTDLYCYLAAKR------NIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINH--PGDVCLGDFGAAC 230 (391)
T ss_pred EEEEecCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcC--CCCEEEEeCCccc
Confidence 9999999998888776432 2788899999999999999999999999999999999984 7889999999986
Q ss_pred ccCC----CccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 007035 572 FQTD----NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCLI 621 (621)
Q Consensus 572 ~~~~----~~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF~ 621 (621)
.... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||+
T Consensus 231 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~ 284 (391)
T PHA03212 231 FPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLF 284 (391)
T ss_pred ccccccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcC
Confidence 4322 2233578999999999999999999999999999999999998874
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=295.91 Aligned_cols=197 Identities=26% Similarity=0.390 Sum_probs=165.1
Q ss_pred eecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCch---------------hhhhHHHHHHHHHHhcccCCCCC
Q 007035 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD---------------FFDQSLDEIKLLKLVNKNDPADE 475 (621)
Q Consensus 411 ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~---------------~~~~~~~Ei~iL~~l~~~~~~~h 475 (621)
...++|++++.||+|.||.|-+|++..+++.||||++.+.+. ..++..+|+.|++++. |
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~------H 167 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLH------H 167 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcC------C
Confidence 345789999999999999999999999999999999875321 2357788999998885 6
Q ss_pred CceEEEeeEeEec--CeEEEEEeccccchHHHHHhhhccCCCcc-ccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccE
Q 007035 476 HHILRLYDYFYHL--EHLFIVCELLRANLYEFQKFNQESGGEAY-FTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENI 552 (621)
Q Consensus 476 pnIvrl~~~f~~~--~~l~LVmEyl~gsLld~l~~~~~~~~~~~-ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NI 552 (621)
||||+|+.+..+. +.+|||+|||..+-... ...... +.+.+++.|++.++.||.|||.+||+||||||+|+
T Consensus 168 ~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w------~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNL 241 (576)
T KOG0585|consen 168 PNVVKLIEVLDDPESDKLYLVLEYCSKGEVKW------CPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNL 241 (576)
T ss_pred cCeeEEEEeecCcccCceEEEEEeccCCcccc------CCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhhe
Confidence 7999999998865 57999999998543222 222333 88999999999999999999999999999999999
Q ss_pred EEeccCCCeEEEEecCCccccCC--------CccccccCCcccCchhhcCCC----CCchhhHHHHHHHHHHHHhCCCCC
Q 007035 553 LIKSYQRCEIKIIDLGSSCFQTD--------NLCLYVQSRSYRAPEVIIGLP----YDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 553 Ll~~~~~~~IKL~DFGls~~~~~--------~~~~~~gt~~Y~APEvl~~~~----~s~ksDIWSLGvILyELltG~~PF 620 (621)
||+. +|+|||+|||.+..... .....+|||.|+|||...+.. .+.+.|||||||+||.|+.|+.||
T Consensus 242 Ll~~--~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF 319 (576)
T KOG0585|consen 242 LLSS--DGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPF 319 (576)
T ss_pred EEcC--CCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCc
Confidence 9995 79999999998875411 123368999999999997732 467899999999999999999999
Q ss_pred C
Q 007035 621 I 621 (621)
Q Consensus 621 ~ 621 (621)
+
T Consensus 320 ~ 320 (576)
T KOG0585|consen 320 F 320 (576)
T ss_pred c
Confidence 6
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=282.18 Aligned_cols=193 Identities=26% Similarity=0.340 Sum_probs=162.4
Q ss_pred eEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc----hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeE
Q 007035 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (621)
Q Consensus 416 Y~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l 491 (621)
|++.+.||+|+||.||++.+..+|+.||+|.+.... .......+|+.+++.+ .|++|+++++++...+.+
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l------~~~~iv~~~~~~~~~~~~ 75 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKV------NSRFVVSLAYAYETKDAL 75 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhc------CCCcEEEEEEEEccCCeE
Confidence 788999999999999999999999999999987532 1223455677777666 467999999999999999
Q ss_pred EEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCc
Q 007035 492 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (621)
Q Consensus 492 ~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls 570 (621)
++||||+.+ +|.+.+..... ..+++..+..++.||+.||.|||+++|+||||||+|||++ .++.++|+|||++
T Consensus 76 ~lv~e~~~~g~L~~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~--~~~~~kl~Dfg~~ 149 (285)
T cd05631 76 CLVLTIMNGGDLKFHIYNMGN----PGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLD--DRGHIRISDLGLA 149 (285)
T ss_pred EEEEEecCCCcHHHHHHhhCC----CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEEC--CCCCEEEeeCCCc
Confidence 999999986 45444432221 2378899999999999999999999999999999999998 4788999999998
Q ss_pred cccCCC--ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 571 CFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 571 ~~~~~~--~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
...... .....+++.|+|||++.+..++.++|||||||++|+|++|+.||
T Consensus 150 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf 201 (285)
T cd05631 150 VQIPEGETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPF 201 (285)
T ss_pred EEcCCCCeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCC
Confidence 764332 23356899999999999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=287.88 Aligned_cols=193 Identities=26% Similarity=0.387 Sum_probs=161.6
Q ss_pred ceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCch----hhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCe
Q 007035 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD----FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (621)
Q Consensus 415 rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~----~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~ 490 (621)
+|++++.||+|+||.||+|++..+++.||+|++.+... .......|..++..+. .|++|+++++++...+.
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-----~~~~i~~~~~~~~~~~~ 75 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSG-----KPPFLTQLHSCFQTMDR 75 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcc-----CCCeEeeEEEEEecCCE
Confidence 48899999999999999999999999999999986432 1223444555554442 46899999999999999
Q ss_pred EEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCC
Q 007035 491 LFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (621)
Q Consensus 491 l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGl 569 (621)
+++||||+.+ +|.+.+.... .+++..+..++.||+.||.|||+++|+||||||+|||++. ++.+||+|||+
T Consensus 76 ~~lv~E~~~~g~L~~~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~--~~~~kL~DfG~ 147 (323)
T cd05616 76 LYFVMEYVNGGDLMYQIQQVG------RFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDS--EGHIKIADFGM 147 (323)
T ss_pred EEEEEcCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECC--CCcEEEccCCC
Confidence 9999999985 6665554322 2788999999999999999999999999999999999984 78899999999
Q ss_pred ccccC---CCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 570 SCFQT---DNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 570 s~~~~---~~~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
+.... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||
T Consensus 148 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf 201 (323)
T cd05616 148 CKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPF 201 (323)
T ss_pred ceecCCCCCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCC
Confidence 86432 2233457899999999999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-33 Score=291.25 Aligned_cols=188 Identities=27% Similarity=0.420 Sum_probs=158.6
Q ss_pred EEeccCCCCceeEEEeCCCCcEEEEEEEecCc----hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeEEEEE
Q 007035 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVC 495 (621)
Q Consensus 420 ~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l~LVm 495 (621)
+.||+|+||.||+++++.+|+.||+|+++... .......+|+.+++.+ .||||+++++++...+++++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l------~hp~i~~~~~~~~~~~~~~lv~ 74 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNT------RHPFLTALKYSFQTHDRLCFVM 74 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC------CCCCCCCEEEEEEcCCEEEEEE
Confidence 36999999999999999999999999997532 2233455666666655 4789999999999999999999
Q ss_pred ecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCccccC
Q 007035 496 ELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQT 574 (621)
Q Consensus 496 Eyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~~~~ 574 (621)
||+.+ +|.+.+.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++....
T Consensus 75 e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~--~~~~kl~DfG~a~~~~ 146 (323)
T cd05571 75 EYANGGELFFHLSRER------VFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDK--DGHIKITDFGLCKEGI 146 (323)
T ss_pred eCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECC--CCCEEEeeCCCCcccc
Confidence 99986 5655554322 2789999999999999999999999999999999999984 7889999999986532
Q ss_pred ---CCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 007035 575 ---DNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCLI 621 (621)
Q Consensus 575 ---~~~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF~ 621 (621)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 147 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~ 196 (323)
T cd05571 147 SDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY 196 (323)
T ss_pred cCCCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCC
Confidence 22334578999999999999999999999999999999999999983
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=296.72 Aligned_cols=194 Identities=23% Similarity=0.380 Sum_probs=163.1
Q ss_pred ecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc----hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEe
Q 007035 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (621)
Q Consensus 412 i~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~ 487 (621)
..++|++.+.||+|+||.||++++..+++.+|+|++.+.. .....+.+|+.+++.+ .||||+++++++..
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~------~hp~iv~~~~~~~~ 114 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA------NSPWVVQLFCAFQD 114 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC------CCCCEeeEEEEEEc
Confidence 3478999999999999999999999999999999987522 1223345666666554 57899999999999
Q ss_pred cCeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEe
Q 007035 488 LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (621)
Q Consensus 488 ~~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~D 566 (621)
..++++||||+.+ +|.+++... .+++..++.++.||+.||.|||+++|+||||||+|||++ .++.+||+|
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~l~~~-------~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~--~~~~~kL~D 185 (370)
T cd05621 115 DKYLYMVMEYMPGGDLVNLMSNY-------DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLD--KHGHLKLAD 185 (370)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEC--CCCCEEEEe
Confidence 9999999999975 677666422 178888999999999999999999999999999999998 478999999
Q ss_pred cCCccccCCC----ccccccCCcccCchhhcCCC----CCchhhHHHHHHHHHHHHhCCCCC
Q 007035 567 LGSSCFQTDN----LCLYVQSRSYRAPEVIIGLP----YDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 567 FGls~~~~~~----~~~~~gt~~Y~APEvl~~~~----~s~ksDIWSLGvILyELltG~~PF 620 (621)
||++...... .....||+.|+|||++.+.. ++.++|||||||+||+|++|+.||
T Consensus 186 FG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf 247 (370)
T cd05621 186 FGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 247 (370)
T ss_pred cccceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCC
Confidence 9998765332 12457899999999997643 788999999999999999999998
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=293.17 Aligned_cols=216 Identities=38% Similarity=0.654 Sum_probs=196.5
Q ss_pred CCCcceeeCeeecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEE
Q 007035 401 NKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILR 480 (621)
Q Consensus 401 ~~~~pi~l~~ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvr 480 (621)
...+-...++.+.+||.|+.++|+|.||.|..+.|..++..||||+++.-....+...-|+++++++....+-+..-+++
T Consensus 76 dGH~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~ 155 (415)
T KOG0671|consen 76 DGHYVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQ 155 (415)
T ss_pred CceEEEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEe
Confidence 33456778999999999999999999999999999999999999999988888888999999999998876556667899
Q ss_pred EeeEeEecCeEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEecc---
Q 007035 481 LYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSY--- 557 (621)
Q Consensus 481 l~~~f~~~~~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~--- 557 (621)
+.++|...+|.|||+|.++.++++++..+.... ++...++.+++||++++.+||+.+++|.||||+|||+.+.
T Consensus 156 m~~wFdyrghiCivfellG~S~~dFlk~N~y~~----fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~ 231 (415)
T KOG0671|consen 156 MRDWFDYRGHICIVFELLGLSTFDFLKENNYIP----FPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYF 231 (415)
T ss_pred eehhhhccCceEEEEeccChhHHHHhccCCccc----cchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceE
Confidence 999999999999999999999999998776554 9999999999999999999999999999999999998531
Q ss_pred ---------------CCCeEEEEecCCccccCCCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 558 ---------------QRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 558 ---------------~~~~IKL~DFGls~~~~~~~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
+...|+|+|||.+..........+.|..|+|||++++.++++++||||+||||+||+||..+|
T Consensus 232 ~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LF 309 (415)
T KOG0671|consen 232 KTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLF 309 (415)
T ss_pred EEeccCCccceeccCCCcceEEEecCCcceeccCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceec
Confidence 134689999999998888888889999999999999999999999999999999999999987
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-32 Score=289.96 Aligned_cols=194 Identities=37% Similarity=0.626 Sum_probs=164.8
Q ss_pred eecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecC---chhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEe
Q 007035 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (621)
Q Consensus 411 ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~---~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~ 487 (621)
.+.++|++.+.||+|+||.||++.+..+|+.||+|++... ........+|+.+++.+ .||||+++++++..
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~~~~~~~~ 91 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCV------NHKNIISLLNVFTP 91 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhC------CCCCEeeeeeeecc
Confidence 4568999999999999999999999999999999998653 22334556677776655 47899999999875
Q ss_pred cC------eEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCe
Q 007035 488 LE------HLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCE 561 (621)
Q Consensus 488 ~~------~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~ 561 (621)
.. .+++||||+++++.+.+.. .+++..+..++.||+.||.|||++||+||||||+|||++. ++.
T Consensus 92 ~~~~~~~~~~~lv~e~~~~~l~~~~~~--------~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~--~~~ 161 (359)
T cd07876 92 QKSLEEFQDVYLVMELMDANLCQVIHM--------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS--DCT 161 (359)
T ss_pred CCCccccceeEEEEeCCCcCHHHHHhc--------cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECC--CCC
Confidence 43 5799999999988776532 1778889999999999999999999999999999999984 789
Q ss_pred EEEEecCCccccCCC--ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 562 IKIIDLGSSCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 562 IKL~DFGls~~~~~~--~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
+||+|||++...... .....+|+.|+|||++.+..++.++|||||||++|+|++|+.||
T Consensus 162 ~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf 222 (359)
T cd07876 162 LKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIF 222 (359)
T ss_pred EEEecCCCccccccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCC
Confidence 999999998654332 23357789999999999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=302.82 Aligned_cols=193 Identities=32% Similarity=0.515 Sum_probs=173.1
Q ss_pred CceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecC----chhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecC
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~----~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~ 489 (621)
+-|++.+.||.|+-|.|.+|+|..||+..|||++.+. ......+.+|+-|++.+. |||++++|++|+...
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~------HpnVl~LydVwe~~~ 85 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIE------HPNVLRLYDVWENKQ 85 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhc------CCCeeeeeeeeccCc
Confidence 5689999999999999999999999999999999765 334567888999999886 679999999999999
Q ss_pred eEEEEEeccc-cchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecC
Q 007035 490 HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (621)
Q Consensus 490 ~l~LVmEyl~-gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFG 568 (621)
++|+|.||+. |.|.+++..... +++.++..+++||+.|+.|+|..+|+||||||+|+||+. .+.|||+|||
T Consensus 86 ~lylvlEyv~gGELFdylv~kG~------l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~--~~nIKIADFG 157 (786)
T KOG0588|consen 86 HLYLVLEYVPGGELFDYLVRKGP------LPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDV--KNNIKIADFG 157 (786)
T ss_pred eEEEEEEecCCchhHHHHHhhCC------CCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhc--ccCEeeeccc
Confidence 9999999998 578888876543 899999999999999999999999999999999999995 5559999999
Q ss_pred CccccCCC--ccccccCCcccCchhhcCCCC-CchhhHHHHHHHHHHHHhCCCCC
Q 007035 569 SSCFQTDN--LCLYVQSRSYRAPEVIIGLPY-DQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 569 ls~~~~~~--~~~~~gt~~Y~APEvl~~~~~-s~ksDIWSLGvILyELltG~~PF 620 (621)
+|...... ..+.||+|.|.|||++.|.+| +.++||||.|||||.||||++||
T Consensus 158 MAsLe~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPF 212 (786)
T KOG0588|consen 158 MASLEVPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPF 212 (786)
T ss_pred eeecccCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCC
Confidence 98765443 456799999999999999998 57899999999999999999999
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=293.40 Aligned_cols=194 Identities=23% Similarity=0.373 Sum_probs=162.3
Q ss_pred ecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc----hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEe
Q 007035 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (621)
Q Consensus 412 i~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~ 487 (621)
..++|++.+.||.|+||.||+++++.+++.+|+|++.... .....+.+|+.+++.+ .||||+++++.+..
T Consensus 41 ~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~------~hp~iv~~~~~~~~ 114 (371)
T cd05622 41 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA------NSPWVVQLFYAFQD 114 (371)
T ss_pred chhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC------CCCCCCeEEEEEEc
Confidence 3478999999999999999999999999999999987522 1223344566665544 57899999999999
Q ss_pred cCeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEe
Q 007035 488 LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (621)
Q Consensus 488 ~~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~D 566 (621)
..++++||||+++ +|.+++... .+++..++.++.||+.||.|||+++|+||||||+|||++. ++.+||+|
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~~-------~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~--~~~ikL~D 185 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSNY-------DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDK--SGHLKLAD 185 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECC--CCCEEEEe
Confidence 9999999999975 666665422 1788889999999999999999999999999999999984 78999999
Q ss_pred cCCccccCCC----ccccccCCcccCchhhcCCC----CCchhhHHHHHHHHHHHHhCCCCC
Q 007035 567 LGSSCFQTDN----LCLYVQSRSYRAPEVIIGLP----YDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 567 FGls~~~~~~----~~~~~gt~~Y~APEvl~~~~----~s~ksDIWSLGvILyELltG~~PF 620 (621)
||++...... .....||+.|+|||++.+.. ++.++|||||||+||+|++|+.||
T Consensus 186 fG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf 247 (371)
T cd05622 186 FGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247 (371)
T ss_pred CCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCC
Confidence 9998765432 22457899999999997543 788999999999999999999998
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=301.78 Aligned_cols=216 Identities=38% Similarity=0.690 Sum_probs=198.5
Q ss_pred CCCcceeeCeeecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEE
Q 007035 401 NKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILR 480 (621)
Q Consensus 401 ~~~~pi~l~~ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvr 480 (621)
...+.+.+++++..+|.|....|+|-|++|.+|.|...|..||||||++...-...-+.|++||++|+...+-+..|+++
T Consensus 419 EGYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclr 498 (752)
T KOG0670|consen 419 EGYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLR 498 (752)
T ss_pred cceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHH
Confidence 35678889999999999999999999999999999999999999999998887788899999999999988878889999
Q ss_pred EeeEeEecCeEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCC
Q 007035 481 LYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRC 560 (621)
Q Consensus 481 l~~~f~~~~~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~ 560 (621)
++..|.+.+|+|||+|.+.-+|.+.++.....-+ |.+..++.++.|++-||..|..+||+|.||||+||||+. ...
T Consensus 499 l~r~F~hknHLClVFE~LslNLRevLKKyG~nvG---L~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE-~k~ 574 (752)
T KOG0670|consen 499 LFRHFKHKNHLCLVFEPLSLNLREVLKKYGRNVG---LHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNE-SKN 574 (752)
T ss_pred HHHHhhhcceeEEEehhhhchHHHHHHHhCcccc---eeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEecc-Ccc
Confidence 9999999999999999999999999987654433 888999999999999999999999999999999999996 567
Q ss_pred eEEEEecCCccccCCC-ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 561 EIKIIDLGSSCFQTDN-LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 561 ~IKL~DFGls~~~~~~-~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
.+||||||.|.....+ .+.+.-+..|+|||+++|.+|++..|+||+||+||||.||+++|
T Consensus 575 iLKLCDfGSA~~~~eneitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlF 635 (752)
T KOG0670|consen 575 ILKLCDFGSASFASENEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILF 635 (752)
T ss_pred eeeeccCccccccccccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceec
Confidence 8999999998876654 55677788899999999999999999999999999999999998
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-32 Score=297.49 Aligned_cols=197 Identities=31% Similarity=0.509 Sum_probs=163.5
Q ss_pred ecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEec---
Q 007035 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL--- 488 (621)
Q Consensus 412 i~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~--- 488 (621)
...+|++.+.||+|+||.||+|.+..+++.||||.+..+.. ...+|+.+++.+ .||||++++++|...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~---~~~~Ei~il~~l------~h~niv~l~~~~~~~~~~ 134 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQ---YKNRELLIMKNL------NHINIIFLKDYYYTECFK 134 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcc---hHHHHHHHHHhc------CCCCCcceeeeEeecccc
Confidence 45689999999999999999999999999999998865543 234678887776 478999999887542
Q ss_pred -----CeEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEE
Q 007035 489 -----EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 563 (621)
Q Consensus 489 -----~~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IK 563 (621)
..+++||||+++++.+++...... ...+++..++.++.||+.||.|||+++|+||||||+|||++. ..+.+|
T Consensus 135 ~~~~~~~l~lvmE~~~~~l~~~~~~~~~~--~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~-~~~~vk 211 (440)
T PTZ00036 135 KNEKNIFLNVVMEFIPQTVHKYMKHYARN--NHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDP-NTHTLK 211 (440)
T ss_pred cCCCceEEEEEEecCCccHHHHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcC-CCCcee
Confidence 257899999999988877643222 223889999999999999999999999999999999999984 345799
Q ss_pred EEecCCccccCC--CccccccCCcccCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 564 IIDLGSSCFQTD--NLCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 564 L~DFGls~~~~~--~~~~~~gt~~Y~APEvl~~~-~~s~ksDIWSLGvILyELltG~~PF 620 (621)
|+|||++..... ......+|+.|+|||++.+. .++.++|||||||+||+|++|.+||
T Consensus 212 L~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf 271 (440)
T PTZ00036 212 LCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIF 271 (440)
T ss_pred eeccccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 999999875432 23345779999999998764 6899999999999999999999998
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-32 Score=277.84 Aligned_cols=197 Identities=30% Similarity=0.498 Sum_probs=166.3
Q ss_pred ceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc---hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEe----
Q 007035 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH---- 487 (621)
Q Consensus 415 rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~---~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~---- 487 (621)
+|++++.||.|+||+||+|+++.+++.||+|.++... .......+|+.+++.+.. ..||||+++++++..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~---~~h~ni~~~~~~~~~~~~~ 77 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEA---FDHPNIVRLMDVCATSRTD 77 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhh---cCCCCeeeeeeeeccccCC
Confidence 5899999999999999999999999999999987532 122345677888877753 358999999998864
Q ss_pred -cCeEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEe
Q 007035 488 -LEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (621)
Q Consensus 488 -~~~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~D 566 (621)
...+++||||+.+++.+++..... ..+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+|
T Consensus 78 ~~~~~~lv~e~~~~~l~~~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~--~~~~kl~d 151 (288)
T cd07863 78 RETKVTLVFEHVDQDLRTYLDKVPP----PGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTS--GGQVKLAD 151 (288)
T ss_pred CCceEEEEEcccccCHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECC--CCCEEECc
Confidence 346899999999988887764332 12889999999999999999999999999999999999984 78899999
Q ss_pred cCCccccCCC--ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 567 LGSSCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 567 FGls~~~~~~--~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
||++...... .....+++.|+|||++.+..++.++|||||||++|+|++|++||
T Consensus 152 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f 207 (288)
T cd07863 152 FGLARIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLF 207 (288)
T ss_pred cCccccccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCc
Confidence 9998765432 23356788999999999988999999999999999999999988
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-32 Score=286.51 Aligned_cols=194 Identities=23% Similarity=0.341 Sum_probs=161.1
Q ss_pred CceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc----hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecC
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~ 489 (621)
++|++++.||+|+||+||++++..+++.||+|++.+.. .....+.+|+.+++.+ .|+||+++++++...+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~------~~~~i~~~~~~~~~~~ 74 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNG------DRRWITNLHYAFQDEN 74 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC------CCCCCCceEEEEecCC
Confidence 47999999999999999999999999999999997532 1223345566665543 5789999999999999
Q ss_pred eEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecC
Q 007035 490 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (621)
Q Consensus 490 ~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFG 568 (621)
++++||||+.+ +|.+++..... .+++..++.++.||+.||+|||+++|+||||||+|||++ .++.+||+|||
T Consensus 75 ~~~lv~e~~~g~~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~--~~~~~kl~Dfg 147 (331)
T cd05597 75 NLYLVMDYYVGGDLLTLLSKFED-----RLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLD--KNGHIRLADFG 147 (331)
T ss_pred eEEEEEecCCCCcHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEEC--CCCCEEEEECC
Confidence 99999999974 77776654221 288899999999999999999999999999999999998 47889999999
Q ss_pred CccccCCCc----cccccCCcccCchhhcC-----CCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 569 SSCFQTDNL----CLYVQSRSYRAPEVIIG-----LPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 569 ls~~~~~~~----~~~~gt~~Y~APEvl~~-----~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
++....... ....||+.|+|||++.. ..++.++|||||||++|+|++|+.||
T Consensus 148 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf 208 (331)
T cd05597 148 SCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPF 208 (331)
T ss_pred ceeecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCC
Confidence 986543321 22468999999999963 34788999999999999999999998
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.2e-32 Score=290.43 Aligned_cols=202 Identities=33% Similarity=0.523 Sum_probs=179.9
Q ss_pred eCeeecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCch----hhhhHHHHHHHHHHhcccCCCCCCceEEEee
Q 007035 408 LNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD----FFDQSLDEIKLLKLVNKNDPADEHHILRLYD 483 (621)
Q Consensus 408 l~~ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~----~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~ 483 (621)
...-+...|.+.+.||.|.||.||+++++.+|+.+|+|++.+... ......+|+.+++++.. ||||+++++
T Consensus 29 ~~~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~-----hpniv~l~~ 103 (382)
T KOG0032|consen 29 FSEDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSG-----HPNIVQLKD 103 (382)
T ss_pred ccccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccC-----CCCEEEEEE
Confidence 344567789999999999999999999999999999999986543 23578899999999863 789999999
Q ss_pred EeEecCeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCC--C
Q 007035 484 YFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQR--C 560 (621)
Q Consensus 484 ~f~~~~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~--~ 560 (621)
.|.+...+++|||++.| .|.+.+... .+++..+..+++||+.|++|||+.||+||||||+|+|+..... +
T Consensus 104 ~~e~~~~~~lvmEL~~GGeLfd~i~~~-------~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~ 176 (382)
T KOG0032|consen 104 AFEDPDSVYLVMELCEGGELFDRIVKK-------HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSG 176 (382)
T ss_pred EEEcCCeEEEEEEecCCchHHHHHHHc-------cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCC
Confidence 99999999999999995 677777654 1899999999999999999999999999999999999986543 5
Q ss_pred eEEEEecCCccccCC--CccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 007035 561 EIKIIDLGSSCFQTD--NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCLI 621 (621)
Q Consensus 561 ~IKL~DFGls~~~~~--~~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF~ 621 (621)
.+|++|||++..... .....+||+.|+|||++...+|+..+||||+|+++|.|++|.+||.
T Consensus 177 ~ik~~DFGla~~~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~ 239 (382)
T KOG0032|consen 177 RIKLIDFGLAKFIKPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFW 239 (382)
T ss_pred cEEEeeCCCceEccCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCc
Confidence 899999999988766 4566899999999999999999999999999999999999999994
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.4e-32 Score=286.90 Aligned_cols=194 Identities=22% Similarity=0.311 Sum_probs=160.9
Q ss_pred CceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCch----hhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecC
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD----FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~----~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~ 489 (621)
++|++++.||+|+||+||+++++.+++.||+|++.+... ....+.+|..++..+ .|++|+++++++...+
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~------~~~~i~~l~~~~~~~~ 74 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNG------DCQWITTLHYAFQDEN 74 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhC------CCCCEeeEEEEEEcCC
Confidence 479999999999999999999999999999999875321 122344455555443 5789999999999999
Q ss_pred eEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecC
Q 007035 490 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (621)
Q Consensus 490 ~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFG 568 (621)
+.|+||||+.+ +|.+++..... .+++..++.++.||+.||.|||+++|+||||||+|||++ .++.+||+|||
T Consensus 75 ~~~lv~Ey~~gg~L~~~l~~~~~-----~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~--~~~~~kl~DfG 147 (331)
T cd05624 75 YLYLVMDYYVGGDLLTLLSKFED-----RLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLD--MNGHIRLADFG 147 (331)
T ss_pred EEEEEEeCCCCCcHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEc--CCCCEEEEecc
Confidence 99999999975 67766654322 278889999999999999999999999999999999998 47889999999
Q ss_pred CccccCCCc----cccccCCcccCchhhcC-----CCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 569 SSCFQTDNL----CLYVQSRSYRAPEVIIG-----LPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 569 ls~~~~~~~----~~~~gt~~Y~APEvl~~-----~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
++....... ....|++.|+|||++.+ ..++.++|||||||+||+|++|+.||
T Consensus 148 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf 208 (331)
T cd05624 148 SCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF 208 (331)
T ss_pred ceeeccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCc
Confidence 986544321 23468999999999875 45788999999999999999999998
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.8e-32 Score=285.68 Aligned_cols=187 Identities=26% Similarity=0.424 Sum_probs=156.8
Q ss_pred EEeccCCCCceeEEEeCCCCcEEEEEEEecCc----hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeEEEEE
Q 007035 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVC 495 (621)
Q Consensus 420 ~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l~LVm 495 (621)
+.||+|+||.||++++..+|+.||+|+++... .......+|+++++.+ .||||+++++.|...+++++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l------~hp~i~~~~~~~~~~~~~~lv~ 74 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT------RHPFLTALKYAFQTHDRLCFVM 74 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC------CCCCCcceeeEEecCCEEEEEE
Confidence 36999999999999999999999999997532 2233445566666655 4789999999999999999999
Q ss_pred ecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCccccC
Q 007035 496 ELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQT 574 (621)
Q Consensus 496 Eyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~~~~ 574 (621)
||+.+ +|...+.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++....
T Consensus 75 E~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~--~~~~kL~Dfg~~~~~~ 146 (323)
T cd05595 75 EYANGGELFFHLSRER------VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDK--DGHIKITDFGLCKEGI 146 (323)
T ss_pred eCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcC--CCCEEecccHHhcccc
Confidence 99986 5555443322 2889999999999999999999999999999999999984 7889999999876432
Q ss_pred C---CccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 575 D---NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 575 ~---~~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
. ......|++.|+|||++.+..++.++|||||||++|+|++|+.||
T Consensus 147 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf 195 (323)
T cd05595 147 SDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 195 (323)
T ss_pred CCCCccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCC
Confidence 2 223356899999999999989999999999999999999999998
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=5e-32 Score=283.74 Aligned_cols=185 Identities=30% Similarity=0.475 Sum_probs=157.4
Q ss_pred eccCCCCceeEEEeCCCCcEEEEEEEecCc----hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeEEEEEec
Q 007035 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCEL 497 (621)
Q Consensus 422 LG~G~fG~Vyka~d~~tg~~VAlKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l~LVmEy 497 (621)
||+|+||+||++++..+++.||+|++.... .......+|+.+++.+ .||||+++++++...+.+++||||
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l------~h~~iv~~~~~~~~~~~~~lv~e~ 74 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQV------NCPFIVPLKFSFQSPEKLYLVLAF 74 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC------CCCcEeceeeEEecCCeEEEEEcC
Confidence 799999999999999999999999987532 2234455677666655 478999999999999999999999
Q ss_pred ccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCccccCC-
Q 007035 498 LRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTD- 575 (621)
Q Consensus 498 l~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~~~~~- 575 (621)
+.+ +|.+.+.... .+++..++.++.||+.||.|||+++|+||||||+|||++. ++.++|+|||++.....
T Consensus 75 ~~~g~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~--~~~~kl~Dfg~~~~~~~~ 146 (312)
T cd05585 75 INGGELFHHLQREG------RFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDY--QGHIALCDFGLCKLNMKD 146 (312)
T ss_pred CCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECC--CCcEEEEECcccccCccC
Confidence 985 6666665322 2788999999999999999999999999999999999984 78899999999865322
Q ss_pred --CccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 576 --NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 576 --~~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||
T Consensus 147 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf 193 (312)
T cd05585 147 DDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPF 193 (312)
T ss_pred CCccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCc
Confidence 223457899999999999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.4e-32 Score=284.43 Aligned_cols=188 Identities=29% Similarity=0.444 Sum_probs=156.0
Q ss_pred EEeccCCCCceeEEEeCCCCcEEEEEEEecCch----hhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeEEEEE
Q 007035 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD----FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVC 495 (621)
Q Consensus 420 ~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~----~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l~LVm 495 (621)
+.||+|+||+||+|++..+++.||+|+++.... .......|..++..+ ..||||+++++++....++++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~-----~~hp~i~~~~~~~~~~~~~~lv~ 75 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALA-----WEHPFLTHLFCTFQTKEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhc-----cCCCCccceeeEEEcCCEEEEEE
Confidence 369999999999999999999999999986432 122333444444332 36899999999999999999999
Q ss_pred ecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCccccC
Q 007035 496 ELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQT 574 (621)
Q Consensus 496 Eyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~~~~ 574 (621)
||+.+ +|...+.... .+++..++.++.||+.||.|||+++|+||||||+|||++. ++.+||+|||++....
T Consensus 76 e~~~gg~L~~~~~~~~------~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~--~~~~kL~Dfg~a~~~~ 147 (316)
T cd05592 76 EYLNGGDLMFHIQSSG------RFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDK--DGHIKIADFGMCKENM 147 (316)
T ss_pred cCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECC--CCCEEEccCcCCeECC
Confidence 99975 5655554322 2888999999999999999999999999999999999984 7889999999986532
Q ss_pred ---CCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 575 ---DNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 575 ---~~~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||
T Consensus 148 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf 196 (316)
T cd05592 148 NGEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPF 196 (316)
T ss_pred CCCCccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCC
Confidence 2233457899999999999989999999999999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.9e-32 Score=285.10 Aligned_cols=193 Identities=25% Similarity=0.416 Sum_probs=161.2
Q ss_pred ceEEEEEeccCCCCceeEEEeC---CCCcEEEEEEEecCc-----hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeE
Q 007035 415 RYYVTEYLGSAAFSKVFQAQDL---HTGVDVCLKIIKNDK-----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (621)
Q Consensus 415 rY~I~~~LG~G~fG~Vyka~d~---~tg~~VAlKii~~~~-----~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~ 486 (621)
+|++++.||+|+||+||++++. .+++.||+|++.+.. ...+....|+.+++.++ .|++|+++++++.
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-----~~~~i~~~~~~~~ 75 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVR-----QSPFLVTLHYAFQ 75 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhcc-----CCCCcccEEEEEe
Confidence 4899999999999999999864 478999999987532 22345566777777664 3689999999999
Q ss_pred ecCeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEE
Q 007035 487 HLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKII 565 (621)
Q Consensus 487 ~~~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~ 565 (621)
..+.+++||||+.+ +|.+.+.... .+++..++.++.||+.||.|||+++|+||||||+|||++. ++.+||+
T Consensus 76 ~~~~~~lv~e~~~~g~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~--~~~~kl~ 147 (332)
T cd05614 76 TEAKLHLILDYVSGGEMFTHLYQRD------NFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDS--EGHVVLT 147 (332)
T ss_pred cCCEEEEEEeCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECC--CCCEEEe
Confidence 99999999999985 6666664322 2888999999999999999999999999999999999984 7889999
Q ss_pred ecCCccccCC----CccccccCCcccCchhhcCCC-CCchhhHHHHHHHHHHHHhCCCCC
Q 007035 566 DLGSSCFQTD----NLCLYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 566 DFGls~~~~~----~~~~~~gt~~Y~APEvl~~~~-~s~ksDIWSLGvILyELltG~~PF 620 (621)
|||++..... ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||
T Consensus 148 DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf 207 (332)
T cd05614 148 DFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPF 207 (332)
T ss_pred eCcCCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCC
Confidence 9999865322 122357899999999998754 788999999999999999999998
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.3e-32 Score=286.78 Aligned_cols=187 Identities=27% Similarity=0.431 Sum_probs=157.2
Q ss_pred EEeccCCCCceeEEEeCCCCcEEEEEEEecCc----hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeEEEEE
Q 007035 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVC 495 (621)
Q Consensus 420 ~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l~LVm 495 (621)
+.||+|+||.||++++..+|+.||+|++.... .......+|+++++.+ .||||+++++++...+++++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l------~hp~iv~~~~~~~~~~~~~lv~ 74 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNT------RHPFLTSLKYSFQTKDRLCFVM 74 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC------CCCCCcceEEEEEcCCEEEEEE
Confidence 36899999999999999999999999997532 2234455566666554 5789999999999999999999
Q ss_pred ecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCccccC
Q 007035 496 ELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQT 574 (621)
Q Consensus 496 Eyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~~~~ 574 (621)
||+.+ +|...+.... .+++..++.++.||+.||.|||+++|+||||||+|||++. ++.+||+|||++....
T Consensus 75 Ey~~~g~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~--~~~~kL~DfG~~~~~~ 146 (328)
T cd05593 75 EYVNGGELFFHLSRER------VFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDK--DGHIKITDFGLCKEGI 146 (328)
T ss_pred eCCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECC--CCcEEEecCcCCccCC
Confidence 99986 5555443322 2889999999999999999999999999999999999984 7889999999986532
Q ss_pred C---CccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 575 D---NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 575 ~---~~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
. ......||+.|+|||++.+..++.++|||||||++|+|++|+.||
T Consensus 147 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf 195 (328)
T cd05593 147 TDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 195 (328)
T ss_pred CcccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCC
Confidence 2 223357899999999999988999999999999999999999998
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.8e-32 Score=283.66 Aligned_cols=193 Identities=26% Similarity=0.384 Sum_probs=161.4
Q ss_pred ceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCch----hhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCe
Q 007035 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD----FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (621)
Q Consensus 415 rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~----~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~ 490 (621)
+|++.+.||+|+||+||+|+++.+|+.||+|++.+... .......|..++..+. .|++|+++++++...+.
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-----~~~~i~~~~~~~~~~~~ 75 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQD-----KPPFLTQLHSCFQTVDR 75 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcc-----CCCchhheeeEEecCCE
Confidence 47889999999999999999999999999999975421 2234455666655543 35689999999999999
Q ss_pred EEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCC
Q 007035 491 LFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (621)
Q Consensus 491 l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGl 569 (621)
+++||||+.+ +|.+.+.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+
T Consensus 76 ~~lv~Ey~~~g~L~~~i~~~~------~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~--~~~ikL~Dfg~ 147 (323)
T cd05615 76 LYFVMEYVNGGDLMYHIQQVG------KFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDS--EGHIKIADFGM 147 (323)
T ss_pred EEEEEcCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECC--CCCEEEecccc
Confidence 9999999985 6665554322 2889999999999999999999999999999999999984 78899999999
Q ss_pred ccccCC---CccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 570 SCFQTD---NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 570 s~~~~~---~~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
+..... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||
T Consensus 148 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf 201 (323)
T cd05615 148 CKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPF 201 (323)
T ss_pred ccccCCCCccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCC
Confidence 865322 223456899999999999988999999999999999999999998
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.8e-33 Score=289.64 Aligned_cols=196 Identities=32% Similarity=0.531 Sum_probs=173.1
Q ss_pred eecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCch----hhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeE
Q 007035 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD----FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (621)
Q Consensus 411 ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~----~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~ 486 (621)
-+.-||++.+.||+|.||+|-+|.+...|+.||||.+++++. ..-.+.+|++|+..| .||||+++|.+|+
T Consensus 50 nlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsL------NHPhII~IyEVFE 123 (668)
T KOG0611|consen 50 NLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSL------NHPHIIQIYEVFE 123 (668)
T ss_pred chhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhc------CCCceeehhhhhc
Confidence 356789999999999999999999999999999999987542 223445566666555 5889999999999
Q ss_pred ecCeEEEEEeccc-cchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEE
Q 007035 487 HLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKII 565 (621)
Q Consensus 487 ~~~~l~LVmEyl~-gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~ 565 (621)
..+.+.|||||.. |.|++++...+. +++.+++.+++||+.|+.|+|+++++|||||.+|||++ +++.+||+
T Consensus 124 NkdKIvivMEYaS~GeLYDYiSer~~------LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD--~N~NiKIA 195 (668)
T KOG0611|consen 124 NKDKIVIVMEYASGGELYDYISERGS------LSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLD--QNNNIKIA 195 (668)
T ss_pred CCceEEEEEEecCCccHHHHHHHhcc------ccHHHHHHHHHHHHHHHHHHhhccceecccchhheeec--CCCCeeee
Confidence 9999999999997 589999886654 89999999999999999999999999999999999999 58899999
Q ss_pred ecCCccccCCC--ccccccCCcccCchhhcCCCC-CchhhHHHHHHHHHHHHhCCCCC
Q 007035 566 DLGSSCFQTDN--LCLYVQSRSYRAPEVIIGLPY-DQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 566 DFGls~~~~~~--~~~~~gt~~Y~APEvl~~~~~-s~ksDIWSLGvILyELltG~~PF 620 (621)
|||++...... ..+++|+|-|.+||++.|.+| ++.+|-||||++||-|..|..||
T Consensus 196 DFGLSNly~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPF 253 (668)
T KOG0611|consen 196 DFGLSNLYADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPF 253 (668)
T ss_pred ccchhhhhccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhccccc
Confidence 99999776543 567899999999999999997 57899999999999999999998
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.6e-32 Score=291.74 Aligned_cols=193 Identities=23% Similarity=0.361 Sum_probs=161.9
Q ss_pred cCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc----hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEec
Q 007035 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (621)
Q Consensus 413 ~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~ 488 (621)
.++|++.+.||+|+||.||++++..+++.||+|++.... .....+.+|+.+++.+ .||||+++++++.+.
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~------~h~~iv~~~~~~~~~ 115 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHA------NSEWIVQLHYAFQDD 115 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC------CCCCcceEEEEEecC
Confidence 468999999999999999999999999999999997532 1223345666666655 478999999999999
Q ss_pred CeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEec
Q 007035 489 EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 567 (621)
Q Consensus 489 ~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DF 567 (621)
.++++||||+.+ +|.+++... .+++..+..++.||+.||.|||+++|+||||||+|||++ .++.+||+||
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~~-------~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~--~~~~~kL~Df 186 (370)
T cd05596 116 KYLYMVMEYMPGGDLVNLMSNY-------DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD--KSGHLKLADF 186 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEc--CCCCEEEEec
Confidence 999999999975 566655321 177888999999999999999999999999999999998 4889999999
Q ss_pred CCccccCCC----ccccccCCcccCchhhcCC----CCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 568 GSSCFQTDN----LCLYVQSRSYRAPEVIIGL----PYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 568 Gls~~~~~~----~~~~~gt~~Y~APEvl~~~----~~s~ksDIWSLGvILyELltG~~PF 620 (621)
|++...... .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||
T Consensus 187 G~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf 247 (370)
T cd05596 187 GTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247 (370)
T ss_pred cceeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCc
Confidence 998654332 2235789999999998754 3788999999999999999999998
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.2e-33 Score=271.94 Aligned_cols=203 Identities=28% Similarity=0.408 Sum_probs=176.8
Q ss_pred eeecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecC
Q 007035 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (621)
Q Consensus 410 ~ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~ 489 (621)
..-.++|.+.+.||.|-||.||+|+.+.++..||+|++.+.+ .....-+-.+.+++.....+.||||+++|++|.+..
T Consensus 18 ~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsq--i~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~ 95 (281)
T KOG0580|consen 18 TWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQ--ILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSK 95 (281)
T ss_pred ccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHH--HHHhcchhhhhheeEeecccCCccHHhhhhheeccc
Confidence 344578999999999999999999999999999999998754 233334445556666667788999999999999999
Q ss_pred eEEEEEeccc-cchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecC
Q 007035 490 HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (621)
Q Consensus 490 ~l~LVmEyl~-gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFG 568 (621)
.+|+++||.. |.++..+...... .+.+...+.+++|++.||.|+|.++|+||||||+|+|++. .+.+||+|||
T Consensus 96 riyLilEya~~gel~k~L~~~~~~----~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~--~~~lkiAdfG 169 (281)
T KOG0580|consen 96 RIYLILEYAPRGELYKDLQEGRMK----RFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGS--AGELKIADFG 169 (281)
T ss_pred eeEEEEEecCCchHHHHHHhcccc----cccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCC--CCCeeccCCC
Confidence 9999999997 6788877743322 2888999999999999999999999999999999999995 8899999999
Q ss_pred CccccC-CCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 569 SSCFQT-DNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 569 ls~~~~-~~~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
.+.... ....+.+||..|.+||+..+..++..+|+|++|++.||++.|.+||
T Consensus 170 wsV~~p~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppF 222 (281)
T KOG0580|consen 170 WSVHAPSNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPF 222 (281)
T ss_pred ceeecCCCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCch
Confidence 987664 4456689999999999999999999999999999999999999998
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.3e-32 Score=283.64 Aligned_cols=197 Identities=31% Similarity=0.455 Sum_probs=169.0
Q ss_pred ecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCch--hhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecC
Q 007035 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD--FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (621)
Q Consensus 412 i~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~--~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~ 489 (621)
-...|++.+.||.|.-++||+|+...+++.||||++..++- ..+.+.+|+..+..+ .||||++++..|....
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~------~HPNIv~~~~sFvv~~ 97 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLI------DHPNIVTYHCSFVVDS 97 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhc------CCCCcceEEEEEEecc
Confidence 35679999999999999999999999999999999986542 244555555555544 6899999999999999
Q ss_pred eEEEEEeccc-cchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecC
Q 007035 490 HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (621)
Q Consensus 490 ~l~LVmEyl~-gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFG 568 (621)
.+|+||++|. |++++++...-..+ +.+..+..|++++++||.|||++|.||||||+.||||+. +|.|||+|||
T Consensus 98 ~LWvVmpfMa~GS~ldIik~~~~~G----l~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~--dG~VkLadFg 171 (516)
T KOG0582|consen 98 ELWVVMPFMAGGSLLDIIKTYYPDG----LEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDS--DGTVKLADFG 171 (516)
T ss_pred eeEEeehhhcCCcHHHHHHHHcccc----ccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcC--CCcEEEcCce
Confidence 9999999998 68888887765544 899999999999999999999999999999999999994 9999999999
Q ss_pred CccccCCC-------ccccccCCcccCchhhcC--CCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 569 SSCFQTDN-------LCLYVQSRSYRAPEVIIG--LPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 569 ls~~~~~~-------~~~~~gt~~Y~APEvl~~--~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
.+....+. ....+||+.|||||++.. ..|+.|+||||||++..||++|..||
T Consensus 172 vsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf 232 (516)
T KOG0582|consen 172 VSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPF 232 (516)
T ss_pred eeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCc
Confidence 76433221 144689999999999644 35999999999999999999999998
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.9e-32 Score=284.29 Aligned_cols=188 Identities=27% Similarity=0.407 Sum_probs=157.6
Q ss_pred EEeccCCCCceeEEEeCCCCcEEEEEEEecCc----hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeEEEEE
Q 007035 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVC 495 (621)
Q Consensus 420 ~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l~LVm 495 (621)
+.||+|+||.||+|++..+++.||+|++.... ........|.+++..+. .||||+++++++...+++++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~-----~hp~i~~~~~~~~~~~~~~lv~ 75 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAA-----KHPFLTALHCCFQTKDRLFFVM 75 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhcc-----CCCCccceeeEEEcCCeEEEEE
Confidence 36999999999999999999999999997642 22334556666665543 5889999999999999999999
Q ss_pred ecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCccccC
Q 007035 496 ELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQT 574 (621)
Q Consensus 496 Eyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~~~~ 574 (621)
||+++ +|...+.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++....
T Consensus 76 E~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~--~~~~kL~Dfg~~~~~~ 147 (321)
T cd05591 76 EYVNGGDLMFQIQRSR------KFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDA--EGHCKLADFGMCKEGI 147 (321)
T ss_pred eCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECC--CCCEEEeecccceecc
Confidence 99986 5555554322 2788899999999999999999999999999999999984 7889999999886432
Q ss_pred ---CCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 575 ---DNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 575 ---~~~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
.......|++.|+|||++.+..++.++|||||||++|+|++|+.||
T Consensus 148 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf 196 (321)
T cd05591 148 LNGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPF 196 (321)
T ss_pred cCCccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCC
Confidence 1233456899999999999989999999999999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=285.86 Aligned_cols=193 Identities=34% Similarity=0.590 Sum_probs=165.0
Q ss_pred ecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecC---chhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEec
Q 007035 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (621)
Q Consensus 412 i~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~---~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~ 488 (621)
+.++|++++.||+|+||.||++.+..+++.||+|.+... ........+|+.+++.+ .||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~~~~~~~~~ 88 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV------NHKNIISLLNVFTPQ 88 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHh------CCCchhceeeeeecc
Confidence 468999999999999999999999999999999998753 22334566777777666 478999999988744
Q ss_pred ------CeEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeE
Q 007035 489 ------EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEI 562 (621)
Q Consensus 489 ------~~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~I 562 (621)
...++||||+++++.+.+.. .++...++.++.||+.||.|||++||+||||||+|||++. ++.+
T Consensus 89 ~~~~~~~~~~lv~e~~~~~l~~~~~~--------~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~--~~~~ 158 (355)
T cd07874 89 KSLEEFQDVYLVMELMDANLCQVIQM--------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS--DCTL 158 (355)
T ss_pred ccccccceeEEEhhhhcccHHHHHhh--------cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECC--CCCE
Confidence 35799999999988776642 1778889999999999999999999999999999999984 7889
Q ss_pred EEEecCCccccCCC--ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 563 KIIDLGSSCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 563 KL~DFGls~~~~~~--~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
||+|||++...... .....+|+.|+|||++.+..++.++|||||||++|+|++|+.||
T Consensus 159 kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf 218 (355)
T cd07874 159 KILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILF 218 (355)
T ss_pred EEeeCcccccCCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 99999998765433 23357899999999999989999999999999999999999998
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.6e-32 Score=287.55 Aligned_cols=194 Identities=27% Similarity=0.387 Sum_probs=162.8
Q ss_pred CceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCch----hhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecC
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD----FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~----~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~ 489 (621)
++|++.+.||+|+||+||+++++.+|+.||+|+++.... ....+.+|+.+++.+ .|+||+++++++...+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~------~~~~i~~~~~~~~~~~ 74 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSIS------NSPWIPQLQYAFQDKD 74 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC------CCCCCcceeeEEecCC
Confidence 469999999999999999999999999999999986432 233455566665543 5789999999999999
Q ss_pred eEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecC
Q 007035 490 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (621)
Q Consensus 490 ~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFG 568 (621)
++++||||+.+ +|.+++..... .+++..++.++.||+.||.|||+++|+||||||+|||++ .++.+||+|||
T Consensus 75 ~~~lv~e~~~~~~L~~~l~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~--~~~~~kL~Dfg 147 (330)
T cd05601 75 NLYLVMEYQPGGDLLSLLNRYED-----QFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLID--RTGHIKLADFG 147 (330)
T ss_pred eEEEEECCCCCCCHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEEC--CCCCEEeccCC
Confidence 99999999974 67776654322 288999999999999999999999999999999999998 47899999999
Q ss_pred CccccCCCc----cccccCCcccCchhhc------CCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 569 SSCFQTDNL----CLYVQSRSYRAPEVII------GLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 569 ls~~~~~~~----~~~~gt~~Y~APEvl~------~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
++....... ....+|+.|+|||++. ...++.++|||||||++|+|++|+.||
T Consensus 148 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf 209 (330)
T cd05601 148 SAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPF 209 (330)
T ss_pred CCeECCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCC
Confidence 987654321 2246899999999987 455788999999999999999999998
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.4e-32 Score=283.45 Aligned_cols=188 Identities=27% Similarity=0.453 Sum_probs=157.5
Q ss_pred EEeccCCCCceeEEEeCCCCcEEEEEEEecCc----hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeEEEEE
Q 007035 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVC 495 (621)
Q Consensus 420 ~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l~LVm 495 (621)
+.||+|+||+||+|+++.+++.||+|++.+.. ........|..++..+. .||||+++++++...+.+++||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-----~h~~iv~~~~~~~~~~~~~iv~ 75 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLAR-----NHPFLTQLYCCFQTPDRLFFVM 75 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcc-----CCCchhceeeEEEcCCEEEEEE
Confidence 36999999999999999999999999987532 22334455666655442 5889999999999999999999
Q ss_pred ecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCccccC
Q 007035 496 ELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQT 574 (621)
Q Consensus 496 Eyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~~~~ 574 (621)
||+.+ +|...+.... .+++..++.++.||+.||.|||+++|+||||||+|||++. ++.+||+|||++....
T Consensus 76 Ey~~~g~L~~~i~~~~------~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~--~~~~kL~DfG~~~~~~ 147 (320)
T cd05590 76 EFVNGGDLMFHIQKSR------RFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDH--EGHCKLADFGMCKEGI 147 (320)
T ss_pred cCCCCchHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECC--CCcEEEeeCCCCeecC
Confidence 99985 5655554332 2888999999999999999999999999999999999984 7889999999876432
Q ss_pred ---CCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 575 ---DNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 575 ---~~~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||
T Consensus 148 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf 196 (320)
T cd05590 148 FNGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPF 196 (320)
T ss_pred cCCCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCC
Confidence 2233457899999999999989999999999999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.3e-32 Score=284.96 Aligned_cols=188 Identities=24% Similarity=0.389 Sum_probs=159.3
Q ss_pred EEeccCCCCceeEEEeCCCCcEEEEEEEecCc----hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeEEEEE
Q 007035 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVC 495 (621)
Q Consensus 420 ~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l~LVm 495 (621)
+.||+|+||.||++++..+++.||+|++++.. ...+.+..|..+++.+. .||||+++++++...+.+++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~-----~hp~Iv~~~~~~~~~~~~~lv~ 75 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETAS-----NHPFLVGLHSCFQTESRLFFVI 75 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcc-----CCCCCCceEEEEEcCCEEEEEE
Confidence 36899999999999999999999999998532 22344566777776653 4789999999999999999999
Q ss_pred ecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCcccc-
Q 007035 496 ELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQ- 573 (621)
Q Consensus 496 Eyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~~~- 573 (621)
||+++ +|...+.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++...
T Consensus 76 e~~~~g~L~~~~~~~~------~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~--~~~~kL~Dfg~~~~~~ 147 (329)
T cd05588 76 EFVSGGDLMFHMQRQR------KLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDA--EGHIKLTDYGMCKEGI 147 (329)
T ss_pred eCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECC--CCCEEECcCccccccc
Confidence 99986 5655554322 2889999999999999999999999999999999999984 788999999988642
Q ss_pred --CCCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 574 --TDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 574 --~~~~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
........||+.|+|||++.+..++.++|||||||++|+|++|+.||
T Consensus 148 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf 196 (329)
T cd05588 148 RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPF 196 (329)
T ss_pred cCCCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCc
Confidence 22234467899999999999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.7e-32 Score=282.82 Aligned_cols=188 Identities=31% Similarity=0.476 Sum_probs=156.8
Q ss_pred EEeccCCCCceeEEEeCCCCcEEEEEEEecCc----hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeEEEEE
Q 007035 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVC 495 (621)
Q Consensus 420 ~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l~LVm 495 (621)
+.||+|+||.||+|+++.+|+.||+|+++... ........|..++... .+||+|+++++++...+++++||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~-----~~~~~i~~~~~~~~~~~~~~lv~ 75 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALA-----WENPFLTHLYCTFQTKEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhc-----cCCCCccCeeEEEEeCCEEEEEE
Confidence 36999999999999999999999999998642 1223344455554433 35889999999999999999999
Q ss_pred ecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCcccc-
Q 007035 496 ELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQ- 573 (621)
Q Consensus 496 Eyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~~~- 573 (621)
||+.+ +|...+.... .+++..+..++.||+.||.|||++||+||||||+|||++. ++.++|+|||++...
T Consensus 76 E~~~~g~L~~~i~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~--~~~~kl~Dfg~~~~~~ 147 (316)
T cd05620 76 EFLNGGDLMFHIQDKG------RFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDR--DGHIKIADFGMCKENV 147 (316)
T ss_pred CCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECC--CCCEEeCccCCCeecc
Confidence 99985 5655554321 2788899999999999999999999999999999999984 778999999987642
Q ss_pred --CCCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 574 --TDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 574 --~~~~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
........|++.|+|||++.+..++.++|||||||++|+|++|+.||
T Consensus 148 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf 196 (316)
T cd05620 148 FGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPF 196 (316)
T ss_pred cCCCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCC
Confidence 22233467899999999999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.8e-32 Score=284.56 Aligned_cols=188 Identities=24% Similarity=0.390 Sum_probs=157.5
Q ss_pred EEeccCCCCceeEEEeCCCCcEEEEEEEecCc----hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeEEEEE
Q 007035 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVC 495 (621)
Q Consensus 420 ~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l~LVm 495 (621)
+.||+|+||+||++++..+++.||+|++++.. ........|+.++..+. .||||+++++++...+.+++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~-----~hp~iv~~~~~~~~~~~~~lv~ 75 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS-----NHPFLVGLHSCFQTESRLFFVI 75 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcC-----CCCcCCceeeEEEeCCEEEEEE
Confidence 36999999999999999999999999998532 22334555666655442 5889999999999999999999
Q ss_pred ecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCccccC
Q 007035 496 ELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQT 574 (621)
Q Consensus 496 Eyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~~~~ 574 (621)
||+.+ +|...+.... .+++..++.++.||+.||.|||+++|+||||||+|||++. ++.+||+|||++....
T Consensus 76 E~~~~~~L~~~~~~~~------~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~--~~~~kL~DfG~~~~~~ 147 (329)
T cd05618 76 EYVNGGDLMFHMQRQR------KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDS--EGHIKLTDYGMCKEGL 147 (329)
T ss_pred eCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECC--CCCEEEeeCCcccccc
Confidence 99986 4544443221 2889999999999999999999999999999999999984 7889999999986432
Q ss_pred ---CCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 575 ---DNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 575 ---~~~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||
T Consensus 148 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf 196 (329)
T cd05618 148 RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPF 196 (329)
T ss_pred CCCCccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCC
Confidence 2233457899999999999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=282.72 Aligned_cols=188 Identities=23% Similarity=0.385 Sum_probs=159.4
Q ss_pred EEeccCCCCceeEEEeCCCCcEEEEEEEecCc----hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeEEEEE
Q 007035 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVC 495 (621)
Q Consensus 420 ~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l~LVm 495 (621)
+.||+|+||+||++++..+++.||+|+++... ...+.+..|+.++..+. .||+|+++++++...+++++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~-----~~~~i~~~~~~~~~~~~~~lv~ 75 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQAS-----SNPFLVGLHSCFQTTSRLFLVI 75 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhc-----CCCCEeeEEEEEEeCCEEEEEE
Confidence 36999999999999999999999999998642 22344566777766653 4789999999999999999999
Q ss_pred ecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCcccc-
Q 007035 496 ELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQ- 573 (621)
Q Consensus 496 Eyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~~~- 573 (621)
||+.+ +|...+.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++...
T Consensus 76 e~~~~~~L~~~~~~~~------~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~--~~~~kl~Dfg~~~~~~ 147 (327)
T cd05617 76 EYVNGGDLMFHMQRQR------KLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDA--DGHIKLTDYGMCKEGL 147 (327)
T ss_pred eCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeC--CCCEEEeccccceecc
Confidence 99985 5655554322 2889999999999999999999999999999999999984 788999999988642
Q ss_pred --CCCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 574 --TDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 574 --~~~~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
.......+||+.|+|||++.+..++.++|||||||+||+|++|+.||
T Consensus 148 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf 196 (327)
T cd05617 148 GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPF 196 (327)
T ss_pred CCCCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCC
Confidence 22234467899999999999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.6e-31 Score=277.18 Aligned_cols=194 Identities=29% Similarity=0.470 Sum_probs=164.5
Q ss_pred CceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc--hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeE
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l 491 (621)
++|.+++.||.|+||.||+|.++.+++.||+|.++... .......+|+.+++.+ .||||+++++++...++.
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l------~h~~iv~~~~~~~~~~~~ 79 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDL------KHANIVTLHDIVHTDKSL 79 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhC------CCCCcceEEEEEeeCCeE
Confidence 67999999999999999999999999999999987532 2223456777777766 478999999999999999
Q ss_pred EEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCcc
Q 007035 492 FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 571 (621)
Q Consensus 492 ~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~ 571 (621)
++||||+++++.+.+..... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++.
T Consensus 80 ~lv~e~~~~~l~~~~~~~~~-----~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~--~~~~kl~Dfg~~~ 152 (309)
T cd07872 80 TLVFEYLDKDLKQYMDDCGN-----IMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINE--RGELKLADFGLAR 152 (309)
T ss_pred EEEEeCCCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECC--CCCEEECccccce
Confidence 99999999988887754322 2788889999999999999999999999999999999984 7889999999986
Q ss_pred ccCCC---ccccccCCcccCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 572 FQTDN---LCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 572 ~~~~~---~~~~~gt~~Y~APEvl~~-~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
..... .....+++.|+|||++.+ ..++.++|||||||++|+|++|++||
T Consensus 153 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf 205 (309)
T cd07872 153 AKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLF 205 (309)
T ss_pred ecCCCccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 54322 223456889999999865 45889999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-31 Score=284.90 Aligned_cols=193 Identities=35% Similarity=0.607 Sum_probs=164.2
Q ss_pred ecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecC---chhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEec
Q 007035 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (621)
Q Consensus 412 i~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~---~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~ 488 (621)
+.++|++.+.||+|+||.||++.+..+++.||||++... ........+|+.+++.+ .||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l------~h~~ii~~~~~~~~~ 95 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCV------NHKNIIGLLNVFTPQ 95 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhc------CCCCccccceeeccc
Confidence 457899999999999999999999999999999998753 22334556677766655 478999999987643
Q ss_pred ------CeEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeE
Q 007035 489 ------EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEI 562 (621)
Q Consensus 489 ------~~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~I 562 (621)
..+++||||+++++.+.+... ++...++.++.||+.||.|||++||+||||||+|||++. ++.+
T Consensus 96 ~~~~~~~~~~lv~e~~~~~l~~~~~~~--------~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~--~~~~ 165 (364)
T cd07875 96 KSLEEFQDVYIVMELMDANLCQVIQME--------LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS--DCTL 165 (364)
T ss_pred ccccccCeEEEEEeCCCCCHHHHHHhc--------CCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECC--CCcE
Confidence 358999999999888776421 678889999999999999999999999999999999984 7889
Q ss_pred EEEecCCccccCCC--ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 563 KIIDLGSSCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 563 KL~DFGls~~~~~~--~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
||+|||++...... .....+++.|+|||++.+..++.++|||||||++|+|++|+.||
T Consensus 166 kL~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf 225 (364)
T cd07875 166 KILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLF 225 (364)
T ss_pred EEEeCCCccccCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCC
Confidence 99999998765433 23357899999999999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=279.61 Aligned_cols=195 Identities=29% Similarity=0.406 Sum_probs=167.8
Q ss_pred ecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecC--chhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecC
Q 007035 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (621)
Q Consensus 412 i~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~--~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~ 489 (621)
..++|++++.||.|+||.||++++..++..+|+|++... ......+.+|+++++.+ .||||+++++++...+
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l------~h~~iv~~~~~~~~~~ 76 (331)
T cd06649 3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC------NSPYIVGFYGAFYSDG 76 (331)
T ss_pred CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHC------CCCCCCeEEEEEEECC
Confidence 357899999999999999999999999999999998754 23345677788887766 4789999999999999
Q ss_pred eEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHC-CeecccCCCccEEEeccCCCeEEEEec
Q 007035 490 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSL-GIIHCDLKPENILIKSYQRCEIKIIDL 567 (621)
Q Consensus 490 ~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~-gIvHrDLKP~NILl~~~~~~~IKL~DF 567 (621)
.+++||||+.+ +|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+|||++. ++.++|+||
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~--~~~~kl~Df 148 (331)
T cd06649 77 EISICMEHMDGGSLDQVLKEAK------RIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNS--RGEIKLCDF 148 (331)
T ss_pred EEEEEeecCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcC--CCcEEEccC
Confidence 99999999986 6666665332 278899999999999999999986 6999999999999984 788999999
Q ss_pred CCccccCCC-ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 568 GSSCFQTDN-LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 568 Gls~~~~~~-~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
|++...... .....+++.|+|||++.+..++.++|||||||++|+|++|+.||
T Consensus 149 g~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~ 202 (331)
T cd06649 149 GVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPI 202 (331)
T ss_pred cccccccccccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCC
Confidence 998654332 33457899999999999989999999999999999999999998
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-33 Score=276.05 Aligned_cols=202 Identities=30% Similarity=0.447 Sum_probs=173.2
Q ss_pred CeeecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecC---chhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEe
Q 007035 409 NTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYF 485 (621)
Q Consensus 409 ~~ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~---~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f 485 (621)
+..+.++|.+.+.||+|.|+.|+++.+..+|+.+|+|++... ....+.+.+|++|.+.++ ||||+++.+.+
T Consensus 6 ~~~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~Lq------HP~IvrL~~ti 79 (355)
T KOG0033|consen 6 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQ------HPNIVRLHDSI 79 (355)
T ss_pred ccccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcC------CCcEeehhhhh
Confidence 345678899999999999999999999999999999998642 234577888888887774 78999999999
Q ss_pred EecCeEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCC-CeEEE
Q 007035 486 YHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQR-CEIKI 564 (621)
Q Consensus 486 ~~~~~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~-~~IKL 564 (621)
.+....|||+|++.|+-+-+-..... ++++..+..+++||++||.|+|.++|||||+||.|+|+.+..+ ..+||
T Consensus 80 ~~~~~~ylvFe~m~G~dl~~eIV~R~-----~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL 154 (355)
T KOG0033|consen 80 QEESFHYLVFDLVTGGELFEDIVARE-----FYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKL 154 (355)
T ss_pred cccceeEEEEecccchHHHHHHHHHH-----HHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceee
Confidence 99999999999999754333322222 3788899999999999999999999999999999999976544 46899
Q ss_pred EecCCccccCCC--ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 007035 565 IDLGSSCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCLI 621 (621)
Q Consensus 565 ~DFGls~~~~~~--~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF~ 621 (621)
+|||++....+. ....+|||.|+|||++...+|+..+|||+.|||||-|+.|.+||.
T Consensus 155 ~~FGvAi~l~~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~ 213 (355)
T KOG0033|consen 155 ADFGLAIEVNDGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFW 213 (355)
T ss_pred cccceEEEeCCccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCC
Confidence 999999876643 345789999999999999999999999999999999999999994
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=282.47 Aligned_cols=194 Identities=22% Similarity=0.323 Sum_probs=159.8
Q ss_pred CceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCch----hhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecC
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD----FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~----~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~ 489 (621)
++|++++.||+|+||+||+++++.+++.+|+|++.+... ....+..|+.++.. ..|++|+++++.+....
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~------~~~~~i~~~~~~~~~~~ 74 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVN------GDNQWITTLHYAFQDEN 74 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhh------CCCCCEeeEEEEEecCC
Confidence 479999999999999999999999999999999865321 12224445544443 35789999999999999
Q ss_pred eEEEEEeccc-cchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecC
Q 007035 490 HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (621)
Q Consensus 490 ~l~LVmEyl~-gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFG 568 (621)
++++||||+. ++|.+++..... .+++..++.++.||+.||.|||+++|+||||||+|||++ .++.+||+|||
T Consensus 75 ~~~lv~ey~~~g~L~~~l~~~~~-----~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~--~~~~~kL~DfG 147 (332)
T cd05623 75 NLYLVMDYYVGGDLLTLLSKFED-----RLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMD--MNGHIRLADFG 147 (332)
T ss_pred EEEEEEeccCCCcHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEC--CCCCEEEeecc
Confidence 9999999997 577777654322 278889999999999999999999999999999999998 47889999999
Q ss_pred CccccCCC----ccccccCCcccCchhhc-----CCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 569 SSCFQTDN----LCLYVQSRSYRAPEVII-----GLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 569 ls~~~~~~----~~~~~gt~~Y~APEvl~-----~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
++...... .....||+.|+|||++. ...++.++|||||||++|||++|+.||
T Consensus 148 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf 208 (332)
T cd05623 148 SCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPF 208 (332)
T ss_pred hheecccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCC
Confidence 88643221 12357899999999986 345788999999999999999999998
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-32 Score=284.87 Aligned_cols=187 Identities=27% Similarity=0.427 Sum_probs=155.4
Q ss_pred EEeccCCCCceeEEEeCCCCcEEEEEEEecCc----hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeEEEEE
Q 007035 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVC 495 (621)
Q Consensus 420 ~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l~LVm 495 (621)
+.||+|+||.||++++..+|+.||+|++.... ........|+++++.+ .||||+++++++...+++++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~------~hp~i~~~~~~~~~~~~~~lv~ 74 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS------RHPFLTALKYSFQTHDRLCFVM 74 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC------CCCCCCceEEEEEcCCEEEEEE
Confidence 36999999999999999999999999997532 1223344555555443 5889999999999999999999
Q ss_pred ecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHH-CCeecccCCCccEEEeccCCCeEEEEecCCcccc
Q 007035 496 ELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS-LGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQ 573 (621)
Q Consensus 496 Eyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs-~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~~~ 573 (621)
||+.+ +|...+.... .+++..++.++.||+.||.|||+ .||+||||||+|||++ .++.+||+|||++...
T Consensus 75 E~~~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~--~~~~~kL~Dfg~~~~~ 146 (325)
T cd05594 75 EYANGGELFFHLSRER------VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLD--KDGHIKITDFGLCKEG 146 (325)
T ss_pred eCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEEC--CCCCEEEecCCCCeec
Confidence 99986 5554443322 28899999999999999999997 7999999999999998 4788999999987643
Q ss_pred C---CCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 574 T---DNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 574 ~---~~~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
. .......||+.|+|||++.+..++.++|||||||++|+|++|+.||
T Consensus 147 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf 196 (325)
T cd05594 147 IKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 196 (325)
T ss_pred CCCCcccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCC
Confidence 2 2223457899999999999989999999999999999999999998
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=279.99 Aligned_cols=188 Identities=31% Similarity=0.502 Sum_probs=156.7
Q ss_pred EEeccCCCCceeEEEeCCCCcEEEEEEEecCc----hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeEEEEE
Q 007035 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVC 495 (621)
Q Consensus 420 ~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l~LVm 495 (621)
+.||+|+||+||+|++..+++.||+|+++... ........|..++..+ ..||||+++++++...+++++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~-----~~hp~iv~~~~~~~~~~~~~lv~ 75 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA-----WEHPFLTHLYCTFQTKENLFFVM 75 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhc-----cCCCcCcceEEEEEeCCEEEEEE
Confidence 36999999999999999999999999997642 2223344455554432 36899999999999999999999
Q ss_pred ecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCccccC
Q 007035 496 ELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQT 574 (621)
Q Consensus 496 Eyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~~~~ 574 (621)
||+.+ +|.+.+.... .+++..+..++.||+.||.|||+++|+||||||+|||++. ++.+||+|||++....
T Consensus 76 ey~~~g~L~~~l~~~~------~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~--~~~~kl~Dfg~~~~~~ 147 (316)
T cd05619 76 EYLNGGDLMFHIQSCH------KFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDT--DGHIKIADFGMCKENM 147 (316)
T ss_pred eCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECC--CCCEEEccCCcceECC
Confidence 99975 6666654322 2788889999999999999999999999999999999984 7789999999986432
Q ss_pred ---CCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 575 ---DNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 575 ---~~~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||
T Consensus 148 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf 196 (316)
T cd05619 148 LGDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPF 196 (316)
T ss_pred CCCCceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCC
Confidence 2233457899999999999989999999999999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=280.34 Aligned_cols=188 Identities=28% Similarity=0.435 Sum_probs=158.4
Q ss_pred EEeccCCCCceeEEEeCCCCcEEEEEEEecCc----hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeEEEEE
Q 007035 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVC 495 (621)
Q Consensus 420 ~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l~LVm 495 (621)
+.||.|+||+||++.+..+++.||+|++++.. ........|.++++.+. .||||+++++++...+++++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~-----~h~~i~~~~~~~~~~~~~~lv~ 75 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAG-----KHPFLTQLHSCFQTKDRLFFVM 75 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhcc-----CCCCccceeeEEEcCCEEEEEE
Confidence 36999999999999999999999999998642 22344556666666553 5889999999999999999999
Q ss_pred ecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCccccC
Q 007035 496 ELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQT 574 (621)
Q Consensus 496 Eyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~~~~ 574 (621)
||+.+ +|...+.... .+++..+..++.||+.||.|||+++|+||||||+|||++. ++.++|+|||++....
T Consensus 76 e~~~~~~L~~~~~~~~------~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~--~~~~kl~Dfg~~~~~~ 147 (318)
T cd05570 76 EYVNGGDLMFHIQRSG------RFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDS--EGHIKIADFGMCKEGI 147 (318)
T ss_pred cCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECC--CCcEEecccCCCeecC
Confidence 99986 5555544322 2889999999999999999999999999999999999984 7889999999875421
Q ss_pred ---CCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 575 ---DNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 575 ---~~~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
.......+++.|+|||++.+..++.++|||||||++|+|++|+.||
T Consensus 148 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf 196 (318)
T cd05570 148 LGGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPF 196 (318)
T ss_pred cCCCcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCC
Confidence 2233356899999999999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=282.33 Aligned_cols=189 Identities=26% Similarity=0.422 Sum_probs=153.7
Q ss_pred EEeccCCCCceeEEEeCCCCcEEEEEEEecCchh----hhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeEEEEE
Q 007035 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDF----FDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVC 495 (621)
Q Consensus 420 ~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~----~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l~LVm 495 (621)
+.||+|+||+||+|++..+++.||+|++...... ......|...+ .....||||+++++++...+.+++||
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~-----l~~~~h~~Iv~~~~~~~~~~~~~lv~ 75 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVL-----LKNVKHPFLVGLHFSFQTADKLYFVL 75 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHH-----HHhCCCCCCCceeEEEEcCCeEEEEE
Confidence 3699999999999999999999999999754321 11222222211 12346899999999999999999999
Q ss_pred ecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCccccC
Q 007035 496 ELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQT 574 (621)
Q Consensus 496 Eyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~~~~ 574 (621)
||+.+ +|.+.+.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++....
T Consensus 76 e~~~~~~L~~~~~~~~------~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~--~~~~kl~DfG~a~~~~ 147 (325)
T cd05602 76 DYINGGELFYHLQRER------CFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDS--QGHIVLTDFGLCKENI 147 (325)
T ss_pred eCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECC--CCCEEEccCCCCcccc
Confidence 99986 5655554322 2778889999999999999999999999999999999984 7889999999986432
Q ss_pred ---CCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 007035 575 ---DNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCLI 621 (621)
Q Consensus 575 ---~~~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF~ 621 (621)
.......||+.|+|||++.+..++.++|||||||++|+|++|++||.
T Consensus 148 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 197 (325)
T cd05602 148 EHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFY 197 (325)
T ss_pred cCCCCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCC
Confidence 22334578999999999999999999999999999999999999983
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-32 Score=284.34 Aligned_cols=195 Identities=29% Similarity=0.433 Sum_probs=163.9
Q ss_pred CceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCch-hhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecC--e
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD-FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE--H 490 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~-~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~--~ 490 (621)
.++...+.||+|+||.||++.+..+|+..|+|.+..... ..+.+.+|+++|..++ ||+||++++...... .
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~------~p~IV~~~G~~~~~~~~~ 90 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLN------HPNIVQYYGSSSSRENDE 90 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCC------CCCEEeeCCccccccCee
Confidence 457788899999999999999999999999998876421 2456788999998886 679999999755444 6
Q ss_pred EEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCC
Q 007035 491 LFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (621)
Q Consensus 491 l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGl 569 (621)
++|.|||+.+ +|.+++..... .+++..++.+++||++||.|||++||+||||||+|||++. ..+.+||+|||+
T Consensus 91 ~~i~mEy~~~GsL~~~~~~~g~-----~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~-~~~~~KlaDFG~ 164 (313)
T KOG0198|consen 91 YNIFMEYAPGGSLSDLIKRYGG-----KLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDP-SNGDVKLADFGL 164 (313)
T ss_pred eEeeeeccCCCcHHHHHHHcCC-----CCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeC-CCCeEEeccCcc
Confidence 9999999984 77777775543 2899999999999999999999999999999999999994 158999999998
Q ss_pred ccccCC------CccccccCCcccCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 570 SCFQTD------NLCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 570 s~~~~~------~~~~~~gt~~Y~APEvl~~~-~~s~ksDIWSLGvILyELltG~~PF 620 (621)
+..... ......||+.|||||++... ....++|||||||++.||+||..|+
T Consensus 165 a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW 222 (313)
T KOG0198|consen 165 AKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPW 222 (313)
T ss_pred ccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcc
Confidence 876542 13347889999999999963 2345999999999999999999996
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=281.53 Aligned_cols=187 Identities=28% Similarity=0.449 Sum_probs=153.0
Q ss_pred EEeccCCCCceeEEEeCCCCcEEEEEEEecCch----hhhhHHHHHH-HHHHhcccCCCCCCceEEEeeEeEecCeEEEE
Q 007035 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD----FFDQSLDEIK-LLKLVNKNDPADEHHILRLYDYFYHLEHLFIV 494 (621)
Q Consensus 420 ~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~----~~~~~~~Ei~-iL~~l~~~~~~~hpnIvrl~~~f~~~~~l~LV 494 (621)
+.||.|+||.||+|++..+++.||+|++.+... ....+..|.. +++ ...||||+++++.+...+..++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~------~~~h~~iv~~~~~~~~~~~~~lv 74 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLK------NLKHPFLVGLHYSFQTAEKLYFV 74 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHH------hCCCCCccceeeEEEcCCEEEEE
Confidence 369999999999999999999999999875432 1122223322 222 34689999999999999999999
Q ss_pred Eecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCcccc
Q 007035 495 CELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQ 573 (621)
Q Consensus 495 mEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~~~ 573 (621)
|||+++ +|...+.... .+++..++.++.||+.||.|||+++|+||||||+|||++. ++.+||+|||++...
T Consensus 75 ~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~--~~~~kl~Dfg~~~~~ 146 (321)
T cd05603 75 LDYVNGGELFFHLQRER------CFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDS--QGHVVLTDFGLCKEG 146 (321)
T ss_pred EcCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECC--CCCEEEccCCCCccC
Confidence 999986 5544443221 2788889999999999999999999999999999999984 789999999987643
Q ss_pred C---CCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 574 T---DNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 574 ~---~~~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
. .......+++.|+|||++.+..++.++|||||||++|+|++|+.||
T Consensus 147 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf 196 (321)
T cd05603 147 VEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPF 196 (321)
T ss_pred CCCCCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCC
Confidence 2 2233457899999999999988999999999999999999999998
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=280.59 Aligned_cols=203 Identities=25% Similarity=0.338 Sum_probs=161.6
Q ss_pred eecCceEEEEEeccCCCCceeEEEe-----CCCCcEEEEEEEecCc--hhhhhHHHHHHHHHHhcccCCCCCCceEEEee
Q 007035 411 VIAGRYYVTEYLGSAAFSKVFQAQD-----LHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYD 483 (621)
Q Consensus 411 ii~~rY~I~~~LG~G~fG~Vyka~d-----~~tg~~VAlKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~ 483 (621)
+-.++|++.+.||.|+||.||+|.+ ..+++.||+|+++... .....+.+|+.++..+. .||||+++++
T Consensus 4 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----~h~niv~~~~ 78 (338)
T cd05102 4 FPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIG-----NHLNVVNLLG 78 (338)
T ss_pred cchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhc-----cCcceeeEEe
Confidence 3457899999999999999999975 3456789999987532 23456778888888774 4789999999
Q ss_pred EeEec-CeEEEEEecccc-chHHHHHhhhccC------------------------------------------------
Q 007035 484 YFYHL-EHLFIVCELLRA-NLYEFQKFNQESG------------------------------------------------ 513 (621)
Q Consensus 484 ~f~~~-~~l~LVmEyl~g-sLld~l~~~~~~~------------------------------------------------ 513 (621)
++... ..+++||||+++ +|.+++.......
T Consensus 79 ~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (338)
T cd05102 79 ACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTN 158 (338)
T ss_pred EecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccc
Confidence 88764 468999999984 6777665432100
Q ss_pred --------CCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCccccCCCc-----ccc
Q 007035 514 --------GEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNL-----CLY 580 (621)
Q Consensus 514 --------~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~~~~~~~-----~~~ 580 (621)
....+++..+..++.||+.||.|||+++|+||||||+|||++. ++.+||+|||++....... ...
T Consensus 159 ~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~--~~~~kl~DfG~a~~~~~~~~~~~~~~~ 236 (338)
T cd05102 159 PPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSE--NNVVKICDFGLARDIYKDPDYVRKGSA 236 (338)
T ss_pred cchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcC--CCcEEEeecccccccccCcchhcccCC
Confidence 0123777888999999999999999999999999999999984 7889999999986543221 122
Q ss_pred ccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 581 VQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 581 ~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
.+++.|+|||++.+..++.++|||||||+||||++ |..||
T Consensus 237 ~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf 277 (338)
T cd05102 237 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPY 277 (338)
T ss_pred CCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCC
Confidence 34578999999999899999999999999999997 99987
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-32 Score=283.09 Aligned_cols=197 Identities=26% Similarity=0.375 Sum_probs=166.3
Q ss_pred ecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCch----hhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEe
Q 007035 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD----FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (621)
Q Consensus 412 i~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~----~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~ 487 (621)
-..+|++++.||+|.-|+||+++...++..+|+|++.+... ...+...|.+||..+ +||+++++|..|+.
T Consensus 75 ~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~l------DHPFlPTLYa~fet 148 (459)
T KOG0610|consen 75 GLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLL------DHPFLPTLYASFET 148 (459)
T ss_pred CHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhc------CCCccchhhheeec
Confidence 34679999999999999999999999999999999987533 234555666666655 68999999999999
Q ss_pred cCeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEe
Q 007035 488 LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (621)
Q Consensus 488 ~~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~D 566 (621)
....|+|||||.| +|..+++... ...|++..++.++.+++-||+|||..|||.|||||+||||. ++|+|-|+|
T Consensus 149 ~~~~cl~meyCpGGdL~~LrqkQp----~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvr--edGHIMLsD 222 (459)
T KOG0610|consen 149 DKYSCLVMEYCPGGDLHSLRQKQP----GKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVR--EDGHIMLSD 222 (459)
T ss_pred cceeEEEEecCCCccHHHHHhhCC----CCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEe--cCCcEEeee
Confidence 9999999999996 5555555332 33499999999999999999999999999999999999999 599999999
Q ss_pred cCCccccC----------------------------------C-C------------------------ccccccCCccc
Q 007035 567 LGSSCFQT----------------------------------D-N------------------------LCLYVQSRSYR 587 (621)
Q Consensus 567 FGls~~~~----------------------------------~-~------------------------~~~~~gt~~Y~ 587 (621)
|.++.... . . ...++||-.|+
T Consensus 223 FDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYl 302 (459)
T KOG0610|consen 223 FDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYL 302 (459)
T ss_pred ccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccc
Confidence 99762100 0 0 01247788899
Q ss_pred CchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 588 APEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 588 APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
|||++.|...+.++|+|+||++||||+.|..||
T Consensus 303 APEvI~G~GHgsAVDWWtfGIflYEmLyG~TPF 335 (459)
T KOG0610|consen 303 APEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPF 335 (459)
T ss_pred cceeeecCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence 999999999999999999999999999999998
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-32 Score=283.12 Aligned_cols=188 Identities=28% Similarity=0.440 Sum_probs=153.9
Q ss_pred EEeccCCCCceeEEEeCCCCcEEEEEEEecCch----hhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeEEEEE
Q 007035 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD----FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVC 495 (621)
Q Consensus 420 ~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~----~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l~LVm 495 (621)
+.||+|+||+||+|+++.+|+.||+|++..... ....+..|..++ + ....||||+++++++...+..++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~--l---~~~~hp~iv~~~~~~~~~~~~~lv~ 75 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVL--L---KNVKHPFLVGLHYSFQTTEKLYFVL 75 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHH--H---HhCCCCCCccEEEEEecCCEEEEEE
Confidence 368999999999999999999999999975422 112223333221 1 1346899999999999999999999
Q ss_pred ecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCccccC
Q 007035 496 ELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQT 574 (621)
Q Consensus 496 Eyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~~~~ 574 (621)
||+.+ +|...+.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++....
T Consensus 76 e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~--~~~~kL~DfG~~~~~~ 147 (325)
T cd05604 76 DFVNGGELFFHLQRER------SFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDS--QGHVVLTDFGLCKEGI 147 (325)
T ss_pred cCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECC--CCCEEEeecCCcccCC
Confidence 99986 5555443322 2889999999999999999999999999999999999984 7889999999976422
Q ss_pred ---CCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 575 ---DNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 575 ---~~~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
.......|++.|+|||++.+..++.++|||||||++|+|++|+.||
T Consensus 148 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf 196 (325)
T cd05604 148 AQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPF 196 (325)
T ss_pred CCCCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCC
Confidence 2233457899999999999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-31 Score=264.13 Aligned_cols=191 Identities=38% Similarity=0.626 Sum_probs=166.0
Q ss_pred eEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhh---HHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeEE
Q 007035 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQ---SLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLF 492 (621)
Q Consensus 416 Y~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~---~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l~ 492 (621)
|++.+.||+|+||+||++++..+++.||+|++......... ..+|+.+++.++ ||||+++++++......+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~------~~~i~~~~~~~~~~~~~~ 74 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLR------HPNIVQILDVFQDDNYLY 74 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHT------BTTBCHEEEEEEESSEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccc------cccccccccccccccccc
Confidence 88999999999999999999999999999999876543222 244788888874 679999999999999999
Q ss_pred EEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCcc
Q 007035 493 IVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 571 (621)
Q Consensus 493 LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~ 571 (621)
+||||+.+ +|.+++..... +++..+..++.||+.||.+||+++|+|+||||+||+++ .++.++|+|||.+.
T Consensus 75 ~v~~~~~~~~L~~~l~~~~~------~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~--~~~~~~l~Dfg~~~ 146 (260)
T PF00069_consen 75 IVMEYCPGGSLQDYLQKNKP------LSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLD--ENGEVKLIDFGSSV 146 (260)
T ss_dssp EEEEEETTEBHHHHHHHHSS------BBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEES--TTSEEEESSGTTTE
T ss_pred cccccccccccccccccccc------cccccccccccccccccccccccccccccccccccccc--cccccccccccccc
Confidence 99999997 78777762222 88999999999999999999999999999999999999 58899999999986
Q ss_pred cc---CCCccccccCCcccCchhhc-CCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 572 FQ---TDNLCLYVQSRSYRAPEVII-GLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 572 ~~---~~~~~~~~gt~~Y~APEvl~-~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
.. ........+++.|+|||++. +..++.++||||||+++|+|++|..||
T Consensus 147 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~ 199 (260)
T PF00069_consen 147 KLSENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPF 199 (260)
T ss_dssp ESTSTTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 42 23334457789999999998 778999999999999999999999997
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=281.84 Aligned_cols=188 Identities=27% Similarity=0.436 Sum_probs=153.8
Q ss_pred EEeccCCCCceeEEEeCCCCcEEEEEEEecCchh----hhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeEEEEE
Q 007035 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDF----FDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVC 495 (621)
Q Consensus 420 ~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~----~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l~LVm 495 (621)
+.||+|+||+||+|++..+|+.||+|++...... ......|..++ .....||||+++++.+...+..++||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~-----~~~l~hp~iv~~~~~~~~~~~~~lv~ 75 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVL-----LKNVKHPFLVGLHYSFQTADKLYFVL 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHH-----HhhCCCCCCCCeeEEEEeCCEEEEEE
Confidence 3699999999999999999999999999754221 12222222221 12346899999999999999999999
Q ss_pred ecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCccccC
Q 007035 496 ELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQT 574 (621)
Q Consensus 496 Eyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~~~~ 574 (621)
||+.+ +|...+.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++....
T Consensus 76 e~~~~g~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~--~~~~kl~Dfg~~~~~~ 147 (323)
T cd05575 76 DYVNGGELFFHLQRER------SFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDS--QGHVVLTDFGLCKEGI 147 (323)
T ss_pred cCCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECC--CCcEEEeccCCCcccc
Confidence 99986 5655554322 2788899999999999999999999999999999999984 7889999999876432
Q ss_pred ---CCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 575 ---DNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 575 ---~~~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
.......|++.|+|||++.+..++.++|||||||++|+|++|+.||
T Consensus 148 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf 196 (323)
T cd05575 148 EHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPF 196 (323)
T ss_pred cCCCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCC
Confidence 2233457899999999999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=283.87 Aligned_cols=194 Identities=33% Similarity=0.607 Sum_probs=165.6
Q ss_pred ecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc---hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEec
Q 007035 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (621)
Q Consensus 412 i~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~---~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~ 488 (621)
+.++|++++.||.|+||+||+|.+..+++.||+|.+.... .......+|+.+++.+ .||||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l------~h~~iv~~~~~~~~~ 86 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHM------KHENVIGLLDVFTPA 86 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhc------CCCchhhhhhhhccc
Confidence 3578999999999999999999999999999999987532 2234455677777766 478999999988643
Q ss_pred ------CeEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeE
Q 007035 489 ------EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEI 562 (621)
Q Consensus 489 ------~~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~I 562 (621)
...+++|++++++|.+.+... .+++..++.++.||+.||.|||+++|+||||||+|||++. ++.+
T Consensus 87 ~~~~~~~~~~~~~~~~~~~l~~~~~~~-------~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~--~~~~ 157 (343)
T cd07878 87 TSIENFNEVYLVTNLMGADLNNIVKCQ-------KLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNE--DCEL 157 (343)
T ss_pred ccccccCcEEEEeecCCCCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECC--CCCE
Confidence 457999999988887766421 2889999999999999999999999999999999999984 7889
Q ss_pred EEEecCCccccCCCccccccCCcccCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 563 KIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 563 KL~DFGls~~~~~~~~~~~gt~~Y~APEvl~~-~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
||+|||++...........+++.|+|||++.+ ..++.++|||||||++|+|++|+.||
T Consensus 158 kl~Dfg~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf 216 (343)
T cd07878 158 RILDFGLARQADDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALF 216 (343)
T ss_pred EEcCCccceecCCCcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCC
Confidence 99999999877666666788999999999977 46889999999999999999999998
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=285.60 Aligned_cols=192 Identities=31% Similarity=0.540 Sum_probs=162.2
Q ss_pred ceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecC---chhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecC--
Q 007035 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE-- 489 (621)
Q Consensus 415 rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~---~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~-- 489 (621)
+|++++.||+|+||.||++.+..+|+.||||.+... .....+..+|+++++.+ .|+||+++++++....
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~~~~~~~~~~~~ 74 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFF------KHDNVLSALDILQPPHID 74 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhC------CCCCcCCHhheecCCCcc
Confidence 478899999999999999999999999999988643 22334566777777766 4789999999998776
Q ss_pred ---eEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEe
Q 007035 490 ---HLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (621)
Q Consensus 490 ---~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~D 566 (621)
++++||||+.++|.+.+.... .+++..++.++.||+.||.|||+++|+||||||+|||++. ++.+||+|
T Consensus 75 ~~~~~~lv~e~~~~~l~~~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~--~~~~kL~D 146 (372)
T cd07853 75 PFEEIYVVTELMQSDLHKIIVSPQ------PLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNS--NCVLKICD 146 (372)
T ss_pred ccceEEEEeeccccCHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECC--CCCEEecc
Confidence 899999999988887765332 2889999999999999999999999999999999999984 78999999
Q ss_pred cCCccccCCC----ccccccCCcccCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 567 LGSSCFQTDN----LCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 567 FGls~~~~~~----~~~~~gt~~Y~APEvl~~~-~~s~ksDIWSLGvILyELltG~~PF 620 (621)
||++...... .....+++.|+|||++.+. .++.++|||||||++|+|++|++||
T Consensus 147 fg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf 205 (372)
T cd07853 147 FGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILF 205 (372)
T ss_pred ccceeecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCC
Confidence 9998654322 2234568899999999875 4789999999999999999999998
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-31 Score=285.66 Aligned_cols=195 Identities=26% Similarity=0.410 Sum_probs=167.1
Q ss_pred CeeecCceEEEEEeccCCCCceeEEEeC--CCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeE
Q 007035 409 NTVIAGRYYVTEYLGSAAFSKVFQAQDL--HTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (621)
Q Consensus 409 ~~ii~~rY~I~~~LG~G~fG~Vyka~d~--~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~ 486 (621)
..++..+|.+++.||.|+||.||++... .+++.|++|.+.... ...+|+++++.++ ||||+++++++.
T Consensus 87 ~~~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~----~~~~E~~il~~l~------h~~iv~~~~~~~ 156 (392)
T PHA03207 87 ASVVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK----TPGREIDILKTIS------HRAIINLIHAYR 156 (392)
T ss_pred chhccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc----cHHHHHHHHHhcC------CCCccceeeeEe
Confidence 3445678999999999999999999754 456889999887543 3457888888774 789999999999
Q ss_pred ecCeEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEe
Q 007035 487 HLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (621)
Q Consensus 487 ~~~~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~D 566 (621)
....+++|||++.+++.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++ ..+.++|+|
T Consensus 157 ~~~~~~lv~e~~~~~l~~~l~~~~------~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~--~~~~~~l~D 228 (392)
T PHA03207 157 WKSTVCMVMPKYKCDLFTYVDRSG------PLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLD--EPENAVLGD 228 (392)
T ss_pred eCCEEEEEehhcCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEc--CCCCEEEcc
Confidence 999999999999999888874322 288999999999999999999999999999999999998 478899999
Q ss_pred cCCccccCCC-----ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 007035 567 LGSSCFQTDN-----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCLI 621 (621)
Q Consensus 567 FGls~~~~~~-----~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF~ 621 (621)
||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.
T Consensus 229 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~ 288 (392)
T PHA03207 229 FGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLF 288 (392)
T ss_pred CccccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence 9998654332 223578999999999999999999999999999999999999984
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-31 Score=278.22 Aligned_cols=187 Identities=27% Similarity=0.417 Sum_probs=156.2
Q ss_pred EEeccCCCCceeEEEeC---CCCcEEEEEEEecCc-----hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeE
Q 007035 420 EYLGSAAFSKVFQAQDL---HTGVDVCLKIIKNDK-----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (621)
Q Consensus 420 ~~LG~G~fG~Vyka~d~---~tg~~VAlKii~~~~-----~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l 491 (621)
+.||+|+||.||++++. .+++.||+|+++... ........|+.+++.+ .||||+++++++...+..
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l------~hp~iv~~~~~~~~~~~~ 75 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAV------KHPFIVDLIYAFQTGGKL 75 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhC------CCCchhceeeEEecCCeE
Confidence 67999999999999864 578999999987532 2223455677777766 478999999999999999
Q ss_pred EEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCc
Q 007035 492 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (621)
Q Consensus 492 ~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls 570 (621)
++||||+.+ +|.+.+.... .+++..+..++.||+.||.|||+++|+||||||+|||++. ++.+||+|||++
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~--~~~~kl~Dfg~~ 147 (323)
T cd05584 76 YLILEYLSGGELFMHLEREG------IFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDA--QGHVKLTDFGLC 147 (323)
T ss_pred EEEEeCCCCchHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECC--CCCEEEeeCcCC
Confidence 999999986 6666554322 2778888999999999999999999999999999999984 789999999997
Q ss_pred cccC---CCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 571 CFQT---DNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 571 ~~~~---~~~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
.... .......|++.|+|||++.+..++.++|||||||++|+|++|+.||
T Consensus 148 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf 200 (323)
T cd05584 148 KESIHEGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPF 200 (323)
T ss_pred eecccCCCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCC
Confidence 6432 1223357899999999999988999999999999999999999998
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.3e-31 Score=270.18 Aligned_cols=194 Identities=27% Similarity=0.330 Sum_probs=162.4
Q ss_pred ceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCch----hhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCe
Q 007035 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD----FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (621)
Q Consensus 415 rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~----~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~ 490 (621)
.|++.+.||+|+||+||++.+..+++.||+|++..... ......+|+.+++.++ ||||+++++.+...++
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~~~~~~~~~ 74 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN------SRFVVSLAYAYETKDA 74 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcC------CCCEeeeeeeecCCCe
Confidence 48899999999999999999999999999999875321 1233456777777664 6899999999999999
Q ss_pred EEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCC
Q 007035 491 LFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (621)
Q Consensus 491 l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGl 569 (621)
+++||||+.+ +|.+.+..... ..+++..+..++.||+.||.|||+.+|+||||||+||+++. ++.++|+|||+
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~--~~~~~l~Dfg~ 148 (285)
T cd05605 75 LCLVLTLMNGGDLKFHIYNMGN----PGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDD--YGHIRISDLGL 148 (285)
T ss_pred EEEEEeccCCCcHHHHHHhcCc----CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECC--CCCEEEeeCCC
Confidence 9999999985 55544432211 22889999999999999999999999999999999999984 78899999999
Q ss_pred ccccCCC--ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 570 SCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 570 s~~~~~~--~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
+...... .....+++.|+|||++.+..++.++||||+||++|+|++|+.||
T Consensus 149 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf 201 (285)
T cd05605 149 AVEIPEGETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPF 201 (285)
T ss_pred ceecCCCCccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCC
Confidence 8764332 22346789999999999888999999999999999999999998
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=268.93 Aligned_cols=189 Identities=28% Similarity=0.348 Sum_probs=156.7
Q ss_pred eccCCCCceeEEEeCCCCcEEEEEEEecCch----hhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeEEEEEec
Q 007035 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD----FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCEL 497 (621)
Q Consensus 422 LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~----~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l~LVmEy 497 (621)
||+|+||+||++.+..+++.||+|.+..... ..+.+..|+++++.+ .|+||+++.+++....+.++||||
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l------~~~~i~~~~~~~~~~~~~~lv~e~ 74 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV------HSRFIVSLAYAFQTKTDLCLVMTI 74 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhC------CCCcEeeeeEEEcCCCeEEEEEeC
Confidence 7999999999999999999999999875322 223455677777766 468999999999999999999999
Q ss_pred ccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCccccCCC
Q 007035 498 LRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN 576 (621)
Q Consensus 498 l~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~~~~~~ 576 (621)
+++ +|...+..... ....+++..+..++.||+.||.|||+++|+||||||+||+++. ++.++|+|||++......
T Consensus 75 ~~~g~L~~~~~~~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~--~~~~~l~dfg~~~~~~~~ 150 (280)
T cd05608 75 MNGGDLRYHIYNVDE--ENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDN--DGNVRISDLGLAVELKDG 150 (280)
T ss_pred CCCCCHHHHHHhccc--cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECC--CCCEEEeeCccceecCCC
Confidence 986 45444432211 1223889999999999999999999999999999999999984 788999999998654332
Q ss_pred ---ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 577 ---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 577 ---~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
.....+++.|+|||++.+..++.++|||||||++|+|++|+.||
T Consensus 151 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf 197 (280)
T cd05608 151 QSKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPF 197 (280)
T ss_pred CccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCC
Confidence 22346789999999999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-31 Score=273.73 Aligned_cols=194 Identities=29% Similarity=0.497 Sum_probs=158.5
Q ss_pred EEeccCCCCceeEEEeC--CCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEe--cCeEEEEE
Q 007035 420 EYLGSAAFSKVFQAQDL--HTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH--LEHLFIVC 495 (621)
Q Consensus 420 ~~LG~G~fG~Vyka~d~--~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~--~~~l~LVm 495 (621)
++||+|+||+||+|+++ .+++.||+|.+..... .....+|+.+++.++ ||||+++++++.. ..++++||
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~E~~~l~~l~------h~niv~~~~~~~~~~~~~~~lv~ 79 (317)
T cd07868 7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-SMSACREIALLRELK------HPNVISLQKVFLSHADRKVWLLF 79 (317)
T ss_pred cccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-cHHHHHHHHHHHhcC------CCCCcceeeeEecCCCcEEEEEE
Confidence 57999999999999965 4678999999875432 345678888888774 7899999999864 45789999
Q ss_pred eccccchHHHHHhhhcc---CCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEec--cCCCeEEEEecCCc
Q 007035 496 ELLRANLYEFQKFNQES---GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS--YQRCEIKIIDLGSS 570 (621)
Q Consensus 496 Eyl~gsLld~l~~~~~~---~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~--~~~~~IKL~DFGls 570 (621)
||+++++.+++...... .....+++..++.++.||+.||.|||++||+||||||+|||+.. ...+.+||+|||++
T Consensus 80 e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 80 DYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred eccCCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 99999988877643221 11224889999999999999999999999999999999999953 24578999999998
Q ss_pred cccCCC------ccccccCCcccCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 571 CFQTDN------LCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 571 ~~~~~~------~~~~~gt~~Y~APEvl~~~-~~s~ksDIWSLGvILyELltG~~PF 620 (621)
...... .....+|+.|+|||++.+. .++.++|||||||++|+|++|++||
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f 216 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 216 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCc
Confidence 764332 2235678999999999874 5899999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-32 Score=278.69 Aligned_cols=197 Identities=27% Similarity=0.387 Sum_probs=168.0
Q ss_pred eecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCch----hhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeE
Q 007035 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD----FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (621)
Q Consensus 411 ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~----~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~ 486 (621)
+--++|..++.||+|.||+|-+++.+.+++.+|||+++++.. ....-+.|-++|+.. .||++..+-..|+
T Consensus 165 vTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~------~HPFLt~LKYsFQ 238 (516)
T KOG0690|consen 165 VTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNC------RHPFLTSLKYSFQ 238 (516)
T ss_pred eccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhc------cCcHHHHhhhhhc
Confidence 344678889999999999999999999999999999987532 222334455555544 5889999999999
Q ss_pred ecCeEEEEEeccccc-hHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEE
Q 007035 487 HLEHLFIVCELLRAN-LYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKII 565 (621)
Q Consensus 487 ~~~~l~LVmEyl~gs-Lld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~ 565 (621)
..+++|+||||..|+ |.-.+.. +..|++...+.+..+|+.||.|||+++||.||||.+|+|++ ++|+|||+
T Consensus 239 t~drlCFVMeyanGGeLf~HLsr------er~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLD--kDGHIKit 310 (516)
T KOG0690|consen 239 TQDRLCFVMEYANGGELFFHLSR------ERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLD--KDGHIKIT 310 (516)
T ss_pred cCceEEEEEEEccCceEeeehhh------hhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheec--cCCceEee
Confidence 999999999999875 3333322 22399999999999999999999999999999999999999 59999999
Q ss_pred ecCCccc---cCCCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 007035 566 DLGSSCF---QTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCLI 621 (621)
Q Consensus 566 DFGls~~---~~~~~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF~ 621 (621)
|||++.. .+.....++|||.|+|||++....|+.++|+|.+||+||||++|++||.
T Consensus 311 DFGLCKE~I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFy 369 (516)
T KOG0690|consen 311 DFGLCKEEIKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFY 369 (516)
T ss_pred ecccchhcccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCccc
Confidence 9999864 3455677999999999999999999999999999999999999999993
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=275.85 Aligned_cols=195 Identities=28% Similarity=0.411 Sum_probs=167.2
Q ss_pred ecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecC--chhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecC
Q 007035 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (621)
Q Consensus 412 i~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~--~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~ 489 (621)
..++|++.++||.|+||.||++.+..++..+|+|++... ......+.+|+++++.+ +|+||+++++++...+
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l------~h~~iv~~~~~~~~~~ 76 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC------NSPYIVGFYGAFYSDG 76 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHC------CCCcccceeEEEEECC
Confidence 457899999999999999999999999999999998754 23345677888888776 4789999999999999
Q ss_pred eEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHC-CeecccCCCccEEEeccCCCeEEEEec
Q 007035 490 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSL-GIIHCDLKPENILIKSYQRCEIKIIDL 567 (621)
Q Consensus 490 ~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~-gIvHrDLKP~NILl~~~~~~~IKL~DF 567 (621)
++++||||+.+ +|.+++.... .+++..+..++.||+.||.|||+. +|+||||||+|||++. ++.+||+||
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~--~~~~kL~Df 148 (333)
T cd06650 77 EISICMEHMDGGSLDQVLKKAG------RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNS--RGEIKLCDF 148 (333)
T ss_pred EEEEEEecCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcC--CCCEEEeeC
Confidence 99999999975 7777665432 278888999999999999999985 7999999999999984 778999999
Q ss_pred CCccccCCC-ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 568 GSSCFQTDN-LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 568 Gls~~~~~~-~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
|++...... .....+++.|+|||++.+..++.++|||||||++|+|++|+.||
T Consensus 149 g~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~ 202 (333)
T cd06650 149 GVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPI 202 (333)
T ss_pred CcchhhhhhccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 998654332 23456889999999999988999999999999999999999997
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=295.41 Aligned_cols=201 Identities=27% Similarity=0.363 Sum_probs=170.2
Q ss_pred ecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecC--chhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEec-
Q 007035 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL- 488 (621)
Q Consensus 412 i~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~--~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~- 488 (621)
-+.-+...+.||+|+||.||+++++.+|+.||||.+++. ....+.+-+|++++++++ |+|||+++++=...
T Consensus 11 ~~y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLn------h~NIVk~f~iee~~~ 84 (732)
T KOG4250|consen 11 ENYLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLN------HPNIVKLFDIEETKF 84 (732)
T ss_pred CCcceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcC------chhhhhhcccCCccc
Confidence 345577788899999999999999999999999999863 344678899999999996 57999999975543
Q ss_pred -----CeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCC--
Q 007035 489 -----EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRC-- 560 (621)
Q Consensus 489 -----~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~-- 560 (621)
....+|||||.+ +|...+....+. .-+++.+++.++..|..||.|||++||+||||||.||++-...+|
T Consensus 85 ~~~~~~~~vlvmEyC~gGsL~~~L~~PEN~---~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~ 161 (732)
T KOG4250|consen 85 LGLVTRLPVLVMEYCSGGSLRKVLNSPENA---YGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQS 161 (732)
T ss_pred cCcccccceEEEeecCCCcHHHHhcCcccc---cCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCce
Confidence 368899999985 566655544333 239999999999999999999999999999999999998653334
Q ss_pred eEEEEecCCccccCCC--ccccccCCcccCchhhc-CCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 007035 561 EIKIIDLGSSCFQTDN--LCLYVQSRSYRAPEVII-GLPYDQKIDLWSLGCILAELWTGEVCLI 621 (621)
Q Consensus 561 ~IKL~DFGls~~~~~~--~~~~~gt~~Y~APEvl~-~~~~s~ksDIWSLGvILyELltG~~PF~ 621 (621)
..||+|||.|+...+. ....+||+.|++||++. ...|+..+|.|||||++|+++||..||+
T Consensus 162 IyKLtDfG~Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~ 225 (732)
T KOG4250|consen 162 IYKLTDFGAARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFI 225 (732)
T ss_pred EEeeecccccccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCC
Confidence 4699999999876654 55689999999999998 4789999999999999999999999996
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=269.56 Aligned_cols=194 Identities=28% Similarity=0.461 Sum_probs=164.5
Q ss_pred CceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc--hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeE
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l 491 (621)
++|++++.||.|+||.||+|.+..+++.||+|.++... .......+|+.+++.+ .||||+++++++...+..
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l------~h~nI~~~~~~~~~~~~~ 79 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDL------KHANIVTLHDIIHTEKSL 79 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhc------CCCCcceEEEEEecCCeE
Confidence 67999999999999999999999999999999987532 2233556777777766 478999999999999999
Q ss_pred EEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCcc
Q 007035 492 FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 571 (621)
Q Consensus 492 ~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~ 571 (621)
++||||++++|.+.+..... .+++..++.++.||+.||.|||+.+|+|+||||+|||++. ++.++|+|||++.
T Consensus 80 ~lv~e~~~~~l~~~l~~~~~-----~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~--~~~~kl~dfg~~~ 152 (301)
T cd07873 80 TLVFEYLDKDLKQYLDDCGN-----SINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINE--RGELKLADFGLAR 152 (301)
T ss_pred EEEEeccccCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECC--CCcEEECcCcchh
Confidence 99999999988887764322 2788899999999999999999999999999999999984 7889999999886
Q ss_pred ccCCC---ccccccCCcccCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 572 FQTDN---LCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 572 ~~~~~---~~~~~gt~~Y~APEvl~~~-~~s~ksDIWSLGvILyELltG~~PF 620 (621)
..... .....+++.|+|||++.+. .++.++|||||||++|+|++|++||
T Consensus 153 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f 205 (301)
T cd07873 153 AKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLF 205 (301)
T ss_pred ccCCCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCC
Confidence 54322 1223568899999998764 4788999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-32 Score=286.25 Aligned_cols=205 Identities=29% Similarity=0.427 Sum_probs=169.7
Q ss_pred eecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHH--HHHHHHhcccCCCCCCceEEEeeEeE-e
Q 007035 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDE--IKLLKLVNKNDPADEHHILRLYDYFY-H 487 (621)
Q Consensus 411 ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~E--i~iL~~l~~~~~~~hpnIvrl~~~f~-~ 487 (621)
.+++||.++.+||.|||+.||+|.|....++||+|+-...+.|.++.+.- ....++.+....++||-||++|++|. +
T Consensus 460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD 539 (775)
T KOG1151|consen 460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD 539 (775)
T ss_pred chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec
Confidence 57889999999999999999999999999999999988776665443221 12334444445568899999999998 4
Q ss_pred cCeEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHC--CeecccCCCccEEEecc-CCCeEEE
Q 007035 488 LEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSL--GIIHCDLKPENILIKSY-QRCEIKI 564 (621)
Q Consensus 488 ~~~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~--gIvHrDLKP~NILl~~~-~~~~IKL 564 (621)
....|-|+|||+|+-+++....... +++++++.|+.||+.||.||.+. .|+|-||||.|||+... .-|.|||
T Consensus 540 tdsFCTVLEYceGNDLDFYLKQhkl-----mSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKI 614 (775)
T KOG1151|consen 540 TDSFCTVLEYCEGNDLDFYLKQHKL-----MSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKI 614 (775)
T ss_pred cccceeeeeecCCCchhHHHHhhhh-----hhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEe
Confidence 5678899999999888887765443 88999999999999999999976 59999999999998642 3578999
Q ss_pred EecCCccccCCCc----------cccccCCcccCchhhcCC----CCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 565 IDLGSSCFQTDNL----------CLYVQSRSYRAPEVIIGL----PYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 565 ~DFGls~~~~~~~----------~~~~gt~~Y~APEvl~~~----~~s~ksDIWSLGvILyELltG~~PF 620 (621)
+|||++.++.+.. ....||++|++||++.-. ..+.++||||+|||+|.++.|+.||
T Consensus 615 TDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPF 684 (775)
T KOG1151|consen 615 TDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPF 684 (775)
T ss_pred eecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCC
Confidence 9999998765432 235789999999998543 3789999999999999999999998
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=288.78 Aligned_cols=195 Identities=27% Similarity=0.397 Sum_probs=166.4
Q ss_pred cCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeEE
Q 007035 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLF 492 (621)
Q Consensus 413 ~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l~ 492 (621)
...+++++.||+|.||+||+|.... ...||+|.++......+.+.+|+.+++.|+ |++||++++++...+.++
T Consensus 205 r~~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~------H~~lV~l~gV~~~~~piy 277 (468)
T KOG0197|consen 205 REELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGSMSPEAFLREAQIMKKLR------HEKLVKLYGVCTKQEPIY 277 (468)
T ss_pred HHHHHHHHHhcCCccceEEEEEEcC-CCcccceEEeccccChhHHHHHHHHHHhCc------ccCeEEEEEEEecCCceE
Confidence 3456677889999999999998532 337999999886666678889999999986 568999999999988999
Q ss_pred EEEeccc-cchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCcc
Q 007035 493 IVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 571 (621)
Q Consensus 493 LVmEyl~-gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~ 571 (621)
|||||+. |+|++++.... ...+...++..++.||++||+||+++++|||||...||||+. +..+||+|||+++
T Consensus 278 IVtE~m~~GsLl~yLr~~~----~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~--~~~vKIsDFGLAr 351 (468)
T KOG0197|consen 278 IVTEYMPKGSLLDYLRTRE----GGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDE--DLVVKISDFGLAR 351 (468)
T ss_pred EEEEecccCcHHHHhhhcC----CCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeecc--CceEEEccccccc
Confidence 9999998 78999988622 223888999999999999999999999999999999999994 7899999999999
Q ss_pred ccCCCccc-ccc---CCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 572 FQTDNLCL-YVQ---SRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 572 ~~~~~~~~-~~g---t~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
...+.... ..+ ...|.|||.+....++.++||||||++||||+| |+.||
T Consensus 352 ~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py 405 (468)
T KOG0197|consen 352 LIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPY 405 (468)
T ss_pred ccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCC
Confidence 65544332 112 456999999999999999999999999999999 88886
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=287.32 Aligned_cols=198 Identities=26% Similarity=0.306 Sum_probs=164.6
Q ss_pred cCceEEEEEeccCCCCceeEEEeCCC-CcEEEEEEEecCc-hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCe
Q 007035 413 AGRYYVTEYLGSAAFSKVFQAQDLHT-GVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (621)
Q Consensus 413 ~~rY~I~~~LG~G~fG~Vyka~d~~t-g~~VAlKii~~~~-~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~ 490 (621)
...|.+.+.||.|++|.||+|.+..+ ++.||+|.+.... .....+..|+.+++.+ +||||+++++++...++
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l------~Hpniv~~~~~~~~~~~ 139 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAAC------DHFGIVKHFDDFKSDDK 139 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhC------CCCCEeEEEEEEEECCE
Confidence 34599999999999999999998877 7889999765433 2233455677766655 57899999999999999
Q ss_pred EEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCC
Q 007035 491 LFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (621)
Q Consensus 491 l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGl 569 (621)
++|||||+.+ +|.+.+..... ....+++..+..++.||+.||.|||+++|+||||||+|||++. ++.+||+|||+
T Consensus 140 ~~lv~E~~~gg~L~~~l~~~~~--~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~--~~~~kL~DFgl 215 (478)
T PTZ00267 140 LLLIMEYGSGGDLNKQIKQRLK--EHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMP--TGIIKLGDFGF 215 (478)
T ss_pred EEEEEECCCCCCHHHHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECC--CCcEEEEeCcC
Confidence 9999999975 67666543221 1233788999999999999999999999999999999999984 78899999999
Q ss_pred ccccCCC-----ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 570 SCFQTDN-----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 570 s~~~~~~-----~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
+...... ....+||+.|+|||++.+..++.++|||||||++|+|++|+.||
T Consensus 216 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf 271 (478)
T PTZ00267 216 SKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPF 271 (478)
T ss_pred ceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCC
Confidence 8765432 23356899999999999989999999999999999999999998
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=266.72 Aligned_cols=193 Identities=28% Similarity=0.472 Sum_probs=168.2
Q ss_pred CceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc----hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecC
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~ 489 (621)
++|++++.||+|++|.||++.+..+++.+|+|++.... ...+...+|+++++.+ +||||+++++++....
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~~~~ 74 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSI------RHPFLVNLYGSFQDDS 74 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC------CCCCccceeeEEEcCC
Confidence 47999999999999999999999999999999987532 2345566677777666 4789999999999999
Q ss_pred eEEEEEeccc-cchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecC
Q 007035 490 HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (621)
Q Consensus 490 ~l~LVmEyl~-gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFG 568 (621)
.+++||||+. ++|.+.+.... .+++..+..++.||+.||.|||+.+|+|+||+|.|||++. ++.+||+|||
T Consensus 75 ~~~~v~e~~~~~~L~~~~~~~~------~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~--~~~~kl~dfg 146 (290)
T cd05580 75 NLYLVMEYVPGGELFSHLRKSG------RFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDS--DGYIKITDFG 146 (290)
T ss_pred eEEEEEecCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECC--CCCEEEeeCC
Confidence 9999999995 67777765442 2888999999999999999999999999999999999984 7889999999
Q ss_pred CccccCCCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 569 SSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 569 ls~~~~~~~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
++...........+++.|+|||.+.+..++.++||||||+++|+|++|+.||
T Consensus 147 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~ 198 (290)
T cd05580 147 FAKRVKGRTYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPF 198 (290)
T ss_pred CccccCCCCCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCC
Confidence 9877665555567899999999998888899999999999999999999998
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=281.26 Aligned_cols=201 Identities=31% Similarity=0.492 Sum_probs=175.8
Q ss_pred eCeeecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc---hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeE
Q 007035 408 LNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDY 484 (621)
Q Consensus 408 l~~ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~---~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~ 484 (621)
.+..|++-|.+.+.||+|.|+.|-+|+|..+|+.||||++.+.+ .....+..|++.++.+ .|||||++|.+
T Consensus 12 ~DgkIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLV------QHpNiVRLYEV 85 (864)
T KOG4717|consen 12 YDGKIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLV------QHPNIVRLYEV 85 (864)
T ss_pred cccceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHh------cCcCeeeeeeh
Confidence 34567888999999999999999999999999999999997654 2334556667666666 47899999999
Q ss_pred eEecCeEEEEEeccc-cchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEE
Q 007035 485 FYHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 563 (621)
Q Consensus 485 f~~~~~l~LVmEyl~-gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IK 563 (621)
......+|||+|+-. |.|++++...... +.+..++.++.||+.|+.|+|+..+|||||||+||.+.. +-|.||
T Consensus 86 iDTQTKlyLiLELGD~GDl~DyImKHe~G-----l~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFE-KlGlVK 159 (864)
T KOG4717|consen 86 IDTQTKLYLILELGDGGDLFDYIMKHEEG-----LNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFE-KLGLVK 159 (864)
T ss_pred hcccceEEEEEEecCCchHHHHHHhhhcc-----ccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEee-ecCceE
Confidence 999999999999887 4899999876543 899999999999999999999999999999999999876 689999
Q ss_pred EEecCCcccc--CCCccccccCCcccCchhhcCCCCC-chhhHHHHHHHHHHHHhCCCCC
Q 007035 564 IIDLGSSCFQ--TDNLCLYVQSRSYRAPEVIIGLPYD-QKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 564 L~DFGls~~~--~~~~~~~~gt~~Y~APEvl~~~~~s-~ksDIWSLGvILyELltG~~PF 620 (621)
|+|||++... +......+|+..|.|||+++|..|+ +++||||||||||.|.+|++||
T Consensus 160 LTDFGFSNkf~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PF 219 (864)
T KOG4717|consen 160 LTDFGFSNKFQPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPF 219 (864)
T ss_pred eeeccccccCCCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCcc
Confidence 9999998654 3456678999999999999999886 5799999999999999999999
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=266.50 Aligned_cols=194 Identities=28% Similarity=0.378 Sum_probs=162.7
Q ss_pred ceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc----hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCe
Q 007035 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (621)
Q Consensus 415 rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~ 490 (621)
.|++.+.||+|+||.||++.+..+++.||+|.+.... ........|+.+++.+ .|++|+++++.+...++
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l------~~~~i~~~~~~~~~~~~ 74 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKV------NSRFVVSLAYAYETKDA 74 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhC------CCCCeeeeeEEEecCCE
Confidence 3788899999999999999999999999999886532 1223455677777666 46789999999999999
Q ss_pred EEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCC
Q 007035 491 LFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (621)
Q Consensus 491 l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGl 569 (621)
+++||||+.+ +|.+.+..... ..+++..+..++.|++.||.|||+.+|+||||||+||+++. ++.++|+|||+
T Consensus 75 ~~lv~e~~~g~~L~~~l~~~~~----~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~--~~~~~l~Dfg~ 148 (285)
T cd05630 75 LCLVLTLMNGGDLKFHIYHMGE----AGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDD--HGHIRISDLGL 148 (285)
T ss_pred EEEEEEecCCCcHHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECC--CCCEEEeeccc
Confidence 9999999985 56665543222 22888999999999999999999999999999999999984 77899999999
Q ss_pred ccccCCC--ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 570 SCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 570 s~~~~~~--~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
+...... .....+++.|+|||++.+..++.++||||||+++|+|++|+.||
T Consensus 149 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf 201 (285)
T cd05630 149 AVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPF 201 (285)
T ss_pred eeecCCCccccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCC
Confidence 8654332 22346899999999999989999999999999999999999998
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-31 Score=280.54 Aligned_cols=190 Identities=27% Similarity=0.360 Sum_probs=157.8
Q ss_pred CceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecC--chhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeE
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~--~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l 491 (621)
.+|+++++||.|+||.||++++..+++.||||++... ......+.+|+++++.+ +|+||+++++++...+.+
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l------~h~~iv~~~~~~~~~~~~ 147 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDV------NHPNVVKCHDMFDHNGEI 147 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhC------CCCCcceeeeEeccCCeE
Confidence 5688889999999999999999999999999998653 23345667788887766 478999999999999999
Q ss_pred EEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCcc
Q 007035 492 FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 571 (621)
Q Consensus 492 ~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~ 571 (621)
++||||+.++.+... ....+..+..++.||+.||.|||+++|+||||||+|||++. ++.+||+|||++.
T Consensus 148 ~lv~e~~~~~~L~~~---------~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~--~~~~kL~DfG~~~ 216 (353)
T PLN00034 148 QVLLEFMDGGSLEGT---------HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINS--AKNVKIADFGVSR 216 (353)
T ss_pred EEEEecCCCCccccc---------ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcC--CCCEEEcccccce
Confidence 999999987543211 11456778889999999999999999999999999999984 7889999999987
Q ss_pred ccCCC---ccccccCCcccCchhhcC-----CCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 572 FQTDN---LCLYVQSRSYRAPEVIIG-----LPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 572 ~~~~~---~~~~~gt~~Y~APEvl~~-----~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
..... .....|+..|+|||++.. ...+.++|||||||++|+|++|+.||
T Consensus 217 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf 273 (353)
T PLN00034 217 ILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPF 273 (353)
T ss_pred ecccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCC
Confidence 64432 234578999999999843 23456899999999999999999998
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=279.21 Aligned_cols=189 Identities=29% Similarity=0.375 Sum_probs=163.0
Q ss_pred CceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeEEE
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFI 493 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l~L 493 (621)
.+|++++.||+|+||.||+|++..+++.||+|+.... ....|+.+++.+ .|+||+++++++......++
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-----~~~~E~~~l~~l------~h~~iv~~~~~~~~~~~~~l 134 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-----TTLIEAMLLQNV------NHPSVIRMKDTLVSGAITCM 134 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-----ccHHHHHHHHhC------CCCCCcChhheEEeCCeeEE
Confidence 4699999999999999999999999999999986543 234577777766 47899999999999999999
Q ss_pred EEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCcccc
Q 007035 494 VCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQ 573 (621)
Q Consensus 494 VmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~~~ 573 (621)
|||++.+++++++..... .+++..++.++.||+.||.|||+++|+||||||+|||++. .+.+||+|||++...
T Consensus 135 v~e~~~~~l~~~l~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~--~~~~kl~DfG~a~~~ 207 (357)
T PHA03209 135 VLPHYSSDLYTYLTKRSR-----PLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFIND--VDQVCIGDLGAAQFP 207 (357)
T ss_pred EEEccCCcHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECC--CCCEEEecCcccccc
Confidence 999999999888764322 2889999999999999999999999999999999999984 778999999998653
Q ss_pred CC--CccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 574 TD--NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 574 ~~--~~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
.. ......||+.|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 208 VVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred ccCcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 32 233457899999999999999999999999999999999866554
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=286.96 Aligned_cols=195 Identities=28% Similarity=0.394 Sum_probs=171.5
Q ss_pred CceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc---hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCe
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~---~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~ 490 (621)
++|.+++++|.|+||.+++++++..+..+++|.+.... ...+....|+.++.+++ ||||+.+.+.|+.++.
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~------hP~iv~y~ds~~~~~~ 77 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLL------HPNIVEYKDSFEEDGQ 77 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhcc------CCCeeeeccchhcCCc
Confidence 57999999999999999999999999999999987543 23346677888887764 7899999999999988
Q ss_pred -EEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecC
Q 007035 491 -LFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (621)
Q Consensus 491 -l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFG 568 (621)
++|||+|++| ++.+.+...+ ...|+++.+..|+.||+.|+.|||++.|+|||||+.||+++. +..|+|.|||
T Consensus 78 ~l~Ivm~Y~eGg~l~~~i~~~k----~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk--~~~VkLgDfG 151 (426)
T KOG0589|consen 78 LLCIVMEYCEGGDLAQLIKEQK----GVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTK--DKKVKLGDFG 151 (426)
T ss_pred eEEEEEeecCCCCHHHHHHHHh----hccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccc--cCceeecchh
Confidence 9999999996 5666665544 234999999999999999999999999999999999999994 7788999999
Q ss_pred CccccCCC---ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 569 SSCFQTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 569 ls~~~~~~---~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
+|...... ....+|||.|++||++.+.+|..|+|||||||++|||++=+++|
T Consensus 152 laK~l~~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF 206 (426)
T KOG0589|consen 152 LAKILNPEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAF 206 (426)
T ss_pred hhhhcCCchhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhccccc
Confidence 99886654 45689999999999999999999999999999999999999887
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-32 Score=285.88 Aligned_cols=193 Identities=31% Similarity=0.443 Sum_probs=169.4
Q ss_pred CceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc--hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeE
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l 491 (621)
..|+.++.||.|+||.||+|.+..+++.||+|++..+. ...+.++.|+.++..+. ++||.++|+.|..+..+
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~------~~~it~yygsyl~g~~L 86 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCD------SPNITEYYGSYLKGTKL 86 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcC------cchHHhhhhheeecccH
Confidence 46888899999999999999999999999999998643 44566778888888775 46899999999999999
Q ss_pred EEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCc
Q 007035 492 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (621)
Q Consensus 492 ~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls 570 (621)
+++|||+.| ++++++..... +.+..+..++++++.||.|||.++.+|||||+.|||+.. .|.+||+|||.+
T Consensus 87 wiiMey~~gGsv~~lL~~~~~------~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~--~g~vkl~DfgVa 158 (467)
T KOG0201|consen 87 WIIMEYCGGGSVLDLLKSGNI------LDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSE--SGDVKLADFGVA 158 (467)
T ss_pred HHHHHHhcCcchhhhhccCCC------CccceeeeehHHHHHHhhhhhhcceecccccccceeEec--cCcEEEEeccee
Confidence 999999985 67776664432 477788889999999999999999999999999999995 599999999998
Q ss_pred cccCCC---ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 571 CFQTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 571 ~~~~~~---~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
...... ...++|||.|||||++.+..|+.++||||||++.+||++|.+|+
T Consensus 159 ~ql~~~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~ 211 (467)
T KOG0201|consen 159 GQLTNTVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPH 211 (467)
T ss_pred eeeechhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCC
Confidence 765443 35689999999999999889999999999999999999999997
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=279.15 Aligned_cols=188 Identities=25% Similarity=0.394 Sum_probs=153.3
Q ss_pred eccCCCCceeEEEeCCCCcEEEEEEEecCch----hhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeEEEEEec
Q 007035 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD----FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCEL 497 (621)
Q Consensus 422 LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~----~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l~LVmEy 497 (621)
||+|+||+||+|++..+++.||+|++.+... .......|..++..+. ...||||+++++.+....++++||||
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~---~~~~p~i~~~~~~~~~~~~~~lv~e~ 77 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTL---LDESPFIVGLKFSFQTDSDLYLVTDY 77 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhc---cCCCCcCcceEEEEecCCeEEEEEcC
Confidence 7999999999999999999999999875321 1122333444444332 22589999999999999999999999
Q ss_pred ccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCccccCC-
Q 007035 498 LRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTD- 575 (621)
Q Consensus 498 l~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~~~~~- 575 (621)
+.+ +|...+.... .+++..++.++.||+.||.|||+++|+||||||+|||++. ++.++|+|||++.....
T Consensus 78 ~~~g~L~~~l~~~~------~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~--~~~~kl~Dfg~a~~~~~~ 149 (330)
T cd05586 78 MSGGELFWHLQKEG------RFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDA--TGHIALCDFGLSKANLTD 149 (330)
T ss_pred CCCChHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECC--CCCEEEecCCcCcCCCCC
Confidence 975 6666554322 2889999999999999999999999999999999999984 78899999999864322
Q ss_pred --CccccccCCcccCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 576 --NLCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 576 --~~~~~~gt~~Y~APEvl~~~-~~s~ksDIWSLGvILyELltG~~PF 620 (621)
......||+.|+|||++.+. .++.++|||||||++|+|++|+.||
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf 197 (330)
T cd05586 150 NKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPF 197 (330)
T ss_pred CCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCC
Confidence 23345789999999999765 4789999999999999999999998
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-30 Score=264.57 Aligned_cols=190 Identities=29% Similarity=0.424 Sum_probs=162.7
Q ss_pred CceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc--hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeE
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l 491 (621)
++|++++.||.|+||.||+|.+..+++.||+|++..+. .....+.+|+.+++.+ +||||+++++.+...+..
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l------~h~~iv~~~~~~~~~~~~ 74 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKC------DSPYIIGFYGAFFVENRI 74 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhC------CCCCeeeEEEEEEECCEE
Confidence 36889999999999999999999999999999987542 2234566677776655 478999999999999999
Q ss_pred EEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCcc
Q 007035 492 FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 571 (621)
Q Consensus 492 ~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~ 571 (621)
++||||++++.++... .+++..+..++.||+.||.|||+.+|+|+||||+|||++. ++.++|+|||++.
T Consensus 75 ~lv~e~~~~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~--~~~~~l~dfg~~~ 143 (279)
T cd06619 75 SICTEFMDGGSLDVYR---------KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNT--RGQVKLCDFGVST 143 (279)
T ss_pred EEEEecCCCCChHHhh---------cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECC--CCCEEEeeCCcce
Confidence 9999999976554331 1677888999999999999999999999999999999984 7899999999986
Q ss_pred ccCC-CccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 572 FQTD-NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 572 ~~~~-~~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
.... ......+++.|+|||++.+..++.++|+|||||++|+|++|+.||
T Consensus 144 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf 193 (279)
T cd06619 144 QLVNSIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPY 193 (279)
T ss_pred ecccccccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCc
Confidence 5433 233457899999999999888999999999999999999999998
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-30 Score=263.02 Aligned_cols=195 Identities=28% Similarity=0.463 Sum_probs=164.1
Q ss_pred ceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc---hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeE
Q 007035 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (621)
Q Consensus 415 rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~---~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l 491 (621)
+|++++.||.|++|.||+|.+..++..||+|.++... .......+|+.+++.+. ||||+++++++.....+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~~~~ 74 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQ------HPNIVCLQDVLMQESRL 74 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcC------CCCEeeeEEEEeeCCeE
Confidence 4889999999999999999999999999999986532 22345667777777764 78999999999999999
Q ss_pred EEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCcc
Q 007035 492 FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 571 (621)
Q Consensus 492 ~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~ 571 (621)
++||||+.+++.+.+..... ...+++..++.++.||+.||.|||+++|+||||+|+||+++. ++.++|+|||++.
T Consensus 75 ~~v~e~~~~~l~~~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~--~~~~~l~dfg~~~ 149 (285)
T cd07861 75 YLIFEFLSMDLKKYLDSLPK---GQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDN--KGVIKLADFGLAR 149 (285)
T ss_pred EEEEecCCCCHHHHHhcCCC---CCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcC--CCcEEECccccee
Confidence 99999999888887754322 123889999999999999999999999999999999999984 7889999999886
Q ss_pred ccCCCc---cccccCCcccCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 572 FQTDNL---CLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 572 ~~~~~~---~~~~gt~~Y~APEvl~~~-~~s~ksDIWSLGvILyELltG~~PF 620 (621)
...... ....+++.|+|||++.+. .++.++|||||||++|+|++|++||
T Consensus 150 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~ 202 (285)
T cd07861 150 AFGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLF 202 (285)
T ss_pred ecCCCcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCC
Confidence 543221 223457889999998754 4788999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=286.13 Aligned_cols=192 Identities=26% Similarity=0.395 Sum_probs=166.1
Q ss_pred ecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeE
Q 007035 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (621)
Q Consensus 412 i~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l 491 (621)
...+|.+.+.||+|+||.||++.+..+++.||||.... ....+|+++++.++ |+||+++++++...+..
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~-----~~~~~E~~iL~~L~------HpnIv~l~~~~~~~~~~ 235 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY-----ASSVHEARLLRRLS------HPAVLALLDVRVVGGLT 235 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc-----cCHHHHHHHHHHCC------CCCCCcEEEEEEECCEE
Confidence 45689999999999999999999999999999996432 34567888888774 78999999999999999
Q ss_pred EEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCcc
Q 007035 492 FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 571 (621)
Q Consensus 492 ~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~ 571 (621)
++|||++.++|++++..... .+++..++.|+.||+.||.|||++||+||||||+||||+. .+.++|+|||++.
T Consensus 236 ~lv~e~~~~~L~~~l~~~~~-----~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~--~~~vkL~DFGla~ 308 (461)
T PHA03211 236 CLVLPKYRSDLYTYLGARLR-----PLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNG--PEDICLGDFGAAC 308 (461)
T ss_pred EEEEEccCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECC--CCCEEEcccCCce
Confidence 99999999998888764322 2889999999999999999999999999999999999984 7789999999986
Q ss_pred ccCCC-----ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 007035 572 FQTDN-----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCLI 621 (621)
Q Consensus 572 ~~~~~-----~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF~ 621 (621)
..... .....||+.|+|||++.+..++.++|||||||+||||++|..|++
T Consensus 309 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf 363 (461)
T PHA03211 309 FARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLF 363 (461)
T ss_pred ecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcc
Confidence 54322 123468999999999999999999999999999999999887653
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-30 Score=264.46 Aligned_cols=194 Identities=26% Similarity=0.347 Sum_probs=162.6
Q ss_pred ceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc----hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCe
Q 007035 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (621)
Q Consensus 415 rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~ 490 (621)
.|++.+.||+|+||+||++.+..+++.+|+|++.... .......+|+.+++.++ |++|+++++.+...+.
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~------~~~i~~~~~~~~~~~~ 74 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVN------SQFVVNLAYAYETKDA 74 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcC------CcCceeEEEEEecCCE
Confidence 3788899999999999999999999999999987532 12234566777777664 6789999999999999
Q ss_pred EEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCC
Q 007035 491 LFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (621)
Q Consensus 491 l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGl 569 (621)
.++||||+.+ +|.+.+..... ..+++..+..++.|++.||.|||+.+|+||||||+||+++. ++.++|+|||+
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~--~~~~kl~Dfg~ 148 (285)
T cd05632 75 LCLVLTIMNGGDLKFHIYNMGN----PGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDD--YGHIRISDLGL 148 (285)
T ss_pred EEEEEEeccCccHHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECC--CCCEEEecCCc
Confidence 9999999986 45444432221 13889999999999999999999999999999999999984 67899999998
Q ss_pred ccccCCC--ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 570 SCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 570 s~~~~~~--~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
+...... .....+++.|+|||++.+..++.++|+||||+++|+|++|..||
T Consensus 149 ~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~ 201 (285)
T cd05632 149 AVKIPEGESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPF 201 (285)
T ss_pred ceecCCCCcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCC
Confidence 8654322 23356899999999999888999999999999999999999998
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-31 Score=282.09 Aligned_cols=194 Identities=23% Similarity=0.375 Sum_probs=164.3
Q ss_pred CceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchh-hhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecC-eE
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDF-FDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE-HL 491 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~-~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~-~l 491 (621)
+.|.-.+.||+|+||.||+|. ..+|..||||.+...... ..++..|+.++.+++ ||||+++++||.+.+ +.
T Consensus 75 ~~Fs~~~~ig~Ggfg~VYkG~-l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~------H~Nlv~LlGyC~e~~~~~ 147 (361)
T KOG1187|consen 75 NNFSESNLIGEGGFGTVYKGV-LSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLR------HPNLVKLLGYCLEGGEHR 147 (361)
T ss_pred hCCchhcceecCCCeEEEEEE-ECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCC------CcCcccEEEEEecCCceE
Confidence 556777889999999999998 456689999988765544 556888888887775 789999999999998 59
Q ss_pred EEEEeccc-cchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCC---eecccCCCccEEEeccCCCeEEEEec
Q 007035 492 FIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLG---IIHCDLKPENILIKSYQRCEIKIIDL 567 (621)
Q Consensus 492 ~LVmEyl~-gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~g---IvHrDLKP~NILl~~~~~~~IKL~DF 567 (621)
+||+||+. |+|.+.+...... .++|..+..|+.++++||+|||+.. |+||||||+|||++ .+...||+||
T Consensus 148 ~LVYEym~nGsL~d~L~~~~~~----~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD--~~~~aKlsDF 221 (361)
T KOG1187|consen 148 LLVYEYMPNGSLEDHLHGKKGE----PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLD--EDFNAKLSDF 221 (361)
T ss_pred EEEEEccCCCCHHHHhCCCCCC----CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeEC--CCCCEEccCc
Confidence 99999998 5777766543321 4899999999999999999999853 99999999999999 5889999999
Q ss_pred CCccccCC-Ccccc---ccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 568 GSSCFQTD-NLCLY---VQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 568 Gls~~~~~-~~~~~---~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
|++..... ..... .||.+|+|||.+.....+.++||||+|++|.||+||+.+.
T Consensus 222 GLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~ 278 (361)
T KOG1187|consen 222 GLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAV 278 (361)
T ss_pred cCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCccc
Confidence 99976554 33222 7899999999999888999999999999999999999764
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=284.64 Aligned_cols=199 Identities=30% Similarity=0.468 Sum_probs=176.7
Q ss_pred ecCceEEE--EEeccCCCCceeEEEeCCCCcEEEEEEEecC---chhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeE
Q 007035 412 IAGRYYVT--EYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (621)
Q Consensus 412 i~~rY~I~--~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~---~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~ 486 (621)
+..-|+|. +.||+|-||+||-|++..+|+.||||++.+. .....+..+|+.||+.+. ||.|+.+...|+
T Consensus 560 ~stvYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~------HPGiV~le~M~E 633 (888)
T KOG4236|consen 560 ISTVYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLH------HPGIVNLECMFE 633 (888)
T ss_pred HHHHHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcC------CCCeeEEEEeec
Confidence 44557765 6799999999999999999999999998753 344577888999998774 778999999999
Q ss_pred ecCeEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccC-CCeEEEE
Q 007035 487 HLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQ-RCEIKII 565 (621)
Q Consensus 487 ~~~~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~-~~~IKL~ 565 (621)
..+.+++|||-+.|.+++.+....... +++...+.++.||+.||+|||-++|+|+||||+|||+.+.. -.++||+
T Consensus 634 T~ervFVVMEKl~GDMLEMILSsEkgR----L~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlC 709 (888)
T KOG4236|consen 634 TPERVFVVMEKLHGDMLEMILSSEKGR----LPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLC 709 (888)
T ss_pred CCceEEEEehhhcchHHHHHHHhhccc----chHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeec
Confidence 999999999999999999988765433 89999999999999999999999999999999999997633 3589999
Q ss_pred ecCCccccCCC--ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 566 DLGSSCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 566 DFGls~~~~~~--~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
|||++++++.. ....+|||.|+|||++..+.|....||||+|||+|--++|..||
T Consensus 710 DFGfARiIgEksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPF 766 (888)
T KOG4236|consen 710 DFGFARIIGEKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPF 766 (888)
T ss_pred cccceeecchhhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccC
Confidence 99999988765 45579999999999999999999999999999999999999998
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=265.61 Aligned_cols=194 Identities=31% Similarity=0.466 Sum_probs=164.2
Q ss_pred ceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc---hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeE
Q 007035 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (621)
Q Consensus 415 rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~---~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l 491 (621)
+|++.+.||.|+||.||+|++..+|+.+|+|.++... .......+|+.+++.++ ||||+++++++.+....
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~------h~~i~~~~~~~~~~~~~ 74 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELK------HKNIVRLYDVLHSDKKL 74 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcC------CCCeeeHHHHhccCCce
Confidence 5899999999999999999999999999999987532 22345567888777764 78999999999999999
Q ss_pred EEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCcc
Q 007035 492 FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 571 (621)
Q Consensus 492 ~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~ 571 (621)
++|+||+++++.+.+..... .+++..++.++.||+.||.|||+++|+||||||+||+++. ++.++|+|||++.
T Consensus 75 ~lv~e~~~~~l~~~~~~~~~-----~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~--~~~~~l~dfg~~~ 147 (284)
T cd07839 75 TLVFEYCDQDLKKYFDSCNG-----DIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINK--NGELKLADFGLAR 147 (284)
T ss_pred EEEEecCCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcC--CCcEEECccchhh
Confidence 99999999998887764321 2889999999999999999999999999999999999984 7889999999886
Q ss_pred ccCCC---ccccccCCcccCchhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCC
Q 007035 572 FQTDN---LCLYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVCLI 621 (621)
Q Consensus 572 ~~~~~---~~~~~gt~~Y~APEvl~~~~-~s~ksDIWSLGvILyELltG~~PF~ 621 (621)
..... .....+++.|+|||++.+.. ++.++|||||||++|+|++|+.||+
T Consensus 148 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~ 201 (284)
T cd07839 148 AFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF 201 (284)
T ss_pred ccCCCCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCc
Confidence 54332 22345688899999987754 7899999999999999999998863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-30 Score=264.03 Aligned_cols=187 Identities=26% Similarity=0.357 Sum_probs=155.5
Q ss_pred eccCCCCceeEEEeCCCCcEEEEEEEecCch----hhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeEEEEEec
Q 007035 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD----FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCEL 497 (621)
Q Consensus 422 LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~----~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l~LVmEy 497 (621)
||+|+||+||+++++.+|+.||+|.+..... .......|+++++.+ .||||+++++.+....+.++||||
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l------~hp~i~~~~~~~~~~~~~~lv~e~ 74 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKV------NSPFIVNLAYAFESKTHLCLVMSL 74 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhc------CCCcEEEEEEEEecCCeEEEEEec
Confidence 7999999999999999999999999864321 122334567777665 478999999999999999999999
Q ss_pred ccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCccccCCC
Q 007035 498 LRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN 576 (621)
Q Consensus 498 l~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~~~~~~ 576 (621)
+.+ +|...+..... ..+++..+..++.||+.||.|||+.||+||||||+||+++. ++.++|+|||++......
T Consensus 75 ~~g~~L~~~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~--~~~~~l~Dfg~~~~~~~~ 148 (277)
T cd05607 75 MNGGDLKYHIYNVGE----RGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDD--QGNCRLSDLGLAVELKDG 148 (277)
T ss_pred CCCCCHHHHHHhccc----cCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcC--CCCEEEeeceeeeecCCC
Confidence 985 56555543322 22778889999999999999999999999999999999984 788999999998654432
Q ss_pred --ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 577 --LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 577 --~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
.....+++.|+|||++.+..++.++|||||||++|+|++|+.||
T Consensus 149 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~ 194 (277)
T cd05607 149 KTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPF 194 (277)
T ss_pred ceeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCC
Confidence 22346789999999999988999999999999999999999998
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-30 Score=267.43 Aligned_cols=201 Identities=24% Similarity=0.319 Sum_probs=160.0
Q ss_pred ecCceEEEEEeccCCCCceeEEEeCC----------------CCcEEEEEEEecCc--hhhhhHHHHHHHHHHhcccCCC
Q 007035 412 IAGRYYVTEYLGSAAFSKVFQAQDLH----------------TGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPA 473 (621)
Q Consensus 412 i~~rY~I~~~LG~G~fG~Vyka~d~~----------------tg~~VAlKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~ 473 (621)
..++|++.+.||+|+||.||+|.+.. ++..||+|++.... .....+.+|+.++..+
T Consensus 3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l------ 76 (304)
T cd05096 3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRL------ 76 (304)
T ss_pred chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhc------
Confidence 35789999999999999999997532 34579999987642 2344567777777766
Q ss_pred CCCceEEEeeEeEecCeEEEEEecccc-chHHHHHhhhcc-------------CCCccccHHHHHHHHHHHHHHHHHHHH
Q 007035 474 DEHHILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQES-------------GGEAYFTLGRLQVITRQCLEALEYLHS 539 (621)
Q Consensus 474 ~hpnIvrl~~~f~~~~~l~LVmEyl~g-sLld~l~~~~~~-------------~~~~~ls~~~i~~I~~qIl~aL~yLHs 539 (621)
.||||+++++++...+..++||||+.+ +|.+++...... .....+++..+..++.||+.||.|||+
T Consensus 77 ~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~ 156 (304)
T cd05096 77 KDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS 156 (304)
T ss_pred CCCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH
Confidence 478999999999999999999999975 777766443211 111236778899999999999999999
Q ss_pred CCeecccCCCccEEEeccCCCeEEEEecCCccccCCCc-----cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHH
Q 007035 540 LGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELW 614 (621)
Q Consensus 540 ~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~~~~~~~-----~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELl 614 (621)
.+|+||||||+|||++. ++.+||+|||++....... ....++..|+|||++.+..++.++||||||+++|+|+
T Consensus 157 ~~ivH~dlkp~Nill~~--~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~ 234 (304)
T cd05096 157 LNFVHRDLATRNCLVGE--NLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234 (304)
T ss_pred CCccccCcchhheEEcC--CccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHH
Confidence 99999999999999984 7889999999986543221 1223467899999999888999999999999999998
Q ss_pred h--CCCCC
Q 007035 615 T--GEVCL 620 (621)
Q Consensus 615 t--G~~PF 620 (621)
+ +..||
T Consensus 235 ~~~~~~p~ 242 (304)
T cd05096 235 MLCKEQPY 242 (304)
T ss_pred HccCCCCC
Confidence 6 55665
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-30 Score=266.49 Aligned_cols=206 Identities=22% Similarity=0.227 Sum_probs=158.3
Q ss_pred eeCeeecCceEEEEEeccCCCCceeEEEeCCC---CcEEEEEEEecCchhh-hh-----HHHHHHHHHHhcccCCCCCCc
Q 007035 407 ILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHT---GVDVCLKIIKNDKDFF-DQ-----SLDEIKLLKLVNKNDPADEHH 477 (621)
Q Consensus 407 ~l~~ii~~rY~I~~~LG~G~fG~Vyka~d~~t---g~~VAlKii~~~~~~~-~~-----~~~Ei~iL~~l~~~~~~~hpn 477 (621)
.+.++..++|++.+.||+|+||+||+|.+..+ +..+++|+........ .+ ...+......+.......|++
T Consensus 5 ~~~~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~ 84 (294)
T PHA02882 5 PLIDITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLG 84 (294)
T ss_pred eeeccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCC
Confidence 34567778999999999999999999998877 6778888654332111 00 011112222223334567899
Q ss_pred eEEEeeEeEecC----eEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEE
Q 007035 478 ILRLYDYFYHLE----HLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENIL 553 (621)
Q Consensus 478 Ivrl~~~f~~~~----~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NIL 553 (621)
|+++++++.... ..++++|++..++.+.+..... +++..++.++.||+.||.|||+++|+||||||+|||
T Consensus 85 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nil 158 (294)
T PHA02882 85 IPKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRIKC------KNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIM 158 (294)
T ss_pred CCcEEEeeeEecCCceEEEEEEehhccCHHHHHHhhcc------CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 999998766543 4688999888777766553321 567778899999999999999999999999999999
Q ss_pred EeccCCCeEEEEecCCccccCC----------CccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 554 IKSYQRCEIKIIDLGSSCFQTD----------NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 554 l~~~~~~~IKL~DFGls~~~~~----------~~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
++. ++.++|+|||++..... ......||+.|+|||++.+..++.++|||||||+||||++|++||
T Consensus 159 l~~--~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~ 233 (294)
T PHA02882 159 VDG--NNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPW 233 (294)
T ss_pred EcC--CCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 984 77899999999865321 122346899999999999999999999999999999999999998
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-31 Score=276.51 Aligned_cols=187 Identities=30% Similarity=0.430 Sum_probs=156.7
Q ss_pred EEeccCCCCceeEEEe---CCCCcEEEEEEEecCch---hhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeEEE
Q 007035 420 EYLGSAAFSKVFQAQD---LHTGVDVCLKIIKNDKD---FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFI 493 (621)
Q Consensus 420 ~~LG~G~fG~Vyka~d---~~tg~~VAlKii~~~~~---~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l~L 493 (621)
+.||+|+||.||++++ ..+|+.||+|++..... .......|+++++.+ .||||+++++++.....+|+
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~~~~~~~~~~~~~l 75 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEV------NHPFIVKLHYAFQTEGKLYL 75 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhC------CCCCcccEEEEEEcCCEEEE
Confidence 5799999999999986 35789999999975331 223445566666655 47899999999999999999
Q ss_pred EEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCccc
Q 007035 494 VCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF 572 (621)
Q Consensus 494 VmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~~ 572 (621)
||||+.+ +|.+.+.... .+++..++.++.||+.||.|||+++|+||||||+|||++. ++.+||+|||++..
T Consensus 76 v~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~--~~~~kL~Dfg~~~~ 147 (318)
T cd05582 76 ILDFLRGGDLFTRLSKEV------MFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDE--EGHIKLTDFGLSKE 147 (318)
T ss_pred EEcCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECC--CCcEEEeeccCCcc
Confidence 9999974 6666654322 2889999999999999999999999999999999999984 78899999999865
Q ss_pred cCCC---ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 573 QTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 573 ~~~~---~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
.... .....|++.|+|||++.+..++.++|||||||++|+|++|+.||
T Consensus 148 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~ 198 (318)
T cd05582 148 SIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPF 198 (318)
T ss_pred cCCCCCceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCC
Confidence 4332 23457899999999999888999999999999999999999998
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-30 Score=286.85 Aligned_cols=199 Identities=26% Similarity=0.323 Sum_probs=163.3
Q ss_pred ecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc---hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEec
Q 007035 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (621)
Q Consensus 412 i~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~---~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~ 488 (621)
..++|++.+.||+|+||+||++++..+|+.||||++.... .......+|+.++.. ..|++|++++..+...
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~------~~h~~iv~~~~~~~~~ 103 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLN------CDFFSIVKCHEDFAKK 103 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhc------CCCCcEEEeecceecc
Confidence 3579999999999999999999999999999999987542 223344555555544 3578999998877643
Q ss_pred C--------eEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCC
Q 007035 489 E--------HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQR 559 (621)
Q Consensus 489 ~--------~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~ 559 (621)
. .+++||||+.+ +|.+.+...... ...+++..++.++.||+.||.|||+++|+||||||+|||++. +
T Consensus 104 ~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~--~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~--~ 179 (496)
T PTZ00283 104 DPRNPENVLMIALVLDYANAGDLRQEIKSRAKT--NRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCS--N 179 (496)
T ss_pred cccCcccceEEEEEEeCCCCCcHHHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeC--C
Confidence 2 47899999984 777766543221 234889999999999999999999999999999999999984 7
Q ss_pred CeEEEEecCCccccCC-----CccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 560 CEIKIIDLGSSCFQTD-----NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 560 ~~IKL~DFGls~~~~~-----~~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
+.+||+|||++..... ......||+.|+|||++.+..++.++|||||||+||+|++|+.||
T Consensus 180 ~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf 245 (496)
T PTZ00283 180 GLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPF 245 (496)
T ss_pred CCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 8899999999865432 223457899999999999999999999999999999999999998
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-30 Score=266.81 Aligned_cols=194 Identities=28% Similarity=0.480 Sum_probs=157.2
Q ss_pred EEeccCCCCceeEEEeCC--CCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEe--cCeEEEEE
Q 007035 420 EYLGSAAFSKVFQAQDLH--TGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH--LEHLFIVC 495 (621)
Q Consensus 420 ~~LG~G~fG~Vyka~d~~--tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~--~~~l~LVm 495 (621)
.+||+|+||+||+|+++. ++..||+|.+..... .....+|+.+++.++ ||||+++++++.. ...+++||
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~E~~~l~~l~------h~niv~~~~~~~~~~~~~~~lv~ 79 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-SMSACREIALLRELK------HPNVIALQKVFLSHSDRKVWLLF 79 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-cHHHHHHHHHHHhCC------CCCeeeEEEEEeccCCCeEEEEE
Confidence 579999999999999654 668899998875432 245667888887764 7899999999864 56789999
Q ss_pred eccccchHHHHHhhhcc---CCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEecc--CCCeEEEEecCCc
Q 007035 496 ELLRANLYEFQKFNQES---GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSY--QRCEIKIIDLGSS 570 (621)
Q Consensus 496 Eyl~gsLld~l~~~~~~---~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~--~~~~IKL~DFGls 570 (621)
||+++++.+.+...... .....+++..++.++.||+.||.|||+.+|+||||||+|||+... .++.+||+|||++
T Consensus 80 e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 80 DYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred eeeCCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 99999988887643221 112347888999999999999999999999999999999999532 4678999999998
Q ss_pred cccCCC------ccccccCCcccCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 571 CFQTDN------LCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 571 ~~~~~~------~~~~~gt~~Y~APEvl~~~-~~s~ksDIWSLGvILyELltG~~PF 620 (621)
...... .....+|+.|+|||++.+. .++.++|||||||++|+|+||++||
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f 216 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 216 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCc
Confidence 754332 2234678899999999774 4789999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=291.81 Aligned_cols=197 Identities=29% Similarity=0.452 Sum_probs=167.5
Q ss_pred cCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEE-ecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeE-e---
Q 007035 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKII-KNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY-H--- 487 (621)
Q Consensus 413 ~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii-~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~-~--- 487 (621)
.-+++|.+.|.+|||+.||+|++...|..||+|++ -.++.....+.+|+.+++.|+ +|+|||.+++... .
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~-----gh~nIV~yidss~~~~~~ 110 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLS-----GHKNIVSYIDSSAINRSS 110 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhc-----CCCceeeEeccccccccC
Confidence 45799999999999999999999988899999965 456777888999999999997 5789999999422 1
Q ss_pred ---cCeEEEEEeccc-cchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCC--eecccCCCccEEEeccCCCe
Q 007035 488 ---LEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLG--IIHCDLKPENILIKSYQRCE 561 (621)
Q Consensus 488 ---~~~l~LVmEyl~-gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~g--IvHrDLKP~NILl~~~~~~~ 561 (621)
.-.++|+||||. ++|.+++....... |++.+++.|+.++++|+.+||.+. |||||||-+||||. .++.
T Consensus 111 ~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~----lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls--~~g~ 184 (738)
T KOG1989|consen 111 NNGVWEVLLLMEYCKGGSLVDFMNTRLQTR----LTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLS--ADGN 184 (738)
T ss_pred CCceeEEEeehhhccCCcHHHHHHHHHhcc----CChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEc--CCCC
Confidence 125889999999 69999987654332 999999999999999999999987 99999999999999 4889
Q ss_pred EEEEecCCccccCCCcc------------ccccCCcccCchhh---cCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 562 IKIIDLGSSCFQTDNLC------------LYVQSRSYRAPEVI---IGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 562 IKL~DFGls~~~~~~~~------------~~~gt~~Y~APEvl---~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
+||||||.+........ ...-|+.|+|||++ .+.+.+.|+|||+|||+||-|++...||
T Consensus 185 ~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PF 258 (738)
T KOG1989|consen 185 YKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPF 258 (738)
T ss_pred EEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCc
Confidence 99999999864332221 12348999999998 5778999999999999999999999998
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-30 Score=261.75 Aligned_cols=195 Identities=19% Similarity=0.264 Sum_probs=157.3
Q ss_pred cCceEEEEEeccCCCCceeEEEeC---CCCcEEEEEEEecCch--hhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEe
Q 007035 413 AGRYYVTEYLGSAAFSKVFQAQDL---HTGVDVCLKIIKNDKD--FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (621)
Q Consensus 413 ~~rY~I~~~LG~G~fG~Vyka~d~---~tg~~VAlKii~~~~~--~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~ 487 (621)
..+|++.+.||+|+||.||+|.++ ..+..||+|.++.... ....+.+|+.+++.+ +||||+++++++..
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l------~h~~iv~~~~~~~~ 77 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQF------DHSNIVRLEGVITR 77 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcC------CCCCcCeEEEEEec
Confidence 467999999999999999999765 4567899999886432 223455566655544 58899999999999
Q ss_pred cCeEEEEEeccccc-hHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEe
Q 007035 488 LEHLFIVCELLRAN-LYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (621)
Q Consensus 488 ~~~l~LVmEyl~gs-Lld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~D 566 (621)
.++.++||||++++ |.+++.... ..+++..++.++.||+.||+|||+++++||||||+|||++. ++.++|+|
T Consensus 78 ~~~~~lv~e~~~~~~L~~~l~~~~-----~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~--~~~~~l~d 150 (266)
T cd05064 78 GNTMMIVTEYMSNGALDSFLRKHE-----GQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNS--DLVCKISG 150 (266)
T ss_pred CCCcEEEEEeCCCCcHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcC--CCcEEECC
Confidence 99999999999875 444444322 13789999999999999999999999999999999999984 78899999
Q ss_pred cCCccccCCCc----cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 567 LGSSCFQTDNL----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 567 FGls~~~~~~~----~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
||.+....... ....++..|+|||.+.+..++.++|||||||++|||++ |+.||
T Consensus 151 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~ 209 (266)
T cd05064 151 FRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPY 209 (266)
T ss_pred CcccccccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCc
Confidence 99865432221 11233568999999999999999999999999999775 99998
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.2e-30 Score=260.48 Aligned_cols=194 Identities=30% Similarity=0.494 Sum_probs=164.4
Q ss_pred CceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc---hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCe
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~---~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~ 490 (621)
++|++.+.||+|++|.||++.++.+|+.||+|++.... ...+.+.+|+.+++.++ |+||+++++++....+
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~------h~~i~~~~~~~~~~~~ 74 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLK------HPNLVNLIEVFRRKRK 74 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCC------CCCEeeeeeEEeeCCE
Confidence 47999999999999999999999999999999886432 22344567888777664 6799999999999999
Q ss_pred EEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCc
Q 007035 491 LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (621)
Q Consensus 491 l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls 570 (621)
.++||||+++++++.+..... .+++..++.++.||+.||.|||+.+|+||||||+||+++. ++.++|+|||++
T Consensus 75 ~~~v~e~~~~~~l~~~~~~~~-----~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~--~~~~~l~dfg~~ 147 (286)
T cd07847 75 LHLVFEYCDHTVLNELEKNPR-----GVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITK--QGQIKLCDFGFA 147 (286)
T ss_pred EEEEEeccCccHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcC--CCcEEECccccc
Confidence 999999999887776643322 2889999999999999999999999999999999999984 788999999998
Q ss_pred cccCCCc---cccccCCcccCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 571 CFQTDNL---CLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 571 ~~~~~~~---~~~~gt~~Y~APEvl~~-~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
....... ....++..|+|||.+.+ ..++.++||||||+++|+|++|++||
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~ 201 (286)
T cd07847 148 RILTGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLW 201 (286)
T ss_pred eecCCCcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCC
Confidence 7654332 23456788999999876 45788999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-30 Score=257.36 Aligned_cols=193 Identities=31% Similarity=0.406 Sum_probs=161.8
Q ss_pred CceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCch------hhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEe
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD------FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~------~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~ 487 (621)
+.|.+.+.||.|++|.||++.+..+++.+|+|.+..... ....+.+|+.+++.+ .||||+++++++..
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l------~~~~i~~~~~~~~~ 75 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL------QHERIVQYYGCLRD 75 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhC------CCCCeeeeEEEEcc
Confidence 468999999999999999999999999999999875321 123455566666555 57899999999999
Q ss_pred cCeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEe
Q 007035 488 LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (621)
Q Consensus 488 ~~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~D 566 (621)
...+++||||+.+ +|.+.+.... .+++..++.++.||+.||.|||+.+|+||||+|+||+++ .++.++|+|
T Consensus 76 ~~~~~~v~e~~~~~~l~~~~~~~~------~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~--~~~~~~l~d 147 (263)
T cd06625 76 DETLSIFMEYMPGGSVKDQLKAYG------ALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRD--SAGNVKLGD 147 (263)
T ss_pred CCeEEEEEEECCCCcHHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc--CCCCEEEee
Confidence 9999999999975 6666665332 278888999999999999999999999999999999998 478899999
Q ss_pred cCCccccCCCc------cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 567 LGSSCFQTDNL------CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 567 FGls~~~~~~~------~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
||++....... ....++..|+|||++.+..++.++||||||+++|+|++|+.||
T Consensus 148 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~ 207 (263)
T cd06625 148 FGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPW 207 (263)
T ss_pred cccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCc
Confidence 99986543211 2245678899999999988999999999999999999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-31 Score=262.21 Aligned_cols=195 Identities=30% Similarity=0.467 Sum_probs=169.7
Q ss_pred CceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecC---------chhhhhHHHHHHHHHHhcccCCCCCCceEEEeeE
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---------KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDY 484 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~---------~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~ 484 (621)
+.|.-.+.||.|..++|.++.++.+|..+|+|++... ....+.-..|+.||+++. +||+|+++.++
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~-----GHP~II~l~D~ 91 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVM-----GHPYIIDLQDV 91 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhc-----CCCcEEEeeee
Confidence 4566677899999999999999999999999998532 123345567888888885 78999999999
Q ss_pred eEecCeEEEEEeccc-cchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEE
Q 007035 485 FYHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 563 (621)
Q Consensus 485 f~~~~~l~LVmEyl~-gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IK 563 (621)
|+....+++|+|.++ |.|.+++...- .+++++.+.|++||++|+.|||.++||||||||+|||++ ++..||
T Consensus 92 yes~sF~FlVFdl~prGELFDyLts~V------tlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILld--dn~~i~ 163 (411)
T KOG0599|consen 92 YESDAFVFLVFDLMPRGELFDYLTSKV------TLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLD--DNMNIK 163 (411)
T ss_pred ccCcchhhhhhhhcccchHHHHhhhhe------eecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeec--cccceE
Confidence 999999999999998 68888887543 389999999999999999999999999999999999999 588899
Q ss_pred EEecCCccccCC--CccccccCCcccCchhhc------CCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 007035 564 IIDLGSSCFQTD--NLCLYVQSRSYRAPEVII------GLPYDQKIDLWSLGCILAELWTGEVCLI 621 (621)
Q Consensus 564 L~DFGls~~~~~--~~~~~~gt~~Y~APEvl~------~~~~s~ksDIWSLGvILyELltG~~PF~ 621 (621)
|+|||+++.... .....+|||+|+|||.+. ...|+..+|+|++|||||-|+.|-+||.
T Consensus 164 isDFGFa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFw 229 (411)
T KOG0599|consen 164 ISDFGFACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFW 229 (411)
T ss_pred EeccceeeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchh
Confidence 999999987654 355689999999999994 3458999999999999999999999993
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=261.39 Aligned_cols=194 Identities=28% Similarity=0.465 Sum_probs=163.6
Q ss_pred CceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCch--hhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeE
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD--FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~--~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l 491 (621)
++|++.+.||.|++|.||+|.++.+++.||+|.+..... ......+|+.+++.++ |+||+++++++...++.
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~------h~~i~~~~~~~~~~~~~ 78 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLK------HANIVTLHDIIHTKKTL 78 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCC------CcceeeEEEEEecCCeE
Confidence 679999999999999999999999999999999875322 2234567888887764 67999999999999999
Q ss_pred EEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCcc
Q 007035 492 FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 571 (621)
Q Consensus 492 ~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~ 571 (621)
++||||+.++|.+.+..... .+++..++.++.||+.||.|||+++|+||||||+||+++. ++.++|+|||++.
T Consensus 79 ~lv~e~~~~~L~~~~~~~~~-----~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~--~~~~kl~dfg~~~ 151 (291)
T cd07844 79 TLVFEYLDTDLKQYMDDCGG-----GLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISE--RGELKLADFGLAR 151 (291)
T ss_pred EEEEecCCCCHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcC--CCCEEECcccccc
Confidence 99999999988887654322 2788999999999999999999999999999999999984 7789999999876
Q ss_pred ccCCC---ccccccCCcccCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 572 FQTDN---LCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 572 ~~~~~---~~~~~gt~~Y~APEvl~~-~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
..... .....+++.|+|||++.+ ..++.++||||||+++|+|++|+.||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~ 204 (291)
T cd07844 152 AKSVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLF 204 (291)
T ss_pred ccCCCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCC
Confidence 53321 122345788999999876 45789999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-30 Score=271.65 Aligned_cols=201 Identities=35% Similarity=0.611 Sum_probs=167.9
Q ss_pred cceeeCe---eecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecC---chhhhhHHHHHHHHHHhcccCCCCCCc
Q 007035 404 LPIILNT---VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHH 477 (621)
Q Consensus 404 ~pi~l~~---ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~---~~~~~~~~~Ei~iL~~l~~~~~~~hpn 477 (621)
+|+.+++ .+.++|++++.||+|+||.||+|.+..+++.||+|++.+. ........+|+.+++.+ .|+|
T Consensus 3 ~~~~~~~~~~~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l------~h~~ 76 (353)
T cd07850 3 YSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLV------NHKN 76 (353)
T ss_pred eeecccchhhhhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhc------CCCC
Confidence 3444444 4578999999999999999999999999999999998642 22234556677777766 4789
Q ss_pred eEEEeeEeEec------CeEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCcc
Q 007035 478 ILRLYDYFYHL------EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPEN 551 (621)
Q Consensus 478 Ivrl~~~f~~~------~~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~N 551 (621)
|++++++|... .+.++||||+.+++.+.+... ++...+..++.||+.||.|||++||+||||||+|
T Consensus 77 iv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~--------l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~N 148 (353)
T cd07850 77 IIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMD--------LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSN 148 (353)
T ss_pred CcceeeeeccCCCccccCcEEEEEeccCCCHHHHHhhc--------CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHH
Confidence 99999988744 358999999999888876421 6788899999999999999999999999999999
Q ss_pred EEEeccCCCeEEEEecCCccccCCCc--cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 552 ILIKSYQRCEIKIIDLGSSCFQTDNL--CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 552 ILl~~~~~~~IKL~DFGls~~~~~~~--~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
|+++. ++.+||+|||++....... ....+++.|+|||++.+..++.++|||||||++|+|++|+.||
T Consensus 149 il~~~--~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf 217 (353)
T cd07850 149 IVVKS--DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLF 217 (353)
T ss_pred EEECC--CCCEEEccCccceeCCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCC
Confidence 99984 7889999999987654432 2345788999999999999999999999999999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=306.42 Aligned_cols=194 Identities=25% Similarity=0.386 Sum_probs=167.0
Q ss_pred cCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecC----chhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEec
Q 007035 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (621)
Q Consensus 413 ~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~----~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~ 488 (621)
.++|.|++.||.|+||.|.+++++.+++.||+|++.+- ......+..|..++.... .+.|+++...|++.
T Consensus 74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~n------s~Wiv~LhyAFQD~ 147 (1317)
T KOG0612|consen 74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGN------SEWIVQLHYAFQDE 147 (1317)
T ss_pred HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCC------cHHHHHHHHHhcCc
Confidence 47899999999999999999999999999999998762 122344566666766544 46899999999999
Q ss_pred CeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEec
Q 007035 489 EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 567 (621)
Q Consensus 489 ~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DF 567 (621)
.++|+||||+.| .|+.++.... .+++..++.++.+|+.||.-||+.|+|||||||+||||+ ..|+|||+||
T Consensus 148 ~~LYlVMdY~pGGDlltLlSk~~------~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld--~~GHikLADF 219 (1317)
T KOG0612|consen 148 RYLYLVMDYMPGGDLLTLLSKFD------RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLD--KSGHIKLADF 219 (1317)
T ss_pred cceEEEEecccCchHHHHHhhcC------CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEec--ccCcEeeccc
Confidence 999999999985 6777776544 289999999999999999999999999999999999999 5999999999
Q ss_pred CCccccCCC----ccccccCCcccCchhhc----C-CCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 568 GSSCFQTDN----LCLYVQSRSYRAPEVII----G-LPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 568 Gls~~~~~~----~~~~~gt~~Y~APEvl~----~-~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
|.+..+... ....+|||.|.+||++. + +.|+..+|+|||||++|||+.|..||
T Consensus 220 GsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPF 281 (1317)
T KOG0612|consen 220 GSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPF 281 (1317)
T ss_pred hhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcc
Confidence 988665532 33468999999999994 3 46899999999999999999999999
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-30 Score=275.69 Aligned_cols=203 Identities=24% Similarity=0.355 Sum_probs=163.2
Q ss_pred eecCceEEEEEeccCCCCceeEEEeCCCC-----cEEEEEEEecCc--hhhhhHHHHHHHHHHhcccCCCCCCceEEEee
Q 007035 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTG-----VDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYD 483 (621)
Q Consensus 411 ii~~rY~I~~~LG~G~fG~Vyka~d~~tg-----~~VAlKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~ 483 (621)
...++|++.+.||.|+||.||+|++...| ..||+|+++... .....+.+|+.+++.+. .|+||+++++
T Consensus 35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~-----~h~nIv~~~~ 109 (374)
T cd05106 35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLG-----QHKNIVNLLG 109 (374)
T ss_pred ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhc-----cCCceeeEee
Confidence 44578999999999999999999865443 579999987532 23455678888887773 4789999999
Q ss_pred EeEecCeEEEEEeccc-cchHHHHHhhhcc--------------------------------------------------
Q 007035 484 YFYHLEHLFIVCELLR-ANLYEFQKFNQES-------------------------------------------------- 512 (621)
Q Consensus 484 ~f~~~~~l~LVmEyl~-gsLld~l~~~~~~-------------------------------------------------- 512 (621)
++.....+++||||+. ++|.+++......
T Consensus 110 ~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (374)
T cd05106 110 ACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSS 189 (374)
T ss_pred EecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccc
Confidence 9999999999999998 4777766432110
Q ss_pred --------------CCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCccccCCCcc
Q 007035 513 --------------GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC 578 (621)
Q Consensus 513 --------------~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~~~~~~~~ 578 (621)
.....+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++........
T Consensus 190 ~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~--~~~~~kL~DfGla~~~~~~~~ 267 (374)
T cd05106 190 SSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLT--DGRVAKICDFGLARDIMNDSN 267 (374)
T ss_pred cccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEe--CCCeEEEeeceeeeeccCCcc
Confidence 0112367888999999999999999999999999999999998 478899999999865432211
Q ss_pred -----ccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 579 -----LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 579 -----~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
...+++.|+|||++.+..++.++|||||||++|+|++ |+.||
T Consensus 268 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf 315 (374)
T cd05106 268 YVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPY 315 (374)
T ss_pred eeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCC
Confidence 1223567999999998899999999999999999997 99997
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=263.82 Aligned_cols=199 Identities=29% Similarity=0.539 Sum_probs=165.6
Q ss_pred ceEEEEEeccCCCCceeEEEeCC--CCcEEEEEEEecCc----hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEec
Q 007035 415 RYYVTEYLGSAAFSKVFQAQDLH--TGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (621)
Q Consensus 415 rY~I~~~LG~G~fG~Vyka~d~~--tg~~VAlKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~ 488 (621)
+|++.++||+|+||.||+|.+.. +++.||+|.+.... .......+|+.+++.++ ||||+++++++...
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~ 74 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK------HENVVSLVEVFLEH 74 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcC------CCCccceEEEEeCC
Confidence 58999999999999999999988 89999999988632 23355667777777664 78999999999988
Q ss_pred --CeEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEecc--CCCeEEE
Q 007035 489 --EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSY--QRCEIKI 564 (621)
Q Consensus 489 --~~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~--~~~~IKL 564 (621)
..+++||||+++++.+.+....... ...+++..++.++.||+.||.|||+.+|+||||||+||+++.+ .++.+||
T Consensus 75 ~~~~~~lv~e~~~~~l~~~~~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl 153 (316)
T cd07842 75 ADKSVYLLFDYAEHDLWQIIKFHRQAK-RVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKI 153 (316)
T ss_pred CCceEEEEEeCCCcCHHHHHHhhccCC-CcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEE
Confidence 8899999999998888776443321 2248899999999999999999999999999999999999841 2688999
Q ss_pred EecCCccccCCCc------cccccCCcccCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 565 IDLGSSCFQTDNL------CLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 565 ~DFGls~~~~~~~------~~~~gt~~Y~APEvl~~~-~~s~ksDIWSLGvILyELltG~~PF 620 (621)
+|||++....... ....+++.|+|||++.+. .++.++|||||||++|+|++|++||
T Consensus 154 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~ 216 (316)
T cd07842 154 GDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIF 216 (316)
T ss_pred CCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCC
Confidence 9999887543322 224568889999998764 5789999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-30 Score=259.33 Aligned_cols=197 Identities=28% Similarity=0.463 Sum_probs=164.8
Q ss_pred cCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEec----
Q 007035 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL---- 488 (621)
Q Consensus 413 ~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~---- 488 (621)
.++|++.+.||.|+||.||+|.+..+++.||+|++.........+..|+.+++.+. +|+||+++++++...
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~-----~h~~i~~~~~~~~~~~~~~ 79 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYS-----HHRNIATYYGAFIKKNPPG 79 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhc-----CCCCeeeEeeEEeecCCCC
Confidence 46799999999999999999999999999999999876555566778888887763 478999999998753
Q ss_pred --CeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEE
Q 007035 489 --EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKII 565 (621)
Q Consensus 489 --~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~ 565 (621)
.+.++||||+++ +|.+++..... ..+++..+..++.||+.||.|||+++|+|+||+|+||+++. ++.++|+
T Consensus 80 ~~~~~~iv~e~~~~~~L~~~l~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~--~~~~~l~ 153 (272)
T cd06637 80 MDDQLWLVMEFCGAGSVTDLIKNTKG----NTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTE--NAEVKLV 153 (272)
T ss_pred CCcEEEEEEEcCCCCcHHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECC--CCCEEEc
Confidence 468999999985 67666654221 23788899999999999999999999999999999999984 7789999
Q ss_pred ecCCccccCC---CccccccCCcccCchhhc-----CCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 566 DLGSSCFQTD---NLCLYVQSRSYRAPEVII-----GLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 566 DFGls~~~~~---~~~~~~gt~~Y~APEvl~-----~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
|||++..... ......+++.|+|||++. +..++.++|||||||++|+|++|+.||
T Consensus 154 Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~ 216 (272)
T cd06637 154 DFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 216 (272)
T ss_pred cCCCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence 9999865432 223356788999999986 335788999999999999999999997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-29 Score=260.67 Aligned_cols=194 Identities=28% Similarity=0.449 Sum_probs=162.7
Q ss_pred CceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCch--hhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeE
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD--FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~--~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l 491 (621)
++|++.+.||+|+||.||+|.+..+|+.||+|++..... ......+|+.+++.+ +|+||+++++++......
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l------~h~ni~~~~~~~~~~~~~ 78 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGL------KHANIVLLHDIIHTKETL 78 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhc------CCCCEeEEEEEEecCCeE
Confidence 679999999999999999999999999999999875432 123456777777766 467999999999999999
Q ss_pred EEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCcc
Q 007035 492 FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 571 (621)
Q Consensus 492 ~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~ 571 (621)
++||||+.+++++.+..... .+++..++.++.||+.||.|||+.+|+|+||||+|||++ .++.++|+|||++.
T Consensus 79 ~lv~e~~~~~l~~~~~~~~~-----~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~--~~~~~~l~Dfg~~~ 151 (291)
T cd07870 79 TFVFEYMHTDLAQYMIQHPG-----GLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLIS--YLGELKLADFGLAR 151 (291)
T ss_pred EEEEecccCCHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEc--CCCcEEEecccccc
Confidence 99999999888887654321 267788889999999999999999999999999999998 47889999999886
Q ss_pred ccCCC---ccccccCCcccCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 572 FQTDN---LCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 572 ~~~~~---~~~~~gt~~Y~APEvl~~~-~~s~ksDIWSLGvILyELltG~~PF 620 (621)
..... .....+++.|+|||.+.+. .++.++||||||+++|+|++|+.||
T Consensus 152 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f 204 (291)
T cd07870 152 AKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAF 204 (291)
T ss_pred ccCCCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 53322 2233568889999998764 4788999999999999999999997
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-29 Score=258.98 Aligned_cols=198 Identities=29% Similarity=0.406 Sum_probs=162.6
Q ss_pred CceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCch--hhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeE
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD--FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~--~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l 491 (621)
++|++++.||+|+||.||++.++.+|+.||+|+++.... ...+...|+.++.+ ..+||||+++++++.....+
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~-----~~~~~~iv~~~~~~~~~~~~ 75 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMR-----SVDCPYTVTFYGALFREGDV 75 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHH-----HcCCCCeeeeeEEEecCCcE
Confidence 469999999999999999999999999999999875422 22334444443322 24689999999999999999
Q ss_pred EEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHC-CeecccCCCccEEEeccCCCeEEEEecCCc
Q 007035 492 FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSL-GIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (621)
Q Consensus 492 ~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~-gIvHrDLKP~NILl~~~~~~~IKL~DFGls 570 (621)
++||||++++|.+++...... ...+++..++.++.||+.||.|||++ +++||||||+||+++. ++.+||+|||++
T Consensus 76 ~lv~e~~~~~l~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~--~~~~kl~dfg~~ 151 (283)
T cd06617 76 WICMEVMDTSLDKFYKKVYDK--GLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINR--NGQVKLCDFGIS 151 (283)
T ss_pred EEEhhhhcccHHHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECC--CCCEEEeecccc
Confidence 999999999888877643222 23489999999999999999999997 9999999999999984 788999999998
Q ss_pred cccCCC--ccccccCCcccCchhhcC----CCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 571 CFQTDN--LCLYVQSRSYRAPEVIIG----LPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 571 ~~~~~~--~~~~~gt~~Y~APEvl~~----~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
...... .....++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||
T Consensus 152 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~ 207 (283)
T cd06617 152 GYLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPY 207 (283)
T ss_pred cccccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCC
Confidence 754332 223467889999999865 44688999999999999999999998
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-29 Score=297.19 Aligned_cols=205 Identities=29% Similarity=0.411 Sum_probs=167.1
Q ss_pred eCeeecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecC---chhhhhHHHHHHHHHHhcccCCCCCCceEEEeeE
Q 007035 408 LNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDY 484 (621)
Q Consensus 408 l~~ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~---~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~ 484 (621)
.+.+..++|.+++.||.|+||+||+|+++.++..+|+|++... ......+..|+.+++.+. ||||++++++
T Consensus 7 ~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~------HPNIVrl~d~ 80 (1021)
T PTZ00266 7 DGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELK------HKNIVRYIDR 80 (1021)
T ss_pred CCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcC------CCCcCeEEEE
Confidence 3556678999999999999999999999999999999998753 233456777888888774 7899999999
Q ss_pred eEec--CeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHC-------CeecccCCCccEEE
Q 007035 485 FYHL--EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSL-------GIIHCDLKPENILI 554 (621)
Q Consensus 485 f~~~--~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~-------gIvHrDLKP~NILl 554 (621)
|... ..+||||||+.+ +|.+++...... ...+++..++.|+.||+.||.|||+. +|+||||||+||||
T Consensus 81 f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~--~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL 158 (1021)
T PTZ00266 81 FLNKANQKLYILMEFCDAGDLSRNIQKCYKM--FGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFL 158 (1021)
T ss_pred EEecCCCEEEEEEeCCCCCcHHHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEe
Confidence 8654 579999999985 777776543221 12389999999999999999999985 49999999999999
Q ss_pred ecc---------------CCCeEEEEecCCccccCCC--ccccccCCcccCchhhcC--CCCCchhhHHHHHHHHHHHHh
Q 007035 555 KSY---------------QRCEIKIIDLGSSCFQTDN--LCLYVQSRSYRAPEVIIG--LPYDQKIDLWSLGCILAELWT 615 (621)
Q Consensus 555 ~~~---------------~~~~IKL~DFGls~~~~~~--~~~~~gt~~Y~APEvl~~--~~~s~ksDIWSLGvILyELlt 615 (621)
+.. ....+||+|||++...... .....+|+.|+|||++.+ ..++.++||||||||||+|++
T Consensus 159 ~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLT 238 (1021)
T PTZ00266 159 STGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCS 238 (1021)
T ss_pred ecCccccccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHH
Confidence 641 2345899999998765332 233578999999999965 347899999999999999999
Q ss_pred CCCCC
Q 007035 616 GEVCL 620 (621)
Q Consensus 616 G~~PF 620 (621)
|+.||
T Consensus 239 Gk~PF 243 (1021)
T PTZ00266 239 GKTPF 243 (1021)
T ss_pred CCCCC
Confidence 99998
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=295.47 Aligned_cols=199 Identities=26% Similarity=0.372 Sum_probs=164.4
Q ss_pred CceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc----hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecC
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~ 489 (621)
++|++.++||+|+||.||+|.+..+|+.||+|+++.+. ...+++.+|+++++.+ .||||+++++++.+.+
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L------~HPNIVkl~~v~~d~~ 75 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADL------IHPGIVPVYSICSDGD 75 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhC------CCcCcCeEEEEEeeCC
Confidence 68999999999999999999999999999999987532 2345567777777766 4789999999999999
Q ss_pred eEEEEEecccc-chHHHHHhhhccC-----CCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEE
Q 007035 490 HLFIVCELLRA-NLYEFQKFNQESG-----GEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 563 (621)
Q Consensus 490 ~l~LVmEyl~g-sLld~l~~~~~~~-----~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IK 563 (621)
..++||||+++ +|.+++....... ....++...+..++.||+.||.|||++||+||||||+|||++. ++.++
T Consensus 76 ~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~--dg~vK 153 (932)
T PRK13184 76 PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGL--FGEVV 153 (932)
T ss_pred EEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcC--CCCEE
Confidence 99999999985 6666664321110 0122556778889999999999999999999999999999984 78899
Q ss_pred EEecCCccccCC---------------------CccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 564 IIDLGSSCFQTD---------------------NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 564 L~DFGls~~~~~---------------------~~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
|+|||++..... .....+||+.|+|||++.+..++.++|||||||++|||+||+.||
T Consensus 154 LiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF 231 (932)
T PRK13184 154 ILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPY 231 (932)
T ss_pred EEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCC
Confidence 999999865411 011246899999999999999999999999999999999999998
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-32 Score=272.19 Aligned_cols=193 Identities=26% Similarity=0.447 Sum_probs=170.9
Q ss_pred CceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeEEE
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFI 493 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l~L 493 (621)
.-|.|+++||.|+||.||+|.|+.+|+.+|||.+..+.+ .+++..|+.|++++. .++++++|+.|.....+||
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sD-LQEIIKEISIMQQC~------S~yVVKYYGSYFK~sDLWI 105 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTD-LQEIIKEISIMQQCK------SKYVVKYYGSYFKHSDLWI 105 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccch-HHHHHHHHHHHHHcC------CchhhhhhhhhccCCceEe
Confidence 347788999999999999999999999999999987765 467788888888775 4689999999999999999
Q ss_pred EEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCccc
Q 007035 494 VCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF 572 (621)
Q Consensus 494 VmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~~ 572 (621)
|||||+. +.-+.+...+. .+++.++..+++..+.||+|||...-+|||||..|||++ .+|+.||+|||.+..
T Consensus 106 VMEYCGAGSiSDI~R~R~K-----~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLN--T~G~AKLADFGVAGQ 178 (502)
T KOG0574|consen 106 VMEYCGAGSISDIMRARRK-----PLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLN--TDGIAKLADFGVAGQ 178 (502)
T ss_pred ehhhcCCCcHHHHHHHhcC-----CccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEc--ccchhhhhhccccch
Confidence 9999995 55555543332 399999999999999999999999999999999999999 489999999999987
Q ss_pred cCCC---ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 573 QTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 573 ~~~~---~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
..+. ..+..|||.|||||++....|..++||||||++..||..|++||
T Consensus 179 LTDTMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPY 229 (502)
T KOG0574|consen 179 LTDTMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPY 229 (502)
T ss_pred hhhhHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCc
Confidence 6653 45578999999999999999999999999999999999999998
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-29 Score=257.20 Aligned_cols=198 Identities=22% Similarity=0.324 Sum_probs=166.4
Q ss_pred eecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCe
Q 007035 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (621)
Q Consensus 411 ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~ 490 (621)
+....|.+.+.||.|+||.||+|.+..+++.||+|++..+......+.+|+++++.+ .|+||+++++++.....
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~~~~~ 76 (263)
T cd05052 3 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI------KHPNLVQLLGVCTREPP 76 (263)
T ss_pred CchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhC------CCCChhheEEEEcCCCC
Confidence 344679999999999999999999999999999999987655556677788887776 47899999999999999
Q ss_pred EEEEEeccc-cchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCC
Q 007035 491 LFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (621)
Q Consensus 491 l~LVmEyl~-gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGl 569 (621)
+++||||+. ++|.+++..... ..+++..++.++.|++.||.|||+++++||||||+||+++ .++.+||+|||+
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~--~~~~~kl~df~~ 150 (263)
T cd05052 77 FYIITEFMTYGNLLDYLRECNR----QEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG--ENHLVKVADFGL 150 (263)
T ss_pred cEEEEEeCCCCcHHHHHHhCCC----CCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEc--CCCcEEeCCCcc
Confidence 999999997 467776654321 2278888999999999999999999999999999999998 478899999999
Q ss_pred ccccCCCccc----cccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 570 SCFQTDNLCL----YVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 570 s~~~~~~~~~----~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
+......... ...++.|+|||.+.+..++.++|||||||++|+|++ |..||
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~ 206 (263)
T cd05052 151 SRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 206 (263)
T ss_pred ccccccceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCC
Confidence 8665433211 123567999999998899999999999999999998 88886
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-29 Score=262.99 Aligned_cols=193 Identities=30% Similarity=0.406 Sum_probs=164.6
Q ss_pred CceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecC--chhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeE
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~--~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l 491 (621)
++|++.+.||+|+||.||++.+..++..+|+|.+..+ .....++.+|+++++.+ +||||+++++.+...+++
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l------~h~~iv~~~~~~~~~~~~ 74 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHEC------NSPYIVGFYGAFYSDGEI 74 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhC------CCCCCCeEEEEEeeCCEE
Confidence 4699999999999999999999999999999998754 22344566777777766 478999999999999999
Q ss_pred EEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHH-CCeecccCCCccEEEeccCCCeEEEEecCC
Q 007035 492 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS-LGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (621)
Q Consensus 492 ~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs-~gIvHrDLKP~NILl~~~~~~~IKL~DFGl 569 (621)
++||||+.+ +|.+++.... .+++..+..++.||+.||.|||+ .+++||||||+|||++. ++.++|+|||+
T Consensus 75 ~lv~ey~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~--~~~~~l~dfg~ 146 (308)
T cd06615 75 SICMEHMDGGSLDQVLKKAG------RIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNS--RGEIKLCDFGV 146 (308)
T ss_pred EEEeeccCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEec--CCcEEEccCCC
Confidence 999999985 6666665432 27889999999999999999997 59999999999999984 77899999998
Q ss_pred ccccCCC-ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 570 SCFQTDN-LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 570 s~~~~~~-~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
+...... .....+++.|+|||.+.+..++.++|+||||+++|+|++|+.||
T Consensus 147 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~ 198 (308)
T cd06615 147 SGQLIDSMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPI 198 (308)
T ss_pred cccccccccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCC
Confidence 7654322 33456789999999998888999999999999999999999997
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-29 Score=255.53 Aligned_cols=197 Identities=28% Similarity=0.403 Sum_probs=164.8
Q ss_pred CceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecC----chhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecC
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~----~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~ 489 (621)
++|++.+.||.|+||.||+|+++.+++.||||.+... ......+.+|+.+++.+ .||||+++++++...+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~~~~ 75 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQL------NHPNVIKYLDSFIEDN 75 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhC------CCcceeeeeeeEEECC
Confidence 5799999999999999999999999999999987642 22334566777777766 4789999999999999
Q ss_pred eEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecC
Q 007035 490 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (621)
Q Consensus 490 ~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFG 568 (621)
..++||||+++ +|.+++...... ...+++..+..++.||+.||.|||+++++|+||+|+||+++. ++.++|+|||
T Consensus 76 ~~~~v~e~~~~~~L~~~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~--~~~~~l~d~g 151 (267)
T cd08228 76 ELNIVLELADAGDLSQMIKYFKKQ--KRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITA--TGVVKLGDLG 151 (267)
T ss_pred eEEEEEEecCCCcHHHHHHHhhhc--cCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcC--CCCEEECccc
Confidence 99999999985 666665433221 223788899999999999999999999999999999999984 7789999999
Q ss_pred CccccCCCc---cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 569 SSCFQTDNL---CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 569 ls~~~~~~~---~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
++....... ....+++.|+|||.+.+..++.++|+||||+++|+|++|+.||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~ 206 (267)
T cd08228 152 LGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF 206 (267)
T ss_pred cceeccchhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCC
Confidence 876644322 1245788899999999888999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-31 Score=266.76 Aligned_cols=201 Identities=30% Similarity=0.487 Sum_probs=172.8
Q ss_pred CceEEEEEeccCCCCceeEEEeCCCCc----EEEEEEEecCc---hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeE
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQDLHTGV----DVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d~~tg~----~VAlKii~~~~---~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~ 486 (621)
..|+++.+||.|.||.||+|..+.++. .+|||.++.++ .......+|+.++++++ |+||+.+..+|.
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~------h~nvi~Lv~Vfl 97 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELK------HPNVISLVKVFL 97 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhc------CCcchhHHHHHh
Confidence 468999999999999999996544432 68999988653 34567889999999996 568999999998
Q ss_pred e-cCeEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEecc--CCCeEE
Q 007035 487 H-LEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSY--QRCEIK 563 (621)
Q Consensus 487 ~-~~~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~--~~~~IK 563 (621)
. ...+++++||.+..|++.+........ ..++...++.|++||+.|+.|||++-|+||||||.||||..+ ..|.||
T Consensus 98 ~~d~~v~l~fdYAEhDL~~II~fHr~~~~-~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VK 176 (438)
T KOG0666|consen 98 SHDKKVWLLFDYAEHDLWHIIKFHRASKA-KQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVK 176 (438)
T ss_pred ccCceEEEEehhhhhhHHHHHHHhccchh-ccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeE
Confidence 7 788999999999999999987765554 569999999999999999999999999999999999999743 358999
Q ss_pred EEecCCccccCCCccc------cccCCcccCchhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCC
Q 007035 564 IIDLGSSCFQTDNLCL------YVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVCLI 621 (621)
Q Consensus 564 L~DFGls~~~~~~~~~------~~gt~~Y~APEvl~~~~-~s~ksDIWSLGvILyELltG~~PF~ 621 (621)
|+|||+++....+... .+-|.+|+|||.+.|.. |+.++||||+|||+.||+|-+++|.
T Consensus 177 IaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~ 241 (438)
T KOG0666|consen 177 IADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFK 241 (438)
T ss_pred eecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCcccc
Confidence 9999999887665433 35589999999999875 9999999999999999999999883
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=274.45 Aligned_cols=197 Identities=28% Similarity=0.386 Sum_probs=172.3
Q ss_pred cCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecC----chhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEec
Q 007035 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (621)
Q Consensus 413 ~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~----~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~ 488 (621)
.+.|+.-+.||+|+||.|+-++...||+-+|+|.+.+. +......+.|..||.+++. ++||.+-..|+..
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s------~FiVslaYAfeTk 257 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSS------PFIVSLAYAFETK 257 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhcc------CcEEEEeeeecCC
Confidence 46689999999999999999999999999999987542 2223456778888888865 4899999999999
Q ss_pred CeEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecC
Q 007035 489 EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (621)
Q Consensus 489 ~~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFG 568 (621)
+.+|+||..|+|+-+.+...+.. ...|++..++.++.+|+.||.+||..+||.|||||+|||++ +.|+|+|+|+|
T Consensus 258 d~LClVLtlMNGGDLkfHiyn~g---~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLD--d~GhvRISDLG 332 (591)
T KOG0986|consen 258 DALCLVLTLMNGGDLKFHIYNHG---NPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLD--DHGHVRISDLG 332 (591)
T ss_pred CceEEEEEeecCCceeEEeeccC---CCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeec--cCCCeEeeccc
Confidence 99999999999877666655433 23499999999999999999999999999999999999999 59999999999
Q ss_pred CccccCCC--ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 569 SSCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 569 ls~~~~~~--~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
+|..+... ....+||.+|||||++.+..|+...|+|||||+||||+.|+-||
T Consensus 333 LAvei~~g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPF 386 (591)
T KOG0986|consen 333 LAVEIPEGKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPF 386 (591)
T ss_pred eEEecCCCCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCch
Confidence 99876543 44468999999999999999999999999999999999999998
|
|
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-29 Score=253.71 Aligned_cols=194 Identities=28% Similarity=0.456 Sum_probs=164.5
Q ss_pred ceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc--hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeEE
Q 007035 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLF 492 (621)
Q Consensus 415 rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l~ 492 (621)
+|++.+.||.|+||.||+++++.+++.+|+|.++... ...+....|+.+++.+ +|+||+++++.+...++++
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~~~~~~~ 74 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKM------KHPNIVAFKESFEADGHLY 74 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhC------CCCCcceEEEEEEECCEEE
Confidence 5899999999999999999999999999999986432 3345566677776655 4789999999999999999
Q ss_pred EEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCcc
Q 007035 493 IVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 571 (621)
Q Consensus 493 LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~ 571 (621)
+||||+++ ++.+.+..... ..+++..+..++.||+.||.|||+++|+|+||||+||+++. ++.++|+|||++.
T Consensus 75 lv~e~~~~~~l~~~~~~~~~----~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~--~~~~~l~dfg~~~ 148 (255)
T cd08219 75 IVMEYCDGGDLMQKIKLQRG----KLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQ--NGKVKLGDFGSAR 148 (255)
T ss_pred EEEeeCCCCcHHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECC--CCcEEEcccCcce
Confidence 99999975 67766653221 23788899999999999999999999999999999999984 7889999999986
Q ss_pred ccCCC---ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 572 FQTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 572 ~~~~~---~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
..... .....+++.|+|||++.+..++.++|+||||+++|+|++|+.||
T Consensus 149 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~ 200 (255)
T cd08219 149 LLTSPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPF 200 (255)
T ss_pred eecccccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCC
Confidence 54332 22356788999999999888999999999999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-29 Score=251.47 Aligned_cols=194 Identities=27% Similarity=0.400 Sum_probs=163.8
Q ss_pred ceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecC---chhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeE
Q 007035 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (621)
Q Consensus 415 rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~---~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l 491 (621)
+|.+.+.||.|++|.||++.+..+++.|++|.+... ......+.+|+++++.+ .||||+++++++...+..
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~~~~~~ 74 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKL------DSSYIIRYYESFLDKGKL 74 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhc------CCCCeehheeeeccCCEE
Confidence 478899999999999999999999999999998753 23345566667666655 478999999999999999
Q ss_pred EEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCc
Q 007035 492 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (621)
Q Consensus 492 ~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls 570 (621)
++||||+.+ +|.+++..... ..++...++.++.||+.||.|||+.+|+|+||+|+||+++. ++.++|+|||++
T Consensus 75 ~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~--~~~~~l~df~~~ 148 (256)
T cd08529 75 NIVMEYAENGDLHKLLKMQRG----RPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDA--YDNVKIGDLGVA 148 (256)
T ss_pred EEEEEeCCCCcHHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeC--CCCEEEcccccc
Confidence 999999974 77776654321 23788899999999999999999999999999999999984 788999999987
Q ss_pred cccCCCc---cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 571 CFQTDNL---CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 571 ~~~~~~~---~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
....... ....+++.|+|||++.+..++.++|+||||+++|+|++|+.||
T Consensus 149 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~ 201 (256)
T cd08529 149 KLLSDNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPF 201 (256)
T ss_pred eeccCccchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCC
Confidence 6544322 2346788999999999988999999999999999999999998
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-29 Score=258.01 Aligned_cols=196 Identities=29% Similarity=0.463 Sum_probs=163.4
Q ss_pred CceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc---hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCe
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~---~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~ 490 (621)
++|++.+.||.|++|.||+|.++.+|+.||+|.+.... .....+.+|+++++.++ |+||+++++++....+
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~~~ 75 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQ------HGNIVRLQDVVHSEKR 75 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhcc------CCCEeeEEEEEecCCe
Confidence 57999999999999999999999999999999886532 22345667777777664 6899999999999999
Q ss_pred EEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCc
Q 007035 491 LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (621)
Q Consensus 491 l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls 570 (621)
.++||||+++++.+.+..... ..+++..++.++.||+.||.|||+++|+|+||+|+||+++. .++.+||+|||++
T Consensus 76 ~~lv~e~~~~~l~~~~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~-~~~~~kl~dfg~~ 150 (294)
T PLN00009 76 LYLVFEYLDLDLKKHMDSSPD----FAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDR-RTNALKLADFGLA 150 (294)
T ss_pred EEEEEecccccHHHHHHhCCC----CCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEEC-CCCEEEEcccccc
Confidence 999999999888887754322 22577888899999999999999999999999999999984 3567999999998
Q ss_pred cccCCC---ccccccCCcccCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 571 CFQTDN---LCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 571 ~~~~~~---~~~~~gt~~Y~APEvl~~~-~~s~ksDIWSLGvILyELltG~~PF 620 (621)
...... .....+++.|+|||.+.+. .++.++||||||+++|+|+||++||
T Consensus 151 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf 204 (294)
T PLN00009 151 RAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLF 204 (294)
T ss_pred cccCCCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 654322 2233567889999998764 5788999999999999999999997
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-29 Score=255.47 Aligned_cols=194 Identities=27% Similarity=0.431 Sum_probs=161.8
Q ss_pred cCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc-hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeE
Q 007035 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (621)
Q Consensus 413 ~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~-~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l 491 (621)
..+|++.+.||+|+||.||+|++..+++.||+|++.... .......+|+.+++.+ +||||+++++.+...+..
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~------~h~~ii~~~~~~~~~~~~ 81 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKEC------KHCNIVAYFGSYLSREKL 81 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhc------CCCCeeeeeEEEEeCCEE
Confidence 467999999999999999999999999999999987532 2234456677766655 578999999999999999
Q ss_pred EEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCc
Q 007035 492 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (621)
Q Consensus 492 ~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls 570 (621)
++||||+++ +|.+.+.... .+++..+..++.|++.||.|||+.+|+||||+|+||+++ .++.++|+|||++
T Consensus 82 ~iv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~--~~~~~~l~dfg~~ 153 (267)
T cd06646 82 WICMEYCGGGSLQDIYHVTG------PLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLT--DNGDVKLADFGVA 153 (267)
T ss_pred EEEEeCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEC--CCCCEEECcCccc
Confidence 999999985 6666554322 278899999999999999999999999999999999998 4778999999998
Q ss_pred cccCCC---ccccccCCcccCchhhc---CCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 571 CFQTDN---LCLYVQSRSYRAPEVII---GLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 571 ~~~~~~---~~~~~gt~~Y~APEvl~---~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
...... .....+++.|+|||.+. ...++.++|+|||||++|+|++|+.||
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~ 209 (267)
T cd06646 154 AKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPM 209 (267)
T ss_pred eeecccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCc
Confidence 754322 22346788999999985 344788999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-29 Score=260.22 Aligned_cols=197 Identities=32% Similarity=0.488 Sum_probs=162.1
Q ss_pred ecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc-hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCe
Q 007035 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (621)
Q Consensus 412 i~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~-~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~ 490 (621)
..+.|++++.||.|+||.||+|++..+++.+++|++.... .....+.+|+.+++.+ .|+||+++++.+.....
T Consensus 10 ~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~~~~~ 83 (292)
T cd06644 10 PNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATC------NHPYIVKLLGAFYWDGK 83 (292)
T ss_pred cchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhC------CCCcEeeeEEEEEeCCe
Confidence 3467999999999999999999999999999999987543 3345566677766655 47899999999999999
Q ss_pred EEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCc
Q 007035 491 LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (621)
Q Consensus 491 l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls 570 (621)
.++||||++++.+..+...... .+++..++.++.||+.||.|||+.+|+||||||+||+++ .++.++|+|||++
T Consensus 84 ~~lv~e~~~~~~l~~~~~~~~~----~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~--~~~~~kl~dfg~~ 157 (292)
T cd06644 84 LWIMIEFCPGGAVDAIMLELDR----GLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLT--LDGDIKLADFGVS 157 (292)
T ss_pred EEEEEecCCCCcHHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEc--CCCCEEEccCccc
Confidence 9999999997655433322111 278899999999999999999999999999999999998 4788999999987
Q ss_pred cccCCC---ccccccCCcccCchhhc-----CCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 571 CFQTDN---LCLYVQSRSYRAPEVII-----GLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 571 ~~~~~~---~~~~~gt~~Y~APEvl~-----~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
...... .....+++.|+|||++. ...++.++|||||||++|+|++|++||
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~ 215 (292)
T cd06644 158 AKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPH 215 (292)
T ss_pred eeccccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCC
Confidence 653322 22346788999999985 345788999999999999999999997
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-29 Score=254.50 Aligned_cols=196 Identities=26% Similarity=0.371 Sum_probs=164.1
Q ss_pred ecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeE
Q 007035 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (621)
Q Consensus 412 i~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l 491 (621)
-.++|+++++||.|+||.||+|.+. .+..||+|.+.......+.+.+|+.+++.++ |+||+++++.+......
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~~~~ 76 (261)
T cd05072 4 PRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTMSVQAFLEEANLMKTLQ------HDKLVRLYAVVTKEEPI 76 (261)
T ss_pred chHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCchhHHHHHHHHHHHHhCC------CCCeeeEEEEEcCCCCc
Confidence 3578999999999999999999864 5667999998765555567778888887764 78999999999999999
Q ss_pred EEEEeccc-cchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCc
Q 007035 492 FIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (621)
Q Consensus 492 ~LVmEyl~-gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls 570 (621)
++||||+. ++|.+++..... ..+++..+..++.||+.||+|||+.+++||||||+||+++. ++.++|+|||++
T Consensus 77 ~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~--~~~~~l~dfg~~ 150 (261)
T cd05072 77 YIITEYMAKGSLLDFLKSDEG----GKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSE--SLMCKIADFGLA 150 (261)
T ss_pred EEEEecCCCCcHHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecC--CCcEEECCCccc
Confidence 99999997 577777654321 22778889999999999999999999999999999999984 788999999998
Q ss_pred cccCCCcc----ccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 571 CFQTDNLC----LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 571 ~~~~~~~~----~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
........ ...++..|+|||.+.+..++.++|||||||++|+|++ |+.||
T Consensus 151 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~ 205 (261)
T cd05072 151 RVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPY 205 (261)
T ss_pred eecCCCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCC
Confidence 76543221 1234567999999988889999999999999999998 99987
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.8e-31 Score=281.01 Aligned_cols=183 Identities=31% Similarity=0.426 Sum_probs=156.1
Q ss_pred eEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeEEEEE
Q 007035 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVC 495 (621)
Q Consensus 416 Y~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l~LVm 495 (621)
..-++-||+|+.|.||+|+ -.++.||||.++.-+ ..+++-|++| +||||+.+.++|......||||
T Consensus 126 IsELeWlGSGaQGAVF~Gr--l~netVAVKKV~elk------ETdIKHLRkL------kH~NII~FkGVCtqsPcyCIiM 191 (904)
T KOG4721|consen 126 ISELEWLGSGAQGAVFLGR--LHNETVAVKKVRELK------ETDIKHLRKL------KHPNIITFKGVCTQSPCYCIIM 191 (904)
T ss_pred hhhhhhhccCcccceeeee--ccCceehhHHHhhhh------hhhHHHHHhc------cCcceeeEeeeecCCceeEEee
Confidence 3445669999999999997 568899999775322 2344455544 5889999999999999999999
Q ss_pred eccc-cchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCccccC
Q 007035 496 ELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQT 574 (621)
Q Consensus 496 Eyl~-gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~~~~ 574 (621)
|||. |-|++.++..+. ++...+..|..+|+.||.|||.+.|||||||.-||||.. +..|||+|||-+....
T Consensus 192 EfCa~GqL~~VLka~~~------itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~--~d~VKIsDFGTS~e~~ 263 (904)
T KOG4721|consen 192 EFCAQGQLYEVLKAGRP------ITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISY--DDVVKISDFGTSKELS 263 (904)
T ss_pred eccccccHHHHHhccCc------cCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeec--cceEEeccccchHhhh
Confidence 9998 677777765433 777888899999999999999999999999999999994 6789999999987765
Q ss_pred CCcc--ccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 575 DNLC--LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 575 ~~~~--~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
+..+ .++||..|||||++.+.+.+.|+|||||||+|||||||+.||
T Consensus 264 ~~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPY 311 (904)
T KOG4721|consen 264 DKSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPY 311 (904)
T ss_pred hhhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCc
Confidence 5433 479999999999999999999999999999999999999998
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-29 Score=256.69 Aligned_cols=194 Identities=32% Similarity=0.544 Sum_probs=167.2
Q ss_pred CceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecC---chhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCe
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~---~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~ 490 (621)
++|++.+.||.|++|.||+|.+..+++.|++|.++.. ......+.+|+++++.+. |+||+++++++...+.
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~------~~~i~~~~~~~~~~~~ 74 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLR------HENIVNLKEAFRRKGR 74 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcC------CCCeeehhheEEECCE
Confidence 4799999999999999999999999999999988653 233456778888888775 6799999999999999
Q ss_pred EEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCc
Q 007035 491 LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (621)
Q Consensus 491 l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls 570 (621)
.++||||+++++++.+..... .+++..++.++.||+.||.|||+.+++|+||+|+||+++. ++.++|+|||++
T Consensus 75 ~~iv~e~~~~~~l~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~--~~~~kl~d~g~~ 147 (288)
T cd07833 75 LYLVFEYVERTLLELLEASPG-----GLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSE--SGVLKLCDFGFA 147 (288)
T ss_pred EEEEEecCCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECC--CCCEEEEeeecc
Confidence 999999999888776554322 2788999999999999999999999999999999999984 888999999987
Q ss_pred cccCCCc----cccccCCcccCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 571 CFQTDNL----CLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 571 ~~~~~~~----~~~~gt~~Y~APEvl~~~-~~s~ksDIWSLGvILyELltG~~PF 620 (621)
....... ....++..|+|||++.+. .++.++||||||+++|+|++|++||
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~ 202 (288)
T cd07833 148 RALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLF 202 (288)
T ss_pred cccCCCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCC
Confidence 6544322 235668889999999888 7899999999999999999999887
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=272.05 Aligned_cols=201 Identities=24% Similarity=0.328 Sum_probs=162.8
Q ss_pred cCceEEEEEeccCCCCceeEEEe-----CCCCcEEEEEEEecCc--hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEe
Q 007035 413 AGRYYVTEYLGSAAFSKVFQAQD-----LHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYF 485 (621)
Q Consensus 413 ~~rY~I~~~LG~G~fG~Vyka~d-----~~tg~~VAlKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f 485 (621)
.++|++.+.||+|+||.||+|.+ ..++..||+|+++... ...+.+.+|+.+++.+. .||||+++++++
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~-----~HpnIv~l~~~~ 108 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG-----NHINIVNLLGAC 108 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhc-----CCcceeeeeeee
Confidence 46899999999999999999974 3567789999987532 23456778888888774 478999999999
Q ss_pred EecCeEEEEEeccc-cchHHHHHhhhcc----------------------------------------------------
Q 007035 486 YHLEHLFIVCELLR-ANLYEFQKFNQES---------------------------------------------------- 512 (621)
Q Consensus 486 ~~~~~l~LVmEyl~-gsLld~l~~~~~~---------------------------------------------------- 512 (621)
......++||||+. |+|.+++......
T Consensus 109 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 188 (375)
T cd05104 109 TVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS 188 (375)
T ss_pred ccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence 99999999999998 4777776532210
Q ss_pred -----------------CCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCccccCC
Q 007035 513 -----------------GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTD 575 (621)
Q Consensus 513 -----------------~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~~~~~ 575 (621)
.....+++..+..++.||+.||.|||+++|+||||||+|||++. ++.+||+|||++.....
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~--~~~~kl~DfG~a~~~~~ 266 (375)
T cd05104 189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTH--GRITKICDFGLARDIRN 266 (375)
T ss_pred cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEEC--CCcEEEecCccceeccC
Confidence 01123678889999999999999999999999999999999984 77899999999865433
Q ss_pred Ccc-----ccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 576 NLC-----LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 576 ~~~-----~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
... ...++..|+|||++.+..++.++|||||||++|+|++ |..||
T Consensus 267 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~ 317 (375)
T cd05104 267 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPY 317 (375)
T ss_pred cccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCC
Confidence 221 1223567999999999999999999999999999998 88887
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-29 Score=257.81 Aligned_cols=198 Identities=27% Similarity=0.448 Sum_probs=164.8
Q ss_pred ecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEe----
Q 007035 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH---- 487 (621)
Q Consensus 412 i~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~---- 487 (621)
..+.|++.+.||.|+||.||+|++..+++.+|+|++............|+.+++.+. .|+||+++++++..
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~-----~h~~i~~~~~~~~~~~~~ 88 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYS-----HHRNIATYYGAFIKKSPP 88 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhc-----CCCcEEEEeeehhccccc
Confidence 347899999999999999999999999999999998876555566777777777764 47899999999863
Q ss_pred --cCeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEE
Q 007035 488 --LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKI 564 (621)
Q Consensus 488 --~~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL 564 (621)
..++++||||+++ +|.+++..... ..+++..++.++.||+.||.|||+.+|+|+||+|+||+++. ++.++|
T Consensus 89 ~~~~~~~iv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~--~~~~~l 162 (282)
T cd06636 89 GHDDQLWLVMEFCGAGSVTDLVKNTKG----NALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTE--NAEVKL 162 (282)
T ss_pred CCCCEEEEEEEeCCCCcHHHHHHHccC----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECC--CCCEEE
Confidence 4689999999986 67666654322 12778889999999999999999999999999999999984 778999
Q ss_pred EecCCccccCC---CccccccCCcccCchhhc-----CCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 565 IDLGSSCFQTD---NLCLYVQSRSYRAPEVII-----GLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 565 ~DFGls~~~~~---~~~~~~gt~~Y~APEvl~-----~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
+|||++..... ......+++.|+|||++. ...++.++|||||||++|+|++|+.||
T Consensus 163 ~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~ 226 (282)
T cd06636 163 VDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPL 226 (282)
T ss_pred eeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCc
Confidence 99998765432 223356788999999986 345788999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-29 Score=251.74 Aligned_cols=196 Identities=29% Similarity=0.460 Sum_probs=164.8
Q ss_pred cCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc-hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeE
Q 007035 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (621)
Q Consensus 413 ~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~-~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l 491 (621)
.++|++.+.||.|+||.||++.+..+++.+++|++.... .....+.+|+.+++.+ +||||+++++.+.....+
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~------~h~~i~~~~~~~~~~~~~ 75 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKEC------RHPNIVAYFGSYLRRDKL 75 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhC------CCCChhceEEEEEeCCEE
Confidence 368999999999999999999999999999999987643 2345666777776665 478999999999999999
Q ss_pred EEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCc
Q 007035 492 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (621)
Q Consensus 492 ~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls 570 (621)
+++|||+++ +|.+++..... .+++..++.++.|++.||.|||+.+|+|+||+|+||+++ .++.++|+|||++
T Consensus 76 ~l~~e~~~~~~l~~~~~~~~~-----~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~--~~~~~~l~d~g~~ 148 (262)
T cd06613 76 WIVMEYCGGGSLQDIYQVTRG-----PLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLT--EDGDVKLADFGVS 148 (262)
T ss_pred EEEEeCCCCCcHHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEEC--CCCCEEECccccc
Confidence 999999986 55555443211 288999999999999999999999999999999999999 4788999999988
Q ss_pred cccCCC---ccccccCCcccCchhhcCC---CCCchhhHHHHHHHHHHHHhCCCCCC
Q 007035 571 CFQTDN---LCLYVQSRSYRAPEVIIGL---PYDQKIDLWSLGCILAELWTGEVCLI 621 (621)
Q Consensus 571 ~~~~~~---~~~~~gt~~Y~APEvl~~~---~~s~ksDIWSLGvILyELltG~~PF~ 621 (621)
...... .....++..|+|||.+.+. .++.++|+||||+++|+|++|++||.
T Consensus 149 ~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~ 205 (262)
T cd06613 149 AQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMF 205 (262)
T ss_pred hhhhhhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCC
Confidence 654432 2334678889999999776 78899999999999999999999983
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-30 Score=279.06 Aligned_cols=198 Identities=26% Similarity=0.389 Sum_probs=167.7
Q ss_pred eeeCeeecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEec---CchhhhhHHHHHHHHHHhcccCCCCCCceEEEe
Q 007035 406 IILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKN---DKDFFDQSLDEIKLLKLVNKNDPADEHHILRLY 482 (621)
Q Consensus 406 i~l~~ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~---~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~ 482 (621)
...+++..+...+.+.||+|.||+||+|++ -| .||||+++. .....+.++.|+..+++-+ |-||+-++
T Consensus 384 ~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~w--hG-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTR------H~NIlLFM 454 (678)
T KOG0193|consen 384 LEEWEIPPEEVLLGERIGSGSFGTVYRGRW--HG-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTR------HENILLFM 454 (678)
T ss_pred ccccccCHHHhhccceeccccccceeeccc--cc-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcc------hhhheeee
Confidence 367788889999999999999999999985 44 499999875 3456788899999998876 45899999
Q ss_pred eEeEecCeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCe
Q 007035 483 DYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCE 561 (621)
Q Consensus 483 ~~f~~~~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~ 561 (621)
+++....+ .||+-+|+| +|+.++...... |....++.|++||++||.|||.++|||||||..||++.. +++
T Consensus 455 G~~~~p~~-AIiTqwCeGsSLY~hlHv~etk-----fdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~--~~k 526 (678)
T KOG0193|consen 455 GACMNPPL-AIITQWCEGSSLYTHLHVQETK-----FDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHE--DLK 526 (678)
T ss_pred hhhcCCce-eeeehhccCchhhhhccchhhh-----hhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEcc--CCc
Confidence 99998888 999999998 677777654432 889999999999999999999999999999999999994 699
Q ss_pred EEEEecCCccccCC-----CccccccCCcccCchhhcC---CCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 562 IKIIDLGSSCFQTD-----NLCLYVQSRSYRAPEVIIG---LPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 562 IKL~DFGls~~~~~-----~~~~~~gt~~Y~APEvl~~---~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
|||+|||++..... ......+...|||||++.. .+|+..+||||||+++|||+||..||
T Consensus 527 VkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPy 593 (678)
T KOG0193|consen 527 VKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPY 593 (678)
T ss_pred EEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCc
Confidence 99999999754332 2222345677999999963 47999999999999999999999998
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.9e-30 Score=284.60 Aligned_cols=203 Identities=23% Similarity=0.322 Sum_probs=158.9
Q ss_pred CeeecCceEEEEEeccCCCCceeEEEeCCCC-cEEEE------------------EEEecCchhhhhHHHHHHHHHHhcc
Q 007035 409 NTVIAGRYYVTEYLGSAAFSKVFQAQDLHTG-VDVCL------------------KIIKNDKDFFDQSLDEIKLLKLVNK 469 (621)
Q Consensus 409 ~~ii~~rY~I~~~LG~G~fG~Vyka~d~~tg-~~VAl------------------Kii~~~~~~~~~~~~Ei~iL~~l~~ 469 (621)
+..+.++|++++.||+|+||+||++..+... ...++ |.+.........+.+|+.+++.+
T Consensus 143 ~~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l-- 220 (501)
T PHA03210 143 DDEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRL-- 220 (501)
T ss_pred chhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhC--
Confidence 3455688999999999999999998754322 22222 22222223344566777777766
Q ss_pred cCCCCCCceEEEeeEeEecCeEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCC
Q 007035 470 NDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKP 549 (621)
Q Consensus 470 ~~~~~hpnIvrl~~~f~~~~~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP 549 (621)
.||||+++++++...+..++|+|++.+++++++........ .......++.++.||+.||.|||++||+||||||
T Consensus 221 ----~HpnIv~l~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~-~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP 295 (501)
T PHA03210 221 ----NHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWK-DRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKL 295 (501)
T ss_pred ----CCCCcCcEeEEEEECCeeEEEEeccccCHHHHHhhcccccc-ccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCH
Confidence 47899999999999999999999999988887754322111 1134567788999999999999999999999999
Q ss_pred ccEEEeccCCCeEEEEecCCccccCCC----ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 550 ENILIKSYQRCEIKIIDLGSSCFQTDN----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 550 ~NILl~~~~~~~IKL~DFGls~~~~~~----~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
+|||++. ++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||+||||++|+.++
T Consensus 296 ~NILl~~--~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p 368 (501)
T PHA03210 296 ENIFLNC--DGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCP 368 (501)
T ss_pred HHEEECC--CCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 9999984 788999999998765432 22357899999999999999999999999999999999998654
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.5e-29 Score=256.52 Aligned_cols=200 Identities=32% Similarity=0.493 Sum_probs=165.4
Q ss_pred CceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCch---hhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCe
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD---FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~---~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~ 490 (621)
++|++.+.||.|+||.||+|.+..+++.||+|.++.... ......+|+.+++.+. .|+||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~-----~~~~i~~~~~~~~~~~~ 75 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLS-----ESIYIVRLLDVEHVEEK 75 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHcc-----CCCCccceeeeEeecCC
Confidence 469999999999999999999999999999998875422 2345677888888775 35799999999987665
Q ss_pred -----EEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEE
Q 007035 491 -----LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKII 565 (621)
Q Consensus 491 -----l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~ 565 (621)
.++||||+++++.+++...... ....+++..++.++.||+.||.|||+++|+||||+|+||+++. .++.++|+
T Consensus 76 ~~~~~~~lv~e~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~-~~~~~kl~ 153 (295)
T cd07837 76 NGKPSLYLVFEYLDSDLKKFMDSNGRG-PGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDK-QKGLLKIA 153 (295)
T ss_pred CCCceEEEEeeccCcCHHHHHHHhccc-CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEec-CCCeEEEe
Confidence 8999999999888887654322 1234889999999999999999999999999999999999984 36789999
Q ss_pred ecCCccccCCCc---cccccCCcccCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 566 DLGSSCFQTDNL---CLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 566 DFGls~~~~~~~---~~~~gt~~Y~APEvl~~-~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
|||++....... ....+++.|+|||++.+ ..++.++||||||+++|+|++|.+||
T Consensus 154 dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~ 212 (295)
T cd07837 154 DLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLF 212 (295)
T ss_pred ecccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCC
Confidence 999886543221 22345788999999865 45789999999999999999999998
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-29 Score=255.43 Aligned_cols=193 Identities=34% Similarity=0.568 Sum_probs=164.0
Q ss_pred ceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc---hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeE
Q 007035 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (621)
Q Consensus 415 rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~---~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l 491 (621)
+|++.+.||.|++|.||+|.+..+|+.||+|++.... .....+.+|+.+++.++ ||||+++++++......
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~------~~~i~~~~~~~~~~~~~ 74 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQ------HPYVVKLLDVFPHGSGF 74 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCC------CCCCcceeeEEecCCee
Confidence 5899999999999999999999999999999987543 23355667777777664 78999999999999999
Q ss_pred EEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCcc
Q 007035 492 FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 571 (621)
Q Consensus 492 ~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~ 571 (621)
++||||++++|.+.+.... ..+++..++.++.||+.||.|||+.+++|+||||+||+++. ++.++|+|||++.
T Consensus 75 ~~v~e~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~--~~~~~l~dfg~~~ 147 (286)
T cd07832 75 VLVMEYMPSDLSEVLRDEE-----RPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISA--DGVLKIADFGLAR 147 (286)
T ss_pred EEEecccCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcC--CCcEEEeeeeecc
Confidence 9999999778888776433 22889999999999999999999999999999999999985 7889999999887
Q ss_pred ccCCC----ccccccCCcccCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 572 FQTDN----LCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 572 ~~~~~----~~~~~gt~~Y~APEvl~~~-~~s~ksDIWSLGvILyELltG~~PF 620 (621)
..... .....++..|+|||++.+. .++.++||||||+++|+|++|++||
T Consensus 148 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~ 201 (286)
T cd07832 148 LFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLF 201 (286)
T ss_pred cccCCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCc
Confidence 65432 2234678899999998654 4688999999999999999998776
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-29 Score=253.27 Aligned_cols=193 Identities=29% Similarity=0.399 Sum_probs=160.3
Q ss_pred CceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc------hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEe
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK------DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~------~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~ 487 (621)
.+|++.+.||+|+||.||++.+..+++.||||.+.... .....+.+|+.+++.+ .||||+++++++.+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l------~h~~i~~~~~~~~~ 75 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNL------LHERIVQYYGCLRD 75 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhc------CCCCeeeEEeEecc
Confidence 46899999999999999999999999999999886421 1234556677777766 47899999999876
Q ss_pred c--CeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEE
Q 007035 488 L--EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKI 564 (621)
Q Consensus 488 ~--~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL 564 (621)
. ..+++||||+++ +|.+.+.... .+++..+..++.|++.||.|||+++|+|+||+|+||+++ .++.++|
T Consensus 76 ~~~~~~~~v~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~--~~~~~~l 147 (265)
T cd06652 76 PMERTLSIFMEHMPGGSIKDQLKSYG------ALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRD--SVGNVKL 147 (265)
T ss_pred CCCceEEEEEEecCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEec--CCCCEEE
Confidence 3 578899999975 6766654322 167888899999999999999999999999999999998 4788999
Q ss_pred EecCCccccCC------CccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 565 IDLGSSCFQTD------NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 565 ~DFGls~~~~~------~~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
+|||++..... ......++..|+|||++.+..++.++|||||||++|+|++|+.||
T Consensus 148 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~ 209 (265)
T cd06652 148 GDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPW 209 (265)
T ss_pred CcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCC
Confidence 99998865332 122345788899999998888999999999999999999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.7e-30 Score=276.73 Aligned_cols=197 Identities=25% Similarity=0.390 Sum_probs=165.6
Q ss_pred eecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchh----hhhHHHHHHHHHHhcccCCCCCCceEEEeeEeE
Q 007035 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDF----FDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (621)
Q Consensus 411 ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~----~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~ 486 (621)
+-..-|..++.||-|+||+|.++....+...||+|.+++.... ....+.|..||.+. +.+.||+||..|+
T Consensus 626 MdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEA------Dn~WVVrLyySFQ 699 (1034)
T KOG0608|consen 626 MDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEA------DNEWVVRLYYSFQ 699 (1034)
T ss_pred ccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhc------CCcceEEEEEEec
Confidence 3345689999999999999999999999999999998864332 23345555666554 4568999999999
Q ss_pred ecCeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEE
Q 007035 487 HLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKII 565 (621)
Q Consensus 487 ~~~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~ 565 (621)
+++.+|+||+|+.| .+..++..... |.+..++.++.++..|+.+.|+.|+|||||||+||||+ .+|+|||+
T Consensus 700 DkdnLYFVMdYIPGGDmMSLLIrmgI------FeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILID--rdGHIKLT 771 (1034)
T KOG0608|consen 700 DKDNLYFVMDYIPGGDMMSLLIRMGI------FEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILID--RDGHIKLT 771 (1034)
T ss_pred cCCceEEEEeccCCccHHHHHHHhcc------CHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEc--cCCceeee
Confidence 99999999999985 67777766543 89999999999999999999999999999999999999 49999999
Q ss_pred ecCCccc---------cCC------------------------------------CccccccCCcccCchhhcCCCCCch
Q 007035 566 DLGSSCF---------QTD------------------------------------NLCLYVQSRSYRAPEVIIGLPYDQK 600 (621)
Q Consensus 566 DFGls~~---------~~~------------------------------------~~~~~~gt~~Y~APEvl~~~~~s~k 600 (621)
|||++.- +.. .....+||+.|+|||++....|+..
T Consensus 772 DFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~ 851 (1034)
T KOG0608|consen 772 DFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQL 851 (1034)
T ss_pred eccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCcccc
Confidence 9998621 000 0012488999999999999999999
Q ss_pred hhHHHHHHHHHHHHhCCCCCC
Q 007035 601 IDLWSLGCILAELWTGEVCLI 621 (621)
Q Consensus 601 sDIWSLGvILyELltG~~PF~ 621 (621)
+|+||.|||||||+.|++||+
T Consensus 852 cdwws~gvil~em~~g~~pf~ 872 (1034)
T KOG0608|consen 852 CDWWSVGVILYEMLVGQPPFL 872 (1034)
T ss_pred chhhHhhHHHHHHhhCCCCcc
Confidence 999999999999999999996
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.7e-29 Score=259.82 Aligned_cols=195 Identities=28% Similarity=0.395 Sum_probs=163.3
Q ss_pred CceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCch----hhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecC
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD----FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~----~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~ 489 (621)
++|++.+.||.|++|.||+|.+..+++.||+|.+..... ....+..|+++++.+ +|+||+++++.+....
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l------~~~~i~~~~~~~~~~~ 74 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATL------DHPFLPTLYASFQTET 74 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhC------CCCCchhheeeeecCC
Confidence 479999999999999999999999999999999876432 334456666666655 4789999999999999
Q ss_pred eEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecC
Q 007035 490 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (621)
Q Consensus 490 ~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFG 568 (621)
..++||||+.+ +|.+++.... ...+++..++.++.||+.||.|||+.|++|+||||+||+++. ++.++|+|||
T Consensus 75 ~~~lv~e~~~~~~L~~~~~~~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~--~~~~~l~dfg 148 (316)
T cd05574 75 YLCLVMDYCPGGELFRLLQRQP----GKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHE--SGHIMLSDFD 148 (316)
T ss_pred EEEEEEEecCCCCHHHHHHhCC----CCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcC--CCCEEEeecc
Confidence 99999999975 7777665322 123888999999999999999999999999999999999984 7889999999
Q ss_pred CccccCCC--------------------------------ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhC
Q 007035 569 SSCFQTDN--------------------------------LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTG 616 (621)
Q Consensus 569 ls~~~~~~--------------------------------~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG 616 (621)
++...... .....|+..|+|||++.+..++.++||||||+++|+|++|
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g 228 (316)
T cd05574 149 LSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYG 228 (316)
T ss_pred hhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhC
Confidence 87543211 1123578889999999998899999999999999999999
Q ss_pred CCCC
Q 007035 617 EVCL 620 (621)
Q Consensus 617 ~~PF 620 (621)
+.||
T Consensus 229 ~~pf 232 (316)
T cd05574 229 TTPF 232 (316)
T ss_pred CCCC
Confidence 9998
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.9e-29 Score=255.18 Aligned_cols=200 Identities=27% Similarity=0.423 Sum_probs=163.8
Q ss_pred ecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeE-----
Q 007035 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY----- 486 (621)
Q Consensus 412 i~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~----- 486 (621)
..++|++++.||.|+||.||++.+..+++.+|+|++.........+..|+.+++.+. +||||+++++++.
T Consensus 16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~-----~h~~i~~~~~~~~~~~~~ 90 (286)
T cd06638 16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALS-----DHPNVVKFYGMYYKKDVK 90 (286)
T ss_pred cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHh-----cCCCeeeeeeeeeecccC
Confidence 457899999999999999999999999999999998765444456777888887774 4789999999874
Q ss_pred ecCeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEE
Q 007035 487 HLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKII 565 (621)
Q Consensus 487 ~~~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~ 565 (621)
.....++||||+++ +|.+++...... ...+++..++.++.|++.||.|||+.+|+||||||+||+++. ++.++|+
T Consensus 91 ~~~~~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~--~~~~kl~ 166 (286)
T cd06638 91 NGDQLWLVLELCNGGSVTDLVKGFLKR--GERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTT--EGGVKLV 166 (286)
T ss_pred CCCeEEEEEeecCCCCHHHHHHHhhcc--CccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECC--CCCEEEc
Confidence 34579999999985 565555422111 223788889999999999999999999999999999999984 6789999
Q ss_pred ecCCccccCCC---ccccccCCcccCchhhcC-----CCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 566 DLGSSCFQTDN---LCLYVQSRSYRAPEVIIG-----LPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 566 DFGls~~~~~~---~~~~~gt~~Y~APEvl~~-----~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
|||++...... .....+++.|+|||++.. ..++.++|||||||++|+|++|+.||
T Consensus 167 dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~ 229 (286)
T cd06638 167 DFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPL 229 (286)
T ss_pred cCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCC
Confidence 99998654322 223467899999999853 34788999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-29 Score=252.22 Aligned_cols=193 Identities=23% Similarity=0.372 Sum_probs=161.1
Q ss_pred CceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeEEE
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFI 493 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l~L 493 (621)
++|++.+.||.|+||.||++..+ .+..+|+|.+.........+..|+.+++.++ ||||+++++++......++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~~~~~i 76 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAMSEEDFIEEAKVMMKLS------HPKLVQLYGVCTQQKPLYI 76 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCccHHHHHHHHHHHHHCC------CCCceeEEEEEccCCCEEE
Confidence 56899999999999999999864 4567999988765544567778888888774 6899999999999999999
Q ss_pred EEeccc-cchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCccc
Q 007035 494 VCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF 572 (621)
Q Consensus 494 VmEyl~-gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~~ 572 (621)
||||+. ++|.+.+..... .+++..+..++.||+.||.|||+++|+||||+|+||+++ .++.++|+|||.+..
T Consensus 77 v~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~--~~~~~kl~d~g~~~~ 149 (256)
T cd05114 77 VTEFMENGCLLNYLRQRQG-----KLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVS--STGVVKVSDFGMTRY 149 (256)
T ss_pred EEEcCCCCcHHHHHHhCcc-----CCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEc--CCCeEEECCCCCccc
Confidence 999997 467666553221 278889999999999999999999999999999999998 478899999998865
Q ss_pred cCCCcc----ccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 573 QTDNLC----LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 573 ~~~~~~----~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
...... ...++..|+|||++.+..++.++||||||+++|+|++ |+.||
T Consensus 150 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~ 202 (256)
T cd05114 150 VLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPF 202 (256)
T ss_pred cCCCceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCC
Confidence 432211 1233557999999998889999999999999999999 89987
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-30 Score=280.20 Aligned_cols=193 Identities=25% Similarity=0.413 Sum_probs=167.8
Q ss_pred ceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecC----chhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCe
Q 007035 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (621)
Q Consensus 415 rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~----~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~ 490 (621)
.|.-++.||+|+||.||.|++..+.+.||||.+.-. ..-...++.|+++|+.++ |||++.+-++|.....
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~------HPntieYkgCyLre~T 100 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLR------HPNTIEYKGCYLREHT 100 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhcc------CCCcccccceeeccch
Confidence 355567799999999999999999999999987642 233456777888887775 7899999999999999
Q ss_pred EEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCc
Q 007035 491 LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (621)
Q Consensus 491 l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls 570 (621)
.|+|||||=|+.-+++...+.. +-+.++..|..+.+.||+|||+.+.||||||..|||++ +.|.|||+|||.+
T Consensus 101 aWLVMEYClGSAsDlleVhkKp-----lqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLs--e~g~VKLaDFGSA 173 (948)
T KOG0577|consen 101 AWLVMEYCLGSASDLLEVHKKP-----LQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLS--EPGLVKLADFGSA 173 (948)
T ss_pred HHHHHHHHhccHHHHHHHHhcc-----chHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEec--CCCeeeeccccch
Confidence 9999999999877777655433 78899999999999999999999999999999999999 5999999999988
Q ss_pred cccCCCccccccCCcccCchhhc---CCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 007035 571 CFQTDNLCLYVQSRSYRAPEVII---GLPYDQKIDLWSLGCILAELWTGEVCLI 621 (621)
Q Consensus 571 ~~~~~~~~~~~gt~~Y~APEvl~---~~~~s~ksDIWSLGvILyELltG~~PF~ 621 (621)
.... +...++|||.|||||++. .+.|+-++||||||++..||...++|+|
T Consensus 174 si~~-PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlF 226 (948)
T KOG0577|consen 174 SIMA-PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 226 (948)
T ss_pred hhcC-chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCcc
Confidence 6544 455689999999999995 3569999999999999999999999986
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=256.71 Aligned_cols=194 Identities=25% Similarity=0.424 Sum_probs=162.5
Q ss_pred cCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc-hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeE
Q 007035 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (621)
Q Consensus 413 ~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~-~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l 491 (621)
.++|++.+.||.|+||.||+|++..+++.||+|+++... .......+|+.+++.+ +||||+++++.+...+..
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l------~h~~ii~~~~~~~~~~~~ 81 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDC------KHSNIVAYFGSYLRRDKL 81 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhC------CCCCeeeEEEEEEeCCEE
Confidence 357889999999999999999999999999999987543 2233455666666655 478999999999999999
Q ss_pred EEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCc
Q 007035 492 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (621)
Q Consensus 492 ~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls 570 (621)
++||||+++ +|.+++.... .+++..++.++.||+.||.|||+.||+|+||||+||+++ .++.++|+|||++
T Consensus 82 ~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~--~~~~~~l~dfg~~ 153 (267)
T cd06645 82 WICMEFCGGGSLQDIYHVTG------PLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLT--DNGHVKLADFGVS 153 (267)
T ss_pred EEEEeccCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC--CCCCEEECcceee
Confidence 999999985 6766664332 288999999999999999999999999999999999998 4788999999987
Q ss_pred cccCCC---ccccccCCcccCchhhc---CCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 571 CFQTDN---LCLYVQSRSYRAPEVII---GLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 571 ~~~~~~---~~~~~gt~~Y~APEvl~---~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
...... .....+++.|+|||++. ...++.++|+|||||++|+|++|+.||
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~ 209 (267)
T cd06645 154 AQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPM 209 (267)
T ss_pred eEccCcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCc
Confidence 654322 23356789999999984 445788999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.1e-29 Score=250.25 Aligned_cols=197 Identities=30% Similarity=0.405 Sum_probs=165.8
Q ss_pred CceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecC----chhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecC
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~----~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~ 489 (621)
++|++.+.||.|+||.||+|.+..+|+.||+|.++.. ......+.+|+++++.+. |++|+++++.+...+
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~------~~~i~~~~~~~~~~~ 75 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD------HPNVIKYLASFIENN 75 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCC------CCCeeeeeeeeecCC
Confidence 5799999999999999999999999999999988642 223456677777777664 678999999999999
Q ss_pred eEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecC
Q 007035 490 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (621)
Q Consensus 490 ~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFG 568 (621)
..++||||+++ +|.+++..... ....+++..+..++.||+.||.|||+.||+||||+|+||+++. ++.++|+|||
T Consensus 76 ~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~--~~~~~l~d~~ 151 (267)
T cd08224 76 ELNIVLELADAGDLSRMIKHFKK--QKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITA--TGVVKLGDLG 151 (267)
T ss_pred eEEEEEecCCCCCHHHHHHHhcc--cCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECC--CCcEEEeccc
Confidence 99999999985 67666654322 1233788999999999999999999999999999999999984 7889999999
Q ss_pred CccccCCC---ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 569 SSCFQTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 569 ls~~~~~~---~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
++...... .....+++.|+|||.+.+..++.++||||||+++|+|++|+.||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~ 206 (267)
T cd08224 152 LGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF 206 (267)
T ss_pred eeeeccCCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCc
Confidence 87654332 22346788899999999888999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7e-29 Score=257.82 Aligned_cols=193 Identities=28% Similarity=0.476 Sum_probs=163.7
Q ss_pred cCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc-hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeE
Q 007035 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (621)
Q Consensus 413 ~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~-~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l 491 (621)
..+|++.+.||.|++|.||++.+..+++.|++|.+.... .....+.+|+.+++.+ .|+||+++++.+....+.
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~------~h~~v~~~~~~~~~~~~~ 92 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN------KNPNIVNYLDSYLVGDEL 92 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhC------CCCCEeeEEEEEEeCCEE
Confidence 468999999999999999999999999999999887533 2234566677777655 478999999999999999
Q ss_pred EEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCc
Q 007035 492 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (621)
Q Consensus 492 ~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls 570 (621)
++||||+.+ +|.+++... .++...+..++.|++.||.|||+.||+||||||+|||++ .++.++|+|||++
T Consensus 93 ~lv~e~~~~~~L~~~~~~~-------~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~--~~~~~kl~dfg~~ 163 (296)
T cd06654 93 WVVMEYLAGGSLTDVVTET-------CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG--MDGSVKLTDFGFC 163 (296)
T ss_pred EEeecccCCCCHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEc--CCCCEEECccccc
Confidence 999999985 666655321 267888999999999999999999999999999999998 4778999999987
Q ss_pred cccCCC---ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 571 CFQTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 571 ~~~~~~---~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
...... .....+++.|+|||.+.+..++.++|||||||++|+|++|+.||
T Consensus 164 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf 216 (296)
T cd06654 164 AQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPY 216 (296)
T ss_pred hhccccccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCC
Confidence 654322 22346788999999999888899999999999999999999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-29 Score=265.44 Aligned_cols=194 Identities=34% Similarity=0.630 Sum_probs=162.0
Q ss_pred ecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecC--chhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEec-
Q 007035 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL- 488 (621)
Q Consensus 412 i~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~--~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~- 488 (621)
+.++|++.+.||+|+||.||+|.+..+|+.||+|.+... ........+|+.+++.++ |+||+++++++...
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~~~~~~~~~~ 76 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFK------HENIIGILDIIRPPS 76 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCC------CCCcCchhheeeccc
Confidence 457899999999999999999999999999999998642 233455667877777775 67899999876644
Q ss_pred ----CeEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEE
Q 007035 489 ----EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKI 564 (621)
Q Consensus 489 ----~~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL 564 (621)
.++++|+||+.+++.+.+... .+++..++.++.||+.||.|||+.+|+||||||+|||++. ++.++|
T Consensus 77 ~~~~~~~~lv~e~~~~~l~~~~~~~-------~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~--~~~~kl 147 (336)
T cd07849 77 FESFNDVYIVQELMETDLYKLIKTQ-------HLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT--NCDLKI 147 (336)
T ss_pred ccccceEEEEehhcccCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECC--CCCEEE
Confidence 368999999998887766432 2888999999999999999999999999999999999984 788999
Q ss_pred EecCCccccCCCc------cccccCCcccCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 565 IDLGSSCFQTDNL------CLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 565 ~DFGls~~~~~~~------~~~~gt~~Y~APEvl~~-~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
+|||++....... ....+++.|+|||.+.+ ..++.++|||||||++|+|++|++||
T Consensus 148 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f 210 (336)
T cd07849 148 CDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLF 210 (336)
T ss_pred CcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 9999886543221 22467889999998765 46889999999999999999999998
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-29 Score=250.85 Aligned_cols=193 Identities=31% Similarity=0.494 Sum_probs=167.1
Q ss_pred CceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeEEE
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFI 493 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l~L 493 (621)
++|++.+.||.|+||.||++.+..+++.+++|.+..... ...+.+|+++++.+ .|+||+++++.+....+.++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~e~~~~~~l------~~~~i~~~~~~~~~~~~~~l 75 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-LQEIIKEISILKQC------DSPYIVKYYGSYFKNTDLWI 75 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-HHHHHHHHHHHHhC------CCCcEeeeeeeeecCCcEEE
Confidence 579999999999999999999988899999999986544 56778888888776 47899999999999999999
Q ss_pred EEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCccc
Q 007035 494 VCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF 572 (621)
Q Consensus 494 VmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~~ 572 (621)
++||+.+ +|.+.+.... ..+++..++.++.|++.||.|||+.+|+|+||+|+||+++. ++.++|+|||++..
T Consensus 76 ~~e~~~~~~L~~~l~~~~-----~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~--~~~~~l~dfg~~~~ 148 (256)
T cd06612 76 VMEYCGAGSVSDIMKITN-----KTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNE--EGQAKLADFGVSGQ 148 (256)
T ss_pred EEecCCCCcHHHHHHhCc-----cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECC--CCcEEEcccccchh
Confidence 9999986 5666554322 22789999999999999999999999999999999999984 77899999999876
Q ss_pred cCCCc---cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 573 QTDNL---CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 573 ~~~~~---~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
..... ....++..|+|||++.+..++.++||||||+++|+|++|+.||
T Consensus 149 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~ 199 (256)
T cd06612 149 LTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPY 199 (256)
T ss_pred cccCccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 54332 2345788999999999988999999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.2e-29 Score=251.95 Aligned_cols=197 Identities=23% Similarity=0.347 Sum_probs=164.1
Q ss_pred eecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCe
Q 007035 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (621)
Q Consensus 411 ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~ 490 (621)
+..++|++.+.||.|++|.||+|.+. .++.||+|.++........+.+|+.+++.++ |+||+++++++...+.
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~~~ 75 (261)
T cd05068 3 IDRTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTMDPKDFLAEAQIMKKLR------HPKLIQLYAVCTLEEP 75 (261)
T ss_pred cchhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcccHHHHHHHHHHHHHCC------CCCccceeEEEecCCC
Confidence 34578999999999999999999864 4577999999865544566778888888774 6799999999999999
Q ss_pred EEEEEeccc-cchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCC
Q 007035 491 LFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (621)
Q Consensus 491 l~LVmEyl~-gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGl 569 (621)
.++||||+. ++|.+.+.... ...+++..+..++.||+.||.+||+.+|+||||||+||+++. ++.++|+|||+
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~--~~~~~l~dfg~ 149 (261)
T cd05068 76 IYIVTELMKYGSLLEYLQGGA----GRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGE--NNICKVADFGL 149 (261)
T ss_pred eeeeeecccCCcHHHHHhccC----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcC--CCCEEECCcce
Confidence 999999995 67887775432 123788999999999999999999999999999999999994 78899999999
Q ss_pred ccccCCCcc-cccc---CCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 570 SCFQTDNLC-LYVQ---SRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 570 s~~~~~~~~-~~~g---t~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
+........ ...+ +..|+|||.+.+..++.++||||||+++|+|++ |+.||
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~ 205 (261)
T cd05068 150 ARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPY 205 (261)
T ss_pred EEEccCCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCC
Confidence 866543211 1122 347999999998889999999999999999999 99887
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-29 Score=256.55 Aligned_cols=201 Identities=24% Similarity=0.298 Sum_probs=164.3
Q ss_pred cCceEEEEEeccCCCCceeEEEeC-----CCCcEEEEEEEecCch--hhhhHHHHHHHHHHhcccCCCCCCceEEEeeEe
Q 007035 413 AGRYYVTEYLGSAAFSKVFQAQDL-----HTGVDVCLKIIKNDKD--FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYF 485 (621)
Q Consensus 413 ~~rY~I~~~LG~G~fG~Vyka~d~-----~tg~~VAlKii~~~~~--~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f 485 (621)
.++|.+++.||.|+||.||+|.+. .+++.||+|+++.... ....+.+|+++++.+. |+||+++++++
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~------~~~i~~~~~~~ 77 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQ------HENIVKFYGVC 77 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcC------CCCchheeeEE
Confidence 356899999999999999999864 3468899999875432 3456778888877764 67999999999
Q ss_pred EecCeEEEEEecccc-chHHHHHhhhc--------cCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEec
Q 007035 486 YHLEHLFIVCELLRA-NLYEFQKFNQE--------SGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS 556 (621)
Q Consensus 486 ~~~~~l~LVmEyl~g-sLld~l~~~~~--------~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~ 556 (621)
......++||||+.+ +|.+++..... ......+++..+..++.||+.||.+||+++++||||||+||+++.
T Consensus 78 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~ 157 (280)
T cd05049 78 TEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGY 157 (280)
T ss_pred ecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcC
Confidence 999999999999985 67666654321 112234788899999999999999999999999999999999984
Q ss_pred cCCCeEEEEecCCccccCCC-----ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCC
Q 007035 557 YQRCEIKIIDLGSSCFQTDN-----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCLI 621 (621)
Q Consensus 557 ~~~~~IKL~DFGls~~~~~~-----~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF~ 621 (621)
++.++|+|||++...... .....+++.|+|||++.+..++.++|||||||++|+|++ |+.||.
T Consensus 158 --~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~ 226 (280)
T cd05049 158 --DLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWY 226 (280)
T ss_pred --CCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCC
Confidence 789999999998643221 122344678999999999999999999999999999998 999983
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.3e-29 Score=257.81 Aligned_cols=193 Identities=28% Similarity=0.473 Sum_probs=163.0
Q ss_pred cCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc-hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeE
Q 007035 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (621)
Q Consensus 413 ~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~-~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l 491 (621)
..+|++++.||.|+||.||++.+..+++.||+|.+.... ...+.+.+|+.+++.+ +|+||+++++++....+.
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~------~h~~i~~~~~~~~~~~~~ 91 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMREN------KNPNIVNYLDSYLVGDEL 91 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhC------CCCCEeeEEEEEecCCEE
Confidence 478999999999999999999999999999999987533 2234455666666654 578999999999999999
Q ss_pred EEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCc
Q 007035 492 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (621)
Q Consensus 492 ~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls 570 (621)
++||||+++ +|.+++.. . .+++..+..++.|++.||.|||+.+|+||||||+|||++ .++.++|+|||++
T Consensus 92 ~lv~e~~~~~~L~~~~~~-~------~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~--~~~~~~l~Dfg~~ 162 (297)
T cd06656 92 WVVMEYLAGGSLTDVVTE-T------CMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLG--MDGSVKLTDFGFC 162 (297)
T ss_pred EEeecccCCCCHHHHHHh-C------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC--CCCCEEECcCccc
Confidence 999999986 55555432 1 277888999999999999999999999999999999998 4788999999987
Q ss_pred cccCCC---ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 571 CFQTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 571 ~~~~~~---~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
...... .....+++.|+|||.+.+..++.++|+|||||++|+|++|+.||
T Consensus 163 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf 215 (297)
T cd06656 163 AQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPY 215 (297)
T ss_pred eEccCCccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 654332 22346788999999999988999999999999999999999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.1e-29 Score=253.40 Aligned_cols=192 Identities=33% Similarity=0.503 Sum_probs=158.8
Q ss_pred eEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCch--hhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEec--CeE
Q 007035 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD--FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL--EHL 491 (621)
Q Consensus 416 Y~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~--~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~--~~l 491 (621)
|++.+.||.|+||.||++.+..+++.||+|.++.... .......|+.+++.+. +|+||+++++++.+. +.+
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~-----~h~~i~~~~~~~~~~~~~~~ 75 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLS-----PHPNILRLIEVLFDRKTGRL 75 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcC-----CCCCccceEEEEecCCCCcE
Confidence 6789999999999999999999999999999875321 1122334555555443 478999999999987 899
Q ss_pred EEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCcc
Q 007035 492 FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 571 (621)
Q Consensus 492 ~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~ 571 (621)
++||||+++++++.+.... ..+++..++.++.||+.||.|||+.+++||||+|+||+++. +.+||+|||++.
T Consensus 76 ~lv~e~~~~~l~~~l~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~---~~~kl~dfg~~~ 147 (282)
T cd07831 76 ALVFELMDMNLYELIKGRK-----RPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD---DILKLADFGSCR 147 (282)
T ss_pred EEEEecCCccHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC---CCeEEEeccccc
Confidence 9999999999888876432 12889999999999999999999999999999999999984 899999999986
Q ss_pred ccCCC--ccccccCCcccCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 572 FQTDN--LCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 572 ~~~~~--~~~~~gt~~Y~APEvl~~-~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
..... .....+++.|+|||.+.. ..++.++|||||||++|+|++|.+||
T Consensus 148 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~ 199 (282)
T cd07831 148 GIYSKPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLF 199 (282)
T ss_pred ccccCCCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCC
Confidence 54332 223457889999998754 45788999999999999999999988
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=248.81 Aligned_cols=194 Identities=27% Similarity=0.394 Sum_probs=166.0
Q ss_pred ceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecC---chhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeE
Q 007035 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (621)
Q Consensus 415 rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~---~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l 491 (621)
+|++++.||.|+||.||.+++..+++.+++|.+... ......+.+|+.+++.+ +|+||+++++++...+.+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~------~h~~i~~~~~~~~~~~~~ 74 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLL------QHPNIIAYYNHFMDDNTL 74 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhC------CCCCeeEEEeEEecCCeE
Confidence 589999999999999999999999999999987643 33345567788887766 478999999999999999
Q ss_pred EEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCc
Q 007035 492 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (621)
Q Consensus 492 ~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls 570 (621)
++||||+.+ +|.+.+.... ...+++..+..++.|++.||.|||+.+++|+||+|+||+++. ++.+||+|||++
T Consensus 75 ~~~~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~--~~~~kl~d~~~~ 148 (256)
T cd08221 75 LIEMEYANGGTLYDKIVRQK----GQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTK--AGLIKLGDFGIS 148 (256)
T ss_pred EEEEEecCCCcHHHHHHhcc----ccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeC--CCCEEECcCcce
Confidence 999999985 7777765432 123788999999999999999999999999999999999984 778999999988
Q ss_pred cccCCCc---cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 571 CFQTDNL---CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 571 ~~~~~~~---~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
....... ....+++.|+|||.+.+..++.++|+||||+++|+|++|+.||
T Consensus 149 ~~~~~~~~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~ 201 (256)
T cd08221 149 KILGSEYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTF 201 (256)
T ss_pred EEcccccccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCC
Confidence 6544332 3456789999999999888899999999999999999999987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.8e-29 Score=259.20 Aligned_cols=195 Identities=30% Similarity=0.461 Sum_probs=162.9
Q ss_pred cCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCch---hhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEec-
Q 007035 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD---FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL- 488 (621)
Q Consensus 413 ~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~---~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~- 488 (621)
.++|++.+.||.|+||.||+|.+..+|+.||+|.++.... ......+|+.+++.+ .|+||+++++++...
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l------~h~~i~~~~~~~~~~~ 79 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNL------RHPNIVELKEVVVGKH 79 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhC------CCCCCcceEEEEecCC
Confidence 4679999999999999999999999999999999874321 223445688887766 467899999998765
Q ss_pred -CeEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEec
Q 007035 489 -EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 567 (621)
Q Consensus 489 -~~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DF 567 (621)
+.+++||||++++|.+++.... ..+++..++.++.||+.||.|||+.|++||||||+||+++. ++.++|+||
T Consensus 80 ~~~~~lv~e~~~~~l~~~l~~~~-----~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~--~~~~kL~df 152 (309)
T cd07845 80 LDSIFLVMEYCEQDLASLLDNMP-----TPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTD--KGCLKIADF 152 (309)
T ss_pred CCeEEEEEecCCCCHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECC--CCCEEECcc
Confidence 5689999999998888776533 22889999999999999999999999999999999999984 788999999
Q ss_pred CCccccCCC---ccccccCCcccCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 568 GSSCFQTDN---LCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 568 Gls~~~~~~---~~~~~gt~~Y~APEvl~~-~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
|++...... .....+++.|+|||++.+ ..++.++|||||||++|+|++|++||
T Consensus 153 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f 209 (309)
T cd07845 153 GLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLL 209 (309)
T ss_pred ceeeecCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCC
Confidence 998765432 222344778999999876 45789999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-29 Score=255.67 Aligned_cols=200 Identities=23% Similarity=0.303 Sum_probs=163.0
Q ss_pred CceEEEEEeccCCCCceeEEEeCCCC-----cEEEEEEEecCc--hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeE
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQDLHTG-----VDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d~~tg-----~~VAlKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~ 486 (621)
++|++++.||.|+||.||+|.+...+ ..|++|.+.... .....+.+|+.++..+ .||||+++++++.
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l------~h~~i~~~~~~~~ 78 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDL------QHPNIVCLLGVCT 78 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhc------CCcccceEEEEEc
Confidence 57999999999999999999876655 679999886532 2345567777777665 4789999999999
Q ss_pred ecCeEEEEEeccc-cchHHHHHhhhccC----------CCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEe
Q 007035 487 HLEHLFIVCELLR-ANLYEFQKFNQESG----------GEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIK 555 (621)
Q Consensus 487 ~~~~l~LVmEyl~-gsLld~l~~~~~~~----------~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~ 555 (621)
.....+++|||+. ++|.+++....... ....+++..+..++.||+.||.|||+++++||||||+||+++
T Consensus 79 ~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~ 158 (283)
T cd05048 79 KEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVG 158 (283)
T ss_pred CCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEc
Confidence 9999999999998 47777776432211 113478889999999999999999999999999999999998
Q ss_pred ccCCCeEEEEecCCccccCCC-----ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCC
Q 007035 556 SYQRCEIKIIDLGSSCFQTDN-----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCLI 621 (621)
Q Consensus 556 ~~~~~~IKL~DFGls~~~~~~-----~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF~ 621 (621)
. ++.++|+|||++...... .....+++.|+|||.+.+..++.++|||||||++|||++ |..||.
T Consensus 159 ~--~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~ 228 (283)
T cd05048 159 E--GLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYY 228 (283)
T ss_pred C--CCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCC
Confidence 4 778999999998654222 122345778999999998889999999999999999998 999973
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.6e-29 Score=257.62 Aligned_cols=200 Identities=22% Similarity=0.279 Sum_probs=161.4
Q ss_pred CceEEEEEeccCCCCceeEEEeCCCCc--EEEEEEEecC--chhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecC
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQDLHTGV--DVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d~~tg~--~VAlKii~~~--~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~ 489 (621)
++|++.+.||.|+||.||+|.+..++. .+++|.++.. ....+.+.+|+.++.++. .||||+++++++....
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~-----~hp~iv~~~~~~~~~~ 76 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLG-----HHPNIINLLGACENRG 76 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhc-----CCCchhheEEEEccCC
Confidence 579999999999999999999877765 4688887642 233455677888777764 3789999999999999
Q ss_pred eEEEEEeccc-cchHHHHHhhhccC----------CCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccC
Q 007035 490 HLFIVCELLR-ANLYEFQKFNQESG----------GEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQ 558 (621)
Q Consensus 490 ~l~LVmEyl~-gsLld~l~~~~~~~----------~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~ 558 (621)
.+++||||++ ++|.+++....... ....+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~-- 154 (297)
T cd05089 77 YLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGE-- 154 (297)
T ss_pred cceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECC--
Confidence 9999999997 57877775432111 1124788899999999999999999999999999999999984
Q ss_pred CCeEEEEecCCccccCCCccc--cccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 559 RCEIKIIDLGSSCFQTDNLCL--YVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 559 ~~~IKL~DFGls~~~~~~~~~--~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
++.+||+|||++......... ...+..|+|||++.+..++.++|||||||++|+|++ |+.||
T Consensus 155 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf 219 (297)
T cd05089 155 NLASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPY 219 (297)
T ss_pred CCeEEECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCC
Confidence 788999999998643222111 122456999999998889999999999999999997 99998
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.7e-29 Score=252.72 Aligned_cols=196 Identities=26% Similarity=0.368 Sum_probs=160.4
Q ss_pred eecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCe
Q 007035 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (621)
Q Consensus 411 ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~ 490 (621)
+..++|++.++||.|+||.||+|++..++ .||+|+++........+.+|+.+++.+. |+||+++++.+. ...
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~-~valK~~~~~~~~~~~~~~E~~~l~~l~------~~~i~~~~~~~~-~~~ 74 (262)
T cd05071 3 IPRESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMSPEAFLQEAQVMKKLR------HEKLVQLYAVVS-EEP 74 (262)
T ss_pred CChHHeeEeeecCCCCCCcEEEEEecCCc-eEEEEecccCccCHHHHHHHHHHHHhCC------CCCcceEEEEEC-CCC
Confidence 34578999999999999999999986654 5999999865544456778888887764 678999999875 456
Q ss_pred EEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCC
Q 007035 491 LFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (621)
Q Consensus 491 l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGl 569 (621)
.++||||+.+ +|.+++..... ..+++..+..++.||+.||.|||+.+|+||||||+||+++. ++.++|+|||.
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~--~~~~~L~dfg~ 148 (262)
T cd05071 75 IYIVTEYMSKGSLLDFLKGEMG----KYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGE--NLVCKVADFGL 148 (262)
T ss_pred cEEEEEcCCCCcHHHHHhhccc----cCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcC--CCcEEeccCCc
Confidence 8999999985 77777654221 23788899999999999999999999999999999999984 78899999999
Q ss_pred ccccCCCcc----ccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 570 SCFQTDNLC----LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 570 s~~~~~~~~----~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
+........ ...++..|+|||++.+..++.++||||||+++|+|++ |.+||
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~ 204 (262)
T cd05071 149 ARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 204 (262)
T ss_pred eeeccccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCC
Confidence 865433221 1234567999999988889999999999999999999 88887
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.1e-29 Score=250.95 Aligned_cols=188 Identities=26% Similarity=0.408 Sum_probs=155.1
Q ss_pred EEeccCCCCceeEEEeCCCCcEEEEEEEecC--chhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeEEEEEec
Q 007035 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCEL 497 (621)
Q Consensus 420 ~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~--~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l~LVmEy 497 (621)
+.||+|+||.||+|.+..+++.+|+|.+... ......+.+|+++++.+ .||||+++++++......++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~~~~~~~lv~e~ 74 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQY------SHPNIVRLIGVCTQKQPIYIVMEL 74 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhC------CCCCcceEEEEEcCCCCeEEEEee
Confidence 3699999999999999999999999987643 33445677787777765 478999999999999999999999
Q ss_pred ccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCccccCCC
Q 007035 498 LRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN 576 (621)
Q Consensus 498 l~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~~~~~~ 576 (621)
+.+ +|.+.+.... ..+++..++.++.|++.||.|||+++|+||||||+|||++ .++.+||+|||++......
T Consensus 75 ~~~~~L~~~~~~~~-----~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~--~~~~~kl~dfg~~~~~~~~ 147 (252)
T cd05084 75 VQGGDFLTFLRTEG-----PRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVT--EKNVLKISDFGMSREEEDG 147 (252)
T ss_pred ccCCcHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEc--CCCcEEECccccCcccccc
Confidence 975 6666654322 1278889999999999999999999999999999999998 4778999999998654322
Q ss_pred ccc-----cccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 577 LCL-----YVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 577 ~~~-----~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
... ...+..|+|||.+.+..++.++||||||+++|+|++ |..||
T Consensus 148 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~ 197 (252)
T cd05084 148 VYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPY 197 (252)
T ss_pred cccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCc
Confidence 111 122356999999998889999999999999999998 88887
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=252.57 Aligned_cols=195 Identities=30% Similarity=0.501 Sum_probs=164.6
Q ss_pred ceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc--hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeEE
Q 007035 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLF 492 (621)
Q Consensus 415 rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l~ 492 (621)
+|++.+.||.|++|.||+|++..+|+.||+|.++... .......+|+.+++.++ |+||+++++++...+..+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~------h~~i~~~~~~~~~~~~~~ 74 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELK------HENIVRLHDVIHTENKLM 74 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhc------CCCEeeeeeeEeeCCcEE
Confidence 5899999999999999999999999999999987542 22345667888887764 679999999999999999
Q ss_pred EEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCccc
Q 007035 493 IVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF 572 (621)
Q Consensus 493 LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~~ 572 (621)
+||||+.+++.+++..... ...+++..+..++.||+.||.|||+.+++||||+|+||+++. ++.++|+|||++..
T Consensus 75 lv~e~~~~~l~~~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~--~~~~~l~d~g~~~~ 149 (284)
T cd07836 75 LVFEYMDKDLKKYMDTHGV---RGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINK--RGELKLADFGLARA 149 (284)
T ss_pred EEEecCCccHHHHHHhcCC---CCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECC--CCcEEEeecchhhh
Confidence 9999999988887764332 223889999999999999999999999999999999999984 78899999998864
Q ss_pred cCCC---ccccccCCcccCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 573 QTDN---LCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 573 ~~~~---~~~~~gt~~Y~APEvl~~~-~~s~ksDIWSLGvILyELltG~~PF 620 (621)
.... .....+++.|++||++.+. .++.++||||||+++|+|++|+.||
T Consensus 150 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~ 201 (284)
T cd07836 150 FGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLF 201 (284)
T ss_pred hcCCccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 4322 1224567889999998664 4688999999999999999999987
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-30 Score=261.81 Aligned_cols=197 Identities=30% Similarity=0.468 Sum_probs=164.6
Q ss_pred CceEEE-EEeccCCCCceeEEEeCCCCcEEEEEEEecCc-hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeE
Q 007035 414 GRYYVT-EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (621)
Q Consensus 414 ~rY~I~-~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~-~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l 491 (621)
+-|++. +.||.|+|+.|-.+....+|..||||++.+.. -...++.+|++++..++ +|+||++++++|++....
T Consensus 77 d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cq-----gh~nilqLiefFEdd~~F 151 (463)
T KOG0607|consen 77 DMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQ-----GHKNILQLIEFFEDDTRF 151 (463)
T ss_pred HHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhc-----CCccHHHHHHHhcccceE
Confidence 345544 57999999999999999999999999997643 34567889999998886 588999999999999999
Q ss_pred EEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEec-cCCCeEEEEecCC
Q 007035 492 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS-YQRCEIKIIDLGS 569 (621)
Q Consensus 492 ~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~-~~~~~IKL~DFGl 569 (621)
|+|||-+.| .|+..++.... |++.++.+++++|+.||.|||.+||.||||||+|||... +.-..|||+||.+
T Consensus 152 YLVfEKm~GGplLshI~~~~~------F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDL 225 (463)
T KOG0607|consen 152 YLVFEKMRGGPLLSHIQKRKH------FNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDL 225 (463)
T ss_pred EEEEecccCchHHHHHHHhhh------ccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeecccc
Confidence 999999985 67777765433 999999999999999999999999999999999999864 2345799999987
Q ss_pred ccccC----------CCccccccCCcccCchhhc-----CCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 007035 570 SCFQT----------DNLCLYVQSRSYRAPEVII-----GLPYDQKIDLWSLGCILAELWTGEVCLI 621 (621)
Q Consensus 570 s~~~~----------~~~~~~~gt~~Y~APEvl~-----~~~~s~ksDIWSLGvILyELltG~~PF~ 621 (621)
..-+. ....+.+|+-.|||||+.. ...|+.+.|.||||||||-|++|-+||.
T Consensus 226 gSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFv 292 (463)
T KOG0607|consen 226 GSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFV 292 (463)
T ss_pred ccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCcc
Confidence 53221 1223357777899999984 2358999999999999999999999995
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.4e-29 Score=258.94 Aligned_cols=197 Identities=24% Similarity=0.380 Sum_probs=165.6
Q ss_pred eecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc----hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeE
Q 007035 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (621)
Q Consensus 411 ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~ 486 (621)
....+|++.+.||+|+||+||+|.+..+++.||+|.+.... .....+.+|+.+++.+ .||||+++++++.
T Consensus 12 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l------~h~niv~~~~~~~ 85 (307)
T cd06607 12 DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQL------RHPNTIEYKGCYL 85 (307)
T ss_pred CcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhC------CCCCEEEEEEEEE
Confidence 34467999999999999999999999999999999886432 2234566677776665 4789999999999
Q ss_pred ecCeEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEe
Q 007035 487 HLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (621)
Q Consensus 487 ~~~~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~D 566 (621)
..+..++||||+.+++.+.+..... .+++..+..++.||+.||.|||+.+|+||||+|+||+++. ++.++|+|
T Consensus 86 ~~~~~~lv~e~~~g~l~~~~~~~~~-----~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~--~~~~kL~d 158 (307)
T cd06607 86 REHTAWLVMEYCLGSASDILEVHKK-----PLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTE--PGTVKLAD 158 (307)
T ss_pred eCCeEEEEHHhhCCCHHHHHHHccc-----CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECC--CCCEEEee
Confidence 9999999999999998887764332 2788999999999999999999999999999999999984 78899999
Q ss_pred cCCccccCCCccccccCCcccCchhhc---CCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 007035 567 LGSSCFQTDNLCLYVQSRSYRAPEVII---GLPYDQKIDLWSLGCILAELWTGEVCLI 621 (621)
Q Consensus 567 FGls~~~~~~~~~~~gt~~Y~APEvl~---~~~~s~ksDIWSLGvILyELltG~~PF~ 621 (621)
||++...... ....+++.|+|||++. ...++.++||||||+++|+|++|++||.
T Consensus 159 fg~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~ 215 (307)
T cd06607 159 FGSASLVSPA-NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 215 (307)
T ss_pred cCcceecCCC-CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCC
Confidence 9988654433 3346788999999984 3457889999999999999999999973
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-29 Score=253.63 Aligned_cols=197 Identities=29% Similarity=0.419 Sum_probs=164.8
Q ss_pred CceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecC----chhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecC
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~----~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~ 489 (621)
++|++.+.||.|++|.||++.++.+++.++||.+... ......+.+|+.+++.+ .|+||+++++++...+
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~------~h~~i~~~~~~~~~~~ 75 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL------NHPNVIKYYASFIEDN 75 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHc------cCCchhhhhheeEeCC
Confidence 4688999999999999999999999999999987642 22334566677777666 4789999999999999
Q ss_pred eEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecC
Q 007035 490 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (621)
Q Consensus 490 ~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFG 568 (621)
..++||||+.+ +|.+++..... ....+++..++.++.||+.||.|||++|++|+||+|+||+++. ++.++|+|||
T Consensus 76 ~~~~v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~--~~~~~l~dfg 151 (267)
T cd08229 76 ELNIVLELADAGDLSRMIKHFKK--QKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITA--TGVVKLGDLG 151 (267)
T ss_pred eEEEEEEecCCCCHHHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcC--CCCEEECcch
Confidence 99999999985 67666653322 1234788999999999999999999999999999999999984 7789999999
Q ss_pred CccccCCCc---cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 569 SSCFQTDNL---CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 569 ls~~~~~~~---~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
++....... ....++..|+|||.+.+..++.++|+||||+++|+|++|..||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~ 206 (267)
T cd08229 152 LGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF 206 (267)
T ss_pred hhhccccCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCc
Confidence 876543322 2346788999999999888999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.8e-29 Score=259.26 Aligned_cols=200 Identities=23% Similarity=0.286 Sum_probs=161.1
Q ss_pred CceEEEEEeccCCCCceeEEEeCCCCcE--EEEEEEecC--chhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecC
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVD--VCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d~~tg~~--VAlKii~~~--~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~ 489 (621)
++|++.+.||+|+||.||+|.++.++.. +++|.++.. ......+.+|+.++.++. .|+||+++++++...+
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~-----~h~~iv~~~~~~~~~~ 81 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG-----HHPNIINLLGACEHRG 81 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhc-----CCCCcceEEEEECCCC
Confidence 5799999999999999999998887765 577766532 233456677888887773 4789999999999999
Q ss_pred eEEEEEeccc-cchHHHHHhhhccC----------CCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccC
Q 007035 490 HLFIVCELLR-ANLYEFQKFNQESG----------GEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQ 558 (621)
Q Consensus 490 ~l~LVmEyl~-gsLld~l~~~~~~~----------~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~ 558 (621)
.+++||||+. ++|.+++....... ....+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~-- 159 (303)
T cd05088 82 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGE-- 159 (303)
T ss_pred CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecC--
Confidence 9999999997 57777775432111 1124788999999999999999999999999999999999984
Q ss_pred CCeEEEEecCCccccCCCccc--cccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 559 RCEIKIIDLGSSCFQTDNLCL--YVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 559 ~~~IKL~DFGls~~~~~~~~~--~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
++.+||+|||++......... ...+..|+|||.+.+..++.++|||||||++|+|+| |..||
T Consensus 160 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~ 224 (303)
T cd05088 160 NYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY 224 (303)
T ss_pred CCcEEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCc
Confidence 778999999998543221111 123567999999988889999999999999999998 99997
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.4e-29 Score=250.48 Aligned_cols=199 Identities=29% Similarity=0.463 Sum_probs=166.0
Q ss_pred cCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecC---
Q 007035 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE--- 489 (621)
Q Consensus 413 ~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~--- 489 (621)
.++|++.+.||.|++|.||+|.+..+++.+++|++.......+.+.+|+.+++.+. .|+||+++++++....
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~-----~h~~i~~~~~~~~~~~~~~ 79 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYS-----NHPNIATFYGAFIKKNPPG 79 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhc-----CCCChheEEEEEEecCCCC
Confidence 47899999999999999999999999999999999877665677888888888774 4789999999997644
Q ss_pred ---eEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEE
Q 007035 490 ---HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKII 565 (621)
Q Consensus 490 ---~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~ 565 (621)
.+++||||+.+ +|.+++...... ...+++..++.++.|++.||.|||+.+++|+||+|+||+++. ++.++|+
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~--~~~~~l~ 155 (275)
T cd06608 80 NDDQLWLVMELCGGGSVTDLVKGLRKK--GKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTK--NAEVKLV 155 (275)
T ss_pred cceEEEEEEEcCCCCcHHHHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEcc--CCeEEEC
Confidence 58999999986 666665543211 123889999999999999999999999999999999999984 7889999
Q ss_pred ecCCccccCCC---ccccccCCcccCchhhcC-----CCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 566 DLGSSCFQTDN---LCLYVQSRSYRAPEVIIG-----LPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 566 DFGls~~~~~~---~~~~~gt~~Y~APEvl~~-----~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
|||++...... .....+++.|+|||++.. ..++.++||||||++||+|++|++||
T Consensus 156 d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~ 218 (275)
T cd06608 156 DFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPL 218 (275)
T ss_pred CCccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCc
Confidence 99987654322 223457888999999854 24678899999999999999999998
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.2e-29 Score=257.79 Aligned_cols=185 Identities=19% Similarity=0.285 Sum_probs=155.4
Q ss_pred EEeccCCCCceeEEEeCCCCcEEEEEEEecCch----hhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEe----cCeE
Q 007035 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD----FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH----LEHL 491 (621)
Q Consensus 420 ~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~----~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~----~~~l 491 (621)
..||.|+++.||+|.. +|+.||+|.++.... ..+.+.+|+.++++++ ||||+++++++.+ ...+
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~------h~nIv~~~g~~~~~~~~~~~~ 97 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRID------SNNILKIYGFIIDIVDDLPRL 97 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcC------CCCEEEEeeeEEecccCCCce
Confidence 4689999999999985 789999999876432 2355668888887764 6799999999887 3578
Q ss_pred EEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHC-CeecccCCCccEEEeccCCCeEEEEecCC
Q 007035 492 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSL-GIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (621)
Q Consensus 492 ~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~-gIvHrDLKP~NILl~~~~~~~IKL~DFGl 569 (621)
++||||+.+ +|.+++.... .+++.....++.|++.||.|||+. +++||||||+|||++. ++.+||+|||+
T Consensus 98 ~lv~Ey~~~g~L~~~l~~~~------~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~--~~~~kl~dfg~ 169 (283)
T PHA02988 98 SLILEYCTRGYLREVLDKEK------DLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTE--NYKLKIICHGL 169 (283)
T ss_pred EEEEEeCCCCcHHHHHhhCC------CCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECC--CCcEEEcccch
Confidence 999999996 5666654322 278888999999999999999984 9999999999999994 78899999999
Q ss_pred ccccCCCccccccCCcccCchhhcC--CCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 570 SCFQTDNLCLYVQSRSYRAPEVIIG--LPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 570 s~~~~~~~~~~~gt~~Y~APEvl~~--~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
+...........+++.|+|||++.+ ..++.++|||||||++|||++|+.||
T Consensus 170 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf 222 (283)
T PHA02988 170 EKILSSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPF 222 (283)
T ss_pred HhhhccccccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCC
Confidence 8765555455678899999999976 57899999999999999999999998
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.8e-29 Score=262.03 Aligned_cols=191 Identities=22% Similarity=0.288 Sum_probs=154.9
Q ss_pred EEEEeccC--CCCceeEEEeCCCCcEEEEEEEecCc---hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeEE
Q 007035 418 VTEYLGSA--AFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLF 492 (621)
Q Consensus 418 I~~~LG~G--~fG~Vyka~d~~tg~~VAlKii~~~~---~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l~ 492 (621)
++++||+| +|++||++.++.+|+.||+|++.... .....+.+|+.+++.+ +||||+++++++...+..+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l------~hpniv~~~~~~~~~~~~~ 75 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLF------NHPNIVPYRATFIADNELW 75 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhc------CCCCeeeEEEEEEECCEEE
Confidence 46789999 67899999999999999999987542 2334556677776655 4789999999999999999
Q ss_pred EEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCcc
Q 007035 493 IVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 571 (621)
Q Consensus 493 LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~ 571 (621)
+||||+.+ ++.+++...... .+++..++.++.||+.||.|||+++|+||||||+|||++. ++.++++||+...
T Consensus 76 lv~e~~~~~~l~~~~~~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~--~~~~~l~~~~~~~ 149 (327)
T cd08227 76 VVTSFMAYGSAKDLICTHFMD----GMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISV--DGKVYLSGLRSNL 149 (327)
T ss_pred EEEeccCCCcHHHHHHhhccC----CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEec--CCcEEEcccchhh
Confidence 99999985 666666543221 2788999999999999999999999999999999999984 7789999998543
Q ss_pred ccCC----------CccccccCCcccCchhhcC--CCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 572 FQTD----------NLCLYVQSRSYRAPEVIIG--LPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 572 ~~~~----------~~~~~~gt~~Y~APEvl~~--~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
.... ......++..|+|||++.+ ..++.++|||||||++|+|++|+.||
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf 210 (327)
T cd08227 150 SMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPF 210 (327)
T ss_pred ccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCC
Confidence 2211 1112345677999999976 35889999999999999999999998
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-29 Score=255.98 Aligned_cols=195 Identities=32% Similarity=0.467 Sum_probs=162.9
Q ss_pred cCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc-hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeE
Q 007035 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (621)
Q Consensus 413 ~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~-~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l 491 (621)
.++|++++.||.|+||.||++.+..++..+|+|++.... .....+..|+.+++.++ |+||+++++.+......
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~~~~ 77 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECK------HPNIVGLYEAYFYENKL 77 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCC------CCceeEEEEEEecCCeE
Confidence 367999999999999999999998899999999987543 33455667777777664 78999999999999999
Q ss_pred EEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCc
Q 007035 492 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (621)
Q Consensus 492 ~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls 570 (621)
++||||+++ +|.+++..... .+++..++.++.|++.||.|||+++|+|+||+|+||+++. ++.++|+|||++
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~~-----~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~--~~~~~l~d~g~~ 150 (280)
T cd06611 78 WILIEFCDGGALDSIMLELER-----GLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTL--DGDVKLADFGVS 150 (280)
T ss_pred EEEeeccCCCcHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECC--CCCEEEccCccc
Confidence 999999987 55555443221 2889999999999999999999999999999999999984 788999999987
Q ss_pred cccCCC---ccccccCCcccCchhhc-----CCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 571 CFQTDN---LCLYVQSRSYRAPEVII-----GLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 571 ~~~~~~---~~~~~gt~~Y~APEvl~-----~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
...... .....+++.|+|||.+. ...++.++||||||+++|+|++|+.||
T Consensus 151 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~ 208 (280)
T cd06611 151 AKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPH 208 (280)
T ss_pred hhhcccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCc
Confidence 654322 23356788999999985 345778999999999999999999997
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.3e-29 Score=250.89 Aligned_cols=197 Identities=26% Similarity=0.374 Sum_probs=163.0
Q ss_pred eeecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecC
Q 007035 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (621)
Q Consensus 410 ~ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~ 489 (621)
.+..++|+++++||+|+||.||+|.+ .+++.||+|.+.........+.+|+.+++.++ |+||+++++++. .+
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~-~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~------h~~i~~~~~~~~-~~ 73 (260)
T cd05067 2 EVPRETLKLVKKLGAGQFGEVWMGYY-NGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQ------HPRLVRLYAVVT-QE 73 (260)
T ss_pred ccchHHceeeeeeccCccceEEeeec-CCCceEEEEEecCCCCcHHHHHHHHHHHHhcC------CcCeeeEEEEEc-cC
Confidence 35568899999999999999999985 46788999999876655567778888887764 679999999864 46
Q ss_pred eEEEEEeccc-cchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecC
Q 007035 490 HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (621)
Q Consensus 490 ~l~LVmEyl~-gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFG 568 (621)
..++||||+. ++|.+.+..... ..+++..+..++.||+.||.|||+.+++||||||+||+++. ++.++|+|||
T Consensus 74 ~~~~v~e~~~~~~L~~~~~~~~~----~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~--~~~~~l~dfg 147 (260)
T cd05067 74 PIYIITEYMENGSLVDFLKTPEG----IKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSE--TLCCKIADFG 147 (260)
T ss_pred CcEEEEEcCCCCCHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcC--CCCEEEccCc
Confidence 7899999997 477776654321 23788899999999999999999999999999999999984 7889999999
Q ss_pred CccccCCCc----cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 569 SSCFQTDNL----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 569 ls~~~~~~~----~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
++....... ....++..|+|||++.+..++.++||||||+++|+|++ |++||
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~ 204 (260)
T cd05067 148 LARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPY 204 (260)
T ss_pred ceeecCCCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCC
Confidence 986544211 12234568999999998889999999999999999999 99998
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-29 Score=257.64 Aligned_cols=193 Identities=35% Similarity=0.510 Sum_probs=160.7
Q ss_pred ceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCch------hhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEec
Q 007035 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD------FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (621)
Q Consensus 415 rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~------~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~ 488 (621)
+|++.+.||.|++|.||+|.+..+++.|++|.+..... ....+..|+.+++.+ .|+||+++++++...
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~------~h~~i~~~~~~~~~~ 74 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQEL------KHPNIIGLLDVFGHK 74 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhc------CCCCChhhhheeecC
Confidence 58899999999999999999999999999999876432 223345566666655 478999999999999
Q ss_pred CeEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecC
Q 007035 489 EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (621)
Q Consensus 489 ~~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFG 568 (621)
+.+++||||+.++|.+++.... ..+++..+..++.||+.||.|||++||+|+||+|+||+++. ++.++|+|||
T Consensus 75 ~~~~lv~e~~~~~L~~~i~~~~-----~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~--~~~~~l~dfg 147 (298)
T cd07841 75 SNINLVFEFMETDLEKVIKDKS-----IVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIAS--DGVLKLADFG 147 (298)
T ss_pred CEEEEEEcccCCCHHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcC--CCCEEEccce
Confidence 9999999999778877775432 13889999999999999999999999999999999999994 7889999999
Q ss_pred CccccCCC---ccccccCCcccCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 569 SSCFQTDN---LCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 569 ls~~~~~~---~~~~~gt~~Y~APEvl~~-~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
++...... .....+++.|+|||.+.+ ..++.++|||||||++|+|++|.+||
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~ 203 (298)
T cd07841 148 LARSFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFL 203 (298)
T ss_pred eeeeccCCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccc
Confidence 98665432 222345778999999865 45788999999999999999997765
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.5e-29 Score=253.07 Aligned_cols=203 Identities=19% Similarity=0.276 Sum_probs=159.9
Q ss_pred eeecCceEEEEEeccCCCCceeEEEeCC-----CCcEEEEEEEecCch--hhhhHHHHHHHHHHhcccCCCCCCceEEEe
Q 007035 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLH-----TGVDVCLKIIKNDKD--FFDQSLDEIKLLKLVNKNDPADEHHILRLY 482 (621)
Q Consensus 410 ~ii~~rY~I~~~LG~G~fG~Vyka~d~~-----tg~~VAlKii~~~~~--~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~ 482 (621)
++..++|++.+.||.|+||.||+|.+.. ++..||+|.+..... ....+.+|+.+++.+ .||||++++
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l------~~~~iv~~~ 75 (277)
T cd05062 2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF------NCHHVVRLL 75 (277)
T ss_pred cccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhC------CCCCeeeEE
Confidence 3567889999999999999999998642 457799998864322 233455666666554 478999999
Q ss_pred eEeEecCeEEEEEecccc-chHHHHHhhhccC----CCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEecc
Q 007035 483 DYFYHLEHLFIVCELLRA-NLYEFQKFNQESG----GEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSY 557 (621)
Q Consensus 483 ~~f~~~~~l~LVmEyl~g-sLld~l~~~~~~~----~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~ 557 (621)
+++....+.++||||+.+ +|.+++....... ....+++..+..++.|++.||.|||+.+++||||||+||+++.
T Consensus 76 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~- 154 (277)
T cd05062 76 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAE- 154 (277)
T ss_pred EEEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcC-
Confidence 999999999999999985 6766664322110 1123567788899999999999999999999999999999994
Q ss_pred CCCeEEEEecCCccccCCCc-----cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 558 QRCEIKIIDLGSSCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 558 ~~~~IKL~DFGls~~~~~~~-----~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
++.++|+|||++....... ....+++.|+|||++.+..++.++|||||||++|+|++ |..||
T Consensus 155 -~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~ 222 (277)
T cd05062 155 -DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY 222 (277)
T ss_pred -CCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCC
Confidence 7889999999876433221 11234678999999998889999999999999999999 68876
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-28 Score=252.78 Aligned_cols=200 Identities=27% Similarity=0.403 Sum_probs=164.0
Q ss_pred ecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEec---
Q 007035 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL--- 488 (621)
Q Consensus 412 i~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~--- 488 (621)
..++|.+.+.||+|+||.||++.+..+++.+|+|++...........+|+.+++.+. +||||+++++++...
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~-----~h~ni~~~~~~~~~~~~~ 94 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLP-----NHPNVVKFYGMFYKADKL 94 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhc-----CCCCeEEEEEEEEecccc
Confidence 357899999999999999999999999999999998765444456677887777663 478999999998754
Q ss_pred --CeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEE
Q 007035 489 --EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKII 565 (621)
Q Consensus 489 --~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~ 565 (621)
...++||||+++ +|.+++...... ...+++..++.++.|++.||.|||+.+|+||||||+||+++. ++.++|+
T Consensus 95 ~~~~~~lv~ey~~~~sL~~~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~--~~~~kl~ 170 (291)
T cd06639 95 VGGQLWLVLELCNGGSVTELVKGLLIC--GQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTT--EGGVKLV 170 (291)
T ss_pred CCCeeEEEEEECCCCcHHHHHHHhhhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcC--CCCEEEe
Confidence 368999999975 666665432211 123788999999999999999999999999999999999984 7789999
Q ss_pred ecCCccccCCC---ccccccCCcccCchhhcCC-----CCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 566 DLGSSCFQTDN---LCLYVQSRSYRAPEVIIGL-----PYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 566 DFGls~~~~~~---~~~~~gt~~Y~APEvl~~~-----~~s~ksDIWSLGvILyELltG~~PF 620 (621)
|||++...... .....++..|+|||.+... .++.++|||||||++|+|++|+.||
T Consensus 171 dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~ 233 (291)
T cd06639 171 DFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL 233 (291)
T ss_pred ecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCC
Confidence 99987654322 2234678889999998643 2678999999999999999999998
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.1e-29 Score=251.57 Aligned_cols=193 Identities=24% Similarity=0.376 Sum_probs=160.0
Q ss_pred CceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeEEE
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFI 493 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l~L 493 (621)
.+|++.+.||.|+||.||++.+. .+..+|+|++.......+.+.+|+.+++.+ .|+||+++++++......++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l------~~~~i~~~~~~~~~~~~~~l 76 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMSEDDFIEEAKVMMKL------SHPNLVQLYGVCTKQRPIFI 76 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCCHHHHHHHHHHHHhC------CCCCEEEEEEEEcCCCceEE
Confidence 46889999999999999999875 466799999876544445677788877765 47899999999999999999
Q ss_pred EEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCccc
Q 007035 494 VCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF 572 (621)
Q Consensus 494 VmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~~ 572 (621)
||||+++ +|.+++..... .+++..++.++.||+.||.|||+++|+||||||+||+++. ++.+||+|||++..
T Consensus 77 v~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~--~~~~kl~dfg~~~~ 149 (256)
T cd05059 77 VTEYMANGCLLNYLRERKG-----KLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGE--DNVVKVSDFGLARY 149 (256)
T ss_pred EEecCCCCCHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECC--CCcEEECCccccee
Confidence 9999975 67777654322 3788999999999999999999999999999999999984 78899999998865
Q ss_pred cCCCccc----cccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 573 QTDNLCL----YVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 573 ~~~~~~~----~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
....... ...+..|+|||.+.+..++.++||||||+++|+|++ |++||
T Consensus 150 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~ 202 (256)
T cd05059 150 VLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPY 202 (256)
T ss_pred cccccccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCC
Confidence 4332111 122347999999998889999999999999999999 88887
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=256.92 Aligned_cols=204 Identities=25% Similarity=0.384 Sum_probs=163.5
Q ss_pred eeecCceEEEEEeccCCCCceeEEEeCC-------CCcEEEEEEEecCc--hhhhhHHHHHHHHHHhcccCCCCCCceEE
Q 007035 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLH-------TGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILR 480 (621)
Q Consensus 410 ~ii~~rY~I~~~LG~G~fG~Vyka~d~~-------tg~~VAlKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~hpnIvr 480 (621)
++..++|.+.+.||+|+||.||++++.. +...+|+|++.... .....+..|+.+++.+. +||||++
T Consensus 14 ~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~-----~h~~i~~ 88 (307)
T cd05098 14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG-----KHKNIIN 88 (307)
T ss_pred eeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhc-----CCCCEee
Confidence 3445789999999999999999998643 23569999987542 23345667777777663 4789999
Q ss_pred EeeEeEecCeEEEEEecccc-chHHHHHhhhccC----------CCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCC
Q 007035 481 LYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESG----------GEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKP 549 (621)
Q Consensus 481 l~~~f~~~~~l~LVmEyl~g-sLld~l~~~~~~~----------~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP 549 (621)
+++++......++||||+.+ +|.+++....... ....+++..+..++.||+.||+|||++|++||||||
T Consensus 89 ~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp 168 (307)
T cd05098 89 LLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAA 168 (307)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccH
Confidence 99999999999999999984 7777776532211 123478889999999999999999999999999999
Q ss_pred ccEEEeccCCCeEEEEecCCccccCCC-----ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 550 ENILIKSYQRCEIKIIDLGSSCFQTDN-----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 550 ~NILl~~~~~~~IKL~DFGls~~~~~~-----~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
+|||++. ++.++|+|||++...... .....+++.|+|||++.+..++.++|||||||++|+|++ |..||
T Consensus 169 ~Nill~~--~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~ 243 (307)
T cd05098 169 RNVLVTE--DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 243 (307)
T ss_pred HheEEcC--CCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCC
Confidence 9999984 788999999998654321 111223467999999998889999999999999999998 88876
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=255.60 Aligned_cols=192 Identities=31% Similarity=0.500 Sum_probs=162.4
Q ss_pred CceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc-hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeEE
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLF 492 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~-~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l~ 492 (621)
.+|++.+.||.|++|.||++.+..+++.|++|.+.... ...+.+.+|+.+++.+ .||||+++++++......+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l------~h~~iv~~~~~~~~~~~~~ 92 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKEL------KNPNIVNFLDSFLVGDELF 92 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhc------CCCceeeeeeeEecCceEE
Confidence 57999999999999999999999999999999886532 2334556677776655 4789999999999999999
Q ss_pred EEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCcc
Q 007035 493 IVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 571 (621)
Q Consensus 493 LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~ 571 (621)
+|+||+.+ +|..++. .. .+++..+..++.||+.||.|||+.|++||||+|+||+++. ++.++|+|||++.
T Consensus 93 lv~e~~~~~~L~~~~~-~~------~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~--~~~~kl~dfg~~~ 163 (296)
T cd06655 93 VVMEYLAGGSLTDVVT-ET------CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGM--DGSVKLTDFGFCA 163 (296)
T ss_pred EEEEecCCCcHHHHHH-hc------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECC--CCCEEEccCccch
Confidence 99999986 4444443 21 2788999999999999999999999999999999999984 7889999999876
Q ss_pred ccCCC---ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 572 FQTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 572 ~~~~~---~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
..... .....+++.|+|||.+.+..++.++|||||||++|+|++|+.||
T Consensus 164 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf 215 (296)
T cd06655 164 QITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPY 215 (296)
T ss_pred hcccccccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 54332 22346788999999999888999999999999999999999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.4e-29 Score=251.37 Aligned_cols=193 Identities=27% Similarity=0.444 Sum_probs=161.7
Q ss_pred ceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc-------hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEe
Q 007035 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-------DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (621)
Q Consensus 415 rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~-------~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~ 487 (621)
+|++.+.||+|++|.||++.+..+++.||+|++.... .....+..|+++++.+ +|+||+++++++.+
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l------~h~~iv~~~~~~~~ 74 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL------NHPHIIRMLGATCE 74 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHc------CCCceehhhceecc
Confidence 4788899999999999999999999999999987532 1235566777777766 46899999999999
Q ss_pred cCeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEe
Q 007035 488 LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (621)
Q Consensus 488 ~~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~D 566 (621)
.++.++||||+.+ +|.+++.... .+++..+..++.||+.||.|||++|++|+||+|+||+++. ....++|+|
T Consensus 75 ~~~~~~v~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~-~~~~~~l~d 147 (268)
T cd06630 75 DSHFNLFVEWMAGGSVSHLLSKYG------AFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDS-TGQRLRIAD 147 (268)
T ss_pred CCeEEEEEeccCCCcHHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC-CCCEEEEcc
Confidence 9999999999986 5666554322 2788999999999999999999999999999999999974 234699999
Q ss_pred cCCccccCCC-------ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 567 LGSSCFQTDN-------LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 567 FGls~~~~~~-------~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
||++...... .....++..|+|||.+.+..++.++|+||||+++|+|++|+.||
T Consensus 148 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~ 208 (268)
T cd06630 148 FGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPW 208 (268)
T ss_pred cccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCC
Confidence 9998654432 12245688999999998888999999999999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=272.56 Aligned_cols=194 Identities=29% Similarity=0.425 Sum_probs=163.0
Q ss_pred cCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEe---cCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecC
Q 007035 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK---NDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (621)
Q Consensus 413 ~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~---~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~ 489 (621)
+..|+++++||+||.++||++... ..+.||+|.+. .+....+-+..|+.+|.+++. |-+|+++|+|-..++
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s-~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg-----~~~IIqL~DYEv~d~ 433 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNS-DKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKG-----HDKIIQLYDYEVTDG 433 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecC-CCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcC-----CceEEEEeeeeccCc
Confidence 457999999999999999999854 44556666443 355667889999999999985 458999999999999
Q ss_pred eEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCC
Q 007035 490 HLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (621)
Q Consensus 490 ~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGl 569 (621)
.+||||||=+..|-..+...... .+.-.++.+..|+|.|+.++|+.||||.||||.|+|+- .|.+||+|||.
T Consensus 434 ~lYmvmE~Gd~DL~kiL~k~~~~-----~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV---kG~LKLIDFGI 505 (677)
T KOG0596|consen 434 YLYMVMECGDIDLNKILKKKKSI-----DPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV---KGRLKLIDFGI 505 (677)
T ss_pred eEEEEeecccccHHHHHHhccCC-----CchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE---eeeEEeeeech
Confidence 99999999888888877755432 33347889999999999999999999999999999998 89999999999
Q ss_pred ccccCCCcc-----ccccCCcccCchhhcCC-----------CCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 570 SCFQTDNLC-----LYVQSRSYRAPEVIIGL-----------PYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 570 s~~~~~~~~-----~~~gt~~Y~APEvl~~~-----------~~s~ksDIWSLGvILyELltG~~PF 620 (621)
|..+....+ ..+||+.||+||.+... ..+.++||||||||||+|+.|++||
T Consensus 506 A~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf 572 (677)
T KOG0596|consen 506 ANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPF 572 (677)
T ss_pred hcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCch
Confidence 876554433 25899999999999532 2678999999999999999999998
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.5e-29 Score=254.95 Aligned_cols=194 Identities=35% Similarity=0.505 Sum_probs=159.8
Q ss_pred ceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc-hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeEEE
Q 007035 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFI 493 (621)
Q Consensus 415 rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~-~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l~L 493 (621)
-|++++.||.|+||.||++.+..++..+++|.+.... .......+|+++++.+ +|+||+++++.+......++
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l------~h~~ii~~~~~~~~~~~~~~ 79 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASC------DHPNIVKLLDAFYYENNLWI 79 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHC------CCCCeeeEEEEEeeCCEEEE
Confidence 3678899999999999999999999999999987533 3345566677777665 47899999999999999999
Q ss_pred EEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCcccc
Q 007035 494 VCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQ 573 (621)
Q Consensus 494 VmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~~~ 573 (621)
||||+.++.+........ ..+++..+..++.||+.||.|||+.+|+||||||+|||++. ++.++|+|||++...
T Consensus 80 v~e~~~~~~l~~~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~--~~~~kl~dfg~~~~~ 153 (282)
T cd06643 80 LIEFCAGGAVDAVMLELE----RPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTL--DGDIKLADFGVSAKN 153 (282)
T ss_pred EEEecCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcc--CCCEEEccccccccc
Confidence 999998755544332211 12888999999999999999999999999999999999984 788999999998654
Q ss_pred CCC---ccccccCCcccCchhhc-----CCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 574 TDN---LCLYVQSRSYRAPEVII-----GLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 574 ~~~---~~~~~gt~~Y~APEvl~-----~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
... .....+++.|+|||++. +..++.++|||||||++|+|++|++||
T Consensus 154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~ 208 (282)
T cd06643 154 TRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPH 208 (282)
T ss_pred cccccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCc
Confidence 332 22346788999999984 345778999999999999999999997
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=249.26 Aligned_cols=197 Identities=26% Similarity=0.349 Sum_probs=164.9
Q ss_pred eecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCe
Q 007035 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (621)
Q Consensus 411 ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~ 490 (621)
+..++|++.+.||+|+||.||++.+. .++.+|+|.+.........+.+|+.+++.++ |+||+++++++.....
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~~~ 75 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMSPEAFLQEAQIMKKLR------HDKLVQLYAVCSEEEP 75 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccCHHHHHHHHHHHhhCC------CCCEeeeeeeeecCCc
Confidence 45678999999999999999999865 5578999999876555567788888887764 6899999999998899
Q ss_pred EEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCC
Q 007035 491 LFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (621)
Q Consensus 491 l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGl 569 (621)
.++||||+.+ +|.+.+..... ..+++..+..++.||+.||.|||+++++|+||+|+||+++. ++.++|+|||+
T Consensus 76 ~~~v~e~~~~~~L~~~i~~~~~----~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~--~~~~~l~d~g~ 149 (261)
T cd05034 76 IYIVTEYMSKGSLLDFLKSGEG----KKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGE--NLVCKIADFGL 149 (261)
T ss_pred eEEEEeccCCCCHHHHHhcccc----CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcC--CCCEEECcccc
Confidence 9999999975 67776654321 23788999999999999999999999999999999999984 78999999998
Q ss_pred ccccCCCcc----ccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 570 SCFQTDNLC----LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 570 s~~~~~~~~----~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
+........ ....+..|+|||.+.+..++.++||||||+++|+|++ |+.||
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~ 205 (261)
T cd05034 150 ARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPY 205 (261)
T ss_pred ceeccchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCC
Confidence 865442211 1123467999999998889999999999999999998 99997
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.5e-29 Score=252.75 Aligned_cols=192 Identities=32% Similarity=0.467 Sum_probs=165.4
Q ss_pred CceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc--hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeE
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l 491 (621)
++|++.+.||.|++|.||+|.+..+++.||+|++.... .....+.+|+.+++.++ |+||+++++++.....+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~~~~ 74 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCR------SPYITKYYGSFLKGSKL 74 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcC------CCCeeeeeEEEEECCeE
Confidence 47899999999999999999999999999999987543 23345667777777664 78999999999999999
Q ss_pred EEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCc
Q 007035 492 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (621)
Q Consensus 492 ~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls 570 (621)
++|+||+.+ +|.+.+... .+++..++.++.||+.||.|||+.+++|+||+|+||+++. ++.++|+|||++
T Consensus 75 ~~v~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~--~~~~~l~d~g~~ 145 (274)
T cd06609 75 WIIMEYCGGGSCLDLLKPG-------KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSE--EGDVKLADFGVS 145 (274)
T ss_pred EEEEEeeCCCcHHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECC--CCCEEEcccccc
Confidence 999999986 666665432 2789999999999999999999999999999999999995 788999999998
Q ss_pred cccCCC---ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 571 CFQTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 571 ~~~~~~---~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
...... .....+++.|+|||.+.+..++.++||||||+++|+|++|++||
T Consensus 146 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~ 198 (274)
T cd06609 146 GQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPL 198 (274)
T ss_pred eeecccccccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence 665433 23356788899999999888999999999999999999999998
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=250.46 Aligned_cols=198 Identities=27% Similarity=0.363 Sum_probs=164.9
Q ss_pred cCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecC-chhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecC--
Q 007035 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND-KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE-- 489 (621)
Q Consensus 413 ~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~-~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~-- 489 (621)
++||+|.+.||.|||+.||++++..+++.+|+|.+.-. ....+...+|++..++++ |||+++++++.....
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~------s~~vl~l~dh~l~~~~D 93 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFN------SPNVLRLVDHQLREEKD 93 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhC------CcchHHHHHHHHHhhcc
Confidence 47999999999999999999999999999999987643 355677788888887775 578999999876443
Q ss_pred ---eEEEEEeccc-cchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCC--eecccCCCccEEEeccCCCeEE
Q 007035 490 ---HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLG--IIHCDLKPENILIKSYQRCEIK 563 (621)
Q Consensus 490 ---~l~LVmEyl~-gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~g--IvHrDLKP~NILl~~~~~~~IK 563 (621)
..||+++|.. |+|++.+......+ ..+++.++..|+.+|++||.+||+.. ++||||||.|||+.. .+.++
T Consensus 94 ~~~~~yll~Pyy~~Gsl~d~i~~~k~kg--~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~--~~~~v 169 (302)
T KOG2345|consen 94 GKHEAYLLLPYYKRGSLLDEIERLKIKG--NFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSD--SGLPV 169 (302)
T ss_pred CceeEEEEeehhccccHHHHHHHHhhcC--CccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecC--CCceE
Confidence 4999999987 67999888765543 34999999999999999999999998 999999999999994 78999
Q ss_pred EEecCCccccCCCccc------------cccCCcccCchhhc---CCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 564 IIDLGSSCFQTDNLCL------------YVQSRSYRAPEVII---GLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 564 L~DFGls~~~~~~~~~------------~~gt~~Y~APEvl~---~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
|.|||++....-.... ..-|..|+|||.+. +...+.++|||||||+||.|+.|.-||
T Consensus 170 l~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPf 241 (302)
T KOG2345|consen 170 LMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPF 241 (302)
T ss_pred EEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcc
Confidence 9999987643322111 12377899999985 345788999999999999999999998
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-29 Score=255.47 Aligned_cols=194 Identities=28% Similarity=0.509 Sum_probs=161.4
Q ss_pred CceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCch---hhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCe
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD---FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~---~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~ 490 (621)
++|++++.||.|+||.||+|.+..+++.||+|++..... ..+.+.+|+++++.++ ||||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~~~ 74 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLR------HENLVNLIEVFRRKKR 74 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcC------CcchhhHHHhcccCCe
Confidence 479999999999999999999998999999998764322 2345567777776654 7899999999999999
Q ss_pred EEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCc
Q 007035 491 LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (621)
Q Consensus 491 l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls 570 (621)
.++||||+.+++++.+..... .+++..++.++.||+.||.|||+.+|+|+||+|+||+++. ++.++|+|||++
T Consensus 75 ~~lv~e~~~~~~l~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~--~~~~~l~dfg~~ 147 (286)
T cd07846 75 LYLVFEFVDHTVLDDLEKYPN-----GLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQ--SGVVKLCDFGFA 147 (286)
T ss_pred EEEEEecCCccHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECC--CCcEEEEeeeee
Confidence 999999999876665543221 2788999999999999999999999999999999999984 788999999987
Q ss_pred cccCCC---ccccccCCcccCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 571 CFQTDN---LCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 571 ~~~~~~---~~~~~gt~~Y~APEvl~~~-~~s~ksDIWSLGvILyELltG~~PF 620 (621)
...... .....++..|+|||++.+. .++.++||||||+++|+|++|++||
T Consensus 148 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~ 201 (286)
T cd07846 148 RTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLF 201 (286)
T ss_pred eeccCCccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCC
Confidence 654322 2234578889999998764 4688999999999999999999887
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=250.51 Aligned_cols=193 Identities=23% Similarity=0.376 Sum_probs=159.1
Q ss_pred CceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeEEE
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFI 493 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l~L 493 (621)
.+|++++.||+|+||.||++.+.. +..+|+|.+.......+.+.+|+.+++.+ +||||+++++++......++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~~~~~~~l 76 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSEDEFIEEAKVMMKL------SHEKLVQLYGVCTKQRPIYI 76 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcccHHHHHHHHHHHhcC------CCCCeeeEEEEEccCCCcEE
Confidence 579999999999999999998643 45699998876544345667777777655 57899999999999899999
Q ss_pred EEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCccc
Q 007035 494 VCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF 572 (621)
Q Consensus 494 VmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~~ 572 (621)
||||+.+ +|.+++..... .+++..++.++.||+.||.|||+.+++|+||||.||+++. ++.+||+|||.+..
T Consensus 77 v~e~~~~~~l~~~i~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~--~~~~kl~d~g~~~~ 149 (256)
T cd05113 77 VTEYMSNGCLLNYLREHGK-----RFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDD--QGCVKVSDFGLSRY 149 (256)
T ss_pred EEEcCCCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcC--CCCEEECCCcccee
Confidence 9999975 67666654322 2789999999999999999999999999999999999984 77899999998765
Q ss_pred cCCCcc----ccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 573 QTDNLC----LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 573 ~~~~~~----~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
...... ...++..|+|||.+.+..++.++||||||+++|+|++ |+.||
T Consensus 150 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~ 202 (256)
T cd05113 150 VLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPY 202 (256)
T ss_pred cCCCceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCc
Confidence 433211 1223567999999998889999999999999999998 99887
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-28 Score=255.24 Aligned_cols=194 Identities=26% Similarity=0.416 Sum_probs=160.3
Q ss_pred CceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc----hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecC
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~ 489 (621)
++|++++.||+|+||.||++.+..+++.|++|.+.... .....+.+|+.+++.+ .||||+++++.+...+
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~------~~~~i~~~~~~~~~~~ 74 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFA------ENPFVVSMFCSFETKR 74 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhC------CCCCeeeeEEEEecCC
Confidence 46899999999999999999999999999999987543 1233455666666654 4789999999999999
Q ss_pred eEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecC
Q 007035 490 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (621)
Q Consensus 490 ~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFG 568 (621)
++++||||+.+ +|.+.+.... .+++..+..++.|++.||.|||+++|+||||||+||+++ ..+.++|+|||
T Consensus 75 ~~~lv~e~~~g~~L~~~l~~~~------~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~--~~~~~~l~dfg 146 (305)
T cd05609 75 HLCMVMEYVEGGDCATLLKNIG------ALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLIT--SMGHIKLTDFG 146 (305)
T ss_pred EEEEEEecCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEEC--CCCCEEEeeCC
Confidence 99999999986 5666654322 278889999999999999999999999999999999998 47889999999
Q ss_pred CccccCCC------------------ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 007035 569 SSCFQTDN------------------LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCLI 621 (621)
Q Consensus 569 ls~~~~~~------------------~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF~ 621 (621)
++...... .....++..|+|||.+.+..++.++|||||||++|+|++|+.||.
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~ 217 (305)
T cd05609 147 LSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFF 217 (305)
T ss_pred CccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 87531100 011346778999999988889999999999999999999999983
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=252.95 Aligned_cols=189 Identities=26% Similarity=0.419 Sum_probs=153.1
Q ss_pred EeccCCCCceeEEEeCCCCcEEEEEEEecCch----hhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeEEEEEe
Q 007035 421 YLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD----FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCE 496 (621)
Q Consensus 421 ~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~----~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l~LVmE 496 (621)
.||+|+||.||++.+..+++.+|+|.+..... ......++..+++.+. ...||+|+.+++.+...+..++|||
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~i~~~~~~~~~~~~~~lv~e 77 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVS---TGDCPFIVCMTYAFHTPDKLCFILD 77 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHh---hCCCCcEeEEEEEEecCCeEEEEEe
Confidence 38999999999999999999999999875421 1122334444444443 2358999999999999999999999
Q ss_pred cccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCccccCC
Q 007035 497 LLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTD 575 (621)
Q Consensus 497 yl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~~~~~ 575 (621)
|+.+ +|.+.+.... .+++..+..++.||+.||.|||+++|+||||||+|||++. ++.++|+|||++.....
T Consensus 78 ~~~~~~L~~~i~~~~------~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~--~~~~~l~dfg~~~~~~~ 149 (279)
T cd05633 78 LMNGGDLHYHLSQHG------VFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDE--HGHVRISDLGLACDFSK 149 (279)
T ss_pred cCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECC--CCCEEEccCCcceeccc
Confidence 9986 4544443221 2889999999999999999999999999999999999984 77899999999865433
Q ss_pred C-ccccccCCcccCchhhc-CCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 576 N-LCLYVQSRSYRAPEVII-GLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 576 ~-~~~~~gt~~Y~APEvl~-~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
. .....+++.|+|||.+. +..++.++||||+||++|+|++|+.||
T Consensus 150 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf 196 (279)
T cd05633 150 KKPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPF 196 (279)
T ss_pred cCccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCc
Confidence 2 22346899999999986 456889999999999999999999998
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=250.40 Aligned_cols=197 Identities=20% Similarity=0.306 Sum_probs=156.6
Q ss_pred eEEEEEeccCCCCceeEEEeCCC---CcEEEEEEEecCc---hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecC
Q 007035 416 YYVTEYLGSAAFSKVFQAQDLHT---GVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (621)
Q Consensus 416 Y~I~~~LG~G~fG~Vyka~d~~t---g~~VAlKii~~~~---~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~ 489 (621)
|++.+.||+|+||.||+|.+..+ +..||+|+++.+. .....+..|+.+++.+ +||||+++++++....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l------~h~~iv~~~~~~~~~~ 74 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDF------DHPNVMKLIGVCFEAS 74 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhC------CCCCeeeEEeeeccCC
Confidence 56788999999999999987653 4789999987542 2334566777776655 4789999999876654
Q ss_pred e------EEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeE
Q 007035 490 H------LFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEI 562 (621)
Q Consensus 490 ~------l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~I 562 (621)
. .++||||+.+ +|...+...........+++..+..++.||+.||.|||+++|+||||||+||+++. ++.+
T Consensus 75 ~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~--~~~~ 152 (273)
T cd05035 75 SLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLRE--DMTV 152 (273)
T ss_pred ccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECC--CCeE
Confidence 4 8999999985 66666544332222334888999999999999999999999999999999999984 7889
Q ss_pred EEEecCCccccCCCc-----cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 563 KIIDLGSSCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 563 KL~DFGls~~~~~~~-----~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
||+|||++....... .....+..|+|||.+.+..++.++|||||||++|||++ |..||
T Consensus 153 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~ 216 (273)
T cd05035 153 CVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPY 216 (273)
T ss_pred EECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCC
Confidence 999999986543321 11234567999999988889999999999999999999 88886
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-29 Score=256.15 Aligned_cols=196 Identities=26% Similarity=0.387 Sum_probs=161.3
Q ss_pred CceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecC--chhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeE
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~--~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l 491 (621)
++|++++.||.|+||.||++++..++..||+|.++.. ......+.+|+.+++.+ .|+||+++++.+...+.+
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~------~~~~i~~~~~~~~~~~~~ 74 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKA------VSPYIVDFYGAFFIEGAV 74 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhc------CCCcHHhhhhheecCCeE
Confidence 4689999999999999999999999999999988753 22335667777777765 368999999999999999
Q ss_pred EEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHH-CCeecccCCCccEEEeccCCCeEEEEecCC
Q 007035 492 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS-LGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (621)
Q Consensus 492 ~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs-~gIvHrDLKP~NILl~~~~~~~IKL~DFGl 569 (621)
++||||+.+ +|..++.... ....+++..+..++.||+.||.|||+ .+|+|+||||+||+++. ++.++|+|||+
T Consensus 75 ~lv~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~--~~~~~l~dfg~ 149 (286)
T cd06622 75 YMCMEYMDAGSLDKLYAGGV---ATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNG--NGQVKLCDFGV 149 (286)
T ss_pred EEEEeecCCCCHHHHHHhcc---ccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECC--CCCEEEeecCC
Confidence 999999987 5544443321 11238899999999999999999997 59999999999999985 78899999998
Q ss_pred ccccCCC-ccccccCCcccCchhhcCCC------CCchhhHHHHHHHHHHHHhCCCCC
Q 007035 570 SCFQTDN-LCLYVQSRSYRAPEVIIGLP------YDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 570 s~~~~~~-~~~~~gt~~Y~APEvl~~~~------~s~ksDIWSLGvILyELltG~~PF 620 (621)
+...... .....+++.|+|||.+.+.. ++.++|||||||++|+|++|+.||
T Consensus 150 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf 207 (286)
T cd06622 150 SGNLVASLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPY 207 (286)
T ss_pred cccccCCccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCC
Confidence 8654322 33346788999999985543 578999999999999999999998
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=248.18 Aligned_cols=194 Identities=22% Similarity=0.363 Sum_probs=165.3
Q ss_pred cCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeEE
Q 007035 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLF 492 (621)
Q Consensus 413 ~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l~ 492 (621)
.++|++.+.||.|+||.||++.. .|+.||+|.+.......+++.+|+.+++.++ |+||+++++++......+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~------~~~i~~~~~~~~~~~~~~ 76 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDSTAAQAFLAEASVMTTLR------HPNLVQLLGVVLQGNPLY 76 (256)
T ss_pred hhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchhHHHHHHHHHHHHHhcC------CcceeeeEEEEcCCCCeE
Confidence 46799999999999999999985 4889999999876655567778888877764 678999999999999999
Q ss_pred EEEeccc-cchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCcc
Q 007035 493 IVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 571 (621)
Q Consensus 493 LVmEyl~-gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~ 571 (621)
+||||++ ++|.+++..... ..+++..+..++.|++.||.|||+++++|+||||+||+++ .++.++|+|||.+.
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~--~~~~~~l~d~g~~~ 150 (256)
T cd05039 77 IVTEYMAKGSLVDYLRSRGR----AVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVS--EDLVAKVSDFGLAK 150 (256)
T ss_pred EEEEecCCCcHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEe--CCCCEEEccccccc
Confidence 9999998 477777654322 1388999999999999999999999999999999999998 47889999999987
Q ss_pred ccCCCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 572 FQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 572 ~~~~~~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
...........+..|+|||.+....++.++||||||+++|+|++ |+.||
T Consensus 151 ~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~ 200 (256)
T cd05039 151 EASQGQDSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY 200 (256)
T ss_pred ccccccccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCC
Confidence 66444333344567999999988889999999999999999997 99887
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=254.86 Aligned_cols=195 Identities=29% Similarity=0.494 Sum_probs=159.8
Q ss_pred cCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc---hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecC
Q 007035 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (621)
Q Consensus 413 ~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~---~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~ 489 (621)
.++|++.+.||.|+||.||+|++..+++.||+|.+.... .......+|+.+++.+ .||||+++++++....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l------~h~~iv~~~~~~~~~~ 84 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLL------KHENVVNLIEICRTKA 84 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhC------CCCCccceEEEEeccc
Confidence 357999999999999999999999999999999886432 1223345677777666 4789999999887543
Q ss_pred --------eEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCe
Q 007035 490 --------HLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCE 561 (621)
Q Consensus 490 --------~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~ 561 (621)
..++||||+++++.+.+.... ..+++..++.++.||+.||.|||+++++|+||||+||+++ .++.
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~l~~~l~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~--~~~~ 157 (310)
T cd07865 85 TPYNRYKGSFYLVFEFCEHDLAGLLSNKN-----VKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILIT--KDGI 157 (310)
T ss_pred ccccCCCceEEEEEcCCCcCHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEC--CCCc
Confidence 469999999998887765432 1288999999999999999999999999999999999998 4788
Q ss_pred EEEEecCCccccCCCc-------cccccCCcccCchhhcCCC-CCchhhHHHHHHHHHHHHhCCCCC
Q 007035 562 IKIIDLGSSCFQTDNL-------CLYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 562 IKL~DFGls~~~~~~~-------~~~~gt~~Y~APEvl~~~~-~s~ksDIWSLGvILyELltG~~PF 620 (621)
+||+|||++....... ....++..|+|||.+.+.. ++.++||||||+++|+|++|++||
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~ 224 (310)
T cd07865 158 LKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIM 224 (310)
T ss_pred EEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCC
Confidence 9999999886543221 1235678899999987653 688999999999999999999887
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8e-29 Score=253.91 Aligned_cols=194 Identities=32% Similarity=0.509 Sum_probs=163.0
Q ss_pred ceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc---hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeE
Q 007035 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (621)
Q Consensus 415 rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~---~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l 491 (621)
+|++++.||.|++|.||+|++..+++.||||.+.... .....+.+|+++++.++ ||||+++++++......
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~------h~~i~~~~~~~~~~~~~ 74 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN------HPNIVKLLDVIHTENKL 74 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcC------CCCCcchhhhcccCCcE
Confidence 4889999999999999999999999999999887532 22345677888877774 78999999999999999
Q ss_pred EEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCcc
Q 007035 492 FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 571 (621)
Q Consensus 492 ~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~ 571 (621)
++||||+.+++...+..... ..+++..++.++.||+.||+|||+.+++|+||+|+||+++. ++.++|+|||++.
T Consensus 75 ~~v~e~~~~~l~~~~~~~~~----~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~--~~~~~l~dfg~~~ 148 (284)
T cd07860 75 YLVFEFLHQDLKKFMDASPL----SGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT--EGAIKLADFGLAR 148 (284)
T ss_pred EEEeeccccCHHHHHHhCCC----CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECC--CCCEEEeeccchh
Confidence 99999998888777654322 22788999999999999999999999999999999999984 7889999999876
Q ss_pred ccCCC---ccccccCCcccCchhhcCCC-CCchhhHHHHHHHHHHHHhCCCCC
Q 007035 572 FQTDN---LCLYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 572 ~~~~~---~~~~~gt~~Y~APEvl~~~~-~s~ksDIWSLGvILyELltG~~PF 620 (621)
..... .....+++.|+|||++.+.. ++.++||||||+++|+|+||+.||
T Consensus 149 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~ 201 (284)
T cd07860 149 AFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALF 201 (284)
T ss_pred hcccCccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 54322 12234578899999987654 588999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=252.28 Aligned_cols=194 Identities=23% Similarity=0.321 Sum_probs=156.0
Q ss_pred cCceEEEEEeccCCCCceeEEEeCCCCc----EEEEEEEecCc--hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeE
Q 007035 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGV----DVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (621)
Q Consensus 413 ~~rY~I~~~LG~G~fG~Vyka~d~~tg~----~VAlKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~ 486 (621)
..+|+++++||.|+||+||+|.+..+++ .||+|+++... .....+..|+.+++.+ .||||+++++++.
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~------~~~~i~~~~~~~~ 79 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGV------GSPYVCRLLGICL 79 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhc------CCCCCceEEEEEc
Confidence 4689999999999999999999877776 48999886532 2334455666655544 5789999999887
Q ss_pred ecCeEEEEEeccc-cchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEE
Q 007035 487 HLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKII 565 (621)
Q Consensus 487 ~~~~l~LVmEyl~-gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~ 565 (621)
.. ..+++|||+. ++|.+.+.... ..+++..+..++.||+.||.|||+++|+||||||+|||++. ++.+||+
T Consensus 80 ~~-~~~l~~~~~~~g~l~~~l~~~~-----~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~--~~~~kL~ 151 (279)
T cd05109 80 TS-TVQLVTQLMPYGCLLDYVRENK-----DRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKS--PNHVKIT 151 (279)
T ss_pred CC-CcEEEEEcCCCCCHHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcC--CCcEEEC
Confidence 54 5678999997 57777765432 13888999999999999999999999999999999999984 7789999
Q ss_pred ecCCccccCCCccc-----cccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 566 DLGSSCFQTDNLCL-----YVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 566 DFGls~~~~~~~~~-----~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
|||++......... ..+++.|+|||.+.+..++.++|||||||++|||++ |..||
T Consensus 152 dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~ 212 (279)
T cd05109 152 DFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPY 212 (279)
T ss_pred CCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCC
Confidence 99998754422211 123567999999998889999999999999999998 88886
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=252.16 Aligned_cols=199 Identities=24% Similarity=0.326 Sum_probs=159.9
Q ss_pred CceEEEEEeccCCCCceeEEEe----CCCCcEEEEEEEecCc--hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEe
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQD----LHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d----~~tg~~VAlKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~ 487 (621)
.+|++.+.||+|+||+||+|.+ ...+..+++|.+.... .....+.+|+.+++.+ .||||+++++++..
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~~~~~~~~ 78 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAEL------HHPNIVCLLGVVTQ 78 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhC------CCCCeeeEEEEEec
Confidence 5689999999999999999985 3456789999987432 2234566777777766 47899999999999
Q ss_pred cCeEEEEEecccc-chHHHHHhhhcc-----------CCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEe
Q 007035 488 LEHLFIVCELLRA-NLYEFQKFNQES-----------GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIK 555 (621)
Q Consensus 488 ~~~l~LVmEyl~g-sLld~l~~~~~~-----------~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~ 555 (621)
....++||||+.+ +|.+++...... .....+++..+..++.||+.||.|||+++|+||||||+|||++
T Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~ 158 (283)
T cd05090 79 EQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIG 158 (283)
T ss_pred CCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEc
Confidence 9999999999985 677766432210 0122377888899999999999999999999999999999998
Q ss_pred ccCCCeEEEEecCCccccCCC-----ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 556 SYQRCEIKIIDLGSSCFQTDN-----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 556 ~~~~~~IKL~DFGls~~~~~~-----~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
. ++.+||+|||++...... .....++..|+|||++.+..++.++||||||+++|+|++ |..||
T Consensus 159 ~--~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~ 227 (283)
T cd05090 159 E--QLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPY 227 (283)
T ss_pred C--CCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCC
Confidence 4 778999999998654322 122334567999999988889999999999999999998 98887
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=261.65 Aligned_cols=194 Identities=35% Similarity=0.625 Sum_probs=164.3
Q ss_pred ecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc---hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEec
Q 007035 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (621)
Q Consensus 412 i~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~---~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~ 488 (621)
+.++|++++.||.|+||.||++.+..++..||+|++.... .....+.+|+.+++.++ ||||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~~~~~~~ 86 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMK------HENVIGLLDVFTPD 86 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcC------CCCccceeeeecCC
Confidence 5688999999999999999999999999999999986432 22345667777777664 77999999998765
Q ss_pred C------eEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeE
Q 007035 489 E------HLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEI 562 (621)
Q Consensus 489 ~------~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~I 562 (621)
. ..++||||+++++.+.+... .+++..++.++.||+.||.|||+.||+||||||+||+++. ++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~l~~~~~~~-------~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~--~~~~ 157 (343)
T cd07880 87 LSLDRFHDFYLVMPFMGTDLGKLMKHE-------KLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNE--DCEL 157 (343)
T ss_pred ccccccceEEEEEecCCCCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC--CCCE
Confidence 3 46899999987777665421 2889999999999999999999999999999999999984 7889
Q ss_pred EEEecCCccccCCCccccccCCcccCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 563 KIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 563 KL~DFGls~~~~~~~~~~~gt~~Y~APEvl~~-~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
+|+|||++...........+++.|+|||.+.+ ..++.++|+||||+++|+|++|++||
T Consensus 158 kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf 216 (343)
T cd07880 158 KILDFGLARQTDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLF 216 (343)
T ss_pred EEeecccccccccCccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 99999998776655555677889999999876 35789999999999999999999998
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=248.20 Aligned_cols=192 Identities=23% Similarity=0.363 Sum_probs=159.7
Q ss_pred CceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeE-ecCeEE
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY-HLEHLF 492 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~-~~~~l~ 492 (621)
.+|++.+.||.|+||.||++.. .|..+++|.++.+.. .+.+.+|+.+++.+. |++++++++++. .....+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~~-~~~~~~e~~~l~~l~------~~~i~~~~~~~~~~~~~~~ 76 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDAT-AQAFLAEASVMTQLR------HSNLVQLLGVIVEEKGGLY 76 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCch-HHHHHHHHHHHHhCC------CCCeeeEEEEEEcCCCceE
Confidence 5799999999999999999975 488899999876543 355677888777664 678999999765 456799
Q ss_pred EEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCcc
Q 007035 493 IVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 571 (621)
Q Consensus 493 LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~ 571 (621)
+||||+++ +|.+++..... ..+++..+..++.||+.||+|||++||+||||||+||+++ .++.+||+|||++.
T Consensus 77 lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~--~~~~~kl~dfg~~~ 150 (256)
T cd05082 77 IVTEYMAKGSLVDYLRSRGR----SVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVS--EDNVAKVSDFGLTK 150 (256)
T ss_pred EEEECCCCCcHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEc--CCCcEEecCCccce
Confidence 99999985 77777654322 2378889999999999999999999999999999999998 47889999999987
Q ss_pred ccCCCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 572 FQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 572 ~~~~~~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
...........+..|+|||++.+..++.++|||||||++|+|++ |++||
T Consensus 151 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~ 200 (256)
T cd05082 151 EASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY 200 (256)
T ss_pred eccccCCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCC
Confidence 65444333445668999999998889999999999999999997 99987
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=268.18 Aligned_cols=201 Identities=23% Similarity=0.325 Sum_probs=161.8
Q ss_pred cCceEEEEEeccCCCCceeEEEeCCC-----CcEEEEEEEecCc--hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEe
Q 007035 413 AGRYYVTEYLGSAAFSKVFQAQDLHT-----GVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYF 485 (621)
Q Consensus 413 ~~rY~I~~~LG~G~fG~Vyka~d~~t-----g~~VAlKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f 485 (621)
.++|.+.+.||.|+||.||+|.+... +..||||+++... ...+.+.+|+++++.+. .||||+++++++
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~-----~HpnIv~l~~~~ 110 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLG-----PHLNIVNLLGAC 110 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcC-----CCCCeeeEEEEE
Confidence 46899999999999999999987433 4569999987532 23456778888887774 378999999999
Q ss_pred EecCeEEEEEeccc-cchHHHHHhhhcc----------------------------------------------------
Q 007035 486 YHLEHLFIVCELLR-ANLYEFQKFNQES---------------------------------------------------- 512 (621)
Q Consensus 486 ~~~~~l~LVmEyl~-gsLld~l~~~~~~---------------------------------------------------- 512 (621)
.....++|||||+. ++|.+++......
T Consensus 111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (400)
T cd05105 111 TKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVP 190 (400)
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccch
Confidence 99999999999998 4777666543210
Q ss_pred --------------------------------------CCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEE
Q 007035 513 --------------------------------------GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILI 554 (621)
Q Consensus 513 --------------------------------------~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl 554 (621)
.....+++..+..++.||+.||.|||+.+|+||||||+|||+
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill 270 (400)
T cd05105 191 MLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLL 270 (400)
T ss_pred hhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEE
Confidence 001236778888999999999999999999999999999999
Q ss_pred eccCCCeEEEEecCCccccCCCc-----cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 555 KSYQRCEIKIIDLGSSCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 555 ~~~~~~~IKL~DFGls~~~~~~~-----~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
+. ++.+||+|||++....... ....+++.|+|||++.+..++.++|||||||++|+|++ |..||
T Consensus 271 ~~--~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~ 340 (400)
T cd05105 271 AQ--GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPY 340 (400)
T ss_pred eC--CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence 84 7789999999986543221 12345678999999999889999999999999999997 88887
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=251.46 Aligned_cols=202 Identities=21% Similarity=0.292 Sum_probs=161.7
Q ss_pred cCceEEEEEeccCCCCceeEEEeCC-----CCcEEEEEEEecCc--hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEe
Q 007035 413 AGRYYVTEYLGSAAFSKVFQAQDLH-----TGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYF 485 (621)
Q Consensus 413 ~~rY~I~~~LG~G~fG~Vyka~d~~-----tg~~VAlKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f 485 (621)
.++|++.+.||+|++|.||+|.+.. ++..|++|.+.... .....+..|+.+++.+ +|+||+++++++
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l------~~~~i~~~~~~~ 78 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKF------NHQNIVRLIGVS 78 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhC------CCCCEeeEEEEE
Confidence 4679999999999999999999877 78889999886432 2223456666666655 478999999999
Q ss_pred EecCeEEEEEeccc-cchHHHHHhhhccC-CCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccC-CCeE
Q 007035 486 YHLEHLFIVCELLR-ANLYEFQKFNQESG-GEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQ-RCEI 562 (621)
Q Consensus 486 ~~~~~l~LVmEyl~-gsLld~l~~~~~~~-~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~-~~~I 562 (621)
......++||||+. ++|.+++....... ....+++..+..++.||+.||.|||+++++||||||+||+++... ...+
T Consensus 79 ~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~ 158 (277)
T cd05036 79 FERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVA 158 (277)
T ss_pred ccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcce
Confidence 99999999999997 57777776543211 122488899999999999999999999999999999999998532 3468
Q ss_pred EEEecCCccccCCCcc-----ccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 563 KIIDLGSSCFQTDNLC-----LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 563 KL~DFGls~~~~~~~~-----~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
||+|||++........ ....+..|+|||++.+..++.++|||||||++|+|++ |..||
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf 222 (277)
T cd05036 159 KIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPY 222 (277)
T ss_pred EeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCC
Confidence 9999999875432211 1223457999999998889999999999999999997 99887
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.7e-29 Score=255.06 Aligned_cols=194 Identities=29% Similarity=0.459 Sum_probs=163.8
Q ss_pred CceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc---hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEec--
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL-- 488 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~---~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~-- 488 (621)
++|++.+.||.|+||.||+|.+..+++.+++|.++... .......+|+.+++.+ .||||+++++++...
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l------~h~ni~~~~~~~~~~~~ 78 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKL------QHPNIVTVKEVVVGSNL 78 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhc------CCCCEEEEEEEEEecCC
Confidence 57999999999999999999999999999999987532 2223455677777766 378999999999877
Q ss_pred CeEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecC
Q 007035 489 EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (621)
Q Consensus 489 ~~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFG 568 (621)
..+++||||++++|.+++..... .+++..++.++.||+.||.|||+++++|+||+|+||+++. ++.++|+|||
T Consensus 79 ~~~~lv~e~~~~~L~~~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~--~~~~~l~d~g 151 (293)
T cd07843 79 DKIYMVMEYVEHDLKSLMETMKQ-----PFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNN--RGILKICDFG 151 (293)
T ss_pred CcEEEEehhcCcCHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECC--CCcEEEeecC
Confidence 89999999999988887765332 3889999999999999999999999999999999999984 7889999999
Q ss_pred CccccCCC---ccccccCCcccCchhhcCCC-CCchhhHHHHHHHHHHHHhCCCCC
Q 007035 569 SSCFQTDN---LCLYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 569 ls~~~~~~---~~~~~gt~~Y~APEvl~~~~-~s~ksDIWSLGvILyELltG~~PF 620 (621)
++...... .....+++.|+|||.+.+.. ++.++||||||+++|+|++|++||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f 207 (293)
T cd07843 152 LAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLF 207 (293)
T ss_pred ceeeccCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCC
Confidence 88765443 22345678899999987654 688999999999999999999987
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-28 Score=245.59 Aligned_cols=194 Identities=23% Similarity=0.354 Sum_probs=160.3
Q ss_pred ceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc---hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEe-cCe
Q 007035 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH-LEH 490 (621)
Q Consensus 415 rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~---~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~-~~~ 490 (621)
+|++++.||.|++|.||++.++.+++.||+|.+.... ...+....|+.+++.+ +|+|++++++.+.. ...
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l------~~~~i~~~~~~~~~~~~~ 74 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQL------KHPNIVAYRESWEGEDGL 74 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhC------CCCCeeeeeeeecCCCCE
Confidence 4899999999999999999999999999999987532 2234455666666655 46789999998874 457
Q ss_pred EEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCC
Q 007035 491 LFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (621)
Q Consensus 491 l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGl 569 (621)
+++||||+++ ++.+.+..... ..+++.+++.++.||+.||.+||++||+||||+|+||+++ .++.++|+|||+
T Consensus 75 ~~lv~e~~~~~~l~~~l~~~~~----~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~--~~~~~~l~df~~ 148 (257)
T cd08223 75 LYIVMGFCEGGDLYHKLKEQKG----KLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLT--RTNIIKVGDLGI 148 (257)
T ss_pred EEEEecccCCCcHHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEe--cCCcEEEecccc
Confidence 8999999985 66666653221 2378999999999999999999999999999999999998 478899999998
Q ss_pred ccccCCC---ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 570 SCFQTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 570 s~~~~~~---~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
+...... .....+++.|+|||++.+..++.++||||||+++|+|++|+.||
T Consensus 149 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~ 202 (257)
T cd08223 149 ARVLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAF 202 (257)
T ss_pred eEEecccCCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCC
Confidence 8654322 23346788999999999988999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=252.54 Aligned_cols=189 Identities=26% Similarity=0.398 Sum_probs=153.7
Q ss_pred EeccCCCCceeEEEeCCCCcEEEEEEEecCch----hhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeEEEEEe
Q 007035 421 YLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD----FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCE 496 (621)
Q Consensus 421 ~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~----~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l~LVmE 496 (621)
.||.|+||.||++.+..+++.||+|++..... .......|..+++.++. ..||+|+++++.+...+..++|||
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~i~~~~~~~~~~~~~~~v~e 77 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST---GDCPFIVCMSYAFHTPDKLSFILD 77 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHh---CCCCcEeeeeeeeecCCEEEEEEe
Confidence 38999999999999999999999999875321 11223444445554443 468999999999999999999999
Q ss_pred ccccc-hHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCccccCC
Q 007035 497 LLRAN-LYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTD 575 (621)
Q Consensus 497 yl~gs-Lld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~~~~~ 575 (621)
|+.++ |.+.+... ..+++..++.++.|++.||.|||+.+|+||||||+||+++. ++.++|+|||++.....
T Consensus 78 ~~~g~~L~~~l~~~------~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~--~~~~kl~dfg~~~~~~~ 149 (278)
T cd05606 78 LMNGGDLHYHLSQH------GVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDE--HGHVRISDLGLACDFSK 149 (278)
T ss_pred cCCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECC--CCCEEEccCcCccccCc
Confidence 99864 54444322 13889999999999999999999999999999999999984 77899999998865432
Q ss_pred -CccccccCCcccCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 576 -NLCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 576 -~~~~~~gt~~Y~APEvl~~~-~~s~ksDIWSLGvILyELltG~~PF 620 (621)
......++..|+|||++.+. .++.++||||+|+++|+|++|+.||
T Consensus 150 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~ 196 (278)
T cd05606 150 KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF 196 (278)
T ss_pred cCCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCC
Confidence 22345789999999999754 5889999999999999999999998
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=258.68 Aligned_cols=194 Identities=23% Similarity=0.332 Sum_probs=157.1
Q ss_pred cCceEEEEEeccCCCCceeEEEeCCCCcE----EEEEEEecCc--hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeE
Q 007035 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVD----VCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (621)
Q Consensus 413 ~~rY~I~~~LG~G~fG~Vyka~d~~tg~~----VAlKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~ 486 (621)
..+|++++.||+|+||+||+|.+..+++. ||+|+++... ....++.+|+.+++.+ .||||+++++++.
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l------~h~niv~~~g~~~ 79 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV------DNPHVCRLLGICL 79 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhC------CCCCCCeEEEEEc
Confidence 46799999999999999999998766654 8999986432 2344566677666655 4789999999987
Q ss_pred ecCeEEEEEeccc-cchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEE
Q 007035 487 HLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKII 565 (621)
Q Consensus 487 ~~~~l~LVmEyl~-gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~ 565 (621)
.. ..++|+||+. ++|.+.+..... .++...+..++.||+.||.|||+++|+||||||+|||++. ++.+||+
T Consensus 80 ~~-~~~~v~e~~~~g~l~~~l~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~--~~~~kl~ 151 (316)
T cd05108 80 TS-TVQLITQLMPFGCLLDYVREHKD-----NIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKT--PQHVKIT 151 (316)
T ss_pred CC-CceeeeecCCCCCHHHHHHhccc-----cCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecC--CCcEEEc
Confidence 65 5678899887 577777764332 2778889999999999999999999999999999999984 7789999
Q ss_pred ecCCccccCCCcc-----ccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 566 DLGSSCFQTDNLC-----LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 566 DFGls~~~~~~~~-----~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
|||++........ ....+..|+|||.+.+..++.++|||||||++|||++ |+.||
T Consensus 152 DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~ 212 (316)
T cd05108 152 DFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 212 (316)
T ss_pred cccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCC
Confidence 9999876543211 1223567999999999899999999999999999998 99987
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=249.70 Aligned_cols=196 Identities=26% Similarity=0.369 Sum_probs=161.1
Q ss_pred eecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCe
Q 007035 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (621)
Q Consensus 411 ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~ 490 (621)
+..++|++.+.||+|+||.||+|.+. .+..+|+|.+.......+.+.+|+.+++.++ |++|+++++++. ...
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~------~~~i~~~~~~~~-~~~ 74 (260)
T cd05070 3 IPRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMSPESFLEEAQIMKKLR------HDKLVQLYAVVS-EEP 74 (260)
T ss_pred CchHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCCHHHHHHHHHHHHhcC------CCceEEEEeEEC-CCC
Confidence 45678999999999999999999865 5667999999875554566778888887764 678999999875 456
Q ss_pred EEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCC
Q 007035 491 LFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (621)
Q Consensus 491 l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGl 569 (621)
.++||||+.+ +|.+.+..... ..+++..++.++.||+.||.|||+.+|+||||||+||+++. ++.++|+|||+
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~--~~~~~l~dfg~ 148 (260)
T cd05070 75 IYIVTEYMSKGSLLDFLKDGEG----RALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGD--GLVCKIADFGL 148 (260)
T ss_pred cEEEEEecCCCcHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeC--CceEEeCCcee
Confidence 8999999975 77776653221 22788999999999999999999999999999999999984 78899999999
Q ss_pred ccccCCCcc----ccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 570 SCFQTDNLC----LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 570 s~~~~~~~~----~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
+........ ...++..|+|||.+.+..++.++||||||+++|+|++ |++||
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~ 204 (260)
T cd05070 149 ARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPY 204 (260)
T ss_pred eeeccCcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCC
Confidence 865443221 1233567999999988889999999999999999999 88887
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.7e-29 Score=263.73 Aligned_cols=203 Identities=25% Similarity=0.341 Sum_probs=160.8
Q ss_pred eecCceEEEEEeccCCCCceeEEEeC-----CCCcEEEEEEEecCc--hhhhhHHHHHHHHHHhcccCCCCCCceEEEee
Q 007035 411 VIAGRYYVTEYLGSAAFSKVFQAQDL-----HTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYD 483 (621)
Q Consensus 411 ii~~rY~I~~~LG~G~fG~Vyka~d~-----~tg~~VAlKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~ 483 (621)
+..++|++.+.||.|+||.||+|.+. .+++.||+|+++... ...+.+..|+.+++.+. .|+||+++++
T Consensus 4 ~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~-----~h~niv~~~~ 78 (337)
T cd05054 4 FPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIG-----HHLNVVNLLG 78 (337)
T ss_pred cCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhc-----cCcchhheee
Confidence 34568999999999999999999743 345789999987532 23345667888777763 4789999999
Q ss_pred EeEec-CeEEEEEecccc-chHHHHHhhhccC------------------------------------------------
Q 007035 484 YFYHL-EHLFIVCELLRA-NLYEFQKFNQESG------------------------------------------------ 513 (621)
Q Consensus 484 ~f~~~-~~l~LVmEyl~g-sLld~l~~~~~~~------------------------------------------------ 513 (621)
++... ..++++|||+.+ +|.+++.......
T Consensus 79 ~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (337)
T cd05054 79 ACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEE 158 (337)
T ss_pred eEecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhccc
Confidence 88754 578999999985 6666664322100
Q ss_pred -------CCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCccccCCCc-----cccc
Q 007035 514 -------GEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNL-----CLYV 581 (621)
Q Consensus 514 -------~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~~~~~~~-----~~~~ 581 (621)
....+++..+..++.||+.||.|||+++|+||||||.|||++. ++.++|+|||++....... ....
T Consensus 159 ~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~--~~~vkL~DfG~a~~~~~~~~~~~~~~~~ 236 (337)
T cd05054 159 DEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSE--NNVVKICDFGLARDIYKDPDYVRKGDAR 236 (337)
T ss_pred chhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeC--CCcEEEeccccchhcccCcchhhccCCC
Confidence 0113788889999999999999999999999999999999984 7889999999987543221 1223
Q ss_pred cCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 582 QSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 582 gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
++..|+|||++.+..++.++|||||||+||+|++ |+.||
T Consensus 237 ~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~ 276 (337)
T cd05054 237 LPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPY 276 (337)
T ss_pred CCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCC
Confidence 4667999999999999999999999999999998 99987
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.6e-30 Score=278.76 Aligned_cols=192 Identities=27% Similarity=0.394 Sum_probs=162.6
Q ss_pred EeccCCCCceeEEEeCCCCcEEEEEEEec-CchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeEEEEEeccc
Q 007035 421 YLGSAAFSKVFQAQDLHTGVDVCLKIIKN-DKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLR 499 (621)
Q Consensus 421 ~LG~G~fG~Vyka~d~~tg~~VAlKii~~-~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l~LVmEyl~ 499 (621)
.||+|.||+||-|+|..+...+|||-+.. +....+-..+|+.+.+.++ |.|||++++.+..++++-|.||-++
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~Lr------HkNIVrYLGs~senGf~kIFMEqVP 655 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLR------HKNIVRYLGSVSENGFFKIFMEQVP 655 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHh------hHhHHHHhhccCCCCeEEEEeecCC
Confidence 59999999999999999999999998864 4445566788888888886 5589999999999999999999999
Q ss_pred cchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCccccCC---C
Q 007035 500 ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTD---N 576 (621)
Q Consensus 500 gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~~~~~---~ 576 (621)
|+.+..+....... ..=++..+..+.+||++||.|||++.|||||||-+||||+. -.|.+||+|||-+.+... -
T Consensus 656 GGSLSsLLrskWGP--lKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNT-ySGvlKISDFGTsKRLAginP~ 732 (1226)
T KOG4279|consen 656 GGSLSSLLRSKWGP--LKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNT-YSGVLKISDFGTSKRLAGINPC 732 (1226)
T ss_pred CCcHHHHHHhccCC--CccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEee-ccceEEecccccchhhccCCcc
Confidence 75555554444322 11267889999999999999999999999999999999986 468999999998876432 3
Q ss_pred ccccccCCcccCchhhcCCC--CCchhhHHHHHHHHHHHHhCCCCCC
Q 007035 577 LCLYVQSRSYRAPEVIIGLP--YDQKIDLWSLGCILAELWTGEVCLI 621 (621)
Q Consensus 577 ~~~~~gt~~Y~APEvl~~~~--~s~ksDIWSLGvILyELltG~~PF~ 621 (621)
..++.||..|||||++..++ |+.++|||||||++.||.||++||+
T Consensus 733 TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ 779 (1226)
T KOG4279|consen 733 TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFV 779 (1226)
T ss_pred ccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCee
Confidence 44578999999999997664 8899999999999999999999995
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.3e-29 Score=250.68 Aligned_cols=192 Identities=28% Similarity=0.424 Sum_probs=163.2
Q ss_pred ceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc----hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCe
Q 007035 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (621)
Q Consensus 415 rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~ 490 (621)
+|++.+.||.|+||.||++.+..+++.||+|++.... ...+.+.+|+++++.+ +||||+++++.+.....
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~~~~~ 74 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQEL------NHPFLVNLWYSFQDEEN 74 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhC------CCCChHHHHHhhcCCCe
Confidence 5899999999999999999999999999999997532 2345566676666655 47899999999999999
Q ss_pred EEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCC
Q 007035 491 LFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (621)
Q Consensus 491 l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGl 569 (621)
+++|+||+.+ +|.+.+... ..+++..+..++.||+.||.|||+++++|+||+|+||+++. ++.++|+|||+
T Consensus 75 ~~lv~e~~~~~~L~~~l~~~------~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~--~~~~~l~d~~~ 146 (258)
T cd05578 75 MYLVVDLLLGGDLRYHLSQK------VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDE--QGHVHITDFNI 146 (258)
T ss_pred EEEEEeCCCCCCHHHHHHhc------CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcC--CCCEEEeeccc
Confidence 9999999986 555555433 12788999999999999999999999999999999999984 78899999998
Q ss_pred ccccCCC--ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 570 SCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 570 s~~~~~~--~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
+...... .....++..|+|||.+.+..++.++|+||||+++|+|++|+.||
T Consensus 147 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~ 199 (258)
T cd05578 147 ATKVTPDTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPY 199 (258)
T ss_pred ccccCCCccccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCC
Confidence 8664433 23346788899999998888999999999999999999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-28 Score=248.25 Aligned_cols=195 Identities=27% Similarity=0.391 Sum_probs=160.4
Q ss_pred ecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeE
Q 007035 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (621)
Q Consensus 412 i~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l 491 (621)
..++|++.+.||.|++|.||++.+... ..+|+|.+.......+.+.+|+.+++.+ .|++++++++++. .+..
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~~~~~~~~E~~~l~~l------~h~~i~~~~~~~~-~~~~ 75 (260)
T cd05069 4 PRESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTMMPEAFLQEAQIMKKL------RHDKLVPLYAVVS-EEPI 75 (260)
T ss_pred ChHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCccHHHHHHHHHHHHhC------CCCCeeeEEEEEc-CCCc
Confidence 457899999999999999999987655 4599998876555556677888888776 4678999998875 4568
Q ss_pred EEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCc
Q 007035 492 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (621)
Q Consensus 492 ~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls 570 (621)
++||||+.+ +|.+.+.... ...+++..+..++.||+.||.|||+.+|+|+||+|+||+++ +++.++|+|||++
T Consensus 76 ~~v~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~--~~~~~~l~dfg~~ 149 (260)
T cd05069 76 YIVTEFMGKGSLLDFLKEGD----GKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVG--DNLVCKIADFGLA 149 (260)
T ss_pred EEEEEcCCCCCHHHHHhhCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEc--CCCeEEECCCccc
Confidence 999999985 7877775432 12378888999999999999999999999999999999998 4788999999998
Q ss_pred cccCCCcc----ccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 571 CFQTDNLC----LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 571 ~~~~~~~~----~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
........ ...++..|+|||.+.+..++.++||||||+++|+|++ |++||
T Consensus 150 ~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~ 204 (260)
T cd05069 150 RLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPY 204 (260)
T ss_pred eEccCCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCC
Confidence 65433221 1234567999999998889999999999999999999 89887
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-28 Score=245.13 Aligned_cols=195 Identities=29% Similarity=0.414 Sum_probs=164.6
Q ss_pred ceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc---hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeE
Q 007035 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (621)
Q Consensus 415 rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~---~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l 491 (621)
+|++.+.||.|++|.||++.+..+++.+|+|.+.... .....+.+|+.+++.+ .||+|+++++.+...+..
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~------~~~~i~~~~~~~~~~~~~ 74 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLL------SHPNIIEYYENFLEDKAL 74 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhC------CCCchhheeeeEecCCEE
Confidence 5899999999999999999999999999999987532 2345566777777766 478999999999999999
Q ss_pred EEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCc
Q 007035 492 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (621)
Q Consensus 492 ~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls 570 (621)
++||||+.+ +|.+++..... ..+++..+..++.|++.||.|||+++|+|+||+|+||+++. ..+.++|+|||++
T Consensus 75 ~lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~-~~~~~~l~d~~~~ 149 (256)
T cd08220 75 MIVMEYAPGGTLAEYIQKRCN----SLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDK-HKMVVKIGDFGIS 149 (256)
T ss_pred EEEEecCCCCCHHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC-CCCEEEEccCCCc
Confidence 999999975 67777654321 22788899999999999999999999999999999999974 3557899999998
Q ss_pred cccCCC--ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 571 CFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 571 ~~~~~~--~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
...... .....+++.|+|||.+.+..++.++||||||+++|+|++|+.||
T Consensus 150 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~ 201 (256)
T cd08220 150 KILSSKSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAF 201 (256)
T ss_pred eecCCCccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCc
Confidence 765433 22356788999999999888899999999999999999999987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-28 Score=250.08 Aligned_cols=196 Identities=33% Similarity=0.501 Sum_probs=165.4
Q ss_pred eEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCch---hhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCe--
Q 007035 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD---FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH-- 490 (621)
Q Consensus 416 Y~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~---~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~-- 490 (621)
|++.+.||.|+||.||++++..+++.||+|+++.... ......+|+.+++++.. ..|+||+++++++.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~---~~h~~i~~~~~~~~~~~~~~ 77 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLES---FEHPNIVRLLDVCHGPRTDR 77 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhc---cCCCCcceEEEEEeeccCCC
Confidence 6889999999999999999988999999999874322 22345567777777753 358999999999998776
Q ss_pred ---EEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEec
Q 007035 491 ---LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 567 (621)
Q Consensus 491 ---l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DF 567 (621)
++++|||+.+++.+++...... .+++..++.++.||+.||.|||+.+++|+||+|+||+++. ++.++|+||
T Consensus 78 ~~~~~l~~e~~~~~l~~~l~~~~~~----~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~--~~~~~l~df 151 (287)
T cd07838 78 ELKLTLVFEHVDQDLATYLSKCPKP----GLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTS--DGQVKIADF 151 (287)
T ss_pred CceeEEEehhcccCHHHHHHHccCC----CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEcc--CCCEEEecc
Confidence 9999999998888877643321 2889999999999999999999999999999999999995 688999999
Q ss_pred CCccccCCC--ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 568 GSSCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 568 Gls~~~~~~--~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
|++...... .....++..|+|||++.+..++.++|||||||++|+|++|++||
T Consensus 152 g~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~ 206 (287)
T cd07838 152 GLARIYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLF 206 (287)
T ss_pred CcceeccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcc
Confidence 988665332 22345688899999999988999999999999999999999887
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-30 Score=280.84 Aligned_cols=194 Identities=31% Similarity=0.472 Sum_probs=169.7
Q ss_pred CceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEec-CchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeEE
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKN-DKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLF 492 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~-~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l~ 492 (621)
+.|.|+..||-|+||+||+|.++.++-..|-|++.. .....+.++.|+.||..+ +||+|+++++.|+..+.++
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~C------dHP~ivkLl~ayy~enkLw 105 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAEC------DHPVIVKLLSAYYFENKLW 105 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcC------CChHHHHHHHHHhccCceE
Confidence 568889999999999999999999999999998864 445567788888888766 5889999999999999999
Q ss_pred EEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCccc
Q 007035 493 IVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF 572 (621)
Q Consensus 493 LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~~ 572 (621)
|+.|+|+|+..+.+...-.. .+++..++.+++|++.||.|||+++|+|||||..|||++. +|.|+|+|||.+..
T Consensus 106 iliEFC~GGAVDaimlEL~r----~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~Tl--dGdirLADFGVSAK 179 (1187)
T KOG0579|consen 106 ILIEFCGGGAVDAIMLELGR----VLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTL--DGDIRLADFGVSAK 179 (1187)
T ss_pred EEEeecCCchHhHHHHHhcc----ccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEe--cCcEeeeccccccc
Confidence 99999999877776644333 3999999999999999999999999999999999999994 89999999998865
Q ss_pred cCCC---ccccccCCcccCchhh-----cCCCCCchhhHHHHHHHHHHHHhCCCC
Q 007035 573 QTDN---LCLYVQSRSYRAPEVI-----IGLPYDQKIDLWSLGCILAELWTGEVC 619 (621)
Q Consensus 573 ~~~~---~~~~~gt~~Y~APEvl-----~~~~~s~ksDIWSLGvILyELltG~~P 619 (621)
.... .-.+.|||+|||||+. ...+|++++||||||++|.||..+++|
T Consensus 180 n~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPP 234 (1187)
T KOG0579|consen 180 NKSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPP 234 (1187)
T ss_pred chhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCC
Confidence 4432 3457999999999997 456899999999999999999999998
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-28 Score=260.78 Aligned_cols=194 Identities=35% Similarity=0.630 Sum_probs=163.3
Q ss_pred ecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc---hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEec
Q 007035 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (621)
Q Consensus 412 i~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~---~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~ 488 (621)
+.++|.+.+.||+|+||.||++.+..+++.||+|++.... .......+|+.+++.+ +||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l------~h~~iv~~~~~~~~~ 88 (345)
T cd07877 15 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM------KHENVIGLLDVFTPA 88 (345)
T ss_pred ccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHc------CCCcccceeeeeeec
Confidence 4578999999999999999999999999999999987532 1234455677766665 478999999988643
Q ss_pred ------CeEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeE
Q 007035 489 ------EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEI 562 (621)
Q Consensus 489 ------~~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~I 562 (621)
...++++++++++|.+.+... .+++..++.++.||+.||.|||+++|+||||||+||+++. ++.+
T Consensus 89 ~~~~~~~~~~lv~~~~~~~L~~~~~~~-------~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~--~~~~ 159 (345)
T cd07877 89 RSLEEFNDVYLVTHLMGADLNNIVKCQ-------KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE--DCEL 159 (345)
T ss_pred ccccccccEEEEehhcccCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcC--CCCE
Confidence 357899999988887766432 1788999999999999999999999999999999999984 7789
Q ss_pred EEEecCCccccCCCccccccCCcccCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 563 KIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 563 KL~DFGls~~~~~~~~~~~gt~~Y~APEvl~~-~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
+|+|||++...........+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||
T Consensus 160 kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf 218 (345)
T cd07877 160 KILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 218 (345)
T ss_pred EEecccccccccccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 99999998776655555678899999999876 46788999999999999999999998
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=250.50 Aligned_cols=202 Identities=21% Similarity=0.299 Sum_probs=161.2
Q ss_pred eecCceEEEEEeccCCCCceeEEEeCCC-----CcEEEEEEEecCch--hhhhHHHHHHHHHHhcccCCCCCCceEEEee
Q 007035 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHT-----GVDVCLKIIKNDKD--FFDQSLDEIKLLKLVNKNDPADEHHILRLYD 483 (621)
Q Consensus 411 ii~~rY~I~~~LG~G~fG~Vyka~d~~t-----g~~VAlKii~~~~~--~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~ 483 (621)
+..++|++.+.||.|+||.||++.++.. +..||+|.+..... ....+.+|+.+++.+ .||||+++++
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~------~~~~i~~~~~ 76 (277)
T cd05032 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEF------NCHHVVRLLG 76 (277)
T ss_pred cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhC------CCCceeEEEE
Confidence 3457899999999999999999987654 48899999875432 223445565555544 5789999999
Q ss_pred EeEecCeEEEEEeccc-cchHHHHHhhhccC----CCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccC
Q 007035 484 YFYHLEHLFIVCELLR-ANLYEFQKFNQESG----GEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQ 558 (621)
Q Consensus 484 ~f~~~~~l~LVmEyl~-gsLld~l~~~~~~~----~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~ 558 (621)
++....+.++||||+. ++|.+++....... ....+++..+..++.||+.||.|||+.+|+||||||+|||++.
T Consensus 77 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~-- 154 (277)
T cd05032 77 VVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAE-- 154 (277)
T ss_pred EEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcC--
Confidence 9999999999999997 57777765432111 1223678889999999999999999999999999999999984
Q ss_pred CCeEEEEecCCccccCCC-----ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 559 RCEIKIIDLGSSCFQTDN-----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 559 ~~~IKL~DFGls~~~~~~-----~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
++.+||+|||++...... .....++..|+|||.+.+..++.++|||||||++|+|++ |+.||
T Consensus 155 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 222 (277)
T cd05032 155 DLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPY 222 (277)
T ss_pred CCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCC
Confidence 788999999987643322 122345678999999988889999999999999999998 99887
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=248.98 Aligned_cols=192 Identities=30% Similarity=0.442 Sum_probs=160.0
Q ss_pred ceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCch----------hhhhHHHHHHHHHHhcccCCCCCCceEEEeeE
Q 007035 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD----------FFDQSLDEIKLLKLVNKNDPADEHHILRLYDY 484 (621)
Q Consensus 415 rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~----------~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~ 484 (621)
+|.+.+.||.|++|.||+|.+..+++.+|+|.+..... ....+.+|+.+++.+ +||||++++++
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~ 74 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKEL------QHENIVQYLGS 74 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhc------CCCCeeeEEEE
Confidence 47788899999999999999999999999998865321 123455666666655 47899999999
Q ss_pred eEecCeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEE
Q 007035 485 FYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 563 (621)
Q Consensus 485 f~~~~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IK 563 (621)
+....+.++||||+++ +|.+++.... .+++..+..++.|++.||.|||+.+++||||+|+||+++ .++.++
T Consensus 75 ~~~~~~~~lv~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~--~~~~~~ 146 (267)
T cd06628 75 SLDADHLNIFLEYVPGGSVAALLNNYG------AFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVD--NKGGIK 146 (267)
T ss_pred EEeCCccEEEEEecCCCCHHHHHHhcc------CccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEc--CCCCEE
Confidence 9999999999999976 5666664322 278888999999999999999999999999999999998 478899
Q ss_pred EEecCCccccCCC---------ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 564 IIDLGSSCFQTDN---------LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 564 L~DFGls~~~~~~---------~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
|+|||.+...... .....++..|+|||.+.+..++.++|+|||||++|+|++|+.||
T Consensus 147 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~ 212 (267)
T cd06628 147 ISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPF 212 (267)
T ss_pred ecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCC
Confidence 9999987654421 11235678899999999888999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-28 Score=249.88 Aligned_cols=194 Identities=31% Similarity=0.505 Sum_probs=164.7
Q ss_pred ceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecC--chhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeEE
Q 007035 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLF 492 (621)
Q Consensus 415 rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~--~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l~ 492 (621)
.|++++.||.|+||.||+|.+..+++.|++|.+... ......+.+|+.+++.+.. ..|||++++++++......+
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~---~~~~~vi~~~~~~~~~~~~~ 78 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQ---SQPPNITKYYGSYLKGPRLW 78 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhcc---CCCCCeeeEeeeeeeCCEEE
Confidence 478889999999999999999999999999998653 3344567788888888865 45899999999999999999
Q ss_pred EEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCcc
Q 007035 493 IVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 571 (621)
Q Consensus 493 LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~ 571 (621)
+||||+.+ +|.+++... .+++..+..++.||+.||.|||+.+|+|+||+|+||+++. .+.++|+|||++.
T Consensus 79 lv~e~~~~~~L~~~~~~~-------~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~--~~~~~l~dfg~~~ 149 (277)
T cd06917 79 IIMEYAEGGSVRTLMKAG-------PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTN--TGNVKLCDFGVAA 149 (277)
T ss_pred EEEecCCCCcHHHHHHcc-------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcC--CCCEEEccCCcee
Confidence 99999976 565554321 2788999999999999999999999999999999999995 7889999999886
Q ss_pred ccCCC---ccccccCCcccCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 572 FQTDN---LCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 572 ~~~~~---~~~~~gt~~Y~APEvl~~-~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
..... .....++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||
T Consensus 150 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~ 202 (277)
T cd06917 150 LLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPY 202 (277)
T ss_pred ecCCCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCC
Confidence 65432 223467888999999865 34688999999999999999999998
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.2e-29 Score=250.84 Aligned_cols=195 Identities=26% Similarity=0.396 Sum_probs=163.3
Q ss_pred cCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCch-hhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeE
Q 007035 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD-FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (621)
Q Consensus 413 ~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~-~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l 491 (621)
..+|++.++||.|+||.||+|.+.. ++.+++|++..... ....+..|+.+++.+ .|+||+++++++......
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l------~~~~i~~~~~~~~~~~~~ 77 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRL------RHKHLISLFAVCSVGEPV 77 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcC------CCcchhheeeeEecCCCe
Confidence 3568999999999999999999877 88999999876543 345667777777655 478999999999999999
Q ss_pred EEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCc
Q 007035 492 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (621)
Q Consensus 492 ~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls 570 (621)
++||||+.+ +|.+++..... ..+++..++.++.||+.||.|||++||+|+||+|+||+++. ++.+||+|||.+
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~--~~~~kl~d~g~~ 151 (261)
T cd05148 78 YIITELMEKGSLLAFLRSPEG----QVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGE--DLVCKVADFGLA 151 (261)
T ss_pred EEEEeecccCCHHHHHhcCCC----CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcC--CceEEEccccch
Confidence 999999985 77777764321 23788899999999999999999999999999999999984 788999999998
Q ss_pred cccCCCcc---ccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 571 CFQTDNLC---LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 571 ~~~~~~~~---~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
........ ...+++.|+|||.+.+..++.++||||||+++|+|++ |+.||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~ 205 (261)
T cd05148 152 RLIKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPY 205 (261)
T ss_pred hhcCCccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCC
Confidence 65543221 1234567999999998889999999999999999998 89987
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=260.98 Aligned_cols=195 Identities=32% Similarity=0.564 Sum_probs=162.8
Q ss_pred ecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecC---chhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEec
Q 007035 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (621)
Q Consensus 412 i~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~---~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~ 488 (621)
+.++|++.+.||.|+||+||++++..+++.||||.+... ........+|+.+++.+ +|+||+++++++...
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l------~h~ni~~~~~~~~~~ 76 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHL------DHENVIAIKDIMPPP 76 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhc------CCCCccchHHheecc
Confidence 456899999999999999999999999999999988642 22234556677777766 378999999988754
Q ss_pred -----CeEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEE
Q 007035 489 -----EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 563 (621)
Q Consensus 489 -----~~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IK 563 (621)
.++++||||++++|.+.+.... .+++..++.++.||+.||.|||+++++||||||+||+++. ++.+|
T Consensus 77 ~~~~~~~~~lv~e~~~~~L~~~~~~~~------~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~--~~~~k 148 (337)
T cd07858 77 HREAFNDVYIVYELMDTDLHQIIRSSQ------TLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNA--NCDLK 148 (337)
T ss_pred cccccCcEEEEEeCCCCCHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcC--CCCEE
Confidence 3589999999998887775432 2889999999999999999999999999999999999984 78899
Q ss_pred EEecCCccccCCC---ccccccCCcccCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 564 IIDLGSSCFQTDN---LCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 564 L~DFGls~~~~~~---~~~~~gt~~Y~APEvl~~-~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
|+|||++...... .....++..|+|||.+.. ..++.++|||||||++|+|++|++||
T Consensus 149 L~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf 209 (337)
T cd07858 149 ICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLF 209 (337)
T ss_pred ECcCccccccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCC
Confidence 9999998754332 223456888999999865 45889999999999999999999997
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-28 Score=250.03 Aligned_cols=192 Identities=33% Similarity=0.549 Sum_probs=163.3
Q ss_pred eEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc---hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEec--Ce
Q 007035 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL--EH 490 (621)
Q Consensus 416 Y~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~---~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~--~~ 490 (621)
|++.+.||.|++|.||+|.+..+++.+|+|.+.... .....+.+|+.+++.+. |+|++++++++... ..
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~------~~~i~~~~~~~~~~~~~~ 74 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLR------HPNIVRLKEIVTSKGKGS 74 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhcc------CCCeeeheeeEecCCCCc
Confidence 688999999999999999999999999999998652 23345667888887774 67999999999988 89
Q ss_pred EEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCc
Q 007035 491 LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (621)
Q Consensus 491 l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls 570 (621)
.++||||+++++.+++.... ..+++..++.++.||+.||.|||+.+++|+||+|+||+++. ++.++|+|||++
T Consensus 75 ~~lv~e~~~~~l~~~~~~~~-----~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~--~~~~~l~d~g~~ 147 (287)
T cd07840 75 IYMVFEYMDHDLTGLLDSPE-----VKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINN--DGVLKLADFGLA 147 (287)
T ss_pred EEEEeccccccHHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcC--CCCEEEccccce
Confidence 99999999988887775432 23889999999999999999999999999999999999994 788999999988
Q ss_pred cccCCCc----cccccCCcccCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 571 CFQTDNL----CLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 571 ~~~~~~~----~~~~gt~~Y~APEvl~~~-~~s~ksDIWSLGvILyELltG~~PF 620 (621)
....... ....++..|+|||.+.+. .++.++||||||+++|+|++|+.||
T Consensus 148 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~ 202 (287)
T cd07840 148 RPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIF 202 (287)
T ss_pred eeccCCCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCC
Confidence 7654432 233557889999987653 5789999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-28 Score=249.35 Aligned_cols=196 Identities=21% Similarity=0.310 Sum_probs=155.7
Q ss_pred EEEEEeccCCCCceeEEEeCCCCc--EEEEEEEecC---chhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEec---
Q 007035 417 YVTEYLGSAAFSKVFQAQDLHTGV--DVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL--- 488 (621)
Q Consensus 417 ~I~~~LG~G~fG~Vyka~d~~tg~--~VAlKii~~~---~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~--- 488 (621)
.+.+.||+|+||.||+|++..++. .+|+|.++.. ......+..|+.+++.+ .|+||+++++.+...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l------~h~~iv~~~~~~~~~~~~ 75 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEF------DHPNVMRLIGVCLQTVES 75 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhC------CCCCcceEEEEEccCCcc
Confidence 467889999999999999877775 6899988653 23345566677777665 478999999976532
Q ss_pred ---CeEEEEEeccc-cchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEE
Q 007035 489 ---EHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKI 564 (621)
Q Consensus 489 ---~~l~LVmEyl~-gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL 564 (621)
...++||||+. ++|.+.+...........+++..+..++.||+.||.|||+++|+||||||+|||++ .++.++|
T Consensus 76 ~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~--~~~~~kl 153 (272)
T cd05075 76 EGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLN--ENMNVCV 153 (272)
T ss_pred cCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEc--CCCCEEE
Confidence 25789999998 46666664433222233488999999999999999999999999999999999998 4788999
Q ss_pred EecCCccccCCCc-----cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 565 IDLGSSCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 565 ~DFGls~~~~~~~-----~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
+|||++....... ....+++.|+|||.+.+..++.++||||||+++|+|++ |+.||
T Consensus 154 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~ 215 (272)
T cd05075 154 ADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPY 215 (272)
T ss_pred CCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCC
Confidence 9999987643321 12234678999999999889999999999999999999 88887
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-28 Score=248.34 Aligned_cols=193 Identities=28% Similarity=0.395 Sum_probs=160.4
Q ss_pred CceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecC------chhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEe
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND------KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~------~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~ 487 (621)
.+|++.+.||+|+||.||++.+..+++.||+|.+... ......+.+|+.+++.++ |+||+++++++.+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~------h~~i~~~~~~~~~ 75 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR------HDRIVQYYGCLRD 75 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcC------CCCcceEEEEEEc
Confidence 4699999999999999999999999999999987542 122345666777777664 6789999999876
Q ss_pred c--CeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEE
Q 007035 488 L--EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKI 564 (621)
Q Consensus 488 ~--~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL 564 (621)
. ..+++||||+.+ +|.+.+.... .+++..++.++.||+.||.|||+++++|+||+|+||+++. ++.++|
T Consensus 76 ~~~~~~~~v~e~~~~~~L~~~~~~~~------~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~--~~~~~l 147 (264)
T cd06653 76 PEEKKLSIFVEYMPGGSIKDQLKAYG------ALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDS--AGNVKL 147 (264)
T ss_pred CCCCEEEEEEEeCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcC--CCCEEE
Confidence 4 568999999975 6666654322 2778889999999999999999999999999999999984 778999
Q ss_pred EecCCccccCC------CccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 565 IDLGSSCFQTD------NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 565 ~DFGls~~~~~------~~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
+|||++..... ......++..|+|||.+.+..++.++|+|||||++|+|++|+.||
T Consensus 148 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~ 209 (264)
T cd06653 148 GDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPW 209 (264)
T ss_pred CccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCC
Confidence 99998865432 112345788999999999888899999999999999999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-28 Score=246.88 Aligned_cols=187 Identities=27% Similarity=0.404 Sum_probs=153.2
Q ss_pred EEeccCCCCceeEEEeCCCCcEEEEEEEecCchhh----hhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeEEEEE
Q 007035 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFF----DQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVC 495 (621)
Q Consensus 420 ~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~----~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l~LVm 495 (621)
+.||.|+||.||+|.+..+++.||+|+++...... .....|..++. ...+|+||+++++++...+.+++||
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~-----~~~~~~~i~~~~~~~~~~~~~~lv~ 76 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMM-----IQGESPYVAKLYYSFQSKDYLYLVM 76 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHh-----hcCCCCCeeeeeeeEEcCCeEEEEE
Confidence 56999999999999999999999999987543211 11222222221 1346899999999999999999999
Q ss_pred ecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCccccC
Q 007035 496 ELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQT 574 (621)
Q Consensus 496 Eyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~~~~ 574 (621)
||+++ +|.+++.... .+++..+..++.||+.||.|||+.+++||||+|+||+++. ++.++|+|||++....
T Consensus 77 e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~--~~~~~l~dfg~~~~~~ 148 (260)
T cd05611 77 EYLNGGDCASLIKTLG------GLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQ--TGHLKLTDFGLSRNGL 148 (260)
T ss_pred eccCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECC--CCcEEEeecccceecc
Confidence 99985 6666654332 2788999999999999999999999999999999999984 7789999999876543
Q ss_pred CCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 575 DNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 575 ~~~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
. .....+++.|+|||.+.+..++.++||||||+++|+|++|..||
T Consensus 149 ~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~ 193 (260)
T cd05611 149 E-NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPF 193 (260)
T ss_pred c-cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCC
Confidence 3 23346788999999998888899999999999999999999998
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.6e-30 Score=256.76 Aligned_cols=197 Identities=29% Similarity=0.424 Sum_probs=166.1
Q ss_pred ecCceEEE-EEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEe---
Q 007035 412 IAGRYYVT-EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH--- 487 (621)
Q Consensus 412 i~~rY~I~-~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~--- 487 (621)
+.++|.|- ++||-|-.|+|..+.++.+|+.+|+|++... .+..+|+++..... .|||||.++++|..
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds----~KARrEVeLHw~~s-----~h~~iV~IidVyeNs~~ 129 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS----PKARREVELHWMAS-----GHPHIVSIIDVYENSYQ 129 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC----HHHHhHhhhhhhhc-----CCCceEEeehhhhhhcc
Confidence 45667766 4699999999999999999999999998754 35567777766654 58999999999874
Q ss_pred -cCeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEecc-CCCeEEE
Q 007035 488 -LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSY-QRCEIKI 564 (621)
Q Consensus 488 -~~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~-~~~~IKL 564 (621)
...+.||||.++| .|+..++.. +...|++.++..|++||..|++|||+.+|.||||||+|+|.... .+..+||
T Consensus 130 ~rkcLLiVmE~meGGeLfsriq~~----g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKL 205 (400)
T KOG0604|consen 130 GRKCLLIVMECMEGGELFSRIQDR----GDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKL 205 (400)
T ss_pred CceeeEeeeecccchHHHHHHHHc----ccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEe
Confidence 3679999999986 566666543 34459999999999999999999999999999999999999753 3567999
Q ss_pred EecCCccccCCC--ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 007035 565 IDLGSSCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCLI 621 (621)
Q Consensus 565 ~DFGls~~~~~~--~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF~ 621 (621)
+|||++.....+ ..+.+-||.|.|||++...+|+...|+|||||++|-|++|-+||-
T Consensus 206 tDfGFAK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFY 264 (400)
T KOG0604|consen 206 TDFGFAKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFY 264 (400)
T ss_pred cccccccccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCccc
Confidence 999999876643 334566999999999999999999999999999999999999993
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-28 Score=244.72 Aligned_cols=194 Identities=24% Similarity=0.395 Sum_probs=163.4
Q ss_pred ceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecC---chhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeE
Q 007035 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (621)
Q Consensus 415 rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~---~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l 491 (621)
+|++.+.||+|+||.||++++..+|+.||+|.+... ......+.+|+.+++.+ +||||+++++++...++.
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l------~~~~i~~~~~~~~~~~~~ 74 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNM------KHPNIVQYQESFEENGNL 74 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhC------CCCCeeeeEeeecCCCeE
Confidence 589999999999999999999999999999998643 22334566777777665 478999999999999999
Q ss_pred EEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCc
Q 007035 492 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (621)
Q Consensus 492 ~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls 570 (621)
++||||+.+ +|.+.+..... ..+++..+..++.|++.||.|||+++++|+||+|+||+++. ++.++|+|||++
T Consensus 75 ~lv~e~~~~~~l~~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~--~~~~~l~d~~~~ 148 (256)
T cd08218 75 YIVMDYCEGGDLYKKINAQRG----VLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTK--DGTIKLGDFGIA 148 (256)
T ss_pred EEEEecCCCCcHHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcC--CCCEEEeeccce
Confidence 999999975 67776654321 12778889999999999999999999999999999999984 778999999988
Q ss_pred cccCCCc---cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 571 CFQTDNL---CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 571 ~~~~~~~---~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
....... ....+++.|+|||++.+..++.++|+|||||++|+|++|+.||
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~ 201 (256)
T cd08218 149 RVLNSTVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAF 201 (256)
T ss_pred eecCcchhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCc
Confidence 6544322 2245788899999999888999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-28 Score=249.39 Aligned_cols=189 Identities=27% Similarity=0.351 Sum_probs=157.2
Q ss_pred CceEEEEEe--ccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeE
Q 007035 414 GRYYVTEYL--GSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (621)
Q Consensus 414 ~rY~I~~~L--G~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l 491 (621)
+.|.+.+.+ |.|+||.||++.++.+++.+|+|++....... .|+.....+. +||||+++++.|...+..
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~----~e~~~~~~~~-----~h~~iv~~~~~~~~~~~~ 84 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA----IEPMVHQLMK-----DNPNFIKLYYSVTTLKGH 84 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch----hhHHHHHHhh-----cCCCEEEEEEEEecCCee
Confidence 456666665 99999999999999999999999987543211 1222222222 589999999999999999
Q ss_pred EEEEeccc-cchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCC-eEEEEecCC
Q 007035 492 FIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRC-EIKIIDLGS 569 (621)
Q Consensus 492 ~LVmEyl~-gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~-~IKL~DFGl 569 (621)
++||||++ ++|.+++.... .+++..++.++.||+.||.|||+.+++||||+|+||+++. ++ .++|+|||+
T Consensus 85 ~iv~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~--~~~~~~l~dfg~ 156 (267)
T PHA03390 85 VLIMDYIKDGDLFDLLKKEG------KLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDR--AKDRIYLCDYGL 156 (267)
T ss_pred EEEEEcCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeC--CCCeEEEecCcc
Confidence 99999997 57877775432 2889999999999999999999999999999999999985 45 899999998
Q ss_pred ccccCCCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 570 SCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 570 s~~~~~~~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
+....... ...++..|+|||++.+..++.++||||||+++|+|++|+.||
T Consensus 157 ~~~~~~~~-~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~ 206 (267)
T PHA03390 157 CKIIGTPS-CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPF 206 (267)
T ss_pred ceecCCCc-cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCC
Confidence 86654332 346788999999999988999999999999999999999998
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-28 Score=251.03 Aligned_cols=193 Identities=25% Similarity=0.274 Sum_probs=156.3
Q ss_pred cCce-EEEEEeccCCCCceeEEE----eCCCCcEEEEEEEecCch--hhhhHHHHHHHHHHhcccCCCCCCceEEEeeEe
Q 007035 413 AGRY-YVTEYLGSAAFSKVFQAQ----DLHTGVDVCLKIIKNDKD--FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYF 485 (621)
Q Consensus 413 ~~rY-~I~~~LG~G~fG~Vyka~----d~~tg~~VAlKii~~~~~--~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f 485 (621)
.+|| ++++.||.|+||+||++. ...++..||+|+++.... ....+.+|+.+++.+ +||||+++++++
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l------~h~~i~~~~~~~ 75 (283)
T cd05080 2 HKRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTL------YHENIVKYKGCC 75 (283)
T ss_pred ChhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhC------CCCCEeeEEEEE
Confidence 3566 899999999999998764 345788999999876432 345566777777766 478999999987
Q ss_pred Eec--CeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeE
Q 007035 486 YHL--EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEI 562 (621)
Q Consensus 486 ~~~--~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~I 562 (621)
... ..+++||||+.+ +|.+++... .+++..++.++.|++.||.|||+++|+||||||+|||++. ++.+
T Consensus 76 ~~~~~~~~~lv~e~~~~~~l~~~~~~~-------~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~--~~~~ 146 (283)
T cd05080 76 SEQGGKGLQLIMEYVPLGSLRDYLPKH-------KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDN--DRLV 146 (283)
T ss_pred ecCCCceEEEEecCCCCCCHHHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcC--CCcE
Confidence 753 468999999986 565555422 1889999999999999999999999999999999999984 7889
Q ss_pred EEEecCCccccCCCcc------ccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 563 KIIDLGSSCFQTDNLC------LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 563 KL~DFGls~~~~~~~~------~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
+|+|||++........ ...++..|+|||.+.+..++.++||||||+++|+|++|..||
T Consensus 147 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~ 210 (283)
T cd05080 147 KIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSK 210 (283)
T ss_pred EEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCC
Confidence 9999999865433211 123456699999998888999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-28 Score=251.93 Aligned_cols=200 Identities=26% Similarity=0.350 Sum_probs=161.6
Q ss_pred cCceEEEEEeccCCCCceeEEEe-----CCCCcEEEEEEEecCc-hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeE
Q 007035 413 AGRYYVTEYLGSAAFSKVFQAQD-----LHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (621)
Q Consensus 413 ~~rY~I~~~LG~G~fG~Vyka~d-----~~tg~~VAlKii~~~~-~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~ 486 (621)
..+|.+.+.||.|+||+||++.+ ..++..+|+|.+.... .....+.+|+.+++.+ .||||+++++++.
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~ 77 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL------QHEHIVKFYGVCV 77 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhC------CCCCcceEEEEEe
Confidence 35799999999999999999985 3355679999887533 3345677788877766 4679999999999
Q ss_pred ecCeEEEEEecccc-chHHHHHhhhc-------cCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccC
Q 007035 487 HLEHLFIVCELLRA-NLYEFQKFNQE-------SGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQ 558 (621)
Q Consensus 487 ~~~~l~LVmEyl~g-sLld~l~~~~~-------~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~ 558 (621)
....+++||||+.+ +|.+++..... ......+++..++.++.||+.||.|||++|++||||||+|||++ .
T Consensus 78 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~--~ 155 (288)
T cd05093 78 EGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVG--E 155 (288)
T ss_pred cCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEc--c
Confidence 99999999999984 66666643221 01122388999999999999999999999999999999999998 4
Q ss_pred CCeEEEEecCCccccCCCc-----cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 559 RCEIKIIDLGSSCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 559 ~~~IKL~DFGls~~~~~~~-----~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
++.++|+|||++....... ....+++.|+|||++.+..++.++|||||||++|+|++ |.+||
T Consensus 156 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~ 223 (288)
T cd05093 156 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPW 223 (288)
T ss_pred CCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 7889999999986543221 11234668999999998889999999999999999998 89987
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-28 Score=244.97 Aligned_cols=196 Identities=29% Similarity=0.431 Sum_probs=164.0
Q ss_pred CceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc--hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeE
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l 491 (621)
++|++.+.||.|+||+||+|.+..++..+++|++.... ...+.+.+|+.+++.+ +|+||+++++.+...+..
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l------~~~~i~~~~~~~~~~~~~ 74 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQC------NHPNVVKYYTSFVVGDEL 74 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhc------CCCCEEEEEEEEeeCCEE
Confidence 47999999999999999999998999999999987543 2345667777777655 478999999999999999
Q ss_pred EEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCc
Q 007035 492 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (621)
Q Consensus 492 ~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls 570 (621)
++|||++.+ +|.+.+..... ...+++..++.++.||+.||.+||+.||+||||+|+||+++. ++.++|+|||++
T Consensus 75 ~iv~e~~~~~~l~~~~~~~~~---~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~--~~~~~l~df~~~ 149 (267)
T cd06610 75 WLVMPYLSGGSLLDIMKSSYP---RGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGE--DGSVKIADFGVS 149 (267)
T ss_pred EEEEeccCCCcHHHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcC--CCCEEEcccchH
Confidence 999999986 56666543321 123788999999999999999999999999999999999984 678999999987
Q ss_pred cccCCCc-------cccccCCcccCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 571 CFQTDNL-------CLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 571 ~~~~~~~-------~~~~gt~~Y~APEvl~~~-~~s~ksDIWSLGvILyELltG~~PF 620 (621)
....... ....++..|+|||++... .++.++|+||||+++|+|++|+.||
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~ 207 (267)
T cd06610 150 ASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPY 207 (267)
T ss_pred HHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCc
Confidence 6544321 224678899999999876 6899999999999999999999997
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=252.95 Aligned_cols=199 Identities=28% Similarity=0.359 Sum_probs=161.7
Q ss_pred CceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc--hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeE
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l 491 (621)
++|...+.||.|+||.||++.+..+++.+|+|.+.... .....+.+|+.++.++. +|+||+++++++......
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~-----~~~~iv~~~~~~~~~~~~ 78 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSS-----DCPYIVKFYGALFREGDC 78 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhc-----CCCCEeeeeeEEecCCcE
Confidence 35667788999999999999999999999999987532 23345666776666553 478999999999999999
Q ss_pred EEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHC-CeecccCCCccEEEeccCCCeEEEEecCCc
Q 007035 492 FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSL-GIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (621)
Q Consensus 492 ~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~-gIvHrDLKP~NILl~~~~~~~IKL~DFGls 570 (621)
+++|||+..++.++....... ....+++..+..++.|++.||+|||+. +|+||||||+||+++. ++.++|+|||++
T Consensus 79 ~~~~e~~~~~l~~l~~~~~~~-~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~--~~~~kl~dfg~~ 155 (288)
T cd06616 79 WICMELMDISLDKFYKYVYEV-LKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDR--NGNIKLCDFGIS 155 (288)
T ss_pred EEEEecccCCHHHHHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEcc--CCcEEEeecchh
Confidence 999999988766654332111 112388999999999999999999975 9999999999999984 778999999998
Q ss_pred cccCCC--ccccccCCcccCchhhcCC---CCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 571 CFQTDN--LCLYVQSRSYRAPEVIIGL---PYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 571 ~~~~~~--~~~~~gt~~Y~APEvl~~~---~~s~ksDIWSLGvILyELltG~~PF 620 (621)
...... .....+++.|+|||++.+. .++.++|||||||++|+|++|++||
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~ 210 (288)
T cd06616 156 GQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPY 210 (288)
T ss_pred HHhccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCc
Confidence 654322 2234678899999999776 6889999999999999999999997
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-28 Score=254.23 Aligned_cols=199 Identities=23% Similarity=0.347 Sum_probs=163.5
Q ss_pred eecCceEEEEEeccCCCCceeEEEe-----CCCCcEEEEEEEecCc--hhhhhHHHHHHHHHHhcccCCCCCCceEEEee
Q 007035 411 VIAGRYYVTEYLGSAAFSKVFQAQD-----LHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYD 483 (621)
Q Consensus 411 ii~~rY~I~~~LG~G~fG~Vyka~d-----~~tg~~VAlKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~ 483 (621)
...++|.+.+.||.|+||.||++.+ ..++..||+|+++... ...+.+.+|+.+++.+. .|+||+++++
T Consensus 32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----~h~~iv~~~~ 106 (302)
T cd05055 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLG-----NHENIVNLLG 106 (302)
T ss_pred ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhcc-----CCCCcceEEE
Confidence 4457899999999999999999975 3355689999887542 23355777888887773 4789999999
Q ss_pred EeEecCeEEEEEeccc-cchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeE
Q 007035 484 YFYHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEI 562 (621)
Q Consensus 484 ~f~~~~~l~LVmEyl~-gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~I 562 (621)
++...+.+++||||+. ++|.+++..... ..+++..+..++.||+.||.|||+++|+|+||||+|||++ .++.+
T Consensus 107 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~----~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~--~~~~~ 180 (302)
T cd05055 107 ACTIGGPILVITEYCCYGDLLNFLRRKRE----SFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLT--HGKIV 180 (302)
T ss_pred EEecCCceEEEEEcCCCCcHHHHHHhCCC----CCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEc--CCCeE
Confidence 9999999999999998 567776653221 2278999999999999999999999999999999999998 47789
Q ss_pred EEEecCCccccCCCcc-----ccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 563 KIIDLGSSCFQTDNLC-----LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 563 KL~DFGls~~~~~~~~-----~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
+|+|||++........ ...+++.|+|||.+.+..++.++|||||||++|+|++ |..||
T Consensus 181 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~ 244 (302)
T cd05055 181 KICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPY 244 (302)
T ss_pred EECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCc
Confidence 9999999865433221 1234677999999998889999999999999999998 99987
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-28 Score=257.32 Aligned_cols=194 Identities=37% Similarity=0.624 Sum_probs=164.3
Q ss_pred ecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecC---chhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEe-
Q 007035 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH- 487 (621)
Q Consensus 412 i~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~---~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~- 487 (621)
+.++|++.+.||.|+||.||++.+..+++.||+|.+... .........|+.+++.+ .||||++++++|..
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l------~hpniv~~~~~~~~~ 81 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHL------RHENIISLSDIFISP 81 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhc------CCCCeeeEeeeEecC
Confidence 568899999999999999999999999999999987642 22334566777777766 47899999999876
Q ss_pred cCeEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEec
Q 007035 488 LEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 567 (621)
Q Consensus 488 ~~~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DF 567 (621)
....++||||++++|...+... .++...+..++.||+.||.|||+.+|+||||+|+||+++. ++.++|+||
T Consensus 82 ~~~~~lv~e~~~~~L~~~~~~~-------~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~--~~~~~l~df 152 (328)
T cd07856 82 LEDIYFVTELLGTDLHRLLTSR-------PLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINE--NCDLKICDF 152 (328)
T ss_pred CCcEEEEeehhccCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECC--CCCEEeCcc
Confidence 5679999999988877666421 1677888899999999999999999999999999999984 788999999
Q ss_pred CCccccCCCccccccCCcccCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 568 GSSCFQTDNLCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 568 Gls~~~~~~~~~~~gt~~Y~APEvl~~-~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
|.+...........+++.|+|||.+.+ ..++.++||||||+++|+|++|++||
T Consensus 153 g~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f 206 (328)
T cd07856 153 GLARIQDPQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLF 206 (328)
T ss_pred ccccccCCCcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCC
Confidence 998765554445567889999999866 56899999999999999999999998
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.8e-29 Score=261.02 Aligned_cols=195 Identities=31% Similarity=0.572 Sum_probs=162.6
Q ss_pred ecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc---hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEe-
Q 007035 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH- 487 (621)
Q Consensus 412 i~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~---~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~- 487 (621)
+..+|++.+.||.|++|.||++.++.+|+.||+|++.... .....+.+|+.+++.++ ||||+++++++..
T Consensus 3 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~iv~~~~~~~~~ 76 (334)
T cd07855 3 VGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFK------HDNIIAIRDILRPP 76 (334)
T ss_pred hhhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcC------CCCccCHHHhcccc
Confidence 3478999999999999999999999999999999987532 23345566777777664 7899999998763
Q ss_pred ---cCeEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEE
Q 007035 488 ---LEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKI 564 (621)
Q Consensus 488 ---~~~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL 564 (621)
...+++||||++++|.+.+.... .+++..++.++.||+.||.|||+.+|+||||||+||+++ .++.+||
T Consensus 77 ~~~~~~~~lv~e~~~~~l~~~~~~~~------~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~--~~~~~kl 148 (334)
T cd07855 77 GADFKDVYVVMDLMESDLHHIIHSDQ------PLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVN--EDCELRI 148 (334)
T ss_pred CCCCceEEEEEehhhhhHHHHhccCC------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc--CCCcEEe
Confidence 35789999999988877765322 288999999999999999999999999999999999998 4889999
Q ss_pred EecCCccccCCCc-------cccccCCcccCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 565 IDLGSSCFQTDNL-------CLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 565 ~DFGls~~~~~~~-------~~~~gt~~Y~APEvl~~-~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
+|||++....... ....++..|+|||.+.+ ..++.++|||||||++|+|++|++||
T Consensus 149 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf 212 (334)
T cd07855 149 GDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLF 212 (334)
T ss_pred cccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCcc
Confidence 9999986543211 23467889999999866 45789999999999999999999998
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=253.32 Aligned_cols=194 Identities=26% Similarity=0.379 Sum_probs=163.5
Q ss_pred cCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecC--chhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCe
Q 007035 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (621)
Q Consensus 413 ~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~--~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~ 490 (621)
.++|++++.||+|+||+||++.+..+|+.||+|++... ......+.+|+++++.+ .||||+++++.+.....
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l------~h~~i~~~~~~~~~~~~ 77 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHEC------RSPYIVSFYGAFLNENN 77 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHc------CCCCcceEeeeEecCCE
Confidence 36799999999999999999999999999999988653 23345667777777665 47899999999999999
Q ss_pred EEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHH-CCeecccCCCccEEEeccCCCeEEEEecC
Q 007035 491 LFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS-LGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (621)
Q Consensus 491 l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs-~gIvHrDLKP~NILl~~~~~~~IKL~DFG 568 (621)
+++||||+++ +|.+.+.... .+++..++.++.+++.||.|||+ .+++||||+|+||+++ .++.++|+|||
T Consensus 78 ~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~--~~~~~~l~d~g 149 (284)
T cd06620 78 ICMCMEFMDCGSLDRIYKKGG------PIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVN--SRGQIKLCDFG 149 (284)
T ss_pred EEEEEecCCCCCHHHHHHhcc------CCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEEC--CCCcEEEccCC
Confidence 9999999986 4544443221 27889999999999999999997 5899999999999998 47889999999
Q ss_pred CccccCC-CccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 569 SSCFQTD-NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 569 ls~~~~~-~~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
++..... ......++..|+|||++.+..++.++|||||||++|+|++|+.||
T Consensus 150 l~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~ 202 (284)
T cd06620 150 VSGELINSIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPF 202 (284)
T ss_pred cccchhhhccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCC
Confidence 8765322 223356789999999998888999999999999999999999998
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-28 Score=247.22 Aligned_cols=195 Identities=24% Similarity=0.345 Sum_probs=157.6
Q ss_pred cCceEEEEEeccCCCCceeEEEeCCCCc---EEEEEEEecCc--hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEe
Q 007035 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGV---DVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (621)
Q Consensus 413 ~~rY~I~~~LG~G~fG~Vyka~d~~tg~---~VAlKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~ 487 (621)
.++|+..+.||.|+||.||+|.++.++. .+++|.+.... ...+.+..|+++++.+ .||||+++.+++..
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~~ 77 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQF------SHHNIIRLEGVVTK 77 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcC------CCCCeeEEEEEEcc
Confidence 4578999999999999999999876654 69999887542 2234556666666554 47899999999999
Q ss_pred cCeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEe
Q 007035 488 LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (621)
Q Consensus 488 ~~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~D 566 (621)
.+..++||||+++ +|.+++.... ..+++..+..++.|++.||.|||+.+++||||||+||+++. ++.++|+|
T Consensus 78 ~~~~~lv~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~--~~~~kl~d 150 (268)
T cd05063 78 FKPAMIITEYMENGALDKYLRDHD-----GEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNS--NLECKVSD 150 (268)
T ss_pred CCCcEEEEEcCCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcC--CCcEEECC
Confidence 9999999999986 5555554322 12788899999999999999999999999999999999984 78899999
Q ss_pred cCCccccCCCccc------cccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 567 LGSSCFQTDNLCL------YVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 567 FGls~~~~~~~~~------~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
||++......... ...++.|+|||++.+..++.++|||||||++|+|++ |+.||
T Consensus 151 fg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~ 211 (268)
T cd05063 151 FGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPY 211 (268)
T ss_pred CccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCC
Confidence 9988654322111 112456999999988889999999999999999997 99998
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-28 Score=253.10 Aligned_cols=198 Identities=28% Similarity=0.502 Sum_probs=163.1
Q ss_pred eeecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc---hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeE
Q 007035 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (621)
Q Consensus 410 ~ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~---~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~ 486 (621)
....++|++.+.||.|+||.||+|.++.+|+.||+|.++... .......+|+.+++.+ .||||+++++++.
T Consensus 3 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l------~h~~i~~~~~~~~ 76 (302)
T cd07864 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQL------NHRNIVNLKEIVT 76 (302)
T ss_pred hhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhC------CCCCeeeeeheec
Confidence 345678999999999999999999999999999999987532 2223455677777666 4789999999987
Q ss_pred ecC----------eEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEec
Q 007035 487 HLE----------HLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS 556 (621)
Q Consensus 487 ~~~----------~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~ 556 (621)
... ++++||||+++++...+..... .+++..++.++.||+.||.|||+.+|+|+||+|+||+++
T Consensus 77 ~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~- 150 (302)
T cd07864 77 DKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLV-----HFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLN- 150 (302)
T ss_pred CcchhhhccccCCcEEEEEcccCccHHHHHhcCCC-----CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC-
Confidence 654 8999999999988877654321 288999999999999999999999999999999999998
Q ss_pred cCCCeEEEEecCCccccCCCc----cccccCCcccCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 557 YQRCEIKIIDLGSSCFQTDNL----CLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 557 ~~~~~IKL~DFGls~~~~~~~----~~~~gt~~Y~APEvl~~~-~~s~ksDIWSLGvILyELltG~~PF 620 (621)
.++.+||+|||++....... ....++..|+|||.+.+. .++.++|||||||++|+|++|++||
T Consensus 151 -~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~ 218 (302)
T cd07864 151 -NKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIF 218 (302)
T ss_pred -CCCcEEeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCC
Confidence 47889999999886543322 122457789999998654 4688999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.2e-28 Score=248.39 Aligned_cols=197 Identities=29% Similarity=0.381 Sum_probs=163.2
Q ss_pred CceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCch--hhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEec--C
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD--FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL--E 489 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~--~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~--~ 489 (621)
++|.+.+.||.|++|.||++.+..+++.+|+|++..... ...++.+|+++++.+ +||||+++++++... .
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l------~h~~iv~~~~~~~~~~~~ 74 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSC------KSPYIVKYYGAFLDESSS 74 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhC------CCCCeeeeeeEEEccCCC
Confidence 478999999999999999999999999999999875432 445667777777665 478999999998754 4
Q ss_pred eEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecC
Q 007035 490 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (621)
Q Consensus 490 ~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFG 568 (621)
.+++||||+++ +|.+++...... ...+++..+..++.||+.||.|||+.+++|+||+|+||+++. ++.++|+|||
T Consensus 75 ~~~lv~e~~~~~~L~~~l~~~~~~--~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~--~~~~~l~dfg 150 (287)
T cd06621 75 SIGIAMEYCEGGSLDSIYKKVKKR--GGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTR--KGQVKLCDFG 150 (287)
T ss_pred eEEEEEEecCCCCHHHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEec--CCeEEEeecc
Confidence 79999999985 666655432221 223788899999999999999999999999999999999984 7789999999
Q ss_pred CccccCCC-ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 569 SSCFQTDN-LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 569 ls~~~~~~-~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
++...... .....++..|+|||.+.+..++.++||||||+++|+|++|+.||
T Consensus 151 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~ 203 (287)
T cd06621 151 VSGELVNSLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPF 203 (287)
T ss_pred ccccccccccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 97654332 22345688899999999888999999999999999999999997
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-28 Score=258.65 Aligned_cols=196 Identities=31% Similarity=0.451 Sum_probs=161.9
Q ss_pred eecCceEEE-EEeccCCCCceeEEEeCCCCcEEEEEEEecCchhh---------------hhHHHHHHHHHHhcccCCCC
Q 007035 411 VIAGRYYVT-EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFF---------------DQSLDEIKLLKLVNKNDPAD 474 (621)
Q Consensus 411 ii~~rY~I~-~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~---------------~~~~~Ei~iL~~l~~~~~~~ 474 (621)
.+.++|..+ +.||.|+||+||+|.+..+++.||+|.+....... ..+.+|+++++.+ .
T Consensus 5 ~~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l------~ 78 (335)
T PTZ00024 5 SISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEI------K 78 (335)
T ss_pred ccccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhC------C
Confidence 456788754 67999999999999999999999999986542211 1355677776666 4
Q ss_pred CCceEEEeeEeEecCeEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEE
Q 007035 475 EHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILI 554 (621)
Q Consensus 475 hpnIvrl~~~f~~~~~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl 554 (621)
|+||+++++++...++.++||||+.++|.+.+.... .+++..+..++.||+.||.|||+.||+|+||+|+||++
T Consensus 79 h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~------~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill 152 (335)
T PTZ00024 79 HENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKI------RLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFI 152 (335)
T ss_pred CcceeeeeEEEecCCcEEEEEeccccCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEE
Confidence 789999999999999999999999998888775432 27889999999999999999999999999999999999
Q ss_pred eccCCCeEEEEecCCccccCC-----------------CccccccCCcccCchhhcCC-CCCchhhHHHHHHHHHHHHhC
Q 007035 555 KSYQRCEIKIIDLGSSCFQTD-----------------NLCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTG 616 (621)
Q Consensus 555 ~~~~~~~IKL~DFGls~~~~~-----------------~~~~~~gt~~Y~APEvl~~~-~~s~ksDIWSLGvILyELltG 616 (621)
+. ++.++|+|||++..... ......+++.|+|||.+.+. .++.++|||||||++|+|++|
T Consensus 153 ~~--~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg 230 (335)
T PTZ00024 153 NS--KGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTG 230 (335)
T ss_pred CC--CCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhC
Confidence 84 78899999998765431 11123457789999999764 468999999999999999999
Q ss_pred CCCC
Q 007035 617 EVCL 620 (621)
Q Consensus 617 ~~PF 620 (621)
.+||
T Consensus 231 ~~p~ 234 (335)
T PTZ00024 231 KPLF 234 (335)
T ss_pred CCCC
Confidence 9987
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-28 Score=245.09 Aligned_cols=192 Identities=32% Similarity=0.522 Sum_probs=163.1
Q ss_pred ceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCch---hhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeE
Q 007035 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD---FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (621)
Q Consensus 415 rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~---~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l 491 (621)
||++.+.||.|+||.||++.+..+++.|++|.++.... ....+.+|+.+++.++ |+||+++++.+...+..
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~------~~~i~~~~~~~~~~~~~ 74 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLK------HPNLVKYYGVEVHREKV 74 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCC------CCChhheeeeEecCCEE
Confidence 68999999999999999999999999999999876433 4566777777777664 67899999999999999
Q ss_pred EEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCc
Q 007035 492 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (621)
Q Consensus 492 ~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls 570 (621)
++|+||+.+ +|.+.+.... .+++..++.++.||+.||.|||+.+|+|+||+|+||+++. ++.+||+|||++
T Consensus 75 ~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~--~~~~kl~d~g~~ 146 (264)
T cd06626 75 YIFMEYCSGGTLEELLEHGR------ILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDH--NGVIKLGDFGCA 146 (264)
T ss_pred EEEEecCCCCcHHHHHhhcC------CCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECC--CCCEEEcccccc
Confidence 999999985 6666554321 2678889999999999999999999999999999999984 788999999988
Q ss_pred cccCCCcc-------ccccCCcccCchhhcCCC---CCchhhHHHHHHHHHHHHhCCCCC
Q 007035 571 CFQTDNLC-------LYVQSRSYRAPEVIIGLP---YDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 571 ~~~~~~~~-------~~~gt~~Y~APEvl~~~~---~s~ksDIWSLGvILyELltG~~PF 620 (621)
........ ...+++.|+|||.+.+.. ++.++||||||+++|+|++|+.||
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf 206 (264)
T cd06626 147 VKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPW 206 (264)
T ss_pred cccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCc
Confidence 66543221 235678899999998766 789999999999999999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-28 Score=251.15 Aligned_cols=194 Identities=22% Similarity=0.303 Sum_probs=153.2
Q ss_pred cCceEEEEEeccCCCCceeEEEeCCCCcE----EEEEEEecCc--hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeE
Q 007035 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVD----VCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (621)
Q Consensus 413 ~~rY~I~~~LG~G~fG~Vyka~d~~tg~~----VAlKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~ 486 (621)
.++|++++.||.|+||+||+|.+..+++. +++|.+.... ....++..|+.++. ...||||+++++++.
T Consensus 6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~------~l~h~~iv~~~~~~~ 79 (279)
T cd05111 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMG------SLDHAYIVRLLGICP 79 (279)
T ss_pred HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHh------cCCCCCcceEEEEEC
Confidence 35789999999999999999998877764 6777665322 12233333433433 346899999999875
Q ss_pred ecCeEEEEEeccc-cchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEE
Q 007035 487 HLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKII 565 (621)
Q Consensus 487 ~~~~l~LVmEyl~-gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~ 565 (621)
. ...++++||+. ++|.+++..... .+++..+..++.||+.||.|||+++++||||||+|||++ .++.+||+
T Consensus 80 ~-~~~~~i~e~~~~gsL~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~--~~~~~kl~ 151 (279)
T cd05111 80 G-ASLQLVTQLSPLGSLLDHVRQHRD-----SLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLK--SDSIVQIA 151 (279)
T ss_pred C-CccEEEEEeCCCCcHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEc--CCCcEEEc
Confidence 4 55778999987 578777754322 278899999999999999999999999999999999998 47889999
Q ss_pred ecCCccccCCC-----ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 566 DLGSSCFQTDN-----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 566 DFGls~~~~~~-----~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
|||++...... .....++..|+|||.+.+..++.++||||||+++|||++ |+.||
T Consensus 152 Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~ 212 (279)
T cd05111 152 DFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPY 212 (279)
T ss_pred CCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCC
Confidence 99998654322 112345678999999998889999999999999999998 99887
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-28 Score=250.53 Aligned_cols=192 Identities=30% Similarity=0.455 Sum_probs=161.7
Q ss_pred CceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc--hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeE
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l 491 (621)
..|++++.||.|+||.||+|.+..++..||+|++.... .....+.+|+.+++.+ .|+||+++++.+......
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~~~~~~ 77 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQC------DSPYVTKYYGSYLKGTKL 77 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhC------CCCCEeeEEEEEEECCEE
Confidence 46888899999999999999999999999999987542 2334556666666655 478999999999999999
Q ss_pred EEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCc
Q 007035 492 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (621)
Q Consensus 492 ~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls 570 (621)
++||||+++ +|.+.+... .+++..+..++.|++.||.|||+.+++|+||+|+||+++. ++.++|+|||++
T Consensus 78 ~lv~e~~~~~~L~~~i~~~-------~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~--~~~~~l~dfg~~ 148 (277)
T cd06640 78 WIIMEYLGGGSALDLLRAG-------PFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSE--QGDVKLADFGVA 148 (277)
T ss_pred EEEEecCCCCcHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcC--CCCEEEcccccc
Confidence 999999986 666655421 2778889999999999999999999999999999999984 778999999998
Q ss_pred cccCCC---ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 571 CFQTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 571 ~~~~~~---~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
...... .....++..|+|||.+.+..++.++|+|||||++|+|++|..||
T Consensus 149 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~ 201 (277)
T cd06640 149 GQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPN 201 (277)
T ss_pred eeccCCccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCC
Confidence 654332 22345678899999998888999999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-28 Score=250.67 Aligned_cols=193 Identities=31% Similarity=0.493 Sum_probs=162.9
Q ss_pred eEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc---hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeEE
Q 007035 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLF 492 (621)
Q Consensus 416 Y~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~---~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l~ 492 (621)
|++++.||.|++|.||+|.++.+|..||+|++.... .....+.+|+.+++.++ ||||+++++++......+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~------~~~iv~~~~~~~~~~~~~ 74 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELN------HPNIVRLLDVVHSENKLY 74 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcC------CCCccCHhheeccCCeEE
Confidence 678899999999999999999999999999987543 22345667888877764 789999999999999999
Q ss_pred EEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCccc
Q 007035 493 IVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF 572 (621)
Q Consensus 493 LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~~ 572 (621)
+||||++++|.+++..... ..+++..+..++.||+.||.|||+++++||||+|+||+++. ++.++|+|||++..
T Consensus 75 iv~e~~~~~l~~~~~~~~~----~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~--~~~~~l~df~~~~~ 148 (283)
T cd07835 75 LVFEFLDLDLKKYMDSSPL----TGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDR--EGALKLADFGLARA 148 (283)
T ss_pred EEEeccCcCHHHHHhhCCC----CCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcC--CCcEEEeecccccc
Confidence 9999998888887764432 23789999999999999999999999999999999999985 78899999999865
Q ss_pred cCCCc---cccccCCcccCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 573 QTDNL---CLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 573 ~~~~~---~~~~gt~~Y~APEvl~~~-~~s~ksDIWSLGvILyELltG~~PF 620 (621)
..... ....+++.|+|||++.+. .++.++||||||+++|+|++|++||
T Consensus 149 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf 200 (283)
T cd07835 149 FGVPVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLF 200 (283)
T ss_pred cCCCccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCC
Confidence 43221 223457889999988664 4788999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-28 Score=244.40 Aligned_cols=193 Identities=33% Similarity=0.472 Sum_probs=166.0
Q ss_pred CceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc--hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeE
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l 491 (621)
++|++.+.||.|++|.||++.+..+++.|++|++.... .....+..|+.++..++ |+||+++++++.....+
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~------~~~i~~~~~~~~~~~~~ 74 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCE------SPYVVKCYGAFYKEGEI 74 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcC------CCCeeeEEEEEccCCeE
Confidence 36899999999999999999999999999999987654 23456677777777664 78999999999999999
Q ss_pred EEEEeccc-cchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHH-CCeecccCCCccEEEeccCCCeEEEEecCC
Q 007035 492 FIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS-LGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (621)
Q Consensus 492 ~LVmEyl~-gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs-~gIvHrDLKP~NILl~~~~~~~IKL~DFGl 569 (621)
++||||+. ++|.+.+... ..+++..+..++.||+.||.|||+ .+++|+||+|+||+++. ++.++|+|||+
T Consensus 75 ~lv~e~~~~~~L~~~l~~~------~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~--~~~~~l~df~~ 146 (264)
T cd06623 75 SIVLEYMDGGSLADLLKKV------GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINS--KGEVKIADFGI 146 (264)
T ss_pred EEEEEecCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECC--CCCEEEccCcc
Confidence 99999999 5777776543 228899999999999999999999 99999999999999984 78899999998
Q ss_pred ccccCCCcc---ccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 570 SCFQTDNLC---LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 570 s~~~~~~~~---~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
+........ ...++..|+|||.+.+..++.++|+||||+++|+|++|+.||
T Consensus 147 ~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~ 200 (264)
T cd06623 147 SKVLENTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPF 200 (264)
T ss_pred ceecccCCCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 865443221 345688899999999888999999999999999999999997
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-28 Score=245.16 Aligned_cols=193 Identities=25% Similarity=0.373 Sum_probs=160.2
Q ss_pred EEeccCCCCceeEEEeCCC---CcEEEEEEEecCchh--hhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeEEEE
Q 007035 420 EYLGSAAFSKVFQAQDLHT---GVDVCLKIIKNDKDF--FDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIV 494 (621)
Q Consensus 420 ~~LG~G~fG~Vyka~d~~t---g~~VAlKii~~~~~~--~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l~LV 494 (621)
+.||.|+||.||+|.+... +..|++|+++..... ...+.+|+++++.++ |+||+++++++......++|
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~------~~~i~~~~~~~~~~~~~~lv 74 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLG------HPNVVRLLGVCTEEEPLYLV 74 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcC------CCChheeeeeecCCCceEEE
Confidence 3699999999999998866 899999999865432 456677777777664 67999999999999999999
Q ss_pred Eeccc-cchHHHHHhhhcc---CCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCc
Q 007035 495 CELLR-ANLYEFQKFNQES---GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (621)
Q Consensus 495 mEyl~-gsLld~l~~~~~~---~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls 570 (621)
|||+. ++|.+.+...... .....+++..++.++.||+.||.|||+++|+||||+|+||+++. ++.++|+|||.+
T Consensus 75 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~--~~~~~l~dfg~~ 152 (262)
T cd00192 75 LEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGE--DLVVKISDFGLS 152 (262)
T ss_pred EEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECC--CCcEEEcccccc
Confidence 99995 6787776654211 00123899999999999999999999999999999999999995 689999999998
Q ss_pred cccCCC-----ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 571 CFQTDN-----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 571 ~~~~~~-----~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
...... .....+++.|+|||.+....++.++||||||+++|+|++ |+.||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~ 208 (262)
T cd00192 153 RDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPY 208 (262)
T ss_pred cccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCC
Confidence 765443 223456788999999988889999999999999999999 58887
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-28 Score=246.76 Aligned_cols=197 Identities=24% Similarity=0.356 Sum_probs=162.7
Q ss_pred eeecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecC
Q 007035 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (621)
Q Consensus 410 ~ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~ 489 (621)
++..++|++.+.||+|+||.||++.+. .+..+++|.+.........+.+|+.+++.++ |+||+++++.+.. .
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~------~~~i~~~~~~~~~-~ 73 (260)
T cd05073 2 EIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQ------HDKLVKLHAVVTK-E 73 (260)
T ss_pred cccccceeEEeEecCccceEEEEEEec-CCccEEEEecCCChhHHHHHHHHHHHHHhcC------CCCcceEEEEEcC-C
Confidence 456789999999999999999999854 5567999998876555567778888887664 6789999999887 7
Q ss_pred eEEEEEeccc-cchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecC
Q 007035 490 HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (621)
Q Consensus 490 ~l~LVmEyl~-gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFG 568 (621)
..+++|||++ ++|.+++.... ...+++..+..++.||+.||.|||+.+++|+||+|+||+++ ..+.++|+|||
T Consensus 74 ~~~~v~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~--~~~~~~l~d~~ 147 (260)
T cd05073 74 PIYIITEFMAKGSLLDFLKSDE----GSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVS--ASLVCKIADFG 147 (260)
T ss_pred CeEEEEEeCCCCcHHHHHHhCC----ccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEc--CCCcEEECCCc
Confidence 8899999997 47877775432 12267888999999999999999999999999999999998 47899999999
Q ss_pred CccccCCCcc----ccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 569 SSCFQTDNLC----LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 569 ls~~~~~~~~----~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
.+........ ...++..|+|||.+.+..++.++|+|||||++|+|++ |++||
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~ 204 (260)
T cd05073 148 LARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPY 204 (260)
T ss_pred ceeeccCCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCC
Confidence 8865432211 1233567999999998889999999999999999999 99987
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-28 Score=248.18 Aligned_cols=194 Identities=24% Similarity=0.362 Sum_probs=158.5
Q ss_pred CceEEEEEeccCCCCceeEEEeCCCCc---EEEEEEEecC--chhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEec
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQDLHTGV---DVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d~~tg~---~VAlKii~~~--~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~ 488 (621)
+.|++.+.||+|+||.||+|.+..+++ .||+|++... ......+..|+.+++.+ .||||+++++++...
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l------~h~ni~~~~~~~~~~ 77 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF------DHPNIIHLEGVVTKS 77 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhC------CCcCcceEEEEECCC
Confidence 568999999999999999999877665 5999998753 33345667777777665 478999999999999
Q ss_pred CeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEec
Q 007035 489 EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 567 (621)
Q Consensus 489 ~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DF 567 (621)
...++||||+++ +|.+++.... ..+++..++.++.|++.||.|||++|++|+||||+||+++ .++.++|+||
T Consensus 78 ~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~--~~~~~kl~df 150 (269)
T cd05065 78 RPVMIITEFMENGALDSFLRQND-----GQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVN--SNLVCKVSDF 150 (269)
T ss_pred CceEEEEecCCCCcHHHHHhhCC-----CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEc--CCCcEEECCC
Confidence 999999999986 5555554322 1378899999999999999999999999999999999998 4778999999
Q ss_pred CCccccCCCcc--c----cc--cCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 568 GSSCFQTDNLC--L----YV--QSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 568 Gls~~~~~~~~--~----~~--gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
|++........ . .. .+..|+|||.+.+..++.++|||||||++|||++ |..||
T Consensus 151 g~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~ 212 (269)
T cd05065 151 GLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY 212 (269)
T ss_pred ccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCC
Confidence 98765432211 0 11 1346999999998889999999999999999886 99997
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-28 Score=245.60 Aligned_cols=192 Identities=30% Similarity=0.421 Sum_probs=161.6
Q ss_pred ceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc------hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEec
Q 007035 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK------DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (621)
Q Consensus 415 rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~------~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~ 488 (621)
+|++.+.||.|++|+||+|.+..+++.|++|.+.... .....+.+|+.+++.+ .|+||+++++++...
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~------~h~~i~~~~~~~~~~ 74 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKL------QHPNIVQYLGTEREE 74 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhc------CCCCchheeeeEecC
Confidence 5778899999999999999998899999999886532 2345566777776655 478999999999999
Q ss_pred CeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEec
Q 007035 489 EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 567 (621)
Q Consensus 489 ~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DF 567 (621)
...++||||+++ +|.+++.... .+++..+..++.||+.||.|||+.+|+|+||+|+||+++. ++.+||+||
T Consensus 75 ~~~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~--~~~~kl~d~ 146 (258)
T cd06632 75 DNLYIFLELVPGGSLAKLLKKYG------SFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDT--NGVVKLADF 146 (258)
T ss_pred CeEEEEEEecCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECC--CCCEEEccC
Confidence 999999999985 6666654322 2788889999999999999999999999999999999984 788999999
Q ss_pred CCccccCCC--ccccccCCcccCchhhcCCC-CCchhhHHHHHHHHHHHHhCCCCC
Q 007035 568 GSSCFQTDN--LCLYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 568 Gls~~~~~~--~~~~~gt~~Y~APEvl~~~~-~s~ksDIWSLGvILyELltG~~PF 620 (621)
|++...... .....+++.|++||.+.... ++.++|+||||+++|+|++|+.||
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf 202 (258)
T cd06632 147 GMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPW 202 (258)
T ss_pred ccceeccccccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCc
Confidence 987654332 23456788899999997766 899999999999999999999998
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-28 Score=252.84 Aligned_cols=204 Identities=25% Similarity=0.401 Sum_probs=164.0
Q ss_pred eeecCceEEEEEeccCCCCceeEEEeC-------CCCcEEEEEEEecC--chhhhhHHHHHHHHHHhcccCCCCCCceEE
Q 007035 410 TVIAGRYYVTEYLGSAAFSKVFQAQDL-------HTGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILR 480 (621)
Q Consensus 410 ~ii~~rY~I~~~LG~G~fG~Vyka~d~-------~tg~~VAlKii~~~--~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvr 480 (621)
.+..++|.+.+.||.|+||.||++++. ..+..||+|.+... ......+.+|+.+++.+. .||||++
T Consensus 11 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~-----~h~~i~~ 85 (304)
T cd05101 11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG-----KHKNIIN 85 (304)
T ss_pred cccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhc-----cCCCchh
Confidence 345678999999999999999999753 23457999988753 233456778888887763 4789999
Q ss_pred EeeEeEecCeEEEEEecccc-chHHHHHhhhccC----------CCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCC
Q 007035 481 LYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESG----------GEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKP 549 (621)
Q Consensus 481 l~~~f~~~~~l~LVmEyl~g-sLld~l~~~~~~~----------~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP 549 (621)
+++++......++||||+.+ +|.+++....... ....+++..+..++.||+.||.|||++||+||||||
T Consensus 86 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp 165 (304)
T cd05101 86 LLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAA 165 (304)
T ss_pred eeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeeccccc
Confidence 99999999999999999985 7777766432211 123477888999999999999999999999999999
Q ss_pred ccEEEeccCCCeEEEEecCCccccCCCc-----cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 550 ENILIKSYQRCEIKIIDLGSSCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 550 ~NILl~~~~~~~IKL~DFGls~~~~~~~-----~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
+|||++ .++.+||+|||++....... ....+++.|+|||++.+..++.++||||||+++|+|++ |..||
T Consensus 166 ~Nili~--~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~ 240 (304)
T cd05101 166 RNVLVT--ENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 240 (304)
T ss_pred ceEEEc--CCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCc
Confidence 999998 47889999999986543221 11234567999999998889999999999999999998 77776
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-28 Score=253.50 Aligned_cols=203 Identities=25% Similarity=0.382 Sum_probs=162.1
Q ss_pred eecCceEEEEEeccCCCCceeEEEeCC-------CCcEEEEEEEecCc--hhhhhHHHHHHHHHHhcccCCCCCCceEEE
Q 007035 411 VIAGRYYVTEYLGSAAFSKVFQAQDLH-------TGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRL 481 (621)
Q Consensus 411 ii~~rY~I~~~LG~G~fG~Vyka~d~~-------tg~~VAlKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl 481 (621)
...++|.+.+.||+|+||.||++++.. ....+|+|+++... .....+..|+.+++.+. .||||+++
T Consensus 9 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~-----~h~~iv~~ 83 (314)
T cd05099 9 FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIG-----KHKNIINL 83 (314)
T ss_pred ccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhcc-----CCCCeeeE
Confidence 345789999999999999999998642 34579999887532 23445667777777663 47899999
Q ss_pred eeEeEecCeEEEEEecccc-chHHHHHhhhcc----------CCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCc
Q 007035 482 YDYFYHLEHLFIVCELLRA-NLYEFQKFNQES----------GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPE 550 (621)
Q Consensus 482 ~~~f~~~~~l~LVmEyl~g-sLld~l~~~~~~----------~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~ 550 (621)
++++......++||||+.+ +|.+++...... .....+++..+..++.||+.||.|||++||+||||||+
T Consensus 84 ~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~ 163 (314)
T cd05099 84 LGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAAR 163 (314)
T ss_pred EEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccce
Confidence 9999999999999999984 777776543211 11234788899999999999999999999999999999
Q ss_pred cEEEeccCCCeEEEEecCCccccCCCc-----cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 551 NILIKSYQRCEIKIIDLGSSCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 551 NILl~~~~~~~IKL~DFGls~~~~~~~-----~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
|||++. ++.+||+|||++....... ....++..|+|||++.+..++.++||||||+++|+|++ |..||
T Consensus 164 Nill~~--~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~ 237 (314)
T cd05099 164 NVLVTE--DNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPY 237 (314)
T ss_pred eEEEcC--CCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCC
Confidence 999984 7889999999986543211 11123457999999998889999999999999999999 88886
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-28 Score=260.19 Aligned_cols=193 Identities=34% Similarity=0.635 Sum_probs=161.1
Q ss_pred ecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecC---chhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEec
Q 007035 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (621)
Q Consensus 412 i~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~---~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~ 488 (621)
+.++|.+.+.||.|+||.||+|.+..+|+.||+|.+... ........+|+.+++.+ .|+||+++++++...
T Consensus 13 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l------~h~niv~~~~~~~~~ 86 (342)
T cd07879 13 LPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHM------QHENVIGLLDVFTSA 86 (342)
T ss_pred cccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhc------CCCCccchhheeccc
Confidence 357899999999999999999999999999999998753 22234456677777665 478999999998754
Q ss_pred ------CeEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeE
Q 007035 489 ------EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEI 562 (621)
Q Consensus 489 ------~~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~I 562 (621)
...++||||+..++..... ..+++..+..++.||+.||.|||+.+|+||||||+||+++. ++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~l~~~~~--------~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~--~~~~ 156 (342)
T cd07879 87 VSGDEFQDFYLVMPYMQTDLQKIMG--------HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNE--DCEL 156 (342)
T ss_pred ccCCCCceEEEEecccccCHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECC--CCCE
Confidence 3469999999876654431 12788999999999999999999999999999999999984 7899
Q ss_pred EEEecCCccccCCCccccccCCcccCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 563 KIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 563 KL~DFGls~~~~~~~~~~~gt~~Y~APEvl~~-~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
+|+|||++...........+++.|+|||++.+ ..++.++|||||||++|+|++|+.||
T Consensus 157 kL~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf 215 (342)
T cd07879 157 KILDFGLARHADAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLF 215 (342)
T ss_pred EEeeCCCCcCCCCCCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCC
Confidence 99999998766555455567889999999876 45889999999999999999999998
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-28 Score=247.61 Aligned_cols=193 Identities=30% Similarity=0.401 Sum_probs=159.6
Q ss_pred CceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc------hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEe
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK------DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~------~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~ 487 (621)
..|++.+.||+|+||.||++.+..++..|++|.+.... .....+.+|+.+++.+ +||||+++++++..
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~~ 75 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNL------QHERIVQYYGCLRD 75 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHc------CCCCeeeEEEEEEc
Confidence 36889999999999999999999999999999886432 1234456677776665 47899999998875
Q ss_pred --cCeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEE
Q 007035 488 --LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKI 564 (621)
Q Consensus 488 --~~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL 564 (621)
...++++|||+.+ +|.+.+.... .+++..++.++.||+.||.|||+++|+||||+|+||+++. ++.++|
T Consensus 76 ~~~~~~~l~~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~--~~~~~l 147 (266)
T cd06651 76 RAEKTLTIFMEYMPGGSVKDQLKAYG------ALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDS--AGNVKL 147 (266)
T ss_pred CCCCEEEEEEeCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECC--CCCEEE
Confidence 3678999999985 6766665322 2778888999999999999999999999999999999984 778999
Q ss_pred EecCCccccCCC------ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 565 IDLGSSCFQTDN------LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 565 ~DFGls~~~~~~------~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
+|||++...... .....++..|+|||.+.+..++.++|||||||++|+|++|+.||
T Consensus 148 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf 209 (266)
T cd06651 148 GDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPW 209 (266)
T ss_pred ccCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCc
Confidence 999988653321 12245688899999999888999999999999999999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-28 Score=250.48 Aligned_cols=202 Identities=25% Similarity=0.371 Sum_probs=162.4
Q ss_pred ecCceEEEEEeccCCCCceeEEEeCCC-----CcEEEEEEEecCc--hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeE
Q 007035 412 IAGRYYVTEYLGSAAFSKVFQAQDLHT-----GVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDY 484 (621)
Q Consensus 412 i~~rY~I~~~LG~G~fG~Vyka~d~~t-----g~~VAlKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~ 484 (621)
-.++|++.+.||+|+||.||++.+... ...+|+|++.... .....+.+|+.+++.+. +|+||++++++
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~-----~h~~i~~~~~~ 84 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIG-----KHKNIINLLGV 84 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhc-----CCCCeeeEEEE
Confidence 357899999999999999999987644 3789999987542 22345667777777663 47899999999
Q ss_pred eEecCeEEEEEecccc-chHHHHHhhhc----------cCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEE
Q 007035 485 FYHLEHLFIVCELLRA-NLYEFQKFNQE----------SGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENIL 553 (621)
Q Consensus 485 f~~~~~l~LVmEyl~g-sLld~l~~~~~----------~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NIL 553 (621)
+.....++++|||+.+ +|..++..... ......+++..+..++.||+.||.|||+.+|+||||||+|||
T Consensus 85 ~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil 164 (293)
T cd05053 85 CTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVL 164 (293)
T ss_pred EcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEE
Confidence 9999999999999974 67766653210 012234888999999999999999999999999999999999
Q ss_pred EeccCCCeEEEEecCCccccCCCc-----cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 554 IKSYQRCEIKIIDLGSSCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 554 l~~~~~~~IKL~DFGls~~~~~~~-----~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
++ .++.+||+|||++....... ....++..|+|||++.+..++.++|||||||++|+|++ |..||
T Consensus 165 ~~--~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~ 235 (293)
T cd05053 165 VT--EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY 235 (293)
T ss_pred Ec--CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCC
Confidence 98 47899999999986543321 11223567999999988889999999999999999997 88886
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.4e-28 Score=238.97 Aligned_cols=193 Identities=35% Similarity=0.566 Sum_probs=166.7
Q ss_pred ceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCch-hhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeEEE
Q 007035 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD-FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFI 493 (621)
Q Consensus 415 rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~-~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l~L 493 (621)
.|.+.+.||.|++|.||++.+..+++.+++|++..... ....+.+|+.+++.+. |++|+++++.+......++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~------~~~i~~~~~~~~~~~~~~l 74 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCK------HPNIVKYYGSYLKKDELWI 74 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCC------CCCEeEEEEEEecCCeEEE
Confidence 47889999999999999999998999999999976543 4566777777777664 6799999999999999999
Q ss_pred EEeccc-cchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCccc
Q 007035 494 VCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF 572 (621)
Q Consensus 494 VmEyl~-gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~~ 572 (621)
++||++ ++|.+.+.... ..+++..+..++.|++.||.+||+.+++||||+|+||+++. ++.++|+|||.+..
T Consensus 75 ~~e~~~~~~L~~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~--~~~~~l~d~~~~~~ 147 (253)
T cd05122 75 VMEFCSGGSLKDLLKSTN-----QTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTS--DGEVKLIDFGLSAQ 147 (253)
T ss_pred EEecCCCCcHHHHHhhcC-----CCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEcc--CCeEEEeecccccc
Confidence 999999 56666655432 23889999999999999999999999999999999999984 78899999999876
Q ss_pred cCCCc--cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 573 QTDNL--CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 573 ~~~~~--~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
..... ....++..|+|||.+.+..++.++|+||||+++|+|++|+.||
T Consensus 148 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~ 197 (253)
T cd05122 148 LSDTKARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPY 197 (253)
T ss_pred ccccccccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCC
Confidence 65443 4556788999999998888899999999999999999999997
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-28 Score=247.14 Aligned_cols=191 Identities=25% Similarity=0.367 Sum_probs=158.5
Q ss_pred ceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCch-------hhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEe
Q 007035 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD-------FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (621)
Q Consensus 415 rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~-------~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~ 487 (621)
+|++.+.||+|+||+||+|.+ .+++.+|+|.+..... ....+.+|+.+++.+ +|+||+++++++..
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l------~~~~i~~~~~~~~~ 73 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSL------KHVNIVQYLGTCLD 73 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhc------CCCCEeeEeeEeec
Confidence 578899999999999999986 5889999998875321 223455666666655 46799999999999
Q ss_pred cCeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEe
Q 007035 488 LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (621)
Q Consensus 488 ~~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~D 566 (621)
....++||||+.+ +|.+++.... .+++..++.++.||+.||.|||+.+|+|+||+|+||+++ .++.++|+|
T Consensus 74 ~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~--~~~~~~l~d 145 (265)
T cd06631 74 DNTISIFMEFVPGGSISSILNRFG------PLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLM--PNGIIKLID 145 (265)
T ss_pred CCeEEEEEecCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEEC--CCCeEEecc
Confidence 9999999999986 6666654322 278889999999999999999999999999999999998 478899999
Q ss_pred cCCccccCC---------CccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 567 LGSSCFQTD---------NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 567 FGls~~~~~---------~~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
||++..... ......++..|+|||++.+..++.++|+||||+++|+|++|+.||
T Consensus 146 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~ 208 (265)
T cd06631 146 FGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPL 208 (265)
T ss_pred chhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCcc
Confidence 998764321 122345788899999999888999999999999999999999998
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-28 Score=256.19 Aligned_cols=204 Identities=25% Similarity=0.369 Sum_probs=163.0
Q ss_pred eeecCceEEEEEeccCCCCceeEEEeCCC-------CcEEEEEEEecCc--hhhhhHHHHHHHHHHhcccCCCCCCceEE
Q 007035 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHT-------GVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILR 480 (621)
Q Consensus 410 ~ii~~rY~I~~~LG~G~fG~Vyka~d~~t-------g~~VAlKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~hpnIvr 480 (621)
++...+|++.+.||+|+||.||++++... +..||+|+++... .....+.+|+.+++.+. .||||++
T Consensus 8 ~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-----~h~~iv~ 82 (334)
T cd05100 8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIG-----KHKNIIN 82 (334)
T ss_pred ccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhc-----CCCCeee
Confidence 34456899999999999999999986432 3468999887532 23456778888887774 3789999
Q ss_pred EeeEeEecCeEEEEEecccc-chHHHHHhhhcc----------CCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCC
Q 007035 481 LYDYFYHLEHLFIVCELLRA-NLYEFQKFNQES----------GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKP 549 (621)
Q Consensus 481 l~~~f~~~~~l~LVmEyl~g-sLld~l~~~~~~----------~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP 549 (621)
+++++.....+++||||+++ +|.+++...... .....++...+..++.||+.||.|||++||+||||||
T Consensus 83 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp 162 (334)
T cd05100 83 LLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAA 162 (334)
T ss_pred eeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeecccccc
Confidence 99999999999999999975 777776543211 1223477888999999999999999999999999999
Q ss_pred ccEEEeccCCCeEEEEecCCccccCCCc-----cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 550 ENILIKSYQRCEIKIIDLGSSCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 550 ~NILl~~~~~~~IKL~DFGls~~~~~~~-----~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
+|||++. ++.+||+|||++....... ....++..|+|||++.+..++.++||||||+++|+|++ |..||
T Consensus 163 ~Nill~~--~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~ 237 (334)
T cd05100 163 RNVLVTE--DNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY 237 (334)
T ss_pred ceEEEcC--CCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCC
Confidence 9999984 7889999999986543321 11223457999999999889999999999999999998 88886
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.1e-28 Score=242.83 Aligned_cols=196 Identities=28% Similarity=0.415 Sum_probs=162.8
Q ss_pred ceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecC---chhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEe--cC
Q 007035 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH--LE 489 (621)
Q Consensus 415 rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~---~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~--~~ 489 (621)
+|++++.||.|+||.||++.+..++..+|+|++... ....+++..|+.+++.+ .|+||+++++.+.. ..
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l------~~~~i~~~~~~~~~~~~~ 74 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILREL------KHPNIVRYYDRIIDRSNQ 74 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhc------CCCccceeeeeeecCCCC
Confidence 588999999999999999999999999999998753 22344566677777666 46799999998764 45
Q ss_pred eEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHH-----HCCeecccCCCccEEEeccCCCeEE
Q 007035 490 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLH-----SLGIIHCDLKPENILIKSYQRCEIK 563 (621)
Q Consensus 490 ~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLH-----s~gIvHrDLKP~NILl~~~~~~~IK 563 (621)
.++++|||+++ +|.+.+..... ....+++..++.++.||+.||.||| +.+++|+||+|+||+++. ++.++
T Consensus 75 ~~~~~~e~~~~~~L~~~l~~~~~--~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~--~~~~k 150 (265)
T cd08217 75 TLYIVMEYCEGGDLAQLIQKCKK--ERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDA--NNNVK 150 (265)
T ss_pred EEEEEehhccCCCHHHHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEec--CCCEE
Confidence 78999999985 67777654322 1223888999999999999999999 889999999999999984 78999
Q ss_pred EEecCCccccCCCc---cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 564 IIDLGSSCFQTDNL---CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 564 L~DFGls~~~~~~~---~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
|+|||++....... ....+++.|+|||.+.+..++.++|+||||+++|+|++|+.||
T Consensus 151 l~d~g~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~ 210 (265)
T cd08217 151 LGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPF 210 (265)
T ss_pred EecccccccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcc
Confidence 99999887654332 2346788999999999888999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.1e-28 Score=249.63 Aligned_cols=202 Identities=20% Similarity=0.303 Sum_probs=158.2
Q ss_pred eecCceEEEEEeccCCCCceeEEEeC-----CCCcEEEEEEEecCchh--hhhHHHHHHHHHHhcccCCCCCCceEEEee
Q 007035 411 VIAGRYYVTEYLGSAAFSKVFQAQDL-----HTGVDVCLKIIKNDKDF--FDQSLDEIKLLKLVNKNDPADEHHILRLYD 483 (621)
Q Consensus 411 ii~~rY~I~~~LG~G~fG~Vyka~d~-----~tg~~VAlKii~~~~~~--~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~ 483 (621)
+..++|++.+.||+|+||.||+|.++ ..+..||+|.+...... ...+.+|+.+++.+ +||||+++++
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l------~~~~i~~~~~ 76 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGF------TCHHVVRLLG 76 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhC------CCCCeeeEEE
Confidence 44678999999999999999999754 23567999988654321 22344555555544 4789999999
Q ss_pred EeEecCeEEEEEeccc-cchHHHHHhhhcc----CCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccC
Q 007035 484 YFYHLEHLFIVCELLR-ANLYEFQKFNQES----GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQ 558 (621)
Q Consensus 484 ~f~~~~~l~LVmEyl~-gsLld~l~~~~~~----~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~ 558 (621)
++......++||||+. ++|.+++...... .....++...+..++.||+.||.|||+++|+||||||+|||++.
T Consensus 77 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~-- 154 (288)
T cd05061 77 VVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAH-- 154 (288)
T ss_pred EEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcC--
Confidence 9999999999999997 5777777543211 11223566788899999999999999999999999999999984
Q ss_pred CCeEEEEecCCccccCCCc-----cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 559 RCEIKIIDLGSSCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 559 ~~~IKL~DFGls~~~~~~~-----~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
++.++|+|||++....... ....++..|+|||.+.+..++.++|||||||++|||++ |+.||
T Consensus 155 ~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~ 222 (288)
T cd05061 155 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPY 222 (288)
T ss_pred CCcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCC
Confidence 7889999999886433211 11234567999999998889999999999999999998 78887
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-28 Score=258.94 Aligned_cols=194 Identities=27% Similarity=0.486 Sum_probs=160.0
Q ss_pred cCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc-hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEec---
Q 007035 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL--- 488 (621)
Q Consensus 413 ~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~-~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~--- 488 (621)
..+|.+.+.||.|+||.||+|.++.+|..||+|.+.... .......+|+.+++.++ ||||+++++.+...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~------h~~i~~~~~~~~~~~~~ 77 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLD------HDNIVKVYEVLGPSGSD 77 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcC------CCcchhhHhhhcccccc
Confidence 579999999999999999999999999999999886543 33455677888877664 67899998776543
Q ss_pred -----------CeEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEecc
Q 007035 489 -----------EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSY 557 (621)
Q Consensus 489 -----------~~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~ 557 (621)
...++||||++++|.+.+... .+++..++.++.||+.||.|||+.||+||||||+||+++.
T Consensus 78 ~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~-------~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~- 149 (342)
T cd07854 78 LTEDVGSLTELNSVYIVQEYMETDLANVLEQG-------PLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINT- 149 (342)
T ss_pred cccccccccccceEEEEeecccccHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcC-
Confidence 368999999998877666421 2788999999999999999999999999999999999975
Q ss_pred CCCeEEEEecCCccccCCC------ccccccCCcccCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 558 QRCEIKIIDLGSSCFQTDN------LCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 558 ~~~~IKL~DFGls~~~~~~------~~~~~gt~~Y~APEvl~~-~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
.++.++|+|||++...... .....++..|+|||++.. ..++.++|||||||++|+|++|+.||
T Consensus 150 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf 219 (342)
T cd07854 150 EDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLF 219 (342)
T ss_pred CCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCC
Confidence 4567999999998654321 122356788999998755 45788999999999999999999998
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=269.35 Aligned_cols=194 Identities=31% Similarity=0.504 Sum_probs=168.4
Q ss_pred cCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCch---hhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecC
Q 007035 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD---FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (621)
Q Consensus 413 ~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~---~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~ 489 (621)
.+.|.++.+||+|.|++|.++++..++..||||++.+... ......+|+++++.+ .||||++++.+.....
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l------~HPnIvkl~~v~~t~~ 128 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSL------NHPNIVKLFSVIETEA 128 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhc------CCcceeeeeeeeeecc
Confidence 4679999999999999999999999999999999987532 234456677777666 4789999999999999
Q ss_pred eEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecC
Q 007035 490 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (621)
Q Consensus 490 ~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFG 568 (621)
.+|+||||..+ .+.+++..... ..+..++.++.|++.|++|||+++|||||||++||||+. +..+||+|||
T Consensus 129 ~lylV~eya~~ge~~~yl~~~gr------~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~--~mnikIaDfg 200 (596)
T KOG0586|consen 129 TLYLVMEYASGGELFDYLVKHGR------MKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDE--NMNIKIADFG 200 (596)
T ss_pred eeEEEEEeccCchhHHHHHhccc------chhhhhhhhhHHHHHHHHHHhhcceeccccchhhccccc--ccceeeeccc
Confidence 99999999974 67777766544 556889999999999999999999999999999999994 6779999999
Q ss_pred CccccCC--CccccccCCcccCchhhcCCCC-CchhhHHHHHHHHHHHHhCCCCC
Q 007035 569 SSCFQTD--NLCLYVQSRSYRAPEVIIGLPY-DQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 569 ls~~~~~--~~~~~~gt~~Y~APEvl~~~~~-s~ksDIWSLGvILyELltG~~PF 620 (621)
++..... .....+|++.|.|||++.+..| +..+|+||||++||-|+.|.+||
T Consensus 201 fS~~~~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPF 255 (596)
T KOG0586|consen 201 FSTFFDYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPF 255 (596)
T ss_pred cceeecccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeeccccc
Confidence 9976543 3556899999999999999886 57899999999999999999998
|
|
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-28 Score=251.05 Aligned_cols=200 Identities=24% Similarity=0.330 Sum_probs=160.1
Q ss_pred cCceEEEEEeccCCCCceeEEEeCC----------------CCcEEEEEEEecCc--hhhhhHHHHHHHHHHhcccCCCC
Q 007035 413 AGRYYVTEYLGSAAFSKVFQAQDLH----------------TGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPAD 474 (621)
Q Consensus 413 ~~rY~I~~~LG~G~fG~Vyka~d~~----------------tg~~VAlKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~ 474 (621)
.++|++.+.||.|+||.||++.+.. ++..+|+|++.... .....+.+|+.+++.++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~------ 77 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLK------ 77 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCC------
Confidence 4689999999999999999986432 34579999987542 23456778888877764
Q ss_pred CCceEEEeeEeEecCeEEEEEeccc-cchHHHHHhhhccC-----CCccccHHHHHHHHHHHHHHHHHHHHCCeecccCC
Q 007035 475 EHHILRLYDYFYHLEHLFIVCELLR-ANLYEFQKFNQESG-----GEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLK 548 (621)
Q Consensus 475 hpnIvrl~~~f~~~~~l~LVmEyl~-gsLld~l~~~~~~~-----~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLK 548 (621)
|+||+++++++......++||||+. ++|.+++....... ....+++..+..++.||+.||+|||+.+|+|||||
T Consensus 78 ~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlk 157 (296)
T cd05095 78 DPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLA 157 (296)
T ss_pred CCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCC
Confidence 6799999999999999999999997 47777665432111 11237778899999999999999999999999999
Q ss_pred CccEEEeccCCCeEEEEecCCccccCCCc-----cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh--CCCCC
Q 007035 549 PENILIKSYQRCEIKIIDLGSSCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT--GEVCL 620 (621)
Q Consensus 549 P~NILl~~~~~~~IKL~DFGls~~~~~~~-----~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt--G~~PF 620 (621)
|+|||++. ++.++|+|||++....... .....++.|++||...+..++.++|||||||++|||++ |..||
T Consensus 158 p~Nili~~--~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~ 234 (296)
T cd05095 158 TRNCLVGK--NYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPY 234 (296)
T ss_pred hheEEEcC--CCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCc
Confidence 99999984 7889999999986543221 11233567999999988889999999999999999998 77776
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-28 Score=244.90 Aligned_cols=191 Identities=27% Similarity=0.422 Sum_probs=158.5
Q ss_pred CceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeEEE
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFI 493 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l~L 493 (621)
++|++.+.||+|+||.||++. .+++.||+|.++.+.. ...+.+|+.+++.+ .||||+++++++... ..++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~~-~~~~~~e~~~l~~~------~~~~i~~~~~~~~~~-~~~~ 75 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDVT-AQAFLEETAVMTKL------HHKNLVRLLGVILHN-GLYI 75 (254)
T ss_pred HHceeeeeeccCCCCceEecc--cCCCceEEEeecCcch-HHHHHHHHHHHHhC------CCCCcCeEEEEEcCC-CcEE
Confidence 679999999999999999986 5788999999876432 35667777777665 478999999998765 4799
Q ss_pred EEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCccc
Q 007035 494 VCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF 572 (621)
Q Consensus 494 VmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~~ 572 (621)
||||+.+ +|.+++..... ..+++..+..++.||+.||.|||+.|++||||||+||+++. ++.++|+|||++..
T Consensus 76 v~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~--~~~~kl~Dfg~~~~ 149 (254)
T cd05083 76 VMELMSKGNLVNFLRTRGR----ALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSE--DGVAKVSDFGLARV 149 (254)
T ss_pred EEECCCCCCHHHHHHhcCc----CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcC--CCcEEECCCcccee
Confidence 9999984 77777754322 23788889999999999999999999999999999999984 78899999999865
Q ss_pred cCCCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 573 QTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 573 ~~~~~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
..........+..|+|||.+.+..++.++|+||||+++|+|++ |++||
T Consensus 150 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~ 198 (254)
T cd05083 150 GSMGVDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPY 198 (254)
T ss_pred ccccCCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCC
Confidence 4433333344667999999988889999999999999999998 99987
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.9e-28 Score=242.98 Aligned_cols=193 Identities=22% Similarity=0.361 Sum_probs=160.5
Q ss_pred CceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeEEE
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFI 493 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l~L 493 (621)
.+|++.+.||.|+||.||++.+. .+..+|+|++.........+.+|+++++.+. ||+|+++++++......++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~------~~~i~~~~~~~~~~~~~~~ 76 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMSEEDFIEEAQVMMKLS------HPKLVQLYGVCTERSPICL 76 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCCHHHHHHHHHHHHhCC------CCCeeeEEEEEccCCceEE
Confidence 47899999999999999999875 4778999998765544456778888888764 6799999999999999999
Q ss_pred EEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCccc
Q 007035 494 VCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF 572 (621)
Q Consensus 494 VmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~~ 572 (621)
||||+.+ +|.+.+.... ..+++..++.++.|++.||.+||+.+++|+||||+||+++ .++.++|+|||++..
T Consensus 77 v~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~--~~~~~~l~d~g~~~~ 149 (256)
T cd05112 77 VFEFMEHGCLSDYLRAQR-----GKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVG--ENQVVKVSDFGMTRF 149 (256)
T ss_pred EEEcCCCCcHHHHHHhCc-----cCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEc--CCCeEEECCCcceee
Confidence 9999986 5555554322 1278888999999999999999999999999999999998 477899999998865
Q ss_pred cCCCcc----ccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 573 QTDNLC----LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 573 ~~~~~~----~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
...... ...++..|+|||.+.+..++.++||||||+++|+|++ |+.||
T Consensus 150 ~~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~ 202 (256)
T cd05112 150 VLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPY 202 (256)
T ss_pred cccCcccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCC
Confidence 433211 1233567999999998889999999999999999998 99997
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.3e-28 Score=246.24 Aligned_cols=196 Identities=24% Similarity=0.334 Sum_probs=158.8
Q ss_pred cCceEEEEEeccCCCCceeEEEeCCCCc---EEEEEEEecCc--hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEe
Q 007035 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGV---DVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (621)
Q Consensus 413 ~~rY~I~~~LG~G~fG~Vyka~d~~tg~---~VAlKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~ 487 (621)
..+|++.+.||.|+||.||+|.++.++. .+|+|.++... .....+..|+.+++.+ +||||+++++++..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~~ 76 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQF------DHPNIIHLEGVVTK 76 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhC------CCCCcceEEEEEec
Confidence 3679999999999999999999865543 69999886532 2234566677666655 47899999999999
Q ss_pred cCeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEe
Q 007035 488 LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (621)
Q Consensus 488 ~~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~D 566 (621)
.+..++||||+++ +|.+++.... ..+++..+..++.|++.||.+||+++++||||||+|||++. ++.++|+|
T Consensus 77 ~~~~~lv~e~~~~~~L~~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~--~~~~~l~d 149 (267)
T cd05066 77 SKPVMIVTEYMENGSLDAFLRKHD-----GQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNS--NLVCKVSD 149 (267)
T ss_pred CCccEEEEEcCCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECC--CCeEEeCC
Confidence 9999999999985 6666664332 12788899999999999999999999999999999999984 78899999
Q ss_pred cCCccccCCCcc------ccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCC
Q 007035 567 LGSSCFQTDNLC------LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCLI 621 (621)
Q Consensus 567 FGls~~~~~~~~------~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF~ 621 (621)
||++........ ...++..|+|||.+.+..++.++|+||||+++|+|++ |+.||.
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~ 211 (267)
T cd05066 150 FGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYW 211 (267)
T ss_pred CCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcc
Confidence 998865433211 1122457999999998889999999999999999886 999973
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.5e-28 Score=245.72 Aligned_cols=195 Identities=25% Similarity=0.352 Sum_probs=159.8
Q ss_pred cCceEEEEEeccCCCCceeEEEeCCC---CcEEEEEEEecCc--hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEe
Q 007035 413 AGRYYVTEYLGSAAFSKVFQAQDLHT---GVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (621)
Q Consensus 413 ~~rY~I~~~LG~G~fG~Vyka~d~~t---g~~VAlKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~ 487 (621)
.++|++.+.||+|+||+||+|.+... ...||+|+++... .....+.+|+.+++.+ +||||+++++.+..
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~~ 76 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQF------DHPNIIRLEGVVTK 76 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhC------CCCCcceEeEEEec
Confidence 35799999999999999999997654 4579999887543 2234556677776655 47899999999999
Q ss_pred cCeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEe
Q 007035 488 LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (621)
Q Consensus 488 ~~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~D 566 (621)
.+..++||||+.+ +|.+++..... .+++..+..++.|++.||.|||+++|+||||||+|||++. ++.++|+|
T Consensus 77 ~~~~~iv~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~--~~~~~l~d 149 (266)
T cd05033 77 SRPVMIITEYMENGSLDKFLRENDG-----KFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNS--NLVCKVSD 149 (266)
T ss_pred CCceEEEEEcCCCCCHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcC--CCCEEECc
Confidence 9999999999985 67666654321 3889999999999999999999999999999999999984 78899999
Q ss_pred cCCccccCCCc---c--ccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 567 LGSSCFQTDNL---C--LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 567 FGls~~~~~~~---~--~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
||++....... . ...+++.|+|||.+.+..++.++||||||+++|+|++ |..||
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~ 209 (266)
T cd05033 150 FGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPY 209 (266)
T ss_pred cchhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCC
Confidence 99987654111 1 1223567999999998889999999999999999998 99987
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=248.96 Aligned_cols=194 Identities=33% Similarity=0.413 Sum_probs=164.5
Q ss_pred CceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc--hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeE
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l 491 (621)
++|++.+.||.|++|.||++.++.+++.+++|.+.... ....++.+|+.+++.+. ||||+++++.+......
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~------~~~i~~~~~~~~~~~~~ 74 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCN------SPYIVGFYGAFYNNGDI 74 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCC------CCchhhhheeeecCCEE
Confidence 36788899999999999999999999999999987653 33345667777766553 78999999999999999
Q ss_pred EEEEeccc-cchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHH-CCeecccCCCccEEEeccCCCeEEEEecCC
Q 007035 492 FIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS-LGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (621)
Q Consensus 492 ~LVmEyl~-gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs-~gIvHrDLKP~NILl~~~~~~~IKL~DFGl 569 (621)
++|+||++ ++|.+++.... ..+++..+..++.||+.||.|||+ .+++|+||+|+||+++. ++.++|+|||.
T Consensus 75 ~lv~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~--~~~~~l~d~g~ 147 (265)
T cd06605 75 SICMEYMDGGSLDKILKEVQ-----GRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNS--RGQIKLCDFGV 147 (265)
T ss_pred EEEEEecCCCcHHHHHHHcc-----CCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECC--CCCEEEeeccc
Confidence 99999999 57777665432 238889999999999999999999 99999999999999995 78899999998
Q ss_pred ccccCCC-ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 570 SCFQTDN-LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 570 s~~~~~~-~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
+...... .....++..|+|||.+.+..++.++||||||+++|+|++|+.||
T Consensus 148 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~ 199 (265)
T cd06605 148 SGQLVNSLAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPY 199 (265)
T ss_pred chhhHHHHhhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 7654322 12256788999999999989999999999999999999999998
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.6e-28 Score=246.75 Aligned_cols=193 Identities=24% Similarity=0.318 Sum_probs=156.0
Q ss_pred EeccCCCCceeEEEeCCCCc--EEEEEEEecC--chhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeEEEEEe
Q 007035 421 YLGSAAFSKVFQAQDLHTGV--DVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCE 496 (621)
Q Consensus 421 ~LG~G~fG~Vyka~d~~tg~--~VAlKii~~~--~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l~LVmE 496 (621)
.||+|+||.||+|++..++. .+++|.++.. ......+..|+.++.++. .||||+++++++.....+++|||
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~-----~h~~iv~~~~~~~~~~~~~lv~e 76 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG-----HHPNIINLLGACEHRGYLYLAIE 76 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhc-----cCCCeeeEEEEEecCCCceEEEE
Confidence 58999999999999888876 4688887642 334456777888887774 47899999999999999999999
Q ss_pred ccc-cchHHHHHhhhcc----------CCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEE
Q 007035 497 LLR-ANLYEFQKFNQES----------GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKII 565 (621)
Q Consensus 497 yl~-gsLld~l~~~~~~----------~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~ 565 (621)
|+. ++|.+++...... .....+++..+..++.|++.||+|||+.+++||||||+|||++ .++.+||+
T Consensus 77 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~--~~~~~kl~ 154 (270)
T cd05047 77 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG--ENYVAKIA 154 (270)
T ss_pred eCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEc--CCCeEEEC
Confidence 997 5787777643211 1122478899999999999999999999999999999999998 47889999
Q ss_pred ecCCccccCCCcc--ccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 566 DLGSSCFQTDNLC--LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 566 DFGls~~~~~~~~--~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
|||++........ ....+..|+|||++.+..++.++|||||||++|+|++ |+.||
T Consensus 155 dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf 212 (270)
T cd05047 155 DFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY 212 (270)
T ss_pred CCCCccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCc
Confidence 9999753221111 1123557999999988889999999999999999997 99997
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-28 Score=247.66 Aligned_cols=194 Identities=31% Similarity=0.492 Sum_probs=164.3
Q ss_pred CceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc----hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecC
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~ 489 (621)
++|.+.+.||+|+||.||++.+..+++.|++|++.... ........|..+++.+. .|+||+++++++...+
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~-----~~~~i~~~~~~~~~~~ 75 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLN-----GHPGIIKLYYTFQDEE 75 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcc-----cCCCchhHHHHhcCCc
Confidence 47999999999999999999999999999999987532 22345566677766664 4789999999999999
Q ss_pred eEEEEEeccc-cchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecC
Q 007035 490 HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (621)
Q Consensus 490 ~l~LVmEyl~-gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFG 568 (621)
..++||||+. ++|.+.+.... .+++..++.++.||+.||.+||+.+++|+||+|+||+++. ++.++|+|||
T Consensus 76 ~~~lv~e~~~~~~L~~~l~~~~------~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~--~~~~~l~df~ 147 (280)
T cd05581 76 NLYFVLEYAPNGELLQYIRKYG------SLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDK--DMHIKITDFG 147 (280)
T ss_pred eEEEEEcCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECC--CCCEEecCCc
Confidence 9999999995 67777775432 2889999999999999999999999999999999999984 7889999999
Q ss_pred CccccCCCc-----------------------cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 569 SSCFQTDNL-----------------------CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 569 ls~~~~~~~-----------------------~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
++....... ....++..|+|||++....++.++||||||+++++|++|+.||
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~ 222 (280)
T cd05581 148 TAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPF 222 (280)
T ss_pred cccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCC
Confidence 876543322 1235678899999998888899999999999999999999997
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.1e-29 Score=240.57 Aligned_cols=199 Identities=28% Similarity=0.412 Sum_probs=164.2
Q ss_pred cCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc--hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCe
Q 007035 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (621)
Q Consensus 413 ~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~ 490 (621)
.+...-+..||+|++|.|=+.++..+|...|+|.++..- ....+.++|+.+..+ ..+.|+++++|+.+.....
T Consensus 45 ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r-----~~~CPf~V~FyGa~~regd 119 (282)
T KOG0984|consen 45 ADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMR-----TVDCPFTVHFYGALFREGD 119 (282)
T ss_pred hhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhcc-----CCCCCeEEEeehhhhcccc
Confidence 345566677999999999999999999999999987532 223344444444332 3578999999999999999
Q ss_pred EEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHC-CeecccCCCccEEEeccCCCeEEEEecCC
Q 007035 491 LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSL-GIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (621)
Q Consensus 491 l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~-gIvHrDLKP~NILl~~~~~~~IKL~DFGl 569 (621)
++|.||.+..+|..+...--..+. .+++..+..|+..++.||.|||++ .|+|||+||+||||+ ..|++||+|||.
T Consensus 120 vwIcME~M~tSldkfy~~v~~~g~--~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn--~~GqVKiCDFGI 195 (282)
T KOG0984|consen 120 VWICMELMDTSLDKFYRKVLKKGG--TIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILIN--YDGQVKICDFGI 195 (282)
T ss_pred EEEeHHHhhhhHHHHHHHHHhcCC--cCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEc--cCCcEEEccccc
Confidence 999999999888777665433332 388999999999999999999976 899999999999999 599999999999
Q ss_pred ccccCCCc--cccccCCcccCchhhcC----CCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 570 SCFQTDNL--CLYVQSRSYRAPEVIIG----LPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 570 s~~~~~~~--~~~~gt~~Y~APEvl~~----~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
+....+.. +...|...|+|||.+.. ..|+.++||||||+++.||.+++.||
T Consensus 196 sG~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY 252 (282)
T KOG0984|consen 196 SGYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPY 252 (282)
T ss_pred ceeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccc
Confidence 98776543 23577889999999853 36899999999999999999999997
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-29 Score=236.65 Aligned_cols=193 Identities=31% Similarity=0.466 Sum_probs=168.1
Q ss_pred ceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc---hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeE
Q 007035 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (621)
Q Consensus 415 rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~---~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l 491 (621)
.|...++||.|.||+|+++++..+++.||+|.++.+. ......++|+-++++++ |.||+++++.....+.+
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelk------hknivrl~dvlhsdkkl 76 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELK------HKNIVRLHDVLHSDKKL 76 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhh------hcceeehhhhhccCcee
Confidence 4667789999999999999999999999999998643 34567899999999996 55899999999999999
Q ss_pred EEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCcc
Q 007035 492 FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 571 (621)
Q Consensus 492 ~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~ 571 (621)
-+|+|||...|..+....+. .+....++.++.|+++||.|+|+.++.||||||.|+||+ .+|.+||+|||+++
T Consensus 77 tlvfe~cdqdlkkyfdslng-----~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin--~ngelkladfglar 149 (292)
T KOG0662|consen 77 TLVFEFCDQDLKKYFDSLNG-----DLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLIN--RNGELKLADFGLAR 149 (292)
T ss_pred EEeHHHhhHHHHHHHHhcCC-----cCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEec--cCCcEEecccchhh
Confidence 99999999888887765433 278889999999999999999999999999999999999 58999999999998
Q ss_pred ccCCCcc---ccccCCcccCchhhcCCC-CCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 572 FQTDNLC---LYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 572 ~~~~~~~---~~~gt~~Y~APEvl~~~~-~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
-.+-+.. ..+-|.+|++|.++.+.. |+...|+||.|||+.|+.. |+++|
T Consensus 150 afgipvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplf 203 (292)
T KOG0662|consen 150 AFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF 203 (292)
T ss_pred hcCCceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCC
Confidence 7665542 245689999999999876 8999999999999999986 66655
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.96 E-value=6e-28 Score=249.05 Aligned_cols=198 Identities=25% Similarity=0.383 Sum_probs=158.3
Q ss_pred ceEEEEEeccCCCCceeEEEeCC-----CCcEEEEEEEecCch--hhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEe
Q 007035 415 RYYVTEYLGSAAFSKVFQAQDLH-----TGVDVCLKIIKNDKD--FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (621)
Q Consensus 415 rY~I~~~LG~G~fG~Vyka~d~~-----tg~~VAlKii~~~~~--~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~ 487 (621)
+|++.+.||+|+||.||+|.+.. ....+++|.+..... ...++.+|+.+++.+ .||||+++++.+..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l------~h~~iv~~~~~~~~ 74 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV------NHPHVIKLYGACSQ 74 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhC------CCCCEeeEEEEEec
Confidence 47889999999999999998753 235689998875432 234566777777765 47899999999999
Q ss_pred cCeEEEEEeccc-cchHHHHHhhhcc------------------CCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCC
Q 007035 488 LEHLFIVCELLR-ANLYEFQKFNQES------------------GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLK 548 (621)
Q Consensus 488 ~~~l~LVmEyl~-gsLld~l~~~~~~------------------~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLK 548 (621)
.+..++||||+. ++|.+++...... .....+++..+..++.|++.||.|||+.+|+|||||
T Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dik 154 (290)
T cd05045 75 DGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLA 154 (290)
T ss_pred CCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhh
Confidence 999999999998 4666665432111 112237888899999999999999999999999999
Q ss_pred CccEEEeccCCCeEEEEecCCccccCCCc-----cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 549 PENILIKSYQRCEIKIIDLGSSCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 549 P~NILl~~~~~~~IKL~DFGls~~~~~~~-----~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
|+|||++. ++.++|+|||++....... ....++..|+|||.+.+..++.++||||||+++|+|++ |+.||
T Consensus 155 p~nill~~--~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~ 230 (290)
T cd05045 155 ARNVLVAE--GRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY 230 (290)
T ss_pred hheEEEcC--CCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCC
Confidence 99999984 7789999999986532221 12234668999999988889999999999999999998 98887
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-28 Score=251.31 Aligned_cols=195 Identities=30% Similarity=0.494 Sum_probs=160.3
Q ss_pred cCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCch---hhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEec-
Q 007035 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD---FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL- 488 (621)
Q Consensus 413 ~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~---~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~- 488 (621)
.++|++.+.||.|+||.||+|.+..+++.+|+|++..... ......+|+++++.++ ||||+++++.+...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~~ 80 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLK------HPNVVPLIDMAVERP 80 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcC------CCCccchhhheeccc
Confidence 5789999999999999999999999999999998864321 2234567888877664 67899999987543
Q ss_pred -------CeEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCe
Q 007035 489 -------EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCE 561 (621)
Q Consensus 489 -------~~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~ 561 (621)
..+++||||+.+++...+.... ..+++..++.++.||++||.|||++||+|+||||+||+++. ++.
T Consensus 81 ~~~~~~~~~~~lv~~~~~~~l~~~~~~~~-----~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~--~~~ 153 (311)
T cd07866 81 DKSKRKRGSVYMVTPYMDHDLSGLLENPS-----VKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDN--QGI 153 (311)
T ss_pred ccccccCceEEEEEecCCcCHHHHHhccc-----cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECC--CCC
Confidence 3579999999988877765432 23889999999999999999999999999999999999984 788
Q ss_pred EEEEecCCccccCCCc--------------cccccCCcccCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 562 IKIIDLGSSCFQTDNL--------------CLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 562 IKL~DFGls~~~~~~~--------------~~~~gt~~Y~APEvl~~~-~~s~ksDIWSLGvILyELltG~~PF 620 (621)
++|+|||++....... ....+++.|+|||.+.+. .++.++|||||||++|+|++|++||
T Consensus 154 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~ 227 (311)
T cd07866 154 LKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPIL 227 (311)
T ss_pred EEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCC
Confidence 9999999886533211 123457789999998654 4789999999999999999999987
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-28 Score=257.03 Aligned_cols=192 Identities=39% Similarity=0.585 Sum_probs=164.9
Q ss_pred ceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecC---chhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecC--
Q 007035 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE-- 489 (621)
Q Consensus 415 rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~---~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~-- 489 (621)
+|++.+.||.|++|.||+|++..+++.||+|.+... ......+.+|+.+++.++ |+||+++++++....
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~------~~~i~~~~~~~~~~~~~ 74 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLR------HENIIGLLDILRPPSPE 74 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcC------CcchhhhhhhhcccCcc
Confidence 689999999999999999999999999999988753 233456777888777664 789999999988775
Q ss_pred ---eEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEe
Q 007035 490 ---HLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (621)
Q Consensus 490 ---~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~D 566 (621)
.+++||||+++++.+.+.... .+++..++.++.||+.||.+||+.||+||||||.|||++. ++.++|+|
T Consensus 75 ~~~~~~lv~e~~~~~l~~~l~~~~------~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~--~~~~~L~d 146 (330)
T cd07834 75 DFNDVYIVTELMETDLHKVIKSPQ------PLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNS--NCDLKICD 146 (330)
T ss_pred cccceEEEecchhhhHHHHHhCCC------CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC--CCCEEEcc
Confidence 899999999988777765332 3889999999999999999999999999999999999995 68999999
Q ss_pred cCCccccCCC------ccccccCCcccCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 567 LGSSCFQTDN------LCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 567 FGls~~~~~~------~~~~~gt~~Y~APEvl~~~-~~s~ksDIWSLGvILyELltG~~PF 620 (621)
||++...... .....+++.|+|||++.+. .++.++|+||||+++|+|++|++||
T Consensus 147 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf 207 (330)
T cd07834 147 FGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLF 207 (330)
T ss_pred cCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCc
Confidence 9998765433 2234568889999999887 7899999999999999999999998
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.7e-28 Score=248.56 Aligned_cols=200 Identities=24% Similarity=0.302 Sum_probs=161.5
Q ss_pred cCceEEEEEeccCCCCceeEEEeCCCC----------------cEEEEEEEecCc--hhhhhHHHHHHHHHHhcccCCCC
Q 007035 413 AGRYYVTEYLGSAAFSKVFQAQDLHTG----------------VDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPAD 474 (621)
Q Consensus 413 ~~rY~I~~~LG~G~fG~Vyka~d~~tg----------------~~VAlKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~ 474 (621)
.++|++++.||.|+||.||++.+...+ ..||+|.+.... .....+.+|+++++.++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~------ 77 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLS------ 77 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcC------
Confidence 468999999999999999999876544 568999987643 33456677888877764
Q ss_pred CCceEEEeeEeEecCeEEEEEecccc-chHHHHHhhhcc-----CCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCC
Q 007035 475 EHHILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQES-----GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLK 548 (621)
Q Consensus 475 hpnIvrl~~~f~~~~~l~LVmEyl~g-sLld~l~~~~~~-----~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLK 548 (621)
||||+++++++......++||||+.+ +|.+++...... .....+++..++.++.||+.||.|||+.+|+|||||
T Consensus 78 ~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlk 157 (296)
T cd05051 78 DPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLA 157 (296)
T ss_pred CCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccc
Confidence 67999999999999999999999985 676666543311 011248899999999999999999999999999999
Q ss_pred CccEEEeccCCCeEEEEecCCccccCCC-----ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh--CCCCC
Q 007035 549 PENILIKSYQRCEIKIIDLGSSCFQTDN-----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT--GEVCL 620 (621)
Q Consensus 549 P~NILl~~~~~~~IKL~DFGls~~~~~~-----~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt--G~~PF 620 (621)
|+||+++. ++.++|+|||++...... .....+++.|+|||.+.+..++.++|||||||++|+|++ |..||
T Consensus 158 p~Nili~~--~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~ 234 (296)
T cd05051 158 TRNCLVGK--NYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPY 234 (296)
T ss_pred hhceeecC--CCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCC
Confidence 99999984 689999999998653322 122344678999999988889999999999999999998 66776
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.4e-28 Score=246.76 Aligned_cols=187 Identities=29% Similarity=0.379 Sum_probs=155.8
Q ss_pred eccCCCCceeEEEeCCCCcEEEEEEEecCc----hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeEEEEEec
Q 007035 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCEL 497 (621)
Q Consensus 422 LG~G~fG~Vyka~d~~tg~~VAlKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l~LVmEy 497 (621)
||.|+||+||++.+..+|+.||+|++.... ........|+++++.++ ||||+++++.+...+..|+||||
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~------~~~i~~~~~~~~~~~~~~lv~e~ 74 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVS------SRFIVSLAYAFETKDDLCLVMTL 74 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCC------CCCEeeeeeEEecCCeEEEEEec
Confidence 689999999999999999999999987532 12234456777776664 78999999999999999999999
Q ss_pred ccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCccccCCC
Q 007035 498 LRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN 576 (621)
Q Consensus 498 l~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~~~~~~ 576 (621)
+++ +|.+.+..... ..+++..+..++.|++.||.|||+++++||||+|+||+++. ++.++|+|||.+......
T Consensus 75 ~~~~~L~~~l~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~--~~~~~l~dfg~~~~~~~~ 148 (277)
T cd05577 75 MNGGDLKYHIYNVGE----PGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDD--HGNVRISDLGLAVELKGG 148 (277)
T ss_pred CCCCcHHHHHHHcCc----CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECC--CCCEEEccCcchhhhccC
Confidence 985 66666554332 23889999999999999999999999999999999999984 778999999987654322
Q ss_pred --ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 577 --LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 577 --~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
.....++..|+|||++.+..++.++||||||+++|+|++|+.||
T Consensus 149 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~ 194 (277)
T cd05577 149 KKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPF 194 (277)
T ss_pred CccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCC
Confidence 22345678899999998888999999999999999999999998
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.9e-28 Score=245.87 Aligned_cols=191 Identities=21% Similarity=0.247 Sum_probs=146.9
Q ss_pred EeccCCCCceeEEEeCC--CCcEEEEEEEecCc--hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeEEEEEe
Q 007035 421 YLGSAAFSKVFQAQDLH--TGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCE 496 (621)
Q Consensus 421 ~LG~G~fG~Vyka~d~~--tg~~VAlKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l~LVmE 496 (621)
.||+|+||+||+|.... ....+++|.+.... .....+.+|+.+++.+ +|+||+++++.+......++|||
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l------~h~nii~~~~~~~~~~~~~lv~e 75 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYREL------NHPNVLQCLGQCIESIPYLLVLE 75 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhC------CCCCcceEEEEECCCCceEEEEE
Confidence 58999999999996432 44578888776432 2233455666666544 57899999999999999999999
Q ss_pred cccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCccccCC
Q 007035 497 LLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTD 575 (621)
Q Consensus 497 yl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~~~~~ 575 (621)
|+.+ +|.+++...... ....+++..++.++.||+.||.|||+++|+||||||+|||++. ++.+||+|||++.....
T Consensus 76 ~~~~g~L~~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~--~~~~kl~dfg~~~~~~~ 152 (269)
T cd05042 76 FCPLGDLKNYLRSNRGM-VAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTA--DLSVKIGDYGLALEQYP 152 (269)
T ss_pred eCCCCcHHHHHHhcccc-ccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecC--CCcEEEecccccccccc
Confidence 9985 677766543321 1222567788899999999999999999999999999999984 78899999998754322
Q ss_pred C-----ccccccCCcccCchhhcC-------CCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 576 N-----LCLYVQSRSYRAPEVIIG-------LPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 576 ~-----~~~~~gt~~Y~APEvl~~-------~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
. .....+++.|+|||++.. ..++.++|||||||++|+|++ |+.||
T Consensus 153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~ 210 (269)
T cd05042 153 EDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPY 210 (269)
T ss_pred chheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCC
Confidence 1 122234667999999743 346889999999999999999 77776
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-28 Score=257.24 Aligned_cols=202 Identities=24% Similarity=0.327 Sum_probs=160.1
Q ss_pred ecCceEEEEEeccCCCCceeEEEe-----CCCCcEEEEEEEecCc--hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeE
Q 007035 412 IAGRYYVTEYLGSAAFSKVFQAQD-----LHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDY 484 (621)
Q Consensus 412 i~~rY~I~~~LG~G~fG~Vyka~d-----~~tg~~VAlKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~ 484 (621)
-.++|++.+.||.|+||.||+|.+ ..+++.||||+++... .....+.+|+.++..+. .||||++++++
T Consensus 5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----~h~niv~~~~~ 79 (343)
T cd05103 5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG-----HHLNVVNLLGA 79 (343)
T ss_pred chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhcc-----CCccHhhhcce
Confidence 357899999999999999999984 3567899999997532 23456778888888774 36899999998
Q ss_pred eEec-CeEEEEEecccc-chHHHHHhhhccC-------------------------------------------------
Q 007035 485 FYHL-EHLFIVCELLRA-NLYEFQKFNQESG------------------------------------------------- 513 (621)
Q Consensus 485 f~~~-~~l~LVmEyl~g-sLld~l~~~~~~~------------------------------------------------- 513 (621)
+... ..+++||||+++ +|.+++.......
T Consensus 80 ~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (343)
T cd05103 80 CTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLS 159 (343)
T ss_pred eecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccc
Confidence 7654 568999999985 6776665321100
Q ss_pred ------------CCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCccccCCCc----
Q 007035 514 ------------GEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNL---- 577 (621)
Q Consensus 514 ------------~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~~~~~~~---- 577 (621)
....+++..+..++.||+.||.|||+++|+||||||+|||++. ++.+||+|||++.......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~--~~~~kl~dfg~~~~~~~~~~~~~ 237 (343)
T cd05103 160 DVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE--NNVVKICDFGLARDIYKDPDYVR 237 (343)
T ss_pred cchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcC--CCcEEEEecccccccccCcchhh
Confidence 0123677888899999999999999999999999999999984 7789999999986543221
Q ss_pred -cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 578 -CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 578 -~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
....+++.|+|||.+.+..++.++||||||+++|+|++ |..||
T Consensus 238 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~ 282 (343)
T cd05103 238 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 282 (343)
T ss_pred cCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence 11233567999999998889999999999999999997 88886
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.9e-28 Score=262.62 Aligned_cols=203 Identities=23% Similarity=0.336 Sum_probs=163.5
Q ss_pred eecCceEEEEEeccCCCCceeEEEeC-----CCCcEEEEEEEecCc--hhhhhHHHHHHHHHHhcccCCCCCCceEEEee
Q 007035 411 VIAGRYYVTEYLGSAAFSKVFQAQDL-----HTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYD 483 (621)
Q Consensus 411 ii~~rY~I~~~LG~G~fG~Vyka~d~-----~tg~~VAlKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~ 483 (621)
+-.++|.+.++||.|+||.||+|++. .+++.||+|+++... .....+..|++++..+. .||||+++++
T Consensus 34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~-----~H~niv~~~~ 108 (401)
T cd05107 34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLG-----PHLNIVNLLG 108 (401)
T ss_pred ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcC-----CCCCeEEEEE
Confidence 44567899999999999999999853 456789999997542 22345677888887764 3789999999
Q ss_pred EeEecCeEEEEEeccc-cchHHHHHhhhcc--------------------------------------------------
Q 007035 484 YFYHLEHLFIVCELLR-ANLYEFQKFNQES-------------------------------------------------- 512 (621)
Q Consensus 484 ~f~~~~~l~LVmEyl~-gsLld~l~~~~~~-------------------------------------------------- 512 (621)
++....++++||||+. ++|.+++......
T Consensus 109 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (401)
T cd05107 109 ACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESAD 188 (401)
T ss_pred EEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccC
Confidence 9999999999999998 5787777543210
Q ss_pred ------------------------------------------CCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCc
Q 007035 513 ------------------------------------------GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPE 550 (621)
Q Consensus 513 ------------------------------------------~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~ 550 (621)
.....+++..+..++.||+.||.|||+.+|+||||||+
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~ 268 (401)
T cd05107 189 YVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAAR 268 (401)
T ss_pred ccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcc
Confidence 01123667788899999999999999999999999999
Q ss_pred cEEEeccCCCeEEEEecCCccccCCC-----ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 551 NILIKSYQRCEIKIIDLGSSCFQTDN-----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 551 NILl~~~~~~~IKL~DFGls~~~~~~-----~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
|||++. .+.++|+|||++...... .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||
T Consensus 269 NiLl~~--~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~ 342 (401)
T cd05107 269 NVLICE--GKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPY 342 (401)
T ss_pred eEEEeC--CCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCC
Confidence 999984 788999999998653221 112345778999999998889999999999999999998 88887
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-28 Score=250.60 Aligned_cols=199 Identities=21% Similarity=0.278 Sum_probs=156.7
Q ss_pred CceEEEEEeccCCCCceeEEEeCC-----CCcEEEEEEEecCch--hhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeE
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQDLH-----TGVDVCLKIIKNDKD--FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d~~-----tg~~VAlKii~~~~~--~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~ 486 (621)
.+|++.+.||.|+||.||+|.+.. .+..||+|+++.... ....+..|+.++..+ .||||+++++++.
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l------~h~~iv~~~~~~~ 78 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRL------QHPNIVCLLGVVT 78 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcC------CCCCcCeEEEEEc
Confidence 457888999999999999998754 357899999875432 233455566555544 5789999999999
Q ss_pred ecCeEEEEEecccc-chHHHHHhhhc----------cCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEe
Q 007035 487 HLEHLFIVCELLRA-NLYEFQKFNQE----------SGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIK 555 (621)
Q Consensus 487 ~~~~l~LVmEyl~g-sLld~l~~~~~----------~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~ 555 (621)
.....++++||+.+ +|.+++..... ......+++..+..++.|++.||.|||++||+||||||+|||++
T Consensus 79 ~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~ 158 (283)
T cd05091 79 KEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVF 158 (283)
T ss_pred CCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEec
Confidence 99999999999985 56666542210 01122377888999999999999999999999999999999998
Q ss_pred ccCCCeEEEEecCCccccCCCc-----cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 556 SYQRCEIKIIDLGSSCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 556 ~~~~~~IKL~DFGls~~~~~~~-----~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
+++.+||+|||++....... ....+++.|+|||.+.+..++.++|||||||++|||++ |..||
T Consensus 159 --~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~ 227 (283)
T cd05091 159 --DKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPY 227 (283)
T ss_pred --CCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCC
Confidence 47789999999876543221 12234678999999988889999999999999999998 77776
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.1e-28 Score=245.08 Aligned_cols=192 Identities=31% Similarity=0.457 Sum_probs=155.5
Q ss_pred EEEEEeccCCCCceeEEEeC----CCCcEEEEEEEecCc--hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCe
Q 007035 417 YVTEYLGSAAFSKVFQAQDL----HTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (621)
Q Consensus 417 ~I~~~LG~G~fG~Vyka~d~----~tg~~VAlKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~ 490 (621)
.+.+.||.|.||.||+|... ..+..|+||+++... ...+.+.+|+++++.++ ||||+++++++...+.
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~------h~ni~~~~g~~~~~~~ 75 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLR------HPNIVKLYGFCIENEP 75 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHS------BTTBE-EEEEEESSSS
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccc------cccccccccccccccc
Confidence 56789999999999999987 457889999996532 23567777777777663 6799999999998888
Q ss_pred EEEEEeccc-cchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCC
Q 007035 491 LFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (621)
Q Consensus 491 l~LVmEyl~-gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGl 569 (621)
.++||||+. ++|.+.+..... ..+++..+..|+.||+.||.|||+++++|++|+++||+++. ++.+||+|||+
T Consensus 76 ~~lv~e~~~~g~L~~~L~~~~~----~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~--~~~~Kl~~f~~ 149 (259)
T PF07714_consen 76 LFLVMEYCPGGSLDDYLKSKNK----EPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDS--NGQVKLSDFGL 149 (259)
T ss_dssp EEEEEE--TTEBHHHHHHHTCT----TTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEET--TTEEEEESTTT
T ss_pred cccccccccccccccccccccc----ccccccccccccccccccccccccccccccccccccccccc--ccccccccccc
Confidence 999999998 578888776511 22889999999999999999999999999999999999995 78999999999
Q ss_pred ccccCCCc-----cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 570 SCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 570 s~~~~~~~-----~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
+....... ........|+|||.+....++.++||||||+++|||++ |+.||
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~ 206 (259)
T PF07714_consen 150 SRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPF 206 (259)
T ss_dssp GEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTT
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 87652211 11234667999999998889999999999999999999 77886
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-27 Score=247.00 Aligned_cols=193 Identities=25% Similarity=0.434 Sum_probs=160.3
Q ss_pred ceEEEEEeccCCCCceeEEEeC---CCCcEEEEEEEecCc-----hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeE
Q 007035 415 RYYVTEYLGSAAFSKVFQAQDL---HTGVDVCLKIIKNDK-----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (621)
Q Consensus 415 rY~I~~~LG~G~fG~Vyka~d~---~tg~~VAlKii~~~~-----~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~ 486 (621)
.|++.+.||.|+||.||++++. .+|+.||+|+++... ...+...+|+++++.+. +|++|+++++.+.
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-----~~~~i~~~~~~~~ 75 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR-----QSPFLVTLHYAFQ 75 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcc-----cCCChhceeeEee
Confidence 4889999999999999999875 478999999987532 23355667888887775 3689999999999
Q ss_pred ecCeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEE
Q 007035 487 HLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKII 565 (621)
Q Consensus 487 ~~~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~ 565 (621)
.....++||||+.+ +|.+.+.... .+++..+..++.||+.||.|||+.+++||||+|+|||++. ++.++|+
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~--~~~~kl~ 147 (290)
T cd05613 76 TDTKLHLILDYINGGELFTHLSQRE------RFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDS--NGHVVLT 147 (290)
T ss_pred cCCeEEEEEecCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECC--CCCEEEe
Confidence 99999999999985 6766665432 2788899999999999999999999999999999999984 7889999
Q ss_pred ecCCccccCCC----ccccccCCcccCchhhcCC--CCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 566 DLGSSCFQTDN----LCLYVQSRSYRAPEVIIGL--PYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 566 DFGls~~~~~~----~~~~~gt~~Y~APEvl~~~--~~s~ksDIWSLGvILyELltG~~PF 620 (621)
|||++...... .....++..|+|||.+... .++.++||||||+++|+|++|+.||
T Consensus 148 dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~ 208 (290)
T cd05613 148 DFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPF 208 (290)
T ss_pred eCccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCC
Confidence 99988654332 1234578899999998753 3678999999999999999999997
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-27 Score=245.77 Aligned_cols=194 Identities=24% Similarity=0.348 Sum_probs=158.9
Q ss_pred cCceEEEEEeccCCCCceeEEEeCCCCc----EEEEEEEecCch--hhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeE
Q 007035 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGV----DVCLKIIKNDKD--FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (621)
Q Consensus 413 ~~rY~I~~~LG~G~fG~Vyka~d~~tg~----~VAlKii~~~~~--~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~ 486 (621)
..+|++.+.||+|+||+||+|.++.+|+ .+|+|.+..... ....+.+|+.+++.+ .||||+++++++.
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~ 79 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASV------DHPHVVRLLGICL 79 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhC------CCCCcceEEEEEe
Confidence 4689999999999999999999876665 589998876532 334566677777665 4789999999988
Q ss_pred ecCeEEEEEeccc-cchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEE
Q 007035 487 HLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKII 565 (621)
Q Consensus 487 ~~~~l~LVmEyl~-gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~ 565 (621)
. ...++||||+. ++|.+.+..... .+++..+..++.||+.||.|||+++|+||||||+||+++ .++.+||+
T Consensus 80 ~-~~~~~v~e~~~~g~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~--~~~~~kL~ 151 (279)
T cd05057 80 S-SQVQLITQLMPLGCLLDYVRNHKD-----NIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVK--TPQHVKIT 151 (279)
T ss_pred c-CceEEEEecCCCCcHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEc--CCCeEEEC
Confidence 7 78999999997 477776654322 278899999999999999999999999999999999998 47789999
Q ss_pred ecCCccccCCCccc-----cccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 566 DLGSSCFQTDNLCL-----YVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 566 DFGls~~~~~~~~~-----~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
|||++......... ...+..|+|||.+....++.++|+||||+++|||++ |+.||
T Consensus 152 dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~ 212 (279)
T cd05057 152 DFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPY 212 (279)
T ss_pred CCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCC
Confidence 99998654432211 112467999999988889999999999999999998 99987
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.2e-28 Score=243.59 Aligned_cols=185 Identities=28% Similarity=0.437 Sum_probs=157.6
Q ss_pred eccCCCCceeEEEeCCCCcEEEEEEEecCc----hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeEEEEEec
Q 007035 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCEL 497 (621)
Q Consensus 422 LG~G~fG~Vyka~d~~tg~~VAlKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l~LVmEy 497 (621)
||.|++|.||++.+..+++.+++|++.... .....+.+|+.+++.+ .||||+++++.+.+....++||||
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~~~~~~~lv~e~ 74 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEEC------NHPFIVKLYRTFKDKKYIYMLMEY 74 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhC------CCCCEeeeeeeEEcCCccEEEEec
Confidence 699999999999999999999999987533 2334566677766655 478999999999999999999999
Q ss_pred cc-cchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCccccCCC
Q 007035 498 LR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN 576 (621)
Q Consensus 498 l~-gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~~~~~~ 576 (621)
+. ++|.+.+..... +++..+..++.||+.||.|||+++++|+||+|+||+++. ++.++|+|||++......
T Consensus 75 ~~~~~L~~~l~~~~~------l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~--~~~~~l~df~~~~~~~~~ 146 (262)
T cd05572 75 CLGGELWTILRDRGL------FDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDS--NGYVKLVDFGFAKKLKSG 146 (262)
T ss_pred CCCCcHHHHHhhcCC------CCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcC--CCCEEEeeCCcccccCcc
Confidence 87 477776654321 788899999999999999999999999999999999984 788999999998765443
Q ss_pred --ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 577 --LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 577 --~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
.....+++.|++||.+.+..++.++|+||||+++|+|++|..||
T Consensus 147 ~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~ 192 (262)
T cd05572 147 QKTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPF 192 (262)
T ss_pred cccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCc
Confidence 23346788999999998888999999999999999999999998
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.4e-28 Score=240.88 Aligned_cols=193 Identities=28% Similarity=0.420 Sum_probs=160.9
Q ss_pred eEEEEEeccCCCCceeEEEeCCCC----cEEEEEEEecCch--hhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecC
Q 007035 416 YYVTEYLGSAAFSKVFQAQDLHTG----VDVCLKIIKNDKD--FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (621)
Q Consensus 416 Y~I~~~LG~G~fG~Vyka~d~~tg----~~VAlKii~~~~~--~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~ 489 (621)
+++.+.||.|+||.||++++...+ ..||+|++..... ....+..|+.+++.+ .|+||+++++++...+
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l------~~~~i~~~~~~~~~~~ 74 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKL------DHPNIVKLLGVCTEEE 74 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhc------CCCchheEEEEEcCCC
Confidence 356789999999999999988766 8999999976543 456677788887766 3679999999999999
Q ss_pred eEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecC
Q 007035 490 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (621)
Q Consensus 490 ~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFG 568 (621)
..+++|||+.+ +|.+.+....... +++..+..++.||+.||.+||+.+++|+||+|+||+++. ++.++|+|||
T Consensus 75 ~~~~i~e~~~~~~l~~~~~~~~~~~----~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~--~~~~~l~dfg 148 (258)
T smart00219 75 PLMIVMEYMEGGDLLDYLRKNRPKE----LSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGE--NLVVKISDFG 148 (258)
T ss_pred eeEEEEeccCCCCHHHHHHhhhhcc----CCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEcc--CCeEEEcccC
Confidence 99999999975 7777765433211 788999999999999999999999999999999999984 7789999999
Q ss_pred CccccCCCcc----ccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 569 SSCFQTDNLC----LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 569 ls~~~~~~~~----~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
++........ ...+++.|+|||.+.+..++.++||||||+++|+|++ |++||
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~ 205 (258)
T smart00219 149 LSRDLYDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPY 205 (258)
T ss_pred CceecccccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCC
Confidence 9865443211 1225678999999988889999999999999999998 78886
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-28 Score=247.08 Aligned_cols=192 Identities=36% Similarity=0.577 Sum_probs=163.9
Q ss_pred eEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCch---hhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeEE
Q 007035 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD---FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLF 492 (621)
Q Consensus 416 Y~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~---~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l~ 492 (621)
|++.+.||.|++|.||++.+..+++.+++|.+..... .......|+.+++.++ |+||+++++++......+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~------~~~i~~~~~~~~~~~~~~ 74 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELN------HPNIIKLLDVFRHKGDLY 74 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhc------CCCcchHHHhhccCCCEE
Confidence 6778899999999999999999999999999875432 3456667777777764 679999999999999999
Q ss_pred EEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCccc
Q 007035 493 IVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF 572 (621)
Q Consensus 493 LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~~ 572 (621)
+||||+++++.+.+.... ..+++..+..++.||+.||.|||+.+|+|+||+|+||+++. ++.++|+|||.+..
T Consensus 75 ~v~e~~~~~l~~~l~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~--~~~~~l~df~~~~~ 147 (283)
T cd05118 75 LVFEFMDTDLYKLIKDRQ-----RGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINT--EGVLKLADFGLARS 147 (283)
T ss_pred EEEeccCCCHHHHHHhhc-----ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECC--CCcEEEeeeeeeEe
Confidence 999999998888776533 12889999999999999999999999999999999999984 78899999998865
Q ss_pred cCCCc---cccccCCcccCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 573 QTDNL---CLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 573 ~~~~~---~~~~gt~~Y~APEvl~~~-~~s~ksDIWSLGvILyELltG~~PF 620 (621)
..... ....++..|+|||.+.+. .++.++|+||||+++|+|++|+.||
T Consensus 148 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~ 199 (283)
T cd05118 148 FGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLF 199 (283)
T ss_pred cCCCcccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCC
Confidence 54432 224567889999999876 6899999999999999999999887
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-28 Score=258.50 Aligned_cols=194 Identities=36% Similarity=0.651 Sum_probs=165.3
Q ss_pred ecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecC---chhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEec
Q 007035 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (621)
Q Consensus 412 i~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~---~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~ 488 (621)
+.++|++.+.||.|++|.||+|++..+++.||+|++... ........+|+.+++.+ .|+||+++++++...
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l------~h~~iv~~~~~~~~~ 86 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHM------DHENVIGLLDVFTPA 86 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhc------cCCCHHHHHHHhhcc
Confidence 467899999999999999999999999999999988643 22334556677777665 467899999888765
Q ss_pred Ce------EEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeE
Q 007035 489 EH------LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEI 562 (621)
Q Consensus 489 ~~------l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~I 562 (621)
+. .++|+||++++|.+++... .+++..++.++.||+.||.|||+.||+||||+|+||+++. ++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~L~~~~~~~-------~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~--~~~~ 157 (343)
T cd07851 87 SSLEDFQDVYLVTHLMGADLNNIVKCQ-------KLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNE--DCEL 157 (343)
T ss_pred ccccccccEEEEEecCCCCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECC--CCCE
Confidence 54 9999999988888877531 2889999999999999999999999999999999999984 7889
Q ss_pred EEEecCCccccCCCccccccCCcccCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 563 KIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 563 KL~DFGls~~~~~~~~~~~gt~~Y~APEvl~~~-~~s~ksDIWSLGvILyELltG~~PF 620 (621)
+|+|||++...........+++.|+|||.+.+. .++.++||||||+++|+|++|+.||
T Consensus 158 kL~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf 216 (343)
T cd07851 158 KILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLF 216 (343)
T ss_pred EEccccccccccccccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCC
Confidence 999999987766555556788899999998653 5788999999999999999999998
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.8e-28 Score=253.57 Aligned_cols=193 Identities=36% Similarity=0.589 Sum_probs=160.1
Q ss_pred ceEEEEEeccCCCCceeEEEeCCC--CcEEEEEEEecC---chhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEec-
Q 007035 415 RYYVTEYLGSAAFSKVFQAQDLHT--GVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL- 488 (621)
Q Consensus 415 rY~I~~~LG~G~fG~Vyka~d~~t--g~~VAlKii~~~---~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~- 488 (621)
+|++.+.||.|+||.||++++..+ +..||+|.+... ........+|+.+++.+. .||||+++++.+...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~-----~h~~iv~~~~~~~~~~ 75 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFR-----GHKNITCLYDMDIVFP 75 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhc-----CCCChheeeeeeeecc
Confidence 589999999999999999999888 899999998742 222345677888887774 478999999875432
Q ss_pred ---CeEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEE
Q 007035 489 ---EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKII 565 (621)
Q Consensus 489 ---~~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~ 565 (621)
...++++||++++|.+.+.... .+++..++.++.||+.||.|||+.||+||||||+|||++. ++.++|+
T Consensus 76 ~~~~~~~~~~e~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~--~~~~kl~ 147 (332)
T cd07857 76 GNFNELYLYEELMEADLHQIIRSGQ------PLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNA--DCELKIC 147 (332)
T ss_pred ccCCcEEEEEecccCCHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcC--CCCEEeC
Confidence 4689999999988888775332 2889999999999999999999999999999999999984 7889999
Q ss_pred ecCCccccCCC-------ccccccCCcccCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 566 DLGSSCFQTDN-------LCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 566 DFGls~~~~~~-------~~~~~gt~~Y~APEvl~~-~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
|||++...... .....+++.|+|||.+.+ ..++.++||||||+++|+|++|++||
T Consensus 148 Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf 210 (332)
T cd07857 148 DFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVF 210 (332)
T ss_pred cCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCC
Confidence 99998654321 123467889999998866 46899999999999999999999987
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6e-29 Score=253.41 Aligned_cols=196 Identities=23% Similarity=0.377 Sum_probs=168.0
Q ss_pred cCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc----hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEec
Q 007035 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (621)
Q Consensus 413 ~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~ 488 (621)
-++|.+++.||.|+|++|.+++++.+.+.+|+|+++++- ...+=.+.|..+..... .||+++-+..+|+..
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~as-----n~pflvglhscfqte 323 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS-----NNPFLVGLHSCFQTE 323 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhcc-----CCCeEEehhhhhccc
Confidence 467999999999999999999999999999999988632 22233445555555443 478999999999999
Q ss_pred CeEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecC
Q 007035 489 EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (621)
Q Consensus 489 ~~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFG 568 (621)
.++++|.||++|+-+-+....+.. ++++.++.+..+|+-||.|||++||+.||||.+|||++ ..|+|||+|+|
T Consensus 324 srlffvieyv~ggdlmfhmqrqrk-----lpeeharfys~ei~lal~flh~rgiiyrdlkldnvlld--aeghikltdyg 396 (593)
T KOG0695|consen 324 SRLFFVIEYVNGGDLMFHMQRQRK-----LPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLD--AEGHIKLTDYG 396 (593)
T ss_pred ceEEEEEEEecCcceeeehhhhhc-----CcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEc--cCCceeecccc
Confidence 999999999997544333333322 89999999999999999999999999999999999999 48999999999
Q ss_pred Cccc---cCCCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 569 SSCF---QTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 569 ls~~---~~~~~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
+... .++...+++|||.|.|||++.+..|+..+|+|+|||+|+||+.|+-||
T Consensus 397 mcke~l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspf 451 (593)
T KOG0695|consen 397 MCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPF 451 (593)
T ss_pred hhhcCCCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCc
Confidence 9764 345577799999999999999999999999999999999999999998
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.5e-28 Score=249.34 Aligned_cols=196 Identities=29% Similarity=0.374 Sum_probs=161.0
Q ss_pred cCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc--hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCe
Q 007035 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (621)
Q Consensus 413 ~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~ 490 (621)
.++|++.+.||.|++|.||+|.+..+++.||||+++... ........|+.++... .+|+||+++++++.....
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~-----~~~~~i~~~~~~~~~~~~ 88 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKS-----HDCPYIVKCYGYFITDSD 88 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhc-----cCCCchHhhheeeecCCe
Confidence 467999999999999999999999899999999987542 2223344455444333 258899999999999999
Q ss_pred EEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHH-CCeecccCCCccEEEeccCCCeEEEEecCC
Q 007035 491 LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS-LGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (621)
Q Consensus 491 l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs-~gIvHrDLKP~NILl~~~~~~~IKL~DFGl 569 (621)
.++||||+++.+..++..... .+++..+..++.||+.||.|||+ .+|+||||+|+||+++ .++.++|+|||+
T Consensus 89 ~~~v~e~~~~~l~~l~~~~~~-----~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~--~~~~~kL~dfg~ 161 (296)
T cd06618 89 VFICMELMSTCLDKLLKRIQG-----PIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLD--ASGNVKLCDFGI 161 (296)
T ss_pred EEEEeeccCcCHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEc--CCCCEEECcccc
Confidence 999999998877777655332 38888999999999999999997 5999999999999998 478899999999
Q ss_pred ccccCCC--ccccccCCcccCchhhcCCC----CCchhhHHHHHHHHHHHHhCCCCC
Q 007035 570 SCFQTDN--LCLYVQSRSYRAPEVIIGLP----YDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 570 s~~~~~~--~~~~~gt~~Y~APEvl~~~~----~s~ksDIWSLGvILyELltG~~PF 620 (621)
+...... .....+++.|+|||.+.+.. ++.++||||||+++|+|++|+.||
T Consensus 162 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~ 218 (296)
T cd06618 162 SGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPY 218 (296)
T ss_pred chhccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCC
Confidence 8654332 22234678899999997653 788999999999999999999998
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-28 Score=253.56 Aligned_cols=192 Identities=24% Similarity=0.412 Sum_probs=157.5
Q ss_pred eEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc-hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeEEEE
Q 007035 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIV 494 (621)
Q Consensus 416 Y~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~-~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l~LV 494 (621)
|.....||.|+||.||++.+..+++.||+|.+.... .....+.+|+.+++.+ .||||+++++.+...+..++|
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l------~hp~i~~~~~~~~~~~~~~iv 96 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDY------QHQNVVEMYKSYLVGEELWVL 96 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhC------CCCchhhhhhheeeCCeEEEE
Confidence 444557999999999999999999999999986432 2234455666655544 578999999999999999999
Q ss_pred EeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCccccC
Q 007035 495 CELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQT 574 (621)
Q Consensus 495 mEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~~~~ 574 (621)
|||+.++.+..+.... .+++..++.++.||+.||.|||+.+|+||||+|+||+++ .++.++|+|||++....
T Consensus 97 ~e~~~~~~L~~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~--~~~~~kL~dfg~~~~~~ 168 (297)
T cd06659 97 MEFLQGGALTDIVSQT------RLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLT--LDGRVKLSDFGFCAQIS 168 (297)
T ss_pred EecCCCCCHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEc--cCCcEEEeechhHhhcc
Confidence 9999864443333221 278889999999999999999999999999999999998 47889999999875433
Q ss_pred CC---ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 007035 575 DN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCLI 621 (621)
Q Consensus 575 ~~---~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF~ 621 (621)
.. .....+++.|+|||++.+..++.++|||||||++|+|++|+.||.
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~ 218 (297)
T cd06659 169 KDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYF 218 (297)
T ss_pred cccccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 22 233567889999999998889999999999999999999999983
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.6e-28 Score=243.38 Aligned_cols=188 Identities=24% Similarity=0.328 Sum_probs=150.3
Q ss_pred EEeccCCCCceeEEEeCCCC----------cEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecC
Q 007035 420 EYLGSAAFSKVFQAQDLHTG----------VDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (621)
Q Consensus 420 ~~LG~G~fG~Vyka~d~~tg----------~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~ 489 (621)
+.||+|+||.||+|.+..++ ..+++|++.........+.+|+.+++.+ .||||+++++++.. .
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~~-~ 73 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQL------SHKHLVKLYGVCVR-D 73 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcC------CCcchhheeeEEec-C
Confidence 36999999999999988777 4588888775543345566666666554 57899999999888 7
Q ss_pred eEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCC-----eEE
Q 007035 490 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRC-----EIK 563 (621)
Q Consensus 490 ~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~-----~IK 563 (621)
..++||||+.+ +|.+++..... .+++..+..++.||+.||.|||+++|+||||||+|||++.+... .++
T Consensus 74 ~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~k 148 (259)
T cd05037 74 ENIMVEEYVKFGPLDVFLHREKN-----NVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIK 148 (259)
T ss_pred CcEEEEEcCCCCcHHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEE
Confidence 78999999986 55555543321 27888899999999999999999999999999999999853211 799
Q ss_pred EEecCCccccCCCccccccCCcccCchhhcCC--CCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 564 IIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGL--PYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 564 L~DFGls~~~~~~~~~~~gt~~Y~APEvl~~~--~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
|+|||++..... .....++..|+|||++.+. .++.++||||||+++|+|++ |..||
T Consensus 149 l~Dfg~a~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~ 207 (259)
T cd05037 149 LSDPGIPITVLS-REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPL 207 (259)
T ss_pred eCCCCccccccc-ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCc
Confidence 999999876543 2234567789999999876 78999999999999999999 57665
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.7e-28 Score=243.00 Aligned_cols=186 Identities=27% Similarity=0.357 Sum_probs=152.1
Q ss_pred EEeccCCCCceeEEEeCCCC---cEEEEEEEecCch--hhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeEEEE
Q 007035 420 EYLGSAAFSKVFQAQDLHTG---VDVCLKIIKNDKD--FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIV 494 (621)
Q Consensus 420 ~~LG~G~fG~Vyka~d~~tg---~~VAlKii~~~~~--~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l~LV 494 (621)
++||+|+||.||+|....++ ..+|+|.+..... ..+.+..|+.+++.+ +|+||+++++++. ....++|
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l------~h~~iv~~~~~~~-~~~~~~v 73 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQL------DHPCIVRLIGVCK-GEPLMLV 73 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhc------CCCCeeeEEEEEc-CCceEEE
Confidence 36999999999999876655 7899999886543 345566677776655 5789999999876 4568999
Q ss_pred Eeccc-cchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCcccc
Q 007035 495 CELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQ 573 (621)
Q Consensus 495 mEyl~-gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~~~ 573 (621)
|||+. ++|.+++.... .+++..+..++.||+.||.|||..+++|+||||+|||++. ++.+||+|||++...
T Consensus 74 ~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~--~~~~kl~df~~~~~~ 145 (257)
T cd05060 74 MELAPLGPLLKYLKKRR------EIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVN--RHQAKISDFGMSRAL 145 (257)
T ss_pred EEeCCCCcHHHHHHhCC------CCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcC--CCcEEecccccccee
Confidence 99987 47777776433 2788999999999999999999999999999999999984 788999999998755
Q ss_pred CCCcccc------ccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 574 TDNLCLY------VQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 574 ~~~~~~~------~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
....... .++..|+|||.+.+..++.++||||||+++|+|++ |++||
T Consensus 146 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~ 199 (257)
T cd05060 146 GAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPY 199 (257)
T ss_pred ecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCc
Confidence 3332211 12356999999998889999999999999999998 99987
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=269.27 Aligned_cols=204 Identities=25% Similarity=0.359 Sum_probs=167.1
Q ss_pred cceeeCeeecCceEEEEEeccCCCCceeEEEeCCCC----cEEEEEEEec----CchhhhhHHHHHHHHHHhcccCCCCC
Q 007035 404 LPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTG----VDVCLKIIKN----DKDFFDQSLDEIKLLKLVNKNDPADE 475 (621)
Q Consensus 404 ~pi~l~~ii~~rY~I~~~LG~G~fG~Vyka~d~~tg----~~VAlKii~~----~~~~~~~~~~Ei~iL~~l~~~~~~~h 475 (621)
++...+.+...+..+.++||+|+||.||+|..+..+ ..||+|..+. .......+.+|.++++.+ +|
T Consensus 147 I~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l------~H 220 (474)
T KOG0194|consen 147 IPRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQL------NH 220 (474)
T ss_pred ccccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhC------CC
Confidence 334455666777788899999999999999876542 2389998874 234556677777777765 57
Q ss_pred CceEEEeeEeEecCeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEE
Q 007035 476 HHILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILI 554 (621)
Q Consensus 476 pnIvrl~~~f~~~~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl 554 (621)
|||+++||+......++||||+|.| +|.++++.++.. ++..+...++.+.+.||+|||+++++||||..+|+|+
T Consensus 221 ~NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~-----v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~ 295 (474)
T KOG0194|consen 221 PNVVRFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKKS-----LPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLY 295 (474)
T ss_pred CCEEEEEEEEcCCCccEEEEEecCCCcHHHHHHhCCCC-----CCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHhee
Confidence 8999999999999999999999985 788888766542 8899999999999999999999999999999999999
Q ss_pred eccCCCeEEEEecCCccccCCCcc---ccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 555 KSYQRCEIKIIDLGSSCFQTDNLC---LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 555 ~~~~~~~IKL~DFGls~~~~~~~~---~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
+. +..+||+|||++.....-.. ...-...|+|||++....|+.++||||+||++||+++ |..||
T Consensus 296 ~~--~~~vKISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py 363 (474)
T KOG0194|consen 296 SK--KGVVKISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPY 363 (474)
T ss_pred cC--CCeEEeCccccccCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCC
Confidence 94 66789999999865431111 1123567999999999999999999999999999999 77787
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=252.37 Aligned_cols=192 Identities=31% Similarity=0.449 Sum_probs=160.4
Q ss_pred CceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc--hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeE
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l 491 (621)
..|++.+.||.|+||.||+|.+..+++.||+|++.... .....+.+|+.+++.+ .||||+++++.+....+.
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~~~~~~ 77 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQC------DSPYITRYYGSYLKGTKL 77 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcC------CCCccHhhhcccccCCce
Confidence 35667788999999999999999999999999987432 2334566677666655 578999999999999999
Q ss_pred EEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCc
Q 007035 492 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (621)
Q Consensus 492 ~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls 570 (621)
++||||+++ +|.+.+.. ..+++..++.++.||+.||.|||+++++|+||+|+||+++. ++.++|+|||++
T Consensus 78 ~lv~e~~~~~~L~~~~~~-------~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~--~~~~~l~dfg~~ 148 (277)
T cd06642 78 WIIMEYLGGGSALDLLKP-------GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSE--QGDVKLADFGVA 148 (277)
T ss_pred EEEEEccCCCcHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeC--CCCEEEcccccc
Confidence 999999986 55555432 12788899999999999999999999999999999999984 788999999998
Q ss_pred cccCCCc---cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 571 CFQTDNL---CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 571 ~~~~~~~---~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
....... ....++..|+|||.+.+..++.++|+||||+++|+|++|+.||
T Consensus 149 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~ 201 (277)
T cd06642 149 GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPN 201 (277)
T ss_pred ccccCcchhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCC
Confidence 6544322 2235688899999999888999999999999999999999997
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-27 Score=251.30 Aligned_cols=195 Identities=25% Similarity=0.411 Sum_probs=162.2
Q ss_pred cCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCch----hhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEec
Q 007035 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD----FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (621)
Q Consensus 413 ~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~----~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~ 488 (621)
...|.+.+.||+|+||.||++++..++..+|+|.+..... ....+..|+.+++.+ .|+|++++++++...
T Consensus 24 ~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l------~h~~iv~~~~~~~~~ 97 (317)
T cd06635 24 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRI------KHPNSIEYKGCYLRE 97 (317)
T ss_pred hhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhC------CCCCEEEEEEEEeeC
Confidence 3457888999999999999999999999999999875322 223455566666554 478999999999999
Q ss_pred CeEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecC
Q 007035 489 EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (621)
Q Consensus 489 ~~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFG 568 (621)
...++||||+.+++.+.+..... .+++..+..++.||+.||.|||+++|+||||+|+||+++. ++.++|+|||
T Consensus 98 ~~~~lv~e~~~g~l~~~~~~~~~-----~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~--~~~~kl~dfg 170 (317)
T cd06635 98 HTAWLVMEYCLGSASDLLEVHKK-----PLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTE--PGQVKLADFG 170 (317)
T ss_pred CeEEEEEeCCCCCHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECC--CCCEEEecCC
Confidence 99999999999988877654322 2788999999999999999999999999999999999984 7889999999
Q ss_pred CccccCCCccccccCCcccCchhhc---CCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 007035 569 SSCFQTDNLCLYVQSRSYRAPEVII---GLPYDQKIDLWSLGCILAELWTGEVCLI 621 (621)
Q Consensus 569 ls~~~~~~~~~~~gt~~Y~APEvl~---~~~~s~ksDIWSLGvILyELltG~~PF~ 621 (621)
++..... .....+++.|+|||.+. ...++.++|||||||++|+|++|+.||.
T Consensus 171 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~ 225 (317)
T cd06635 171 SASIASP-ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 225 (317)
T ss_pred CccccCC-cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCC
Confidence 8765433 23346788999999984 3457889999999999999999999983
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.7e-28 Score=248.88 Aligned_cols=193 Identities=29% Similarity=0.473 Sum_probs=162.0
Q ss_pred cCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecC-chhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeE
Q 007035 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND-KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (621)
Q Consensus 413 ~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~-~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l 491 (621)
.++|.+.+.||+|+||.||++.+..++..|++|.+... ....+.+.+|+.+++.+ .||||+++++.+...+..
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l------~hp~i~~~~~~~~~~~~~ 91 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMREN------KHPNIVNYLDSYLVGDEL 91 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhc------CCCCeeehhheeeeCCcE
Confidence 47899999999999999999999899999999998643 22234556666666544 578999999999999999
Q ss_pred EEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCc
Q 007035 492 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (621)
Q Consensus 492 ~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls 570 (621)
++|+||+.+ +|.+++... .+++..+..++.||+.||.|||++|++|+||+|+||+++. ++.++|+|||++
T Consensus 92 ~lv~e~~~~~~L~~~~~~~-------~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~--~~~~kL~dfg~~ 162 (293)
T cd06647 92 WVVMEYLAGGSLTDVVTET-------CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGM--DGSVKLTDFGFC 162 (293)
T ss_pred EEEEecCCCCcHHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcC--CCCEEEccCcce
Confidence 999999985 666655421 2778889999999999999999999999999999999984 778999999987
Q ss_pred cccCCC---ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 571 CFQTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 571 ~~~~~~---~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
...... .....+++.|+|||.+.+..++.++|+||||+++|+|++|+.||
T Consensus 163 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf 215 (293)
T cd06647 163 AQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPY 215 (293)
T ss_pred ecccccccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 544322 22345788899999998888899999999999999999999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=245.22 Aligned_cols=193 Identities=25% Similarity=0.350 Sum_probs=156.4
Q ss_pred CceEEEEEeccCCCCceeEEE----eCCCCcEEEEEEEecCc-hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEe-
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQ----DLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH- 487 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~----d~~tg~~VAlKii~~~~-~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~- 487 (621)
.+|++++.||.|+||.||++. +..+++.||+|.+.... .....+.+|+.+++.+ +||||+++++++..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l------~h~~iv~~~~~~~~~ 77 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSL------QHDNIVKYKGVCYSA 77 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhC------CCCCeeEEEEEEccC
Confidence 479999999999999999997 45678999999987543 2345567787777765 47899999998754
Q ss_pred -cCeEEEEEeccc-cchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEE
Q 007035 488 -LEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKII 565 (621)
Q Consensus 488 -~~~l~LVmEyl~-gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~ 565 (621)
...+++||||+. ++|.+++..... .+++..++.++.||+.||.|||++||+||||||+||+++. ++.++|+
T Consensus 78 ~~~~~~lv~e~~~~~~L~~~l~~~~~-----~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~--~~~~~l~ 150 (284)
T cd05081 78 GRRNLRLVMEYLPYGSLRDYLQKHRE-----RLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVES--ENRVKIG 150 (284)
T ss_pred CCCceEEEEEecCCCCHHHHHHhcCc-----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECC--CCeEEEC
Confidence 346899999997 577777654321 2788899999999999999999999999999999999984 7889999
Q ss_pred ecCCccccCCCccc------cccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCC
Q 007035 566 DLGSSCFQTDNLCL------YVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVC 619 (621)
Q Consensus 566 DFGls~~~~~~~~~------~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~P 619 (621)
|||++......... ..++..|+|||++.+..++.++|||||||++|||++|..|
T Consensus 151 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~ 210 (284)
T cd05081 151 DFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDK 210 (284)
T ss_pred CCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCc
Confidence 99998764332211 1223459999999988899999999999999999998655
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=241.09 Aligned_cols=195 Identities=27% Similarity=0.407 Sum_probs=163.2
Q ss_pred ceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc---hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeE
Q 007035 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (621)
Q Consensus 415 rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~---~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l 491 (621)
+|.+.+.||.|+||.||++.++.+|..+|+|.+.... ...+...+|+.+++.++ |+||+++++.+......
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~------h~~i~~~~~~~~~~~~~ 74 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMK------HPNIVTFFASFQENGRL 74 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCC------CCChhhhhheeccCCeE
Confidence 5899999999999999999999999999999987532 23355667777777664 67999999999999999
Q ss_pred EEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCc
Q 007035 492 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (621)
Q Consensus 492 ~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls 570 (621)
++|+||+.+ +|.+.+..... ..+++..+..++.||+.||.|||+.+++|+||+|+||+++. ....++|+|||.+
T Consensus 75 ~lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~-~~~~~~l~d~~~~ 149 (257)
T cd08225 75 FIVMEYCDGGDLMKRINRQRG----VLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSK-NGMVAKLGDFGIA 149 (257)
T ss_pred EEEEecCCCCcHHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcC-CCCeEEecccccc
Confidence 999999975 67666654321 12788899999999999999999999999999999999985 2345799999988
Q ss_pred cccCCCc---cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 571 CFQTDNL---CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 571 ~~~~~~~---~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
....... ....+++.|+|||++.+..++.++|+||||+++|+|++|+.||
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~ 202 (257)
T cd08225 150 RQLNDSMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPF 202 (257)
T ss_pred hhccCCcccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 6554322 2235788899999998888999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.9e-28 Score=247.67 Aligned_cols=201 Identities=22% Similarity=0.289 Sum_probs=161.9
Q ss_pred cCceEEEEEeccCCCCceeEEEeCC-----CCcEEEEEEEecCc--hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEe
Q 007035 413 AGRYYVTEYLGSAAFSKVFQAQDLH-----TGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYF 485 (621)
Q Consensus 413 ~~rY~I~~~LG~G~fG~Vyka~d~~-----tg~~VAlKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f 485 (621)
.++|++.+.||.|+||.||++.+.. ++..||+|++.... .....+.+|+.+++.+ .||||+++++++
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l------~h~~iv~~~~~~ 77 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF------DHPNIVKLLGVC 77 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhc------CCCchheEEEEE
Confidence 4679999999999999999998753 67889999987543 2334566777777766 478999999999
Q ss_pred EecCeEEEEEecccc-chHHHHHhhhcc----------------CCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCC
Q 007035 486 YHLEHLFIVCELLRA-NLYEFQKFNQES----------------GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLK 548 (621)
Q Consensus 486 ~~~~~l~LVmEyl~g-sLld~l~~~~~~----------------~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLK 548 (621)
......++||||+.+ +|.+++...... .....+++..++.++.||+.||.|||+++++|||||
T Consensus 78 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~ 157 (288)
T cd05050 78 AVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLA 157 (288)
T ss_pred cCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeeccccc
Confidence 999999999999985 777776533210 111237788899999999999999999999999999
Q ss_pred CccEEEeccCCCeEEEEecCCccccCCC-----ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCC
Q 007035 549 PENILIKSYQRCEIKIIDLGSSCFQTDN-----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCLI 621 (621)
Q Consensus 549 P~NILl~~~~~~~IKL~DFGls~~~~~~-----~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF~ 621 (621)
|+||+++ .++.++|+|||++...... ......+..|+|||.+.+..++.++|||||||++|+|++ |..||.
T Consensus 158 p~nil~~--~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~ 234 (288)
T cd05050 158 TRNCLVG--ENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYY 234 (288)
T ss_pred HhheEec--CCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 9999998 4788999999987643221 112234567999999998889999999999999999997 888873
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=243.96 Aligned_cols=192 Identities=30% Similarity=0.440 Sum_probs=157.9
Q ss_pred ceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCch-----------hhhhHHHHHHHHHHhcccCCCCCCceEEEee
Q 007035 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD-----------FFDQSLDEIKLLKLVNKNDPADEHHILRLYD 483 (621)
Q Consensus 415 rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~-----------~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~ 483 (621)
+|.+.+.||.|+||.||+|.+..+|+.+|+|.++.... ..+.+..|+.+++.+ +|+||+++++
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~ 75 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL------DHLNIVQYLG 75 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhc------CCCCcceEEE
Confidence 58889999999999999999999999999998864211 112344555555544 5789999999
Q ss_pred EeEecCeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeE
Q 007035 484 YFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEI 562 (621)
Q Consensus 484 ~f~~~~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~I 562 (621)
++...+..++||||+.+ +|.+.+... ..+++..++.++.||+.||.|||+.+++||||+|+||+++ .++.+
T Consensus 76 ~~~~~~~~~lv~e~~~~~~L~~~l~~~------~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~--~~~~~ 147 (272)
T cd06629 76 FETTEEYLSIFLEYVPGGSIGSCLRTY------GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVD--ADGIC 147 (272)
T ss_pred EeccCCceEEEEecCCCCcHHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEc--CCCeE
Confidence 99999999999999975 566665433 1278889999999999999999999999999999999998 47899
Q ss_pred EEEecCCccccCCC-----ccccccCCcccCchhhcCCC--CCchhhHHHHHHHHHHHHhCCCCC
Q 007035 563 KIIDLGSSCFQTDN-----LCLYVQSRSYRAPEVIIGLP--YDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 563 KL~DFGls~~~~~~-----~~~~~gt~~Y~APEvl~~~~--~s~ksDIWSLGvILyELltG~~PF 620 (621)
+|+|||++...... .....++..|+|||.+.... ++.++|+||||+++|+|++|..||
T Consensus 148 ~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~ 212 (272)
T cd06629 148 KISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPW 212 (272)
T ss_pred EEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCC
Confidence 99999988654322 12245688899999987654 788999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=244.90 Aligned_cols=191 Identities=31% Similarity=0.459 Sum_probs=159.6
Q ss_pred ceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc--hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeEE
Q 007035 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLF 492 (621)
Q Consensus 415 rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l~ 492 (621)
-|++++.||.|+||.||+|.+..+++.+|+|++.... .....+.+|+.+++.+ .||||+++++.+......+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l------~h~~iv~~~~~~~~~~~~~ 78 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC------DSPYVTKYYGSYLKDTKLW 78 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhc------CCCCEeEEEEEEEeCCeEE
Confidence 3778899999999999999999999999999876432 2334455666666655 5789999999999999999
Q ss_pred EEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCcc
Q 007035 493 IVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 571 (621)
Q Consensus 493 LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~ 571 (621)
+||||+++ +|.+.+... .+++..+..++.|++.||.+||+.+++|+||+|+||+++. ++.++|+|||++.
T Consensus 79 lv~e~~~~~~l~~~i~~~-------~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~--~~~~~l~dfg~~~ 149 (277)
T cd06641 79 IIMEYLGGGSALDLLEPG-------PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSE--HGEVKLADFGVAG 149 (277)
T ss_pred EEEEeCCCCcHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECC--CCCEEEeecccce
Confidence 99999986 555554321 2788899999999999999999999999999999999984 7889999999876
Q ss_pred ccCCC---ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 572 FQTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 572 ~~~~~---~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
..... .....++..|+|||.+.+..++.++|+|||||++|+|++|..||
T Consensus 150 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~ 201 (277)
T cd06641 150 QLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPH 201 (277)
T ss_pred ecccchhhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCC
Confidence 54332 12245688899999998888899999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.7e-28 Score=242.96 Aligned_cols=185 Identities=26% Similarity=0.356 Sum_probs=149.9
Q ss_pred EeccCCCCceeEEEe--CCCCcEEEEEEEecCc---hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeEEEEE
Q 007035 421 YLGSAAFSKVFQAQD--LHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVC 495 (621)
Q Consensus 421 ~LG~G~fG~Vyka~d--~~tg~~VAlKii~~~~---~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l~LVm 495 (621)
.||+|+||.||+|.+ +.++..+|+|+++... ...+.+..|+.+++.+ +||||+++++++. .+..++||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~-~~~~~lv~ 74 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQL------DNPYIVRMIGICE-AESWMLVM 74 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhC------CCCCcceEEEEEc-CCCcEEEE
Confidence 589999999999964 5678899999987542 2345566777777665 5789999999875 45678999
Q ss_pred ecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCccccC
Q 007035 496 ELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQT 574 (621)
Q Consensus 496 Eyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~~~~ 574 (621)
||+++ +|.+++.... .+++..+..++.||+.||.|||+++|+||||||.||+++. ++.++|+|||++....
T Consensus 75 e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~--~~~~kl~Dfg~~~~~~ 146 (257)
T cd05116 75 ELAELGPLNKFLQKNK------HVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVT--QHYAKISDFGLSKALG 146 (257)
T ss_pred ecCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcC--CCeEEECCCccccccC
Confidence 99985 5666664322 2788999999999999999999999999999999999984 7789999999986543
Q ss_pred CCcc------ccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 575 DNLC------LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 575 ~~~~------~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
.... ...+++.|+|||.+....++.++|||||||++|||++ |+.||
T Consensus 147 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~ 199 (257)
T cd05116 147 ADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPY 199 (257)
T ss_pred CCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCC
Confidence 3221 1223568999999988888999999999999999998 99997
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-27 Score=237.08 Aligned_cols=192 Identities=31% Similarity=0.420 Sum_probs=166.3
Q ss_pred ceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc---hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEec--C
Q 007035 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL--E 489 (621)
Q Consensus 415 rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~---~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~--~ 489 (621)
+|++.+.||.|++|.||+|.+..+++.|++|++.... ...+.+.+|+.+++.+. |+||+++++.+... .
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~------~~~i~~~~~~~~~~~~~ 74 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQ------HPNIVRYYGSERDEEKN 74 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcC------CCCEeeEEEEEecCCCC
Confidence 4888999999999999999999999999999987654 34566777888777774 78999999999988 8
Q ss_pred eEEEEEeccc-cchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecC
Q 007035 490 HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (621)
Q Consensus 490 ~l~LVmEyl~-gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFG 568 (621)
..++|+||+. ++|.+++.... .+++..++.++.|++.||.|||+.+++|+||+|+||+++. ++.++|+|||
T Consensus 75 ~~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~--~~~~~l~d~~ 146 (260)
T cd06606 75 TLNIFLEYVSGGSLSSLLKKFG------KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDS--DGVVKLADFG 146 (260)
T ss_pred eEEEEEEecCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcC--CCCEEEcccc
Confidence 9999999995 56776665432 2889999999999999999999999999999999999995 7889999999
Q ss_pred CccccCCC-----ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 569 SSCFQTDN-----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 569 ls~~~~~~-----~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
.+...... .....++..|+|||.+.+..++.++||||||+++|+|++|+.||
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~ 203 (260)
T cd06606 147 CAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPW 203 (260)
T ss_pred cEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 88765443 23356788999999998888999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6e-29 Score=248.34 Aligned_cols=195 Identities=29% Similarity=0.376 Sum_probs=162.4
Q ss_pred CceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc--hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeE
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l 491 (621)
++.+++..||+|.-|+||++..+.+|..+|||.+.+.. ....++++.+.+....+ +.|+||+.+++|..+..+
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~-----dcpyIV~c~GyFi~n~dV 166 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSH-----DCPYIVQCFGYFITNTDV 166 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhcc-----CCCeeeeeeeEEeeCchH
Confidence 34577788999999999999999999999999998643 33344555555444332 578999999999999999
Q ss_pred EEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHC-CeecccCCCccEEEeccCCCeEEEEecCCc
Q 007035 492 FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSL-GIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (621)
Q Consensus 492 ~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~-gIvHrDLKP~NILl~~~~~~~IKL~DFGls 570 (621)
+|.||.+..-...+++..+.. +++..+..+...++.||.||.++ +|+|||+||+|||++ ..|.|||+|||.+
T Consensus 167 ~IcMelMs~C~ekLlkrik~p-----iPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlD--e~GniKlCDFGIs 239 (391)
T KOG0983|consen 167 FICMELMSTCAEKLLKRIKGP-----IPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLD--ERGNIKLCDFGIS 239 (391)
T ss_pred HHHHHHHHHHHHHHHHHhcCC-----chHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEc--cCCCEEeeccccc
Confidence 999999987666666554332 89999999999999999999965 899999999999999 5999999999999
Q ss_pred cccCCC--ccccccCCcccCchhhcC---CCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 571 CFQTDN--LCLYVQSRSYRAPEVIIG---LPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 571 ~~~~~~--~~~~~gt~~Y~APEvl~~---~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
.+..+. .+...|.+.|||||.+.- ..|+.++||||||++|+||.||+.||
T Consensus 240 GrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy 294 (391)
T KOG0983|consen 240 GRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPY 294 (391)
T ss_pred ceeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCC
Confidence 876543 344688999999999953 35899999999999999999999998
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=246.89 Aligned_cols=200 Identities=25% Similarity=0.336 Sum_probs=161.0
Q ss_pred cCceEEEEEeccCCCCceeEEEeC-----CCCcEEEEEEEecCch-hhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeE
Q 007035 413 AGRYYVTEYLGSAAFSKVFQAQDL-----HTGVDVCLKIIKNDKD-FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (621)
Q Consensus 413 ~~rY~I~~~LG~G~fG~Vyka~d~-----~tg~~VAlKii~~~~~-~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~ 486 (621)
..+|.+.+.||.|+||.||++++. .++..+++|.+..... ....+.+|+.+++.+ .|+||+++++++.
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~ 77 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL------QHEHIVKFYGVCG 77 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcC------CCCCcceEEEEEc
Confidence 357999999999999999999853 3456689998875432 234566677666655 4789999999999
Q ss_pred ecCeEEEEEeccc-cchHHHHHhhhcc----------CCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEe
Q 007035 487 HLEHLFIVCELLR-ANLYEFQKFNQES----------GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIK 555 (621)
Q Consensus 487 ~~~~l~LVmEyl~-gsLld~l~~~~~~----------~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~ 555 (621)
.....++||||+. ++|.+++...... .....+++..++.++.||+.||.|||+++|+||||||+|||++
T Consensus 78 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~ 157 (291)
T cd05094 78 DGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVG 157 (291)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEc
Confidence 9999999999997 5777766543210 1122378899999999999999999999999999999999998
Q ss_pred ccCCCeEEEEecCCccccCCCc-----cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 556 SYQRCEIKIIDLGSSCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 556 ~~~~~~IKL~DFGls~~~~~~~-----~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
. ++.++|+|||++....... ....+++.|+|||++.+..++.++|||||||++|+|++ |+.||
T Consensus 158 ~--~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 226 (291)
T cd05094 158 A--NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPW 226 (291)
T ss_pred c--CCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 4 7899999999986543321 22345678999999999889999999999999999999 99997
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.2e-28 Score=249.85 Aligned_cols=200 Identities=24% Similarity=0.321 Sum_probs=158.0
Q ss_pred cCceEEEEEeccCCCCceeEEEeCCCC--------------cEEEEEEEecCc--hhhhhHHHHHHHHHHhcccCCCCCC
Q 007035 413 AGRYYVTEYLGSAAFSKVFQAQDLHTG--------------VDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEH 476 (621)
Q Consensus 413 ~~rY~I~~~LG~G~fG~Vyka~d~~tg--------------~~VAlKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~hp 476 (621)
.++|++.+.||+|+||.||++.+..++ ..||+|.++... .....+.+|+++++.++ |+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~------h~ 77 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLK------NP 77 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCC------CC
Confidence 468999999999999999999875432 358999987542 23345677888777664 78
Q ss_pred ceEEEeeEeEecCeEEEEEecccc-chHHHHHhhhcc------CCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCC
Q 007035 477 HILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQES------GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKP 549 (621)
Q Consensus 477 nIvrl~~~f~~~~~l~LVmEyl~g-sLld~l~~~~~~------~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP 549 (621)
||+++++++......++||||+.+ +|.+++...... .....+++..+..++.||+.||.|||+.+++||||||
T Consensus 78 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp 157 (295)
T cd05097 78 NIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLAT 157 (295)
T ss_pred CcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccCh
Confidence 999999999999999999999985 666665432110 0111267888999999999999999999999999999
Q ss_pred ccEEEeccCCCeEEEEecCCccccCCCc-----cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh--CCCCC
Q 007035 550 ENILIKSYQRCEIKIIDLGSSCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT--GEVCL 620 (621)
Q Consensus 550 ~NILl~~~~~~~IKL~DFGls~~~~~~~-----~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt--G~~PF 620 (621)
+||+++. ++.+||+|||++....... ....++..|+|||++.+..++.++|||||||++|+|++ |..||
T Consensus 158 ~Nill~~--~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~ 233 (295)
T cd05097 158 RNCLVGN--HYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPY 233 (295)
T ss_pred hhEEEcC--CCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCC
Confidence 9999984 7789999999986533221 11233568999999998889999999999999999988 56665
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-28 Score=252.90 Aligned_cols=193 Identities=26% Similarity=0.411 Sum_probs=159.4
Q ss_pred CceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc-hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeEE
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLF 492 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~-~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l~ 492 (621)
+.|.....||.|+||.||++.+..++..||||.+.... ...+.+.+|+.+++.+ .|+||+++++.+...++.+
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l------~h~~ii~~~~~~~~~~~~~ 95 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDY------HHENVVDMYNSYLVGDELW 95 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhC------CCCcHHHHHHheecCCeEE
Confidence 44566678999999999999999999999999886533 2234456676666655 4789999999999999999
Q ss_pred EEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCccc
Q 007035 493 IVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF 572 (621)
Q Consensus 493 LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~~ 572 (621)
+||||++++.+..+.... .+++..++.++.||+.||.|||+++|+||||||+||+++. ++.++|+|||++..
T Consensus 96 lv~e~~~~~~L~~~~~~~------~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~--~~~~kL~dfg~~~~ 167 (292)
T cd06658 96 VVMEFLEGGALTDIVTHT------RMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTS--DGRIKLSDFGFCAQ 167 (292)
T ss_pred EEEeCCCCCcHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcC--CCCEEEccCcchhh
Confidence 999999875443333221 1788899999999999999999999999999999999984 68899999998764
Q ss_pred cCCC---ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 573 QTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 573 ~~~~---~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
.... .....+++.|+|||.+.+..++.++||||||+++|||++|+.||
T Consensus 168 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~ 218 (292)
T cd06658 168 VSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPY 218 (292)
T ss_pred cccccccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 3322 22346788999999998888999999999999999999999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.4e-28 Score=247.65 Aligned_cols=193 Identities=24% Similarity=0.277 Sum_probs=156.9
Q ss_pred ceEEEEEeccCCCCceeEEEe----CCCCcEEEEEEEecC--chhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEec
Q 007035 415 RYYVTEYLGSAAFSKVFQAQD----LHTGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (621)
Q Consensus 415 rY~I~~~LG~G~fG~Vyka~d----~~tg~~VAlKii~~~--~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~ 488 (621)
-|++++.||+|+||.||+++. ..++..||+|.++.. ......+.+|+.+++.+ .||||+++++++...
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~~~ 78 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL------YHENIVKYKGICTED 78 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhC------CCCCeeeeeeEEecC
Confidence 478999999999999999973 567889999998754 23345667788877766 478999999998875
Q ss_pred --CeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEE
Q 007035 489 --EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKII 565 (621)
Q Consensus 489 --~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~ 565 (621)
...++||||+++ +|.+++..... .+++..+..++.||+.||.|||++||+||||||+||+++. ++.++|+
T Consensus 79 ~~~~~~lv~e~~~g~~L~~~l~~~~~-----~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~--~~~~~l~ 151 (284)
T cd05079 79 GGNGIKLIMEFLPSGSLKEYLPRNKN-----KINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVES--EHQVKIG 151 (284)
T ss_pred CCCceEEEEEccCCCCHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcC--CCCEEEC
Confidence 578999999975 66666543221 2788899999999999999999999999999999999984 7789999
Q ss_pred ecCCccccCCCc------cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 566 DLGSSCFQTDNL------CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 566 DFGls~~~~~~~------~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
|||++....... ....++..|+|||++.+..++.++||||||+++|+|++++.|+
T Consensus 152 dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~ 212 (284)
T cd05079 152 DFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSE 212 (284)
T ss_pred CCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCC
Confidence 999986543321 1234566799999998888999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=243.98 Aligned_cols=191 Identities=20% Similarity=0.230 Sum_probs=149.6
Q ss_pred EeccCCCCceeEEEeC--CCCcEEEEEEEecCch--hhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeEEEEEe
Q 007035 421 YLGSAAFSKVFQAQDL--HTGVDVCLKIIKNDKD--FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCE 496 (621)
Q Consensus 421 ~LG~G~fG~Vyka~d~--~tg~~VAlKii~~~~~--~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l~LVmE 496 (621)
.||+|+||.||+|... .++..+|+|.++.... ....+.+|+.+++.+ +||||+++++++.+....++|||
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l------~h~~iv~~~~~~~~~~~~~lv~e 75 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSL------QHSNLLQCLGQCTEVTPYLLVME 75 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhC------CCCCEeeEEEEEcCCCCcEEEEE
Confidence 5899999999999754 4567799998875432 223556677666655 47899999999999999999999
Q ss_pred ccc-cchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCccccCC
Q 007035 497 LLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTD 575 (621)
Q Consensus 497 yl~-gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~~~~~ 575 (621)
|+. ++|.+++...... .....++..++.++.|++.||.|||+++++|+||||+||+++. .+.++|+|||++.....
T Consensus 76 ~~~~g~L~~~l~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~--~~~~kL~dfg~~~~~~~ 152 (269)
T cd05087 76 FCPLGDLKGYLRSCRKA-ELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTA--DLTVKIGDYGLSHNKYK 152 (269)
T ss_pred CCCCCcHHHHHHHhhhc-ccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcC--CCcEEECCccccccccC
Confidence 998 4666666543221 1223566778889999999999999999999999999999984 78899999998864332
Q ss_pred C-----ccccccCCcccCchhhcCC-------CCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 576 N-----LCLYVQSRSYRAPEVIIGL-------PYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 576 ~-----~~~~~gt~~Y~APEvl~~~-------~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
. .....+++.|+|||++.+. .++.++||||||+++|||++ |+.||
T Consensus 153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~ 210 (269)
T cd05087 153 EDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPY 210 (269)
T ss_pred cceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCC
Confidence 2 1123457789999998642 35789999999999999996 99997
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=241.99 Aligned_cols=186 Identities=24% Similarity=0.341 Sum_probs=149.4
Q ss_pred EeccCCCCceeEEEeC--CCCcEEEEEEEecCc--hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeEEEEEe
Q 007035 421 YLGSAAFSKVFQAQDL--HTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCE 496 (621)
Q Consensus 421 ~LG~G~fG~Vyka~d~--~tg~~VAlKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l~LVmE 496 (621)
.||.|+||.||+|.+. ..+..||+|++.... ...+.+.+|+.+++.+ +|+||+++++++. ....++|||
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l------~h~~ii~~~~~~~-~~~~~lv~e 74 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQL------DNPYIVRMIGVCE-AEALMLVME 74 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhc------CCCCeEEEEEEEc-CCCeEEEEE
Confidence 3899999999999764 445679999987543 2345567788888776 4789999999875 457899999
Q ss_pred cccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCccccCC
Q 007035 497 LLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTD 575 (621)
Q Consensus 497 yl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~~~~~ 575 (621)
|+++ +|.+++.... ..+++..++.++.||+.||.|||++|++||||||+|||++ .++.+||+|||++.....
T Consensus 75 ~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~--~~~~~kl~dfg~~~~~~~ 147 (257)
T cd05115 75 MASGGPLNKFLSGKK-----DEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLV--NQHYAKISDFGLSKALGA 147 (257)
T ss_pred eCCCCCHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEc--CCCcEEeccCCccccccC
Confidence 9985 5665554322 2388999999999999999999999999999999999998 478899999998864432
Q ss_pred Ccc------ccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 576 NLC------LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 576 ~~~------~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
... ...+++.|+|||++.+..++.++|||||||++|+|++ |..||
T Consensus 148 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~ 199 (257)
T cd05115 148 DDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPY 199 (257)
T ss_pred CccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCc
Confidence 211 1122467999999988889999999999999999996 99997
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=246.10 Aligned_cols=196 Identities=30% Similarity=0.448 Sum_probs=167.7
Q ss_pred ecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeE
Q 007035 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (621)
Q Consensus 412 i~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l 491 (621)
..+.|++.+.||.|++|.||++.+..++..+++|++.........+.+|+.+++.++ |+||+++++.+......
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~------~~~i~~~~~~~~~~~~~ 90 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCK------HPNIVDYYDSYLVGDEL 90 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCC------CCCeeEEEEEEEECCEE
Confidence 456689999999999999999999989999999999865544556677877777664 67999999999999999
Q ss_pred EEEEeccc-cchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCc
Q 007035 492 FIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (621)
Q Consensus 492 ~LVmEyl~-gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls 570 (621)
++|+||++ ++|.+++.... ..+++..+..++.||+.||.|||+.||+|+||+|+||+++. ++.++|+|||++
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~-----~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~--~~~~~l~d~~~~ 163 (286)
T cd06614 91 WVVMEYMDGGSLTDIITQNF-----VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSK--DGSVKLADFGFA 163 (286)
T ss_pred EEEEeccCCCcHHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcC--CCCEEECccchh
Confidence 99999999 57777776543 13888999999999999999999999999999999999984 788999999987
Q ss_pred cccCCC---ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 571 CFQTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 571 ~~~~~~---~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
...... .....+++.|+|||.+.+..++.++|+||||+++|+|++|+.||
T Consensus 164 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~ 216 (286)
T cd06614 164 AQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPY 216 (286)
T ss_pred hhhccchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCC
Confidence 654332 12335678899999999888999999999999999999999997
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=245.91 Aligned_cols=200 Identities=28% Similarity=0.370 Sum_probs=160.2
Q ss_pred cCceEEEEEeccCCCCceeEEEe-----CCCCcEEEEEEEecCc-hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeE
Q 007035 413 AGRYYVTEYLGSAAFSKVFQAQD-----LHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (621)
Q Consensus 413 ~~rY~I~~~LG~G~fG~Vyka~d-----~~tg~~VAlKii~~~~-~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~ 486 (621)
..+|.+.+.||+|+||.||+++. ..++..+++|.+.... .....+.+|+++++.+ .|+||+++++++.
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~ 77 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVL------QHQHIVRFYGVCT 77 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcC------CCCCCceEEEEEe
Confidence 45788999999999999999974 3356789999876432 3345567777777655 4789999999999
Q ss_pred ecCeEEEEEecccc-chHHHHHhhhc---------cCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEec
Q 007035 487 HLEHLFIVCELLRA-NLYEFQKFNQE---------SGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS 556 (621)
Q Consensus 487 ~~~~l~LVmEyl~g-sLld~l~~~~~---------~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~ 556 (621)
.....++||||+.+ +|.+++..... ......+++..++.++.||+.||.|||+.+|+||||||+|||++
T Consensus 78 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~- 156 (280)
T cd05092 78 EGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVG- 156 (280)
T ss_pred cCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEc-
Confidence 99999999999985 67666653321 01112378889999999999999999999999999999999998
Q ss_pred cCCCeEEEEecCCccccCCCc-----cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 557 YQRCEIKIIDLGSSCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 557 ~~~~~IKL~DFGls~~~~~~~-----~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
+++.++|+|||++....... ....+++.|+|||.+.+..++.++|||||||++|+|++ |.+||
T Consensus 157 -~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~ 225 (280)
T cd05092 157 -QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPW 225 (280)
T ss_pred -CCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCC
Confidence 47889999999986443221 12234678999999999899999999999999999998 99998
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-28 Score=276.56 Aligned_cols=200 Identities=26% Similarity=0.350 Sum_probs=168.0
Q ss_pred cCceEEEEEeccCCCCceeEEEeC-----CCCcEEEEEEEecCch--hhhhHHHHHHHHHHhcccCCCCCCceEEEeeEe
Q 007035 413 AGRYYVTEYLGSAAFSKVFQAQDL-----HTGVDVCLKIIKNDKD--FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYF 485 (621)
Q Consensus 413 ~~rY~I~~~LG~G~fG~Vyka~d~-----~tg~~VAlKii~~~~~--~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f 485 (621)
..+.+..+.||.|+||+||+|+-. .....||||.++...+ ...++.+|++++..++ |||||++++++
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~------H~nIVrLlGVC 558 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQ------HPNIVRLLGVC 558 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhcc------CCCeEEEEEEE
Confidence 456777888999999999999843 2446799999986443 4677899999998885 78999999999
Q ss_pred EecCeEEEEEeccc-cchHHHHHhhhccCC--------CccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEec
Q 007035 486 YHLEHLFIVCELLR-ANLYEFQKFNQESGG--------EAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS 556 (621)
Q Consensus 486 ~~~~~l~LVmEyl~-gsLld~l~~~~~~~~--------~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~ 556 (621)
..++.+++|+|||. |+|.+++........ ...++..+...|+.||+.||.||-++.+|||||..+|+||.
T Consensus 559 ~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVg- 637 (774)
T KOG1026|consen 559 REGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVG- 637 (774)
T ss_pred ccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceec-
Confidence 99999999999998 788888875433221 22388889999999999999999999999999999999999
Q ss_pred cCCCeEEEEecCCccccCCCcccccc-----CCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 557 YQRCEIKIIDLGSSCFQTDNLCLYVQ-----SRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 557 ~~~~~IKL~DFGls~~~~~~~~~~~g-----t~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
+.-.|||+|||+++..-......++ ..+|||||.|+..+|+.++||||+||+|||+++ |+.|+
T Consensus 638 -e~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy 706 (774)
T KOG1026|consen 638 -ENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPY 706 (774)
T ss_pred -cceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcc
Confidence 4889999999999865544333333 568999999999999999999999999999998 88776
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-27 Score=248.54 Aligned_cols=194 Identities=25% Similarity=0.405 Sum_probs=161.9
Q ss_pred CceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc----hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecC
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~ 489 (621)
+.|...+.||+|+||+||+|++..+++.|++|.+.... .....+..|+.+++.+ .|||++++++++.+..
T Consensus 21 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l------~h~~iv~~~~~~~~~~ 94 (313)
T cd06633 21 EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQL------KHPNTIEYKGCYLKEH 94 (313)
T ss_pred HHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhC------CCCCCccEEEEEEeCC
Confidence 34777888999999999999999999999999986432 2234456666666655 4789999999999999
Q ss_pred eEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCC
Q 007035 490 HLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (621)
Q Consensus 490 ~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGl 569 (621)
..++||||+.+++.+.+..... .+++..+..++.||+.||.|||++||+|+||+|+||+++. ++.++|+|||+
T Consensus 95 ~~~lv~e~~~~~l~~~l~~~~~-----~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~--~~~~kL~dfg~ 167 (313)
T cd06633 95 TAWLVMEYCLGSASDLLEVHKK-----PLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTE--PGQVKLADFGS 167 (313)
T ss_pred EEEEEEecCCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECC--CCCEEEeecCC
Confidence 9999999999988887764322 2788899999999999999999999999999999999984 78899999998
Q ss_pred ccccCCCccccccCCcccCchhhc---CCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 007035 570 SCFQTDNLCLYVQSRSYRAPEVII---GLPYDQKIDLWSLGCILAELWTGEVCLI 621 (621)
Q Consensus 570 s~~~~~~~~~~~gt~~Y~APEvl~---~~~~s~ksDIWSLGvILyELltG~~PF~ 621 (621)
+..... .....++..|+|||++. ...++.++|||||||++|+|++|..||.
T Consensus 168 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~ 221 (313)
T cd06633 168 ASKSSP-ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 221 (313)
T ss_pred CcccCC-CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 764432 23456788999999984 3557889999999999999999999973
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.3e-28 Score=255.51 Aligned_cols=196 Identities=33% Similarity=0.551 Sum_probs=161.8
Q ss_pred eecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecC---chhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEe
Q 007035 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (621)
Q Consensus 411 ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~---~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~ 487 (621)
.+.++|++.+.||.|+||.||+|.+..+++.+|+|.+... ........+|+.+++.+. +|+||+++++++..
T Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~-----~h~ni~~~~~~~~~ 78 (337)
T cd07852 4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELG-----DHPNIVKLLNVIKA 78 (337)
T ss_pred hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhc-----CCCCccceeeeecc
Confidence 4567899999999999999999999999999999987542 222344566777777662 47899999999865
Q ss_pred c--CeEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEE
Q 007035 488 L--EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKII 565 (621)
Q Consensus 488 ~--~~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~ 565 (621)
. ..+++||||++++|.+.+... .+.+..++.++.||+.||.|||+.||+||||+|+||+++ .++.++|+
T Consensus 79 ~~~~~~~lv~e~~~~~L~~~~~~~-------~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~--~~~~~kl~ 149 (337)
T cd07852 79 ENDKDIYLVFEYMETDLHAVIRAN-------ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLN--SDCRVKLA 149 (337)
T ss_pred CCCceEEEEecccccCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc--CCCcEEEe
Confidence 4 478999999998887776532 277888889999999999999999999999999999998 48899999
Q ss_pred ecCCccccCCC--------ccccccCCcccCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 566 DLGSSCFQTDN--------LCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 566 DFGls~~~~~~--------~~~~~gt~~Y~APEvl~~-~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
|||++...... .....+++.|+|||.+.+ ..++.++||||||+++|+|++|++||
T Consensus 150 d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf 213 (337)
T cd07852 150 DFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLF 213 (337)
T ss_pred eccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCC
Confidence 99988654322 223467889999998865 45788999999999999999999997
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.1e-27 Score=236.59 Aligned_cols=192 Identities=31% Similarity=0.440 Sum_probs=164.6
Q ss_pred ceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc---hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeE
Q 007035 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (621)
Q Consensus 415 rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~---~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l 491 (621)
+|++.+.||+|++|.||++.+..+++.|++|.+.... ...+.+.+|++++..++ |++++++++++...+..
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~------~~~i~~~~~~~~~~~~~ 74 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLK------HPNIVKYIGSIETSDSL 74 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCC------CCCccEEEEEEEeCCEE
Confidence 5889999999999999999999999999999987654 34456677777776663 67899999999999999
Q ss_pred EEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCc
Q 007035 492 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (621)
Q Consensus 492 ~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls 570 (621)
++||||+.+ +|.+.+.... .+++..++.++.|++.||.+||+.||+||||+|+||+++. ++.++|+|||.+
T Consensus 75 ~~v~e~~~~~~L~~~~~~~~------~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~--~~~~~l~d~~~~ 146 (254)
T cd06627 75 YIILEYAENGSLRQIIKKFG------PFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTK--DGVVKLADFGVA 146 (254)
T ss_pred EEEEecCCCCcHHHHHHhcc------CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECC--CCCEEEeccccc
Confidence 999999986 6666655331 2889999999999999999999999999999999999985 788999999988
Q ss_pred cccCCCcc---ccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 571 CFQTDNLC---LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 571 ~~~~~~~~---~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
........ ...++..|+|||.+.+..++.++||||||+++|+|++|+.||
T Consensus 147 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~ 199 (254)
T cd06627 147 TKLNDVSKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPY 199 (254)
T ss_pred eecCCCcccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCC
Confidence 76544322 346788899999998888899999999999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=240.90 Aligned_cols=188 Identities=28% Similarity=0.388 Sum_probs=154.4
Q ss_pred EEeccCCCCceeEEEeCC-CC--cEEEEEEEecCch--hhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeEEEE
Q 007035 420 EYLGSAAFSKVFQAQDLH-TG--VDVCLKIIKNDKD--FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIV 494 (621)
Q Consensus 420 ~~LG~G~fG~Vyka~d~~-tg--~~VAlKii~~~~~--~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l~LV 494 (621)
+.||.|++|.||+|.+.. .+ ..||+|.+..... ..+.+..|+.+++.+ .||||+++++.+.. ...++|
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l------~h~~iv~~~~~~~~-~~~~~v 73 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSL------DHENLIRLYGVVLT-HPLMMV 73 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhc------CCCCccceeEEEcC-CeEEEE
Confidence 368999999999999765 33 3689999886543 345566677776655 47899999999988 899999
Q ss_pred Eeccc-cchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCcccc
Q 007035 495 CELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQ 573 (621)
Q Consensus 495 mEyl~-gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~~~ 573 (621)
|||+. ++|.+.+..... ..+++..++.++.||+.||.|||+++++|+||+|+||+++. ++.+||+|||++...
T Consensus 74 ~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~--~~~~kl~dfg~~~~~ 147 (257)
T cd05040 74 TELAPLGSLLDRLRKDAL----GHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLAS--DDKVKIGDFGLMRAL 147 (257)
T ss_pred EEecCCCcHHHHHHhccc----ccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEec--CCEEEeccccccccc
Confidence 99997 577777654331 23789999999999999999999999999999999999995 689999999988665
Q ss_pred CCCc------cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 574 TDNL------CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 574 ~~~~------~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
.... ....++..|+|||.+.+..++.++|||||||++|+|++ |+.||
T Consensus 148 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~ 201 (257)
T cd05040 148 PQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPW 201 (257)
T ss_pred cccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCC
Confidence 3321 12345678999999998889999999999999999998 99997
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-27 Score=240.51 Aligned_cols=192 Identities=28% Similarity=0.399 Sum_probs=156.3
Q ss_pred EEEeccCCCCceeEEEeCCCCcEEEEEEEecCc-hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeEEEEEec
Q 007035 419 TEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCEL 497 (621)
Q Consensus 419 ~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~-~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l~LVmEy 497 (621)
...||+|+||.||+|.+..++..|++|.+.... .....+.+|+.+++.+ .|+||+++++++...+..++|+||
T Consensus 13 ~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l------~h~~iv~~~~~~~~~~~~~lv~e~ 86 (268)
T cd06624 13 RVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYL------KHRNIVQYLGSDSENGFFKIFMEQ 86 (268)
T ss_pred eEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhc------CCCCeeeeeeeeccCCEEEEEEec
Confidence 357999999999999999999999999887543 2345667788777766 478999999999999999999999
Q ss_pred ccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCccccCCC
Q 007035 498 LRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN 576 (621)
Q Consensus 498 l~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~~~~~~ 576 (621)
+.+ +|.+.+...... ...+...+..++.||+.||.|||+++|+||||||+||+++. ..+.++|+|||++......
T Consensus 87 ~~~~~L~~~l~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~-~~~~~~l~dfg~~~~~~~~ 162 (268)
T cd06624 87 VPGGSLSALLRSKWGP---LKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNT-YSGVVKISDFGTSKRLAGI 162 (268)
T ss_pred CCCCCHHHHHHHhccc---CCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcC-CCCeEEEecchhheecccC
Confidence 985 666666533211 11267788899999999999999999999999999999974 3568999999987654321
Q ss_pred ---ccccccCCcccCchhhcCCC--CCchhhHHHHHHHHHHHHhCCCCC
Q 007035 577 ---LCLYVQSRSYRAPEVIIGLP--YDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 577 ---~~~~~gt~~Y~APEvl~~~~--~s~ksDIWSLGvILyELltG~~PF 620 (621)
.....+++.|+|||.+.+.. ++.++|+||||+++|+|++|+.||
T Consensus 163 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~ 211 (268)
T cd06624 163 NPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPF 211 (268)
T ss_pred CCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCC
Confidence 22345788999999986643 788999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-27 Score=236.60 Aligned_cols=196 Identities=31% Similarity=0.450 Sum_probs=166.7
Q ss_pred ceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc---hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeE
Q 007035 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (621)
Q Consensus 415 rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~---~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l 491 (621)
+|.+.+.||.|++|.||++.+..++..+++|++.... .....+.+|+++++.++ |+|++++++.+......
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~------~~~~~~~~~~~~~~~~~ 74 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLN------HPNIIKYYESFEEKGKL 74 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcC------CCChhheEEEEecCCEE
Confidence 5899999999999999999999999999999987542 34456677777777664 67999999999999999
Q ss_pred EEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCc
Q 007035 492 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (621)
Q Consensus 492 ~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls 570 (621)
++|+||+++ +|.+.+..... ....+++..+..++.+|+.||.+||+.|++|+||+|+||+++. ++.++|+|||++
T Consensus 75 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~--~~~~~l~d~~~~ 150 (258)
T cd08215 75 CIVMEYADGGDLSQKIKKQKK--EGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTS--NGLVKLGDFGIS 150 (258)
T ss_pred EEEEEecCCCcHHHHHHHhhc--cCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcC--CCcEEECCccce
Confidence 999999985 67776655421 1233899999999999999999999999999999999999984 788999999988
Q ss_pred cccCCCc---cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 571 CFQTDNL---CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 571 ~~~~~~~---~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
....... ....+++.|+|||.+.+..++.++|+||||+++|+|++|+.||
T Consensus 151 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~ 203 (258)
T cd08215 151 KVLSSTVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPF 203 (258)
T ss_pred eecccCcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCC
Confidence 6544332 2346788899999999888999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-27 Score=241.78 Aligned_cols=197 Identities=30% Similarity=0.471 Sum_probs=158.7
Q ss_pred ceEEEEEeccCCCCceeEEEeCC-CCcEEEEEEEecCc-----------hhhhhHHHHHHHHHHhcccCCCCCCceEEEe
Q 007035 415 RYYVTEYLGSAAFSKVFQAQDLH-TGVDVCLKIIKNDK-----------DFFDQSLDEIKLLKLVNKNDPADEHHILRLY 482 (621)
Q Consensus 415 rY~I~~~LG~G~fG~Vyka~d~~-tg~~VAlKii~~~~-----------~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~ 482 (621)
.|++.+.||.|+||.||++.+.. +++.+|+|.+.... ....+...|+.++.. ...||||++++
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~-----~~~h~~i~~~~ 75 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKE-----QLRHPNIVRYY 75 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhh-----cCCCCCeeeEE
Confidence 37888999999999999999887 78899999875321 112223344443332 24689999999
Q ss_pred eEeEecCeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHH-CCeecccCCCccEEEeccCCC
Q 007035 483 DYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS-LGIIHCDLKPENILIKSYQRC 560 (621)
Q Consensus 483 ~~f~~~~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs-~gIvHrDLKP~NILl~~~~~~ 560 (621)
+++...++.++||||+.+ +|.+.+...... ...+++..++.++.|++.||.|||+ .+++|+||+|+||+++. ++
T Consensus 76 ~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~--~~ 151 (269)
T cd08528 76 KTFLENDRLYIVMDLIEGAPLGEHFNSLKEK--KQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGE--DD 151 (269)
T ss_pred eeEccCCeEEEEEecCCCCcHHHHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECC--CC
Confidence 999999999999999985 676666432221 1238889999999999999999996 68999999999999984 78
Q ss_pred eEEEEecCCccccCCC--ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 561 EIKIIDLGSSCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 561 ~IKL~DFGls~~~~~~--~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
.++|+|||.+...... .....++..|+|||.+.+..++.++|+||||+++|+|++|+.||
T Consensus 152 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~ 213 (269)
T cd08528 152 KVTITDFGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPF 213 (269)
T ss_pred cEEEecccceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcc
Confidence 8999999998664433 23356788899999999888999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-27 Score=244.81 Aligned_cols=194 Identities=25% Similarity=0.327 Sum_probs=160.8
Q ss_pred CceEEEEEeccCCCCceeEEEeC----CCCcEEEEEEEecCch--hhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEe
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQDL----HTGVDVCLKIIKNDKD--FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d~----~tg~~VAlKii~~~~~--~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~ 487 (621)
.+|++++.||+|+||.||++... .++..+|+|++..... ....+.+|+++++.+ .|+||+++++++..
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l------~~~~i~~~~~~~~~ 77 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTL------DHENIVKYKGVCEK 77 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhC------CCCChheEEeeeec
Confidence 46888999999999999999854 3588999999986544 356677787777766 36799999999887
Q ss_pred --cCeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEE
Q 007035 488 --LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKI 564 (621)
Q Consensus 488 --~~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL 564 (621)
....++||||+.+ +|.+++..... .+++..+..++.||+.||.|||++||+|+||||+||+++. ++.++|
T Consensus 78 ~~~~~~~lv~e~~~~~~l~~~l~~~~~-----~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~--~~~~~l 150 (284)
T cd05038 78 PGGRSLRLIMEYLPSGSLRDYLQRHRD-----QINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVES--EDLVKI 150 (284)
T ss_pred CCCCceEEEEecCCCCCHHHHHHhCcc-----ccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcC--CCCEEE
Confidence 5689999999974 77777754332 2888899999999999999999999999999999999984 688999
Q ss_pred EecCCccccCCCcc------ccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 565 IDLGSSCFQTDNLC------LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 565 ~DFGls~~~~~~~~------~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
+|||++........ ...++..|+|||.+.+..++.++||||||+++|+|++|+.||
T Consensus 151 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~ 212 (284)
T cd05038 151 SDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPS 212 (284)
T ss_pred cccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCc
Confidence 99999876552211 123355699999998888999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-27 Score=241.92 Aligned_cols=195 Identities=24% Similarity=0.342 Sum_probs=157.6
Q ss_pred ecCceEEEEEeccCCCCceeEEEeCCC---CcEEEEEEEecCc--hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeE
Q 007035 412 IAGRYYVTEYLGSAAFSKVFQAQDLHT---GVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (621)
Q Consensus 412 i~~rY~I~~~LG~G~fG~Vyka~d~~t---g~~VAlKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~ 486 (621)
-..+|.+.+.||.|+||.||+|.+... ...|++|...... ...+.+.+|+.+++.+ .||||+++++++.
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~------~h~~i~~~~~~~~ 77 (270)
T cd05056 4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQF------DHPHIVKLIGVIT 77 (270)
T ss_pred chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhC------CCCchhceeEEEc
Confidence 346799999999999999999987544 4568999887543 3445667777777766 4789999999887
Q ss_pred ecCeEEEEEeccc-cchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEE
Q 007035 487 HLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKII 565 (621)
Q Consensus 487 ~~~~l~LVmEyl~-gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~ 565 (621)
. ...++||||+. ++|.+++..... .+++..++.++.||+.||.|||+.+++||||||+||+++. .+.++|+
T Consensus 78 ~-~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~--~~~~~l~ 149 (270)
T cd05056 78 E-NPVWIVMELAPLGELRSYLQVNKY-----SLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSS--PDCVKLG 149 (270)
T ss_pred C-CCcEEEEEcCCCCcHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEec--CCCeEEc
Confidence 5 55789999997 467777654322 2788999999999999999999999999999999999984 7789999
Q ss_pred ecCCccccCCCcc----ccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 566 DLGSSCFQTDNLC----LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 566 DFGls~~~~~~~~----~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
|||++........ ...++..|+|||.+....++.++||||||+++|+|++ |..||
T Consensus 150 d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf 209 (270)
T cd05056 150 DFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPF 209 (270)
T ss_pred cCceeeecccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCC
Confidence 9998865433211 1223467999999988889999999999999999986 99998
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-28 Score=264.96 Aligned_cols=196 Identities=29% Similarity=0.515 Sum_probs=173.4
Q ss_pred CceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhh---------hHHHHHHHHHHhcccCCCCCCceEEEeeE
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFD---------QSLDEIKLLKLVNKNDPADEHHILRLYDY 484 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~---------~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~ 484 (621)
..|..+..||.|+||.|++|.++.+...|+||.+.+++-..+ .+-.|+.||..++++ .|+||++++++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~---sH~NIlKlLdf 637 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKH---SHENILKLLDF 637 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhc---Cccchhhhhhe
Confidence 459999999999999999999999999999999987654333 344599999999876 48999999999
Q ss_pred eEecCeEEEEEecccc--chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeE
Q 007035 485 FYHLEHLFIVCELLRA--NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEI 562 (621)
Q Consensus 485 f~~~~~l~LVmEyl~g--sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~I 562 (621)
|+++++.||+||..+. .|.+++..... +.+.+++.|++|++.|+++||+.||||||||-+||.+++ +|-+
T Consensus 638 FEddd~yyl~te~hg~gIDLFd~IE~kp~------m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~--~g~~ 709 (772)
T KOG1152|consen 638 FEDDDYYYLETEVHGEGIDLFDFIEFKPR------MDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDS--NGFV 709 (772)
T ss_pred eecCCeeEEEecCCCCCcchhhhhhccCc------cchHHHHHHHHHHHhccccccccCceecccccccEEEec--CCeE
Confidence 9999999999998874 57777766543 889999999999999999999999999999999999995 8999
Q ss_pred EEEecCCccccC-CCccccccCCcccCchhhcCCCC-CchhhHHHHHHHHHHHHhCCCCC
Q 007035 563 KIIDLGSSCFQT-DNLCLYVQSRSYRAPEVIIGLPY-DQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 563 KL~DFGls~~~~-~~~~~~~gt~~Y~APEvl~~~~~-s~ksDIWSLGvILyELltG~~PF 620 (621)
||+|||.+.... .+.-.++||..|.|||++.|.+| +..-|||+||++||-+...+.||
T Consensus 710 klidfgsaa~~ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpy 769 (772)
T KOG1152|consen 710 KLIDFGSAAYTKSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPY 769 (772)
T ss_pred EEeeccchhhhcCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCC
Confidence 999999987654 45667899999999999999886 67799999999999999999998
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-27 Score=238.12 Aligned_cols=187 Identities=27% Similarity=0.399 Sum_probs=152.0
Q ss_pred EEeccCCCCceeEEEeCCCCcEEEEEEEecCc--hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeEEEEEec
Q 007035 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCEL 497 (621)
Q Consensus 420 ~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l~LVmEy 497 (621)
+.||+|+||.||++.. .++..+|+|++.... .....+.+|+.+++.+ +||||+++++++......++||||
T Consensus 1 ~~ig~g~~g~vy~~~~-~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~~~~~~~lv~e~ 73 (250)
T cd05085 1 ELLGKGNFGEVFKGTL-KDKTPVAVKTCKEDLPQELKIKFLSEARILKQY------DHPNIVKLIGVCTQRQPIYIVMEL 73 (250)
T ss_pred CccCCCCCceEEEEEe-cCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhC------CCCCcCeEEEEEecCCccEEEEEC
Confidence 3689999999999985 578899999987543 2233456677766655 578999999999999999999999
Q ss_pred ccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCccccCCC
Q 007035 498 LRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN 576 (621)
Q Consensus 498 l~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~~~~~~ 576 (621)
+.+ +|.+.+.... ..+.+..+..++.|++.||.|||++|++||||+|+||+++ .++.++|+|||++......
T Consensus 74 ~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~--~~~~~~l~d~g~~~~~~~~ 146 (250)
T cd05085 74 VPGGDFLSFLRKKK-----DELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVG--ENNVLKISDFGMSRQEDDG 146 (250)
T ss_pred CCCCcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEc--CCCeEEECCCccceecccc
Confidence 975 6666554322 1278889999999999999999999999999999999998 4788999999998654332
Q ss_pred cc----ccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 577 LC----LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 577 ~~----~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
.. ...+++.|+|||++.+..++.++||||||+++|+|++ |..||
T Consensus 147 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~ 195 (250)
T cd05085 147 IYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPY 195 (250)
T ss_pred ccccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCC
Confidence 21 1233567999999988889999999999999999998 99887
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-27 Score=242.00 Aligned_cols=190 Identities=21% Similarity=0.266 Sum_probs=146.0
Q ss_pred EEeccCCCCceeEEEeCC------------CCcEEEEEEEecCch-hhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeE
Q 007035 420 EYLGSAAFSKVFQAQDLH------------TGVDVCLKIIKNDKD-FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (621)
Q Consensus 420 ~~LG~G~fG~Vyka~d~~------------tg~~VAlKii~~~~~-~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~ 486 (621)
+.||.|+||.||+|.... ....|++|.+..... ....+.+|+.+++.+ .||||+++++++.
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l------~hp~iv~~~~~~~ 74 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQV------SHKHIVLLYGVCV 74 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhC------CCCCEeeEEEEEe
Confidence 368999999999998432 233588888765332 223445555555544 5789999999999
Q ss_pred ecCeEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCC-----Ce
Q 007035 487 HLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQR-----CE 561 (621)
Q Consensus 487 ~~~~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~-----~~ 561 (621)
.....++||||++++.++.+..... ..+++..+..++.||+.||+|||+++|+||||||+|||++.+.. ..
T Consensus 75 ~~~~~~lv~e~~~~~~l~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~ 150 (262)
T cd05077 75 RDVENIMVEEFVEFGPLDLFMHRKS----DVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPF 150 (262)
T ss_pred cCCCCEEEEecccCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCce
Confidence 9999999999999765554433221 22788899999999999999999999999999999999974221 23
Q ss_pred EEEEecCCccccCCCccccccCCcccCchhhc-CCCCCchhhHHHHHHHHHHHH-hCCCCC
Q 007035 562 IKIIDLGSSCFQTDNLCLYVQSRSYRAPEVII-GLPYDQKIDLWSLGCILAELW-TGEVCL 620 (621)
Q Consensus 562 IKL~DFGls~~~~~~~~~~~gt~~Y~APEvl~-~~~~s~ksDIWSLGvILyELl-tG~~PF 620 (621)
++++|||++...... ....++..|+|||.+. +..++.++|||||||++|+|+ +|+.||
T Consensus 151 ~~l~d~g~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~ 210 (262)
T cd05077 151 IKLSDPGIPITVLSR-QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPL 210 (262)
T ss_pred eEeCCCCCCccccCc-ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCC
Confidence 899999988654332 2245678899999987 456899999999999999998 588876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-27 Score=242.37 Aligned_cols=199 Identities=21% Similarity=0.316 Sum_probs=162.1
Q ss_pred CceEEEEEeccCCCCceeEEEeCC-----CCcEEEEEEEecCch--hhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeE
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQDLH-----TGVDVCLKIIKNDKD--FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d~~-----tg~~VAlKii~~~~~--~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~ 486 (621)
.+|++++.||.|+||+||+|+.+. ..+.+++|.+..... ....+.+|+++++.+. |+||+++++++.
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~~~~~ 78 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLS------HKNVVRLLGLCR 78 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcC------CcceeeeEEEEC
Confidence 679999999999999999999654 356799998865432 3566788888888774 679999999999
Q ss_pred ecCeEEEEEeccc-cchHHHHHhhhccC---CCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeE
Q 007035 487 HLEHLFIVCELLR-ANLYEFQKFNQESG---GEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEI 562 (621)
Q Consensus 487 ~~~~l~LVmEyl~-gsLld~l~~~~~~~---~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~I 562 (621)
.....++||||+. ++|.+++....... ....+++..+..++.||+.||.|||+++|+||||||+||+++. ++.+
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~--~~~~ 156 (275)
T cd05046 79 EAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSS--QREV 156 (275)
T ss_pred CCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeC--CCcE
Confidence 9899999999998 57777776443111 1123889999999999999999999999999999999999984 7889
Q ss_pred EEEecCCccccCCC----ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 563 KIIDLGSSCFQTDN----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 563 KL~DFGls~~~~~~----~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
+|+|||++...... .....++..|+|||.+.+..++.++||||||+++|+|++ |..||
T Consensus 157 ~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~ 219 (275)
T cd05046 157 KVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPF 219 (275)
T ss_pred EEcccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCc
Confidence 99999987543221 122344667999999988888999999999999999998 78787
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.3e-27 Score=241.81 Aligned_cols=201 Identities=22% Similarity=0.274 Sum_probs=160.6
Q ss_pred ecCceEEEEEeccCCCCceeEEEeCC----CCcEEEEEEEecCc--hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEe
Q 007035 412 IAGRYYVTEYLGSAAFSKVFQAQDLH----TGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYF 485 (621)
Q Consensus 412 i~~rY~I~~~LG~G~fG~Vyka~d~~----tg~~VAlKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f 485 (621)
-.++|++.+.||+|+||.||+|.+.. ++..|++|++.... .....+.+|+.+++.+ .|+||+++++++
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l------~h~ni~~~~~~~ 77 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGL------SHQNILPILHVC 77 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhC------CCCCCCeEEEEE
Confidence 35789999999999999999999876 36889999887532 2344556676666655 578999999987
Q ss_pred Ee-cCeEEEEEeccc-cchHHHHHhhhccC--CCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCe
Q 007035 486 YH-LEHLFIVCELLR-ANLYEFQKFNQESG--GEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCE 561 (621)
Q Consensus 486 ~~-~~~l~LVmEyl~-gsLld~l~~~~~~~--~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~ 561 (621)
.. ....++++||+. ++|.+++....... ....+++..+..++.||+.||.|||+++++||||||+||+++. ++.
T Consensus 78 ~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~--~~~ 155 (280)
T cd05043 78 IEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDE--ELQ 155 (280)
T ss_pred ecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcC--CCc
Confidence 65 467899999997 57777665432210 1134889999999999999999999999999999999999984 788
Q ss_pred EEEEecCCccccCCCc-----cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 562 IKIIDLGSSCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 562 IKL~DFGls~~~~~~~-----~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
+||+|||++....... ....++..|+|||++.+..++.++|||||||++|+|++ |++||
T Consensus 156 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~ 220 (280)
T cd05043 156 VKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPY 220 (280)
T ss_pred EEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCc
Confidence 9999999986542211 11234667999999998889999999999999999999 99998
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.8e-27 Score=237.54 Aligned_cols=196 Identities=29% Similarity=0.386 Sum_probs=163.0
Q ss_pred ceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc---hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeE
Q 007035 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (621)
Q Consensus 415 rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~---~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l 491 (621)
+|++.+.||.|++|.||++++..+++.+++|.+.... .......+|+.+++.+ .|+||+++++++......
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l------~~~~i~~~~~~~~~~~~~ 74 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASV------NHPNIISYKEAFLDGNKL 74 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhC------CCCCchhhhhhhccCCEE
Confidence 5899999999999999999999999999999987532 2233445566666555 378999999999999999
Q ss_pred EEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCc
Q 007035 492 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (621)
Q Consensus 492 ~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls 570 (621)
++||||+++ +|.+.+...... ...+++..++.++.|++.||.|||+.|++|+||+|.||+++. ++.++|+|||++
T Consensus 75 ~~v~e~~~~~~L~~~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~--~~~~kl~d~g~~ 150 (256)
T cd08530 75 CIVMEYAPFGDLSKAISKRKKK--RKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVA--NDLVKIGDLGIS 150 (256)
T ss_pred EEEehhcCCCCHHHHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEec--CCcEEEeeccch
Confidence 999999975 666665543221 223788899999999999999999999999999999999995 778999999988
Q ss_pred cccCCC-ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 571 CFQTDN-LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 571 ~~~~~~-~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
...... .....+++.|++||.+.+..++.++|+||||+++|+|++|+.||
T Consensus 151 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~ 201 (256)
T cd08530 151 KVLKKNMAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPF 201 (256)
T ss_pred hhhccCCcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 655433 22245688999999999988999999999999999999999997
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=244.64 Aligned_cols=194 Identities=34% Similarity=0.561 Sum_probs=160.1
Q ss_pred eEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhh--hhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeEEE
Q 007035 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFF--DQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFI 493 (621)
Q Consensus 416 Y~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~--~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l~L 493 (621)
|++.+.||.|++|+||+|++..+++.|+||.+....... ....+|+..++.+. .|+||+++++++...++.++
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~-----~h~~i~~~~~~~~~~~~~~l 75 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLN-----EHPNIVKLKEVFRENDELYF 75 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhcc-----CCCCchhHHHHhhcCCcEEE
Confidence 678899999999999999998899999999887543211 22334555554442 37899999999999999999
Q ss_pred EEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCcccc
Q 007035 494 VCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQ 573 (621)
Q Consensus 494 VmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~~~ 573 (621)
||||+++++++.+..... ..+++..+..++.||+.+|.|||+++++|+||+|+||+++. ++.++|+|||++...
T Consensus 76 v~e~~~~~l~~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~--~~~~~l~d~~~~~~~ 149 (283)
T cd07830 76 VFEYMEGNLYQLMKDRKG----KPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSG--PEVVKIADFGLAREI 149 (283)
T ss_pred EEecCCCCHHHHHHhccc----ccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcC--CCCEEEeecccceec
Confidence 999998898888765431 22789999999999999999999999999999999999994 889999999998655
Q ss_pred CCC--ccccccCCcccCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 574 TDN--LCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 574 ~~~--~~~~~gt~~Y~APEvl~~-~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
... .....++..|+|||++.+ ..++.++|+||||+++|+|++|++||
T Consensus 150 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~ 199 (283)
T cd07830 150 RSRPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLF 199 (283)
T ss_pred cCCCCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCcc
Confidence 432 223467888999998854 45789999999999999999999887
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=243.42 Aligned_cols=192 Identities=34% Similarity=0.524 Sum_probs=164.0
Q ss_pred eEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecC---chhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeEE
Q 007035 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLF 492 (621)
Q Consensus 416 Y~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~---~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l~ 492 (621)
|++.+.||.|++|.||+|++..+++.+|+|++... .........|+.+++.++ |++|+++++++......+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~------~~~i~~~~~~~~~~~~~~ 74 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELK------HPNIVKLLDVIHTERKLY 74 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcC------CCCHHHHHhhhhcCCceE
Confidence 67788999999999999999999999999998864 333455667777777664 789999999999999999
Q ss_pred EEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCccc
Q 007035 493 IVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF 572 (621)
Q Consensus 493 LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~~ 572 (621)
+||||++++|.+++.... ..+++..+..++.||+.||.+||+++|+||||+|+||+++. ++.++|+|||.+..
T Consensus 75 ~v~e~~~~~l~~~i~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~--~~~~~l~d~g~~~~ 147 (282)
T cd07829 75 LVFEYCDMDLKKYLDKRP-----GPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINR--DGVLKLADFGLARA 147 (282)
T ss_pred EEecCcCcCHHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcC--CCCEEEecCCcccc
Confidence 999999998888877542 12889999999999999999999999999999999999984 78899999998865
Q ss_pred cCCCc---cccccCCcccCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 573 QTDNL---CLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 573 ~~~~~---~~~~gt~~Y~APEvl~~~-~~s~ksDIWSLGvILyELltG~~PF 620 (621)
..... ....++..|+|||.+.+. .++.++||||||+++|+|++|++||
T Consensus 148 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~ 199 (282)
T cd07829 148 FGIPLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLF 199 (282)
T ss_pred cCCCccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCC
Confidence 43322 223457789999999776 7899999999999999999999887
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.3e-28 Score=243.88 Aligned_cols=189 Identities=22% Similarity=0.344 Sum_probs=149.0
Q ss_pred EEeccCCCCceeEEEeCCCCcE-------EEEEEEecCc-hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeE
Q 007035 420 EYLGSAAFSKVFQAQDLHTGVD-------VCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (621)
Q Consensus 420 ~~LG~G~fG~Vyka~d~~tg~~-------VAlKii~~~~-~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l 491 (621)
+.||+|+||.||+|.+...+.. +++|.+.... ...+.+.+|..+++.+ .||||+++++++......
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~------~h~~iv~~~~~~~~~~~~ 74 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQL------SHKHLVLNYGVCVCGDES 74 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhC------CCCChhheeeEEEeCCCc
Confidence 3699999999999998655443 8888876433 2334556666666554 578999999999999999
Q ss_pred EEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCC------CeEEE
Q 007035 492 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQR------CEIKI 564 (621)
Q Consensus 492 ~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~------~~IKL 564 (621)
++||||+.+ +|.+++..... .+++..+..++.||+.||.|||+++|+||||||+|||++.+.. +.+++
T Consensus 75 ~lv~e~~~~g~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l 149 (258)
T cd05078 75 IMVQEYVKFGSLDTYLKKNKN-----LINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKL 149 (258)
T ss_pred EEEEecCCCCcHHHHHhcCCC-----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEe
Confidence 999999986 56666554322 2788889999999999999999999999999999999985322 24899
Q ss_pred EecCCccccCCCccccccCCcccCchhhcCC-CCCchhhHHHHHHHHHHHHhCC-CCC
Q 007035 565 IDLGSSCFQTDNLCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGE-VCL 620 (621)
Q Consensus 565 ~DFGls~~~~~~~~~~~gt~~Y~APEvl~~~-~~s~ksDIWSLGvILyELltG~-~PF 620 (621)
+|||++...... ....+++.|+|||++.+. .++.++||||||+++|+|++|. +||
T Consensus 150 ~d~g~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~ 206 (258)
T cd05078 150 SDPGISITVLPK-EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPL 206 (258)
T ss_pred cccccccccCCc-hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCCh
Confidence 999987654332 234678899999999874 4789999999999999999995 554
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=248.80 Aligned_cols=194 Identities=24% Similarity=0.399 Sum_probs=161.8
Q ss_pred cCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecC----chhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEec
Q 007035 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (621)
Q Consensus 413 ~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~----~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~ 488 (621)
..+|.+.+.||.|+||.||+|+++.+++.+++|.+... .....++.+|+++++.+ .|+|++++++++...
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~~~ 87 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL------RHPNTIQYRGCYLRE 87 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhC------CCCCcccEEEEEEcC
Confidence 34588888999999999999999999999999988642 12234455677766665 478999999999999
Q ss_pred CeEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecC
Q 007035 489 EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (621)
Q Consensus 489 ~~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFG 568 (621)
...++||||+.+++.+.+..... .+++..+..++.|++.||.|||+.+++||||+|+||+++. ++.++|+|||
T Consensus 88 ~~~~lv~e~~~~~l~~~~~~~~~-----~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~--~~~~kl~dfg 160 (308)
T cd06634 88 HTAWLVMEYCLGSASDLLEVHKK-----PLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSE--PGLVKLGDFG 160 (308)
T ss_pred CeeEEEEEccCCCHHHHHHHcCC-----CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECC--CCcEEECCcc
Confidence 99999999999888777654321 2788899999999999999999999999999999999984 7889999999
Q ss_pred CccccCCCccccccCCcccCchhhc---CCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 569 SSCFQTDNLCLYVQSRSYRAPEVII---GLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 569 ls~~~~~~~~~~~gt~~Y~APEvl~---~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
++...... ....+++.|+|||.+. ...++.++|||||||++|+|++|..||
T Consensus 161 ~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~ 214 (308)
T cd06634 161 SASIMAPA-NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214 (308)
T ss_pred cceeecCc-ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCC
Confidence 88654432 3346788999999985 345788999999999999999999997
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.8e-27 Score=236.14 Aligned_cols=187 Identities=26% Similarity=0.401 Sum_probs=153.2
Q ss_pred EEeccCCCCceeEEEeCCCCcEEEEEEEecCch--hhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeEEEEEec
Q 007035 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD--FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCEL 497 (621)
Q Consensus 420 ~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~--~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l~LVmEy 497 (621)
++||.|+||.||++.+.. ++.|++|++..... ....+..|+.+++.+ +|+||+++++++....+.++||||
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l------~~~~i~~~~~~~~~~~~~~~v~e~ 73 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQY------DHPNIVKLIGVCVQKQPIYIVMEL 73 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhC------CCCCeEEEEEEEecCCCeEEEEEc
Confidence 369999999999999877 99999998875432 334566677766655 578999999999999999999999
Q ss_pred ccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCccccCCC
Q 007035 498 LRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN 576 (621)
Q Consensus 498 l~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~~~~~~ 576 (621)
+.+ +|.+.+..... .++...+..++.+++.||.|||+++++||||+|+||+++ .++.++|+|||++......
T Consensus 74 ~~~~~l~~~l~~~~~-----~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~--~~~~~~l~d~g~~~~~~~~ 146 (251)
T cd05041 74 VPGGSLLTFLRKKKN-----RLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVG--ENNVLKISDFGMSREEEGG 146 (251)
T ss_pred CCCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEc--CCCcEEEeeccccccccCC
Confidence 975 56666543221 278888999999999999999999999999999999998 4788999999998654422
Q ss_pred cc-----ccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 577 LC-----LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 577 ~~-----~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
.. ....+..|+|||.+.+..++.++||||||+++|+|++ |..||
T Consensus 147 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~ 196 (251)
T cd05041 147 IYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPY 196 (251)
T ss_pred cceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCC
Confidence 11 1122456999999988889999999999999999999 88886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-27 Score=242.01 Aligned_cols=194 Identities=23% Similarity=0.351 Sum_probs=154.0
Q ss_pred EeccCCCCceeEEEeCCCC------cEEEEEEEecCc--hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeEE
Q 007035 421 YLGSAAFSKVFQAQDLHTG------VDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLF 492 (621)
Q Consensus 421 ~LG~G~fG~Vyka~d~~tg------~~VAlKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l~ 492 (621)
.||+|+||.||+|+++... +.+++|.+.... .....+.+|+.+++.+ +||||+++++++......+
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~~~~~~~ 75 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNF------NHPNIVKLLGVCLLNEPQY 75 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhc------CCCCeeeEeeeecCCCCeE
Confidence 5899999999999976544 789999876543 2344566677666655 5789999999999999999
Q ss_pred EEEeccc-cchHHHHHhhhccC-CCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccC---CCeEEEEec
Q 007035 493 IVCELLR-ANLYEFQKFNQESG-GEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQ---RCEIKIIDL 567 (621)
Q Consensus 493 LVmEyl~-gsLld~l~~~~~~~-~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~---~~~IKL~DF 567 (621)
+||||+. ++|.+.+....... ....+++..+..++.||+.||.|||+.+++|+||+|+||+++.+. ...++|+||
T Consensus 76 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~df 155 (269)
T cd05044 76 IIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDF 155 (269)
T ss_pred EEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCc
Confidence 9999997 47777765432211 223478889999999999999999999999999999999998522 127999999
Q ss_pred CCccccCCC-----ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 568 GSSCFQTDN-----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 568 Gls~~~~~~-----~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
|++...... ......+..|+|||.+.+..++.++|||||||++|+|++ |+.||
T Consensus 156 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~ 214 (269)
T cd05044 156 GLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPY 214 (269)
T ss_pred ccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCC
Confidence 988643321 112234678999999998889999999999999999998 99887
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-27 Score=238.33 Aligned_cols=185 Identities=35% Similarity=0.502 Sum_probs=155.7
Q ss_pred eccCCCCceeEEEeCCCCcEEEEEEEecCc----hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeEEEEEec
Q 007035 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCEL 497 (621)
Q Consensus 422 LG~G~fG~Vyka~d~~tg~~VAlKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l~LVmEy 497 (621)
||.|+||.||++++..+|+.+++|++.... .....+.+|+++++.+ .||||+++++.+......++||||
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~------~h~~i~~~~~~~~~~~~~~lv~e~ 74 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQA------QSPYVVKLYYSFQGKKNLYLVMEY 74 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhC------CCcchhHHHHheecCcEEEEEEec
Confidence 689999999999999999999999987543 2344556666666655 378999999999999999999999
Q ss_pred ccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCccccCCC
Q 007035 498 LRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN 576 (621)
Q Consensus 498 l~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~~~~~~ 576 (621)
+.+ +|.+++.... .+++..+..++.||+.||.|||+++++|+||+|+||+++. ++.++|+|||++......
T Consensus 75 ~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~--~~~~~l~dfg~~~~~~~~ 146 (265)
T cd05579 75 LPGGDLASLLENVG------SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDS--NGHLKLTDFGLSKVGLVR 146 (265)
T ss_pred CCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcC--CCCEEEEecccchhcccC
Confidence 975 6766665432 2889999999999999999999999999999999999984 788999999987643222
Q ss_pred -----------ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 577 -----------LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 577 -----------~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
.....++..|+|||......++.++|+||||+++|+|++|+.||
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~ 201 (265)
T cd05579 147 RQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPF 201 (265)
T ss_pred cccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCC
Confidence 22345678899999998888899999999999999999999997
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-27 Score=246.92 Aligned_cols=194 Identities=23% Similarity=0.307 Sum_probs=154.9
Q ss_pred cCceEEEEEeccCCCCceeEEEeCCCCc----EEEEEEEecCch--hhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeE
Q 007035 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGV----DVCLKIIKNDKD--FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (621)
Q Consensus 413 ~~rY~I~~~LG~G~fG~Vyka~d~~tg~----~VAlKii~~~~~--~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~ 486 (621)
.++|++.+.||+|+||.||++.+..+|+ .+|+|++..... ....+.+|+.+++.+ .||||+++++++.
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l------~h~niv~~~~~~~ 79 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASM------DHPHLVRLLGVCL 79 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhC------CCCCcccEEEEEc
Confidence 3678999999999999999999887776 468888765432 222445566555554 5789999999887
Q ss_pred ecCeEEEEEeccc-cchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEE
Q 007035 487 HLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKII 565 (621)
Q Consensus 487 ~~~~l~LVmEyl~-gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~ 565 (621)
.. ..++++||+. ++|.+.+..... .+++..+..++.||+.||.|||+++|+||||||+||+++. ++.+||+
T Consensus 80 ~~-~~~~v~e~~~~g~l~~~~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~--~~~~kL~ 151 (303)
T cd05110 80 SP-TIQLVTQLMPHGCLLDYVHEHKD-----NIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKS--PNHVKIT 151 (303)
T ss_pred CC-CceeeehhcCCCCHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecC--CCceEEc
Confidence 54 4678999998 567777654321 2788889999999999999999999999999999999984 6789999
Q ss_pred ecCCccccCCCc-----cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 566 DLGSSCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 566 DFGls~~~~~~~-----~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
|||++....... ....++..|+|||.+.+..++.++||||||+++|||++ |+.||
T Consensus 152 Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~ 212 (303)
T cd05110 152 DFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPY 212 (303)
T ss_pred cccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCC
Confidence 999987543221 11234668999999998889999999999999999997 88887
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.7e-27 Score=242.25 Aligned_cols=189 Identities=20% Similarity=0.261 Sum_probs=144.1
Q ss_pred EeccCCCCceeEEEeCC------------------------CCcEEEEEEEecCch-hhhhHHHHHHHHHHhcccCCCCC
Q 007035 421 YLGSAAFSKVFQAQDLH------------------------TGVDVCLKIIKNDKD-FFDQSLDEIKLLKLVNKNDPADE 475 (621)
Q Consensus 421 ~LG~G~fG~Vyka~d~~------------------------tg~~VAlKii~~~~~-~~~~~~~Ei~iL~~l~~~~~~~h 475 (621)
+||+|+||.||+|.... ....|++|++..... ....+.+|+.+++. ..|
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~------l~h 75 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQ------VSH 75 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhc------CCC
Confidence 59999999999997432 224588888865332 22334445444443 458
Q ss_pred CceEEEeeEeEecCeEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEe
Q 007035 476 HHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIK 555 (621)
Q Consensus 476 pnIvrl~~~f~~~~~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~ 555 (621)
|||+++++++......++||||++++.++.+..... ..+++..+..++.||+.||.|||+++|+||||||+|||++
T Consensus 76 ~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~ 151 (274)
T cd05076 76 IHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEK----GRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLA 151 (274)
T ss_pred CCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEe
Confidence 899999999999999999999999765544433211 1278888999999999999999999999999999999997
Q ss_pred ccC-----CCeEEEEecCCccccCCCccccccCCcccCchhhcC-CCCCchhhHHHHHHHHHHHH-hCCCCC
Q 007035 556 SYQ-----RCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELW-TGEVCL 620 (621)
Q Consensus 556 ~~~-----~~~IKL~DFGls~~~~~~~~~~~gt~~Y~APEvl~~-~~~s~ksDIWSLGvILyELl-tG~~PF 620 (621)
... ...++|+|||++...... ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.||
T Consensus 152 ~~~~~~~~~~~~kl~d~g~~~~~~~~-~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~ 222 (274)
T cd05076 152 RLGLAEGTSPFIKLSDPGVSFTALSR-EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPL 222 (274)
T ss_pred ccCcccCccceeeecCCccccccccc-cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCc
Confidence 422 235899999987543322 22356788999999875 45899999999999999985 688887
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.4e-27 Score=241.54 Aligned_cols=192 Identities=26% Similarity=0.420 Sum_probs=159.9
Q ss_pred ceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc-hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeEEE
Q 007035 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFI 493 (621)
Q Consensus 415 rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~-~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l~L 493 (621)
+|...+.||.|++|.||++.+..+++.+++|.+.... ...+.+.+|+.+++.+ .|+||+++++++...++.++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~------~h~~vv~~~~~~~~~~~~~~ 93 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDY------QHPNIVEMYSSYLVGDELWV 93 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHc------CCCChheEEEEEEcCCeEEE
Confidence 4566689999999999999999999999999886433 2234456677766665 47899999999999999999
Q ss_pred EEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCccc
Q 007035 494 VCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF 572 (621)
Q Consensus 494 VmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~~ 572 (621)
|+||+.+ +|.+.+.. . .++...+..++.||+.||+|||+++|+||||+|+||+++ .++.++|+|||.+..
T Consensus 94 v~e~~~~~~L~~~~~~-~------~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~--~~~~~~l~d~g~~~~ 164 (285)
T cd06648 94 VMEFLEGGALTDIVTH-T------RMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLT--SDGRVKLSDFGFCAQ 164 (285)
T ss_pred EEeccCCCCHHHHHHh-C------CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEc--CCCcEEEcccccchh
Confidence 9999975 66655543 1 178889999999999999999999999999999999998 478999999998754
Q ss_pred cCCC---ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 007035 573 QTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCLI 621 (621)
Q Consensus 573 ~~~~---~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF~ 621 (621)
.... .....+++.|+|||.+.+..++.++||||||+++|+|++|+.||.
T Consensus 165 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~ 216 (285)
T cd06648 165 VSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYF 216 (285)
T ss_pred hccCCcccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCc
Confidence 3322 223457889999999998889999999999999999999999983
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.4e-27 Score=239.37 Aligned_cols=197 Identities=21% Similarity=0.294 Sum_probs=153.7
Q ss_pred eEEEEEeccCCCCceeEEEeC---CCCcEEEEEEEecCc---hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecC
Q 007035 416 YYVTEYLGSAAFSKVFQAQDL---HTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (621)
Q Consensus 416 Y~I~~~LG~G~fG~Vyka~d~---~tg~~VAlKii~~~~---~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~ 489 (621)
|++.+.||+|+||.||+|.+. .+++.||||++..+. ...+++.+|+++++.+ .||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l------~h~~i~~~~~~~~~~~ 74 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEF------DHPNVIKLIGVSLRSR 74 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcC------CCCCcceEEEEEccCC
Confidence 567889999999999999854 467899999987532 2344566677766655 4789999999886542
Q ss_pred ------eEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeE
Q 007035 490 ------HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEI 562 (621)
Q Consensus 490 ------~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~I 562 (621)
..++++||+.+ ++.+++...........++...++.++.||+.||+|||+++|+||||||+||+++ .++.+
T Consensus 75 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~--~~~~~ 152 (273)
T cd05074 75 AKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLN--ENMTV 152 (273)
T ss_pred CCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEc--CCCCE
Confidence 35788999874 5555554322111222378888999999999999999999999999999999998 47889
Q ss_pred EEEecCCccccCCCc-----cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 563 KIIDLGSSCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 563 KL~DFGls~~~~~~~-----~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
||+|||++....... ....+++.|++||.+.+..++.++|||||||++|+|++ |++||
T Consensus 153 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~ 216 (273)
T cd05074 153 CVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPY 216 (273)
T ss_pred EECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCC
Confidence 999999987543221 12234567999999998889999999999999999999 88887
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.4e-28 Score=265.57 Aligned_cols=194 Identities=30% Similarity=0.509 Sum_probs=165.0
Q ss_pred cCceE-EEEEeccCCCCceeEEEeCCCCcEEEEEEEe-----cCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeE
Q 007035 413 AGRYY-VTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK-----NDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (621)
Q Consensus 413 ~~rY~-I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~-----~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~ 486 (621)
.+||. ..+.||+|+|-+||+|.|..+|..||--.++ +.....+++..|+.+|+-| +|+||+++|++|.
T Consensus 38 ~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL------~H~NIirfy~SW~ 111 (632)
T KOG0584|consen 38 TGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSL------KHPNIIRFYDSWV 111 (632)
T ss_pred CCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccC------CCCceeeeeehee
Confidence 45654 3467999999999999999999998865443 3344557888888888876 4789999999999
Q ss_pred ecC--eEEEEEeccc-cchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCC--eecccCCCccEEEeccCCCe
Q 007035 487 HLE--HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLG--IIHCDLKPENILIKSYQRCE 561 (621)
Q Consensus 487 ~~~--~l~LVmEyl~-gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~g--IvHrDLKP~NILl~~~~~~~ 561 (621)
+.. .+.+|+|.+. |+|..+++..+. ++.+.++.|++||++||.|||++. |+|||||-+||+|+. ..|.
T Consensus 112 d~~n~~in~iTEL~TSGtLr~Y~kk~~~------vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG-~~G~ 184 (632)
T KOG0584|consen 112 DTDNKTINFITELFTSGTLREYRKKHRR------VNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNG-NLGE 184 (632)
T ss_pred cCCCceeeeeeecccCCcHHHHHHHhcc------CCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcC-CcCc
Confidence 765 4889999998 688888776654 778899999999999999999884 999999999999986 6899
Q ss_pred EEEEecCCccccCCC-ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 562 IKIIDLGSSCFQTDN-LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 562 IKL~DFGls~~~~~~-~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
|||+|+|+|...... ....+|||.|||||++. ..|...+||||||++|+||+|+..||
T Consensus 185 VKIGDLGLAtl~r~s~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPY 243 (632)
T KOG0584|consen 185 VKIGDLGLATLLRKSHAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPY 243 (632)
T ss_pred eeecchhHHHHhhccccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCCh
Confidence 999999999776544 44469999999999998 57999999999999999999999998
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-29 Score=250.40 Aligned_cols=205 Identities=27% Similarity=0.354 Sum_probs=165.7
Q ss_pred eCeeecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc--hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEe
Q 007035 408 LNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYF 485 (621)
Q Consensus 408 l~~ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f 485 (621)
+.+.-.++.+-+..||.|+||+|++..++.+|+.+|||.++... ....+++.|.....+.. ..|+|+++|+..
T Consensus 58 ~~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~-----~cp~IVkfyGa~ 132 (361)
T KOG1006|consen 58 LHTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSS-----NCPNIVKFYGAL 132 (361)
T ss_pred ccccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhc-----CCcHHHHHhhhh
Confidence 33444556677788999999999999999999999999987543 23345555555443332 468999999999
Q ss_pred EecCeEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHC-CeecccCCCccEEEeccCCCeEEE
Q 007035 486 YHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSL-GIIHCDLKPENILIKSYQRCEIKI 564 (621)
Q Consensus 486 ~~~~~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~-gIvHrDLKP~NILl~~~~~~~IKL 564 (621)
..++..||.||.|.-++..+.+.-... ....+++..+..|....+.||.||... .|+|||+||+|||++ ..|.|||
T Consensus 133 F~EGdcWiCMELMd~SlDklYk~vy~v-q~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILld--r~G~vKL 209 (361)
T KOG1006|consen 133 FSEGDCWICMELMDISLDKLYKRVYSV-QKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLD--RHGDVKL 209 (361)
T ss_pred hcCCceeeeHHHHhhhHHHHHHHHHHH-HhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEe--cCCCEee
Confidence 999999999999998877766543211 122388999999999999999999964 899999999999999 4899999
Q ss_pred EecCCccccCCC--ccccccCCcccCchhhcC--CCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 565 IDLGSSCFQTDN--LCLYVQSRSYRAPEVIIG--LPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 565 ~DFGls~~~~~~--~~~~~gt~~Y~APEvl~~--~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
+|||.+....+. .+.-+|...|+|||.+.. ..|+.++|+||||++|||+.||+.||
T Consensus 210 CDFGIcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPy 269 (361)
T KOG1006|consen 210 CDFGICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPY 269 (361)
T ss_pred ecccchHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCc
Confidence 999998765443 344578899999999953 35899999999999999999999997
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.6e-27 Score=239.94 Aligned_cols=193 Identities=28% Similarity=0.413 Sum_probs=158.5
Q ss_pred ceEEEEEeccCCCCceeEEEeC---CCCcEEEEEEEecCc-----hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeE
Q 007035 415 RYYVTEYLGSAAFSKVFQAQDL---HTGVDVCLKIIKNDK-----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (621)
Q Consensus 415 rY~I~~~LG~G~fG~Vyka~d~---~tg~~VAlKii~~~~-----~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~ 486 (621)
+|++.+.||+|++|.||++++. .+++.||+|+++... ........|+.+++.+. +||+|+++++.+.
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~-----~~~~i~~~~~~~~ 75 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVR-----RCPFLVTLHYAFQ 75 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhcc-----CCcchhhhheeee
Confidence 4889999999999999999864 467889999987532 22344567777777664 3689999999999
Q ss_pred ecCeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEE
Q 007035 487 HLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKII 565 (621)
Q Consensus 487 ~~~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~ 565 (621)
.....++||||+.+ +|.+.+.... .+++..++.++.|++.||.|||+.+++||||+|.||+++. ++.++|+
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~--~~~~~l~ 147 (288)
T cd05583 76 TDTKLHLILDYVNGGELFTHLYQRE------HFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDS--EGHVVLT 147 (288)
T ss_pred cCCEEEEEEecCCCCcHHHHHhhcC------CcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECC--CCCEEEE
Confidence 99999999999985 6666554321 2788899999999999999999999999999999999984 7789999
Q ss_pred ecCCccccCCC----ccccccCCcccCchhhcCCC--CCchhhHHHHHHHHHHHHhCCCCC
Q 007035 566 DLGSSCFQTDN----LCLYVQSRSYRAPEVIIGLP--YDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 566 DFGls~~~~~~----~~~~~gt~~Y~APEvl~~~~--~s~ksDIWSLGvILyELltG~~PF 620 (621)
|||++...... .....+++.|+|||.+.+.. .+.++||||||+++|+|++|..||
T Consensus 148 dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~ 208 (288)
T cd05583 148 DFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPF 208 (288)
T ss_pred ECccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCc
Confidence 99987653322 12245788999999987765 688999999999999999999997
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-27 Score=240.19 Aligned_cols=195 Identities=27% Similarity=0.387 Sum_probs=157.1
Q ss_pred ceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc------hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEec
Q 007035 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK------DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (621)
Q Consensus 415 rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~------~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~ 488 (621)
+|.+.+.||+|+||.||++.+...+..+++|+++... ....+...|+.+++.+ .||||+++++++...
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~~~ 74 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKL------DHPAIVKFHASFLER 74 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhC------CCCcHHHHHHHHhcC
Confidence 6899999999999999999998888878888766421 1122344455555544 478999999999999
Q ss_pred CeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEec
Q 007035 489 EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 567 (621)
Q Consensus 489 ~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DF 567 (621)
...++||||+.+ +|.+.+...... ...+++..++.++.|++.||.|||+.|++|+||+|+||+++ .+.++|+||
T Consensus 75 ~~~~lv~e~~~~~~l~~~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~---~~~~~l~d~ 149 (260)
T cd08222 75 DAFCIITEYCEGRDLDCKLEELKHT--GKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLK---NNLLKIGDF 149 (260)
T ss_pred CceEEEEEeCCCCCHHHHHHHHhhc--ccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEee---cCCEeeccc
Confidence 999999999986 565555432211 12388999999999999999999999999999999999997 456999999
Q ss_pred CCccccCCC---ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 568 GSSCFQTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 568 Gls~~~~~~---~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
|++...... .....+++.|+|||.+.+..++.++|+||||+++|+|++|+.||
T Consensus 150 g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~ 205 (260)
T cd08222 150 GVSRLLMGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAF 205 (260)
T ss_pred CceeecCCCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 987654332 22345688899999998888899999999999999999999987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.95 E-value=5e-27 Score=235.91 Aligned_cols=178 Identities=25% Similarity=0.290 Sum_probs=148.3
Q ss_pred CCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeEEEEEecccc-chH
Q 007035 425 AAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRA-NLY 503 (621)
Q Consensus 425 G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l~LVmEyl~g-sLl 503 (621)
|.+|.||+++++.+++.||+|.+...... ..|...+. ...||||+++++++......++||||+.+ +|.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~~----~~~~~~~~------~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 73 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSEY----SRERLTII------PHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLW 73 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhhh----hhHHHHHH------hcCCCceeehhhheecCCeEEEEEecCCCCCHH
Confidence 88999999999999999999999765422 12222211 12478999999999999999999999985 676
Q ss_pred HHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCccccCCCccccccC
Q 007035 504 EFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQS 583 (621)
Q Consensus 504 d~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~~~~~~~~~~~gt 583 (621)
+.+.... .+++..+..++.||+.||.|||+++|+||||||+||+++. ++.++|+|||.+...........++
T Consensus 74 ~~l~~~~------~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~--~~~~~l~df~~~~~~~~~~~~~~~~ 145 (237)
T cd05576 74 SHISKFL------NIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDD--RGHIQLTYFSRWSEVEDSCDGEAVE 145 (237)
T ss_pred HHHHHhc------CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcC--CCCEEEecccchhccccccccCCcC
Confidence 7665432 1788999999999999999999999999999999999984 7789999999876655544445567
Q ss_pred CcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 584 RSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 584 ~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
..|+|||.+.+..++.++|+||+|+++|+|++|+.||
T Consensus 146 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~ 182 (237)
T cd05576 146 NMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLV 182 (237)
T ss_pred ccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchh
Confidence 7899999998888899999999999999999999775
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.4e-27 Score=236.74 Aligned_cols=188 Identities=21% Similarity=0.266 Sum_probs=144.7
Q ss_pred EEeccCCCCceeEEEeCC---CCcEEEEEEEecCc--hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeE-ecCeEEE
Q 007035 420 EYLGSAAFSKVFQAQDLH---TGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY-HLEHLFI 493 (621)
Q Consensus 420 ~~LG~G~fG~Vyka~d~~---tg~~VAlKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~-~~~~l~L 493 (621)
+.||+|+||.||+|.+.. .+..+|+|.+.... .....+.+|+.+++. .+||||+++++++. .....++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~------l~h~~iv~~~~~~~~~~~~~~l 74 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKD------FSHPNVLSLLGICLPSEGSPLV 74 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHcc------CCCCCcceEEEEeecCCCCcEE
Confidence 368999999999998653 34679999875422 223445556555544 45889999999765 4556899
Q ss_pred EEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCccc
Q 007035 494 VCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF 572 (621)
Q Consensus 494 VmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~~ 572 (621)
||||+.+ +|.+++..... .+++..+..++.||+.||.|||+.+++||||||+|||++. ++.+||+|||++..
T Consensus 75 v~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~--~~~~kl~dfg~~~~ 147 (262)
T cd05058 75 VLPYMKHGDLRNFIRSETH-----NPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDE--SFTVKVADFGLARD 147 (262)
T ss_pred EEecCCCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcC--CCcEEECCcccccc
Confidence 9999984 67666653322 1566778889999999999999999999999999999984 77899999999865
Q ss_pred cCCC-------ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhC-CCCC
Q 007035 573 QTDN-------LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTG-EVCL 620 (621)
Q Consensus 573 ~~~~-------~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG-~~PF 620 (621)
.... .....+++.|+|||.+.+..++.++|||||||++|||++| .+||
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~ 203 (262)
T cd05058 148 IYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 203 (262)
T ss_pred ccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCC
Confidence 4321 1122346689999999888899999999999999999995 5554
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.9e-27 Score=234.68 Aligned_cols=185 Identities=34% Similarity=0.531 Sum_probs=159.2
Q ss_pred eccCCCCceeEEEeCCCCcEEEEEEEecCch----hhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeEEEEEec
Q 007035 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD----FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCEL 497 (621)
Q Consensus 422 LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~----~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l~LVmEy 497 (621)
||.|+||.||++.+..+++.+++|++..... ....+..|+.+++.++ |+||+++++.+.....+++||||
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~~~~~~v~e~ 74 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRIN------HPFIVKLHYAFQTEEKLYLVLEY 74 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcC------CCcHHHHHHHeecCCeeEEEEec
Confidence 6899999999999999999999999876432 3446677777777664 78999999999999999999999
Q ss_pred c-ccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCccccCCC
Q 007035 498 L-RANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN 576 (621)
Q Consensus 498 l-~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~~~~~~ 576 (621)
+ +++|.+.+.... .+++..+..++.||+.||.|||+.+++|+||+|+||+++. ++.++|+|||++......
T Consensus 75 ~~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~--~~~~~l~d~~~~~~~~~~ 146 (250)
T cd05123 75 APGGELFSHLSKEG------RFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDA--DGHIKLTDFGLAKELSSE 146 (250)
T ss_pred CCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcC--CCcEEEeecCcceecccC
Confidence 9 467877776443 2788999999999999999999999999999999999984 778999999998765432
Q ss_pred ---ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 577 ---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 577 ---~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
.....++..|++||.+.+...+.++|+||||+++|+|++|+.||
T Consensus 147 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~ 193 (250)
T cd05123 147 GSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPF 193 (250)
T ss_pred CCcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCC
Confidence 33456788999999998888899999999999999999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.8e-27 Score=246.89 Aligned_cols=189 Identities=21% Similarity=0.287 Sum_probs=149.4
Q ss_pred EEeccC--CCCceeEEEeCCCCcEEEEEEEecCch---hhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeEEEE
Q 007035 420 EYLGSA--AFSKVFQAQDLHTGVDVCLKIIKNDKD---FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIV 494 (621)
Q Consensus 420 ~~LG~G--~fG~Vyka~d~~tg~~VAlKii~~~~~---~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l~LV 494 (621)
..||.| +||+||++++..+|+.||+|++..... ..+.+.+|+.+++.+ +||||++++++|...+..++|
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l------~h~niv~~~~~~~~~~~~~~v 77 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFF------RHPNIMTSWTVFTTGSWLWVI 77 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhC------CCCCcceEeeeEecCCceEEE
Confidence 356666 999999999999999999999875432 234455565555443 578999999999999999999
Q ss_pred Eecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCcccc
Q 007035 495 CELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQ 573 (621)
Q Consensus 495 mEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~~~ 573 (621)
|||+.+ ++.+++...... .+++..++.++.||+.||.|||+++|+||||||+|||++. ++.++++||+.+...
T Consensus 78 ~e~~~~~~l~~~l~~~~~~----~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~--~~~~~~~~~~~~~~~ 151 (328)
T cd08226 78 SPFMAYGSANSLLKTYFPE----GMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISG--DGLVSLSGLSHLYSL 151 (328)
T ss_pred EecccCCCHHHHHHhhccc----CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeC--CCcEEEechHHHhhh
Confidence 999985 666666543221 2788899999999999999999999999999999999984 788999999754322
Q ss_pred CCC----------ccccccCCcccCchhhcCC--CCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 574 TDN----------LCLYVQSRSYRAPEVIIGL--PYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 574 ~~~----------~~~~~gt~~Y~APEvl~~~--~~s~ksDIWSLGvILyELltG~~PF 620 (621)
... .....++..|+|||++.+. .++.++|||||||++|+|++|+.||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~ 210 (328)
T cd08226 152 VRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPF 210 (328)
T ss_pred hccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 110 1112335669999999764 4788999999999999999999998
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.7e-29 Score=264.14 Aligned_cols=195 Identities=27% Similarity=0.404 Sum_probs=169.2
Q ss_pred cCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecC----chhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEec
Q 007035 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (621)
Q Consensus 413 ~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~----~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~ 488 (621)
-.+++++..||-|+||.|=++.-......+|+|++++. ..+.+.+..|.+|+..++ .|+|+++|-.|.+.
T Consensus 419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~------s~fIvrLYrTfrd~ 492 (732)
T KOG0614|consen 419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECR------SDFIVRLYRTFRDS 492 (732)
T ss_pred hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcC------chHHHHHHHHhccc
Confidence 35678889999999999999986666666899998763 445566777888888776 36999999999999
Q ss_pred CeEEEEEeccc-cchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEec
Q 007035 489 EHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 567 (621)
Q Consensus 489 ~~l~LVmEyl~-gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DF 567 (621)
.++|++||-|= |.++..+...+. |.....+.++.++++|+.|||.+|||.|||||+|+|++ .+|-+||.||
T Consensus 493 kyvYmLmEaClGGElWTiLrdRg~------Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd--~~Gy~KLVDF 564 (732)
T KOG0614|consen 493 KYVYMLMEACLGGELWTILRDRGS------FDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLD--NRGYLKLVDF 564 (732)
T ss_pred hhhhhhHHhhcCchhhhhhhhcCC------cccchhhhhHHHHHHHHHHHHhcCceeccCChhheeec--cCCceEEeeh
Confidence 99999999875 567776654332 88899999999999999999999999999999999999 5899999999
Q ss_pred CCccccCCC--ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 007035 568 GSSCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCLI 621 (621)
Q Consensus 568 Gls~~~~~~--~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF~ 621 (621)
|++...... .-+++|||.|.|||+++++..+.++|+||||+++|||++|.+||-
T Consensus 565 GFAKki~~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs 620 (732)
T KOG0614|consen 565 GFAKKIGSGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFS 620 (732)
T ss_pred hhHHHhccCCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCC
Confidence 999887654 445899999999999999999999999999999999999999993
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-26 Score=240.80 Aligned_cols=190 Identities=23% Similarity=0.366 Sum_probs=156.5
Q ss_pred EEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc-hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeEEEEE
Q 007035 417 YVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVC 495 (621)
Q Consensus 417 ~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~-~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l~LVm 495 (621)
....+||.|+||.||++.+..+++.||+|.+.... .....+.+|+.+++.+ .|+||+++++.+...++.++||
T Consensus 23 ~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l------~h~~iv~~~~~~~~~~~~~lv~ 96 (292)
T cd06657 23 DNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY------QHENVVEMYNSYLVGDELWVVM 96 (292)
T ss_pred hhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhc------CCcchhheeeEEEeCCEEEEEE
Confidence 33467999999999999999999999999886433 2334566677766655 4789999999999999999999
Q ss_pred eccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCccccCC
Q 007035 496 ELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTD 575 (621)
Q Consensus 496 Eyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~~~~~ 575 (621)
||+++..+..+.... .+++..++.++.||+.||+|||+.|++||||+|+||+++. ++.++|+|||++.....
T Consensus 97 e~~~~~~L~~~~~~~------~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~--~~~~~l~dfg~~~~~~~ 168 (292)
T cd06657 97 EFLEGGALTDIVTHT------RMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTH--DGRVKLSDFGFCAQVSK 168 (292)
T ss_pred ecCCCCcHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECC--CCCEEEcccccceeccc
Confidence 999874443333221 2788889999999999999999999999999999999984 67899999998765432
Q ss_pred C---ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 576 N---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 576 ~---~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
. .....+++.|+|||.+.+..++.++|+||+|+++|+|++|..||
T Consensus 169 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~ 216 (292)
T cd06657 169 EVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPY 216 (292)
T ss_pred ccccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 2 22346788999999998888899999999999999999999997
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-27 Score=260.74 Aligned_cols=194 Identities=28% Similarity=0.403 Sum_probs=164.9
Q ss_pred ecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeE
Q 007035 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (621)
Q Consensus 412 i~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l 491 (621)
+.+.|.+...+|.|+|+.|-.+.+..+++..++|++.+.. ....+|+.++.... +||||+++.+.+.+..++
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~---~~~~~e~~~~~~~~-----~h~niv~~~~v~~~~~~~ 391 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA---DDNQDEIPISLLVR-----DHPNIVKSHDVYEDGKEI 391 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc---cccccccchhhhhc-----CCCcceeecceecCCcee
Confidence 4577999999999999999999999999999999998763 34456676776665 578999999999999999
Q ss_pred EEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCcc
Q 007035 492 FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 571 (621)
Q Consensus 492 ~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~ 571 (621)
|+|||.+.|..+-.....+.. +. .++..|+.+|+.|+.|||.+|||||||||+|||+. +..++++|+|||.+.
T Consensus 392 ~~v~e~l~g~ell~ri~~~~~-----~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~-~~~g~lrltyFG~a~ 464 (612)
T KOG0603|consen 392 YLVMELLDGGELLRRIRSKPE-----FC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLD-GSAGHLRLTYFGFWS 464 (612)
T ss_pred eeeehhccccHHHHHHHhcch-----hH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeec-CCCCcEEEEEechhh
Confidence 999999997544333333221 33 67788999999999999999999999999999995 258899999999988
Q ss_pred ccCCCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 572 FQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 572 ~~~~~~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
.........+-|..|.|||++....|+.++||||||++||+|++|+.||
T Consensus 465 ~~~~~~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~ 513 (612)
T KOG0603|consen 465 ELERSCDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLF 513 (612)
T ss_pred hCchhhcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCcc
Confidence 7766644445578899999999999999999999999999999999998
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-26 Score=235.85 Aligned_cols=190 Identities=18% Similarity=0.199 Sum_probs=144.3
Q ss_pred EeccCCCCceeEEEeCCC--CcEEEEEEEecCc--hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeEEEEEe
Q 007035 421 YLGSAAFSKVFQAQDLHT--GVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCE 496 (621)
Q Consensus 421 ~LG~G~fG~Vyka~d~~t--g~~VAlKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l~LVmE 496 (621)
.||+|+||+||+++.... ...+++|.+.... .....+.+|+.+++. +.||||+++++.+......++|||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~------l~h~~iv~~~~~~~~~~~~~lv~e 75 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRI------LQHPNILQCLGQCVEAIPYLLVFE 75 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhc------cCCcchhheEEEecCCCccEEEEe
Confidence 589999999999975333 3346677665432 223445555555543 458899999999999999999999
Q ss_pred cccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCccccCC
Q 007035 497 LLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTD 575 (621)
Q Consensus 497 yl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~~~~~ 575 (621)
|+.+ +|.+++...... ...++...++.++.||+.||.|||+.+|+||||||+|||++. ++.++|+|||++.....
T Consensus 76 ~~~~~~L~~~l~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~--~~~~~l~Dfg~~~~~~~ 151 (268)
T cd05086 76 YCELGDLKSYLSQEQWH--RRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTS--DLTVKVGDYGIGPSRYK 151 (268)
T ss_pred cCCCCcHHHHHHhhhcc--cccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcC--CccEEecccccccccCc
Confidence 9985 777776543221 122667778899999999999999999999999999999984 78899999998754221
Q ss_pred -----CccccccCCcccCchhhcC-------CCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 576 -----NLCLYVQSRSYRAPEVIIG-------LPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 576 -----~~~~~~gt~~Y~APEvl~~-------~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
......++..|+|||++.. ..++.++||||||+++|||++ |..||
T Consensus 152 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~ 209 (268)
T cd05086 152 EDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPY 209 (268)
T ss_pred chhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCC
Confidence 1223456788999999853 235778999999999999997 56676
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.6e-26 Score=265.40 Aligned_cols=144 Identities=27% Similarity=0.430 Sum_probs=122.4
Q ss_pred CceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc----hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecC
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~ 489 (621)
++|+++++||.|+||+||+|.+..+++.||||+++... .....+..|+.+++.+ +||||+++++++....
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l------~hp~Iv~~~~~~~~~~ 77 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALS------KSPFIVHLYYSLQSAN 77 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhc------CCCCcCeEEEEEEECC
Confidence 67999999999999999999999999999999997532 2234556666666554 5789999999999999
Q ss_pred eEEEEEeccc-cchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecC
Q 007035 490 HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (621)
Q Consensus 490 ~l~LVmEyl~-gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFG 568 (621)
++||||||+. ++|.+++.... .+++..++.|+.||+.||.|||.++|+||||||+||||+. ++.+||+|||
T Consensus 78 ~~~lVmEy~~g~~L~~li~~~~------~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~--~g~vkL~DFG 149 (669)
T cd05610 78 NVYLVMEYLIGGDVKSLLHIYG------YFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISN--EGHIKLTDFG 149 (669)
T ss_pred EEEEEEeCCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcC--CCCEEEEeCC
Confidence 9999999996 47777665432 2788889999999999999999999999999999999984 7889999999
Q ss_pred Ccc
Q 007035 569 SSC 571 (621)
Q Consensus 569 ls~ 571 (621)
++.
T Consensus 150 ls~ 152 (669)
T cd05610 150 LSK 152 (669)
T ss_pred CCc
Confidence 764
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.9e-28 Score=235.66 Aligned_cols=200 Identities=27% Similarity=0.474 Sum_probs=168.1
Q ss_pred cceeeCeeecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEee
Q 007035 404 LPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYD 483 (621)
Q Consensus 404 ~pi~l~~ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~ 483 (621)
+.+.++ -.++|++.+++|.|-+++|+.|.+..+++.++||+++.-+ ...+.+|++||+.+. ++|||+.+++
T Consensus 30 ~~i~wg--~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk--kkKIkREikIL~nL~-----gg~NIi~L~D 100 (338)
T KOG0668|consen 30 LVIDWG--NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK--KKKIKREIKILQNLR-----GGPNIIKLLD 100 (338)
T ss_pred eeeecc--ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH--HHHHHHHHHHHHhcc-----CCCCeeehhh
Confidence 334444 3478999999999999999999999999999999998654 367899999999886 5789999999
Q ss_pred EeEec--CeEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCe
Q 007035 484 YFYHL--EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCE 561 (621)
Q Consensus 484 ~f~~~--~~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~ 561 (621)
...+. ....+|+||++..-.. +..+. ++.-.++.++.||+.||.|+|++||.|||+||.||+|+. ..-.
T Consensus 101 iV~Dp~SktpaLiFE~v~n~Dfk--~ly~t------l~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh-~~rk 171 (338)
T KOG0668|consen 101 IVKDPESKTPSLIFEYVNNTDFK--QLYPT------LTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDH-ELRK 171 (338)
T ss_pred hhcCccccCchhHhhhhccccHH--HHhhh------hchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeech-hhce
Confidence 98865 4688999999864222 22221 777889999999999999999999999999999999996 5668
Q ss_pred EEEEecCCccccCCCcc--ccccCCcccCchhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCC
Q 007035 562 IKIIDLGSSCFQTDNLC--LYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVCLI 621 (621)
Q Consensus 562 IKL~DFGls~~~~~~~~--~~~gt~~Y~APEvl~~~~-~s~ksDIWSLGvILyELltG~~PF~ 621 (621)
++|+|+|++........ ..+.+..|.-||.+...+ |++..|+|||||+|..|+..+.||+
T Consensus 172 LrlIDWGLAEFYHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFF 234 (338)
T KOG0668|consen 172 LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF 234 (338)
T ss_pred eeeeecchHhhcCCCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCccc
Confidence 99999999987665433 345688899999997665 8999999999999999999999996
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.8e-27 Score=271.93 Aligned_cols=202 Identities=22% Similarity=0.322 Sum_probs=161.3
Q ss_pred eecCceEEEEEeccCCCCceeEEEeCCCC-----cEEEEEEEecCch--hhhhHHHHHHHHHHhcccCCCCCCceEEEee
Q 007035 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTG-----VDVCLKIIKNDKD--FFDQSLDEIKLLKLVNKNDPADEHHILRLYD 483 (621)
Q Consensus 411 ii~~rY~I~~~LG~G~fG~Vyka~d~~tg-----~~VAlKii~~~~~--~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~ 483 (621)
+-....+..+.||+|+||.||.|.-.... ..||+|.+++..+ ....+++|..++ ...+||||+++++
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m------~~f~HpNiv~liG 762 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLM------SKFDHPNIVSLIG 762 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHH------hcCCCcceeeEEE
Confidence 33456788899999999999999864432 3489998876532 233444444444 4557899999999
Q ss_pred EeEecCeEEEEEeccc-cchHHHHHhhhccC-CCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCe
Q 007035 484 YFYHLEHLFIVCELLR-ANLYEFQKFNQESG-GEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCE 561 (621)
Q Consensus 484 ~f~~~~~l~LVmEyl~-gsLld~l~~~~~~~-~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~ 561 (621)
++.+....+|++|||. |+|+.++....... ....++..++..++.+|++|+.||+++++|||||..+|+||+. +..
T Consensus 763 v~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~--~r~ 840 (1025)
T KOG1095|consen 763 VCLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDE--RRV 840 (1025)
T ss_pred eecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecc--cCc
Confidence 9999999999999998 57888887652221 2334889999999999999999999999999999999999995 688
Q ss_pred EEEEecCCccccCCCcccc-----ccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 562 IKIIDLGSSCFQTDNLCLY-----VQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 562 IKL~DFGls~~~~~~~~~~-----~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
+||+|||+|+.+....... .-...|||||.+....++.|+|||||||+|||++| |..||
T Consensus 841 VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY 905 (1025)
T KOG1095|consen 841 VKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPY 905 (1025)
T ss_pred EEEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCC
Confidence 9999999998544332222 22457999999999999999999999999999999 88887
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.5e-27 Score=272.90 Aligned_cols=192 Identities=30% Similarity=0.437 Sum_probs=157.0
Q ss_pred ecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecC--chhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEe--
Q 007035 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH-- 487 (621)
Q Consensus 412 i~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~--~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~-- 487 (621)
...+|+.++.||+||||.||+++++-+|+.||||.+... .....++.+|++++.+++ |||||++|..|..
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLn------HpNVVRYysAWVEs~ 550 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLN------HPNVVRYYSAWVEST 550 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcC------CcceeeeehhhhccC
Confidence 456788999999999999999999999999999998765 445667888888888875 6789998876510
Q ss_pred --------------------------------------------------------------------------------
Q 007035 488 -------------------------------------------------------------------------------- 487 (621)
Q Consensus 488 -------------------------------------------------------------------------------- 487 (621)
T Consensus 551 ~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~ 630 (1351)
T KOG1035|consen 551 AELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNL 630 (1351)
T ss_pred CccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccc
Confidence
Q ss_pred -----------------------------c--------CeEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHH
Q 007035 488 -----------------------------L--------EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQC 530 (621)
Q Consensus 488 -----------------------------~--------~~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qI 530 (621)
. ..+||-||||+..++..+...+... -.....+++++||
T Consensus 631 S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~----~~~d~~wrLFreI 706 (1351)
T KOG1035|consen 631 SNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN----SQRDEAWRLFREI 706 (1351)
T ss_pred ccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc----hhhHHHHHHHHHH
Confidence 0 2379999999987776665443321 1367899999999
Q ss_pred HHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCccccC---------------------CCccccccCCcccCc
Q 007035 531 LEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQT---------------------DNLCLYVQSRSYRAP 589 (621)
Q Consensus 531 l~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~~~~---------------------~~~~~~~gt~~Y~AP 589 (621)
++||.|+|++|||||||||.||++++ +..|||+|||++.... ...+..+||.-|+||
T Consensus 707 lEGLaYIH~~giIHRDLKP~NIFLd~--~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAP 784 (1351)
T KOG1035|consen 707 LEGLAYIHDQGIIHRDLKPRNIFLDS--RNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAP 784 (1351)
T ss_pred HHHHHHHHhCceeeccCCcceeEEcC--CCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecH
Confidence 99999999999999999999999994 8889999999986510 023346889999999
Q ss_pred hhhcCCC---CCchhhHHHHHHHHHHHHh
Q 007035 590 EVIIGLP---YDQKIDLWSLGCILAELWT 615 (621)
Q Consensus 590 Evl~~~~---~s~ksDIWSLGvILyELlt 615 (621)
|++.+.. |+.|+||||||+||+||+.
T Consensus 785 Ell~~~~~~~Yn~KiDmYSLGIVlFEM~y 813 (1351)
T KOG1035|consen 785 ELLSDTSSNKYNSKIDMYSLGIVLFEMLY 813 (1351)
T ss_pred HHhcccccccccchhhhHHHHHHHHHHhc
Confidence 9997654 9999999999999999985
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.7e-28 Score=281.84 Aligned_cols=194 Identities=34% Similarity=0.489 Sum_probs=165.3
Q ss_pred cCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEec---CchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecC
Q 007035 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKN---DKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (621)
Q Consensus 413 ~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~---~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~ 489 (621)
.-|++-..+||.|.||.||.|.+..+|+..|+|-++. +......+.+|..++..++ |||++++|++-.+.+
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~ln------HpNlV~YyGVEvHRe 1307 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLN------HPNLVRYYGVEVHRE 1307 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhcc------CccccccCceeecHH
Confidence 3467778889999999999999999999999997653 3455677889999998885 679999999999999
Q ss_pred eEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecC
Q 007035 490 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (621)
Q Consensus 490 ~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFG 568 (621)
.++|.||||.+ +|.+++..... ..+...+.+..|++.|+.|||+.|||||||||.||+++. +|.||+.|||
T Consensus 1308 kv~IFMEyC~~GsLa~ll~~gri------~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~--~g~iK~~DFG 1379 (1509)
T KOG4645|consen 1308 KVYIFMEYCEGGSLASLLEHGRI------EDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDF--NGLIKYGDFG 1379 (1509)
T ss_pred HHHHHHHHhccCcHHHHHHhcch------hhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeec--CCcEEeeccc
Confidence 99999999986 55555544322 667778889999999999999999999999999999994 8899999999
Q ss_pred CccccCCCc-------cccccCCcccCchhhcCCC---CCchhhHHHHHHHHHHHHhCCCCC
Q 007035 569 SSCFQTDNL-------CLYVQSRSYRAPEVIIGLP---YDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 569 ls~~~~~~~-------~~~~gt~~Y~APEvl~~~~---~s~ksDIWSLGvILyELltG~~PF 620 (621)
.|.....+. ...+||+.|||||++.+.. -..+.|||||||++.||+||+.|.
T Consensus 1380 sa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW 1441 (1509)
T KOG4645|consen 1380 SAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPW 1441 (1509)
T ss_pred ceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCch
Confidence 987755443 3368999999999997643 466899999999999999999985
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.94 E-value=4e-26 Score=237.85 Aligned_cols=183 Identities=25% Similarity=0.298 Sum_probs=147.7
Q ss_pred CCCceeEEEeCCCCcEEEEEEEecC---chhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeEEEEEecccc-c
Q 007035 426 AFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRA-N 501 (621)
Q Consensus 426 ~fG~Vyka~d~~tg~~VAlKii~~~---~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l~LVmEyl~g-s 501 (621)
+++.||++++..+++.||+|++... ......+..|+.+++.+ +|+||+++++++...+..+++|||+++ +
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l------~h~~i~~~~~~~~~~~~~~~~~e~~~~~~ 85 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQL------QHPNILPYVTSFIVDSELYVVSPLMAYGS 85 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhc------CCcchhhhhheeecCCeEEEEEeccCCCC
Confidence 5566777777789999999998754 33445677777777766 478999999999999999999999985 5
Q ss_pred hHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCccccCCC-----
Q 007035 502 LYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN----- 576 (621)
Q Consensus 502 Lld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~~~~~~----- 576 (621)
+.+++...... .+++..+..++.||+.||.|||+++|+||||||+||+++. ++.++|+|||.+......
T Consensus 86 l~~~l~~~~~~----~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~--~~~~kl~d~~~~~~~~~~~~~~~ 159 (314)
T cd08216 86 CEDLLKTHFPE----GLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSG--DGKVVLSGLRYSVSMIKHGKRQR 159 (314)
T ss_pred HHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEec--CCceEEecCccceeecccccccc
Confidence 65555433211 2788899999999999999999999999999999999984 788999999987543221
Q ss_pred -----ccccccCCcccCchhhcCC--CCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 577 -----LCLYVQSRSYRAPEVIIGL--PYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 577 -----~~~~~gt~~Y~APEvl~~~--~~s~ksDIWSLGvILyELltG~~PF 620 (621)
.....++..|+|||++... .++.++||||+||++|+|++|+.||
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf 210 (314)
T cd08216 160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPF 210 (314)
T ss_pred ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCC
Confidence 1223456789999999763 4788999999999999999999998
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-26 Score=259.07 Aligned_cols=198 Identities=26% Similarity=0.438 Sum_probs=172.3
Q ss_pred cCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEec----
Q 007035 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL---- 488 (621)
Q Consensus 413 ~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~---- 488 (621)
.+-|+|++.||.|.+|.||+++++.+++..|+||...+.+..+++..|.+|++.+. .|||++.+|++|...
T Consensus 18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~-----~hpnv~~fyg~~~k~~~~~ 92 (953)
T KOG0587|consen 18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYS-----HHPNVATFYGAFIKKDPGN 92 (953)
T ss_pred CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhcc-----CCCCcceEEEEEEEecCCC
Confidence 45699999999999999999999999999999999988877788888888888775 589999999999843
Q ss_pred -CeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEe
Q 007035 489 -EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (621)
Q Consensus 489 -~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~D 566 (621)
+.+|||||||++ +.-++++.... ..+.+..+..|++.++.||.+||.+.++|||||-.|||++ ..+.|||.|
T Consensus 93 ~DqLWLVMEfC~gGSVTDLVKn~~g----~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT--~e~~VKLvD 166 (953)
T KOG0587|consen 93 GDQLWLVMEFCGGGSVTDLVKNTKG----NRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLT--ENAEVKLVD 166 (953)
T ss_pred CCeEEEEeeccCCccHHHHHhhhcc----cchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEe--ccCcEEEee
Confidence 579999999995 67777765442 2288899999999999999999999999999999999999 589999999
Q ss_pred cCCccccCCC---ccccccCCcccCchhhcC-----CCCCchhhHHHHHHHHHHHHhCCCCCC
Q 007035 567 LGSSCFQTDN---LCLYVQSRSYRAPEVIIG-----LPYDQKIDLWSLGCILAELWTGEVCLI 621 (621)
Q Consensus 567 FGls~~~~~~---~~~~~gt~~Y~APEvl~~-----~~~s~ksDIWSLGvILyELltG~~PF~ 621 (621)
||.+...... ..+.+|||.|||||++.- ..|+..+|+||||++..||.-|.+|+.
T Consensus 167 FGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~ 229 (953)
T KOG0587|consen 167 FGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLC 229 (953)
T ss_pred eeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCcc
Confidence 9998765543 445789999999999953 247789999999999999999999973
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.3e-26 Score=248.63 Aligned_cols=198 Identities=23% Similarity=0.343 Sum_probs=175.3
Q ss_pred eecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCe
Q 007035 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (621)
Q Consensus 411 ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~ 490 (621)
+-..+..+..+||-|-||.||.|.+++..-.||||.++.+....++++.|..+++.++ |||+|+++++|.....
T Consensus 264 meRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeik------HpNLVqLLGVCT~EpP 337 (1157)
T KOG4278|consen 264 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK------HPNLVQLLGVCTHEPP 337 (1157)
T ss_pred ccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhc------CccHHHHhhhhccCCC
Confidence 3345567788999999999999999999999999999999888899999999999885 6799999999999999
Q ss_pred EEEEEeccc-cchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCC
Q 007035 491 LFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (621)
Q Consensus 491 l~LVmEyl~-gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGl 569 (621)
.|||+|||. |+|++++....... ++.-.+..++.||..||.||..+++|||||...|+|+. .+..|||+|||+
T Consensus 338 FYIiTEfM~yGNLLdYLRecnr~e----v~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVg--EnhiVKvADFGL 411 (1157)
T KOG4278|consen 338 FYIITEFMCYGNLLDYLRECNRSE----VPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG--ENHIVKVADFGL 411 (1157)
T ss_pred eEEEEecccCccHHHHHHHhchhh----cchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhcccc--ccceEEeeccch
Confidence 999999987 89999998776543 77778889999999999999999999999999999999 488899999999
Q ss_pred ccccCCCccc-ccc---CCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 570 SCFQTDNLCL-YVQ---SRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 570 s~~~~~~~~~-~~g---t~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
++.+.....+ ..| ...|.|||.+....++.|+|||+|||+|||+.| |.-||
T Consensus 412 sRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPY 467 (1157)
T KOG4278|consen 412 SRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPY 467 (1157)
T ss_pred hhhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCC
Confidence 9987655433 333 456999999999999999999999999999988 66665
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.4e-26 Score=240.41 Aligned_cols=200 Identities=25% Similarity=0.381 Sum_probs=166.9
Q ss_pred ccCCCcceeeCeeecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCce
Q 007035 399 EENKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHI 478 (621)
Q Consensus 399 ~~~~~~pi~l~~ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnI 478 (621)
.+...+|+.....++.+..+++.||+|.||+||+|+ .-|+.||||++....+ +.+.+|.+|++.+ .+.|+||
T Consensus 196 GSGSGlplLVQRTiarqI~L~e~IGkGRyGEVwrG~--wrGe~VAVKiF~srdE--~SWfrEtEIYqTv----mLRHENI 267 (513)
T KOG2052|consen 196 GSGSGLPLLVQRTIARQIVLQEIIGKGRFGEVWRGR--WRGEDVAVKIFSSRDE--RSWFRETEIYQTV----MLRHENI 267 (513)
T ss_pred CCCCCchhHhHHhhhheeEEEEEecCccccceeecc--ccCCceEEEEecccch--hhhhhHHHHHHHH----Hhccchh
Confidence 355778899999999999999999999999999997 5799999999986543 6788999998876 3468999
Q ss_pred EEEeeEeEec----CeEEEEEeccc-cchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHH-----C---Ceecc
Q 007035 479 LRLYDYFYHL----EHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS-----L---GIIHC 545 (621)
Q Consensus 479 vrl~~~f~~~----~~l~LVmEyl~-gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs-----~---gIvHr 545 (621)
+.+++.=... ..++||++|.+ |+|++++.... ++......++..++.||++||. + .|.||
T Consensus 268 LgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r~t-------v~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHR 340 (513)
T KOG2052|consen 268 LGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNRNT-------VTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHR 340 (513)
T ss_pred hhhhhccccCCCceEEEEEeeecccCCcHHHHHhhcc-------CCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhcc
Confidence 9998874433 36999999998 79999998632 8888999999999999999994 2 49999
Q ss_pred cCCCccEEEeccCCCeEEEEecCCccccC-------CCccccccCCcccCchhhcCCC----C-C-chhhHHHHHHHHHH
Q 007035 546 DLKPENILIKSYQRCEIKIIDLGSSCFQT-------DNLCLYVQSRSYRAPEVIIGLP----Y-D-QKIDLWSLGCILAE 612 (621)
Q Consensus 546 DLKP~NILl~~~~~~~IKL~DFGls~~~~-------~~~~~~~gt~~Y~APEvl~~~~----~-s-~ksDIWSLGvILyE 612 (621)
|||..||||. +++...|+|+|+|.... ......+||.+|||||++...- + + ..+||||||+++||
T Consensus 341 DlKSKNILVK--kn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWE 418 (513)
T KOG2052|consen 341 DLKSKNILVK--KNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWE 418 (513)
T ss_pred ccccccEEEc--cCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHH
Confidence 9999999999 48899999999986533 2345579999999999995431 1 2 35999999999999
Q ss_pred HHh
Q 007035 613 LWT 615 (621)
Q Consensus 613 Llt 615 (621)
++.
T Consensus 419 iar 421 (513)
T KOG2052|consen 419 IAR 421 (513)
T ss_pred HHH
Confidence 874
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.6e-28 Score=240.58 Aligned_cols=187 Identities=32% Similarity=0.562 Sum_probs=151.3
Q ss_pred EEeccCCCCceeEEEeCCCCcEEEEEEEecCc---hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEec-----CeE
Q 007035 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL-----EHL 491 (621)
Q Consensus 420 ~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~---~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~-----~~l 491 (621)
+-||.|+||.||.+.|.++|+.||+|.+.+-- ....+..+|+++|...+ |.|++..++..+-. +.+
T Consensus 59 RPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFk------HdNVLSaLDILQPph~dfFqEi 132 (449)
T KOG0664|consen 59 RPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFR------HDNVLSLLDILQPANPSFFQEL 132 (449)
T ss_pred CcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhc------cccHHHHHHhcCCCCchHHHHH
Confidence 35999999999999999999999999876421 22345666777776665 45677777766543 247
Q ss_pred EEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCcc
Q 007035 492 FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 571 (621)
Q Consensus 492 ~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~ 571 (621)
|+++|.+...|...+...+ .++...++.+++||++||.|||+.+|.||||||.|+|+++ ++.+||+|||+++
T Consensus 133 YV~TELmQSDLHKIIVSPQ------~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNS--NCvLKICDFGLAR 204 (449)
T KOG0664|consen 133 YVLTELMQSDLHKIIVSPQ------ALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNS--NCILKICDFGLAR 204 (449)
T ss_pred HHHHHHHHhhhhheeccCC------CCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEecc--CceEEeccccccc
Confidence 8888888877766655433 3888899999999999999999999999999999999995 9999999999997
Q ss_pred ccCCC----ccccccCCcccCchhhcCCC-CCchhhHHHHHHHHHHHHhCCCCC
Q 007035 572 FQTDN----LCLYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 572 ~~~~~----~~~~~gt~~Y~APEvl~~~~-~s~ksDIWSLGvILyELltG~~PF 620 (621)
..... .+..+-|..|+|||+++|.. |+.++||||+|||+.||+..+.+|
T Consensus 205 vee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILF 258 (449)
T KOG0664|consen 205 TWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILF 258 (449)
T ss_pred ccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhh
Confidence 54332 23345588899999999875 999999999999999999998887
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=5e-25 Score=215.89 Aligned_cols=192 Identities=39% Similarity=0.596 Sum_probs=163.8
Q ss_pred eEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCch--hhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeEEE
Q 007035 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD--FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFI 493 (621)
Q Consensus 416 Y~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~--~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l~L 493 (621)
|.+.+.||.|++|.||++.+..+++.+++|.+..... ....+.+|+..++.+ .|+|++++++++......++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~------~~~~i~~~~~~~~~~~~~~~ 74 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKL------KHPNIVKLYGVFEDPEPLYL 74 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhC------CCCChhhheeeeecCCceEE
Confidence 5678899999999999999988899999999986543 356677777777766 46789999999999899999
Q ss_pred EEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCccc
Q 007035 494 VCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF 572 (621)
Q Consensus 494 VmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~~ 572 (621)
++|++.+ +|.+.+...... +++..+..++.+++.+|.+||+.+++|+||+|.||+++. .+.++|+|||.+..
T Consensus 75 v~e~~~~~~L~~~~~~~~~~-----~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~--~~~~~l~d~g~~~~ 147 (225)
T smart00221 75 VMEYCEGGDLFDYLRKKGGK-----LSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGM--DGLVKLADFGLARF 147 (225)
T ss_pred EEeccCCCCHHHHHHhcccC-----CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC--CCCEEEeeCceeeE
Confidence 9999997 777776643221 678889999999999999999999999999999999995 58899999998876
Q ss_pred cCCCc----cccccCCcccCchhh-cCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 573 QTDNL----CLYVQSRSYRAPEVI-IGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 573 ~~~~~----~~~~gt~~Y~APEvl-~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
..... ....++..|++||.+ ....++.++|+|+||+++++|++|+.||
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf 200 (225)
T smart00221 148 IHRDLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPF 200 (225)
T ss_pred ecCcccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCc
Confidence 65432 445678889999999 6667888999999999999999999998
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.6e-26 Score=245.94 Aligned_cols=198 Identities=24% Similarity=0.318 Sum_probs=162.7
Q ss_pred eeecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc--hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEe
Q 007035 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (621)
Q Consensus 410 ~ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~ 487 (621)
+....+..+.++||+|-||.|.+++ ...+..||+|+++.+. .....+.+|+++|.++ +||||++++++|..
T Consensus 534 EfPRs~L~~~ekiGeGqFGEVhLCe-veg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqL------khPNIveLvGVC~~ 606 (807)
T KOG1094|consen 534 EFPRSRLRFKEKIGEGQFGEVHLCE-VEGPLKVAVKILRPDATKNARNDFLKEIKILSRL------KHPNIVELLGVCVQ 606 (807)
T ss_pred hcchhheehhhhhcCcccceeEEEE-ecCceEEEEeecCcccchhHHHHHHHHHHHHhcc------CCCCeeEEEeeeec
Confidence 4445778899999999999999998 4557999999998653 2345677788877766 47899999999999
Q ss_pred cCeEEEEEeccc-cchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEe
Q 007035 488 LEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (621)
Q Consensus 488 ~~~l~LVmEyl~-gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~D 566 (621)
++.+++|+||++ |.|.+++....... +.......|+.||+.||+||.+.++|||||.+.|+|++ +..++||+|
T Consensus 607 DePicmI~EYmEnGDLnqFl~aheapt----~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~--~e~~iKiad 680 (807)
T KOG1094|consen 607 DDPLCMITEYMENGDLNQFLSAHELPT----AETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVD--GEFTIKIAD 680 (807)
T ss_pred CCchHHHHHHHhcCcHHHHHHhccCcc----cccchhHHHHHHHHHHHHHHHhhchhhccccccceeec--CcccEEecC
Confidence 999999999998 67888877654321 33445567999999999999999999999999999999 589999999
Q ss_pred cCCccccCCCcccc-----ccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh--CCCCC
Q 007035 567 LGSSCFQTDNLCLY-----VQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT--GEVCL 620 (621)
Q Consensus 567 FGls~~~~~~~~~~-----~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt--G~~PF 620 (621)
||+++..-...... +-..+|||||.+...+++.++|+|++|++|||+++ .+.||
T Consensus 681 fgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py 741 (807)
T KOG1094|consen 681 FGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPY 741 (807)
T ss_pred cccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCch
Confidence 99998654433332 33678999999999999999999999999999754 55555
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.9e-26 Score=252.58 Aligned_cols=194 Identities=26% Similarity=0.398 Sum_probs=162.1
Q ss_pred CceEEEEEeccCCCCceeEEEeCCCC---cEEEEEEEecCch--hhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEec
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQDLHTG---VDVCLKIIKNDKD--FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d~~tg---~~VAlKii~~~~~--~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~ 488 (621)
++.++.++||.|.||.|++|.++..+ ..||||+++.+.. ..+.+++|+.++..+ .|+|++|+|++..+
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L------~H~hliRLyGvVl~- 182 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKL------QHPHLIRLYGVVLD- 182 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhc------cCcceeEEeeeecc-
Confidence 56777889999999999999886533 4589999987543 456777888777766 47899999999887
Q ss_pred CeEEEEEeccc-cchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEec
Q 007035 489 EHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 567 (621)
Q Consensus 489 ~~l~LVmEyl~-gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DF 567 (621)
..+.+|||++. |+|++.+.... ...|....+..++.||+.||.||.++++|||||...|||+-+ ...|||+||
T Consensus 183 qp~mMV~ELaplGSLldrLrka~----~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllas--prtVKI~DF 256 (1039)
T KOG0199|consen 183 QPAMMVFELAPLGSLLDRLRKAK----KAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLAS--PRTVKICDF 256 (1039)
T ss_pred chhhHHhhhcccchHHHHHhhcc----ccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecc--cceeeeecc
Confidence 77889999998 68888776522 223888899999999999999999999999999999999985 678999999
Q ss_pred CCccccCCCcccccc------CCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 568 GSSCFQTDNLCLYVQ------SRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 568 Gls~~~~~~~~~~~g------t~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
|+.+....+...++. ...|+|||.+....++.++|+|++||+||||+| |+.|.
T Consensus 257 GLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW 316 (1039)
T KOG0199|consen 257 GLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPW 316 (1039)
T ss_pred cceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCC
Confidence 999877665544433 345999999999999999999999999999998 66665
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.6e-27 Score=234.26 Aligned_cols=196 Identities=27% Similarity=0.504 Sum_probs=161.1
Q ss_pred ecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEec---CchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEe-
Q 007035 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKN---DKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH- 487 (621)
Q Consensus 412 i~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~---~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~- 487 (621)
..+.|..+.+||+|.||+|++|+.+.+|+.||+|++-- ...+....++|+++|+.++ |+|++.++..+..
T Consensus 15 ~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lk------Henv~nliEic~tk 88 (376)
T KOG0669|consen 15 EVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLK------HENVVNLIEICRTK 88 (376)
T ss_pred cchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhc------chhHHHHHHHHhhc
Confidence 34678888999999999999999999999999986533 2335566788999998886 5567777766543
Q ss_pred -------cCeEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCC
Q 007035 488 -------LEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRC 560 (621)
Q Consensus 488 -------~~~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~ 560 (621)
...+|+||.+|+..|..++....- .+++.+++.++.+++.||.|+|...|+|||+|+.|+||+ +++
T Consensus 89 ~Tp~~r~r~t~ylVf~~cehDLaGlLsn~~v-----r~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt--~dg 161 (376)
T KOG0669|consen 89 ATPTNRDRATFYLVFDFCEHDLAGLLSNRKV-----RFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLIT--KDG 161 (376)
T ss_pred cCCcccccceeeeeHHHhhhhHHHHhcCccc-----cccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEc--CCc
Confidence 235999999999988877754322 289999999999999999999999999999999999999 589
Q ss_pred eEEEEecCCccccCCC-------ccccccCCcccCchhhcCCC-CCchhhHHHHHHHHHHHHhCCCCC
Q 007035 561 EIKIIDLGSSCFQTDN-------LCLYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 561 ~IKL~DFGls~~~~~~-------~~~~~gt~~Y~APEvl~~~~-~s~ksDIWSLGvILyELltG~~PF 620 (621)
.+||+|||+++..... -+..+-|.+|++||.+.|.. |+.+.|||..|||+.||.||.+.|
T Consensus 162 ilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspim 229 (376)
T KOG0669|consen 162 ILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIM 229 (376)
T ss_pred eEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccc
Confidence 9999999998543221 12245589999999998865 899999999999999999998875
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.6e-26 Score=250.39 Aligned_cols=196 Identities=23% Similarity=0.333 Sum_probs=161.2
Q ss_pred ecCceEEEEEeccCCCCceeEEEeCCCC---cEEEEEEEecCc--hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeE
Q 007035 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTG---VDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (621)
Q Consensus 412 i~~rY~I~~~LG~G~fG~Vyka~d~~tg---~~VAlKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~ 486 (621)
-....+|.+.||.|-||.|++|+.+..| ..||||.++... .+... +|.+.....+.+||||++|.++..
T Consensus 627 d~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gytekqrrd------FL~EAsIMGQFdHPNIIrLEGVVT 700 (996)
T KOG0196|consen 627 DPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRD------FLSEASIMGQFDHPNIIRLEGVVT 700 (996)
T ss_pred ChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhh------hhhhhhhcccCCCCcEEEEEEEEe
Confidence 3456789999999999999999987776 459999998643 23333 444445555678999999999999
Q ss_pred ecCeEEEEEeccc-cchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEE
Q 007035 487 HLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKII 565 (621)
Q Consensus 487 ~~~~l~LVmEyl~-gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~ 565 (621)
....+.||+|||+ |+|..++..+. ..|+..++.-+++.|+.||+||-+.+.|||||...||||++ +-..|++
T Consensus 701 ks~PvMIiTEyMENGsLDsFLR~~D-----GqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNs--nLvCKVs 773 (996)
T KOG0196|consen 701 KSKPVMIITEYMENGSLDSFLRQND-----GQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNS--NLVCKVS 773 (996)
T ss_pred cCceeEEEhhhhhCCcHHHHHhhcC-----CceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeecc--ceEEEec
Confidence 9999999999998 56666665443 22888899999999999999999999999999999999995 7889999
Q ss_pred ecCCccccCCCccc----ccc--CCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 566 DLGSSCFQTDNLCL----YVQ--SRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 566 DFGls~~~~~~~~~----~~g--t~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
|||+++...+.... ..| ..+|.|||.+...+++.++||||+|++|||.++ |+.||
T Consensus 774 DFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPY 835 (996)
T KOG0196|consen 774 DFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY 835 (996)
T ss_pred cccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcc
Confidence 99999876543311 111 467999999999999999999999999999765 99887
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-25 Score=238.89 Aligned_cols=187 Identities=25% Similarity=0.328 Sum_probs=155.8
Q ss_pred CceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecC----
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE---- 489 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~---- 489 (621)
...++++.||+|.||.||+|+ -+++.||||++.... .+.++.|.+|+... ...|+||+++++.-....
T Consensus 210 ~pl~l~eli~~Grfg~V~Kaq--L~~~~VAVKifp~~~--kqs~~~Ek~Iy~lp----~m~h~nIl~Fi~~ekr~t~~~~ 281 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQ--LDNRLVAVKIFPEQE--KQSFQNEKNIYSLP----GMKHENILQFIGAEKRGTADRM 281 (534)
T ss_pred CchhhHHHhhcCccceeehhh--ccCceeEEEecCHHH--HHHHHhHHHHHhcc----CccchhHHHhhchhccCCcccc
Confidence 446778889999999999997 466999999998644 36788888888776 457999999999876555
Q ss_pred eEEEEEeccc-cchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHH---------CCeecccCCCccEEEeccCC
Q 007035 490 HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS---------LGIIHCDLKPENILIKSYQR 559 (621)
Q Consensus 490 ~l~LVmEyl~-gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs---------~gIvHrDLKP~NILl~~~~~ 559 (621)
..+||+||.+ |+|.++++.+- +++....+|+..+++||+|||+ ..|+|||||..||||.+ +
T Consensus 282 eywLVt~fh~kGsL~dyL~~nt-------isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~--D 352 (534)
T KOG3653|consen 282 EYWLVTEFHPKGSLCDYLKANT-------ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKN--D 352 (534)
T ss_pred ceeEEeeeccCCcHHHHHHhcc-------ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEcc--C
Confidence 7999999998 78999888653 8899999999999999999995 35999999999999995 8
Q ss_pred CeEEEEecCCccccCC-----CccccccCCcccCchhhcCCC-CC-----chhhHHHHHHHHHHHHhCC
Q 007035 560 CEIKIIDLGSSCFQTD-----NLCLYVQSRSYRAPEVIIGLP-YD-----QKIDLWSLGCILAELWTGE 617 (621)
Q Consensus 560 ~~IKL~DFGls~~~~~-----~~~~~~gt~~Y~APEvl~~~~-~s-----~ksDIWSLGvILyELltG~ 617 (621)
+...|+|||+|.+... .....+||.+|||||++.+.- +. .++||||+|.+||||++.-
T Consensus 353 lTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC 421 (534)
T KOG3653|consen 353 LTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRC 421 (534)
T ss_pred CcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhc
Confidence 8899999999976442 233378999999999997642 22 3699999999999998753
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.3e-25 Score=247.59 Aligned_cols=197 Identities=23% Similarity=0.253 Sum_probs=137.4
Q ss_pred cCceEEEEEeccCCCCceeEEEeCCC----CcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeE----
Q 007035 413 AGRYYVTEYLGSAAFSKVFQAQDLHT----GVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDY---- 484 (621)
Q Consensus 413 ~~rY~I~~~LG~G~fG~Vyka~d~~t----g~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~---- 484 (621)
.++|.+.+.||+|+||.||+|.+..+ +..||+|.+..... .|..+...+.+.. +.++..+...
T Consensus 131 ~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~------~e~~~~e~l~~~~---~~~~~~~~~~~~~~ 201 (566)
T PLN03225 131 KDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA------VEIWMNERVRRAC---PNSCADFVYGFLEP 201 (566)
T ss_pred cCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch------hHHHHHHHHHhhc---hhhHHHHHHhhhcc
Confidence 46899999999999999999999988 99999998764322 1222222222110 1111111111
Q ss_pred --eEecCeEEEEEecccc-chHHHHHhhhcc--------------CCCccccHHHHHHHHHHHHHHHHHHHHCCeecccC
Q 007035 485 --FYHLEHLFIVCELLRA-NLYEFQKFNQES--------------GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDL 547 (621)
Q Consensus 485 --f~~~~~l~LVmEyl~g-sLld~l~~~~~~--------------~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDL 547 (621)
.......++||||+++ +|.+++...... ..........+..++.||+.||.|||+++|+||||
T Consensus 202 ~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDL 281 (566)
T PLN03225 202 VSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDV 281 (566)
T ss_pred cccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcC
Confidence 2345679999999985 676666532110 00001223456789999999999999999999999
Q ss_pred CCccEEEeccCCCeEEEEecCCccccCCC----ccccccCCcccCchhhcCC----------------------CCCchh
Q 007035 548 KPENILIKSYQRCEIKIIDLGSSCFQTDN----LCLYVQSRSYRAPEVIIGL----------------------PYDQKI 601 (621)
Q Consensus 548 KP~NILl~~~~~~~IKL~DFGls~~~~~~----~~~~~gt~~Y~APEvl~~~----------------------~~s~ks 601 (621)
||+|||++. ..+.+||+|||++...... .....+++.|+|||.+... .+..++
T Consensus 282 KP~NILl~~-~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~ 360 (566)
T PLN03225 282 KPQNIIFSE-GSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF 360 (566)
T ss_pred CHHHEEEeC-CCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence 999999984 3578999999998654322 2345779999999976432 233456
Q ss_pred hHHHHHHHHHHHHhCCCC
Q 007035 602 DLWSLGCILAELWTGEVC 619 (621)
Q Consensus 602 DIWSLGvILyELltG~~P 619 (621)
|||||||+||||+++..+
T Consensus 361 DVwSlGviL~el~~~~~~ 378 (566)
T PLN03225 361 DIYSAGLIFLQMAFPNLR 378 (566)
T ss_pred ccHHHHHHHHHHHhCcCC
Confidence 999999999999997665
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=7e-25 Score=263.03 Aligned_cols=185 Identities=21% Similarity=0.312 Sum_probs=149.3
Q ss_pred CceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeEEE
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFI 493 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l~L 493 (621)
..+...+.||+|+||.||+|+++.++..||+|.+...... ...|+++++++ +||||+++++++.+....++
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~l~~l------~HpnIv~~~~~~~~~~~~~l 760 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI---PSSEIADMGKL------QHPNIVKLIGLCRSEKGAYL 760 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc---cHHHHHHHhhC------CCCCcceEEEEEEcCCCCEE
Confidence 4567778999999999999999999999999988754321 22345555444 68999999999999999999
Q ss_pred EEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHH---HCCeecccCCCccEEEeccCCCeEEEEecCC
Q 007035 494 VCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLH---SLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (621)
Q Consensus 494 VmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLH---s~gIvHrDLKP~NILl~~~~~~~IKL~DFGl 569 (621)
||||+++ +|.+.+.. +++..+..++.||+.||+||| +.+|+||||||+||+++. ++..++. |+.
T Consensus 761 v~Ey~~~g~L~~~l~~---------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~--~~~~~~~-~~~ 828 (968)
T PLN00113 761 IHEYIEGKNLSEVLRN---------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDG--KDEPHLR-LSL 828 (968)
T ss_pred EEeCCCCCcHHHHHhc---------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECC--CCceEEE-ecc
Confidence 9999984 66666531 678889999999999999999 669999999999999985 4444443 554
Q ss_pred ccccCCCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 570 SCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 570 s~~~~~~~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
....... ....+++.|+|||++.+..++.++|||||||++|||+||+.||
T Consensus 829 ~~~~~~~-~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~ 878 (968)
T PLN00113 829 PGLLCTD-TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPA 878 (968)
T ss_pred ccccccC-CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCC
Confidence 3322211 2236789999999999999999999999999999999999997
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.6e-25 Score=237.59 Aligned_cols=193 Identities=26% Similarity=0.387 Sum_probs=158.6
Q ss_pred ceEEEEEeccCCCCceeEEEeC----CCCcEEEEEEEecC--chhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEec
Q 007035 415 RYYVTEYLGSAAFSKVFQAQDL----HTGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (621)
Q Consensus 415 rY~I~~~LG~G~fG~Vyka~d~----~tg~~VAlKii~~~--~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~ 488 (621)
.....++||.|-||.||+|... ...-.||||.++.+ .+..+.++.|.-+++. .+||||+++++++.+
T Consensus 390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrn------fdHphIikLIGv~~e- 462 (974)
T KOG4257|consen 390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRN------FDHPHIIKLIGVCVE- 462 (974)
T ss_pred hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHh------CCCcchhheeeeeec-
Confidence 3445567999999999999743 23345899999874 2335566666666654 478999999999876
Q ss_pred CeEEEEEeccc-cchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEec
Q 007035 489 EHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 567 (621)
Q Consensus 489 ~~l~LVmEyl~-gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DF 567 (621)
...|||||.+. |.|..+++.+... ++...+..++.||+.||.|||+..+|||||...|||+.+ ..-|||+||
T Consensus 463 ~P~WivmEL~~~GELr~yLq~nk~s-----L~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsS--p~CVKLaDF 535 (974)
T KOG4257|consen 463 QPMWIVMELAPLGELREYLQQNKDS-----LPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSS--PQCVKLADF 535 (974)
T ss_pred cceeEEEecccchhHHHHHHhcccc-----chHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecC--cceeeeccc
Confidence 57899999998 7888888877654 889999999999999999999999999999999999996 556999999
Q ss_pred CCccccCCCccccc----cCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCC
Q 007035 568 GSSCFQTDNLCLYV----QSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCLI 621 (621)
Q Consensus 568 Gls~~~~~~~~~~~----gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF~ 621 (621)
|+++...+...... -...|||||.+.-.+++.++|||.|||++||++. |..||.
T Consensus 536 GLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfq 594 (974)
T KOG4257|consen 536 GLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQ 594 (974)
T ss_pred chhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccc
Confidence 99998777644322 2456999999999999999999999999999865 888883
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.6e-24 Score=210.17 Aligned_cols=181 Identities=40% Similarity=0.634 Sum_probs=155.3
Q ss_pred CCCceeEEEeCCCCcEEEEEEEecCchh--hhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeEEEEEecccc-ch
Q 007035 426 AFSKVFQAQDLHTGVDVCLKIIKNDKDF--FDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRA-NL 502 (621)
Q Consensus 426 ~fG~Vyka~d~~tg~~VAlKii~~~~~~--~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l~LVmEyl~g-sL 502 (621)
+||.||+|.+..+++.+++|++...... .+.+.+|++.++.+ .|++|+++++.+......++++||+++ +|
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l------~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L 74 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKL------KHPNIVRLYDVFEDEDKLYLVMEYCDGGDL 74 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhC------CCCcHHHHHhheeeCCEEEEEEeCCCCCCH
Confidence 5899999999989999999998764332 46677788777766 477999999999999999999999997 77
Q ss_pred HHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCccccCC--Ccccc
Q 007035 503 YEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTD--NLCLY 580 (621)
Q Consensus 503 ld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~~~~~--~~~~~ 580 (621)
.+.+..... ++...+..++.+++.+|.+||+.+++|+||+|.||+++. ++.++|+|||.+..... .....
T Consensus 75 ~~~~~~~~~------~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~--~~~~~l~d~~~~~~~~~~~~~~~~ 146 (244)
T smart00220 75 FDLLKKRGR------LSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDE--DGHVKLADFGLARQLDPGGLLTTF 146 (244)
T ss_pred HHHHHhccC------CCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECC--CCcEEEccccceeeeccccccccc
Confidence 776654321 778889999999999999999999999999999999995 68899999999876554 23445
Q ss_pred ccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 581 VQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 581 ~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
.+++.|++||.+.+..++.++||||||+++|+|++|..||
T Consensus 147 ~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~ 186 (244)
T smart00220 147 VGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPF 186 (244)
T ss_pred cCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 6788999999999888899999999999999999999987
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.7e-26 Score=226.43 Aligned_cols=197 Identities=22% Similarity=0.342 Sum_probs=163.5
Q ss_pred ecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeE-eEecCe
Q 007035 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDY-FYHLEH 490 (621)
Q Consensus 412 i~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~-f~~~~~ 490 (621)
+.+.|.|.+.||.|.||.+.+++|+.++..+++|.++........+.+|...--.|. .|+||+..|+. |+..+.
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls-----~H~hIi~tY~vaFqt~d~ 96 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLS-----PHQHIIDTYEVAFQTSDA 96 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeec-----cchhhhHHHHHHhhcCce
Confidence 467899999999999999999999999999999999987766666777665433333 46789887764 777888
Q ss_pred EEEEEeccc-cchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCC
Q 007035 491 LFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (621)
Q Consensus 491 l~LVmEyl~-gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGl 569 (621)
.++++||++ |+|...+.... +-+...+.++.|++.||.|||++++||||||.+||||-..+..+|||+|||+
T Consensus 97 YvF~qE~aP~gdL~snv~~~G-------igE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~ 169 (378)
T KOG1345|consen 97 YVFVQEFAPRGDLRSNVEAAG-------IGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGL 169 (378)
T ss_pred EEEeeccCccchhhhhcCccc-------ccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeeccc
Confidence 999999998 56655444321 6678889999999999999999999999999999999766677999999999
Q ss_pred ccccCCCccccccCCcccCchhhcCC-----CCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 570 SCFQTDNLCLYVQSRSYRAPEVIIGL-----PYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 570 s~~~~~~~~~~~gt~~Y~APEvl~~~-----~~s~ksDIWSLGvILyELltG~~PF 620 (621)
+...+......-.+..|.+||..... ...+.+|||.||+++|.++||.+|.
T Consensus 170 t~k~g~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PW 225 (378)
T KOG1345|consen 170 TRKVGTTVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPW 225 (378)
T ss_pred ccccCceehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcc
Confidence 88777666665667789999997533 2567899999999999999999985
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.2e-25 Score=249.30 Aligned_cols=189 Identities=29% Similarity=0.373 Sum_probs=156.4
Q ss_pred EEeccCCCCc-eeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeEEEEEecc
Q 007035 420 EYLGSAAFSK-VFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELL 498 (621)
Q Consensus 420 ~~LG~G~fG~-Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l~LVmEyl 498 (621)
+.+|+|+.|+ ||+|. ..|+.||||.+-.+ ..+.+.+|+..|+... .||||+|+|+.-++.+++||+.|.|
T Consensus 515 eilG~Gs~Gt~Vf~G~--ye~R~VAVKrll~e--~~~~A~rEi~lL~eSD-----~H~NviRyyc~E~d~qF~YIalELC 585 (903)
T KOG1027|consen 515 EILGYGSNGTVVFRGV--YEGREVAVKRLLEE--FFDFAQREIQLLQESD-----EHPNVIRYYCSEQDRQFLYIALELC 585 (903)
T ss_pred HHcccCCCCcEEEEEe--eCCceehHHHHhhH--hHHHHHHHHHHHHhcc-----CCCceEEEEeeccCCceEEEEehHh
Confidence 4589999986 78886 78999999987643 3467788999888775 5899999999999999999999999
Q ss_pred ccchHHHHHhh-hccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEec---cCCCeEEEEecCCccccC
Q 007035 499 RANLYEFQKFN-QESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS---YQRCEIKIIDLGSSCFQT 574 (621)
Q Consensus 499 ~gsLld~l~~~-~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~---~~~~~IKL~DFGls~~~~ 574 (621)
..+|.+++... ..... ......+.++.|++.||++||+.+||||||||.||||.. +....++|+|||++....
T Consensus 586 ~~sL~dlie~~~~d~~~---~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 586 ACSLQDLIESSGLDVEM---QSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred hhhHHHHHhccccchhh---cccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 99999999864 11110 111446778999999999999999999999999999986 345689999999997754
Q ss_pred CC------ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhC-CCCC
Q 007035 575 DN------LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTG-EVCL 620 (621)
Q Consensus 575 ~~------~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG-~~PF 620 (621)
.. .....||-+|+|||++....-..++|||||||++|+.++| .+||
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpF 715 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPF 715 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCC
Confidence 33 2335789999999999998888899999999999999996 8888
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=6e-25 Score=224.10 Aligned_cols=193 Identities=36% Similarity=0.619 Sum_probs=165.6
Q ss_pred eecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecC---chhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEe
Q 007035 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (621)
Q Consensus 411 ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~---~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~ 487 (621)
.+..||.-+..+|.|+- .|.-+.|.-.++.||+|..... .....+..+|+.++..+. |+||++++.+|.-
T Consensus 14 tv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~------~~nii~l~n~ftP 86 (369)
T KOG0665|consen 14 TVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVN------HKNIISLLNVFTP 86 (369)
T ss_pred eeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhc------ccceeeeeeccCc
Confidence 45678999999999998 8888999999999999976542 223456677888777775 5689999999985
Q ss_pred cC------eEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCe
Q 007035 488 LE------HLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCE 561 (621)
Q Consensus 488 ~~------~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~ 561 (621)
.. ..|+|||++..++.+.+... +.-..+..|+.|++.|++|||+.||+||||||+||++.. ++.
T Consensus 87 ~~~l~~~~e~y~v~e~m~~nl~~vi~~e--------lDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~--~~~ 156 (369)
T KOG0665|consen 87 QKTLEEFQEVYLVMELMDANLCQVILME--------LDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNS--DCT 156 (369)
T ss_pred cccHHHHHhHHHHHHhhhhHHHHHHHHh--------cchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecc--hhh
Confidence 43 58999999999998888722 667889999999999999999999999999999999994 899
Q ss_pred EEEEecCCccccCCC--ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 562 IKIIDLGSSCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 562 IKL~DFGls~~~~~~--~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
+||.|||++...... .+.++.+..|+|||++.+..|...+||||+||++.||++|.++|
T Consensus 157 lKi~dfg~ar~e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf 217 (369)
T KOG0665|consen 157 LKILDFGLARTEDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLF 217 (369)
T ss_pred eeeccchhhcccCcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEe
Confidence 999999999765443 55678899999999999999999999999999999999999887
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-23 Score=234.64 Aligned_cols=205 Identities=21% Similarity=0.348 Sum_probs=146.3
Q ss_pred cCceEEEEEeccCCCCceeEEEeC----------------CCCcEEEEEEEecCchh-h--------------hhHHHHH
Q 007035 413 AGRYYVTEYLGSAAFSKVFQAQDL----------------HTGVDVCLKIIKNDKDF-F--------------DQSLDEI 461 (621)
Q Consensus 413 ~~rY~I~~~LG~G~fG~Vyka~d~----------------~tg~~VAlKii~~~~~~-~--------------~~~~~Ei 461 (621)
.++|.+.++||+|+||+||+|.+. ..++.||||.+...... . +....|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 467999999999999999999742 34577999998753221 1 1223355
Q ss_pred HHHHHhcccCCCCCCceEEEeeEeEe--------cCeEEEEEecccc-chHHHHHhhhcc------------------CC
Q 007035 462 KLLKLVNKNDPADEHHILRLYDYFYH--------LEHLFIVCELLRA-NLYEFQKFNQES------------------GG 514 (621)
Q Consensus 462 ~iL~~l~~~~~~~hpnIvrl~~~f~~--------~~~l~LVmEyl~g-sLld~l~~~~~~------------------~~ 514 (621)
.++.++++. ...+.++++++++|.. ....++||||+++ +|.+++...... ..
T Consensus 224 ~~l~~l~~~-~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 224 YMCAKIKRN-PIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHhhcc-cchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 555566543 2334566777777653 3568999999985 666665432100 01
Q ss_pred CccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCccccCCCc--c--ccccCCcccCch
Q 007035 515 EAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNL--C--LYVQSRSYRAPE 590 (621)
Q Consensus 515 ~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~~~~~~~--~--~~~gt~~Y~APE 590 (621)
...+++..++.++.||+.||.|||+.+|+||||||+|||++. ++.+||+|||++....... . ....++.|+|||
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~--~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE 380 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTV--DGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE 380 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECC--CCcEEEEeCcCccccccCCccCccccCCCcceeChh
Confidence 112456778899999999999999999999999999999984 6789999999986543211 1 123478999999
Q ss_pred hhcCCC--------------------C--CchhhHHHHHHHHHHHHhCCC-CC
Q 007035 591 VIIGLP--------------------Y--DQKIDLWSLGCILAELWTGEV-CL 620 (621)
Q Consensus 591 vl~~~~--------------------~--s~ksDIWSLGvILyELltG~~-PF 620 (621)
++.... + ..+.||||+|||+|+|++|.. ||
T Consensus 381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~ 433 (507)
T PLN03224 381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPV 433 (507)
T ss_pred hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCc
Confidence 986432 1 124799999999999999876 54
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.4e-24 Score=228.29 Aligned_cols=194 Identities=27% Similarity=0.439 Sum_probs=163.0
Q ss_pred ecCceEEEEEeccCCCCceeEEEeCC---CCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEec
Q 007035 412 IAGRYYVTEYLGSAAFSKVFQAQDLH---TGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (621)
Q Consensus 412 i~~rY~I~~~LG~G~fG~Vyka~d~~---tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~ 488 (621)
+.+.|.++++||.|.|++||++.+.. ..+.||+|.+..... ..++..|+++|..+... .||+.+.+++..+
T Consensus 34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~-p~ri~~El~~L~~~gG~-----~ni~~~~~~~rnn 107 (418)
T KOG1167|consen 34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS-PSRILNELEMLYRLGGS-----DNIIKLNGCFRNN 107 (418)
T ss_pred hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC-chHHHHHHHHHHHhccc-----hhhhcchhhhccC
Confidence 34568999999999999999999887 789999998875443 36789999999999754 5999999999999
Q ss_pred CeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEec
Q 007035 489 EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 567 (621)
Q Consensus 489 ~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DF 567 (621)
+...+|+||++. ...+++.. ++...++.+++.++.||.++|.+|||||||||.|+|.+. ..++-.|+||
T Consensus 108 d~v~ivlp~~~H~~f~~l~~~---------l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~-~t~rg~LvDF 177 (418)
T KOG1167|consen 108 DQVAIVLPYFEHDRFRDLYRS---------LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNR-RTQRGVLVDF 177 (418)
T ss_pred CeeEEEecccCccCHHHHHhc---------CCHHHHHHHHHHHHHHhhhhhccCccccCCCcccccccc-ccCCceEEec
Confidence 999999999986 34443321 678889999999999999999999999999999999986 6778899999
Q ss_pred CCcccc-----------------CC----------------C--------------ccccccCCcccCchhhcCCC-CCc
Q 007035 568 GSSCFQ-----------------TD----------------N--------------LCLYVQSRSYRAPEVIIGLP-YDQ 599 (621)
Q Consensus 568 Gls~~~-----------------~~----------------~--------------~~~~~gt~~Y~APEvl~~~~-~s~ 599 (621)
|++... .. + .....||++|+|||++...+ .+.
T Consensus 178 gLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtt 257 (418)
T KOG1167|consen 178 GLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTT 257 (418)
T ss_pred hhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCC
Confidence 987510 00 0 01147799999999998765 678
Q ss_pred hhhHHHHHHHHHHHHhCCCCCC
Q 007035 600 KIDLWSLGCILAELWTGEVCLI 621 (621)
Q Consensus 600 ksDIWSLGvILyELltG~~PF~ 621 (621)
++||||.|+|+.-+++++.||+
T Consensus 258 aiDiws~GVI~Lslls~~~PFf 279 (418)
T KOG1167|consen 258 AIDIWSAGVILLSLLSRRYPFF 279 (418)
T ss_pred ccceeeccceeehhhccccccc
Confidence 9999999999999999999996
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.2e-23 Score=238.45 Aligned_cols=204 Identities=25% Similarity=0.380 Sum_probs=165.4
Q ss_pred eeecCceEEEEEeccCCCCceeEEEeCC-------CCcEEEEEEEecCc--hhhhhHHHHHHHHHHhcccCCCCCCceEE
Q 007035 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLH-------TGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILR 480 (621)
Q Consensus 410 ~ii~~rY~I~~~LG~G~fG~Vyka~d~~-------tg~~VAlKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~hpnIvr 480 (621)
.+...+..+.+.||+|+||+|++|.-.. ....||+|.++... ...+.+..|+++++.+. .|+||+.
T Consensus 292 e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g-----~H~niv~ 366 (609)
T KOG0200|consen 292 EIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELG-----KHPNIVN 366 (609)
T ss_pred eechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhc-----CCcchhh
Confidence 3444556677799999999999997321 14669999987533 34567888999998886 5889999
Q ss_pred EeeEeEecCeEEEEEeccc-cchHHHHHhhh---ccCCC-------ccccHHHHHHHHHHHHHHHHHHHHCCeecccCCC
Q 007035 481 LYDYFYHLEHLFIVCELLR-ANLYEFQKFNQ---ESGGE-------AYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKP 549 (621)
Q Consensus 481 l~~~f~~~~~l~LVmEyl~-gsLld~l~~~~---~~~~~-------~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP 549 (621)
+++++...+.+++|+||+. |+|+.++...+ ..... ..++...+..+++||+.||+||++..++||||..
T Consensus 367 llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAa 446 (609)
T KOG0200|consen 367 LLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAA 446 (609)
T ss_pred heeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhh
Confidence 9999999999999999998 68888887766 11111 1388899999999999999999999999999999
Q ss_pred ccEEEeccCCCeEEEEecCCccccCCCcccc-cc-----CCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 550 ENILIKSYQRCEIKIIDLGSSCFQTDNLCLY-VQ-----SRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 550 ~NILl~~~~~~~IKL~DFGls~~~~~~~~~~-~g-----t~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
+|||+.. +..+||+|||+++......... .+ ...|||||.+....|+.++||||+|++||||+| |..||
T Consensus 447 RNVLi~~--~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PY 522 (609)
T KOG0200|consen 447 RNVLITK--NKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPY 522 (609)
T ss_pred hhEEecC--CCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCC
Confidence 9999994 6789999999998644432221 11 334999999999999999999999999999998 77776
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.2e-24 Score=239.95 Aligned_cols=191 Identities=25% Similarity=0.318 Sum_probs=154.7
Q ss_pred eEEEEEeccCCCCceeEEEeCCCCcE----EEEEEEecCchh--hhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecC
Q 007035 416 YYVTEYLGSAAFSKVFQAQDLHTGVD----VCLKIIKNDKDF--FDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (621)
Q Consensus 416 Y~I~~~LG~G~fG~Vyka~d~~tg~~----VAlKii~~~~~~--~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~ 489 (621)
.+..++||+|+||+||+|.+...|+. ||||++...... ..++++|.-++ ..++|||++|+++++....
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~m------asldHpnl~RLLgvc~~s~ 771 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRM------ASLDHPNLLRLLGVCMLST 771 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHH------hcCCCchHHHHhhhcccch
Confidence 45567899999999999998766654 788877654332 34444444443 4567999999999998766
Q ss_pred eEEEEEeccc-cchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecC
Q 007035 490 HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (621)
Q Consensus 490 ~l~LVmEyl~-gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFG 568 (621)
+.||++|++ |.|++++...+.. +-.+....|..||++||.|||++++|||||..+||||.+ ..++||+|||
T Consensus 772 -~qlvtq~mP~G~LlDyvr~hr~~-----igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVks--P~hvkitdfg 843 (1177)
T KOG1025|consen 772 -LQLVTQLMPLGCLLDYVREHRDN-----IGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKS--PNHVKITDFG 843 (1177)
T ss_pred -HHHHHHhcccchHHHHHHHhhcc-----ccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecC--CCeEEEEecc
Confidence 889999998 6899999876544 667788999999999999999999999999999999994 7789999999
Q ss_pred CccccCCCccc-----cccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 569 SSCFQTDNLCL-----YVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 569 ls~~~~~~~~~-----~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
++......... ..-.+.|+|-|.+....|+.++||||+||++|||+| |..|+
T Consensus 844 la~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py 901 (1177)
T KOG1025|consen 844 LAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPY 901 (1177)
T ss_pred hhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCcc
Confidence 99765443221 122566999999999999999999999999999998 88776
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.1e-22 Score=211.93 Aligned_cols=200 Identities=28% Similarity=0.342 Sum_probs=167.2
Q ss_pred ceEEEEEeccCCCCceeEEEeCCCC-cEEEEEEEecCchh-hhhHHHHHHHHHHhcccCCCCCCceEEEeeEe-EecCeE
Q 007035 415 RYYVTEYLGSAAFSKVFQAQDLHTG-VDVCLKIIKNDKDF-FDQSLDEIKLLKLVNKNDPADEHHILRLYDYF-YHLEHL 491 (621)
Q Consensus 415 rY~I~~~LG~G~fG~Vyka~d~~tg-~~VAlKii~~~~~~-~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f-~~~~~l 491 (621)
+|++.++||+|+||.||++.+..++ ..+|+|+....... ...+..|..++..+.. ....+|++++++.+ ....+.
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~--~~~~~~~~~~~~~G~~~~~~~ 96 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEK--KNGPSHFPKLLDHGRSTEDFN 96 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhh--hcCCCCCCEEEEeccCCCcee
Confidence 8999999999999999999987775 67999988764322 2268889999999886 12235899999999 577899
Q ss_pred EEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccC-C--CeEEEEecC
Q 007035 492 FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQ-R--CEIKIIDLG 568 (621)
Q Consensus 492 ~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~-~--~~IKL~DFG 568 (621)
+|||+.++.+|.++..... ...++..++..|+.|++.+|.+||+.|++||||||.|+++.... . ..+.|+|||
T Consensus 97 ~iVM~l~G~sL~dl~~~~~----~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 97 FIVMSLLGPSLEDLRKRNP----PGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred EEEEeccCccHHHHHHhCC----CCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 9999999999999886554 22399999999999999999999999999999999999998532 1 579999999
Q ss_pred Ccc--ccCC----------C-ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 569 SSC--FQTD----------N-LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 569 ls~--~~~~----------~-~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
+++ .... . .....||..|.++.+..+...+.+.|+||++.++.+|+.|..|.
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW 237 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPW 237 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCC
Confidence 998 3111 1 12345899999999999999999999999999999999998874
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.7e-22 Score=189.08 Aligned_cols=180 Identities=43% Similarity=0.678 Sum_probs=152.5
Q ss_pred eccCCCCceeEEEeCCCCcEEEEEEEecCch--hhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeEEEEEeccc
Q 007035 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD--FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLR 499 (621)
Q Consensus 422 LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~--~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l~LVmEyl~ 499 (621)
||.|.+|.||++.+..+++.+++|++..... ....+.+|+..++.+. |++|+++++++......+++||++.
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~------~~~i~~~~~~~~~~~~~~~~~e~~~ 74 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLN------HPNIVKLYGVFEDENHLYLVMEYCE 74 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcC------CCCeeeEeeeeecCCeEEEEEecCC
Confidence 6899999999999988899999999987654 2456778888888775 4689999999999999999999999
Q ss_pred -cchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCccccCCC--
Q 007035 500 -ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN-- 576 (621)
Q Consensus 500 -gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~~~~~~-- 576 (621)
++|.+++.... ..++...++.++.+++.+|.+||+.+++|+||+|.||+++. ..+.++|+|||.+......
T Consensus 75 ~~~l~~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~-~~~~~~l~d~~~~~~~~~~~~ 148 (215)
T cd00180 75 GGSLKDLLKENE-----GKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDS-DNGKVKLADFGLSKLLTSDKS 148 (215)
T ss_pred CCcHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeC-CCCcEEEecCCceEEccCCcc
Confidence 57777765432 12788899999999999999999999999999999999984 1578999999998765544
Q ss_pred -ccccccCCcccCchhhcCC-CCCchhhHHHHHHHHHHH
Q 007035 577 -LCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAEL 613 (621)
Q Consensus 577 -~~~~~gt~~Y~APEvl~~~-~~s~ksDIWSLGvILyEL 613 (621)
.....+...|++||.+... .++.+.|+|+||+++++|
T Consensus 149 ~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l 187 (215)
T cd00180 149 LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187 (215)
T ss_pred hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence 3345668889999999887 788999999999999987
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=8e-23 Score=201.65 Aligned_cols=199 Identities=22% Similarity=0.372 Sum_probs=172.8
Q ss_pred eecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCe
Q 007035 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (621)
Q Consensus 411 ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~ 490 (621)
+..+.|+++++||+|+||.+|+|....+|+.||||+-..... ..+...|.++++.++.. ..|+.+..++.+..+
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~-hpqL~yEskvY~iL~~g-----~GiP~i~~y~~e~~y 85 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK-HPQLLYESKVYRILQGG-----VGIPHIRHYGTEKDY 85 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC-CcchhHHHHHHHHhccC-----CCCchhhhhcccccc
Confidence 567899999999999999999999999999999998775443 35778899999999864 468888888889999
Q ss_pred EEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccC-CCeEEEEecCC
Q 007035 491 LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQ-RCEIKIIDLGS 569 (621)
Q Consensus 491 l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~-~~~IKL~DFGl 569 (621)
-.+||+.++.+|.++...+... |+.+++..++-|++.-++|+|.++++||||||+|+|+.-.. ..++.|+|||+
T Consensus 86 nvlVMdLLGPsLEdLfnfC~R~-----ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGL 160 (341)
T KOG1163|consen 86 NVLVMDLLGPSLEDLFNFCSRR-----FTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGL 160 (341)
T ss_pred ceeeeeccCccHHHHHHHHhhh-----hhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccc
Confidence 9999999999999999887665 99999999999999999999999999999999999986433 34689999999
Q ss_pred ccccCCC----------ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 570 SCFQTDN----------LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 570 s~~~~~~----------~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
|....+. .....||-+|.+-....+...+.+.|+-|+|.+|.++.-|.+|.
T Consensus 161 aKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPW 221 (341)
T KOG1163|consen 161 AKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPW 221 (341)
T ss_pred hhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcc
Confidence 9764432 22357889999988888888899999999999999999999885
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=9e-22 Score=201.64 Aligned_cols=199 Identities=23% Similarity=0.329 Sum_probs=176.6
Q ss_pred eecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCe
Q 007035 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (621)
Q Consensus 411 ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~ 490 (621)
++.-.|+|.++||.|+||.++.|.+..++++||||.-.... ...++..|.+.++.|... +.|+..|.+.+.+.+
T Consensus 25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS-~APQLrdEYr~YKlL~g~-----~GIP~vYYFGqeG~~ 98 (449)
T KOG1165|consen 25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS-EAPQLRDEYRTYKLLGGT-----EGIPQVYYFGQEGKY 98 (449)
T ss_pred EecccceeccccccCcceeeecccccccCceEEEEeccccC-CcchHHHHHHHHHHHcCC-----CCCCceeeeccccch
Confidence 56778999999999999999999999999999999765433 346788999999999743 689999999999999
Q ss_pred EEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEecc---CCCeEEEEec
Q 007035 491 LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSY---QRCEIKIIDL 567 (621)
Q Consensus 491 l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~---~~~~IKL~DF 567 (621)
-.||+|+++.+|.+++..+.+. |+.+++..++.|++.-++++|++.+|.|||||+|+||... +...|.|+||
T Consensus 99 NiLVidLLGPSLEDLFD~CgR~-----FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDF 173 (449)
T KOG1165|consen 99 NILVIDLLGPSLEDLFDLCGRR-----FSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDF 173 (449)
T ss_pred hhhhhhhhCcCHHHHHHHhcCc-----ccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEec
Confidence 9999999999999999888765 9999999999999999999999999999999999999752 2346999999
Q ss_pred CCccccCCCcc----------ccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 568 GSSCFQTDNLC----------LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 568 Gls~~~~~~~~----------~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
|++....++.+ ...||-+||+--..+|...+.+.|+-|||-++.+.|-|.+|.
T Consensus 174 GmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPW 236 (449)
T KOG1165|consen 174 GMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPW 236 (449)
T ss_pred cchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcc
Confidence 99987655432 257899999999999999999999999999999999999985
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.6e-23 Score=227.82 Aligned_cols=194 Identities=27% Similarity=0.430 Sum_probs=163.6
Q ss_pred cCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc-hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeE
Q 007035 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (621)
Q Consensus 413 ~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~-~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l 491 (621)
.++|+++..+|+|.+|.||+++|+.+++..|+|+++... +...-+..|+.+++.+ +||||+.+++.+.....+
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc------~h~nivay~gsylr~dkl 87 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDC------RHPNIVAYFGSYLRRDKL 87 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecC------CCcChHHHHhhhhhhcCc
Confidence 467999999999999999999999999999999998754 2344556666666655 578999999999999999
Q ss_pred EEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCc
Q 007035 492 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (621)
Q Consensus 492 ~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls 570 (621)
+|+||||++ +|.+..... ..+++.++..+.++.+++|.|||+.|-+|||||-.|||++ +.+.+|++|||.+
T Consensus 88 wicMEycgggslQdiy~~T------gplselqiayvcRetl~gl~ylhs~gk~hRdiKGanillt--d~gDvklaDfgvs 159 (829)
T KOG0576|consen 88 WICMEYCGGGSLQDIYHVT------GPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLT--DEGDVKLADFGVS 159 (829)
T ss_pred EEEEEecCCCcccceeeec------ccchhHHHHHHHhhhhccchhhhcCCcccccccccceeec--ccCceeecccCch
Confidence 999999996 555544322 2388999999999999999999999999999999999999 5889999999998
Q ss_pred cccCCC---ccccccCCcccCchhhc---CCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 571 CFQTDN---LCLYVQSRSYRAPEVII---GLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 571 ~~~~~~---~~~~~gt~~Y~APEvl~---~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
..++.. ...+.|||.|||||+.. ...|...+|||++|++..|+..=++|.
T Consensus 160 aqitati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqppl 215 (829)
T KOG0576|consen 160 AQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPL 215 (829)
T ss_pred hhhhhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcc
Confidence 766543 34578999999999973 446889999999999999987766664
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.4e-20 Score=201.99 Aligned_cols=167 Identities=21% Similarity=0.187 Sum_probs=126.1
Q ss_pred cceeeCeeecCceEEEEEeccCCCCceeEEEeCC-CCcEEEEEEEecC------chhhhhHHHHHHHHHHhcccCCCCCC
Q 007035 404 LPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLH-TGVDVCLKIIKND------KDFFDQSLDEIKLLKLVNKNDPADEH 476 (621)
Q Consensus 404 ~pi~l~~ii~~rY~I~~~LG~G~fG~Vyka~d~~-tg~~VAlKii~~~------~~~~~~~~~Ei~iL~~l~~~~~~~hp 476 (621)
+|......+.++|.+.+.||+|+||+||+|.+.. +++.+|||++... ......+.+|+++++.++ |+
T Consensus 8 ~~~~~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~------h~ 81 (365)
T PRK09188 8 LPGDQIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVR------GI 81 (365)
T ss_pred CcccccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhcc------CC
Confidence 4444556778899999999999999999999876 6788899986532 123455788999998886 44
Q ss_pred ceE-EEeeEeEecCeEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccC-CCccEEE
Q 007035 477 HIL-RLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDL-KPENILI 554 (621)
Q Consensus 477 nIv-rl~~~f~~~~~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDL-KP~NILl 554 (621)
+++ ++++. +..++||||+.|..+.... . .. ...++.|++.||.|||++||+|||| ||+|||+
T Consensus 82 ~iv~~l~~~----~~~~LVmE~~~G~~L~~~~---~------~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv 145 (365)
T PRK09188 82 GVVPQLLAT----GKDGLVRGWTEGVPLHLAR---P------HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLM 145 (365)
T ss_pred CCCcEEEEc----CCcEEEEEccCCCCHHHhC---c------cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEE
Confidence 566 45542 4689999999876554221 0 01 1457889999999999999999999 9999999
Q ss_pred eccCCCeEEEEecCCccccCCCc-----------cccccCCcccCchhhcC
Q 007035 555 KSYQRCEIKIIDLGSSCFQTDNL-----------CLYVQSRSYRAPEVIIG 594 (621)
Q Consensus 555 ~~~~~~~IKL~DFGls~~~~~~~-----------~~~~gt~~Y~APEvl~~ 594 (621)
+. ++.++|+|||++....... +...+++.|.|||.+..
T Consensus 146 ~~--~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 146 GP--DGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred cC--CCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 74 6789999999987543322 23456778999999854
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=2e-21 Score=228.97 Aligned_cols=139 Identities=19% Similarity=0.198 Sum_probs=111.4
Q ss_pred ceEEEeeEe-------EecCeEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCC
Q 007035 477 HILRLYDYF-------YHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKP 549 (621)
Q Consensus 477 nIvrl~~~f-------~~~~~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP 549 (621)
||++++++| .....++++||+++++|.+.+.... ..+++..++.+++||+.||.|||++||+||||||
T Consensus 34 ~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP 108 (793)
T PLN00181 34 YVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDNPD-----RSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRP 108 (793)
T ss_pred HHHHhhcccCCccccccccchhhhhhccCCccHHHHHhccc-----ccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCc
Confidence 677777776 2334678899999999998886322 2288999999999999999999999999999999
Q ss_pred ccEEEec-----------------cCCCeEEEEecCCccccCC-------------------CccccccCCcccCchhhc
Q 007035 550 ENILIKS-----------------YQRCEIKIIDLGSSCFQTD-------------------NLCLYVQSRSYRAPEVII 593 (621)
Q Consensus 550 ~NILl~~-----------------~~~~~IKL~DFGls~~~~~-------------------~~~~~~gt~~Y~APEvl~ 593 (621)
+||||+. +.++.+||+|||++..... .....++|+.|+|||++.
T Consensus 109 ~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~ 188 (793)
T PLN00181 109 SCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDN 188 (793)
T ss_pred hhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhc
Confidence 9999963 2345677888887753211 011135788899999999
Q ss_pred CCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 594 GLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 594 ~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
+..++.++|||||||+||||++|.+||
T Consensus 189 ~~~~~~~sDVwSlGviL~ELl~~~~~~ 215 (793)
T PLN00181 189 GSSSNCASDVYRLGVLLFELFCPVSSR 215 (793)
T ss_pred cCCCCchhhhhhHHHHHHHHhhCCCch
Confidence 999999999999999999999998876
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.7e-19 Score=179.53 Aligned_cols=192 Identities=35% Similarity=0.530 Sum_probs=156.4
Q ss_pred eEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCch----hhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeE
Q 007035 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD----FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (621)
Q Consensus 416 Y~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~----~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l 491 (621)
|.+.+.||.|+|+.||++.+. ..+++|.+..... ....+.+|+.++..+.+. ++|+++++.+......
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~-----~~i~~~~~~~~~~~~~ 73 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHP-----PNIVKLYDFFQDEGSL 73 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCC-----cceeeEEEEEecCCEE
Confidence 788999999999999999977 7889998875432 345677777777777543 2799999999888888
Q ss_pred EEEEeccccchHH-HHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCC-eEEEEecCC
Q 007035 492 FIVCELLRANLYE-FQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRC-EIKIIDLGS 569 (621)
Q Consensus 492 ~LVmEyl~gsLld-~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~-~IKL~DFGl 569 (621)
+++++++.+..+. ++...... ..+.......++.|++.++.++|+.+++|||+||+||+++. .. .++++|||.
T Consensus 74 ~~~~~~~~~~~l~~~~~~~~~~---~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~--~~~~~~l~dfg~ 148 (384)
T COG0515 74 YLVMEYVDGGSLEDLLKKIGRK---GPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDR--DGRVVKLIDFGL 148 (384)
T ss_pred EEEEecCCCCcHHHHHHhcccc---cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecC--CCCeEEEeccCc
Confidence 9999999964444 33322110 23788899999999999999999999999999999999995 44 799999998
Q ss_pred ccccCCC---------ccccccCCcccCchhhcC---CCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 570 SCFQTDN---------LCLYVQSRSYRAPEVIIG---LPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 570 s~~~~~~---------~~~~~gt~~Y~APEvl~~---~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
+...... .....++..|++||.+.+ ..++...|+||+|++++++++|..||
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~ 211 (384)
T COG0515 149 AKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPF 211 (384)
T ss_pred ceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCC
Confidence 8644332 355688999999999988 57889999999999999999999986
|
|
| >cd08677 C2A_Synaptotagmin-13 C2 domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=9.3e-21 Score=171.37 Aligned_cols=96 Identities=13% Similarity=-0.004 Sum_probs=82.0
Q ss_pred CcceEEEEecC-CCccccCcCCCCcceEeecCCCCCCcccceeeccccCCCceeccceeeecccccccccccccccccCC
Q 007035 265 NDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDN 343 (621)
Q Consensus 265 ~~~l~v~l~e~-~L~~~d~~g~sDpyVK~~Llp~~~~~~k~kt~v~k~tlnP~fnE~f~f~~~~~~~~~~k~L~~~V~D~ 343 (621)
.+.|+|.|.+| ||+ + .|.+|||||++|+|+.++ .|+||+++|+|+||+|||+|.|. +..++..+++|.++|||+
T Consensus 13 ~~~L~V~vikA~~L~-~--~g~sDPYVKv~L~~~~k~-~k~kT~v~rktlnPvfnE~f~F~-v~~~~l~~~tL~~~V~d~ 87 (118)
T cd08677 13 KAELHVNILEAENIS-V--DAGCECYISGCVSVSEGQ-KEAQTALKKLALHTQWEEELVFP-LPEEESLDGTLTLTLRCC 87 (118)
T ss_pred CCEEEEEEEEecCCC-C--CCCCCeEEEEEEcCCcCc-cEEEcceecCCCCCccccEEEEe-CCHHHhCCcEEEEEEEeC
Confidence 67899999999 998 3 477999999999997653 47799999999999999999998 344445588899999999
Q ss_pred CCCCCCCccccccccccccccc
Q 007035 344 SDTRDGEVNGALHEGKADAEEH 365 (621)
Q Consensus 344 d~~~r~d~iG~v~~~~a~~~~~ 365 (621)
|++++|++||++..+..+.+..
T Consensus 88 Drfs~~d~IG~v~l~l~~~~~~ 109 (118)
T cd08677 88 DRFSRHSTLGELRLKLADVSMM 109 (118)
T ss_pred CCCCCCceEEEEEEccccccCC
Confidence 9999999999999988765443
|
Synaptotagmin is a membrane-trafficking protein characterized by a N-terminal transmembrane region, a linker, and 2 C-terminal C2 domains. Synaptotagmin 13, a member of class 6 synaptotagmins, is located in the brain. It functions are unknown. It, like synaptotagmins 8 and 12, does not have any consensus Ca2+ binding sites. Previously all synaptotagmins were thought to be calcium sensors in the regulation of neurotransmitter release and hormone secretion, but it has been shown that not all of them bind calcium. Of the 17 identified synaptotagmins only 8 bind calcium (1-3, 5-7, 9, 10). The function of the two C2 domains that bind calcium are: regulating the fusion step of synaptic vesicle exocytosis (C2A) and binding to phosphatidyl-inositol-3,4,5-triphosphate (PIP3) in the absence of calcium ions and to phosphatidylinositol bisphosphate (PIP2) in their presence (C2B). C2B also regulates also the recycling step of synaptic vesicles. C2 domain |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=6.7e-20 Score=190.99 Aligned_cols=202 Identities=22% Similarity=0.275 Sum_probs=153.0
Q ss_pred eecCceEEEEEeccCCCCceeEEEeCCCC-----cEEEEEEEecCch--hhhhHHHHHHHHHHhcccCCCCCCceEEEee
Q 007035 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTG-----VDVCLKIIKNDKD--FFDQSLDEIKLLKLVNKNDPADEHHILRLYD 483 (621)
Q Consensus 411 ii~~rY~I~~~LG~G~fG~Vyka~d~~tg-----~~VAlKii~~~~~--~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~ 483 (621)
+-..|++....+..|.||.||.|.+.... +.|-+|.++.... +...++.|-.++. ...|||+..+.+
T Consensus 281 v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly------~~sH~nll~V~~ 354 (563)
T KOG1024|consen 281 VQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLY------GASHPNLLSVLG 354 (563)
T ss_pred hhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHh------cCcCCCccceeE
Confidence 34567888889999999999999765432 3355665554322 2233334433333 234889999999
Q ss_pred EeEe-cCeEEEEEeccc-cchHHHHHhhhccC--CCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCC
Q 007035 484 YFYH-LEHLFIVCELLR-ANLYEFQKFNQESG--GEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQR 559 (621)
Q Consensus 484 ~f~~-~~~l~LVmEyl~-gsLld~l~~~~~~~--~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~ 559 (621)
+... ....++++.+++ |+|..++...+... ....++..++..++.|++.|++|||..+|||.||..+|++|+ +.
T Consensus 355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvId--d~ 432 (563)
T KOG1024|consen 355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVID--DQ 432 (563)
T ss_pred EEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceeh--hh
Confidence 8764 467888999998 78888887544222 223366667778999999999999999999999999999999 47
Q ss_pred CeEEEEecCCccccCCCcccccc-----CCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 560 CEIKIIDLGSSCFQTDNLCLYVQ-----SRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 560 ~~IKL~DFGls~~~~~~~~~~~g-----t~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
-++||+|=.+++..-.......| ...||+||.+....|+.++|+||||++||||+| |+.||
T Consensus 433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~Py 499 (563)
T KOG1024|consen 433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPY 499 (563)
T ss_pred eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCc
Confidence 89999999988764433322222 556999999999999999999999999999998 88886
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.3e-19 Score=182.49 Aligned_cols=177 Identities=15% Similarity=0.203 Sum_probs=128.5
Q ss_pred cceeeCeeecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCch----hhhh------HHHHHHHHHHhcccCCC
Q 007035 404 LPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD----FFDQ------SLDEIKLLKLVNKNDPA 473 (621)
Q Consensus 404 ~pi~l~~ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~----~~~~------~~~Ei~iL~~l~~~~~~ 473 (621)
+....++.+.++|++++.||.|+||.||++.+ ++..+|||+++.... .... ..+|+..+.++.
T Consensus 21 ~~~~~~~~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~----- 93 (232)
T PRK10359 21 YKEIFDDFLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVR----- 93 (232)
T ss_pred HHHHHHHHhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHH-----
Confidence 45567788899999999999999999999764 467899999974322 1122 456777777775
Q ss_pred CCCceEEEeeEeEec--------CeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeec
Q 007035 474 DEHHILRLYDYFYHL--------EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIH 544 (621)
Q Consensus 474 ~hpnIvrl~~~f~~~--------~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvH 544 (621)
|++|..+.+++... ...+|||||++| +|.+... +++ ....+++.+|..||..|++|
T Consensus 94 -~~GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~----------~~~----~~~~~i~~~l~~lH~~gi~H 158 (232)
T PRK10359 94 -SEGLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE----------ISE----DVKAKIKASIESLHQHGMVS 158 (232)
T ss_pred -HCCCCcceEeeeecccccccccCCeEEEEEEECCccHHHhhh----------ccH----HHHHHHHHHHHHHHHcCCcc
Confidence 45677777775533 358999999998 4544311 222 24569999999999999999
Q ss_pred ccCCCccEEEeccCCCeEEEEecCCccccCCCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHH
Q 007035 545 CDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELW 614 (621)
Q Consensus 545 rDLKP~NILl~~~~~~~IKL~DFGls~~~~~~~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELl 614 (621)
||+||+||+++. ++ ++|+|||........... ....+...|..++|+|+||+++..+.
T Consensus 159 ~Dikp~Nili~~--~g-i~liDfg~~~~~~e~~a~---------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 159 GDPHKGNFIVSK--NG-LRIIDLSGKRCTAQRKAK---------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCCChHHEEEeC--CC-EEEEECCCcccccchhhH---------HHHHHHhHhcccccccceeEeehHHH
Confidence 999999999985 55 999999986543221111 11334445677999999999987654
|
|
| >cd08680 C2_Kibra C2 domain found in Human protein Kibra | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.8e-19 Score=165.24 Aligned_cols=100 Identities=14% Similarity=0.035 Sum_probs=89.1
Q ss_pred CcceEEEEecC-CCccccCcCCCCcceEeecCCCCCC-cccceeeccccCCCceeccceeeecccccc-ccccccccccc
Q 007035 265 NDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGT-EKSSSYSSSKRGSSIDWIEGFKGSSDLHFK-GAEKDLMPAEI 341 (621)
Q Consensus 265 ~~~l~v~l~e~-~L~~~d~~g~sDpyVK~~Llp~~~~-~~k~kt~v~k~tlnP~fnE~f~f~~~~~~~-~~~k~L~~~V~ 341 (621)
.+.|+|.|.+| ||++++.+|.+|||||++|+|++++ ..++||+++|+|+||+|||+|.|. ++.+ ..+++|.++||
T Consensus 13 ~~~L~V~V~~arnL~~~~~~~~~dpyVKv~Llp~~~~~~~~~kT~v~~~t~nPvfnE~F~f~--v~~~~L~~~~L~~~V~ 90 (124)
T cd08680 13 DSSLVISVEQLRNLSALSIPENSKVYVRVALLPCSSSTSCLFRTKALEDQDKPVFNEVFRVP--ISSTKLYQKTLQVDVC 90 (124)
T ss_pred CCEEEEEEeEecCCcccccCCCCCeEEEEEEccCCCCCCceEEcCccCCCCCCccccEEEEE--CCHHHhhcCEEEEEEE
Confidence 57899999999 9999999999999999999999987 368899999999999999999998 5544 44889999999
Q ss_pred CCCCCCCCCcccccccccccccccC
Q 007035 342 DNSDTRDGEVNGALHEGKADAEEHG 366 (621)
Q Consensus 342 D~d~~~r~d~iG~v~~~~a~~~~~~ 366 (621)
|++++++++++|+++.++++.+...
T Consensus 91 ~~~~~~~~~~lG~~~i~L~~~~~~~ 115 (124)
T cd08680 91 SVGPDQQEECLGGAQISLADFESSE 115 (124)
T ss_pred eCCCCCceeEEEEEEEEhhhccCCC
Confidence 9999999999999999887775543
|
Kibra is thought to be a regulator of the Salvador (Sav)/Warts (Wts)/Hippo (Hpo) (SWH) signaling network, which limits tissue growth by inhibiting cell proliferation and promoting apoptosis. The core of the pathway consists of a MST and LATS family kinase cascade that ultimately phosphorylates and inactivates the YAP/Yorkie (Yki) transcription coactivator. The FERM domain proteins Merlin (Mer) and Expanded (Ex) are part of the upstream regulation controlling pathway mechanism. Kibra colocalizes and associates with Mer and Ex and is thought to transduce an extracellular signal via the SWH network. The apical scaffold machinery that contains Hpo, Wts, and Ex recruits Yki to the apical membrane facilitating its inhibitory phosphorlyation by Wts. Since Kibra associates with Ex and is apically located it is hypothesized that KIBRA is part of the scaffold, helps in the Hpo/Wts complex, and helps recruit Yki for inactivation that prom |
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.1e-18 Score=171.43 Aligned_cols=139 Identities=17% Similarity=0.214 Sum_probs=102.8
Q ss_pred EEEeccCCCCceeEEEeCCCCcEEEEEEEecCchh---------------------------hhhHHHHHHHHHHhcccC
Q 007035 419 TEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDF---------------------------FDQSLDEIKLLKLVNKND 471 (621)
Q Consensus 419 ~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~---------------------------~~~~~~Ei~iL~~l~~~~ 471 (621)
.+.||+|+||.||+|.+. +|+.||+|+++..... ......|++++..+....
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 457999999999999986 8999999999754210 012234888888887542
Q ss_pred CCCCCceEEEeeEeEecCeEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHH-HHCCeecccCCCc
Q 007035 472 PADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYL-HSLGIIHCDLKPE 550 (621)
Q Consensus 472 ~~~hpnIvrl~~~f~~~~~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yL-Hs~gIvHrDLKP~ 550 (621)
. .+|++.. ... .+|||||++++.+....... ..+++..+..++.||+.+|.+| |+.||+||||||+
T Consensus 81 v-~~p~~~~------~~~-~~iVmE~i~g~~l~~~~~~~-----~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~ 147 (190)
T cd05147 81 I-PCPEPIL------LKS-HVLVMEFIGDDGWAAPRLKD-----APLSESKARELYLQVIQIMRILYQDCRLVHADLSEY 147 (190)
T ss_pred C-CCCcEEE------ecC-CEEEEEEeCCCCCcchhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHH
Confidence 2 2344431 122 37999999975433221111 1278889999999999999999 7999999999999
Q ss_pred cEEEeccCCCeEEEEecCCccccC
Q 007035 551 NILIKSYQRCEIKIIDLGSSCFQT 574 (621)
Q Consensus 551 NILl~~~~~~~IKL~DFGls~~~~ 574 (621)
|||++ ++.++|+|||++....
T Consensus 148 NIli~---~~~v~LiDFG~a~~~~ 168 (190)
T cd05147 148 NLLYH---DGKLYIIDVSQSVEHD 168 (190)
T ss_pred HEEEE---CCcEEEEEccccccCC
Confidence 99998 4679999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd08407 C2B_Synaptotagmin-13 C2 domain second repeat present in Synaptotagmin 13 | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.5e-19 Score=167.19 Aligned_cols=94 Identities=14% Similarity=0.009 Sum_probs=84.6
Q ss_pred CcceEEEEecC-CCccccCc--CCCCcceEeecCCCCCCcccceeeccccCCCceeccceeeecccccccc-cccccccc
Q 007035 265 NDYGYLSSKEA-DLIDLQHN--VVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAE 340 (621)
Q Consensus 265 ~~~l~v~l~e~-~L~~~d~~--g~sDpyVK~~Llp~~~~~~k~kt~v~k~tlnP~fnE~f~f~~~~~~~~~-~k~L~~~V 340 (621)
++.|+|.|.+| ||.++|.+ +.+|||||++|+|+.++..|+||+++|+++||+|||+|.|. ++.+.. +.+|.++|
T Consensus 14 ~~~L~V~V~karnL~~~d~~~~~~~DpYVKv~l~~~~~k~~kkkT~v~k~t~nPvfNE~f~F~--v~~~~L~~~~L~~~V 91 (138)
T cd08407 14 ANRLLVVVIKAKNLHSDQLKLLLGIDVSVKVTLKHQNAKLKKKQTKRAKHKINPVWNEMIMFE--LPSELLAASSVELEV 91 (138)
T ss_pred CCeEEEEEEEecCCCccccCCCCCCCeEEEEEEEcCCcccceeccceeeCCCCCccccEEEEE--CCHHHhCccEEEEEE
Confidence 67889999999 99999954 55899999999999988899999999999999999999998 655555 78899999
Q ss_pred cCCCCCCCCCcccccccccc
Q 007035 341 IDNSDTRDGEVNGALHEGKA 360 (621)
Q Consensus 341 ~D~d~~~r~d~iG~v~~~~a 360 (621)
||+|++++++++|++..+..
T Consensus 92 ~d~d~~~~~d~iG~v~lg~~ 111 (138)
T cd08407 92 LNQDSPGQSLPLGRCSLGLH 111 (138)
T ss_pred EeCCCCcCcceeceEEecCc
Confidence 99999999999999988764
|
Synaptotagmin is a membrane-trafficking protein characterized by a N-terminal transmembrane region, a linker, and 2 C-terminal C2 domains. Synaptotagmin 13, a member of class 6 synaptotagmins, is located in the brain. It functions are unknown. It, like synaptotagmins 8 and 12, does not have any consensus Ca2+ binding sites. Previously all synaptotagmins were thought to be calcium sensors in the regulation of neurotransmitter release and hormone secretion, but it has been shown that not all of them bind calcium. Of the 17 identified synaptotagmins only 8 bind calcium (1-3, 5-7, 9, 10). The function of the two C2 domains that bind calcium are: regulating the fusion step of synaptic vesicle exocytosis (C2A) and binding to phosphatidyl-inositol-3,4,5-triphosphate (PIP3) in the absence of calcium ions and to phosphatidylinositol bisphosphate (PIP2) in their presence (C2B). C2B also regulates also the recy |
| >cd04028 C2B_RIM1alpha C2 domain second repeat contained in Rab3-interacting molecule (RIM) proteins | Back alignment and domain information |
|---|
Probab=99.76 E-value=5.3e-19 Score=166.38 Aligned_cols=97 Identities=9% Similarity=-0.046 Sum_probs=86.9
Q ss_pred CcceEEEEecC-CCcccc-CcCCCCcceEeecCCCCCCcccceeeccccCCCceeccceeeeccccccccccccccccc-
Q 007035 265 NDYGYLSSKEA-DLIDLQ-HNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEI- 341 (621)
Q Consensus 265 ~~~l~v~l~e~-~L~~~d-~~g~sDpyVK~~Llp~~~~~~k~kt~v~k~tlnP~fnE~f~f~~~~~~~~~~k~L~~~V~- 341 (621)
.+.|+|.|.+| ||.++| .+|.+|||||++|+|++++..|+||+++|+|+||+|||+|.|. +. ..+++|.++||
T Consensus 28 ~~~L~V~Vi~ArnL~~~~~~~g~sDPYVKv~Llp~~~~~~k~KT~v~kktlnPvfNE~F~f~--v~--l~~~~L~v~V~~ 103 (146)
T cd04028 28 KGQLEVEVIRARGLVQKPGSKVLPAPYVKVYLLEGKKCIAKKKTKIARKTLDPLYQQQLVFD--VS--PTGKTLQVIVWG 103 (146)
T ss_pred CCEEEEEEEEeeCCCcccCCCCCcCCeEEEEEECCCccccceeceecCCCCCCccCCeEEEE--Ec--CCCCEEEEEEEe
Confidence 56789999999 999985 6889999999999999998889999999999999999999999 44 45778999999
Q ss_pred CCCCCCCCCccccccccccccccc
Q 007035 342 DNSDTRDGEVNGALHEGKADAEEH 365 (621)
Q Consensus 342 D~d~~~r~d~iG~v~~~~a~~~~~ 365 (621)
|++++++++++|++..++..++-.
T Consensus 104 d~~~~~~~~~iG~~~i~L~~l~~~ 127 (146)
T cd04028 104 DYGRMDKKVFMGVAQILLDDLDLS 127 (146)
T ss_pred CCCCCCCCceEEEEEEEcccccCC
Confidence 799999999999999988777543
|
RIMs are believed to organize specialized sites of the plasma membrane called active zones. They also play a role in controlling neurotransmitter release, plasticity processes, as well as memory and learning. RIM contains an N-terminal zinc finger domain, a PDZ domain, and two C-terminal C2 domains (C2A, C2B). C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involving their N- and C-terminal beta strands. Many C2 domains are Ca2+-dependent membrane-targeting modules that bind a wide variety of substances including bind phospholipids, inositol polyphosphates, and intracellular proteins. Most C2 domain proteins are either signal transduction enzymes that contain a single C2 domain, such as protein kinase C, or membrane trafficking proteins which contain at least two C2 domains, such as |
| >cd08392 C2A_SLP-3 C2 domain first repeat present in Synaptotagmin-like protein 3 | Back alignment and domain information |
|---|
Probab=99.76 E-value=4.8e-19 Score=163.38 Aligned_cols=100 Identities=11% Similarity=-0.011 Sum_probs=90.1
Q ss_pred CcceEEEEecC-CCccccCc-CCCCcceEeecCCCCCCcccceeeccccCCCceeccceeeecccccccc-ccccccccc
Q 007035 265 NDYGYLSSKEA-DLIDLQHN-VVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEI 341 (621)
Q Consensus 265 ~~~l~v~l~e~-~L~~~d~~-g~sDpyVK~~Llp~~~~~~k~kt~v~k~tlnP~fnE~f~f~~~~~~~~~-~k~L~~~V~ 341 (621)
.+.|+|.|.+| ||+++|.+ |.+|||||++|+|++++..++||+++++++||+|||+|.|. ++.+.. +++|.+.||
T Consensus 14 ~~~L~V~V~~a~nL~~~d~~~g~~dpYVkv~llp~~~~~~k~kT~v~~~t~nPvfNE~F~f~--v~~~~l~~~~L~v~V~ 91 (128)
T cd08392 14 TSCLEITIKACRNLAYGDEKKKKCHPYVKVCLLPDKSHNSKRKTAVKKGTVNPVFNETLKYV--VEADLLSSRQLQVSVW 91 (128)
T ss_pred CCEEEEEEEecCCCCccCCCCCCCCeEEEEEEEeCCcccceeecccccCCCCCccceEEEEE--cCHHHhCCcEEEEEEE
Confidence 57889999999 99999985 99999999999999988889999999999999999999998 555444 778999999
Q ss_pred CCCCCCCCCcccccccccccccccC
Q 007035 342 DNSDTRDGEVNGALHEGKADAEEHG 366 (621)
Q Consensus 342 D~d~~~r~d~iG~v~~~~a~~~~~~ 366 (621)
|++++++++++|+++.++++++-.+
T Consensus 92 ~~~~~~~~~~lG~~~i~L~~~~~~~ 116 (128)
T cd08392 92 HSRTLKRRVFLGEVLIPLADWDFED 116 (128)
T ss_pred eCCCCcCcceEEEEEEEcCCcccCC
Confidence 9999999999999999998886654
|
All Slp members basically share an N-terminal Slp homology domain (SHD) and C-terminal tandem C2 domains (named the C2A domain and the C2B domain) with the SHD and C2 domains being separated by a linker sequence of various length. SHD of Slp (except for the Slp4-SHD) function as a specific Rab27A/B-binding domain. In addition to Slp, rabphilin, Noc2, and Munc13-4 also function as Rab27-binding proteins. Little is known about the expression or localization of Slp3. The C2A domain of Slp3 is Ca2+ dependent. It has been demonstrated that Slp3 promotes dense-core vesicle exocytosis. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involving their N- and C-terminal beta strands. Many C2 domains are Ca2+-dependent membrane-targeting modules that bind a wide variety of substances including bind phospholipids |
| >cd08406 C2B_Synaptotagmin-12 C2 domain second repeat present in Synaptotagmin 12 | Back alignment and domain information |
|---|
Probab=99.76 E-value=4e-19 Score=165.59 Aligned_cols=94 Identities=12% Similarity=-0.005 Sum_probs=85.6
Q ss_pred CcceEEEEecC-CCccccCcCCCCcceEeecCCCCCCcccceeeccccCCCceeccceeeecccccccc-cccccccccC
Q 007035 265 NDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEID 342 (621)
Q Consensus 265 ~~~l~v~l~e~-~L~~~d~~g~sDpyVK~~Llp~~~~~~k~kt~v~k~tlnP~fnE~f~f~~~~~~~~~-~k~L~~~V~D 342 (621)
++.|+|.|.+| ||+++|.+|.+|||||++|+|++++..|+||+++|+|+||+|||+|.|. ++.+.. +.+|.++|||
T Consensus 14 ~~~L~V~Vi~A~nL~~~~~~g~~DpyVkv~l~~~~~~~~k~kT~v~k~t~nP~~nE~f~F~--v~~~~l~~~~l~~~V~~ 91 (136)
T cd08406 14 AERLTVVVVKARNLVWDNGKTTADPFVKVYLLQDGRKISKKKTSVKRDDTNPIFNEAMIFS--VPAIVLQDLSLRVTVAE 91 (136)
T ss_pred CCEEEEEEEEeeCCCCccCCCCCCeEEEEEEEeCCccccccCCccccCCCCCeeceeEEEE--CCHHHhCCcEEEEEEEe
Confidence 57889999999 9999999999999999999999988889999999999999999999998 555444 7889999999
Q ss_pred CCCCCCCCcccccccccc
Q 007035 343 NSDTRDGEVNGALHEGKA 360 (621)
Q Consensus 343 ~d~~~r~d~iG~v~~~~a 360 (621)
+|++++++++|.+..+..
T Consensus 92 ~d~~~~~~~iG~v~lg~~ 109 (136)
T cd08406 92 STEDGKTPNVGHVIIGPA 109 (136)
T ss_pred CCCCCCCCeeEEEEECCC
Confidence 999999999999977654
|
Synaptotagmin is a membrane-trafficking protein characterized by a N-terminal transmembrane region, a linker, and 2 C-terminal C2 domains. Synaptotagmin 12, a member of class 6 synaptotagmins, is located in the brain. It functions are unknown. It, like synaptotagmins 8 and 13, do not have any consensus Ca2+ binding sites. Previously all synaptotagmins were thought to be calcium sensors in the regulation of neurotransmitter release and hormone secretion, but it has been shown that not all of them bind calcium. Of the 17 identified synaptotagmins only 8 bind calcium (1-3, 5-7, 9, 10). The function of the two C2 domains that bind calcium are: regulating the fusion step of synaptic vesicle exocytosis (C2A) and binding to phosphatidyl-inositol-3,4,5-triphosphate (PIP3) in the absence of calcium ions and to phosphatidylinositol bisphosphate (PIP2) in their presence (C2B). C2B also regulates also the recycl |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.7e-18 Score=164.06 Aligned_cols=104 Identities=31% Similarity=0.402 Sum_probs=89.1
Q ss_pred cchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCccccCCCccc
Q 007035 500 ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL 579 (621)
Q Consensus 500 gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~~~~~~~~~ 579 (621)
|+|.+++..... .+++..++.++.||+.||.|||+++ ||+|||++ .++.+++ ||++........
T Consensus 1 GsL~~~l~~~~~-----~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~--~~~~~~~--fG~~~~~~~~~~- 64 (176)
T smart00750 1 VSLADILEVRGR-----PLNEEEIWAVCLQCLRALRELHRQA------KSGNILLT--WDGLLKL--DGSVAFKTPEQS- 64 (176)
T ss_pred CcHHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEc--Cccceee--ccceEeeccccC-
Confidence 466676654322 2899999999999999999999998 99999998 4778888 999876544332
Q ss_pred cccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 580 YVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 580 ~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
.+++.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 65 -~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~ 104 (176)
T smart00750 65 -RVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPY 104 (176)
T ss_pred -CCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCc
Confidence 5789999999999999999999999999999999999998
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.75 E-value=1e-17 Score=164.17 Aligned_cols=139 Identities=18% Similarity=0.191 Sum_probs=101.6
Q ss_pred EEEeccCCCCceeEEEeCCCCcEEEEEEEecCchh---------------------------hhhHHHHHHHHHHhcccC
Q 007035 419 TEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDF---------------------------FDQSLDEIKLLKLVNKND 471 (621)
Q Consensus 419 ~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~---------------------------~~~~~~Ei~iL~~l~~~~ 471 (621)
.+.||+|++|+||+|.+. +|+.||||+++..... ......|...+.++....
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 567999999999999987 8999999998864210 111245677777776542
Q ss_pred CCCCCceEEEeeEeEecCeEEEEEeccccc-hHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHH-CCeecccCCC
Q 007035 472 PADEHHILRLYDYFYHLEHLFIVCELLRAN-LYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS-LGIIHCDLKP 549 (621)
Q Consensus 472 ~~~hpnIvrl~~~f~~~~~l~LVmEyl~gs-Lld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs-~gIvHrDLKP 549 (621)
. . ++..+.. . ..+|||||+++. +....... ..++...+..++.|++.+|.+||+ .||+||||||
T Consensus 81 i-~---~p~~~~~--~--~~~lVmE~~~g~~~~~~~l~~------~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP 146 (190)
T cd05145 81 V-P---VPEPILL--K--KNVLVMEFIGDDGSPAPRLKD------VPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSE 146 (190)
T ss_pred C-C---CceEEEe--c--CCEEEEEEecCCCchhhhhhh------ccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCh
Confidence 1 1 1222221 2 248999999975 32222211 126778889999999999999999 9999999999
Q ss_pred ccEEEeccCCCeEEEEecCCccccCC
Q 007035 550 ENILIKSYQRCEIKIIDLGSSCFQTD 575 (621)
Q Consensus 550 ~NILl~~~~~~~IKL~DFGls~~~~~ 575 (621)
+|||++ ++.++|+|||++.....
T Consensus 147 ~NIll~---~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 147 YNILYH---DGKPYIIDVSQAVELDH 169 (190)
T ss_pred hhEEEE---CCCEEEEEcccceecCC
Confidence 999998 57899999999866543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >cd08381 C2B_PI3K_class_II C2 domain second repeat present in class II phosphatidylinositol 3-kinases (PI3Ks) | Back alignment and domain information |
|---|
Probab=99.75 E-value=7.9e-19 Score=160.50 Aligned_cols=101 Identities=12% Similarity=0.013 Sum_probs=89.1
Q ss_pred CcceEEEEecC-CCccccCcCCCCcceEeecCCCCCCcccceeeccccCCCceeccceeeecccccccccccccccccCC
Q 007035 265 NDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDN 343 (621)
Q Consensus 265 ~~~l~v~l~e~-~L~~~d~~g~sDpyVK~~Llp~~~~~~k~kt~v~k~tlnP~fnE~f~f~~~~~~~~~~k~L~~~V~D~ 343 (621)
.+.|+|.|.+| ||+++| +|.+|||||++|+|+.++..++||+++++++||+|||+|.|.+....+..+.+|.++|||+
T Consensus 12 ~~~L~V~Vi~A~~L~~~~-~~~~DpyVkv~l~~~~~~~~~~kT~v~~~~~nP~wnE~F~f~~~~~~~l~~~~L~~~V~d~ 90 (122)
T cd08381 12 NGTLFVMVMHAKNLPLLD-GSDPDPYVKTYLLPDPQKTTKRKTKVVRKTRNPTFNEMLVYDGLPVEDLQQRVLQVSVWSH 90 (122)
T ss_pred CCEEEEEEEEeeCCCCCC-CCCCCCEEEEEEeeCCccCCceeCCccCCCCCCCcccEEEEecCChHHhCCCEEEEEEEeC
Confidence 56789999999 999999 9999999999999998888899999999999999999999984333444577899999999
Q ss_pred CCCCCCCcccccccccccccccC
Q 007035 344 SDTRDGEVNGALHEGKADAEEHG 366 (621)
Q Consensus 344 d~~~r~d~iG~v~~~~a~~~~~~ 366 (621)
|++++++++|++..++..+....
T Consensus 91 d~~~~~~~lG~~~i~l~~l~~~~ 113 (122)
T cd08381 91 DSLVENEFLGGVCIPLKKLDLSQ 113 (122)
T ss_pred CCCcCCcEEEEEEEeccccccCC
Confidence 99999999999999888776543
|
There are 3 classes of PI3Ks based on structure, regulation, and specificity. All classes contain a N-terminal C2 domain, a PIK domain, and a kinase catalytic domain. Unlike class I and class III, class II PI3Ks have additionally a PX domain and a C-terminal C2 domain containing a nuclear localization signal both of which bind phospholipids though in a slightly different fashion. PI3Ks (AKA phosphatidylinositol (PtdIns) 3-kinases) regulate cell processes such as cell growth, differentiation, proliferation, and motility. PI3Ks work on phosphorylation of phosphatidylinositol, phosphatidylinositide (4)P (PtdIns (4)P),2 or PtdIns(4,5)P2. Specifically they phosphorylate the D3 hydroxyl group of phosphoinositol lipids on the inositol ring. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permut |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.8e-17 Score=164.47 Aligned_cols=180 Identities=16% Similarity=0.104 Sum_probs=136.2
Q ss_pred EEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhh-----hHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeE
Q 007035 417 YVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFD-----QSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (621)
Q Consensus 417 ~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~-----~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l 491 (621)
.+...|++|+||+|+++. ..+.+++.+.+.....+.. .+.+|+++++++.+ ++++++++++ ...
T Consensus 5 ~~~~~l~~~~f~~v~~~~--~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~-----~~~vP~ll~~----~~~ 73 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVR--GGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDG-----LPRTPRLLHW----DGR 73 (218)
T ss_pred ccceeecCCCcceEEEee--cCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCC-----CCCCCEEEEE----cCE
Confidence 456789999999999876 4788888888876665444 57889999999864 3567888775 456
Q ss_pred EEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccC-CCccEEEeccCCCeEEEEecCCc
Q 007035 492 FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDL-KPENILIKSYQRCEIKIIDLGSS 570 (621)
Q Consensus 492 ~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDL-KP~NILl~~~~~~~IKL~DFGls 570 (621)
+++|||+.|..+.... +.. ...++.|++.+|.++|++||+|||| ||.|||++. ++.++|+|||++
T Consensus 74 ~lvmeyI~G~~L~~~~-----------~~~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~--~g~i~LIDFG~A 139 (218)
T PRK12274 74 HLDRSYLAGAAMYQRP-----------PRG-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQE--DGSPAVIDFQLA 139 (218)
T ss_pred EEEEeeecCccHHhhh-----------hhh-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcC--CCCEEEEECCCc
Confidence 9999999986543211 011 1347789999999999999999999 799999984 678999999998
Q ss_pred cccCCCcc----------------ccccCCcccCchhhcCC-CCC-chhhHHHHHHHHHHHHhCCCCCC
Q 007035 571 CFQTDNLC----------------LYVQSRSYRAPEVIIGL-PYD-QKIDLWSLGCILAELWTGEVCLI 621 (621)
Q Consensus 571 ~~~~~~~~----------------~~~gt~~Y~APEvl~~~-~~s-~ksDIWSLGvILyELltG~~PF~ 621 (621)
........ ....++.|++|+...-. ..+ ...++++.|+.+|.++|+++|+.
T Consensus 140 ~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~ 208 (218)
T PRK12274 140 VRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW 208 (218)
T ss_pred eecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence 75443321 01237788888876443 234 56899999999999999999863
|
|
| >cd08692 C2B_Tac2-N C2 domain second repeat found in Tac2-N (Tandem C2 protein in Nucleus) | Back alignment and domain information |
|---|
Probab=99.74 E-value=7.7e-19 Score=162.55 Aligned_cols=97 Identities=12% Similarity=0.044 Sum_probs=86.4
Q ss_pred CcceEEEEecC-CCccccCcCCCCcceEeecCCCCCCcccceeeccccCC-CceeccceeeecccccccccccccccccC
Q 007035 265 NDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGS-SIDWIEGFKGSSDLHFKGAEKDLMPAEID 342 (621)
Q Consensus 265 ~~~l~v~l~e~-~L~~~d~~g~sDpyVK~~Llp~~~~~~k~kt~v~k~tl-nP~fnE~f~f~~~~~~~~~~k~L~~~V~D 342 (621)
++.|+|.|.+| ||++|+..+..|||||+.|++++++.+|+||+++|+|+ ||+|||+|.|+ ++.+..+.+|.++|||
T Consensus 13 ~~rLtV~VikarnL~~~~~~~~~dpYVKV~L~~~~k~~~KkKT~v~k~t~~~P~fNEsF~Fd--v~~~~~~v~l~v~v~d 90 (135)
T cd08692 13 NSRIQLQILEAQNLPSSSTPLTLSFFVKVGMFSTGGLLYKKKTRLVKSSNGQVKWGETMIFP--VTQQEHGIQFLIKLYS 90 (135)
T ss_pred CCeEEEEEEEccCCCcccCCCCCCcEEEEEEEECCCcceeecCccEECCCCCceecceEEEe--CCchhheeEEEEEEEe
Confidence 78899999999 99999777788999999999999999999999999996 69999999999 5555557789999999
Q ss_pred CCCCCCCCccccccccccccc
Q 007035 343 NSDTRDGEVNGALHEGKADAE 363 (621)
Q Consensus 343 ~d~~~r~d~iG~v~~~~a~~~ 363 (621)
+|++++|++||.+..+..+..
T Consensus 91 ~~~~~~n~~IG~v~lG~~~~~ 111 (135)
T cd08692 91 RSSVRRKHFLGQVWISSDSSS 111 (135)
T ss_pred CCCCcCCceEEEEEECCccCC
Confidence 999999999999988775433
|
Tac2-N contains two C2 domains and a short C-terminus including a WHXL motif, which are key in stabilizing transport vesicles to the plasma membrane by binding to a plasma membrane. However unlike the usual carboxyl-terminal-type (C-type) tandem C2 proteins, it lacks a transmembrane domain, a Slp-homology domain, and a Munc13-1-interacting domain. Homology search analysis indicate that no known protein motifs are located in its N-terminus, making Tac2-N a novel class of Ca2+-independent, C-type tandem C2 proteins. The C2 domain was first identified in PKC. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involving their N- and C-terminal beta strands. Many C2 domains are Ca2+-dependent membrane-targeting modules that bind a wide variety of substances including bind phospholipids, inositol polypho |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.74 E-value=7.1e-18 Score=196.62 Aligned_cols=201 Identities=19% Similarity=0.267 Sum_probs=157.9
Q ss_pred eeeCeeecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEe
Q 007035 406 IILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYF 485 (621)
Q Consensus 406 i~l~~ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f 485 (621)
.....+-+..|.|.+.||.|+||+||+|.+.. |+.||||+-+....|. +--..+++.+|+ . .--+.|..+...+
T Consensus 690 ~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WE--fYI~~q~~~RLk-~--~~~~~~~~~~~a~ 763 (974)
T KOG1166|consen 690 NTEFEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWE--FYICLQVMERLK-P--QMLPSIMHISSAH 763 (974)
T ss_pred cceeeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCcee--eeehHHHHHhhc-h--hhhcchHHHHHHH
Confidence 33444556789999999999999999999766 9999999987655432 112223344443 1 1123577777777
Q ss_pred EecCeEEEEEeccc-cchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEecc-----CC
Q 007035 486 YHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSY-----QR 559 (621)
Q Consensus 486 ~~~~~l~LVmEyl~-gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~-----~~ 559 (621)
.-.+.-++|+||.+ |+|++++.. ....++..+..++.|++..+..||..+|||+||||+|.||... +.
T Consensus 764 ~~~~~S~lv~ey~~~Gtlld~~N~------~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~ 837 (974)
T KOG1166|consen 764 VFQNASVLVSEYSPYGTLLDLINT------NKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDS 837 (974)
T ss_pred ccCCcceeeeeccccccHHHhhcc------CCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcc
Confidence 77788899999998 899998872 2347888899999999999999999999999999999999641 23
Q ss_pred CeEEEEecCCccccCC-----CccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCC
Q 007035 560 CEIKIIDLGSSCFQTD-----NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEV 618 (621)
Q Consensus 560 ~~IKL~DFGls~~~~~-----~~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~ 618 (621)
.-++|+|||-+..+.- .....++|-.+-.+|+..|.+|++.+|.|.|+.+++-||.|+.
T Consensus 838 ~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 838 KGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred cceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 4599999998865331 2344677888999999999999999999999999999999974
|
|
| >cd08393 C2A_SLP-1_2 C2 domain first repeat present in Synaptotagmin-like proteins 1 and 2 | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.9e-18 Score=158.57 Aligned_cols=99 Identities=10% Similarity=-0.004 Sum_probs=88.4
Q ss_pred CcceEEEEecC-CCccccCc-CCCCcceEeecCCCCCCcccceeeccccCCCceeccceeeeccccccc-cccccccccc
Q 007035 265 NDYGYLSSKEA-DLIDLQHN-VVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKG-AEKDLMPAEI 341 (621)
Q Consensus 265 ~~~l~v~l~e~-~L~~~d~~-g~sDpyVK~~Llp~~~~~~k~kt~v~k~tlnP~fnE~f~f~~~~~~~~-~~k~L~~~V~ 341 (621)
...|+|.|.+| ||+++|.+ |.+|||||++|+|+++...++||+++++|+||+|||+|.|. ++.+. .+++|.++||
T Consensus 14 ~~~L~V~vi~a~~L~~~d~~~g~~dpyVkv~l~p~~~~~~~~kT~v~~~t~nP~~nE~f~f~--v~~~~l~~~~L~~~V~ 91 (125)
T cd08393 14 LRELHVHVIQCQDLAAADPKKQRSDPYVKTYLLPDKSNRGKRKTSVKKKTLNPVFNETLRYK--VEREELPTRVLNLSVW 91 (125)
T ss_pred CCEEEEEEEEeCCCCCcCCCCCCCCcEEEEEEEcCCCccccccCccCcCCCCCccCceEEEE--CCHHHhCCCEEEEEEE
Confidence 46789999999 99999986 89999999999999988788899999999999999999998 55444 4678999999
Q ss_pred CCCCCCCCCccccccccccccccc
Q 007035 342 DNSDTRDGEVNGALHEGKADAEEH 365 (621)
Q Consensus 342 D~d~~~r~d~iG~v~~~~a~~~~~ 365 (621)
|+|++++++++|++..+++..+..
T Consensus 92 d~~~~~~~~~iG~~~i~L~~~~~~ 115 (125)
T cd08393 92 HRDSLGRNSFLGEVEVDLGSWDWS 115 (125)
T ss_pred eCCCCCCCcEeEEEEEecCccccC
Confidence 999999999999999988877654
|
All Slp members basically share an N-terminal Slp homology domain (SHD) and C-terminal tandem C2 domains (named the C2A domain and the C2B domain) with the SHD and C2 domains being separated by a linker sequence of various length. Slp1/JFC1 and Slp2/exophilin 4 promote granule docking to the plasma membrane. Additionally, their C2A domains are both Ca2+ independent, unlike Slp3 and Slp4/granuphilin which are Ca2+ dependent. It is thought that SHD (except for the Slp4-SHD) functions as a specific Rab27A/B-binding domain. In addition to Slps, rabphilin, Noc2, and Munc13-4 also function as Rab27-binding proteins. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involving their N- and C-terminal beta strands. Many C2 domains are Ca2+-dependent membrane-targeting modules that bind a wide variety |
| >cd08685 C2_RGS-like C2 domain of the Regulator Of G-Protein Signaling (RGS) family | Back alignment and domain information |
|---|
Probab=99.72 E-value=3e-18 Score=156.05 Aligned_cols=98 Identities=15% Similarity=0.098 Sum_probs=87.4
Q ss_pred CcceEEEEecC-CCccccCcCCCCcceEeecCCCCCCcccceeeccccCCCceeccceeeecccccccccccccccccCC
Q 007035 265 NDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDN 343 (621)
Q Consensus 265 ~~~l~v~l~e~-~L~~~d~~g~sDpyVK~~Llp~~~~~~k~kt~v~k~tlnP~fnE~f~f~~~~~~~~~~k~L~~~V~D~ 343 (621)
.+.|+|.|.+| ||.++| +|.+|||||++|+|++++..++||+++++|+||+|||+|.|. ++.+..++.|.++|||.
T Consensus 11 ~~~L~V~Vi~ar~L~~~~-~g~~dpYVkv~l~p~~~~~~~~kT~v~~~t~~P~~nE~F~f~--v~~~~~~~~l~v~V~~~ 87 (119)
T cd08685 11 NRKLTLHVLEAKGLRSTN-SGTCNSYVKISLSPDKEVRFRQKTSTVPDSANPLFHETFSFD--VNERDYQKRLLVTVWNK 87 (119)
T ss_pred CCEEEEEEEEEECCCCCC-CCCCCeeEEEEEEeCCCCcceEeCccccCCCCCccccEEEEE--cChHHhCCEEEEEEECC
Confidence 57889999999 999999 889999999999999988889999999999999999999998 55555556789999999
Q ss_pred CCCCC-CCccccccccccccccc
Q 007035 344 SDTRD-GEVNGALHEGKADAEEH 365 (621)
Q Consensus 344 d~~~r-~d~iG~v~~~~a~~~~~ 365 (621)
++.++ ++++|+++.++.++...
T Consensus 88 ~~~~~~~~~lG~~~i~l~~~~~~ 110 (119)
T cd08685 88 LSKSRDSGLLGCMSFGVKSIVNQ 110 (119)
T ss_pred CCCcCCCEEEEEEEecHHHhccC
Confidence 99874 79999999999888643
|
This CD contains members of the regulator of G-protein signaling (RGS) family. RGS is a GTPase activating protein which inhibits G-protein mediated signal transduction. The protein is largely cytosolic, but G-protein activation leads to translocation of this protein to the plasma membrane. A nuclear form of this protein has also been described, but its sequence has not been identified. There are multiple alternatively spliced transcript variants in this family with some members having additional domains (ex. PDZ and RGS) downstream of the C2 domain. The C2 domain was first identified in PKC. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involving their N- and C-terminal beta strands. Many C2 domains are Ca2+-dependent membrane-targeting modules that bind a wide variety of substances including bind pho |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.72 E-value=1e-16 Score=166.30 Aligned_cols=204 Identities=22% Similarity=0.325 Sum_probs=127.6
Q ss_pred ceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCch----hhhhHHHHHHHHHHhcccCCC----CCCceEEEeeEeE
Q 007035 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD----FFDQSLDEIKLLKLVNKNDPA----DEHHILRLYDYFY 486 (621)
Q Consensus 415 rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~----~~~~~~~Ei~iL~~l~~~~~~----~hpnIvrl~~~f~ 486 (621)
.+...+.||.|+++.||.+.|..+|+.+|+|++..... ..+++++|.-....+...... .|-.++-.++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 35566789999999999999999999999999864332 122333333222111100000 0101222222211
Q ss_pred ---------ec---C-----eEEEEEeccccchHHHHHhhhccCC-CccccHHHHHHHHHHHHHHHHHHHHCCeecccCC
Q 007035 487 ---------HL---E-----HLFIVCELLRANLYEFQKFNQESGG-EAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLK 548 (621)
Q Consensus 487 ---------~~---~-----~l~LVmEyl~gsLld~l~~~~~~~~-~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLK 548 (621)
.. . ..+++|+-+.++|.+++........ ...+.......+..|+++.+++||..||+|+||+
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~ 172 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIK 172 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-S
T ss_pred EcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccc
Confidence 11 1 2477888888888887664332221 1223334445677999999999999999999999
Q ss_pred CccEEEeccCCCeEEEEecCCccccCCCccccccCCcccCchhhcC--------CCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 549 PENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIG--------LPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 549 P~NILl~~~~~~~IKL~DFGls~~~~~~~~~~~gt~~Y~APEvl~~--------~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
|+|++++. +|.+.|+||+.....+........+..|.+||.... ..++.+.|.|+||+++|.|.+|+.||
T Consensus 173 ~~nfll~~--~G~v~Lg~F~~~~r~g~~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf 250 (288)
T PF14531_consen 173 PENFLLDQ--DGGVFLGDFSSLVRAGTRYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPF 250 (288)
T ss_dssp GGGEEE-T--TS-EEE--GGGEEETTEEEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-ST
T ss_pred eeeEEEcC--CCCEEEcChHHHeecCceeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCC
Confidence 99999994 899999999877665554333344677999998743 24788999999999999999999998
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.2e-16 Score=159.62 Aligned_cols=139 Identities=22% Similarity=0.306 Sum_probs=107.4
Q ss_pred EEEeccCCCCceeEEEeCCCCcEEEEEEEecC-chhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecC---eEE-E
Q 007035 419 TEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND-KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE---HLF-I 493 (621)
Q Consensus 419 ~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~-~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~---~l~-L 493 (621)
.+.||+|+|+.||. +..++.. +||++... ....+...+|+++++.+.+. ..+||||+++++++++.. .++ +
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~-~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRR-LIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred cceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhcc-CCCCcccceeeEEEEeCCCCeEEEEE
Confidence 46799999999996 6777766 69988753 22456789999999999763 467999999999999873 434 7
Q ss_pred EEeccc---cchHHHHHhhhccCCCccccHHHHHHHHHHHHHHH-HHHHHCCeecccCCCccEEEecc--CCCeEEEEe-
Q 007035 494 VCELLR---ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEAL-EYLHSLGIIHCDLKPENILIKSY--QRCEIKIID- 566 (621)
Q Consensus 494 VmEyl~---gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL-~yLHs~gIvHrDLKP~NILl~~~--~~~~IKL~D- 566 (621)
||||.+ ++|.+++.... +++. ..++.|++.++ .|||+++|+||||||+|||++.. ....++|+|
T Consensus 83 I~e~~G~~~~tL~~~l~~~~-------~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQCR-------YEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred EecCCCCcchhHHHHHHccc-------ccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 899955 58888875421 4444 35678888887 89999999999999999999853 234799999
Q ss_pred cCCc
Q 007035 567 LGSS 570 (621)
Q Consensus 567 FGls 570 (621)
||..
T Consensus 154 ~G~~ 157 (210)
T PRK10345 154 IGES 157 (210)
T ss_pred CCCc
Confidence 5543
|
|
| >cd04029 C2A_SLP-4_5 C2 domain first repeat present in Synaptotagmin-like proteins 4 and 5 | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.2e-17 Score=153.30 Aligned_cols=100 Identities=11% Similarity=0.021 Sum_probs=87.9
Q ss_pred CcceEEEEecC-CCccccC-cCCCCcceEeecCCCCCCcccceeeccccCCCceeccceeeeccccccc-cccccccccc
Q 007035 265 NDYGYLSSKEA-DLIDLQH-NVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKG-AEKDLMPAEI 341 (621)
Q Consensus 265 ~~~l~v~l~e~-~L~~~d~-~g~sDpyVK~~Llp~~~~~~k~kt~v~k~tlnP~fnE~f~f~~~~~~~~-~~k~L~~~V~ 341 (621)
.+.|+|.|.+| ||.++|. +|.+|||||++++|++.+..++||+++++++||+|||+|.|. ++.+. .++.|.++||
T Consensus 14 ~~~L~V~Vi~a~~L~~~~~~~~~~DpyVkv~l~p~~~~~~~~kT~v~~~t~nP~wnE~f~f~--i~~~~l~~~~L~~~V~ 91 (125)
T cd04029 14 TQSLNVHVKECRNLAYGDEAKKRSNPYVKTYLLPDKSRQSKRKTSIKRNTTNPVYNETLKYS--ISHSQLETRTLQLSVW 91 (125)
T ss_pred CCeEEEEEEEecCCCccCCCCCCCCcEEEEEEEcCCccccceEeeeeeCCCCCcccceEEEE--CCHHHhCCCEEEEEEE
Confidence 56789999999 9999986 589999999999999988788899999999999999999998 55443 4677999999
Q ss_pred CCCCCCCCCcccccccccccccccC
Q 007035 342 DNSDTRDGEVNGALHEGKADAEEHG 366 (621)
Q Consensus 342 D~d~~~r~d~iG~v~~~~a~~~~~~ 366 (621)
|+|.+++++++|++..++...+...
T Consensus 92 d~~~~~~~~~lG~~~i~l~~~~~~~ 116 (125)
T cd04029 92 HYDRFGRNTFLGEVEIPLDSWNFDS 116 (125)
T ss_pred ECCCCCCCcEEEEEEEeCCcccccC
Confidence 9999999999999999887766554
|
All Slp members basically share an N-terminal Slp homology domain (SHD) and C-terminal tandem C2 domains (named the C2A domain and the C2B domain) with the SHD and C2 domains being separated by a linker sequence of various length. SHD of Slp (except for the Slp4-SHD) function as a specific Rab27A/B-binding domain. In addition to Slp, rabphilin, Noc2, and Munc13-4 also function as Rab27-binding proteins. It has been demonstrated that Slp4/granuphilin promotes dense-core vesicle exocytosis. The C2A domain of Slp4 is Ca2+ dependent. Slp5 mRNA has been shown to be restricted to human placenta and liver suggesting a role in Rab27A-dependent membrane trafficking in specific tissues. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involving their N- and C-terminal beta strands. Many C2 domains are Ca2 |
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.8e-16 Score=161.24 Aligned_cols=145 Identities=16% Similarity=0.155 Sum_probs=108.2
Q ss_pred eEEEEEeccCCCCceeEEE-eCCCCcEEEEEEEecCch-------------------------hhhhHHHHHHHHHHhcc
Q 007035 416 YYVTEYLGSAAFSKVFQAQ-DLHTGVDVCLKIIKNDKD-------------------------FFDQSLDEIKLLKLVNK 469 (621)
Q Consensus 416 Y~I~~~LG~G~fG~Vyka~-d~~tg~~VAlKii~~~~~-------------------------~~~~~~~Ei~iL~~l~~ 469 (621)
|.+.+.||.|++|.||+|. +..+|+.||+|+++.... .......|+.+++.+..
T Consensus 30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~ 109 (237)
T smart00090 30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE 109 (237)
T ss_pred HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 7888999999999999998 778999999999875321 01224578888888864
Q ss_pred cCCCCCCceEEEeeEeEecCeEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCC-eecccCC
Q 007035 470 NDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLG-IIHCDLK 548 (621)
Q Consensus 470 ~~~~~hpnIvrl~~~f~~~~~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~g-IvHrDLK 548 (621)
. ...+++++.. ...++||||+++..+....... ..+....+..++.||+.+|.+||+.| |+|||||
T Consensus 110 ~----~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dik 176 (237)
T smart00090 110 A----GVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD-----VEPEEEEEFELYDDILEEMRKLYKEGELVHGDLS 176 (237)
T ss_pred c----CCCCCeeeEe----cCceEEEEEecCCccccccccc-----CCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCC
Confidence 2 1234444442 2348999999985433222111 11455667889999999999999999 9999999
Q ss_pred CccEEEeccCCCeEEEEecCCccccCCC
Q 007035 549 PENILIKSYQRCEIKIIDLGSSCFQTDN 576 (621)
Q Consensus 549 P~NILl~~~~~~~IKL~DFGls~~~~~~ 576 (621)
|+||+++ ++.++|+|||.+.....+
T Consensus 177 p~NIli~---~~~i~LiDFg~a~~~~~~ 201 (237)
T smart00090 177 EYNILVH---DGKVVIIDVSQSVELDHP 201 (237)
T ss_pred hhhEEEE---CCCEEEEEChhhhccCCc
Confidence 9999998 568999999998654443
|
|
| >cd08395 C2C_Munc13 C2 domain third repeat in Munc13 (mammalian uncoordinated) proteins | Back alignment and domain information |
|---|
Probab=99.67 E-value=6.8e-17 Score=147.37 Aligned_cols=100 Identities=15% Similarity=0.003 Sum_probs=81.6
Q ss_pred ceEEEEecC-CCccccCcCCCCcceEeecCC--CCCCcccceeeccccCCCceeccceeeecccccccccccccccccCC
Q 007035 267 YGYLSSKEA-DLIDLQHNVVGDSSTDCDLAP--HPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDN 343 (621)
Q Consensus 267 ~l~v~l~e~-~L~~~d~~g~sDpyVK~~Llp--~~~~~~k~kt~v~k~tlnP~fnE~f~f~~~~~~~~~~k~L~~~V~D~ 343 (621)
+|+|.|.+| ||+++| .|.+|||||++|.- ...++.|+||+++++|+||+|||+|.|............|.+.|||+
T Consensus 1 kL~V~Vi~A~~L~~~d-~g~~DPYVkV~l~g~~~~~k~~k~kTkv~~~tlnPvwNE~f~F~v~~~~~~~~~~L~~~V~D~ 79 (120)
T cd08395 1 KVTVKVVAANDLKWQT-TGMFRPFVEVNLIGPHLSDKKRKFATKSKNNNWSPKYNETFQFILGNEDDPESYELHICVKDY 79 (120)
T ss_pred CEEEEEEECcCCCccc-CCCCCCEEEEEEecCCCcccccEeeeEEecCCCCCccCcEEEEEeeCcCCCceeEEEEEEEEe
Confidence 478999999 999998 49999999999952 23344567888899999999999999994322233467799999999
Q ss_pred CCCCCCCcccccccccccccccCC
Q 007035 344 SDTRDGEVNGALHEGKADAEEHGV 367 (621)
Q Consensus 344 d~~~r~d~iG~v~~~~a~~~~~~~ 367 (621)
|.++++++||.+..++......+.
T Consensus 80 d~~~~dd~IG~~~l~l~~~~~~~~ 103 (120)
T cd08395 80 CFARDDRLVGVTVLQLRDIAQAGS 103 (120)
T ss_pred cccCCCCEEEEEEEEHHHCcCCCc
Confidence 988889999999999888886664
|
C2-like domains are thought to be involved in phospholipid binding in a Ca2+ independent manner in both Unc13 and Munc13. Caenorabditis elegans Unc13 has a central domain with sequence similarity to PKC, which includes C1 and C2-related domains. Unc13 binds phorbol esters and DAG with high affinity in a phospholipid manner. Mutations in Unc13 results in abnormal neuronal connections and impairment in cholinergic neurotransmission in the nematode. Munc13 is the mammalian homolog which are expressed in the brain. There are 3 isoforms (Munc13-1, -2, -3) and are thought to play a role in neurotransmitter release and are hypothesized to be high-affinity receptors for phorbol esters. Unc13 and Munc13 contain both C1 and C2 domains. There are two C2 related domains present, one central and one at the carboxyl end. Munc13-1 contains a third C2-like domain. Munc13 interacts with syntaxin, synaptobrevi |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.66 E-value=4.1e-17 Score=185.78 Aligned_cols=194 Identities=25% Similarity=0.324 Sum_probs=150.3
Q ss_pred EEEEeccCCCCceeEEEeCCCCcEEEEEEEecC--chhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeEEEEE
Q 007035 418 VTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVC 495 (621)
Q Consensus 418 I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~--~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l~LVm 495 (621)
-.+.+|.|++|.|+.+.........+.|.++.. ... ........+..++-....+.|++++..+..+++.....-+|
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~-s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTE-SERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcc-cHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 456799999999998887777776666655421 111 11111222555666666788999988888777766655569
Q ss_pred eccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCccccC-
Q 007035 496 ELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQT- 574 (621)
Q Consensus 496 Eyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~~~~- 574 (621)
|||+..|..++..... +...++..+++||+.|++|||+.||.||||||+|+++.. .+.+||+|||.+....
T Consensus 401 E~~~~Dlf~~~~~~~~------~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~--~g~lki~Dfg~~~vf~~ 472 (601)
T KOG0590|consen 401 EYCPYDLFSLVMSNGK------LTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTE--NGILKIIDFGAASVFRY 472 (601)
T ss_pred hcccHHHHHHHhcccc------cchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEec--CCceEEeecCcceeecc
Confidence 9999877777765422 777889999999999999999999999999999999994 7899999999864322
Q ss_pred ------CCccccccCCcccCchhhcCCCCCc-hhhHHHHHHHHHHHHhCCCCC
Q 007035 575 ------DNLCLYVQSRSYRAPEVIIGLPYDQ-KIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 575 ------~~~~~~~gt~~Y~APEvl~~~~~s~-ksDIWSLGvILyELltG~~PF 620 (621)
......+|+..|+|||++.+..|.. ..||||.|+++..|.+|+.|+
T Consensus 473 ~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~W 525 (601)
T KOG0590|consen 473 PWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPW 525 (601)
T ss_pred CcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCcc
Confidence 1233468899999999999998875 599999999999999999886
|
|
| >cd08408 C2B_Synaptotagmin-14_16 C2 domain second repeat present in Synaptotagmins 14 and 16 | Back alignment and domain information |
|---|
Probab=99.66 E-value=5.9e-17 Score=151.40 Aligned_cols=95 Identities=16% Similarity=0.111 Sum_probs=83.7
Q ss_pred CcceEEEEecC-CCccccCcCCCCcceEeecCCCCCC-cccceeeccccCCCceeccceeeecccccccc-ccccccccc
Q 007035 265 NDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGT-EKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEI 341 (621)
Q Consensus 265 ~~~l~v~l~e~-~L~~~d~~g~sDpyVK~~Llp~~~~-~~k~kt~v~k~tlnP~fnE~f~f~~~~~~~~~-~k~L~~~V~ 341 (621)
.+.|.|.|.+| ||++++.+|.+|||||++|+|+.++ ..++||+++++++||+|||+|.|. ++.+.. +++|.++||
T Consensus 14 ~~~L~V~VikarnL~~~~~~~~~dpyVkv~llp~~~~~~~~~kT~v~~~t~nPvfnEtF~f~--i~~~~l~~~~L~~~V~ 91 (138)
T cd08408 14 TGRLSVEVIKGSNFKNLAMNKAPDTYVKLTLLNSDGQEISKSKTSIRRGQPDPEFKETFVFQ--VALFQLSEVTLMFSVY 91 (138)
T ss_pred CCeEEEEEEEecCCCccccCCCCCeeEEEEEEeCCCcceeeccceeecCCCCCcEeeeEEEE--CCHHHhCccEEEEEEE
Confidence 67889999999 9999999999999999999996544 467899999999999999999999 555554 788999999
Q ss_pred CCCCCCCCCccccccccccc
Q 007035 342 DNSDTRDGEVNGALHEGKAD 361 (621)
Q Consensus 342 D~d~~~r~d~iG~v~~~~a~ 361 (621)
|++++++++++|++..+...
T Consensus 92 ~~~~~~~~~~iG~v~l~~~~ 111 (138)
T cd08408 92 NKRKMKRKEMIGWFSLGLNS 111 (138)
T ss_pred ECCCCCCCcEEEEEEECCcC
Confidence 99999999999998776543
|
Synaptotagmin 14 and 16 are membrane-trafficking proteins in specific tissues outside the brain. Both of these contain C-terminal tandem C2 repeats, but only Synaptotagmin 14 has an N-terminal transmembrane domain and a putative fatty-acylation site. Previously all synaptotagmins were thought to be calcium sensors in the regulation of neurotransmitter release and hormone secretion, but it has been shown that not all of them bind calcium and this is indeed the case here. Of the 17 identified synaptotagmins only 8 bind calcium (1-3, 5-7, 9, 10). The function of the two C2 domains that bind calcium are: regulating the fusion step of synaptic vesicle exocytosis (C2A) and binding to phosphatidyl-inositol-3,4,5-triphosphate (PIP3) in the absence of calcium ions and to phosphatidylinositol bisphosphate (PIP2) in their presence (C2B). C2B also regulates also the recycling step of synaptic vesicle |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.65 E-value=6.8e-17 Score=185.66 Aligned_cols=192 Identities=28% Similarity=0.405 Sum_probs=145.5
Q ss_pred ceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc--hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeEE
Q 007035 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLF 492 (621)
Q Consensus 415 rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l~ 492 (621)
.|...+.||++.|=+|.+|++ ..|. |++|++-+.. ...+.+.++++-++.. ...+||.+.+.-+.......|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~-~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~----l~~~pn~lPfqk~~~t~kAAy 97 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKD-REGL-VVVKVFVKQDPTISLRPFKQRLEEIKFA----LMKAPNCLPFQKVLVTDKAAY 97 (1431)
T ss_pred ceeeecccCchhhhhhhhccC-CCce-EEEEEEeccCCCCCchHHHHHHHHHHHH----hhcCCcccchHHHHHhhHHHH
Confidence 677888999999999999985 5666 9999876533 2233344444333322 235789998888777778899
Q ss_pred EEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCccc
Q 007035 493 IVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF 572 (621)
Q Consensus 493 LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~~ 572 (621)
||-+|+..+|++.+...+. +.+.+.+.|+.||+.||..+|..||+|||||.+||||++ ..=+.|+||..-..
T Consensus 98 lvRqyvkhnLyDRlSTRPF------L~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTS--WNW~~LtDFAsFKP 169 (1431)
T KOG1240|consen 98 LVRQYVKHNLYDRLSTRPF------LVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITS--WNWLYLTDFASFKP 169 (1431)
T ss_pred HHHHHHhhhhhhhhccchH------HHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEee--echhhhhcccccCC
Confidence 9999999999998875543 788889999999999999999999999999999999995 44578999985422
Q ss_pred --c-CCC---ccccccC----CcccCchhhcCC----------C-CCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 573 --Q-TDN---LCLYVQS----RSYRAPEVIIGL----------P-YDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 573 --~-~~~---~~~~~gt----~~Y~APEvl~~~----------~-~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
. .++ ...+..| ..|.|||.+... + .+++.||||+||+++||++ |++||
T Consensus 170 tYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF 239 (1431)
T KOG1240|consen 170 TYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLF 239 (1431)
T ss_pred ccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcc
Confidence 1 111 1222223 249999998541 2 5678999999999999987 68877
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.65 E-value=2.4e-17 Score=181.58 Aligned_cols=183 Identities=27% Similarity=0.376 Sum_probs=146.6
Q ss_pred eccCCCCceeEEEe---CCCCcEEEEEEEecCchh---hhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeEEEEE
Q 007035 422 LGSAAFSKVFQAQD---LHTGVDVCLKIIKNDKDF---FDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVC 495 (621)
Q Consensus 422 LG~G~fG~Vyka~d---~~tg~~VAlKii~~~~~~---~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l~LVm 495 (621)
+|.|.||.|++++. ...|..+|+|+.++.... ......|..++..++ .||+++++...|+....+++++
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~-----~~~f~v~lhyafqt~~kl~l~l 76 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVH-----NTPFLVKLHYAFQTDGKLYLIL 76 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhcc-----CCCceeeeeeeeccccchhHhh
Confidence 78999999998763 345677899987653211 113344555666654 3679999999999999999999
Q ss_pred eccccc-hHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCccccC
Q 007035 496 ELLRAN-LYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQT 574 (621)
Q Consensus 496 Eyl~gs-Lld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~~~~ 574 (621)
++..++ +...+.. ...+.+...+.+...++-++.++|+.+|+|||+|++||+++. .|++++.|||++...-
T Consensus 77 d~~rgg~lft~l~~------~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~--~Ghi~~tdfglske~v 148 (612)
T KOG0603|consen 77 DFLRGGDLFTRLSK------EVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLL--EGHIKLTDFGLSKEAV 148 (612)
T ss_pred hhcccchhhhcccc------CCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecc--cCccccCCchhhhHhH
Confidence 999874 3332221 223788888899999999999999999999999999999994 9999999999987655
Q ss_pred CCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 575 DNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 575 ~~~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
..... +||..|||||++. .....+|+||+|+++++|+||-.||
T Consensus 149 ~~~~~-cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf 191 (612)
T KOG0603|consen 149 KEKIA-CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPF 191 (612)
T ss_pred hhhhc-ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCC
Confidence 44333 8999999999999 4577899999999999999999998
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.64 E-value=2.5e-16 Score=181.02 Aligned_cols=159 Identities=29% Similarity=0.450 Sum_probs=117.7
Q ss_pred cCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHH-HhcccCCCCCCceEEEeeEeEecCeE
Q 007035 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLK-LVNKNDPADEHHILRLYDYFYHLEHL 491 (621)
Q Consensus 413 ~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~-~l~~~~~~~hpnIvrl~~~f~~~~~l 491 (621)
..+|..++.|-.|++|.||+++|+.+.+.+|+|+-++. . |++ ++. -.+.|+++
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~-l----------ilRnilt---~a~npfvv------------ 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQN-L----------ILRNILT---FAGNPFVV------------ 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcccccc-h----------hhhcccc---ccCCccee------------
Confidence 46799999999999999999999999999999654332 1 222 111 11122232
Q ss_pred EEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCcc
Q 007035 492 FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 571 (621)
Q Consensus 492 ~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~ 571 (621)
|.-..+++.... ++.. ++.+++|||..||+|||+||+|.||+. -|++|++|||++.
T Consensus 136 --------gDc~tllk~~g~------lPvd--------mvla~Eylh~ygivhrdlkpdnllIT~--mGhiKlTDfgLsk 191 (1205)
T KOG0606|consen 136 --------GDCATLLKNIGP------LPVD--------MVLAVEYLHSYGIVHRDLKPDNLLITS--MGHIKLTDFGLSK 191 (1205)
T ss_pred --------chhhhhcccCCC------Ccch--------hhHHhHhhccCCeecCCCCCCcceeee--cccccccchhhhh
Confidence 211112221111 2222 267999999999999999999999995 8999999999875
Q ss_pred ccCC------------------CccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 007035 572 FQTD------------------NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCLI 621 (621)
Q Consensus 572 ~~~~------------------~~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF~ 621 (621)
.... .....+|||.|+|||++....|+..+|+|++|+|+||.+-|.+||+
T Consensus 192 ~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpff 259 (1205)
T KOG0606|consen 192 KGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFF 259 (1205)
T ss_pred hhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeecc
Confidence 3111 1122588999999999999999999999999999999999999996
|
|
| >KOG1028 consensus Ca2+-dependent phospholipid-binding protein Synaptotagmin, required for synaptic vesicle and secretory granule exocytosis [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.7e-16 Score=173.61 Aligned_cols=99 Identities=11% Similarity=-0.016 Sum_probs=88.1
Q ss_pred CcceEEEEecC-CCccccCcCCCCcceEeecCCCCCCcccceeeccccCCCceeccceeeecccccccccccccccccCC
Q 007035 265 NDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDN 343 (621)
Q Consensus 265 ~~~l~v~l~e~-~L~~~d~~g~sDpyVK~~Llp~~~~~~k~kt~v~k~tlnP~fnE~f~f~~~~~~~~~~k~L~~~V~D~ 343 (621)
.+-|+|.|.+| +|+++|.+|.+|||||++|+|++ +.|.||+++|+||||+|||+|.|. +...+...++|.++|||+
T Consensus 166 ~~~L~V~V~qa~~Lp~~d~~g~sdpyVK~~llPdk--~~k~kT~v~r~tlnP~fnEtf~f~-v~~~~l~~~~L~l~V~~~ 242 (421)
T KOG1028|consen 166 LNLLTVRVIQAHDLPAKDRGGTSDPYVKVYLLPDK--KGKFKTRVHRKTLNPVFNETFRFE-VPYEELSNRVLHLSVYDF 242 (421)
T ss_pred CCEEEEEEEEecCCCcccCCCCCCCeeEEEEcCCC--CCcceeeeeecCcCCccccceEee-cCHHHhccCEEEEEEEec
Confidence 56789999999 99999988899999999999999 558899999999999999999999 455556689999999999
Q ss_pred CCCCCCCcccccccccccccccC
Q 007035 344 SDTRDGEVNGALHEGKADAEEHG 366 (621)
Q Consensus 344 d~~~r~d~iG~v~~~~a~~~~~~ 366 (621)
|+|+|++++|++..++...+...
T Consensus 243 drfsr~~~iGev~~~l~~~~~~~ 265 (421)
T KOG1028|consen 243 DRFSRHDFIGEVILPLGEVDLLS 265 (421)
T ss_pred CCcccccEEEEEEecCccccccc
Confidence 99999999999988866665554
|
|
| >cd04020 C2B_SLP_1-2-3-4 C2 domain second repeat present in Synaptotagmin-like proteins 1-4 | Back alignment and domain information |
|---|
Probab=99.63 E-value=3.2e-16 Score=150.36 Aligned_cols=119 Identities=18% Similarity=0.168 Sum_probs=99.6
Q ss_pred cCcceEEEEecC-CCccccCcCCCCcceEeecCCCCCCcccceeeccccCCCceeccceeeecccccccccccccccccC
Q 007035 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEID 342 (621)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyVK~~Llp~~~~~~k~kt~v~k~tlnP~fnE~f~f~~~~~~~~~~k~L~~~V~D 342 (621)
+.+.|+|.|.+| ||+++|..|.+|||||++++|+..+..++||+++++|+||.|||+|.|......+..+..|.++|||
T Consensus 25 ~~g~L~V~Vi~A~nL~~~d~~g~~DPYVkv~l~~~~~~~~~~kT~vi~~t~nP~WnE~f~f~~~~~~~l~~~~L~i~V~d 104 (162)
T cd04020 25 STGELHVWVKEAKNLPALKSGGTSDSFVKCYLLPDKSKKSKQKTPVVKKSVNPVWNHTFVYDGVSPEDLSQACLELTVWD 104 (162)
T ss_pred CCceEEEEEEeeeCCCCCCCCCCCCCEEEEEEEcCCCCCcceeCCccCCCCCCCCCCEEEEecCCHHHhCCCEEEEEEEe
Confidence 356789999999 9999999999999999999999888889999999999999999999998544445556779999999
Q ss_pred CCCCCCCCcccccccccccccccCCCCccchhccchhhhhhhh
Q 007035 343 NSDTRDGEVNGALHEGKADAEEHGVATPDLLMFDNLEEECEIF 385 (621)
Q Consensus 343 ~d~~~r~d~iG~v~~~~a~~~~~~~~~~~ll~~~~l~eE~e~~ 385 (621)
+|.+++++++|++..++.+....+.. ..|+...-+|..++
T Consensus 105 ~d~~~~d~~lG~v~i~l~~~~~~~~~---~~w~~~~~~~~~~w 144 (162)
T cd04020 105 HDKLSSNDFLGGVRLGLGTGKSYGQA---VDWMDSTGEEILLW 144 (162)
T ss_pred CCCCCCCceEEEEEEeCCccccCCCc---cccccCChHHHHHH
Confidence 99999999999999988877665532 23776666665554
|
All Slp members basically share an N-terminal Slp homology domain (SHD) and C-terminal tandem C2 domains (named the C2A domain and the C2B domain) with the SHD and C2 domains being separated by a linker sequence of various length. Slp1/JFC1 and Slp2/exophilin 4 promote granule docking to the plasma membrane. Additionally, their C2A domains are both Ca2+ independent, unlike the case in Slp3 and Slp4/granuphilin in which their C2A domains are Ca2+ dependent. It is thought that SHD (except for the Slp4-SHD) functions as a specific Rab27A/B-binding domain. In addition to Slps, rabphilin, Noc2, and Munc13-4 also function as Rab27-binding proteins. It has been demonstrated that Slp3 and Slp4/granuphilin promote dense-core vesicle exocytosis. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involvin |
| >cd08389 C2A_Synaptotagmin-14_16 C2A domain first repeat present in Synaptotagmins 14 and 16 | Back alignment and domain information |
|---|
Probab=99.62 E-value=3.1e-16 Score=143.73 Aligned_cols=99 Identities=11% Similarity=-0.051 Sum_probs=86.4
Q ss_pred CcceEEEEecC-CCccccCcCCCCcceEeecCCCCCCcccceeeccccCCCceeccceeeecccccccccccccccccCC
Q 007035 265 NDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDN 343 (621)
Q Consensus 265 ~~~l~v~l~e~-~L~~~d~~g~sDpyVK~~Llp~~~~~~k~kt~v~k~tlnP~fnE~f~f~~~~~~~~~~k~L~~~V~D~ 343 (621)
...|.|.|.+| ||+++|.+|.+|||||+.++|++++ ++||+++++ +||+|||+|.|.++...+..+++|.+.|||+
T Consensus 15 ~~~L~V~Vi~a~nL~~~~~~~~~d~yVk~~llp~~~~--~~kTkv~~~-~nP~fnE~F~f~~i~~~~l~~~~L~~~V~~~ 91 (124)
T cd08389 15 ARKLTVTVIRAQDIPTKDRGGASSWQVHLVLLPSKKQ--RAKTKVQRG-PNPVFNETFTFSRVEPEELNNMALRFRLYGV 91 (124)
T ss_pred CCEEEEEEEEecCCCchhcCCCCCcEEEEEEccCCcc--eeecccccC-CCCcccCEEEECCCCHHHhccCEEEEEEEEC
Confidence 56889999999 9999999999999999999998754 677888777 9999999999985555555688899999999
Q ss_pred CCCCCCCcccccccccccccccC
Q 007035 344 SDTRDGEVNGALHEGKADAEEHG 366 (621)
Q Consensus 344 d~~~r~d~iG~v~~~~a~~~~~~ 366 (621)
+++++++++|++..++..+....
T Consensus 92 ~~~~~~~~lG~~~i~L~~l~~~~ 114 (124)
T cd08389 92 ERMRKERLIGEKVVPLSQLNLEG 114 (124)
T ss_pred CCcccCceEEEEEEeccccCCCC
Confidence 99999999999999988775543
|
Synaptotagmin 14 and 16 are membrane-trafficking proteins in specific tissues outside the brain. Both of these contain C-terminal tandem C2 repeats, but only Synaptotagmin 14 has an N-terminal transmembrane domain and a putative fatty-acylation site. Previously all synaptotagmins were thought to be calcium sensors in the regulation of neurotransmitter release and hormone secretion, but it has been shown that not all of them bind calcium and this is indeed the case here. Of the 17 identified synaptotagmins only 8 bind calcium (1-3, 5-7, 9, 10). The function of the two C2 domains that bind calcium are: regulating the fusion step of synaptic vesicle exocytosis (C2A) and binding to phosphatidyl-inositol-3,4,5-triphosphate (PIP3) in the absence of calcium ions and to phosphatidylinositol bisphosphate (PIP2) in their presence (C2B). C2B also regulates also the recycling step of synaptic vesicle |
| >cd08388 C2A_Synaptotagmin-4-11 C2A domain first repeat present in Synaptotagmins 4 and 11 | Back alignment and domain information |
|---|
Probab=99.61 E-value=4.2e-16 Score=143.70 Aligned_cols=98 Identities=14% Similarity=0.023 Sum_probs=82.5
Q ss_pred CcceEEEEecC-CCccccCc-CCCCcceEeecCCCCCCcccceeeccccCCCceeccceeeecccccccccccccccccC
Q 007035 265 NDYGYLSSKEA-DLIDLQHN-VVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEID 342 (621)
Q Consensus 265 ~~~l~v~l~e~-~L~~~d~~-g~sDpyVK~~Llp~~~~~~k~kt~v~k~tlnP~fnE~f~f~~~~~~~~~~k~L~~~V~D 342 (621)
...|+|.|.+| ||+++|.. |.+|||||+.|+|++++ +.||+++++|+||+|||+|.|..+...+..+..|.+.|||
T Consensus 15 ~~~L~V~Vi~a~~L~~~~~~~~~~DpyV~v~l~~~~~~--~~kT~v~~~t~nP~wnE~F~f~~~~~~~~~~~~L~~~V~d 92 (128)
T cd08388 15 KKALLVNIIECRDLPAMDEQSGTSDPYVKLQLLPEKEH--KVKTRVLRKTRNPVYDETFTFYGIPYNQLQDLSLHFAVLS 92 (128)
T ss_pred CCEEEEEEEEeECCCCCCCCCCCcCCEEEEEEeCCcCc--eeeccEEcCCCCCceeeEEEEcccCHHHhCCCEEEEEEEE
Confidence 56789999999 99999986 99999999999997654 5678888999999999999994333334446679999999
Q ss_pred CCCCCCCCcccccccccccccc
Q 007035 343 NSDTRDGEVNGALHEGKADAEE 364 (621)
Q Consensus 343 ~d~~~r~d~iG~v~~~~a~~~~ 364 (621)
+|++++++++|++..++++++-
T Consensus 93 ~d~~~~d~~lG~~~i~L~~l~~ 114 (128)
T cd08388 93 FDRYSRDDVIGEVVCPLAGADL 114 (128)
T ss_pred cCCCCCCceeEEEEEeccccCC
Confidence 9999999999999988876644
|
Synaptotagmin is a membrane-trafficking protein characterized by a N-terminal transmembrane region, a linker, and 2 C-terminal C2 domains. Synaptotagmins 4 and 11, class 4 synaptotagmins, are located in the brain. Their functions are unknown. They are distinguished from the other synaptotagmins by having and Asp to Ser substitution in their C2A domains. Previously all synaptotagmins were thought to be calcium sensors in the regulation of neurotransmitter release and hormone secretion, but it has been shown that not all of them bind calcium. Of the 17 identified synaptotagmins only 8 bind calcium (1-3, 5-7, 9, 10). The function of the two C2 domains that bind calcium are: regulating the fusion step of synaptic vesicle exocytosis (C2A) and binding to phosphatidyl-inositol-3,4,5-triphosphate (PIP3) in the absence of calcium ions and to phosphatidylinositol bisphosphate (PIP2) in their presence |
| >cd08404 C2B_Synaptotagmin-4 C2 domain second repeat present in Synaptotagmin 4 | Back alignment and domain information |
|---|
Probab=99.60 E-value=6.4e-16 Score=143.64 Aligned_cols=95 Identities=14% Similarity=0.039 Sum_probs=84.3
Q ss_pred CcceEEEEecC-CCccccCcCCCCcceEeecCCCCCCcccceeeccccCCCceeccceeeecccccccc-cccccccccC
Q 007035 265 NDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEID 342 (621)
Q Consensus 265 ~~~l~v~l~e~-~L~~~d~~g~sDpyVK~~Llp~~~~~~k~kt~v~k~tlnP~fnE~f~f~~~~~~~~~-~k~L~~~V~D 342 (621)
...|+|.|.+| ||+++|..|.+|||||+++.+++++..++||+++++|+||+|||+|.|. ++.... +..|.++|||
T Consensus 14 ~~~L~V~vi~a~~L~~~d~~g~~Dpyv~v~l~~~~~~~~~~kT~v~k~t~nP~w~e~F~f~--v~~~~~~~~~l~~~v~d 91 (136)
T cd08404 14 TNRLTVVVLKARHLPKMDVSGLADPYVKVNLYYGKKRISKKKTHVKKCTLNPVFNESFVFD--IPSEELEDISVEFLVLD 91 (136)
T ss_pred CCeEEEEEEEeeCCCccccCCCCCeEEEEEEEcCCceeeeEcCccccCCCCCccCceEEEE--CCHHHhCCCEEEEEEEE
Confidence 56788999999 9999999999999999999998777778899999999999999999998 554443 5679999999
Q ss_pred CCCCCCCCccccccccccc
Q 007035 343 NSDTRDGEVNGALHEGKAD 361 (621)
Q Consensus 343 ~d~~~r~d~iG~v~~~~a~ 361 (621)
+|.+++++++|++..+...
T Consensus 92 ~d~~~~~~~iG~~~~~~~~ 110 (136)
T cd08404 92 SDRVTKNEVIGRLVLGPKA 110 (136)
T ss_pred CCCCCCCccEEEEEECCcC
Confidence 9999999999999887765
|
Synaptotagmin is a membrane-trafficking protein characterized by a N-terminal transmembrane region, a linker, and 2 C-terminal C2 domains. Synaptotagmin 4, a member of class 4 synaptotagmins, is located in the brain. It functions are unknown. It, like synaptotagmin-11, has an Asp to Ser substitution in its C2A domain. Previously all synaptotagmins were thought to be calcium sensors in the regulation of neurotransmitter release and hormone secretion, but it has been shown that not all of them bind calcium. Of the 17 identified synaptotagmins only 8 bind calcium (1-3, 5-7, 9, 10). The function of the two C2 domains that bind calcium are: regulating the fusion step of synaptic vesicle exocytosis (C2A) and binding to phosphatidyl-inositol-3,4,5-triphosphate (PIP3) in the absence of calcium ions and to phosphatidylinositol bisphosphate (PIP2) in their presence (C2B). C2B also regulates also the recycling s |
| >cd08384 C2B_Rabphilin_Doc2 C2 domain second repeat present in Rabphilin and Double C2 domain | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.2e-15 Score=141.06 Aligned_cols=95 Identities=16% Similarity=0.146 Sum_probs=84.9
Q ss_pred CcceEEEEecC-CCccccCcCCCCcceEeecCCCCCCcccceeeccccCCCceeccceeeecccccccc-cccccccccC
Q 007035 265 NDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEID 342 (621)
Q Consensus 265 ~~~l~v~l~e~-~L~~~d~~g~sDpyVK~~Llp~~~~~~k~kt~v~k~tlnP~fnE~f~f~~~~~~~~~-~k~L~~~V~D 342 (621)
.+.|+|.|.+| ||+++|..|.+|||||+.+.|+..+..+.||+++++|+||+|||+|.|. ++.... ++.|.++|||
T Consensus 12 ~~~L~V~Vi~a~~L~~~d~~~~~DpyV~v~l~~~~~~~~~~kT~v~~~t~nP~wne~f~f~--~~~~~l~~~~l~~~V~d 89 (133)
T cd08384 12 RRGLIVGIIRCVNLAAMDANGYSDPFVKLYLKPDAGKKSKHKTQVKKKTLNPEFNEEFFYD--IKHSDLAKKTLEITVWD 89 (133)
T ss_pred CCEEEEEEEEEcCCCCcCCCCCCCcEEEEEEEcCCCccCCceeeeEeccCCCCcccEEEEE--CCHHHhCCCEEEEEEEe
Confidence 57889999999 9999999999999999999998877788999999999999999999998 554333 6779999999
Q ss_pred CCCCCCCCccccccccccc
Q 007035 343 NSDTRDGEVNGALHEGKAD 361 (621)
Q Consensus 343 ~d~~~r~d~iG~v~~~~a~ 361 (621)
+|..++++++|++..++..
T Consensus 90 ~d~~~~~~~lG~~~i~l~~ 108 (133)
T cd08384 90 KDIGKSNDYIGGLQLGINA 108 (133)
T ss_pred CCCCCCccEEEEEEEecCC
Confidence 9999999999999987753
|
Rabphilin is found neurons and in neuroendrocrine cells, while Doc2 is found not only in the brain but in tissues, including mast cells, chromaffin cells, and osteoblasts. Rabphilin and Doc2s share highly homologous tandem C2 domains, although their N-terminal structures are completely different: rabphilin contains an N-terminal Rab-binding domain (RBD),7 whereas Doc2 contains an N-terminal Munc13-1-interacting domain (MID). C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involving their N- and C-terminal beta strands. Many C2 domains are Ca2+-dependent membrane-targeting modules that bind a wide variety of substances including bind phospholipids, inositol polyphosphates, and intracellular proteins. Most C2 domain proteins are either signal transduction enzymes that contain a single C2 domai |
| >cd04031 C2A_RIM1alpha C2 domain first repeat contained in Rab3-interacting molecule (RIM) proteins | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.6e-15 Score=138.21 Aligned_cols=98 Identities=16% Similarity=0.143 Sum_probs=85.3
Q ss_pred CcceEEEEecC-CCccccCcCCCCcceEeecCCCCCCcccceeeccccCCCceeccceeeecccccccccccccccccCC
Q 007035 265 NDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDN 343 (621)
Q Consensus 265 ~~~l~v~l~e~-~L~~~d~~g~sDpyVK~~Llp~~~~~~k~kt~v~k~tlnP~fnE~f~f~~~~~~~~~~k~L~~~V~D~ 343 (621)
...|+|.|.+| ||+++|.+|.+||||++++.++.....++||+++++|+||+|||+|.|......+..+..|.++|||+
T Consensus 15 ~~~L~V~vi~a~~L~~~~~~~~~dpyv~v~l~~~~~~~~~~kT~v~~~t~nP~wne~f~f~~~~~~~l~~~~l~~~V~d~ 94 (125)
T cd04031 15 TSQLIVTVLQARDLPPRDDGSLRNPYVKVYLLPDRSEKSKRRTKTVKKTLNPEWNQTFEYSNVRRETLKERTLEVTVWDY 94 (125)
T ss_pred CCEEEEEEEEecCCCCcCCCCCCCCEEEEEEccCCCccccccccccCCCCCCccccEEEEcccCHHHhCCCEEEEEEEeC
Confidence 56789999999 99999999999999999999987766788999999999999999999984333344467799999999
Q ss_pred CCCCCCCcccccccccccc
Q 007035 344 SDTRDGEVNGALHEGKADA 362 (621)
Q Consensus 344 d~~~r~d~iG~v~~~~a~~ 362 (621)
+.+++++++|.+..++.+.
T Consensus 95 ~~~~~~~~iG~~~i~l~~~ 113 (125)
T cd04031 95 DRDGENDFLGEVVIDLADA 113 (125)
T ss_pred CCCCCCcEeeEEEEecccc
Confidence 9999999999999988763
|
RIMs are believed to organize specialized sites of the plasma membrane called active zones. They also play a role in controlling neurotransmitter release, plasticity processes, as well as memory and learning. RIM contains an N-terminal zinc finger domain, a PDZ domain, and two C-terminal C2 domains (C2A, C2B). C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involving their N- and C-terminal beta strands. Many C2 domains are Ca2+-dependent membrane-targeting modules that bind a wide variety of substances including bind phospholipids, inositol polyphosphates, and intracellular proteins. Most C2 domain proteins are either signal transduction enzymes that contain a single C2 domain, such as protein kinase C, or membrane trafficking proteins which contain at least two C2 domains, such as |
| >cd08409 C2B_Synaptotagmin-15 C2 domain second repeat present in Synaptotagmin 15 | Back alignment and domain information |
|---|
Probab=99.58 E-value=7.3e-16 Score=143.79 Aligned_cols=92 Identities=14% Similarity=0.096 Sum_probs=82.3
Q ss_pred CcceEEEEecC-CCccccCcCCCCcceEeecCCCCCCcccceeeccccCCCceeccceeeecccccccc-cccccccccC
Q 007035 265 NDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEID 342 (621)
Q Consensus 265 ~~~l~v~l~e~-~L~~~d~~g~sDpyVK~~Llp~~~~~~k~kt~v~k~tlnP~fnE~f~f~~~~~~~~~-~k~L~~~V~D 342 (621)
+..|+|.|.+| ||.++| .+.+|||||+.|+|+.++..++||+++++++||+|||+|.|. ++.+.. +.+|.++|||
T Consensus 14 ~~~L~V~V~~a~nL~~~~-~~~~d~yVkv~l~~~~~~~~~~kT~v~~~~~nP~fnE~F~f~--i~~~~l~~~~L~~~V~~ 90 (137)
T cd08409 14 LNRLTVVVLRARGLRQLD-HAHTSVYVKVSLMIHNKVVKTKKTEVVDGAASPSFNESFSFK--VTSRQLDTASLSLSVMQ 90 (137)
T ss_pred CCeEEEEEEEecCCCccc-CCCCCeEEEEEEEECCEEeeeeecccEeCCCCCcccceEEEE--CCHHHhCccEEEEEEEe
Confidence 57889999999 999999 788999999999998777678899999999999999999998 665555 6789999999
Q ss_pred CCCCCCCCccccccccc
Q 007035 343 NSDTRDGEVNGALHEGK 359 (621)
Q Consensus 343 ~d~~~r~d~iG~v~~~~ 359 (621)
.+.+++++++|++..+.
T Consensus 91 ~~~~~~~~~lG~v~ig~ 107 (137)
T cd08409 91 SGGVRKSKLLGRVVLGP 107 (137)
T ss_pred CCCCCCcceEEEEEECC
Confidence 99999999999998763
|
Synaptotagmin is a membrane-trafficking protein characterized by a N-terminal transmembrane region, a linker, and 2 C-terminal C2 domains. It is thought to be involved in the trafficking and exocytosis of secretory vesicles in non-neuronal tissues and is Ca2+ independent. Human synaptotagmin 15 has 2 alternatively spliced forms that encode proteins with different C-termini. The larger, SYT15a, contains a N-terminal TM region, a putative fatty-acylation site, and 2 tandem C terminal C2 domains. The smaller, SYT15b, lacks the C-terminal portion of the second C2 domain. Unlike most other synaptotagmins it is nearly absent in the brain and rather is found in the heart, lungs, skeletal muscle, and testis. Previously all synaptotagmins were thought to be calcium sensors in the regulation of neurotransmitter release and hormone secretion, but it has been shown that not all of them bind calcium. Of the 17 id |
| >cd08410 C2B_Synaptotagmin-17 C2 domain second repeat present in Synaptotagmin 17 | Back alignment and domain information |
|---|
Probab=99.58 E-value=8.1e-16 Score=143.03 Aligned_cols=92 Identities=12% Similarity=0.019 Sum_probs=80.9
Q ss_pred CcceEEEEecC-CCccccCcCCCCcceEeecCCCCCCcccceeeccccCCCceeccceeeecccccccc-cccccccccC
Q 007035 265 NDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEID 342 (621)
Q Consensus 265 ~~~l~v~l~e~-~L~~~d~~g~sDpyVK~~Llp~~~~~~k~kt~v~k~tlnP~fnE~f~f~~~~~~~~~-~k~L~~~V~D 342 (621)
.+.|+|.|.+| ||+++|..|.+|||||+++.++.+...++||+++++|+||+|||+|.|. ++.+.. +..|.++|||
T Consensus 13 ~~~L~V~vi~a~~L~~~d~~g~~DPyV~v~l~~~~~~~~~~kT~v~~~t~nP~wnE~F~f~--i~~~~l~~~~l~~~V~d 90 (135)
T cd08410 13 AGRLNVDIIRAKQLLQTDMSQGSDPFVKIQLVHGLKLIKTKKTSCMRGTIDPFYNESFSFK--VPQEELENVSLVFTVYG 90 (135)
T ss_pred CCeEEEEEEEecCCCcccCCCCCCeEEEEEEEcCCcccceEcCccccCCCCCccceeEEEe--CCHHHhCCCEEEEEEEe
Confidence 56788999999 9999999999999999999887776677889999999999999999999 554444 6679999999
Q ss_pred CCCCCCCCcccccccc
Q 007035 343 NSDTRDGEVNGALHEG 358 (621)
Q Consensus 343 ~d~~~r~d~iG~v~~~ 358 (621)
+|..++++++|++..+
T Consensus 91 ~d~~~~~~~iG~~~l~ 106 (135)
T cd08410 91 HNVKSSNDFIGRIVIG 106 (135)
T ss_pred CCCCCCCcEEEEEEEc
Confidence 9999999999998643
|
Synaptotagmin is a membrane-trafficking protein characterized by a N-terminal transmembrane region, a linker, and 2 C-terminal C2 domains. Synaptotagmin 17 is located in the brain, kidney, and prostate and is thought to be a peripheral membrane protein. Previously all synaptotagmins were thought to be calcium sensors in the regulation of neurotransmitter release and hormone secretion, but it has been shown that not all of them bind calcium. Of the 17 identified synaptotagmins only 8 bind calcium (1-3, 5-7, 9, 10). The function of the two C2 domains that bind calcium are: regulating the fusion step of synaptic vesicle exocytosis (C2A) and binding to phosphatidyl-inositol-3,4,5-triphosphate (PIP3) in the absence of calcium ions and to phosphatidylinositol bisphosphate (PIP2) in their presence (C2B). C2B also regulates also the recycling step of synaptic vesicles. C2 domains fold into an 8-standed beta- |
| >cd08521 C2A_SLP C2 domain first repeat present in Synaptotagmin-like proteins | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.6e-15 Score=137.79 Aligned_cols=99 Identities=11% Similarity=0.022 Sum_probs=86.9
Q ss_pred CcceEEEEecC-CCcccc-CcCCCCcceEeecCCCCCCcccceeeccccCCCceeccceeeecccccccc-ccccccccc
Q 007035 265 NDYGYLSSKEA-DLIDLQ-HNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEI 341 (621)
Q Consensus 265 ~~~l~v~l~e~-~L~~~d-~~g~sDpyVK~~Llp~~~~~~k~kt~v~k~tlnP~fnE~f~f~~~~~~~~~-~k~L~~~V~ 341 (621)
.+.|+|.|.+| ||++++ ..|.+|||||++++|+.....+.||+++++++||+|||+|.|. ++.... .+.|.+.||
T Consensus 13 ~~~L~V~v~~a~~L~~~~~~~~~~dpyv~v~l~~~~~~~~~~kT~v~~~t~~P~wne~f~f~--i~~~~l~~~~l~i~v~ 90 (123)
T cd08521 13 TGSLEVHIKECRNLAYADEKKKRSNPYVKVYLLPDKSKQSKRKTSVKKNTTNPVFNETLKYH--ISKSQLETRTLQLSVW 90 (123)
T ss_pred CCEEEEEEEEecCCCCcCCCCCCCCcEEEEEEecCCCcCceeeccccCCCCCCcccceEEEe--CCHHHhCCCEEEEEEE
Confidence 56789999999 999999 8899999999999998876678899999999999999999998 555443 667999999
Q ss_pred CCCCCCCCCccccccccccccccc
Q 007035 342 DNSDTRDGEVNGALHEGKADAEEH 365 (621)
Q Consensus 342 D~d~~~r~d~iG~v~~~~a~~~~~ 365 (621)
|++.+++++++|++..++.+....
T Consensus 91 d~~~~~~~~~iG~~~i~l~~l~~~ 114 (123)
T cd08521 91 HHDRFGRNTFLGEVEIPLDSWDLD 114 (123)
T ss_pred eCCCCcCCceeeEEEEeccccccc
Confidence 999999999999999988777533
|
All Slp members basically share an N-terminal Slp homology domain (SHD) and C-terminal tandem C2 domains (named the C2A domain and the C2B domain) with the SHD and C2 domains being separated by a linker sequence of various length. Slp1/JFC1 and Slp2/exophilin 4 promote granule docking to the plasma membrane. Additionally, their C2A domains are both Ca2+ independent, unlike the case in Slp3 and Slp4/granuphilin in which their C2A domains are Ca2+ dependent. It is thought that SHD (except for the Slp4-SHD) functions as a specific Rab27A/B-binding domain. In addition to Slps, rabphilin, Noc2, and Munc13-4 also function as Rab27-binding proteins. It has been demonstrated that Slp3 and Slp4/granuphilin promote dense-core vesicle exocytosis. Slp5 mRNA has been shown to be restricted to human placenta and liver suggesting a role in Rab27A-dependent membrane trafficking in specific tissues. C2 domains fold into |
| >cd08387 C2A_Synaptotagmin-8 C2A domain first repeat present in Synaptotagmin 8 | Back alignment and domain information |
|---|
Probab=99.57 E-value=2.2e-15 Score=137.59 Aligned_cols=98 Identities=13% Similarity=0.064 Sum_probs=85.1
Q ss_pred CcceEEEEecC-CCccccCcCCCCcceEeecCCCCCCcccceeeccccCCCceeccceeeeccccccc-ccccccccccC
Q 007035 265 NDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKG-AEKDLMPAEID 342 (621)
Q Consensus 265 ~~~l~v~l~e~-~L~~~d~~g~sDpyVK~~Llp~~~~~~k~kt~v~k~tlnP~fnE~f~f~~~~~~~~-~~k~L~~~V~D 342 (621)
.+.+.|.|.+| ||+++|..|.+||||+++++|++.. +.||+++++++||+|||+|.|. ++... .++.|.++|||
T Consensus 15 ~~~L~V~v~~a~~L~~~d~~g~~dpyv~v~l~~~~~~--~~kT~v~~~t~~P~wne~f~f~--v~~~~l~~~~l~i~V~d 90 (124)
T cd08387 15 MGILNVKLIQARNLQPRDFSGTADPYCKVRLLPDRSN--TKQSKIHKKTLNPEFDESFVFE--VPPQELPKRTLEVLLYD 90 (124)
T ss_pred CCEEEEEEEEeeCCCCCCCCCCCCCeEEEEEecCCCC--cEeCceEcCCCCCCcccEEEEe--CCHHHhCCCEEEEEEEE
Confidence 46788999999 9999999999999999999987654 5678888999999999999998 55444 36779999999
Q ss_pred CCCCCCCCcccccccccccccccC
Q 007035 343 NSDTRDGEVNGALHEGKADAEEHG 366 (621)
Q Consensus 343 ~d~~~r~d~iG~v~~~~a~~~~~~ 366 (621)
++.+++++++|.+..++.++...+
T Consensus 91 ~~~~~~~~~iG~~~i~l~~~~~~~ 114 (124)
T cd08387 91 FDQFSRDECIGVVELPLAEVDLSE 114 (124)
T ss_pred CCCCCCCceeEEEEEecccccCCC
Confidence 999999999999999988877544
|
Synaptotagmin is a membrane-trafficking protein characterized by a N-terminal transmembrane region, a linker, and 2 C-terminal C2 domains. Previously all synaptotagmins were thought to be calcium sensors in the regulation of neurotransmitter release and hormone secretion, but it has been shown that not all of them bind calcium. Of the 17 identified synaptotagmins only 8 bind calcium (1-3, 5-7, 9, 10). The function of the two C2 domains that bind calcium are: regulating the fusion step of synaptic vesicle exocytosis (C2A) and binding to phosphatidyl-inositol-3,4,5-triphosphate (PIP3) in the absence of calcium ions and to phosphatidylinositol bisphosphate (PIP2) in their presence (C2B). C2B also regulates also the recycling step of synaptic vesicles. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involv |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.56 E-value=2.1e-14 Score=141.23 Aligned_cols=137 Identities=23% Similarity=0.216 Sum_probs=101.1
Q ss_pred eEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCch-----------------------hhhhHHHHHHHHHHhcccCC
Q 007035 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD-----------------------FFDQSLDEIKLLKLVNKNDP 472 (621)
Q Consensus 416 Y~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~-----------------------~~~~~~~Ei~iL~~l~~~~~ 472 (621)
|.+.+.||.|+||.||++.+ .+|+.||||+++.... .......|..++..+....
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~- 94 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALD-PDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG- 94 (198)
T ss_pred hhcCCccccCcceEEEEEEc-CCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC-
Confidence 77888999999999999986 4899999998765321 0112456777777775432
Q ss_pred CCCCceEEEeeEeEecCeEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccE
Q 007035 473 ADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENI 552 (621)
Q Consensus 473 ~~hpnIvrl~~~f~~~~~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NI 552 (621)
..++..++. ...++||||+++..+..+.. ......++.+|+.++.++|+.||+||||+|.||
T Consensus 95 ---i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~-----------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Ni 156 (198)
T cd05144 95 ---FPVPKPIDW----NRHAVVMEYIDGVELYRVRV-----------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNI 156 (198)
T ss_pred ---CCCCceeec----CCceEEEEEeCCcchhhccc-----------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccE
Confidence 134444432 34589999999754432211 023567889999999999999999999999999
Q ss_pred EEeccCCCeEEEEecCCccccC
Q 007035 553 LIKSYQRCEIKIIDLGSSCFQT 574 (621)
Q Consensus 553 Ll~~~~~~~IKL~DFGls~~~~ 574 (621)
+++. ++.++|+|||.+....
T Consensus 157 ll~~--~~~~~liDfg~~~~~~ 176 (198)
T cd05144 157 LVDD--DEKIYIIDWPQMVSTD 176 (198)
T ss_pred EEcC--CCcEEEEECCccccCC
Confidence 9984 7899999999985444
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >cd04010 C2B_RasA3 C2 domain second repeat present in RAS p21 protein activator 3 (RasA3) | Back alignment and domain information |
|---|
Probab=99.55 E-value=4.5e-15 Score=140.26 Aligned_cols=97 Identities=13% Similarity=0.009 Sum_probs=83.4
Q ss_pred ceEEEEecC-CCccccCcCCCCcceEeecCCCCCCcccceeeccccCCCceeccceeeecc-----------cccccc-c
Q 007035 267 YGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSD-----------LHFKGA-E 333 (621)
Q Consensus 267 ~l~v~l~e~-~L~~~d~~g~sDpyVK~~Llp~~~~~~k~kt~v~k~tlnP~fnE~f~f~~~-----------~~~~~~-~ 333 (621)
+|+|.|.+| ||.+ .+|.+|||||+++.+.++++.++||+++++|+||+|||+|.|... ++.+.. .
T Consensus 1 kL~V~Vi~ArnL~~--~~g~sDPYV~V~l~~~~~k~~~~kT~v~~~t~nP~wNE~F~F~v~~~~~~~~~~~~~~~~~~~~ 78 (148)
T cd04010 1 KLSVRVIECSDLAL--KNGTCDPYASVTLIYSNKKQDTKRTKVKKKTNNPQFDEAFYFDVTIDSSPEKKQFEMPEEDAEK 78 (148)
T ss_pred CEEEEEEeCcCCCC--CCCCCCceEEEEEeCCcccCcccCCccEeCCCCCccceEEEEEEecccccccccccCCcccccE
Confidence 478999999 9998 689999999999999887777889999999999999999999942 123333 4
Q ss_pred ccccccccCCCCCCCCCccccccccccccccc
Q 007035 334 KDLMPAEIDNSDTRDGEVNGALHEGKADAEEH 365 (621)
Q Consensus 334 k~L~~~V~D~d~~~r~d~iG~v~~~~a~~~~~ 365 (621)
..|.+.|||.+.+++++++|++..++..+...
T Consensus 79 ~~L~i~V~d~~~~~~ddfLG~v~i~l~~l~~~ 110 (148)
T cd04010 79 LELRVDLWHASMGGGDVFLGEVRIPLRGLDLQ 110 (148)
T ss_pred EEEEEEEEcCCCCCCCceeEEEEEeccccccc
Confidence 67999999999999999999999988877765
|
RasA3 are members of GTPase activating protein 1 (GAP1), a Ras-specific GAP, which suppresses Ras function by enhancing the GTPase activity of Ras proteins resulting in the inactive GDP-bound form of Ras. In this way it can control cellular proliferation and differentiation. RasA3 contains an N-terminal C2 domain, a Ras-GAP domain, a plextrin homology (PH)-like domain, and a Bruton's Tyrosine Kinase (BTK) zinc binding domain. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involving their N- and C-terminal beta strands. Many C2 domains are Ca2+-dependent membrane-targeting modules that bind a wide variety of substances including bind phospholipids, inositol polyphosphates, and intracellular proteins. Most C2 domain proteins are either signal transduction enzymes that contain a single C2 domain |
| >cd08402 C2B_Synaptotagmin-1 C2 domain second repeat present in Synaptotagmin 1 | Back alignment and domain information |
|---|
Probab=99.55 E-value=3.1e-15 Score=139.00 Aligned_cols=95 Identities=16% Similarity=0.111 Sum_probs=83.3
Q ss_pred CcceEEEEecC-CCccccCcCCCCcceEeecCCCCCCcccceeeccccCCCceeccceeeecccccccc-cccccccccC
Q 007035 265 NDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEID 342 (621)
Q Consensus 265 ~~~l~v~l~e~-~L~~~d~~g~sDpyVK~~Llp~~~~~~k~kt~v~k~tlnP~fnE~f~f~~~~~~~~~-~k~L~~~V~D 342 (621)
.+.++|.|.+| ||+++|..|.+|||||+++.+..++..++||+++++++||+|||+|.|. ++.... +..|.++|||
T Consensus 14 ~~~l~V~Vi~a~~L~~~d~~g~~dpyv~v~l~~~~~~~~~~kT~v~~~t~nP~wne~f~f~--i~~~~l~~~~l~~~v~d 91 (136)
T cd08402 14 AGKLTVVILEAKNLKKMDVGGLSDPYVKIHLMQNGKRLKKKKTTIKKRTLNPYYNESFSFE--VPFEQIQKVHLIVTVLD 91 (136)
T ss_pred CCeEEEEEEEeeCCCcccCCCCCCCeEEEEEEECCcccceeeccceeCCCCCcccceEEEE--CCHHHhCCCEEEEEEEe
Confidence 56788999999 9999999999999999999987776678889989999999999999998 444433 5569999999
Q ss_pred CCCCCCCCccccccccccc
Q 007035 343 NSDTRDGEVNGALHEGKAD 361 (621)
Q Consensus 343 ~d~~~r~d~iG~v~~~~a~ 361 (621)
++++++++++|++..++..
T Consensus 92 ~~~~~~~~~iG~~~i~~~~ 110 (136)
T cd08402 92 YDRIGKNDPIGKVVLGCNA 110 (136)
T ss_pred CCCCCCCceeEEEEECCcc
Confidence 9999999999999887754
|
Synaptotagmin is a membrane-trafficking protein characterized by a N-terminal transmembrane region, a linker, and 2 C-terminal C2 domains. Synaptotagmin 1, a member of the class 1 synaptotagmins, is located in the brain and endocranium and localized to the synaptic vesicles and secretory granules. It functions as a Ca2+ sensor for fast exocytosis. It, like synaptotagmin-2, has an N-glycosylated N-terminus. Synaptotagmin 4, a member of class 4 synaptotagmins, is located in the brain. It functions are unknown. It, like synaptotagmin-11, has an Asp to Ser substitution in its C2A domain. Previously all synaptotagmins were thought to be calcium sensors in the regulation of neurotransmitter release and hormone secretion, but it has been shown that not all of them bind calcium. Of the 17 identified synaptotagmins only 8 bind calcium (1-3, 5-7, 9, 10). The function of the two C2 domains that bind calcium are: |
| >cd04041 C2A_fungal C2 domain first repeat; fungal group | Back alignment and domain information |
|---|
Probab=99.55 E-value=5.2e-15 Score=132.80 Aligned_cols=97 Identities=13% Similarity=0.002 Sum_probs=80.9
Q ss_pred ceEEEEecC-CCccccCc-CCCCcceEeecCCCCCCcccceeeccccCCCceeccceeeecccccccccccccccccCCC
Q 007035 267 YGYLSSKEA-DLIDLQHN-VVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDNS 344 (621)
Q Consensus 267 ~l~v~l~e~-~L~~~d~~-g~sDpyVK~~Llp~~~~~~k~kt~v~k~tlnP~fnE~f~f~~~~~~~~~~k~L~~~V~D~d 344 (621)
.|+|.|.+| ||+++|.. |.+|||||+++.+.++ .+.||+++++|+||+|||+|.|.....+...+..|.++|||+|
T Consensus 2 ~L~V~v~~a~~L~~~d~~~~~~Dpyv~v~~~~~~~--~~~kT~v~~~t~nP~Wne~f~f~~~~~~~~~~~~l~~~V~d~d 79 (111)
T cd04041 2 VLVVTIHRATDLPKADFGTGSSDPYVTASFAKFGK--PLYSTRIIRKDLNPVWEETWFVLVTPDEVKAGERLSCRLWDSD 79 (111)
T ss_pred EEEEEEEEeeCCCcccCCCCCCCccEEEEEccCCC--ccEeeeeECCCCCCccceeEEEEeCchhccCCCEEEEEEEeCC
Confidence 578999999 99999998 9999999999987653 3568888999999999999999732332223567999999999
Q ss_pred CCCCCCccccccccccccccc
Q 007035 345 DTRDGEVNGALHEGKADAEEH 365 (621)
Q Consensus 345 ~~~r~d~iG~v~~~~a~~~~~ 365 (621)
++++++++|.+..++.++.+.
T Consensus 80 ~~~~dd~lG~~~i~l~~l~~~ 100 (111)
T cd04041 80 RFTADDRLGRVEIDLKELIED 100 (111)
T ss_pred CCCCCCcceEEEEEHHHHhcC
Confidence 999999999999988777643
|
C2 domains were first identified in Protein Kinase C (PKC). C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involving their N- and C-terminal beta strands. Many C2 domains are Ca2+-dependent membrane-targeting modules that bind a wide variety of substances including bind phospholipids, inositol polyphosphates, and intracellular proteins. Most C2 domain proteins are either signal transduction enzymes that contain a single C2 domain, such as protein kinase C, or membrane trafficking proteins which contain at least two C2 domains, such as synaptotagmin 1. However, there are a few exceptions to this including RIM isoforms and some splice variants of piccolo/aczonin and intersectin which only have a single C2 domain. C2 domains with a calcium binding region have negatively charged residues, primarily aspartates, that serve as ligan |
| >cd08385 C2A_Synaptotagmin-1-5-6-9-10 C2A domain first repeat present in Synaptotagmins 1, 5, 6, 9, and 10 | Back alignment and domain information |
|---|
Probab=99.55 E-value=5.3e-15 Score=134.96 Aligned_cols=96 Identities=13% Similarity=0.082 Sum_probs=83.5
Q ss_pred CcceEEEEecC-CCccccCcCCCCcceEeecCCCCCCcccceeeccccCCCceeccceeeeccccccc-ccccccccccC
Q 007035 265 NDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKG-AEKDLMPAEID 342 (621)
Q Consensus 265 ~~~l~v~l~e~-~L~~~d~~g~sDpyVK~~Llp~~~~~~k~kt~v~k~tlnP~fnE~f~f~~~~~~~~-~~k~L~~~V~D 342 (621)
.+.|+|.|.+| ||+++|..|.+|||||+++.|++++ +.||+++++++||+|||+|.|. +.... .+..|.+.|||
T Consensus 15 ~~~L~V~v~~a~~L~~~d~~~~~dpyv~v~l~~~~~~--~~kT~v~~~t~nP~wne~f~f~--i~~~~l~~~~l~~~V~d 90 (124)
T cd08385 15 SNQLTVGIIQAADLPAMDMGGTSDPYVKVYLLPDKKK--KFETKVHRKTLNPVFNETFTFK--VPYSELGNKTLVFSVYD 90 (124)
T ss_pred CCEEEEEEEEeeCCCCccCCCCCCCEEEEEEEcCCCC--ceecccCcCCCCCceeeeEEEe--CCHHHhCCCEEEEEEEe
Confidence 56789999999 9999999999999999999987654 6788888999999999999998 44433 35679999999
Q ss_pred CCCCCCCCcccccccccccccc
Q 007035 343 NSDTRDGEVNGALHEGKADAEE 364 (621)
Q Consensus 343 ~d~~~r~d~iG~v~~~~a~~~~ 364 (621)
+|++++++++|++..++.++..
T Consensus 91 ~d~~~~~~~lG~~~i~l~~~~~ 112 (124)
T cd08385 91 FDRFSKHDLIGEVRVPLLTVDL 112 (124)
T ss_pred CCCCCCCceeEEEEEecCcccC
Confidence 9999999999999998877655
|
Synaptotagmin is a membrane-trafficking protein characterized by a N-terminal transmembrane region, a linker, and 2 C-terminal C2 domains. Synaptotagmin 1, a member of class 1 synaptotagmins, is located in the brain and endocranium and localized to the synaptic vesicles and secretory granules. It functions as a Ca2+ sensor for fast exocytosis as do synaptotagmins 5, 6, and 10. It is distinguished from the other synaptotagmins by having an N-glycosylated N-terminus. Synaptotagmins 5, 6, and 10, members of class 3 synaptotagmins, are located primarily in the brain and localized to the active zone and plasma membrane. They is distinguished from the other synaptotagmins by having disulfide bonds at its N-terminus. Synaptotagmin 6 also regulates the acrosome reaction, a unique Ca2+-regulated exocytosis, in sperm. Synaptotagmin 9, a class 5 synaptotagmins, is located in the brain and |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.54 E-value=4.5e-14 Score=139.37 Aligned_cols=132 Identities=22% Similarity=0.320 Sum_probs=101.2
Q ss_pred EEeccCCCCceeEEEeCCCCcEEEEEEEecCch---------hhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCe
Q 007035 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD---------FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (621)
Q Consensus 420 ~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~---------~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~ 490 (621)
+.||+|++|.||+|.+ .|..+++|+...... ...+..+|+.++..+.+. +|+....++.....
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~------~i~~p~~~~~~~~~ 73 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKA------GVNVPAVYFVDPEN 73 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHC------CCCCCeEEEEeCCC
Confidence 5799999999999985 778899998653211 123456777888777643 45544555566778
Q ss_pred EEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCC
Q 007035 491 LFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (621)
Q Consensus 491 l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGl 569 (621)
.++||||++| +|.+.+... .. ....++.+|+.+|.+||+.+++|||++|.|||++ .+.++|+|||.
T Consensus 74 ~~lv~e~~~G~~L~~~~~~~---------~~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~---~~~~~liDf~~ 140 (211)
T PRK14879 74 FIIVMEYIEGEPLKDLINSN---------GM-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS---GGKIYLIDFGL 140 (211)
T ss_pred CEEEEEEeCCcCHHHHHHhc---------cH-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE---CCCEEEEECCc
Confidence 8999999986 555554321 11 6778999999999999999999999999999998 57799999998
Q ss_pred ccc
Q 007035 570 SCF 572 (621)
Q Consensus 570 s~~ 572 (621)
+..
T Consensus 141 a~~ 143 (211)
T PRK14879 141 AEF 143 (211)
T ss_pred ccC
Confidence 865
|
|
| >cd08405 C2B_Synaptotagmin-7 C2 domain second repeat present in Synaptotagmin 7 | Back alignment and domain information |
|---|
Probab=99.54 E-value=4.3e-15 Score=138.01 Aligned_cols=96 Identities=15% Similarity=0.090 Sum_probs=84.1
Q ss_pred CcceEEEEecC-CCccccCcCCCCcceEeecCCCCCCcccceeeccccCCCceeccceeeecccccccc-cccccccccC
Q 007035 265 NDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEID 342 (621)
Q Consensus 265 ~~~l~v~l~e~-~L~~~d~~g~sDpyVK~~Llp~~~~~~k~kt~v~k~tlnP~fnE~f~f~~~~~~~~~-~k~L~~~V~D 342 (621)
.+.|+|.|.+| ||+++|..|.+|||||+++.+..++..+.||+++++++||+|||+|.|. ++.+.. +..|.++|||
T Consensus 14 ~~~L~v~vi~a~~L~~~~~~g~~dpyV~v~l~~~~~~~~~~kT~v~~~t~~P~wne~F~f~--i~~~~~~~~~l~~~v~d 91 (136)
T cd08405 14 ANRITVNIIKARNLKAMDINGTSDPYVKVWLMYKDKRVEKKKTVIKKRTLNPVFNESFIFN--IPLERLRETTLIITVMD 91 (136)
T ss_pred CCeEEEEEEEeeCCCccccCCCCCceEEEEEEeCCCccccccCcceeCCCCCcccceEEEe--CCHHHhCCCEEEEEEEE
Confidence 46789999999 9999999999999999999987766667899999999999999999998 554444 6679999999
Q ss_pred CCCCCCCCcccccccccccc
Q 007035 343 NSDTRDGEVNGALHEGKADA 362 (621)
Q Consensus 343 ~d~~~r~d~iG~v~~~~a~~ 362 (621)
++.+++++++|++..+..+.
T Consensus 92 ~~~~~~~~~lG~~~i~~~~~ 111 (136)
T cd08405 92 KDRLSRNDLIGKIYLGWKSG 111 (136)
T ss_pred CCCCCCCcEeEEEEECCccC
Confidence 99999999999998877653
|
Synaptotagmin is a membrane-trafficking protein characterized by a N-terminal transmembrane region, a linker, and 2 C-terminal C2 domains. Synaptotagmin 7, a member of class 2 synaptotagmins, is located in presynaptic plasma membranes in neurons, dense-core vesicles in endocrine cells, and lysosomes in fibroblasts. It has been shown to play a role in regulation of Ca2+-dependent lysosomal exocytosis in fibroblasts and may also function as a vesicular Ca2+-sensor. It is distinguished from the other synaptotagmins by having over 12 splice forms. Previously all synaptotagmins were thought to be calcium sensors in the regulation of neurotransmitter release and hormone secretion, but it has been shown that not all of them bind calcium. Of the 17 identified synaptotagmins only 8 bind calcium (1-3, 5-7, 9, 10). The function of the two C2 domains that bind calcium are: regulating the fusion step of synaptic ves |
| >cd08403 C2B_Synaptotagmin-3-5-6-9-10 C2 domain second repeat present in Synaptotagmins 3, 5, 6, 9, and 10 | Back alignment and domain information |
|---|
Probab=99.54 E-value=4.7e-15 Score=137.40 Aligned_cols=94 Identities=16% Similarity=0.083 Sum_probs=83.1
Q ss_pred CcceEEEEecC-CCccccCcCCCCcceEeecCCCCCCcccceeeccccCCCceeccceeeecccccccc-cccccccccC
Q 007035 265 NDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEID 342 (621)
Q Consensus 265 ~~~l~v~l~e~-~L~~~d~~g~sDpyVK~~Llp~~~~~~k~kt~v~k~tlnP~fnE~f~f~~~~~~~~~-~k~L~~~V~D 342 (621)
++.|+|.|.+| +|+++|..|.+|||||++|.++.++..++||+++++++||.|||+|.|. ++.+.. +..|.++|||
T Consensus 13 ~~~L~V~v~~A~~L~~~d~~g~~dpyvkv~l~~~~~~~~~~kT~v~~~t~nP~wne~f~f~--i~~~~~~~~~l~~~v~d 90 (134)
T cd08403 13 AGRLTLTIIKARNLKAMDITGFSDPYVKVSLMCEGRRLKKKKTSVKKNTLNPTYNEALVFD--VPPENVDNVSLIIAVVD 90 (134)
T ss_pred CCEEEEEEEEeeCCCccccCCCCCceEEEEEEeCCcccceecCCcccCCCCCcccceEEEE--CCHHHhCCCEEEEEEEE
Confidence 57889999999 9999999999999999999987777678889888999999999999998 554444 4569999999
Q ss_pred CCCCCCCCcccccccccc
Q 007035 343 NSDTRDGEVNGALHEGKA 360 (621)
Q Consensus 343 ~d~~~r~d~iG~v~~~~a 360 (621)
+|+++++++||++..+..
T Consensus 91 ~~~~~~~~~IG~~~l~~~ 108 (134)
T cd08403 91 YDRVGHNELIGVCRVGPN 108 (134)
T ss_pred CCCCCCCceeEEEEECCC
Confidence 999999999999988754
|
Synaptotagmin is a membrane-trafficking protein characterized by a N-terminal transmembrane region, a linker, and 2 C-terminal C2 domains. Synaptotagmin 3, a member of class 3 synaptotagmins, is located in the brain and localized to the active zone and plasma membrane. It functions as a Ca2+ sensor for fast exocytosis. It, along with synaptotagmins 5,6, and 10, has disulfide bonds at its N-terminus. Synaptotagmin 9, a class 5 synaptotagmins, is located in the brain and localized to the synaptic vesicles. It is thought to be a Ca2+-sensor for dense-core vesicle exocytosis. Previously all synaptotagmins were thought to be calcium sensors in the regulation of neurotransmitter release and hormone secretion, but it has been shown that not all of them bind calcium. Of the 17 identified synaptotagmins only 8 bind calcium (1-3, 5-7, 9, 10). The function of the two C2 domains that bind |
| >cd04030 C2C_KIAA1228 C2 domain third repeat present in uncharacterized human KIAA1228-like proteins | Back alignment and domain information |
|---|
Probab=99.54 E-value=7.1e-15 Score=134.48 Aligned_cols=99 Identities=13% Similarity=0.098 Sum_probs=86.9
Q ss_pred CcceEEEEecC-CCccccCcCCCCcceEeecCCCCCCcccceeeccccCCCceeccceeeecccccccc-cccccccccC
Q 007035 265 NDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEID 342 (621)
Q Consensus 265 ~~~l~v~l~e~-~L~~~d~~g~sDpyVK~~Llp~~~~~~k~kt~v~k~tlnP~fnE~f~f~~~~~~~~~-~k~L~~~V~D 342 (621)
.+.|+|.|.+| ||+++|..|.+|||||++++++++...++||+++++++||+|||+|.|. ++.... +..|.+.|||
T Consensus 15 ~~~L~V~vi~a~~L~~~~~~~~~dpyv~v~l~~~~~~~~~~kT~v~~~~~nP~wne~f~f~--i~~~~l~~~~l~i~v~~ 92 (127)
T cd04030 15 RQKLIVTVHKCRNLPPCDSSDIPDPYVRLYLLPDKSKSTRRKTSVKKDNLNPVFDETFEFP--VSLEELKRRTLDVAVKN 92 (127)
T ss_pred CCEEEEEEEEEECCCCccCCCCCCceEEEEEEcCCCCCceEecccccCCCCCEECeEEEEe--cCHHHhcCCEEEEEEEE
Confidence 46789999999 9999999999999999999998877788999999999999999999998 554444 5679999999
Q ss_pred CCCC--CCCCccccccccccccccc
Q 007035 343 NSDT--RDGEVNGALHEGKADAEEH 365 (621)
Q Consensus 343 ~d~~--~r~d~iG~v~~~~a~~~~~ 365 (621)
.+.+ ++++++|++..++.++...
T Consensus 93 ~~~~~~~~~~~iG~~~i~l~~l~~~ 117 (127)
T cd04030 93 SKSFLSREKKLLGQVLIDLSDLDLS 117 (127)
T ss_pred CCcccCCCCceEEEEEEeccccccc
Confidence 9986 6799999999988876554
|
KIAA proteins are uncharacterized human proteins. They were compiled by the Kazusa mammalian cDNA project which identified more than 2000 human genes. They are identified by 4 digit codes that precede the KIAA designation. Many KIAA genes are still functionally uncharacterized including KIAA1228. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involving their N- and C-terminal beta strands. Many C2 domains are Ca2+-dependent membrane-targeting modules that bind a wide variety of substances including bind phospholipids, inositol polyphosphates, and intracellular proteins. Most C2 domain proteins are either signal transduction enzymes that contain a single C2 domain, such as protein kinase C, or membrane trafficking proteins which contain at least two C2 domains, such as synaptotagmin 1 |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.53 E-value=8.9e-14 Score=136.11 Aligned_cols=129 Identities=19% Similarity=0.295 Sum_probs=95.6
Q ss_pred EeccCCCCceeEEEeCCCCcEEEEEEEecCc----h-----hhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeE
Q 007035 421 YLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----D-----FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (621)
Q Consensus 421 ~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~----~-----~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l 491 (621)
.||+|+||.||++. ..|..+++|...... . ...+..+|+++++.+.+.. -+++.++ +......
T Consensus 1 ~ig~G~~~~vy~~~--~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~----i~~p~~~--~~~~~~~ 72 (199)
T TIGR03724 1 LIAKGAEAIIYLGD--FLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAG----VNTPVVY--DVDPDNK 72 (199)
T ss_pred CCCCCceEEEEEee--cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCC----CCCCEEE--EEECCCC
Confidence 38999999999998 467889999865321 0 1245567888888887532 1233333 3455667
Q ss_pred EEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCc
Q 007035 492 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (621)
Q Consensus 492 ~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls 570 (621)
++||||++| ++.+.+.... ..++.+++.+|.+||+.|++|+|++|.||+++ .+.++|+|||++
T Consensus 73 ~lv~e~~~g~~l~~~~~~~~-------------~~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~---~~~~~liDfg~a 136 (199)
T TIGR03724 73 TIVMEYIEGKPLKDVIEEGN-------------DELLREIGRLVGKLHKAGIVHGDLTTSNIIVR---DDKLYLIDFGLG 136 (199)
T ss_pred EEEEEEECCccHHHHHhhcH-------------HHHHHHHHHHHHHHHHCCeecCCCCcceEEEE---CCcEEEEECCCC
Confidence 899999986 4444432110 07899999999999999999999999999998 678999999987
Q ss_pred ccc
Q 007035 571 CFQ 573 (621)
Q Consensus 571 ~~~ 573 (621)
...
T Consensus 137 ~~~ 139 (199)
T TIGR03724 137 KYS 139 (199)
T ss_pred cCC
Confidence 653
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.53 E-value=5.1e-14 Score=136.30 Aligned_cols=137 Identities=23% Similarity=0.268 Sum_probs=94.7
Q ss_pred EEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhH-------------------------HHHHHHHHHhcccCCC
Q 007035 419 TEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQS-------------------------LDEIKLLKLVNKNDPA 473 (621)
Q Consensus 419 ~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~-------------------------~~Ei~iL~~l~~~~~~ 473 (621)
.+.||+|+||+||+|.+. +++.||||+++......... ..|...+..+....
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~-- 78 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAG-- 78 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcC--
Confidence 467999999999999976 89999999987542211111 23444444444321
Q ss_pred CCCceEEEeeEeEecCeEEEEEeccccch-H-HHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHH-CCeecccCCCc
Q 007035 474 DEHHILRLYDYFYHLEHLFIVCELLRANL-Y-EFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS-LGIIHCDLKPE 550 (621)
Q Consensus 474 ~hpnIvrl~~~f~~~~~l~LVmEyl~gsL-l-d~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs-~gIvHrDLKP~ 550 (621)
..+++++.. ...++||||+++.. . ..+.... . ...++.++.+++.++.++|. .+|+|+||||+
T Consensus 79 --~~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-------~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~ 144 (187)
T cd05119 79 --VPVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-------L-LEDPEELYDQILELMRKLYREAGLVHGDLSEY 144 (187)
T ss_pred --CCCCceEec----CCCEEEEEEeCCCCccChhhhhhh-------h-cccHHHHHHHHHHHHHHHhhccCcCcCCCChh
Confidence 124444433 24689999999721 1 1111000 1 15678899999999999999 99999999999
Q ss_pred cEEEeccCCCeEEEEecCCccccCC
Q 007035 551 NILIKSYQRCEIKIIDLGSSCFQTD 575 (621)
Q Consensus 551 NILl~~~~~~~IKL~DFGls~~~~~ 575 (621)
||+++ ++.++|+|||.+.....
T Consensus 145 Nili~---~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 145 NILVD---DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred hEEEE---CCcEEEEECcccccccC
Confidence 99998 67899999999865443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd08386 C2A_Synaptotagmin-7 C2A domain first repeat present in Synaptotagmin 7 | Back alignment and domain information |
|---|
Probab=99.52 E-value=1.4e-14 Score=132.22 Aligned_cols=99 Identities=13% Similarity=0.028 Sum_probs=84.4
Q ss_pred CcceEEEEecC-CCccccCcCCCCcceEeecCCCCCCcccceeeccccCCCceeccceeeecccccccccccccccccCC
Q 007035 265 NDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDN 343 (621)
Q Consensus 265 ~~~l~v~l~e~-~L~~~d~~g~sDpyVK~~Llp~~~~~~k~kt~v~k~tlnP~fnE~f~f~~~~~~~~~~k~L~~~V~D~ 343 (621)
...+.|.|.+| ||+++|..|.+||||+++++|++.. +.||+++++++||+|||+|.|.+.......++.|.++|||+
T Consensus 15 ~~~L~v~v~~a~~L~~~d~~~~~dpyv~v~~~~~~~~--~~kT~v~~~t~~P~Wne~f~f~~~~~~~l~~~~l~~~v~d~ 92 (125)
T cd08386 15 ESTLTLKILKAVELPAKDFSGTSDPFVKIYLLPDKKH--KLETKVKRKNLNPHWNETFLFEGFPYEKLQQRVLYLQVLDY 92 (125)
T ss_pred CCEEEEEEEEecCCCCccCCCCCCceEEEEECCCCCc--ceeeeeecCCCCCccceeEEEcccCHHHhCCCEEEEEEEeC
Confidence 45678999999 9999999999999999999987654 57888889999999999999974333334467799999999
Q ss_pred CCCCCCCccccccccccccccc
Q 007035 344 SDTRDGEVNGALHEGKADAEEH 365 (621)
Q Consensus 344 d~~~r~d~iG~v~~~~a~~~~~ 365 (621)
|++++++++|++..++.++...
T Consensus 93 d~~~~~~~iG~~~i~l~~l~~~ 114 (125)
T cd08386 93 DRFSRNDPIGEVSLPLNKVDLT 114 (125)
T ss_pred CCCcCCcEeeEEEEecccccCC
Confidence 9999999999999988877653
|
Synaptotagmin is a membrane-trafficking protein characterized by a N-terminal transmembrane region, a linker, and 2 C-terminal C2 domains. Synaptotagmin 7, a member of class 2 synaptotagmins, is located in presynaptic plasma membranes in neurons, dense-core vesicles in endocrine cells, and lysosomes in fibroblasts. It has been shown to play a role in regulation of Ca2+-dependent lysosomal exocytosis in fibroblasts and may also function as a vesicular Ca2+-sensor. It is distinguished from the other synaptotagmins by having over 12 splice forms. Previously all synaptotagmins were thought to be calcium sensors in the regulation of neurotransmitter release and hormone secretion, but it has been shown that not all of them bind calcium. Of the 17 identified synaptotagmins only 8 bind calcium (1-3, 5-7, 9, 10). The function of the two C2 domains that bind calcium are: regulating the fusion step of synaptic ves |
| >cd04009 C2B_Munc13-like C2 domain second repeat in Munc13 (mammalian uncoordinated)-like proteins | Back alignment and domain information |
|---|
Probab=99.52 E-value=1.3e-14 Score=134.56 Aligned_cols=101 Identities=14% Similarity=0.003 Sum_probs=84.8
Q ss_pred CcceEEEEecC-CCccccCcCCCCcceEeecCCCCC--CcccceeeccccCCCceeccceeeecccccc-cccccccccc
Q 007035 265 NDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPG--TEKSSSYSSSKRGSSIDWIEGFKGSSDLHFK-GAEKDLMPAE 340 (621)
Q Consensus 265 ~~~l~v~l~e~-~L~~~d~~g~sDpyVK~~Llp~~~--~~~k~kt~v~k~tlnP~fnE~f~f~~~~~~~-~~~k~L~~~V 340 (621)
...++|.|.+| ||++++..|.+||||++++.++.+ ...++||+++++|+||+|||+|.|.+..... ..+..|.++|
T Consensus 15 ~~~L~V~Vi~A~~L~~~~~~g~~dPyv~v~l~~~~~~~~~~~~kT~v~~~t~nP~wnE~f~f~i~~~~~~~~~~~l~~~V 94 (133)
T cd04009 15 EQSLRVEILNARNLLPLDSNGSSDPFVKVELLPRHLFPDVPTPKTQVKKKTLFPLFDESFEFNVPPEQCSVEGALLLFTV 94 (133)
T ss_pred CCEEEEEEEEeeCCCCcCCCCCCCCEEEEEEECCCcCccccccccccCcCCCCCccCCEEEEEechhhcccCCCEEEEEE
Confidence 46788999999 999999999999999999998764 3568899999999999999999998322212 2366799999
Q ss_pred cCCCCCCCCCccccccccccccccc
Q 007035 341 IDNSDTRDGEVNGALHEGKADAEEH 365 (621)
Q Consensus 341 ~D~d~~~r~d~iG~v~~~~a~~~~~ 365 (621)
||++++++++++|++..++.++...
T Consensus 95 ~d~d~~~~d~~iG~~~i~l~~l~~~ 119 (133)
T cd04009 95 KDYDLLGSNDFEGEAFLPLNDIPGV 119 (133)
T ss_pred EecCCCCCCcEeEEEEEeHHHCCcc
Confidence 9999999999999999988766643
|
C2-like domains are thought to be involved in phospholipid binding in a Ca2+ independent manner in both Unc13 and Munc13. Caenorabditis elegans Unc13 has a central domain with sequence similarity to PKC, which includes C1 and C2-related domains. Unc13 binds phorbol esters and DAG with high affinity in a phospholipid manner. Mutations in Unc13 results in abnormal neuronal connections and impairment in cholinergic neurotransmission in the nematode. Munc13 is the mammalian homolog which are expressed in the brain. There are 3 isoforms (Munc13-1, -2, -3) and are thought to play a role in neurotransmitter release and are hypothesized to be high-affinity receptors for phorbol esters. Unc13 and Munc13 contain both C1 and C2 domains. There are two C2 related domains present, one central and one at the carboxyl end. Munc13-1 contains a third C2-like domain. Munc13 interacts with syntaxin, s |
| >KOG1028 consensus Ca2+-dependent phospholipid-binding protein Synaptotagmin, required for synaptic vesicle and secretory granule exocytosis [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.7e-14 Score=157.88 Aligned_cols=94 Identities=14% Similarity=0.029 Sum_probs=85.8
Q ss_pred CcceEEEEecC-CCccccCcCCCCcceEeecCCCCCCcccceeeccccCCCceeccceeeecccccccc-cccccccccC
Q 007035 265 NDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEID 342 (621)
Q Consensus 265 ~~~l~v~l~e~-~L~~~d~~g~sDpyVK~~Llp~~~~~~k~kt~v~k~tlnP~fnE~f~f~~~~~~~~~-~k~L~~~V~D 342 (621)
++.++|.|.+| ||+.||.+|.+|||||++|+++.++.+|+||.++|+++||+|||+|.|. ++.+.. +..|.++|||
T Consensus 297 ~g~ltv~v~kar~L~~~~~~~~~d~~Vk~~l~~~~~~~~kkkT~~~~~~~npv~nesf~F~--vp~~~l~~~~l~l~V~d 374 (421)
T KOG1028|consen 297 AGRLTVVVIKARNLKSMDVGGLSDPYVKVTLLDGDKRLSKKKTSVKKKTLNPVFNETFVFD--VPPEQLAEVSLELTVWD 374 (421)
T ss_pred CCeEEEEEEEecCCCcccCCCCCCccEEEEEecCCceeeeeeeecccCCCCCcccccEEEe--CCHHHhheeEEEEEEEE
Confidence 68899999999 9999999999999999999999999999999999999999999999997 666666 5579999999
Q ss_pred CCCCCCCCcccccccccc
Q 007035 343 NSDTRDGEVNGALHEGKA 360 (621)
Q Consensus 343 ~d~~~r~d~iG~v~~~~a 360 (621)
+|++++++++|.+..+..
T Consensus 375 ~d~~~~~~~iG~~~lG~~ 392 (421)
T KOG1028|consen 375 HDTLGSNDLIGRCILGSD 392 (421)
T ss_pred cccccccceeeEEEecCC
Confidence 999999999998866543
|
|
| >cd04039 C2_PSD C2 domain present in Phosphatidylserine decarboxylase (PSD) | Back alignment and domain information |
|---|
Probab=99.49 E-value=2.9e-14 Score=127.71 Aligned_cols=93 Identities=10% Similarity=-0.046 Sum_probs=76.4
Q ss_pred cceEEEEecC-CCccccCc----CCCCcceEeecCCCCCCcccceeeccccCCCceeccceeeecccccccccccccccc
Q 007035 266 DYGYLSSKEA-DLIDLQHN----VVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAE 340 (621)
Q Consensus 266 ~~l~v~l~e~-~L~~~d~~----g~sDpyVK~~Llp~~~~~~k~kt~v~k~tlnP~fnE~f~f~~~~~~~~~~k~L~~~V 340 (621)
+.|+|.|.+| ||+++|.. +.+||||++.+. ..++||+++++++||+|||+|.|. +.....+..|.+.|
T Consensus 1 g~l~v~v~~A~~L~~~~~~~~~~~~~DPYv~v~~~-----~~~~kT~v~~~t~nPvWne~f~f~--v~~~~~~~~L~~~V 73 (108)
T cd04039 1 GVVFMEIKSITDLPPLKNMTRTGFDMDPFVIISFG-----RRVFRTSWRRHTLNPVFNERLAFE--VYPHEKNFDIQFKV 73 (108)
T ss_pred CEEEEEEEeeeCCCCccccCCCCCccCceEEEEEC-----CEeEeeeeecCCCCCcccceEEEE--EeCccCCCEEEEEE
Confidence 3578999999 99998742 357999999983 245689999999999999999998 44333456799999
Q ss_pred cCCCCCCCCCccccccccccccccc
Q 007035 341 IDNSDTRDGEVNGALHEGKADAEEH 365 (621)
Q Consensus 341 ~D~d~~~r~d~iG~v~~~~a~~~~~ 365 (621)
||+|++++++++|.+..++.++...
T Consensus 74 ~D~d~~~~dd~IG~~~l~L~~l~~~ 98 (108)
T cd04039 74 LDKDKFSFNDYVATGSLSVQELLNA 98 (108)
T ss_pred EECCCCCCCcceEEEEEEHHHHHhh
Confidence 9999999999999999988766554
|
PSD is involved in the biosynthesis of aminophospholipid by converting phosphatidylserine (PtdSer) to phosphatidylethanolamine (PtdEtn). There is a single C2 domain present and it is thought to confer PtdSer binding motif that is common to PKC and synaptotagmin. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involving their N- and C-terminal beta strands. Many C2 domains are Ca2+-dependent membrane-targeting modules that bind a wide variety of substances including bind phospholipids, inositol polyphosphates, and intracellular proteins. Most C2 domain proteins are either signal transduction enzymes that contain a single C2 domain, such as protein kinase C, or membrane trafficking proteins which contain at least two C2 domains, such as synaptotagmin 1. However, there are a few exceptions to this including RIM |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.9e-13 Score=154.73 Aligned_cols=136 Identities=21% Similarity=0.242 Sum_probs=100.8
Q ss_pred CceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecC----c-----hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeE
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND----K-----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDY 484 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~----~-----~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~ 484 (621)
..|...+.||+|+||+||++.+.. ..+++|..... . ....+..+|+++++.++ |++++....+
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~--~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~------~~~i~~p~~~ 404 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLG--RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEAR------RAGVPTPVIY 404 (535)
T ss_pred cccCccceeccCCcEEEEEEeecC--ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhc------ccCCCeeEEE
Confidence 345667889999999999998543 34444432211 1 12245677888888875 4567766666
Q ss_pred eEecCeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEE
Q 007035 485 FYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 563 (621)
Q Consensus 485 f~~~~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IK 563 (621)
.......++||||+++ +|.+.+. ....++.+++.+|.+||+.+|+||||||+|||++ ++.++
T Consensus 405 ~~~~~~~~lv~E~~~g~~L~~~l~--------------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~---~~~~~ 467 (535)
T PRK09605 405 DVDPEEKTIVMEYIGGKDLKDVLE--------------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR---DDRLY 467 (535)
T ss_pred EEeCCCCEEEEEecCCCcHHHHHH--------------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEE---CCcEE
Confidence 6676778999999986 4544432 2456899999999999999999999999999994 67899
Q ss_pred EEecCCccccC
Q 007035 564 IIDLGSSCFQT 574 (621)
Q Consensus 564 L~DFGls~~~~ 574 (621)
|+|||++....
T Consensus 468 liDFGla~~~~ 478 (535)
T PRK09605 468 LIDFGLGKYSD 478 (535)
T ss_pred EEeCcccccCC
Confidence 99999986643
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.49 E-value=3.5e-13 Score=123.14 Aligned_cols=133 Identities=20% Similarity=0.218 Sum_probs=107.0
Q ss_pred EEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeEEEEEec
Q 007035 418 VTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCEL 497 (621)
Q Consensus 418 I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l~LVmEy 497 (621)
+++.||.|.++.||++.+.. ..+++|+...... ......|..+++.++.. ..++++++.++...+..+++|||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~-~~~~~~e~~~~~~l~~~----~~~~p~~~~~~~~~~~~~~v~e~ 74 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK-GADREREVAILQLLARK----GLPVPKVLASGESDGWSYLLMEW 74 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc-hhHHHHHHHHHHHHHHc----CCCCCeEEEEcCCCCccEEEEEe
Confidence 45789999999999998643 7899999876543 45678899999999764 24678888888877889999999
Q ss_pred cccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHC---CeecccCCCccEEEeccCCCeEEEEecCCcc
Q 007035 498 LRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSL---GIIHCDLKPENILIKSYQRCEIKIIDLGSSC 571 (621)
Q Consensus 498 l~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~---gIvHrDLKP~NILl~~~~~~~IKL~DFGls~ 571 (621)
+.+.....+ +......++.+++.+|.+||.. +++|+|++|.||+++. .+.++++|||.+.
T Consensus 75 ~~g~~~~~~------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~--~~~~~l~Df~~~~ 137 (155)
T cd05120 75 IEGETLDEV------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDD--GKILGIIDWEYAG 137 (155)
T ss_pred cCCeecccC------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEEC--CcEEEEEeccccc
Confidence 986533211 3345667889999999999985 6999999999999984 6889999999874
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.48 E-value=1.4e-13 Score=144.68 Aligned_cols=142 Identities=25% Similarity=0.370 Sum_probs=110.6
Q ss_pred CCCCceEEEeeEeEe---------------------------cCeEEEEEeccccchHHHHHhhhccCCCccccHHHHHH
Q 007035 473 ADEHHILRLYDYFYH---------------------------LEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQV 525 (621)
Q Consensus 473 ~~hpnIvrl~~~f~~---------------------------~~~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~ 525 (621)
.+||||+++..+|.+ ...+|+||.....+|.+++..+. .+....+.
T Consensus 273 a~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~~~~-------~s~r~~~~ 345 (598)
T KOG4158|consen 273 AKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLWTRH-------RSYRTGRV 345 (598)
T ss_pred CCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHhcCC-------CchHHHHH
Confidence 579999999988764 23589999999999999887554 45667788
Q ss_pred HHHHHHHHHHHHHHCCeecccCCCccEEEeccCC--CeEEEEecCCccccCC---------CccccccCCcccCchhhcC
Q 007035 526 ITRQCLEALEYLHSLGIIHCDLKPENILIKSYQR--CEIKIIDLGSSCFQTD---------NLCLYVQSRSYRAPEVIIG 594 (621)
Q Consensus 526 I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~--~~IKL~DFGls~~~~~---------~~~~~~gt~~Y~APEvl~~ 594 (621)
++.|+++|+.|||++||.|||+|.+||||.-+++ ..++|+|||.+--... ......|.-.-||||+...
T Consensus 346 ~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 346 ILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 9999999999999999999999999999965444 4689999996522111 1111234555799999865
Q ss_pred CC------CCchhhHHHHHHHHHHHHhCCCCCC
Q 007035 595 LP------YDQKIDLWSLGCILAELWTGEVCLI 621 (621)
Q Consensus 595 ~~------~s~ksDIWSLGvILyELltG~~PF~ 621 (621)
.+ --.++|.|+.|.+.||+++...||.
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY 458 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFY 458 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCccc
Confidence 43 1247999999999999999999983
|
|
| >cd08682 C2_Rab11-FIP_classI C2 domain found in Rab11-family interacting proteins (FIP) class I | Back alignment and domain information |
|---|
Probab=99.48 E-value=4e-14 Score=129.79 Aligned_cols=88 Identities=16% Similarity=0.081 Sum_probs=75.8
Q ss_pred EEEEecC-CCccccCcCCCCcceEeecCCCCCCcccceeeccccCCCceeccceeeeccccc----ccccccccccccCC
Q 007035 269 YLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHF----KGAEKDLMPAEIDN 343 (621)
Q Consensus 269 ~v~l~e~-~L~~~d~~g~sDpyVK~~Llp~~~~~~k~kt~v~k~tlnP~fnE~f~f~~~~~~----~~~~k~L~~~V~D~ 343 (621)
.|.|.+| ||.++|.+|.+||||++.+.. .+.||+++++|+||+|||+|.|. ++. +.....|.+.|||+
T Consensus 2 ~V~V~~A~~L~~~d~~g~~dpYv~v~l~~-----~~~kT~v~~~t~nP~Wne~f~F~--v~~~~~~~~~~~~l~~~v~d~ 74 (126)
T cd08682 2 QVTVLQARGLLCKGKSGTNDAYVIIQLGK-----EKYSTSVKEKTTSPVWKEECSFE--LPGLLSGNGNRATLQLTVMHR 74 (126)
T ss_pred EEEEEECcCCcCCCCCcCCCceEEEEECC-----eeeeeeeecCCCCCEeCceEEEE--ecCcccCCCcCCEEEEEEEEc
Confidence 5888999 999999999999999999952 46689999999999999999998 443 23356699999999
Q ss_pred CCCCCCCccccccccccccc
Q 007035 344 SDTRDGEVNGALHEGKADAE 363 (621)
Q Consensus 344 d~~~r~d~iG~v~~~~a~~~ 363 (621)
+.+++++++|.+..++.++.
T Consensus 75 ~~~~~d~~iG~~~i~l~~l~ 94 (126)
T cd08682 75 NLLGLDKFLGQVSIPLNDLD 94 (126)
T ss_pred cccCCCceeEEEEEEHHHhh
Confidence 99999999999999887765
|
Rab GTPases recruit various effector proteins to organelles and vesicles. Rab11-family interacting proteins (FIPs) are involved in mediating the role of Rab11. FIPs can be divided into three classes: class I FIPs (Rip11a, Rip11b, RCP, and FIP2) which contain a C2 domain after N-terminus of the protein, class II FIPs (FIP3 and FIP4) which contain two EF-hands and a proline rich region, and class III FIPs (FIP1) which exhibits no homology to known protein domains. All FIP proteins contain a highly conserved, 20-amino acid motif at the C-terminus of the protein, known as Rab11/25 binding domain (RBD). Class I FIPs are thought to bind to endocytic membranes via their C2 domain, which interacts directly with phospholipids. Class II FIPs do not have any membrane binding domains leaving much to speculate about the mechanism involving FIP3 and FIP4 interactions with endocytic membranes. The member |
| >cd08688 C2_KIAA0528-like C2 domain found in the Human KIAA0528 cDNA clone | Back alignment and domain information |
|---|
Probab=99.48 E-value=3.6e-14 Score=127.14 Aligned_cols=91 Identities=12% Similarity=0.081 Sum_probs=78.5
Q ss_pred eEEEEecC-CCccccC-cCCCCcceEeecCCCCCCcccceeeccccCCCcee-ccceeeecccccccc-cccccccccCC
Q 007035 268 GYLSSKEA-DLIDLQH-NVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDW-IEGFKGSSDLHFKGA-EKDLMPAEIDN 343 (621)
Q Consensus 268 l~v~l~e~-~L~~~d~-~g~sDpyVK~~Llp~~~~~~k~kt~v~k~tlnP~f-nE~f~f~~~~~~~~~-~k~L~~~V~D~ 343 (621)
|+|.|.+| ||++||. .|.+||||++++.. .+.||+++++++||+| ||+|.|. ++.... +..|.++|||+
T Consensus 1 l~V~v~~a~~L~~~d~~~~~~Dpyv~v~~~~-----~~~kT~v~~~~~nP~W~ne~f~f~--i~~~~l~~~~l~i~V~d~ 73 (110)
T cd08688 1 LKVRVVAARDLPVMDRSSDLTDAFVEVKFGS-----TTYKTDVVKKSLNPVWNSEWFRFE--VDDEELQDEPLQIRVMDH 73 (110)
T ss_pred CEEEEEEEECCCccccCCCCCCceEEEEECC-----eeEecceecCCCCCcccCcEEEEE--cChHHcCCCeEEEEEEeC
Confidence 46889999 9999995 78999999999964 5778888999999999 9999998 554433 56799999999
Q ss_pred CCCCCCCccccccccccccccc
Q 007035 344 SDTRDGEVNGALHEGKADAEEH 365 (621)
Q Consensus 344 d~~~r~d~iG~v~~~~a~~~~~ 365 (621)
|.+++++++|++..++.++...
T Consensus 74 d~~~~~~~iG~~~~~l~~l~~~ 95 (110)
T cd08688 74 DTYSANDAIGKVYIDLNPLLLK 95 (110)
T ss_pred CCCCCCCceEEEEEeHHHhccc
Confidence 9999999999999988877764
|
The members of this CD are named after the Human KIAA0528 cDNA clone. All members here contain a single C2 repeat. No other information on this protein is currently known. The C2 domain was first identified in PKC. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involving their N- and C-terminal beta strands. Many C2 domains are Ca2+-dependent membrane-targeting modules that bind a wide variety of substances including bind phospholipids, inositol polyphosphates, and intracellular proteins. Most C2 domain proteins are either signal transduction enzymes that contain a single C2 domain, such as protein kinase C, or membrane trafficking proteins which contain at least two C2 domains, such as synaptotagmin 1. However, there are a few exceptions to this including RIM isoforms and some splice variants of piccolo/a |
| >cd08401 C2A_RasA2_RasA3 C2 domain first repeat present in RasA2 and RasA3 | Back alignment and domain information |
|---|
Probab=99.46 E-value=6.9e-14 Score=127.73 Aligned_cols=90 Identities=18% Similarity=0.057 Sum_probs=74.9
Q ss_pred eEEEEecC-CCcccc-CcCCCCcceEeecCCCCCCcccceeeccccCCCceeccceeeecccccccccccccccccCCCC
Q 007035 268 GYLSSKEA-DLIDLQ-HNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDNSD 345 (621)
Q Consensus 268 l~v~l~e~-~L~~~d-~~g~sDpyVK~~Llp~~~~~~k~kt~v~k~tlnP~fnE~f~f~~~~~~~~~~k~L~~~V~D~d~ 345 (621)
++|.|.+| ||++++ .+|.+||||++++. .+.+.||+++++|+||.|||+|.|. ++.. .+.|.+.|||+|+
T Consensus 2 l~v~v~~a~~L~~~~~~~g~sDpYv~v~l~----~~~~~kT~v~~kt~~P~WnE~F~f~--v~~~--~~~l~~~v~d~~~ 73 (121)
T cd08401 2 LKIKIGEAKNLPPRSGPNKMRDCYCTVNLD----QEEVFRTKTVEKSLCPFFGEDFYFE--IPRT--FRHLSFYIYDRDV 73 (121)
T ss_pred eEEEEEEccCCCCCCCCCCCcCcEEEEEEC----CccEEEeeEEECCCCCccCCeEEEE--cCCC--CCEEEEEEEECCC
Confidence 56888999 999985 57899999999993 2235778888999999999999999 5533 3579999999999
Q ss_pred CCCCCccccccccccccccc
Q 007035 346 TRDGEVNGALHEGKADAEEH 365 (621)
Q Consensus 346 ~~r~d~iG~v~~~~a~~~~~ 365 (621)
+++++++|.+..++.++...
T Consensus 74 ~~~~~~iG~~~i~l~~l~~~ 93 (121)
T cd08401 74 LRRDSVIGKVAIKKEDLHKY 93 (121)
T ss_pred CCCCceEEEEEEEHHHccCC
Confidence 99999999998887766653
|
RasA2 and RasA3 are GAP1s (GTPase activating protein 1s ), Ras-specific GAP members, which suppresses Ras function by enhancing the GTPase activity of Ras proteins resulting in the inactive GDP-bound form of Ras. In this way it can control cellular proliferation and differentiation. RasA2 and RasA3 are both inositol 1,3,4,5-tetrakisphosphate-binding proteins and contain an N-terminal C2 domain, a Ras-GAP domain, a pleckstrin-homology (PH) domain which localizes it to the plasma membrane, and Bruton's Tyrosine Kinase (BTK) a zinc binding domain. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involving their N- and C-terminal beta strands. Many C2 domains are Ca2+-dependent membrane-targeting modules that bind a wide variety of substances including bind phospholipids, inositol polyphosphates, and intracellular p |
| >cd04032 C2_Perforin C2 domain of Perforin | Back alignment and domain information |
|---|
Probab=99.46 E-value=9.8e-14 Score=127.84 Aligned_cols=89 Identities=11% Similarity=-0.041 Sum_probs=73.5
Q ss_pred CcceEEEEecC-CCccccCcCCCCcceEeecCCCCCCcccceeeccccCCCceeccceeeecccccccccccccccccCC
Q 007035 265 NDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDN 343 (621)
Q Consensus 265 ~~~l~v~l~e~-~L~~~d~~g~sDpyVK~~Llp~~~~~~k~kt~v~k~tlnP~fnE~f~f~~~~~~~~~~k~L~~~V~D~ 343 (621)
...|+|.|.+| ||+ +|..|.+|||||+++.- .+.||+++++++||+|||+|.|.. .....+..|.++|||+
T Consensus 27 ~~~L~V~V~~A~~L~-~d~~g~~DPYVkV~~~~-----~~~kT~vi~~t~nPvWNE~F~f~~--~~~~~~~~L~v~V~D~ 98 (127)
T cd04032 27 LATLTVTVLRATGLW-GDYFTSTDGYVKVFFGG-----QEKRTEVIWNNNNPRWNATFDFGS--VELSPGGKLRFEVWDR 98 (127)
T ss_pred cEEEEEEEEECCCCC-cCcCCCCCeEEEEEECC-----ccccCceecCCCCCcCCCEEEEec--ccCCCCCEEEEEEEeC
Confidence 46778999999 997 58888999999999841 277888999999999999999962 2212355699999999
Q ss_pred CCCCCCCccccccccccc
Q 007035 344 SDTRDGEVNGALHEGKAD 361 (621)
Q Consensus 344 d~~~r~d~iG~v~~~~a~ 361 (621)
|.+++++++|.+..++..
T Consensus 99 d~~s~dd~IG~~~i~l~~ 116 (127)
T cd04032 99 DNGWDDDLLGTCSVVPEA 116 (127)
T ss_pred CCCCCCCeeEEEEEEecC
Confidence 999999999999887653
|
Perforin contains a single copy of a C2 domain in its C-terminus and plays a role in lymphocyte-mediated cytotoxicity. Mutations in perforin leads to familial hemophagocytic lymphohistiocytosis type 2. The function of perforin is calcium dependent and the C2 domain is thought to confer this binding to target cell membranes. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involving their N- and C-terminal beta strands. Many C2 domains are Ca2+-dependent membrane-targeting modules that bind a wide variety of substances including bind phospholipids, inositol polyphosphates, and intracellular proteins. Most C2 domain proteins are either signal transduction enzymes that contain a single C2 domain, such as protein kinase C, or membrane trafficking proteins which contain at least two C2 domains, such as synaptotagmin 1. However, there are a few |
| >cd08390 C2A_Synaptotagmin-15-17 C2A domain first repeat present in Synaptotagmins 15 and 17 | Back alignment and domain information |
|---|
Probab=99.46 E-value=5.2e-14 Score=128.04 Aligned_cols=98 Identities=15% Similarity=0.047 Sum_probs=83.6
Q ss_pred CcceEEEEecC-CCcccc-CcCCCCcceEeecCCCCCCcccceeeccccCCCceeccceeeecccccccc-ccccccccc
Q 007035 265 NDYGYLSSKEA-DLIDLQ-HNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEI 341 (621)
Q Consensus 265 ~~~l~v~l~e~-~L~~~d-~~g~sDpyVK~~Llp~~~~~~k~kt~v~k~tlnP~fnE~f~f~~~~~~~~~-~k~L~~~V~ 341 (621)
+..|+|.|.+| ||+++| ..|.+||||+++++|+.++ +.+|+++++++||+|||+|.|. ++.... .+.|.+.||
T Consensus 13 ~~~L~V~v~~a~~L~~~~~~~~~~dpyV~v~l~~~~~~--~~~T~v~~~~~~P~wne~f~f~--i~~~~l~~~~l~i~v~ 88 (123)
T cd08390 13 EEQLTVSLIKARNLPPRTKDVAHCDPFVKVCLLPDERR--SLQSKVKRKTQNPNFDETFVFQ--VSFKELQRRTLRLSVY 88 (123)
T ss_pred CCEEEEEEEEecCCCCccCCCCCCCcEEEEEEeeCCCC--ceEeeeEcCCCCCccceEEEEE--cCHHHhcccEEEEEEE
Confidence 56789999999 999999 6889999999999987654 5678888999999999999998 555444 567999999
Q ss_pred CCCCCCCCCcccccccccccccccC
Q 007035 342 DNSDTRDGEVNGALHEGKADAEEHG 366 (621)
Q Consensus 342 D~d~~~r~d~iG~v~~~~a~~~~~~ 366 (621)
|++..++++++|.+..++.++....
T Consensus 89 d~~~~~~~~~iG~~~i~L~~l~~~~ 113 (123)
T cd08390 89 DVDRFSRHCIIGHVLFPLKDLDLVK 113 (123)
T ss_pred ECCcCCCCcEEEEEEEeccceecCC
Confidence 9999999999999998887666644
|
Synaptotagmin is a membrane-trafficking protein characterized by a N-terminal transmembrane region, a linker, and 2 C-terminal C2 domains. It is thought to be involved in the trafficking and exocytosis of secretory vesicles in non-neuronal tissues and is Ca2+ independent. Human synaptotagmin 15 has 2 alternatively spliced forms that encode proteins with different C-termini. The larger, SYT15a, contains a N-terminal TM region, a putative fatty-acylation site, and 2 tandem C terminal C2 domains. The smaller, SYT15b, lacks the C-terminal portion of the second C2 domain. Unlike most other synaptotagmins it is nearly absent in the brain and rather is found in the heart, lungs, skeletal muscle, and testis. Synaptotagmin 17 is located in the brain, kidney, and prostate and is thought to be a peripheral membrane protein. Previously all synaptotagmins were thought to be calcium sensors in the regulat |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.46 E-value=3.8e-14 Score=142.48 Aligned_cols=191 Identities=19% Similarity=0.264 Sum_probs=143.4
Q ss_pred CceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc---hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCe
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~---~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~ 490 (621)
.+..++.+|.....|+.|+|++ .|..++.|++.... ...+.+..|.-.|+ ...||||+.+++.+....+
T Consensus 190 ~~lnl~tkl~e~hsgelwrgrw--qgndivakil~vr~~t~risrdfneefp~lr------ifshpnilpvlgacnsppn 261 (448)
T KOG0195|consen 190 SSLNLITKLAESHSGELWRGRW--QGNDIVAKILNVREVTARISRDFNEEFPALR------IFSHPNILPVLGACNSPPN 261 (448)
T ss_pred hhhhhhhhhccCCCcccccccc--cCcchhhhhhhhhhcchhhcchhhhhCccee------eecCCchhhhhhhccCCCC
Confidence 4566777899999999999985 45667778776432 22233334443333 4468999999999999999
Q ss_pred EEEEEeccc-cchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCC--eecccCCCccEEEeccCCCeEEEEec
Q 007035 491 LFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLG--IIHCDLKPENILIKSYQRCEIKIIDL 567 (621)
Q Consensus 491 l~LVmEyl~-gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~g--IvHrDLKP~NILl~~~~~~~IKL~DF 567 (621)
+.++..|++ ++|+..+... ....+...++.+++.+|++|++|||+.. |.---|....|+|+.+-+.++..+|-
T Consensus 262 lv~isq~mp~gslynvlhe~----t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~ 337 (448)
T KOG0195|consen 262 LVIISQYMPFGSLYNVLHEQ----TSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADT 337 (448)
T ss_pred ceEeeeeccchHHHHHHhcC----ccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccc
Confidence 999999998 7888887643 2344677888999999999999999875 44556888999999755556666664
Q ss_pred CCccccCCCccccccCCcccCchhhcCCCCC---chhhHHHHHHHHHHHHhCCCCC
Q 007035 568 GSSCFQTDNLCLYVQSRSYRAPEVIIGLPYD---QKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 568 Gls~~~~~~~~~~~gt~~Y~APEvl~~~~~s---~ksDIWSLGvILyELltG~~PF 620 (621)
-++..... ..-.|.|++||.+...+-+ .++|+|||+++||||-|.++||
T Consensus 338 kfsfqe~g----r~y~pawmspealqrkped~n~raadmwsfaillwel~trevpf 389 (448)
T KOG0195|consen 338 KFSFQEVG----RAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPF 389 (448)
T ss_pred eeeeeccc----cccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhcccccc
Confidence 44322221 1237899999999877633 5799999999999999999998
|
|
| >cd08690 C2_Freud-1 C2 domain found in 5' repressor element under dual repression binding protein-1 (Freud-1) | Back alignment and domain information |
|---|
Probab=99.43 E-value=1.8e-13 Score=130.01 Aligned_cols=97 Identities=14% Similarity=0.008 Sum_probs=77.3
Q ss_pred eEEEEecC-C--CccccCcCCCCcceEeecCCCCCCcccceeeccccCCCceeccceeeecccccc-------ccccccc
Q 007035 268 GYLSSKEA-D--LIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFK-------GAEKDLM 337 (621)
Q Consensus 268 l~v~l~e~-~--L~~~d~~g~sDpyVK~~Llp~~~~~~k~kt~v~k~tlnP~fnE~f~f~~~~~~~-------~~~k~L~ 337 (621)
+.++|+.| | |++.+.+|.+|||||++|+....+..+.||+++|+|+||+|||+|.|. ++.. ..++.|.
T Consensus 4 ~el~i~~~~~~~l~~~~~~~~~DpYVk~~l~~p~~~~~k~KT~v~k~TlnPvfNE~f~f~--I~~~~~~~~R~l~~~~L~ 81 (155)
T cd08690 4 IELTIVRCIGIPLPSGWNPKDLDTYVKFEFPYPNEEPQSGKTSTIKDTNSPEYNESFKLN--INRKHRSFQRVFKRHGLK 81 (155)
T ss_pred eEEEEEEeeccccCCCcCCCCCCeEEEEEEecCCCCCceeecCcccCCCCCcccceEEEE--eccccchhhhhccCCcEE
Confidence 34555555 4 889998999999999997433556789999999999999999999999 4444 2356699
Q ss_pred ccccCCCCCC-CCCcccccccccccccccC
Q 007035 338 PAEIDNSDTR-DGEVNGALHEGKADAEEHG 366 (621)
Q Consensus 338 ~~V~D~d~~~-r~d~iG~v~~~~a~~~~~~ 366 (621)
++|||.+.+. +++++|.+..++...+...
T Consensus 82 ~~V~d~~~f~~~D~~iG~~~i~L~~l~~~~ 111 (155)
T cd08690 82 FEVYHKGGFLRSDKLLGTAQVKLEPLETKC 111 (155)
T ss_pred EEEEeCCCcccCCCeeEEEEEEcccccccC
Confidence 9999999985 6999999988776665543
|
Freud-1 is a novel calcium-regulated repressor that negatively regulates basal 5-HT1A receptor expression in neurons. It may also play a role in the altered regulation of 5-HT1A receptors associated with anxiety or major depression. Freud-1 contains two DM-14 basic repeats, a helix-loop-helix DNA binding domain, and a C2 domain. The Freud-1 C2 domain is thought to be calcium insensitive and it lacks several acidic residues that mediate calcium binding of the PKC C2 domain. In addition, it contains a poly-basic insert that is not present in calcium-dependent C2 domains and may function as a nuclear localization signal. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involving their N- and C-terminal beta strands. Many C2 domains are Ca2+-dependent membrane-targeting modules tha |
| >cd08376 C2B_MCTP_PRT C2 domain second repeat found in Multiple C2 domain and Transmembrane region Proteins (MCTP) | Back alignment and domain information |
|---|
Probab=99.42 E-value=1.5e-13 Score=123.87 Aligned_cols=90 Identities=14% Similarity=0.133 Sum_probs=76.5
Q ss_pred eEEEEecC-CCccccCcCCCCcceEeecCCCCCCcccceeeccccCCCceeccceeeecccccccccccccccccCCCCC
Q 007035 268 GYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDNSDT 346 (621)
Q Consensus 268 l~v~l~e~-~L~~~d~~g~sDpyVK~~Llp~~~~~~k~kt~v~k~tlnP~fnE~f~f~~~~~~~~~~k~L~~~V~D~d~~ 346 (621)
++|.|.+| ||+++|..|.+||||++++. ..+.||+++++|+||.|||+|.|. +... .+..|.++|||++.+
T Consensus 2 ~~V~v~~a~~L~~~~~~~~~dPyv~v~~~-----~~~~kT~v~~~t~nP~Wne~f~f~--~~~~-~~~~l~v~v~d~~~~ 73 (116)
T cd08376 2 VTIVLVEGKNLPPMDDNGLSDPYVKFRLG-----NEKYKSKVCSKTLNPQWLEQFDLH--LFDD-QSQILEIEVWDKDTG 73 (116)
T ss_pred EEEEEEEEECCCCCCCCCCCCcEEEEEEC-----CEeEecccccCCCCCceeEEEEEE--ecCC-CCCEEEEEEEECCCC
Confidence 57889999 99999999999999999983 346788888999999999999998 4432 355699999999999
Q ss_pred CCCCccccccccccccccc
Q 007035 347 RDGEVNGALHEGKADAEEH 365 (621)
Q Consensus 347 ~r~d~iG~v~~~~a~~~~~ 365 (621)
++++++|.+..++.++...
T Consensus 74 ~~~~~iG~~~~~l~~l~~~ 92 (116)
T cd08376 74 KKDEFIGRCEIDLSALPRE 92 (116)
T ss_pred CCCCeEEEEEEeHHHCCCC
Confidence 9999999999887765543
|
MCTPs are involved in Ca2+ signaling at the membrane. MCTP is composed of a variable N-terminal sequence, three C2 domains, two transmembrane regions (TMRs), and a short C-terminal sequence. It is one of four protein classes that are anchored to membranes via a transmembrane region; the others being synaptotagmins, extended synaptotagmins, and ferlins. MCTPs are the only membrane-bound C2 domain proteins that contain two functional TMRs. MCTPs are unique in that they bind Ca2+ but not phospholipids. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involving their N- and C-terminal beta strands. Many C2 domains are Ca2+-dependent membrane-targeting modules that bind a wide variety of substances including bind phospholipids, inositol polyphosphates, and intracellular protei |
| >cd04036 C2_cPLA2 C2 domain present in cytosolic PhosphoLipase A2 (cPLA2) | Back alignment and domain information |
|---|
Probab=99.42 E-value=1.5e-13 Score=124.67 Aligned_cols=92 Identities=11% Similarity=0.021 Sum_probs=76.7
Q ss_pred eEEEEecC-CCccccCcCCCCcceEeecCCCCCCcccceeeccccCCCceeccceeeecccccccccccccccccCCCCC
Q 007035 268 GYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDNSDT 346 (621)
Q Consensus 268 l~v~l~e~-~L~~~d~~g~sDpyVK~~Llp~~~~~~k~kt~v~k~tlnP~fnE~f~f~~~~~~~~~~k~L~~~V~D~d~~ 346 (621)
|+|.|.+| ||++.|..|.+||||++.+...+. .++||+++++++||+|||+|.|. +... ....|.++|||+|.+
T Consensus 2 L~V~vi~a~~L~~~~~~~~~Dpyv~v~~~~~~~--~~~kT~vv~~t~nP~Wne~f~f~--i~~~-~~~~l~v~v~d~d~~ 76 (119)
T cd04036 2 LTVRVLRATNITKGDLLSTPDCYVELWLPTASD--EKKRTKTIKNSINPVWNETFEFR--IQSQ-VKNVLELTVMDEDYV 76 (119)
T ss_pred eEEEEEEeeCCCccCCCCCCCcEEEEEEcCCCC--ccCccceecCCCCCccceEEEEE--eCcc-cCCEEEEEEEECCCC
Confidence 57899999 999999999999999999965443 46788888999999999999998 4433 344599999999999
Q ss_pred CCCCccccccccccccccc
Q 007035 347 RDGEVNGALHEGKADAEEH 365 (621)
Q Consensus 347 ~r~d~iG~v~~~~a~~~~~ 365 (621)
+++++|.+..++..+...
T Consensus 77 -~~~~iG~~~~~l~~l~~g 94 (119)
T cd04036 77 -MDDHLGTVLFDVSKLKLG 94 (119)
T ss_pred -CCcccEEEEEEHHHCCCC
Confidence 899999999887765543
|
A single copy of the C2 domain is present in cPLA2 which releases arachidonic acid from membranes initiating the biosynthesis of potent inflammatory mediators such as prostaglandins, leukotrienes, and platelet-activating factor. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involving their N- and C-terminal beta strands. Many C2 domains are Ca2+-dependent membrane-targeting modules that bind a wide variety of substances including bind phospholipids, inositol polyphosphates, and intracellular proteins. Most C2 domain proteins are either signal transduction enzymes that contain a single C2 domain, such as protein kinase C, or membrane trafficking proteins which contain at least two C2 domains, such as synaptotagmin 1. However, there are a few exceptions to this including RIM isoforms and some splice variants o |
| >cd04022 C2A_MCTP_PRT_plant C2 domain first repeat found in Multiple C2 domain and Transmembrane region Proteins (MCTP); plant subset | Back alignment and domain information |
|---|
Probab=99.42 E-value=1.4e-13 Score=126.28 Aligned_cols=92 Identities=9% Similarity=-0.004 Sum_probs=77.4
Q ss_pred ceEEEEecC-CCccccCcCCCCcceEeecCCCCCCcccceeeccccCCCceeccceeeecccccccccccccccccCCCC
Q 007035 267 YGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDNSD 345 (621)
Q Consensus 267 ~l~v~l~e~-~L~~~d~~g~sDpyVK~~Llp~~~~~~k~kt~v~k~tlnP~fnE~f~f~~~~~~~~~~k~L~~~V~D~d~ 345 (621)
+|+|.|.+| ||.++|.+|.+||||++++.. .++||+++++++||+|||+|.|....+....+..|.++|||.++
T Consensus 1 ~L~V~vi~A~~L~~~d~~g~~dpyv~v~~~~-----~~~rT~v~~~t~nP~Wne~f~f~~~~~~~~~~~~l~~~V~d~~~ 75 (127)
T cd04022 1 KLVVEVVDAQDLMPKDGQGSSSAYVELDFDG-----QKKRTRTKPKDLNPVWNEKLVFNVSDPSRLSNLVLEVYVYNDRR 75 (127)
T ss_pred CeEEEEEEeeCCCCCCCCCCcCcEEEEEECC-----EEecceeEcCCCCCccceEEEEEccCHHHccCCeEEEEEeeCCC
Confidence 478999999 999999999999999999874 35688888999999999999998332233335679999999999
Q ss_pred CC-CCCccccccccccccc
Q 007035 346 TR-DGEVNGALHEGKADAE 363 (621)
Q Consensus 346 ~~-r~d~iG~v~~~~a~~~ 363 (621)
++ +++++|++..++.++.
T Consensus 76 ~~~~d~~lG~v~i~l~~l~ 94 (127)
T cd04022 76 SGRRRSFLGRVRISGTSFV 94 (127)
T ss_pred CcCCCCeeeEEEEcHHHcC
Confidence 97 7999999998876665
|
MCTPs are involved in Ca2+ signaling at the membrane. Plant-MCTPs are composed of a variable N-terminal sequence, four C2 domains, two transmembrane regions (TMRs), and a short C-terminal sequence. It is one of four protein classes that are anchored to membranes via a transmembrane region; the others being synaptotagmins, extended synaptotagmins, and ferlins. MCTPs are the only membrane-bound C2 domain proteins that contain two functional TMRs. MCTPs are unique in that they bind Ca2+ but not phospholipids. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involving their N- and C-terminal beta strands. Many C2 domains are Ca2+-dependent membrane-targeting modules that bind a wide variety of substances including bind phospholipids, inositol polyphosphates |
| >cd04035 C2A_Rabphilin_Doc2 C2 domain first repeat present in Rabphilin and Double C2 domain | Back alignment and domain information |
|---|
Probab=99.42 E-value=1.9e-13 Score=124.60 Aligned_cols=100 Identities=12% Similarity=0.036 Sum_probs=85.0
Q ss_pred CcceEEEEecC-CCccccCcCCCCcceEeecCCCCCCcccceeeccccCCCceeccceeeecccccccccccccccccCC
Q 007035 265 NDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDN 343 (621)
Q Consensus 265 ~~~l~v~l~e~-~L~~~d~~g~sDpyVK~~Llp~~~~~~k~kt~v~k~tlnP~fnE~f~f~~~~~~~~~~k~L~~~V~D~ 343 (621)
+..++|.|.+| ||++++..|.+|||||++++++.....+.||+++++++||+|||+|.|......+..+..|.++|||+
T Consensus 14 ~~~L~V~v~~a~~L~~~~~~~~~dpyv~v~~~~~~~~~~~~rT~v~~~~~~P~Wne~f~f~~~~~~~~~~~~l~~~v~d~ 93 (123)
T cd04035 14 NSALHCTIIRAKGLKAMDANGLSDPYVKLNLLPGASKATKLRTKTVHKTRNPEFNETLTYYGITEEDIQRKTLRLLVLDE 93 (123)
T ss_pred CCEEEEEEEEeeCCCCCCCCCCCCceEEEEEecCCCCCCceeeeeecCCCCCCccceEEEcCCCHHHhCCCEEEEEEEEc
Confidence 45788999999 99999999999999999999887766788999999999999999999964444444456799999999
Q ss_pred CCCCCCCccccccccccccccc
Q 007035 344 SDTRDGEVNGALHEGKADAEEH 365 (621)
Q Consensus 344 d~~~r~d~iG~v~~~~a~~~~~ 365 (621)
+.+ +++++|.+..+++++...
T Consensus 94 ~~~-~~~~iG~~~i~l~~l~~~ 114 (123)
T cd04035 94 DRF-GNDFLGETRIPLKKLKPN 114 (123)
T ss_pred CCc-CCeeEEEEEEEcccCCCC
Confidence 999 889999999887665544
|
Rabphilin is found neurons and in neuroendrocrine cells, while Doc2 is found not only in the brain but in tissues, including mast cells, chromaffin cells, and osteoblasts. Rabphilin and Doc2s share highly homologous tandem C2 domains, although their N-terminal structures are completely different: rabphilin contains an N-terminal Rab-binding domain (RBD),7 whereas Doc2 contains an N-terminal Munc13-1-interacting domain (MID). C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involving their N- and C-terminal beta strands. Many C2 domains are Ca2+-dependent membrane-targeting modules that bind a wide variety of substances including bind phospholipids, inositol polyphosphates, and intracellular proteins. Most C2 domain proteins are either signal transduction enzymes that contain a single C2 domain |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.40 E-value=3.5e-12 Score=129.91 Aligned_cols=135 Identities=17% Similarity=0.196 Sum_probs=96.8
Q ss_pred Eec-cCCCCceeEEEeCCCCcEEEEEEEecCc--------------hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEe
Q 007035 421 YLG-SAAFSKVFQAQDLHTGVDVCLKIIKNDK--------------DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYF 485 (621)
Q Consensus 421 ~LG-~G~fG~Vyka~d~~tg~~VAlKii~~~~--------------~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f 485 (621)
.|| .|+.|+||++.. .+..++||.+.... ....+..+|+.++..+.+.. ..+++.+++.
T Consensus 38 ~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~g----i~vP~pl~~~ 111 (239)
T PRK01723 38 VVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAG----LPVPRPIAAR 111 (239)
T ss_pred eeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCC----CCCceeEeee
Confidence 577 889999999974 47889999885421 12245677999999887643 2245666554
Q ss_pred Eec-C---eEEEEEecccc--chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCC
Q 007035 486 YHL-E---HLFIVCELLRA--NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQR 559 (621)
Q Consensus 486 ~~~-~---~l~LVmEyl~g--sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~ 559 (621)
... . ..++|||++++ +|.+++... .++.. .+.+|+.+|.+||+.||+||||||.|||++. +
T Consensus 112 ~~~~~~~~~~~lV~e~l~G~~~L~~~l~~~-------~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~--~ 178 (239)
T PRK01723 112 VVRHGLFYRADILIERIEGARDLVALLQEA-------PLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLDP--D 178 (239)
T ss_pred eeecCcceeeeEEEEecCCCCCHHHHHhcC-------CCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEcC--C
Confidence 332 2 24699999986 555554321 13333 3578999999999999999999999999985 5
Q ss_pred CeEEEEecCCccccC
Q 007035 560 CEIKIIDLGSSCFQT 574 (621)
Q Consensus 560 ~~IKL~DFGls~~~~ 574 (621)
+.++|+|||.+....
T Consensus 179 ~~v~LIDfg~~~~~~ 193 (239)
T PRK01723 179 GKFWLIDFDRGELRT 193 (239)
T ss_pred CCEEEEECCCcccCC
Confidence 689999999876543
|
|
| >cd04026 C2_PKC_alpha_gamma C2 domain in Protein Kinase C (PKC) alpha and gamma | Back alignment and domain information |
|---|
Probab=99.40 E-value=2.8e-13 Score=124.87 Aligned_cols=115 Identities=21% Similarity=0.253 Sum_probs=94.2
Q ss_pred CcceEEEEecC-CCccccCcCCCCcceEeecCCCCCCcccceeeccccCCCceeccceeeecccccccccccccccccCC
Q 007035 265 NDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDN 343 (621)
Q Consensus 265 ~~~l~v~l~e~-~L~~~d~~g~sDpyVK~~Llp~~~~~~k~kt~v~k~tlnP~fnE~f~f~~~~~~~~~~k~L~~~V~D~ 343 (621)
...++|.|.+| ||++.|..|.+||||++.+.+...+..+.||+++++++||.|||+|.|. +.....++.|.++|||.
T Consensus 12 ~~~l~v~i~~a~nL~~~~~~~~~dpyv~v~~~~~~~~~~~~rT~v~~~~~~P~wne~f~~~--~~~~~~~~~l~v~v~d~ 89 (131)
T cd04026 12 DNKLTVEVREAKNLIPMDPNGLSDPYVKLKLIPDPKNETKQKTKTIKKTLNPVWNETFTFD--LKPADKDRRLSIEVWDW 89 (131)
T ss_pred CCEEEEEEEEeeCCCCcCCCCCCCCcEEEEEEcCCCCCceecceeecCCCCCCccceEEEe--CCchhcCCEEEEEEEEC
Confidence 35678999999 9999999999999999999987766678889889999999999999998 44433456799999999
Q ss_pred CCCCCCCcccccccccccccccCCCCccchhccchhhhhhhh
Q 007035 344 SDTRDGEVNGALHEGKADAEEHGVATPDLLMFDNLEEECEIF 385 (621)
Q Consensus 344 d~~~r~d~iG~v~~~~a~~~~~~~~~~~ll~~~~l~eE~e~~ 385 (621)
+.+++++++|.+..++.++....... |+....++...+
T Consensus 90 ~~~~~~~~iG~~~~~l~~l~~~~~~~----w~~L~~~~~~~~ 127 (131)
T cd04026 90 DRTTRNDFMGSLSFGVSELIKMPVDG----WYKLLNQEEGEY 127 (131)
T ss_pred CCCCCcceeEEEEEeHHHhCcCccCc----eEECcCcccccc
Confidence 99999999999999988777553333 776666554443
|
A single C2 domain is found in PKC alpha and gamma. The PKC family of serine/threonine kinases regulates apoptosis, proliferation, migration, motility, chemo-resistance, and differentiation. There are 3 groups: group 1(alpha, betaI, beta II, gamma) which require phospholipids and calcium, group 2 (delta, epsilon, theta, eta) which do not require calcium for activation, and group 3 (xi, iota/lambda) which are atypical and can be activated in the absence of diacylglycerol and calcium. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involving their N- and C-terminal beta strands. Many C2 domains are Ca2+-dependent membrane-targeting modules that bind a wide variety of substances including bind phospholipids, inositol polyphosphates, and intracellular proteins. Most C2 domain proteins are either signal transd |
| >cd04025 C2B_RasA1_RasA4 C2 domain second repeat present in RasA1 and RasA4 | Back alignment and domain information |
|---|
Probab=99.38 E-value=4.2e-13 Score=122.35 Aligned_cols=91 Identities=16% Similarity=0.039 Sum_probs=77.2
Q ss_pred ceEEEEecC-CCccccCcCCCCcceEeecCCCCCCcccceeeccccCCCceeccceeeecccccccccccccccccCCCC
Q 007035 267 YGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDNSD 345 (621)
Q Consensus 267 ~l~v~l~e~-~L~~~d~~g~sDpyVK~~Llp~~~~~~k~kt~v~k~tlnP~fnE~f~f~~~~~~~~~~k~L~~~V~D~d~ 345 (621)
+|+|.|.+| ||.++|..|.+||||++++. ..+.+|+++++|+||.|||+|.|. +.... ...|.++|||++.
T Consensus 1 ~L~v~vi~a~~L~~~d~~~~~DPyv~v~~~-----~~~~kT~v~~~t~nP~Wne~f~f~--~~~~~-~~~l~~~v~d~~~ 72 (123)
T cd04025 1 RLRCHVLEARDLAPKDRNGTSDPFVRVFYN-----GQTLETSVVKKSCYPRWNEVFEFE--LMEGA-DSPLSVEVWDWDL 72 (123)
T ss_pred CEEEEEEEeeCCCCCCCCCCcCceEEEEEC-----CEEEeceeecCCCCCccCcEEEEE--cCCCC-CCEEEEEEEECCC
Confidence 478999999 99999999999999999983 235678888999999999999998 44322 4569999999999
Q ss_pred CCCCCccccccccccccccc
Q 007035 346 TRDGEVNGALHEGKADAEEH 365 (621)
Q Consensus 346 ~~r~d~iG~v~~~~a~~~~~ 365 (621)
+++++++|.+..+++++...
T Consensus 73 ~~~~~~iG~~~~~l~~l~~~ 92 (123)
T cd04025 73 VSKNDFLGKVVFSIQTLQQA 92 (123)
T ss_pred CCCCcEeEEEEEEHHHcccC
Confidence 99999999999988776553
|
RasA1 and RasA4 are GAP1s (GTPase activating protein 1s ), Ras-specific GAP members, which suppresses Ras function by enhancing the GTPase activity of Ras proteins resulting in the inactive GDP-bound form of Ras. In this way it can control cellular proliferation and differentiation. Both proteins contain two C2 domains, a Ras-GAP domain, a plextrin homology (PH)-like domain, and a Bruton's Tyrosine Kinase (BTK) zinc binding domain. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involving their N- and C-terminal beta strands. Many C2 domains are Ca2+-dependent membrane-targeting modules that bind a wide variety of substances including bind phospholipids, inositol polyphosphates, and intracellular proteins. Most C2 domain proteins are either signal transduction enzymes that contain a single C2 domain, such a |
| >cd08686 C2_ABR C2 domain in the Active BCR (Breakpoint cluster region) Related protein | Back alignment and domain information |
|---|
Probab=99.38 E-value=3.8e-13 Score=121.65 Aligned_cols=80 Identities=10% Similarity=0.058 Sum_probs=67.4
Q ss_pred eEEEEecC-CCccccCcCCCCcceEeecCCCCCCcccceeeccccCCCceeccceeeecccccccccccccccccCC---
Q 007035 268 GYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDN--- 343 (621)
Q Consensus 268 l~v~l~e~-~L~~~d~~g~sDpyVK~~Llp~~~~~~k~kt~v~k~tlnP~fnE~f~f~~~~~~~~~~k~L~~~V~D~--- 343 (621)
|.|.|.+| ||+ |.+||||++.+.+.++...+.||+++++|+||+|||+|.|. ++ ..++|.+.|||+
T Consensus 1 L~V~V~~A~~L~-----~~sDPYV~l~v~~~~~~~~~~KTk~i~~TlnPvWnE~F~i~--l~---~s~~L~~~v~d~~~~ 70 (118)
T cd08686 1 LNVIVHSAQGFK-----QSANLYCTLEVDSFGYFVKKAKTRVCRDTTEPNWNEEFEIE--LE---GSQTLRILCYEKCYS 70 (118)
T ss_pred CEEEEEeCCCCC-----CCCCCEEEEEEcCccccceeeeeeeecCCCCCccceEEEEE--eC---CCCEEEEEEEEcccc
Confidence 56899999 996 67999999999998776678999999999999999999998 43 245799999998
Q ss_pred ----CCCCCCCccccccc
Q 007035 344 ----SDTRDGEVNGALHE 357 (621)
Q Consensus 344 ----d~~~r~d~iG~v~~ 357 (621)
|.++.++++|....
T Consensus 71 ~~~~d~~~~d~~~G~g~i 88 (118)
T cd08686 71 KVKLDGEGTDAIMGKGQI 88 (118)
T ss_pred cccccccCcccEEEEEEE
Confidence 56777888876644
|
The ABR protein is similar to the breakpoint cluster region protein. It has homology to guanine nucleotide exchange proteins and GTPase-activating proteins (GAPs). ABR is expressed primarily in the brain, but also includes non-neuronal tissues such as the heart. It has been associated with human diseases such as Miller-Dieker syndrome in which mental retardation and malformations of the heart are present. ABR contains a RhoGEF domain and a PH-like domain upstream of its C2 domain and a RhoGAP domain downstream of this domain. A few members also contain a Bcr-Abl oncoprotein oligomerization domain at the very N-terminal end. Splice variants of ABR have been identified. ABR is found in a wide variety of organisms including chimpanzee, dog, mouse, rat, fruit fly, and mosquito. The C2 domain was first identified in PKC. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arr |
| >cd04042 C2A_MCTP_PRT C2 domain first repeat found in Multiple C2 domain and Transmembrane region Proteins (MCTP) | Back alignment and domain information |
|---|
Probab=99.38 E-value=5.2e-13 Score=121.43 Aligned_cols=89 Identities=12% Similarity=0.059 Sum_probs=75.6
Q ss_pred eEEEEecC-CCccccCcCCCCcceEeecCCCCCCcccceeeccccCCCceeccceeeecccccccccccccccccCCCCC
Q 007035 268 GYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDNSDT 346 (621)
Q Consensus 268 l~v~l~e~-~L~~~d~~g~sDpyVK~~Llp~~~~~~k~kt~v~k~tlnP~fnE~f~f~~~~~~~~~~k~L~~~V~D~d~~ 346 (621)
|+|.|.+| ||+++|..|.+||||++.+.. +...||+++++|+||+|||+|.|. +.. .+..|.++|||+|.+
T Consensus 2 L~v~v~~a~~L~~~d~~g~~Dpyv~v~~~~----~~~~kT~~~~~t~nP~Wne~f~f~--v~~--~~~~l~~~v~D~d~~ 73 (121)
T cd04042 2 LDIHLKEGRNLAARDRGGTSDPYVKFKYGG----KTVYKSKTIYKNLNPVWDEKFTLP--IED--VTQPLYIKVFDYDRG 73 (121)
T ss_pred eEEEEEEeeCCCCcCCCCCCCCeEEEEECC----EEEEEeeeccCCCCCccceeEEEE--ecC--CCCeEEEEEEeCCCC
Confidence 67899999 999999999999999999842 346788888999999999999998 432 245699999999999
Q ss_pred CCCCcccccccccccccc
Q 007035 347 RDGEVNGALHEGKADAEE 364 (621)
Q Consensus 347 ~r~d~iG~v~~~~a~~~~ 364 (621)
++++++|.++.++.++..
T Consensus 74 ~~~~~iG~~~~~l~~l~~ 91 (121)
T cd04042 74 LTDDFMGSAFVDLSTLEL 91 (121)
T ss_pred CCCcceEEEEEEHHHcCC
Confidence 999999999998766554
|
MCTPs are involved in Ca2+ signaling at the membrane. MCTP is composed of a variable N-terminal sequence, three C2 domains, two transmembrane regions (TMRs), and a short C-terminal sequence. It is one of four protein classes that are anchored to membranes via a transmembrane region; the others being synaptotagmins, extended synaptotagmins, and ferlins. MCTPs are the only membrane-bound C2 domain proteins that contain two functional TMRs. MCTPs are unique in that they bind Ca2+ but not phospholipids. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involving their N- and C-terminal beta strands. Many C2 domains are Ca2+-dependent membrane-targeting modules that bind a wide variety of substances including bind phospholipids, inositol polyphosphates, and intracellular protein |
| >cd08379 C2D_MCTP_PRT_plant C2 domain fourth repeat found in Multiple C2 domain and Transmembrane region Proteins (MCTP); plant subset | Back alignment and domain information |
|---|
Probab=99.37 E-value=4.5e-13 Score=123.28 Aligned_cols=89 Identities=15% Similarity=0.050 Sum_probs=73.7
Q ss_pred eEEEEecC-C---CccccCcCCCCcceEeecCCCCCCcccceeeccccCCCceeccceeeecccccccccccccccccCC
Q 007035 268 GYLSSKEA-D---LIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDN 343 (621)
Q Consensus 268 l~v~l~e~-~---L~~~d~~g~sDpyVK~~Llp~~~~~~k~kt~v~k~tlnP~fnE~f~f~~~~~~~~~~k~L~~~V~D~ 343 (621)
|+|.|.+| | |.++|..|.+||||++++- ..+.||+++++++||+|||+|.|. +.. ....|.++|||.
T Consensus 2 L~v~v~~A~~~~~l~~~d~~g~sDPYv~i~~g-----~~~~rTk~~~~~~nP~WnE~f~f~--v~~--~~~~l~v~V~d~ 72 (126)
T cd08379 2 LEVGILGAQGLDVLRAKDGRGSTDAYCVAKYG-----PKWVRTRTVEDSSNPRWNEQYTWP--VYD--PCTVLTVGVFDN 72 (126)
T ss_pred eEEEEEEeECCccccccccCCCCCeeEEEEEC-----CEEeEcCcccCCCCCcceeEEEEE--ecC--CCCEEEEEEEEC
Confidence 67999999 9 8999999999999999984 236688888999999999999998 332 223699999999
Q ss_pred CCCC------CCCccccccccccccccc
Q 007035 344 SDTR------DGEVNGALHEGKADAEEH 365 (621)
Q Consensus 344 d~~~------r~d~iG~v~~~~a~~~~~ 365 (621)
+.++ +++++|++..++..+...
T Consensus 73 d~~~~~~~~~~dd~lG~~~i~l~~l~~~ 100 (126)
T cd08379 73 SQSHWKEAVQPDVLIGKVRIRLSTLEDD 100 (126)
T ss_pred CCccccccCCCCceEEEEEEEHHHccCC
Confidence 9984 789999998876665443
|
MCTPs are involved in Ca2+ signaling at the membrane. Plant-MCTPs are composed of a variable N-terminal sequence, four C2 domains, two transmembrane regions (TMRs), and a short C-terminal sequence. It is one of four protein classes that are anchored to membranes via a transmembrane region; the others being synaptotagmins, extended synaptotagmins, and ferlins. MCTPs are the only membrane-bound C2 domain proteins that contain two functional TMRs. MCTPs are unique in that they bind Ca2+ but not phospholipids. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involving their N- and C-terminal beta strands. Many C2 domains are Ca2+-dependent membrane-targeting modules that bind a wide variety of substances including bind phospholipids, inositol polyphosphate |
| >cd04018 C2C_Ferlin C2 domain third repeat in Ferlin | Back alignment and domain information |
|---|
Probab=99.37 E-value=4.6e-13 Score=127.02 Aligned_cols=93 Identities=15% Similarity=0.114 Sum_probs=76.4
Q ss_pred eEEEEecC-CCccccCcC--------------CCCcceEeecCCCCCCcccceeeccccCCCceeccceeeecccccccc
Q 007035 268 GYLSSKEA-DLIDLQHNV--------------VGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA 332 (621)
Q Consensus 268 l~v~l~e~-~L~~~d~~g--------------~sDpyVK~~Llp~~~~~~k~kt~v~k~tlnP~fnE~f~f~~~~~~~~~ 332 (621)
++|.|.+| +|++||..+ .+|||||+.+.. .+.||+++++++||+|||+|.|. +.....
T Consensus 2 ~~V~V~~A~dLp~~d~~~~~~~~~~~~~~~~~~~DPYV~V~~~g-----~~~kT~v~~~t~nPvWNE~f~f~--v~~p~~ 74 (151)
T cd04018 2 FIFKIYRAEDLPQMDSGIMANVKKAFLGEKKELVDPYVEVSFAG-----QKVKTSVKKNSYNPEWNEQIVFP--EMFPPL 74 (151)
T ss_pred eEEEEEEeCCCCccChhhhccceeccccCCCCCcCcEEEEEECC-----EeeecceEcCCCCCCcceEEEEE--eeCCCc
Confidence 67899999 999999664 689999999864 24578889999999999999998 332233
Q ss_pred cccccccccCCCCCCCCCcccccccccccccccCC
Q 007035 333 EKDLMPAEIDNSDTRDGEVNGALHEGKADAEEHGV 367 (621)
Q Consensus 333 ~k~L~~~V~D~d~~~r~d~iG~v~~~~a~~~~~~~ 367 (621)
+..|.++|||+|.+++++++|.+..++..+...+.
T Consensus 75 ~~~l~~~v~D~d~~~~dd~iG~~~l~l~~l~~~~~ 109 (151)
T cd04018 75 CERIKIQIRDWDRVGNDDVIGTHFIDLSKISNSGD 109 (151)
T ss_pred CCEEEEEEEECCCCCCCCEEEEEEEeHHHhccCCc
Confidence 45699999999999999999999888776655543
|
Ferlins are involved in vesicle fusion events. Ferlins and other proteins, such as Synaptotagmins, are implicated in facilitating the fusion process when cell membranes fuse together. There are six known human Ferlins: Dysferlin (Fer1L1), Otoferlin (Fer1L2), Myoferlin (Fer1L3), Fer1L4, Fer1L5, and Fer1L6. Defects in these genes can lead to a wide range of diseases including muscular dystrophy (dysferlin), deafness (otoferlin), and infertility (fer-1, fertilization factor-1). Structurally they have 6 tandem C2 domains, designated as (C2A-C2F) and a single C-terminal transmembrane domain, though there is a new study that disputes this and claims that there are actually 7 tandem C2 domains with another C2 domain inserted between C2D and C2E. In a subset of them (Dysferlin, Myoferlin, and Fer1) there is an additional conserved domain called DysF. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangemen |
| >cd04019 C2C_MCTP_PRT_plant C2 domain third repeat found in Multiple C2 domain and Transmembrane region Proteins (MCTP); plant subset | Back alignment and domain information |
|---|
Probab=99.35 E-value=9e-13 Score=124.96 Aligned_cols=91 Identities=20% Similarity=0.146 Sum_probs=76.0
Q ss_pred ceEEEEecC-CCccccCcCCCCcceEeecCCCCCCcccceeecccc-CCCceeccceeeecccccccccccccccccCCC
Q 007035 267 YGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKR-GSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDNS 344 (621)
Q Consensus 267 ~l~v~l~e~-~L~~~d~~g~sDpyVK~~Llp~~~~~~k~kt~v~k~-tlnP~fnE~f~f~~~~~~~~~~k~L~~~V~D~d 344 (621)
||.|.|.+| ||+++|.+|.+||||++.+.. .+.||+++++ |+||+|||+|.|. +... ....|.+.|||++
T Consensus 1 ~L~V~Vi~A~~L~~~d~~g~sDPYV~v~l~~-----~~~kTk~~~~~t~nP~WNE~F~f~--v~~~-~~~~l~v~V~d~~ 72 (150)
T cd04019 1 YLRVTVIEAQDLVPSDKNRVPEVFVKAQLGN-----QVLRTRPSQTRNGNPSWNEELMFV--AAEP-FEDHLILSVEDRV 72 (150)
T ss_pred CEEEEEEEeECCCCCCCCCCCCeEEEEEECC-----EEeeeEeccCCCCCCcccCcEEEE--ecCc-cCCeEEEEEEEec
Confidence 578999999 999999999999999999974 3567777654 7999999999997 4332 2346899999999
Q ss_pred CCCCCCccccccccccccccc
Q 007035 345 DTRDGEVNGALHEGKADAEEH 365 (621)
Q Consensus 345 ~~~r~d~iG~v~~~~a~~~~~ 365 (621)
..++++++|.+..++..+...
T Consensus 73 ~~~~dd~lG~v~i~L~~l~~~ 93 (150)
T cd04019 73 GPNKDEPLGRAVIPLNDIERR 93 (150)
T ss_pred CCCCCCeEEEEEEEHHHCccc
Confidence 999999999999998877553
|
MCTPs are involved in Ca2+ signaling at the membrane. Plant-MCTPs are composed of a variable N-terminal sequence, four C2 domains, two transmembrane regions (TMRs), and a short C-terminal sequence. It is one of four protein classes that are anchored to membranes via a transmembrane region; the others being synaptotagmins, extended synaptotagmins, and ferlins. MCTPs are the only membrane-bound C2 domain proteins that contain two functional TMRs. MCTPs are unique in that they bind Ca2+ but not phospholipids. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involving their N- and C-terminal beta strands. Many C2 domains are Ca2+-dependent membrane-targeting modules that bind a wide variety of substances including bind phospholipids, inositol polyphosphates |
| >cd00276 C2B_Synaptotagmin C2 domain second repeat present in Synaptotagmin | Back alignment and domain information |
|---|
Probab=99.35 E-value=4.8e-13 Score=123.16 Aligned_cols=95 Identities=17% Similarity=0.087 Sum_probs=84.1
Q ss_pred CcceEEEEecC-CCccccCcCCCCcceEeecCCCCCCcccceeeccccCCCceeccceeeecccccccc-cccccccccC
Q 007035 265 NDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEID 342 (621)
Q Consensus 265 ~~~l~v~l~e~-~L~~~d~~g~sDpyVK~~Llp~~~~~~k~kt~v~k~tlnP~fnE~f~f~~~~~~~~~-~k~L~~~V~D 342 (621)
...|+|.|.+| ||++++..+..||||++++.++.....+++|++++++.||.|||+|.|. +..... +..|.++|||
T Consensus 13 ~~~L~V~v~~a~~L~~~~~~~~~dpyv~v~l~~~~~~~~~~~T~~~~~~~~P~wne~f~f~--i~~~~l~~~~l~~~v~d 90 (134)
T cd00276 13 AERLTVVVLKARNLPPSDGKGLSDPYVKVSLLQGGKKLKKKKTSVKKGTLNPVFNEAFSFD--VPAEQLEEVSLVITVVD 90 (134)
T ss_pred CCEEEEEEEEeeCCCCccCCCCCCcEEEEEEEcCCeEeeeecCcceecCCCCeeeeeEEEE--CCHHHhCCcEEEEEEEe
Confidence 46789999999 9999999999999999999998776677888888999999999999998 555443 5679999999
Q ss_pred CCCCCCCCccccccccccc
Q 007035 343 NSDTRDGEVNGALHEGKAD 361 (621)
Q Consensus 343 ~d~~~r~d~iG~v~~~~a~ 361 (621)
.+.+++++++|.+..++.+
T Consensus 91 ~~~~~~~~~lG~~~i~l~~ 109 (134)
T cd00276 91 KDSVGRNEVIGQVVLGPDS 109 (134)
T ss_pred cCCCCCCceeEEEEECCCC
Confidence 9999999999999998877
|
Synaptotagmin is a membrane-trafficking protein characterized by a N-terminal transmembrane region, a linker, and 2 C-terminal C2 domains. There are several classes of Synaptotagmins. Previously all synaptotagmins were thought to be calcium sensors in the regulation of neurotransmitter release and hormone secretion, but it has been shown that not all of them bind calcium. Of the 17 identified synaptotagmins only 8 bind calcium (1-3, 5-7, 9, 10). The function of the two C2 domains that bind calcium are: regulating the fusion step of synaptic vesicle exocytosis (C2A) and binding to phosphatidyl-inositol-3,4,5-triphosphate (PIP3) in the absence of calcium ions and to phosphatidylinositol bisphosphate (PIP2) in their presence (C2B). C2B also regulates also the recycling step of synaptic vesicles. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distin |
| >cd04033 C2_NEDD4_NEDD4L C2 domain present in the Human neural precursor cell-expressed, developmentally down-regulated 4 (NEDD4) and NEDD4-like (NEDD4L/NEDD42) | Back alignment and domain information |
|---|
Probab=99.35 E-value=1.1e-12 Score=121.05 Aligned_cols=95 Identities=15% Similarity=0.096 Sum_probs=79.4
Q ss_pred eEEEEecC-CCccccCcCCCCcceEeecCCCC--CCcccceeeccccCCCceeccceeeecccccccccccccccccCCC
Q 007035 268 GYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHP--GTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDNS 344 (621)
Q Consensus 268 l~v~l~e~-~L~~~d~~g~sDpyVK~~Llp~~--~~~~k~kt~v~k~tlnP~fnE~f~f~~~~~~~~~~k~L~~~V~D~d 344 (621)
|+|.|.+| ||+++|..|.+||||++.+...+ +...+.||+++++|+||.|||+|.|. ++.. +..|.++|||++
T Consensus 2 L~v~Vi~a~~L~~~d~~~~~Dpyv~v~~~~~~~~~~~~~~kT~v~~~t~nP~Wne~f~f~--~~~~--~~~l~~~v~d~~ 77 (133)
T cd04033 2 LRVKVLAGIDLAKKDIFGASDPYVKISLYDPDGNGEIDSVQTKTIKKTLNPKWNEEFFFR--VNPR--EHRLLFEVFDEN 77 (133)
T ss_pred EEEEEEEeECCCcccCCCCcCcEEEEEEECCCCCCcccceeeeEEcCCCCCcEeeEEEEE--EcCC--CCEEEEEEEECC
Confidence 67899999 99999999999999999998752 23346688888999999999999998 4332 346899999999
Q ss_pred CCCCCCcccccccccccccccC
Q 007035 345 DTRDGEVNGALHEGKADAEEHG 366 (621)
Q Consensus 345 ~~~r~d~iG~v~~~~a~~~~~~ 366 (621)
.+++++++|.+..++.+.....
T Consensus 78 ~~~~~~~iG~~~i~l~~l~~~~ 99 (133)
T cd04033 78 RLTRDDFLGQVEVPLNNLPTET 99 (133)
T ss_pred CCCCCCeeEEEEEEHHHCCCcC
Confidence 9999999999999877766543
|
Nedd4 and Nedd4-2 are two of the nine members of the Human Nedd4 family. All vertebrates appear to have both Nedd4 and Nedd4-2 genes. They are thought to participate in the regulation of epithelial Na+ channel (ENaC) activity. They also have identical specificity for ubiquitin conjugating enzymes (E2). Nedd4 and Nedd4-2 are composed of a C2 domain, 2-4 WW domains, and a ubiquitin ligase Hect domain. Their WW domains can bind PPxY (PY) or LPSY motifs, and in vitro studies suggest that WW3 and WW4 of both proteins bind PY motifs in the key substrates, with WW3 generally exhibiting higher affinity. Most Nedd4 family members, especially Nedd4-2, also have multiple splice variants, which might play different roles in regulating their substrates. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangemen |
| >cd04016 C2_Tollip C2 domain present in Toll-interacting protein (Tollip) | Back alignment and domain information |
|---|
Probab=99.35 E-value=1.2e-12 Score=119.64 Aligned_cols=86 Identities=8% Similarity=-0.038 Sum_probs=70.7
Q ss_pred cceEEEEecC-CCccccCcCCCCcceEeecCCCCCCcccceeeccc-cCCCceeccceeeecccccccccccccccccCC
Q 007035 266 DYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSK-RGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDN 343 (621)
Q Consensus 266 ~~l~v~l~e~-~L~~~d~~g~sDpyVK~~Llp~~~~~~k~kt~v~k-~tlnP~fnE~f~f~~~~~~~~~~k~L~~~V~D~ 343 (621)
+.|.|.|.+| +|+..+ -|.+||||++.+- ..+.||++.+ +++||+|||+|.|. +... ...|.++|||.
T Consensus 2 g~L~v~v~~Ak~l~~~~-~g~sDPYv~i~lg-----~~~~kT~v~~~~~~nP~WNe~F~f~--v~~~--~~~l~~~V~d~ 71 (121)
T cd04016 2 GRLSITVVQAKLVKNYG-LTRMDPYCRIRVG-----HAVYETPTAYNGAKNPRWNKTIQCT--LPEG--VDSIYIEIFDE 71 (121)
T ss_pred cEEEEEEEEccCCCcCC-CCCCCceEEEEEC-----CEEEEeEEccCCCCCCccCeEEEEE--ecCC--CcEEEEEEEeC
Confidence 4678999999 888777 6899999999993 2456888865 58999999999998 4432 24599999999
Q ss_pred CCCCCCCccccccccccc
Q 007035 344 SDTRDGEVNGALHEGKAD 361 (621)
Q Consensus 344 d~~~r~d~iG~v~~~~a~ 361 (621)
|.+++++++|.+..++..
T Consensus 72 d~~~~dd~iG~~~i~l~~ 89 (121)
T cd04016 72 RAFTMDERIAWTHITIPE 89 (121)
T ss_pred CCCcCCceEEEEEEECch
Confidence 999999999999887753
|
Tollip is a part of the Interleukin-1 receptor (IL-1R) signaling pathway. Tollip is proposed to link serine/threonine kinase IRAK to IL-1Rs as well as inhibiting phosphorylation of IRAK. There is a single C2 domain present in Tollip. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involving their N- and C-terminal beta strands. Many C2 domains are Ca2+-dependent membrane-targeting modules that bind a wide variety of substances including bind phospholipids, inositol polyphosphates, and intracellular proteins. Most C2 domain proteins are either signal transduction enzymes that contain a single C2 domain, such as protein kinase C, or membrane trafficking proteins which contain at least two C2 domains, such as synaptotagmin 1. However, there are a few exceptions to this including RIM isoforms and some splice varian |
| >cd08375 C2_Intersectin C2 domain present in Intersectin | Back alignment and domain information |
|---|
Probab=99.34 E-value=1.2e-12 Score=122.16 Aligned_cols=92 Identities=12% Similarity=0.007 Sum_probs=78.4
Q ss_pred CcceEEEEecC-CCccccCcCCCCcceEeecCCCCCCcccceeeccccCCCceeccceeeecccccccccccccccccCC
Q 007035 265 NDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDN 343 (621)
Q Consensus 265 ~~~l~v~l~e~-~L~~~d~~g~sDpyVK~~Llp~~~~~~k~kt~v~k~tlnP~fnE~f~f~~~~~~~~~~k~L~~~V~D~ 343 (621)
.+.|+|.|.+| ||+++|..|.+||||++++. ..+.||+++++|+||.|||+|.|. +.. .....|.++|||+
T Consensus 14 ~G~L~V~Vi~A~~L~~~d~~g~~DPYv~v~~~-----~~~~kT~vi~~t~nP~Wne~f~f~--v~~-~~~~~l~i~V~D~ 85 (136)
T cd08375 14 IGRLMVVIVEGRDLKPCNSNGKSDPYCEVSMG-----SQEHKTKVVSDTLNPKWNSSMQFF--VKD-LEQDVLCITVFDR 85 (136)
T ss_pred cEEEEEEEEEeeCCCCCCCCCCcCcEEEEEEC-----CEeeeccccCCCCCCccCceEEEE--ecC-ccCCEEEEEEEEC
Confidence 56778999999 99999999999999999984 346788889999999999999998 432 2245699999999
Q ss_pred CCCCCCCcccccccccccccc
Q 007035 344 SDTRDGEVNGALHEGKADAEE 364 (621)
Q Consensus 344 d~~~r~d~iG~v~~~~a~~~~ 364 (621)
|.+++++++|.+..++.++..
T Consensus 86 d~~~~d~~lG~~~i~l~~l~~ 106 (136)
T cd08375 86 DFFSPDDFLGRTEIRVADILK 106 (136)
T ss_pred CCCCCCCeeEEEEEEHHHhcc
Confidence 999999999999888766655
|
A single instance of the C2 domain is located C terminally in the intersectin protein. Intersectin functions as a scaffolding protein, providing a link between the actin cytoskeleton and the components of endocytosis and plays a role in signal transduction. In addition to C2, intersectin contains several additional domains including: Eps15 homology domains, SH3 domains, a RhoGEF domain, and a PH domain. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involving their N- and C-terminal beta strands. Many C2 domains are Ca2+-dependent membrane-targeting modules that bind a wide variety of substances including bind phospholipids, inositol polyphosphates, and intracellular proteins. Most C2 domain proteins are either signal transduction enzymes that contain a single C2 domain, such as protein kinase C, or membrane trafficking pro |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.34 E-value=3.4e-13 Score=146.63 Aligned_cols=119 Identities=35% Similarity=0.510 Sum_probs=97.5
Q ss_pred CeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEec
Q 007035 489 EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 567 (621)
Q Consensus 489 ~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DF 567 (621)
.+++|.|++|.. +|.+.+.... .... .++...+.++.|+..|+.| ++.+|+|+||.||+... +.++||.||
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~-~~e~--~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~--d~q~kIgDF 400 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRR-TGEE--RSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSD--DDQLKIGDF 400 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCC-cccc--cchhHHHHHHHhhccchhh---ccchhhhcccccccccc--chhhhhhhh
Confidence 468999999985 5555554332 2222 5677788999999999999 99999999999999984 668999999
Q ss_pred CCccccCCC---------ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh
Q 007035 568 GSSCFQTDN---------LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT 615 (621)
Q Consensus 568 Gls~~~~~~---------~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt 615 (621)
|+....... .+..+||..||+||.+.+..|+.++||||||+||+||+.
T Consensus 401 gl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 401 GLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred hheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 987544332 234688999999999999999999999999999999986
|
|
| >KOG1030 consensus Predicted Ca2+-dependent phospholipid-binding protein [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.33 E-value=1.2e-12 Score=123.76 Aligned_cols=85 Identities=12% Similarity=0.060 Sum_probs=74.0
Q ss_pred cceEEEEecC-CCccccCcCCCCcceEeecCCCCCCcccceeeccccCCCceeccceeeecccccccccccccccccCCC
Q 007035 266 DYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDNS 344 (621)
Q Consensus 266 ~~l~v~l~e~-~L~~~d~~g~sDpyVK~~Llp~~~~~~k~kt~v~k~tlnP~fnE~f~f~~~~~~~~~~k~L~~~V~D~d 344 (621)
+-|+|.|+.+ ||...|+.+.|||||-+.+. ..|.||+++++++||+|||.|+|. + ......|.++|||+|
T Consensus 6 GLL~v~v~~g~~L~~rD~~~sSDPyVVl~lg-----~q~lkT~~v~~n~NPeWNe~ltf~--v--~d~~~~lkv~VyD~D 76 (168)
T KOG1030|consen 6 GLLRVRVKRGKNLAIRDFLGSSDPYVVLELG-----NQKLKTRVVYKNLNPEWNEELTFT--V--KDPNTPLKVTVYDKD 76 (168)
T ss_pred eEEEEEEEeecCeeeeccccCCCCeEEEEEC-----CeeeeeeeecCCCCCcccceEEEE--e--cCCCceEEEEEEeCC
Confidence 4468999999 99999999999999999997 568889899999999999999997 3 233456899999999
Q ss_pred CCCCCCccccccccc
Q 007035 345 DTRDGEVNGALHEGK 359 (621)
Q Consensus 345 ~~~r~d~iG~v~~~~ 359 (621)
.+++.|++|+...++
T Consensus 77 ~fs~dD~mG~A~I~l 91 (168)
T KOG1030|consen 77 TFSSDDFMGEATIPL 91 (168)
T ss_pred CCCcccccceeeecc
Confidence 999999999986644
|
|
| >cd04017 C2D_Ferlin C2 domain fourth repeat in Ferlin | Back alignment and domain information |
|---|
Probab=99.33 E-value=1.7e-12 Score=120.55 Aligned_cols=86 Identities=14% Similarity=0.011 Sum_probs=70.6
Q ss_pred ceEEEEecC-CCccccCcCCCCcceEeecCCCCCCcccceeeccccCCCceeccceeeecccc----cccc--ccccccc
Q 007035 267 YGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLH----FKGA--EKDLMPA 339 (621)
Q Consensus 267 ~l~v~l~e~-~L~~~d~~g~sDpyVK~~Llp~~~~~~k~kt~v~k~tlnP~fnE~f~f~~~~~----~~~~--~k~L~~~ 339 (621)
.+.|.|.+| ||+++|..|.+|||||+.+. ..++||+++++|+||+|||+|.|..... .... ...|.++
T Consensus 2 ~l~v~V~~a~~L~~~d~~g~~dpyv~v~~~-----~~~~kT~v~~~t~nP~Wne~~~f~~~~~~~~~~~~~~~~~~l~v~ 76 (135)
T cd04017 2 QLRAYIYQARDLLAADKSGLSDPFARVSFL-----NQSQETEVIKETLSPTWDQTLIFDEVELYGSPEEIAQNPPLVVVE 76 (135)
T ss_pred EEEEEEEEeecCcCCCCCCCCCCEEEEEEC-----CeeeEeeeEcCCCCCccCcEEEEeeeeccCChHHhhcCCCEEEEE
Confidence 357889999 99999999999999999986 2467888899999999999999973221 1111 2458999
Q ss_pred ccCCCCCCCCCccccccc
Q 007035 340 EIDNSDTRDGEVNGALHE 357 (621)
Q Consensus 340 V~D~d~~~r~d~iG~v~~ 357 (621)
|||+|.+++++++|++..
T Consensus 77 V~d~d~~~~d~~iG~~~i 94 (135)
T cd04017 77 LFDQDSVGKDEFLGRSVA 94 (135)
T ss_pred EEeCcCCCCCccceEEEe
Confidence 999999999999999974
|
Ferlins are involved in vesicle fusion events. Ferlins and other proteins, such as Synaptotagmins, are implicated in facilitating the fusion process when cell membranes fuse together. There are six known human Ferlins: Dysferlin (Fer1L1), Otoferlin (Fer1L2), Myoferlin (Fer1L3), Fer1L4, Fer1L5, and Fer1L6. Defects in these genes can lead to a wide range of diseases including muscular dystrophy (dysferlin), deafness (otoferlin), and infertility (fer-1, fertilization factor-1). Structurally they have 6 tandem C2 domains, designated as (C2A-C2F) and a single C-terminal transmembrane domain, though there is a new study that disputes this and claims that there are actually 7 tandem C2 domains with another C2 domain inserted between C2D and C2E. In a subset of them (Dysferlin, Myoferlin, and Fer1) there is an additional conserved domain called DysF. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangeme |
| >cd08691 C2_NEDL1-like C2 domain present in NEDL1 (NEDD4-like ubiquitin protein ligase-1) | Back alignment and domain information |
|---|
Probab=99.33 E-value=1.5e-12 Score=121.65 Aligned_cols=96 Identities=16% Similarity=-0.011 Sum_probs=78.3
Q ss_pred eEEEEecC-CCccccCcCCCCcceEeecCCCCCC--------cccceeeccccCCCcee-ccceeeeccccccccccccc
Q 007035 268 GYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGT--------EKSSSYSSSKRGSSIDW-IEGFKGSSDLHFKGAEKDLM 337 (621)
Q Consensus 268 l~v~l~e~-~L~~~d~~g~sDpyVK~~Llp~~~~--------~~k~kt~v~k~tlnP~f-nE~f~f~~~~~~~~~~k~L~ 337 (621)
.+|.+.+| ||+ +|.-|.+|||||+.+.|+++. ..++||+++++|+||+| ||+|.|. +. .+..|.
T Consensus 3 ~~~~~~~A~~L~-~~~fg~~DPyvki~~~~~~~~~~~~~~~~~~~~kT~v~~~tlnP~W~nE~f~f~--v~---~~~~L~ 76 (137)
T cd08691 3 FSLSGLQARNLK-KGMFFNPDPYVKISIQPGKRHIFPALPHHGQECRTSIVENTINPVWHREQFVFV--GL---PTDVLE 76 (137)
T ss_pred EEEEEEEeCCCC-CccCCCCCceEEEEEECCCcccccccccccceeeeeeEcCCCCCceEceEEEEE--cC---CCCEEE
Confidence 36778888 998 788899999999999988765 45889999999999999 9999998 32 223599
Q ss_pred ccccCCCCCCC---CCcccccccccccccccCCCC
Q 007035 338 PAEIDNSDTRD---GEVNGALHEGKADAEEHGVAT 369 (621)
Q Consensus 338 ~~V~D~d~~~r---~d~iG~v~~~~a~~~~~~~~~ 369 (621)
++|||++..++ ++++|.+..++.++.+.+...
T Consensus 77 v~V~D~~~~~~~~~~d~lG~~~i~l~~l~~~~~~~ 111 (137)
T cd08691 77 IEVKDKFAKSRPIIRRFLGKLSIPVQRLLERHAIG 111 (137)
T ss_pred EEEEecCCCCCccCCceEEEEEEEHHHhcccccCC
Confidence 99999876554 699999999887776655443
|
NEDL1 (AKA HECW1(HECT, C2 and WW domain containing E3 ubiquitin protein ligase 1)) is a newly identified HECT-type E3 ubiquitin protein ligase highly expressed in favorable neuroblastomas. In vertebrates it is found primarily in neuronal tissues, including the spinal cord. NEDL1 is thought to normally function in the quality control of cellular proteins by eliminating misfolded proteins. This is thought to be accomplished via a mechanism analogous to that of ER-associated degradation by forming tight complexes and aggregating misfolded proteins that have escaped ubiquitin-mediated degradation. NEDL1, is composed of a C2 domain, two WW domains, and a ubiquitin ligase Hect domain. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involving their N- and C-terminal beta strands. Many C2 domains are C |
| >cd04024 C2A_Synaptotagmin-like C2 domain first repeat present in Synaptotagmin-like proteins | Back alignment and domain information |
|---|
Probab=99.32 E-value=1.8e-12 Score=118.50 Aligned_cols=90 Identities=10% Similarity=-0.027 Sum_probs=76.8
Q ss_pred ceEEEEecC-CCccccC--cCCCCcceEeecCCCCCCcccceeeccccCCCceeccceeeecccccccccccccccccCC
Q 007035 267 YGYLSSKEA-DLIDLQH--NVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDN 343 (621)
Q Consensus 267 ~l~v~l~e~-~L~~~d~--~g~sDpyVK~~Llp~~~~~~k~kt~v~k~tlnP~fnE~f~f~~~~~~~~~~k~L~~~V~D~ 343 (621)
.|.|.|.+| ||+++|. .|.+||||++++. ..+.||+++++|+||.|||+|.|. +.. ...+.|.++|||+
T Consensus 2 ~l~v~v~~a~~L~~~~~~~~~~~dPyv~v~~~-----~~~~kT~~~~~t~~P~Wne~f~~~--~~~-~~~~~l~i~v~d~ 73 (128)
T cd04024 2 VLRVHVVEAKDLAAKDRSGKGKSDPYAILSVG-----AQRFKTQTIPNTLNPKWNYWCEFP--IFS-AQNQLLKLILWDK 73 (128)
T ss_pred EEEEEEEEeeCCCcccCCCCCCcCCeEEEEEC-----CEEEecceecCCcCCccCCcEEEE--ecC-CCCCEEEEEEEEC
Confidence 568899999 9999999 8999999999983 246788888999999999999997 443 2356799999999
Q ss_pred CCCCCCCcccccccccccccc
Q 007035 344 SDTRDGEVNGALHEGKADAEE 364 (621)
Q Consensus 344 d~~~r~d~iG~v~~~~a~~~~ 364 (621)
+.+++++++|.+..++.++..
T Consensus 74 ~~~~~~~~lG~~~i~l~~~~~ 94 (128)
T cd04024 74 DRFAGKDYLGEFDIALEEVFA 94 (128)
T ss_pred CCCCCCCcceEEEEEHHHhhc
Confidence 999999999999998877664
|
Synaptotagmin is a membrane-trafficking protein characterized by a N-terminal transmembrane region, a linker, and 2 C-terminal C2 domains. Previously all synaptotagmins were thought to be calcium sensors in the regulation of neurotransmitter release and hormone secretion, but it has been shown that not all of them bind calcium. Of the 17 identified synaptotagmins only 8 bind calcium (1-3, 5-7, 9, 10). The function of the two C2 domains that bind calcium are: regulating the fusion step of synaptic vesicle exocytosis (C2A) and binding to phosphatidyl-inositol-3,4,5-triphosphate (PIP3) in the absence of calcium ions and to phosphatidylinositol bisphosphate (PIP2) in their presence (C2B). C2B also regulates also the recycling step of synaptic vesicles. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permu |
| >cd08676 C2A_Munc13-like C2 domain first repeat in Munc13 (mammalian uncoordinated)-like proteins | Back alignment and domain information |
|---|
Probab=99.31 E-value=1.8e-12 Score=123.11 Aligned_cols=96 Identities=15% Similarity=0.083 Sum_probs=77.8
Q ss_pred CcceEEEEecC-CCccccCcCCCCcceEeecCCCCCCc------------------------ccceeeccccCCCceecc
Q 007035 265 NDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTE------------------------KSSSYSSSKRGSSIDWIE 319 (621)
Q Consensus 265 ~~~l~v~l~e~-~L~~~d~~g~sDpyVK~~Llp~~~~~------------------------~k~kt~v~k~tlnP~fnE 319 (621)
...|.|.|.+| ||.++|.+|.+||||++++.+..++. ...+|.++++|+||.|||
T Consensus 27 ~~~L~V~vi~a~~L~~~d~~g~~DPyv~v~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kT~v~~~tlnP~WnE 106 (153)
T cd08676 27 IFVLKVTVIEAKGLLAKDVNGFSDPYCMLGIVPASRERNSEKSKKRKSHRKKAVLKDTVPAKSIKVTEVKPQTLNPVWNE 106 (153)
T ss_pred eEEEEEEEEeccCCcccCCCCCCCceEEEEEcccccccccccccccccccccccccccccccccEecceecCCCCCcccc
Confidence 45778999999 99999999999999999998754321 236788889999999999
Q ss_pred ceeeecccccccccccccccccCCCCCCCCCcccccccccccccccCC
Q 007035 320 GFKGSSDLHFKGAEKDLMPAEIDNSDTRDGEVNGALHEGKADAEEHGV 367 (621)
Q Consensus 320 ~f~f~~~~~~~~~~k~L~~~V~D~d~~~r~d~iG~v~~~~a~~~~~~~ 367 (621)
+|.|. +.. ..+..|.++|||++ ++++|++..++.++.....
T Consensus 107 ~F~f~--v~~-~~~~~L~i~V~D~d----d~~IG~v~i~l~~l~~~~~ 147 (153)
T cd08676 107 TFRFE--VED-VSNDQLHLDIWDHD----DDFLGCVNIPLKDLPSCGL 147 (153)
T ss_pred EEEEE--ecc-CCCCEEEEEEEecC----CCeEEEEEEEHHHhCCCCC
Confidence 99998 432 23556999999998 8899999998877774333
|
C2-like domains are thought to be involved in phospholipid binding in a Ca2+ independent manner in both Unc13 and Munc13. Caenorabditis elegans Unc13 has a central domain with sequence similarity to PKC, which includes C1 and C2-related domains. Unc13 binds phorbol esters and DAG with high affinity in a phospholipid manner. Mutations in Unc13 results in abnormal neuronal connections and impairment in cholinergic neurotransmission in the nematode. Munc13 is the mammalian homolog which are expressed in the brain. There are 3 isoforms (Munc13-1, -2, -3) and are thought to play a role in neurotransmitter release and are hypothesized to be high-affinity receptors for phorbol esters. Unc13 and Munc13 contain both C1 and C2 domains. There are two C2 related domains present, one central and one at the carboxyl end. Munc13-1 contains a third C2-like domain. Munc13 interacts with syntaxin, sy |
| >cd04011 C2B_Ferlin C2 domain second repeat in Ferlin | Back alignment and domain information |
|---|
Probab=99.31 E-value=1.7e-12 Score=116.27 Aligned_cols=89 Identities=13% Similarity=0.023 Sum_probs=73.6
Q ss_pred eEEEEecC-CCccccCcCCCCcceEeecCCCCCCcccceeeccccCCCceeccceeeecccccccc-cccccccccCCCC
Q 007035 268 GYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEIDNSD 345 (621)
Q Consensus 268 l~v~l~e~-~L~~~d~~g~sDpyVK~~Llp~~~~~~k~kt~v~k~tlnP~fnE~f~f~~~~~~~~~-~k~L~~~V~D~d~ 345 (621)
+.|.|.+| ||. +|.+||||++.+.. .++||+++++++||.|||+|.|....+.... +..|.++|||++.
T Consensus 6 l~V~v~~a~~L~----~~~~dpyv~v~~~~-----~~~kT~~~~~t~nP~wne~f~f~~~~~~~~l~~~~l~i~V~d~~~ 76 (111)
T cd04011 6 VRVRVIEARQLV----GGNIDPVVKVEVGG-----QKKYTSVKKGTNCPFYNEYFFFNFHESPDELFDKIIKISVYDSRS 76 (111)
T ss_pred EEEEEEEcccCC----CCCCCCEEEEEECC-----EeeeeeEEeccCCCccccEEEEecCCCHHHHhcCeEEEEEEcCcc
Confidence 47999999 998 68899999999973 3557888899999999999999843433332 5679999999999
Q ss_pred CCCCCccccccccccccccc
Q 007035 346 TRDGEVNGALHEGKADAEEH 365 (621)
Q Consensus 346 ~~r~d~iG~v~~~~a~~~~~ 365 (621)
+++++++|++..++..+...
T Consensus 77 ~~~~~~iG~~~i~l~~v~~~ 96 (111)
T cd04011 77 LRSDTLIGSFKLDVGTVYDQ 96 (111)
T ss_pred cccCCccEEEEECCccccCC
Confidence 99999999999988766544
|
Ferlins are involved in vesicle fusion events. Ferlins and other proteins, such as Synaptotagmins, are implicated in facilitating the fusion process when cell membranes fuse together. There are six known human Ferlins: Dysferlin (Fer1L1), Otoferlin (Fer1L2), Myoferlin (Fer1L3), Fer1L4, Fer1L5, and Fer1L6. Defects in these genes can lead to a wide range of diseases including muscular dystrophy (dysferlin), deafness (otoferlin), and infertility (fer-1, fertilization factor-1). Structurally they have 6 tandem C2 domains, designated as (C2A-C2F) and a single C-terminal transmembrane domain, though there is a new study that disputes this and claims that there are actually 7 tandem C2 domains with another C2 domain inserted between C2D and C2E. In a subset of them (Dysferlin, Myoferlin, and Fer1) there is an additional conserved domain called DysF. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangeme |
| >cd04043 C2_Munc13_fungal C2 domain in Munc13 (mammalian uncoordinated) proteins; fungal group | Back alignment and domain information |
|---|
Probab=99.31 E-value=3.4e-12 Score=116.64 Aligned_cols=91 Identities=11% Similarity=-0.040 Sum_probs=75.7
Q ss_pred ceEEEEecC-CCccccCcCCCCcceEeecCCCCCCcccceeeccccCCCceeccceeeecccccccccccccccccCCCC
Q 007035 267 YGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDNSD 345 (621)
Q Consensus 267 ~l~v~l~e~-~L~~~d~~g~sDpyVK~~Llp~~~~~~k~kt~v~k~tlnP~fnE~f~f~~~~~~~~~~k~L~~~V~D~d~ 345 (621)
.++|.|.+| ||+++|.+|.+||||++++...+ ..+.||+++++++||.|||+|.|. +... .+..|.++|||++.
T Consensus 2 ~~~V~v~~a~~L~~~~~~~~~Dpyv~v~~~~~~--~~~~kT~~~~~t~~P~Wne~f~f~--i~~~-~~~~L~i~v~d~d~ 76 (126)
T cd04043 2 LFTIRIVRAENLKADSSNGLSDPYVTLVDTNGK--RRIAKTRTIYDTLNPRWDEEFELE--VPAG-EPLWISATVWDRSF 76 (126)
T ss_pred EEEEEEEEeECCCCCCCCCCCCceEEEEECCCC--eeeecccEecCCCCCcccceEEEE--cCCC-CCCEEEEEEEECCC
Confidence 357899999 99999999999999999976443 335688888999999999999998 4443 34569999999999
Q ss_pred CCCCCcccccccccccc
Q 007035 346 TRDGEVNGALHEGKADA 362 (621)
Q Consensus 346 ~~r~d~iG~v~~~~a~~ 362 (621)
+++++++|.+..++...
T Consensus 77 ~~~~~~iG~~~i~l~~~ 93 (126)
T cd04043 77 VGKHDLCGRASLKLDPK 93 (126)
T ss_pred CCCCceEEEEEEecCHH
Confidence 99999999998877654
|
C2-like domains are thought to be involved in phospholipid binding in a Ca2+ independent manner in both Unc13 and Munc13. Caenorabditis elegans Unc13 has a central domain with sequence similarity to PKC, which includes C1 and C2-related domains. Unc13 binds phorbol esters and DAG with high affinity in a phospholipid manner. Mutations in Unc13 results in abnormal neuronal connections and impairment in cholinergic neurotransmission in the nematode. Munc13 is the mammalian homolog which are expressed in the brain. There are 3 isoforms (Munc13-1, -2, -3) and are thought to play a role in neurotransmitter release and are hypothesized to be high-affinity receptors for phorbol esters. Unc13 and Munc13 contain both C1 and C2 domains. There are two C2 related domains present, one central and one at the carboxyl end. Munc13-1 contains a third C2-like domain. Munc13 interacts with syntaxin, synap |
| >cd04054 C2A_Rasal1_RasA4 C2 domain first repeat present in RasA1 and RasA4 | Back alignment and domain information |
|---|
Probab=99.30 E-value=2.4e-12 Score=117.39 Aligned_cols=87 Identities=13% Similarity=0.030 Sum_probs=72.9
Q ss_pred eEEEEecC-CCccccCcCCCCcceEeecCCCCCCcccceeeccccCCCceeccceeeecccccccccccccccccCCCCC
Q 007035 268 GYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDNSDT 346 (621)
Q Consensus 268 l~v~l~e~-~L~~~d~~g~sDpyVK~~Llp~~~~~~k~kt~v~k~tlnP~fnE~f~f~~~~~~~~~~k~L~~~V~D~d~~ 346 (621)
|+|.|.+| ||+++|.+|.+||||++++.. +...||+++++|+||+|||.|.|. +.. .++.|.+.|||++.+
T Consensus 2 l~v~vi~a~~L~~~d~~g~~DPYv~v~~~~----~~~~kT~v~~~t~nP~Wne~f~~~--~~~--~~~~l~v~v~d~~~~ 73 (121)
T cd04054 2 LYIRIVEGKNLPAKDITGSSDPYCIVKVDN----EVIIRTATVWKTLNPFWGEEYTVH--LPP--GFHTVSFYVLDEDTL 73 (121)
T ss_pred EEEEEEEeeCCcCCCCCCCCCceEEEEECC----EeeeeeeeEcCCCCCcccceEEEe--eCC--CCCEEEEEEEECCCC
Confidence 68999999 999999999999999999832 224588888999999999999998 432 235699999999999
Q ss_pred CCCCcccccccccccc
Q 007035 347 RDGEVNGALHEGKADA 362 (621)
Q Consensus 347 ~r~d~iG~v~~~~a~~ 362 (621)
++++++|.+..+...+
T Consensus 74 ~~d~~iG~~~~~~~~~ 89 (121)
T cd04054 74 SRDDVIGKVSLTREVI 89 (121)
T ss_pred CCCCEEEEEEEcHHHh
Confidence 9999999998875444
|
Rasal1 and RasA4 are both members of GAP1 (GTPase activating protein 1). Rasal1 responds to repetitive Ca2+ signals by associating with the plasma membrane and deactivating Ras. RasA4 suppresses Ras function by enhancing the GTPase activity of Ras proteins resulting in the inactive GDP-bound form of Ras. In this way it can control cellular proliferation and differentiation. Both of these proteins contains two C2 domains, a Ras-GAP domain, a plextrin homology (PH)-like domain, and a Bruton's Tyrosine Kinase (BTK) zinc binding domain. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involving their N- and C-terminal beta strands. Many C2 domains are Ca2+-dependent membrane-targeting modules that bind a wide variety of substances including bind phospholipids, inositol polyphosphates, and intracellular proteins. |
| >cd04047 C2B_Copine C2 domain second repeat in Copine | Back alignment and domain information |
|---|
Probab=99.30 E-value=2e-12 Score=115.49 Aligned_cols=94 Identities=10% Similarity=-0.035 Sum_probs=74.8
Q ss_pred EEEEecCCCccccCcCCCCcceEeecCCCC-CCcccceeeccccCCCceeccceeeecc-cccccccccccccccCCCCC
Q 007035 269 YLSSKEADLIDLQHNVVGDSSTDCDLAPHP-GTEKSSSYSSSKRGSSIDWIEGFKGSSD-LHFKGAEKDLMPAEIDNSDT 346 (621)
Q Consensus 269 ~v~l~e~~L~~~d~~g~sDpyVK~~Llp~~-~~~~k~kt~v~k~tlnP~fnE~f~f~~~-~~~~~~~k~L~~~V~D~d~~ 346 (621)
++.+.+.+|+++|..|.+||||++++.++. +...++||+++++|+||+|| +|.+... +.....++.|.++|||++.+
T Consensus 4 ~~~i~a~~L~~~d~~~~~DPyv~v~~~~~~~~~~~~~kT~vi~~t~nP~Wn-~f~~~~~~l~~~~~~~~l~~~V~d~d~~ 82 (110)
T cd04047 4 ELQFSGKKLDKKDFFGKSDPFLEISRQSEDGTWVLVYRTEVIKNTLNPVWK-PFTIPLQKLCNGDYDRPIKIEVYDYDSS 82 (110)
T ss_pred EEEEEeCCCCCCCCCCCCCeeEEEEEECCCCCEEEEEeeeEeccCCCCceE-EEEEEHHHhcCCCcCCEEEEEEEEeCCC
Confidence 455555599999999999999999998765 44567899999999999999 6776521 11122256799999999999
Q ss_pred CCCCccccccccccccc
Q 007035 347 RDGEVNGALHEGKADAE 363 (621)
Q Consensus 347 ~r~d~iG~v~~~~a~~~ 363 (621)
++++++|.+..++.++.
T Consensus 83 ~~d~~iG~~~~~l~~l~ 99 (110)
T cd04047 83 GKHDLIGEFETTLDELL 99 (110)
T ss_pred CCCcEEEEEEEEHHHHh
Confidence 99999999988776665
|
There are 2 copies of the C2 domain present in copine, a protein involved in membrane trafficking, protein-protein interactions, and perhaps even cell division and growth. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involving their N- and C-terminal beta strands. Many C2 domains are Ca2+-dependent membrane-targeting modules that bind a wide variety of substances including bind phospholipids, inositol polyphosphates, and intracellular proteins. Most C2 domain proteins are either signal transduction enzymes that contain a single C2 domain, such as protein kinase C, or membrane trafficking proteins which contain at least two C2 domains, such as synaptotagmin 1. However, there are a few exceptions to this including RIM isoforms and some splice variants of piccolo/aczonin and intersectin which only have a single C2 domain. C2 dom |
| >cd08678 C2_C21orf25-like C2 domain found in the Human chromosome 21 open reading frame 25 (C21orf25) protein | Back alignment and domain information |
|---|
Probab=99.30 E-value=2.4e-12 Score=118.04 Aligned_cols=90 Identities=17% Similarity=0.114 Sum_probs=73.7
Q ss_pred eEEEEecC-CCccccCcCCCCcceEeecCCCCCCcccceeeccccCCCceeccceeeecccccccccccccccccCCCCC
Q 007035 268 GYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDNSDT 346 (621)
Q Consensus 268 l~v~l~e~-~L~~~d~~g~sDpyVK~~Llp~~~~~~k~kt~v~k~tlnP~fnE~f~f~~~~~~~~~~k~L~~~V~D~d~~ 346 (621)
|+|.|.+| ||+. .+|.+||||++++. ....+.||+++++|+||+|||.|.|. +... ...|.+.|||++.+
T Consensus 1 l~v~v~~A~~L~~--~~g~~dpyv~v~~~---~~~~~~kT~v~~~t~nP~Wne~f~f~--~~~~--~~~l~~~v~d~~~~ 71 (126)
T cd08678 1 LLVKNIKANGLSE--AAGSSNPYCVLEMD---EPPQKYQSSTQKNTSNPFWDEHFLFE--LSPN--SKELLFEVYDNGKK 71 (126)
T ss_pred CEEEEEEecCCCC--CCCCcCCEEEEEEC---CCCcEEEeEEEecCCCCccCceEEEE--eCCC--CCEEEEEEEECCCC
Confidence 56888889 9998 78899999999984 11346788889999999999999998 4322 44599999999999
Q ss_pred CCCCcccccccccccccccC
Q 007035 347 RDGEVNGALHEGKADAEEHG 366 (621)
Q Consensus 347 ~r~d~iG~v~~~~a~~~~~~ 366 (621)
++++++|.+..++.++....
T Consensus 72 ~~~~~lG~~~i~l~~l~~~~ 91 (126)
T cd08678 72 SDSKFLGLAIVPFDELRKNP 91 (126)
T ss_pred CCCceEEEEEEeHHHhccCC
Confidence 99999999998876655443
|
The members in this cd are named after the Human C21orf25 which contains a single C2 domain. Several other members contain a C1 domain downstream of the C2 domain. No other information on this protein is currently known. The C2 domain was first identified in PKC. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involving their N- and C-terminal beta strands. Many C2 domains are Ca2+-dependent membrane-targeting modules that bind a wide variety of substances including bind phospholipids, inositol polyphosphates, and intracellular proteins. Most C2 domain proteins are either signal transduction enzymes that contain a single C2 domain, such as protein kinase C, or membrane trafficking proteins which contain at least two C2 domains, such as synaptotagmin 1. However, there are a |
| >cd04048 C2A_Copine C2 domain first repeat in Copine | Back alignment and domain information |
|---|
Probab=99.30 E-value=1.7e-12 Score=117.93 Aligned_cols=94 Identities=14% Similarity=0.032 Sum_probs=76.4
Q ss_pred EEEEecCCCccccCcCCCCcceEeecCCCC--CCcccceeeccccCCCceeccceeeecccccccccccccccccCCCC-
Q 007035 269 YLSSKEADLIDLQHNVVGDSSTDCDLAPHP--GTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDNSD- 345 (621)
Q Consensus 269 ~v~l~e~~L~~~d~~g~sDpyVK~~Llp~~--~~~~k~kt~v~k~tlnP~fnE~f~f~~~~~~~~~~k~L~~~V~D~d~- 345 (621)
++.+.+.+|+++|..|.+||||++++.+.. +...+.||.++++++||+|||+|.|. +..+. ...|.++|||+|.
T Consensus 4 ~~~i~a~~L~~~d~~g~~DPyv~v~~~~~~~~~~~~~~kT~vi~~t~nP~wne~f~f~--~~~~~-~~~l~~~V~d~d~~ 80 (120)
T cd04048 4 ELSISCRNLLDKDVLSKSDPFVVVYVKTGGSGQWVEIGRTEVIKNNLNPDFVTTFTVD--YYFEE-VQKLRFEVYDVDSK 80 (120)
T ss_pred EEEEEccCCCCCCCCCCCCcEEEEEEEcCCCCceEEeccEeEeCCCCCCCceEEEEEE--EEeEe-eeEEEEEEEEecCC
Confidence 445555599999999999999999999876 44567899999999999999999997 33222 3359999999997
Q ss_pred ---CCCCCccccccccccccccc
Q 007035 346 ---TRDGEVNGALHEGKADAEEH 365 (621)
Q Consensus 346 ---~~r~d~iG~v~~~~a~~~~~ 365 (621)
.++++++|.+..++.++...
T Consensus 81 ~~~~~~~d~iG~~~i~l~~l~~~ 103 (120)
T cd04048 81 SKDLSDHDFLGEAECTLGEIVSS 103 (120)
T ss_pred cCCCCCCcEEEEEEEEHHHHhcC
Confidence 78899999998877666543
|
There are 2 copies of the C2 domain present in copine, a protein involved in membrane trafficking, protein-protein interactions, and perhaps even cell division and growth. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involving their N- and C-terminal beta strands. Many C2 domains are Ca2+-dependent membrane-targeting modules that bind a wide variety of substances including bind phospholipids, inositol polyphosphates, and intracellular proteins. Most C2 domain proteins are either signal transduction enzymes that contain a single C2 domain, such as protein kinase C, or membrane trafficking proteins which contain at least two C2 domains, such as synaptotagmin 1. However, there are a few exceptions to this including RIM isoforms and some splice variants of piccolo/aczonin and intersectin which only have a single C2 domain. C2 doma |
| >cd08681 C2_fungal_Inn1p-like C2 domain found in fungal Ingression 1 (Inn1) proteins | Back alignment and domain information |
|---|
Probab=99.30 E-value=2.9e-12 Score=115.76 Aligned_cols=90 Identities=12% Similarity=0.089 Sum_probs=73.5
Q ss_pred cceEEEEecC-CCccccCcCCCCcceEeecCCCCCCcccceeecc-ccCCCceeccceeeecccccccccccccccccCC
Q 007035 266 DYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSS-KRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDN 343 (621)
Q Consensus 266 ~~l~v~l~e~-~L~~~d~~g~sDpyVK~~Llp~~~~~~k~kt~v~-k~tlnP~fnE~f~f~~~~~~~~~~k~L~~~V~D~ 343 (621)
+.|+|.|.+| ||++.|..|.+||||++.+.. .++||+++ ++++||+|||.|.|. +... ....|.++|||+
T Consensus 1 g~L~V~v~~A~~L~~~~~~~~~dpyv~v~~~~-----~~~kT~~~~~~~~nP~Wne~f~f~--v~~~-~~~~l~i~v~d~ 72 (118)
T cd08681 1 GTLVVVVLKARNLPNKRKLDKQDPYCVLRIGG-----VTKKTKTDFRGGQHPEWDEELRFE--ITED-KKPILKVAVFDD 72 (118)
T ss_pred CEEEEEEEEccCCCCCCcCCCCCceEEEEECC-----CccccccccCCCCCCccCceEEEE--ecCC-CCCEEEEEEEeC
Confidence 3578999999 999999999999999999864 34566664 568999999999998 5443 345699999999
Q ss_pred CCCCCCCcccccccccccccc
Q 007035 344 SDTRDGEVNGALHEGKADAEE 364 (621)
Q Consensus 344 d~~~r~d~iG~v~~~~a~~~~ 364 (621)
+..+ ++++|++..++.++..
T Consensus 73 ~~~~-~~~iG~~~~~l~~~~~ 92 (118)
T cd08681 73 DKRK-PDLIGDTEVDLSPALK 92 (118)
T ss_pred CCCC-CcceEEEEEecHHHhh
Confidence 9877 8999999988766544
|
Saccharomyces cerevisiae Inn1 associates with the contractile actomyosin ring at the end of mitosis and is needed for cytokinesis. The C2 domain of Inn1, located at the N-terminus, is required for ingression of the plasma membrane. The C-terminus is relatively unstructured and contains eight PXXP motifs that are thought to mediate interaction of Inn1 with other proteins with SH3 domains in the cytokinesis proteins Hof1 (an F-BAR protein) and Cyk3 (whose overexpression can restore primary septum formation in Inn1Delta cells) as well as recruiting Inn1 to the bud-neck by binding to Cyk3. Inn1 and Cyk3 appear to cooperate in activating chitin synthase Chs2 for primary septum formation, which allows coordination of actomyosin ring contraction with ingression of the cleavage furrow. It is thought that the C2 domain of Inn1 helps to preserve the link between the actomyosin ring and the plasma membrane, contr |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 621 | ||||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-41 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 3e-41 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 4e-41 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 3e-39 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 4e-39 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 5e-39 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 8e-32 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 8e-32 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 2e-29 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 5e-29 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 1e-26 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 3e-24 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 3e-24 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 3e-24 | ||
| 2x7g_A | 389 | Structure Of Human Serine-Arginine-Rich Protein-Spe | 3e-24 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 5e-24 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 5e-23 | ||
| 1wbp_A | 397 | Srpk1 Bound To 9mer Docking Motif Peptide Length = | 8e-23 | ||
| 3beg_A | 381 | Crystal Structure Of Sr Protein Kinase 1 Complexed | 1e-22 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 4e-22 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 5e-22 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-22 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 5e-22 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 5e-22 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 6e-22 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 7e-22 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 7e-22 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 8e-22 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 8e-22 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 8e-22 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 8e-22 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 8e-22 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 9e-22 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 9e-22 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 9e-22 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 9e-22 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 9e-22 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 9e-22 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-21 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-21 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-21 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-21 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-21 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-21 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-21 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-21 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-21 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-21 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-21 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-21 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-21 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-21 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-21 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-21 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-21 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-21 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-21 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-21 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-21 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-21 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-21 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-21 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-21 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-21 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-21 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 3e-21 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-21 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-21 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-21 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-21 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-21 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-21 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 4e-21 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 4e-21 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 4e-21 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 6e-21 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 7e-21 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 7e-21 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 7e-21 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-21 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 8e-21 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 8e-21 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 9e-21 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-20 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-20 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-20 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-20 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-20 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-20 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-20 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-20 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-20 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-20 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-20 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-20 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 3e-20 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-20 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-20 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-20 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-20 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-20 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 3e-20 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-20 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-20 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-20 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-20 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 4e-20 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 4e-20 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 8e-20 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 8e-20 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-19 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-19 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-19 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 3e-19 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-19 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-19 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 8e-19 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-19 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 9e-19 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 9e-19 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 9e-19 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-18 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-18 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-18 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-18 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-18 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-18 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-18 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-18 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-18 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-18 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-18 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-18 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-18 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-18 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-18 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-18 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-18 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-18 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-18 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 3e-18 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-18 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 4e-18 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-18 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 4e-18 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 5e-18 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 6e-18 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 6e-18 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 6e-18 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 7e-18 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-18 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 9e-18 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-17 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-17 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-17 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-17 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-17 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-17 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-17 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-17 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-17 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-17 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-17 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-17 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-17 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-17 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-17 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-17 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-17 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-17 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 3e-17 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 3e-17 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 3e-17 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 3e-17 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 3e-17 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 4e-17 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-17 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-17 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-17 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 5e-17 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 5e-17 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-17 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-17 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-17 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-17 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-17 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 6e-17 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-17 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 7e-17 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 7e-17 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 7e-17 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-17 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-16 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-16 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-16 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-16 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-16 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-16 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-16 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-16 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-16 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-16 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-16 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-16 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-16 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-16 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-16 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-16 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-16 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-16 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-16 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-16 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-16 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-16 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-16 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-16 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-16 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-16 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-16 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-16 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-16 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 5e-16 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 7e-16 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 7e-16 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-15 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-15 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-15 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-15 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-15 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-15 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-15 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-15 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-15 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-15 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-15 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 3e-15 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-15 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-15 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 4e-15 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-15 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-15 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 4e-15 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 5e-15 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 5e-15 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 5e-15 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 5e-15 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 7e-15 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 7e-15 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 7e-15 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 8e-15 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 8e-15 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-15 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 8e-15 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 8e-15 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 8e-15 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 9e-15 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 9e-15 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 9e-15 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 9e-15 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 9e-15 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-14 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-14 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-14 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-14 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-14 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-14 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-14 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-14 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-14 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-14 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-14 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-14 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-14 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-14 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-14 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-14 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-14 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-14 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-14 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-14 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-14 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-14 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-14 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-14 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-14 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-14 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-14 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-14 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-14 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-14 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-14 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-14 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-14 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-14 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 3e-14 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-14 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-14 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-14 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-14 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-14 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-14 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-14 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-14 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-14 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-14 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-14 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 4e-14 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-14 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 4e-14 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 4e-14 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-14 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-14 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 4e-14 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 4e-14 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 4e-14 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 4e-14 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 4e-14 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 4e-14 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 5e-14 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 5e-14 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 5e-14 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 5e-14 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 5e-14 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 5e-14 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 5e-14 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 6e-14 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 6e-14 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 6e-14 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 6e-14 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 6e-14 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-14 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 6e-14 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 6e-14 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 6e-14 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 6e-14 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 6e-14 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-14 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 7e-14 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 7e-14 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 7e-14 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 7e-14 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 7e-14 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-14 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 7e-14 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 8e-14 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 8e-14 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 9e-14 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 9e-14 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-13 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-13 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-13 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-13 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 1e-13 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 1e-13 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-13 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-13 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-13 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-13 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-13 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-13 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-13 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-13 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-13 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-13 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-13 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 3e-13 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-13 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-13 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-13 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 4e-13 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 5e-13 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 5e-13 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 6e-13 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 6e-13 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 7e-13 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 7e-13 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 7e-13 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 8e-13 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 8e-13 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-12 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-12 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-12 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-12 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-12 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-12 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-12 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-12 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-12 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-12 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-12 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-12 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-12 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-12 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-12 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-12 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 2e-12 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-12 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-12 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-12 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-12 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-12 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-12 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 3e-12 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 3e-12 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 4e-12 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 4e-12 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 4e-12 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 4e-12 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 4e-12 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 4e-12 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 4e-12 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 4e-12 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 4e-12 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 4e-12 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 4e-12 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 4e-12 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 5e-12 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 5e-12 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 5e-12 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 5e-12 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 5e-12 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 6e-12 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-12 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 6e-12 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 6e-12 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 6e-12 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 6e-12 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 6e-12 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 6e-12 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-12 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 6e-12 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 6e-12 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 7e-12 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 7e-12 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 7e-12 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 7e-12 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 7e-12 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 8e-12 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 8e-12 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 8e-12 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 8e-12 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 9e-12 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 9e-12 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 1e-11 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-11 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-11 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-11 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-11 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-11 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-11 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-11 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-11 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-11 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-11 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-11 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-11 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 3e-11 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-11 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 3e-11 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-11 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-11 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 4e-11 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 4e-11 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 5e-11 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 5e-11 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 5e-11 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-11 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 6e-11 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 6e-11 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 6e-11 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-11 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 7e-11 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 7e-11 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 7e-11 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 7e-11 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 7e-11 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 8e-11 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 8e-11 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 8e-11 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 8e-11 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 8e-11 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-11 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 8e-11 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-11 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 8e-11 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 9e-11 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 9e-11 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 9e-11 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 9e-11 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 9e-11 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 9e-11 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 9e-11 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 9e-11 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 9e-11 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 9e-11 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 9e-11 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 9e-11 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-10 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-10 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 1e-10 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 1e-10 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-10 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 1e-10 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 1e-10 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 1e-10 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 1e-10 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-10 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-10 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-10 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-10 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 1e-10 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 1e-10 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 1e-10 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-10 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 1e-10 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 1e-10 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-10 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 1e-10 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-10 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-10 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-10 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 1e-10 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 1e-10 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 1e-10 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-10 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-10 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-10 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-10 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-10 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-10 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-10 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 2e-10 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-10 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-10 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-10 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-10 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-10 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-10 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-10 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-10 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-10 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 3e-10 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-10 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 3e-10 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 3e-10 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 3e-10 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 3e-10 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 4e-10 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 4e-10 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 4e-10 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 4e-10 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 4e-10 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 4e-10 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 4e-10 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 4e-10 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 4e-10 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 4e-10 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 4e-10 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 4e-10 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 4e-10 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 5e-10 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 5e-10 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 5e-10 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 6e-10 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 6e-10 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 6e-10 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 6e-10 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 6e-10 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 6e-10 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 6e-10 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 6e-10 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-10 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 7e-10 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 8e-10 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 8e-10 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-09 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 1e-09 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-09 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-09 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-09 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-09 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-09 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-09 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 1e-09 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 1e-09 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-09 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-09 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-09 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-09 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-09 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-09 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-09 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-09 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-09 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-09 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-09 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-09 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-09 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 3e-09 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-09 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 3e-09 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 3e-09 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-09 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-09 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-09 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-09 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 4e-09 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 4e-09 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-09 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 4e-09 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 4e-09 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 4e-09 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 4e-09 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 4e-09 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 5e-09 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 5e-09 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 5e-09 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 5e-09 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-09 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 6e-09 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 6e-09 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 7e-09 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 7e-09 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 8e-09 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 8e-09 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 8e-09 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-08 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-08 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-08 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-08 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-08 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-08 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-08 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-08 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-08 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-08 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-08 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-08 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-08 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-08 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-08 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-08 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-08 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-08 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 3e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 4e-08 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 5e-08 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 5e-08 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 5e-08 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 5e-08 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 6e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 6e-08 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 6e-08 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-08 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-08 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 8e-08 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 8e-08 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-07 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-07 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-07 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-07 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-07 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-07 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 2e-07 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 2e-07 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-07 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-07 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-07 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-07 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 3e-07 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-07 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-07 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 4e-07 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-07 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 4e-07 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 5e-07 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 5e-07 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-07 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-07 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-07 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 6e-07 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-07 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 6e-07 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 6e-07 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 7e-07 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-07 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-07 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 7e-07 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 7e-07 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 7e-07 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 7e-07 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-07 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 7e-07 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 8e-07 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 8e-07 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 8e-07 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 8e-07 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-07 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 8e-07 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 8e-07 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 8e-07 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 9e-07 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 9e-07 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-07 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 9e-07 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 9e-07 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 9e-07 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 9e-07 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 9e-07 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 9e-07 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 9e-07 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-06 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-06 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 1e-06 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-06 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-06 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-06 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-06 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-06 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-06 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-06 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-06 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-06 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-06 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-06 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-06 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 1e-06 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-06 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-06 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-06 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-06 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-06 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 1e-06 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-06 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-06 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-06 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-06 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-06 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-06 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-06 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-06 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-06 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-06 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-06 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-06 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-06 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-06 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-06 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-06 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-06 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-06 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-06 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-06 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-06 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 3e-06 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-06 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-06 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-06 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 3e-06 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 3e-06 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-06 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 3e-06 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-06 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-06 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-06 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-06 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-06 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 5e-06 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 5e-06 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 5e-06 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 5e-06 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 5e-06 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 5e-06 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 5e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 6e-06 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-06 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 6e-06 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 6e-06 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 6e-06 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 7e-06 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 7e-06 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 7e-06 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 7e-06 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 7e-06 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 7e-06 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 8e-06 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 8e-06 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 8e-06 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-05 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-05 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-05 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-05 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-05 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-05 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-05 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-05 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-05 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-05 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-05 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-05 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-05 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-05 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-05 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-05 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 4e-05 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-05 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 4e-05 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-05 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 4e-05 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 5e-05 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 5e-05 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 7e-05 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 8e-05 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 8e-05 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-04 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-04 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-04 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-04 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-04 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-04 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-04 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-04 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-04 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-04 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-04 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-04 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-04 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-04 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-04 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-04 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-04 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 4e-04 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 4e-04 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-04 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 4e-04 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 4e-04 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 5e-04 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 5e-04 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 5e-04 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 6e-04 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 6e-04 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-04 | ||
| 2csn_A | 297 | Binary Complex Of Casein Kinase-1 With Cki7 Length | 6e-04 | ||
| 1eh4_A | 298 | Binary Complex Of Casein Kinase-1 From S. Pombe Wit | 6e-04 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-04 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 6e-04 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 6e-04 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 6e-04 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 7e-04 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 7e-04 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 7e-04 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 7e-04 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 7e-04 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 7e-04 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 7e-04 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 7e-04 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 7e-04 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-04 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 8e-04 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 8e-04 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 8e-04 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 8e-04 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-04 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 8e-04 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 9e-04 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 9e-04 |
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397 | Back alignment and structure |
|
| >pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2CSN|A Chain A, Binary Complex Of Casein Kinase-1 With Cki7 Length = 297 | Back alignment and structure |
|
| >pdb|1EH4|A Chain A, Binary Complex Of Casein Kinase-1 From S. Pombe With An Atp Competitive Inhibitor, Ic261 Length = 298 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 336 bits (864), Expect = e-110
Identities = 90/227 (39%), Positives = 133/227 (58%), Gaps = 5/227 (2%)
Query: 393 KNRTGF-EENKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK 451
N G+ ++ + + +A RY V + +G +F +V +A D V LK+++N+K
Sbjct: 75 PNNGGYDDDQGSYVQVPHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK 134
Query: 452 DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQE 511
F Q+ +EI++L+ + K D + +++ + + F H+ + ELL NLYE K N+
Sbjct: 135 RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKF 194
Query: 512 SGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 571
G F+L ++ L+ L+ LH IIHCDLKPENIL+K R IK+ID GSSC
Sbjct: 195 QG----FSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSC 250
Query: 572 FQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEV 618
++ + Y+QSR YRAPEVI+G Y ID+WSLGCILAEL TG
Sbjct: 251 YEHQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYP 297
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 333 bits (855), Expect = e-109
Identities = 94/241 (39%), Positives = 138/241 (57%), Gaps = 11/241 (4%)
Query: 385 FHLRIIHRKNRTGF-----EENKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTG 439
F H+K R + ++N D + RY + +G +F +V +A D
Sbjct: 20 FQSMSSHKKERKVYNDGYDDDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQ 79
Query: 440 VDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLR 499
V +KIIKN K F +Q+ E++LL+L+NK+D +++I+ L +F HL +V E+L
Sbjct: 80 EWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLS 139
Query: 500 ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS--LGIIHCDLKPENILIKSY 557
NLY+ + G +L + +Q AL +L + L IIHCDLKPENIL+ +
Sbjct: 140 YNLYDLLRNTNFRG----VSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNP 195
Query: 558 QRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGE 617
+R IKI+D GSSC + Y+QSR YR+PEV++G+PYD ID+WSLGCIL E+ TGE
Sbjct: 196 KRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
Query: 618 V 618
Sbjct: 256 P 256
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 314 bits (807), Expect = e-103
Identities = 75/236 (31%), Positives = 121/236 (51%), Gaps = 22/236 (9%)
Query: 401 NKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTG-VDVCLKIIKNDKDFFDQSLD 459
+ L V++ RY + + LG AF KV + D G V +KI+KN + + +
Sbjct: 1 SMHLICQSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARS 60
Query: 460 EIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFT 519
EI++L+ +N DP +++ ++F H H+ IV ELL + Y+F K N F
Sbjct: 61 EIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLP----FR 116
Query: 520 LGRLQVITRQCLEALEYLHSLGIIHCDLKPENILI-----------------KSYQRCEI 562
L ++ + Q +++ +LHS + H DLKPENIL ++ +I
Sbjct: 117 LDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDI 176
Query: 563 KIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEV 618
K++D GS+ + ++ V +R YRAPEVI+ L + Q D+WS+GCIL E + G
Sbjct: 177 KVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFT 232
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 311 bits (799), Expect = e-101
Identities = 74/237 (31%), Positives = 111/237 (46%), Gaps = 22/237 (9%)
Query: 400 ENKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTG-VDVCLKIIKNDKDFFDQSL 458
+ L + + RY + LG F KV + D G V LKII+N + + +
Sbjct: 5 KEGHLVCRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAAR 64
Query: 459 DEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYF 518
EI +LK + + D ++ + + D+F H+ I ELL N +EF K N +
Sbjct: 65 LEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQP----Y 120
Query: 519 TLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILI-----------------KSYQRCE 561
L ++ + Q AL +LH + H DLKPENIL KS +
Sbjct: 121 PLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTS 180
Query: 562 IKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEV 618
I++ D GS+ F ++ V +R YR PEVI+ L + Q D+WS+GCIL E + G
Sbjct: 181 IRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFT 237
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 311 bits (799), Expect = e-101
Identities = 69/261 (26%), Positives = 120/261 (45%), Gaps = 33/261 (12%)
Query: 386 HLRIIHRKNRTGF-----EENKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGV 440
H H R +E ++ + V +G F +V Q +
Sbjct: 2 HHHHHHSSGRENLYFQGDDEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKK 61
Query: 441 DVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRA 500
+K+++N K + + E +LK + +D + ++I++ + F + +H+ ++ E L
Sbjct: 62 YYAVKVVRNIKKYTRSAKIEADILKKIQNDDI-NNNNIVKYHGKFMYYDHMCLIFEPLGP 120
Query: 501 NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS---- 556
+LYE N +G F + +++ + L+AL YL + + H DLKPENIL+
Sbjct: 121 SLYEIITRNNYNG----FHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFE 176
Query: 557 -------------------YQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPY 597
+ IK+ID G + F++D + +R YRAPEVI+ L +
Sbjct: 177 KSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGW 236
Query: 598 DQKIDLWSLGCILAELWTGEV 618
D D+WS GC+LAEL+TG +
Sbjct: 237 DVSSDMWSFGCVLAELYTGSL 257
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 288 bits (738), Expect = 4e-92
Identities = 81/221 (36%), Positives = 124/221 (56%), Gaps = 18/221 (8%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKND 471
RY + LG FS V+ A+D+ V +KI++ DK + + + DEIKLL+ VN D
Sbjct: 17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDAD 76
Query: 472 PADE-----HHILRLYDYFYH----LEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGR 522
E +HIL+L D+F H H+ +V E+L NL K + G L
Sbjct: 77 NTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRG----IPLIY 132
Query: 523 LQVITRQCLEALEYLHS-LGIIHCDLKPENILIKSYQRCE----IKIIDLGSSCFQTDNL 577
++ I++Q L L+Y+H GIIH D+KPEN+L++ E IKI DLG++C+ ++
Sbjct: 133 VKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY 192
Query: 578 CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEV 618
+Q+R YR+PEV++G P+ D+WS C++ EL TG+
Sbjct: 193 TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDF 233
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 180 bits (457), Expect = 7e-51
Identities = 75/268 (27%), Positives = 127/268 (47%), Gaps = 58/268 (21%)
Query: 404 LPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKL 463
+ + + GRY+V LG FS V+ + D+ V +K++K+ + + + +LDEI+L
Sbjct: 27 HLVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRL 86
Query: 464 LKLVNKNDPADE--HHILRLYDYFYHL----EHLFIVCELLRANLYEFQKFNQESGGEAY 517
LK V +DP D +++L D F H+ +V E+L +L ++ + G
Sbjct: 87 LKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQG---- 142
Query: 518 FTLGRLQVITRQCLEALEYLHS-LGIIHCDLKPENILI---------------------- 554
L ++ I +Q L+ L+YLH+ IIH D+KPENIL+
Sbjct: 143 LPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGA 202
Query: 555 -------------------------KSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAP 589
K+ ++ ++KI DLG++C+ + +Q+R YR+
Sbjct: 203 PPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSL 262
Query: 590 EVIIGLPYDQKIDLWSLGCILAELWTGE 617
EV+IG Y+ D+WS C+ EL TG+
Sbjct: 263 EVLIGSGYNTPADIWSTACMAFELATGD 290
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 1e-41
Identities = 62/213 (29%), Positives = 107/213 (50%), Gaps = 23/213 (10%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPAD 474
Y T+ +G+ +F V+QA+ +G V +K + DK F E+++++ ++
Sbjct: 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF---KNRELQIMRKLD------ 105
Query: 475 EH-HILRLYDYFYHLE------HLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVIT 527
H +I+RL +FY +L +V + + +Y + + + +++
Sbjct: 106 -HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQT--LPVIYVKLYM 162
Query: 528 RQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS--SCFQTDNLCLYVQSRS 585
Q +L Y+HS GI H D+KP+N+L+ +K+ D GS + + Y+ SR
Sbjct: 163 YQLFRSLAYIHSFGICHRDIKPQNLLLDP-DTAVLKLCDFGSAKQLVRGEPNVSYICSRY 221
Query: 586 YRAPEVIIGLP-YDQKIDLWSLGCILAELWTGE 617
YRAPE+I G Y ID+WS GC+LAEL G+
Sbjct: 222 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 2e-40
Identities = 63/250 (25%), Positives = 106/250 (42%), Gaps = 42/250 (16%)
Query: 391 HRKNRTGFE-ENKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKII-- 447
H + +G + ++L +V Y + + +GS SKVFQ + + +K +
Sbjct: 4 HHHHSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQI-YAIKYVNL 62
Query: 448 -KNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCEL----LRANL 502
+ D D +EI L + ++ I+RLYDY +++++V E L + L
Sbjct: 63 EEADNQTLDSYRNEIAYLNKLQQHSD----KIIRLYDYEITDQYIYMVMECGNIDLNSWL 118
Query: 503 YEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEI 562
+ + + + + LEA+ +H GI+H DLKP N LI +
Sbjct: 119 KKKKSIDPW----------ERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV---DGML 165
Query: 563 KIIDLG-SSCFQTDNLCLYVQSR----SYRAPEVIIGLP-----------YDQKIDLWSL 606
K+ID G ++ Q D + S+ +Y PE I + K D+WSL
Sbjct: 166 KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSL 225
Query: 607 GCILAELWTG 616
GCIL + G
Sbjct: 226 GCILYYMTYG 235
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 2e-39
Identities = 70/221 (31%), Positives = 108/221 (48%), Gaps = 33/221 (14%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD------EIKLLK 465
+ RY +GS A+ V A D TG+ V +K + F + E++LLK
Sbjct: 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR---PFQSIIHAKRTYRELRLLK 83
Query: 466 LVN-KNDPADEHHILRLYDYFY------HLEHLFIVCELLRANLYEFQKFNQESGGEAYF 518
+ +N ++ L D F +++V L+ A+L K +
Sbjct: 84 HMKHEN-------VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-------L 129
Query: 519 TLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC 578
T +Q + Q L L+Y+HS IIH DLKP N+ + CE+KI+D G + D +
Sbjct: 130 TDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE--DCELKILDFGLARHTADEMT 187
Query: 579 LYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEV 618
YV +R YRAPE+++ Y+Q +D+WS+GCI+AEL TG
Sbjct: 188 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 228
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 3e-39
Identities = 58/225 (25%), Positives = 96/225 (42%), Gaps = 33/225 (14%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKII-KNDKDFFDQSLDEIKLLKLVNKNDPA 473
Y + LG FS V + LH G LK I +++ +++ E + +L N
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFN----- 84
Query: 474 DEH-HILRLYDYFYHLE----HLFIVCEL-LRANLYEFQKFNQESGGEAYFTLGRLQVIT 527
H +ILRL Y +++ R L+ + ++ G + T ++ +
Sbjct: 85 --HPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGN--FLTEDQILWLL 140
Query: 528 RQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSR--- 584
LE +H+ G H DLKP NIL+ + ++DLGS ++ Q+
Sbjct: 141 LGICRGLEAIHAKGYAHRDLKPTNILL--GDEGQPVLMDLGSMNQACIHVEGSRQALTLQ 198
Query: 585 ---------SYRAPEVIIGLPY---DQKIDLWSLGCILAELWTGE 617
SYRAPE+ + D++ D+WSLGC+L + GE
Sbjct: 199 DWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGE 243
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 4e-39
Identities = 62/213 (29%), Positives = 107/213 (50%), Gaps = 24/213 (11%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPAD 474
Y + +G+ +F VFQA+ + + +V +K + DK F E++++++V
Sbjct: 41 AYTNCKVIGNGSFGVVFQAKLVESD-EVAIKKVLQDKRF---KNRELQIMRIVK------ 90
Query: 475 EH-HILRLYDYFYHLEH------LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVIT 527
H +++ L +FY L +V E + +Y + + + +++
Sbjct: 91 -HPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQT--MPMLLIKLYM 147
Query: 528 RQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS--SCFQTDNLCLYVQSRS 585
Q L +L Y+HS+GI H D+KP+N+L+ +K+ID GS + Y+ SR
Sbjct: 148 YQLLRSLAYIHSIGICHRDIKPQNLLLDP-PSGVLKLIDFGSAKILIAGEPNVSYICSRY 206
Query: 586 YRAPEVIIGLP-YDQKIDLWSLGCILAELWTGE 617
YRAPE+I G Y ID+WS GC++AEL G+
Sbjct: 207 YRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 4e-39
Identities = 52/228 (22%), Positives = 90/228 (39%), Gaps = 38/228 (16%)
Query: 405 PIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDE 460
++++ RY +LG F+K F+ D T KI+ ++ E
Sbjct: 6 EVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSME 65
Query: 461 IKLLKLVNKNDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFT 519
I + + + H H++ + +F + +F+V EL
Sbjct: 66 ISIHRSLA-------HQHVVGFHGFFEDNDFVFVVLELC-------------RRRSLLEL 105
Query: 520 L---GRLQ-----VITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG-SS 570
L RQ + +YLH +IH DLK N+ + E+KI D G ++
Sbjct: 106 HKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNE--DLEVKIGDFGLAT 163
Query: 571 CFQTDNLCLYVQ--SRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTG 616
+ D V + +Y APEV+ + ++D+WS+GCI+ L G
Sbjct: 164 KVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVG 211
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 5e-39
Identities = 73/221 (33%), Positives = 110/221 (49%), Gaps = 39/221 (17%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD------EIKLLKLVN 468
RY + +GS A V A D +V +K + F E+ L+K VN
Sbjct: 26 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR---PFQNQTHAKRAYRELVLMKCVN 82
Query: 469 -KNDPADEHHILRLYDYFY------HLEHLFIVCELLRANLYEF--QKFNQESGGEAYFT 519
KN I+ L + F + ++IV EL+ ANL + + + E
Sbjct: 83 HKN-------IIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHE-------- 127
Query: 520 LGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG--SSCFQTDNL 577
R+ + Q L +++LHS GIIH DLKP NI++KS C +KI+D G + + +
Sbjct: 128 --RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS--DCTLKILDFGLARTAGTSFMM 183
Query: 578 CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEV 618
YV +R YRAPEVI+G+ Y + +D+WS+GCI+ E+ G V
Sbjct: 184 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGV 224
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 6e-39
Identities = 66/223 (29%), Positives = 111/223 (49%), Gaps = 38/223 (17%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD------EIKLLK 465
+ Y ++GS A+ V A D +G V +K + F + E+ LLK
Sbjct: 22 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSR---PFQSEIFAKRAYRELLLLK 78
Query: 466 LVN-KNDPADEHHILRLYDYFY------HLEHLFIVCELLRANLYEF--QKFNQESGGEA 516
+ +N ++ L D F + ++V ++ +L + KF++E
Sbjct: 79 HMQHEN-------VIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEE----- 126
Query: 517 YFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN 576
++Q + Q L+ L+Y+HS G++H DLKP N+ + CE+KI+D G +
Sbjct: 127 -----KIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNE--DCELKILDFGLARHADAE 179
Query: 577 LCLYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEV 618
+ YV +R YRAPEVI+ Y+Q +D+WS+GCI+AE+ TG+
Sbjct: 180 MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKT 222
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 6e-39
Identities = 52/228 (22%), Positives = 91/228 (39%), Gaps = 38/228 (16%)
Query: 405 PIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDE 460
++++ RY +LG F+K F+ D T KI+ ++ E
Sbjct: 32 EVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSME 91
Query: 461 IKLLKLVNKNDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFT 519
I + + + H H++ + +F + +F+V EL
Sbjct: 92 ISIHRSLA-------HQHVVGFHGFFEDNDFVFVVLELC-------------RRRSLLEL 131
Query: 520 L---GRL-----QVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG-SS 570
L + RQ + +YLH +IH DLK N+ + E+KI D G ++
Sbjct: 132 HKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNE--DLEVKIGDFGLAT 189
Query: 571 CFQTDNLCLYVQ--SRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTG 616
+ D V + +Y APEV+ + ++D+WS+GCI+ L G
Sbjct: 190 KVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVG 237
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 7e-39
Identities = 60/230 (26%), Positives = 98/230 (42%), Gaps = 41/230 (17%)
Query: 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKII---KNDKDFFDQSLDEIKLLKL 466
+V Y + + +GS SKVFQ + + +K + + D D +EI L
Sbjct: 5 SVKGRIYSILKQIGSGGSSKVFQVLNEKKQI-YAIKYVNLEEADNQTLDSYRNEIAYLNK 63
Query: 467 VNKNDPADEHHILRLYDYFYHLEHLFIVCEL----LRANLYEFQKFNQESGGEAYFTLGR 522
+ ++ I+RLYDY +++++V E L + L + + +
Sbjct: 64 LQQHSD----KIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPW----------E 109
Query: 523 LQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG-SSCFQTDNLCLYV 581
+ + LEA+ +H GI+H DLKP N LI +K+ID G ++ Q D +
Sbjct: 110 RKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV---DGMLKLIDFGIANQMQPDTTSVVK 166
Query: 582 QSR----SYRAPEVIIGLP-----------YDQKIDLWSLGCILAELWTG 616
S+ +Y PE I + K D+WSLGCIL + G
Sbjct: 167 DSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYG 216
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 2e-38
Identities = 68/221 (30%), Positives = 105/221 (47%), Gaps = 33/221 (14%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD------EIKLLK 465
+ Y + +GS A+ V A D TG V +K + F L E++LLK
Sbjct: 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR---PFQSELFAKRAYRELRLLK 79
Query: 466 LVN-KNDPADEHHILRLYDYFY------HLEHLFIVCELLRANLYEFQKFNQESGGEAYF 518
+ +N ++ L D F ++V + +L + K +
Sbjct: 80 HMRHEN-------VIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK-------L 125
Query: 519 TLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC 578
R+Q + Q L+ L Y+H+ GIIH DLKP N+ + CE+KI+D G + +
Sbjct: 126 GEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNE--DCELKILDFGLARQADSEMT 183
Query: 579 LYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEV 618
YV +R YRAPEVI+ Y Q +D+WS+GCI+AE+ TG+
Sbjct: 184 GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKT 224
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 2e-38
Identities = 59/232 (25%), Positives = 97/232 (41%), Gaps = 45/232 (19%)
Query: 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQS-----LDEIKLL 464
+V Y + + +GS SKVFQ + +K + + + D +EI L
Sbjct: 52 SVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYV--NLEEADNQTLDSYRNEIAYL 108
Query: 465 KLVNKNDPADEHHILRLYDYFYHLEHLFIVCEL----LRANLYEFQKFNQESGGEAYFTL 520
+ ++ I+RLYDY +++++V E L + L + + +
Sbjct: 109 NKLQQHSD----KIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPW--------- 155
Query: 521 GRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG-SSCFQTDNLCL 579
+ + LEA+ +H GI+H DLKP N LI +K+ID G ++ Q D +
Sbjct: 156 -ERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV---DGMLKLIDFGIANQMQPDTTSV 211
Query: 580 YVQSR----SYRAPEVIIGLP-----------YDQKIDLWSLGCILAELWTG 616
S+ +Y PE I + K D+WSLGCIL + G
Sbjct: 212 VKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYG 263
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 3e-38
Identities = 61/217 (28%), Positives = 100/217 (46%), Gaps = 25/217 (11%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPAD 474
R+ V G F V ++ TG+ V +K + D F ++ L ++ L ++
Sbjct: 24 RFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVL------- 76
Query: 475 EHH--ILRLYDYFYHLEH-------LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQV 525
HH I++L YFY L L +V E + L+ + ++V
Sbjct: 77 -HHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVA--PPPILIKV 133
Query: 526 ITRQCLEALEYLH--SLGIIHCDLKPENILIKSYQRCEIKIIDLGS--SCFQTDNLCLYV 581
Q + ++ LH S+ + H D+KP N+L+ + +K+ D GS ++ Y+
Sbjct: 134 FLFQLIRSIGCLHLPSVNVCHRDIKPHNVLV-NEADGTLKLCDFGSAKKLSPSEPNVAYI 192
Query: 582 QSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGE 617
SR YRAPE+I G Y +D+WS+GCI AE+ GE
Sbjct: 193 CSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 144 bits (363), Expect = 4e-38
Identities = 33/232 (14%), Positives = 68/232 (29%), Gaps = 30/232 (12%)
Query: 414 GRYYVT-EYLGSAAFSKVFQAQDLHTGVDVCLKII----KNDKDFFDQSLDEIKLLKLVN 468
R E L S VF +D+ D LK+ +N + ++ + +
Sbjct: 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLL 120
Query: 469 KNDPADEHHILRLYDYF--------------------YHLEHLFIVCELLRANLYEFQK- 507
P + RL Y + + ++ +L
Sbjct: 121 GESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFST 180
Query: 508 FNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 567
+ + L ++T Q + L S G++H P+N+ I + + D+
Sbjct: 181 LDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIM--PDGRLMLGDV 238
Query: 568 GSSCFQTDNLCLYVQSRSYRAPEVI--IGLPYDQKIDLWSLGCILAELWTGE 617
+ +Y E + + ++ W LG + +W
Sbjct: 239 SALWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 6e-38
Identities = 57/241 (23%), Positives = 97/241 (40%), Gaps = 36/241 (14%)
Query: 394 NRTGFEENKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLK-IIKNDKD 452
N GF+ + RY + LG VF A D V +K I+ D
Sbjct: 3 NIHGFD------------LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQ 50
Query: 453 FFDQSLDEIKLLKLVN-KN-------DPADEHHILRLYDYFYHLEHLFIVCELLRANLYE 504
+L EIK+++ ++ N + L ++IV E + +L
Sbjct: 51 SVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLAN 110
Query: 505 FQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKI 564
+ ++ Q L L+Y+HS ++H DLKP N+ I + + +KI
Sbjct: 111 VLEQGP-------LLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINT-EDLVLKI 162
Query: 565 IDLG------SSCFQTDNLCLYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGE 617
D G +L + ++ YR+P +++ Y + ID+W+ GCI AE+ TG+
Sbjct: 163 GDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
Query: 618 V 618
Sbjct: 223 T 223
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 7e-38
Identities = 69/219 (31%), Positives = 108/219 (49%), Gaps = 35/219 (15%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD------EIKLLKLVN 468
RY + +GS A V A D +V +K + F E+ L+K VN
Sbjct: 63 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR---PFQNQTHAKRAYRELVLMKCVN 119
Query: 469 -KNDPADEHHILRLYDYFY------HLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLG 521
KN I+ L + F + +++V EL+ ANL + +
Sbjct: 120 HKN-------IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--------MELDHE 164
Query: 522 RLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL-- 579
R+ + Q L +++LHS GIIH DLKP NI++KS C +KI+D G + + +
Sbjct: 165 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS--DCTLKILDFGLARTAGTSFMMTP 222
Query: 580 YVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEV 618
YV +R YRAPEVI+G+ Y + +D+WS+GCI+ E+ ++
Sbjct: 223 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI 261
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 1e-37
Identities = 56/234 (23%), Positives = 94/234 (40%), Gaps = 33/234 (14%)
Query: 400 ENKDLPIILNTVIAG--RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQS 457
E D + VI G + + LG A + + + DV +K I + F +
Sbjct: 8 EQDDGDEETSVVIVGKISFCPKDVLGHGAEGTIV-YRGMFDNRDVAVKRI--LPECFSFA 64
Query: 458 LDEIKLLKLVNKNDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEF--QKFNQESGG 514
E++LL+ DEH +++R + + +I EL A L E+ QK G
Sbjct: 65 DREVQLLRES------DEHPNVIRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGL 118
Query: 515 EAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS---YQRCEIKIIDLGSSC 571
E + +Q L +LHSL I+H DLKP NILI + + + I D G
Sbjct: 119 EP-------ITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCK 171
Query: 572 FQTDNLCLYVQ------SRSYRAPEVIIGLP---YDQKIDLWSLGCILAELWTG 616
+ + + + APE++ +D++S GC+ + +
Sbjct: 172 KLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISE 225
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 1e-37
Identities = 56/232 (24%), Positives = 89/232 (38%), Gaps = 36/232 (15%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKND 471
+ + LG + V Q G V +K + DF D +L EIKLL
Sbjct: 13 LKNLVVSEKILGYGSSGTVV-FQGSFQGRPVAVKRM--LIDFCDIALMEIKLLTES---- 65
Query: 472 PADEH-HILRLYDYFYHLEHLFIVCELLRANLYEF-QKFNQESGGEAYFTLGRLQVITRQ 529
D+H +++R Y L+I EL NL + + N + RQ
Sbjct: 66 --DDHPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQ 123
Query: 530 CLEALEYLHSLGIIHCDLKPENILIKS-----------YQRCEIKIIDLGSSCFQTDNLC 578
+ +LHSL IIH DLKP+NIL+ + + I I D G
Sbjct: 124 IASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQS 183
Query: 579 LYVQSRS-------YRAPEVIIGL-------PYDQKIDLWSLGCILAELWTG 616
+ + + +RAPE++ + ID++S+GC+ + +
Sbjct: 184 SFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 1e-37
Identities = 58/220 (26%), Positives = 83/220 (37%), Gaps = 34/220 (15%)
Query: 409 NTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD-------EI 461
Y + LG F VF L + V +K+I ++ L E+
Sbjct: 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEV 85
Query: 462 KLLKLVNKNDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE--AYF 518
LL V H ++RL D+F E +V E + Y
Sbjct: 86 ALLWKVGA---GGGHPGVIRLLDWFETQEGFMLVLER------------PLPAQDLFDYI 130
Query: 519 TL-GRLQ-----VITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF 572
T G L Q + A+++ HS G++H D+K ENILI +R K+ID GS
Sbjct: 131 TEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDL-RRGCAKLIDFGSGAL 189
Query: 573 QTDNLCL-YVQSRSYRAPEVIIGLPYD-QKIDLWSLGCIL 610
D + +R Y PE I Y +WSLG +L
Sbjct: 190 LHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILL 229
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 3e-37
Identities = 60/226 (26%), Positives = 96/226 (42%), Gaps = 34/226 (15%)
Query: 409 NTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD-------EI 461
+ +Y V LGS F V+ + + V +K ++ D+ L E+
Sbjct: 38 KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEV 97
Query: 462 KLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE--AYFT 519
LLK V+ ++RL D+F + ++ E E + + T
Sbjct: 98 VLLKKVSSGFS----GVIRLLDWFERPDSFVLILERP------------EPVQDLFDFIT 141
Query: 520 L-GRLQ-----VITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQ 573
G LQ Q LEA+ + H+ G++H D+K ENILI R E+K+ID GS
Sbjct: 142 ERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILI-DLNRGELKLIDFGSGALL 200
Query: 574 TDNLCL-YVQSRSYRAPEVIIGLPYD-QKIDLWSLGCILAELWTGE 617
D + + +R Y PE I Y + +WSLG +L ++ G+
Sbjct: 201 KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 246
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 3e-37
Identities = 58/228 (25%), Positives = 93/228 (40%), Gaps = 36/228 (15%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDF------FDQSLD------ 459
+ Y V ++ S ++ V D G+ V +K + N S
Sbjct: 20 MQSPYTVQRFISSGSYGAVCAGVD-SEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLR 78
Query: 460 EIKLLKLVN-KNDPADEHHILRLYDYFY-----HLEHLFIVCELLRANLYEFQKFNQESG 513
EI+LL + N IL L D F + L++V EL+R +L + +
Sbjct: 79 EIRLLNHFHHPN-------ILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIV- 130
Query: 514 GEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG--SSC 571
+ +Q L L LH G++H DL P NIL+ +I I D
Sbjct: 131 ----ISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLAD--NNDITICDFNLARED 184
Query: 572 FQTDNLCLYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEV 618
N YV R YRAPE+++ + + +D+WS GC++AE++ +
Sbjct: 185 TADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKA 232
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 3e-37
Identities = 65/226 (28%), Positives = 102/226 (45%), Gaps = 39/226 (17%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD------EIKLLK 465
+ RY Y+G A+ V A D V V +K I F+ EIK+L
Sbjct: 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP----FEHQTYCQRTLREIKILL 80
Query: 466 LVN-KNDPADEHHILRLYDYFY-----HLEHLFIVCELLRANLYEFQKFNQESGGEAYFT 519
+N I+ + D ++ ++IV +L+ +LY+ K +
Sbjct: 81 RFRHEN-------IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH-------LS 126
Query: 520 LGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG------SSCFQ 573
+ Q L L+Y+HS ++H DLKP N+L+ + C++KI D G
Sbjct: 127 NDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT--TCDLKICDFGLARVADPDHDH 184
Query: 574 TDNLCLYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEV 618
T L YV +R YRAPE+++ Y + ID+WS+GCILAE+ +
Sbjct: 185 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 230
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 4e-37
Identities = 46/231 (19%), Positives = 88/231 (38%), Gaps = 40/231 (17%)
Query: 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD----EIKLLK 465
+ + +++ LG A + VF+ + TG +K+ + F + +D E ++LK
Sbjct: 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVF--NNISFLRPVDVQMREFEVLK 62
Query: 466 LVNKNDPADEH-HILRLYDYF--YHLEHLFIVCEL-----LRANLYEFQKFNQESGGEAY 517
+N H +I++L+ H ++ E L L E E
Sbjct: 63 KLN-------HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEF- 114
Query: 518 FTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQ--RCEIKIIDLGSSCFQTD 575
++ R + + +L GI+H ++KP NI+ + + K+ D G++ D
Sbjct: 115 ------LIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED 168
Query: 576 NLCLYVQ--SRSYRAPEVIIGL--------PYDQKIDLWSLGCILAELWTG 616
+ + Y P++ Y +DLWS+G TG
Sbjct: 169 DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATG 219
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 5e-37
Identities = 58/220 (26%), Positives = 92/220 (41%), Gaps = 42/220 (19%)
Query: 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNK 469
+ + LG F V+ A++ + + LK++ + Q E+++ +
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR- 67
Query: 470 NDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTL---GRL-- 523
H +ILRLY YF+ ++++ E G Y L +
Sbjct: 68 ------HPNILRLYGYFHDATRVYLILEYA-------------PLGTVYRELQKLSKFDE 108
Query: 524 ---QVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN---- 576
+ AL Y HS +IH D+KPEN+L+ S E+KI D G S +
Sbjct: 109 QRTATYITELANALSYCHSKRVIHRDIKPENLLLGS--AGELKIADFGWSVHAPSSRRTD 166
Query: 577 LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTG 616
LC + Y PE+I G +D+K+DLWSLG + E G
Sbjct: 167 LC---GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 203
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 8e-37
Identities = 63/249 (25%), Positives = 110/249 (44%), Gaps = 55/249 (22%)
Query: 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKN 470
+ +Y + + LG+ +F V + D+ +G LK + D + E+ ++K+++
Sbjct: 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY---KNRELDIMKVLD-- 58
Query: 471 DPADEH-HILRLYDYFYHLEH--------------------------------------L 491
H +I++L DYFY L
Sbjct: 59 -----HVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYL 113
Query: 492 FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPEN 551
++ E + L++ K SG + + + Q A+ ++HSLGI H D+KP+N
Sbjct: 114 NVIMEYVPDTLHKVLKSFIRSGRS--IPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQN 171
Query: 552 ILIKSYQRCEIKIIDLGS--SCFQTDNLCLYVQSRSYRAPEVIIGLP-YDQKIDLWSLGC 608
+L+ S + +K+ D GS ++ Y+ SR YRAPE+++G Y IDLWS+GC
Sbjct: 172 LLVNS-KDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGC 230
Query: 609 ILAELWTGE 617
+ EL G+
Sbjct: 231 VFGELILGK 239
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 1e-36
Identities = 70/211 (33%), Positives = 100/211 (47%), Gaps = 32/211 (15%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSL-DEIKLLKLVNKN 470
I + E LGS AFS+VF + TG LK IK F D SL +EI +LK +
Sbjct: 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIK-- 64
Query: 471 DPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE--------AYFTLG 521
H +I+ L D + H ++V +L+ SGGE +T
Sbjct: 65 -----HENIVTLEDIYESTTHYYLVMQLV-------------SGGELFDRILERGVYTEK 106
Query: 522 RLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQR-CEIKIIDLG-SSCFQTDNLCL 579
++ +Q L A++YLH GI+H DLKPEN+L + + +I I D G S Q +
Sbjct: 107 DASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMST 166
Query: 580 YVQSRSYRAPEVIIGLPYDQKIDLWSLGCIL 610
+ Y APEV+ PY + +D WS+G I
Sbjct: 167 ACGTPGYVAPEVLAQKPYSKAVDCWSIGVIT 197
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 1e-36
Identities = 55/228 (24%), Positives = 97/228 (42%), Gaps = 39/228 (17%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKII-KNDKDFFDQSLDEIKLLKLVNKNDPA 473
R V L F+ V++AQD+ +G + LK + N+++ + E+ +K ++ +
Sbjct: 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHP-- 86
Query: 474 DEHHILRLYDYFYHLEH--------LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQV 525
+I++ + ++ EL + L EF K + G + +
Sbjct: 87 ---NIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRG---PLSCDTVLK 140
Query: 526 ITRQCLEALEYLHSLG--IIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQS 583
I Q A++++H IIH DLK EN+L+ + IK+ D GS+ + +
Sbjct: 141 IFYQTCRAVQHMHRQKPPIIHRDLKVENLLL--SNQGTIKLCDFGSATTISHYPDYSWSA 198
Query: 584 R---------------SYRAPEVI---IGLPYDQKIDLWSLGCILAEL 613
+ YR PE+I P +K D+W+LGCIL L
Sbjct: 199 QRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLL 246
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 1e-36
Identities = 58/211 (27%), Positives = 96/211 (45%), Gaps = 22/211 (10%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD---FFDQSLDEIKLLKLVNKND 471
+Y +G ++ VF+ ++ TG V +K +D +L EI++LK +
Sbjct: 4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLK--- 60
Query: 472 PADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQC 530
H +++ L + F L +V E + Q ++ IT Q
Sbjct: 61 ----HPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRG-----VPEHLVKSITWQT 111
Query: 531 LEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG---SSCFQTDNLCLYVQSRSYR 587
L+A+ + H IH D+KPENILI IK+ D G +D V +R YR
Sbjct: 112 LQAVNFCHKHNCIHRDVKPENILITK--HSVIKLCDFGFARLLTGPSDYYDDEVATRWYR 169
Query: 588 APEVIIGLP-YDQKIDLWSLGCILAELWTGE 617
+PE+++G Y +D+W++GC+ AEL +G
Sbjct: 170 SPELLVGDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-36
Identities = 54/208 (25%), Positives = 99/208 (47%), Gaps = 23/208 (11%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPAD 474
Y + LG +S+VF+A ++ V +KI+K K + EIK+L+ + + P
Sbjct: 37 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK--KKIKREIKILENL-RGGP-- 91
Query: 475 EHHILRLYDYFY---HLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCL 531
+I+ L D + + + + + T ++ + L
Sbjct: 92 --NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ---------TLTDYDIRFYMYEIL 140
Query: 532 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL--YVQSRSYRAP 589
+AL+Y HS+GI+H D+KP N++I + ++++ID G + F V SR ++ P
Sbjct: 141 KALDYCHSMGIMHRDVKPHNVMIDH-EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGP 199
Query: 590 EVIIGLP-YDQKIDLWSLGCILAELWTG 616
E+++ YD +D+WSLGC+LA +
Sbjct: 200 ELLVDYQMYDYSLDMWSLGCMLASMIFR 227
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 144 bits (363), Expect = 2e-36
Identities = 57/219 (26%), Positives = 93/219 (42%), Gaps = 21/219 (9%)
Query: 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQS--LDEIKLLKLV 467
T G + + E LG+ F V + TG V +K + + ++ EI+++K +
Sbjct: 10 TQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKL 69
Query: 468 NKNDPADEH-HILRLYDYFYHLEHL------FIVCELLRANLYEFQKFNQESGGEAYFTL 520
N H +++ + L+ L + E + +K+ +
Sbjct: 70 N-------HPNVVSAREVPDGLQKLAPNDLPLLAMEY--CEGGDLRKYLNQFENCCGLKE 120
Query: 521 GRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSY-QRCEIKIIDLGSSCFQTDNLCL 579
G ++ + AL YLH IIH DLKPENI+++ QR KIIDLG +
Sbjct: 121 GPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELC 180
Query: 580 --YVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTG 616
+V + Y APE++ Y +D WS G + E TG
Sbjct: 181 TEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITG 219
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 3e-36
Identities = 56/220 (25%), Positives = 92/220 (41%), Gaps = 42/220 (19%)
Query: 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNK 469
+ + LG F V+ A++ + LK++ + Q EI++ +
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR- 72
Query: 470 NDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTL---GRLQ- 524
H +ILR+Y+YF+ + ++++ E GE Y L GR
Sbjct: 73 ------HPNILRMYNYFHDRKRIYLMLEFA-------------PRGELYKELQKHGRFDE 113
Query: 525 ----VITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN---- 576
+ +AL Y H +IH D+KPEN+L+ + E+KI D G S
Sbjct: 114 QRSATFMEELADALHYCHERKVIHRDIKPENLLMGY--KGELKIADFGWSVHAPSLRRRT 171
Query: 577 LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTG 616
+C + Y PE+I G +D+K+DLW G + E G
Sbjct: 172 MC---GTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVG 208
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 5e-36
Identities = 65/233 (27%), Positives = 104/233 (44%), Gaps = 46/233 (19%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD------EIKLLK 465
I+ + + LG A+ V A TG V +K I+ FD+ L EIK+LK
Sbjct: 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEP----FDKPLFALRTLREIKILK 64
Query: 466 LVN-KNDPADEHHILRLYDYFY-----HLEHLFIVCELLRANLYEFQKFNQESGGEAYFT 519
+N I+ +++ + ++I+ EL++ +L+ +
Sbjct: 65 HFKHEN-------IITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQM-------LS 110
Query: 520 LGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG----------- 568
+Q Q L A++ LH +IH DLKP N+LI S C++K+ D G
Sbjct: 111 DDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINS--NCDLKVCDFGLARIIDESAAD 168
Query: 569 --SSCFQTDNLCLYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEV 618
Q + +V +R YRAPEV++ Y + +D+WS GCILAEL+
Sbjct: 169 NSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRP 221
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 5e-36
Identities = 46/229 (20%), Positives = 86/229 (37%), Gaps = 36/229 (15%)
Query: 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLV 467
+ + +++ LG A + VF+ + TG +K+ N D + E ++LK +
Sbjct: 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64
Query: 468 NKNDPADEH-HILRLYDYFYHL--EHLFIVCEL-----LRANLYEFQKFNQESGGEAYFT 519
N H +I++L+ H ++ E L L E E
Sbjct: 65 N-------HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEF--- 114
Query: 520 LGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQ--RCEIKIIDLGSSCFQTDNL 577
++ R + + +L GI+H ++KP NI+ + + K+ D G++ D+
Sbjct: 115 ----LIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE 170
Query: 578 CL--YVQSRSYRAPEVIIGL--------PYDQKIDLWSLGCILAELWTG 616
+ Y P++ Y +DLWS+G TG
Sbjct: 171 QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATG 219
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 6e-36
Identities = 54/211 (25%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNK 469
+ V LG +F+ V++A+ +HTG++V +K+I + +E+K+ +
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK- 69
Query: 470 NDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITR 528
H IL LY+YF ++++V E+ E ++ + F+ +
Sbjct: 70 ------HPSILELYNYFEDSNYVYLVLEMCHNG--EMNRYLKNRVK--PFSENEARHFMH 119
Query: 529 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG-SSCFQTDNLCLYVQ--SRS 585
Q + + YLHS GI+H DL N+L+ IKI D G ++ + + Y + +
Sbjct: 120 QIITGMLYLHSHGILHRDLTLSNLLLTR--NMNIKIADFGLATQLKMPHEKHYTLCGTPN 177
Query: 586 YRAPEVIIGLPYDQKIDLWSLGCILAELWTG 616
Y +PE+ + + D+WSLGC+ L G
Sbjct: 178 YISPEIATRSAHGLESDVWSLGCMFYTLLIG 208
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 1e-35
Identities = 49/230 (21%), Positives = 93/230 (40%), Gaps = 36/230 (15%)
Query: 407 ILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKL 466
++ + E +GS F +VF+A+ G +K +K + + ++ E+K L
Sbjct: 4 TVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE---KAEREVKALAK 60
Query: 467 VNKNDPADEH-HILRLYDYFYHLEH----------------LFIVCELL-RANLYEFQKF 508
++ H +I+ + ++ LFI E + L ++ +
Sbjct: 61 LD-------HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEK 113
Query: 509 NQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568
+ + Q + ++Y+HS +I+ DLKP NI + + ++KI D G
Sbjct: 114 RRGE----KLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTK--QVKIGDFG 167
Query: 569 SSCF--QTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTG 616
+ Y +PE I Y +++DL++LG ILAEL
Sbjct: 168 LVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHV 217
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 2e-35
Identities = 48/247 (19%), Positives = 91/247 (36%), Gaps = 36/247 (14%)
Query: 398 FEENKDLPIILN----TVIAGRYYVTEYLGSAAFSKVFQA-----QDLHTGVDVCLKIIK 448
FE LP I + + YV LG AF++V++A D LK+ K
Sbjct: 45 FEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQK 104
Query: 449 NDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRA----NLYE 504
+ + +L+ + P+ +H ++ Y +V EL N
Sbjct: 105 PANPW-----EFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAIN 159
Query: 505 FQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCE--- 561
K E G + + L +E +H IIH D+KP+N ++ + +
Sbjct: 160 LYKNTPEKV----MPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDE 215
Query: 562 ------IKIIDLGSSCF-----QTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCIL 610
+ +IDLG S + ++ ++ E++ P++ +ID + + +
Sbjct: 216 DDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATV 275
Query: 611 AELWTGE 617
+ G
Sbjct: 276 YCMLFGT 282
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-35
Identities = 64/208 (30%), Positives = 94/208 (45%), Gaps = 34/208 (16%)
Query: 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADE 475
+ LG +FS + + +KII K + EI LKL +
Sbjct: 13 DLKDKPLGEGSFSICRKCVHKKSNQAFAVKII--SKRMEANTQKEITALKLC------EG 64
Query: 476 H-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE--------AYFTLGRLQVI 526
H +I++L++ F+ H F+V ELL GGE +F+ I
Sbjct: 65 HPNIVKLHEVFHDQLHTFLVMELLN-------------GGELFERIKKKKHFSETEASYI 111
Query: 527 TRQCLEALEYLHSLGIIHCDLKPENILIKSYQR-CEIKIIDLG-SSCFQTDNLCLY--VQ 582
R+ + A+ ++H +G++H DLKPEN+L EIKIID G + DN L
Sbjct: 112 MRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCF 171
Query: 583 SRSYRAPEVIIGLPYDQKIDLWSLGCIL 610
+ Y APE++ YD+ DLWSLG IL
Sbjct: 172 TLHYAAPELLNQNGYDESCDLWSLGVIL 199
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 3e-35
Identities = 62/245 (25%), Positives = 94/245 (38%), Gaps = 55/245 (22%)
Query: 409 NTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVN 468
+ A + LG AF +V +A++ +K I++ ++ L E+ LL +N
Sbjct: 1 SLRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLN 60
Query: 469 KNDPADEH-HILRLYDYFYHLEH-------------LFIVCEL-----LRANLYEFQKFN 509
H +++R Y + + LFI E L ++
Sbjct: 61 -------HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQ 113
Query: 510 QESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569
Q + RQ LEAL Y+HS GIIH DLKP NI I +KI D G
Sbjct: 114 QRD---------EYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDE--SRNVKIGDFGL 162
Query: 570 SCFQTDNLCLYVQSRS-----------------YRAPEVIIGLP-YDQKIDLWSLGCILA 611
+ +L + Y A EV+ G Y++KID++SLG I
Sbjct: 163 AKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFF 222
Query: 612 ELWTG 616
E+
Sbjct: 223 EMIYP 227
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 5e-35
Identities = 48/210 (22%), Positives = 82/210 (39%), Gaps = 22/210 (10%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK----NDKDFFDQSLDEIKLLKLVNKN 470
+ LG ++ +VF+ + G +K KD + L E+ + V ++
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDR-ARKLAEVGSHEKVGQH 116
Query: 471 DPADEHHILRLYDYFYHLEHLFIVCELLRANLYEF-QKFNQESGGEAYFTLGRLQVITRQ 529
+RL + L++ EL +L + + + ++ R
Sbjct: 117 P-----CCVRLEQAWEEGGILYLQTELCGPSLQQHCEAWGA------SLPEAQVWGYLRD 165
Query: 530 CLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQ--SRSYR 587
L AL +LHS G++H D+KP NI + R K+ D G VQ Y
Sbjct: 166 TLLALAHLHSQGLVHLDVKPANIFLGPRGR--CKLGDFGLLVELGTAGAGEVQEGDPRYM 223
Query: 588 APEVIIGLPYDQKIDLWSLGCILAELWTGE 617
APE++ G Y D++SLG + E+
Sbjct: 224 APELLQG-SYGTAADVFSLGLTILEVACNM 252
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 7e-35
Identities = 51/211 (24%), Positives = 96/211 (45%), Gaps = 22/211 (10%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD---FFDQSLDEIKLLKLVNKND 471
+Y +G ++ V + ++ TG V +K D ++ EIKLLK +
Sbjct: 26 KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLR--- 82
Query: 472 PADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQC 530
H +++ L + + ++V E + + + + +Q Q
Sbjct: 83 ----HENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNG-----LDYQVVQKYLFQI 133
Query: 531 LEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG---SSCFQTDNLCLYVQSRSYR 587
+ + + HS IIH D+KPENIL+ +K+ D G + + V +R YR
Sbjct: 134 INGIGFCHSHNIIHRDIKPENILVSQ--SGVVKLCDFGFARTLAAPGEVYDDEVATRWYR 191
Query: 588 APEVIIGLP-YDQKIDLWSLGCILAELWTGE 617
APE+++G Y + +D+W++GC++ E++ GE
Sbjct: 192 APELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 8e-35
Identities = 62/245 (25%), Positives = 99/245 (40%), Gaps = 56/245 (22%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD------EIKLLK 465
+ Y + +G ++ V+ A D +T +V +K + F+ +D EI +L
Sbjct: 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNR---MFEDLIDCKRILREITILN 80
Query: 466 LVNKNDPADEH-HILRLYDYFY-----HLEHLFIVCELLRANLYEFQKFNQESGGEAYFT 519
+ +I+RLYD + L+IV E+ ++L + K + T
Sbjct: 81 RLK-------SDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPI------FLT 127
Query: 520 LGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG----------- 568
++ I L ++H GIIH DLKP N L+ C +K+ D G
Sbjct: 128 EEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQ--DCSVKVCDFGLARTINSEKDT 185
Query: 569 --------------SSCFQTDNLCLYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAEL 613
+ L +V +R YRAPE+I+ Y + ID+WS GCI AEL
Sbjct: 186 NIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAEL 245
Query: 614 WTGEV 618
Sbjct: 246 LNMLQ 250
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-34
Identities = 57/239 (23%), Positives = 90/239 (37%), Gaps = 41/239 (17%)
Query: 390 IHRKNRTGFEENKDLPIILNTVIAGRYYVT-EYLGSAAFSKVFQAQDLHTGVDVCLKIIK 448
H + +G E P + Y ++ + LG KV + TG LK++
Sbjct: 4 HHHHHSSGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLY 63
Query: 449 NDKDFFDQSLDEIKLLKLVNKNDPADEH-HILRLYDYF----YHLEHLFIVCELLRANLY 503
+ E+ + HI+ + D + + L I+ E +
Sbjct: 64 DSPKARQ----EVDHHWQASG------GPHIVCILDVYENMHHGKRCLLIIMECME---- 109
Query: 504 EFQKFNQESGGE----------AYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENIL 553
GGE FT I R A+++LHS I H D+KPEN+L
Sbjct: 110 ---------GGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLL 160
Query: 554 IKS-YQRCEIKIIDLG-SSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCIL 610
S + +K+ D G + + L + Y APEV+ YD+ D+WSLG I+
Sbjct: 161 YTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 219
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 1e-34
Identities = 36/240 (15%), Positives = 74/240 (30%), Gaps = 40/240 (16%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIK--------LLKL 466
LG +A D TG + + + ++ ++K L +
Sbjct: 74 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133
Query: 467 VNKNDPADEHHILRLYDYFYHLEHLFIVCELLRAN---------LYEFQKFNQESGGEAY 517
N+ + +D + ++ L LY + N ++ GE
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 193
Query: 518 FTLGRLQ---------VITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568
+ +T Q + L LH G++H L+P +I++ R + +
Sbjct: 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQ--RGGVFLTGFE 251
Query: 569 SSCFQTDNLCLYVQSRSYRAPEVII-----------GLPYDQKIDLWSLGCILAELWTGE 617
+ + SR + PE+ D W+LG ++ +W +
Sbjct: 252 HLV-RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-34
Identities = 67/221 (30%), Positives = 105/221 (47%), Gaps = 35/221 (15%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK----NDKDFFDQSLDEIKLLKLV 467
+ RY LG +F +V +D TG + +K+I K + L E++LLK +
Sbjct: 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL 83
Query: 468 NKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE--------AYFT 519
D +I++LY++F + ++V E+ +GGE F+
Sbjct: 84 ------DHPNIMKLYEFFEDKGYFYLVGEVY-------------TGGELFDEIISRKRFS 124
Query: 520 LGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS-YQRCEIKIIDLGSSCF--QTDN 576
I RQ L + Y+H I+H DLKPEN+L++S + I+IID G S +
Sbjct: 125 EVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK 184
Query: 577 LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGE 617
+ + + Y APEV+ G YD+K D+WS G IL L +G
Sbjct: 185 MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGC 224
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 1e-34
Identities = 67/220 (30%), Positives = 109/220 (49%), Gaps = 41/220 (18%)
Query: 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD-----EIKLLKLVN 468
G Y + + +G F+KV A+ + TG +V +KII DK + + E++++K++N
Sbjct: 15 GNYRLLKTIGKGNFAKVKLARHILTGREVAIKII--DKTQLNPTSLQKLFREVRIMKILN 72
Query: 469 KNDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTL---GRLQ 524
H +I++L++ + L+++ E SGGE + L GR++
Sbjct: 73 -------HPNIVKLFEVIETEKTLYLIMEYA-------------SGGEVFDYLVAHGRMK 112
Query: 525 -----VITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN--L 577
RQ + A++Y H I+H DLK EN+L+ + IKI D G S T L
Sbjct: 113 EKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDA--DMNIKIADFGFSNEFTVGGKL 170
Query: 578 CLYVQSRSYRAPEVIIGLPYD-QKIDLWSLGCILAELWTG 616
+ + Y APE+ G YD ++D+WSLG IL L +G
Sbjct: 171 DAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 210
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-34
Identities = 52/215 (24%), Positives = 85/215 (39%), Gaps = 42/215 (19%)
Query: 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEH-HI 478
+G +F +V + +D TG +K + ++E+ ++ I
Sbjct: 64 PRVGRGSFGEVHRMKDKQTGFQCAVKKV----RLEVFRVEELVACAGLS-------SPRI 112
Query: 479 LRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGG------EAY--FTLGRLQVITRQC 530
+ LY + I ELL GG + R Q
Sbjct: 113 VPLYGAVREGPWVNIFMELL-------------EGGSLGQLIKQMGCLPEDRALYYLGQA 159
Query: 531 LEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG-SSCFQTDNLCLYVQSRS---- 585
LE LEYLH+ I+H D+K +N+L+ S + D G + C Q D L + +
Sbjct: 160 LEGLEYLHTRRILHGDVKADNVLL-SSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPG 218
Query: 586 ---YRAPEVIIGLPYDQKIDLWSLGCILAELWTGE 617
+ APEV++G P D K+D+WS C++ + G
Sbjct: 219 TETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGC 253
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-34
Identities = 67/225 (29%), Positives = 97/225 (43%), Gaps = 42/225 (18%)
Query: 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD---------EIKLL 464
+Y LGS AF V+ A D +V +K IK +K D ++ EI +L
Sbjct: 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAIL 83
Query: 465 KLVNKNDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE--AYFTL- 520
V H +I+++ D F + +V E SG + A+
Sbjct: 84 SRVE-------HANIIKVLDIFENQGFFQLVMEK------------HGSGLDLFAFIDRH 124
Query: 521 GRLQ-----VITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTD 575
RL I RQ + A+ YL IIH D+K ENI+I IK+ID GS+ +
Sbjct: 125 PRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAE--DFTIKLIDFGSAAYLER 182
Query: 576 NLCLYVQ--SRSYRAPEVIIGLPYD-QKIDLWSLGCILAELWTGE 617
Y + Y APEV++G PY ++++WSLG L L E
Sbjct: 183 GKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEE 227
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 3e-34
Identities = 53/211 (25%), Positives = 87/211 (41%), Gaps = 32/211 (15%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKN 470
I Y + +G ++ +V A T + K I + D+ EI+++K +
Sbjct: 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSL--- 63
Query: 471 DPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE--------AYFTLGR 522
D +I+RLY+ F +++V EL +GGE F
Sbjct: 64 ---DHPNIIRLYETFEDNTDIYLVMELC-------------TGGELFERVVHKRVFRESD 107
Query: 523 LQVITRQCLEALEYLHSLGIIHCDLKPENILIKS-YQRCEIKIIDLGSSCFQTDNLCLY- 580
I + L A+ Y H L + H DLKPEN L + +K+ID G + +
Sbjct: 108 AARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRT 167
Query: 581 -VQSRSYRAPEVIIGLPYDQKIDLWSLGCIL 610
V + Y +P+V+ G Y + D WS G ++
Sbjct: 168 KVGTPYYVSPQVLEG-LYGPECDEWSAGVMM 197
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 3e-34
Identities = 57/214 (26%), Positives = 96/214 (44%), Gaps = 35/214 (16%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD---EIKLLKLVN 468
+ Y V E LG AFS V + TG++ KII K E ++ + +
Sbjct: 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQ 63
Query: 469 KNDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE--------AYFT 519
H +I+RL+D ++V +L+ +GGE +++
Sbjct: 64 -------HPNIVRLHDSIQEESFHYLVFDLV-------------TGGELFEDIVAREFYS 103
Query: 520 LGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQR-CEIKIIDLGSSCFQTDNLC 578
+Q LE++ Y HS GI+H +LKPEN+L+ S + +K+ D G + D+
Sbjct: 104 EADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA 163
Query: 579 LY--VQSRSYRAPEVIIGLPYDQKIDLWSLGCIL 610
+ + Y +PEV+ PY + +D+W+ G IL
Sbjct: 164 WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 197
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 5e-34
Identities = 49/212 (23%), Positives = 95/212 (44%), Gaps = 23/212 (10%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK----NDKDFFDQSLDEIKLLKLVNKN 470
+Y + +G +F K + G +K I + K+ ++S E+ +L +
Sbjct: 25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKER-EESRREVAVLANMK-- 81
Query: 471 DPADEH-HILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITR 528
H +I++ + F L+IV + +L F++ N + G F ++
Sbjct: 82 -----HPNIVQYRESFEENGSLYIVMDYCEGGDL--FKRINAQKGV--LFQEDQILDWFV 132
Query: 529 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF---QTDNLCLYVQSRS 585
Q AL+++H I+H D+K +NI + +++ D G + + + +
Sbjct: 133 QICLALKHVHDRKILHRDIKSQNIFLTKDGT--VQLGDFGIARVLNSTVELARACIGTPY 190
Query: 586 YRAPEVIIGLPYDQKIDLWSLGCILAELWTGE 617
Y +PE+ PY+ K D+W+LGC+L EL T +
Sbjct: 191 YLSPEICENKPYNNKSDIWALGCVLYELCTLK 222
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 5e-34
Identities = 57/210 (27%), Positives = 92/210 (43%), Gaps = 31/210 (14%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKND 471
++ + V LG A S V++ + T LK++K D EI +L +
Sbjct: 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK-KIVRTEIGVLLRL---- 105
Query: 472 PADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE--------AYFTLGRL 523
+I++L + F + +V EL+ +GGE Y++
Sbjct: 106 --SHPNIIKLKEIFETPTEISLVLELV-------------TGGELFDRIVEKGYYSERDA 150
Query: 524 QVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQR-CEIKIIDLGSSCFQTDNLCLY-- 580
+Q LEA+ YLH GI+H DLKPEN+L + +KI D G S + +
Sbjct: 151 ADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTV 210
Query: 581 VQSRSYRAPEVIIGLPYDQKIDLWSLGCIL 610
+ Y APE++ G Y ++D+WS+G I
Sbjct: 211 CGTPGYCAPEILRGCAYGPEVDMWSVGIIT 240
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 5e-34
Identities = 67/223 (30%), Positives = 102/223 (45%), Gaps = 45/223 (20%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK---------NDKDFFDQSLDEIK 462
+ Y +++ LGS A +V A + T V +KII + D EI+
Sbjct: 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIE 67
Query: 463 LLKLVNKNDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE------ 515
+LK +N H I+++ + F+ E +IV EL+ GGE
Sbjct: 68 ILKKLN-------HPCIIKIKN-FFDAEDYYIVLELM-------------EGGELFDKVV 106
Query: 516 --AYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSY-QRCEIKIIDLGSSCF 572
++ Q L A++YLH GIIH DLKPEN+L+ S + C IKI D G S
Sbjct: 107 GNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 166
Query: 573 QTDNLCLY--VQSRSYRAPEVIIGL---PYDQKIDLWSLGCIL 610
+ + + +Y APEV++ + Y++ +D WSLG IL
Sbjct: 167 LGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 6e-34
Identities = 56/213 (26%), Positives = 96/213 (45%), Gaps = 36/213 (16%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKND 471
Y V E +G ++S + T ++ +KII K +EI++L +
Sbjct: 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR---DPTEEIEILLRYGQ-- 74
Query: 472 PADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE--------AYFTLGR 522
H +I+ L D + +++++V EL++ GGE +F+
Sbjct: 75 ----HPNIITLKDVYDDGKYVYVVTELMK-------------GGELLDKILRQKFFSERE 117
Query: 523 LQVITRQCLEALEYLHSLGIIHCDLKPENILI--KSYQRCEIKIIDLG-SSCFQTDNLCL 579
+ + +EYLH+ G++H DLKP NIL +S I+I D G + + +N L
Sbjct: 118 ASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLL 177
Query: 580 Y--VQSRSYRAPEVIIGLPYDQKIDLWSLGCIL 610
+ ++ APEV+ YD D+WSLG +L
Sbjct: 178 MTPCYTANFVAPEVLERQGYDAACDIWSLGVLL 210
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 7e-34
Identities = 68/221 (30%), Positives = 104/221 (47%), Gaps = 36/221 (16%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKII---KNDKDFFDQSLDEIKLLKLVN 468
++ Y + LGS A+ +V +D T V+ +KII + L+E+ +LKL++
Sbjct: 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLD 94
Query: 469 KNDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE--------AYFT 519
H +I++LYD+F + ++V E GGE F
Sbjct: 95 -------HPNIMKLYDFFEDKRNYYLVMECY-------------KGGELFDEIIHRMKFN 134
Query: 520 LGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS-YQRCEIKIIDLGSSCF--QTDN 576
VI +Q L + YLH I+H DLKPEN+L++S + IKI+D G S
Sbjct: 135 EVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK 194
Query: 577 LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGE 617
+ + + Y APEV+ YD+K D+WS+G IL L G
Sbjct: 195 MKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGY 234
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 8e-34
Identities = 62/238 (26%), Positives = 109/238 (45%), Gaps = 50/238 (21%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD------EIKLLK 465
+ +Y + + LG A+ V+++ D TG V +K I + F S D EI +L
Sbjct: 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFD---AFQNSTDAQRTFREIMILT 63
Query: 466 LVNKNDPADEHHILRLYDYFY--HLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRL 523
++ ++ +I+ L + + +++V + + +L+ + N
Sbjct: 64 ELSGHE-----NIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANI-------LEPVHK 111
Query: 524 QVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG--------------- 568
Q + Q ++ ++YLHS G++H D+KP NIL+ + C +K+ D G
Sbjct: 112 QYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNA--ECHVKVADFGLSRSFVNIRRVTNNI 169
Query: 569 ---------SSCFQTDNLCLYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTG 616
+ L YV +R YRAPE+++G Y + ID+WSLGCIL E+ G
Sbjct: 170 PLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCG 227
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 9e-34
Identities = 61/213 (28%), Positives = 97/213 (45%), Gaps = 20/213 (9%)
Query: 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK----NDKDFFDQSLDEIKLLKLVNK 469
+ + + +G FS+V++A L GV V LK ++ D + EI LLK +N
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN- 90
Query: 470 NDPADEH-HILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVIT 527
H ++++ Y F L IV EL A +L K ++ +
Sbjct: 91 ------HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKR--LIPERTVWKYF 142
Query: 528 RQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL---YVQSR 584
Q ALE++HS ++H D+KP N+ I + +K+ DLG F + V +
Sbjct: 143 VQLCSALEHMHSRRVMHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTTAAHSLVGTP 200
Query: 585 SYRAPEVIIGLPYDQKIDLWSLGCILAELWTGE 617
Y +PE I Y+ K D+WSLGC+L E+ +
Sbjct: 201 YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQ 233
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 1e-33
Identities = 65/232 (28%), Positives = 105/232 (45%), Gaps = 47/232 (20%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK--------------NDKDFFDQS 457
I Y+ LGS A+ +V ++ + + +K+IK N + F ++
Sbjct: 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEI 93
Query: 458 LDEIKLLKLVNKNDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE- 515
+EI LLK ++ H +I++L+D F ++ ++V E GGE
Sbjct: 94 YNEISLLKSLD-------HPNIIKLFDVFEDKKYFYLVTEFY-------------EGGEL 133
Query: 516 -------AYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS-YQRCEIKIIDL 567
F I +Q L + YLH I+H D+KPENIL+++ IKI+D
Sbjct: 134 FEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDF 193
Query: 568 GSSCFQTDNLCLY--VQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGE 617
G S F + + L + + Y APEV+ Y++K D+WS G I+ L G
Sbjct: 194 GLSSFFSKDYKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGY 244
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 1e-33
Identities = 68/235 (28%), Positives = 103/235 (43%), Gaps = 44/235 (18%)
Query: 391 HRKNRTGFEENKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKII--- 447
H R A RY + LG +F +V + +D T + +K+I
Sbjct: 7 HSSGRENLYFQGT--------FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKA 58
Query: 448 KNDKDFFDQSLDEIKLLKLVNKNDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQ 506
L E++LLK ++ H +I++L++ +IV EL
Sbjct: 59 SAKNKDTSTILREVELLKKLD-------HPNIMKLFEILEDSSSFYIVGELY-------- 103
Query: 507 KFNQESGGE--------AYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQ 558
+GGE F+ I +Q + Y+H I+H DLKPENIL++S +
Sbjct: 104 -----TGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKE 158
Query: 559 R-CEIKIIDLGSSCFQTDNLCLY--VQSRSYRAPEVIIGLPYDQKIDLWSLGCIL 610
+ C+IKIID G S N + + + Y APEV+ G YD+K D+WS G IL
Sbjct: 159 KDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVIL 212
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-33
Identities = 62/221 (28%), Positives = 91/221 (41%), Gaps = 42/221 (19%)
Query: 409 NTVIAGRYYVT-EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLV 467
I Y VT + LG KV Q + T LK++++ E++L
Sbjct: 56 KNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR----EVELHWRA 111
Query: 468 NKNDPADEH-HILRLYDYF----YHLEHLFIVCELLRANLYEFQKFNQESGGE------- 515
++ HI+R+ D + + L IV E L GGE
Sbjct: 112 SQ------CPHIVRIVDVYENLYAGRKCLLIVMECLD-------------GGELFSRIQD 152
Query: 516 ---AYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS-YQRCEIKIIDLGSSC 571
FT I + EA++YLHS+ I H D+KPEN+L S +K+ D G +
Sbjct: 153 RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 212
Query: 572 FQTDNLCLY--VQSRSYRAPEVIIGLPYDQKIDLWSLGCIL 610
T + L + Y APEV+ YD+ D+WSLG I+
Sbjct: 213 ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 253
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-33
Identities = 71/242 (29%), Positives = 109/242 (45%), Gaps = 40/242 (16%)
Query: 391 HRKNRTGFEENKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKII--- 447
H + + EN + A RY + LG +F +V + +D T + +K+I
Sbjct: 3 HHHHHSSGREN----LYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKA 58
Query: 448 KNDKDFFDQSLDEIKLLKLVNKNDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQ 506
L E++LLK ++ H +I++L++ +IV EL
Sbjct: 59 SAKNKDTSTILREVELLKKLD-------HPNIMKLFEILEDSSSFYIVGELY-------- 103
Query: 507 KFNQESGGE--------AYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS-Y 557
+GGE F+ I +Q + Y+H I+H DLKPENIL++S
Sbjct: 104 -----TGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKE 158
Query: 558 QRCEIKIIDLGSSCFQTDNLCLY--VQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT 615
+ C+IKIID G S N + + + Y APEV+ G YD+K D+WS G IL L +
Sbjct: 159 KDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLS 217
Query: 616 GE 617
G
Sbjct: 218 GT 219
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 3e-33
Identities = 48/219 (21%), Positives = 88/219 (40%), Gaps = 28/219 (12%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK----NDKDFFDQSLDEIKLLKLVNKN 470
Y V +G+ ++ + + + G + K + + + + E+ LL+ +
Sbjct: 7 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEK-QMLVSEVNLLRELK-- 63
Query: 471 DPADEH-HILRLYDYFYHLE--HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVI 526
H +I+R YD L+IV E +L + Y + +
Sbjct: 64 -----HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKER--QYLDEEFVLRV 116
Query: 527 TRQCLEALEYLHSLG-----IIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL-- 579
Q AL+ H ++H DLKP N+ + Q +K+ D G + +
Sbjct: 117 MTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQN--VKLGDFGLARILNHDTSFAK 174
Query: 580 -YVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGE 617
+V + Y +PE + + Y++K D+WSLGC+L EL
Sbjct: 175 TFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALM 213
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 3e-33
Identities = 58/214 (27%), Positives = 98/214 (45%), Gaps = 35/214 (16%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKII---KNDKDFFDQSLDEIKLLKLVN 468
+ Y V E LG AFS V + TG++ KII K F + E ++ + +
Sbjct: 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQ 86
Query: 469 KNDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE--------AYFT 519
H +I+RL+D ++V +L+ +GGE +++
Sbjct: 87 -------HPNIVRLHDSIQEESFHYLVFDLV-------------TGGELFEDIVAREFYS 126
Query: 520 LGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQR-CEIKIIDLGSSCFQTDNLC 578
+Q LE++ Y HS GI+H +LKPEN+L+ S + +K+ D G + D+
Sbjct: 127 EADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA 186
Query: 579 LY--VQSRSYRAPEVIIGLPYDQKIDLWSLGCIL 610
+ + Y +PEV+ PY + +D+W+ G IL
Sbjct: 187 WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 220
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 5e-33
Identities = 70/219 (31%), Positives = 100/219 (45%), Gaps = 38/219 (17%)
Query: 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNK 469
G Y + + LG F KV + TG V +KI+ K D + EI+ LKL
Sbjct: 11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFR- 69
Query: 470 NDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTL---GRLQ- 524
H HI++LY F+V E + SGGE + + GR++
Sbjct: 70 ------HPHIIKLYQVISTPTDFFMVMEYV-------------SGGELFDYICKHGRVEE 110
Query: 525 ----VITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLY 580
+ +Q L A++Y H ++H DLKPEN+L+ ++ KI D G S +D L
Sbjct: 111 MEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMN--AKIADFGLSNMMSDGEFLR 168
Query: 581 VQ--SRSYRAPEVIIGLPYD-QKIDLWSLGCILAELWTG 616
S +Y APEVI G Y ++D+WS G IL L G
Sbjct: 169 TSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCG 207
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 5e-33
Identities = 66/223 (29%), Positives = 103/223 (46%), Gaps = 45/223 (20%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD---------EIK 462
+ Y +++ LGS A +V A + T V ++II K + + EI+
Sbjct: 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIE 192
Query: 463 LLKLVNKNDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE------ 515
+LK +N H I+++ + F+ E +IV EL+ GGE
Sbjct: 193 ILKKLN-------HPCIIKIKN-FFDAEDYYIVLELM-------------EGGELFDKVV 231
Query: 516 --AYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSY-QRCEIKIIDLGSSCF 572
++ Q L A++YLH GIIH DLKPEN+L+ S + C IKI D G S
Sbjct: 232 GNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 291
Query: 573 QTDNLCLY--VQSRSYRAPEVIIGL---PYDQKIDLWSLGCIL 610
+ + + +Y APEV++ + Y++ +D WSLG IL
Sbjct: 292 LGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 334
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 7e-33
Identities = 64/210 (30%), Positives = 106/210 (50%), Gaps = 16/210 (7%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD--FFDQSLDEIKLLKLVNKNDP 472
++ E LG+ ++ V++ + TGV V LK +K D + ++ EI L+K +
Sbjct: 6 QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELK---- 61
Query: 473 ADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCL 531
H +I+RLYD + L +V E + +L ++ L ++ Q L
Sbjct: 62 ---HENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLL 118
Query: 532 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLY---VQSRSYRA 588
+ L + H I+H DLKP+N+LI R ++K+ D G + + + V + YRA
Sbjct: 119 QGLAFCHENKILHRDLKPQNLLINK--RGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRA 176
Query: 589 PEVIIGLP-YDQKIDLWSLGCILAELWTGE 617
P+V++G Y ID+WS GCILAE+ TG+
Sbjct: 177 PDVLMGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 9e-33
Identities = 59/226 (26%), Positives = 89/226 (39%), Gaps = 48/226 (21%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK----------NDKDFFDQSLDEI 461
Y E LG S V + T + +KII ++ + +L E+
Sbjct: 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEV 74
Query: 462 KLLKLVNKNDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE----- 515
+L+ V H +I++L D + F+V +L+ GE
Sbjct: 75 DILRKV------SGHPNIIQLKDTYETNTFFFLVFDLM-------------KKGELFDYL 115
Query: 516 ---AYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF 572
+ + I R LE + LH L I+H DLKPENIL+ IK+ D G SC
Sbjct: 116 TEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDD--DMNIKLTDFGFSCQ 173
Query: 573 QTDNLCLY--VQSRSYRAPEVIIGL------PYDQKIDLWSLGCIL 610
L + SY APE+I Y +++D+WS G I+
Sbjct: 174 LDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-32
Identities = 57/209 (27%), Positives = 82/209 (39%), Gaps = 32/209 (15%)
Query: 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPA 473
RY + +GS F +D T V +K I+ + EI + +
Sbjct: 20 DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLR----- 74
Query: 474 DEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTL---GRLQVIT-- 527
H +I+R + HL I+ E SGGE Y + GR
Sbjct: 75 --HPNIVRFKEVILTPTHLAIIMEYA-------------SGGELYERICNAGRFSEDEAR 119
Query: 528 ---RQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL--YVQ 582
+Q L + Y HS+ I H DLK EN L+ +KI D G S + V
Sbjct: 120 FFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 179
Query: 583 SRSYRAPEVIIGLPYD-QKIDLWSLGCIL 610
+ +Y APEV++ YD + D+WS G L
Sbjct: 180 TPAYIAPEVLLRQEYDGKIADVWSCGVTL 208
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-32
Identities = 57/232 (24%), Positives = 94/232 (40%), Gaps = 25/232 (10%)
Query: 386 HLRIIHRKNRTGFEENKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLK 445
H H R I + LGS AF V ++ +G++ +K
Sbjct: 2 HHHHHHSSGRENLYFQGT--------IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIK 53
Query: 446 IIKNDKDFFDQS--LDEIKLLKLVNKNDPADEH-HILRLYDYFYHLEHLFIVCELLRANL 502
I D+ EI++LK ++ H +I+++++ F +++IV E
Sbjct: 54 TINKDRSQVPMEQIEAEIEVLKSLD-------HPNIIKIFEVFEDYHNMYIVMETCEGG- 105
Query: 503 YE-FQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS-YQRC 560
E ++ + G + + +Q + AL Y HS ++H DLKPENIL +
Sbjct: 106 -ELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHS 164
Query: 561 EIKIIDLGSSCFQTDNLCLY--VQSRSYRAPEVIIGLPYDQKIDLWSLGCIL 610
IKIID G + + + Y APEV K D+WS G ++
Sbjct: 165 PIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFKR-DVTFKCDIWSAGVVM 215
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-32
Identities = 61/245 (24%), Positives = 102/245 (41%), Gaps = 61/245 (24%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD------EIKLLK 465
I RY + +G+ ++ V +A D V +K I F+ +D EI +L
Sbjct: 51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRV---FEDLIDCKRILREIAILN 107
Query: 466 LVNKNDPADEH-HILRLYDYFY-----HLEHLFIVCELLRANLYEFQKFNQESGGEAYFT 519
+N H H++++ D + L++V E+ ++ + + Y T
Sbjct: 108 RLN-------HDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPV------YLT 154
Query: 520 LGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG----------- 568
++ + L ++Y+HS GI+H DLKP N L+ C +K+ D G
Sbjct: 155 ELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQ--DCSVKVCDFGLARTVDYPENG 212
Query: 569 -------------------SSCFQTDNLCLYVQSRSYRAPEVIIGLP-YDQKIDLWSLGC 608
+ L +V +R YRAPE+I+ Y + ID+WS+GC
Sbjct: 213 NSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGC 272
Query: 609 ILAEL 613
I AEL
Sbjct: 273 IFAEL 277
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-32
Identities = 50/224 (22%), Positives = 86/224 (38%), Gaps = 41/224 (18%)
Query: 409 NTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD------EIK 462
+ + Y + E +G FS V + + TG +KI+ K L E
Sbjct: 19 DVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREAS 78
Query: 463 LLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE------- 515
+ ++ HI+ L + + L++V E + G +
Sbjct: 79 ICHML------KHPHIVELLETYSSDGMLYMVFEFM-------------DGADLCFEIVK 119
Query: 516 -----AYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQR-CEIKIIDLGS 569
++ RQ LEAL Y H IIH D+KP +L+ S + +K+ G
Sbjct: 120 RADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGV 179
Query: 570 SCFQTDNLCLY---VQSRSYRAPEVIIGLPYDQKIDLWSLGCIL 610
+ ++ + V + + APEV+ PY + +D+W G IL
Sbjct: 180 AIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVIL 223
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 1e-32
Identities = 50/211 (23%), Positives = 83/211 (39%), Gaps = 32/211 (15%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKND 471
+ +Y + E LG F V + + + K +K EI +L +
Sbjct: 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIAR--- 59
Query: 472 PADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE---------AYFTLG 521
H +IL L++ F +E L ++ E + SG +
Sbjct: 60 ----HRNILHLHESFESMEELVMIFEFI-------------SGLDIFERINTSAFELNER 102
Query: 522 RLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYV 581
+ Q EAL++LHS I H D++PENI+ ++ + IKII+ G + +
Sbjct: 103 EIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL 162
Query: 582 Q--SRSYRAPEVIIGLPYDQKIDLWSLGCIL 610
+ Y APEV D+WSLG ++
Sbjct: 163 LFTAPEYYAPEVHQHDVVSTATDMWSLGTLV 193
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-32
Identities = 55/232 (23%), Positives = 91/232 (39%), Gaps = 43/232 (18%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK--NDKDFFDQSLDEIKLLKLVNKNDP 472
+ + LG F VF+A++ + +K I+ N + ++ + E+K L +
Sbjct: 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE---- 61
Query: 473 ADEH-HILRLYDYF------------YHLEHLFIVCELL-RANLYEFQKFNQESGGEAYF 518
H I+R ++ + +L+I +L + NL ++
Sbjct: 62 ---HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMN---GRCTIEER 115
Query: 519 TLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF------ 572
I Q EA+E+LHS G++H DLKP NI +K+ D G
Sbjct: 116 ERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDD--VVKVGDFGLVTAMDQDEE 173
Query: 573 ---------QTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT 615
V ++ Y +PE I G Y K+D++SLG IL EL
Sbjct: 174 EQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-32
Identities = 62/223 (27%), Positives = 103/223 (46%), Gaps = 38/223 (17%)
Query: 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD-----EIKLLKLVN 468
G+Y + + LG ++ KV + D T +KI+K K + + EI+LL+ +
Sbjct: 5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLR 64
Query: 469 KNDPADEH-HILRLYDYFYHLE--HLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQV 525
H ++++L D Y+ E +++V E + E + R V
Sbjct: 65 -------HKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEM--LD-------SVPEKRFPV 108
Query: 526 IT-----RQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS----CFQTDN 576
Q ++ LEYLHS GI+H D+KP N+L+ + +KI LG + F D+
Sbjct: 109 CQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGT--LKISALGVAEALHPFAADD 166
Query: 577 LCLYVQ-SRSYRAPEVIIGL-PYD-QKIDLWSLGCILAELWTG 616
C Q S +++ PE+ GL + K+D+WS G L + TG
Sbjct: 167 TCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTG 209
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 4e-32
Identities = 60/217 (27%), Positives = 105/217 (48%), Gaps = 24/217 (11%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK--NDKDFFDQ----SLDEIKLLKLVN 468
RY +G A+ V++A+D H+G V LK ++ N ++ E+ LL+ +
Sbjct: 10 RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLE 69
Query: 469 KNDPADEH-HILRLYDYFYHLEH-----LFIVCELLRANLYEFQKFNQESGGEAYFTLGR 522
+ H +++RL D + +V E + +L + +
Sbjct: 70 AFE----HPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYL----DKAPPPGLPAET 121
Query: 523 LQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL--Y 580
++ + RQ L L++LH+ I+H DLKPENIL+ S +K+ D G + + + L
Sbjct: 122 IKDLMRQFLRGLDFLHANCIVHRDLKPENILVTS--GGTVKLADFGLARIYSYQMALTPV 179
Query: 581 VQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGE 617
V + YRAPEV++ Y +D+WS+GCI AE++ +
Sbjct: 180 VVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 4e-32
Identities = 38/253 (15%), Positives = 77/253 (30%), Gaps = 40/253 (15%)
Query: 403 DLPIILNTVIAGRYYVT---EYLGSAAFSKVFQAQDLHTGVDVCLKII----KNDKDFFD 455
P + + + R LG +A D TG + + + +
Sbjct: 64 GQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIK 123
Query: 456 QSLDEIKLLKLV----NKNDPADEHHILRLYDYFYHLEHLFIVCELLRAN---------L 502
Q +E+ L+L+ N+ + +D + ++ L L
Sbjct: 124 QMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFL 183
Query: 503 YEFQKFNQESGGEAYFTLGRLQV---------ITRQCLEALEYLHSLGIIHCDLKPENIL 553
Y + N ++ GE + +T Q + L LH G++H L+P +I+
Sbjct: 184 YPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIV 243
Query: 554 IKSYQRCEIKIIDLGSSCFQTDNLC----LYVQSRSYRAPEVIIGLP-----YDQKIDLW 604
+ QR + + + A ++ D W
Sbjct: 244 LD--QRGGVFLTGFEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTW 301
Query: 605 SLGCILAELWTGE 617
+LG + +W +
Sbjct: 302 TLGLAIYWIWCAD 314
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 4e-32
Identities = 45/225 (20%), Positives = 83/225 (36%), Gaps = 30/225 (13%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK---NDKDFFDQSLDEIKLLKLVNKND 471
++ E +GS F VF+ G +K K +L E+ ++ ++
Sbjct: 12 EFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHS 71
Query: 472 PADEHHILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQC 530
H++R + + +H+ I E +L + N YF L+ + Q
Sbjct: 72 -----HVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMS--YFKEAELKDLLLQV 124
Query: 531 LEALEYLHSLGIIHCDLKPENILI-----------------KSYQRCEIKIIDLGSSCFQ 573
L Y+HS+ ++H D+KP NI I + + KI DLG +
Sbjct: 125 GRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT-R 183
Query: 574 TDNLCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGE 617
+ + + A EV+ + K D+++L + E
Sbjct: 184 ISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE 228
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 5e-32
Identities = 54/215 (25%), Positives = 95/215 (44%), Gaps = 36/215 (16%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKII-KNDKDFFDQS--LDEIKLLKLVN 468
Y + E LG AFS V + + G + II D E ++ +L+
Sbjct: 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLK 68
Query: 469 KNDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE--------AYFT 519
H +I+RL+D H +++ +L+ +GGE Y++
Sbjct: 69 -------HPNIVRLHDSISEEGHHYLIFDLV-------------TGGELFEDIVAREYYS 108
Query: 520 LGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQR-CEIKIIDLG-SSCFQTDNL 577
+Q LEA+ + H +G++H +LKPEN+L+ S + +K+ D G + + +
Sbjct: 109 EADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ 168
Query: 578 CLY--VQSRSYRAPEVIIGLPYDQKIDLWSLGCIL 610
+ + Y +PEV+ PY + +DLW+ G IL
Sbjct: 169 AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVIL 203
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 6e-32
Identities = 54/216 (25%), Positives = 94/216 (43%), Gaps = 40/216 (18%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD-------EIKLLKLV 467
Y + E LGS F+ V + ++ TG++ K IK + + E+ +L+ V
Sbjct: 13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQV 72
Query: 468 NKNDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE--------AYF 518
H +++ L+D + + + ++ EL+ SGGE
Sbjct: 73 L-------HHNVITLHDVYENRTDVVLILELV-------------SGGELFDFLAQKESL 112
Query: 519 TLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILI--KSYQRCEIKIIDLGSSCFQTDN 576
+ +Q L+ + YLH+ I H DLKPENI++ K+ IK+ID G + D
Sbjct: 113 SEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG 172
Query: 577 LCLYVQ--SRSYRAPEVIIGLPYDQKIDLWSLGCIL 610
+ + + APE++ P + D+WS+G I
Sbjct: 173 VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 8e-32
Identities = 69/221 (31%), Positives = 95/221 (42%), Gaps = 43/221 (19%)
Query: 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD------EIKLLKLV 467
G Y + E LG +F KV A T V LK I + +S EI LKL+
Sbjct: 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFI--SRQLLKKSDMHMRVEREISYLKLL 66
Query: 468 NKNDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTL---GRL 523
H HI++LYD + +V E +GGE + + R+
Sbjct: 67 R-------HPHIIKLYDVITTPTDIVMVIEY--------------AGGELFDYIVEKKRM 105
Query: 524 Q-----VITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC 578
+Q + A+EY H I+H DLKPEN+L+ +KI D G S TD
Sbjct: 106 TEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLN--VKIADFGLSNIMTDGNF 163
Query: 579 LYVQ--SRSYRAPEVIIGLPYD-QKIDLWSLGCILAELWTG 616
L S +Y APEVI G Y ++D+WS G +L + G
Sbjct: 164 LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVG 204
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-31
Identities = 56/216 (25%), Positives = 90/216 (41%), Gaps = 40/216 (18%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD-------EIKLLKLV 467
Y + E LGS F+ V + + TG + K IK + + E+ +L+ +
Sbjct: 6 HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI 65
Query: 468 NKNDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE--------AYF 518
H +I+ L+D F + + ++ EL+ SGGE
Sbjct: 66 R-------HPNIITLHDIFENKTDVVLILELV-------------SGGELFDFLAEKESL 105
Query: 519 TLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILI--KSYQRCEIKIIDLGSSCFQTDN 576
T +Q L+ + YLHS I H DLKPENI++ K+ IK+ID G +
Sbjct: 106 TEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAG 165
Query: 577 LCLYVQ--SRSYRAPEVIIGLPYDQKIDLWSLGCIL 610
+ + APE++ P + D+WS+G I
Sbjct: 166 NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 201
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 2e-31
Identities = 70/219 (31%), Positives = 99/219 (45%), Gaps = 38/219 (17%)
Query: 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNK 469
G Y + + LG F KV + TG V +KI+ K D + EI+ LKL
Sbjct: 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFR- 74
Query: 470 NDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTL---GRLQ- 524
H HI++LY +F+V E + SGGE + + GRL
Sbjct: 75 ------HPHIIKLYQVISTPSDIFMVMEYV-------------SGGELFDYICKNGRLDE 115
Query: 525 ----VITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLY 580
+ +Q L ++Y H ++H DLKPEN+L+ ++ KI D G S +D L
Sbjct: 116 KESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMN--AKIADFGLSNMMSDGEFLR 173
Query: 581 VQ--SRSYRAPEVIIGLPYD-QKIDLWSLGCILAELWTG 616
S +Y APEVI G Y ++D+WS G IL L G
Sbjct: 174 TSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCG 212
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-31
Identities = 59/244 (24%), Positives = 102/244 (41%), Gaps = 36/244 (14%)
Query: 391 HRKNRTGFEENKDLPIILNTVIAGRYY-VTEYLGSAAFSKVFQAQDLHTGVDVCLKII-- 447
+N+ + + + GR+ +G +F V++ D T V+V +
Sbjct: 2 EERNQQQDDIEELETKAVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQD 61
Query: 448 -KNDKDFFDQSLDEIKLLK-LVNKNDPADEHHILRLYDYFYHL----EHLFIVCEL---- 497
K K + +E ++LK L + N I+R YD + + + +V EL
Sbjct: 62 RKLTKSERQRFKEEAEMLKGLQHPN-------IVRFYDSWESTVKGKKCIVLVTELMTSG 114
Query: 498 -LRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLG--IIHCDLKPENILI 554
L+ L F+ + L+ RQ L+ L++LH+ IIH DLK +NI I
Sbjct: 115 TLKTYLKRFKVMK----------IKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFI 164
Query: 555 KSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSY-RAPEVIIGLPYDQKIDLWSLGCILAEL 613
+KI DLG + + + V APE+ YD+ +D+++ G + E+
Sbjct: 165 TGPT-GSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEM 222
Query: 614 WTGE 617
T E
Sbjct: 223 ATSE 226
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 128 bits (322), Expect = 2e-31
Identities = 50/215 (23%), Positives = 90/215 (41%), Gaps = 39/215 (18%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK----NDKDFFDQSLDEIKLLKLV 467
+ Y + E LG+ AF V + + TG + K + +DK+ + EI+ + ++
Sbjct: 155 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRK---EIQTMSVL 211
Query: 468 NKNDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE---------AY 517
H ++ L+D F + ++ E + SGGE
Sbjct: 212 R-------HPTLVNLHDAFEDDNEMVMIYEFM-------------SGGELFEKVADEHNK 251
Query: 518 FTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF--QTD 575
+ RQ + L ++H +H DLKPENI+ + + E+K+ID G +
Sbjct: 252 MSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 311
Query: 576 NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCIL 610
++ + + + APEV G P D+WS+G +
Sbjct: 312 SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLS 346
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 4e-31
Identities = 56/210 (26%), Positives = 100/210 (47%), Gaps = 21/210 (10%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD--FFDQSLDEIKLLKLVNKNDP 472
Y + LG ++ V++ + T V LK I+ + + ++ E+ LLK +
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLK---- 58
Query: 473 ADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCL 531
H +I+ L+D + + L +V E L +L ++ + +++ Q L
Sbjct: 59 ---HANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGN-----IINMHNVKLFLFQLL 110
Query: 532 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLY---VQSRSYRA 588
L Y H ++H DLKP+N+LI R E+K+ D G + ++ Y V + YR
Sbjct: 111 RGLAYCHRQKVLHRDLKPQNLLINE--RGELKLADFGLARAKSIPTKTYDNEVVTLWYRP 168
Query: 589 PEVIIGLP-YDQKIDLWSLGCILAELWTGE 617
P++++G Y +ID+W +GCI E+ TG
Sbjct: 169 PDILLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 4e-31
Identities = 55/224 (24%), Positives = 91/224 (40%), Gaps = 45/224 (20%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---------DFFDQSLDEIK 462
+Y + +G S V + TG + +KI++ + + + E
Sbjct: 92 FYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETH 151
Query: 463 LLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE------- 515
+L+ V A HI+ L D + +F+V +L+ GE
Sbjct: 152 ILRQV-----AGHPHIITLIDSYESSSFMFLVFDLM-------------RKGELFDYLTE 193
Query: 516 -AYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQT 574
+ + I R LEA+ +LH+ I+H DLKPENIL+ +I++ D G SC
Sbjct: 194 KVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDD--NMQIRLSDFGFSCHLE 251
Query: 575 DNLCLY--VQSRSYRAPEVIIGL------PYDQKIDLWSLGCIL 610
L + Y APE++ Y +++DLW+ G IL
Sbjct: 252 PGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 5e-31
Identities = 53/218 (24%), Positives = 91/218 (41%), Gaps = 38/218 (17%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD-------EIKLL 464
+ Y E LGS F+ V + ++ TG+ K IK + + E+ +L
Sbjct: 9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 68
Query: 465 KLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE--------A 516
K + +++ L++ + + + ++ EL+ +GGE
Sbjct: 69 KEI------QHPNVITLHEVYENKTDVILILELV-------------AGGELFDFLAEKE 109
Query: 517 YFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILI--KSYQRCEIKIIDLGSSCFQT 574
T +Q L + YLHSL I H DLKPENI++ ++ + IKIID G +
Sbjct: 110 SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 169
Query: 575 DNLCLYVQ--SRSYRAPEVIIGLPYDQKIDLWSLGCIL 610
+ + APE++ P + D+WS+G I
Sbjct: 170 FGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 207
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 5e-31
Identities = 50/209 (23%), Positives = 89/209 (42%), Gaps = 33/209 (15%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSL-DEIKLLKLVNKNDPA 473
Y + E LGS AF V + + TG K I ++ +EI ++ ++
Sbjct: 52 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLH----- 106
Query: 474 DEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE---------AYFTLGRL 523
H ++ L+D F + ++ E L SGGE + +
Sbjct: 107 --HPKLINLHDAFEDKYEMVLILEFL-------------SGGELFDRIAAEDYKMSEAEV 151
Query: 524 QVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQ- 582
RQ E L+++H I+H D+KPENI+ ++ + +KIID G + + + V
Sbjct: 152 INYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT 211
Query: 583 -SRSYRAPEVIIGLPYDQKIDLWSLGCIL 610
+ + APE++ P D+W++G +
Sbjct: 212 ATAEFAAPEIVDREPVGFYTDMWAIGVLG 240
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 5e-31
Identities = 51/221 (23%), Positives = 91/221 (41%), Gaps = 39/221 (17%)
Query: 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKND 471
+ + + LG A+ +V A + T V +KI+ + D + EI + K++N
Sbjct: 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN--- 63
Query: 472 PADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTL---GRLQVIT 527
H ++++ Y + ++ E SGGE + + +
Sbjct: 64 ----HENVVKFYGHRREGNIQYLFLEYC-------------SGGELFDRIEPDIGMPEPD 106
Query: 528 -----RQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN-----L 577
Q + + YLH +GI H D+KPEN+L+ +KI D G + N L
Sbjct: 107 AQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN--LKISDFGLATVFRYNNRERLL 164
Query: 578 CLYVQSRSYRAPEVIIGLPYD-QKIDLWSLGCILAELWTGE 617
+ Y APE++ + + +D+WS G +L + GE
Sbjct: 165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 6e-31
Identities = 55/216 (25%), Positives = 94/216 (43%), Gaps = 40/216 (18%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK-------NDKDFFDQSLDEIKLLKLV 467
Y + E LGS F+ V + ++ TG++ K IK ++ E+ +L+ V
Sbjct: 13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQV 72
Query: 468 NKNDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE--------AYF 518
H +I+ L+D + + + ++ EL+ SGGE
Sbjct: 73 L-------HPNIITLHDVYENRTDVVLILELV-------------SGGELFDFLAQKESL 112
Query: 519 TLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILI--KSYQRCEIKIIDLGSSCFQTDN 576
+ +Q L+ + YLH+ I H DLKPENI++ K+ IK+ID G + D
Sbjct: 113 SEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG 172
Query: 577 LCLYVQ--SRSYRAPEVIIGLPYDQKIDLWSLGCIL 610
+ + + APE++ P + D+WS+G I
Sbjct: 173 VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 8e-31
Identities = 50/214 (23%), Positives = 99/214 (46%), Gaps = 24/214 (11%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK--NDKDFFDQ-SLDEIKLLKLVNKND 471
RY LG + +V++A D T V +K I+ ++++ ++ E+ LLK +
Sbjct: 35 RYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQ--- 91
Query: 472 PADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQC 530
H +I+ L +H L ++ E +L ++ N + ++ ++ Q
Sbjct: 92 ----HRNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKNPD------VSMRVIKSFLYQL 141
Query: 531 LEALEYLHSLGIIHCDLKPENILI---KSYQRCEIKIIDLGSSCFQTDNLCLY---VQSR 584
+ + + HS +H DLKP+N+L+ + + +KI D G + + + + +
Sbjct: 142 INGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITL 201
Query: 585 SYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGE 617
YR PE+++G Y +D+WS+ CI AE+
Sbjct: 202 WYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 9e-31
Identities = 60/209 (28%), Positives = 98/209 (46%), Gaps = 22/209 (10%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK--NDKDFFD-QSLDEIKLLKLVNKND 471
+Y E +G + VF+A++ T V LK ++ +D + +L EI LLK +
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELK--- 59
Query: 472 PADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQC 530
H +I+RL+D + + L +V E +L ++ ++ Q
Sbjct: 60 ----HKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGD-----LDPEIVKSFLFQL 110
Query: 531 LEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLY---VQSRSYR 587
L+ L + HS ++H DLKP+N+LI E+K+ + G + + Y V + YR
Sbjct: 111 LKGLGFCHSRNVLHRDLKPQNLLINR--NGELKLANFGLARAFGIPVRCYSAEVVTLWYR 168
Query: 588 APEVIIGLP-YDQKIDLWSLGCILAELWT 615
P+V+ G Y ID+WS GCI AEL
Sbjct: 169 PPDVLFGAKLYSTSIDMWSAGCIFAELAN 197
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 1e-30
Identities = 60/235 (25%), Positives = 101/235 (42%), Gaps = 27/235 (11%)
Query: 395 RTGFEENKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK-NDKDF 453
R+ E + + ++ LG + V+ +DL V + +K I D +
Sbjct: 3 RSTEEGDCESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRY 62
Query: 454 FDQSLDEIKLLKLVNKNDPADEH-HILRLYDYFYHLEHLFIVCELLR----ANLYEFQKF 508
+EI L K + H +I++ F + I E + + L K+
Sbjct: 63 SQPLHEEIALHKHLK-------HKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLR-SKW 114
Query: 509 NQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568
E + T+Q LE L+YLH I+H D+K +N+LI +Y +KI D G
Sbjct: 115 GPLKDNEQT-----IGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGV-LKISDFG 168
Query: 569 SSCFQTDNLCLYVQSRS----YRAPEVIIGLP--YDQKIDLWSLGCILAELWTGE 617
+S + + ++ + Y APE+I P Y + D+WSLGC + E+ TG+
Sbjct: 169 TSK-RLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGK 222
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-30
Identities = 56/270 (20%), Positives = 92/270 (34%), Gaps = 44/270 (16%)
Query: 391 HRKNRTGFEENKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND 450
H + + EN + +Y++ +G ++ V A + T +KI+ +
Sbjct: 3 HHHHHSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKN 62
Query: 451 KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELL------------ 498
K D ++ V +I RLY+ + +++ +V EL
Sbjct: 63 KIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVF 122
Query: 499 -----------------------RANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALE 535
+ + I RQ AL
Sbjct: 123 IDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALH 182
Query: 536 YLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF-------QTDNLCLYVQSRSYRA 588
YLH+ GI H D+KPEN L + + EIK++D G S + + + + A
Sbjct: 183 YLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVA 242
Query: 589 PEVIIGL--PYDQKIDLWSLGCILAELWTG 616
PEV+ Y K D WS G +L L G
Sbjct: 243 PEVLNTTNESYGPKCDAWSAGVLLHLLLMG 272
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 59/217 (27%), Positives = 92/217 (42%), Gaps = 45/217 (20%)
Query: 420 EYLGSAAFSKVFQAQDLHTGVDVCLKII-KNDKDFFDQSLDEIKLLKLVNKNDPADEH-H 477
+ LG A ++V +L T + +KII K + E+++L H +
Sbjct: 19 DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQ------GHRN 72
Query: 478 ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE--------AYFTLGRLQVITRQ 529
+L L ++F + ++V E +R GG +F V+ +
Sbjct: 73 VLELIEFFEEEDRFYLVFEKMR-------------GGSILSHIHKRRHFNELEASVVVQD 119
Query: 530 CLEALEYLHSLGIIHCDLKPENILIKS-YQRCEIKIIDLG-SSCFQTDNLCLYVQSRS-- 585
AL++LH+ GI H DLKPENIL + Q +KI D S + + C + +
Sbjct: 120 VASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELL 179
Query: 586 -------YRAPEVIIGL-----PYDQKIDLWSLGCIL 610
Y APEV+ YD++ DLWSLG IL
Sbjct: 180 TPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 3e-30
Identities = 55/241 (22%), Positives = 96/241 (39%), Gaps = 41/241 (17%)
Query: 391 HRKNRTGFEENKDLPIILNTV--IAGRYYVT-EYLGSAAFSKVFQAQDLHTGVDVCLKII 447
H + + + + ++ Y +T + LG F+ V Q TG + K +
Sbjct: 3 HHHHHSSGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFL 62
Query: 448 KNDKDFFDQSLD---EIKLLKLVNKNDPADEHH--ILRLYDYFYHLEHLFIVCELLRANL 502
K + D + EI +L+L ++ L++ + + + ++ E
Sbjct: 63 KKRRRGQDCRAEILHEIAVLELAK-------SCPRVINLHEVYENTSEIILILEYA---- 111
Query: 503 YEFQKFNQESGGE----------AYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENI 552
+GGE + + + +Q LE + YLH I+H DLKP+NI
Sbjct: 112 ---------AGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNI 162
Query: 553 LIKS-YQRCEIKIIDLGSSCFQTDNLCLYVQ--SRSYRAPEVIIGLPYDQKIDLWSLGCI 609
L+ S Y +IKI+D G S L + Y APE++ P D+W++G I
Sbjct: 163 LLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGII 222
Query: 610 L 610
Sbjct: 223 A 223
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 4e-30
Identities = 59/211 (27%), Positives = 100/211 (47%), Gaps = 23/211 (10%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK--NDKDFFDQS-LDEIKLLKLVNKND 471
+Y+ E +G + V++AQ+ + G LK I+ + + + + EI +LK +
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELK--- 58
Query: 472 PADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQC 530
H +I++LYD + + L +V E L +L + + + Q
Sbjct: 59 ----HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG-----LESVTAKSFLLQL 109
Query: 531 LEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLY---VQSRSYR 587
L + Y H ++H DLKP+N+LI E+KI D G + + Y + + YR
Sbjct: 110 LNGIAYCHDRRVLHRDLKPQNLLINR--EGELKIADFGLARAFGIPVRKYTHEIVTLWYR 167
Query: 588 APEVIIGLP-YDQKIDLWSLGCILAELWTGE 617
AP+V++G Y ID+WS+GCI AE+ G
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 8e-30
Identities = 51/221 (23%), Positives = 91/221 (41%), Gaps = 39/221 (17%)
Query: 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKND 471
+ + + LG A+ +V A + T V +KI+ + D + EI + K++N
Sbjct: 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN--- 63
Query: 472 PADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTL---GRLQVIT 527
H ++++ Y + ++ E SGGE + + +
Sbjct: 64 ----HENVVKFYGHRREGNIQYLFLEYC-------------SGGELFDRIEPDIGMPEPD 106
Query: 528 -----RQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN-----L 577
Q + + YLH +GI H D+KPEN+L+ +KI D G + N L
Sbjct: 107 AQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN--LKISDFGLATVFRYNNRERLL 164
Query: 578 CLYVQSRSYRAPEVIIGLPYD-QKIDLWSLGCILAELWTGE 617
+ Y APE++ + + +D+WS G +L + GE
Sbjct: 165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 8e-30
Identities = 57/208 (27%), Positives = 91/208 (43%), Gaps = 39/208 (18%)
Query: 419 TEYLGSAAFSKVFQAQDLHTGVDVCLKIIK----NDKDFFDQSLDEIKLLKLVNKNDPAD 474
TE LG F +V + ++ TG+ + KIIK DK+ +EI ++ ++
Sbjct: 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEV---KNEISVMNQLD------ 144
Query: 475 EH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE---------AYFTLGRLQ 524
H ++++LYD F + +V E + GGE T
Sbjct: 145 -HANLIQLYDAFESKNDIVLVMEYV-------------DGGELFDRIIDESYNLTELDTI 190
Query: 525 VITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQ-- 582
+ +Q E + ++H + I+H DLKPENIL + +IKIID G + L V
Sbjct: 191 LFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFG 250
Query: 583 SRSYRAPEVIIGLPYDQKIDLWSLGCIL 610
+ + APEV+ D+WS+G I
Sbjct: 251 TPEFLAPEVVNYDFVSFPTDMWSVGVIA 278
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-29
Identities = 66/214 (30%), Positives = 103/214 (48%), Gaps = 25/214 (11%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQ------SLDEIKLLKLVN 468
RY ++LG F+ V++A+D +T V +K IK + +L EIKLL+ ++
Sbjct: 11 RYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS 70
Query: 469 KNDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVIT 527
H +I+ L D F H ++ +V + + +L K N T ++
Sbjct: 71 -------HPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLV-----LTPSHIKAYM 118
Query: 528 RQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLY---VQSR 584
L+ LEYLH I+H DLKP N+L+ +K+ D G + Y V +R
Sbjct: 119 LMTLQGLEYLHQHWILHRDLKPNNLLLDE--NGVLKLADFGLAKSFGSPNRAYTHQVVTR 176
Query: 585 SYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGE 617
YRAPE++ G Y +D+W++GCILAEL
Sbjct: 177 WYRAPELLFGARMYGVGVDMWAVGCILAELLLRV 210
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 60/211 (28%), Positives = 103/211 (48%), Gaps = 23/211 (10%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK--NDKDFFD-QSLDEIKLLKLVNKND 471
+Y E +G + V++A+D G V LK I+ + + ++ EI LLK ++
Sbjct: 22 KYQKLEKVGEGTYGVVYKAKD-SQGRIVALKRIRLDAEDEGIPSTAIREISLLKELH--- 77
Query: 472 PADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQC 530
H +I+ L D + L +V E + +L + N+ ++++ Q
Sbjct: 78 ----HPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTG-----LQDSQIKIYLYQL 128
Query: 531 LEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLY---VQSRSYR 587
L + + H I+H DLKP+N+LI S +K+ D G + + Y V + YR
Sbjct: 129 LRGVAHCHQHRILHRDLKPQNLLINS--DGALKLADFGLARAFGIPVRSYTHEVVTLWYR 186
Query: 588 APEVIIGLP-YDQKIDLWSLGCILAELWTGE 617
AP+V++G Y +D+WS+GCI AE+ TG+
Sbjct: 187 APDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 61/215 (28%), Positives = 109/215 (50%), Gaps = 22/215 (10%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDL-HTGVDVCLKIIK--NDKDFFD-QSLDEIKLLKLVNKN 470
+Y +G A+ KVF+A+DL + G V LK ++ ++ ++ E+ +L+ +
Sbjct: 12 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 71
Query: 471 DPADEH-HILRLYDYFY-----HLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQ 524
+ H +++RL+D L +V E + +L + + E ++
Sbjct: 72 E----HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYL----DKVPEPGVPTETIK 123
Query: 525 VITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL--YVQ 582
+ Q L L++LHS ++H DLKP+NIL+ S +IK+ D G + + + L V
Sbjct: 124 DMMFQLLRGLDFLHSHRVVHRDLKPQNILVTS--SGQIKLADFGLARIYSFQMALTSVVV 181
Query: 583 SRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGE 617
+ YRAPEV++ Y +DLWS+GCI AE++ +
Sbjct: 182 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 3e-29
Identities = 40/232 (17%), Positives = 84/232 (36%), Gaps = 43/232 (18%)
Query: 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK------------------NDKDFFD 455
Y + L F+K+ + LK + + K +D
Sbjct: 31 NDYRIIRTLNQGKFNKIILCE--KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYD 88
Query: 456 QSLDEIKLLKLVNKNDPADEH-HILRLYDYFYHLEHLFIVCELLRA-NLYEF--QKFNQE 511
+E++++ + + + L + + ++I+ E + ++ +F F +
Sbjct: 89 DFKNELQIITDIK-------NEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLD 141
Query: 512 SGGEAYFTLGRLQVITRQCLEALEYLHS-LGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570
+ + ++ I + L + Y+H+ I H D+KP NIL+ +K+ D G S
Sbjct: 142 KNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDK--NGRVKLSDFGES 199
Query: 571 CFQTDNL----CLYVQSRSYRAPEVIIGLP--YDQKIDLWSLGCILAELWTG 616
+ D + + PE K+D+WSLG L ++
Sbjct: 200 EYMVDKKIKGSR---GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYN 248
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 9e-29
Identities = 60/206 (29%), Positives = 97/206 (47%), Gaps = 21/206 (10%)
Query: 418 VTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEH- 476
V E +G AF V +A+ DV +K I+++ + + E++ L VN H
Sbjct: 12 VEEVVGRGAFGVVCKAK--WRAKDVAIKQIESESER-KAFIVELRQLSRVN-------HP 61
Query: 477 HILRLYDYFYHLEHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALE 535
+I++LY L + +V E +LY + Y+T QC + +
Sbjct: 62 NIVKLYGA--CLNPVCLVMEYAEGGSLY---NVLHGAEPLPYYTAAHAMSWCLQCSQGVA 116
Query: 536 YLHSL---GIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVI 592
YLHS+ +IH DLKP N+L+ + +KI D G++C ++ S ++ APEV
Sbjct: 117 YLHSMQPKALIHRDLKPPNLLLVAGGTV-LKICDFGTACDIQTHMTNNKGSAAWMAPEVF 175
Query: 593 IGLPYDQKIDLWSLGCILAELWTGEV 618
G Y +K D++S G IL E+ T
Sbjct: 176 EGSNYSEKCDVFSWGIILWEVITRRK 201
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-28
Identities = 56/218 (25%), Positives = 99/218 (45%), Gaps = 25/218 (11%)
Query: 417 YVTEYLGSAAFSKVFQAQDLH--TGVDVCLKIIKNDKDFFDQSLDEIKLLK-LVNKNDPA 473
Y +G + V++A+ D LK I+ + EI LL+ L + N
Sbjct: 24 YEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT-GISMSACREIALLRELKHPN--- 79
Query: 474 DEHHILRLYDYFYH--LEHLFIVCELLRANLY---EFQKFNQESGGEAYFTLGRLQVITR 528
++ L F ++++ + +L+ +F + ++ + G ++ +
Sbjct: 80 ----VISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLY 135
Query: 529 QCLEALEYLHSLGIIHCDLKPENILIKSY--QRCEIKIIDLGSSCFQTDNLCLYVQSRS- 585
Q L+ + YLH+ ++H DLKP NIL+ +R +KI D+G + L
Sbjct: 136 QILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPV 195
Query: 586 -----YRAPEVIIGLP-YDQKIDLWSLGCILAELWTGE 617
YRAPE+++G Y + ID+W++GCI AEL T E
Sbjct: 196 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 52/270 (19%), Positives = 88/270 (32%), Gaps = 74/270 (27%)
Query: 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK--NDKDFFDQSLDEIKLLKLVNKNDPA 473
+ + +G F VF+A++ + +K I+ N + ++ + E+K L +
Sbjct: 8 FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 67
Query: 474 DEHH---------------------------------------------------ILRLY 482
+ +
Sbjct: 68 RYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQL 127
Query: 483 DYFYHLEHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLG 541
+L+I +L + NL ++ G I Q EA+E+LHS G
Sbjct: 128 QPSSPKVYLYIQMQLCRKENLKDWMN---RRCSLEDREHGVCLHIFIQIAEAVEFLHSKG 184
Query: 542 IIHCDLKPENILIKSYQRCEIKIIDLG---------------SSCFQTDNLCLYVQSRSY 586
++H DLKP NI +K+ D G + V ++ Y
Sbjct: 185 LMHRDLKPSNIFFTM--DDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242
Query: 587 RAPEVIIGLPYDQKIDLWSLGCILAELWTG 616
+PE I G Y K+D++SLG IL EL
Sbjct: 243 MSPEQIHGNNYSHKVDIFSLGLILFELLYS 272
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 64/222 (28%), Positives = 90/222 (40%), Gaps = 28/222 (12%)
Query: 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKN 470
Y + E +GS A + V A V +K I +K D+ L EI+ + +
Sbjct: 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCH-- 71
Query: 471 DPADEH-HILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQ--VI 526
H +I+ Y F + L++V +LL ++ + K G L I
Sbjct: 72 -----HPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATI 126
Query: 527 TRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSY 586
R+ LE LEYLH G IH D+K NIL+ ++I D G S F +
Sbjct: 127 LREVLEGLEYLHKNGQIHRDVKAGNILLGE--DGSVQIADFGVSAFLATGGDITRNKV-- 182
Query: 587 R----------APEVII-GLPYDQKIDLWSLGCILAELWTGE 617
R APEV+ YD K D+WS G EL TG
Sbjct: 183 RKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGA 224
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 5e-28
Identities = 49/246 (19%), Positives = 92/246 (37%), Gaps = 65/246 (26%)
Query: 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKII-------------------------- 447
+Y + + +G ++ V A + + +K++
Sbjct: 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGG 72
Query: 448 -KNDKDFFDQSLDEIKLLKLVNKNDPADEH-HILRLYDYFYHLE--HLFIVCELLRANLY 503
+ +Q EI +LK ++ H ++++L + HL++V EL+
Sbjct: 73 CIQPRGPIEQVYQEIAILKKLD-------HPNVVKLVEVLDDPNEDHLYMVFELV----- 120
Query: 504 EFQKFNQESGGE--AYFTLGRLQVIT-----RQCLEALEYLHSLGIIHCDLKPENILIKS 556
+ G TL L + ++ +EYLH IIH D+KP N+L+
Sbjct: 121 --------NQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGE 172
Query: 557 YQRCEIKIIDLGSSCFQTDNLCL---YVQSRSYRAPEVIIGL--PYD-QKIDLWSLGCIL 610
IKI D G S + L V + ++ APE + + + +D+W++G L
Sbjct: 173 DGH--IKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230
Query: 611 AELWTG 616
G
Sbjct: 231 YCFVFG 236
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 8e-28
Identities = 58/219 (26%), Positives = 84/219 (38%), Gaps = 59/219 (26%)
Query: 409 NTVIAGRYYVT-EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLV 467
I Y VT + LG KV Q + T LK++++ E++L
Sbjct: 12 KNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKA----RREVELHWRA 67
Query: 468 NKNDPADEH-HILRLYDYF----YHLEHLFIVCELLRANLYEFQKFNQESGGE------- 515
++ HI+R+ D + + L IV E L GGE
Sbjct: 68 SQ------CPHIVRIVDVYENLYAGRKCLLIVMECL-------------DGGELFSRIQD 108
Query: 516 ---AYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQR-CEIKIIDLGSSC 571
FT I + EA++YLHS+ I H D+KPEN+L S + +K+ D G
Sbjct: 109 RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG--- 165
Query: 572 FQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCIL 610
A E G YD+ D+WSLG I+
Sbjct: 166 ---------------FAKET-TGEKYDKSCDMWSLGVIM 188
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 1e-27
Identities = 62/223 (27%), Positives = 101/223 (45%), Gaps = 34/223 (15%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK--NDKDFFDQ-SLDEIKLLKLVNKND 471
+Y +G F +VF+A+ TG V LK + N+K+ F +L EIK+L+L+
Sbjct: 18 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLK--- 74
Query: 472 PADEH-HILRLYD--------YFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGR 522
H +++ L + Y +++V + +L + FTL
Sbjct: 75 ----HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLL----SNVLVK-FTLSE 125
Query: 523 LQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG----SSCFQTDNLC 578
++ + + L L Y+H I+H D+K N+LI +K+ D G S +
Sbjct: 126 IKRVMQMLLNGLYYIHRNKILHRDMKAANVLITR--DGVLKLADFGLARAFSLAKNSQPN 183
Query: 579 LY---VQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGE 617
Y V + YR PE+++G Y IDLW GCI+AE+WT
Sbjct: 184 RYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 2e-27
Identities = 47/219 (21%), Positives = 85/219 (38%), Gaps = 34/219 (15%)
Query: 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKN-DKDFFDQSLDEIKLLKLVNKNDPADEH-H 477
E LG F + + TG + +K + D++ L E+K+++ + H +
Sbjct: 16 EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLE-------HPN 68
Query: 478 ILRLYDYFYHLEHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEY 536
+L+ Y + L + E + L K ++ + + + + Y
Sbjct: 69 VLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSM-----DSQYPWSQRVSFAKDIASGMAY 123
Query: 537 LHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR--------- 587
LHS+ IIH DL N L++ + + D G + D RS +
Sbjct: 124 LHSMNIIHRDLNSHNCLVRENKNV--VVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYT 181
Query: 588 --------APEVIIGLPYDQKIDLWSLGCILAELWTGEV 618
APE+I G YD+K+D++S G +L E+
Sbjct: 182 VVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVN 220
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 62/221 (28%), Positives = 91/221 (41%), Gaps = 41/221 (18%)
Query: 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKII--KNDKDFFDQSLDEIKLLKLVNKN 470
+ E +G +F +VF+ D T V +KII + +D + EI +L
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC--- 77
Query: 471 DPADEHHILRLYDYFYHLEHLFIVCELLRA----NLYEFQKFNQESGGEAYFTLGRLQVI 526
D ++ + Y + L+I+ E L +L E + E + I
Sbjct: 78 ---DSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLD-----ETQ-----IATI 124
Query: 527 TRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSY 586
R+ L+ L+YLHS IH D+K N+L+ E+K+ D G + TD
Sbjct: 125 LREILKGLDYLHSEKKIHRDIKAANVLLSE--HGEVKLADFGVAGQLTDTQ-------IK 175
Query: 587 R----------APEVIIGLPYDQKIDLWSLGCILAELWTGE 617
R APEVI YD K D+WSLG EL GE
Sbjct: 176 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGE 216
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 50/223 (22%), Positives = 91/223 (40%), Gaps = 50/223 (22%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK-NDKDFFDQSLDEIKLLKLVNKNDPA 473
+G + V A++ H+G V +K++ + + +E+ +++
Sbjct: 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMR-------- 97
Query: 474 DEHH--ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGG-------EAYFTLGRLQ 524
D H ++ +Y + E L+++ E L GG + ++
Sbjct: 98 DYQHFNVVEMYKSYLVGEELWVLMEFL-------------QGGALTDIVSQVRLNEEQIA 144
Query: 525 VITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSR 584
+ L+AL YLH+ G+IH D+K ++IL+ +K+ D G C Q
Sbjct: 145 TVCEAVLQALAYLHAQGVIHRDIKSDSILLTL--DGRVKLSDFG-FCAQISK------DV 195
Query: 585 SYR----------APEVIIGLPYDQKIDLWSLGCILAELWTGE 617
R APEVI Y ++D+WSLG ++ E+ GE
Sbjct: 196 PKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGE 238
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 59/223 (26%), Positives = 100/223 (44%), Gaps = 50/223 (22%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK-NDKDFFDQSLDEIKLLKLVNKNDPA 473
+Y E +G A V+ A D+ TG +V ++ + + + ++EI +++
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMR-------- 72
Query: 474 DEHH--ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGG-------EAYFTLGRLQ 524
+ + I+ D + + L++V E L +GG E G++
Sbjct: 73 ENKNPNIVNYLDSYLVGDELWVVMEYL-------------AGGSLTDVVTETCMDEGQIA 119
Query: 525 VITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSR 584
+ R+CL+ALE+LHS +IH D+K +NIL+ +K+ D G C Q +
Sbjct: 120 AVCRECLQALEFLHSNQVIHRDIKSDNILLGM--DGSVKLTDFG-FCAQITP------EQ 170
Query: 585 SYR----------APEVIIGLPYDQKIDLWSLGCILAELWTGE 617
S R APEV+ Y K+D+WSLG + E+ GE
Sbjct: 171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 4e-26
Identities = 57/230 (24%), Positives = 100/230 (43%), Gaps = 52/230 (22%)
Query: 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLH-TGVDVCLKIIKN--DKDFFDQSLDEIKLLKL 466
++AG+Y V + ++ A D + G V LK + + D + ++ E + L
Sbjct: 76 DIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAE 135
Query: 467 VNKNDPADEH-HILRLYDYFYHLEH-----LFIVCELLRANLYEFQKFNQESGGEAYFTL 520
V H I++++++ H + +IV E + GG+ +L
Sbjct: 136 VV-------HPSIVQIFNFVEHTDRHGDPVGYIVMEYV--------------GGQ---SL 171
Query: 521 -----GRLQV-----ITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG-- 568
+L V + L AL YLHS+G+++ DLKPENI++ Q +K+IDLG
Sbjct: 172 KRSKGQKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEEQ---LKLIDLGAV 228
Query: 569 SSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEV 618
S L + ++APE++ P D++++G LA L
Sbjct: 229 SRINSFGYL---YGTPGFQAPEIVRTGPTVAT-DIYTVGRTLAALTLDLP 274
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 5e-26
Identities = 53/204 (25%), Positives = 89/204 (43%), Gaps = 25/204 (12%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIK--NDKDFFDQSLDEIKLLKLVNKNDPADEHHIL 479
LG+ VF+ +G+ + K+I +Q + E+++L + +I+
Sbjct: 41 LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLH------ECNSPYIV 94
Query: 480 RLYDYFYHLEHLFIVCELLRA----NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALE 535
Y FY + I E + + + E L ++ ++ L
Sbjct: 95 GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQ---------ILGKVSIAVIKGLT 145
Query: 536 YLHS-LGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC-LYVQSRSYRAPEVII 593
YL I+H D+KP NIL+ S R EIK+ D G S D++ +V +RSY +PE +
Sbjct: 146 YLREKHKIMHRDVKPSNILVNS--RGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQ 203
Query: 594 GLPYDQKIDLWSLGCILAELWTGE 617
G Y + D+WS+G L E+ G
Sbjct: 204 GTHYSVQSDIWSMGLSLVEMAVGR 227
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 8e-26
Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 18/207 (8%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPAD 474
+ V E LG ++ V++A TG V +K + + D + + EI +++ D
Sbjct: 30 VFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDL-QEIIKEISIMQ------QCD 82
Query: 475 EHHILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEA 533
H+++ Y ++ L+IV E A ++ + + ++ E + I + L+
Sbjct: 83 SPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDE-----IATILQSTLKG 137
Query: 534 LEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC---LYVQSRSYRAPE 590
LEYLH + IH D+K NIL+ + K+ D G + TD + + + + APE
Sbjct: 138 LEYLHFMRKIHRDIKAGNILLNT--EGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPE 195
Query: 591 VIIGLPYDQKIDLWSLGCILAELWTGE 617
VI + Y+ D+WSLG E+ G+
Sbjct: 196 VIQEIGYNCVADIWSLGITAIEMAEGK 222
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 41/218 (18%), Positives = 77/218 (35%), Gaps = 31/218 (14%)
Query: 418 VTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD--------EIKLLKLVNK 469
+ +G F V + + + V +K + + + E+ ++ +N
Sbjct: 23 YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN- 81
Query: 470 NDPADEH-HILRLYDYFYHLEHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVIT 527
H +I++LY +V E + +LY +
Sbjct: 82 ------HPNIVKLYGLM--HNPPRMVMEFVPCGDLYHRLLDKAHP-----IKWSVKLRLM 128
Query: 528 RQCLEALEYLHSLG--IIHCDLKPENILIKSYQRCE---IKIIDLGSSCFQTDNLCLYVQ 582
+EY+ + I+H DL+ NI ++S K+ D G S ++ +
Sbjct: 129 LDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSGLLG 188
Query: 583 SRSYRAPEVIIG--LPYDQKIDLWSLGCILAELWTGEV 618
+ + APE I Y +K D +S IL + TGE
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEG 226
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 57/212 (26%), Positives = 95/212 (44%), Gaps = 22/212 (10%)
Query: 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK--NDKDFFDQSLDEIKLLKLVNKNDPA 473
+GS +V++ + TG + +K ++ +K+ + L ++ ++ +
Sbjct: 27 LENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSH----- 81
Query: 474 DEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEA 533
D +I++ + F +FI EL+ + +K Q E L +T ++A
Sbjct: 82 DCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERI-----LGKMTVAIVKA 136
Query: 534 LEYLHS-LGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNL--CLYVQSRSYRAPE 590
L YL G+IH D+KP NIL+ R +IK+ D G S D+ +Y APE
Sbjct: 137 LYYLKEKHGVIHRDVKPSNILLDE--RGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPE 194
Query: 591 VI-----IGLPYDQKIDLWSLGCILAELWTGE 617
I YD + D+WSLG L EL TG+
Sbjct: 195 RIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 53/209 (25%), Positives = 91/209 (43%), Gaps = 24/209 (11%)
Query: 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKN---DKDFFDQSLDEIKLLKLVNKNDPADEH 476
E +G+ +F V +A+ G DV +KI+ + ++ L E+ ++K + H
Sbjct: 43 EKIGAGSFGTVHRAE--WHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLR-------H 93
Query: 477 -HILRLYDYFYHLEHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEAL 534
+I+ +L IV E L R +LY + +SG R + + +
Sbjct: 94 PNIVLFMGAVTQPPNLSIVTEYLSRGSLY---RLLHKSGAREQLDERRRLSMAYDVAKGM 150
Query: 535 EYLHSLG--IIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSR-SYR--AP 589
YLH+ I+H +LK N+L+ K+ D G S + + + AP
Sbjct: 151 NYLHNRNPPIVHRNLKSPNLLVDKKYTV--KVCDFGLSRLKASTFLSSKSAAGTPEWMAP 208
Query: 590 EVIIGLPYDQKIDLWSLGCILAELWTGEV 618
EV+ P ++K D++S G IL EL T +
Sbjct: 209 EVLRDEPSNEKSDVYSFGVILWELATLQQ 237
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 4e-25
Identities = 47/210 (22%), Positives = 91/210 (43%), Gaps = 21/210 (10%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKII----KNDKDFFDQSLDEIKLLKLVNKN 470
+ +G +F V+ A+D+ V +K + K + + + E++ L+
Sbjct: 55 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ----- 109
Query: 471 DPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQC 530
+ ++ + ++V E + + + +++ E + +T
Sbjct: 110 -KLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVE-----IAAVTHGA 163
Query: 531 LEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPE 590
L+ L YLHS +IH D+K NIL+ + +K+ D GS+ +V + + APE
Sbjct: 164 LQGLAYLHSHNMIHRDVKAGNILLS--EPGLVKLGDFGSAS-IMAPANSFVGTPYWMAPE 220
Query: 591 VIIGL---PYDQKIDLWSLGCILAELWTGE 617
VI+ + YD K+D+WSLG EL +
Sbjct: 221 VILAMDEGQYDGKVDVWSLGITCIELAERK 250
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 5e-25
Identities = 57/223 (25%), Positives = 99/223 (44%), Gaps = 32/223 (14%)
Query: 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDP 472
AG + + E +G+ + +V++ + + TG +K++ D ++ EI +LK
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLK-----KY 77
Query: 473 ADEHHILRLYDYFYHL------EHLFIVCELLRA----NLYEFQKFNQESGGEAYFTLGR 522
+ +I Y F + L++V E A +L + K N E +
Sbjct: 78 SHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLK--EEW----- 130
Query: 523 LQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL--- 579
+ I R+ L L +LH +IH D+K +N+L+ + E+K++D G S +
Sbjct: 131 IAYICREILRGLSHLHQHKVIHRDIKGQNVLLT--ENAEVKLVDFGVSAQLDRTVGRRNT 188
Query: 580 YVQSRSYRAPEVI-----IGLPYDQKIDLWSLGCILAELWTGE 617
++ + + APEVI YD K DLWSLG E+ G
Sbjct: 189 FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGA 231
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 6e-25
Identities = 53/210 (25%), Positives = 91/210 (43%), Gaps = 24/210 (11%)
Query: 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIK--NDKDFFDQSLDEIKLLKLVNKNDPADEHH 477
LG A+ V + + + +G + +K I+ + + L ++ +
Sbjct: 13 MELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP-----F 67
Query: 478 ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGG---EAYFTLGRLQVITRQCLEAL 534
+ Y + ++I EL+ +L +F K + G E L I ++AL
Sbjct: 68 TVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDI-----LGKIAVSIVKAL 122
Query: 535 EYLHS-LGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNL--CLYVQSRSYRAPEV 591
E+LHS L +IH D+KP N+LI + ++K+ D G S + D++ + + Y APE
Sbjct: 123 EHLHSKLSVIHRDVKPSNVLINA--LGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPER 180
Query: 592 IIG----LPYDQKIDLWSLGCILAELWTGE 617
I Y K D+WSLG + EL
Sbjct: 181 INPELNQKGYSVKSDIWSLGITMIELAILR 210
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 54/215 (25%), Positives = 88/215 (40%), Gaps = 44/215 (20%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHH 477
LG +FS V A++L T + +KI++ ++ E ++ ++ H
Sbjct: 38 LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD--------H 89
Query: 478 --ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQC----- 530
++LY F E L+ GE + ++ C
Sbjct: 90 PFFVKLYFTFQDDEKLYFGLSYA-------------KNGELLKYIRKIGSFDETCTRFYT 136
Query: 531 ---LEALEYLHSLGIIHCDLKPENILIKSYQRCEI------KIIDLGSSCFQTDNLCLYV 581
+ ALEYLH GIIH DLKPENIL+ +I K++ S + ++
Sbjct: 137 AEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTA 196
Query: 582 QSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTG 616
Q Y +PE++ + DLW+LGCI+ +L G
Sbjct: 197 Q---YVSPELLTEKSACKSSDLWALGCIIYQLVAG 228
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 57/208 (27%), Positives = 90/208 (43%), Gaps = 19/208 (9%)
Query: 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIK--NDKDFFDQSLDEIK-LLKLVNKNDPADEH 476
+G A+ V + +G + +K I+ D+ Q L ++ +++ D
Sbjct: 28 GEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSS------DCP 81
Query: 477 HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEY 536
+I++ Y + +I EL+ + +F K+ + L IT ++AL +
Sbjct: 82 YIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDV-IPEEILGKITLATVKALNH 140
Query: 537 LHS-LGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNL--CLYVQSRSYRAPEVI- 592
L L IIH D+KP NIL+ IK+ D G S D++ R Y APE I
Sbjct: 141 LKENLKIIHRDIKPSNILLDR--SGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERID 198
Query: 593 ---IGLPYDQKIDLWSLGCILAELWTGE 617
YD + D+WSLG L EL TG
Sbjct: 199 PSASRQGYDVRSDVWSLGITLYELATGR 226
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 3e-24
Identities = 58/219 (26%), Positives = 81/219 (36%), Gaps = 39/219 (17%)
Query: 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD-----FFDQSLDEIKLLKLVNKNDPAD 474
E +G F KV++A G +V +K ++D D + E KL ++
Sbjct: 13 EIIGIGGFGKVYRA--FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLK------ 64
Query: 475 EH-HILRLYDYFYHLEHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITRQCLE 532
H +I+ L +L +V E L + L Q
Sbjct: 65 -HPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR-------IPPDILVNWAVQIAR 116
Query: 533 ALEYLHSLG---IIHCDLKPENILI------KSYQRCEIKIIDLGSSCFQTDNLCLYVQS 583
+ YLH IIH DLK NILI +KI D G + S
Sbjct: 117 GMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRT---TKMS 173
Query: 584 R--SYR--APEVIIGLPYDQKIDLWSLGCILAELWTGEV 618
+Y APEVI + + D+WS G +L EL TGEV
Sbjct: 174 AAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEV 212
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 63/223 (28%), Positives = 98/223 (43%), Gaps = 39/223 (17%)
Query: 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK-NDKDFFDQSLDEIKLLKLVNKND 471
+ + LG AF KV++A++ TG K+I+ ++ + + EI++L +
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCD--- 74
Query: 472 PADEH-HILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQ 529
H +I++L +YH L+I+ E + E +QV+ RQ
Sbjct: 75 ----HPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQ-----IQVVCRQ 125
Query: 530 CLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR-- 587
LEAL +LHS IIH DLK N+L+ +I++ D G S + R
Sbjct: 126 MLEALNFLHSKRIIHRDLKAGNVLMTL--EGDIRLADFGVSAKNLK-------TLQKRDS 176
Query: 588 --------APEVII-----GLPYDQKIDLWSLGCILAELWTGE 617
APEV++ PYD K D+WSLG L E+ E
Sbjct: 177 FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIE 219
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 7e-24
Identities = 52/226 (23%), Positives = 97/226 (42%), Gaps = 39/226 (17%)
Query: 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK----NDKDFFDQSLDEIKLL- 464
+I RY + + LG S V+ A+D + V +K I ++ + E+
Sbjct: 7 KIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSS 66
Query: 465 KLVNKNDPADEHHILRLYDYFYHLEHLFIVCEL-----LRANLYEFQKFNQESGGEAYFT 519
+L + +I+ + D + ++V E L + +
Sbjct: 67 QL---SHQ----NIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIES----------HGPLS 109
Query: 520 LGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG-------SSCF 572
+ T Q L+ +++ H + I+H D+KP+NILI S + +KI D G +S
Sbjct: 110 VDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKT--LKIFDFGIAKALSETSLT 167
Query: 573 QTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEV 618
QT+++ + + Y +PE G D+ D++S+G +L E+ GE
Sbjct: 168 QTNHV---LGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEP 210
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 44/213 (20%), Positives = 78/213 (36%), Gaps = 30/213 (14%)
Query: 423 GSAAFSKVFQAQDLHTGVDVCLKII---KNDKDFFDQSLDEIKLLKLVNKNDPADEH-HI 478
G V A+ TG V ++ I + E+ + KL N H +I
Sbjct: 36 GFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFN-------HPNI 88
Query: 479 LRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYL 537
+ F L++V + + + + G + I + L+AL+Y+
Sbjct: 89 VPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDG----MNELAIAYILQGVLKALDYI 144
Query: 538 HSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR---------- 587
H +G +H +K +ILI ++ + L S+ + +
Sbjct: 145 HHMGYVHRSVKASHILISV--DGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWL 202
Query: 588 APEVI--IGLPYDQKIDLWSLGCILAELWTGEV 618
+PEV+ YD K D++S+G EL G V
Sbjct: 203 SPEVLQQNLQGYDAKSDIYSVGITACELANGHV 235
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 4e-23
Identities = 53/229 (23%), Positives = 82/229 (35%), Gaps = 53/229 (23%)
Query: 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK----NDKDF---FDQSLDEIKLLKL 466
G Y + +G V++A+D V LK++ +D F + L
Sbjct: 34 GPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRL-- 91
Query: 467 VNKNDPADEHHILRLYDYFYHLEHLFIVCEL-----LRANLYEFQKFNQESGGEAYFTLG 521
E H++ ++D+ L++ L L A L G
Sbjct: 92 -------QEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQ---------------G 129
Query: 522 RLQV-----ITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG-------S 569
L I RQ AL+ H+ G H D+KPENIL+ + ++D G
Sbjct: 130 PLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDF--AYLVDFGIASATTDE 187
Query: 570 SCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEV 618
Q N V + Y APE + D+++L C+L E TG
Sbjct: 188 KLTQLGNT---VGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSP 233
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 8e-23
Identities = 45/222 (20%), Positives = 85/222 (38%), Gaps = 42/222 (18%)
Query: 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD---EIKLLKLVNKNDPADEH 476
E +G F +V+ + H +V +++I ++D DQ E+ +
Sbjct: 39 ELIGKGRFGQVYHGR-WHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQT--------R 87
Query: 477 H--ILRLYDYFYHLEHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEA 533
H ++ HL I+ L LY + + + + + I ++ ++
Sbjct: 88 HENVVLFMGACMSPPHLAIITSLCKGRTLYSVVR-----DAKIVLDVNKTRQIAQEIVKG 142
Query: 534 LEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSR------SYR 587
+ YLH+ GI+H DLK +N+ + + + I D G + +
Sbjct: 143 MGYLHAKGILHKDLKSKNVFYDNGK---VVITDFGLFSISGVLQAGRREDKLRIQNGWLC 199
Query: 588 --APEVI---------IGLPYDQKIDLWSLGCILAELWTGEV 618
APE+I LP+ + D+++LG I EL E
Sbjct: 200 HLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREW 241
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 2e-22
Identities = 54/213 (25%), Positives = 88/213 (41%), Gaps = 33/213 (15%)
Query: 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKN---DKDFFDQSLDEIKLLKLVNKNDPADEH 476
+ +GS +F V++ H DV +K++ +E+ +L+
Sbjct: 30 QRIGSGSFGTVYKG-KWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKT--------R 78
Query: 477 H--ILRLYDYFYHLEHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEA 533
H IL Y L IV + ++LY E F + +L I RQ
Sbjct: 79 HVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLH-----ASETKFEMKKLIDIARQTARG 132
Query: 534 LEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS-----YRA 588
++YLH+ IIH DLK NI + KI D G + ++ + + + A
Sbjct: 133 MDYLHAKSIIHRDLKSNNIFLHEDNTV--KIGDFGLATEKSRWSGSHQFEQLSGSILWMA 190
Query: 589 PEVIIG---LPYDQKIDLWSLGCILAELWTGEV 618
PEVI PY + D+++ G +L EL TG++
Sbjct: 191 PEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQL 223
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 6e-22
Identities = 62/246 (25%), Positives = 99/246 (40%), Gaps = 71/246 (28%)
Query: 409 NTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK----NDKDF---FDQ----- 456
+ ++ RY + E LG S+V A+DL DV +K+++ D F F +
Sbjct: 7 PSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNA 66
Query: 457 -SLDEIKLLKLVNKNDPADEHHILRLYDY----FYHLEHLFIVCEL-----LRANLYEFQ 506
+L N P I+ +YD +IV E LR ++
Sbjct: 67 AAL-----------NHP----AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE- 110
Query: 507 KFNQESGGEAYFTLGRLQV-----ITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCE 561
G + + +AL + H GIIH D+KP NI+I +
Sbjct: 111 --------------GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNA-- 154
Query: 562 IKIIDLG---------SSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAE 612
+K++D G +S QT + + + Y +PE G D + D++SLGC+L E
Sbjct: 155 VKVMDFGIARAIADSGNSVTQTAAV---IGTAQYLSPEQARGDSVDARSDVYSLGCVLYE 211
Query: 613 LWTGEV 618
+ TGE
Sbjct: 212 VLTGEP 217
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 8e-22
Identities = 50/223 (22%), Positives = 87/223 (39%), Gaps = 28/223 (12%)
Query: 409 NTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVN 468
N V+ Y V +G +F +F+ +L V +K D Q DE + KL+
Sbjct: 5 NNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-PQLRDEYRTYKLLA 63
Query: 469 KNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITR 528
I +Y + H +V +LL +L + F++ + + +
Sbjct: 64 GC-----TGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRK-----FSVKTVAMAAK 113
Query: 529 QCLEALEYLHSLGIIHCDLKPENILI---KSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS 585
Q L ++ +H +++ D+KP+N LI S I ++D G F D + Q
Sbjct: 114 QMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVT--KQHIP 171
Query: 586 YRAPEVIIG----------LPYDQ--KIDLWSLGCILAELWTG 616
YR + + G L +Q + DL +LG + G
Sbjct: 172 YREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRG 214
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 98.2 bits (244), Expect = 8e-22
Identities = 46/220 (20%), Positives = 96/220 (43%), Gaps = 28/220 (12%)
Query: 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKN 470
+ ++ + +GS +F +++ ++ T +V +K+ Q L E K+ +++
Sbjct: 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-PQLLYESKIYRILQG- 61
Query: 471 DPADEHHILRLYDYFYHLEHLFIVCELLRANLYE-FQKFNQESGGEAYFTLGRLQVITRQ 529
I + + ++ +V +LL +L + F +++ +L + ++ Q
Sbjct: 62 ----GTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRK------LSLKTVLMLADQ 111
Query: 530 CLEALEYLHSLGIIHCDLKPENILIKSYQRC-EIKIIDLGSSCFQTDNLCLYVQSRSYRA 588
+ +E++HS +H D+KP+N L+ +R ++ IID G + D Q YR
Sbjct: 112 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH--QHIPYRE 169
Query: 589 PEVIIG----------LPYDQ--KIDLWSLGCILAELWTG 616
+ + G L +Q + DL SLG +L G
Sbjct: 170 NKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRG 209
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 1e-21
Identities = 47/234 (20%), Positives = 87/234 (37%), Gaps = 50/234 (21%)
Query: 409 NTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVN 468
++ + V + +G F ++ ++L+T V +K+ Q E + K +
Sbjct: 4 VLMVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA-PQLHLEYRFYKQLG 62
Query: 469 KNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITR 528
I ++Y + ++ +V ELL +L + + F+L + +I
Sbjct: 63 SG-----DGIPQVYYFGPCGKYNAMVLELLGPSLEDLFDLCDRT-----FSLKTVLMIAI 112
Query: 529 QCLEALEYLHSLGIIHCDLKPENILI---KSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS 585
Q + +EY+HS +I+ D+KPEN LI + + I IID ++
Sbjct: 113 QLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFAL-------------AKE 159
Query: 586 YRAPEVIIGLPYDQKI-----------------------DLWSLGCILAELWTG 616
Y PE +PY + DL +LG + G
Sbjct: 160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRG 213
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 5e-21
Identities = 55/219 (25%), Positives = 96/219 (43%), Gaps = 57/219 (26%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHH 477
LG+ +F +V + +G +KI+ + +L+E ++L+ VN
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN--------F 100
Query: 478 --ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITR------- 528
+++L F +L++V E + +GGE + L R+ +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYV-------------AGGEMFSHLRRIGRFSEPHARFYA 147
Query: 529 -QCLEALEYLHSLGIIHCDLKPENILIKS--YQRCEIKIIDLGSSCFQTDNLCLYVQSRS 585
Q + EYLHSL +I+ DLKPEN+LI Y I++ D G V+ R+
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY----IQVTDFG--------FAKRVKGRT 195
Query: 586 --------YRAPEVIIGLPYDQKIDLWSLGCILAELWTG 616
APE+I+ Y++ +D W+LG ++ E+ G
Sbjct: 196 WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAG 234
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 6e-21
Identities = 52/219 (23%), Positives = 90/219 (41%), Gaps = 26/219 (11%)
Query: 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKN 470
+ RY + +GS +F ++ D+ G +V +K+ Q E K+ K++
Sbjct: 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP-QLHIESKIYKMMQGG 64
Query: 471 DPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQC 530
I + ++ +V ELL +L + F F+L + ++ Q
Sbjct: 65 -----VGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK-----FSLKTVLLLADQM 114
Query: 531 LEALEYLHSLGIIHCDLKPENILIKSYQRC-EIKIIDLGSSCFQTDNLCLYVQSRSYRAP 589
+ +EY+HS IH D+KP+N L+ ++ + IID G + D Q YR
Sbjct: 115 ISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH--QHIPYREN 172
Query: 590 EVIIG----------LPYDQ--KIDLWSLGCILAELWTG 616
+ + G L +Q + DL SLG +L G
Sbjct: 173 KNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLG 211
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 7e-20
Identities = 28/214 (13%), Positives = 58/214 (27%), Gaps = 45/214 (21%)
Query: 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK----NDKDFFDQSLDEIKLLK 465
+ GRY + + G + +QA D V L + D ++L L
Sbjct: 27 RIANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLS 86
Query: 466 LVNKNDPADEHHILRLYDYFYHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQ 524
++ P + R+ D + +V E +R +L E ++ +
Sbjct: 87 RID--KP----GVARVLDVVHTRAGGLVVAEWIRGGSLQEVA----DTSPSPVGAIR--- 133
Query: 525 VITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSR 584
+ A + H G+ P + + + +
Sbjct: 134 -AMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGD--VVLAYPA---------------- 174
Query: 585 SYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEV 618
+ + D+ +G L L
Sbjct: 175 -TMPDA-------NPQDDIRGIGASLYALLVNRW 200
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 8e-20
Identities = 37/215 (17%), Positives = 70/215 (32%), Gaps = 33/215 (15%)
Query: 418 VTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD---EIKLLKLVNKNDPAD 474
L ++++ G D+ +K++K +S D E L++ +
Sbjct: 14 FLTKLNENHSGELWKG--RWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFS------ 65
Query: 475 EH-HILRLYDYFYH--LEHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITRQC 530
H ++L + H ++ + +LY G +
Sbjct: 66 -HPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLH----EGTNFVVDQSQAVKFALDM 120
Query: 531 LEALEYLHSLG--IIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR- 587
+ +LH+L I L +++I +I +Y +
Sbjct: 121 ARGMAFLHTLEPLIPRHALNSRSVMIDEDMTA--RISMADVKFSFQSPGRMY----APAW 174
Query: 588 -APEVIIGLPYD---QKIDLWSLGCILAELWTGEV 618
APE + P D + D+WS +L EL T EV
Sbjct: 175 VAPEALQKKPEDTNRRSADMWSFAVLLWELVTREV 209
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 89.1 bits (222), Expect = 1e-19
Identities = 60/219 (27%), Positives = 96/219 (43%), Gaps = 57/219 (26%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHH 477
LG+ +F +V + H G +K++K + + + DE +L +V H
Sbjct: 14 LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT--------H 65
Query: 478 --ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQV----ITR--- 528
I+R++ F + +F++ + + GGE + L + Q + +
Sbjct: 66 PFIIRMWGTFQDAQQIFMIMDYI-------------EGGELFSLLRKSQRFPNPVAKFYA 112
Query: 529 -QCLEALEYLHSLGIIHCDLKPENILIKS--YQRCEIKIIDLGSSCFQTDNLCLYVQSRS 585
+ ALEYLHS II+ DLKPENIL+ + IKI D G YV +
Sbjct: 113 AEVCLALEYLHSKDIIYRDLKPENILLDKNGH----IKITDFG--------FAKYVPDVT 160
Query: 586 --------YRAPEVIIGLPYDQKIDLWSLGCILAELWTG 616
Y APEV+ PY++ ID WS G ++ E+ G
Sbjct: 161 YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAG 199
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 2e-19
Identities = 45/228 (19%), Positives = 85/228 (37%), Gaps = 49/228 (21%)
Query: 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIK--NDKDFFDQSLDEIKLLKLVNKNDPADEH- 476
E +G + +V++ G +V +KI ++K +F ++ E+ ++ H
Sbjct: 14 ECVGKGRYGEVWRGS--WQGENVAVKIFSSRDEKSWFRET--ELYNTVMLR-------HE 62
Query: 477 HILRLY----DYFYHLEHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITRQCL 531
+IL + L+++ +LY++ + I
Sbjct: 63 NILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT-------LDTVSCLRIVLSIA 115
Query: 532 EALEYLHSL--------GIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQS 583
L +LH I H DLK +NIL+K +C I DLG + + +
Sbjct: 116 SGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQC--CIADLGLAVMHSQSTNQLDVG 173
Query: 584 RS-------YRAPEVIIGLP------YDQKIDLWSLGCILAELWTGEV 618
+ Y APEV+ +++D+W+ G +L E+ V
Sbjct: 174 NNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMV 221
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 89.9 bits (223), Expect = 5e-19
Identities = 56/208 (26%), Positives = 87/208 (41%), Gaps = 31/208 (14%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHH 477
LG F +V Q TG K ++ + +L+E ++L+ VN
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN--------S 243
Query: 478 --ILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEAL 534
++ L + + L +V L+ +L KF+ G+A F R + L
Sbjct: 244 RFVVSLAYAYETKDALCLVLTLMNGGDL----KFHIYHMGQAGFPEARAVFYAAEICCGL 299
Query: 535 EYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS------YRA 588
E LH I++ DLKPENIL+ + I+I DLG + + + Y A
Sbjct: 300 EDLHRERIVYRDLKPENILLDDHGH--IRISDLGLAVHVPEG----QTIKGRVGTVGYMA 353
Query: 589 PEVIIGLPYDQKIDLWSLGCILAELWTG 616
PEV+ Y D W+LGC+L E+ G
Sbjct: 354 PEVVKNERYTFSPDWWALGCLLYEMIAG 381
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 89.9 bits (223), Expect = 5e-19
Identities = 52/214 (24%), Positives = 94/214 (43%), Gaps = 42/214 (19%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHH 477
+G F +V+ + TG +K + K +L+E +L LV+ D
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD-----C 251
Query: 478 --ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITR------- 528
I+ + F+ + L + +L+ +GG+ ++ L + V +
Sbjct: 252 PFIVCMSYAFHTPDKLSFILDLM-------------NGGDLHYHLSQHGVFSEADMRFYA 298
Query: 529 -QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF----QTDNLCLYVQS 583
+ + LE++H+ +++ DLKP NIL+ + ++I DLG +C +
Sbjct: 299 AEIILGLEHMHNRFVVYRDLKPANILLDEHG--HVRISDLGLACDFSKKKPHASVGTHG- 355
Query: 584 RSYRAPEVII-GLPYDQKIDLWSLGCILAELWTG 616
Y APEV+ G+ YD D +SLGC+L +L G
Sbjct: 356 --YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 387
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 7e-19
Identities = 39/263 (14%), Positives = 79/263 (30%), Gaps = 57/263 (21%)
Query: 392 RKNRTGFEENKDLP--IILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKN 449
+ ++ P +L+ + ++ + + +GS F ++ A + ++K
Sbjct: 13 LGTENLYFQSMPFPEGKVLDDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKV 72
Query: 450 DKDFFDQSLDEIKLLKLVNKNDPADEHH---------ILRLYDYFYHL----EHLFIVCE 496
+ E+K + V K D + I Y + F+V E
Sbjct: 73 EYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVME 132
Query: 497 LLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS 556
L +L + N F + + + L+ LEY+H +H D+K N+L+
Sbjct: 133 RLGIDLQKISGQNGT------FKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGY 186
Query: 557 YQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKI--------------- 601
++ + D G S Y + +
Sbjct: 187 KNPDQVYLADYGL-------------SYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHK 233
Query: 602 --------DLWSLGCILAELWTG 616
D+ LG + G
Sbjct: 234 GVALSRRSDVEILGYCMLRWLCG 256
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 1e-18
Identities = 49/243 (20%), Positives = 89/243 (36%), Gaps = 45/243 (18%)
Query: 403 DLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIK 462
LP+++ IA + + + +G + +V+ + G V +K+ ++ EI
Sbjct: 26 GLPLLVQRTIAKQIQMVKQIGKGRYGEVWMGK--WRGEKVAVKVFFTTEEASWFRETEIY 83
Query: 463 LLKLVNKNDPADEH-HILRLY----DYFYHLEHLFIVCELL-RANLYEFQKFNQESGGEA 516
L+ H +IL L+++ + +LY++ K
Sbjct: 84 QTVLMR-------HENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT------ 130
Query: 517 YFTLGRLQVITRQCLEALEYLHSL--------GIIHCDLKPENILIKSYQRCEIKIIDLG 568
+ + + L +LH+ I H DLK +NIL+K C I DLG
Sbjct: 131 -LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTC--CIADLG 187
Query: 569 SSC-FQTDNLCLYVQSRS------YRAPEVIIG------LPYDQKIDLWSLGCILAELWT 615
+ F +D + + + Y PEV+ D++S G IL E+
Sbjct: 188 LAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVAR 247
Query: 616 GEV 618
V
Sbjct: 248 RCV 250
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 2e-18
Identities = 49/218 (22%), Positives = 86/218 (39%), Gaps = 49/218 (22%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHH 477
+G +++KV + T +K++K + + D E + + + H
Sbjct: 17 IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN-------H 69
Query: 478 --ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE--------AYFTLGRLQVIT 527
++ L+ F LF V E + +GG+ + +
Sbjct: 70 PFLVGLHSCFQTESRLFFVIEYV-------------NGGDLMFHMQRQRKLPEEHARFYS 116
Query: 528 RQCLEALEYLHSLGIIHCDLKPENILIKSYQRCE--IKIIDLGSSCFQTDNLCLYVQSRS 585
+ AL YLH GII+ DLK +N+L+ S E IK+ D G + L + +
Sbjct: 117 AEISLALNYLHERGIIYRDLKLDNVLLDS----EGHIKLTDYGMC---KEGLRPGDTTST 169
Query: 586 ------YRAPEVIIGLPYDQKIDLWSLGCILAELWTGE 617
Y APE++ G Y +D W+LG ++ E+ G
Sbjct: 170 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 207
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 3e-18
Identities = 47/242 (19%), Positives = 91/242 (37%), Gaps = 49/242 (20%)
Query: 404 LPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK--NDKDFFDQSLDEI 461
LP+++ IA + E +G F +V++ + G +V +KI ++ +F ++ EI
Sbjct: 32 LPLLVQRTIARTIVLQESIGKGRFGEVWRGK--WRGEEVAVKIFSSREERSWFREA--EI 87
Query: 462 KLLKLVNKNDPADEH-HILRLY----DYFYHLEHLFIVCELL-RANLYEFQKFNQESGGE 515
++ H +IL L++V + +L+++
Sbjct: 88 YQTVMLR-------HENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT----- 135
Query: 516 AYFTLGRLQVITRQCLEALEYLHS--------LGIIHCDLKPENILIKSYQRCEIKIIDL 567
T+ + + L +LH I H DLK +NIL+K C I DL
Sbjct: 136 --VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC--CIADL 191
Query: 568 GSSCFQTDNLCLYVQSRS-------YRAPEVIIG------LPYDQKIDLWSLGCILAELW 614
G + + + Y APEV+ ++ D++++G + E+
Sbjct: 192 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 251
Query: 615 TG 616
Sbjct: 252 RR 253
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 86.4 bits (214), Expect = 6e-18
Identities = 52/210 (24%), Positives = 88/210 (41%), Gaps = 30/210 (14%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHH 477
LG F +VF Q TG K + + + ++ E K+L V+
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVH--------S 244
Query: 478 --ILRLYDYFYHLEHLFIVCELLRAN--LYEFQKFNQESGGEAYFTLGRLQVITRQCLEA 533
I+ L F L +V ++ Y ++++ G F R T Q +
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPG---FQEPRAIFYTAQIVSG 301
Query: 534 LEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS------YR 587
LE+LH II+ DLKPEN+L+ ++I DLG + + +++ +
Sbjct: 302 LEHLHQRNIIYRDLKPENVLLDDDGN--VRISDLGLAV---ELKAGQTKTKGYAGTPGFM 356
Query: 588 APEVIIGLPYDQKIDLWSLGCILAELWTGE 617
APE+++G YD +D ++LG L E+
Sbjct: 357 APELLLGEEYDFSVDYFALGVTLYEMIAAR 386
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 8e-18
Identities = 48/216 (22%), Positives = 83/216 (38%), Gaps = 46/216 (21%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHH 477
+G +F KV Q T +K + ++ E+++++ + H
Sbjct: 23 IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLE--------H 74
Query: 478 --ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITR------- 528
++ L+ F E +F+V +LL GG+ + L +
Sbjct: 75 PFLVNLWYSFQDEEDMFMVVDLL-------------LGGDLRYHLQQNVHFKEETVKLFI 121
Query: 529 -QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS-- 585
+ + AL+YL + IIH D+KP+NIL+ + I D + + + +
Sbjct: 122 CELVMALDYLQNQRIIHRDMKPDNILLDE--HGHVHITDFNIAAMLPRETQIT--TMAGT 177
Query: 586 --YRAPEVI---IGLPYDQKIDLWSLGCILAELWTG 616
Y APE+ G Y +D WSLG EL G
Sbjct: 178 KPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRG 213
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 1e-17
Identities = 50/218 (22%), Positives = 87/218 (39%), Gaps = 49/218 (22%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIK----NDKDFFDQSLDEIKLLKLVNKNDPADEHH 477
+G +++KV + T ++++K ND + D E + + + H
Sbjct: 60 IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASN-------H 112
Query: 478 --ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE--------AYFTLGRLQVIT 527
++ L+ F LF V E + +GG+ + +
Sbjct: 113 PFLVGLHSCFQTESRLFFVIEYV-------------NGGDLMFHMQRQRKLPEEHARFYS 159
Query: 528 RQCLEALEYLHSLGIIHCDLKPENILIKSYQRCE--IKIIDLGSSCFQTDNLCLYVQSRS 585
+ AL YLH GII+ DLK +N+L+ S E IK+ D G + L + +
Sbjct: 160 AEISLALNYLHERGIIYRDLKLDNVLLDS----EGHIKLTDYGMC---KEGLRPGDTTST 212
Query: 586 ------YRAPEVIIGLPYDQKIDLWSLGCILAELWTGE 617
Y APE++ G Y +D W+LG ++ E+ G
Sbjct: 213 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 250
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 2e-17
Identities = 54/216 (25%), Positives = 92/216 (42%), Gaps = 45/216 (20%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHH 477
LG +F KV A+ TG +K++K D D + ++ E ++L L H
Sbjct: 31 LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARN-------H 83
Query: 478 --ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE--------AYFTLGRLQVIT 527
+ +L+ F + LF V E + +GG+ F R +
Sbjct: 84 PFLTQLFCCFQTPDRLFFVMEFV-------------NGGDLMFHIQKSRRFDEARARFYA 130
Query: 528 RQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS-- 585
+ + AL +LH GII+ DLK +N+L+ K+ D G + +C V + +
Sbjct: 131 AEIISALMFLHDKGIIYRDLKLDNVLLDH--EGHCKLADFGMC---KEGICNGVTTATFC 185
Query: 586 ----YRAPEVIIGLPYDQKIDLWSLGCILAELWTGE 617
Y APE++ + Y +D W++G +L E+ G
Sbjct: 186 GTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGH 221
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 3e-17
Identities = 57/223 (25%), Positives = 91/223 (40%), Gaps = 60/223 (26%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHH 477
LG F KV ++ TG +KI++ + KD ++ E ++L+ H
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR--------H 64
Query: 478 --ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITR------- 528
+ L F + L V E +GGE +F L R +V T
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYA-------------NGGELFFHLSRERVFTEERARFYG 111
Query: 529 -QCLEALEYLHSLGIIHCDLKPENILIKSYQRCE--IKIIDLGSSCFQTDNLC---LYVQ 582
+ + ALEYLHS +++ D+K EN+++ + IKI D G LC +
Sbjct: 112 AEIVSALEYLHSRDVVYRDIKLENLMLDK----DGHIKITDFG--------LCKEGISDG 159
Query: 583 SRS--------YRAPEVIIGLPYDQKIDLWSLGCILAELWTGE 617
+ Y APEV+ Y + +D W LG ++ E+ G
Sbjct: 160 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 3e-17
Identities = 56/221 (25%), Positives = 96/221 (43%), Gaps = 55/221 (24%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHH 477
LG +F KVF A+ T +K +K D D + ++ E ++L L ++ P
Sbjct: 25 LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH-P----F 79
Query: 478 ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITR--------Q 529
+ ++ F E+LF V E L +GG+ + + +
Sbjct: 80 LTHMFCTFQTKENLFFVMEYL-------------NGGDLMYHIQSCHKFDLSRATFYAAE 126
Query: 530 CLEALEYLHSLGIIHCDLKPENILIKSYQRCE--IKIIDLGSSCFQTDNLC---LYVQSR 584
+ L++LHS GI++ DLK +NIL+ + IKI D G +C + ++
Sbjct: 127 IILGLQFLHSKGIVYRDLKLDNILLDK----DGHIKIADFG--------MCKENMLGDAK 174
Query: 585 --------SYRAPEVIIGLPYDQKIDLWSLGCILAELWTGE 617
Y APE+++G Y+ +D WS G +L E+ G+
Sbjct: 175 TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 215
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 6e-17
Identities = 63/310 (20%), Positives = 113/310 (36%), Gaps = 71/310 (22%)
Query: 345 DTRDGEVNGALHEGKADAEEHGVATPDLL-MFDNLEEECEIFHLRIIHRKNRTGFEENKD 403
+ R ++ + +G A + LL + L +EC LR KN + E
Sbjct: 3 EVRLRQLEQFILDGPAQTNGQCFSVETLLDILICLYDECNNSPLRRE--KNILEYLEWAK 60
Query: 404 LPIILNTVIAGRYYVTEY-----LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSL 458
+ V R + ++ +G AF +V + + +KI+ K
Sbjct: 61 P--FTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILN--KW------ 110
Query: 459 DEIKLLKLVNKNDPA---DEHHILRLYDYFYHLEHLFIVCELLRANL-YEFQKFNQ---- 510
+++ + + A +E +L + + +I L Y FQ N
Sbjct: 111 ------EMLKRAETACFREERDVLV------NGDSKWIT------TLHYAFQDDNNLYLV 152
Query: 511 ---ESGGEAYFTLGRLQVI---------TRQCLEALEYLHSLGIIHCDLKPENILIKSYQ 558
GG+ L + + + + A++ +H L +H D+KP+NIL+
Sbjct: 153 MDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNG 212
Query: 559 RCEIKIIDLGSSCFQTDNLCLYVQSRS------YRAPEVIIGLP-----YDQKIDLWSLG 607
I++ D GS VQS Y +PE++ + Y + D WSLG
Sbjct: 213 --HIRLADFGSC--LKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLG 268
Query: 608 CILAELWTGE 617
+ E+ GE
Sbjct: 269 VCMYEMLYGE 278
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 6e-17
Identities = 52/220 (23%), Positives = 93/220 (42%), Gaps = 53/220 (24%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHH 477
LG +F KV ++ T +KI+K D D + ++ E ++L L K
Sbjct: 28 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK------PP 81
Query: 478 -ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITR-------- 528
+ +L+ F ++ L+ V E + +GG+ + + ++
Sbjct: 82 FLTQLHSCFQTMDRLYFVMEYV-------------NGGDLMYHIQQVGRFKEPHAVFYAA 128
Query: 529 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC---LYVQSRS 585
+ L +L S GII+ DLK +N+++ S IKI D G +C ++ +
Sbjct: 129 EIAIGLFFLQSKGIIYRDLKLDNVMLDS--EGHIKIADFG--------MCKENIWDGVTT 178
Query: 586 --------YRAPEVIIGLPYDQKIDLWSLGCILAELWTGE 617
Y APE+I PY + +D W+ G +L E+ G+
Sbjct: 179 KTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 83.1 bits (205), Expect = 8e-17
Identities = 53/215 (24%), Positives = 95/215 (44%), Gaps = 43/215 (20%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHH 477
LG +F KV ++ T +KI+K D D + ++ E ++L L K
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK------PP 402
Query: 478 -ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITR-------- 528
+ +L+ F ++ L+ V E + +GG+ + + ++
Sbjct: 403 FLTQLHSCFQTMDRLYFVMEYV-------------NGGDLMYHIQQVGRFKEPHAVFYAA 449
Query: 529 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS--- 585
+ L +L S GII+ DLK +N+++ S IKI D G +N+ V +++
Sbjct: 450 EIAIGLFFLQSKGIIYRDLKLDNVMLDS--EGHIKIADFGMC---KENIWDGVTTKTFCG 504
Query: 586 ---YRAPEVIIGLPYDQKIDLWSLGCILAELWTGE 617
Y APE+I PY + +D W+ G +L E+ G+
Sbjct: 505 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 9e-17
Identities = 58/221 (26%), Positives = 90/221 (40%), Gaps = 55/221 (24%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHH 477
LG F KV ++ TG +KI+K + KD +L E ++L+ H
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR-------HP 208
Query: 478 -ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITR-------- 528
+ L F + L V E +GGE +F L R +V +
Sbjct: 209 FLTALKYSFQTHDRLCFVMEYA-------------NGGELFFHLSRERVFSEDRARFYGA 255
Query: 529 QCLEALEYLHS-LGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC---LYVQSR 584
+ + AL+YLHS +++ DLK EN+++ IKI D G LC + +
Sbjct: 256 EIVSALDYLHSEKNVVYRDLKLENLMLDK--DGHIKITDFG--------LCKEGIKDGAT 305
Query: 585 S--------YRAPEVIIGLPYDQKIDLWSLGCILAELWTGE 617
Y APEV+ Y + +D W LG ++ E+ G
Sbjct: 306 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 346
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 79.1 bits (196), Expect = 4e-16
Identities = 59/230 (25%), Positives = 98/230 (42%), Gaps = 70/230 (30%)
Query: 422 LGSAAFSKVFQAQDL---HTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHI 478
LG + KVFQ + + +TG +K++K K ++ + K E +I
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLK--KAMIVRNAKDTAHTK--------AERNI 74
Query: 479 LRLYDYFYHLEHLFIVCELLRANL-YEFQKFNQE---------SGGEAYFTLGRLQVITR 528
L ++H FIV +L Y FQ SGGE + L R +
Sbjct: 75 LE------EVKHPFIV------DLIYAFQ--TGGKLYLILEYLSGGELFMQLEREGIFME 120
Query: 529 --------QCLEALEYLHSLGIIHCDLKPENILIKSYQRCE--IKIIDLGSSCFQTDNLC 578
+ AL +LH GII+ DLKPENI++ + +K+ D G LC
Sbjct: 121 DTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNH----QGHVKLTDFG--------LC 168
Query: 579 ---LYVQSRS--------YRAPEVIIGLPYDQKIDLWSLGCILAELWTGE 617
++ + + Y APE+++ +++ +D WSLG ++ ++ TG
Sbjct: 169 KESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGA 218
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 4e-16
Identities = 60/230 (26%), Positives = 95/230 (41%), Gaps = 73/230 (31%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPA---DEHHI 478
+G +F KV A+ V +K+++ K ++ K + E ++
Sbjct: 46 IGKGSFGKVLLARHKAEEVFYAVKVLQ--KKA------------ILKKKEEKHIMSERNV 91
Query: 479 LRLYDYFYHLEHLFIVCELLRANL-YEFQKFNQE---------SGGEAYFTLGRLQVITR 528
L +++H F+V L + FQ + +GGE ++ L R +
Sbjct: 92 LLK-----NVKHPFLV------GLHFSFQ--TADKLYFVLDYINGGELFYHLQRERCFLE 138
Query: 529 --------QCLEALEYLHSLGIIHCDLKPENILIKSYQRCE--IKIIDLGSSCFQTDNLC 578
+ AL YLHSL I++ DLKPENIL+ S + I + D G LC
Sbjct: 139 PRARFYAAEIASALGYLHSLNIVYRDLKPENILLDS----QGHIVLTDFG--------LC 186
Query: 579 ---LYVQSRS--------YRAPEVIIGLPYDQKIDLWSLGCILAELWTGE 617
+ S + Y APEV+ PYD+ +D W LG +L E+ G
Sbjct: 187 KENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGL 236
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 1e-15
Identities = 44/206 (21%), Positives = 80/206 (38%), Gaps = 31/206 (15%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEH- 476
LG + +V++ + V +K +K D ++F L E ++K + H
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEF----LKEAAVMKEIK-------HP 276
Query: 477 HILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALE 535
++++L +I+ E + NL ++ + + L + Q A+E
Sbjct: 277 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLR----ECNRQEVSAVVLLYMATQISSAME 332
Query: 536 YLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR------AP 589
YL IH +L N L+ K+ D G S T + Y + AP
Sbjct: 333 YLEKKNFIHRNLAARNCLVGENHLV--KVADFGLSRLMTGD--TYTAHAGAKFPIKWTAP 388
Query: 590 EVIIGLPYDQKIDLWSLGCILAELWT 615
E + + K D+W+ G +L E+ T
Sbjct: 389 ESLAYNKFSIKSDVWAFGVLLWEIAT 414
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 2e-15
Identities = 47/224 (20%), Positives = 84/224 (37%), Gaps = 53/224 (23%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHH 477
+G AFS+V + TG +KI+ + +E +L +
Sbjct: 69 IGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGD--------R 120
Query: 478 --ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVI--------- 526
I +L+ F +L++V E GG+ L +
Sbjct: 121 RWITQLHFAFQDENYLYLVMEYY-------------VGGDLLTLLSKFGERIPAEMARFY 167
Query: 527 TRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS- 585
+ + A++ +H LG +H D+KP+NIL+ I++ D GS V+S
Sbjct: 168 LAEIVMAIDSVHRLGYVHRDIKPDNILLDRCG--HIRLADFGSC--LKLRADGTVRSLVA 223
Query: 586 -----YRAPEVIIGL-------PYDQKIDLWSLGCILAELWTGE 617
Y +PE++ + Y + D W+LG E++ G+
Sbjct: 224 VGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 5e-15
Identities = 45/219 (20%), Positives = 87/219 (39%), Gaps = 48/219 (21%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHH 477
+G AF +V + T +K++ + +E ++ N
Sbjct: 77 IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN--------S 128
Query: 478 --ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQV---ITR---- 528
+++L+ F +L++V E + GG+ + V R
Sbjct: 129 PWVVQLFYAFQDDRYLYMVMEYM-------------PGGDLVNLMSNYDVPEKWARFYTA 175
Query: 529 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS--- 585
+ + AL+ +HS+G IH D+KP+N+L+ + +K+ D G+ V+ +
Sbjct: 176 EVVLALDAIHSMGFIHRDVKPDNMLLD--KSGHLKLADFGTCMKMNKE--GMVRCDTAVG 231
Query: 586 ---YRAPEVIIG----LPYDQKIDLWSLGCILAELWTGE 617
Y +PEV+ Y ++ D WS+G L E+ G+
Sbjct: 232 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 270
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 6e-15
Identities = 59/226 (26%), Positives = 91/226 (40%), Gaps = 66/226 (29%)
Query: 422 LGSAAFSKVFQAQ---DLHTGVDVCLKIIKNDKDFFDQ-----SLDEIKLLKLVNKNDPA 473
LG +F KVF + +K++K K + E +L VN
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLK--KATLKVRDRVRTKMERDILVEVN----- 84
Query: 474 DEHH--ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE--------AYFTLGRL 523
H I++L+ F L+++ + L GG+ FT +
Sbjct: 85 ---HPFIVKLHYAFQTEGKLYLILDFL-------------RGGDLFTRLSKEVMFTEEDV 128
Query: 524 QVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCE--IKIIDLGSSCFQTDNLC--- 578
+ + AL++LHSLGII+ DLKPENIL+ E IK+ D G L
Sbjct: 129 KFYLAELALALDHLHSLGIIYRDLKPENILLDE----EGHIKLTDFG--------LSKES 176
Query: 579 LYVQSRS--------YRAPEVIIGLPYDQKIDLWSLGCILAELWTG 616
+ + ++ Y APEV+ + Q D WS G ++ E+ TG
Sbjct: 177 IDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 222
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 9e-15
Identities = 32/215 (14%), Positives = 76/215 (35%), Gaps = 39/215 (18%)
Query: 407 ILNTVIAGRYYVTEYLGSAAFSKVFQA-----QDLHTGVDVCLKIIKNDKDFFDQSLDEI 461
I+ + A + V +G F ++ A + + + +K+ +D E+
Sbjct: 28 IITDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNG---PLFTEL 84
Query: 462 KLLKLVNKNDPADEHH---------ILRLYDYFYH----LEHLFIVCELLRANLYEFQKF 508
K + K + + + + + H + F++ + ++L + +
Sbjct: 85 KFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEA 144
Query: 509 NQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568
N + F+ + ++ + L+ LEY+H +H D+K N+L+ ++ ++D G
Sbjct: 145 NAKR-----FSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYG 199
Query: 569 SSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDL 603
+ Y V D K
Sbjct: 200 L-------------AYRYCPEGVHKAYAADPKRCH 221
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 2e-14
Identities = 51/213 (23%), Positives = 87/213 (40%), Gaps = 37/213 (17%)
Query: 422 LGSAAFSKVFQA----QDLHTGVDVCLKIIKND-----KDFFDQSLDEIKLLKLVNKNDP 472
LG F V +TG V +K +++ +DF EI++LK +
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDF----EREIEILKSLQ---- 69
Query: 473 ADEH-HILRLYD--YFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITR 528
H +I++ Y +L ++ E L +L ++ + ++E +L T
Sbjct: 70 ---HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER-----IDHIKLLQYTS 121
Query: 529 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR- 587
Q + +EYL + IH DL NIL+++ R KI D G + + +
Sbjct: 122 QICKGMEYLGTKRYIHRDLATRNILVENENRV--KIGDFGLTKVLPQDKEFFKVKEPGES 179
Query: 588 -----APEVIIGLPYDQKIDLWSLGCILAELWT 615
APE + + D+WS G +L EL+T
Sbjct: 180 PIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 3e-14
Identities = 48/224 (21%), Positives = 78/224 (34%), Gaps = 46/224 (20%)
Query: 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIK-NDKDFFDQSLDEIKLLKLVNKNDPADEH-H 477
E F V++AQ V +KI DK + E+ L + +H +
Sbjct: 30 EVKARGRFGCVWKAQ--LLNEYVAVKIFPIQDKQSWQNEY-EVYSLPGM-------KHEN 79
Query: 478 ILRLYDY----FYHLEHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITRQCLE 532
IL+ L+++ + +L +F K N + L I
Sbjct: 80 ILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV-------VSWNELCHIAETMAR 132
Query: 533 ALEYLHS----------LGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQ 582
L YLH I H D+K +N+L+K+ I D G +
Sbjct: 133 GLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTA--CIADFGLALKFEAGKSAGDT 190
Query: 583 SRS-----YRAPEVIIG-----LPYDQKIDLWSLGCILAELWTG 616
Y APEV+ G +ID++++G +L EL +
Sbjct: 191 HGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASR 234
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 4e-14
Identities = 51/212 (24%), Positives = 86/212 (40%), Gaps = 35/212 (16%)
Query: 422 LGSAAFSKVFQA----QDLHTGVDVCLKIIKND-----KDFFDQSLDEIKLLKLVNKNDP 472
LG F V +TG V +K +++ +DF EI++LK +
Sbjct: 49 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDF----EREIEILKSL----- 99
Query: 473 ADEHHILRLYD--YFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQ 529
+I++ Y +L ++ E L +L ++ + ++E +L T Q
Sbjct: 100 -QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER-----IDHIKLLQYTSQ 153
Query: 530 CLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR-- 587
+ +EYL + IH DL NIL+++ R KI D G + + Y
Sbjct: 154 ICKGMEYLGTKRYIHRDLATRNILVENENRV--KIGDFGLTKVLPQDKEYYKVKEPGESP 211
Query: 588 ----APEVIIGLPYDQKIDLWSLGCILAELWT 615
APE + + D+WS G +L EL+T
Sbjct: 212 IFWYAPESLTESKFSVASDVWSFGVVLYELFT 243
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 74.5 bits (183), Expect = 4e-14
Identities = 49/203 (24%), Positives = 83/203 (40%), Gaps = 23/203 (11%)
Query: 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHIL 479
LG F +V+ + V +K +K + L E +++K + ++
Sbjct: 273 VKLGQGCFGEVWMGT-WNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKL------RHEKLV 325
Query: 480 RLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLH 538
+LY E ++IV E + +L +F K Y L +L + Q + Y+
Sbjct: 326 QLYAVVSE-EPIYIVTEYMSKGSLLDFLK----GETGKYLRLPQLVDMAAQIASGMAYVE 380
Query: 539 SLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR------APEVI 592
+ +H DL+ NIL+ C K+ D G + DN Y + + APE
Sbjct: 381 RMNYVHRDLRAANILVGENLVC--KVADFGLARLIEDN--EYTARQGAKFPIKWTAPEAA 436
Query: 593 IGLPYDQKIDLWSLGCILAELWT 615
+ + K D+WS G +L EL T
Sbjct: 437 LYGRFTIKSDVWSFGILLTELTT 459
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 73.3 bits (180), Expect = 7e-14
Identities = 49/203 (24%), Positives = 83/203 (40%), Gaps = 23/203 (11%)
Query: 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHIL 479
LG F +V+ + V +K +K + L E +++K + ++
Sbjct: 190 VKLGQGCFGEVWMGT-WNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKL------RHEKLV 242
Query: 480 RLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLH 538
+LY E ++IV E + +L +F K Y L +L + Q + Y+
Sbjct: 243 QLYAVVSE-EPIYIVTEYMSKGSLLDFLK----GETGKYLRLPQLVDMAAQIASGMAYVE 297
Query: 539 SLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR------APEVI 592
+ +H DL+ NIL+ C K+ D G + DN Y + + APE
Sbjct: 298 RMNYVHRDLRAANILVGENLVC--KVADFGLARLIEDN--EYTARQGAKFPIKWTAPEAA 353
Query: 593 IGLPYDQKIDLWSLGCILAELWT 615
+ + K D+WS G +L EL T
Sbjct: 354 LYGRFTIKSDVWSFGILLTELTT 376
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 9e-14
Identities = 50/201 (24%), Positives = 85/201 (42%), Gaps = 23/201 (11%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRL 481
LG+ F +V+ A + V +K +K + L E ++K + +++L
Sbjct: 196 LGAGQFGEVWMAT-YNKHTKVAVKTMKPGSMSVEAFLAEANVMKTL------QHDKLVKL 248
Query: 482 YDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSL 540
+ E ++I+ E + +L +F K S + L +L + Q E + ++
Sbjct: 249 HAVVTK-EPIYIITEFMAKGSLLDFLK----SDEGSKQPLPKLIDFSAQIAEGMAFIEQR 303
Query: 541 GIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR------APEVIIG 594
IH DL+ NIL+ + C KI D G + DN Y + APE I
Sbjct: 304 NYIHRDLRAANILVSASLVC--KIADFGLARVIEDN--EYTAREGAKFPIKWTAPEAINF 359
Query: 595 LPYDQKIDLWSLGCILAELWT 615
+ K D+WS G +L E+ T
Sbjct: 360 GSFTIKSDVWSFGILLMEIVT 380
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 71.8 bits (176), Expect = 1e-13
Identities = 45/233 (19%), Positives = 78/233 (33%), Gaps = 56/233 (24%)
Query: 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIK--NDKDFFDQSLDEIKLLKLVNKNDPADEH- 476
E +G + V++ V +K+ N ++F ++ I + L+ EH
Sbjct: 19 ELIGRGRYGAVYKGS--LDERPVAVKVFSFANRQNFINEK--NIYRVPLM-------EHD 67
Query: 477 HILRLY-----DYFYHLEHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITRQC 530
+I R +V E +L ++ + +
Sbjct: 68 NIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT-------SDWVSSCRLAHSV 120
Query: 531 LEALEYLHS---------LGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYV 581
L YLH+ I H DL N+L+K+ C I D G S T N +
Sbjct: 121 TRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTC--VISDFGLSMRLTGNRLVRP 178
Query: 582 QSRS-----------YRAPEVIIGL-------PYDQKIDLWSLGCILAELWTG 616
Y APEV+ G +++D+++LG I E++
Sbjct: 179 GEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMR 231
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 2e-13
Identities = 48/211 (22%), Positives = 84/211 (39%), Gaps = 31/211 (14%)
Query: 420 EYLGSAAFSKVFQAQDLHTG---VDVCLKIIKND------KDFFDQSLDEIKLLKLVNKN 470
+ +G+ F +V + + V +K +K +DF L E ++
Sbjct: 51 KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF----LGEASIMGQF--- 103
Query: 471 DPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQC 530
D +I+RL + + IV E + F ++ + FT+ +L + R
Sbjct: 104 ---DHPNIIRLEGVVTKSKPVMIVTEYME--NGSLDSFLRKHDAQ--FTVIQLVGMLRGI 156
Query: 531 LEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR--- 587
++YL +G +H DL NILI S C K+ D G D+ +R +
Sbjct: 157 ASGMKYLSDMGYVHRDLAARNILINSNLVC--KVSDFGLGRVLEDDPEAAYTTRGGKIPI 214
Query: 588 ---APEVIIGLPYDQKIDLWSLGCILAELWT 615
+PE I + D+WS G +L E+ +
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 2e-13
Identities = 49/208 (23%), Positives = 77/208 (37%), Gaps = 33/208 (15%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKND------KDFFDQSLDEIKLLKLVNKNDPADE 475
+G F +VF + V +K + F L E ++LK
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKF----LQEARILKQY------SH 171
Query: 476 HHILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEAL 534
+I+RL + ++IV EL++ + F + + L + +
Sbjct: 172 PNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGAR-----LRVKTLLQMVGDAAAGM 226
Query: 535 EYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR------- 587
EYL S IH DL N L+ KI D G S + D +Y S R
Sbjct: 227 EYLESKCCIHRDLAARNCLVTEKNVL--KISDFGMSREEADG--VYAASGGLRQVPVKWT 282
Query: 588 APEVIIGLPYDQKIDLWSLGCILAELWT 615
APE + Y + D+WS G +L E ++
Sbjct: 283 APEALNYGRYSSESDVWSFGILLWETFS 310
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 2e-13
Identities = 56/230 (24%), Positives = 97/230 (42%), Gaps = 68/230 (29%)
Query: 422 LGSAAFSKVFQAQDL---HTGVDVCLKIIK------NDKDFFDQSLDEIKLLKLVNKNDP 472
LG+ A+ KVF + + TG +K++K K + + E ++L+ +
Sbjct: 62 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTT-EHTRTERQVLEHIR---- 116
Query: 473 ADEHH--ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE--------AYFTLGR 522
++ L+ F L ++ + + +GGE FT
Sbjct: 117 ---QSPFLVTLHYAFQTETKLHLILDYI-------------NGGELFTHLSQRERFTEHE 160
Query: 523 LQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCE--IKIIDLGSSCFQTDNLC-L 579
+Q+ + + ALE+LH LGII+ D+K ENIL+ S + + D G L
Sbjct: 161 VQIYVGEIVLALEHLHKLGIIYRDIKLENILLDS----NGHVVLTDFG--------LSKE 208
Query: 580 YVQSRS-----------YRAPEVIIGLP--YDQKIDLWSLGCILAELWTG 616
+V + Y AP+++ G +D+ +D WSLG ++ EL TG
Sbjct: 209 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTG 258
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 2e-13
Identities = 47/213 (22%), Positives = 84/213 (39%), Gaps = 34/213 (15%)
Query: 420 EYLGSAAFSKVFQA----QDLHTGVDVCLKIIKND------KDFFDQSLDEIKLLKLVNK 469
+ +G+ F +V++ V V +K +K DF L E ++
Sbjct: 50 KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDF----LGEAGIMGQF-- 103
Query: 470 NDPADEHHILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITR 528
H+I+RL + + I+ E + L +F + F++ +L + R
Sbjct: 104 ----SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE-----FSVLQLVGMLR 154
Query: 529 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR- 587
++YL ++ +H DL NIL+ S C K+ D G S D+ + +
Sbjct: 155 GIAAGMKYLANMNYVHRDLAARNILVNSNLVC--KVSDFGLSRVLEDDPEATYTTSGGKI 212
Query: 588 -----APEVIIGLPYDQKIDLWSLGCILAELWT 615
APE I + D+WS G ++ E+ T
Sbjct: 213 PIRWTAPEAISYRKFTSASDVWSFGIVMWEVMT 245
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 3e-13
Identities = 50/212 (23%), Positives = 81/212 (38%), Gaps = 33/212 (15%)
Query: 420 EYLGSAAFSKVFQAQDLHTG---VDVCLKIIKND------KDFFDQSLDEIKLLKLVNKN 470
+ +GS +V + G V V +K +K +DF L E ++
Sbjct: 55 KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDF----LSEASIMGQF--- 107
Query: 471 DPADEHHILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQ 529
D +I+RL IV E + +L F + + FT+ +L + R
Sbjct: 108 ---DHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQ-----FTIMQLVGMLRG 159
Query: 530 CLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR-- 587
+ YL LG +H DL N+L+ S C K+ D G S D+ + +
Sbjct: 160 VGAGMRYLSDLGYVHRDLAARNVLVDSNLVC--KVSDFGLSRVLEDDPDAAYTTTGGKIP 217
Query: 588 ----APEVIIGLPYDQKIDLWSLGCILAELWT 615
APE I + D+WS G ++ E+
Sbjct: 218 IRWTAPEAIAFRTFSSASDVWSFGVVMWEVLA 249
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 3e-13
Identities = 44/205 (21%), Positives = 79/205 (38%), Gaps = 29/205 (14%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHH 477
LG + +V++ + V +K +K D ++F L E ++K + +
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEF----LKEAAVMKEI------KHPN 70
Query: 478 ILRLYDYFYHLEHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEY 536
+++L +I+ E + NL ++ + + L + Q A+EY
Sbjct: 71 LVQLLGVCTREPPFYIITEFMTYGNLLDYLR----ECNRQEVSAVVLLYMATQISSAMEY 126
Query: 537 LHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR------APE 590
L IH DL N L+ K+ D G S T + Y + APE
Sbjct: 127 LEKKNFIHRDLAARNCLVGENHLV--KVADFGLSRLMTGD--TYTAHAGAKFPIKWTAPE 182
Query: 591 VIIGLPYDQKIDLWSLGCILAELWT 615
+ + K D+W+ G +L E+ T
Sbjct: 183 SLAYNKFSIKSDVWAFGVLLWEIAT 207
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 69.5 bits (171), Expect = 3e-13
Identities = 44/207 (21%), Positives = 79/207 (38%), Gaps = 31/207 (14%)
Query: 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADE 475
+ LGS F V + DV +K+IK +F E + + +
Sbjct: 14 KELGSGQFGVVKLGK-WKGQYDVAVKMIKEGSMSEDEF----FQEAQTMMKL------SH 62
Query: 476 HHILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEAL 534
+++ Y ++IV E + L + + + + +L + E +
Sbjct: 63 PKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKG-----LEPSQLLEMCYDVCEGM 117
Query: 535 EYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR------A 588
+L S IH DL N L+ K+ D G + + D+ YV S + A
Sbjct: 118 AFLESHQFIHRDLAARNCLVDRDLCV--KVSDFGMTRYVLDD--QYVSSVGTKFPVKWSA 173
Query: 589 PEVIIGLPYDQKIDLWSLGCILAELWT 615
PEV Y K D+W+ G ++ E+++
Sbjct: 174 PEVFHYFKYSSKSDVWAFGILMWEVFS 200
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 5e-13
Identities = 25/179 (13%), Positives = 59/179 (32%), Gaps = 24/179 (13%)
Query: 407 ILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGV--------DVCLKIIKNDKDFFDQSL 458
+L ++ + + +++A T LK+ D F++
Sbjct: 35 VLTDKSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQN 94
Query: 459 --------DEIKLLKLVNKNDPADEHHILRLYDYFYHL-EHLFIVCELLRANLYEFQKFN 509
++ K + I + H ++ F+V L +L +
Sbjct: 95 FFQRAAKPLQVNKWKKLYSTP---LLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSA--LD 149
Query: 510 QESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568
+ + + + L+ALE+LH +H ++ ENI + + ++ + G
Sbjct: 150 VSPKHV--LSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYG 206
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 9e-13
Identities = 46/210 (21%), Positives = 81/210 (38%), Gaps = 45/210 (21%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEH-H 477
+G F V + G V +K IKND + F L E ++ + H +
Sbjct: 201 IGKGEFGDVMLG--DYRGNKVAVKCIKNDATAQAF----LAEASVMTQLR-------HSN 247
Query: 478 ILRLY-----DYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCL 531
+++L + L+IV E + +L ++ + S G + L +
Sbjct: 248 LVQLLGVIVEEK----GGLYIVTEYMAKGSLVDYLR----SRGRSVLGGDCLLKFSLDVC 299
Query: 532 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR---- 587
EA+EYL +H DL N+L+ K+ D G + + +
Sbjct: 300 EAMEYLEGNNFVHRDLAARNVLVSEDNVA--KVSDFGLTKE------ASSTQDTGKLPVK 351
Query: 588 --APEVIIGLPYDQKIDLWSLGCILAELWT 615
APE + + K D+WS G +L E+++
Sbjct: 352 WTAPEALREKKFSTKSDVWSFGILLWEIYS 381
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 1e-12
Identities = 45/206 (21%), Positives = 81/206 (39%), Gaps = 33/206 (16%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEH- 476
+GS F V V +K I+ +DF ++E +++ ++ H
Sbjct: 16 IGSGQFGLVHLGY-WLNKDKVAIKTIREGAMSEEDF----IEEAEVMMKLS-------HP 63
Query: 477 HILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALE 535
+++LY + +V E + L ++ + + F L + E +
Sbjct: 64 KLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGL-----FAAETLLGMCLDVCEGMA 118
Query: 536 YLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR------AP 589
YL +IH DL N L+ Q K+ D G + F D+ Y S + +P
Sbjct: 119 YLEEACVIHRDLAARNCLVGENQVI--KVSDFGMTRFVLDD--QYTSSTGTKFPVKWASP 174
Query: 590 EVIIGLPYDQKIDLWSLGCILAELWT 615
EV Y K D+WS G ++ E+++
Sbjct: 175 EVFSFSRYSSKSDVWSFGVLMWEVFS 200
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 1e-12
Identities = 53/212 (25%), Positives = 88/212 (41%), Gaps = 35/212 (16%)
Query: 422 LGSAAFSKVFQA----QDLHTGVDVCLKIIKND-----KDFFDQSLDEIKLLKLVNKNDP 472
LG F V +TG V +K +++ +DF EI++LK +
Sbjct: 31 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDF----QREIQILKAL----- 81
Query: 473 ADEHHILRLYD--YFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQ 529
I++ Y + L +V E L + L +F + ++ RL + + Q
Sbjct: 82 -HSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR-----LDASRLLLYSSQ 135
Query: 530 CLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR-- 587
+ +EYL S +H DL NIL++S KI D G + + YV +
Sbjct: 136 ICKGMEYLGSRRCVHRDLAARNILVESEAHV--KIADFGLAKLLPLDKDYYVVREPGQSP 193
Query: 588 ----APEVIIGLPYDQKIDLWSLGCILAELWT 615
APE + + ++ D+WS G +L EL+T
Sbjct: 194 IFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 225
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 2e-12
Identities = 48/214 (22%), Positives = 82/214 (38%), Gaps = 38/214 (17%)
Query: 422 LGSAAFSKVFQA----QDLHTGVDVCLKIIKND------KDFFDQSLDEIKLLKLVNKND 471
LG F KV + +TG V +K +K + D EI++L+ +
Sbjct: 29 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADL----KKEIEILRNLY--- 81
Query: 472 PADEH-HILRLYD--YFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVIT 527
H +I++ + ++ E L + +L E+ N+ L +
Sbjct: 82 ----HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK-----INLKQQLKYA 132
Query: 528 RQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR 587
Q + ++YL S +H DL N+L++S + KI D G + + Y
Sbjct: 133 VQICKGMDYLGSRQYVHRDLAARNVLVESEHQV--KIGDFGLTKAIETDKEYYTVKDDRD 190
Query: 588 ------APEVIIGLPYDQKIDLWSLGCILAELWT 615
APE ++ + D+WS G L EL T
Sbjct: 191 SPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT 224
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 1e-11
Identities = 52/205 (25%), Positives = 83/205 (40%), Gaps = 31/205 (15%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHH 477
LG+ F +V+ + V +K +K F L E L+K +
Sbjct: 21 LGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSPDAF----LAEANLMKQL------QHQR 69
Query: 478 ILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEY 536
++RLY E ++I+ E + +L +F K + T+ +L + Q E + +
Sbjct: 70 LVRLYAVVTQ-EPIYIITEYMENGSLVDFLK----TPSGIKLTINKLLDMAAQIAEGMAF 124
Query: 537 LHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR------APE 590
+ IH DL+ NIL+ C KI D G + DN Y + APE
Sbjct: 125 IEERNYIHRDLRAANILVSDTLSC--KIADFGLARLIEDN--EYTAREGAKFPIKWTAPE 180
Query: 591 VIIGLPYDQKIDLWSLGCILAELWT 615
I + K D+WS G +L E+ T
Sbjct: 181 AINYGTFTIKSDVWSFGILLTEIVT 205
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 2e-11
Identities = 46/205 (22%), Positives = 85/205 (41%), Gaps = 31/205 (15%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHH 477
LG+ F V + DV +K+IK +F ++E K++ +
Sbjct: 32 LGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSEDEF----IEEAKVMMNL------SHEK 80
Query: 478 ILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEY 536
+++LY +FI+ E + L + + + F +L + + EA+EY
Sbjct: 81 LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR-----FQTQQLLEMCKDVCEAMEY 135
Query: 537 LHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR------APE 590
L S +H DL N L+ K+ D G S + D+ Y S + PE
Sbjct: 136 LESKQFLHRDLAARNCLVNDQGVV--KVSDFGLSRYVLDD--EYTSSVGSKFPVRWSPPE 191
Query: 591 VIIGLPYDQKIDLWSLGCILAELWT 615
V++ + K D+W+ G ++ E+++
Sbjct: 192 VLMYSKFSSKSDIWAFGVLMWEIYS 216
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 2e-11
Identities = 45/205 (21%), Positives = 80/205 (39%), Gaps = 35/205 (17%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHI 478
+G F V + G V +K IKND + F L E ++ + ++
Sbjct: 29 IGKGEFGDVMLG--DYRGNKVAVKCIKNDATAQAF----LAEASVMTQL------RHSNL 76
Query: 479 LRLYDY-FYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEY 536
++L L+IV E + +L ++ + S G + L + EA+EY
Sbjct: 77 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLR----SRGRSVLGGDCLLKFSLDVCEAMEY 132
Query: 537 LHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR------APE 590
L +H DL N+L+ K+ D G + + + + APE
Sbjct: 133 LEGNNFVHRDLAARNVLVSEDNVA--KVSDFGLT---KE---ASSTQDTGKLPVKWTAPE 184
Query: 591 VIIGLPYDQKIDLWSLGCILAELWT 615
+ + K D+WS G +L E+++
Sbjct: 185 ALREKKFSTKSDVWSFGILLWEIYS 209
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 1e-10
Identities = 49/213 (23%), Positives = 78/213 (36%), Gaps = 38/213 (17%)
Query: 422 LGSAAFSKVFQAQ----DLHTGVDVCLKIIKND------KDFFDQSLDEIKLLKLVNKND 471
LG F KV + TG V +K +K D + EI +L+ +
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGW----KQEIDILRTL---- 90
Query: 472 PADEHHILRLYD--YFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITR 528
HI++ L +V E + +L ++ + L +L + +
Sbjct: 91 --YHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS-------IGLAQLLLFAQ 141
Query: 529 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR- 587
Q E + YLH+ IH DL N+L+ + + KI D G + + Y
Sbjct: 142 QICEGMAYLHAQHYIHRDLAARNVLLDNDRLV--KIGDFGLAKAVPEGHEYYRVREDGDS 199
Query: 588 -----APEVIIGLPYDQKIDLWSLGCILAELWT 615
APE + + D+WS G L EL T
Sbjct: 200 PVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 232
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 2e-10
Identities = 52/217 (23%), Positives = 79/217 (36%), Gaps = 46/217 (21%)
Query: 422 LGSAAFSKVFQA---QDLHTGVDVCLKIIKND--------KDFFDQSLDEIKLLKLVNKN 470
LG +F V + V V +K +K D DF + E+ + ++
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDF----IREVNAMHSLD-- 79
Query: 471 DPADEH-HILRLY----DYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQ 524
H +++RLY + +V EL +L + + +Q F LG L
Sbjct: 80 -----HRNLIRLYGVVLT-----PPMKMVTELAPLGSLLDRLRKHQGH-----FLLGTLS 124
Query: 525 VITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSR 584
Q E + YL S IH DL N+L+ + KI D G N YV
Sbjct: 125 RYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLV--KIGDFGLMRALPQNDDHYVMQE 182
Query: 585 SYR------APEVIIGLPYDQKIDLWSLGCILAELWT 615
+ APE + + D W G L E++T
Sbjct: 183 HRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 219
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 3e-10
Identities = 46/210 (21%), Positives = 80/210 (38%), Gaps = 35/210 (16%)
Query: 422 LGSAAFSKVFQA--QDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEH 476
LGS F V + Q V +KI+KN+ D+ L E +++ + D
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL------DNP 78
Query: 477 HILRLY----DYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCL 531
+I+R+ E +V E+ L ++ + N+ + + Q
Sbjct: 79 YIVRMIGICEA-----ESWMLVMEMAELGPLNKYLQQNRH------VKDKNIIELVHQVS 127
Query: 532 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR---- 587
++YL +H DL N+L+ + KI D G S + Y +
Sbjct: 128 MGMKYLEESNFVHRDLAARNVLLVTQHYA--KISDFGLSKALRADENYYKAQTHGKWPVK 185
Query: 588 --APEVIIGLPYDQKIDLWSLGCILAELWT 615
APE I + K D+WS G ++ E ++
Sbjct: 186 WYAPECINYYKFSSKSDVWSFGVLMWEAFS 215
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 3e-10
Identities = 44/216 (20%), Positives = 81/216 (37%), Gaps = 46/216 (21%)
Query: 422 LGSAAFSKVFQA----QDLHTGVDVCLKIIKND------KDFFDQSLDEIKLLKLVNKND 471
LGS F V + + + VC+K+I++ + D + + +
Sbjct: 21 LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAV----TDHMLAIGSL---- 72
Query: 472 PADEHHILRLY----DYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVI 526
D HI+RL L +V + L +L + + ++ + L
Sbjct: 73 --DHAHIVRLLGLCPG-----SSLQLVTQYLPLGSLLDHVRQHRGA-----LGPQLLLNW 120
Query: 527 TRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG-SSCFQTDNLCLYVQSRS 585
Q + + YL G++H +L N+L+KS + ++ D G + D+ +
Sbjct: 121 GVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQV--QVADFGVADLLPPDD--KQLLYSE 176
Query: 586 YR------APEVIIGLPYDQKIDLWSLGCILAELWT 615
+ A E I Y + D+WS G + EL T
Sbjct: 177 AKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMT 212
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 5e-10
Identities = 40/223 (17%), Positives = 79/223 (35%), Gaps = 50/223 (22%)
Query: 420 EYLGSAAFSKVFQAQDLHTG-------VDVCLKIIKND-----KDFFDQSLDEIKLLKLV 467
E LG F+K+F+ G +V LK++ + F + ++ +
Sbjct: 14 ESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESF----FEAASMMSKL 69
Query: 468 NKNDPADEHHILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVI 526
H++ Y + +V E ++ +L + K N+ + +
Sbjct: 70 ------SHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNC-----INILWKLEV 118
Query: 527 TRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCE------IKIIDLGSSCFQTDNLCLY 580
+Q A+ +L +IH ++ +NIL+ + + IK+ D G + +
Sbjct: 119 AKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPG--------ISIT 170
Query: 581 VQSRSYR-------APEVII-GLPYDQKIDLWSLGCILAELWT 615
V + PE I + D WS G L E+ +
Sbjct: 171 VLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICS 213
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 61.1 bits (148), Expect = 7e-10
Identities = 45/205 (21%), Positives = 77/205 (37%), Gaps = 25/205 (12%)
Query: 422 LGSAAFSKVFQAQDLHTG---VDVCLKIIKNDKDFFDQS--LDEIKLLKLVNKNDPADEH 476
LG F V Q +DV +K++K + D + E +++ + D
Sbjct: 344 LGCGNFGSVRQGV-YRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL------DNP 396
Query: 477 HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEY 536
+I+RL E L +V E+ A KF E + + + Q ++Y
Sbjct: 397 YIVRLIGVCQA-EALMLVMEM--AGGGPLHKFLVGKREE--IPVSNVAELLHQVSMGMKY 451
Query: 537 LHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR------APE 590
L +H +L N+L+ + KI D G S + Y + + APE
Sbjct: 452 LEEKNFVHRNLAARNVLLVNRHYA--KISDFGLSKALGADDSYYTARSAGKWPLKWYAPE 509
Query: 591 VIIGLPYDQKIDLWSLGCILAELWT 615
I + + D+WS G + E +
Sbjct: 510 CINFRKFSSRSDVWSYGVTMWEALS 534
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 8e-10
Identities = 44/217 (20%), Positives = 84/217 (38%), Gaps = 48/217 (22%)
Query: 422 LGSAAFSKVFQA----QDLHTGVDVCLKIIKND------KDFFDQSLDEIKLLKLVNKND 471
LGS AF V++ + + V +K ++ K+ LDE ++ V+
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEI----LDEAYVMASVD--- 75
Query: 472 PADEH-HILRLY----DYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQV 525
+ H+ RL + ++ +L+ L ++ + ++++ L
Sbjct: 76 ----NPHVCRLLGICLT-----STVQLITQLMPFGCLLDYVREHKDN-----IGSQYLLN 121
Query: 526 ITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG-SSCFQTDNLCLYVQSR 584
Q + + YL ++H DL N+L+K+ Q KI D G + + +
Sbjct: 122 WCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHV--KITDFGLAKLLGAEE--KEYHAE 177
Query: 585 SYR------APEVIIGLPYDQKIDLWSLGCILAELWT 615
+ A E I+ Y + D+WS G + EL T
Sbjct: 178 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 1e-09
Identities = 44/213 (20%), Positives = 78/213 (36%), Gaps = 41/213 (19%)
Query: 422 LGSAAFSKVFQAQ--DLHTGVDVCLKIIKND------KDFFDQSLDEIKLLKLVNKNDPA 473
LG F V Q +DV +K++K ++ + E +++ ++
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEM----MREAQIMHQLD----- 68
Query: 474 DEH-HILRLY----DYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITR 528
+ +I+RL E L +V E+ A KF E + + +
Sbjct: 69 --NPYIVRLIGVCQA-----EALMLVMEM--AGGGPLHKFLVGKREE--IPVSNVAELLH 117
Query: 529 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR- 587
Q ++YL +H DL N+L+ + KI D G S + Y + +
Sbjct: 118 QVSMGMKYLEEKNFVHRDLAARNVLLVNRHYA--KISDFGLSKALGADDSYYTARSAGKW 175
Query: 588 -----APEVIIGLPYDQKIDLWSLGCILAELWT 615
APE I + + D+WS G + E +
Sbjct: 176 PLKWYAPECINFRKFSSRSDVWSYGVTMWEALS 208
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 1e-09
Identities = 52/223 (23%), Positives = 81/223 (36%), Gaps = 40/223 (17%)
Query: 422 LGSAAFSKVFQA-----QDLHTGVDVCLKIIKNDKDFFDQS--LDEIKLLKLVNKNDPAD 474
LG+ AF KV +A + V +K++K ++ + E+K+L +
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN----- 85
Query: 475 EH-HILRLYDYFYHLEHLFIVCEL---------LRAN----LYEFQKFNQESGGEAYFTL 520
H +I+ L ++ E LR + E L
Sbjct: 86 -HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 144
Query: 521 GRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS--CFQTDNLC 578
L + Q + + +L S IH DL NIL+ + KI D G + N
Sbjct: 145 EDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRIT--KICDFGLARDIKNDSN-- 200
Query: 579 LYVQSRSYR------APEVIIGLPYDQKIDLWSLGCILAELWT 615
YV + R APE I Y + D+WS G L EL++
Sbjct: 201 -YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 3e-09
Identities = 47/219 (21%), Positives = 88/219 (40%), Gaps = 36/219 (16%)
Query: 422 LGSAAFSKVFQAQDLHTG-----VDVCLKIIKNDKDFFDQS--LDEIKLLKLVNKNDPAD 474
LG+ AF KV +A G + V +K++K+ ++ + E+K++ + +
Sbjct: 54 LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQ----- 108
Query: 475 EH-HILRLYDYFYHLEHLFIVCEL---------LRANLYEFQKFNQESGGEAYFTLGRLQ 524
H +I+ L H + ++ E LR + + + + L
Sbjct: 109 -HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLL 167
Query: 525 VITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS--CFQTDNLCLYVQ 582
+ Q + + +L S IH D+ N+L+ + KI D G + N Y+
Sbjct: 168 HFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVA--KIGDFGLARDIMNDSN---YIV 222
Query: 583 SRSYR------APEVIIGLPYDQKIDLWSLGCILAELWT 615
+ R APE I Y + D+WS G +L E+++
Sbjct: 223 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 58.7 bits (142), Expect = 3e-09
Identities = 48/215 (22%), Positives = 77/215 (35%), Gaps = 42/215 (19%)
Query: 420 EYLGSAAFSKVFQAQDLHTG---VDVCLKIIKND------KDFFDQSLDEIKLLKLVNKN 470
+G F V Q + + V +K KN + F L E ++
Sbjct: 396 RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKF----LQEALTMRQF--- 448
Query: 471 DPADEHHILRLY----DYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVI 526
D HI++L + ++I+ EL E + F Q L L +
Sbjct: 449 ---DHPHIVKLIGVITE-----NPVWIIMELCTLG--ELRSFLQVRKFS--LDLASLILY 496
Query: 527 TRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSY 586
Q AL YL S +H D+ N+L+ S K+ D G S + D+ Y ++
Sbjct: 497 AYQLSTALAYLESKRFVHRDIAARNVLVSSNDCV--KLGDFGLSRYMEDS--TYYKASKG 552
Query: 587 R------APEVIIGLPYDQKIDLWSLGCILAELWT 615
+ APE I + D+W G + E+
Sbjct: 553 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEILM 587
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 1e-08
Identities = 43/218 (19%), Positives = 80/218 (36%), Gaps = 39/218 (17%)
Query: 422 LGSAAFSKVFQA---QDLHTGVDVCLKIIKND-------KDFFDQSLDEIKLLKLVNKND 471
LG F V + Q+ T + V +K +K D ++F L E +K
Sbjct: 42 LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEF----LSEAACMKDF---- 93
Query: 472 PADEHHILRLY-----DYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQV 525
+++RL + ++ ++ +L+ + +++ G + L L
Sbjct: 94 --SHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLK 151
Query: 526 ITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS--CFQTDNLCLYVQS 583
+EYL + +H DL N +++ + D G S + D Y Q
Sbjct: 152 FMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTV--CVADFGLSKKIYSGD---YYRQG 206
Query: 584 RSYR------APEVIIGLPYDQKIDLWSLGCILAELWT 615
R + A E + Y K D+W+ G + E+ T
Sbjct: 207 RIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 44/217 (20%), Positives = 84/217 (38%), Gaps = 48/217 (22%)
Query: 422 LGSAAFSKVFQA----QDLHTGVDVCLKIIKND------KDFFDQSLDEIKLLKLVNKND 471
LGS AF V++ + + V +K ++ K+ LDE ++ V+
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEI----LDEAYVMASVD--- 75
Query: 472 PADEH-HILRLY----DYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQV 525
+ H+ RL + ++ +L+ L ++ + ++++ L
Sbjct: 76 ----NPHVCRLLGICLT-----STVQLITQLMPFGCLLDYVREHKDN-----IGSQYLLN 121
Query: 526 ITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG-SSCFQTDNLCLYVQSR 584
Q + + YL ++H DL N+L+K+ Q KI D G + + +
Sbjct: 122 WCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHV--KITDFGLAKLLGAEE--KEYHAE 177
Query: 585 SYR------APEVIIGLPYDQKIDLWSLGCILAELWT 615
+ A E I+ Y + D+WS G + EL T
Sbjct: 178 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 53/227 (23%), Positives = 87/227 (38%), Gaps = 48/227 (21%)
Query: 422 LGSAAFSKVFQA-------QDLHTGVDVCLKIIKND------KDFFDQSLDEIKLLKLVN 468
LG AF +V A + V +K++K+D D + E++++K++
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDL----ISEMEMMKMIG 132
Query: 469 KNDPADEH-HILRLYDYFYHLEHLFIVCEL---------LRAN--LYEFQKFNQESGGEA 516
K H +I+ L L+++ E L+A +N E
Sbjct: 133 K------HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 186
Query: 517 YFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS--CFQT 574
+ L Q +EYL S IH DL N+L+ KI D G +
Sbjct: 187 QLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVM--KIADFGLARDIHHI 244
Query: 575 DNLCLYVQSRSYR------APEVIIGLPYDQKIDLWSLGCILAELWT 615
D Y ++ + R APE + Y + D+WS G +L E++T
Sbjct: 245 DY---YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 46/219 (21%), Positives = 79/219 (36%), Gaps = 40/219 (18%)
Query: 422 LGSAAFSKVFQA---QDLHTGVDVCLKIIKND-------KDFFDQSLDEIKLLKLVNKND 471
LG F V +A Q+ + V V +K++K D ++F L E +K
Sbjct: 31 LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEF----LREAACMKEF---- 82
Query: 472 PADEHHILRLY------DYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQ 524
D H+ +L L ++ ++ +L+ F ++ L L
Sbjct: 83 --DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLV 140
Query: 525 VITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS--CFQTDNLCLYVQ 582
+EYL S IH DL N ++ + + + D G S + D Y Q
Sbjct: 141 RFMVDIACGMEYLSSRNFIHRDLAARNCML-AEDMT-VCVADFGLSRKIYSGD---YYRQ 195
Query: 583 SRSYR------APEVIIGLPYDQKIDLWSLGCILAELWT 615
+ + A E + Y D+W+ G + E+ T
Sbjct: 196 GCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMT 234
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 54.9 bits (133), Expect = 2e-08
Identities = 48/216 (22%), Positives = 78/216 (36%), Gaps = 44/216 (20%)
Query: 420 EYLGSAAFSKVFQAQDLHTG---VDVCLKIIKND------KDFFDQSLDEIKLLKLVNKN 470
+G F V Q + + V +K KN + F L E ++
Sbjct: 21 RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKF----LQEALTMRQF--- 73
Query: 471 DPADEHHILRLY----DYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQV 525
D HI++L + ++I+ EL L F + + S L L +
Sbjct: 74 ---DHPHIVKLIGVITE-----NPVWIIMELCTLGELRSFLQVRKYS-----LDLASLIL 120
Query: 526 ITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS 585
Q AL YL S +H D+ N+L+ S K+ D G S + D+ Y ++
Sbjct: 121 YAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCV--KLGDFGLSRYMEDS--TYYKASK 176
Query: 586 YR------APEVIIGLPYDQKIDLWSLGCILAELWT 615
+ APE I + D+W G + E+
Sbjct: 177 GKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILM 212
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 4e-08
Identities = 55/223 (24%), Positives = 89/223 (39%), Gaps = 40/223 (17%)
Query: 422 LGSAAFSKVFQA-------QDLHTGVDVCLKIIK---NDKDFFDQSLDEIKLLKLVNKND 471
LG AF +V A V V +K++K +KD D + E++++K++ K+
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDL-VSEMEMMKMIGKHK 101
Query: 472 PADEHHILRLYDYFYHLEHLFIVCEL---------LRAN--LYEFQKFNQESGGEAYFTL 520
+I+ L L+++ E LRA ++ E T
Sbjct: 102 -----NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 156
Query: 521 GRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS--CFQTDNLC 578
L T Q +EYL S IH DL N+L+ KI D G + D
Sbjct: 157 KDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVM--KIADFGLARDINNIDY-- 212
Query: 579 LYVQSRSYR------APEVIIGLPYDQKIDLWSLGCILAELWT 615
Y ++ + R APE + Y + D+WS G ++ E++T
Sbjct: 213 -YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 4e-08
Identities = 47/219 (21%), Positives = 80/219 (36%), Gaps = 40/219 (18%)
Query: 422 LGSAAFSKVFQAQ--DLHTGVDVCLKIIKND------KDFFDQSLDEIKLLKLVNKNDPA 473
+G F +V +A+ +D +K +K +DF E+++L + +
Sbjct: 33 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDF----AGELEVLCKLGHHP-- 86
Query: 474 DEHHILRLYDYFYHLEHLFIVCEL---------LRAN--LYEFQKFNQESGGEAYFTLGR 522
+I+ L H +L++ E LR + L F + + + +
Sbjct: 87 ---NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 143
Query: 523 LQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQ 582
L ++YL IH DL NIL+ KI D G S + YV+
Sbjct: 144 LLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVA--KIADFGLS-RGQEV---YVK 197
Query: 583 SRSYR------APEVIIGLPYDQKIDLWSLGCILAELWT 615
R A E + Y D+WS G +L E+ +
Sbjct: 198 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 5e-08
Identities = 53/226 (23%), Positives = 87/226 (38%), Gaps = 46/226 (20%)
Query: 422 LGSAAFSKVFQA-------QDLHTGVDVCLKIIKND------KDFFDQSLDEIKLLKLVN 468
LG F +V A V V +K++K+D D + E++++K++
Sbjct: 89 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDL----VSEMEMMKMIG 144
Query: 469 KNDPADEHHILRLYDYFYHLEHLFIVCEL---------LRAN--LYEFQKFNQESGGEAY 517
K+ +I+ L L+++ E LRA ++ E
Sbjct: 145 KHK-----NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 199
Query: 518 FTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS--CFQTD 575
T L T Q +EYL S IH DL N+L+ KI D G + D
Sbjct: 200 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVM--KIADFGLARDINNID 257
Query: 576 NLCLYVQSRSYR------APEVIIGLPYDQKIDLWSLGCILAELWT 615
Y ++ + R APE + Y + D+WS G ++ E++T
Sbjct: 258 Y---YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 53.7 bits (130), Expect = 5e-08
Identities = 45/215 (20%), Positives = 84/215 (39%), Gaps = 42/215 (19%)
Query: 420 EYLGSAAFSKVFQA---QDLHTGVDVCLKIIKND------KDFFDQSLDEIKLLKLVNKN 470
LG F +V++ ++V +K K D + F + E ++K +
Sbjct: 18 RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKF----MSEAVIMKNL--- 70
Query: 471 DPADEHHILRLY----DYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVI 526
D HI++L + E +I+ EL E + + + + L +
Sbjct: 71 ---DHPHIVKLIGIIEE-----EPTWIIMEL--YPYGELGHYLERNKNS--LKVLTLVLY 118
Query: 527 TRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSY 586
+ Q +A+ YL S+ +H D+ NIL+ S + K+ D G S + D Y ++
Sbjct: 119 SLQICKAMAYLESINCVHRDIAVRNILVASPECV--KLGDFGLSRYIEDE--DYYKASVT 174
Query: 587 R------APEVIIGLPYDQKIDLWSLGCILAELWT 615
R +PE I + D+W + E+ +
Sbjct: 175 RLPIKWMSPESINFRRFTTASDVWMFAVCMWEILS 209
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 7e-08
Identities = 52/231 (22%), Positives = 87/231 (37%), Gaps = 51/231 (22%)
Query: 422 LGSAAFSKVFQAQ-----DLHTGVDVCLKIIKND------KDFFDQSLDEIKLLKLVNKN 470
LGS AF KV A + V +K++K + + E+K++ + +
Sbjct: 53 LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREAL----MSELKMMTQLGSH 108
Query: 471 DPADEHHILRLYDYFYHLEHLFIVCEL---------LRAN---------LYEFQKFNQES 512
+ +I+ L ++++ E LR+ YE QK +E
Sbjct: 109 E-----NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEE 163
Query: 513 GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS-- 570
T L Q + +E+L +H DL N+L+ + KI D G +
Sbjct: 164 EDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVV--KICDFGLARD 221
Query: 571 CFQTDNLCLYVQSRSYR------APEVIIGLPYDQKIDLWSLGCILAELWT 615
N YV + R APE + Y K D+WS G +L E+++
Sbjct: 222 IMSDSN---YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 1e-07
Identities = 57/228 (25%), Positives = 84/228 (36%), Gaps = 54/228 (23%)
Query: 422 LGSAAFSKVFQAQ-----DLHTGVDVCLKIIKND-----KDFFDQSLDEIKLLKLVNKND 471
LG AF KVF A+ + V +K +K+ KDF E +LL +
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDF----QREAELLTNL---- 74
Query: 472 PADEHHILRLYDYFYHLEHLFIVCEL---------LRAN--LYEFQKFNQESGGEAYFTL 520
HI++ Y + L +V E LRA+ Q + L
Sbjct: 75 --QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGL 132
Query: 521 GRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLY 580
++ I Q + YL S +H DL N L+ + +KI D G +
Sbjct: 133 SQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGA--NLLVKIGDFG--------MSRD 182
Query: 581 VQSRSY-----------R--APEVIIGLPYDQKIDLWSLGCILAELWT 615
V S Y R PE I+ + + D+WS G IL E++T
Sbjct: 183 VYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 53.0 bits (126), Expect = 1e-07
Identities = 38/197 (19%), Positives = 62/197 (31%), Gaps = 47/197 (23%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD---------FFDQSLDEIKLLK 465
+ E +G F +VFQ HT V +KII + F++ L EI + K
Sbjct: 21 KLQRCEKIGEGVFGEVFQTIADHT--PVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISK 78
Query: 466 LVNKNDPADEHHILRLYDYFYHLEHLFIV-----CELLRANLYEFQKFNQESGGEAYF-- 518
++ + + F L + V LL+A + + +F
Sbjct: 79 ELSLLSGEVCNRT----EGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKD 134
Query: 519 ------------------------TLGRLQVITRQCLEALEYLH-SLGIIHCDLKPENIL 553
+L + I Q +L SL H DL N+L
Sbjct: 135 DQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVL 194
Query: 554 IKSYQRCEIKIIDLGSS 570
+K ++ G S
Sbjct: 195 LKKTSLKKLHYTLNGKS 211
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 2e-07
Identities = 52/230 (22%), Positives = 88/230 (38%), Gaps = 55/230 (23%)
Query: 422 LGSAAFSKVFQAQ-----DLHTGVDVCLKIIKND------KDFFDQSLDEIKLLKLVNKN 470
LG AF +V +A T V +K++K + + E+K+L + +
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRAL----MSELKILIHIGHH 90
Query: 471 DPADEHHILRLY------DYFYHLEHLFIVCEL---------LRAN--LYEFQKFNQESG 513
+++ L L ++ E LR+ + K E
Sbjct: 91 L-----NVVNLLGACTKPG-----GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 140
Query: 514 GEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS--C 571
+ + TL L + Q + +E+L S IH DL NIL+ KI D G +
Sbjct: 141 YKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVV--KICDFGLARDI 198
Query: 572 FQTDNLCLYVQSRSYR------APEVIIGLPYDQKIDLWSLGCILAELWT 615
++ + YV+ R APE I Y + D+WS G +L E+++
Sbjct: 199 YKDPD---YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 52.5 bits (126), Expect = 2e-07
Identities = 39/210 (18%), Positives = 71/210 (33%), Gaps = 27/210 (12%)
Query: 420 EYLGSAAFSKVFQA---QDLHTGVDVCLKIIKNDKDFFDQS--LDEIKLLKLVNKNDPAD 474
E +G F V+ + + +K + D + S L E ++K
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF------S 148
Query: 475 EHHILRLYDYFYHLEH-LFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLE 532
++L L E +V ++ +L F + + T+ L Q +
Sbjct: 149 HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN-----PTVKDLIGFGLQVAK 203
Query: 533 ALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG-SSCFQTDNLCLYVQSRSYR---- 587
+++L S +H DL N ++ K+ D G + +
Sbjct: 204 GMKFLASKKFVHRDLAARNCMLDEKFTV--KVADFGLARDMYDKEFDSVHNKTGAKLPVK 261
Query: 588 --APEVIIGLPYDQKIDLWSLGCILAELWT 615
A E + + K D+WS G +L EL T
Sbjct: 262 WMALESLQTQKFTTKSDVWSFGVLLWELMT 291
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 5e-07
Identities = 42/214 (19%), Positives = 83/214 (38%), Gaps = 31/214 (14%)
Query: 422 LGSAAFSKVFQAQ-----DLHTGVDVCLKIIKNDKDFFDQS--LDEIKLLKLVNKNDPAD 474
LG +F V++ V +K + ++ L+E ++K N
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNC----- 87
Query: 475 EHHILRLYDYFYHLEHLFIVCEL-----LRANLYEFQKFNQESGGEAYFTLGRLQVITRQ 529
HH++RL + ++ EL L++ L + + A +L ++ + +
Sbjct: 88 -HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGE 146
Query: 530 CLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS--CFQTDNLCLYVQSRSYR 587
+ + YL++ +H DL N ++ KI D G + ++TD Y +
Sbjct: 147 IADGMAYLNANKFVHRDLAARNCMVAEDFTV--KIGDFGMTRDIYETDY---YRKGGKGL 201
Query: 588 ------APEVIIGLPYDQKIDLWSLGCILAELWT 615
+PE + + D+WS G +L E+ T
Sbjct: 202 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 49.5 bits (119), Expect = 2e-06
Identities = 56/233 (24%), Positives = 90/233 (38%), Gaps = 55/233 (23%)
Query: 422 LGSAAFSKVFQAQ-----DLHTGVDVCLKIIKND------KDFFDQSLDEIKLLKLVNKN 470
LG F KV +A V +K++K + +D L E +LK VN
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDL----LSEFNVLKQVN-- 84
Query: 471 DPADEH-HILRLYDYFYHLEHLFIVCEL---------LRAN----------LYEFQKFNQ 510
H H+++LY L ++ E LR + +
Sbjct: 85 -----HPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSL 139
Query: 511 ESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570
+ E T+G L Q + ++YL + ++H DL NIL+ ++ KI D G S
Sbjct: 140 DHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKM--KISDFGLS 197
Query: 571 --CFQTDNLCLYVQSRSYR------APEVIIGLPYDQKIDLWSLGCILAELWT 615
++ D+ YV+ R A E + Y + D+WS G +L E+ T
Sbjct: 198 RDVYEEDS---YVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 2e-06
Identities = 57/228 (25%), Positives = 84/228 (36%), Gaps = 55/228 (24%)
Query: 422 LGSAAFSKVFQAQ-----DLHTGVDVCLKIIKND-----KDFFDQSLDEIKLLKLVNKND 471
LG AF KVF A+ + V +K +K +DF E +LL ++
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDF----QREAELLTML---- 100
Query: 472 PADEHHILRLYDYFYHLEHLFIVCEL---------LRAN-LYEFQKFNQESGGEAYFTLG 521
HI+R + L +V E LR++ E LG
Sbjct: 101 --QHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLG 158
Query: 522 RLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS--CFQTDNLCL 579
+L + Q + YL L +H DL N L+ +KI D G S + TD
Sbjct: 159 QLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQ--GLVVKIGDFGMSRDIYSTD---- 212
Query: 580 YVQSRSYR------------APEVIIGLPYDQKIDLWSLGCILAELWT 615
Y YR PE I+ + + D+WS G +L E++T
Sbjct: 213 Y-----YRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 48.7 bits (117), Expect = 2e-06
Identities = 43/231 (18%), Positives = 77/231 (33%), Gaps = 55/231 (23%)
Query: 420 EYLGSAAFSKVFQAQ-----DLHTGVDVCLKIIKND------KDFFDQSLDEIKLLKLVN 468
E LG F KV++ V +K +K+ ++F E L +
Sbjct: 15 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEF----RHEAMLRARL- 69
Query: 469 KNDPADEHHILRLYDYFYHLEHLFIVCEL---------LRAN--LYEFQKFNQESGGEAY 517
+++ L + L ++ L + + + ++
Sbjct: 70 -----QHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSA 124
Query: 518 FTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNL 577
+ Q +EYL S ++H DL N+L+ KI DLG L
Sbjct: 125 LEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNV--KISDLG--------L 174
Query: 578 CLYVQSRS-YR------------APEVIIGLPYDQKIDLWSLGCILAELWT 615
V + Y+ APE I+ + D+WS G +L E+++
Sbjct: 175 FREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 3e-06
Identities = 44/223 (19%), Positives = 75/223 (33%), Gaps = 45/223 (20%)
Query: 420 EYLGSAAFSKVFQAQ-----DLHTGVDVCLKIIKND------KDFFDQSLDEIKLLKLVN 468
LG AF +V++ Q + + + V +K + DF L E ++ N
Sbjct: 77 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDF----LMEALIISKFN 132
Query: 469 KNDPADEHHILRLYDYFYHLEHLFIVCELLRA-NLYEF-QKFNQESGGEAYFTLGRLQVI 526
+I+R FI+ EL+ +L F ++ + + L +
Sbjct: 133 ------HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 186
Query: 527 TRQCLEALEYLHSLGIIHCDLKPENILIKSY-QRCEIKIIDLGSSCFQTDNLCLYVQSRS 585
R +YL IH D+ N L+ KI D G + +
Sbjct: 187 ARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFG--------MARDIYRAG 238
Query: 586 YR-------------APEVIIGLPYDQKIDLWSLGCILAELWT 615
Y PE + + K D WS G +L E+++
Sbjct: 239 YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 4e-06
Identities = 41/213 (19%), Positives = 73/213 (34%), Gaps = 33/213 (15%)
Query: 420 EYLGSAAFSKVFQA---QDLHTGVDVCLKIIKNDKDFFDQS--LDEIKLLKLVNKNDPAD 474
E +G F V+ + + +K + D + S L E ++K
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF------S 84
Query: 475 EHHILRLYDYFYHLEH-LFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLE 532
++L L E +V ++ +L F + + T+ L Q +
Sbjct: 85 HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN-----PTVKDLIGFGLQVAK 139
Query: 533 ALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS--CFQTDNLCLYVQSRSYR--- 587
++YL S +H DL N ++ K+ D G + + + Y
Sbjct: 140 GMKYLASKKFVHRDLAARNCMLDEKFTV--KVADFGLARDMYDKE---YYSVHNKTGAKL 194
Query: 588 -----APEVIIGLPYDQKIDLWSLGCILAELWT 615
A E + + K D+WS G +L EL T
Sbjct: 195 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 227
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 5e-06
Identities = 43/218 (19%), Positives = 77/218 (35%), Gaps = 35/218 (16%)
Query: 420 EYLGSAAFSKVFQAQ-----DLHTGVDVCLKIIKND------KDFFDQSLDEIKLLKLVN 468
LG AF +V++ Q + + + V +K + DF L E ++
Sbjct: 36 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDF----LMEALIISKF- 90
Query: 469 KNDPADEHHILRLYDYFYHLEHLFIVCELLRA-NLYEF-QKFNQESGGEAYFTLGRLQVI 526
+ +I+R FI+ EL+ +L F ++ + + L +
Sbjct: 91 -----NHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 145
Query: 527 TRQCLEALEYLHSLGIIHCDLKPENILIKSY-QRCEIKIIDLGSS--CFQTDNLCLYVQS 583
R +YL IH D+ N L+ KI D G + ++ Y +
Sbjct: 146 ARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS---YYRKG 202
Query: 584 RSYR------APEVIIGLPYDQKIDLWSLGCILAELWT 615
PE + + K D WS G +L E+++
Sbjct: 203 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 6e-06
Identities = 39/212 (18%), Positives = 74/212 (34%), Gaps = 35/212 (16%)
Query: 422 LGSAAFSKVFQAQDLHTG---VDVCLKIIKNDKDFFDQS--LDEIKLLKLVNKNDPADEH 476
+G F V+ + + + +K + + L E L++ + +
Sbjct: 29 IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGL------NHP 82
Query: 477 HILRLYDYFYHLE-HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEAL 534
++L L E ++ + +L +F + Q + T+ L Q +
Sbjct: 83 NVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRN-----PTVKDLISFGLQVARGM 137
Query: 535 EYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS--CFQTDNLCLYVQSRSYR----- 587
EYL +H DL N ++ K+ D G + + Y + +R
Sbjct: 138 EYLAEQKFVHRDLAARNCMLDESFTV--KVADFGLARDILDRE----YYSVQQHRHARLP 191
Query: 588 ----APEVIIGLPYDQKIDLWSLGCILAELWT 615
A E + + K D+WS G +L EL T
Sbjct: 192 VKWTALESLQTYRFTTKSDVWSFGVLLWELLT 223
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 46.4 bits (109), Expect = 3e-05
Identities = 93/627 (14%), Positives = 164/627 (26%), Gaps = 206/627 (32%)
Query: 114 HGNSEASSESLSQFDTARDY--DLQNDFYWHDEKDE--GYFMTPSYGGSDFFGCPSEDKF 169
H + E D + ++F D +D
Sbjct: 6 HMDFETGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEI--DHIIMSKDAV-- 61
Query: 170 IMTSEADRLFE--------------------------NPLAVYDQSEGLHSEASTDYLDK 203
S RLF +P+ + + + + D+
Sbjct: 62 ---SGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDR 118
Query: 204 PCLFHIVPLNDDKEVGVTDYYRFEKTNQPEAGGIKEKL------------------KDC- 244
L++ + V R + + +++ L K
Sbjct: 119 --LYNDNQVFAKYNV-----SRLQPYLK-----LRQALLELRPAKNVLIDGVLGSGKTWV 166
Query: 245 AAYGCSEPLCKCCAGEGK--INNDYGYLSSKEADLIDLQ---HNVVGDSSTDCD------ 293
A C +C +N +S E L LQ + + + ++ D
Sbjct: 167 ALDVCLSYKVQCKMDFKIFWLN--LKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIK 224
Query: 294 LAPHPGTEKSSSYSSSKRGSS----ID--W----IEGFKGSSDLHFKGAEKDLMPAEIDN 343
L H + SK + + F S K L+
Sbjct: 225 LRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSC--------KILLT----- 271
Query: 344 SDTRDGEVN---GALHEGKADAEEHGVA-TPD----LLM------FDNL-EEECEI--FH 386
TR +V A + H + TPD LL+ +L E
Sbjct: 272 --TRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRR 329
Query: 387 LRIIHRKNRTGFEENKDLPII----LNTVIAGRYYVTEYLGSAAFSKVFQA-----QDLH 437
L II R G + + L T+I L A + K+F H
Sbjct: 330 LSIIAESIRDGLATWDNWKHVNCDKLTTIIESSL---NVLEPAEYRKMFDRLSVFPPSAH 386
Query: 438 TGVDVCLKIIKNDKDFFD--QSLDEIKLLKLVNKN-------------------DPADEH 476
+ L +I D D ++++ LV K +
Sbjct: 387 IPTIL-LSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYAL 445
Query: 477 H--------ILRLYD-----------YFY-HLE-HLFIV-----CELLRANLY---EF-- 505
H I + +D YFY H+ HL + L R ++ F
Sbjct: 446 HRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFR-MVFLDFRFLE 504
Query: 506 QK-----FNQESGGEAYFTLGRLQV----ITRQCLEALEYLHSLGIIHCDLKPENILIKS 556
QK + G TL +L+ I + +++ I+ K E LI S
Sbjct: 505 QKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNA--ILDFLPKIEENLICS 562
Query: 557 YQRCEIKIIDLGSSCFQTDNLCLYVQS 583
++I ++ ++ ++
Sbjct: 563 KYTDLLRIA------LMAEDEAIFEEA 583
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 45.3 bits (107), Expect = 4e-05
Identities = 32/106 (30%), Positives = 48/106 (45%), Gaps = 13/106 (12%)
Query: 518 FTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS--CFQTD 575
TL L + Q + +E+L S IH DL NIL+ KI D G + ++
Sbjct: 190 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVV--KICDFGLARDIYKDP 247
Query: 576 NLCLYVQSRSYR------APEVIIGLPYDQKIDLWSLGCILAELWT 615
+ YV+ R APE I Y + D+WS G +L E+++
Sbjct: 248 D---YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 7e-05
Identities = 48/234 (20%), Positives = 78/234 (33%), Gaps = 53/234 (22%)
Query: 420 EYLGSAAFSKVFQAQ-----DLHTGVDVCLKIIKND------KDFFDQSLDEIKLLKLVN 468
+G AF +VFQA+ V +K++K + DF E L+
Sbjct: 53 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF----QREAALMAEF- 107
Query: 469 KNDPADEHHILRLYDYFYHLEHLFIVCEL---------LRAN----------LYEFQKFN 509
D +I++L + + ++ E LR+ +
Sbjct: 108 -----DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRAR 162
Query: 510 QESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569
S G + I RQ + YL +H DL N L+ KI D G
Sbjct: 163 VSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVV--KIADFGL 220
Query: 570 S--CFQTDNLCLYVQSRSYR------APEVIIGLPYDQKIDLWSLGCILAELWT 615
S + D Y + PE I Y + D+W+ G +L E+++
Sbjct: 221 SRNIYSADY---YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 621 | |||
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 99.98 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 99.98 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 99.98 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 99.98 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 99.98 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 99.98 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.98 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 99.98 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 99.98 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.98 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 99.98 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 99.98 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.98 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 99.98 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 99.98 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.98 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 99.98 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 99.98 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 99.98 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 99.98 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.98 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 99.98 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 99.98 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 99.98 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 99.98 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 99.98 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 99.98 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 99.97 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.97 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 99.97 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 99.97 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 99.97 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 99.97 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.97 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.97 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 99.97 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.97 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 99.97 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 99.97 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.97 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.97 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 99.97 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.97 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.97 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 99.97 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 99.97 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.97 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.97 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 99.97 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.97 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.97 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.96 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.96 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.93 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.87 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.83 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.76 | |
| 2z0u_A | 155 | WW domain-containing protein 1; C2 domain, alterna | 99.66 | |
| 3fbk_A | 153 | RGS3, RGP3, regulator of G-protein signaling 3; al | 99.65 | |
| 1v27_A | 141 | Regulating synaptic membrane exocytosis protein 2; | 99.64 | |
| 3rdl_A | 137 | Protein kinase C alpha type; protein kinase PKC, t | 99.63 | |
| 1a25_A | 149 | CALB, protein kinase C (beta); calcium++/phospholi | 99.62 | |
| 2bwq_A | 129 | Regulating synaptic membrane exocytosis protein 2; | 99.61 | |
| 2b3r_A | 134 | Phosphatidylinositol-4-phosphate 3-kinase C2 DOMA | 99.61 | |
| 3fdw_A | 148 | Synaptotagmin-like protein 4; structural genomics, | 99.59 | |
| 2dmg_A | 142 | KIAA1228 protein; beta-sandwich, structural genomi | 99.58 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.57 | |
| 1ugk_A | 138 | Synaptotagmin IV, KIAA1342; beta sandwich, structu | 99.57 | |
| 3n5a_A | 138 | Synaptotagmin-7; calcium/phospholipid binding prot | 99.57 | |
| 1w15_A | 153 | Synaptotagmin IV; metal binding protein, endocytos | 99.57 | |
| 2chd_A | 142 | Rabphilin-3A, exophilin-1; C2 domain, C2A, calcium | 99.57 | |
| 2d8k_A | 141 | Synaptotagmin VII; exocytosis, calcium binding, ly | 99.56 | |
| 1wfm_A | 138 | Synaptotagmin XIII; C2 domain, exocytosis, neurotr | 99.55 | |
| 2enp_A | 147 | B/K protein; C2 type 1,beta sandwich, structural g | 99.55 | |
| 2cm5_A | 166 | Rabphilin-3A; protein transport, zinc-finger, Ca2+ | 99.55 | |
| 3f04_A | 143 | Synaptotagmin-1; C2A, calcium, cell junction, cyto | 99.54 | |
| 1rh8_A | 142 | Piccolo protein; beta-sandwich, metal binding prot | 99.54 | |
| 2q3x_A | 171 | Regulating synaptic membrane exocytosis protein 1; | 99.53 | |
| 1tjx_A | 159 | Similar to synaptotagmini/P65; C2B domain, calcium | 99.53 | |
| 1rsy_A | 152 | Synaptotagmin I; calcium/phospholipid binding prot | 99.52 | |
| 2fk9_A | 157 | Protein kinase C, ETA type; ATP-binding, metal-bin | 99.48 | |
| 1dqv_A | 296 | Synaptotagmin III; beta sandwich, calcium ION, C2 | 99.47 | |
| 1rlw_A | 126 | Phospholipase A2, CALB domain; hydrolase, C2 domai | 99.46 | |
| 2dmh_A | 140 | Myoferlin; beta-sandwich, FER-1-like protein 3, mu | 99.45 | |
| 3pyc_A | 132 | E3 ubiquitin-protein ligase smurf1; phospholipid b | 99.43 | |
| 1gmi_A | 136 | Protein kinase C, epsilon type; PKC, C2 domain, X- | 99.43 | |
| 3b7y_A | 153 | E3 ubiquitin-protein ligase NEDD4; C2 domain, UBL- | 99.42 | |
| 2ep6_A | 133 | MCTP2 protein; beta sandwich, Ca2+ binding, membra | 99.41 | |
| 3m7f_B | 176 | E3 ubiquitin-protein ligase NEDD4; C2 domain, GRB1 | 99.41 | |
| 2r83_A | 284 | Synaptotagmin-1; C2A-C2B, exocytosis, calcium, cel | 99.41 | |
| 1wfj_A | 136 | Putative elicitor-responsive gene; C2 domain, rike | 99.4 | |
| 1dqv_A | 296 | Synaptotagmin III; beta sandwich, calcium ION, C2 | 99.39 | |
| 2r83_A | 284 | Synaptotagmin-1; C2A-C2B, exocytosis, calcium, cel | 99.37 | |
| 3nsj_A | 540 | Perforin-1; pore forming protein, immune system; H | 99.36 | |
| 3kwu_A | 148 | MUNC13-1; calcium binding protein, phospholipid bi | 99.36 | |
| 2nq3_A | 173 | Itchy homolog E3 ubiquitin protein ligase; C2 doma | 99.32 | |
| 2cjt_A | 131 | UNC-13 homolog A, MUNC13-1; phorbol-ester binding, | 99.26 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.17 | |
| 2cjs_A | 167 | UNC-13 homolog A, MUNC13-1; neurotransmitter trans | 99.15 | |
| 1cjy_A | 749 | CPLA2, protein (cytosolic phospholipase A2); lipid | 99.08 | |
| 3jzy_A | 510 | Intersectin 2; C2 domain, structural genomics cons | 99.08 | |
| 1djx_A | 624 | PLC-D1, phosphoinositide-specific phospholipase C, | 99.08 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.0 | |
| 3l9b_A | 144 | Otoferlin; C2-domain, beta-sheets, cell membrane, | 98.97 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.92 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.87 | |
| 3bxj_A | 483 | RAS GTPase-activating protein syngap; GTPase activ | 98.73 | |
| 3qr0_A | 816 | Phospholipase C-beta (PLC-beta); PH domain, EF han | 98.56 | |
| 2zkm_X | 799 | 1-phosphatidylinositol-4,5-bisphosphate phosphodie | 98.53 | |
| 3ohm_B | 885 | 1-phosphatidylinositol-4,5-bisphosphate phosphodi | 98.51 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.33 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.33 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.23 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.99 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.89 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.69 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.65 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.6 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.36 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.13 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.92 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 96.87 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.85 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.8 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.75 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.68 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.29 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.12 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 95.98 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.78 | |
| 1yrk_A | 126 | NPKC-delta, protein kinase C, delta type; C2 domai | 95.28 | |
| 2enj_A | 138 | NPKC-theta, protein kinase C theta type; beta-sand | 95.24 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.95 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 93.99 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 92.28 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 92.1 |
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-55 Score=500.50 Aligned_cols=378 Identities=21% Similarity=0.321 Sum_probs=296.5
Q ss_pred ccccccccCcCCCccccccccCCCCCccccccceeccccCCCccCCcccccccccccccCCCCccccCCCCcccCcceEE
Q 007035 191 GLHSEASTDYLDKPCLFHIVPLNDDKEVGVTDYYRFEKTNQPEAGGIKEKLKDCAAYGCSEPLCKCCAGEGKINNDYGYL 270 (621)
Q Consensus 191 ~~~~~~~~~~~~k~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~c~~~~g~~~~s~~~l~v 270 (621)
|+.-..=.--+|++|..+++++||.|++..++.+++..+. ..+.|+|
T Consensus 130 g~~C~~C~~~~H~~C~~~v~~~C~~d~~~~~g~i~~~~~~---------------------------------~~~~L~V 176 (674)
T 3pfq_A 130 GMKCDTCMMNVHKRCVMNVPSLCGTDHTERRGRIYIQAHI---------------------------------DREVLIV 176 (674)
T ss_dssp EECCSSSCCCBCSSTTSSSCCCSSSCSSCCSCEEEEEEEE---------------------------------CSSEEEE
T ss_pred ccccccCCcchhhhhhhccCccccccccccccccccccee---------------------------------ccceeee
Confidence 3343333446899999999999999999999887733332 2356889
Q ss_pred EEecC-CCccccCcCCCCcceEeecCCCCCCcccceeeccccCCCceeccceeeecccccccccccccccccCCCCCCCC
Q 007035 271 SSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDNSDTRDG 349 (621)
Q Consensus 271 ~l~e~-~L~~~d~~g~sDpyVK~~Llp~~~~~~k~kt~v~k~tlnP~fnE~f~f~~~~~~~~~~k~L~~~V~D~d~~~r~ 349 (621)
.|.+| ||.++|.+|.+|||||+.++|+++...++||+++++|+||+|||+|.|. +.....+++|.++|||+|.++++
T Consensus 177 ~v~~a~~L~~~d~~g~sDPyvkv~l~p~~~~~~k~kT~v~~~tlnP~wne~f~f~--~~~~~~~~~L~v~v~d~d~~~~d 254 (674)
T 3pfq_A 177 VVRDAKNLVPMDPNGLSDPYVKLKLIPDPKSESKQKTKTIKSSLNPEWNETFRFQ--LKESDKDRRLSVEIWDWDLTSRN 254 (674)
T ss_dssp EEEEEESCCCCSTTSSCCEEEEEEEESCSSCCSCEECCCCSSCSSCEEEEEEEEE--CCSTTTTCEEEEEEEECCSSSCC
T ss_pred eeecccccCCCCcccccCcccccccccCccccccccccccccccCCCccceeeee--cccCCccceeeeEEeeccccccc
Confidence 99999 9999999999999999999999988889999999999999999999998 55555667799999999999999
Q ss_pred CcccccccccccccccCCCCccchhccchhhhhhhheeeeeeccc-------cCCc------------cc--CCCcc---
Q 007035 350 EVNGALHEGKADAEEHGVATPDLLMFDNLEEECEIFHLRIIHRKN-------RTGF------------EE--NKDLP--- 405 (621)
Q Consensus 350 d~iG~v~~~~a~~~~~~~~~~~ll~~~~l~eE~e~~~lr~i~~~~-------r~~~------------~~--~~~~p--- 405 (621)
+++|++..++.++....... |+..+..+...+......... +... .+ .....
T Consensus 255 d~iG~~~i~l~~l~~~~~~~----w~~Lls~~~g~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (674)
T 3pfq_A 255 DFMGSLSFGISELQKAGVDG----WFKLLSQEEGEYFNVPVPPEGSEGNEELRQKFERAKIGQGTKAPEEKTANTISKFD 330 (674)
T ss_dssp EECCBCCCBTTHHHHCCEEE----EEECBCTTGGGTCCEECCC-------------------------------------
T ss_pred ccccccccchhhhccCCccc----ceeecccccceecccCCCCccccccHHHHHHHhhccccCCCCCccccccccccccc
Confidence 99999999988877766544 555554333332111110000 0000 00 00000
Q ss_pred --eeeCeeecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc----hhhhhHHHHHHHHHHhcccCCCCCCceE
Q 007035 406 --IILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHIL 479 (621)
Q Consensus 406 --i~l~~ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~hpnIv 479 (621)
.....+..++|++++.||+|+||+||+|+++.+++.||||++++.. ........|..++..+. .||+|+
T Consensus 331 ~~~~~~~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~-----~~~~i~ 405 (674)
T 3pfq_A 331 NNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG-----KPPFLT 405 (674)
T ss_dssp ---------CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTT-----CCTTBC
T ss_pred ccCccccccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhcc-----CCCeEE
Confidence 0011233478999999999999999999999999999999998642 22344555666555443 578999
Q ss_pred EEeeEeEecCeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccC
Q 007035 480 RLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQ 558 (621)
Q Consensus 480 rl~~~f~~~~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~ 558 (621)
+++++|++.+++||||||+.+ +|..++..... +++..++.++.||+.||.|||++||+||||||+||||+ .
T Consensus 406 ~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~------~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~--~ 477 (674)
T 3pfq_A 406 QLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGR------FKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLD--S 477 (674)
T ss_dssp CEEEECBCSSEEEEEEECCCSCBHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEEC--S
T ss_pred EEEEEEEeCCEEEEEEeCcCCCcHHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEc--C
Confidence 999999999999999999985 67766654322 89999999999999999999999999999999999998 4
Q ss_pred CCeEEEEecCCccccC---CCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 559 RCEIKIIDLGSSCFQT---DNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 559 ~~~IKL~DFGls~~~~---~~~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
++.+||+|||++.... ......+||+.|+|||++.+..|+.++|||||||+||||++|++||
T Consensus 478 ~g~ikL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf 542 (674)
T 3pfq_A 478 EGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPF 542 (674)
T ss_dssp SSCEEECCCTTCEECCCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSS
T ss_pred CCcEEEeecceeeccccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCC
Confidence 7899999999987532 2344578999999999999999999999999999999999999998
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=376.35 Aligned_cols=195 Identities=23% Similarity=0.375 Sum_probs=167.5
Q ss_pred CceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecC---chhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCe
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~---~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~ 490 (621)
++|++++.||+|+||+||+|+++.+|+.||||++... ....+++.+|+++++.++ ||||++++++|.+.+.
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~------HpnIV~~~~~~~~~~~ 97 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMK------HPNIVQYRESFEENGS 97 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCC------CTTBCCEEEEEEETTE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCC------CCCCCcEEEEEEECCE
Confidence 6899999999999999999999999999999999754 234567788999988874 7899999999999999
Q ss_pred EEEEEeccc-cchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCC
Q 007035 491 LFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (621)
Q Consensus 491 l~LVmEyl~-gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGl 569 (621)
+||||||+. |+|.+++..... ..+++..++.|+.||+.||.|||++||+||||||+||||+. ++.+||+|||+
T Consensus 98 ~yiVmEy~~gg~L~~~i~~~~~----~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~--~g~vKl~DFGl 171 (350)
T 4b9d_A 98 LYIVMDYCEGGDLFKRINAQKG----VLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTK--DGTVQLGDFGI 171 (350)
T ss_dssp EEEEEECCTTCBHHHHHHHTTT----CCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECT--TCCEEECSTTE
T ss_pred EEEEEeCCCCCcHHHHHHHcCC----CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECC--CCCEEEccccc
Confidence 999999998 588888764432 23789999999999999999999999999999999999984 78999999999
Q ss_pred ccccCCC---ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 570 SCFQTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 570 s~~~~~~---~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
|...... ....+||+.|+|||++.+..|+.++|||||||+||||+||++||
T Consensus 172 a~~~~~~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF 225 (350)
T 4b9d_A 172 ARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAF 225 (350)
T ss_dssp ESCCCHHHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSC
T ss_pred ceeecCCcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 9765433 23468999999999999999999999999999999999999999
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=363.12 Aligned_cols=193 Identities=34% Similarity=0.530 Sum_probs=160.5
Q ss_pred CceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc----hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecC
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~ 489 (621)
++|++++.||+|+||+||+|+++.+|+.||||++.+.. ....++.+|+.+++.++ ||||++++++|.+.+
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~------HpnIv~~~~~~~~~~ 86 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR------HPHIIKLYDVIKSKD 86 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCC------CTTBCCEEEEEECSS
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCC------CCCCCeEEEEEEECC
Confidence 68999999999999999999999999999999997532 33456788999988874 789999999999999
Q ss_pred eEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCC
Q 007035 490 HLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (621)
Q Consensus 490 ~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGl 569 (621)
++||||||++|+|++.+.... .+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||+
T Consensus 87 ~~~ivmEy~~g~L~~~l~~~~------~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~--~~~~vkl~DFGl 158 (275)
T 3hyh_A 87 EIIMVIEYAGNELFDYIVQRD------KMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLD--EHLNVKIADFGL 158 (275)
T ss_dssp EEEEEEECCCEEHHHHHHHSC------SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEEC--TTCCEEECCSSC
T ss_pred EEEEEEeCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEEC--CCCCEEEeecCC
Confidence 999999999999999887543 289999999999999999999999999999999999998 478999999999
Q ss_pred ccccCCC--ccccccCCcccCchhhcCCCC-CchhhHHHHHHHHHHHHhCCCCC
Q 007035 570 SCFQTDN--LCLYVQSRSYRAPEVIIGLPY-DQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 570 s~~~~~~--~~~~~gt~~Y~APEvl~~~~~-s~ksDIWSLGvILyELltG~~PF 620 (621)
|...... ....+||+.|+|||++.+..| +.++|||||||+||+|+||++||
T Consensus 159 a~~~~~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF 212 (275)
T 3hyh_A 159 SNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPF 212 (275)
T ss_dssp C---------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred CeecCCCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCC
Confidence 9765432 345789999999999998886 57999999999999999999998
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=370.63 Aligned_cols=193 Identities=28% Similarity=0.465 Sum_probs=171.5
Q ss_pred CceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc----hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecC
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~ 489 (621)
++|++++.||+|+||+||+|+++.+|+.||||++.+.. .....+.+|+++++.+ +||||++++++|++.+
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l------~HpnIv~l~~~~~~~~ 105 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL------DHPFFVKLYFTFQDDE 105 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC------CCTTBCCEEEEEECSS
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhC------CCCCCCeEEEEEEeCC
Confidence 67999999999999999999999999999999997532 2345677788877655 5889999999999999
Q ss_pred eEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecC
Q 007035 490 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (621)
Q Consensus 490 ~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFG 568 (621)
++||||||+.| +|.+++..... +++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||
T Consensus 106 ~~yivmEy~~gG~L~~~i~~~~~------l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~--~~g~vKl~DFG 177 (311)
T 4aw0_A 106 KLYFGLSYAKNGELLKYIRKIGS------FDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLN--EDMHIQITDFG 177 (311)
T ss_dssp EEEEEECCCTTEEHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--TTSCEEECCCT
T ss_pred EEEEEEecCCCCCHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEc--CCCCEEEEEcC
Confidence 99999999985 88888765432 89999999999999999999999999999999999998 48899999999
Q ss_pred CccccCC-----CccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 569 SSCFQTD-----NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 569 ls~~~~~-----~~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
+|..... .....+||+.|+|||++.+..|+.++|||||||+||+|++|++||
T Consensus 178 la~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF 234 (311)
T 4aw0_A 178 TAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 234 (311)
T ss_dssp TCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSS
T ss_pred CceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 9976532 234568999999999999999999999999999999999999999
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-43 Score=371.78 Aligned_cols=194 Identities=23% Similarity=0.383 Sum_probs=172.0
Q ss_pred cCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc-hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeE
Q 007035 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (621)
Q Consensus 413 ~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~-~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l 491 (621)
..+|+++++||+|+||+||+|+++.+|+.||||++.... ...+.+.+|+.+++.++ ||||++++++|.+.+++
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~------HpnIV~l~~~~~~~~~~ 146 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQ------HENVVEMYNSYLVGDEL 146 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCC------CTTBCCEEEEEEETTEE
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCC------CCCCCcEEEEEEECCEE
Confidence 357999999999999999999999999999999997533 33456789999998874 78999999999999999
Q ss_pred EEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCc
Q 007035 492 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (621)
Q Consensus 492 ~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls 570 (621)
||||||+++ +|.+++... .+++..++.++.||+.||.|||++||+||||||+||||+ .++.+||+|||+|
T Consensus 147 ~ivmEy~~gg~L~~~l~~~-------~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~--~~g~vKl~DFGla 217 (346)
T 4fih_A 147 WVVMEFLEGGALTDIVTHT-------RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLT--HDGRVKLSDFGFC 217 (346)
T ss_dssp EEEECCCTTEEHHHHHHHS-------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC--TTCCEEECCCTTC
T ss_pred EEEEeCCCCCcHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEC--CCCCEEEecCcCc
Confidence 999999986 666665431 189999999999999999999999999999999999998 4789999999999
Q ss_pred cccCC---CccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 007035 571 CFQTD---NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCLI 621 (621)
Q Consensus 571 ~~~~~---~~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF~ 621 (621)
..... .....+||+.|+|||++.+..|+.++||||||||||||++|++||.
T Consensus 218 ~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~ 271 (346)
T 4fih_A 218 AQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYF 271 (346)
T ss_dssp EECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred eecCCCCCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 76543 2445789999999999999999999999999999999999999993
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=373.99 Aligned_cols=194 Identities=23% Similarity=0.381 Sum_probs=172.2
Q ss_pred cCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc-hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeE
Q 007035 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (621)
Q Consensus 413 ~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~-~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l 491 (621)
..+|++++.||+|+||+||+|+++.+|+.||||++.... ...+.+.+|+.+++.++ ||||++++++|.+.+++
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~------HpnIV~l~~~~~~~~~~ 223 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQ------HENVVEMYNSYLVGDEL 223 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCC------CTTBCCEEEEEEETTEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCC------CCCCCceEEEEEECCEE
Confidence 357999999999999999999999999999999997543 33456789999998874 78999999999999999
Q ss_pred EEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCc
Q 007035 492 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (621)
Q Consensus 492 ~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls 570 (621)
|||||||.| +|.+++... .+++..++.|+.||+.||.|||++||+||||||+||||+. ++.+||+|||++
T Consensus 224 ~iVmEy~~gG~L~~~i~~~-------~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~--~g~vKl~DFGla 294 (423)
T 4fie_A 224 WVVMEFLEGGALTDIVTHT-------RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTH--DGRVKLSDFGFC 294 (423)
T ss_dssp EEEEECCTTEEHHHHHHHS-------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECT--TCCEEECCCTTC
T ss_pred EEEEeCCCCCcHHHHHhcc-------CCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcC--CCCEEEecCccc
Confidence 999999985 666665432 1899999999999999999999999999999999999984 789999999999
Q ss_pred cccCC---CccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 007035 571 CFQTD---NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCLI 621 (621)
Q Consensus 571 ~~~~~---~~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF~ 621 (621)
..... .....+||+.|+|||++.+..|+.++||||||||||||++|++||.
T Consensus 295 ~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~ 348 (423)
T 4fie_A 295 AQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYF 348 (423)
T ss_dssp EECCSSCCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred eECCCCCccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 76543 2445789999999999999999999999999999999999999993
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=352.89 Aligned_cols=195 Identities=27% Similarity=0.426 Sum_probs=166.3
Q ss_pred ecCce-EEEEEeccCCCCceeEEEeCCCCcEEEEEEEecC---chhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEe
Q 007035 412 IAGRY-YVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (621)
Q Consensus 412 i~~rY-~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~---~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~ 487 (621)
..++| ++.++||+|+||+||+|.++.+++.||+|++... ....+++.+|+++++.+ .||||++++++|..
T Consensus 23 ~~gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l------~HpnIV~~~~~~~~ 96 (290)
T 3fpq_A 23 NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL------QHPNIVRFYDSWES 96 (290)
T ss_dssp TTSSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTC------CCTTBCCEEEEEEE
T ss_pred CCCceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhC------CCCCCCcEEEEEee
Confidence 34566 6778899999999999999999999999998753 23345677888888766 48899999999975
Q ss_pred ----cCeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCC--eecccCCCccEEEeccCCC
Q 007035 488 ----LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLG--IIHCDLKPENILIKSYQRC 560 (621)
Q Consensus 488 ----~~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~g--IvHrDLKP~NILl~~~~~~ 560 (621)
...+||||||+.+ +|.+++.... .+++..++.|+.||+.||.|||+++ |+||||||+||||+. .++
T Consensus 97 ~~~~~~~~~lvmEy~~gg~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~-~~g 169 (290)
T 3fpq_A 97 TVKGKKCIVLVTELMTSGTLKTYLKRFK------VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITG-PTG 169 (290)
T ss_dssp EETTEEEEEEEEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESS-TTS
T ss_pred ccCCCcEEEEEEeCCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEEC-CCC
Confidence 3579999999985 7777776443 2889999999999999999999998 999999999999974 368
Q ss_pred eEEEEecCCccccCCC-ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 561 EIKIIDLGSSCFQTDN-LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 561 ~IKL~DFGls~~~~~~-~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
.+||+|||+|...... ....+||+.|+|||++.+ +|+.++|||||||+||||+||++||
T Consensus 170 ~vKl~DFGla~~~~~~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf 229 (290)
T 3fpq_A 170 SVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPY 229 (290)
T ss_dssp CEEECCTTGGGGCCTTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred CEEEEeCcCCEeCCCCccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 8999999999765433 445789999999999876 6999999999999999999999998
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=361.02 Aligned_cols=189 Identities=25% Similarity=0.358 Sum_probs=164.3
Q ss_pred CceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeEEE
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFI 493 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l~L 493 (621)
+.|++.++||+|+||+||+|+++.+|+.||||+++.+.. ..+|+.+++. +.||||++++++|.+.+++||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~----~~~E~~il~~------l~HpnIV~l~~~~~~~~~~~i 127 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF----RVEELVACAG------LSSPRIVPLYGAVREGPWVNI 127 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC----CTHHHHTTTT------CCCTTBCCEEEEEEETTEEEE
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh----HHHHHHHHHh------CCCCCCCcEEEEEEECCEEEE
Confidence 569999999999999999999999999999999986543 2356666554 468999999999999999999
Q ss_pred EEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCC-eEEEEecCCcc
Q 007035 494 VCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRC-EIKIIDLGSSC 571 (621)
Q Consensus 494 VmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~-~IKL~DFGls~ 571 (621)
||||++| +|.+++..... +++..++.++.||+.||.|||+++|+||||||+||||+. ++ ++||+|||+|.
T Consensus 128 vmEy~~gg~L~~~l~~~~~------l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~--~g~~vKl~DFGla~ 199 (336)
T 4g3f_A 128 FMELLEGGSLGQLIKQMGC------LPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSS--DGSRAALCDFGHAL 199 (336)
T ss_dssp EECCCTTCBHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECT--TSCCEEECCCTTCE
T ss_pred EEeccCCCcHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeC--CCCEEEEeeCCCCe
Confidence 9999985 78887765432 899999999999999999999999999999999999985 55 69999999997
Q ss_pred ccCCC--------ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 572 FQTDN--------LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 572 ~~~~~--------~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
..... ....+||+.|+|||++.+.+|+.++|||||||+||||+||++||
T Consensus 200 ~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf 256 (336)
T 4g3f_A 200 CLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPW 256 (336)
T ss_dssp EC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred EccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCC
Confidence 64321 12357999999999999999999999999999999999999998
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-42 Score=357.90 Aligned_cols=193 Identities=27% Similarity=0.385 Sum_probs=162.6
Q ss_pred CceEEEEEeccCCCCceeEEEeC---CCCcEEEEEEEecCch---hhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEe
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQDL---HTGVDVCLKIIKNDKD---FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d~---~tg~~VAlKii~~~~~---~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~ 487 (621)
++|++++.||+|+||+||+|++. .+++.||||++++... ...++.+|+. ....++||||++++++|++
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~------il~~l~HpnIv~l~~~~~~ 97 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERD------ILVEVNHPFIVKLHYAFQT 97 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------C------CCCCCCCTTEECEEEEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHH------HHHHCCCCCCCeEEEEEEE
Confidence 68999999999999999999874 4688999999975421 1223344444 4445679999999999999
Q ss_pred cCeEEEEEeccc-cchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEe
Q 007035 488 LEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (621)
Q Consensus 488 ~~~l~LVmEyl~-gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~D 566 (621)
.+++||||||++ |+|.+++..... +++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|
T Consensus 98 ~~~~~ivmEy~~gg~L~~~l~~~~~------l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~--~~g~vKl~D 169 (304)
T 3ubd_A 98 EGKLYLILDFLRGGDLFTRLSKEVM------FTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLD--EEGHIKLTD 169 (304)
T ss_dssp TTEEEEEECCCTTCEEHHHHHHHCC------CCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEEC--TTSCEEEES
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEc--CCCCEEecc
Confidence 999999999998 588888765432 89999999999999999999999999999999999998 488999999
Q ss_pred cCCccccC---CCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 567 LGSSCFQT---DNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 567 FGls~~~~---~~~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
||+|.... ......+||+.|+|||++.+..|+.++|||||||+||||+||++||
T Consensus 170 FGla~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF 226 (304)
T 3ubd_A 170 FGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPF 226 (304)
T ss_dssp SEEEEC-----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred cccceeccCCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCC
Confidence 99997543 2344578999999999999999999999999999999999999999
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-41 Score=362.74 Aligned_cols=195 Identities=33% Similarity=0.576 Sum_probs=169.9
Q ss_pred ecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc---hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEe-
Q 007035 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH- 487 (621)
Q Consensus 412 i~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~---~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~- 487 (621)
+.++|++++.||+|+||+||+|+++.+|+.||||++++.. ....++.+|+++++.++ ||||+++++++..
T Consensus 52 i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~------HpnIv~l~~~~~~~ 125 (398)
T 4b99_A 52 VGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFK------HDNIIAIKDILRPT 125 (398)
T ss_dssp CCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCC------CTTBCCEEEECCCS
T ss_pred CCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcC------CCCcceEeeeeecc
Confidence 4578999999999999999999999999999999997543 23456778999988874 7899999998764
Q ss_pred -----cCeEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeE
Q 007035 488 -----LEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEI 562 (621)
Q Consensus 488 -----~~~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~I 562 (621)
.+++||||||++|+|.+++.... .+++..++.+++||+.||.|||++||+||||||+|||++ .++.+
T Consensus 126 ~~~~~~~~~~ivmE~~~g~L~~~i~~~~------~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~--~~~~~ 197 (398)
T 4b99_A 126 VPYGEFKSVYVVLDLMESDLHQIIHSSQ------PLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVN--ENCEL 197 (398)
T ss_dssp SCTTTCCCEEEEEECCSEEHHHHHTSSS------CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC--TTCCE
T ss_pred cccccCCEEEEEEeCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccC--CCCCE
Confidence 36899999999999988886432 289999999999999999999999999999999999998 48899
Q ss_pred EEEecCCccccCC-------CccccccCCcccCchhhcCCC-CCchhhHHHHHHHHHHHHhCCCCC
Q 007035 563 KIIDLGSSCFQTD-------NLCLYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 563 KL~DFGls~~~~~-------~~~~~~gt~~Y~APEvl~~~~-~s~ksDIWSLGvILyELltG~~PF 620 (621)
||+|||++..... .....+||+.|+|||++.+.. |+.++||||||||+|||++|++||
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF 263 (398)
T 4b99_A 198 KIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLF 263 (398)
T ss_dssp EECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSS
T ss_pred EEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCC
Confidence 9999999975422 234578999999999998764 689999999999999999999998
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=347.83 Aligned_cols=202 Identities=25% Similarity=0.348 Sum_probs=166.4
Q ss_pred eecCceEEEEEeccCCCCceeEEEeC-----CCCcEEEEEEEecCc-hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeE
Q 007035 411 VIAGRYYVTEYLGSAAFSKVFQAQDL-----HTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDY 484 (621)
Q Consensus 411 ii~~rY~I~~~LG~G~fG~Vyka~d~-----~tg~~VAlKii~~~~-~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~ 484 (621)
+-.++|.+.+.||+|+||+||+|++. .+++.||||+++... ...+++.+|+++++.+ .||||++++++
T Consensus 10 I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l------~HpnIV~l~g~ 83 (299)
T 4asz_A 10 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL------QHEHIVKFYGV 83 (299)
T ss_dssp CCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTC------CCTTBCCEEEE
T ss_pred cCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhC------CCCCCccEEEE
Confidence 33568999999999999999999864 468899999997643 3345667777777655 58899999999
Q ss_pred eEecCeEEEEEeccc-cchHHHHHhhhc-------cCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEec
Q 007035 485 FYHLEHLFIVCELLR-ANLYEFQKFNQE-------SGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS 556 (621)
Q Consensus 485 f~~~~~l~LVmEyl~-gsLld~l~~~~~-------~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~ 556 (621)
+.+.+.++|||||++ |+|.+++..... ......+++..+..++.||+.||.|||+++|+||||||+||||+.
T Consensus 84 ~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~ 163 (299)
T 4asz_A 84 CVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGE 163 (299)
T ss_dssp ECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred EeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECC
Confidence 999999999999998 578888765321 112334899999999999999999999999999999999999984
Q ss_pred cCCCeEEEEecCCccccCCC-----ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 557 YQRCEIKIIDLGSSCFQTDN-----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 557 ~~~~~IKL~DFGls~~~~~~-----~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
++.+||+|||+|+..... .....||+.|+|||++.+..|+.++|||||||+||||+| |+.||
T Consensus 164 --~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf 231 (299)
T 4asz_A 164 --NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPW 231 (299)
T ss_dssp --GGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred --CCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCC
Confidence 789999999999754332 222468999999999999999999999999999999999 99998
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=348.98 Aligned_cols=194 Identities=21% Similarity=0.394 Sum_probs=165.7
Q ss_pred ecCceEEEEEeccCCCCceeEEEeC---CCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEec
Q 007035 412 IAGRYYVTEYLGSAAFSKVFQAQDL---HTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (621)
Q Consensus 412 i~~rY~I~~~LG~G~fG~Vyka~d~---~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~ 488 (621)
+.++|++.++||+|+||+||+|+++ .+++.||+|.+..... ..+..+|+++++.+. .||||++++++|.+.
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~-~~~~~~E~~~l~~~~-----~h~nIv~l~~~~~~~ 92 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH-PIRIAAELQCLTVAG-----GQDNVMGVKYCFRKN 92 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC-HHHHHHHHHHHHHTC-----SBTTBCCCSEEEEET
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC-HHHHHHHHHHHHHhc-----CCCCCceEEEEEEEC
Confidence 4578999999999999999999875 4688999999876543 356778888888774 478999999999999
Q ss_pred CeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEec
Q 007035 489 EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 567 (621)
Q Consensus 489 ~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DF 567 (621)
+++||||||+++ +|.+++. .+++..++.+++||+.||.|||++||+||||||+|||++. +.+.+||+||
T Consensus 93 ~~~~lvmE~~~g~~L~~~~~---------~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~-~~~~~kl~DF 162 (361)
T 4f9c_A 93 DHVVIAMPYLEHESFLDILN---------SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNR-RLKKYALVDF 162 (361)
T ss_dssp TEEEEEEECCCCCCHHHHHT---------TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEET-TTTEEEECCC
T ss_pred CEEEEEEeCCCcccHHHHHc---------CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeC-CCCeEEECcC
Confidence 999999999984 6777652 1889999999999999999999999999999999999985 3479999999
Q ss_pred CCccccCCC-------------------------------ccccccCCcccCchhhcCCC-CCchhhHHHHHHHHHHHHh
Q 007035 568 GSSCFQTDN-------------------------------LCLYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWT 615 (621)
Q Consensus 568 Gls~~~~~~-------------------------------~~~~~gt~~Y~APEvl~~~~-~s~ksDIWSLGvILyELlt 615 (621)
|+|...... ....+||+.|+|||++.+.+ |+.++||||+|||+|||++
T Consensus 163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~ 242 (361)
T 4f9c_A 163 GLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLS 242 (361)
T ss_dssp TTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHH
T ss_pred CCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHH
Confidence 998643321 22357999999999998864 8999999999999999999
Q ss_pred CCCCCC
Q 007035 616 GEVCLI 621 (621)
Q Consensus 616 G~~PF~ 621 (621)
|++||.
T Consensus 243 G~~Pf~ 248 (361)
T 4f9c_A 243 GRYPFY 248 (361)
T ss_dssp TCSSSS
T ss_pred CCCCCC
Confidence 999994
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-40 Score=343.21 Aligned_cols=202 Identities=21% Similarity=0.281 Sum_probs=169.0
Q ss_pred eecCceEEEEEeccCCCCceeEEEeC-----CCCcEEEEEEEecC--chhhhhHHHHHHHHHHhcccCCCCCCceEEEee
Q 007035 411 VIAGRYYVTEYLGSAAFSKVFQAQDL-----HTGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYD 483 (621)
Q Consensus 411 ii~~rY~I~~~LG~G~fG~Vyka~d~-----~tg~~VAlKii~~~--~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~ 483 (621)
+-..+++++++||+|+||+||+|+.. .+++.||||+++.. ....+++.+|+.++..++ ||||+++++
T Consensus 23 i~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~------HpNIV~l~g 96 (308)
T 4gt4_A 23 ISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQ------HPNVVCLLG 96 (308)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCC------CTTBCCEEE
T ss_pred CCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCC------CCCCCCcce
Confidence 34467899999999999999999853 46789999998753 233467888999998874 789999999
Q ss_pred EeEecCeEEEEEeccc-cchHHHHHhhhccC----------CCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccE
Q 007035 484 YFYHLEHLFIVCELLR-ANLYEFQKFNQESG----------GEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENI 552 (621)
Q Consensus 484 ~f~~~~~l~LVmEyl~-gsLld~l~~~~~~~----------~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NI 552 (621)
++...+.++|||||++ |+|.+++....... ....+++..+..|+.||+.||.|||+++|+||||||+||
T Consensus 97 ~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NI 176 (308)
T 4gt4_A 97 VVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNV 176 (308)
T ss_dssp EECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred EEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccce
Confidence 9999999999999998 58888876432211 123488999999999999999999999999999999999
Q ss_pred EEeccCCCeEEEEecCCccccCC-----CccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 553 LIKSYQRCEIKIIDLGSSCFQTD-----NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 553 Ll~~~~~~~IKL~DFGls~~~~~-----~~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
||+. ++.+||+|||+++.... ......||+.|+|||++.+..|+.++|||||||+||||+| |+.||
T Consensus 177 Ll~~--~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf 248 (308)
T 4gt4_A 177 LVYD--KLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPY 248 (308)
T ss_dssp EECG--GGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred EECC--CCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCC
Confidence 9994 78999999999875432 2334578999999999999999999999999999999998 89998
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-40 Score=345.30 Aligned_cols=200 Identities=26% Similarity=0.359 Sum_probs=162.1
Q ss_pred cCceEEEEEeccCCCCceeEEEeC-----CCCcEEEEEEEecCc-hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeE
Q 007035 413 AGRYYVTEYLGSAAFSKVFQAQDL-----HTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (621)
Q Consensus 413 ~~rY~I~~~LG~G~fG~Vyka~d~-----~tg~~VAlKii~~~~-~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~ 486 (621)
..+|.+.++||+|+||+||+|++. .+++.||||+++... ...+++.+|+++++.+ .||||+++++++.
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l------~HpnIV~l~g~~~ 113 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTML------QHQHIVRFFGVCT 113 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTC------CCTTBCCEEEEEC
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhC------CCCCCCcEEEEEE
Confidence 467899999999999999999864 468999999997543 3345677777777655 5889999999999
Q ss_pred ecCeEEEEEeccc-cchHHHHHhhhcc---------CCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEec
Q 007035 487 HLEHLFIVCELLR-ANLYEFQKFNQES---------GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS 556 (621)
Q Consensus 487 ~~~~l~LVmEyl~-gsLld~l~~~~~~---------~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~ 556 (621)
+.+.++|||||++ |+|.+++...... .....+++..+..|+.||+.||.|||+++|+||||||+||||+
T Consensus 114 ~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~- 192 (329)
T 4aoj_A 114 EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVG- 192 (329)
T ss_dssp SSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE-
T ss_pred ECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEEC-
Confidence 9999999999998 5787777643221 1123489999999999999999999999999999999999999
Q ss_pred cCCCeEEEEecCCccccCCC-----ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 557 YQRCEIKIIDLGSSCFQTDN-----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 557 ~~~~~IKL~DFGls~~~~~~-----~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
.++.+||+|||+++..... .....||+.|+|||++.+..|+.++|||||||+||||+| |+.||
T Consensus 193 -~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf 261 (329)
T 4aoj_A 193 -QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPW 261 (329)
T ss_dssp -TTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred -CCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCC
Confidence 4889999999999754322 233578999999999999999999999999999999999 99998
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=340.50 Aligned_cols=191 Identities=28% Similarity=0.385 Sum_probs=151.9
Q ss_pred CceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc--hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecC--
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE-- 489 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~-- 489 (621)
++|++++.||+|+||+||+|+++.+|+.||||+++... ...+++.+|+++++.+ .||||++++++|.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l------~HpnIV~~~~~~~~~~~~ 78 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL------EHPGIVRYFNAWLEKNTT 78 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTC------CCTTBCCEEEEEEEEC--
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhC------CCCCCCeEEEEEEecCcc
Confidence 46999999999999999999999999999999987533 2335566777776655 5899999999998654
Q ss_pred ----------eEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccC
Q 007035 490 ----------HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQ 558 (621)
Q Consensus 490 ----------~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~ 558 (621)
++||||||+.+ +|.+++...... ....+..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 79 ~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~---~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~-- 153 (299)
T 4g31_A 79 EKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTI---EERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTM-- 153 (299)
T ss_dssp --------CEEEEEEEECCCSCCHHHHHHTCCSG---GGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT--
T ss_pred ccccccCCCcEEEEEEecCCCCcHHHHHHhcCCC---ChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECC--
Confidence 48999999985 777777543221 11445668899999999999999999999999999999984
Q ss_pred CCeEEEEecCCccccCCC---------------ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh
Q 007035 559 RCEIKIIDLGSSCFQTDN---------------LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT 615 (621)
Q Consensus 559 ~~~IKL~DFGls~~~~~~---------------~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt 615 (621)
++.+||+|||+|...... ....+||+.|+|||++.+..|+.++|||||||+||||++
T Consensus 154 ~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~ 225 (299)
T 4g31_A 154 DDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225 (299)
T ss_dssp TCCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS
T ss_pred CCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc
Confidence 789999999998764321 123579999999999999999999999999999999996
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-40 Score=342.56 Aligned_cols=195 Identities=29% Similarity=0.436 Sum_probs=159.4
Q ss_pred CeeecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecC---chhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEe
Q 007035 409 NTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYF 485 (621)
Q Consensus 409 ~~ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~---~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f 485 (621)
+++-.+++++.++||+|+||+||+|++. ..||||+++.. ....+.+.+|+.+++.+ .||||+++++++
T Consensus 31 Wei~~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l------~HpNIV~l~g~~ 101 (307)
T 3omv_A 31 WEIEASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKT------RHVNILLFMGYM 101 (307)
T ss_dssp CBCCTTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTC------CCTTBCCEEEEE
T ss_pred cEEcHHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhC------CCCCEeeEEEEE
Confidence 3455678899999999999999999853 35999998743 33445667777777655 588999999987
Q ss_pred EecCeEEEEEeccc-cchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEE
Q 007035 486 YHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKI 564 (621)
Q Consensus 486 ~~~~~l~LVmEyl~-gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL 564 (621)
.. +.++|||||++ |+|.+++..... .+++..+..|+.||+.||.|||+++|+||||||+||||+ .++.+||
T Consensus 102 ~~-~~~~iVmEy~~gGsL~~~l~~~~~-----~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~--~~~~~Ki 173 (307)
T 3omv_A 102 TK-DNLAIVTQWCEGSSLYKHLHVQET-----KFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLH--EGLTVKI 173 (307)
T ss_dssp CS-SSCEEEEECCSSCBHHHHHHTSCC-----CCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEE--TTEEEEE
T ss_pred EC-CeEEEEEEcCCCCCHHHHHhhcCC-----CCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEEC--CCCcEEE
Confidence 54 56899999998 577777754322 289999999999999999999999999999999999998 4889999
Q ss_pred EecCCccccCC-----CccccccCCcccCchhhcC---CCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 565 IDLGSSCFQTD-----NLCLYVQSRSYRAPEVIIG---LPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 565 ~DFGls~~~~~-----~~~~~~gt~~Y~APEvl~~---~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
+|||+|..... .....+||+.|+|||++.+ .+|+.++|||||||+||||+||+.||
T Consensus 174 ~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf 237 (307)
T 3omv_A 174 GDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPY 237 (307)
T ss_dssp CCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred eeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCC
Confidence 99999975432 2334689999999999964 35899999999999999999999998
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=367.86 Aligned_cols=197 Identities=25% Similarity=0.412 Sum_probs=170.5
Q ss_pred cCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc----hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEec
Q 007035 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (621)
Q Consensus 413 ~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~ 488 (621)
.++|++++.||+|+||+||+|+++.+|+.||||++.+.. .......+|..++..++. .+||||++++++|++.
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~---~~HP~IV~l~~~f~~~ 264 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST---GDCPFIVCMSYAFHTP 264 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSS---SCCTTBCCEEEEEECS
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhh---CCCCCEeEEEEEEEEC
Confidence 367999999999999999999999999999999997532 222344556666666653 4699999999999999
Q ss_pred CeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEec
Q 007035 489 EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 567 (621)
Q Consensus 489 ~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DF 567 (621)
+++||||||+.| +|.+++.... .+++..++.|+.||+.||.|||++||+||||||+||||+ .+|++||+||
T Consensus 265 ~~lylVmEy~~GGdL~~~l~~~~------~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld--~~G~vKL~DF 336 (689)
T 3v5w_A 265 DKLSFILDLMNGGDLHYHLSQHG------VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLD--EHGHVRISDL 336 (689)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEEC--TTSCEEECCC
T ss_pred CEEEEEEecCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEe--CCCCEEeccc
Confidence 999999999985 7777776443 289999999999999999999999999999999999998 4889999999
Q ss_pred CCccccCC-CccccccCCcccCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 568 GSSCFQTD-NLCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 568 Gls~~~~~-~~~~~~gt~~Y~APEvl~~-~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
|+|..... .....+||+.|+|||++.+ ..|+.++||||||||||||++|++||
T Consensus 337 GlA~~~~~~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF 391 (689)
T 3v5w_A 337 GLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF 391 (689)
T ss_dssp TTCEECSSCCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred ceeeecCCCCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 99976543 3456799999999999974 57999999999999999999999999
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=359.30 Aligned_cols=198 Identities=24% Similarity=0.380 Sum_probs=175.5
Q ss_pred ecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc-hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCe
Q 007035 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (621)
Q Consensus 412 i~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~-~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~ 490 (621)
+.++|++++.||+|+||+||+|+++.+|+.||+|++.... ...+.+.+|+.+|+.++ ||||++++++|.+.++
T Consensus 155 il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~------hpnIv~l~~~~~~~~~ 228 (573)
T 3uto_A 155 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLR------HPTLVNLHDAFEDDNE 228 (573)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTC------CTTBCCEEEEEECSSE
T ss_pred CccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCC------CCCCCeEEEEEEECCE
Confidence 4478999999999999999999999999999999987643 33456788999988874 7899999999999999
Q ss_pred EEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCC
Q 007035 491 LFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (621)
Q Consensus 491 l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGl 569 (621)
+||||||+.| +|.+++..... .+++..++.+++||+.||.|||+++|+||||||+|||++.+..+.+||+|||+
T Consensus 229 ~~iv~E~~~gg~L~~~i~~~~~-----~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~ 303 (573)
T 3uto_A 229 MVMIYEFMSGGELFEKVADEHN-----KMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGL 303 (573)
T ss_dssp EEEEEECCCCCBHHHHHTCTTS-----CEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSS
T ss_pred EEEEEeecCCCcHHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccc
Confidence 9999999985 77777753321 28999999999999999999999999999999999999876668999999999
Q ss_pred ccccCCC--ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 570 SCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 570 s~~~~~~--~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
+...... ....+||+.|+|||++.+.+|+.++|||||||+||+|++|++||
T Consensus 304 a~~~~~~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf 356 (573)
T 3uto_A 304 TAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPF 356 (573)
T ss_dssp CEECCTTSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSS
T ss_pred eeEccCCCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 9876543 34568999999999999999999999999999999999999998
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=339.84 Aligned_cols=203 Identities=24% Similarity=0.348 Sum_probs=170.2
Q ss_pred eecCceEEEEEeccCCCCceeEEEeCCC-----CcEEEEEEEecCc--hhhhhHHHHHHHHHHhcccCCCCCCceEEEee
Q 007035 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHT-----GVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYD 483 (621)
Q Consensus 411 ii~~rY~I~~~LG~G~fG~Vyka~d~~t-----g~~VAlKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~ 483 (621)
+-.++|++.+.||+|+||+||+|.+..+ ++.||||+++... ...+.+.+|++++..+.+ ||||+++++
T Consensus 61 i~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~h-----hpnIV~l~g 135 (353)
T 4ase_A 61 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH-----HLNVVNLLG 135 (353)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCC-----CTTBCCEEE
T ss_pred ecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCC-----CCcEEEEEE
Confidence 4457899999999999999999987654 4679999997643 334568889999999864 579999999
Q ss_pred EeEec-CeEEEEEeccc-cchHHHHHhhhcc----------CCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCcc
Q 007035 484 YFYHL-EHLFIVCELLR-ANLYEFQKFNQES----------GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPEN 551 (621)
Q Consensus 484 ~f~~~-~~l~LVmEyl~-gsLld~l~~~~~~----------~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~N 551 (621)
++... +.++||||||+ |+|.+++...... .....+++..+..++.||+.||.|||+++||||||||+|
T Consensus 136 ~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~N 215 (353)
T 4ase_A 136 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN 215 (353)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred EEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccc
Confidence 98764 67999999998 5788887654321 112348899999999999999999999999999999999
Q ss_pred EEEeccCCCeEEEEecCCccccCCC-----ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 552 ILIKSYQRCEIKIIDLGSSCFQTDN-----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 552 ILl~~~~~~~IKL~DFGls~~~~~~-----~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
||++. ++.+||+|||+|+..... .....||+.|+|||++.+..|+.++|||||||+||||+| |+.||
T Consensus 216 ILl~~--~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf 288 (353)
T 4ase_A 216 ILLSE--KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 288 (353)
T ss_dssp EEECG--GGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred eeeCC--CCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCC
Confidence 99984 789999999999765332 223567999999999999999999999999999999998 99998
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-39 Score=333.82 Aligned_cols=192 Identities=22% Similarity=0.299 Sum_probs=154.2
Q ss_pred ecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecC--
Q 007035 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE-- 489 (621)
Q Consensus 412 i~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~-- 489 (621)
+..+|.+.+.||+|+||+||+|++ +|+.||||++..... .....|.+ +.....+.||||+++++++...+
T Consensus 1 Iar~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~--~~~~~e~E----i~~~~~l~HpNIv~l~g~~~~~~~~ 72 (303)
T 3hmm_A 1 IARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE--RSWFREAE----IYQTVMLRHENILGFIAADNKDNGT 72 (303)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGH--HHHHHHHH----HHTSTTCCCTTBCCEEEEEEEECSS
T ss_pred CCcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch--hhHHHHHH----HHHHhcCCCCCCCcEEEEEEecCCC
Confidence 356799999999999999999986 689999999976442 22333333 33333467999999999998654
Q ss_pred --eEEEEEeccc-cchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHC--------CeecccCCCccEEEeccC
Q 007035 490 --HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSL--------GIIHCDLKPENILIKSYQ 558 (621)
Q Consensus 490 --~l~LVmEyl~-gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~--------gIvHrDLKP~NILl~~~~ 558 (621)
.++|||||++ |+|.+++... .+++..+..++.|++.||.|||++ +|+||||||+||||+ .
T Consensus 73 ~~~~~lV~Ey~~~gsL~~~l~~~-------~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~--~ 143 (303)
T 3hmm_A 73 WTQLWLVSDYHEHGSLFDYLNRY-------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK--K 143 (303)
T ss_dssp SEEEEEEEECCTTCBHHHHHHHC-------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEEC--T
T ss_pred ceEEEEEecCCCCCcHHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEEC--C
Confidence 6899999998 5777777532 188899999999999999999987 999999999999998 4
Q ss_pred CCeEEEEecCCccccCCC-------ccccccCCcccCchhhcCC------CCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 559 RCEIKIIDLGSSCFQTDN-------LCLYVQSRSYRAPEVIIGL------PYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 559 ~~~IKL~DFGls~~~~~~-------~~~~~gt~~Y~APEvl~~~------~~s~ksDIWSLGvILyELltG~~PF 620 (621)
++.+||+|||++...... ....+||+.|+|||++.+. .++.++|||||||+||||+||++||
T Consensus 144 ~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~ 218 (303)
T 3hmm_A 144 NGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG 218 (303)
T ss_dssp TSCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBT
T ss_pred CCCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCC
Confidence 889999999998764332 2235799999999999764 3677999999999999999998765
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=327.31 Aligned_cols=214 Identities=30% Similarity=0.565 Sum_probs=191.9
Q ss_pred CCcceeeCeeecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEE
Q 007035 402 KDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRL 481 (621)
Q Consensus 402 ~~~pi~l~~ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl 481 (621)
..+....+.++.++|+++++||+|+||+||+|++..+++.||||+++...........|+.+++.+.. ....||||+++
T Consensus 23 ~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~-~~~~h~~iv~~ 101 (360)
T 3llt_A 23 VHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQN-DDINNNNIVKY 101 (360)
T ss_dssp GSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCC-CSTTGGGBCCE
T ss_pred eeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcc-cCCCCCCeecc
Confidence 34556677889999999999999999999999999999999999998777667778889999999985 34679999999
Q ss_pred eeEeEecCeEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEec-----
Q 007035 482 YDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS----- 556 (621)
Q Consensus 482 ~~~f~~~~~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~----- 556 (621)
++++...++.++||||++++|.+++...... .+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 102 ~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~ 177 (360)
T 3llt_A 102 HGKFMYYDHMCLIFEPLGPSLYEIITRNNYN----GFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEK 177 (360)
T ss_dssp EEEEEETTEEEEEECCCCCBHHHHHHHTTTC----CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCE
T ss_pred cceeeECCeeEEEEcCCCCCHHHHHHhcCCC----CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccc
Confidence 9999999999999999988999988765432 2889999999999999999999999999999999999974
Q ss_pred ------------------cCCCeEEEEecCCccccCCCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCC
Q 007035 557 ------------------YQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEV 618 (621)
Q Consensus 557 ------------------~~~~~IKL~DFGls~~~~~~~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~ 618 (621)
...+.+||+|||++...........+|+.|+|||++.+..++.++|||||||++|+|++|+.
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~ 257 (360)
T 3llt_A 178 SLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSL 257 (360)
T ss_dssp EEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSC
T ss_pred cccchhcccccccccccccCCCCEEEEeccCceecCCCCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCC
Confidence 23678999999999877766667789999999999999999999999999999999999999
Q ss_pred CC
Q 007035 619 CL 620 (621)
Q Consensus 619 PF 620 (621)
||
T Consensus 258 pf 259 (360)
T 3llt_A 258 LF 259 (360)
T ss_dssp SC
T ss_pred CC
Confidence 98
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=331.03 Aligned_cols=221 Identities=32% Similarity=0.557 Sum_probs=192.0
Q ss_pred CCcccCCCcceeeCeeecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccC--CC
Q 007035 396 TGFEENKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKND--PA 473 (621)
Q Consensus 396 ~~~~~~~~~pi~l~~ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~--~~ 473 (621)
..+.....+++.+++++.++|++++.||+|+||+||+|++..+++.||||+++......+.+.+|+.+++.+++.. ..
T Consensus 19 ~~~~~~~~~~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~ 98 (397)
T 1wak_A 19 NDYCKGGYHLVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDP 98 (397)
T ss_dssp ---CC--CCSSCTTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCG
T ss_pred ccCCCCCceEEehhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCC
Confidence 4455566788899999999999999999999999999999999999999999887777788899999999998653 23
Q ss_pred CCCceEEEeeEeE----ecCeEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHC-CeecccCC
Q 007035 474 DEHHILRLYDYFY----HLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSL-GIIHCDLK 548 (621)
Q Consensus 474 ~hpnIvrl~~~f~----~~~~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~-gIvHrDLK 548 (621)
.|+||+++++++. ...++++||||+++++++.+...... .+++..++.++.||+.||.|||++ ||+|||||
T Consensus 99 ~~~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~----~~~~~~~~~i~~qi~~aL~~lH~~~givHrDik 174 (397)
T 1wak_A 99 NREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQ----GLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIK 174 (397)
T ss_dssp GGGGBCCEEEEEEEEETTEEEEEEEECCCCCBHHHHHHHTTTS----CCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCS
T ss_pred CcceeeeeecceeecCCCCceEEEEEeccCccHHHHHHhcccC----CCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCC
Confidence 4789999999998 55689999999999999888754322 288999999999999999999998 99999999
Q ss_pred CccEEEeccC-----------------------------------------------CCeEEEEecCCccccCCCccccc
Q 007035 549 PENILIKSYQ-----------------------------------------------RCEIKIIDLGSSCFQTDNLCLYV 581 (621)
Q Consensus 549 P~NILl~~~~-----------------------------------------------~~~IKL~DFGls~~~~~~~~~~~ 581 (621)
|+|||++.+. ...+||+|||++...........
T Consensus 175 p~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~ 254 (397)
T 1wak_A 175 PENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDI 254 (397)
T ss_dssp GGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCSCSCC
T ss_pred HHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccCccCC
Confidence 9999998531 13799999999987766666678
Q ss_pred cCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 582 QSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 582 gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
+|+.|+|||++.+..++.++|||||||+||+|++|+.||
T Consensus 255 gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf 293 (397)
T 1wak_A 255 QTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLF 293 (397)
T ss_dssp SCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred CCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCC
Confidence 999999999999999999999999999999999999998
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-37 Score=333.97 Aligned_cols=210 Identities=42% Similarity=0.727 Sum_probs=192.0
Q ss_pred eeCeeecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeE
Q 007035 407 ILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (621)
Q Consensus 407 ~l~~ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~ 486 (621)
...+.+..+|++++.||+|+||+||+|.+..+++.||||+++..........+|+++++.+++.....|+||+++++++.
T Consensus 90 ~~~~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~ 169 (429)
T 3kvw_A 90 VPHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFT 169 (429)
T ss_dssp CTTCEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEE
T ss_pred cCCCcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecc
Confidence 44567889999999999999999999999999999999999988777788899999999999988889999999999999
Q ss_pred ecCeEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEe
Q 007035 487 HLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (621)
Q Consensus 487 ~~~~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~D 566 (621)
...++++||||++++|.+++....... +++..++.++.||+.||.|||+++|+||||||+|||++.+....+||+|
T Consensus 170 ~~~~~~lv~e~~~~~L~~~l~~~~~~~----~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~D 245 (429)
T 3kvw_A 170 FRNHICMTFELLSMNLYELIKKNKFQG----FSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVID 245 (429)
T ss_dssp ETTEEEEEECCCCCBHHHHHHHTTTCC----CCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECC
T ss_pred cCCeEEEEEeccCCCHHHHHHhccCCC----CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEee
Confidence 999999999999999999887654322 8899999999999999999999999999999999999964334499999
Q ss_pred cCCccccCCCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 567 LGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 567 FGls~~~~~~~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
||++...........+|+.|+|||++.+..++.++|||||||+||+|++|++||
T Consensus 246 FG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf 299 (429)
T 3kvw_A 246 FGSSCYEHQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLL 299 (429)
T ss_dssp CTTCEETTCCCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred cccceecCCcccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCC
Confidence 999988777777778999999999999999999999999999999999999998
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=315.56 Aligned_cols=213 Identities=35% Similarity=0.612 Sum_probs=192.2
Q ss_pred cceeeCeeecCceEEEEEeccCCCCceeEEEe-CCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEe
Q 007035 404 LPIILNTVIAGRYYVTEYLGSAAFSKVFQAQD-LHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLY 482 (621)
Q Consensus 404 ~pi~l~~ii~~rY~I~~~LG~G~fG~Vyka~d-~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~ 482 (621)
++...++++.++|++++.||+|+||+||+|.+ ..+++.||+|+++......+...+|+.+++.+++.....|++|++++
T Consensus 4 ~~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~ 83 (339)
T 1z57_A 4 LICQSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQML 83 (339)
T ss_dssp GTCSTTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEE
T ss_pred eeeecCCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeee
Confidence 45567889999999999999999999999998 56899999999988777778889999999999998888888999999
Q ss_pred eEeEecCeEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccC----
Q 007035 483 DYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQ---- 558 (621)
Q Consensus 483 ~~f~~~~~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~---- 558 (621)
+++...+++++||||++++|.+++...... .+++..++.++.||+.||.|||++||+||||||+|||++...
T Consensus 84 ~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~ 159 (339)
T 1z57_A 84 EWFEHHGHICIVFELLGLSTYDFIKENGFL----PFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEA 159 (339)
T ss_dssp EEEEETTEEEEEEECCCCBHHHHHHHTTTC----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEE
T ss_pred cccccCCcEEEEEcCCCCCHHHHHHhcCCC----CCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccc
Confidence 999999999999999999999988755322 388999999999999999999999999999999999998533
Q ss_pred -------------CCeEEEEecCCccccCCCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 559 -------------RCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 559 -------------~~~IKL~DFGls~~~~~~~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
++.+||+|||++...........+|+.|+|||++.+..++.++|||||||++|+|++|+.||
T Consensus 160 ~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf 234 (339)
T 1z57_A 160 YNPKIKRDERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVF 234 (339)
T ss_dssp EC----CEEEEESCCCEEECCCSSCEETTSCCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred cCCccccccccccCCCceEeeCcccccCccccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCC
Confidence 56799999999987776666678999999999999999999999999999999999999998
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=323.87 Aligned_cols=214 Identities=41% Similarity=0.658 Sum_probs=194.1
Q ss_pred CcceeeCeeecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEe
Q 007035 403 DLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLY 482 (621)
Q Consensus 403 ~~pi~l~~ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~ 482 (621)
.+++..++.+.++|++.+.||+|+||+||+|.+..+++.||||+++...........|+++++.+++.....+++|++++
T Consensus 43 ~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~ 122 (382)
T 2vx3_A 43 DYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLK 122 (382)
T ss_dssp CBCCCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEE
T ss_pred cEEeecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEee
Confidence 45667788889999999999999999999999999999999999998777778888999999999877667778899999
Q ss_pred eEeEecCeEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHH--HCCeecccCCCccEEEeccCCC
Q 007035 483 DYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLH--SLGIIHCDLKPENILIKSYQRC 560 (621)
Q Consensus 483 ~~f~~~~~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLH--s~gIvHrDLKP~NILl~~~~~~ 560 (621)
+++...+++++||||++++|.+++...... .+++..++.++.||+.||.||| +.||+||||||+|||++.+.++
T Consensus 123 ~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~ 198 (382)
T 2vx3_A 123 RHFMFRNHLCLVFEMLSYNLYDLLRNTNFR----GVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRS 198 (382)
T ss_dssp EEEEETTEEEEEEECCCCBHHHHHHHTTTS----CCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSC
T ss_pred eeeccCCceEEEEecCCCCHHHHHhhcCcC----CCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCC
Confidence 999999999999999999999988765422 2889999999999999999999 5799999999999999765678
Q ss_pred eEEEEecCCccccCCCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 561 EIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 561 ~IKL~DFGls~~~~~~~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
.+||+|||++...........+|+.|+|||++.+..++.++|||||||++|+|++|++||
T Consensus 199 ~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf 258 (382)
T 2vx3_A 199 AIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLF 258 (382)
T ss_dssp CEEECCCTTCEETTCCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred cEEEEeccCceecccccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 899999999988777667778999999999999999999999999999999999999998
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-36 Score=313.07 Aligned_cols=216 Identities=33% Similarity=0.549 Sum_probs=193.8
Q ss_pred CCCcceeeCeeecCceEEEEEeccCCCCceeEEEeCCCC-cEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceE
Q 007035 401 NKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTG-VDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHIL 479 (621)
Q Consensus 401 ~~~~pi~l~~ii~~rY~I~~~LG~G~fG~Vyka~d~~tg-~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIv 479 (621)
...+++.+++.+.++|++.+.||+|+||+||+|.+..++ +.||+|+++......+...+|+.+++.+++.....+++++
T Consensus 6 ~~~~~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~ 85 (355)
T 2eu9_A 6 EGHLVCRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCV 85 (355)
T ss_dssp TSCBCCCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBC
T ss_pred CCCcccccCceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEE
Confidence 445677889999999999999999999999999998877 7899999987766677888999999999988777778899
Q ss_pred EEeeEeEecCeEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEec---
Q 007035 480 RLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS--- 556 (621)
Q Consensus 480 rl~~~f~~~~~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~--- 556 (621)
.+++++...++.++||||+++++++.+...... .+++..++.++.||+.||.|||++||+||||||+|||+..
T Consensus 86 ~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~----~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~ 161 (355)
T 2eu9_A 86 LMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQ----PYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEF 161 (355)
T ss_dssp CEEEEEEETTEEEEEEECCCCBHHHHHHHTTTC----CCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCE
T ss_pred EeeeeeeeCCeEEEEEeccCCChHHHHHhccCC----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccc
Confidence 999999999999999999999999888754322 2889999999999999999999999999999999999943
Q ss_pred --------------cCCCeEEEEecCCccccCCCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 557 --------------YQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 557 --------------~~~~~IKL~DFGls~~~~~~~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
...+.+||+|||++...........+|+.|+|||++.+..++.++|||||||++|+|++|+.||
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf 239 (355)
T 2eu9_A 162 ETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLF 239 (355)
T ss_dssp EEEECCC-CCCEEEESCCCEEECCCTTCEETTSCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred cccccccccccccccCCCcEEEeecCccccccccccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCC
Confidence 2478899999999987776666778999999999999999999999999999999999999998
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-36 Score=308.34 Aligned_cols=204 Identities=29% Similarity=0.492 Sum_probs=172.0
Q ss_pred eCeeecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc------hhhhhHHHHHHHHHHhcccCCCCCCceEEE
Q 007035 408 LNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK------DFFDQSLDEIKLLKLVNKNDPADEHHILRL 481 (621)
Q Consensus 408 l~~ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~------~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl 481 (621)
+++++.++|++++.||+|+||+||+|++..+++.||||++.... .......+|+.+++.++.. .||||+++
T Consensus 3 ~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~---~h~niv~~ 79 (308)
T 3g33_A 3 LGSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAF---EHPNVVRL 79 (308)
T ss_dssp -------CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHH---CCTTBCCE
T ss_pred CCcccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhc---CCCCeEEe
Confidence 45677899999999999999999999999999999999987422 2234667888888888743 48999999
Q ss_pred eeEeEecC-----eEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEec
Q 007035 482 YDYFYHLE-----HLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS 556 (621)
Q Consensus 482 ~~~f~~~~-----~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~ 556 (621)
++++.... ++++||||++++|.+++...... .+++..++.++.||+.||.|||+++|+||||||+|||++.
T Consensus 80 ~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~ 155 (308)
T 3g33_A 80 MDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPP----GLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTS 155 (308)
T ss_dssp EEEEEECCSSSEEEEEEEEECCCCBHHHHHHTCCTT----CSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECT
T ss_pred eeeeeccCCCCceeEEEEehhhhcCHHHHHhhccCC----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcC
Confidence 99998765 68999999999999888754332 2889999999999999999999999999999999999984
Q ss_pred cCCCeEEEEecCCccccCC--CccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 557 YQRCEIKIIDLGSSCFQTD--NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 557 ~~~~~IKL~DFGls~~~~~--~~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
++.+||+|||++..... ......+|+.|+|||++.+..++.++|||||||++|+|++|++||
T Consensus 156 --~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf 219 (308)
T 3g33_A 156 --GGTVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLF 219 (308)
T ss_dssp --TSCEEECSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSC
T ss_pred --CCCEEEeeCccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCC
Confidence 78999999999876543 234467899999999999999999999999999999999999998
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=311.90 Aligned_cols=194 Identities=29% Similarity=0.512 Sum_probs=171.5
Q ss_pred cCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc----hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEec
Q 007035 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (621)
Q Consensus 413 ~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~ 488 (621)
.++|++++.||+|+||+||+|+++.+|+.||+|++++.. ...+...+|..+++.+ .||||+++++++.+.
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l------~hp~Iv~~~~~~~~~ 78 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV------THPFIIRMWGTFQDA 78 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC------CBTTBCCEEEEEECS
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhC------CCCCCceEeEEEEeC
Confidence 468999999999999999999999999999999997642 2234556676666654 588999999999999
Q ss_pred CeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEec
Q 007035 489 EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 567 (621)
Q Consensus 489 ~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DF 567 (621)
..+++||||+.+ +|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+||
T Consensus 79 ~~~~lv~e~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~--~~g~~kL~Df 150 (318)
T 1fot_A 79 QQIFMIMDYIEGGELFSLLRKSQ------RFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLD--KNGHIKITDF 150 (318)
T ss_dssp SEEEEEECCCCSCBHHHHHHHTS------SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEEC--TTSCEEECCC
T ss_pred CEEEEEEeCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEc--CCCCEEEeec
Confidence 999999999985 7777776432 288999999999999999999999999999999999998 4789999999
Q ss_pred CCccccCCCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 568 GSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 568 Gls~~~~~~~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
|++..........+||+.|+|||++.+..++.++|||||||++|+|++|+.||
T Consensus 151 g~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf 203 (318)
T 1fot_A 151 GFAKYVPDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPF 203 (318)
T ss_dssp SSCEECSSCBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTT
T ss_pred CcceecCCccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCC
Confidence 99988776666778999999999999999999999999999999999999998
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-36 Score=318.37 Aligned_cols=196 Identities=26% Similarity=0.434 Sum_probs=166.4
Q ss_pred ecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc----hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEe
Q 007035 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (621)
Q Consensus 412 i~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~ 487 (621)
-.++|++++.||+|+||+||+|+++.+|+.||||++++.. ........|..+++.+. .||||+++++++..
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~-----~hp~Iv~l~~~~~~ 95 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLAR-----NHPFLTQLFCCFQT 95 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTT-----TCTTBCCEEEEEEC
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhcc-----CCCceeeEEEEEEe
Confidence 3478999999999999999999999999999999998642 23345667777777664 48899999999999
Q ss_pred cCeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEe
Q 007035 488 LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (621)
Q Consensus 488 ~~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~D 566 (621)
.+++|+||||+.+ +|...+..... +++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|
T Consensus 96 ~~~~~lv~E~~~gg~L~~~l~~~~~------~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~--~~g~ikL~D 167 (353)
T 3txo_A 96 PDRLFFVMEFVNGGDLMFHIQKSRR------FDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLD--HEGHCKLAD 167 (353)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC--TTSCEEECC
T ss_pred CCEEEEEEeCCCCCcHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEEC--CCCCEEEcc
Confidence 9999999999985 67766654432 89999999999999999999999999999999999998 478999999
Q ss_pred cCCccccC---CCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 567 LGSSCFQT---DNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 567 FGls~~~~---~~~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
||++.... ......+||+.|+|||++.+..++.++|||||||++|||++|++||
T Consensus 168 FG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf 224 (353)
T 3txo_A 168 FGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPF 224 (353)
T ss_dssp CTTCBCSCC---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSS
T ss_pred ccceeecccCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCC
Confidence 99987532 2344568999999999999888999999999999999999999998
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=308.65 Aligned_cols=197 Identities=23% Similarity=0.278 Sum_probs=173.3
Q ss_pred eecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCe
Q 007035 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (621)
Q Consensus 411 ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~ 490 (621)
++.++|++.+.||+|+||+||+|++..+|+.||||++..... .+.+.+|+.+++.+. .||||+++++++....+
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~E~~~l~~l~-----~h~~i~~~~~~~~~~~~ 79 (330)
T 2izr_A 6 MVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR-APQLHLEYRFYKQLG-----SGDGIPQVYYFGPCGKY 79 (330)
T ss_dssp EETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS-SCCHHHHHHHHHHHC-----SCTTSCCEEEEEEETTE
T ss_pred EEcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc-hHHHHHHHHHHHHhh-----CCCCCCEEEEEEecCCc
Confidence 567899999999999999999999999999999999876533 356889999999984 37899999999999999
Q ss_pred EEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCe-----EEEE
Q 007035 491 LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCE-----IKII 565 (621)
Q Consensus 491 l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~-----IKL~ 565 (621)
.++||||++++|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||++. ++. +||+
T Consensus 80 ~~lv~e~~~~~L~~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~--~~~~~~~~~kl~ 152 (330)
T 2izr_A 80 NAMVLELLGPSLEDLFDLCDR-----TFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGR--PGNKTQQVIHII 152 (330)
T ss_dssp EEEEEECCCCBHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECC--GGGTCTTSEEEC
T ss_pred cEEEEEeCCCCHHHHHHHcCC-----CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecc--CCCCCCceEEEE
Confidence 999999998889988875422 2899999999999999999999999999999999999985 444 9999
Q ss_pred ecCCccccCCC----------ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 566 DLGSSCFQTDN----------LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 566 DFGls~~~~~~----------~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||
T Consensus 153 DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf 217 (330)
T 2izr_A 153 DFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPW 217 (330)
T ss_dssp CCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred EcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCc
Confidence 99998764332 13467899999999999999999999999999999999999998
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=313.38 Aligned_cols=197 Identities=28% Similarity=0.470 Sum_probs=170.5
Q ss_pred eecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc----hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeE
Q 007035 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (621)
Q Consensus 411 ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~ 486 (621)
+..++|++.+.||+|+||+||+|+++.+|+.||||++++.. ........|..++..+. .||||++++++++
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~-----~hp~iv~l~~~~~ 88 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW-----EHPFLTHMFCTFQ 88 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHT-----TCTTBCCEEEEEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcC-----CCCCCCcEEEEEE
Confidence 44578999999999999999999999999999999998642 23355667777777652 5889999999999
Q ss_pred ecCeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEE
Q 007035 487 HLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKII 565 (621)
Q Consensus 487 ~~~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~ 565 (621)
+.+++++||||+.+ +|.+++..... +++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+
T Consensus 89 ~~~~~~lv~E~~~gg~L~~~l~~~~~------~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~--~g~vkL~ 160 (345)
T 1xjd_A 89 TKENLFFVMEYLNGGDLMYHIQSCHK------FDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDK--DGHIKIA 160 (345)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECT--TSCEEEC
T ss_pred eCCEEEEEEeCCCCCcHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECC--CCCEEEe
Confidence 99999999999975 77777664332 889999999999999999999999999999999999984 7899999
Q ss_pred ecCCccccC---CCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 566 DLGSSCFQT---DNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 566 DFGls~~~~---~~~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
|||++.... ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||
T Consensus 161 DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf 218 (345)
T 1xjd_A 161 DFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPF 218 (345)
T ss_dssp CCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred EChhhhhcccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCC
Confidence 999987532 2344568999999999999999999999999999999999999998
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=320.19 Aligned_cols=195 Identities=23% Similarity=0.380 Sum_probs=170.4
Q ss_pred cCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc----hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEec
Q 007035 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (621)
Q Consensus 413 ~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~ 488 (621)
.++|++++.||+|+||+||+|+++.+++.||+|++++.. ........|..+++.+. .||||++++++|++.
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~-----~hp~Iv~l~~~~~~~ 125 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQAS-----NHPFLVGLHSCFQTE 125 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHT-----TCTTBCCEEEEEECS
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcC-----CCCCcCeeEEEEEEC
Confidence 468999999999999999999999999999999998642 23345678888887764 478999999999999
Q ss_pred CeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEec
Q 007035 489 EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 567 (621)
Q Consensus 489 ~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DF 567 (621)
+++++||||+.+ +|...+..... +++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+||
T Consensus 126 ~~~~lV~E~~~gg~L~~~l~~~~~------l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~--~~g~ikL~DF 197 (396)
T 4dc2_A 126 SRLFFVIEYVNGGDLMFHMQRQRK------LPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLD--SEGHIKLTDY 197 (396)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC--TTSCEEECCC
T ss_pred CEEEEEEEcCCCCcHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEC--CCCCEEEeec
Confidence 999999999986 66666654322 89999999999999999999999999999999999998 4789999999
Q ss_pred CCcccc---CCCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 568 GSSCFQ---TDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 568 Gls~~~---~~~~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
|++... .......+||+.|+|||++.+..++.++|||||||++|||++|++||
T Consensus 198 Gla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf 253 (396)
T 4dc2_A 198 GMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPF 253 (396)
T ss_dssp TTCBCCCCTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred ceeeecccCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCC
Confidence 998752 23345578999999999999999999999999999999999999998
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=305.10 Aligned_cols=200 Identities=25% Similarity=0.390 Sum_probs=168.2
Q ss_pred eeCeeecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc----hhhhhHHHHHHHHHHhcccCCCCCCceEEEe
Q 007035 407 ILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLY 482 (621)
Q Consensus 407 ~l~~ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~ 482 (621)
.++.++.++|++++.||+|+||.||+|++..+++.||+|++.... .....+.+|+.+++.+ .||||++++
T Consensus 4 ~~g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l------~hp~iv~~~ 77 (294)
T 4eqm_A 4 MIGKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQL------SHQNIVSMI 77 (294)
T ss_dssp CCSSCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTC------CBTTBCCEE
T ss_pred chhhHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcC------CCCCCceEE
Confidence 457788999999999999999999999999999999999986432 2334455566555544 588999999
Q ss_pred eEeEecCeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCe
Q 007035 483 DYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCE 561 (621)
Q Consensus 483 ~~f~~~~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~ 561 (621)
+++...+..++||||+.+ +|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.
T Consensus 78 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~--~~~ 149 (294)
T 4eqm_A 78 DVDEEDDCYYLVMEYIEGPTLSEYIESHG------PLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDS--NKT 149 (294)
T ss_dssp EEEECSSEEEEEEECCCSCBHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT--TSC
T ss_pred EeeeeCCeEEEEEeCCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECC--CCC
Confidence 999999999999999975 7777776443 2889999999999999999999999999999999999984 788
Q ss_pred EEEEecCCccccCCC----ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 562 IKIIDLGSSCFQTDN----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 562 IKL~DFGls~~~~~~----~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
+||+|||++...... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||
T Consensus 150 ~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf 212 (294)
T 4eqm_A 150 LKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPF 212 (294)
T ss_dssp EEECCCSSSTTC-------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSS
T ss_pred EEEEeCCCccccccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCC
Confidence 999999998765432 22356899999999999999999999999999999999999998
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-35 Score=301.73 Aligned_cols=195 Identities=30% Similarity=0.441 Sum_probs=168.4
Q ss_pred CceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc---hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCe
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~---~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~ 490 (621)
++|++++.||+|+||+||+|++..+++.||+|++.... .......+|+.+++.+ .||||+++++++.+.++
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l------~h~~iv~~~~~~~~~~~ 75 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL------KHKNIVRLHDVLHSDKK 75 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTC------CCTTBCCEEEEEEETTE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcC------CCCCEeeEEeEEEeCCE
Confidence 58999999999999999999999999999999997543 2234556677666555 47899999999999999
Q ss_pred EEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCc
Q 007035 491 LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (621)
Q Consensus 491 l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls 570 (621)
+++||||+++++++.+..... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++
T Consensus 76 ~~lv~e~~~~~l~~~~~~~~~-----~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~--~~~~kl~Dfg~~ 148 (292)
T 3o0g_A 76 LTLVFEFCDQDLKKYFDSCNG-----DLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINR--NGELKLANFGLA 148 (292)
T ss_dssp EEEEEECCSEEHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT--TSCEEECCCTTC
T ss_pred EEEEEecCCCCHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC--CCCEEEeecccc
Confidence 999999999998888765432 2899999999999999999999999999999999999984 789999999999
Q ss_pred cccCCC---ccccccCCcccCchhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCC
Q 007035 571 CFQTDN---LCLYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVCLI 621 (621)
Q Consensus 571 ~~~~~~---~~~~~gt~~Y~APEvl~~~~-~s~ksDIWSLGvILyELltG~~PF~ 621 (621)
...... .....+|+.|+|||++.+.. ++.++|||||||++|+|++|..||+
T Consensus 149 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~ 203 (292)
T 3o0g_A 149 RAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF 203 (292)
T ss_dssp EECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSC
T ss_pred eecCCccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCc
Confidence 765432 33457799999999998766 8999999999999999999988863
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=312.88 Aligned_cols=194 Identities=25% Similarity=0.406 Sum_probs=168.2
Q ss_pred cCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc----hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEec
Q 007035 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (621)
Q Consensus 413 ~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~ 488 (621)
.++|++++.||+|+||+||+|+++.+|+.||+|++++.. .......+|+.+++.+ .||||+++++++...
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l------~hp~iv~l~~~~~~~ 77 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT------RHPFLTALKYAFQTH 77 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC------CCTTBCCEEEEEECS
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhC------CCCcCcceEEEEEeC
Confidence 468999999999999999999999999999999997642 2334566677776644 588999999999999
Q ss_pred CeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEec
Q 007035 489 EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 567 (621)
Q Consensus 489 ~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DF 567 (621)
+++++||||+.+ +|...+.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+||
T Consensus 78 ~~~~lv~E~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~--~g~vkL~DF 149 (337)
T 1o6l_A 78 DRLCFVMEYANGGELFFHLSRER------VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDK--DGHIKITDF 149 (337)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECT--TSCEEECCC
T ss_pred CEEEEEEeCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECC--CCCEEEeec
Confidence 999999999986 6666665432 2889999999999999999999999999999999999984 789999999
Q ss_pred CCccccC---CCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 568 GSSCFQT---DNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 568 Gls~~~~---~~~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
|++.... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 150 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf 205 (337)
T 1o6l_A 150 GLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 205 (337)
T ss_dssp TTCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSS
T ss_pred cchhhcccCCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCC
Confidence 9987532 2344568899999999999999999999999999999999999998
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=306.38 Aligned_cols=210 Identities=21% Similarity=0.230 Sum_probs=173.9
Q ss_pred cccCCCcceeeCeeecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCch---hhhhHHHHHHHHHHhcccCCCC
Q 007035 398 FEENKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD---FFDQSLDEIKLLKLVNKNDPAD 474 (621)
Q Consensus 398 ~~~~~~~pi~l~~ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~---~~~~~~~Ei~iL~~l~~~~~~~ 474 (621)
+......|...++++.++|+++++||+|+||+||+|++..+|+.||||++..... ...+...|+..+..+ ..
T Consensus 41 ~~~~~~~p~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~-----~~ 115 (311)
T 3p1a_A 41 LQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKV-----GQ 115 (311)
T ss_dssp CCCTTCCTTSSSCHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHH-----CC
T ss_pred cCCCCCCCCCccchhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHh-----cC
Confidence 3445556777888889999999999999999999999999999999999865322 222333333333333 25
Q ss_pred CCceEEEeeEeEecCeEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEE
Q 007035 475 EHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILI 554 (621)
Q Consensus 475 hpnIvrl~~~f~~~~~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl 554 (621)
||||+++++++...+++++||||++++|.+.+..... .+++..++.++.||+.||.|||+++|+||||||+|||+
T Consensus 116 h~~iv~l~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll 190 (311)
T 3p1a_A 116 HPCCVRLEQAWEEGGILYLQTELCGPSLQQHCEAWGA-----SLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFL 190 (311)
T ss_dssp CTTBCCEEEEEEETTEEEEEEECCCCBHHHHHHHHCS-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred CCcEEEEEEEEEeCCEEEEEEeccCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEE
Confidence 8899999999999999999999999999988876532 28999999999999999999999999999999999999
Q ss_pred eccCCCeEEEEecCCccccCCC--ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 555 KSYQRCEIKIIDLGSSCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 555 ~~~~~~~IKL~DFGls~~~~~~--~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
+. ++.+||+|||++...... .....||+.|+|||++.+ .++.++|||||||++|+|++|..||
T Consensus 191 ~~--~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~ 255 (311)
T 3p1a_A 191 GP--RGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELP 255 (311)
T ss_dssp CG--GGCEEECCCTTCEECC------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCC
T ss_pred CC--CCCEEEccceeeeecccCCCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCC
Confidence 84 788999999998765433 233568999999999887 7899999999999999999997765
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=309.11 Aligned_cols=198 Identities=26% Similarity=0.389 Sum_probs=175.2
Q ss_pred ecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeE
Q 007035 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (621)
Q Consensus 412 i~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l 491 (621)
+.++|++.+.||+|+||+||+|.+..+++.||+|++.........+.+|+.+++.++ ||||+++++++.+.+.+
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~------hpnIv~~~~~~~~~~~~ 76 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIAR------HRNILHLHESFESMEEL 76 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSC------CTTBCCEEEEEEETTEE
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCC------CCCCCeEeEEEecCCEE
Confidence 468999999999999999999999999999999999876665667788999888774 78999999999999999
Q ss_pred EEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCc
Q 007035 492 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (621)
Q Consensus 492 ~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls 570 (621)
++||||+.+ +|.+.+.... ..+++..++.++.||+.||.|||++||+||||||+|||++...++.+||+|||++
T Consensus 77 ~lv~e~~~g~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a 151 (321)
T 1tki_A 77 VMIFEFISGLDIFERINTSA-----FELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQA 151 (321)
T ss_dssp EEEECCCCCCBHHHHHTSSS-----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTC
T ss_pred EEEEEeCCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCC
Confidence 999999985 7777765332 1288999999999999999999999999999999999998655789999999999
Q ss_pred cccCCC--ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 571 CFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 571 ~~~~~~--~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
...... .....+|+.|+|||++.+..++.++|||||||++|+|++|+.||
T Consensus 152 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf 203 (321)
T 1tki_A 152 RQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPF 203 (321)
T ss_dssp EECCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTT
T ss_pred eECCCCCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 765433 33467899999999999988999999999999999999999998
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-35 Score=309.52 Aligned_cols=195 Identities=29% Similarity=0.517 Sum_probs=170.8
Q ss_pred ecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecC---chhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEec
Q 007035 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (621)
Q Consensus 412 i~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~---~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~ 488 (621)
..++|++++.||+|+||.||+|++..+|+.||||++... .....++.+|+++++.++ ||||+++++++...
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~------hpnIv~l~~~~~~~ 86 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILN------HPNIVKLFEVIETE 86 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCC------CTTBCCEEEEEECS
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCC------CCCEeeEEEEEEEC
Confidence 457899999999999999999999999999999999753 234456778888888774 78999999999999
Q ss_pred CeEEEEEeccc-cchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEec
Q 007035 489 EHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 567 (621)
Q Consensus 489 ~~l~LVmEyl~-gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DF 567 (621)
+.+++||||+. ++|.+++..... +++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+||
T Consensus 87 ~~~~lv~e~~~~~~L~~~l~~~~~------l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~--~~~~~kl~DF 158 (328)
T 3fe3_A 87 KTLYLIMEYASGGEVFDYLVAHGR------MKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLD--ADMNIKIADF 158 (328)
T ss_dssp SEEEEEECCCTTCBHHHHHHHHCC------CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC--TTSCEEECST
T ss_pred CEEEEEEECCCCCcHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEc--CCCCEEEeec
Confidence 99999999997 578777765432 88999999999999999999999999999999999998 4789999999
Q ss_pred CCccccCC--CccccccCCcccCchhhcCCCCC-chhhHHHHHHHHHHHHhCCCCC
Q 007035 568 GSSCFQTD--NLCLYVQSRSYRAPEVIIGLPYD-QKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 568 Gls~~~~~--~~~~~~gt~~Y~APEvl~~~~~s-~ksDIWSLGvILyELltG~~PF 620 (621)
|++..... .....+||+.|+|||++.+..+. .++|||||||++|+|++|+.||
T Consensus 159 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf 214 (328)
T 3fe3_A 159 GFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPF 214 (328)
T ss_dssp TCCGGGSSSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSS
T ss_pred cCceecCCCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCC
Confidence 99875443 34456899999999999988875 7999999999999999999998
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-35 Score=311.74 Aligned_cols=201 Identities=17% Similarity=0.241 Sum_probs=168.8
Q ss_pred ecCceEEEEEeccCCCCceeEEEeCCC-----CcEEEEEEEecCchhhhhHHHHHHHHHHhcc---------cCCCCCCc
Q 007035 412 IAGRYYVTEYLGSAAFSKVFQAQDLHT-----GVDVCLKIIKNDKDFFDQSLDEIKLLKLVNK---------NDPADEHH 477 (621)
Q Consensus 412 i~~rY~I~~~LG~G~fG~Vyka~d~~t-----g~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~---------~~~~~hpn 477 (621)
..++|++.+.||+|+||.||+|.+..+ ++.||||++.... .....|+++++.+.+ ...+.|||
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~ 109 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDN---GPLFTELKFYQRAAKPEQIQKWIRTRKLKYLG 109 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTC---HHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccc---hhHHHHHHHHHhhhhhHHHHHHHHHhhccCCC
Confidence 345999999999999999999998764 5889999998654 245566666666544 35678999
Q ss_pred eEEEeeEeEec----CeEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEE
Q 007035 478 ILRLYDYFYHL----EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENIL 553 (621)
Q Consensus 478 Ivrl~~~f~~~----~~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NIL 553 (621)
|+++++++... .+.+|||||++++|.+++..... .+++..++.++.||+.||.|||+++|+||||||+|||
T Consensus 110 iv~~~~~~~~~~~~~~~~~lv~e~~g~~L~~~~~~~~~-----~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nil 184 (364)
T 3op5_A 110 VPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAK-----RFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLL 184 (364)
T ss_dssp SCCEEEEEEEEETTEEEEEEEEECEEEEHHHHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred CCeEEeeeeeccCCcceEEEEEeCCCCCHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEE
Confidence 99999999875 56999999997788888765322 2899999999999999999999999999999999999
Q ss_pred EeccCCCeEEEEecCCccccCCC----------ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 554 IKSYQRCEIKIIDLGSSCFQTDN----------LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 554 l~~~~~~~IKL~DFGls~~~~~~----------~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
++...++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||+||+|++|+.||
T Consensus 185 l~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf 261 (364)
T 3op5_A 185 LNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPW 261 (364)
T ss_dssp EESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTT
T ss_pred EecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence 98555789999999998654321 12345899999999999999999999999999999999999998
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=313.63 Aligned_cols=195 Identities=25% Similarity=0.431 Sum_probs=171.7
Q ss_pred ecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc----hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEe
Q 007035 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (621)
Q Consensus 412 i~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~ 487 (621)
..++|++++.||+|+||.||+|+++.+|+.||||++.+.. .......+|+.+++.+ .||||+++++++.+
T Consensus 39 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l------~hp~iv~~~~~~~~ 112 (350)
T 1rdq_E 39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV------NFPFLVKLEFSFKD 112 (350)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC------CCTTBCCEEEEEEC
T ss_pred CHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhC------CCCCCCeEEEEEEc
Confidence 3578999999999999999999999999999999997543 2234455666666544 58999999999999
Q ss_pred cCeEEEEEeccc-cchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEe
Q 007035 488 LEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (621)
Q Consensus 488 ~~~l~LVmEyl~-gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~D 566 (621)
..++++||||+. ++|.+++..... +++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|
T Consensus 113 ~~~~~lv~e~~~gg~L~~~l~~~~~------~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~--~~g~~kL~D 184 (350)
T 1rdq_E 113 NSNLYMVMEYVAGGEMFSHLRRIGR------FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID--QQGYIQVTD 184 (350)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHCC------CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC--TTSCEEECC
T ss_pred CCEEEEEEcCCCCCcHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEEC--CCCCEEEcc
Confidence 999999999997 577777764422 88999999999999999999999999999999999998 478999999
Q ss_pred cCCccccCCCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 567 LGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 567 FGls~~~~~~~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
||++..........+||+.|+|||++.+..++.++|||||||++|+|++|++||
T Consensus 185 Fg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf 238 (350)
T 1rdq_E 185 FGFAKRVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238 (350)
T ss_dssp CTTCEECSSCBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred cccceeccCCcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCC
Confidence 999988776666778999999999999999999999999999999999999998
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-35 Score=305.69 Aligned_cols=199 Identities=30% Similarity=0.453 Sum_probs=170.4
Q ss_pred eCeeecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc---hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeE
Q 007035 408 LNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDY 484 (621)
Q Consensus 408 l~~ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~---~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~ 484 (621)
..+.+.++|++++.||+|+||+||+|++. +|+.||+|++.... .......+|+.+++.++ ||||++++++
T Consensus 15 ~~q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~------hp~iv~~~~~ 87 (311)
T 3niz_A 15 YFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELH------HPNIVSLIDV 87 (311)
T ss_dssp CEECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCC------CTTBCCEEEE
T ss_pred eecchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcC------CCCEeeeeeE
Confidence 44567899999999999999999999985 59999999987543 23456778888888774 7899999999
Q ss_pred eEecCeEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEE
Q 007035 485 FYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKI 564 (621)
Q Consensus 485 f~~~~~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL 564 (621)
+....++++||||+++++.+.+..... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||
T Consensus 88 ~~~~~~~~lv~e~~~~~l~~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~--~~~~kl 160 (311)
T 3niz_A 88 IHSERCLTLVFEFMEKDLKKVLDENKT-----GLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINS--DGALKL 160 (311)
T ss_dssp ECCSSCEEEEEECCSEEHHHHHHTCTT-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT--TCCEEE
T ss_pred EccCCEEEEEEcCCCCCHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECC--CCCEEE
Confidence 999999999999999999888865432 2889999999999999999999999999999999999984 788999
Q ss_pred EecCCccccCCC---ccccccCCcccCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 565 IDLGSSCFQTDN---LCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 565 ~DFGls~~~~~~---~~~~~gt~~Y~APEvl~~-~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
+|||++...... .....+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||
T Consensus 161 ~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf 220 (311)
T 3niz_A 161 ADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLF 220 (311)
T ss_dssp CCCTTCEETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred ccCcCceecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCC
Confidence 999999765422 333577999999999976 45899999999999999999999998
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-35 Score=310.84 Aligned_cols=196 Identities=23% Similarity=0.365 Sum_probs=170.5
Q ss_pred ecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc----hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEe
Q 007035 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (621)
Q Consensus 412 i~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~ 487 (621)
-.++|++++.||+|+||+||+|+++.+++.||+|++++.. .......+|..+++.+. .||||+++++++..
T Consensus 7 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~-----~hp~iv~l~~~~~~ 81 (345)
T 3a8x_A 7 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS-----NHPFLVGLHSCFQT 81 (345)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTT-----TCTTBCCEEEEEEC
T ss_pred chhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcC-----CCCccCeEEEEEEe
Confidence 3478999999999999999999999999999999998642 23455677777777653 58899999999999
Q ss_pred cCeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEe
Q 007035 488 LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (621)
Q Consensus 488 ~~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~D 566 (621)
...+++||||+.+ +|.+.+.... .+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|
T Consensus 82 ~~~~~lv~e~~~gg~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~--~~g~~kL~D 153 (345)
T 3a8x_A 82 ESRLFFVIEYVNGGDLMFHMQRQR------KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLD--SEGHIKLTD 153 (345)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC--TTSCEEECC
T ss_pred CCEEEEEEeCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEC--CCCCEEEEe
Confidence 9999999999975 7776665432 288999999999999999999999999999999999998 478999999
Q ss_pred cCCccccC---CCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 567 LGSSCFQT---DNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 567 FGls~~~~---~~~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
||++.... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 154 FG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf 210 (345)
T 3a8x_A 154 YGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPF 210 (345)
T ss_dssp GGGCBCSCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred ccccccccCCCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCc
Confidence 99987532 2344568999999999999999999999999999999999999998
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=315.83 Aligned_cols=198 Identities=30% Similarity=0.554 Sum_probs=161.6
Q ss_pred CeeecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecC---chhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEe
Q 007035 409 NTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYF 485 (621)
Q Consensus 409 ~~ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~---~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f 485 (621)
+..+.++|++++.||+|+||.||+|.+..+|+.||||++... .....+..+|+.+++.+. .||||+++++++
T Consensus 4 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~-----~h~niv~l~~~~ 78 (388)
T 3oz6_A 4 DRHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELS-----GHENIVNLLNVL 78 (388)
T ss_dssp CHHHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTT-----TCTTBCCEEEEE
T ss_pred cCcccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhcc-----CCCCCCeeeeEE
Confidence 345678999999999999999999999999999999998642 334456677888888775 478999999999
Q ss_pred EecC--eEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEE
Q 007035 486 YHLE--HLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 563 (621)
Q Consensus 486 ~~~~--~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IK 563 (621)
...+ ++|+||||++++|...+... .+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+|
T Consensus 79 ~~~~~~~~~lv~e~~~~~L~~~~~~~-------~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~--~~~~k 149 (388)
T 3oz6_A 79 RADNDRDVYLVFDYMETDLHAVIRAN-------ILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNA--ECHVK 149 (388)
T ss_dssp ECTTSSCEEEEEECCSEEHHHHHHHT-------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT--TCCEE
T ss_pred ecCCCCEEEEEecccCcCHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcC--CCCEE
Confidence 8554 79999999999988887642 2888999999999999999999999999999999999984 78999
Q ss_pred EEecCCccccCC------------------------CccccccCCcccCchhhcC-CCCCchhhHHHHHHHHHHHHhCCC
Q 007035 564 IIDLGSSCFQTD------------------------NLCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEV 618 (621)
Q Consensus 564 L~DFGls~~~~~------------------------~~~~~~gt~~Y~APEvl~~-~~~s~ksDIWSLGvILyELltG~~ 618 (621)
|+|||++..... .....++|+.|+|||++.+ ..++.++|||||||++|||++|++
T Consensus 150 l~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~ 229 (388)
T 3oz6_A 150 VADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKP 229 (388)
T ss_dssp ECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred ecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCC
Confidence 999999865422 1233578999999999987 578999999999999999999999
Q ss_pred CC
Q 007035 619 CL 620 (621)
Q Consensus 619 PF 620 (621)
||
T Consensus 230 pf 231 (388)
T 3oz6_A 230 IF 231 (388)
T ss_dssp SC
T ss_pred CC
Confidence 98
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=311.61 Aligned_cols=217 Identities=36% Similarity=0.622 Sum_probs=186.5
Q ss_pred cCCCcceeeCeee-cCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccC-----CC
Q 007035 400 ENKDLPIILNTVI-AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKND-----PA 473 (621)
Q Consensus 400 ~~~~~pi~l~~ii-~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~-----~~ 473 (621)
+...+|...+..+ .++|++.+.||+|+||+||+|++..+++.||||++..+........+|+.+++.+.+.. ..
T Consensus 4 ~~~~~p~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~ 83 (373)
T 1q8y_A 4 PGGYHPAFKGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSM 83 (373)
T ss_dssp ---CCCCCTTCEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHH
T ss_pred CCCceeeecCCcccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhcc
Confidence 3445666666665 46999999999999999999999999999999999887766778889999999998643 22
Q ss_pred CCCceEEEeeEeEecC----eEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHC-CeecccCC
Q 007035 474 DEHHILRLYDYFYHLE----HLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSL-GIIHCDLK 548 (621)
Q Consensus 474 ~hpnIvrl~~~f~~~~----~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~-gIvHrDLK 548 (621)
.|+||+++++++...+ ++++||||++++|.+++...... .+++..++.++.||+.||.|||++ ||+|||||
T Consensus 84 ~~~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~----~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dik 159 (373)
T 1q8y_A 84 GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHR----GIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIK 159 (373)
T ss_dssp HHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTS----CCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCS
T ss_pred ccchHHHHHHHhhccCCCCceEEEEEecCCCCHHHHHHHhhcc----CCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCC
Confidence 4789999999998764 89999999988999988764322 288999999999999999999998 99999999
Q ss_pred CccEEEecc----CCCeEEEEecCCccccCCCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 549 PENILIKSY----QRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 549 P~NILl~~~----~~~~IKL~DFGls~~~~~~~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
|+|||++.+ ..+.+||+|||++...........+|+.|+|||++.+..++.++|||||||++|+|++|+.||
T Consensus 160 p~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf 235 (373)
T 1q8y_A 160 PENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLF 235 (373)
T ss_dssp GGGEEEEEEETTTTEEEEEECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC
T ss_pred hHHeEEeccCCCcCcceEEEcccccccccCCCCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCC
Confidence 999999642 345899999999987766666678899999999999999999999999999999999999998
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-35 Score=311.31 Aligned_cols=197 Identities=28% Similarity=0.345 Sum_probs=165.6
Q ss_pred ecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeE
Q 007035 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (621)
Q Consensus 412 i~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l 491 (621)
..++|++++.||+|+||+||++++..+++.||||++...........+|+.+++.++ ||||+++++++...+++
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~------hpniv~~~~~~~~~~~~ 91 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLR------HPNIVRFKEVILTPTHL 91 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCC------CTTBCCEEEEEECSSEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCC------CCCCCcEEEEEeeCCEE
Confidence 357999999999999999999999999999999999876666677888998888774 78999999999999999
Q ss_pred EEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCc
Q 007035 492 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (621)
Q Consensus 492 ~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls 570 (621)
++||||+.+ +|.+.+..... +++..++.++.||+.||.|||++||+||||||+|||++.+..+.+||+|||++
T Consensus 92 ~lv~e~~~~~~L~~~l~~~~~------~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a 165 (361)
T 3uc3_A 92 AIIMEYASGGELYERICNAGR------FSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYS 165 (361)
T ss_dssp EEEEECCCSCBHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC
T ss_pred EEEEEeCCCCCHHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcc
Confidence 999999974 77777654332 88999999999999999999999999999999999998655567999999998
Q ss_pred cccC--CCccccccCCcccCchhhcCCCCCch-hhHHHHHHHHHHHHhCCCCC
Q 007035 571 CFQT--DNLCLYVQSRSYRAPEVIIGLPYDQK-IDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 571 ~~~~--~~~~~~~gt~~Y~APEvl~~~~~s~k-sDIWSLGvILyELltG~~PF 620 (621)
.... .......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||
T Consensus 166 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf 218 (361)
T 3uc3_A 166 KSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPF 218 (361)
T ss_dssp ---------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSC
T ss_pred ccccccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCC
Confidence 6432 23344678999999999988887665 89999999999999999998
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-35 Score=312.53 Aligned_cols=206 Identities=20% Similarity=0.319 Sum_probs=171.4
Q ss_pred eeecCceEEEEEeccCCCCceeEE-----EeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeE
Q 007035 410 TVIAGRYYVTEYLGSAAFSKVFQA-----QDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDY 484 (621)
Q Consensus 410 ~ii~~rY~I~~~LG~G~fG~Vyka-----~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~ 484 (621)
.+..++|++.+.||+|+||+||+| .+..+++.||+|++.... ...+..|+.+++.++.. .|+||++++++
T Consensus 61 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~e~~~~~~l~~~---~~~~iv~~~~~ 135 (365)
T 3e7e_A 61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN--PWEFYIGTQLMERLKPS---MQHMFMKFYSA 135 (365)
T ss_dssp ECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC--HHHHHHHHHHHHHSCGG---GGGGBCCEEEE
T ss_pred EECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC--hhHHHHHHHHHHHhhhh---hhhhhhhhhee
Confidence 344578999999999999999999 467889999999997654 35677888888888643 58999999999
Q ss_pred eEecCeEEEEEeccc-cchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEec-------
Q 007035 485 FYHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS------- 556 (621)
Q Consensus 485 f~~~~~l~LVmEyl~-gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~------- 556 (621)
+...+..+|||||+. ++|.+++...... ....+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 136 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~-~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~ 214 (365)
T 3e7e_A 136 HLFQNGSVLVGELYSYGTLLNAINLYKNT-PEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDD 214 (365)
T ss_dssp EECSSCEEEEECCCCSCBHHHHHHHHHTS-TTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC--
T ss_pred eecCCCcEEEEeccCCCcHHHHHHHhhcc-cccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccc
Confidence 999999999999997 5888887654322 2234899999999999999999999999999999999999984
Q ss_pred --cCCCeEEEEecCCccccC-----CCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 007035 557 --YQRCEIKIIDLGSSCFQT-----DNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCLI 621 (621)
Q Consensus 557 --~~~~~IKL~DFGls~~~~-----~~~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF~ 621 (621)
...+.+||+|||++.... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 215 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~ 286 (365)
T 3e7e_A 215 EDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKV 286 (365)
T ss_dssp ----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCE
T ss_pred cccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccc
Confidence 116889999999996532 12334578999999999999999999999999999999999999983
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-35 Score=305.51 Aligned_cols=200 Identities=32% Similarity=0.506 Sum_probs=158.6
Q ss_pred cCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc--hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCe
Q 007035 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (621)
Q Consensus 413 ~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~ 490 (621)
.++|++++.||+|+||+||+|.++.+|+.||+|+++... .......+|+.+++.+ .||||+++++++...+.
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l------~hp~iv~~~~~~~~~~~ 77 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKEL------KHENIVRLYDVIHTENK 77 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTC------CBTTBCCEEEEECCTTE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhc------CCCCcceEEEEEEECCe
Confidence 468999999999999999999999999999999997543 2235567777777655 47899999999999999
Q ss_pred EEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCc
Q 007035 491 LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (621)
Q Consensus 491 l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls 570 (621)
+++||||++++|.+++...........+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++
T Consensus 78 ~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~--~~~~kl~Dfg~~ 155 (317)
T 2pmi_A 78 LTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINK--RGQLKLGDFGLA 155 (317)
T ss_dssp EEEEEECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT--TCCEEECCCSSC
T ss_pred EEEEEEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcC--CCCEEECcCccc
Confidence 999999999999998876654333344889999999999999999999999999999999999984 789999999998
Q ss_pred cccCCC---ccccccCCcccCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 571 CFQTDN---LCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 571 ~~~~~~---~~~~~gt~~Y~APEvl~~~-~~s~ksDIWSLGvILyELltG~~PF 620 (621)
...... .....+|+.|+|||++.+. .++.++|||||||++|+|++|+.||
T Consensus 156 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf 209 (317)
T 2pmi_A 156 RAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLF 209 (317)
T ss_dssp EETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred eecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 765432 3345789999999999874 5899999999999999999999998
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-35 Score=323.24 Aligned_cols=194 Identities=34% Similarity=0.589 Sum_probs=165.2
Q ss_pred eecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecC---chhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEe
Q 007035 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (621)
Q Consensus 411 ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~---~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~ 487 (621)
.+.++|++++.||+|+||+||+|++..+|+.||||++... .....+..+|+.+++.++ ||||+++++++..
T Consensus 59 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~------hpnIv~l~~~~~~ 132 (464)
T 3ttj_A 59 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN------HKNIISLLNVFTP 132 (464)
T ss_dssp EEETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCC------CTTBCCCSEEECS
T ss_pred eecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCC------CCCCCcEEEEEcc
Confidence 4568999999999999999999999999999999999753 334556778888887774 7899999999975
Q ss_pred c------CeEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCe
Q 007035 488 L------EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCE 561 (621)
Q Consensus 488 ~------~~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~ 561 (621)
. .++||||||+++++.+.+.. .+++..++.++.||+.||.|||++||+||||||+|||++. ++.
T Consensus 133 ~~~~~~~~~~~lv~E~~~~~l~~~~~~--------~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~--~~~ 202 (464)
T 3ttj_A 133 QKTLEEFQDVYLVMELMDANLCQVIQM--------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS--DCT 202 (464)
T ss_dssp CCSTTTCCEEEEEEECCSEEHHHHHTS--------CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT--TSC
T ss_pred CCccccCCeEEEEEeCCCCCHHHHHhh--------cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeC--CCC
Confidence 4 46899999999998877642 1788999999999999999999999999999999999994 789
Q ss_pred EEEEecCCccccCCC--ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 562 IKIIDLGSSCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 562 IKL~DFGls~~~~~~--~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
+||+|||++...... ....++|+.|+|||++.+..|+.++|||||||+||+|++|++||
T Consensus 203 ~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF 263 (464)
T 3ttj_A 203 LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILF 263 (464)
T ss_dssp EEECCCCCC-----CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSS
T ss_pred EEEEEEEeeeecCCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCC
Confidence 999999999765543 34468899999999999999999999999999999999999998
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=296.41 Aligned_cols=201 Identities=22% Similarity=0.310 Sum_probs=174.2
Q ss_pred CeeecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEec
Q 007035 409 NTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (621)
Q Consensus 409 ~~ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~ 488 (621)
+.++.++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+|+.+++.+. .|++++++++++...
T Consensus 5 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~~~~l~-----~~~~i~~~~~~~~~~ 78 (298)
T 1csn_A 5 NNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLA-----GCTGIPNVYYFGQEG 78 (298)
T ss_dssp -CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTT-----TCTTCCCEEEEEEET
T ss_pred CcccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC-ccHHHHHHHHHHHHHh-----cCCCCCeEEeecCCC
Confidence 5678899999999999999999999999999999999987543 2356788999988885 367899999999999
Q ss_pred CeEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEecc---CCCeEEEE
Q 007035 489 EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSY---QRCEIKII 565 (621)
Q Consensus 489 ~~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~---~~~~IKL~ 565 (621)
.+.++||||++++|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||++.+ ....+||+
T Consensus 79 ~~~~lv~e~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~ 153 (298)
T 1csn_A 79 LHNVLVIDLLGPSLEDLLDLCGR-----KFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVV 153 (298)
T ss_dssp TEEEEEEECCCCBHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEEC
T ss_pred ceeEEEEEecCCCHHHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEE
Confidence 99999999998899988875432 28899999999999999999999999999999999999852 22349999
Q ss_pred ecCCccccCCC----------ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 566 DLGSSCFQTDN----------LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 566 DFGls~~~~~~----------~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
|||++...... .....+|+.|+|||++.+..++.++||||||+++|+|++|+.||
T Consensus 154 Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf 218 (298)
T 1csn_A 154 DFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPW 218 (298)
T ss_dssp CCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred ECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCc
Confidence 99998764432 23456899999999999999999999999999999999999998
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-35 Score=319.72 Aligned_cols=194 Identities=23% Similarity=0.375 Sum_probs=168.3
Q ss_pred ecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc----hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEe
Q 007035 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (621)
Q Consensus 412 i~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~ 487 (621)
..++|++++.||+|+||+||+|+++.+++.||+|++++.. .....+.+|+.+++.+ .||||++++++|.+
T Consensus 67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l------~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA------NSPWVVQLFYAFQD 140 (410)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHC------CCTTBCCEEEEEEC
T ss_pred CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhC------CCCCCCeEEEEEEE
Confidence 3578999999999999999999999999999999997532 2234467888888776 47899999999999
Q ss_pred cCeEEEEEeccc-cchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEe
Q 007035 488 LEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (621)
Q Consensus 488 ~~~l~LVmEyl~-gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~D 566 (621)
..++||||||+. ++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~~~-------~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~--~~g~ikL~D 211 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMSNY-------DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD--KSGHLKLAD 211 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHC-------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC--TTSCEEECC
T ss_pred CCEEEEEEeCCCCCcHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeEC--CCCCEEEec
Confidence 999999999996 5777766432 188999999999999999999999999999999999998 488999999
Q ss_pred cCCccccCCC----ccccccCCcccCchhhcCCC----CCchhhHHHHHHHHHHHHhCCCCC
Q 007035 567 LGSSCFQTDN----LCLYVQSRSYRAPEVIIGLP----YDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 567 FGls~~~~~~----~~~~~gt~~Y~APEvl~~~~----~s~ksDIWSLGvILyELltG~~PF 620 (621)
||++...... ....+||+.|+|||++.+.. ++.++|||||||+||||++|++||
T Consensus 212 FG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf 273 (410)
T 3v8s_A 212 FGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 273 (410)
T ss_dssp CTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTT
T ss_pred cceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCC
Confidence 9999765443 23568999999999998765 788999999999999999999998
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-35 Score=312.55 Aligned_cols=196 Identities=26% Similarity=0.381 Sum_probs=167.7
Q ss_pred ecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc----hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEe
Q 007035 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (621)
Q Consensus 412 i~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~ 487 (621)
..++|++++.||+|+||+||+|+++.+|+.||||++++.. ........|..++..+ ..||+|++++++++.
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~-----~~hp~iv~l~~~~~~ 92 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALP-----GKPPFLTQLHSCFQT 92 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCT-----TCCTTBCCEEEEEEC
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhc-----CCCCEEeeEEEEEEc
Confidence 3478999999999999999999999999999999998643 2233445565555433 258999999999999
Q ss_pred cCeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEe
Q 007035 488 LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (621)
Q Consensus 488 ~~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~D 566 (621)
.+++|+||||+.+ +|.+.+..... +++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|
T Consensus 93 ~~~~~lv~E~~~gg~L~~~l~~~~~------~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~--~g~vkL~D 164 (353)
T 2i0e_A 93 MDRLYFVMEYVNGGDLMYHIQQVGR------FKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDS--EGHIKIAD 164 (353)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECT--TSCEEECC
T ss_pred CCEEEEEEeCCCCCcHHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcC--CCcEEEEe
Confidence 9999999999975 77777664322 889999999999999999999999999999999999984 78999999
Q ss_pred cCCccccC---CCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 567 LGSSCFQT---DNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 567 FGls~~~~---~~~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
||++.... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 165 FG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf 221 (353)
T 2i0e_A 165 FGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPF 221 (353)
T ss_dssp CTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSS
T ss_pred CCcccccccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCC
Confidence 99987532 2344568999999999999999999999999999999999999998
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-35 Score=310.42 Aligned_cols=197 Identities=34% Similarity=0.502 Sum_probs=171.4
Q ss_pred eeecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc----hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEe
Q 007035 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYF 485 (621)
Q Consensus 410 ~ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f 485 (621)
....++|++.+.||+|+||+||+|.+..+++.||+|++.... .....+.+|+.+++.+ .||||+++++++
T Consensus 5 ~~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l------~hpnIv~l~~~~ 78 (336)
T 3h4j_B 5 KRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLL------RHPHIIKLYDVI 78 (336)
T ss_dssp CSEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTC------CCTTBCCEEEEE
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhC------CCCCCCeEEEEE
Confidence 345688999999999999999999999999999999997532 2234566777777655 478999999999
Q ss_pred EecCeEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEE
Q 007035 486 YHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKII 565 (621)
Q Consensus 486 ~~~~~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~ 565 (621)
...+.+++||||++++|++.+..... +++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+
T Consensus 79 ~~~~~~~lv~E~~~g~l~~~l~~~~~------l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~--~~~~~kl~ 150 (336)
T 3h4j_B 79 TTPTDIVMVIEYAGGELFDYIVEKKR------MTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLD--DNLNVKIA 150 (336)
T ss_dssp ECSSEEEEEECCCCEEHHHHHHHHCS------CCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEEC--TTCCEEEC
T ss_pred EeCCEEEEEEECCCCcHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEc--CCCCEEEE
Confidence 99999999999999999998875432 88999999999999999999999999999999999998 47889999
Q ss_pred ecCCccccCCC--ccccccCCcccCchhhcCCCC-CchhhHHHHHHHHHHHHhCCCCC
Q 007035 566 DLGSSCFQTDN--LCLYVQSRSYRAPEVIIGLPY-DQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 566 DFGls~~~~~~--~~~~~gt~~Y~APEvl~~~~~-s~ksDIWSLGvILyELltG~~PF 620 (621)
|||++...... ....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||
T Consensus 151 DFG~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf 208 (336)
T 3h4j_B 151 DFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPF 208 (336)
T ss_dssp CSSCTBTTTTSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSS
T ss_pred EeccceeccCCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCC
Confidence 99998765433 344678999999999988776 78999999999999999999998
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-35 Score=301.70 Aligned_cols=194 Identities=28% Similarity=0.469 Sum_probs=169.0
Q ss_pred ecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc-hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCe
Q 007035 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (621)
Q Consensus 412 i~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~-~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~ 490 (621)
..++|++.+.||+|+||+||+|.+..+++.||+|++.... ...+.+.+|+.+++.+ .||||+++++++...+.
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l------~hp~iv~~~~~~~~~~~ 91 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN------KNPNIVNYLDSYLVGDE 91 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHC------CCTTBCCEEEEEEETTE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcC------CCCCCCeEeEEEEECCE
Confidence 3578999999999999999999999999999999987533 2345567788888776 47899999999999999
Q ss_pred EEEEEeccc-cchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCC
Q 007035 491 LFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (621)
Q Consensus 491 l~LVmEyl~-gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGl 569 (621)
.++||||+. ++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+
T Consensus 92 ~~lv~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~--~~~~kl~Dfg~ 162 (297)
T 3fxz_A 92 LWVVMEYLAGGSLTDVVTET-------CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGM--DGSVKLTDFGF 162 (297)
T ss_dssp EEEEEECCTTCBHHHHHHHS-------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT--TCCEEECCCTT
T ss_pred EEEEEECCCCCCHHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECC--CCCEEEeeCCC
Confidence 999999996 4777766532 2888999999999999999999999999999999999984 78899999999
Q ss_pred ccccCCC---ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 570 SCFQTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 570 s~~~~~~---~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
+...... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||
T Consensus 163 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf 216 (297)
T 3fxz_A 163 CAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPY 216 (297)
T ss_dssp CEECCSTTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred ceecCCcccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 8764432 33457899999999999999999999999999999999999998
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-35 Score=308.09 Aligned_cols=202 Identities=25% Similarity=0.371 Sum_probs=172.4
Q ss_pred eecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCch------hhhhHHHHHHHHHHhcccCCCCCCceEEEeeE
Q 007035 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD------FFDQSLDEIKLLKLVNKNDPADEHHILRLYDY 484 (621)
Q Consensus 411 ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~------~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~ 484 (621)
.+.++|++.+.||+|+||+||+|.++.+|+.||||++..... ..+.+.+|+.+++.++ ||||++++++
T Consensus 21 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~------hpnIv~~~~~ 94 (351)
T 3c0i_A 21 LFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLK------HPHIVELLET 94 (351)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCC------CTTBCCEEEE
T ss_pred ccccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCC------CCCCCcEEEE
Confidence 456789999999999999999999999999999999874321 2456788998888774 7899999999
Q ss_pred eEecCeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccC-CCeE
Q 007035 485 FYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQ-RCEI 562 (621)
Q Consensus 485 f~~~~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~-~~~I 562 (621)
+...+.+++||||+.+ +|.+.+...... ...+++..++.++.||+.||.|||+++|+||||||+|||++.+. ...+
T Consensus 95 ~~~~~~~~lv~e~~~g~~L~~~l~~~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~v 172 (351)
T 3c0i_A 95 YSSDGMLYMVFEFMDGADLCFEIVKRADA--GFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPV 172 (351)
T ss_dssp EEETTEEEEEEECCSSCBHHHHHHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCE
T ss_pred EEeCCEEEEEEeCCCCCCHHHHHHHhccc--CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcE
Confidence 9999999999999984 676666544322 12378999999999999999999999999999999999998532 3569
Q ss_pred EEEecCCccccCCC---ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 563 KIIDLGSSCFQTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 563 KL~DFGls~~~~~~---~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||
T Consensus 173 kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf 233 (351)
T 3c0i_A 173 KLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPF 233 (351)
T ss_dssp EECCCTTCEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred EEecCcceeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCC
Confidence 99999998765443 23457899999999999999999999999999999999999998
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-35 Score=310.72 Aligned_cols=200 Identities=27% Similarity=0.432 Sum_probs=171.5
Q ss_pred eeecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCch-------hhhhHHHHHHHHHHhcccCCCCCCceEEEe
Q 007035 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD-------FFDQSLDEIKLLKLVNKNDPADEHHILRLY 482 (621)
Q Consensus 410 ~ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~-------~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~ 482 (621)
..+.++|++.+.||+|+||+||+|+++.+|+.||+|+++.... ..+.+.+|+.+++.+ .||||++++
T Consensus 8 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l------~hpnIv~l~ 81 (361)
T 2yab_A 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQV------LHPNIITLH 81 (361)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTC------CCTTBCCEE
T ss_pred CChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhC------CCcCCCcEE
Confidence 3467889999999999999999999999999999999976432 234567777777655 488999999
Q ss_pred eEeEecCeEEEEEeccc-cchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccC--C
Q 007035 483 DYFYHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQ--R 559 (621)
Q Consensus 483 ~~f~~~~~l~LVmEyl~-gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~--~ 559 (621)
+++.....+++||||+. ++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.+. .
T Consensus 82 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~~------~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~ 155 (361)
T 2yab_A 82 DVYENRTDVVLILELVSGGELFDFLAQKE------SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPI 155 (361)
T ss_dssp EEEECSSEEEEEEECCCSCBHHHHHTTCS------CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSS
T ss_pred EEEEeCCEEEEEEEcCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCc
Confidence 99999999999999996 57777775322 289999999999999999999999999999999999998522 1
Q ss_pred CeEEEEecCCccccCCC--ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 007035 560 CEIKIIDLGSSCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCLI 621 (621)
Q Consensus 560 ~~IKL~DFGls~~~~~~--~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF~ 621 (621)
..+||+|||++...... ....+||+.|+|||++.+..++.++|||||||++|+|++|.+||.
T Consensus 156 ~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~ 219 (361)
T 2yab_A 156 PHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 219 (361)
T ss_dssp CCEEECCCSSCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSC
T ss_pred cCEEEEecCCceEcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCC
Confidence 27999999998765443 344679999999999999999999999999999999999999983
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-35 Score=319.82 Aligned_cols=196 Identities=21% Similarity=0.307 Sum_probs=168.5
Q ss_pred ecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc----hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEe
Q 007035 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (621)
Q Consensus 412 i~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~ 487 (621)
..++|+++++||+|+||+||+|+++.+++.||+|++++.. .....+.+|..++..+ .||||++++++|.+
T Consensus 72 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~------~hp~Iv~l~~~~~~ 145 (437)
T 4aw2_A 72 HREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNG------DSKWITTLHYAFQD 145 (437)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHS------CTTTBCCEEEEEEC
T ss_pred ChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhC------CCCCEEEEEEEEee
Confidence 3578999999999999999999999999999999997532 2223467788888765 47899999999999
Q ss_pred cCeEEEEEeccc-cchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEe
Q 007035 488 LEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (621)
Q Consensus 488 ~~~l~LVmEyl~-gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~D 566 (621)
.++++|||||+. ++|.+++..... .+++..++.++.||+.||.|||+++|+||||||+|||++ .++.+||+|
T Consensus 146 ~~~~~lV~Ey~~gg~L~~~l~~~~~-----~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~--~~g~vkL~D 218 (437)
T 4aw2_A 146 DNNLYLVMDYYVGGDLLTLLSKFED-----RLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMD--MNGHIRLAD 218 (437)
T ss_dssp SSEEEEEECCCTTCBHHHHHHTTTT-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC--TTSCEEECC
T ss_pred CCEEEEEEecCCCCcHHHHHHHccC-----CCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEc--CCCCEEEcc
Confidence 999999999996 577777764322 289999999999999999999999999999999999998 488999999
Q ss_pred cCCccccCCC----ccccccCCcccCchhhc-----CCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 567 LGSSCFQTDN----LCLYVQSRSYRAPEVII-----GLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 567 FGls~~~~~~----~~~~~gt~~Y~APEvl~-----~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
||++...... ....+||+.|+|||++. ...++.++|||||||+||||++|++||
T Consensus 219 FGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf 281 (437)
T 4aw2_A 219 FGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPF 281 (437)
T ss_dssp CTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTT
T ss_pred hhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCC
Confidence 9998654432 22358999999999997 456899999999999999999999998
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-35 Score=316.72 Aligned_cols=196 Identities=23% Similarity=0.331 Sum_probs=169.0
Q ss_pred ecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc----hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEe
Q 007035 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (621)
Q Consensus 412 i~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~ 487 (621)
..++|++++.||+|+||+||+++++.+|+.||||++++.. .....+.+|..++..+ .||||++++++|++
T Consensus 59 ~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~------~hp~Iv~l~~~~~~ 132 (412)
T 2vd5_A 59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNG------DRRWITQLHFAFQD 132 (412)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHS------CTTTBCCEEEEEEC
T ss_pred ChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhc------CCCCeeeEEEEEee
Confidence 4578999999999999999999999999999999997532 2234567788887765 47899999999999
Q ss_pred cCeEEEEEeccc-cchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEe
Q 007035 488 LEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (621)
Q Consensus 488 ~~~l~LVmEyl~-gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~D 566 (621)
.+++||||||+. ++|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||++ .++++||+|
T Consensus 133 ~~~~~lVmE~~~gg~L~~~l~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld--~~g~vkL~D 205 (412)
T 2vd5_A 133 ENYLYLVMEYYVGGDLLTLLSKFGE-----RIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLD--RCGHIRLAD 205 (412)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHSS-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC--TTSCEEECC
T ss_pred CCEEEEEEcCCCCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeec--CCCCEEEee
Confidence 999999999996 578777764322 288999999999999999999999999999999999998 478999999
Q ss_pred cCCccccCCCc----cccccCCcccCchhhc-------CCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 567 LGSSCFQTDNL----CLYVQSRSYRAPEVII-------GLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 567 FGls~~~~~~~----~~~~gt~~Y~APEvl~-------~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
||++....... ...+||+.|+|||++. ...++.++|||||||++|||++|+.||
T Consensus 206 FGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf 270 (412)
T 2vd5_A 206 FGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPF 270 (412)
T ss_dssp CTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTT
T ss_pred chhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCC
Confidence 99987654332 2358999999999997 356899999999999999999999998
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=310.71 Aligned_cols=200 Identities=26% Similarity=0.408 Sum_probs=164.2
Q ss_pred eecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcc-cCCCCCCceEEEeeEeEecC
Q 007035 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNK-NDPADEHHILRLYDYFYHLE 489 (621)
Q Consensus 411 ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~-~~~~~hpnIvrl~~~f~~~~ 489 (621)
+..++|++++.||+|+||+||+|+++.+++.||||++++....... .+..++++... .....||||++++++|+..+
T Consensus 35 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~--~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~ 112 (373)
T 2r5t_A 35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKK--EEKHIMSERNVLLKNVKHPFLVGLHFSFQTAD 112 (373)
T ss_dssp CCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC---------------CCBCCCCCTTBCCEEEEEECSS
T ss_pred CChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhH--HHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCC
Confidence 3457899999999999999999999999999999999865322111 11222232222 34568999999999999999
Q ss_pred eEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecC
Q 007035 490 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (621)
Q Consensus 490 ~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFG 568 (621)
++|+||||+.+ +|.+.+.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++++||+|||
T Consensus 113 ~~~lv~E~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~--~g~ikL~DFG 184 (373)
T 2r5t_A 113 KLYFVLDYINGGELFYHLQRER------CFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDS--QGHIVLTDFG 184 (373)
T ss_dssp EEEEEEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT--TSCEEECCCC
T ss_pred EEEEEEeCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECC--CCCEEEeeCc
Confidence 99999999985 6777665432 2888999999999999999999999999999999999984 7899999999
Q ss_pred CccccC---CCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 569 SSCFQT---DNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 569 ls~~~~---~~~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
++.... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 185 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf 239 (373)
T 2r5t_A 185 LCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPF 239 (373)
T ss_dssp BCGGGBCCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred cccccccCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCC
Confidence 987532 2344568999999999999999999999999999999999999998
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=308.90 Aligned_cols=201 Identities=29% Similarity=0.462 Sum_probs=173.6
Q ss_pred eCeeecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc---hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeE
Q 007035 408 LNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDY 484 (621)
Q Consensus 408 l~~ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~---~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~ 484 (621)
....+.++|++.+.||+|+||.||+|.++.+|+.||+|++.... ...+.+.+|+.+++.++ ||||++++++
T Consensus 23 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~------hpnIv~~~~~ 96 (362)
T 2bdw_A 23 ASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQ------HPNIVRLHDS 96 (362)
T ss_dssp -CCHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCC------CTTBCCEEEE
T ss_pred CCCCcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCC------CCCCCeEEEE
Confidence 34456789999999999999999999999999999999997543 33456778888888774 7899999999
Q ss_pred eEecCeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccC-CCeE
Q 007035 485 FYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQ-RCEI 562 (621)
Q Consensus 485 f~~~~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~-~~~I 562 (621)
+.+.+..++||||+.+ +|.+.+.... .+++..++.++.||+.||.|||++||+||||||+|||++.+. .+.+
T Consensus 97 ~~~~~~~~lv~e~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~ 170 (362)
T 2bdw_A 97 IQEESFHYLVFDLVTGGELFEDIVARE------FYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAV 170 (362)
T ss_dssp EECSSEEEEEECCCCSCBHHHHHTTCS------CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCE
T ss_pred EEeCCEEEEEEecCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCE
Confidence 9999999999999985 7777665332 388999999999999999999999999999999999998633 3579
Q ss_pred EEEecCCccccCCC--ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 563 KIIDLGSSCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 563 KL~DFGls~~~~~~--~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|++||
T Consensus 171 kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf 230 (362)
T 2bdw_A 171 KLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPF 230 (362)
T ss_dssp EECCCTTCBCCTTCCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred EEeecCcceEecCCcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCC
Confidence 99999998765433 23467899999999999999999999999999999999999998
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=311.37 Aligned_cols=197 Identities=24% Similarity=0.414 Sum_probs=169.4
Q ss_pred eeecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc----hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEe
Q 007035 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYF 485 (621)
Q Consensus 410 ~ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f 485 (621)
.+..++|++++.||+|+||.||++++..+++.||+|++.... .....+.+|+.+++.+ .||||++++++|
T Consensus 11 ~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l------~hp~Iv~l~~~~ 84 (384)
T 4fr4_A 11 DVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGL------EHPFLVNLWYSF 84 (384)
T ss_dssp CCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC------CCTTBCCEEEEE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhC------CCCCCCcEEEEE
Confidence 345588999999999999999999999999999999997543 2335566777777765 478999999999
Q ss_pred EecCeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEE
Q 007035 486 YHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKI 564 (621)
Q Consensus 486 ~~~~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL 564 (621)
.+...+++||||+.+ +|..++.... .+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||
T Consensus 85 ~~~~~~~lv~e~~~gg~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~--~~g~vkL 156 (384)
T 4fr4_A 85 QDEEDMFMVVDLLLGGDLRYHLQQNV------HFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLD--EHGHVHI 156 (384)
T ss_dssp ECSSEEEEEECCCTTEEHHHHHHTTC------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC--TTSCEEE
T ss_pred EeCCEEEEEEecCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEC--CCCCEEE
Confidence 999999999999975 6666665322 289999999999999999999999999999999999998 4889999
Q ss_pred EecCCccccCC--CccccccCCcccCchhhcC---CCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 565 IDLGSSCFQTD--NLCLYVQSRSYRAPEVIIG---LPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 565 ~DFGls~~~~~--~~~~~~gt~~Y~APEvl~~---~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
+|||++..... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||
T Consensus 157 ~DFG~a~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf 217 (384)
T 4fr4_A 157 TDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPY 217 (384)
T ss_dssp CCCTTCEECCTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSS
T ss_pred eccceeeeccCCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCC
Confidence 99999976543 3445789999999999974 45899999999999999999999998
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-35 Score=297.95 Aligned_cols=193 Identities=30% Similarity=0.501 Sum_probs=163.1
Q ss_pred CceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCch---hhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCe
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD---FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~---~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~ 490 (621)
++|++++.||+|+||+||+|++ .+|+.||+|++..... ......+|+.+++.+ .||||+++++++...++
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l------~h~~iv~~~~~~~~~~~ 74 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKEL------KHSNIVKLYDVIHTKKR 74 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGC------CCTTBCCEEEEEECSSC
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhc------CCCCEeeeeeEEccCCe
Confidence 5899999999999999999998 7899999999875432 234556677666655 48899999999999999
Q ss_pred EEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCc
Q 007035 491 LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (621)
Q Consensus 491 l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls 570 (621)
.++||||+.++|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++
T Consensus 75 ~~lv~e~~~~~l~~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~--~~~~kl~Dfg~~ 147 (288)
T 1ob3_A 75 LVLVFEHLDQDLKKLLDVCEG-----GLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINR--EGELKIADFGLA 147 (288)
T ss_dssp EEEEEECCSEEHHHHHHTSTT-----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT--TSCEEECCTTHH
T ss_pred EEEEEEecCCCHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcC--CCCEEEeECccc
Confidence 999999999999888865432 2888999999999999999999999999999999999984 789999999998
Q ss_pred cccCCC---ccccccCCcccCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 571 CFQTDN---LCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 571 ~~~~~~---~~~~~gt~~Y~APEvl~~~-~~s~ksDIWSLGvILyELltG~~PF 620 (621)
...... .....+|+.|+|||++.+. .++.++|||||||++|+|++|++||
T Consensus 148 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf 201 (288)
T 1ob3_A 148 RAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLF 201 (288)
T ss_dssp HHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred cccCccccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 764432 2335679999999999764 5899999999999999999999998
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-35 Score=319.35 Aligned_cols=192 Identities=31% Similarity=0.515 Sum_probs=153.0
Q ss_pred eecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecC---chhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEe
Q 007035 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (621)
Q Consensus 411 ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~---~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~ 487 (621)
.+.++|++++.||+|+||+||+|+++.+++.||||++... .....++.+|+++++.++ ||||+++++++..
T Consensus 50 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~l~~~~~~ 123 (458)
T 3rp9_A 50 QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLN------HDHVVKVLDIVIP 123 (458)
T ss_dssp CSCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCC------CTTBCCEEEECCC
T ss_pred ccCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCC------CCCCCceEEEEec
Confidence 3458999999999999999999999999999999998653 234466778998888874 7899999999954
Q ss_pred c-----CeEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeE
Q 007035 488 L-----EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEI 562 (621)
Q Consensus 488 ~-----~~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~I 562 (621)
. ..+|+||||++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+||||+. ++.+
T Consensus 124 ~~~~~~~~~~lv~e~~~~~L~~~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~--~~~~ 195 (458)
T 3rp9_A 124 KDVEKFDELYVVLEIADSDFKKLFRTPV------YLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQ--DCSV 195 (458)
T ss_dssp SCTTTCCCEEEEECCCSEEHHHHHHSSC------CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECT--TCCE
T ss_pred CCcccCceEEEEEeccccchhhhcccCC------CCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECC--CCCE
Confidence 3 5799999999999988886432 2899999999999999999999999999999999999984 7899
Q ss_pred EEEecCCccccCC------------------------------CccccccCCcccCchhh-cCCCCCchhhHHHHHHHHH
Q 007035 563 KIIDLGSSCFQTD------------------------------NLCLYVQSRSYRAPEVI-IGLPYDQKIDLWSLGCILA 611 (621)
Q Consensus 563 KL~DFGls~~~~~------------------------------~~~~~~gt~~Y~APEvl-~~~~~s~ksDIWSLGvILy 611 (621)
||+|||++..... .....+||+.|+|||++ .+..++.++||||||||||
T Consensus 196 kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ 275 (458)
T 3rp9_A 196 KVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFA 275 (458)
T ss_dssp EECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHH
T ss_pred eecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHH
Confidence 9999999876431 12345779999999987 4556999999999999999
Q ss_pred HHHhC
Q 007035 612 ELWTG 616 (621)
Q Consensus 612 ELltG 616 (621)
||++|
T Consensus 276 elltg 280 (458)
T 3rp9_A 276 ELLNM 280 (458)
T ss_dssp HHHTT
T ss_pred HHHHh
Confidence 99993
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-34 Score=300.78 Aligned_cols=199 Identities=27% Similarity=0.419 Sum_probs=172.0
Q ss_pred eeecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCch-------hhhhHHHHHHHHHHhcccCCCCCCceEEEe
Q 007035 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD-------FFDQSLDEIKLLKLVNKNDPADEHHILRLY 482 (621)
Q Consensus 410 ~ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~-------~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~ 482 (621)
..+.++|++.+.||+|+||.||+|.+..+|+.||+|++..... ..+.+.+|+.+++.++ ||||++++
T Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~------hp~iv~~~ 80 (326)
T 2y0a_A 7 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ------HPNVITLH 80 (326)
T ss_dssp SCHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCC------CTTBCCEE
T ss_pred CCcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCC------CCCCCcEE
Confidence 3456789999999999999999999999999999999875432 2456788999988874 78999999
Q ss_pred eEeEecCeEEEEEeccc-cchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccC--C
Q 007035 483 DYFYHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQ--R 559 (621)
Q Consensus 483 ~~f~~~~~l~LVmEyl~-gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~--~ 559 (621)
+++.....+++||||+. ++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.+. .
T Consensus 81 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~ 154 (326)
T 2y0a_A 81 EVYENKTDVILILELVAGGELFDFLAEKE------SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPK 154 (326)
T ss_dssp EEEECSSEEEEEEECCCSCBHHHHHTTSS------CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSS
T ss_pred EEEEeCCEEEEEEEcCCCCCHHHHHHhcC------CcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCC
Confidence 99999999999999997 57777765322 289999999999999999999999999999999999998522 2
Q ss_pred CeEEEEecCCccccCC--CccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 560 CEIKIIDLGSSCFQTD--NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 560 ~~IKL~DFGls~~~~~--~~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
..+||+|||++..... ......+|+.|+|||++.+..++.++|||||||++|+|++|+.||
T Consensus 155 ~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf 217 (326)
T 2y0a_A 155 PRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217 (326)
T ss_dssp CCEEECCCTTCEECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSS
T ss_pred CCEEEEECCCCeECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCC
Confidence 2799999999876542 334467899999999999999999999999999999999999998
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=316.25 Aligned_cols=199 Identities=28% Similarity=0.436 Sum_probs=171.7
Q ss_pred eeecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc---hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeE
Q 007035 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (621)
Q Consensus 410 ~ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~---~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~ 486 (621)
..+.++|++.+.||+|+||+||+|.++.+|+.+|+|++.... .....+.+|+.+++.++ ||||+++++++.
T Consensus 7 ~~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~------hpnIv~l~~~~~ 80 (444)
T 3soa_A 7 TRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLK------HPNIVRLHDSIS 80 (444)
T ss_dssp CHHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCC------BTTBCCEEEEEE
T ss_pred ccccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCC------CcCCCeEEEEEE
Confidence 345688999999999999999999999999999999997643 23455778888888774 789999999999
Q ss_pred ecCeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEecc-CCCeEEE
Q 007035 487 HLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSY-QRCEIKI 564 (621)
Q Consensus 487 ~~~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~-~~~~IKL 564 (621)
+.+..++||||+.+ +|.+.+.... .+++..+..++.||+.||.|||++||+||||||+|||++.+ .++.+||
T Consensus 81 ~~~~~~lv~E~~~gg~L~~~i~~~~------~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL 154 (444)
T 3soa_A 81 EEGHHYLIFDLVTGGELFEDIVARE------YYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKL 154 (444)
T ss_dssp CSSEEEEEECCCBCCBHHHHHHHCS------CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEE
T ss_pred ECCEEEEEEEeCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEE
Confidence 99999999999985 7777776432 28999999999999999999999999999999999999854 3578999
Q ss_pred EecCCccccCCC---ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 565 IDLGSSCFQTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 565 ~DFGls~~~~~~---~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|++||
T Consensus 155 ~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf 213 (444)
T 3soa_A 155 ADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPF 213 (444)
T ss_dssp CCCSSCBCCCTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred ccCceeEEecCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCC
Confidence 999999765443 23467899999999999999999999999999999999999998
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-34 Score=298.32 Aligned_cols=202 Identities=27% Similarity=0.395 Sum_probs=162.7
Q ss_pred CeeecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEec
Q 007035 409 NTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (621)
Q Consensus 409 ~~ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~ 488 (621)
...+.++|++.+.||+|+||.||+|++..+++.||||+++....... .....+.+++.....+.||||+++++++...
T Consensus 7 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 84 (311)
T 3ork_A 7 PSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDP--SFYLRFRREAQNAAALNHPAIVAVYDTGEAE 84 (311)
T ss_dssp CSEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSH--HHHHHHHHHHTTCCCCCCTTBCCEEEEEEEE
T ss_pred cceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCH--HHHHHHHHHHHHHHcCCCCCcceEEEeeecc
Confidence 45678999999999999999999999999999999999986432111 1122344555555566899999999998865
Q ss_pred C----eEEEEEeccc-cchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEE
Q 007035 489 E----HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 563 (621)
Q Consensus 489 ~----~l~LVmEyl~-gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IK 563 (621)
. ..++||||+. ++|.+++.... .+++..++.++.||+.||.|||+++|+||||||+|||++. ++.+|
T Consensus 85 ~~~~~~~~lv~e~~~g~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~--~~~~k 156 (311)
T 3ork_A 85 TPAGPLPYIVMEYVDGVTLRDIVHTEG------PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISA--TNAVK 156 (311)
T ss_dssp ETTEEEEEEEEECCCEEEHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET--TSCEE
T ss_pred CCCCcccEEEEecCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcC--CCCEE
Confidence 4 4599999997 57777776432 2889999999999999999999999999999999999984 78899
Q ss_pred EEecCCccccCCC------ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 564 IIDLGSSCFQTDN------LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 564 L~DFGls~~~~~~------~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
|+|||++...... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||
T Consensus 157 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf 219 (311)
T 3ork_A 157 VMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPF 219 (311)
T ss_dssp ECCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSC
T ss_pred EeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCC
Confidence 9999998754332 22346899999999999999999999999999999999999998
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-34 Score=296.16 Aligned_cols=195 Identities=23% Similarity=0.405 Sum_probs=168.1
Q ss_pred cCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEec-CchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeE
Q 007035 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKN-DKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (621)
Q Consensus 413 ~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~-~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l 491 (621)
.++|++.+.||+|+||+||+|.+..+++.||+|++.. +....+.+.+|+.+++.+ .||||+++++++.+.+..
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l------~hp~iv~~~~~~~~~~~~ 82 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCL------EHPNVLKFIGVLYKDKRL 82 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTC------CCTTBCCEEEEEEETTEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhC------CCcCcccEEEEEecCCee
Confidence 5789999999999999999999999999999998865 334456677777777655 488999999999999999
Q ss_pred EEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCc
Q 007035 492 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (621)
Q Consensus 492 ~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls 570 (621)
++||||+.+ +|.+++..... .+++..+..++.||+.||.|||+++|+||||||+|||++ .++.+||+|||++
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~--~~~~~kl~Dfg~~ 155 (310)
T 3s95_A 83 NFITEYIKGGTLRGIIKSMDS-----QYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVR--ENKNVVVADFGLA 155 (310)
T ss_dssp EEEEECCTTCBHHHHHHHCCT-----TSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEC--TTSCEEECCCTTC
T ss_pred EEEEEecCCCcHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEEC--CCCCEEEeecccc
Confidence 999999975 77777764322 288999999999999999999999999999999999998 4788999999998
Q ss_pred cccCCCcc-----------------ccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 571 CFQTDNLC-----------------LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 571 ~~~~~~~~-----------------~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
........ ...||+.|+|||++.+..++.++||||||+++|+|++|..||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~ 222 (310)
T 3s95_A 156 RLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNAD 222 (310)
T ss_dssp EECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSS
T ss_pred eecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCC
Confidence 75433211 357899999999999999999999999999999999999886
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-34 Score=298.58 Aligned_cols=202 Identities=21% Similarity=0.365 Sum_probs=170.3
Q ss_pred eeecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc--hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEe
Q 007035 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (621)
Q Consensus 410 ~ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~ 487 (621)
.++.++|++.+.||+|+||+||+|++..+++.||||++.... ...+...+|+++++.++ ||||+++++++..
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~~~~~~ 78 (319)
T 4euu_A 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN------HKNIVKLFAIEEE 78 (319)
T ss_dssp ECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCC------CTTBCCEEEEEEC
T ss_pred cCCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcC------CCCcceEEEEeec
Confidence 456789999999999999999999999999999999997543 23456678888888874 7899999999987
Q ss_pred cC--eEEEEEeccc-cchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEec--cCCCeE
Q 007035 488 LE--HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS--YQRCEI 562 (621)
Q Consensus 488 ~~--~l~LVmEyl~-gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~--~~~~~I 562 (621)
.. +.++||||+. ++|.+++...... ..+++..++.++.||+.||.|||++||+||||||+|||+.. +..+.+
T Consensus 79 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~ 155 (319)
T 4euu_A 79 TTTRHKVLIMEFCPCGSLYTVLEEPSNA---YGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVY 155 (319)
T ss_dssp TTTCCEEEEEECCTTCBHHHHHHSGGGT---TCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEE
T ss_pred CCCceEEEEEeCCCCCCHHHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceE
Confidence 65 8899999997 5777777654322 12889999999999999999999999999999999999822 246789
Q ss_pred EEEecCCccccCCC--ccccccCCcccCchhhc--------CCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 563 KIIDLGSSCFQTDN--LCLYVQSRSYRAPEVII--------GLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 563 KL~DFGls~~~~~~--~~~~~gt~~Y~APEvl~--------~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
||+|||++...... .....+|+.|+|||++. +..++.++|||||||++|+|++|+.||
T Consensus 156 kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf 223 (319)
T 4euu_A 156 KLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPF 223 (319)
T ss_dssp EECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSE
T ss_pred EEccCCCceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 99999999765433 33457899999999986 567899999999999999999999998
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-34 Score=313.79 Aligned_cols=196 Identities=32% Similarity=0.514 Sum_probs=166.5
Q ss_pred eecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecC---chhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEe
Q 007035 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (621)
Q Consensus 411 ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~---~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~ 487 (621)
.+.++|++++.||+|+||.||+|+++.+++.||||++... .....++.+|+++++.++ ||||+++++++..
T Consensus 23 ~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~------h~nIv~l~~~~~~ 96 (432)
T 3n9x_A 23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLK------SDYIIRLYDLIIP 96 (432)
T ss_dssp CCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCC------CTTBCCEEEECCC
T ss_pred eecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcC------CCCcceEEEEEec
Confidence 4578999999999999999999999999999999999753 233456778888888874 7899999999987
Q ss_pred c-----CeEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeE
Q 007035 488 L-----EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEI 562 (621)
Q Consensus 488 ~-----~~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~I 562 (621)
. ..+|+||||++++|.+.+.... .+++..++.++.||+.||.|||+.||+||||||+|||++ .++.+
T Consensus 97 ~~~~~~~~~~lv~e~~~~~L~~~~~~~~------~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~--~~~~~ 168 (432)
T 3n9x_A 97 DDLLKFDELYIVLEIADSDLKKLFKTPI------FLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLN--QDCSV 168 (432)
T ss_dssp SCTTTCCCEEEEEECCSEEHHHHHHSSC------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC--TTCCE
T ss_pred CCCCcCCeEEEEEecCCcCHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEEC--CCCCE
Confidence 6 5799999999999988886432 289999999999999999999999999999999999998 47899
Q ss_pred EEEecCCccccCCC-------------------------ccccccCCcccCchhh-cCCCCCchhhHHHHHHHHHHHHhC
Q 007035 563 KIIDLGSSCFQTDN-------------------------LCLYVQSRSYRAPEVI-IGLPYDQKIDLWSLGCILAELWTG 616 (621)
Q Consensus 563 KL~DFGls~~~~~~-------------------------~~~~~gt~~Y~APEvl-~~~~~s~ksDIWSLGvILyELltG 616 (621)
||+|||++...... ....++|+.|+|||++ ....++.++|||||||+||||++|
T Consensus 169 kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g 248 (432)
T 3n9x_A 169 KVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNM 248 (432)
T ss_dssp EECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTT
T ss_pred EEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhc
Confidence 99999998764322 2456889999999997 455699999999999999999986
Q ss_pred CCCC
Q 007035 617 EVCL 620 (621)
Q Consensus 617 ~~PF 620 (621)
..||
T Consensus 249 ~~p~ 252 (432)
T 3n9x_A 249 LQSH 252 (432)
T ss_dssp CTTT
T ss_pred cccc
Confidence 5554
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-34 Score=302.00 Aligned_cols=196 Identities=29% Similarity=0.413 Sum_probs=166.2
Q ss_pred eecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecC---chhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEe
Q 007035 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (621)
Q Consensus 411 ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~---~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~ 487 (621)
+..++|++++.||+|+||.||++.+ .+++.||||++... ....+.+.+|+.+++.+++. ||||+++++++..
T Consensus 6 ~~~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~----~~~iv~~~~~~~~ 80 (343)
T 3dbq_A 6 VKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH----SDKIIRLYDYEIT 80 (343)
T ss_dssp SSSCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTT----CTTBCCEEEEEEC
T ss_pred eecCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhc----CCceEEEeeeEee
Confidence 3467899999999999999999997 56899999998753 23346678899999999752 4799999999999
Q ss_pred cCeEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEec
Q 007035 488 LEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 567 (621)
Q Consensus 488 ~~~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DF 567 (621)
..++++|||+.+++|.+++.... .+++..++.++.||+.||.|||+++|+||||||+|||++ ++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~---~~~~kl~DF 151 (343)
T 3dbq_A 81 DQYIYMVMECGNIDLNSWLKKKK------SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV---DGMLKLIDF 151 (343)
T ss_dssp SSEEEEEECCCSEEHHHHHHHSC------CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE---TTEEEECCC
T ss_pred CCEEEEEEeCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE---CCcEEEeec
Confidence 99999999988889999887543 288899999999999999999999999999999999997 678999999
Q ss_pred CCccccCCC-----ccccccCCcccCchhhcC-----------CCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 568 GSSCFQTDN-----LCLYVQSRSYRAPEVIIG-----------LPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 568 Gls~~~~~~-----~~~~~gt~~Y~APEvl~~-----------~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
|++...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||
T Consensus 152 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf 220 (343)
T 3dbq_A 152 GIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 220 (343)
T ss_dssp SSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred ccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcc
Confidence 998765432 224578999999999965 56899999999999999999999998
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-34 Score=304.99 Aligned_cols=194 Identities=35% Similarity=0.597 Sum_probs=161.5
Q ss_pred eecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecC---chhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEe
Q 007035 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (621)
Q Consensus 411 ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~---~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~ 487 (621)
.+.++|++++.||+|+||.||+|.+..+++.||||++... ......+.+|+.+++.+ .||||+++++++..
T Consensus 22 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l------~hpniv~~~~~~~~ 95 (371)
T 2xrw_A 22 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCV------NHKNIIGLLNVFTP 95 (371)
T ss_dssp EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHC------CCTTBCCEEEEECS
T ss_pred chhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhc------CCCCccceEEeecc
Confidence 3568999999999999999999999999999999999753 23345667788888776 37899999999986
Q ss_pred cC------eEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCe
Q 007035 488 LE------HLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCE 561 (621)
Q Consensus 488 ~~------~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~ 561 (621)
.. ..++||||++++|.+.+.. .+++..++.++.||+.||.|||++||+||||||+|||++. ++.
T Consensus 96 ~~~~~~~~~~~lv~e~~~~~l~~~~~~--------~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~--~~~ 165 (371)
T 2xrw_A 96 QKSLEEFQDVYIVMELMDANLCQVIQM--------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS--DCT 165 (371)
T ss_dssp CCSTTTCCEEEEEEECCSEEHHHHHHS--------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT--TSC
T ss_pred ccccccccceEEEEEcCCCCHHHHHhh--------ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcC--CCC
Confidence 64 7999999999998887742 1788999999999999999999999999999999999984 789
Q ss_pred EEEEecCCccccCCC--ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 562 IKIIDLGSSCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 562 IKL~DFGls~~~~~~--~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
+||+|||++...... .....+|+.|+|||++.+..++.++|||||||++|+|++|+.||
T Consensus 166 ~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf 226 (371)
T 2xrw_A 166 LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLF 226 (371)
T ss_dssp EEECCCCC----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSS
T ss_pred EEEEEeecccccccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCC
Confidence 999999998765433 33457899999999999999999999999999999999999998
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-34 Score=307.24 Aligned_cols=194 Identities=35% Similarity=0.620 Sum_probs=165.2
Q ss_pred ecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecC---chhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEec
Q 007035 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (621)
Q Consensus 412 i~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~---~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~ 488 (621)
+.++|++++.||+|+||.||+|.+..+|+.||||++... .....++.+|+++++.++ ||||+++++++...
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~------hpnIv~l~~~~~~~ 96 (367)
T 1cm8_A 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMR------HENVIGLLDVFTPD 96 (367)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCC------BTTBCCCSEEECSC
T ss_pred ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCC------CcCCCCceeeEecC
Confidence 467899999999999999999999999999999998642 233456778888888774 78999999999865
Q ss_pred C------eEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeE
Q 007035 489 E------HLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEI 562 (621)
Q Consensus 489 ~------~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~I 562 (621)
. .+++||||++++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+
T Consensus 97 ~~~~~~~~~~lv~e~~~~~L~~~~~~~-------~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~--~~~~ 167 (367)
T 1cm8_A 97 ETLDDFTDFYLVMPFMGTDLGKLMKHE-------KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNE--DCEL 167 (367)
T ss_dssp SSTTTCCCCEEEEECCSEEHHHHHHHC-------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT--TCCE
T ss_pred CccccCceEEEEEecCCCCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcC--CCCE
Confidence 3 46999999988888877642 2889999999999999999999999999999999999984 7899
Q ss_pred EEEecCCccccCCCccccccCCcccCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 563 KIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 563 KL~DFGls~~~~~~~~~~~gt~~Y~APEvl~~-~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
||+|||++...........+|+.|+|||++.+ ..++.++|||||||++|+|++|++||
T Consensus 168 kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf 226 (367)
T 1cm8_A 168 KILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLF 226 (367)
T ss_dssp EECCCTTCEECCSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSS
T ss_pred EEEeeecccccccccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCC
Confidence 99999999887766667788999999999987 67999999999999999999999998
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=307.54 Aligned_cols=196 Identities=14% Similarity=0.166 Sum_probs=157.1
Q ss_pred CceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc----hhhhhHHHHHHHHHHhcccCCCCCCceEEEe-------
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLY------- 482 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~------- 482 (621)
.+|++.+.||+|+||+||+|++..+|+.||||++.... .....+.+|+.+++.++. .||||++++
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~----~hp~iv~~~~~~~~p~ 137 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG----ESPEEARDRRRLLLPS 137 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC--------------CBCCCC
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc----cChhhhhhceeEEeee
Confidence 45999999999999999999999999999999998743 345566778777888864 589988765
Q ss_pred eEeEec-----------------CeEEEEEeccccchHHHHHhhhccCCCccccHHHH------HHHHHHHHHHHHHHHH
Q 007035 483 DYFYHL-----------------EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRL------QVITRQCLEALEYLHS 539 (621)
Q Consensus 483 ~~f~~~-----------------~~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i------~~I~~qIl~aL~yLHs 539 (621)
+++... .+++|||||++++|.+++...... +....+ ..++.||+.||.|||+
T Consensus 138 d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~-----~~~~~~~~~~vk~~i~~qi~~aL~~LH~ 212 (371)
T 3q60_A 138 DAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFV-----YVFRGDEGILALHILTAQLIRLAANLQS 212 (371)
T ss_dssp EEEEETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHHS-----CCCCHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred hheecCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhccc-----cchhhhhhhhhHHHHHHHHHHHHHHHHH
Confidence 344322 348999999999999998865432 333334 5677999999999999
Q ss_pred CCeecccCCCccEEEeccCCCeEEEEecCCccccCCCccccccCCcccCchhhcC--CCCCchhhHHHHHHHHHHHHhCC
Q 007035 540 LGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIG--LPYDQKIDLWSLGCILAELWTGE 617 (621)
Q Consensus 540 ~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~~~~~~~~~~~gt~~Y~APEvl~~--~~~s~ksDIWSLGvILyELltG~ 617 (621)
+||+||||||+|||++. ++.+||+|||++...........+|+.|+|||++.+ ..++.++|||||||+||+|++|+
T Consensus 213 ~~ivHrDikp~NIll~~--~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~ 290 (371)
T 3q60_A 213 KGLVHGHFTPDNLFIMP--DGRLMLGDVSALWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290 (371)
T ss_dssp TTEEETTCSGGGEEECT--TSCEEECCGGGEEETTCEEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSS
T ss_pred CCCccCcCCHHHEEECC--CCCEEEEecceeeecCCCccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCC
Confidence 99999999999999984 788999999999877665545667799999999987 67999999999999999999999
Q ss_pred CCC
Q 007035 618 VCL 620 (621)
Q Consensus 618 ~PF 620 (621)
.||
T Consensus 291 ~Pf 293 (371)
T 3q60_A 291 LPF 293 (371)
T ss_dssp CST
T ss_pred CCC
Confidence 998
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-35 Score=313.35 Aligned_cols=202 Identities=17% Similarity=0.268 Sum_probs=168.8
Q ss_pred cCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecC----chhhhhHHHHHHHHHHhcccCCCCCCceEEEe------
Q 007035 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHHILRLY------ 482 (621)
Q Consensus 413 ~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~----~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~------ 482 (621)
.++|++.+.||+|+||+||+|+++.+|+.||||++... ....+.+.+|+.+++.+. .+.||||++++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~---~l~hpniv~~~~~~~~~ 148 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLR---GIKNQKQAKVHLRFIFP 148 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGST---TCCSHHHHHHHHCBCCC
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhcc---ccCCHHHHHHHhhhhhh
Confidence 47899999999999999999999999999999998742 234456677776666554 45799999998
Q ss_pred -eEeEecC-----------------eEEEEEeccccchHHHHHhhhccCC-CccccHHHHHHHHHHHHHHHHHHHHCCee
Q 007035 483 -DYFYHLE-----------------HLFIVCELLRANLYEFQKFNQESGG-EAYFTLGRLQVITRQCLEALEYLHSLGII 543 (621)
Q Consensus 483 -~~f~~~~-----------------~l~LVmEyl~gsLld~l~~~~~~~~-~~~ls~~~i~~I~~qIl~aL~yLHs~gIv 543 (621)
+++...+ ..+|||||++|+|.+++........ ...+++..++.++.||+.||.|||++||+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iv 228 (377)
T 3byv_A 149 FDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLV 228 (377)
T ss_dssp SEEEECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred hhhhhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCee
Confidence 6655443 3899999999999998876543211 23355688888999999999999999999
Q ss_pred cccCCCccEEEeccCCCeEEEEecCCccccCCCccccccCCcccCchhhcCC-----------CCCchhhHHHHHHHHHH
Q 007035 544 HCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGL-----------PYDQKIDLWSLGCILAE 612 (621)
Q Consensus 544 HrDLKP~NILl~~~~~~~IKL~DFGls~~~~~~~~~~~gt~~Y~APEvl~~~-----------~~s~ksDIWSLGvILyE 612 (621)
||||||+|||++. ++.+||+|||++...........| +.|+|||++.+. .++.++|||||||+||+
T Consensus 229 HrDikp~NIll~~--~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~e 305 (377)
T 3byv_A 229 HTYLRPVDIVLDQ--RGGVFLTGFEHLVRDGARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYW 305 (377)
T ss_dssp CSCCCGGGEEECT--TCCEEECCGGGCEETTCEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHH
T ss_pred cCCCCHHHEEEcC--CCCEEEEechhheecCCcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHH
Confidence 9999999999994 789999999999876666666677 999999999887 79999999999999999
Q ss_pred HHhCCCCC
Q 007035 613 LWTGEVCL 620 (621)
Q Consensus 613 LltG~~PF 620 (621)
|++|+.||
T Consensus 306 lltg~~Pf 313 (377)
T 3byv_A 306 IWCADLPI 313 (377)
T ss_dssp HHHSSCCC
T ss_pred HHHCCCCC
Confidence 99999998
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=302.04 Aligned_cols=200 Identities=25% Similarity=0.431 Sum_probs=163.2
Q ss_pred CeeecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCch---hhhhHHHHHHHHHHhcccCCCCCCceEEEeeEe
Q 007035 409 NTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD---FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYF 485 (621)
Q Consensus 409 ~~ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~---~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f 485 (621)
.....++|++++.||+|+||+||+|++..+++.||||+++.... ....+.+|+.+++.+ .||||+++++++
T Consensus 29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l------~h~~iv~~~~~~ 102 (329)
T 3gbz_A 29 SATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKEL------QHRNIIELKSVI 102 (329)
T ss_dssp ---CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGC------CCTTBCCEEEEE
T ss_pred cccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHc------CCCCcceEEEEE
Confidence 34556899999999999999999999999999999999975432 233455677776655 478999999999
Q ss_pred EecCeEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEecc---CCCeE
Q 007035 486 YHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSY---QRCEI 562 (621)
Q Consensus 486 ~~~~~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~---~~~~I 562 (621)
...+.+++||||++++|.+++..... +++..++.++.||+.||.|||+++|+||||||+|||++.+ ..+.+
T Consensus 103 ~~~~~~~lv~e~~~~~L~~~~~~~~~------~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~ 176 (329)
T 3gbz_A 103 HHNHRLHLIFEYAENDLKKYMDKNPD------VSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVL 176 (329)
T ss_dssp EETTEEEEEEECCSEEHHHHHHHCTT------CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEE
T ss_pred ecCCEEEEEEecCCCCHHHHHhhcCC------CCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceE
Confidence 99999999999999999988875432 8899999999999999999999999999999999999631 35679
Q ss_pred EEEecCCccccCC---CccccccCCcccCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 563 KIIDLGSSCFQTD---NLCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 563 KL~DFGls~~~~~---~~~~~~gt~~Y~APEvl~~~-~~s~ksDIWSLGvILyELltG~~PF 620 (621)
||+|||++..... ......+|+.|+|||++.+. .++.++|||||||++|+|++|+.||
T Consensus 177 kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf 238 (329)
T 3gbz_A 177 KIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLF 238 (329)
T ss_dssp EECCTTHHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred EECcCCCccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCc
Confidence 9999999876442 23345679999999999875 4899999999999999999999998
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-34 Score=299.39 Aligned_cols=196 Identities=25% Similarity=0.383 Sum_probs=162.1
Q ss_pred eecCceEEEEEeccCCCCceeEEEeC---CCCcEEEEEEEecCc-----hhhhhHHHHHHHHHHhcccCCCCCCceEEEe
Q 007035 411 VIAGRYYVTEYLGSAAFSKVFQAQDL---HTGVDVCLKIIKNDK-----DFFDQSLDEIKLLKLVNKNDPADEHHILRLY 482 (621)
Q Consensus 411 ii~~rY~I~~~LG~G~fG~Vyka~d~---~tg~~VAlKii~~~~-----~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~ 482 (621)
+..++|++++.||+|+||.||++++. .+|+.||+|++++.. .......+|+.+++.++ ||||++++
T Consensus 14 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~------hp~iv~~~ 87 (327)
T 3a62_A 14 IRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVK------HPFIVDLI 87 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCC------CTTBCCEE
T ss_pred CCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCC------CCCcccee
Confidence 44678999999999999999999985 689999999997642 22345667888888774 78999999
Q ss_pred eEeEecCeEEEEEeccc-cchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCe
Q 007035 483 DYFYHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCE 561 (621)
Q Consensus 483 ~~f~~~~~l~LVmEyl~-gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~ 561 (621)
+++...+++++||||+. ++|.+.+.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.
T Consensus 88 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~--~~~ 159 (327)
T 3a62_A 88 YAFQTGGKLYLILEYLSGGELFMQLEREG------IFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNH--QGH 159 (327)
T ss_dssp EEEECSSCEEEEEECCTTEEHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECT--TSC
T ss_pred EEEEcCCEEEEEEeCCCCCcHHHHHHhCC------CCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECC--CCc
Confidence 99999999999999997 57777765432 2788999999999999999999999999999999999984 789
Q ss_pred EEEEecCCccccCC---CccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 562 IKIIDLGSSCFQTD---NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 562 IKL~DFGls~~~~~---~~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
+||+|||++..... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||
T Consensus 160 ~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf 221 (327)
T 3a62_A 160 VKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPF 221 (327)
T ss_dssp EEECCCSCC----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred EEEEeCCcccccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCC
Confidence 99999999865322 233457899999999999999999999999999999999999998
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-34 Score=289.53 Aligned_cols=199 Identities=24% Similarity=0.329 Sum_probs=165.3
Q ss_pred eecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCe
Q 007035 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (621)
Q Consensus 411 ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~ 490 (621)
.+.++|++.+.||+|+||+||+|++..+++.||+|++..... ...+.+|+.+++.+++. +++..+..++.....
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~e~~~l~~l~~~-----~~i~~~~~~~~~~~~ 79 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGG-----VGIPTIRWCGAEGDY 79 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC----CCCHHHHHHHHHHHTTS-----TTCCCEEEEEEETTE
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc-chHHHHHHHHHHHhcCC-----CCCCeeeeecCCCCc
Confidence 456899999999999999999999999999999998765433 35678899999998753 356666666678889
Q ss_pred EEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEec-cCCCeEEEEecCC
Q 007035 491 LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS-YQRCEIKIIDLGS 569 (621)
Q Consensus 491 l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~-~~~~~IKL~DFGl 569 (621)
.++||||++++|.+++..... .+++..++.++.||+.||.|||+++|+||||||+|||++. +..+.+||+|||+
T Consensus 80 ~~lv~e~~~~~L~~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~ 154 (296)
T 4hgt_A 80 NVMVMELLGPSLEDLFNFCSR-----KFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGL 154 (296)
T ss_dssp EEEEEECCCCBHHHHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTT
T ss_pred eEEEEEccCCCHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCcc
Confidence 999999998899888864432 2889999999999999999999999999999999999931 1478899999999
Q ss_pred ccccCCC----------ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 570 SCFQTDN----------LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 570 s~~~~~~----------~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
+...... .....+|+.|+|||++.+..++.++|||||||++|+|++|+.||
T Consensus 155 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf 215 (296)
T 4hgt_A 155 AKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPW 215 (296)
T ss_dssp CEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred ceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCC
Confidence 8764432 12457899999999999999999999999999999999999998
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-34 Score=302.08 Aligned_cols=203 Identities=18% Similarity=0.235 Sum_probs=162.1
Q ss_pred CeeecCceEEEEEeccCCCCceeEEEeCC---CCcEEEEEEEecCchhhhhHHHHHHHHHHh---------cccCCCCCC
Q 007035 409 NTVIAGRYYVTEYLGSAAFSKVFQAQDLH---TGVDVCLKIIKNDKDFFDQSLDEIKLLKLV---------NKNDPADEH 476 (621)
Q Consensus 409 ~~ii~~rY~I~~~LG~G~fG~Vyka~d~~---tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l---------~~~~~~~hp 476 (621)
.++..++|++.+.||+|+||+||+|.+.. ++..+|+|++..... ....|+.+++.+ .......||
T Consensus 32 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~---~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ 108 (345)
T 2v62_A 32 DDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENG---PLFSELKFYQRVAKKDCIKKWIERKQLDYL 108 (345)
T ss_dssp ECTTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-C---HHHHHHHHHHHHCCHHHHHHHHHHHTCSCC
T ss_pred ccccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCc---chHHHHHHHHHHhhhHHHHHHHhhcccccc
Confidence 44456799999999999999999999987 889999999886542 223334333333 223345799
Q ss_pred ceEEEeeEeEe----cCeEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccE
Q 007035 477 HILRLYDYFYH----LEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENI 552 (621)
Q Consensus 477 nIvrl~~~f~~----~~~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NI 552 (621)
||+++++++.. ..+.++||||++++|.+++.... .+++..++.++.||+.||.|||+++|+||||||+||
T Consensus 109 ni~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NI 182 (345)
T 2v62_A 109 GIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNG------TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANL 182 (345)
T ss_dssp CCCCEEEEEEEESSSCEEEEEEEECEEEEHHHHCBGGG------BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred CcceeecccccccCCCcEEEEEEeccCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHE
Confidence 99999999998 78999999999778888776443 289999999999999999999999999999999999
Q ss_pred EEeccCCCeEEEEecCCccccCCC----------ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 553 LIKSYQRCEIKIIDLGSSCFQTDN----------LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 553 Ll~~~~~~~IKL~DFGls~~~~~~----------~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
|++.+..+.+||+|||++...... .....+|+.|+|||++.+..++.++|||||||++|+|++|+.||
T Consensus 183 ll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf 260 (345)
T 2v62_A 183 LLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPW 260 (345)
T ss_dssp EEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred EEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence 999644459999999998654221 13457899999999999999999999999999999999999998
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-34 Score=298.57 Aligned_cols=195 Identities=29% Similarity=0.500 Sum_probs=167.2
Q ss_pred cCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc---hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEe--
Q 007035 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH-- 487 (621)
Q Consensus 413 ~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~---~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~-- 487 (621)
.++|++++.||+|+||+||+|++..+|+.||+|++.... .......+|+.+++.++ ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~~~~~~~~ 89 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLK------HENVVNLIEICRTKA 89 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCC------CTTBCCEEEEEEEC-
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhcc------CCCcccHhheeeccc
Confidence 478999999999999999999999999999999986532 22346678888888874 7899999999987
Q ss_pred ------cCeEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCe
Q 007035 488 ------LEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCE 561 (621)
Q Consensus 488 ------~~~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~ 561 (621)
.+.+++||||+++++.+.+..... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.
T Consensus 90 ~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~--~~~ 162 (351)
T 3mi9_A 90 SPYNRCKGSIYLVFDFCEHDLAGLLSNVLV-----KFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITR--DGV 162 (351)
T ss_dssp -------CEEEEEEECCSEEHHHHHHCTTS-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT--TSC
T ss_pred cccccCCceEEEEEeccCCCHHHHHhhccC-----CCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcC--CCC
Confidence 457999999999998888765432 2889999999999999999999999999999999999984 789
Q ss_pred EEEEecCCccccCC-------CccccccCCcccCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 562 IKIIDLGSSCFQTD-------NLCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 562 IKL~DFGls~~~~~-------~~~~~~gt~~Y~APEvl~~~-~~s~ksDIWSLGvILyELltG~~PF 620 (621)
+||+|||++..... ......+|+.|+|||++.+. .++.++|||||||++|+|++|++||
T Consensus 163 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf 229 (351)
T 3mi9_A 163 LKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIM 229 (351)
T ss_dssp EEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred EEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCC
Confidence 99999999865431 22335679999999999764 5899999999999999999999998
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-34 Score=305.00 Aligned_cols=198 Identities=32% Similarity=0.584 Sum_probs=165.3
Q ss_pred eecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEe---
Q 007035 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH--- 487 (621)
Q Consensus 411 ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~--- 487 (621)
...++|++.+.||+|+||+||+|++..+|+.||||++..+... ..+|+.+++.+ .||||++++++|..
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~---~~~E~~il~~l------~hpnIv~l~~~~~~~~~ 74 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY---KNRELDIMKVL------DHVNIIKLVDYFYTTGD 74 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS---CCHHHHHHTTC------CCTTBCCEEEEEEEC--
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch---HHHHHHHHHHc------CCCCccchhheeeecCc
Confidence 3467899999999999999999999999999999999765432 33677777655 58899999999854
Q ss_pred -----------------------------------cCeEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHH
Q 007035 488 -----------------------------------LEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLE 532 (621)
Q Consensus 488 -----------------------------------~~~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~ 532 (621)
..++++||||++++|.+.+....... ..+++..++.++.||+.
T Consensus 75 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~--~~l~~~~~~~i~~qi~~ 152 (383)
T 3eb0_A 75 EEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSG--RSIPMNLISIYIYQLFR 152 (383)
T ss_dssp -----------------------------------CCEEEEEECCCSEEHHHHHHHHHHTT--CCCCHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcC--CCCCHHHHHHHHHHHHH
Confidence 34589999999998887776432222 23889999999999999
Q ss_pred HHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCccccCC--CccccccCCcccCchhhcCCC-CCchhhHHHHHHH
Q 007035 533 ALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTD--NLCLYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCI 609 (621)
Q Consensus 533 aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~~~~~--~~~~~~gt~~Y~APEvl~~~~-~s~ksDIWSLGvI 609 (621)
||.|||++||+||||||+|||++. .++.+||+|||++..... ......+|+.|+|||++.+.. ++.++|||||||+
T Consensus 153 aL~~LH~~gi~H~Dikp~Nil~~~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 231 (383)
T 3eb0_A 153 AVGFIHSLGICHRDIKPQNLLVNS-KDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV 231 (383)
T ss_dssp HHHHHHTTTEECSCCCGGGEEEET-TTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred HHHHHHHCcCccCccCHHHEEEcC-CCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence 999999999999999999999974 478999999999975432 344467899999999998754 8999999999999
Q ss_pred HHHHHhCCCCC
Q 007035 610 LAELWTGEVCL 620 (621)
Q Consensus 610 LyELltG~~PF 620 (621)
+|+|++|++||
T Consensus 232 l~ell~g~~pf 242 (383)
T 3eb0_A 232 FGELILGKPLF 242 (383)
T ss_dssp HHHHHHSSCSS
T ss_pred HHHHHhCCCCC
Confidence 99999999998
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-34 Score=294.71 Aligned_cols=195 Identities=25% Similarity=0.403 Sum_probs=160.8
Q ss_pred eecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCch---------------------------hhhhHHHHHHH
Q 007035 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD---------------------------FFDQSLDEIKL 463 (621)
Q Consensus 411 ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~---------------------------~~~~~~~Ei~i 463 (621)
+..++|++.+.||+|+||.||+|++..+++.||||++..... ..+.+.+|+.+
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 89 (298)
T 2zv2_A 10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI 89 (298)
T ss_dssp CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence 345789999999999999999999999999999999875431 12456778877
Q ss_pred HHHhcccCCCCCCceEEEeeEeEe--cCeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHC
Q 007035 464 LKLVNKNDPADEHHILRLYDYFYH--LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSL 540 (621)
Q Consensus 464 L~~l~~~~~~~hpnIvrl~~~f~~--~~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~ 540 (621)
++.+ .||||+++++++.. ..++++||||+++ +|.++.. ...+++..++.++.||+.||.|||++
T Consensus 90 l~~l------~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-------~~~~~~~~~~~~~~qi~~~l~~lH~~ 156 (298)
T 2zv2_A 90 LKKL------DHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-------LKPLSEDQARFYFQDLIKGIEYLHYQ 156 (298)
T ss_dssp HHTC------CCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-------SSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHhC------CCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-------cCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 7766 47899999999987 5789999999985 4433211 12389999999999999999999999
Q ss_pred CeecccCCCccEEEeccCCCeEEEEecCCccccCCC---ccccccCCcccCchhhcCCC---CCchhhHHHHHHHHHHHH
Q 007035 541 GIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN---LCLYVQSRSYRAPEVIIGLP---YDQKIDLWSLGCILAELW 614 (621)
Q Consensus 541 gIvHrDLKP~NILl~~~~~~~IKL~DFGls~~~~~~---~~~~~gt~~Y~APEvl~~~~---~s~ksDIWSLGvILyELl 614 (621)
||+||||||+|||++. ++.+||+|||++...... .....+|+.|+|||++.+.. ++.++|||||||++|+|+
T Consensus 157 ~ivH~Dlkp~Nil~~~--~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~ 234 (298)
T 2zv2_A 157 KIIHRDIKPSNLLVGE--DGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFV 234 (298)
T ss_dssp TEECCCCCGGGEEECT--TSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHH
T ss_pred CeeccCCCHHHEEECC--CCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHH
Confidence 9999999999999984 789999999998765433 23457899999999998765 377899999999999999
Q ss_pred hCCCCC
Q 007035 615 TGEVCL 620 (621)
Q Consensus 615 tG~~PF 620 (621)
+|+.||
T Consensus 235 ~g~~pf 240 (298)
T 2zv2_A 235 FGQCPF 240 (298)
T ss_dssp HSSCSS
T ss_pred HCCCCC
Confidence 999998
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-34 Score=290.49 Aligned_cols=203 Identities=27% Similarity=0.337 Sum_probs=155.8
Q ss_pred eecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCe
Q 007035 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (621)
Q Consensus 411 ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~ 490 (621)
+..++|++++.||+|+||+||+|++..+|+.||+|+++.............+.... .....||||+++++++...++
T Consensus 4 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~---~~~~~h~~iv~~~~~~~~~~~ 80 (290)
T 3fme_A 4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDIS---MRTVDCPFTVTFYGALFREGD 80 (290)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHH---HTTCCCTTBCCEEEEEECSSS
T ss_pred ccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHH---HHhCCCCeEEEEeeeeeccCC
Confidence 45689999999999999999999999999999999997643222211111111111 234579999999999999999
Q ss_pred EEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHC-CeecccCCCccEEEeccCCCeEEEEecCC
Q 007035 491 LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSL-GIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (621)
Q Consensus 491 l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~-gIvHrDLKP~NILl~~~~~~~IKL~DFGl 569 (621)
.++||||+++++.+++....... ..+++..++.++.||+.||.|||++ ||+||||||+|||++. ++.+||+|||+
T Consensus 81 ~~lv~e~~~~~l~~~l~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~--~~~~kl~Dfg~ 156 (290)
T 3fme_A 81 VWICMELMDTSLDKFYKQVIDKG--QTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINA--LGQVKMCDFGI 156 (290)
T ss_dssp EEEEEECCSEEHHHHHHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECT--TCCEEBCCC--
T ss_pred EEEEEehhccchHHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECC--CCCEEEeecCC
Confidence 99999999999888776533222 2389999999999999999999998 9999999999999984 78999999999
Q ss_pred ccccCCC--ccccccCCcccCchhh----cCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 570 SCFQTDN--LCLYVQSRSYRAPEVI----IGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 570 s~~~~~~--~~~~~gt~~Y~APEvl----~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
+...... .....+|+.|+|||++ .+..++.++||||||+++|+|++|+.||
T Consensus 157 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~ 213 (290)
T 3fme_A 157 SGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPY 213 (290)
T ss_dssp -------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSS
T ss_pred cccccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCc
Confidence 8765433 2234789999999996 4557899999999999999999999998
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=301.73 Aligned_cols=194 Identities=28% Similarity=0.459 Sum_probs=161.5
Q ss_pred CceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchh--hhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeE
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDF--FDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~--~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l 491 (621)
++|++++.||+|+||+||+|++..+++.||+|++...... .....+|+.+++.+ .||||+++++++...+..
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l------~h~~iv~~~~~~~~~~~~ 75 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDL------KHANIVTLHDIIHTEKSL 75 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCC------CCTTBCCEEEEEECSSCE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhc------CCCCCCeeeeEEeeCCEE
Confidence 5799999999999999999999999999999998754321 12344567666554 478999999999999999
Q ss_pred EEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCcc
Q 007035 492 FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 571 (621)
Q Consensus 492 ~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~ 571 (621)
++||||++++|.+.+..... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++.
T Consensus 76 ~lv~e~~~~~l~~~~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~--~~~~kl~Dfg~a~ 148 (324)
T 3mtl_A 76 TLVFEYLDKDLKQYLDDCGN-----IINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINE--RGELKLADFGLAR 148 (324)
T ss_dssp EEEEECCSEEHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECT--TCCEEECSSSEEE
T ss_pred EEEecccccCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECC--CCCEEEccCcccc
Confidence 99999999999988875432 2889999999999999999999999999999999999984 7889999999986
Q ss_pred ccCCC---ccccccCCcccCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 572 FQTDN---LCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 572 ~~~~~---~~~~~gt~~Y~APEvl~~-~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
..... .....+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||
T Consensus 149 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf 201 (324)
T 3mtl_A 149 AKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLF 201 (324)
T ss_dssp CC------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred cccCCccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 54432 233467999999999987 56899999999999999999999998
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-34 Score=301.70 Aligned_cols=195 Identities=25% Similarity=0.393 Sum_probs=166.0
Q ss_pred ecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc--hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecC
Q 007035 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (621)
Q Consensus 412 i~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~ 489 (621)
+.++|++++.||+|+||+||+|++..+++.||+|++.... ...+.+.+|+.+++.++ ||||+++++++...+
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~------hpnIv~~~~~~~~~~ 78 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN------HENVVKFYGHRREGN 78 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCC------CTTBCCEEEEEECSS
T ss_pred HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCC------CCCCCeEEEEEecCC
Confidence 4578999999999999999999999999999999987543 23356778888888774 789999999999999
Q ss_pred eEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecC
Q 007035 490 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (621)
Q Consensus 490 ~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFG 568 (621)
..++||||+.+ +|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~--~~~~~kl~Dfg 150 (323)
T 3tki_A 79 IQYLFLEYCSGGELFDRIEPD------IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLD--ERDNLKISDFG 150 (323)
T ss_dssp EEEEEEECCTTEEGGGGSBTT------TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--TTCCEEECCCT
T ss_pred eEEEEEEcCCCCcHHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEe--CCCCEEEEEee
Confidence 99999999975 666655432 2288999999999999999999999999999999999998 47889999999
Q ss_pred CccccCC-----CccccccCCcccCchhhcCCCC-CchhhHHHHHHHHHHHHhCCCCC
Q 007035 569 SSCFQTD-----NLCLYVQSRSYRAPEVIIGLPY-DQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 569 ls~~~~~-----~~~~~~gt~~Y~APEvl~~~~~-s~ksDIWSLGvILyELltG~~PF 620 (621)
++..... ......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||
T Consensus 151 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf 208 (323)
T 3tki_A 151 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW 208 (323)
T ss_dssp TCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSC
T ss_pred ccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCC
Confidence 9865322 2234578999999999988775 77899999999999999999998
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-33 Score=292.00 Aligned_cols=195 Identities=29% Similarity=0.464 Sum_probs=162.8
Q ss_pred cCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc---hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecC
Q 007035 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (621)
Q Consensus 413 ~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~---~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~ 489 (621)
.++|++++.||+|+||+||+|++..+|+.||+|++.... .......+|+.+++.++ ||||+++++++...+
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~------h~~i~~~~~~~~~~~ 75 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLK------HPNLVNLLEVFRRKR 75 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCC------CTTBCCEEEEEEETT
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCC------CCCccchhheeecCC
Confidence 478999999999999999999999999999999986543 23455677888888774 789999999999999
Q ss_pred eEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCC
Q 007035 490 HLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (621)
Q Consensus 490 ~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGl 569 (621)
..++||||++++++..+..... .+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+
T Consensus 76 ~~~lv~e~~~~~~l~~~~~~~~-----~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~--~~~~~kl~Dfg~ 148 (311)
T 4agu_A 76 RLHLVFEYCDHTVLHELDRYQR-----GVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILIT--KHSVIKLCDFGF 148 (311)
T ss_dssp EEEEEEECCSEEHHHHHHHTSS-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC--TTSCEEECCCTT
T ss_pred eEEEEEEeCCCchHHHHHhhhc-----CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEc--CCCCEEEeeCCC
Confidence 9999999999876655543322 288999999999999999999999999999999999998 478999999999
Q ss_pred ccccCCC---ccccccCCcccCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 570 SCFQTDN---LCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 570 s~~~~~~---~~~~~gt~~Y~APEvl~~-~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
+...... .....+|+.|+|||++.+ ..++.++||||||+++|+|++|++||
T Consensus 149 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~ 203 (311)
T 4agu_A 149 ARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLW 203 (311)
T ss_dssp CEECC------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred chhccCcccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCC
Confidence 8765432 234578999999999986 56899999999999999999999998
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-34 Score=307.46 Aligned_cols=198 Identities=24% Similarity=0.358 Sum_probs=170.2
Q ss_pred ecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCch-hhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCe
Q 007035 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD-FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (621)
Q Consensus 412 i~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~-~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~ 490 (621)
+.++|++++.||+|+||+||+|.++.+|+.||+|++..... ....+.+|+.+++.+ .||||+++++++.....
T Consensus 49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l------~hpnIv~~~~~~~~~~~ 122 (387)
T 1kob_A 49 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQL------HHPKLINLHDAFEDKYE 122 (387)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTC------CSTTBCCEEEEEECSSE
T ss_pred cccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhC------CCcCCCeEEEEEEeCCE
Confidence 45789999999999999999999999999999999976432 234556677766554 58899999999999999
Q ss_pred EEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCC
Q 007035 491 LFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (621)
Q Consensus 491 l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGl 569 (621)
+++||||+.+ +|.+.+.... ..+++..++.++.||+.||.|||++||+||||||+|||++.+..+.+||+|||+
T Consensus 123 ~~lv~E~~~gg~L~~~l~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~ 197 (387)
T 1kob_A 123 MVLILEFLSGGELFDRIAAED-----YKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGL 197 (387)
T ss_dssp EEEEEECCCCCBHHHHTTCTT-----CCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTT
T ss_pred EEEEEEcCCCCcHHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEeccc
Confidence 9999999975 6766664322 128999999999999999999999999999999999999865668899999999
Q ss_pred ccccCCC--ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 570 SCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 570 s~~~~~~--~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
+...... .....+|+.|+|||++.+..++.++|||||||++|+|++|+.||
T Consensus 198 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf 250 (387)
T 1kob_A 198 ATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPF 250 (387)
T ss_dssp CEECCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSS
T ss_pred ceecCCCcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCC
Confidence 9765433 23457899999999999999999999999999999999999998
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-34 Score=300.49 Aligned_cols=195 Identities=24% Similarity=0.396 Sum_probs=170.3
Q ss_pred cCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc----hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEec
Q 007035 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (621)
Q Consensus 413 ~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~ 488 (621)
..+|++++.||+|+||+||+|++..+|+.||||++.... .....+.+|+++++.++ ||||+++++++...
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~------hpniv~~~~~~~~~ 126 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR------HPNTIQYRGCYLRE 126 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCC------CTTBCCEEEEEEET
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCC------CCCEeeEEEEEEEC
Confidence 467999999999999999999999999999999987532 23356778888888774 78999999999999
Q ss_pred CeEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecC
Q 007035 489 EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (621)
Q Consensus 489 ~~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFG 568 (621)
+..++||||+.+++.+.+..... .+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||
T Consensus 127 ~~~~lv~e~~~g~l~~~l~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~--~~~~~kL~DfG 199 (348)
T 1u5q_A 127 HTAWLVMEYCLGSASDLLEVHKK-----PLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLS--EPGLVKLGDFG 199 (348)
T ss_dssp TEEEEEEECCSEEHHHHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEE--TTTEEEECCCT
T ss_pred CeEEEEEecCCCCHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEC--CCCCEEEeecc
Confidence 99999999999999888765432 288999999999999999999999999999999999998 47899999999
Q ss_pred CccccCCCccccccCCcccCchhhc---CCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 007035 569 SSCFQTDNLCLYVQSRSYRAPEVII---GLPYDQKIDLWSLGCILAELWTGEVCLI 621 (621)
Q Consensus 569 ls~~~~~~~~~~~gt~~Y~APEvl~---~~~~s~ksDIWSLGvILyELltG~~PF~ 621 (621)
++...... ....+|+.|+|||++. ...++.++|||||||++|+|++|+.||.
T Consensus 200 ~a~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~ 254 (348)
T 1u5q_A 200 SASIMAPA-NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 254 (348)
T ss_dssp TCBSSSSB-CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred CceecCCC-CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 98765433 3457899999999985 4578999999999999999999999983
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-33 Score=302.85 Aligned_cols=196 Identities=23% Similarity=0.302 Sum_probs=168.0
Q ss_pred cCceEEEEEeccC--CCCceeEEEeCCCCcEEEEEEEecCc---hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEe
Q 007035 413 AGRYYVTEYLGSA--AFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (621)
Q Consensus 413 ~~rY~I~~~LG~G--~fG~Vyka~d~~tg~~VAlKii~~~~---~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~ 487 (621)
.++|++++.||+| +||+||+|++..+|+.||||++.... .....+.+|+.+++.++ ||||+++++++..
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~~~~~~~~ 97 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFN------HPNIVPYRATFIA 97 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCC------CTTBCCEEEEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCC------CCCCCcEeEEEEE
Confidence 4789999999999 99999999999999999999997643 33456677888888774 7899999999999
Q ss_pred cCeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEe
Q 007035 488 LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (621)
Q Consensus 488 ~~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~D 566 (621)
.+.+++||||+.+ +|.+++...... .+++..++.++.||+.||.|||+++|+||||||+|||++ .++.+||+|
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~----~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~--~~~~~kl~d 171 (389)
T 3gni_B 98 DNELWVVTSFMAYGSAKDLICTHFMD----GMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILIS--VDGKVYLSG 171 (389)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHTCTT----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC--TTCCEEECC
T ss_pred CCEEEEEEEccCCCCHHHHHhhhccc----CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc--CCCCEEEcc
Confidence 9999999999984 777776543222 288999999999999999999999999999999999998 478999999
Q ss_pred cCCccccC----------CCccccccCCcccCchhhcC--CCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 567 LGSSCFQT----------DNLCLYVQSRSYRAPEVIIG--LPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 567 FGls~~~~----------~~~~~~~gt~~Y~APEvl~~--~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
||++.... .......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||
T Consensus 172 fg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf 237 (389)
T 3gni_B 172 LRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPF 237 (389)
T ss_dssp GGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred cccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCC
Confidence 99875321 11223478899999999988 57899999999999999999999998
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-34 Score=304.70 Aligned_cols=196 Identities=27% Similarity=0.427 Sum_probs=168.7
Q ss_pred eecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCe
Q 007035 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (621)
Q Consensus 411 ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~ 490 (621)
.+.++|++.+.||+|+||+||+|.++.+|+.||||++..... ...+|+.++..+. .||||+++++++.+..+
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~---~~~~E~~~l~~~~-----~hp~iv~~~~~~~~~~~ 90 (342)
T 2qr7_A 19 QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR---DPTEEIEILLRYG-----QHPNIITLKDVYDDGKY 90 (342)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC---CCHHHHHHHHHHT-----TSTTBCCEEEEEECSSE
T ss_pred CccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC---ChHHHHHHHHHhc-----CCCCcCeEEEEEEcCCE
Confidence 356789999999999999999999999999999999986542 3456788877764 48899999999999999
Q ss_pred EEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccC--CCeEEEEec
Q 007035 491 LFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQ--RCEIKIIDL 567 (621)
Q Consensus 491 l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~--~~~IKL~DF 567 (621)
+++||||+.+ +|.+.+.... .+++..++.++.||+.||.|||++||+||||||+|||+.... .+.+||+||
T Consensus 91 ~~lv~E~~~gg~L~~~i~~~~------~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Df 164 (342)
T 2qr7_A 91 VYVVTELMKGGELLDKILRQK------FFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDF 164 (342)
T ss_dssp EEEEECCCCSCBHHHHHHTCT------TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCC
T ss_pred EEEEEeCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEEC
Confidence 9999999975 7777776432 289999999999999999999999999999999999986422 246999999
Q ss_pred CCccccCCC---ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 568 GSSCFQTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 568 Gls~~~~~~---~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
|++...... ....++|+.|+|||++.+..++.++|||||||++|+|++|+.||
T Consensus 165 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf 220 (342)
T 2qr7_A 165 GFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPF 220 (342)
T ss_dssp TTCEECBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSS
T ss_pred CCcccCcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCC
Confidence 998764432 33457899999999998888899999999999999999999998
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=286.63 Aligned_cols=198 Identities=29% Similarity=0.447 Sum_probs=171.3
Q ss_pred eecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc---hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEe
Q 007035 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (621)
Q Consensus 411 ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~---~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~ 487 (621)
.+.++|++.+.||+|+||.||+|.+..+|+.||+|++.... .....+.+|+.+++.++ ||||+++++++..
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~ 76 (284)
T 3kk8_A 3 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQ------HPNIVRLHDSIQE 76 (284)
T ss_dssp TTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCC------CTTBCCEEEEEEC
T ss_pred hhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcC------CCCcCeEEEEEEc
Confidence 45789999999999999999999999999999999997543 33456677888888774 7899999999999
Q ss_pred cCeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccC-CCeEEEE
Q 007035 488 LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQ-RCEIKII 565 (621)
Q Consensus 488 ~~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~-~~~IKL~ 565 (621)
....++||||+.+ +|.+.+..... +++..++.++.||+.||.|||++||+||||||+|||++.+. .+.+||+
T Consensus 77 ~~~~~~v~e~~~~~~l~~~~~~~~~------~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~ 150 (284)
T 3kk8_A 77 ESFHYLVFDLVTGGELFEDIVAREF------YSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLA 150 (284)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEEC
T ss_pred CCEEEEEEecCCCCCHHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEe
Confidence 9999999999985 67676654432 88999999999999999999999999999999999998532 3569999
Q ss_pred ecCCccccCCCc--cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 566 DLGSSCFQTDNL--CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 566 DFGls~~~~~~~--~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
|||++....... ....+++.|+|||++.+..++.++||||||+++|+|++|+.||
T Consensus 151 Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf 207 (284)
T 3kk8_A 151 DFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPF 207 (284)
T ss_dssp CCTTCEECCSSCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred eceeeEEcccCccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCC
Confidence 999987654432 3457899999999999999999999999999999999999998
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-34 Score=305.59 Aligned_cols=194 Identities=29% Similarity=0.408 Sum_probs=166.0
Q ss_pred cCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecC---chhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecC
Q 007035 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (621)
Q Consensus 413 ~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~---~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~ 489 (621)
..+|++++.||+|+||+||++.+.. ++.||||++... ....+.+.+|+.+++.+.+ .||||+++++++...+
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~----~~~~iv~~~~~~~~~~ 129 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ----HSDKIIRLYDYEITDQ 129 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTT----TCTTBCCEEEEEECSS
T ss_pred CCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHccc----CCCeEEEEEEEEecCC
Confidence 4579999999999999999999765 999999999753 3345678899999999975 3689999999999999
Q ss_pred eEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCC
Q 007035 490 HLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (621)
Q Consensus 490 ~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGl 569 (621)
.++||||+.+++|.+++.... .+++..++.++.||+.||.|||+++|+||||||+|||++ ++.+||+|||+
T Consensus 130 ~~~lv~E~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~---~~~~kl~DFG~ 200 (390)
T 2zmd_A 130 YIYMVMECGNIDLNSWLKKKK------SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV---DGMLKLIDFGI 200 (390)
T ss_dssp EEEEEEECCSEEHHHHHHHCS------SCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES---SSCEEECCCSS
T ss_pred EEEEEEecCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE---CCeEEEEecCc
Confidence 999999987788988887543 278888999999999999999999999999999999996 57899999999
Q ss_pred ccccCCC-----ccccccCCcccCchhhcC-----------CCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 570 SCFQTDN-----LCLYVQSRSYRAPEVIIG-----------LPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 570 s~~~~~~-----~~~~~gt~~Y~APEvl~~-----------~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
+...... ....+||+.|+|||++.+ ..++.++|||||||+||+|++|+.||
T Consensus 201 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf 267 (390)
T 2zmd_A 201 ANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 267 (390)
T ss_dssp SCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred cccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcc
Confidence 8765432 234578999999999975 36889999999999999999999998
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-34 Score=294.52 Aligned_cols=198 Identities=27% Similarity=0.365 Sum_probs=163.0
Q ss_pred ecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc--hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecC
Q 007035 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (621)
Q Consensus 412 i~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~ 489 (621)
+.++|++++.||+|+||.||+|+++.+|+.||||+++... ...+.+.+|+++++.+ .||||++++++|....
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l------~hpniv~~~~~~~~~~ 77 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL------EHPGIVRYFNAWLETP 77 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSC------CCTTBCCEEEEEEECC
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhC------CCCCEeeEEEEEEEec
Confidence 3568999999999999999999999999999999997532 3345667777777665 4889999999986543
Q ss_pred ---------------------------------------------------------eEEEEEecccc-chHHHHHhhhc
Q 007035 490 ---------------------------------------------------------HLFIVCELLRA-NLYEFQKFNQE 511 (621)
Q Consensus 490 ---------------------------------------------------------~l~LVmEyl~g-sLld~l~~~~~ 511 (621)
++++||||+.+ +|.+++.....
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~ 157 (332)
T 3qd2_B 78 PEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS 157 (332)
T ss_dssp SCHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS
T ss_pred cchhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC
Confidence 48999999986 77777664332
Q ss_pred cCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCccccCCC---------------
Q 007035 512 SGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN--------------- 576 (621)
Q Consensus 512 ~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~~~~~~--------------- 576 (621)
.....+..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++......
T Consensus 158 ---~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~--~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~ 232 (332)
T 3qd2_B 158 ---LEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTM--DDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYAT 232 (332)
T ss_dssp ---GGGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT--TCCEEECCCTTCEECSCC--------------C
T ss_pred ---ccchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeC--CCCEEEeecCcccccccchhhcccccccccccc
Confidence 122556678999999999999999999999999999999984 789999999998765432
Q ss_pred ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 577 LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 577 ~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
.....+|+.|+|||++.+..++.++|||||||++|+|++|..|+
T Consensus 233 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~ 276 (332)
T 3qd2_B 233 HTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQ 276 (332)
T ss_dssp CCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCH
T ss_pred ccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCCh
Confidence 12346899999999999999999999999999999999998764
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=305.02 Aligned_cols=196 Identities=32% Similarity=0.420 Sum_probs=161.0
Q ss_pred ecCceEEE-EEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEe---
Q 007035 412 IAGRYYVT-EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH--- 487 (621)
Q Consensus 412 i~~rY~I~-~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~--- 487 (621)
+.++|.+. +.||.|+||+||++.++.+|+.||||++... ....+|+.++.++. .||||++++++|..
T Consensus 59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~E~~~~~~~~-----~hp~iv~l~~~~~~~~~ 129 (400)
T 1nxk_A 59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRAS-----QCPHIVRIVDVYENLYA 129 (400)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHT-----TSTTBCCEEEEEEEEET
T ss_pred ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc----hhHHHHHHHHHHhc-----CCCCcceEeEEEeeccc
Confidence 34567776 7899999999999999999999999999754 34567777775553 58899999999876
Q ss_pred -cCeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccC-CCeEEE
Q 007035 488 -LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQ-RCEIKI 564 (621)
Q Consensus 488 -~~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~-~~~IKL 564 (621)
..+++|||||+.+ +|.+++..... ..+++..++.++.||+.||.|||++||+||||||+|||++... ++.+||
T Consensus 130 ~~~~~~lv~E~~~gg~L~~~l~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl 205 (400)
T 1nxk_A 130 GRKCLLIVMECLDGGELFSRIQDRGD----QAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKL 205 (400)
T ss_dssp TEEEEEEEEECCCSEEHHHHHHCC-------CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEE
T ss_pred CCcEEEEEEEeCCCCcHHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEE
Confidence 6789999999975 78887764322 2389999999999999999999999999999999999998532 688999
Q ss_pred EecCCccccCCC--ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 565 IDLGSSCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 565 ~DFGls~~~~~~--~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
+|||++...... ....++|+.|+|||++.+..++.++|||||||+||+|++|+.||
T Consensus 206 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf 263 (400)
T 1nxk_A 206 TDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 263 (400)
T ss_dssp CCCTTCEECC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSC
T ss_pred EecccccccCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCC
Confidence 999998765432 34467899999999999999999999999999999999999998
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-33 Score=286.81 Aligned_cols=199 Identities=24% Similarity=0.329 Sum_probs=170.3
Q ss_pred eecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCe
Q 007035 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (621)
Q Consensus 411 ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~ 490 (621)
.+.++|++.+.||+|+||.||+|++..+|+.||+|++..... .+.+.+|+.+++.+++. +++..+..++.....
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~e~~~l~~l~~~-----~~i~~~~~~~~~~~~ 79 (296)
T 3uzp_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGG-----VGIPTIRWCGAEGDY 79 (296)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS-CCHHHHHHHHHHHHTTS-----TTCCCEEEEEEETTE
T ss_pred eeccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc-hhHHHHHHHHHHHhhcC-----CCCCccccccCCCCc
Confidence 467899999999999999999999999999999999876543 35678999999999754 345556666678889
Q ss_pred EEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEec-cCCCeEEEEecCC
Q 007035 491 LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS-YQRCEIKIIDLGS 569 (621)
Q Consensus 491 l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~-~~~~~IKL~DFGl 569 (621)
.++||||++++|.+++..... .+++..++.++.||+.||.|||+++|+||||||+|||++. +.++.+||+|||+
T Consensus 80 ~~lv~e~~~~~L~~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~ 154 (296)
T 3uzp_A 80 NVMVMELLGPSLEDLFNFCSR-----KFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGL 154 (296)
T ss_dssp EEEEEECCCCBHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTT
T ss_pred eEEEEEecCCCHHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCC
Confidence 999999998899888864432 2899999999999999999999999999999999999942 2477899999999
Q ss_pred ccccCCC----------ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 570 SCFQTDN----------LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 570 s~~~~~~----------~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
+...... .....+|+.|+|||++.+..++.++|||||||++|+|++|+.||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf 215 (296)
T 3uzp_A 155 AKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPW 215 (296)
T ss_dssp CEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred cccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCC
Confidence 8764432 23457899999999999999999999999999999999999998
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-34 Score=311.47 Aligned_cols=200 Identities=24% Similarity=0.356 Sum_probs=162.6
Q ss_pred eecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCe
Q 007035 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (621)
Q Consensus 411 ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~ 490 (621)
+..++|++++.||+|+||.||+|++..+|+.||||++........ .....+++++.....+.||||+++++++...++
T Consensus 145 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~ 222 (446)
T 4ejn_A 145 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAK--DEVAHTLTENRVLQNSRHPFLTALKYSFQTHDR 222 (446)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC---------------CCCCCSCTTSCCEEEEEEETTE
T ss_pred CChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhh--HHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCE
Confidence 345789999999999999999999999999999999975321111 111123344444455679999999999999999
Q ss_pred EEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHH-CCeecccCCCccEEEeccCCCeEEEEecC
Q 007035 491 LFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS-LGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (621)
Q Consensus 491 l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs-~gIvHrDLKP~NILl~~~~~~~IKL~DFG 568 (621)
++|||||+.+ +|.+.+.... .+++..++.++.||+.||.|||+ .||+||||||+|||++. ++.+||+|||
T Consensus 223 ~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~--~~~~kl~DFG 294 (446)
T 4ejn_A 223 LCFVMEYANGGELFFHLSRER------VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDK--DGHIKITDFG 294 (446)
T ss_dssp EEEEECCCSSCBHHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECS--SSCEEECCCC
T ss_pred EEEEEeeCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECC--CCCEEEccCC
Confidence 9999999986 6666665432 28899999999999999999998 99999999999999984 7899999999
Q ss_pred CccccCC---CccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 569 SSCFQTD---NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 569 ls~~~~~---~~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
++..... .....+||+.|+|||++.+..++.++|||||||+||+|++|+.||
T Consensus 295 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf 349 (446)
T 4ejn_A 295 LCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 349 (446)
T ss_dssp CCCTTCC-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred CceeccCCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCC
Confidence 9865322 234568899999999999999999999999999999999999998
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-34 Score=305.72 Aligned_cols=194 Identities=35% Similarity=0.634 Sum_probs=151.8
Q ss_pred ecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecC---chhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEec
Q 007035 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (621)
Q Consensus 412 i~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~---~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~ 488 (621)
+.++|++++.||+|+||.||+|.+..+|+.||||++... .....+..+|+++++.++ ||||+++++++...
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~------hpnIv~~~~~~~~~ 100 (367)
T 2fst_X 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK------HENVIGLLDVFTPA 100 (367)
T ss_dssp EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCC------CTTBCCCSEEECSC
T ss_pred CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCC------CCCCCcEEEEEecC
Confidence 468999999999999999999999999999999998653 233456678888888774 78999999998754
Q ss_pred ------CeEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeE
Q 007035 489 ------EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEI 562 (621)
Q Consensus 489 ------~~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~I 562 (621)
...++|||+++++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+
T Consensus 101 ~~~~~~~~~~lv~e~~~~~L~~~~~~~-------~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~--~~~~ 171 (367)
T 2fst_X 101 RSLEEFNDVYLVTHLMGADLNNIVKCQ-------KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE--DCEL 171 (367)
T ss_dssp SSGGGCCCCEEEEECCCEECC-----C-------CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT--TCCE
T ss_pred CccccCCeEEEEecccCCCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECC--CCCE
Confidence 568999999998888776531 2889999999999999999999999999999999999984 7899
Q ss_pred EEEecCCccccCCCccccccCCcccCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 563 KIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 563 KL~DFGls~~~~~~~~~~~gt~~Y~APEvl~~-~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
||+|||++...........+|+.|+|||++.+ ..++.++|||||||++|+|++|++||
T Consensus 172 kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf 230 (367)
T 2fst_X 172 KILDFGLARHTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 230 (367)
T ss_dssp EECC---------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSC
T ss_pred EEeeccccccccccCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 99999999877666666789999999999987 67899999999999999999999998
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=293.52 Aligned_cols=200 Identities=27% Similarity=0.437 Sum_probs=172.2
Q ss_pred CeeecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCch-------hhhhHHHHHHHHHHhcccCCCCCCceEEE
Q 007035 409 NTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD-------FFDQSLDEIKLLKLVNKNDPADEHHILRL 481 (621)
Q Consensus 409 ~~ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~-------~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl 481 (621)
...+.++|++.+.||+|+||.||+|++..+|+.||+|++..... ..+.+.+|+.+++.++ ||||+++
T Consensus 7 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~ 80 (321)
T 2a2a_A 7 QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL------HHNVITL 80 (321)
T ss_dssp CSCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCC------CTTBCCE
T ss_pred chhhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCC------CCCcceE
Confidence 34567899999999999999999999999999999999876432 2456788888888774 7899999
Q ss_pred eeEeEecCeEEEEEeccc-cchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCC-
Q 007035 482 YDYFYHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQR- 559 (621)
Q Consensus 482 ~~~f~~~~~l~LVmEyl~-gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~- 559 (621)
++++......++||||+. ++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.+..
T Consensus 81 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~ 154 (321)
T 2a2a_A 81 HDVYENRTDVVLILELVSGGELFDFLAQKE------SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIP 154 (321)
T ss_dssp EEEEECSSEEEEEECCCCSCBHHHHHHTCS------CEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSS
T ss_pred EEEEecCCEEEEEEEcCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCC
Confidence 999999999999999996 57877775432 2899999999999999999999999999999999999985221
Q ss_pred -CeEEEEecCCccccCCC--ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 560 -CEIKIIDLGSSCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 560 -~~IKL~DFGls~~~~~~--~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
..+||+|||++...... .....+|+.|+|||++.+..++.++||||||+++|+|++|+.||
T Consensus 155 ~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf 218 (321)
T 2a2a_A 155 IPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218 (321)
T ss_dssp SCCEEECCCTTCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSS
T ss_pred cCCEEEccCccceecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCC
Confidence 17999999998765433 33457899999999999999999999999999999999999998
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-34 Score=300.83 Aligned_cols=199 Identities=29% Similarity=0.424 Sum_probs=158.9
Q ss_pred eeecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecC
Q 007035 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (621)
Q Consensus 410 ~ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~ 489 (621)
..+.++|++.+.||+|+||.||+|++..+++.||||+++.... .+.+.+|+.+++.++ ||||+++++++....
T Consensus 49 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~E~~~l~~l~------h~niv~~~~~~~~~~ 121 (349)
T 2w4o_A 49 DALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVD-KKIVRTEIGVLLRLS------HPNIIKLKEIFETPT 121 (349)
T ss_dssp SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------CHHHHHCC------CTTBCCEEEEEECSS
T ss_pred ccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchh-HHHHHHHHHHHHhCC------CCCCcceeeeEecCC
Confidence 3456789999999999999999999999999999999986542 355677888888874 789999999999999
Q ss_pred eEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEec-cCCCeEEEEec
Q 007035 490 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS-YQRCEIKIIDL 567 (621)
Q Consensus 490 ~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~-~~~~~IKL~DF 567 (621)
..++||||+.+ +|.+.+.... .+++..++.++.||+.||.|||++||+||||||+|||++. +.++.+||+||
T Consensus 122 ~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Df 195 (349)
T 2w4o_A 122 EISLVLELVTGGELFDRIVEKG------YYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADF 195 (349)
T ss_dssp EEEEEECCCCSCBHHHHHTTCS------SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCC
T ss_pred eEEEEEEeCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccC
Confidence 99999999974 7777765332 2889999999999999999999999999999999999974 34788999999
Q ss_pred CCccccCCC--ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 007035 568 GSSCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCLI 621 (621)
Q Consensus 568 Gls~~~~~~--~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF~ 621 (621)
|++...... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.
T Consensus 196 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 251 (349)
T 2w4o_A 196 GLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFY 251 (349)
T ss_dssp C----------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTC
T ss_pred ccccccCcccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCC
Confidence 998765432 234578999999999999999999999999999999999999983
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=307.03 Aligned_cols=196 Identities=31% Similarity=0.548 Sum_probs=165.1
Q ss_pred cCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEec----
Q 007035 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL---- 488 (621)
Q Consensus 413 ~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~---- 488 (621)
..+|++.+.||+|+||.||+|++..+|+.||||++..+.. ...+|+++++.+ .||||++++++|...
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~E~~il~~l------~hpniv~l~~~~~~~~~~~ 123 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---FKNRELQIMRKL------DHCNIVRLRYFFYSSGEKK 123 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT---SCCHHHHHHHTC------CCTTBCCEEEEEEEEETTT
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHc------CCCCccceeeEEeccCCCC
Confidence 4579999999999999999999999999999999976543 234688888766 478999999998642
Q ss_pred --CeEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEe
Q 007035 489 --EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (621)
Q Consensus 489 --~~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~D 566 (621)
.++++||||+++++++.+...... ...+++..++.++.||+.||.|||++||+||||||+|||++. +.+.+||+|
T Consensus 124 ~~~~~~lv~e~~~~~l~~~~~~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~-~~~~~kl~D 200 (420)
T 1j1b_A 124 DEVYLNLVLDYVPETVYRVARHYSRA--KQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP-DTAVLKLCD 200 (420)
T ss_dssp TEEEEEEEEECCCEEHHHHHHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEET-TTTEEEECC
T ss_pred cceeEEeehhcccccHHHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeC-CCCeEEecc
Confidence 247899999999888776643222 223889999999999999999999999999999999999985 346799999
Q ss_pred cCCccccCC--CccccccCCcccCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 567 LGSSCFQTD--NLCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 567 FGls~~~~~--~~~~~~gt~~Y~APEvl~~~-~~s~ksDIWSLGvILyELltG~~PF 620 (621)
||++..... ......+|+.|+|||++.+. .++.++|||||||+||||++|++||
T Consensus 201 FG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf 257 (420)
T 1j1b_A 201 FGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 257 (420)
T ss_dssp CTTCEECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred chhhhhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCC
Confidence 999976432 33446789999999999775 6899999999999999999999998
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-33 Score=316.38 Aligned_cols=200 Identities=26% Similarity=0.340 Sum_probs=171.9
Q ss_pred eecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc----hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeE
Q 007035 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (621)
Q Consensus 411 ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~ 486 (621)
+..++|++++.||+|+||+||+|+++.+|+.||||++.+.. .....+..|+.+++.+ .||||++++++|.
T Consensus 182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l------~hp~Iv~l~~~~~ 255 (543)
T 3c4z_A 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV------HSRFIVSLAYAFE 255 (543)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC------CCTTBCCEEEEEE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhc------CCCCEeeEEEEEe
Confidence 34578999999999999999999999999999999997543 2235567788888877 4789999999999
Q ss_pred ecCeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEE
Q 007035 487 HLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKII 565 (621)
Q Consensus 487 ~~~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~ 565 (621)
....+|+||||+.+ +|.+.+..... ....+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+
T Consensus 256 ~~~~l~lVmE~~~gg~L~~~l~~~~~--~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~--~~g~vkL~ 331 (543)
T 3c4z_A 256 TKTDLCLVMTIMNGGDIRYHIYNVDE--DNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLD--DDGNVRIS 331 (543)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHTSST--TSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC--TTSCEEEC
T ss_pred eCCEEEEEEEeccCCCHHHHHHHhhc--ccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEe--CCCCEEEe
Confidence 99999999999985 66666554321 122389999999999999999999999999999999999998 48899999
Q ss_pred ecCCccccCCC---ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 566 DLGSSCFQTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 566 DFGls~~~~~~---~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
|||++...... ....+||+.|+|||++.+..++.++|||||||++|||++|++||
T Consensus 332 DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF 389 (543)
T 3c4z_A 332 DLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPF 389 (543)
T ss_dssp CCTTCEECCTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred ecceeeeccCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCC
Confidence 99999765433 23358999999999999999999999999999999999999998
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-34 Score=296.72 Aligned_cols=203 Identities=27% Similarity=0.398 Sum_probs=166.9
Q ss_pred ecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecC------chhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEe
Q 007035 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND------KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYF 485 (621)
Q Consensus 412 i~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~------~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f 485 (621)
+.++|++.+.||+|+||+||+|.+..+++.||+|++... ....+.+.+|+++++.++ ||||+++++++
T Consensus 24 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~------hpniv~~~~~~ 97 (345)
T 3hko_A 24 LQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLH------HPNIARLYEVY 97 (345)
T ss_dssp HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCC------CTTBCCEEEEE
T ss_pred hhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCC------CCCcceeehhh
Confidence 568899999999999999999999999999999998753 234467788888888874 78999999999
Q ss_pred EecCeEEEEEeccc-cchHHHHHhhhcc----------------------------------CCCccccHHHHHHHHHHH
Q 007035 486 YHLEHLFIVCELLR-ANLYEFQKFNQES----------------------------------GGEAYFTLGRLQVITRQC 530 (621)
Q Consensus 486 ~~~~~l~LVmEyl~-gsLld~l~~~~~~----------------------------------~~~~~ls~~~i~~I~~qI 530 (621)
.+.+..++||||+. ++|.+++...... .....+++..++.++.||
T Consensus 98 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi 177 (345)
T 3hko_A 98 EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQI 177 (345)
T ss_dssp ECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHH
T ss_pred ccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHH
Confidence 99999999999997 4676665321100 012225678889999999
Q ss_pred HHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCccccCC-------CccccccCCcccCchhhcC--CCCCchh
Q 007035 531 LEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTD-------NLCLYVQSRSYRAPEVIIG--LPYDQKI 601 (621)
Q Consensus 531 l~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~~~~~-------~~~~~~gt~~Y~APEvl~~--~~~s~ks 601 (621)
+.||.|||+++|+||||||+|||++.+....+||+|||++..... ......+|+.|+|||++.+ ..++.++
T Consensus 178 ~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 178 FSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 999999999999999999999999865555899999999875422 1234578999999999975 5789999
Q ss_pred hHHHHHHHHHHHHhCCCCC
Q 007035 602 DLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 602 DIWSLGvILyELltG~~PF 620 (621)
|||||||++|+|++|+.||
T Consensus 258 DiwslG~il~el~~g~~pf 276 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPF 276 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSS
T ss_pred HHHHHHHHHHHHHHCCCCC
Confidence 9999999999999999998
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-34 Score=298.05 Aligned_cols=195 Identities=32% Similarity=0.488 Sum_probs=152.5
Q ss_pred cCceEEE---EEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecC
Q 007035 413 AGRYYVT---EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (621)
Q Consensus 413 ~~rY~I~---~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~ 489 (621)
.++|.+. +.||+|+||+||+|.++.+++.||||++.... .....+|+.+++.+. .||||+++++++.+..
T Consensus 7 ~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~e~~~l~~l~-----~h~niv~~~~~~~~~~ 79 (325)
T 3kn6_A 7 YQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM--EANTQKEITALKLCE-----GHPNIVKLHEVFHDQL 79 (325)
T ss_dssp HHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGG--HHHHHHHHHHHHHTT-----TCTTBCCEEEEEECSS
T ss_pred hhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhh--hhhHHHHHHHHHHhc-----CCCCeeEEEEEEEcCC
Confidence 3567775 67999999999999999999999999997543 356778888888875 4889999999999999
Q ss_pred eEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccC-CCeEEEEec
Q 007035 490 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQ-RCEIKIIDL 567 (621)
Q Consensus 490 ~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~-~~~IKL~DF 567 (621)
+.++||||+.+ +|.+.+.... .+++..++.++.||+.||.|||++||+||||||+|||++.+. ...+||+||
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Df 153 (325)
T 3kn6_A 80 HTFLVMELLNGGELFERIKKKK------HFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDF 153 (325)
T ss_dssp EEEEEECCCCSCBHHHHHHHCS------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCC
T ss_pred EEEEEEEccCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEecc
Confidence 99999999975 7777776432 289999999999999999999999999999999999998522 338999999
Q ss_pred CCccccCCC---ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 568 GSSCFQTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 568 Gls~~~~~~---~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
|++...... .....+|+.|+|||++.+..++.++|||||||++|+|++|+.||
T Consensus 154 g~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf 209 (325)
T 3kn6_A 154 GFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPF 209 (325)
T ss_dssp TTCEECCC----------------------CCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred ccceecCCCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCC
Confidence 998754332 23456799999999999999999999999999999999999998
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-34 Score=298.83 Aligned_cols=195 Identities=31% Similarity=0.478 Sum_probs=169.0
Q ss_pred ecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCch---------hhhhHHHHHHHHHHhcccCCCCCCceEEEe
Q 007035 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD---------FFDQSLDEIKLLKLVNKNDPADEHHILRLY 482 (621)
Q Consensus 412 i~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~---------~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~ 482 (621)
+.++|++++.||+|+||+||+|+++.+++.||||++..... ....+.+|+.+++.+ .||||++++
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l------~h~~Iv~~~ 95 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRV------EHANIIKVL 95 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTC------CCTTBCCEE
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhC------CCCCEeeEE
Confidence 45789999999999999999999999999999999986431 234566788888766 478999999
Q ss_pred eEeEecCeEEEEEecccc--chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCC
Q 007035 483 DYFYHLEHLFIVCELLRA--NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRC 560 (621)
Q Consensus 483 ~~f~~~~~l~LVmEyl~g--sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~ 560 (621)
+++...+..++||||+.. +|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++
T Consensus 96 ~~~~~~~~~~lv~e~~~~g~~l~~~~~~~~------~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~--~~ 167 (335)
T 3dls_A 96 DIFENQGFFQLVMEKHGSGLDLFAFIDRHP------RLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAE--DF 167 (335)
T ss_dssp EEEECSSEEEEEEECCTTSCBHHHHHHTCC------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT--TS
T ss_pred EEEeeCCEEEEEEEeCCCCccHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcC--CC
Confidence 999999999999999864 6777665432 2889999999999999999999999999999999999984 78
Q ss_pred eEEEEecCCccccCCC--ccccccCCcccCchhhcCCCC-CchhhHHHHHHHHHHHHhCCCCC
Q 007035 561 EIKIIDLGSSCFQTDN--LCLYVQSRSYRAPEVIIGLPY-DQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 561 ~IKL~DFGls~~~~~~--~~~~~gt~~Y~APEvl~~~~~-s~ksDIWSLGvILyELltG~~PF 620 (621)
.+||+|||++...... .....||+.|+|||++.+..+ +.++|||||||++|+|++|+.||
T Consensus 168 ~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf 230 (335)
T 3dls_A 168 TIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPF 230 (335)
T ss_dssp CEEECCCTTCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSC
T ss_pred cEEEeecccceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCch
Confidence 9999999998765433 334678999999999998876 78999999999999999999998
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-33 Score=300.45 Aligned_cols=197 Identities=28% Similarity=0.400 Sum_probs=162.8
Q ss_pred CceEE--EEEeccCCCCceeEEEeCCCCcEEEEEEEecCc-hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCe
Q 007035 414 GRYYV--TEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (621)
Q Consensus 414 ~rY~I--~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~-~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~ 490 (621)
..|.+ .+.||+|+||.||+|.+..+|+.||+|+++... ...+.+.+|+.+++.+ .||||+++++++...+.
T Consensus 87 ~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~hpnIv~~~~~~~~~~~ 160 (373)
T 2x4f_A 87 SFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQL------DHANLIQLYDAFESKND 160 (373)
T ss_dssp GTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTC------CCTTBCCEEEEEECSSE
T ss_pred cceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhC------CCCCCCeEEEEEEECCE
Confidence 34555 678999999999999999999999999998643 3345566777776655 58899999999999999
Q ss_pred EEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCC
Q 007035 491 LFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (621)
Q Consensus 491 l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGl 569 (621)
++|||||+.+ +|.+.+..... .+++..++.++.||+.||.|||+++|+||||||+|||+..+..+.+||+|||+
T Consensus 161 ~~lv~E~~~~~~L~~~l~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~ 235 (373)
T 2x4f_A 161 IVLVMEYVDGGELFDRIIDESY-----NLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGL 235 (373)
T ss_dssp EEEEEECCTTCEEHHHHHHTGG-----GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSS
T ss_pred EEEEEeCCCCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCC
Confidence 9999999974 78777764332 28889999999999999999999999999999999999655678999999999
Q ss_pred ccccCCC--ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 007035 570 SCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCLI 621 (621)
Q Consensus 570 s~~~~~~--~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF~ 621 (621)
+...... .....+|+.|+|||++.+..++.++|||||||++|+|++|+.||.
T Consensus 236 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~ 289 (373)
T 2x4f_A 236 ARRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFL 289 (373)
T ss_dssp CEECCTTCBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTC
T ss_pred ceecCCccccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCC
Confidence 8765433 334578999999999999889999999999999999999999983
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=287.48 Aligned_cols=200 Identities=22% Similarity=0.309 Sum_probs=175.5
Q ss_pred CeeecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEec
Q 007035 409 NTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (621)
Q Consensus 409 ~~ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~ 488 (621)
..+..++|++.+.||+|+||.||+|.+..+++.||+|++..+....+.+.+|+.+++.++ ||||+++++++...
T Consensus 8 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~------h~~i~~~~~~~~~~ 81 (288)
T 3kfa_A 8 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK------HPNLVQLLGVCTRE 81 (288)
T ss_dssp TBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCC------CTTBCCEEEEECSS
T ss_pred ccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCC------CCCEeeEEEEEccC
Confidence 345678999999999999999999999999999999999887777778889999998885 78999999999999
Q ss_pred CeEEEEEeccc-cchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEec
Q 007035 489 EHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 567 (621)
Q Consensus 489 ~~l~LVmEyl~-gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DF 567 (621)
...++||||+. ++|.+++..... ..+++..++.++.||+.||.|||++||+||||||+||+++. ++.++|+||
T Consensus 82 ~~~~~v~e~~~~~~L~~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~--~~~~~l~Df 155 (288)
T 3kfa_A 82 PPFYIITEFMTYGNLLDYLRECNR----QEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGE--NHLVKVADF 155 (288)
T ss_dssp SSEEEEEECCTTEEHHHHHHHCCT----TTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECG--GGCEEECCC
T ss_pred CCEEEEEEcCCCCcHHHHHHhccc----CCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcC--CCCEEEccC
Confidence 99999999998 588887765332 23889999999999999999999999999999999999984 788999999
Q ss_pred CCccccCCCcc----ccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 568 GSSCFQTDNLC----LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 568 Gls~~~~~~~~----~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
|++........ ...+++.|+|||++.+..++.++||||||+++|+|++ |..||
T Consensus 156 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~ 213 (288)
T 3kfa_A 156 GLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 213 (288)
T ss_dssp CGGGTSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred ccceeccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 99876543321 2345778999999999899999999999999999999 99887
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-33 Score=288.05 Aligned_cols=198 Identities=27% Similarity=0.485 Sum_probs=162.8
Q ss_pred CeeecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc-hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeE-
Q 007035 409 NTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY- 486 (621)
Q Consensus 409 ~~ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~-~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~- 486 (621)
+..+.++|++++.||+|+||.||+|.+..+++.||+|++.... ...+.+.+|+.+++.+ .||||+++++++.
T Consensus 6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l------~h~~iv~~~~~~~~ 79 (320)
T 2i6l_A 6 GFDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRL------DHDNIVKVFEILGP 79 (320)
T ss_dssp CEEETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTC------CCTTBCCEEEEECT
T ss_pred cCccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhc------CCCCeeEEEEeccc
Confidence 5567899999999999999999999999999999999987543 3445667788877766 4789999999873
Q ss_pred -------------ecCeEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEE
Q 007035 487 -------------HLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENIL 553 (621)
Q Consensus 487 -------------~~~~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NIL 553 (621)
.....++||||++++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 80 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil 152 (320)
T 2i6l_A 80 SGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQG-------PLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLF 152 (320)
T ss_dssp TSCBCCC----CCSCSEEEEEEECCSEEHHHHHTTC-------CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEE
T ss_pred cccccccccccccccCceeEEeeccCCCHHHHhhcC-------CccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEE
Confidence 44689999999999988877531 2788999999999999999999999999999999999
Q ss_pred EeccCCCeEEEEecCCccccCC------CccccccCCcccCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 554 IKSYQRCEIKIIDLGSSCFQTD------NLCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 554 l~~~~~~~IKL~DFGls~~~~~------~~~~~~gt~~Y~APEvl~~-~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
++. .++.+||+|||++..... ......+++.|+|||++.+ ..++.++|||||||++|+|++|+.||
T Consensus 153 ~~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf 225 (320)
T 2i6l_A 153 INT-EDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLF 225 (320)
T ss_dssp EET-TTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSS
T ss_pred EcC-CCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCC
Confidence 974 357899999999876432 1233466889999999876 67899999999999999999999998
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-33 Score=291.39 Aligned_cols=201 Identities=26% Similarity=0.388 Sum_probs=158.3
Q ss_pred eeecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecC-chhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeE--
Q 007035 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND-KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY-- 486 (621)
Q Consensus 410 ~ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~-~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~-- 486 (621)
++...+|++.+.||+|+||.||+|++..+++.||+|++... ......+.+|+.+++.+. .||||+++++++.
T Consensus 24 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----~h~~iv~~~~~~~~~ 98 (337)
T 3ll6_A 24 ELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLS-----GHPNIVQFCSAASIG 98 (337)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHT-----TSTTBCCEEEEEEEC
T ss_pred eccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhc-----cCCChhhcccccccc
Confidence 33456899999999999999999999999999999987653 334566788888888885 4789999999984
Q ss_pred ------ecCeEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCC--eecccCCCccEEEeccC
Q 007035 487 ------HLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLG--IIHCDLKPENILIKSYQ 558 (621)
Q Consensus 487 ------~~~~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~g--IvHrDLKP~NILl~~~~ 558 (621)
.....++||||++++|.+++...... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.
T Consensus 99 ~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~-- 173 (337)
T 3ll6_A 99 KEESDTGQAEFLLLTELCKGQLVEFLKKMESR---GPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSN-- 173 (337)
T ss_dssp TTTSTTSSEEEEEEEECCSEEHHHHHHHHHTT---CSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECT--
T ss_pred ccccccCCceEEEEEEecCCCHHHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECC--
Confidence 34568999999999999988754322 23899999999999999999999999 999999999999984
Q ss_pred CCeEEEEecCCccccCCCcc---------------ccccCCcccCchhh---cCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 559 RCEIKIIDLGSSCFQTDNLC---------------LYVQSRSYRAPEVI---IGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 559 ~~~IKL~DFGls~~~~~~~~---------------~~~gt~~Y~APEvl---~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
++.+||+|||++........ ...+|+.|+|||++ .+..++.++|||||||++|+|++|+.||
T Consensus 174 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~ 253 (337)
T 3ll6_A 174 QGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF 253 (337)
T ss_dssp TSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC
T ss_pred CCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCC
Confidence 78899999999876543211 34579999999998 5667899999999999999999999998
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-33 Score=295.29 Aligned_cols=199 Identities=30% Similarity=0.502 Sum_probs=157.2
Q ss_pred cCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecC---
Q 007035 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE--- 489 (621)
Q Consensus 413 ~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~--- 489 (621)
.++|++.+.||+|+||+||+|++..+|+.||||++..+.....+..++++.+..+ .||||+++++++....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l------~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVL------HHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHH------CCTTBCCEEEEEEEECSSC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhc------CCCCcccHHHhhhcccccc
Confidence 4789999999999999999999999999999999987665555566666666665 4789999999997643
Q ss_pred ----eEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHH--HCCeecccCCCccEEEeccCCCeEE
Q 007035 490 ----HLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLH--SLGIIHCDLKPENILIKSYQRCEIK 563 (621)
Q Consensus 490 ----~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLH--s~gIvHrDLKP~NILl~~~~~~~IK 563 (621)
.+++||||+++++...+...... ...+++..++.++.||+.||.||| ++||+||||||+|||++. .++.+|
T Consensus 96 ~~~~~~~lv~e~~~~~l~~~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~-~~~~~k 172 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPDTLHRCCRNYYRR--QVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNE-ADGTLK 172 (360)
T ss_dssp TTCEEEEEEEECCSCBHHHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEET-TTTEEE
T ss_pred ccceeEEEEeecccccHHHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeC-CCCcEE
Confidence 38999999999887766543222 223788999999999999999999 999999999999999984 367999
Q ss_pred EEecCCccccCCC--ccccccCCcccCchhhcCCC-CCchhhHHHHHHHHHHHHhCCCCC
Q 007035 564 IIDLGSSCFQTDN--LCLYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 564 L~DFGls~~~~~~--~~~~~gt~~Y~APEvl~~~~-~s~ksDIWSLGvILyELltG~~PF 620 (621)
|+|||++...... .....+|+.|+|||++.+.. ++.++|||||||++|+|++|+.||
T Consensus 173 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf 232 (360)
T 3e3p_A 173 LCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIF 232 (360)
T ss_dssp ECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred EeeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCc
Confidence 9999998765432 33457899999999997655 899999999999999999999998
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-33 Score=299.76 Aligned_cols=203 Identities=24% Similarity=0.382 Sum_probs=169.9
Q ss_pred eecCceEEEEEeccCCCCceeEEEeC-------CCCcEEEEEEEecCc--hhhhhHHHHHHHHHHhcccCCCCCCceEEE
Q 007035 411 VIAGRYYVTEYLGSAAFSKVFQAQDL-------HTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRL 481 (621)
Q Consensus 411 ii~~rY~I~~~LG~G~fG~Vyka~d~-------~tg~~VAlKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl 481 (621)
+..++|++.+.||+|+||+||+|++. .++..||+|+++... .....+.+|+.+++.+. .||||+++
T Consensus 78 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----~hpnIv~~ 152 (370)
T 2psq_A 78 FPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG-----KHKNIINL 152 (370)
T ss_dssp CCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSC-----CCTTBCCE
T ss_pred ccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhc-----CCCCEeeE
Confidence 34578999999999999999999864 356679999997643 33456788888888874 47899999
Q ss_pred eeEeEecCeEEEEEecccc-chHHHHHhhhcc----------CCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCc
Q 007035 482 YDYFYHLEHLFIVCELLRA-NLYEFQKFNQES----------GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPE 550 (621)
Q Consensus 482 ~~~f~~~~~l~LVmEyl~g-sLld~l~~~~~~----------~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~ 550 (621)
++++...+.+++||||+.+ +|.+++...... .....+++..++.++.||+.||.|||++||+||||||+
T Consensus 153 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~ 232 (370)
T 2psq_A 153 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAAR 232 (370)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGG
T ss_pred EEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchh
Confidence 9999999999999999985 888887654321 11234788999999999999999999999999999999
Q ss_pred cEEEeccCCCeEEEEecCCccccCCC-----ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 551 NILIKSYQRCEIKIIDLGSSCFQTDN-----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 551 NILl~~~~~~~IKL~DFGls~~~~~~-----~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
|||++ .++.+||+|||++...... .....+++.|+|||++.+..++.++|||||||++|||++ |+.||
T Consensus 233 NIll~--~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~ 306 (370)
T 2psq_A 233 NVLVT--ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 306 (370)
T ss_dssp GEEEC--TTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred hEEEC--CCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCC
Confidence 99998 4789999999998754432 222355788999999999999999999999999999999 99997
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=301.48 Aligned_cols=193 Identities=33% Similarity=0.643 Sum_probs=165.0
Q ss_pred ecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecC---chhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEec
Q 007035 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (621)
Q Consensus 412 i~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~---~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~ 488 (621)
+.++|.+.+.||+|+||+||+|.++.+|+.||||++... ......+.+|+.+++.++ ||||+++++++...
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~~~~~~~~~ 113 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQ------HENVIGLLDVFTPA 113 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCC------CTTBCCCSEEECSC
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcC------CCCchhhhhheecc
Confidence 568999999999999999999999999999999999763 233466778888888774 78999999999877
Q ss_pred CeE------EEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeE
Q 007035 489 EHL------FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEI 562 (621)
Q Consensus 489 ~~l------~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~I 562 (621)
... ++||||+.++|.+.+.. .+++..++.++.||+.||.|||++||+||||||+|||++ .++.+
T Consensus 114 ~~~~~~~~~~lv~e~~~~~l~~~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~--~~~~~ 183 (371)
T 4exu_A 114 SSLRNFYDFYLVMPFMQTDLQKIMGM--------EFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVN--EDCEL 183 (371)
T ss_dssp SSSTTCCCCEEEEECCCEEHHHHTTS--------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC--TTCCE
T ss_pred CCcccceeEEEEEccccccHHHHhhc--------CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEEC--CCCCE
Confidence 654 99999999988766521 188999999999999999999999999999999999998 47889
Q ss_pred EEEecCCccccCCCccccccCCcccCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 563 KIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 563 KL~DFGls~~~~~~~~~~~gt~~Y~APEvl~~-~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
||+|||++...........+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||
T Consensus 184 kL~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf 242 (371)
T 4exu_A 184 KILDFGLARHADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLF 242 (371)
T ss_dssp EECSTTCC--------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSC
T ss_pred EEEecCcccccccCcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCC
Confidence 99999999877766667788999999999987 67899999999999999999999998
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-33 Score=291.75 Aligned_cols=196 Identities=25% Similarity=0.442 Sum_probs=165.0
Q ss_pred ecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc---hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEec
Q 007035 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (621)
Q Consensus 412 i~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~---~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~ 488 (621)
..++|++++.||+|+||.||+|++..+|+.||+|++.... .....+.+|+.+++.++ ||||+++++++...
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~~~~~~~ 96 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLR------HENLVNLLEVCKKK 96 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCC------CTTBCCEEEEEEET
T ss_pred hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCC------CCCEeeEEEEeecC
Confidence 3478999999999999999999999999999999986532 23445667888888774 78999999999999
Q ss_pred CeEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecC
Q 007035 489 EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (621)
Q Consensus 489 ~~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFG 568 (621)
+..++||||++++++..+..... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||
T Consensus 97 ~~~~lv~e~~~~~~l~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~--~~~~kl~Dfg 169 (331)
T 4aaa_A 97 KRWYLVFEFVDHTILDDLELFPN-----GLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQ--SGVVKLCDFG 169 (331)
T ss_dssp TEEEEEEECCSEEHHHHHHHSTT-----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT--TSCEEECCCT
T ss_pred CEEEEEEecCCcchHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcC--CCcEEEEeCC
Confidence 99999999999877766543322 2889999999999999999999999999999999999984 7899999999
Q ss_pred CccccCCC---ccccccCCcccCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 569 SSCFQTDN---LCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 569 ls~~~~~~---~~~~~gt~~Y~APEvl~~~-~~s~ksDIWSLGvILyELltG~~PF 620 (621)
++...... .....+++.|+|||++.+. .++.++|||||||++|+|++|++||
T Consensus 170 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf 225 (331)
T 4aaa_A 170 FARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLF 225 (331)
T ss_dssp TC------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred CceeecCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCC
Confidence 98654332 2345789999999999875 6899999999999999999999998
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-33 Score=284.14 Aligned_cols=203 Identities=22% Similarity=0.276 Sum_probs=168.4
Q ss_pred eeecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecC---chhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeE
Q 007035 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (621)
Q Consensus 410 ~ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~---~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~ 486 (621)
..+.++|++++.||+|+||+||+|.+..+++.||+|++... ........+|+.++..+. .||||+++++++.
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~-----~h~~iv~~~~~~~ 81 (289)
T 1x8b_A 7 SRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLG-----QHSHVVRYFSAWA 81 (289)
T ss_dssp CHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSC-----SCTTBCCEEEEEE
T ss_pred ccccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhC-----CCCCeeeeeeeee
Confidence 34568899999999999999999999999999999999853 223445566666666553 5889999999999
Q ss_pred ecCeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEecc--------
Q 007035 487 HLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSY-------- 557 (621)
Q Consensus 487 ~~~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~-------- 557 (621)
..+..++||||+++ +|.+++....... ..+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 82 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~ 159 (289)
T 1x8b_A 82 EDDHMLIQNEYCNGGSLADAISENYRIM--SYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASE 159 (289)
T ss_dssp ETTEEEEEEECCTTCBHHHHHHHHHHHT--CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----------
T ss_pred cCCeEEEEEEecCCCcHHHHHHhhcccc--cCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCccccc
Confidence 99999999999975 8888877553321 228899999999999999999999999999999999999842
Q ss_pred ---------CCCeEEEEecCCccccCCCccccccCCcccCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 558 ---------QRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 558 ---------~~~~IKL~DFGls~~~~~~~~~~~gt~~Y~APEvl~~~-~~s~ksDIWSLGvILyELltG~~PF 620 (621)
....+||+|||++....... ...+|+.|+|||++.+. .++.++|||||||++|+|++|.+|+
T Consensus 160 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~ 231 (289)
T 1x8b_A 160 EGDEDDWASNKVMFKIGDLGHVTRISSPQ-VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLP 231 (289)
T ss_dssp ----------CCCEEECCCTTCEETTCSC-CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCC
T ss_pred ccccccccCCceEEEEcccccccccCCcc-ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCC
Confidence 24479999999987765443 34689999999999876 5668999999999999999999875
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=294.25 Aligned_cols=198 Identities=25% Similarity=0.372 Sum_probs=161.6
Q ss_pred eeecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc---hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeE
Q 007035 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (621)
Q Consensus 410 ~ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~---~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~ 486 (621)
++..++|++.+.||+|+||+||+|++ +|+.||+|++.... .....+.+|+.+++.++ ||||+++++++.
T Consensus 33 ~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~------hp~iv~~~~~~~ 104 (309)
T 3p86_A 33 DIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLR------HPNIVLFMGAVT 104 (309)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCC------CTTBCCEEEEEC
T ss_pred cCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCC------CCCEeeEEEEEE
Confidence 34567999999999999999999986 68899999987543 33456778888888874 789999999999
Q ss_pred ecCeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCC--eecccCCCccEEEeccCCCeEE
Q 007035 487 HLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLG--IIHCDLKPENILIKSYQRCEIK 563 (621)
Q Consensus 487 ~~~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~g--IvHrDLKP~NILl~~~~~~~IK 563 (621)
....+++||||+.+ +|.+++..... ...+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+|
T Consensus 105 ~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~--~~~~~k 179 (309)
T 3p86_A 105 QPPNLSIVTEYLSRGSLYRLLHKSGA---REQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVD--KKYTVK 179 (309)
T ss_dssp STTCCEEEEECCTTCBHHHHHHSTTH---HHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEEC--TTCCEE
T ss_pred ECCceEEEEecCCCCcHHHHHhhcCC---CCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEe--CCCcEE
Confidence 99999999999975 77777764321 123888999999999999999999999 99999999999998 478999
Q ss_pred EEecCCccccCCC---ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 564 IIDLGSSCFQTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 564 L~DFGls~~~~~~---~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
|+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||
T Consensus 180 L~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf 239 (309)
T 3p86_A 180 VCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPW 239 (309)
T ss_dssp ECCCC-----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTT
T ss_pred ECCCCCCccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 9999998654433 33457899999999999999999999999999999999999998
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-33 Score=287.54 Aligned_cols=202 Identities=30% Similarity=0.469 Sum_probs=168.3
Q ss_pred eeecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCch--hhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEe
Q 007035 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD--FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (621)
Q Consensus 410 ~ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~--~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~ 487 (621)
..+.++|++.+.||+|+||+||++++..+++.+|+|++..... ..+.+.+|+++++.+ .||||+++++++..
T Consensus 18 g~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l------~hp~iv~~~~~~~~ 91 (285)
T 3is5_A 18 GTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSL------DHPNIIKIFEVFED 91 (285)
T ss_dssp SCHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTC------CCTTBCCEEEEEEC
T ss_pred CChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhC------CCchHHhHHHheec
Confidence 3567899999999999999999999999999999999876432 346677888888766 47899999999999
Q ss_pred cCeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEecc-CCCeEEEE
Q 007035 488 LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSY-QRCEIKII 565 (621)
Q Consensus 488 ~~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~-~~~~IKL~ 565 (621)
....++||||+.+ +|.+.+....... ..+++..++.++.||+.||.|||++||+||||||+|||++.. ..+.+||+
T Consensus 92 ~~~~~lv~e~~~~~~L~~~l~~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~ 169 (285)
T 3is5_A 92 YHNMYIVMETCEGGELLERIVSAQARG--KALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKII 169 (285)
T ss_dssp SSEEEEEECCCSCCBHHHHHHHHHHHT--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEEC
T ss_pred CCeEEEEEEeCCCCcHHHHHHhhhhcc--cCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEE
Confidence 9999999999985 7877776543221 238899999999999999999999999999999999999642 35789999
Q ss_pred ecCCccccCC--CccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 566 DLGSSCFQTD--NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 566 DFGls~~~~~--~~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
|||++..... ......+++.|+|||++.+ .++.++||||||+++|+|++|+.||
T Consensus 170 Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~il~~ll~g~~pf 225 (285)
T 3is5_A 170 DFGLAELFKSDEHSTNAAGTALYMAPEVFKR-DVTFKCDIWSAGVVMYFLLTGCLPF 225 (285)
T ss_dssp CCCCCCC----------CTTGGGCCHHHHTT-CCCHHHHHHHHHHHHHHHHHSSCSS
T ss_pred eeecceecCCcccCcCcccccCcCChHHhcc-CCCcccCeehHHHHHHHHHhCCCCC
Confidence 9999875433 2344578999999999864 6899999999999999999999998
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-33 Score=298.36 Aligned_cols=193 Identities=33% Similarity=0.596 Sum_probs=167.2
Q ss_pred cCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecC--chhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEec--
Q 007035 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL-- 488 (621)
Q Consensus 413 ~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~--~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~-- 488 (621)
.++|++++.||+|+||.||+|.+..+++.||||++... ......+.+|+++++.++ ||||+++++++...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~~~~~~~~~~~ 99 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR------HENIIGINDIIRAPTI 99 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCC------CTTBCCCCEEECCSST
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcC------CCCCccceeEEecCCc
Confidence 47999999999999999999999999999999999753 233466778888888874 78999999998765
Q ss_pred ---CeEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEE
Q 007035 489 ---EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKII 565 (621)
Q Consensus 489 ---~~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~ 565 (621)
...++||||++++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+
T Consensus 100 ~~~~~~~iv~e~~~~~L~~~l~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~--~~~~~kl~ 170 (364)
T 3qyz_A 100 EQMKDVYIVQDLMETDLYKLLKTQ-------HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN--TTCDLKIC 170 (364)
T ss_dssp TTCCCEEEEEECCSEEHHHHHHHC-------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC--TTCCEEEC
T ss_pred cccceEEEEEcccCcCHHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEEC--CCCCEEEE
Confidence 479999999999998887542 188999999999999999999999999999999999998 47889999
Q ss_pred ecCCccccCCC------ccccccCCcccCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 566 DLGSSCFQTDN------LCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 566 DFGls~~~~~~------~~~~~gt~~Y~APEvl~~-~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
|||++...... .....+|+.|+|||++.+ ..++.++|||||||++|+|++|++||
T Consensus 171 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf 232 (364)
T 3qyz_A 171 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 232 (364)
T ss_dssp CCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSS
T ss_pred eCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCC
Confidence 99998754322 234578999999998765 45899999999999999999999998
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-33 Score=294.95 Aligned_cols=199 Identities=31% Similarity=0.525 Sum_probs=169.2
Q ss_pred eeCeeecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecC--chhhhhHHHHHHHHHHhcccCCCCCCceEEEeeE
Q 007035 407 ILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDY 484 (621)
Q Consensus 407 ~l~~ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~--~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~ 484 (621)
.+...+.++|++.+.||+|+||.||+|.+..+|+.||||++... ........+|+.+++.++ ||||++++++
T Consensus 4 ~~~~~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~~~ 77 (353)
T 2b9h_A 4 RIVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFK------HENIITIFNI 77 (353)
T ss_dssp TCCCCSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCC------CTTBCCEEEE
T ss_pred ccccccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCc------CCCcCCeeee
Confidence 34456778999999999999999999999999999999999743 233456678888888774 7899999998
Q ss_pred eEec-----CeEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCC
Q 007035 485 FYHL-----EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQR 559 (621)
Q Consensus 485 f~~~-----~~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~ 559 (621)
+... ...++||||++++|.+.+... .+++..++.++.||+.||.|||++||+||||||+|||++. +
T Consensus 78 ~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~-------~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~--~ 148 (353)
T 2b9h_A 78 QRPDSFENFNEVYIIQELMQTDLHRVISTQ-------MLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINS--N 148 (353)
T ss_dssp CCCSCSTTCCCEEEEECCCSEEHHHHHHHC-------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECT--T
T ss_pred ecccccCccceEEEEEeccCccHHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcC--C
Confidence 7754 679999999999988877642 2889999999999999999999999999999999999984 7
Q ss_pred CeEEEEecCCccccCCC-------------ccccccCCcccCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 560 CEIKIIDLGSSCFQTDN-------------LCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 560 ~~IKL~DFGls~~~~~~-------------~~~~~gt~~Y~APEvl~~-~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
+.+||+|||++...... .....+|+.|+|||++.+ ..++.++|||||||++|+|++|++||
T Consensus 149 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf 223 (353)
T 2b9h_A 149 CDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIF 223 (353)
T ss_dssp CCEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSC
T ss_pred CcEEEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCC
Confidence 88999999998754321 122467999999999865 67899999999999999999999998
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=292.58 Aligned_cols=199 Identities=29% Similarity=0.447 Sum_probs=164.9
Q ss_pred eecCceEEE-EEeccCCCCceeEEEeCCCCcEEEEEEEecCc-hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEec
Q 007035 411 VIAGRYYVT-EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (621)
Q Consensus 411 ii~~rY~I~-~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~-~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~ 488 (621)
.+.++|++. +.||+|+||+||+|++..+++.||||++.... .....+.+|+.++..+. .||||+++++++...
T Consensus 9 ~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~-----~h~~i~~~~~~~~~~ 83 (316)
T 2ac3_A 9 RFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQ-----GHRNVLELIEFFEEE 83 (316)
T ss_dssp CTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTC-----CCTTBCCEEEEEEET
T ss_pred ccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhc-----CCCCeeeEEEEEeeC
Confidence 456789996 78999999999999999999999999997643 33466788888887753 588999999999999
Q ss_pred CeEEEEEeccc-cchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCC-CeEEEEe
Q 007035 489 EHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQR-CEIKIID 566 (621)
Q Consensus 489 ~~l~LVmEyl~-gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~-~~IKL~D 566 (621)
+++++||||+. ++|.+++.... .+++..++.++.||+.||.|||+++|+||||||+|||++.+.. ..+||+|
T Consensus 84 ~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~D 157 (316)
T 2ac3_A 84 DRFYLVFEKMRGGSILSHIHKRR------HFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICD 157 (316)
T ss_dssp TEEEEEEECCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECC
T ss_pred CEEEEEEEcCCCCcHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEE
Confidence 99999999997 57887776543 2889999999999999999999999999999999999985322 3499999
Q ss_pred cCCccccCC----------CccccccCCcccCchhhcC-----CCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 567 LGSSCFQTD----------NLCLYVQSRSYRAPEVIIG-----LPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 567 FGls~~~~~----------~~~~~~gt~~Y~APEvl~~-----~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
||++..... ......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||
T Consensus 158 fg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf 226 (316)
T 2ac3_A 158 FDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPF 226 (316)
T ss_dssp TTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSC
T ss_pred ccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCC
Confidence 999865321 1123468999999999975 45788999999999999999999998
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-33 Score=283.25 Aligned_cols=195 Identities=22% Similarity=0.342 Sum_probs=168.2
Q ss_pred ecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeE
Q 007035 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (621)
Q Consensus 412 i~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l 491 (621)
..++|++.+.||+|+||.||+|.+. +++.||+|++.......+.+.+|+.+++.++ ||||+++++++.+....
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~------h~~i~~~~~~~~~~~~~ 80 (269)
T 4hcu_A 8 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLS------HPKLVQLYGVCLEQAPI 80 (269)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCC------CTTBCCEEEEECSSSSE
T ss_pred ChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCHHHHHHHHHHHHhCC------CCCEeeEEEEEecCCce
Confidence 3578999999999999999999976 5778999999876655677888988888774 78999999999999999
Q ss_pred EEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCc
Q 007035 492 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (621)
Q Consensus 492 ~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls 570 (621)
++||||+++ +|.+++..... .+++..++.++.||+.||.|||+++|+||||||+|||++. ++.+||+|||++
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~--~~~~kl~Dfg~~ 153 (269)
T 4hcu_A 81 CLVFEFMEHGCLSDYLRTQRG-----LFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGE--NQVIKVSDFGMT 153 (269)
T ss_dssp EEEEECCTTCBHHHHHHTTTT-----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECG--GGCEEECCTTGG
T ss_pred EEEEEeCCCCcHHHHHHhcCc-----ccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcC--CCCEEecccccc
Confidence 999999975 67776654322 2889999999999999999999999999999999999984 788999999998
Q ss_pred cccCCC----ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 571 CFQTDN----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 571 ~~~~~~----~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
...... .....+++.|+|||++.+..++.++||||||+++|+|++ |+.||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~ 208 (269)
T 4hcu_A 154 RFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPY 208 (269)
T ss_dssp GGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred ccccccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCC
Confidence 754432 222345778999999998899999999999999999999 99998
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-33 Score=283.34 Aligned_cols=198 Identities=27% Similarity=0.429 Sum_probs=168.7
Q ss_pred eecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCch-------hhhhHHHHHHHHHHhcccCCCCCCceEEEee
Q 007035 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD-------FFDQSLDEIKLLKLVNKNDPADEHHILRLYD 483 (621)
Q Consensus 411 ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~-------~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~ 483 (621)
++.++|++.+.||+|+||.||+|++..+++.||+|+++.... ..+.+.+|+.+++.++ ||||+++++
T Consensus 2 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~------h~~i~~~~~ 75 (283)
T 3bhy_A 2 MVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR------HPNIITLHD 75 (283)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCC------CTTBCCEEE
T ss_pred chhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCC------CCCeeehhh
Confidence 456789999999999999999999999999999999875421 2456788888888774 789999999
Q ss_pred EeEecCeEEEEEeccc-cchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccC--CC
Q 007035 484 YFYHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQ--RC 560 (621)
Q Consensus 484 ~f~~~~~l~LVmEyl~-gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~--~~ 560 (621)
++......++||||+. ++|.+++.... .+++..++.++.||+.||.|||++||+||||||+||+++.+. ..
T Consensus 76 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~ 149 (283)
T 3bhy_A 76 IFENKTDVVLILELVSGGELFDFLAEKE------SLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNP 149 (283)
T ss_dssp EEECSSEEEEEEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSC
T ss_pred eecCCCeEEEEEeecCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCC
Confidence 9999999999999996 57777775432 288999999999999999999999999999999999998532 23
Q ss_pred eEEEEecCCccccCCC--ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 561 EIKIIDLGSSCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 561 ~IKL~DFGls~~~~~~--~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
.+||+|||++...... .....+++.|+|||++.+..++.++||||||+++|+|++|+.||
T Consensus 150 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~ 211 (283)
T 3bhy_A 150 RIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 211 (283)
T ss_dssp CEEECCCTTCEECC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred ceEEEecccceeccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCC
Confidence 7999999998765432 23456899999999999989999999999999999999999998
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-33 Score=289.13 Aligned_cols=198 Identities=28% Similarity=0.456 Sum_probs=166.3
Q ss_pred ecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEe----
Q 007035 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH---- 487 (621)
Q Consensus 412 i~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~---- 487 (621)
..++|++.+.||+|+||.||+|++..+|+.||||++.........+.+|+.+++.+. .||||+++++++..
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~-----~h~~i~~~~~~~~~~~~~ 96 (326)
T 2x7f_A 22 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYS-----HHRNIATYYGAFIKKNPP 96 (326)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHC-----CSTTBCCEEEEEEECC--
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhcc-----CCCCeeeeeeEEeeccCc
Confidence 468999999999999999999999999999999999876666678889999998884 47899999999987
Q ss_pred --cCeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEE
Q 007035 488 --LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKI 564 (621)
Q Consensus 488 --~~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL 564 (621)
...+++||||+++ +|.+++..... ..+++..++.++.||+.||.|||+.||+||||||+|||++ .++.+||
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~--~~~~~kl 170 (326)
T 2x7f_A 97 GMDDQLWLVMEFCGAGSVTDLIKNTKG----NTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLT--ENAEVKL 170 (326)
T ss_dssp CCCCEEEEEEECCTTEEHHHHHHHSGG----GCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEC--TTCCEEE
T ss_pred cccceEEEEEEcCCCCcHHHHHHhccc----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEc--CCCCEEE
Confidence 4689999999985 88887765432 2388999999999999999999999999999999999998 4788999
Q ss_pred EecCCccccCCC---ccccccCCcccCchhhc-----CCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 565 IDLGSSCFQTDN---LCLYVQSRSYRAPEVII-----GLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 565 ~DFGls~~~~~~---~~~~~gt~~Y~APEvl~-----~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
+|||++...... .....+++.|+|||++. +..++.++|||||||++|+|++|+.||
T Consensus 171 ~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~ 234 (326)
T 2x7f_A 171 VDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 234 (326)
T ss_dssp CCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTT
T ss_pred eeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCC
Confidence 999998764432 23457899999999997 556899999999999999999999998
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-33 Score=288.31 Aligned_cols=193 Identities=28% Similarity=0.470 Sum_probs=166.1
Q ss_pred ecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEe--cC
Q 007035 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH--LE 489 (621)
Q Consensus 412 i~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~--~~ 489 (621)
..++|++.+.||+|+||+||+|++..+++.||+|+++... ...+.+|+.+++.++ .||||+++++++.. ..
T Consensus 34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~-----~~~~i~~~~~~~~~~~~~ 106 (330)
T 3nsz_A 34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK--KKKIKREIKILENLR-----GGPNIITLADIVKDPVSR 106 (330)
T ss_dssp EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC--HHHHHHHHHHHHHHT-----TSTTBCCEEEEEECTTTC
T ss_pred CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc--hHHHHHHHHHHHHcC-----CCCCEEEeeeeeccCCCC
Confidence 4578999999999999999999999999999999997544 367889999999986 37899999999997 67
Q ss_pred eEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCC
Q 007035 490 HLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (621)
Q Consensus 490 ~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGl 569 (621)
+.++||||+.+..+..+.. .+++..++.++.||+.||.|||++||+||||||+|||++. +...+||+|||+
T Consensus 107 ~~~lv~e~~~~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~-~~~~~kl~Dfg~ 177 (330)
T 3nsz_A 107 TPALVFEHVNNTDFKQLYQ--------TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDH-EHRKLRLIDWGL 177 (330)
T ss_dssp CEEEEEECCCCCCHHHHGG--------GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET-TTTEEEECCCTT
T ss_pred ceEEEEeccCchhHHHHHH--------hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcC-CCCEEEEEeCCC
Confidence 8999999998644333321 1788899999999999999999999999999999999985 234899999999
Q ss_pred ccccCC--CccccccCCcccCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 570 SCFQTD--NLCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 570 s~~~~~--~~~~~~gt~~Y~APEvl~~-~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
+..... ......+++.|+|||++.+ ..++.++|||||||++|+|++|+.||
T Consensus 178 a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~ 231 (330)
T 3nsz_A 178 AEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231 (330)
T ss_dssp CEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred ceEcCCCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCc
Confidence 975433 2344578999999999987 56899999999999999999999998
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-33 Score=317.45 Aligned_cols=198 Identities=28% Similarity=0.364 Sum_probs=171.5
Q ss_pred eecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc----hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeE
Q 007035 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (621)
Q Consensus 411 ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~ 486 (621)
+..++|++++.||+|+||.||+|+++.+|+.||+|++.+.. .......+|+.+++.++ ||||+++++++.
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~------hp~Iv~l~~~~~ 254 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN------SRFVVSLAYAYE 254 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCC------CTTBCCEEEEEE
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcC------CCCEeeEEEEEe
Confidence 44578999999999999999999999999999999997532 22345677888888763 789999999999
Q ss_pred ecCeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEE
Q 007035 487 HLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKII 565 (621)
Q Consensus 487 ~~~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~ 565 (621)
+.+++++||||+.+ +|.+.+..... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+
T Consensus 255 ~~~~l~lVmEy~~gg~L~~~l~~~~~----~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld--~~g~vKL~ 328 (576)
T 2acx_A 255 TKDALCLVLTLMNGGDLKFHIYHMGQ----AGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLD--DHGHIRIS 328 (576)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHSSSS----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC--TTSCEEEC
T ss_pred eCCEEEEEEEcCCCCcHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEe--CCCCeEEE
Confidence 99999999999975 67666654322 2388999999999999999999999999999999999998 47899999
Q ss_pred ecCCccccCCC--ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 566 DLGSSCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 566 DFGls~~~~~~--~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
|||++...... ....+||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 329 DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF 385 (576)
T 2acx_A 329 DLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPF 385 (576)
T ss_dssp CCTTCEECCTTCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSS
T ss_pred ecccceecccCccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCC
Confidence 99999765433 34468999999999999989999999999999999999999998
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-33 Score=293.08 Aligned_cols=208 Identities=28% Similarity=0.426 Sum_probs=173.2
Q ss_pred CCcceeeCeeecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCch-------hhhhHHHHHHHHHHhcccCCCC
Q 007035 402 KDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD-------FFDQSLDEIKLLKLVNKNDPAD 474 (621)
Q Consensus 402 ~~~pi~l~~ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~-------~~~~~~~Ei~iL~~l~~~~~~~ 474 (621)
...|......+.++|++.+.||+|+||.||+|++..+++.||||++..... ....+.+|+.+++.+.+ .
T Consensus 31 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~----~ 106 (320)
T 3a99_A 31 KLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS----G 106 (320)
T ss_dssp ---------CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCS----S
T ss_pred ccCcccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhcc----C
Confidence 344556667788999999999999999999999999999999999976431 22456789999999875 4
Q ss_pred CCceEEEeeEeEecCeEEEEEeccc--cchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccE
Q 007035 475 EHHILRLYDYFYHLEHLFIVCELLR--ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENI 552 (621)
Q Consensus 475 hpnIvrl~~~f~~~~~l~LVmEyl~--gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NI 552 (621)
|+||+++++++...+..++|||++. ++|.+++.... .+++..++.++.||+.||.|||+++|+||||||+||
T Consensus 107 ~~~i~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~------~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NI 180 (320)
T 3a99_A 107 FSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG------ALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENI 180 (320)
T ss_dssp SCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred CCCceEEEEEEecCCcEEEEEEcCCCCccHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHE
Confidence 7899999999999999999999997 67888776532 288999999999999999999999999999999999
Q ss_pred EEeccCCCeEEEEecCCccccCCC-ccccccCCcccCchhhcCCCC-CchhhHHHHHHHHHHHHhCCCCC
Q 007035 553 LIKSYQRCEIKIIDLGSSCFQTDN-LCLYVQSRSYRAPEVIIGLPY-DQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 553 Ll~~~~~~~IKL~DFGls~~~~~~-~~~~~gt~~Y~APEvl~~~~~-s~ksDIWSLGvILyELltG~~PF 620 (621)
|++. .++.+||+|||++...... .....+|+.|+|||++.+..+ +.++||||||+++|+|++|+.||
T Consensus 181 ll~~-~~~~~kL~Dfg~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf 249 (320)
T 3a99_A 181 LIDL-NRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 249 (320)
T ss_dssp EEET-TTTEEEECCCTTCEECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSC
T ss_pred EEeC-CCCCEEEeeCccccccccccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCC
Confidence 9984 3678999999998765443 334578999999999987765 67899999999999999999998
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-33 Score=283.48 Aligned_cols=197 Identities=28% Similarity=0.422 Sum_probs=169.0
Q ss_pred eecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecC-chhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecC
Q 007035 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND-KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (621)
Q Consensus 411 ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~-~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~ 489 (621)
.+.++|++.+.||+|+||.||+|.+..++..||+|.+... ....+.+.+|+.+++.+ .||||+++++++....
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l------~h~~i~~~~~~~~~~~ 79 (277)
T 3f3z_A 6 DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSL------DHPNIIRLYETFEDNT 79 (277)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTC------CCTTBCCEEEEEECSS
T ss_pred hhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhC------CCCCEeeEEEEEecCC
Confidence 3567899999999999999999999999999999998753 23346677888888766 4789999999999999
Q ss_pred eEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEec-cCCCeEEEEec
Q 007035 490 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS-YQRCEIKIIDL 567 (621)
Q Consensus 490 ~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~-~~~~~IKL~DF 567 (621)
..++||||+.+ +|.+.+..... +++..++.++.||+.||.|||++||+||||||+|||+.. +.++.++|+||
T Consensus 80 ~~~lv~e~~~~~~L~~~~~~~~~------~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Df 153 (277)
T 3f3z_A 80 DIYLVMELCTGGELFERVVHKRV------FRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDF 153 (277)
T ss_dssp EEEEEEECCCSCBHHHHHHHHCS------CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCC
T ss_pred eEEEEEeccCCCcHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEec
Confidence 99999999975 77776654332 889999999999999999999999999999999999943 14778999999
Q ss_pred CCccccCCC--ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 568 GSSCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 568 Gls~~~~~~--~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
|++...... .....+|+.|+|||++.+. ++.++||||||+++|+|++|+.||
T Consensus 154 g~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~ 207 (277)
T 3f3z_A 154 GLAARFKPGKMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPF 207 (277)
T ss_dssp TTCEECCTTSCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSS
T ss_pred ccceeccCccchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCC
Confidence 998764432 3345789999999998765 899999999999999999999998
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-33 Score=283.32 Aligned_cols=196 Identities=21% Similarity=0.327 Sum_probs=169.1
Q ss_pred eecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCe
Q 007035 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (621)
Q Consensus 411 ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~ 490 (621)
+..++|++++.||+|+||.||+|.+. ++..||+|+++......+.+.+|+.+++.++ ||||+++++++.....
T Consensus 5 l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~------h~~i~~~~~~~~~~~~ 77 (268)
T 3sxs_A 5 LKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSEDEFFQEAQTMMKLS------HPKLVKFYGVCSKEYP 77 (268)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCHHHHHHHHHHHHHCC------CTTBCCEEEEECSSSS
T ss_pred echhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcHHHHHHHHHHHHhCC------CCCEeeEEEEEccCCc
Confidence 44678999999999999999999865 6778999999876655677888999988874 7899999999999999
Q ss_pred EEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCC
Q 007035 491 LFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (621)
Q Consensus 491 l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGl 569 (621)
.++||||+++ +|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.++|+|||+
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~--~~~~~l~Dfg~ 150 (268)
T 3sxs_A 78 IYIVTEYISNGCLLNYLRSHGK-----GLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDR--DLCVKVSDFGM 150 (268)
T ss_dssp EEEEEECCTTCBHHHHHHHHGG-----GCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECT--TCCEEECCTTC
T ss_pred eEEEEEccCCCcHHHHHHHcCC-----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECC--CCCEEEccCcc
Confidence 9999999974 67777765432 2889999999999999999999999999999999999984 78999999999
Q ss_pred ccccCCCcc----ccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 570 SCFQTDNLC----LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 570 s~~~~~~~~----~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
+........ ...+++.|+|||++.+..++.++||||||+++|+|++ |+.||
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~ 206 (268)
T 3sxs_A 151 TRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPY 206 (268)
T ss_dssp EEECCTTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTT
T ss_pred ceecchhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCc
Confidence 876543321 2344667999999998889999999999999999999 99997
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-33 Score=286.00 Aligned_cols=199 Identities=21% Similarity=0.279 Sum_probs=166.0
Q ss_pred CeeecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchh--------hhhHHHHHHHHHHhcccCCCCCCceEE
Q 007035 409 NTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDF--------FDQSLDEIKLLKLVNKNDPADEHHILR 480 (621)
Q Consensus 409 ~~ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~--------~~~~~~Ei~iL~~l~~~~~~~hpnIvr 480 (621)
..+..++|++.+.||+|+||+||+|++..+++.||+|++...... .+.+.+|+.+++.+ .||||++
T Consensus 14 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l------~h~~i~~ 87 (287)
T 4f0f_A 14 PTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL------NHPNIVK 87 (287)
T ss_dssp CBCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTC------CCTTBCC
T ss_pred hhhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhC------CCCCchh
Confidence 345568999999999999999999999999999999998653321 14556677666655 4889999
Q ss_pred EeeEeEecCeEEEEEeccc-cchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCC--eecccCCCccEEEecc
Q 007035 481 LYDYFYHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLG--IIHCDLKPENILIKSY 557 (621)
Q Consensus 481 l~~~f~~~~~l~LVmEyl~-gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~g--IvHrDLKP~NILl~~~ 557 (621)
+++++.... ++||||+. ++|.+.+..... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.+
T Consensus 88 ~~~~~~~~~--~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~ 160 (287)
T 4f0f_A 88 LYGLMHNPP--RMVMEFVPCGDLYHRLLDKAH-----PIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSL 160 (287)
T ss_dssp EEEEETTTT--EEEEECCTTCBHHHHHHCTTS-----CCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCC
T ss_pred hheeecCCC--eEEEEecCCCCHHHHHhcccC-----CccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEecc
Confidence 999987665 68999998 577777754332 3889999999999999999999999 9999999999999752
Q ss_pred C---CCeEEEEecCCccccCCCccccccCCcccCchhhc--CCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 558 Q---RCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVII--GLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 558 ~---~~~IKL~DFGls~~~~~~~~~~~gt~~Y~APEvl~--~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
. ...+||+|||++...........+|+.|+|||++. ...++.++|||||||++|+|++|+.||
T Consensus 161 ~~~~~~~~kl~Dfg~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf 228 (287)
T 4f0f_A 161 DENAPVCAKVADFGLSQQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPF 228 (287)
T ss_dssp CTTCSCCEEECCCTTCBCCSSCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTT
T ss_pred CCCCceeEEeCCCCccccccccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCC
Confidence 2 22399999999987776666678999999999984 455789999999999999999999998
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-33 Score=309.39 Aligned_cols=199 Identities=33% Similarity=0.545 Sum_probs=171.0
Q ss_pred CeeecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecC---chhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEe
Q 007035 409 NTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYF 485 (621)
Q Consensus 409 ~~ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~---~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f 485 (621)
...+.++|++++.||+|+||+||+|++..+++.||||++... ......+.+|+.+++.++ ||||+++++++
T Consensus 17 ~g~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~------hpniv~~~~~~ 90 (486)
T 3mwu_A 17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLD------HPNIMKLFEIL 90 (486)
T ss_dssp CCHHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCC------CTTBCCEEEEE
T ss_pred cCChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCC------CCCcCeEEEEE
Confidence 345678999999999999999999999999999999998642 223456788999988874 78999999999
Q ss_pred EecCeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEecc-CCCeEE
Q 007035 486 YHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSY-QRCEIK 563 (621)
Q Consensus 486 ~~~~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~-~~~~IK 563 (621)
.....+++||||+.+ +|.+.+..... +++..++.++.||+.||.|||++||+||||||+|||++.. .++.+|
T Consensus 91 ~~~~~~~lv~e~~~~~~L~~~~~~~~~------~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~k 164 (486)
T 3mwu_A 91 EDSSSFYIVGELYTGGELFDEIIKRKR------FSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIK 164 (486)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEE
T ss_pred EcCCEEEEEEEcCCCCcHHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEE
Confidence 999999999999975 77777654432 8899999999999999999999999999999999999652 356899
Q ss_pred EEecCCccccCCC--ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 564 IIDLGSSCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 564 L~DFGls~~~~~~--~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
|+|||++...... .....||+.|+|||++.+ .++.++|||||||++|+|++|++||
T Consensus 165 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf 222 (486)
T 3mwu_A 165 IIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPF 222 (486)
T ss_dssp ECSCSCTTTBCCC----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSS
T ss_pred EEECCcCeECCCCCccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCC
Confidence 9999998754432 334578999999999987 5899999999999999999999998
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-33 Score=301.29 Aligned_cols=199 Identities=31% Similarity=0.559 Sum_probs=164.8
Q ss_pred CeeecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEec
Q 007035 409 NTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (621)
Q Consensus 409 ~~ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~ 488 (621)
+.....+|++.+.||+|+||+||+|++..+++ +|+|.+...... ..+|+.+++.+ .||||++++++|...
T Consensus 35 ~~~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~---~~~E~~il~~l------~h~niv~l~~~~~~~ 104 (394)
T 4e7w_A 35 GEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF---KNRELQIMRIV------KHPNVVDLKAFFYSN 104 (394)
T ss_dssp CCEEEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS---CCHHHHHHHTC------CCTTBCCEEEEEEEE
T ss_pred CCcccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch---HHHHHHHHHhC------CCCCcceEEEEEEec
Confidence 34566789999999999999999999877776 888877655432 23688888766 478999999999754
Q ss_pred C------eEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeE
Q 007035 489 E------HLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEI 562 (621)
Q Consensus 489 ~------~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~I 562 (621)
. .+++||||+.++++..+....... ..+++..++.++.||+.||.|||++||+||||||+|||++. .++.+
T Consensus 105 ~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~-~~~~~ 181 (394)
T 4e7w_A 105 GDKKDEVFLNLVLEYVPETVYRASRHYAKLK--QTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDP-PSGVL 181 (394)
T ss_dssp SSSSSCEEEEEEEECCSEEHHHHHHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEET-TTTEE
T ss_pred CCCCCceEEEEEeeccCccHHHHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcC-CCCcE
Confidence 3 489999999998877665432221 23889999999999999999999999999999999999983 47899
Q ss_pred EEEecCCccccC--CCccccccCCcccCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 563 KIIDLGSSCFQT--DNLCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 563 KL~DFGls~~~~--~~~~~~~gt~~Y~APEvl~~~-~~s~ksDIWSLGvILyELltG~~PF 620 (621)
||+|||++.... .......+|+.|+|||++.+. .++.++|||||||++|+|++|++||
T Consensus 182 kL~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf 242 (394)
T 4e7w_A 182 KLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLF 242 (394)
T ss_dssp EECCCTTCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred EEeeCCCcccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 999999997643 334456789999999999775 4899999999999999999999998
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-33 Score=288.03 Aligned_cols=191 Identities=23% Similarity=0.350 Sum_probs=158.6
Q ss_pred CeeecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEec
Q 007035 409 NTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (621)
Q Consensus 409 ~~ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~ 488 (621)
..++.++|++.+.||+|+||+||+|++ +++.||||++.... ......|.+++.... ..||||+++++++...
T Consensus 3 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~--~~~~~~e~~~~~~~~----l~h~niv~~~~~~~~~ 74 (301)
T 3q4u_A 3 QRTVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD--EKSWFRETELYNTVM----LRHENILGFIASDMTS 74 (301)
T ss_dssp -CCCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG--HHHHHHHHHHHHHTC----CCCTTBCCEEEEEEEE
T ss_pred cccccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc--chhhHHHHHHHHHhh----ccCcCeeeEEEeeccc
Confidence 456788999999999999999999986 69999999997643 345566777766643 4689999999987653
Q ss_pred ----CeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHH--------HCCeecccCCCccEEEe
Q 007035 489 ----EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLH--------SLGIIHCDLKPENILIK 555 (621)
Q Consensus 489 ----~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLH--------s~gIvHrDLKP~NILl~ 555 (621)
..+++||||+.+ +|.+++... .+++..++.++.||+.||.||| +.+|+||||||+|||++
T Consensus 75 ~~~~~~~~lv~e~~~~g~L~~~l~~~-------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~ 147 (301)
T 3q4u_A 75 RHSSTQLWLITHYHEMGSLYDYLQLT-------TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVK 147 (301)
T ss_dssp ETTEEEEEEEECCCTTCBHHHHHTTC-------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEEC
T ss_pred cCCCceeEEehhhccCCCHHHHHhhc-------ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEc
Confidence 568999999985 787777422 2889999999999999999999 99999999999999998
Q ss_pred ccCCCeEEEEecCCccccCCCc-------cccccCCcccCchhhcCC------CCCchhhHHHHHHHHHHHHhC
Q 007035 556 SYQRCEIKIIDLGSSCFQTDNL-------CLYVQSRSYRAPEVIIGL------PYDQKIDLWSLGCILAELWTG 616 (621)
Q Consensus 556 ~~~~~~IKL~DFGls~~~~~~~-------~~~~gt~~Y~APEvl~~~------~~s~ksDIWSLGvILyELltG 616 (621)
. ++.+||+|||++....... ....+|+.|+|||++.+. .++.++|||||||++|+|++|
T Consensus 148 ~--~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg 219 (301)
T 3q4u_A 148 K--NGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR 219 (301)
T ss_dssp T--TSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred C--CCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhh
Confidence 4 7899999999986543322 224789999999999876 445789999999999999999
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-33 Score=284.75 Aligned_cols=198 Identities=27% Similarity=0.406 Sum_probs=169.9
Q ss_pred CeeecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc----hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeE
Q 007035 409 NTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDY 484 (621)
Q Consensus 409 ~~ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~ 484 (621)
+....++|++.+.||+|+||.||++.+..+++.||+|++.... ...+.+.+|+.+++.+ .||||++++++
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l------~h~~iv~~~~~ 83 (294)
T 2rku_A 10 DPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL------AHQHVVGFHGF 83 (294)
T ss_dssp ETTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTC------CCTTBCCEEEE
T ss_pred CCCcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhC------CCCCEeeeeee
Confidence 3445678999999999999999999999999999999987542 2345566677777655 47899999999
Q ss_pred eEecCeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEE
Q 007035 485 FYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 563 (621)
Q Consensus 485 f~~~~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IK 563 (621)
+...+..++||||+.+ +|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+|
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~--~~~~k 155 (294)
T 2rku_A 84 FEDNDFVFVVLELCRRRSLLELHKRRK------ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNE--DLEVK 155 (294)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT--TCCEE
T ss_pred eccCCEEEEEEecCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcC--CCCEE
Confidence 9999999999999984 6766655432 2889999999999999999999999999999999999984 78899
Q ss_pred EEecCCccccCC---CccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 564 IIDLGSSCFQTD---NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 564 L~DFGls~~~~~---~~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
|+|||++..... ......+++.|+|||++.+..++.++||||||+++|+|++|+.||
T Consensus 156 l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~ 215 (294)
T 2rku_A 156 IGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPF 215 (294)
T ss_dssp ECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred EEeccCceecccCccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 999999876432 233457899999999999988999999999999999999999998
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-33 Score=288.98 Aligned_cols=200 Identities=30% Similarity=0.498 Sum_probs=171.3
Q ss_pred ecCceEEEEEeccCCCCceeEEEeC-CCCcEEEEEEEecCc---hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeE-
Q 007035 412 IAGRYYVTEYLGSAAFSKVFQAQDL-HTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY- 486 (621)
Q Consensus 412 i~~rY~I~~~LG~G~fG~Vyka~d~-~tg~~VAlKii~~~~---~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~- 486 (621)
..++|++++.||+|+||.||+|++. .+|+.||+|+++... .......+|+.+++.+.. ..||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~---~~h~~i~~~~~~~~~ 85 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET---FEHPNVVRLFDVCTV 85 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHH---TCCTTBCCEEEEEEE
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhc---cCCCCeEeeeeeeee
Confidence 3578999999999999999999985 678999999987532 223466788888888864 35899999999987
Q ss_pred ----ecCeEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeE
Q 007035 487 ----HLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEI 562 (621)
Q Consensus 487 ----~~~~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~I 562 (621)
.....++||||++++|.+++...... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+
T Consensus 86 ~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~--~~~~ 159 (326)
T 1blx_A 86 SRTDRETKLTLVFEHVDQDLTTYLDKVPEP----GVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTS--SGQI 159 (326)
T ss_dssp EECSSEEEEEEEEECCSCBHHHHHHHSCTT----CSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT--TCCE
T ss_pred cccCCCceEEEEEecCCCCHHHHHHhcccC----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcC--CCCE
Confidence 55789999999999998888754322 2889999999999999999999999999999999999984 7899
Q ss_pred EEEecCCccccCCC--ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 563 KIIDLGSSCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 563 KL~DFGls~~~~~~--~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
||+|||++...... .....+++.|+|||++.+..++.++||||||+++|+|++|+.||
T Consensus 160 kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf 219 (326)
T 1blx_A 160 KLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLF 219 (326)
T ss_dssp EECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred EEecCcccccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCC
Confidence 99999998764432 23457799999999999999999999999999999999999998
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-33 Score=310.04 Aligned_cols=198 Identities=33% Similarity=0.523 Sum_probs=169.7
Q ss_pred CeeecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc----hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeE
Q 007035 409 NTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDY 484 (621)
Q Consensus 409 ~~ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~ 484 (621)
+.+..++|.+.+.||+|+||+||+|++..+|+.||||++.... .....+.+|+.+++.+ .||||++++++
T Consensus 11 ~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l------~HpnIv~l~~~ 84 (476)
T 2y94_A 11 GRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLF------RHPHIIKLYQV 84 (476)
T ss_dssp SCCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTC------CCTTBCCEEEE
T ss_pred CCceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhC------CCCCCCcEEEE
Confidence 4456789999999999999999999999999999999997543 2234566677666544 58899999999
Q ss_pred eEecCeEEEEEeccc-cchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEE
Q 007035 485 FYHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 563 (621)
Q Consensus 485 f~~~~~l~LVmEyl~-gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IK 563 (621)
+...+.+++||||+. ++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+|
T Consensus 85 ~~~~~~~~lv~E~~~gg~L~~~l~~~~------~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~--~~~vk 156 (476)
T 2y94_A 85 ISTPSDIFMVMEYVSGGELFDYICKNG------RLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDA--HMNAK 156 (476)
T ss_dssp EECSSEEEEEEECCSSEEHHHHTTSSS------SCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECT--TCCEE
T ss_pred EEECCEEEEEEeCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEec--CCCeE
Confidence 999999999999996 57777665322 2899999999999999999999999999999999999984 78899
Q ss_pred EEecCCccccCCC--ccccccCCcccCchhhcCCCC-CchhhHHHHHHHHHHHHhCCCCC
Q 007035 564 IIDLGSSCFQTDN--LCLYVQSRSYRAPEVIIGLPY-DQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 564 L~DFGls~~~~~~--~~~~~gt~~Y~APEvl~~~~~-s~ksDIWSLGvILyELltG~~PF 620 (621)
|+|||++...... ....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||
T Consensus 157 L~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf 216 (476)
T 2y94_A 157 IADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPF 216 (476)
T ss_dssp ECCCSSCEECCTTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSS
T ss_pred EEeccchhhccccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCC
Confidence 9999998765432 344678999999999998775 68999999999999999999998
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-33 Score=281.95 Aligned_cols=197 Identities=24% Similarity=0.342 Sum_probs=170.4
Q ss_pred CeeecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEe-
Q 007035 409 NTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH- 487 (621)
Q Consensus 409 ~~ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~- 487 (621)
+..+.++|++.+.||+|+||.||+|++..+++.||+|++.... ....+|+++++.++ ||||+++++++..
T Consensus 6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~l~~l~------h~~i~~~~~~~~~~ 76 (284)
T 2a19_B 6 DKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAEREVKALAKLD------HVNIVHYNGCWDGF 76 (284)
T ss_dssp CHHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS---GGGHHHHHHHHHCC------CTTBCCEEEEEEEE
T ss_pred cchhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHhCC------CCCEEEEeeeEecc
Confidence 4557789999999999999999999999999999999998654 45678888888774 7899999998865
Q ss_pred ---------------cCeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCcc
Q 007035 488 ---------------LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPEN 551 (621)
Q Consensus 488 ---------------~~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~N 551 (621)
...+++||||+.+ +|.+++...... .+++..++.++.||+.||.|||++||+||||||+|
T Consensus 77 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~N 152 (284)
T 2a19_B 77 DYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE----KLDKVLALELFEQITKGVDYIHSKKLINRDLKPSN 152 (284)
T ss_dssp EEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGS----CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred ccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCC----CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHH
Confidence 4568999999986 888887654322 28899999999999999999999999999999999
Q ss_pred EEEeccCCCeEEEEecCCccccCCC--ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 552 ILIKSYQRCEIKIIDLGSSCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 552 ILl~~~~~~~IKL~DFGls~~~~~~--~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
||++. ++.+||+|||++...... .....+++.|+|||++.+..++.++||||||+++|+|++|..||
T Consensus 153 il~~~--~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~ 221 (284)
T 2a19_B 153 IFLVD--TKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTA 221 (284)
T ss_dssp EEEEE--TTEEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSH
T ss_pred EEEcC--CCCEEECcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcc
Confidence 99984 789999999998765432 33456899999999999999999999999999999999999886
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-33 Score=294.59 Aligned_cols=211 Identities=26% Similarity=0.371 Sum_probs=174.7
Q ss_pred CCCcceeeCeeecCceEEE-EEeccCCCCceeEEEeCCCCcEEEEEEEecCc---hhhhhHHHHHHHHHHhcccCCCCCC
Q 007035 401 NKDLPIILNTVIAGRYYVT-EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEH 476 (621)
Q Consensus 401 ~~~~pi~l~~ii~~rY~I~-~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~---~~~~~~~~Ei~iL~~l~~~~~~~hp 476 (621)
...+.+...+.+.++|.+. +.||+|+||+||+|.+..+++.||+|++.... .....+.+|+.+++.+. .||
T Consensus 15 ~~n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-----~~~ 89 (327)
T 3lm5_A 15 TENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAK-----SCP 89 (327)
T ss_dssp -CCCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTT-----TCT
T ss_pred chhhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhcc-----CCC
Confidence 3445555667788999998 89999999999999999999999999987633 23456778888888875 368
Q ss_pred ceEEEeeEeEecCeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEe
Q 007035 477 HILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIK 555 (621)
Q Consensus 477 nIvrl~~~f~~~~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~ 555 (621)
||+++++++......++||||+.+ +|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 90 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~ 165 (327)
T 3lm5_A 90 RVINLHEVYENTSEIILILEYAAGGEIFSLCLPEL----AEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLS 165 (327)
T ss_dssp TBCCEEEEEECSSEEEEEEECCTTEEGGGGGSSCC-----CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEES
T ss_pred CEEEEEEEEEeCCeEEEEEEecCCCcHHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEe
Confidence 999999999999999999999986 6666553221 22388999999999999999999999999999999999998
Q ss_pred cc-CCCeEEEEecCCccccCCC--ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 556 SY-QRCEIKIIDLGSSCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 556 ~~-~~~~IKL~DFGls~~~~~~--~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
.. ..+.+||+|||++...... .....+|+.|+|||++.+..++.++||||||+++|+|++|+.||
T Consensus 166 ~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf 233 (327)
T 3lm5_A 166 SIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPF 233 (327)
T ss_dssp CBTTBCCEEECCGGGCEEC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred cCCCCCcEEEeeCccccccCCccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 42 2578999999998765433 23457899999999999999999999999999999999999998
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-33 Score=297.42 Aligned_cols=199 Identities=27% Similarity=0.401 Sum_probs=168.6
Q ss_pred eCeeecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc--hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEe
Q 007035 408 LNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYF 485 (621)
Q Consensus 408 l~~ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f 485 (621)
.+.+..++|++++.||+|+||+||+|.+..+++.||+|++.... .....+.+|+.+++.+ .||||+++++++
T Consensus 27 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l------~h~~iv~~~~~~ 100 (360)
T 3eqc_A 27 VGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC------NSPYIVGFYGAF 100 (360)
T ss_dssp CCCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGC------CCTTBCCEEEEE
T ss_pred ccccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHC------CCCCEEEEeEEE
Confidence 45667889999999999999999999999999999999998642 2334455565555544 589999999999
Q ss_pred EecCeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHC-CeecccCCCccEEEeccCCCeEE
Q 007035 486 YHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSL-GIIHCDLKPENILIKSYQRCEIK 563 (621)
Q Consensus 486 ~~~~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~-gIvHrDLKP~NILl~~~~~~~IK 563 (621)
...+..++||||+.+ +|.+++..... +++..+..++.||+.||.|||+. ||+||||||+|||++. ++.+|
T Consensus 101 ~~~~~~~lv~e~~~~~~L~~~l~~~~~------~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~--~~~~k 172 (360)
T 3eqc_A 101 YSDGEISICMEHMDGGSLDQVLKKAGR------IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNS--RGEIK 172 (360)
T ss_dssp EETTEEEEEECCCTTCBHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECT--TCCEE
T ss_pred EECCEEEEEEECCCCCCHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECC--CCCEE
Confidence 999999999999975 78777765432 88999999999999999999996 9999999999999984 78899
Q ss_pred EEecCCccccC-CCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 564 IIDLGSSCFQT-DNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 564 L~DFGls~~~~-~~~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
|+|||++.... .......+|+.|+|||++.+..++.++|||||||++|+|++|+.||
T Consensus 173 l~Dfg~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf 230 (360)
T 3eqc_A 173 LCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 230 (360)
T ss_dssp ECCCCCCHHHHHHC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCS
T ss_pred EEECCCCcccccccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 99999986432 2233457899999999999999999999999999999999999998
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-33 Score=284.12 Aligned_cols=197 Identities=23% Similarity=0.382 Sum_probs=166.5
Q ss_pred eeecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecC
Q 007035 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (621)
Q Consensus 410 ~ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~ 489 (621)
.+..++|++++.||+|+||.||++.+. ++..||+|+++......+.+.+|+++++.++ ||||+++++++...+
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~------h~~i~~~~~~~~~~~ 92 (283)
T 3gen_A 20 EIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLS------HEKLVQLYGVCTKQR 92 (283)
T ss_dssp BCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCC------CTTBCCEEEEECSSS
T ss_pred cCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCHHHHHHHHHHHhcCC------CCCEeeEEEEEecCC
Confidence 345679999999999999999999865 6778999999876655677888888888774 789999999999999
Q ss_pred eEEEEEeccc-cchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecC
Q 007035 490 HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (621)
Q Consensus 490 ~l~LVmEyl~-gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFG 568 (621)
..++||||+. ++|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||
T Consensus 93 ~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~--~~~~~kl~Dfg 165 (283)
T 3gen_A 93 PIFIITEYMANGCLLNYLREMRH-----RFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVN--DQGVVKVSDFG 165 (283)
T ss_dssp SEEEEECCCTTCBHHHHHHCGGG-----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEEC--TTSCEEECSTT
T ss_pred CeEEEEeccCCCcHHHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEc--CCCCEEEcccc
Confidence 9999999996 577777764332 288999999999999999999999999999999999998 47889999999
Q ss_pred CccccCCC----ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 569 SSCFQTDN----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 569 ls~~~~~~----~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
++...... .....+++.|+|||++.+..++.++||||||+++|+|++ |+.||
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~ 222 (283)
T 3gen_A 166 LSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPY 222 (283)
T ss_dssp GGGGBCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred ccccccccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCc
Confidence 98755432 222345778999999998899999999999999999998 99998
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-33 Score=294.69 Aligned_cols=199 Identities=25% Similarity=0.329 Sum_probs=165.1
Q ss_pred CeeecCceEEEEEeccCCCCceeEEEeCCCCc---EEEEEEEecC--chhhhhHHHHHHHHHHhcccCCCCCCceEEEee
Q 007035 409 NTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGV---DVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYD 483 (621)
Q Consensus 409 ~~ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~---~VAlKii~~~--~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~ 483 (621)
..+..++|++.+.||+|+||+||+|++..+++ .||||+++.. ......+.+|+.+++.+ .||||+++++
T Consensus 44 ~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l------~h~~iv~~~~ 117 (325)
T 3kul_A 44 REIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQF------DHPNIIRLEG 117 (325)
T ss_dssp CBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTC------CCTTBCCEEE
T ss_pred cccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhC------CCCCCCcEEE
Confidence 34567899999999999999999999986555 4999999863 23345566777776655 4889999999
Q ss_pred EeEecCeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeE
Q 007035 484 YFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEI 562 (621)
Q Consensus 484 ~f~~~~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~I 562 (621)
++...+..++||||+.+ +|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||++ .++.+
T Consensus 118 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~--~~~~~ 190 (325)
T 3kul_A 118 VVTRGRLAMIVTEYMENGSLDTFLRTHDG-----QFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVD--SNLVC 190 (325)
T ss_dssp EECGGGCCEEEEECCTTCBHHHHHHTTTT-----CSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--TTCCE
T ss_pred EEEeCCccEEEeeCCCCCcHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEC--CCCCE
Confidence 99999999999999975 77777654322 288999999999999999999999999999999999998 47899
Q ss_pred EEEecCCccccCCCc------cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 563 KIIDLGSSCFQTDNL------CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 563 KL~DFGls~~~~~~~------~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
||+|||++....... ....+|+.|+|||++.+..++.++|||||||++|+|++ |+.||
T Consensus 191 kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~ 255 (325)
T 3kul_A 191 KVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPY 255 (325)
T ss_dssp EECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred EECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCc
Confidence 999999987654321 12244678999999998899999999999999999999 99998
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-33 Score=287.99 Aligned_cols=199 Identities=24% Similarity=0.314 Sum_probs=165.0
Q ss_pred CeeecCceEEEEEeccCCCCceeEEE----eCCCCcEEEEEEEecCc-hhhhhHHHHHHHHHHhcccCCCCCCceEEEee
Q 007035 409 NTVIAGRYYVTEYLGSAAFSKVFQAQ----DLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYD 483 (621)
Q Consensus 409 ~~ii~~rY~I~~~LG~G~fG~Vyka~----d~~tg~~VAlKii~~~~-~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~ 483 (621)
..+..++|++++.||+|+||+||+|+ +..+++.||+|++.... ...+.+.+|+.+++.++ ||||+++++
T Consensus 5 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~~ 78 (295)
T 3ugc_A 5 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ------HDNIVKYKG 78 (295)
T ss_dssp -CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCC------CTTBCCEEE
T ss_pred CcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCC------CCCEeeEEE
Confidence 34567899999999999999999998 67789999999987643 33456778888887764 789999999
Q ss_pred EeEec--CeEEEEEeccc-cchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCC
Q 007035 484 YFYHL--EHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRC 560 (621)
Q Consensus 484 ~f~~~--~~l~LVmEyl~-gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~ 560 (621)
++... .++++||||+. ++|.+++..... .+++..+..++.||+.||.|||+++|+||||||+|||++. ++
T Consensus 79 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~--~~ 151 (295)
T 3ugc_A 79 VCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE-----RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVEN--EN 151 (295)
T ss_dssp EECHHHHTSCEEEEECCTTCBHHHHHHHCGG-----GCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEE--TT
T ss_pred EEecCCCCceEEEEEeCCCCCHHHHHHhccc-----ccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcC--CC
Confidence 98654 56899999996 588888765433 2888999999999999999999999999999999999984 78
Q ss_pred eEEEEecCCccccCCC------ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 561 EIKIIDLGSSCFQTDN------LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 561 ~IKL~DFGls~~~~~~------~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
.+||+|||++...... .....+++.|+|||++.+..++.++||||||+++|+|++|..||
T Consensus 152 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~ 217 (295)
T 3ugc_A 152 RVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKS 217 (295)
T ss_dssp EEEECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTT
T ss_pred eEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhccccc
Confidence 9999999998765432 12234567799999999999999999999999999999998886
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-33 Score=307.45 Aligned_cols=202 Identities=31% Similarity=0.517 Sum_probs=169.5
Q ss_pred eeeCeeecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc--------------hhhhhHHHHHHHHHHhcccC
Q 007035 406 IILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--------------DFFDQSLDEIKLLKLVNKND 471 (621)
Q Consensus 406 i~l~~ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~--------------~~~~~~~~Ei~iL~~l~~~~ 471 (621)
......+.++|++++.||+|+||+||+|+++.+++.||+|++.... ...+.+.+|+.+++.+
T Consensus 28 ~~~~~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---- 103 (504)
T 3q5i_A 28 RKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL---- 103 (504)
T ss_dssp CEECSCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTC----
T ss_pred eccCCCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhC----
Confidence 3344557889999999999999999999999999999999987543 2345667788887766
Q ss_pred CCCCCceEEEeeEeEecCeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCc
Q 007035 472 PADEHHILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPE 550 (621)
Q Consensus 472 ~~~hpnIvrl~~~f~~~~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~ 550 (621)
.||||+++++++....++++||||+.+ +|.+.+..... +++..++.++.||+.||.|||++||+||||||+
T Consensus 104 --~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~ 175 (504)
T 3q5i_A 104 --DHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHK------FDECDAANIMKQILSGICYLHKHNIVHRDIKPE 175 (504)
T ss_dssp --CCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSC------CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred --CCCCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHH
Confidence 478999999999999999999999975 77777764432 889999999999999999999999999999999
Q ss_pred cEEEeccCC-CeEEEEecCCccccCCC--ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 551 NILIKSYQR-CEIKIIDLGSSCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 551 NILl~~~~~-~~IKL~DFGls~~~~~~--~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
|||++.+.. ..+||+|||++...... .....||+.|+|||++.+ .++.++|||||||++|+|++|++||
T Consensus 176 Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf 247 (504)
T 3q5i_A 176 NILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPF 247 (504)
T ss_dssp GEEESSTTCCSSEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred HEEEecCCCCccEEEEECCCCEEcCCCCccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCC
Confidence 999985322 37999999999765433 344678999999999875 6899999999999999999999998
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-33 Score=290.74 Aligned_cols=192 Identities=24% Similarity=0.412 Sum_probs=164.6
Q ss_pred ceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCch-hhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeEEE
Q 007035 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD-FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFI 493 (621)
Q Consensus 415 rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~-~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l~L 493 (621)
.|...+.||+|+||.||+|++..+|+.||||++..... ..+.+.+|+.+++.+ .||||+++++++...+..++
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~~~~~~~~~~~~~l 119 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDY------QHFNVVEMYKSYLVGEELWV 119 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTC------CCTTBCCEEEEEEETTEEEE
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhC------CCCCcceEEEEEEECCEEEE
Confidence 57888899999999999999999999999999975432 334566777776555 47899999999999999999
Q ss_pred EEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCccc
Q 007035 494 VCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF 572 (621)
Q Consensus 494 VmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~~ 572 (621)
||||+.+ +|.+++.. . .+++..+..++.||+.||.|||+.||+||||||+|||++. ++.+||+|||++..
T Consensus 120 v~e~~~~~~L~~~l~~-~------~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~--~~~~kl~Dfg~~~~ 190 (321)
T 2c30_A 120 LMEFLQGGALTDIVSQ-V------RLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTL--DGRVKLSDFGFCAQ 190 (321)
T ss_dssp EECCCCSCBHHHHHTT-C------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT--TCCEEECCCTTCEE
T ss_pred EEecCCCCCHHHHHHh-c------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECC--CCcEEEeeeeeeee
Confidence 9999986 55555432 1 2889999999999999999999999999999999999984 78899999999876
Q ss_pred cCCC---ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 007035 573 QTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCLI 621 (621)
Q Consensus 573 ~~~~---~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF~ 621 (621)
.... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||.
T Consensus 191 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~ 242 (321)
T 2c30_A 191 ISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYF 242 (321)
T ss_dssp CCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred cccCccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 5432 334578999999999999999999999999999999999999983
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-33 Score=310.16 Aligned_cols=199 Identities=33% Similarity=0.535 Sum_probs=170.9
Q ss_pred CeeecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecC----chhhhhHHHHHHHHHHhcccCCCCCCceEEEeeE
Q 007035 409 NTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDY 484 (621)
Q Consensus 409 ~~ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~----~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~ 484 (621)
...+.++|++.+.||+|+||+||+|++..+|+.||||++... ......+.+|+.+++.+ .||||++++++
T Consensus 21 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l------~hpniv~~~~~ 94 (484)
T 3nyv_A 21 TAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL------DHPNIMKLYEF 94 (484)
T ss_dssp CCCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTC------CCTTBCCEEEE
T ss_pred CCcccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhC------CCCCCCcEEEE
Confidence 456778999999999999999999999999999999998753 22345667777777655 58899999999
Q ss_pred eEecCeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEec-cCCCeE
Q 007035 485 FYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS-YQRCEI 562 (621)
Q Consensus 485 f~~~~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~-~~~~~I 562 (621)
+...+..++||||+.+ +|.+.+.... .+++..++.++.||+.||.|||++||+||||||+|||++. ..++.+
T Consensus 95 ~~~~~~~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~ 168 (484)
T 3nyv_A 95 FEDKGYFYLVGEVYTGGELFDEIISRK------RFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANI 168 (484)
T ss_dssp EECSSEEEEEECCCCSCBHHHHHHTCS------CCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCE
T ss_pred EEeCCEEEEEEecCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcE
Confidence 9999999999999974 7777765432 2899999999999999999999999999999999999964 246789
Q ss_pred EEEecCCccccCCC--ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 563 KIIDLGSSCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 563 KL~DFGls~~~~~~--~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
||+|||++...... .....||+.|+|||++.+ .++.++|||||||++|+|++|++||
T Consensus 169 kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf 227 (484)
T 3nyv_A 169 RIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPF 227 (484)
T ss_dssp EECCTTHHHHBCCCCSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred EEEeeeeeEEcccccccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCC
Confidence 99999998765433 334678999999999987 6899999999999999999999998
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-33 Score=283.43 Aligned_cols=195 Identities=28% Similarity=0.435 Sum_probs=163.6
Q ss_pred ecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCch----hhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEe
Q 007035 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD----FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (621)
Q Consensus 412 i~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~----~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~ 487 (621)
..++|++.+.||+|+||+||+|.+..+++.||+|++..... ....+.+|+.+++.+ .||||+++++++..
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~~ 80 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL------RHPNILRLYGYFHD 80 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTC------CCTTBCCEEEEEEC
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcC------CCCCCcchhheEec
Confidence 34789999999999999999999999999999999875321 223455566555544 58899999999999
Q ss_pred cCeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEe
Q 007035 488 LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (621)
Q Consensus 488 ~~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~D 566 (621)
....++||||+.+ +|.+.+..... +++..++.++.||+.||.|||++||+||||||+|||++. ++.++|+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~------~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~--~~~~~l~D 152 (279)
T 3fdn_A 81 ATRVYLILEYAPLGTVYRELQKLSK------FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGS--AGELKIAD 152 (279)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECT--TSCEEECS
T ss_pred CCEEEEEEecCCCCcHHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcC--CCCEEEEe
Confidence 9999999999984 77777654322 889999999999999999999999999999999999984 78899999
Q ss_pred cCCccccCCC-ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 567 LGSSCFQTDN-LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 567 FGls~~~~~~-~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
||++...... .....+++.|+|||++.+..++.++||||||+++|+|++|+.||
T Consensus 153 fg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~ 207 (279)
T 3fdn_A 153 FGWSVHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 207 (279)
T ss_dssp CCEESCC--------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTT
T ss_pred ccccccCCcccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCC
Confidence 9987654332 34457899999999999999999999999999999999999998
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-33 Score=285.61 Aligned_cols=197 Identities=27% Similarity=0.455 Sum_probs=164.4
Q ss_pred eeecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecC
Q 007035 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (621)
Q Consensus 410 ~ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~ 489 (621)
....++|++.+.||.|+||.||+|.+..+|+.||+|++..... ...+.+|+.+++.+ .||||+++++++...+
T Consensus 25 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~e~~~l~~l------~h~~i~~~~~~~~~~~ 97 (314)
T 3com_A 25 KQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD-LQEIIKEISIMQQC------DSPHVVKYYGSYFKNT 97 (314)
T ss_dssp -----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC-CHHHHHHHHHHHTC------CCTTBCCEEEEEEETT
T ss_pred hcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH-HHHHHHHHHHHHhC------CCCCCccEEEEEEeCC
Confidence 4456789999999999999999999999999999999986543 35677888887766 4789999999999999
Q ss_pred eEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecC
Q 007035 490 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (621)
Q Consensus 490 ~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFG 568 (621)
..++||||+++ +|.+++..... .+++..++.++.||+.||.|||+.||+||||||+||+++. ++.+||+|||
T Consensus 98 ~~~lv~e~~~~~~L~~~~~~~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~--~~~~kl~dfg 170 (314)
T 3com_A 98 DLWIVMEYCGAGSVSDIIRLRNK-----TLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNT--EGHAKLADFG 170 (314)
T ss_dssp EEEEEEECCTTEEHHHHHHHHTC-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT--TCCEEECCCT
T ss_pred EEEEEeecCCCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECC--CCCEEEeecc
Confidence 99999999986 77777653322 2889999999999999999999999999999999999984 7889999999
Q ss_pred CccccCCC---ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 569 SSCFQTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 569 ls~~~~~~---~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
++...... .....+++.|+|||++.+..++.++||||||+++|+|++|+.||
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~ 225 (314)
T 3com_A 171 VAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPY 225 (314)
T ss_dssp TCEECBTTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTT
T ss_pred cchhhhhhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCC
Confidence 98765433 23456899999999999989999999999999999999999998
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=294.85 Aligned_cols=191 Identities=26% Similarity=0.275 Sum_probs=157.7
Q ss_pred cCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecC---
Q 007035 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE--- 489 (621)
Q Consensus 413 ~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~--- 489 (621)
.++|++.+.||+|+||+||+|++. ++.||||++............|+.++ ..+.||||+++++++....
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~E~~~l------~~l~hpniv~~~~~~~~~~~~~ 94 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQNEYEVYSL------PGMKHENILQFIGAEKRGTSVD 94 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGHHHHHHHHHHHTS------TTCCCTTBCCEEEEEEEECSSS
T ss_pred hhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCchHHHHHHHHHHHH------hcCCCCCchhhcceeccCCCCC
Confidence 468999999999999999999864 89999999976554333333444433 3446899999999998753
Q ss_pred -eEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHC----------CeecccCCCccEEEecc
Q 007035 490 -HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSL----------GIIHCDLKPENILIKSY 557 (621)
Q Consensus 490 -~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~----------gIvHrDLKP~NILl~~~ 557 (621)
++++||||+.+ +|.+++... .+++..++.++.||+.||.|||+. +|+||||||+|||++
T Consensus 95 ~~~~lv~e~~~~g~L~~~l~~~-------~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~-- 165 (322)
T 3soc_A 95 VDLWLITAFHEKGSLSDFLKAN-------VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLK-- 165 (322)
T ss_dssp EEEEEEEECCTTCBHHHHHHHC-------CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEEC--
T ss_pred ceEEEEEecCCCCCHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEEC--
Confidence 58999999975 787777542 188999999999999999999999 999999999999998
Q ss_pred CCCeEEEEecCCccccCCC-----ccccccCCcccCchhhcCC-----CCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 558 QRCEIKIIDLGSSCFQTDN-----LCLYVQSRSYRAPEVIIGL-----PYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 558 ~~~~IKL~DFGls~~~~~~-----~~~~~gt~~Y~APEvl~~~-----~~s~ksDIWSLGvILyELltG~~PF 620 (621)
.++.+||+|||++...... .....+|+.|+|||++.+. .++.++|||||||++|+|++|+.||
T Consensus 166 ~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf 238 (322)
T 3soc_A 166 NNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAA 238 (322)
T ss_dssp TTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTS
T ss_pred CCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCC
Confidence 4789999999998654332 2235789999999999873 4566889999999999999999987
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-33 Score=283.25 Aligned_cols=194 Identities=27% Similarity=0.484 Sum_probs=146.2
Q ss_pred CceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCch----hhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecC
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD----FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~----~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~ 489 (621)
++|++.+.||+|+||.||+|++..+|+.||+|++..... ....+.+|+.+++.+ .||||+++++++...+
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~~~~ 84 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQL------KHPSILELYNYFEDSN 84 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTB------CCTTBCCEEEEEECSS
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhC------CCCCeEeEEEEEccCC
Confidence 579999999999999999999999999999999975432 224556666666554 4789999999999999
Q ss_pred eEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecC
Q 007035 490 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (621)
Q Consensus 490 ~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFG 568 (621)
..++||||+++ +|.+++.... ..+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~--~~~~kl~dfg 157 (278)
T 3cok_A 85 YVYLVLEMCHNGEMNRYLKNRV-----KPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTR--NMNIKIADFG 157 (278)
T ss_dssp EEEEEEECCTTEEHHHHHHTCS-----SCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECT--TCCEEECCCT
T ss_pred eEEEEEecCCCCcHHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcC--CCCEEEEeec
Confidence 99999999975 6766665322 23889999999999999999999999999999999999984 7889999999
Q ss_pred CccccCCC---ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 569 SSCFQTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 569 ls~~~~~~---~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
++...... .....+++.|+|||++.+..++.++||||||+++|+|++|+.||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~ 212 (278)
T 3cok_A 158 LATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPF 212 (278)
T ss_dssp TCEECC----------------------------CTHHHHHHHHHHHHHHSSCSS
T ss_pred ceeeccCCCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 98765422 23457899999999999988999999999999999999999998
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-33 Score=290.60 Aligned_cols=197 Identities=27% Similarity=0.404 Sum_probs=169.7
Q ss_pred eeecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc----hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEe
Q 007035 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYF 485 (621)
Q Consensus 410 ~ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f 485 (621)
....++|++.+.||+|+||.||++.+..+++.||+|++.... ...+.+.+|+.+++.+ .||||+++++++
T Consensus 37 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l------~h~~iv~~~~~~ 110 (335)
T 2owb_A 37 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL------AHQHVVGFHGFF 110 (335)
T ss_dssp TTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTC------CCTTBCCEEEEE
T ss_pred cccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhC------CCCCCCeEEEEE
Confidence 344578999999999999999999999999999999987542 3345566777777655 478999999999
Q ss_pred EecCeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEE
Q 007035 486 YHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKI 564 (621)
Q Consensus 486 ~~~~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL 564 (621)
.+.+.+++||||+.+ +|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||
T Consensus 111 ~~~~~~~lv~e~~~~~~L~~~~~~~~------~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~--~~~~kl 182 (335)
T 2owb_A 111 EDNDFVFVVLELCRRRSLLELHKRRK------ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNE--DLEVKI 182 (335)
T ss_dssp ECSSEEEEEECCCTTCBHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECT--TCCEEE
T ss_pred ecCCeEEEEEecCCCCCHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcC--CCCEEE
Confidence 999999999999985 6777665432 2889999999999999999999999999999999999984 788999
Q ss_pred EecCCccccCC---CccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 565 IDLGSSCFQTD---NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 565 ~DFGls~~~~~---~~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
+|||++..... ......+++.|+|||++.+..++.++||||||+++|+|++|+.||
T Consensus 183 ~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf 241 (335)
T 2owb_A 183 GDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPF 241 (335)
T ss_dssp CCCTTCEECCSTTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred eeccCceecccCcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCC
Confidence 99999876432 233457899999999999999999999999999999999999998
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-33 Score=297.75 Aligned_cols=205 Identities=20% Similarity=0.243 Sum_probs=168.1
Q ss_pred eeecCceEEEEEeccCCCCceeEEE-----eCCCCcEEEEEEEecC--chhhhhHHHHHHHHHHhcccCCCCCCceEEEe
Q 007035 410 TVIAGRYYVTEYLGSAAFSKVFQAQ-----DLHTGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLY 482 (621)
Q Consensus 410 ~ii~~rY~I~~~LG~G~fG~Vyka~-----d~~tg~~VAlKii~~~--~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~ 482 (621)
.+..++|++++.||+|+||+||+|+ +..+++.||||+++.. ......+.+|+.+++.+ .||||++++
T Consensus 67 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l------~hpnIv~~~ 140 (367)
T 3l9p_A 67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF------NHQNIVRCI 140 (367)
T ss_dssp BCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHC------CCTTBCCEE
T ss_pred hcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhC------CCCCCCeEE
Confidence 4456789999999999999999999 5567889999998753 33344667788888777 478999999
Q ss_pred eEeEecCeEEEEEeccc-cchHHHHHhhhccC-CCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccC-C
Q 007035 483 DYFYHLEHLFIVCELLR-ANLYEFQKFNQESG-GEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQ-R 559 (621)
Q Consensus 483 ~~f~~~~~l~LVmEyl~-gsLld~l~~~~~~~-~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~-~ 559 (621)
+++......++||||+. ++|.+++....... ....+++..++.++.||+.||.|||++||+||||||+|||++.+. .
T Consensus 141 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~ 220 (367)
T 3l9p_A 141 GVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPG 220 (367)
T ss_dssp EEECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTT
T ss_pred EEEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCC
Confidence 99999999999999996 58888877654221 223488999999999999999999999999999999999998532 3
Q ss_pred CeEEEEecCCccccC-----CCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 560 CEIKIIDLGSSCFQT-----DNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 560 ~~IKL~DFGls~~~~-----~~~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
..+||+|||++.... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||
T Consensus 221 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf 287 (367)
T 3l9p_A 221 RVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY 287 (367)
T ss_dssp CCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred ceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 469999999986421 22233567889999999999999999999999999999998 99998
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-33 Score=281.86 Aligned_cols=195 Identities=27% Similarity=0.448 Sum_probs=169.2
Q ss_pred ecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc----hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEe
Q 007035 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (621)
Q Consensus 412 i~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~ 487 (621)
..++|++.+.||+|+||.||+|++..+++.||+|++.... .....+.+|+.+++.+ .||||+++++++..
T Consensus 12 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~~ 85 (284)
T 2vgo_A 12 TIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHL------RHPNILRMYNYFHD 85 (284)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC------CCTTBCCEEEEEEC
T ss_pred hhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcC------CCCCEeeEEEEEEc
Confidence 3478999999999999999999999999999999987532 2234566777777766 47899999999999
Q ss_pred cCeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEe
Q 007035 488 LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (621)
Q Consensus 488 ~~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~D 566 (621)
.+..++||||+.+ +|.+.+..... +++..++.++.||+.||.|||++||+||||||+||+++. ++.++|+|
T Consensus 86 ~~~~~lv~e~~~~~~L~~~l~~~~~------~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~--~~~~kl~D 157 (284)
T 2vgo_A 86 RKRIYLMLEFAPRGELYKELQKHGR------FDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGY--KGELKIAD 157 (284)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECT--TCCEEECC
T ss_pred CCEEEEEEEeCCCCcHHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcC--CCCEEEec
Confidence 9999999999974 78877765432 889999999999999999999999999999999999984 78899999
Q ss_pred cCCccccCC-CccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 567 LGSSCFQTD-NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 567 FGls~~~~~-~~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
||++..... ......+++.|+|||++.+..++.++||||||+++|+|++|+.||
T Consensus 158 fg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf 212 (284)
T 2vgo_A 158 FGWSVHAPSLRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPF 212 (284)
T ss_dssp CTTCEECSSSCBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTT
T ss_pred ccccccCcccccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCC
Confidence 999865443 233457899999999999999999999999999999999999998
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-33 Score=295.63 Aligned_cols=200 Identities=15% Similarity=0.177 Sum_probs=164.7
Q ss_pred cCceEEEEEeccCCCCceeEEEeCC--------CCcEEEEEEEecCchhhhhHHHHHHHHHHhcccC---------CCCC
Q 007035 413 AGRYYVTEYLGSAAFSKVFQAQDLH--------TGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKND---------PADE 475 (621)
Q Consensus 413 ~~rY~I~~~LG~G~fG~Vyka~d~~--------tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~---------~~~h 475 (621)
.++|++.+.||+|+||.||+|++.. .++.||+|++... ..+.+|+.+++.+++++ ...+
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence 5799999999999999999999987 4889999999865 35678888888886421 1123
Q ss_pred CceEEEeeEeEe-cCeEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEE
Q 007035 476 HHILRLYDYFYH-LEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILI 554 (621)
Q Consensus 476 pnIvrl~~~f~~-~~~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl 554 (621)
++++++++++.. ....++||||++++|.+++..... ..+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 117 ~~i~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~ 192 (352)
T 2jii_A 117 LAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPK----HVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFV 192 (352)
T ss_dssp CSCCCCCEEEEETTTEEEEEEECCCEEHHHHHHHSGG----GCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEE
T ss_pred cCccchhhccccCCcEEEEEecCCCcCHHHHHHhCCc----CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEE
Confidence 445557888876 688999999998899998875422 228999999999999999999999999999999999999
Q ss_pred eccCCCeEEEEecCCccccCCC----------ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 555 KSYQRCEIKIIDLGSSCFQTDN----------LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 555 ~~~~~~~IKL~DFGls~~~~~~----------~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
+.+....+||+|||++...... .....+|+.|+|||++.+..++.++|||||||+||+|++|+.||
T Consensus 193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf 268 (352)
T 2jii_A 193 DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPW 268 (352)
T ss_dssp ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTT
T ss_pred cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence 9522238999999998654321 13347899999999999999999999999999999999999998
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-33 Score=298.35 Aligned_cols=196 Identities=34% Similarity=0.512 Sum_probs=163.3
Q ss_pred ecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCch------hhhhHHHHHHHHHHhcccCCCCCCceEEEeeEe
Q 007035 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD------FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYF 485 (621)
Q Consensus 412 i~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~------~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f 485 (621)
..++|++.+.||+|+||.||+|.+..+|+.||+|++..... ....+.+|+.+++.++ ||||+++++++
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~~~~ 81 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS------HPNIIGLLDAF 81 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCC------CTTBCCEEEEE
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCC------CCCCCeEEEEE
Confidence 35789999999999999999999999999999999875321 2345678888888774 78999999999
Q ss_pred EecCeEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEE
Q 007035 486 YHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKII 565 (621)
Q Consensus 486 ~~~~~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~ 565 (621)
......++||||+++++.+.+.... ..+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+
T Consensus 82 ~~~~~~~lv~e~~~~~l~~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~--~~~~kl~ 154 (346)
T 1ua2_A 82 GHKSNISLVFDFMETDLEVIIKDNS-----LVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDE--NGVLKLA 154 (346)
T ss_dssp CCTTCCEEEEECCSEEHHHHHTTCC-----SSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT--TCCEEEC
T ss_pred eeCCceEEEEEcCCCCHHHHHHhcC-----cCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcC--CCCEEEE
Confidence 9999999999999998888776432 23788899999999999999999999999999999999984 7899999
Q ss_pred ecCCccccCCC---ccccccCCcccCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 566 DLGSSCFQTDN---LCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 566 DFGls~~~~~~---~~~~~gt~~Y~APEvl~~~-~~s~ksDIWSLGvILyELltG~~PF 620 (621)
|||++...... .....+|+.|+|||++.+. .++.++|||||||++|+|++|.+||
T Consensus 155 Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~ 213 (346)
T 1ua2_A 155 DFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFL 213 (346)
T ss_dssp CCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSS
T ss_pred ecccceeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCC
Confidence 99998765332 3345789999999999764 4899999999999999999999987
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-33 Score=286.32 Aligned_cols=199 Identities=32% Similarity=0.480 Sum_probs=169.6
Q ss_pred eeecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCch-hhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEec
Q 007035 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD-FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (621)
Q Consensus 410 ~ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~-~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~ 488 (621)
..+.++|++.+.||+|+||.||++++..+|+.||+|++..... ....+.+|+.+++.++ ||||+++++++...
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~ 78 (304)
T 2jam_A 5 TNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIK------HENIVTLEDIYEST 78 (304)
T ss_dssp -CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCC------CTTBCCEEEEEECS
T ss_pred cchhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCC------CCCeeehhhhcccC
Confidence 3466899999999999999999999999999999999986532 2345678888888774 78999999999999
Q ss_pred CeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEec-cCCCeEEEEe
Q 007035 489 EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS-YQRCEIKIID 566 (621)
Q Consensus 489 ~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~-~~~~~IKL~D 566 (621)
...++||||+.+ +|.+.+.... .+++..++.++.||+.||.|||++||+||||||+|||+.. +.++.++|+|
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~D 152 (304)
T 2jam_A 79 THYYLVMQLVSGGELFDRILERG------VYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITD 152 (304)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCS
T ss_pred CEEEEEEEcCCCccHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEcc
Confidence 999999999974 7777775433 2889999999999999999999999999999999999942 2578899999
Q ss_pred cCCccccCCC-ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 567 LGSSCFQTDN-LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 567 FGls~~~~~~-~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
||++...... .....+++.|+|||++.+..++.++||||||+++|+|++|+.||
T Consensus 153 fg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf 207 (304)
T 2jam_A 153 FGLSKMEQNGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPF 207 (304)
T ss_dssp CSTTCCCCCBTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred CCcceecCCCccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCC
Confidence 9998654432 33456899999999999999999999999999999999999998
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-32 Score=280.31 Aligned_cols=197 Identities=30% Similarity=0.465 Sum_probs=169.7
Q ss_pred eecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc----------hhhhhHHHHHHHHHHhcccCCCCCCceEE
Q 007035 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----------DFFDQSLDEIKLLKLVNKNDPADEHHILR 480 (621)
Q Consensus 411 ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~----------~~~~~~~~Ei~iL~~l~~~~~~~hpnIvr 480 (621)
.+.++|++.+.||+|+||.||+|.++.+|+.||||++.... ...+...+|+.+++.+. .||||++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-----~h~~i~~ 88 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVS-----GHPNIIQ 88 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHT-----TCTTBCC
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhc-----CCCCEee
Confidence 45689999999999999999999999999999999997542 23456678888888875 4789999
Q ss_pred EeeEeEecCeEEEEEeccc-cchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCC
Q 007035 481 LYDYFYHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQR 559 (621)
Q Consensus 481 l~~~f~~~~~l~LVmEyl~-gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~ 559 (621)
+++++......++||||+. ++|.+++.... .+++..++.++.||+.||.|||++||+||||||+||+++ .+
T Consensus 89 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~--~~ 160 (298)
T 1phk_A 89 LKDTYETNTFFFLVFDLMKKGELFDYLTEKV------TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLD--DD 160 (298)
T ss_dssp EEEEEECSSEEEEEEECCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--TT
T ss_pred eeeeeccCCeEEEEEeccCCCcHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEc--CC
Confidence 9999999999999999998 57877776432 288999999999999999999999999999999999998 47
Q ss_pred CeEEEEecCCccccCC--CccccccCCcccCchhhc------CCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 560 CEIKIIDLGSSCFQTD--NLCLYVQSRSYRAPEVII------GLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 560 ~~IKL~DFGls~~~~~--~~~~~~gt~~Y~APEvl~------~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
+.+||+|||++..... ......+++.|+|||++. ...++.++||||||+++|+|++|+.||
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~ 229 (298)
T 1phk_A 161 MNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 229 (298)
T ss_dssp CCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred CcEEEecccchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCC
Confidence 8899999999876543 233457899999999985 456889999999999999999999998
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-33 Score=307.43 Aligned_cols=197 Identities=34% Similarity=0.545 Sum_probs=165.0
Q ss_pred eecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc---hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEe
Q 007035 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (621)
Q Consensus 411 ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~---~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~ 487 (621)
.+.++|++++.||+|+||+||+|+++.+++.||+|++.... .....+.+|+.+++.+ .||||+++++++..
T Consensus 34 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l------~hpniv~~~~~~~~ 107 (494)
T 3lij_A 34 HLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLL------DHPNIMKLYDFFED 107 (494)
T ss_dssp CHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTC------CCTTBCCEEEEEEC
T ss_pred chhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhC------CCCCCCeEEEEEEe
Confidence 45678999999999999999999999999999999997642 2345567777777655 58899999999999
Q ss_pred cCeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEecc-CCCeEEEE
Q 007035 488 LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSY-QRCEIKII 565 (621)
Q Consensus 488 ~~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~-~~~~IKL~ 565 (621)
....++||||+.+ +|.+.+..... +++..++.++.||+.||.|||++||+||||||+|||++.. ..+.+||+
T Consensus 108 ~~~~~lv~e~~~~g~L~~~~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~ 181 (494)
T 3lij_A 108 KRNYYLVMECYKGGELFDEIIHRMK------FNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIV 181 (494)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEEC
T ss_pred CCEEEEEEecCCCCcHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEE
Confidence 9999999999985 77777654422 8899999999999999999999999999999999999753 24679999
Q ss_pred ecCCccccCCC--ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 566 DLGSSCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 566 DFGls~~~~~~--~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
|||++...... .....||+.|+|||++.+ .++.++|||||||++|+|++|++||
T Consensus 182 DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf 237 (494)
T 3lij_A 182 DFGLSAVFENQKKMKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPF 237 (494)
T ss_dssp CCTTCEECBTTBCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred ECCCCeECCCCccccccCCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCC
Confidence 99998765433 334678999999999864 6899999999999999999999998
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-33 Score=284.79 Aligned_cols=200 Identities=20% Similarity=0.314 Sum_probs=166.7
Q ss_pred CeeecCceEEEEEeccCCCCceeEEEeCCCC-------cEEEEEEEecCc-hhhhhHHHHHHHHHHhcccCCCCCCceEE
Q 007035 409 NTVIAGRYYVTEYLGSAAFSKVFQAQDLHTG-------VDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILR 480 (621)
Q Consensus 409 ~~ii~~rY~I~~~LG~G~fG~Vyka~d~~tg-------~~VAlKii~~~~-~~~~~~~~Ei~iL~~l~~~~~~~hpnIvr 480 (621)
..+..++|++.+.||+|+||+||+|.+..++ ..||+|++.... ...+.+.+|+.+++.++ ||||++
T Consensus 3 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~ 76 (289)
T 4fvq_A 3 HKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLS------HKHLVL 76 (289)
T ss_dssp CBCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSC------CTTBCC
T ss_pred EEechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCC------CCCEeE
Confidence 3456789999999999999999999998877 479999987543 34466777888877664 789999
Q ss_pred EeeEeEecCeEEEEEeccc-cchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCC
Q 007035 481 LYDYFYHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQR 559 (621)
Q Consensus 481 l~~~f~~~~~l~LVmEyl~-gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~ 559 (621)
+++++...+..++||||+. ++|.+++..... .+++..++.++.||+.||.|||+++|+||||||+|||++.+..
T Consensus 77 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~ 151 (289)
T 4fvq_A 77 NYGVCVCGDENILVQEFVKFGSLDTYLKKNKN-----CINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREED 151 (289)
T ss_dssp EEEEECCTTCCEEEEECCTTCBHHHHHHHTGG-----GCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCB
T ss_pred EEEEEEeCCCCEEEEECCCCCCHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCc
Confidence 9999999999999999998 588887765432 2788999999999999999999999999999999999985322
Q ss_pred ------CeEEEEecCCccccCCCccccccCCcccCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 560 ------CEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 560 ------~~IKL~DFGls~~~~~~~~~~~gt~~Y~APEvl~~-~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
+.+||+|||++...... ....+++.|+|||++.+ ..++.++||||||+++|+|++|..|+
T Consensus 152 ~~~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~ 218 (289)
T 4fvq_A 152 RKTGNPPFIKLSDPGISITVLPK-DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP 218 (289)
T ss_dssp GGGTBCCEEEECCCCSCTTTSCH-HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred ccccccceeeeccCcccccccCc-cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCC
Confidence 12999999998655433 33467899999999987 67899999999999999999965554
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-33 Score=307.60 Aligned_cols=200 Identities=21% Similarity=0.346 Sum_probs=173.4
Q ss_pred eeecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecC
Q 007035 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (621)
Q Consensus 410 ~ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~ 489 (621)
..+.++|++.++||+|+||.||+|++..+++.||||++..... ..++..|+++++.+.+. ++|..+..++....
T Consensus 3 ~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~E~~il~~L~~~-----~~i~~i~~~~~~~~ 76 (483)
T 3sv0_A 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLLYESKIYRILQGG-----TGIPNVRWFGVEGD 76 (483)
T ss_dssp CEETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS-SCCHHHHHHHHHHTTTS-----TTCCCEEEEEEETT
T ss_pred CCcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc-cHHHHHHHHHHHHhcCC-----CCCCeEEEEEeeCC
Confidence 4577899999999999999999999999999999999876443 35678899999998753 46777777788889
Q ss_pred eEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEec-cCCCeEEEEecC
Q 007035 490 HLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS-YQRCEIKIIDLG 568 (621)
Q Consensus 490 ~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~-~~~~~IKL~DFG 568 (621)
..+|||||++++|.+++..... .+++..++.|+.||+.||.|||+++|+||||||+||||+. +..+.+||+|||
T Consensus 77 ~~~lvme~~g~sL~~ll~~~~~-----~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFG 151 (483)
T 3sv0_A 77 YNVLVMDLLGPSLEDLFNFCSR-----KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFG 151 (483)
T ss_dssp EEEEEEECCCCBHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCT
T ss_pred EEEEEEECCCCCHHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCC
Confidence 9999999998899998875432 2899999999999999999999999999999999999942 147889999999
Q ss_pred CccccCCCc----------cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 569 SSCFQTDNL----------CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 569 ls~~~~~~~----------~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
++....... ....||+.|+|||++.+..++.++|||||||+||+|++|+.||
T Consensus 152 la~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf 213 (483)
T 3sv0_A 152 LAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 213 (483)
T ss_dssp TCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred cceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCC
Confidence 987654332 1457899999999999999999999999999999999999998
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-33 Score=294.82 Aligned_cols=193 Identities=33% Similarity=0.639 Sum_probs=163.2
Q ss_pred ecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecC---chhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEec
Q 007035 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (621)
Q Consensus 412 i~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~---~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~ 488 (621)
+.++|.+.+.||+|+||.||+|.+..+|+.||||++... ......+.+|+.+++.++ ||||+++++++...
T Consensus 22 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~~~~~~~ 95 (353)
T 3coi_A 22 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQ------HENVIGLLDVFTPA 95 (353)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCC------CTTBCCCSEEECSC
T ss_pred cCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcC------CCCcccHhheEecc
Confidence 568999999999999999999999999999999999753 233456677888887774 78999999999876
Q ss_pred Ce------EEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeE
Q 007035 489 EH------LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEI 562 (621)
Q Consensus 489 ~~------l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~I 562 (621)
.. .++||||+.++|.+.+.. .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+
T Consensus 96 ~~~~~~~~~~lv~e~~~~~l~~~~~~--------~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~--~~~~ 165 (353)
T 3coi_A 96 SSLRNFYDFYLVMPFMQTDLQKIMGL--------KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNE--DCEL 165 (353)
T ss_dssp SSGGGCCCCEEEEECCSEEGGGTTTS--------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECT--TCCE
T ss_pred cccccceeEEEEeccccCCHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECC--CCcE
Confidence 54 599999999887655421 2889999999999999999999999999999999999984 7889
Q ss_pred EEEecCCccccCCCccccccCCcccCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 563 KIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 563 KL~DFGls~~~~~~~~~~~gt~~Y~APEvl~~-~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
||+|||++...........+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||
T Consensus 166 kl~Dfg~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf 224 (353)
T 3coi_A 166 KILDFGLARHADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLF 224 (353)
T ss_dssp EECSTTCTTC--------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSS
T ss_pred EEeecccccCCCCCccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 99999999876666666788999999999987 67899999999999999999999998
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-33 Score=285.40 Aligned_cols=203 Identities=22% Similarity=0.259 Sum_probs=168.7
Q ss_pred ceeeCeeecCceEEEEEeccCCCCceeEEE----eCCCCcEEEEEEEecCc--hhhhhHHHHHHHHHHhcccCCCCCCce
Q 007035 405 PIILNTVIAGRYYVTEYLGSAAFSKVFQAQ----DLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHI 478 (621)
Q Consensus 405 pi~l~~ii~~rY~I~~~LG~G~fG~Vyka~----d~~tg~~VAlKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~hpnI 478 (621)
++........+|++++.||+|+||.||+|+ +..+++.||+|++.... .....+.+|+.+++.++ ||||
T Consensus 12 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~------h~~i 85 (302)
T 4e5w_A 12 EVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLY------HENI 85 (302)
T ss_dssp CCCTTBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCC------CTTB
T ss_pred ecChhhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCC------CCCe
Confidence 344455567889999999999999999998 67899999999987543 23456778888887764 7899
Q ss_pred EEEeeEeEec--CeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEe
Q 007035 479 LRLYDYFYHL--EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIK 555 (621)
Q Consensus 479 vrl~~~f~~~--~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~ 555 (621)
+++++++... ..+++||||+.+ +|.+++...... +++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 86 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~ 160 (302)
T 4e5w_A 86 VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK-----INLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVE 160 (302)
T ss_dssp CCEEEEEEC---CCEEEEEECCTTCBHHHHHHHHTTT-----CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE
T ss_pred eeeeeEEecCCCceEEEEEEeCCCCcHHHHHHhcccc-----CCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEc
Confidence 9999999876 679999999975 788877544322 88999999999999999999999999999999999998
Q ss_pred ccCCCeEEEEecCCccccCCC------ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 556 SYQRCEIKIIDLGSSCFQTDN------LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 556 ~~~~~~IKL~DFGls~~~~~~------~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
. ++.+||+|||++...... .....+|+.|+|||++.+..++.++||||||+++|+|++|+.|+
T Consensus 161 ~--~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~ 229 (302)
T 4e5w_A 161 S--EHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSD 229 (302)
T ss_dssp E--TTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGG
T ss_pred C--CCCEEECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCC
Confidence 4 789999999998765432 22345677899999999988999999999999999999998875
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-33 Score=295.18 Aligned_cols=195 Identities=26% Similarity=0.421 Sum_probs=166.0
Q ss_pred cCceEEEEEeccCCCCceeEEEeC---CCCcEEEEEEEecCc-----hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeE
Q 007035 413 AGRYYVTEYLGSAAFSKVFQAQDL---HTGVDVCLKIIKNDK-----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDY 484 (621)
Q Consensus 413 ~~rY~I~~~LG~G~fG~Vyka~d~---~tg~~VAlKii~~~~-----~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~ 484 (621)
.++|++++.||+|+||+||++++. .+++.||||+++... .......+|+.+++.+. .||||++++++
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----~h~~iv~~~~~ 127 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR-----QSPFLVTLHYA 127 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHH-----TCTTBCCEEEE
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHcc-----CCCceeEEEEE
Confidence 478999999999999999999984 589999999986532 23456678899999886 36899999999
Q ss_pred eEecCeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEE
Q 007035 485 FYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 563 (621)
Q Consensus 485 f~~~~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IK 563 (621)
+.....+++||||+.+ +|.+++.... .+++..++.++.||+.||.|||+++|+||||||+|||++ .++.+|
T Consensus 128 ~~~~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~--~~~~~k 199 (355)
T 1vzo_A 128 FQTETKLHLILDYINGGELFTHLSQRE------RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLD--SNGHVV 199 (355)
T ss_dssp EEETTEEEEEECCCCSCBHHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC--TTSCEE
T ss_pred EeeCceEEEEeecCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC--CCCcEE
Confidence 9999999999999985 7777776432 288999999999999999999999999999999999998 478999
Q ss_pred EEecCCccccCC----CccccccCCcccCchhhcCC--CCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 564 IIDLGSSCFQTD----NLCLYVQSRSYRAPEVIIGL--PYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 564 L~DFGls~~~~~----~~~~~~gt~~Y~APEvl~~~--~~s~ksDIWSLGvILyELltG~~PF 620 (621)
|+|||++..... ......||+.|+|||++.+. .++.++|||||||+||+|++|+.||
T Consensus 200 l~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf 262 (355)
T 1vzo_A 200 LTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPF 262 (355)
T ss_dssp ESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTT
T ss_pred EeeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCC
Confidence 999999865432 22335789999999999863 4789999999999999999999998
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-33 Score=302.11 Aligned_cols=202 Identities=21% Similarity=0.365 Sum_probs=169.0
Q ss_pred eeecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc--hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEe
Q 007035 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (621)
Q Consensus 410 ~ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~ 487 (621)
.++.++|++.+.||+|+||+||+|++..+|+.||||++.... ...+...+|+++++.++ ||||+++++++..
T Consensus 5 ~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~------hpnIv~~~~~~~~ 78 (396)
T 4eut_A 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN------HKNIVKLFAIEEE 78 (396)
T ss_dssp ECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCC------CTTBCCEEEEEEC
T ss_pred CCCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcC------CCCCCeEEEeecc
Confidence 456789999999999999999999999999999999997543 22456678888888874 7899999999987
Q ss_pred cC--eEEEEEeccc-cchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEec--cCCCeE
Q 007035 488 LE--HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS--YQRCEI 562 (621)
Q Consensus 488 ~~--~l~LVmEyl~-gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~--~~~~~I 562 (621)
.. +.++||||+. ++|.+++...... ..+++..++.++.||+.||.|||++||+||||||+|||+.. +..+.+
T Consensus 79 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~ 155 (396)
T 4eut_A 79 TTTRHKVLIMEFCPCGSLYTVLEEPSNA---YGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVY 155 (396)
T ss_dssp TTTCCEEEEECCCTTEEHHHHTTSGGGT---TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEE
T ss_pred CCCCeeEEEEecCCCCCHHHHHHhhhcc---cCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeE
Confidence 65 8899999997 5777776543322 12889999999999999999999999999999999999822 246679
Q ss_pred EEEecCCccccCCC--ccccccCCcccCchhhcC--------CCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 563 KIIDLGSSCFQTDN--LCLYVQSRSYRAPEVIIG--------LPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 563 KL~DFGls~~~~~~--~~~~~gt~~Y~APEvl~~--------~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
||+|||++...... .....+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||
T Consensus 156 kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf 223 (396)
T 4eut_A 156 KLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPF 223 (396)
T ss_dssp EECCGGGCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSE
T ss_pred EEecCCCceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 99999999765433 234578999999999865 45778999999999999999999998
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-32 Score=281.24 Aligned_cols=194 Identities=30% Similarity=0.446 Sum_probs=169.0
Q ss_pred ecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc--hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecC
Q 007035 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (621)
Q Consensus 412 i~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~ 489 (621)
...+|++++.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.+++.+ .||||+++++++....
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~~~~ 93 (303)
T 3a7i_A 20 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC------DSPYVTKYYGSYLKDT 93 (303)
T ss_dssp GGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHC------CCTTBCCEEEEEEETT
T ss_pred hHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhC------CCCCEeEEEEEEecCC
Confidence 3467999999999999999999999999999999997542 3456677888888776 4789999999999999
Q ss_pred eEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecC
Q 007035 490 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (621)
Q Consensus 490 ~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFG 568 (621)
.+++||||+++ +|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+||+++. ++.+||+|||
T Consensus 94 ~~~lv~e~~~~~~L~~~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~--~~~~kl~Dfg 164 (303)
T 3a7i_A 94 KLWIIMEYLGGGSALDLLEP-------GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSE--HGEVKLADFG 164 (303)
T ss_dssp EEEEEEECCTTEEHHHHHTT-------SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT--TSCEEECCCT
T ss_pred eEEEEEEeCCCCcHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECC--CCCEEEeecc
Confidence 99999999986 66666542 12889999999999999999999999999999999999984 7889999999
Q ss_pred CccccCCC---ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 569 SSCFQTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 569 ls~~~~~~---~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
++...... .....+++.|+|||++.+..++.++||||||+++|+|++|+.||
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~ 219 (303)
T 3a7i_A 165 VAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPH 219 (303)
T ss_dssp TCEECBTTBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred cceecCccccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCC
Confidence 98765432 23457899999999999999999999999999999999999998
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-33 Score=292.18 Aligned_cols=204 Identities=24% Similarity=0.342 Sum_probs=169.6
Q ss_pred eeecCceEEEEEeccCCCCceeEEE-----eCCCCcEEEEEEEecCc--hhhhhHHHHHHHHHHhcccCCCCCCceEEEe
Q 007035 410 TVIAGRYYVTEYLGSAAFSKVFQAQ-----DLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLY 482 (621)
Q Consensus 410 ~ii~~rY~I~~~LG~G~fG~Vyka~-----d~~tg~~VAlKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~ 482 (621)
.+..++|++.+.||+|+||.||+|+ +..+++.||||+++... ...+.+.+|+++++.+. .||||++++
T Consensus 18 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----~hpniv~~~ 92 (359)
T 3vhe_A 18 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG-----HHLNVVNLL 92 (359)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHC-----CCTTBCCEE
T ss_pred cccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhc-----CCcceeeee
Confidence 3456899999999999999999998 56778999999997643 33456888999999885 378999999
Q ss_pred eEeEecC-eEEEEEecccc-chHHHHHhhhccC-----------------------------------------------
Q 007035 483 DYFYHLE-HLFIVCELLRA-NLYEFQKFNQESG----------------------------------------------- 513 (621)
Q Consensus 483 ~~f~~~~-~l~LVmEyl~g-sLld~l~~~~~~~----------------------------------------------- 513 (621)
+++...+ .+++||||+.+ +|.+++.......
T Consensus 93 ~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (359)
T 3vhe_A 93 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKS 172 (359)
T ss_dssp EEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------
T ss_pred eeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccc
Confidence 9988754 59999999985 7888776543210
Q ss_pred -------------CCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCccccCCC----
Q 007035 514 -------------GEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN---- 576 (621)
Q Consensus 514 -------------~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~~~~~~---- 576 (621)
....+++..++.++.||+.||.|||+++|+||||||+|||++. ++.+||+|||++......
T Consensus 173 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~--~~~~kl~Dfg~a~~~~~~~~~~ 250 (359)
T 3vhe_A 173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE--KNVVKICDFGLARDIYKDPDYV 250 (359)
T ss_dssp -----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG--GGCEEECCCGGGSCTTSCTTCE
T ss_pred cchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcC--CCcEEEEeccceeeecccccch
Confidence 0122888999999999999999999999999999999999984 788999999998754322
Q ss_pred -ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 577 -LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 577 -~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
.....+|+.|+|||++.+..++.++|||||||++|+|++ |+.||
T Consensus 251 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~ 296 (359)
T 3vhe_A 251 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 296 (359)
T ss_dssp EC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred hccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCC
Confidence 223456888999999999999999999999999999998 99998
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-33 Score=299.58 Aligned_cols=198 Identities=24% Similarity=0.365 Sum_probs=168.1
Q ss_pred eeecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecC--chhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEe
Q 007035 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (621)
Q Consensus 410 ~ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~--~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~ 487 (621)
.+..++|++.+.||+|+||.||+|.+..+++.||||+++.. ......+.+|+++++.+ .||||+++++++..
T Consensus 110 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l------~hpniv~~~~~~~~ 183 (377)
T 3cbl_A 110 VLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQY------SHPNIVRLIGVCTQ 183 (377)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTC------CCTTBCCEEEEECS
T ss_pred EEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhC------CCCCEEEEEEEEec
Confidence 34457899999999999999999999999999999998754 23345667787777655 58899999999999
Q ss_pred cCeEEEEEeccc-cchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEe
Q 007035 488 LEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (621)
Q Consensus 488 ~~~l~LVmEyl~-gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~D 566 (621)
.+.+++||||+. ++|.+++..... .+++..+..++.||+.||.|||+++|+||||||+|||++. ++.+||+|
T Consensus 184 ~~~~~lv~e~~~~g~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~--~~~~kl~D 256 (377)
T 3cbl_A 184 KQPIYIVMELVQGGDFLTFLRTEGA-----RLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTE--KNVLKISD 256 (377)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHGG-----GCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT--TCCEEECC
T ss_pred CCCcEEEEEcCCCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcC--CCcEEECc
Confidence 999999999997 578887765432 2788999999999999999999999999999999999984 78999999
Q ss_pred cCCccccCCCccc-----cccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 567 LGSSCFQTDNLCL-----YVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 567 FGls~~~~~~~~~-----~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
||++......... ..+++.|+|||++.+..++.++|||||||++|||++ |+.||
T Consensus 257 fG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~ 316 (377)
T 3cbl_A 257 FGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPY 316 (377)
T ss_dssp GGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred CCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 9998764433211 224667999999998889999999999999999998 99997
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-32 Score=283.89 Aligned_cols=203 Identities=29% Similarity=0.390 Sum_probs=168.2
Q ss_pred cceeeCeeecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecC---chhhhhHHHHHHHHHHhcccCCCCCCceEE
Q 007035 404 LPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILR 480 (621)
Q Consensus 404 ~pi~l~~ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~---~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvr 480 (621)
+......+..++|++++.||+|+||.||++.+. +++.||+|++... ....+.+.+|+.+++.+++. |+||++
T Consensus 18 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~----~~~iv~ 92 (313)
T 3cek_A 18 LYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH----SDKIIR 92 (313)
T ss_dssp --CCEEEETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGG----CTTBCC
T ss_pred CCeeeeeeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhcccc----CCceEE
Confidence 334444556678999999999999999999974 5899999998653 33456778899999999752 579999
Q ss_pred EeeEeEecCeEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCC
Q 007035 481 LYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRC 560 (621)
Q Consensus 481 l~~~f~~~~~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~ 560 (621)
+++++......++|||+.+++|.+++.... .+++..++.++.||+.||.|||+++|+||||||+|||++ ++
T Consensus 93 ~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~---~~ 163 (313)
T 3cek_A 93 LYDYEITDQYIYMVMECGNIDLNSWLKKKK------SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV---DG 163 (313)
T ss_dssp EEEEEECSSEEEEEECCCSEEHHHHHHHCS------SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE---TT
T ss_pred EEEEeecCCEEEEEEecCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE---CC
Confidence 999999999999999988889998887543 278889999999999999999999999999999999997 58
Q ss_pred eEEEEecCCccccCCCc-----cccccCCcccCchhhcC-----------CCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 561 EIKIIDLGSSCFQTDNL-----CLYVQSRSYRAPEVIIG-----------LPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 561 ~IKL~DFGls~~~~~~~-----~~~~gt~~Y~APEvl~~-----------~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
.+||+|||++....... ....+++.|+|||++.+ ..++.++||||||+++|+|++|+.||
T Consensus 164 ~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf 239 (313)
T 3cek_A 164 MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 239 (313)
T ss_dssp EEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred eEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCch
Confidence 89999999987654322 23468999999999976 46888999999999999999999998
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-33 Score=293.31 Aligned_cols=196 Identities=30% Similarity=0.535 Sum_probs=160.0
Q ss_pred eecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc------------hhhhhHHHHHHHHHHhcccCCCCCCce
Q 007035 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK------------DFFDQSLDEIKLLKLVNKNDPADEHHI 478 (621)
Q Consensus 411 ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~------------~~~~~~~~Ei~iL~~l~~~~~~~hpnI 478 (621)
.+.++|++.+.||+|+||.||+|.+.. |+.||||++.... .....+.+|+++++.++ ||||
T Consensus 19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~------h~~i 91 (362)
T 3pg1_A 19 AMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH------HPNI 91 (362)
T ss_dssp HTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCC------CTTB
T ss_pred HhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCC------CcCc
Confidence 356789999999999999999999754 9999999986422 12356788888888774 7899
Q ss_pred EEEeeEeEe-----cCeEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEE
Q 007035 479 LRLYDYFYH-----LEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENIL 553 (621)
Q Consensus 479 vrl~~~f~~-----~~~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NIL 553 (621)
+++++++.. ..++++||||++++|.+.+..... .+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 92 v~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl 166 (362)
T 3pg1_A 92 LGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRI-----VISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNIL 166 (362)
T ss_dssp CCCSEEEEECCTTTCCEEEEEEECCSEEHHHHHHCTTS-----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEE
T ss_pred cceeeeEEeccCCCcceEEEEEccCCCCHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEE
Confidence 999999854 347899999999999988874332 3889999999999999999999999999999999999
Q ss_pred EeccCCCeEEEEecCCccccCC--CccccccCCcccCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 554 IKSYQRCEIKIIDLGSSCFQTD--NLCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 554 l~~~~~~~IKL~DFGls~~~~~--~~~~~~gt~~Y~APEvl~~-~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
++ .++.+||+|||++..... ......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||
T Consensus 167 ~~--~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf 234 (362)
T 3pg1_A 167 LA--DNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALF 234 (362)
T ss_dssp EC--TTCCEEECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred Ec--CCCCEEEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCC
Confidence 98 478899999999865332 2334578999999999987 66899999999999999999999998
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-32 Score=293.68 Aligned_cols=204 Identities=24% Similarity=0.363 Sum_probs=171.8
Q ss_pred eeecCceEEEEEeccCCCCceeEEEeCCC-------CcEEEEEEEecCc--hhhhhHHHHHHHHHHhcccCCCCCCceEE
Q 007035 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHT-------GVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILR 480 (621)
Q Consensus 410 ~ii~~rY~I~~~LG~G~fG~Vyka~d~~t-------g~~VAlKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~hpnIvr 480 (621)
.+..++|++.+.||+|+||+||+|++..+ +..||+|+++... ....++.+|+++++.+. .||||++
T Consensus 65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----~hpnIv~ 139 (382)
T 3tt0_A 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG-----KHKNIIN 139 (382)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHC-----CCTTBCC
T ss_pred ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhc-----CCchhhh
Confidence 45568999999999999999999997543 3579999997643 33466788999998884 4789999
Q ss_pred EeeEeEecCeEEEEEecccc-chHHHHHhhhcc----------CCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCC
Q 007035 481 LYDYFYHLEHLFIVCELLRA-NLYEFQKFNQES----------GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKP 549 (621)
Q Consensus 481 l~~~f~~~~~l~LVmEyl~g-sLld~l~~~~~~----------~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP 549 (621)
+++++...+..++||||+.+ +|.+++...... .....+++..++.++.||+.||.|||+++|+||||||
T Consensus 140 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp 219 (382)
T 3tt0_A 140 LLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAA 219 (382)
T ss_dssp EEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred heeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCc
Confidence 99999999999999999975 888887754321 1123489999999999999999999999999999999
Q ss_pred ccEEEeccCCCeEEEEecCCccccCCC-----ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 550 ENILIKSYQRCEIKIIDLGSSCFQTDN-----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 550 ~NILl~~~~~~~IKL~DFGls~~~~~~-----~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
+|||++. ++.+||+|||++...... .....+|+.|+|||++.+..++.++|||||||++|+|++ |+.||
T Consensus 220 ~NIll~~--~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~ 294 (382)
T 3tt0_A 220 RNVLVTE--DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 294 (382)
T ss_dssp GGEEECT--TCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred ceEEEcC--CCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCC
Confidence 9999984 789999999998755432 223456788999999999999999999999999999999 99987
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-33 Score=289.19 Aligned_cols=202 Identities=21% Similarity=0.286 Sum_probs=151.8
Q ss_pred eecCceEEEEEeccCCCCceeEEEeCCCCc---EEEEEEEecC---chhhhhHHHHHHHHHHhcccCCCCCCceEEEeeE
Q 007035 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGV---DVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDY 484 (621)
Q Consensus 411 ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~---~VAlKii~~~---~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~ 484 (621)
+..++|++.+.||+|+||+||+|++..++. .||+|+++.. ....+.+.+|+.+++.+ .||||++++++
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l------~h~~iv~~~~~ 93 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF------DHPHVAKLVGV 93 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTC------CCTTBCCCCEE
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHC------CCCceehhhce
Confidence 445789999999999999999999887775 8999998753 23345566677666655 58899999999
Q ss_pred eEecCeE------EEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEecc
Q 007035 485 FYHLEHL------FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSY 557 (621)
Q Consensus 485 f~~~~~l------~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~ 557 (621)
+...... ++||||+.+ +|.+++...........+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 94 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~- 172 (323)
T 3qup_A 94 SLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAE- 172 (323)
T ss_dssp EECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECT-
T ss_pred eeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcC-
Confidence 9877654 999999986 77777765543333334889999999999999999999999999999999999984
Q ss_pred CCCeEEEEecCCccccCCC-----ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 558 QRCEIKIIDLGSSCFQTDN-----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 558 ~~~~IKL~DFGls~~~~~~-----~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
++.+||+|||++...... .....+++.|+|||++.+..++.++|||||||++|+|++ |+.||
T Consensus 173 -~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~ 240 (323)
T 3qup_A 173 -DMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPY 240 (323)
T ss_dssp -TSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred -CCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCc
Confidence 789999999998754332 222345778999999999999999999999999999999 89987
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-33 Score=280.22 Aligned_cols=195 Identities=24% Similarity=0.388 Sum_probs=166.0
Q ss_pred ecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc--hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecC
Q 007035 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (621)
Q Consensus 412 i~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~ 489 (621)
+.++|++.+.||+|+||.||+|.+..+++.||+|++.... ...+.+.+|+.+++.+ .||||+++++++...+
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~~~~ 78 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML------NHENVVKFYGHRREGN 78 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTC------CCTTBCCEEEEEEETT
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhc------CCCCceeeeeEEEcCC
Confidence 3478999999999999999999999999999999987543 3345667777777655 4789999999999999
Q ss_pred eEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecC
Q 007035 490 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (621)
Q Consensus 490 ~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFG 568 (621)
..++||||+.+ +|.+.+... ..+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~--~~~~kl~dfg 150 (276)
T 2yex_A 79 IQYLFLEYCSGGELFDRIEPD------IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDE--RDNLKISDFG 150 (276)
T ss_dssp EEEEEEECCTTEEGGGGSBTT------TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT--TCCEEECCCT
T ss_pred EEEEEEEecCCCcHHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEcc--CCCEEEeeCC
Confidence 99999999975 776655322 23889999999999999999999999999999999999984 7889999999
Q ss_pred CccccCC-----CccccccCCcccCchhhcCCCC-CchhhHHHHHHHHHHHHhCCCCC
Q 007035 569 SSCFQTD-----NLCLYVQSRSYRAPEVIIGLPY-DQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 569 ls~~~~~-----~~~~~~gt~~Y~APEvl~~~~~-s~ksDIWSLGvILyELltG~~PF 620 (621)
++..... ......+++.|+|||++.+..+ +.++||||||+++|+|++|+.||
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~ 208 (276)
T 2yex_A 151 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW 208 (276)
T ss_dssp TCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCC
T ss_pred CccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCC
Confidence 9865432 1234578999999999988765 77899999999999999999998
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-32 Score=290.72 Aligned_cols=197 Identities=28% Similarity=0.486 Sum_probs=169.3
Q ss_pred eecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc---------hhhhhHHHHHHHHHHhcccCCCCCCceEEE
Q 007035 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---------DFFDQSLDEIKLLKLVNKNDPADEHHILRL 481 (621)
Q Consensus 411 ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~---------~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl 481 (621)
.+.++|++.+.||+|+||.||+|.+..+|+.||||+++... ...+.+.+|+.+++.+. .||||+++
T Consensus 91 ~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----~hp~iv~~ 165 (365)
T 2y7j_A 91 EFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVA-----GHPHIITL 165 (365)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHT-----TCTTBCCE
T ss_pred hhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhc-----CCCCEeEE
Confidence 34578999999999999999999999999999999987543 12345677888888874 47899999
Q ss_pred eeEeEecCeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCC
Q 007035 482 YDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRC 560 (621)
Q Consensus 482 ~~~f~~~~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~ 560 (621)
++++......++||||+.+ +|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++ .++
T Consensus 166 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~------~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~--~~~ 237 (365)
T 2y7j_A 166 IDSYESSSFMFLVFDLMRKGELFDYLTEKV------ALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLD--DNM 237 (365)
T ss_dssp EEEEEBSSEEEEEECCCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--TTC
T ss_pred EEEEeeCCEEEEEEEeCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC--CCC
Confidence 9999999999999999986 7777765432 288999999999999999999999999999999999998 478
Q ss_pred eEEEEecCCccccCCC--ccccccCCcccCchhhcC------CCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 561 EIKIIDLGSSCFQTDN--LCLYVQSRSYRAPEVIIG------LPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 561 ~IKL~DFGls~~~~~~--~~~~~gt~~Y~APEvl~~------~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
.+||+|||++...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||
T Consensus 238 ~ikl~DfG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf 305 (365)
T 2y7j_A 238 QIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPF 305 (365)
T ss_dssp CEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSS
T ss_pred CEEEEecCcccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCC
Confidence 9999999998765432 344678999999999863 35888999999999999999999998
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-32 Score=282.49 Aligned_cols=200 Identities=29% Similarity=0.406 Sum_probs=160.3
Q ss_pred eecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecC----chhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeE
Q 007035 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (621)
Q Consensus 411 ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~----~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~ 486 (621)
...++|++.+.||+|+||.||+|.+..+|+.||+|++... ......+.+|+.+++.+ .||||+++++++.
T Consensus 29 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l------~h~~i~~~~~~~~ 102 (310)
T 2wqm_A 29 NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL------NHPNVIKYYASFI 102 (310)
T ss_dssp SSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTC------CCTTBCCEEEEEE
T ss_pred ccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhC------CCCCEeeEEEEEE
Confidence 4457899999999999999999999999999999999752 23345566777777765 4789999999999
Q ss_pred ecCeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEE
Q 007035 487 HLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKII 565 (621)
Q Consensus 487 ~~~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~ 565 (621)
..+..++||||+.+ +|.+++...... ...+++..++.++.||+.||.|||+.||+||||||+|||++ .++.+||+
T Consensus 103 ~~~~~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~--~~~~~kl~ 178 (310)
T 2wqm_A 103 EDNELNIVLELADAGDLSRMIKHFKKQ--KRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFIT--ATGVVKLG 178 (310)
T ss_dssp ETTEEEEEEECCCSCBHHHHHHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC--TTSCEEEC
T ss_pred cCCcEEEEEecCCCCCHHHHHHHhccc--ccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEc--CCCCEEEE
Confidence 99999999999986 777777643322 12388999999999999999999999999999999999998 47899999
Q ss_pred ecCCccccCCC---ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 566 DLGSSCFQTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 566 DFGls~~~~~~---~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
|||++...... .....+++.|+|||++.+..++.++||||||+++|+|++|+.||
T Consensus 179 Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~ 236 (310)
T 2wqm_A 179 DLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF 236 (310)
T ss_dssp CC------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred eccceeeecCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 99998654432 23356799999999999999999999999999999999999998
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-32 Score=278.77 Aligned_cols=198 Identities=33% Similarity=0.520 Sum_probs=161.9
Q ss_pred CeeecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc----hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeE
Q 007035 409 NTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDY 484 (621)
Q Consensus 409 ~~ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~ 484 (621)
+.+..++|++.+.||+|+||.||+|.+..+|+.||+|++.... .....+.+|+.+++.+ .||||++++++
T Consensus 6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~ 79 (276)
T 2h6d_A 6 GRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLF------RHPHIIKLYQV 79 (276)
T ss_dssp -CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC------CCTTBCCEEEE
T ss_pred CcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcC------CCCCEeEEEEE
Confidence 4456789999999999999999999999999999999997532 2234566777777655 47899999999
Q ss_pred eEecCeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEE
Q 007035 485 FYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 563 (621)
Q Consensus 485 f~~~~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IK 563 (621)
+...+..++||||+.+ +|.+++..... +++..++.++.||+.||.|||++||+||||||+||+++. ++.++
T Consensus 80 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~------~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~--~~~~~ 151 (276)
T 2h6d_A 80 ISTPTDFFMVMEYVSGGELFDYICKHGR------VEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDA--HMNAK 151 (276)
T ss_dssp EECSSEEEEEEECCCSCBHHHHHHHHCS------CCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECT--TSCEE
T ss_pred EecCCeEEEEEeccCCCcHHHHHhccCC------CCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECC--CCCEE
Confidence 9999999999999974 78777765422 788999999999999999999999999999999999984 78899
Q ss_pred EEecCCccccCCC--ccccccCCcccCchhhcCCCC-CchhhHHHHHHHHHHHHhCCCCC
Q 007035 564 IIDLGSSCFQTDN--LCLYVQSRSYRAPEVIIGLPY-DQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 564 L~DFGls~~~~~~--~~~~~gt~~Y~APEvl~~~~~-s~ksDIWSLGvILyELltG~~PF 620 (621)
|+|||++...... .....+++.|+|||++.+..+ +.++||||||+++|+|++|+.||
T Consensus 152 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~ 211 (276)
T 2h6d_A 152 IADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPF 211 (276)
T ss_dssp ECCCCGGGCCCC-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSS
T ss_pred EeecccccccCCCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCC
Confidence 9999998765433 234567999999999988765 68999999999999999999998
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-33 Score=301.18 Aligned_cols=202 Identities=28% Similarity=0.482 Sum_probs=157.4
Q ss_pred ecCceEEE-EEeccCCCCceeEEEeC--CCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEe-
Q 007035 412 IAGRYYVT-EYLGSAAFSKVFQAQDL--HTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH- 487 (621)
Q Consensus 412 i~~rY~I~-~~LG~G~fG~Vyka~d~--~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~- 487 (621)
+.+.|++. ++||+|+||+||+|+++ .+++.||||++..... ...+.+|+.+++.++ ||||+++++++..
T Consensus 18 ~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~E~~~l~~l~------hpniv~~~~~~~~~ 90 (405)
T 3rgf_A 18 VEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-SMSACREIALLRELK------HPNVISLQKVFLSH 90 (405)
T ss_dssp HHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC-CHHHHHHHHHHHHCC------CTTBCCCCEEEEET
T ss_pred hhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-CHHHHHHHHHHHhcC------CCCeeeEeeEEecC
Confidence 34567774 47999999999999965 5789999999976432 356788999998884 7899999999965
Q ss_pred -cCeEEEEEeccccchHHHHHhhhccC---CCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEec--cCCCe
Q 007035 488 -LEHLFIVCELLRANLYEFQKFNQESG---GEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS--YQRCE 561 (621)
Q Consensus 488 -~~~l~LVmEyl~gsLld~l~~~~~~~---~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~--~~~~~ 561 (621)
..++++||||++++|++++....... ....+++..++.++.||+.||.|||++||+||||||+|||+.. +..+.
T Consensus 91 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~ 170 (405)
T 3rgf_A 91 ADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGR 170 (405)
T ss_dssp TTTEEEEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTC
T ss_pred CCCeEEEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCc
Confidence 67899999999999998887543221 1223889999999999999999999999999999999999943 24689
Q ss_pred EEEEecCCccccCCC------ccccccCCcccCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 562 IKIIDLGSSCFQTDN------LCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 562 IKL~DFGls~~~~~~------~~~~~gt~~Y~APEvl~~~-~~s~ksDIWSLGvILyELltG~~PF 620 (621)
+||+|||++...... ....++|+.|+|||++.+. .++.++|||||||+||+|++|++||
T Consensus 171 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf 236 (405)
T 3rgf_A 171 VKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 236 (405)
T ss_dssp EEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred EEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCC
Confidence 999999999765432 2345789999999999875 4899999999999999999999998
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-32 Score=283.40 Aligned_cols=204 Identities=25% Similarity=0.328 Sum_probs=171.2
Q ss_pred eeecCceEEEEEeccCCCCceeEEEe-----CCCCcEEEEEEEecCc--hhhhhHHHHHHHHHHhcccCCCCCCceEEEe
Q 007035 410 TVIAGRYYVTEYLGSAAFSKVFQAQD-----LHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLY 482 (621)
Q Consensus 410 ~ii~~rY~I~~~LG~G~fG~Vyka~d-----~~tg~~VAlKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~ 482 (621)
.+..++|++.+.||+|+||.||+|.+ ..+++.||+|+++... ...+.+.+|+.+++.+. .||||++++
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----~h~~i~~~~ 93 (313)
T 1t46_A 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG-----NHMNIVNLL 93 (313)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHC-----CCTTBCCEE
T ss_pred ccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcc-----cCCCeeeEE
Confidence 34567999999999999999999984 5678899999998643 23466788999998884 478999999
Q ss_pred eEeEecCeEEEEEecccc-chHHHHHhhhcc------------CCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCC
Q 007035 483 DYFYHLEHLFIVCELLRA-NLYEFQKFNQES------------GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKP 549 (621)
Q Consensus 483 ~~f~~~~~l~LVmEyl~g-sLld~l~~~~~~------------~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP 549 (621)
+++...+..++||||+.+ +|.+++...... .....+++..++.++.||+.||.|||++||+||||||
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp 173 (313)
T 1t46_A 94 GACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAA 173 (313)
T ss_dssp EEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred EEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCcc
Confidence 999999999999999975 888887654321 1122388999999999999999999999999999999
Q ss_pred ccEEEeccCCCeEEEEecCCccccCCCcc-----ccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 550 ENILIKSYQRCEIKIIDLGSSCFQTDNLC-----LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 550 ~NILl~~~~~~~IKL~DFGls~~~~~~~~-----~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
+|||++ .++.+||+|||++........ ...+++.|+|||++.+..++.++||||||+++|+|++ |+.||
T Consensus 174 ~Nil~~--~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~ 248 (313)
T 1t46_A 174 RNILLT--HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY 248 (313)
T ss_dssp GGEEEE--TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred ceEEEc--CCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCC
Confidence 999998 478999999999876543321 2345778999999999899999999999999999999 99997
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-33 Score=284.90 Aligned_cols=197 Identities=28% Similarity=0.445 Sum_probs=162.4
Q ss_pred ecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc-----hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeE
Q 007035 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (621)
Q Consensus 412 i~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~-----~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~ 486 (621)
+.++|++.+.||+|+||.||++.+..+++.||+|+++... .....+.+|+.+++.+ .||||+++++++.
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l------~h~~i~~~~~~~~ 76 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRL------RHKNVIQLVDVLY 76 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTC------CCTTBCCEEEEEE
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhc------CCCCeeEEEEEEE
Confidence 4578999999999999999999999999999999997542 2234556666666554 5889999999984
Q ss_pred --ecCeEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEE
Q 007035 487 --HLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKI 564 (621)
Q Consensus 487 --~~~~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL 564 (621)
.....++||||+.+++.+++..... ..+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||
T Consensus 77 ~~~~~~~~lv~e~~~~~l~~~~~~~~~----~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~--~~~~kl 150 (305)
T 2wtk_C 77 NEEKQKMYMVMEYCVCGMQEMLDSVPE----KRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTT--GGTLKI 150 (305)
T ss_dssp CC---CEEEEEECCSEEHHHHHHHSTT----CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT--TCCEEE
T ss_pred cCCCCeEEEEehhccCCHHHHHHhCcc----cccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcC--CCcEEe
Confidence 4568999999999988887765432 23889999999999999999999999999999999999984 788999
Q ss_pred EecCCccccCC-----CccccccCCcccCchhhcCCC--CCchhhHHHHHHHHHHHHhCCCCC
Q 007035 565 IDLGSSCFQTD-----NLCLYVQSRSYRAPEVIIGLP--YDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 565 ~DFGls~~~~~-----~~~~~~gt~~Y~APEvl~~~~--~s~ksDIWSLGvILyELltG~~PF 620 (621)
+|||++..... ......+++.|+|||++.+.. ++.++||||||+++|+|++|+.||
T Consensus 151 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~ 213 (305)
T 2wtk_C 151 SALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPF 213 (305)
T ss_dssp CCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSC
T ss_pred eccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCC
Confidence 99999876432 122356899999999998754 377999999999999999999998
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-33 Score=289.81 Aligned_cols=203 Identities=23% Similarity=0.295 Sum_probs=168.3
Q ss_pred eeecCceEEEEEeccCCCCceeEEEeC-----CCCcEEEEEEEecCc--hhhhhHHHHHHHHHHhcccCCCCCCceEEEe
Q 007035 410 TVIAGRYYVTEYLGSAAFSKVFQAQDL-----HTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLY 482 (621)
Q Consensus 410 ~ii~~rY~I~~~LG~G~fG~Vyka~d~-----~tg~~VAlKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~ 482 (621)
.+..++|++++.||+|+||.||+|++. .+++.||+|+++... .....+.+|+.+++.+ .||||++++
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l------~hp~iv~~~ 116 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF------DNPNIVKLL 116 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTC------CCTTBCCEE
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhC------CCCCEEEEE
Confidence 455689999999999999999999987 456899999997643 3345677788887766 478999999
Q ss_pred eEeEecCeEEEEEecccc-chHHHHHhhhccC------------------CCccccHHHHHHHHHHHHHHHHHHHHCCee
Q 007035 483 DYFYHLEHLFIVCELLRA-NLYEFQKFNQESG------------------GEAYFTLGRLQVITRQCLEALEYLHSLGII 543 (621)
Q Consensus 483 ~~f~~~~~l~LVmEyl~g-sLld~l~~~~~~~------------------~~~~ls~~~i~~I~~qIl~aL~yLHs~gIv 543 (621)
+++...+..++||||+.+ +|.+++....... ....+++..++.++.||+.||.|||++||+
T Consensus 117 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iv 196 (343)
T 1luf_A 117 GVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFV 196 (343)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred EEEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 999999999999999985 8888776532110 113488999999999999999999999999
Q ss_pred cccCCCccEEEeccCCCeEEEEecCCccccCC-----CccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CC
Q 007035 544 HCDLKPENILIKSYQRCEIKIIDLGSSCFQTD-----NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GE 617 (621)
Q Consensus 544 HrDLKP~NILl~~~~~~~IKL~DFGls~~~~~-----~~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~ 617 (621)
||||||+|||++. ++.+||+|||++..... ......+++.|+|||++.+..++.++||||||+++|+|++ |+
T Consensus 197 H~Dlkp~NIl~~~--~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~ 274 (343)
T 1luf_A 197 HRDLATRNCLVGE--NMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 274 (343)
T ss_dssp CSCCSGGGEEECG--GGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred cCCCCcceEEECC--CCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCC
Confidence 9999999999984 78999999999865432 1223466889999999999899999999999999999999 99
Q ss_pred CCC
Q 007035 618 VCL 620 (621)
Q Consensus 618 ~PF 620 (621)
.||
T Consensus 275 ~p~ 277 (343)
T 1luf_A 275 QPY 277 (343)
T ss_dssp CTT
T ss_pred CcC
Confidence 998
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-33 Score=287.24 Aligned_cols=198 Identities=33% Similarity=0.482 Sum_probs=164.4
Q ss_pred eeecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc---------hhhhhHHHHHHHHHHhcccCCCCCCceEE
Q 007035 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---------DFFDQSLDEIKLLKLVNKNDPADEHHILR 480 (621)
Q Consensus 410 ~ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~---------~~~~~~~~Ei~iL~~l~~~~~~~hpnIvr 480 (621)
..+.++|++.+.||+|+||.||+|.+..+++.||||++.... .....+.+|+.+++.+ .||||++
T Consensus 6 ~~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l------~h~~i~~ 79 (322)
T 2ycf_A 6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKL------NHPCIIK 79 (322)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHC------CCTTBCC
T ss_pred hhhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhC------CCCCCce
Confidence 345689999999999999999999999999999999987532 1234567888888877 3789999
Q ss_pred EeeEeEecCeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccC-
Q 007035 481 LYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQ- 558 (621)
Q Consensus 481 l~~~f~~~~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~- 558 (621)
+++++.... .++||||+.+ +|.+.+.... .+++..++.++.||+.||.|||++||+||||||+|||++.+.
T Consensus 80 ~~~~~~~~~-~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~ 152 (322)
T 2ycf_A 80 IKNFFDAED-YYIVLELMEGGELFDKVVGNK------RLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEE 152 (322)
T ss_dssp EEEEEESSS-EEEEEECCTTEETHHHHSTTC------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSS
T ss_pred EeeEEcCCc-eEEEEecCCCCcHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCC
Confidence 999987655 8999999975 7877765332 288999999999999999999999999999999999998532
Q ss_pred CCeEEEEecCCccccCCCc--cccccCCcccCchhhc---CCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 559 RCEIKIIDLGSSCFQTDNL--CLYVQSRSYRAPEVII---GLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 559 ~~~IKL~DFGls~~~~~~~--~~~~gt~~Y~APEvl~---~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
.+.+||+|||++....... ....+|+.|+|||++. ...++.++|||||||++|+|++|+.||
T Consensus 153 ~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf 219 (322)
T 2ycf_A 153 DCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF 219 (322)
T ss_dssp SCCEEECCCTTCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSS
T ss_pred CCeEEEccCccceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 3469999999987665432 2356899999999974 456899999999999999999999998
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-33 Score=289.04 Aligned_cols=196 Identities=23% Similarity=0.333 Sum_probs=161.2
Q ss_pred eecCceEEEEEeccCCCCceeEEEeCCCCcE----EEEEEEecC--chhhhhHHHHHHHHHHhcccCCCCCCceEEEeeE
Q 007035 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVD----VCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDY 484 (621)
Q Consensus 411 ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~----VAlKii~~~--~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~ 484 (621)
+..++|++++.||+|+||+||+|.+..+++. ||+|.+... ........+|+.+++.+ .||||++++++
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l------~h~~iv~~~~~ 83 (325)
T 3kex_A 10 FKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL------DHAHIVRLLGL 83 (325)
T ss_dssp CCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTC------CCTTBCCEEEE
T ss_pred cCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcC------CCCCcCeEEEE
Confidence 3457899999999999999999999888876 677776533 22335566777777655 47899999998
Q ss_pred eEecCeEEEEEeccc-cchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEE
Q 007035 485 FYHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 563 (621)
Q Consensus 485 f~~~~~l~LVmEyl~-gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IK 563 (621)
+. ....++||||+. ++|.+.+..... .+++..+..++.||+.||.|||++||+||||||+|||++ .++.+|
T Consensus 84 ~~-~~~~~~v~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~--~~~~~k 155 (325)
T 3kex_A 84 CP-GSSLQLVTQYLPLGSLLDHVRQHRG-----ALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLK--SPSQVQ 155 (325)
T ss_dssp EC-BSSEEEEEECCTTCBSHHHHHSSGG-----GSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEES--SSSCEE
T ss_pred Ec-CCccEEEEEeCCCCCHHHHHHHccc-----cCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEEC--CCCeEE
Confidence 86 467889999998 588887764322 288889999999999999999999999999999999998 478899
Q ss_pred EEecCCccccCCC-----ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 564 IIDLGSSCFQTDN-----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 564 L~DFGls~~~~~~-----~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
|+|||++...... .....+++.|+|||++.+..++.++|||||||++|+|++ |+.||
T Consensus 156 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~ 218 (325)
T 3kex_A 156 VADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPY 218 (325)
T ss_dssp ECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred ECCCCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCc
Confidence 9999999765332 223456778999999998899999999999999999999 99998
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-33 Score=290.67 Aligned_cols=203 Identities=28% Similarity=0.375 Sum_probs=150.1
Q ss_pred ceeeCeeecCceEEEE-EeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEee
Q 007035 405 PIILNTVIAGRYYVTE-YLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYD 483 (621)
Q Consensus 405 pi~l~~ii~~rY~I~~-~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~ 483 (621)
|......+.++|++++ .||+|+||+||+|.++.+|+.||||++...... .+|+..+... ..||||+++++
T Consensus 19 p~~~~~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~e~~~~~~~-----~~h~~i~~~~~ 89 (336)
T 3fhr_A 19 PEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKA----RQEVDHHWQA-----SGGPHIVCILD 89 (336)
T ss_dssp -CCBCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHHH----HHHHHHHHHH-----TTSTTBCCEEE
T ss_pred CCCCCccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHHH----HHHHHHHHHh-----cCCCChHHHHH
Confidence 4444556788999966 599999999999999999999999999765432 2333322222 25889999999
Q ss_pred EeEe----cCeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEecc-
Q 007035 484 YFYH----LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSY- 557 (621)
Q Consensus 484 ~f~~----~~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~- 557 (621)
++.. ...+++||||+.+ +|.+++..... ..+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 90 ~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~----~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~ 165 (336)
T 3fhr_A 90 VYENMHHGKRCLLIIMECMEGGELFSRIQERGD----QAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKE 165 (336)
T ss_dssp EEEEEETTEEEEEEEEECCTTEEHHHHHHTC-C----CCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSS
T ss_pred HHhhccCCCceEEEEEeccCCCCHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecC
Confidence 9986 5569999999975 88887765432 238999999999999999999999999999999999999853
Q ss_pred CCCeEEEEecCCccccCCC-ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 558 QRCEIKIIDLGSSCFQTDN-LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 558 ~~~~IKL~DFGls~~~~~~-~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
..+.+||+|||++...... .....+|+.|+|||++.+..++.++|||||||++|+|++|+.||
T Consensus 166 ~~~~~kl~Dfg~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf 229 (336)
T 3fhr_A 166 KDAVLKLTDFGFAKETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPF 229 (336)
T ss_dssp TTCCEEECCCTTCEEC----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC
T ss_pred CCceEEEeccccceeccccccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCC
Confidence 2567999999998765433 33457799999999998888999999999999999999999998
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-32 Score=283.78 Aligned_cols=203 Identities=25% Similarity=0.379 Sum_probs=167.6
Q ss_pred eeecCceEEEEEeccCCCCceeEEEeC-----CCCcEEEEEEEecCc--hhhhhHHHHHHHHHHhcccCCCCCCceEEEe
Q 007035 410 TVIAGRYYVTEYLGSAAFSKVFQAQDL-----HTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLY 482 (621)
Q Consensus 410 ~ii~~rY~I~~~LG~G~fG~Vyka~d~-----~tg~~VAlKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~ 482 (621)
++..++|++.+.||+|+||.||+|.+. .+++.||+|+++... ...+.+.+|+++++.+ .||||++++
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l------~hp~iv~~~ 92 (314)
T 2ivs_A 19 EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQV------NHPHVIKLY 92 (314)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTC------CCTTBCCEE
T ss_pred ccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhC------CCCceeeEE
Confidence 344678999999999999999999873 456899999997543 2335566677666555 588999999
Q ss_pred eEeEecCeEEEEEeccc-cchHHHHHhhhccC------------------CCccccHHHHHHHHHHHHHHHHHHHHCCee
Q 007035 483 DYFYHLEHLFIVCELLR-ANLYEFQKFNQESG------------------GEAYFTLGRLQVITRQCLEALEYLHSLGII 543 (621)
Q Consensus 483 ~~f~~~~~l~LVmEyl~-gsLld~l~~~~~~~------------------~~~~ls~~~i~~I~~qIl~aL~yLHs~gIv 543 (621)
+++...+..++||||+. ++|.+++....... ....+++..++.++.||+.||.|||++||+
T Consensus 93 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iv 172 (314)
T 2ivs_A 93 GACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLV 172 (314)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred EEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCc
Confidence 99999999999999998 58888876543211 123488999999999999999999999999
Q ss_pred cccCCCccEEEeccCCCeEEEEecCCccccCCCc-----cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CC
Q 007035 544 HCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GE 617 (621)
Q Consensus 544 HrDLKP~NILl~~~~~~~IKL~DFGls~~~~~~~-----~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~ 617 (621)
||||||+|||++ .++.+||+|||++....... ....+++.|+|||++.+..++.++||||||+++|+|++ |+
T Consensus 173 H~dikp~NIli~--~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~ 250 (314)
T 2ivs_A 173 HRDLAARNILVA--EGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGG 250 (314)
T ss_dssp CCCCSGGGEEEE--TTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSC
T ss_pred ccccchheEEEc--CCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCC
Confidence 999999999999 47889999999987654321 22355788999999999889999999999999999999 99
Q ss_pred CCC
Q 007035 618 VCL 620 (621)
Q Consensus 618 ~PF 620 (621)
.||
T Consensus 251 ~p~ 253 (314)
T 2ivs_A 251 NPY 253 (314)
T ss_dssp CSS
T ss_pred CCC
Confidence 997
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-33 Score=301.17 Aligned_cols=198 Identities=33% Similarity=0.498 Sum_probs=159.3
Q ss_pred eeecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc---------hhhhhHHHHHHHHHHhcccCCCCCCceEE
Q 007035 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---------DFFDQSLDEIKLLKLVNKNDPADEHHILR 480 (621)
Q Consensus 410 ~ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~---------~~~~~~~~Ei~iL~~l~~~~~~~hpnIvr 480 (621)
..+.++|.+.+.||+|+||+||+|.+..+++.||+|++.... .....+.+|+.+++.++ ||||++
T Consensus 131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~------hpniv~ 204 (419)
T 3i6u_A 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLN------HPCIIK 204 (419)
T ss_dssp HHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCC------CTTBCC
T ss_pred hhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCC------CCCEee
Confidence 345789999999999999999999999999999999987542 12234678888888873 789999
Q ss_pred EeeEeEecCeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEecc-C
Q 007035 481 LYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSY-Q 558 (621)
Q Consensus 481 l~~~f~~~~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~-~ 558 (621)
+++++. .+..++||||+.+ +|.+.+... ..+++..++.++.||+.||.|||+++|+||||||+|||++.. .
T Consensus 205 l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~------~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~ 277 (419)
T 3i6u_A 205 IKNFFD-AEDYYIVLELMEGGELFDKVVGN------KRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEE 277 (419)
T ss_dssp CCEEEE-SSEEEEEEECCTTCBGGGGTSSS------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSS
T ss_pred EEEEEe-cCceEEEEEcCCCCcHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCC
Confidence 999975 4568999999975 665554422 238899999999999999999999999999999999999752 2
Q ss_pred CCeEEEEecCCccccCCC--ccccccCCcccCchhhcC---CCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 559 RCEIKIIDLGSSCFQTDN--LCLYVQSRSYRAPEVIIG---LPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 559 ~~~IKL~DFGls~~~~~~--~~~~~gt~~Y~APEvl~~---~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
...+||+|||++...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|++||
T Consensus 278 ~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf 344 (419)
T 3i6u_A 278 DCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF 344 (419)
T ss_dssp SCCEEECCSSTTTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSS
T ss_pred cceEEEeecccceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCC
Confidence 456999999999765443 234678999999999864 56788999999999999999999998
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-33 Score=307.05 Aligned_cols=199 Identities=21% Similarity=0.314 Sum_probs=173.2
Q ss_pred eeecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecC
Q 007035 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (621)
Q Consensus 410 ~ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~ 489 (621)
.+...+|++.+.||+|+||.||+|.++.++..||||+++.+....+.+.+|+.+++.++ ||||+++++++....
T Consensus 216 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~------hpniv~l~~~~~~~~ 289 (495)
T 1opk_A 216 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK------HPNLVQLLGVCTREP 289 (495)
T ss_dssp BCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCC------CTTBCCEEEEECSSS
T ss_pred ccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcC------CCCEeeEEEEEecCC
Confidence 34567899999999999999999999999999999999877666678889999998884 789999999999999
Q ss_pred eEEEEEeccc-cchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecC
Q 007035 490 HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (621)
Q Consensus 490 ~l~LVmEyl~-gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFG 568 (621)
.++|||||+. ++|.+++..... ..+++..+..++.||+.||.|||+++|+||||||+|||++. ++.+||+|||
T Consensus 290 ~~~lv~E~~~~g~L~~~l~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~--~~~~kl~DFG 363 (495)
T 1opk_A 290 PFYIITEFMTYGNLLDYLRECNR----QEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGE--NHLVKVADFG 363 (495)
T ss_dssp SCEEEEECCTTCBHHHHHHHSCT----TTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECG--GGCEEECCTT
T ss_pred cEEEEEEccCCCCHHHHHHhcCc----CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECC--CCcEEEeecc
Confidence 9999999998 588888765322 22888999999999999999999999999999999999984 7899999999
Q ss_pred CccccCCCc----cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 569 SSCFQTDNL----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 569 ls~~~~~~~----~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
++....... ....+++.|+|||++.+..++.++|||||||+||||++ |+.||
T Consensus 364 ~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~ 420 (495)
T 1opk_A 364 LSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 420 (495)
T ss_dssp CEECCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred cceeccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCC
Confidence 987654322 12234678999999998889999999999999999999 99987
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-32 Score=277.25 Aligned_cols=198 Identities=24% Similarity=0.380 Sum_probs=166.7
Q ss_pred cCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecC---chhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEe--
Q 007035 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH-- 487 (621)
Q Consensus 413 ~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~---~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~-- 487 (621)
.++|++++.||+|+||.||+++++.+++.||+|++... ....+.+.+|+.+++.++ ||||+++++++..
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~~ 78 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK------HPNIVRYYDRIIDRT 78 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCC------CTTBCCEEEEEEEGG
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcC------CCCCCeEEEEEecCC
Confidence 46899999999999999999999999999999999753 234456778888888774 7899999998864
Q ss_pred cCeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCC-----eecccCCCccEEEeccCCCe
Q 007035 488 LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLG-----IIHCDLKPENILIKSYQRCE 561 (621)
Q Consensus 488 ~~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~g-----IvHrDLKP~NILl~~~~~~~ 561 (621)
...+++||||+++ +|.+++...... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++ .++.
T Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~--~~~~ 154 (279)
T 2w5a_A 79 NTTLYIVMEYCEGGDLASVITKGTKE--RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLD--GKQN 154 (279)
T ss_dssp GTEEEEEEECCTTEEHHHHHHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEEC--SSSC
T ss_pred CceEEEEEeCCCCCCHHHHHHhhccc--CCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEc--CCCC
Confidence 5789999999975 888887654332 223889999999999999999999999 99999999999998 4788
Q ss_pred EEEEecCCccccCCCc---cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 562 IKIIDLGSSCFQTDNL---CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 562 IKL~DFGls~~~~~~~---~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
+||+|||++....... ....+++.|+|||++.+..++.++||||||+++|+|++|+.||
T Consensus 155 ~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~ 216 (279)
T 2w5a_A 155 VKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPF 216 (279)
T ss_dssp EEECCCCHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSS
T ss_pred EEEecCchheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCC
Confidence 9999999987654332 2356899999999999999999999999999999999999998
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-32 Score=282.27 Aligned_cols=195 Identities=26% Similarity=0.344 Sum_probs=157.2
Q ss_pred ecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCch----hhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEe
Q 007035 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD----FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (621)
Q Consensus 412 i~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~----~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~ 487 (621)
..++|++.+.||+|+||.||+|++..+++.||+|++..... ..+.+.+|+.+++.+ .||||+++++++..
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l------~hp~iv~~~~~~~~ 105 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRL------QEPHVVPIHDFGEI 105 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTC------CCTTBCCEEEEEEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhc------CCCCeeEEEEEEee
Confidence 35789999999999999999999999999999999875432 234555666665544 57899999999999
Q ss_pred cCeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEe
Q 007035 488 LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (621)
Q Consensus 488 ~~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~D 566 (621)
.+..++||||+.+ +|.+++.... .+++..++.++.||+.||.|||+++|+||||||+|||++. ++.+||+|
T Consensus 106 ~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~--~~~~kl~D 177 (309)
T 2h34_A 106 DGQLYVDMRLINGVDLAAMLRRQG------PLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSA--DDFAYLVD 177 (309)
T ss_dssp TTEEEEEEECCCCEEHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT--TSCEEECS
T ss_pred CCeEEEEEEecCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcC--CCCEEEec
Confidence 9999999999985 7877776432 2889999999999999999999999999999999999984 78899999
Q ss_pred cCCccccCCC----ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 567 LGSSCFQTDN----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 567 FGls~~~~~~----~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
||++...... .....+++.|+|||++.+..++.++||||||+++|+|++|+.||
T Consensus 178 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf 235 (309)
T 2h34_A 178 FGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPY 235 (309)
T ss_dssp CCC----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSS
T ss_pred CccCccccccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCC
Confidence 9998654432 22356899999999999989999999999999999999999998
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-32 Score=299.61 Aligned_cols=195 Identities=23% Similarity=0.345 Sum_probs=165.4
Q ss_pred eecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecC-
Q 007035 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE- 489 (621)
Q Consensus 411 ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~- 489 (621)
+..++|++.+.||+|+||.||+|.+. |+.||||+++... ..+.+.+|+.+++.+ .||||+++++++....
T Consensus 190 i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~-~~~~~~~E~~~l~~l------~h~niv~~~~~~~~~~~ 260 (450)
T 1k9a_A 190 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-TAQAFLAEASVMTQL------RHSNLVQLLGVIVEEKG 260 (450)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT-TSHHHHHHHHHHHTC------CCTTBCCEEEEEECTTS
T ss_pred cChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch-HHHHHHHHHHHHHhc------cCCCEEEEEEEEEcCCC
Confidence 34578999999999999999999864 7899999998754 346778888888876 4789999999987665
Q ss_pred eEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecC
Q 007035 490 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (621)
Q Consensus 490 ~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFG 568 (621)
.++|||||+.+ +|.+++..... ..+++..+..++.||+.||.|||+++|+||||||+|||++. ++.+||+|||
T Consensus 261 ~~~iv~e~~~~g~L~~~l~~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~--~~~~kl~DfG 334 (450)
T 1k9a_A 261 GLYIVTEYMAKGSLVDYLRSRGR----SVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSE--DNVAKVSDFG 334 (450)
T ss_dssp CEEEEEECCTTCBHHHHHHHHCT----TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECT--TSCEEECCCT
T ss_pred ceEEEEEecCCCcHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECC--CCCEEEeeCC
Confidence 79999999975 88888775432 22688899999999999999999999999999999999984 7899999999
Q ss_pred CccccCCCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 569 SSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 569 ls~~~~~~~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
++...........+++.|+|||++.+..++.++|||||||+||||++ |+.||
T Consensus 335 ~a~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~ 387 (450)
T 1k9a_A 335 LTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY 387 (450)
T ss_dssp TCEECC------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred CcccccccccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 99765544444567889999999999999999999999999999998 99998
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-32 Score=277.80 Aligned_cols=194 Identities=28% Similarity=0.370 Sum_probs=154.0
Q ss_pred ecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc-----hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeE
Q 007035 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (621)
Q Consensus 412 i~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~-----~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~ 486 (621)
..++|++.+.||+|+||.||+|.+. ++.||+|+++... ...+.+.+|+++++.++ ||||+++++++.
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~ 76 (271)
T 3dtc_A 5 DFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLK------HPNIIALRGVCL 76 (271)
T ss_dssp CTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCC------CTTBCCEEEEEC
T ss_pred chhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcC------CCCEeeEEEEEe
Confidence 3578999999999999999999964 8899999987542 22356777888888774 789999999999
Q ss_pred ecCeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCC---eecccCCCccEEEecc-----
Q 007035 487 HLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLG---IIHCDLKPENILIKSY----- 557 (621)
Q Consensus 487 ~~~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~g---IvHrDLKP~NILl~~~----- 557 (621)
..+..++||||+.+ +|.+++. .. .+++..++.++.||+.||.|||+++ |+||||||+|||++..
T Consensus 77 ~~~~~~lv~e~~~~~~L~~~~~-~~------~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~ 149 (271)
T 3dtc_A 77 KEPNLCLVMEFARGGPLNRVLS-GK------RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGD 149 (271)
T ss_dssp CC--CEEEEECCTTEEHHHHHT-SS------CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSC
T ss_pred cCCceEEEEEcCCCCCHHHHhh-cC------CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEeccccccc
Confidence 99999999999975 5555543 11 2889999999999999999999999 8999999999999842
Q ss_pred -CCCeEEEEecCCccccCCC-ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 558 -QRCEIKIIDLGSSCFQTDN-LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 558 -~~~~IKL~DFGls~~~~~~-~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
..+.+||+|||++...... .....+++.|+|||++.+..++.++||||||+++|+|++|+.||
T Consensus 150 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~ 214 (271)
T 3dtc_A 150 LSNKILKITDFGLAREWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPF 214 (271)
T ss_dssp CSSCCEEECCCCC-------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTT
T ss_pred ccCcceEEccCCcccccccccccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 2678999999998754432 33457899999999999999999999999999999999999998
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-32 Score=280.59 Aligned_cols=197 Identities=24% Similarity=0.330 Sum_probs=155.0
Q ss_pred eeecCceEEEEEeccCCCCceeEEEeCCC---CcEEEEEEEecC--chhhhhHHHHHHHHHHhcccCCCCCCceEEEeeE
Q 007035 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHT---GVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDY 484 (621)
Q Consensus 410 ~ii~~rY~I~~~LG~G~fG~Vyka~d~~t---g~~VAlKii~~~--~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~ 484 (621)
.+..++|++.+.||+|+||.||+|.+..+ +..||+|++... ....+.+.+|+.+++.+ .||||++++++
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l------~h~~iv~~~~~ 84 (281)
T 1mp8_A 11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF------DHPHIVKLIGV 84 (281)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTC------CCTTBCCEEEE
T ss_pred EEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhC------CCCccceEEEE
Confidence 45568999999999999999999998654 557999998753 23345566777777655 48899999999
Q ss_pred eEecCeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEE
Q 007035 485 FYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 563 (621)
Q Consensus 485 f~~~~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IK 563 (621)
+. .+..++||||+.+ +|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+|
T Consensus 85 ~~-~~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~--~~~~k 156 (281)
T 1mp8_A 85 IT-ENPVWIIMELCTLGELRSFLQVRKY-----SLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSS--NDCVK 156 (281)
T ss_dssp EC-SSSCEEEEECCTTEEHHHHHHHTTT-----TSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEE--TTEEE
T ss_pred Ec-cCccEEEEecCCCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECC--CCCEE
Confidence 74 5678999999985 77777764322 2889999999999999999999999999999999999994 78999
Q ss_pred EEecCCccccCCCc----cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 564 IIDLGSSCFQTDNL----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 564 L~DFGls~~~~~~~----~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
|+|||++....... ....+++.|+|||++.+..++.++||||||+++|+|++ |+.||
T Consensus 157 l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf 218 (281)
T 1mp8_A 157 LGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF 218 (281)
T ss_dssp ECC-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred ECccccccccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCC
Confidence 99999987654322 22345778999999998899999999999999999997 99998
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-32 Score=284.40 Aligned_cols=204 Identities=28% Similarity=0.351 Sum_probs=149.8
Q ss_pred CeeecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCch--hhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeE
Q 007035 409 NTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD--FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (621)
Q Consensus 409 ~~ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~--~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~ 486 (621)
..+..++|++++.||+|+||.||+|.++.+|+.||||++..... ...+...|+.. .+ ....||||+++++++.
T Consensus 17 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~--~~---~~~~h~niv~~~~~~~ 91 (327)
T 3aln_A 17 WDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDV--VM---RSSDCPYIVQFYGALF 91 (327)
T ss_dssp ECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHH--HH---SSCCCTTBCCEEEEEE
T ss_pred cccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHH--HH---HcCCCCcEeeeeeEEE
Confidence 34456899999999999999999999999999999999976432 12222333321 12 2357999999999999
Q ss_pred ecCeEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHC-CeecccCCCccEEEeccCCCeEEEE
Q 007035 487 HLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSL-GIIHCDLKPENILIKSYQRCEIKII 565 (621)
Q Consensus 487 ~~~~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~-gIvHrDLKP~NILl~~~~~~~IKL~ 565 (621)
..+..++||||+.++|.+++...... ....+++..++.++.||+.||.|||+. ||+||||||+|||++ .++.+||+
T Consensus 92 ~~~~~~lv~e~~~~~l~~~~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~--~~~~~kl~ 168 (327)
T 3aln_A 92 REGDCWICMELMSTSFDKFYKYVYSV-LDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLD--RSGNIKLC 168 (327)
T ss_dssp CSSEEEEEECCCSEEHHHHHHHHHHT-TCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEE--TTTEEEEC
T ss_pred eCCceEEEEeecCCChHHHHHHHHhh-hcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEc--CCCCEEEc
Confidence 99999999999999988887643221 122388999999999999999999999 999999999999998 48899999
Q ss_pred ecCCccccCCC--ccccccCCcccCchhh----cCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 566 DLGSSCFQTDN--LCLYVQSRSYRAPEVI----IGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 566 DFGls~~~~~~--~~~~~gt~~Y~APEvl----~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
|||++...... .....+++.|+|||++ .+..++.++||||||+++|+|++|+.||
T Consensus 169 Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf 229 (327)
T 3aln_A 169 DFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPY 229 (327)
T ss_dssp CCSSSCC------------------------------CCSHHHHHHHHHHHHHHHHSCCCS
T ss_pred cCCCceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCC
Confidence 99998765433 2234689999999999 4566899999999999999999999998
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-32 Score=281.86 Aligned_cols=198 Identities=31% Similarity=0.461 Sum_probs=162.8
Q ss_pred eeecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc-hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEec
Q 007035 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (621)
Q Consensus 410 ~ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~-~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~ 488 (621)
....++|++++.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.+++.+ .||||+++++++...
T Consensus 15 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~~~ 88 (302)
T 2j7t_A 15 LDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATC------DHPYIVKLLGAYYHD 88 (302)
T ss_dssp SCGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHC------CCTTBCCEEEEEECC
T ss_pred cCCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcC------CCCCEeeeeeeeeeC
Confidence 345689999999999999999999999999999999987532 3346677888888776 378999999999999
Q ss_pred CeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEec
Q 007035 489 EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 567 (621)
Q Consensus 489 ~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DF 567 (621)
+..++||||+.+ +|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+||
T Consensus 89 ~~~~lv~e~~~~~~l~~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~--~~~~kl~Df 161 (302)
T 2j7t_A 89 GKLWIMIEFCPGGAVDAIMLELDR-----GLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTL--EGDIRLADF 161 (302)
T ss_dssp -CEEEEEECCTTEEHHHHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECT--TSCEEECCC
T ss_pred CeEEEEEEeCCCCcHHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECC--CCCEEEEEC
Confidence 999999999986 55555543222 2889999999999999999999999999999999999984 788999999
Q ss_pred CCccccC---CCccccccCCcccCchhhc-----CCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 568 GSSCFQT---DNLCLYVQSRSYRAPEVII-----GLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 568 Gls~~~~---~~~~~~~gt~~Y~APEvl~-----~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
|++.... .......+++.|+|||++. +..++.++||||||+++|+|++|+.||
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~ 222 (302)
T 2j7t_A 162 GVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPH 222 (302)
T ss_dssp HHHHHHHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTT
T ss_pred CCCccccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCC
Confidence 9865322 1223356899999999983 667899999999999999999999997
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-32 Score=276.98 Aligned_cols=194 Identities=26% Similarity=0.398 Sum_probs=163.1
Q ss_pred cCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc---hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEe--
Q 007035 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH-- 487 (621)
Q Consensus 413 ~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~---~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~-- 487 (621)
...|++.+.||+|+||.||+|.+..++..||+|++.... ...+.+.+|+.+++.+ .||||+++++++..
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l------~h~~iv~~~~~~~~~~ 98 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL------QHPNIVRFYDSWESTV 98 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTC------CCTTBCCEEEEEEEES
T ss_pred ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhC------CCCCeeeeeeeecccc
Confidence 356899999999999999999999999999999987532 2334556666666555 58899999999876
Q ss_pred --cCeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCC--eecccCCCccEEEeccCCCeE
Q 007035 488 --LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLG--IIHCDLKPENILIKSYQRCEI 562 (621)
Q Consensus 488 --~~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~g--IvHrDLKP~NILl~~~~~~~I 562 (621)
..++++||||+.+ +|.+++..... +++..++.++.||+.||.|||+.+ |+||||||+|||++. .++.+
T Consensus 99 ~~~~~~~lv~e~~~~~~L~~~l~~~~~------~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~-~~~~~ 171 (290)
T 1t4h_A 99 KGKKCIVLVTELMTSGTLKTYLKRFKV------MKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITG-PTGSV 171 (290)
T ss_dssp SSCEEEEEEEECCCSCBHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESS-TTSCE
T ss_pred CCCceEEEEEEecCCCCHHHHHHHccC------CCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEEC-CCCCE
Confidence 4679999999975 77777764322 788999999999999999999999 999999999999973 47789
Q ss_pred EEEecCCccccCCC-ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 563 KIIDLGSSCFQTDN-LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 563 KL~DFGls~~~~~~-~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
||+|||++...... .....+++.|+|||++.+ .++.++||||||+++|+|++|+.||
T Consensus 172 kl~Dfg~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf 229 (290)
T 1t4h_A 172 KIGDLGLATLKRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPY 229 (290)
T ss_dssp EECCTTGGGGCCTTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred EEeeCCCcccccccccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCC
Confidence 99999998655443 334578999999998875 5899999999999999999999998
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-32 Score=285.60 Aligned_cols=199 Identities=22% Similarity=0.333 Sum_probs=163.2
Q ss_pred CCCcceeeCeeecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEE
Q 007035 401 NKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILR 480 (621)
Q Consensus 401 ~~~~pi~l~~ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvr 480 (621)
....|......+.++|++.+.||+|+||.||+|++. ++.||||++..... .....|.+++..+ ...||||++
T Consensus 24 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~--~~~~~e~~~~~~~----~~~h~~i~~ 95 (337)
T 3mdy_A 24 GSGLPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEE--ASWFRETEIYQTV----LMRHENILG 95 (337)
T ss_dssp CSSSCHHHHTTHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGGH--HHHHHHHHHHTST----TCCCTTBCC
T ss_pred CCCCCcccccccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecccc--chhhhHHHHHHHH----hhcCCCeee
Confidence 445566677788899999999999999999999864 89999999975443 3334444444333 346999999
Q ss_pred EeeEeEec----CeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHC--------CeecccC
Q 007035 481 LYDYFYHL----EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSL--------GIIHCDL 547 (621)
Q Consensus 481 l~~~f~~~----~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~--------gIvHrDL 547 (621)
+++++... ..+++||||+.+ +|.+++... .+++..++.++.||+.||.|||++ +|+||||
T Consensus 96 ~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Di 168 (337)
T 3mdy_A 96 FIAADIKGTGSWTQLYLITDYHENGSLYDYLKST-------TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDL 168 (337)
T ss_dssp EEEEEEESCGGGCEEEEEECCCTTCBHHHHHHHC-------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCC
T ss_pred EEEEEccCCCCCCceEEEEeccCCCcHHHHhhcc-------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEeccc
Confidence 99999987 789999999975 888877532 288999999999999999999998 9999999
Q ss_pred CCccEEEeccCCCeEEEEecCCccccCCCc-------cccccCCcccCchhhcCCCCCch------hhHHHHHHHHHHHH
Q 007035 548 KPENILIKSYQRCEIKIIDLGSSCFQTDNL-------CLYVQSRSYRAPEVIIGLPYDQK------IDLWSLGCILAELW 614 (621)
Q Consensus 548 KP~NILl~~~~~~~IKL~DFGls~~~~~~~-------~~~~gt~~Y~APEvl~~~~~s~k------sDIWSLGvILyELl 614 (621)
||+|||++. ++.+||+|||++....... ....||+.|+|||++.+..+..+ +|||||||++|||+
T Consensus 169 kp~Nill~~--~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~ 246 (337)
T 3mdy_A 169 KSKNILVKK--NGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVA 246 (337)
T ss_dssp CGGGEEECT--TSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHH
T ss_pred chHHEEECC--CCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHH
Confidence 999999984 7899999999986543321 23578999999999988766654 99999999999999
Q ss_pred hC
Q 007035 615 TG 616 (621)
Q Consensus 615 tG 616 (621)
+|
T Consensus 247 tg 248 (337)
T 3mdy_A 247 RR 248 (337)
T ss_dssp TT
T ss_pred hc
Confidence 99
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-32 Score=275.49 Aligned_cols=194 Identities=22% Similarity=0.350 Sum_probs=167.5
Q ss_pred cCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeEE
Q 007035 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLF 492 (621)
Q Consensus 413 ~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l~ 492 (621)
.++|++.+.||+|+||.||++.+. +++.||+|++.......+.+.+|+.+++.+ .||||+++++++...+..+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~~~~~~~ 79 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKL------SHPKLVQLYGVCLEQAPIC 79 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCHHHHHHHHHHHHTC------CCTTBCCEEEEECSSSSCE
T ss_pred hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCHHHHHHHHHHHHhC------CCCCEeeEEEEEccCCCeE
Confidence 478999999999999999999975 678899999987665556778888888776 4789999999999999999
Q ss_pred EEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCcc
Q 007035 493 IVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 571 (621)
Q Consensus 493 LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~ 571 (621)
+||||+.+ +|.+++..... .+++..+..++.||+.||.|||++||+||||||+||+++. ++.+||+|||++.
T Consensus 80 lv~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~--~~~~kl~dfg~~~ 152 (267)
T 3t9t_A 80 LVTEFMEHGCLSDYLRTQRG-----LFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGE--NQVIKVSDFGMTR 152 (267)
T ss_dssp EEECCCTTCBHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECG--GGCEEECCTTGGG
T ss_pred EEEeCCCCCcHHHHHhhCcc-----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECC--CCCEEEccccccc
Confidence 99999974 77777754322 2789999999999999999999999999999999999984 7889999999987
Q ss_pred ccCCC----ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 572 FQTDN----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 572 ~~~~~----~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
..... .....+++.|+|||++.+..++.++||||||+++|+|++ |+.||
T Consensus 153 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~ 206 (267)
T 3t9t_A 153 FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPY 206 (267)
T ss_dssp GBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred ccccccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCC
Confidence 65332 122355778999999998889999999999999999999 89998
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-32 Score=287.18 Aligned_cols=203 Identities=22% Similarity=0.311 Sum_probs=167.8
Q ss_pred eecCceEEEEEeccCCCCceeEEEe-----CCCCcEEEEEEEecC--chhhhhHHHHHHHHHHhcccCCCCCCceEEEee
Q 007035 411 VIAGRYYVTEYLGSAAFSKVFQAQD-----LHTGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYD 483 (621)
Q Consensus 411 ii~~rY~I~~~LG~G~fG~Vyka~d-----~~tg~~VAlKii~~~--~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~ 483 (621)
+..++|++.+.||+|+||.||+|.+ ..+++.||+|+++.. ......+.+|+.+++.+. .||||+++++
T Consensus 42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----~hp~iv~~~~ 116 (344)
T 1rjb_A 42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLG-----SHENIVNLLG 116 (344)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHC-----CCTTBCCEEE
T ss_pred cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhc-----CCCCeeeEEE
Confidence 3457899999999999999999997 346778999999753 234567888999999884 4789999999
Q ss_pred EeEecCeEEEEEecccc-chHHHHHhhhccC-----------------CCccccHHHHHHHHHHHHHHHHHHHHCCeecc
Q 007035 484 YFYHLEHLFIVCELLRA-NLYEFQKFNQESG-----------------GEAYFTLGRLQVITRQCLEALEYLHSLGIIHC 545 (621)
Q Consensus 484 ~f~~~~~l~LVmEyl~g-sLld~l~~~~~~~-----------------~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHr 545 (621)
++...+..++||||+.+ +|.+++....... ....+++..++.++.||+.||.|||++||+||
T Consensus 117 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~ 196 (344)
T 1rjb_A 117 ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHR 196 (344)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred EEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence 99999999999999975 8888876543210 01237889999999999999999999999999
Q ss_pred cCCCccEEEeccCCCeEEEEecCCccccCCCc-----cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCC
Q 007035 546 DLKPENILIKSYQRCEIKIIDLGSSCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVC 619 (621)
Q Consensus 546 DLKP~NILl~~~~~~~IKL~DFGls~~~~~~~-----~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~P 619 (621)
||||+|||++ .++.+||+|||++....... ....+|+.|+|||++.+..++.++||||||+++|+|++ |+.|
T Consensus 197 Dikp~NIll~--~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 274 (344)
T 1rjb_A 197 DLAARNVLVT--HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274 (344)
T ss_dssp TCSGGGEEEE--TTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred CCChhhEEEc--CCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCC
Confidence 9999999998 47899999999987543321 22355778999999999899999999999999999998 9999
Q ss_pred C
Q 007035 620 L 620 (621)
Q Consensus 620 F 620 (621)
|
T Consensus 275 ~ 275 (344)
T 1rjb_A 275 Y 275 (344)
T ss_dssp S
T ss_pred c
Confidence 8
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-32 Score=283.82 Aligned_cols=203 Identities=25% Similarity=0.401 Sum_probs=168.3
Q ss_pred eecCceEEEEEeccCCCCceeEEEeC-------CCCcEEEEEEEecCc--hhhhhHHHHHHHHHHhcccCCCCCCceEEE
Q 007035 411 VIAGRYYVTEYLGSAAFSKVFQAQDL-------HTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRL 481 (621)
Q Consensus 411 ii~~rY~I~~~LG~G~fG~Vyka~d~-------~tg~~VAlKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl 481 (621)
+..++|++.+.||+|+||.||+|++. .+++.||+|+++... .....+.+|+.+++.+. .||||+++
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----~hp~iv~~ 106 (334)
T 2pvf_A 32 FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG-----KHKNIINL 106 (334)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHC-----CCTTBCCE
T ss_pred CCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhh-----cCCCEeeE
Confidence 45689999999999999999999975 467889999997643 34466788999998884 47899999
Q ss_pred eeEeEecCeEEEEEecccc-chHHHHHhhhccC----------CCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCc
Q 007035 482 YDYFYHLEHLFIVCELLRA-NLYEFQKFNQESG----------GEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPE 550 (621)
Q Consensus 482 ~~~f~~~~~l~LVmEyl~g-sLld~l~~~~~~~----------~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~ 550 (621)
++++...+.+++||||+.+ +|.+++....... ....+++..++.++.||+.||.|||++||+||||||+
T Consensus 107 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~ 186 (334)
T 2pvf_A 107 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAAR 186 (334)
T ss_dssp EEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred EEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccc
Confidence 9999999999999999975 8888876543211 1223788999999999999999999999999999999
Q ss_pred cEEEeccCCCeEEEEecCCccccCCC-----ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 551 NILIKSYQRCEIKIIDLGSSCFQTDN-----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 551 NILl~~~~~~~IKL~DFGls~~~~~~-----~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
|||++ .++.+||+|||++...... .....+++.|+|||++.+..++.++||||||+++|+|++ |+.||
T Consensus 187 NIll~--~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~ 260 (334)
T 2pvf_A 187 NVLVT--ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260 (334)
T ss_dssp GEEEC--TTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred eEEEc--CCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCc
Confidence 99998 4788999999998765432 222345788999999998889999999999999999999 99997
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-32 Score=277.73 Aligned_cols=191 Identities=32% Similarity=0.457 Sum_probs=158.3
Q ss_pred ecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEe----
Q 007035 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH---- 487 (621)
Q Consensus 412 i~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~---- 487 (621)
+.++|++++.||+|+||.||+|++..+++.||||++.......+.+.+|+.+++.+ .||||+++++++..
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l------~h~~i~~~~~~~~~~~~~ 77 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASL------NHQYVVRYYAAWLERRNF 77 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTC------CCTTBCCEEEEEEECCCC
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhc------CchHHHHHHHHHHhhcch
Confidence 45789999999999999999999999999999999987665566677787777655 47899999998865
Q ss_pred ---------cCeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEecc
Q 007035 488 ---------LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSY 557 (621)
Q Consensus 488 ---------~~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~ 557 (621)
....++||||+.+ +|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 78 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~-- 150 (303)
T 1zy4_A 78 VKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENL-----NQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFID-- 150 (303)
T ss_dssp CC------CEEEEEEEEECCCSCBHHHHHHHSCG-----GGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC--
T ss_pred hhhhcccccCCceEEEEecCCCCCHHHhhhcccc-----ccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEc--
Confidence 4679999999975 88887764322 277889999999999999999999999999999999998
Q ss_pred CCCeEEEEecCCccccCC-----------------CccccccCCcccCchhhcCC-CCCchhhHHHHHHHHHHHHh
Q 007035 558 QRCEIKIIDLGSSCFQTD-----------------NLCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWT 615 (621)
Q Consensus 558 ~~~~IKL~DFGls~~~~~-----------------~~~~~~gt~~Y~APEvl~~~-~~s~ksDIWSLGvILyELlt 615 (621)
.++.+||+|||++..... ......+++.|+|||++.+. .++.++|||||||++|+|++
T Consensus 151 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~ 226 (303)
T 1zy4_A 151 ESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY 226 (303)
T ss_dssp TTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS
T ss_pred CCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh
Confidence 478899999999865432 12335678999999999865 68999999999999999998
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-32 Score=280.26 Aligned_cols=199 Identities=27% Similarity=0.388 Sum_probs=163.8
Q ss_pred ecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecC-chhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEe---
Q 007035 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND-KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH--- 487 (621)
Q Consensus 412 i~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~-~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~--- 487 (621)
..++|++.+.||+|+||.||++++..+|+.||||++... ....+.+.+|+.+++.+ .||||+++++++..
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~h~~iv~~~~~~~~~~~ 100 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLF------NHPNILRLVAYCLRERG 100 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTC------CCTTBCCCCEEEEEEET
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhc------CCCCeeeEEEEEEeccC
Confidence 357899999999999999999999999999999988643 33456677788877766 47899999999873
Q ss_pred -cCeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEE
Q 007035 488 -LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKII 565 (621)
Q Consensus 488 -~~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~ 565 (621)
....++||||+.+ +|.+++...... ...+++..++.++.||+.||.|||+++|+||||||+|||++ .++.+||+
T Consensus 101 ~~~~~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~--~~~~~kl~ 176 (317)
T 2buj_A 101 AKHEAWLLLPFFKRGTLWNEIERLKDK--GNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLG--DEGQPVLM 176 (317)
T ss_dssp TEEEEEEEEECCTTCBHHHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC--TTSCEEEC
T ss_pred CCceeEEEEEeCCCCcHHHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEc--CCCCEEEE
Confidence 3579999999986 888777654322 22389999999999999999999999999999999999998 47889999
Q ss_pred ecCCccccCCCc------------cccccCCcccCchhhcCCC---CCchhhHHHHHHHHHHHHhCCCCC
Q 007035 566 DLGSSCFQTDNL------------CLYVQSRSYRAPEVIIGLP---YDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 566 DFGls~~~~~~~------------~~~~gt~~Y~APEvl~~~~---~s~ksDIWSLGvILyELltG~~PF 620 (621)
|||++....... ....+|+.|+|||++.+.. ++.++||||||+++|+|++|+.||
T Consensus 177 dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~ 246 (317)
T 2buj_A 177 DLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPY 246 (317)
T ss_dssp CCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTT
T ss_pred ecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCCh
Confidence 999876543211 1235689999999997654 688999999999999999999997
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=2.8e-32 Score=277.03 Aligned_cols=197 Identities=27% Similarity=0.380 Sum_probs=166.9
Q ss_pred eeecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecC
Q 007035 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (621)
Q Consensus 410 ~ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~ 489 (621)
.+..++|++.+.||+|+||.||+|.+. .+..||+|++.......+.+.+|+++++.++ ||||+++++++. .+
T Consensus 9 ~v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~------h~~i~~~~~~~~-~~ 80 (279)
T 1qpc_A 9 EVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQ------HQRLVRLYAVVT-QE 80 (279)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCC------CTTBCCEEEEEC-SS
T ss_pred ccCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcccHHHHHHHHHHHHhCC------CcCcceEEEEEc-CC
Confidence 455689999999999999999999964 6778999999876655677888999988874 789999999876 45
Q ss_pred eEEEEEeccc-cchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecC
Q 007035 490 HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (621)
Q Consensus 490 ~l~LVmEyl~-gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFG 568 (621)
..++||||+. ++|.+++...... .+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||
T Consensus 81 ~~~~v~e~~~~~~L~~~l~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~--~~~~~kl~Dfg 154 (279)
T 1qpc_A 81 PIYIITEYMENGSLVDFLKTPSGI----KLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVS--DTLSCKIADFG 154 (279)
T ss_dssp SCEEEEECCTTCBHHHHTTSHHHH----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--TTSCEEECCCT
T ss_pred CcEEEEecCCCCCHHHHHhcCCCC----CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEc--CCCCEEECCCc
Confidence 6899999996 5777776543221 288999999999999999999999999999999999998 47889999999
Q ss_pred CccccCCCc----cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 569 SSCFQTDNL----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 569 ls~~~~~~~----~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
++....... ....+++.|+|||++.+..++.++||||||+++|+|++ |+.||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~ 211 (279)
T 1qpc_A 155 LARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY 211 (279)
T ss_dssp TCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred ccccccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCC
Confidence 987654332 22345778999999998889999999999999999999 99987
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=2.1e-32 Score=286.14 Aligned_cols=196 Identities=22% Similarity=0.321 Sum_probs=157.5
Q ss_pred eecCceEEEEEeccCCCCceeEEEeCCCCcEE----EEEEEecC--chhhhhHHHHHHHHHHhcccCCCCCCceEEEeeE
Q 007035 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDV----CLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDY 484 (621)
Q Consensus 411 ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~V----AlKii~~~--~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~ 484 (621)
+..++|++++.||+|+||+||+|++..+++.+ |+|.++.. ......+.+|+.+++.++ ||||++++++
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~~~ 85 (327)
T 3poz_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD------NPHVCRLLGI 85 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCC------BTTBCCEEEE
T ss_pred cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCC------CCCEeEEEEE
Confidence 34578999999999999999999998887765 77766532 233466788888888774 7899999999
Q ss_pred eEecCeEEEEEeccc-cchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEE
Q 007035 485 FYHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 563 (621)
Q Consensus 485 f~~~~~l~LVmEyl~-gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IK 563 (621)
+.... .++|+||+. ++|.+++..... .+++..++.++.||+.||.|||+++|+||||||+|||++. ++.+|
T Consensus 86 ~~~~~-~~~v~e~~~~g~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~--~~~~k 157 (327)
T 3poz_A 86 CLTST-VQLITQLMPFGCLLDYVREHKD-----NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKT--PQHVK 157 (327)
T ss_dssp EESSS-EEEEEECCTTCBHHHHHHHSTT-----SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEE--TTEEE
T ss_pred EecCC-eEEEEEecCCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECC--CCCEE
Confidence 98765 677888887 578877765432 2889999999999999999999999999999999999984 78999
Q ss_pred EEecCCccccCCCc-----cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 564 IIDLGSSCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 564 L~DFGls~~~~~~~-----~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
|+|||++....... ....+|+.|+|||++.+..++.++|||||||++|+|++ |+.||
T Consensus 158 l~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~ 220 (327)
T 3poz_A 158 ITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 220 (327)
T ss_dssp ECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred EccCcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCc
Confidence 99999987543321 22345778999999999999999999999999999999 99998
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2e-32 Score=278.30 Aligned_cols=195 Identities=23% Similarity=0.345 Sum_probs=157.5
Q ss_pred eecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEec-C
Q 007035 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL-E 489 (621)
Q Consensus 411 ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~-~ 489 (621)
+..++|++.+.||+|+||+||++.+ +|+.||+|+++... ..+.+.+|+.+++.+ .||||+++++++... +
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-~~~~~~~E~~~l~~l------~h~~iv~~~~~~~~~~~ 88 (278)
T 1byg_A 18 LNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-TAQAFLAEASVMTQL------RHSNLVQLLGVIVEEKG 88 (278)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC---HHHHHTHHHHTTC------CCTTBCCEEEEECCC--
T ss_pred CChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchh-HHHHHHHHHHHHHhC------CCCCEeeEEEEEEcCCC
Confidence 4457899999999999999999986 48899999998654 345667777777655 478999999987654 5
Q ss_pred eEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecC
Q 007035 490 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (621)
Q Consensus 490 ~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFG 568 (621)
..++||||+.+ +|.+++..... ..+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~--~~~~~l~Dfg 162 (278)
T 1byg_A 89 GLYIVTEYMAKGSLVDYLRSRGR----SVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSE--DNVAKVSDFG 162 (278)
T ss_dssp CCEEEECCCTTEEHHHHHHHHHH----HHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECT--TSCEEECCCC
T ss_pred ceEEEEecCCCCCHHHHHHhccc----ccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeC--CCcEEEeecc
Confidence 79999999985 88888765432 12778899999999999999999999999999999999984 7899999999
Q ss_pred CccccCCCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 569 SSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 569 ls~~~~~~~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
++...........+++.|+|||++.+..++.++||||||+++|+|++ |+.||
T Consensus 163 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~ 215 (278)
T 1byg_A 163 LTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY 215 (278)
T ss_dssp C------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSC
T ss_pred ccccccccccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCC
Confidence 98776655555567889999999999899999999999999999998 99997
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=5.7e-33 Score=288.77 Aligned_cols=199 Identities=22% Similarity=0.298 Sum_probs=164.8
Q ss_pred eecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc-hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecC
Q 007035 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (621)
Q Consensus 411 ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~-~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~ 489 (621)
...++|++.+.||+|+||+||+|.+ .+++.||+|++.... ...+.+.+|+.+++. +.||||+++++++...+
T Consensus 36 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~------l~h~~iv~~~~~~~~~~ 108 (321)
T 2qkw_B 36 EATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPESSQGIEEFETEIETLSF------CRHPHLVSLIGFCDERN 108 (321)
T ss_dssp CCCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCCSSHHHHHHHHHHGGGS------CCCTTBCCEEEECCCTT
T ss_pred HHHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccChHHHHHHHHHHHHHHh------CCCCCEeeEEEEEcCCC
Confidence 3557899999999999999999995 578999999887543 233455666665544 45899999999999999
Q ss_pred eEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecC
Q 007035 490 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (621)
Q Consensus 490 ~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFG 568 (621)
..++||||+.+ +|.+++..... ....+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~--~~~~~kl~Dfg 184 (321)
T 2qkw_B 109 EMILIYKYMENGNLKRHLYGSDL--PTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLD--ENFVPKITDFG 184 (321)
T ss_dssp CCEEEEECCTTCBTGGGSSSSCC--CSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEEC--TTCCEEECCCT
T ss_pred eEEEEEEcCCCCcHHHHHhccCC--CccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEEC--CCCCEEEeecc
Confidence 99999999985 77665543221 223488999999999999999999999999999999999998 47899999999
Q ss_pred CccccCCC-----ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 569 SSCFQTDN-----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 569 ls~~~~~~-----~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
++...... .....+|+.|+|||++.+..++.++||||||+++|+|++|+.||
T Consensus 185 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~ 241 (321)
T 2qkw_B 185 ISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAI 241 (321)
T ss_dssp TCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTC
T ss_pred cccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcc
Confidence 98754321 22345799999999999889999999999999999999999998
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=3.2e-32 Score=283.88 Aligned_cols=206 Identities=20% Similarity=0.244 Sum_probs=165.6
Q ss_pred CeeecCceEEEEEeccCCCCceeEEE-----eCCCCcEEEEEEEecC--chhhhhHHHHHHHHHHhcccCCCCCCceEEE
Q 007035 409 NTVIAGRYYVTEYLGSAAFSKVFQAQ-----DLHTGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRL 481 (621)
Q Consensus 409 ~~ii~~rY~I~~~LG~G~fG~Vyka~-----d~~tg~~VAlKii~~~--~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl 481 (621)
..+..++|++.+.||+|+||.||+|+ +..+++.||+|++... .....++.+|+.+++.+ .||||+++
T Consensus 25 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l------~h~~iv~~ 98 (327)
T 2yfx_A 25 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF------NHQNIVRC 98 (327)
T ss_dssp CBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHC------CCTTBCCE
T ss_pred ccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhC------CCCCCCeE
Confidence 45667899999999999999999999 5678889999999643 23345667788887776 47899999
Q ss_pred eeEeEecCeEEEEEeccc-cchHHHHHhhhccC-CCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccC-
Q 007035 482 YDYFYHLEHLFIVCELLR-ANLYEFQKFNQESG-GEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQ- 558 (621)
Q Consensus 482 ~~~f~~~~~l~LVmEyl~-gsLld~l~~~~~~~-~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~- 558 (621)
++++......++||||+. ++|.+++....... ....+++..++.++.||+.||.|||++||+||||||+|||++.+.
T Consensus 99 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~ 178 (327)
T 2yfx_A 99 IGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGP 178 (327)
T ss_dssp EEEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSST
T ss_pred EEEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCC
Confidence 999999999999999995 68888877553221 123488899999999999999999999999999999999998532
Q ss_pred CCeEEEEecCCccccCC-----CccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 559 RCEIKIIDLGSSCFQTD-----NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 559 ~~~IKL~DFGls~~~~~-----~~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
...+||+|||++..... ......+++.|+|||++.+..++.++||||||+++|+|++ |+.||
T Consensus 179 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~ 246 (327)
T 2yfx_A 179 GRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY 246 (327)
T ss_dssp TCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred cceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCC
Confidence 45699999998864322 1223466889999999998899999999999999999998 99987
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=8.7e-32 Score=277.75 Aligned_cols=196 Identities=28% Similarity=0.366 Sum_probs=146.0
Q ss_pred cCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhh--hhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCe
Q 007035 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFF--DQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (621)
Q Consensus 413 ~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~--~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~ 490 (621)
.++|++++.||+|+||.||+|++..+|+.||||++....... .+...|... .+. ...||||+++++++...+.
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~--~~~---~~~h~~i~~~~~~~~~~~~ 98 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDV--VLK---SHDCPYIVQCFGTFITNTD 98 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHH--HHH---TTTCTTBCCEEEEEECSSE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHH--HHH---hcCCCceeeEEEEEecCCc
Confidence 478999999999999999999999999999999998653221 122222221 122 2368999999999999999
Q ss_pred EEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHC-CeecccCCCccEEEeccCCCeEEEEecCC
Q 007035 491 LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSL-GIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (621)
Q Consensus 491 l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~-gIvHrDLKP~NILl~~~~~~~IKL~DFGl 569 (621)
+++||||+++.+..+...... .+++..++.++.||+.||.|||++ ||+||||||+|||++. ++.+||+|||+
T Consensus 99 ~~lv~e~~~~~~~~l~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~--~~~~kl~dfg~ 171 (318)
T 2dyl_A 99 VFIAMELMGTCAEKLKKRMQG-----PIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDE--RGQIKLCDFGI 171 (318)
T ss_dssp EEEEECCCSEEHHHHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECT--TSCEEECCCTT
T ss_pred EEEEEeccCCcHHHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECC--CCCEEEEECCC
Confidence 999999996655555443222 288999999999999999999995 9999999999999984 78899999999
Q ss_pred ccccCCC--ccccccCCcccCchhhc-----CCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 570 SCFQTDN--LCLYVQSRSYRAPEVII-----GLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 570 s~~~~~~--~~~~~gt~~Y~APEvl~-----~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
+...... .....+++.|+|||++. ...++.++||||||+++|+|++|+.||
T Consensus 172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf 229 (318)
T 2dyl_A 172 SGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPY 229 (318)
T ss_dssp C--------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred chhccCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCC
Confidence 8654332 23356899999999994 456889999999999999999999998
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=3.6e-32 Score=283.51 Aligned_cols=195 Identities=26% Similarity=0.323 Sum_probs=166.3
Q ss_pred cCceEEEEEeccCCCCceeEEE----eCCCCcEEEEEEEecCc-hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeE-
Q 007035 413 AGRYYVTEYLGSAAFSKVFQAQ----DLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY- 486 (621)
Q Consensus 413 ~~rY~I~~~LG~G~fG~Vyka~----d~~tg~~VAlKii~~~~-~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~- 486 (621)
.++|++++.||+|+||.||+|+ +..+++.||+|++.... ...+.+.+|+.+++.+ .||||+++++++.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~h~~i~~~~~~~~~ 95 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKAL------HSDFIVKYRGVSYG 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTC------CCTTBCCEEEEEEC
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhc------CCCceeEEEEEEec
Confidence 3689999999999999999998 67889999999997643 3345677888888777 4789999999887
Q ss_pred -ecCeEEEEEeccc-cchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEE
Q 007035 487 -HLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKI 564 (621)
Q Consensus 487 -~~~~l~LVmEyl~-gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL 564 (621)
....+++||||++ ++|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||
T Consensus 96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~--~~~~kl 168 (327)
T 3lxl_A 96 PGRQSLRLVMEYLPSGCLRDFLQRHRA-----RLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVES--EAHVKI 168 (327)
T ss_dssp SSSCEEEEEEECCTTCBHHHHHHHHGG-----GCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEE--TTEEEE
T ss_pred CCCceEEEEEeecCCCCHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECC--CCCEEE
Confidence 4567999999996 578877765432 2889999999999999999999999999999999999984 789999
Q ss_pred EecCCccccCCCc------cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 565 IDLGSSCFQTDNL------CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 565 ~DFGls~~~~~~~------~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
+|||++....... ....+++.|+|||++.+..++.++||||||+++|+|++|+.||
T Consensus 169 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~ 230 (327)
T 3lxl_A 169 ADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKS 230 (327)
T ss_dssp CCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGG
T ss_pred cccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCC
Confidence 9999987654322 2245677899999999988999999999999999999999987
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=3.7e-32 Score=278.50 Aligned_cols=196 Identities=28% Similarity=0.415 Sum_probs=153.0
Q ss_pred eCeeecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc---hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeE
Q 007035 408 LNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDY 484 (621)
Q Consensus 408 l~~ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~---~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~ 484 (621)
.+++..++|++.+.||+|+||+||+|++. ..||+|+++... ...+.+.+|+.+++.+ .||||++++++
T Consensus 18 ~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l------~h~~iv~~~~~ 88 (289)
T 3og7_A 18 DWEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT------RHVNILLFMGY 88 (289)
T ss_dssp CCBCCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHTTC------CCTTBCCEEEE
T ss_pred CCccCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHHhC------CCCcEEEEEee
Confidence 45677899999999999999999999853 359999987543 2334566677666655 48899999995
Q ss_pred eEecCeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEE
Q 007035 485 FYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 563 (621)
Q Consensus 485 f~~~~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IK 563 (621)
. .....++||||+.+ +|.+.+.... ..+++..++.++.||+.||.|||+++|+||||||+|||++. ++.+|
T Consensus 89 ~-~~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~--~~~~k 160 (289)
T 3og7_A 89 S-TAPQLAIVTQWCEGSSLYHHLHASE-----TKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHE--DNTVK 160 (289)
T ss_dssp E-CSSSCEEEEECCCEEEHHHHHTTC--------CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEET--TTEEE
T ss_pred c-cCCccEEEEEecCCCcHHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECC--CCCEE
Confidence 4 55678999999984 6766664332 22889999999999999999999999999999999999994 78999
Q ss_pred EEecCCccccCC-----CccccccCCcccCchhhc---CCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 564 IIDLGSSCFQTD-----NLCLYVQSRSYRAPEVII---GLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 564 L~DFGls~~~~~-----~~~~~~gt~~Y~APEvl~---~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
|+|||++..... ......+|+.|+|||++. +..++.++||||||+++|+|++|+.||
T Consensus 161 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~ 225 (289)
T 3og7_A 161 IGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPY 225 (289)
T ss_dssp ECCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred EccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCc
Confidence 999999865432 223356899999999996 567889999999999999999999998
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=8.7e-32 Score=293.49 Aligned_cols=203 Identities=27% Similarity=0.326 Sum_probs=160.0
Q ss_pred eeecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecC
Q 007035 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (621)
Q Consensus 410 ~ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~ 489 (621)
..+.+.|.+.+.||+|+||+||.+. ..+|+.||||++..+. .+...+|+.+++.+. .||||+++++++...+
T Consensus 11 ~~l~~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~~--~~~~~~E~~~l~~l~-----~HpnIv~~~~~~~~~~ 82 (434)
T 2rio_A 11 QSLKNLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDF--CDIALMEIKLLTESD-----DHPNVIRYYCSETTDR 82 (434)
T ss_dssp CSCSSCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGGG--HHHHHHHHHHHHHHT-----TSTTBCCEEEEEECSS
T ss_pred hhhhheeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHHH--HHHHHHHHHHHHhcc-----CCCCcCeEEEEEecCC
Confidence 3456778888999999999998754 5789999999987643 356778888888763 4889999999999999
Q ss_pred eEEEEEeccccchHHHHHhhhccCCC-ccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEecc-----------
Q 007035 490 HLFIVCELLRANLYEFQKFNQESGGE-AYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSY----------- 557 (621)
Q Consensus 490 ~l~LVmEyl~gsLld~l~~~~~~~~~-~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~----------- 557 (621)
.++|||||++++|.+++......... ...++..++.++.||+.||.|||++||+||||||+|||++..
T Consensus 83 ~~~lv~E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~ 162 (434)
T 2rio_A 83 FLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGA 162 (434)
T ss_dssp EEEEEECCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCC
T ss_pred eEEEEEecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCC
Confidence 99999999999999988754432111 112344567899999999999999999999999999999752
Q ss_pred CCCeEEEEecCCccccCCC-------ccccccCCcccCchhhcC-------CCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 558 QRCEIKIIDLGSSCFQTDN-------LCLYVQSRSYRAPEVIIG-------LPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 558 ~~~~IKL~DFGls~~~~~~-------~~~~~gt~~Y~APEvl~~-------~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
....+||+|||++...... .....||+.|+|||++.+ ..++.++|||||||++|+|++ |+.||
T Consensus 163 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf 240 (434)
T 2rio_A 163 ENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF 240 (434)
T ss_dssp CSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTT
T ss_pred CceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCC
Confidence 3458999999998765432 123578999999999976 568999999999999999999 99998
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=5.1e-32 Score=280.75 Aligned_cols=205 Identities=19% Similarity=0.267 Sum_probs=167.3
Q ss_pred eCeeecCceEEEEEeccCCCCceeEEEeC-----CCCcEEEEEEEecCch--hhhhHHHHHHHHHHhcccCCCCCCceEE
Q 007035 408 LNTVIAGRYYVTEYLGSAAFSKVFQAQDL-----HTGVDVCLKIIKNDKD--FFDQSLDEIKLLKLVNKNDPADEHHILR 480 (621)
Q Consensus 408 l~~ii~~rY~I~~~LG~G~fG~Vyka~d~-----~tg~~VAlKii~~~~~--~~~~~~~Ei~iL~~l~~~~~~~hpnIvr 480 (621)
...+..++|++.+.||+|+||.||+|.+. .+++.||+|++..... ....+.+|+.+++.+ .||||++
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l------~h~~i~~ 92 (322)
T 1p4o_A 19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF------NCHHVVR 92 (322)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGC------CCTTBCC
T ss_pred hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhc------CCCCEee
Confidence 44566789999999999999999999876 4678899999975432 223455666665544 5889999
Q ss_pred EeeEeEecCeEEEEEecccc-chHHHHHhhhcc----CCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEe
Q 007035 481 LYDYFYHLEHLFIVCELLRA-NLYEFQKFNQES----GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIK 555 (621)
Q Consensus 481 l~~~f~~~~~l~LVmEyl~g-sLld~l~~~~~~----~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~ 555 (621)
+++++...+..++||||+.+ +|.+++...... .....+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 93 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~ 172 (322)
T 1p4o_A 93 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA 172 (322)
T ss_dssp EEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEEC
T ss_pred eEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEc
Confidence 99999999999999999975 888877653321 1112368899999999999999999999999999999999998
Q ss_pred ccCCCeEEEEecCCccccCCCc-----cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 556 SYQRCEIKIIDLGSSCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 556 ~~~~~~IKL~DFGls~~~~~~~-----~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
. ++.+||+|||++....... ....+++.|+|||++.+..++.++||||||+++|+|++ |+.||
T Consensus 173 ~--~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~ 241 (322)
T 1p4o_A 173 E--DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY 241 (322)
T ss_dssp T--TCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTT
T ss_pred C--CCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCcc
Confidence 4 7899999999987543321 22355788999999999899999999999999999999 88887
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=99.98 E-value=3.1e-32 Score=298.56 Aligned_cols=197 Identities=25% Similarity=0.353 Sum_probs=167.1
Q ss_pred eeecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecC
Q 007035 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (621)
Q Consensus 410 ~ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~ 489 (621)
.+..++|++.+.||+|+||+||+|.+. .+..||||+++......+.+.+|+.+++.+ .||||+++++++. .+
T Consensus 184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l------~h~~iv~l~~~~~-~~ 255 (454)
T 1qcf_A 184 EIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTL------QHDKLVKLHAVVT-KE 255 (454)
T ss_dssp BCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHTTC------CCTTBCCEEEEEC-SS
T ss_pred eechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCccHHHHHHHHHHHhhC------CCCCEeeEEEEEe-CC
Confidence 455678999999999999999999974 577899999987665567778888887765 4789999999986 66
Q ss_pred eEEEEEeccc-cchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecC
Q 007035 490 HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (621)
Q Consensus 490 ~l~LVmEyl~-gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFG 568 (621)
.++|||||+. ++|.+++...... .+++..+..++.||+.||.|||+++|+||||||+|||++. ++.+||+|||
T Consensus 256 ~~~lv~e~~~~g~L~~~l~~~~~~----~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~--~~~~kl~DFG 329 (454)
T 1qcf_A 256 PIYIITEFMAKGSLLDFLKSDEGS----KQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSA--SLVCKIADFG 329 (454)
T ss_dssp SCEEEECCCTTCBHHHHHHSHHHH----TCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECT--TCCEEECSTT
T ss_pred ccEEEEeecCCCcHHHHHHhccCC----CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECC--CCcEEEeeCC
Confidence 7899999997 5888887654322 2788899999999999999999999999999999999984 7899999999
Q ss_pred CccccCCC----ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 569 SSCFQTDN----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 569 ls~~~~~~----~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
++...... .....+++.|+|||++....++.++|||||||+||||++ |+.||
T Consensus 330 ~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~ 386 (454)
T 1qcf_A 330 LARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPY 386 (454)
T ss_dssp GGGGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred CceEcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCC
Confidence 99765432 122345678999999998899999999999999999999 99998
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=5.6e-32 Score=276.59 Aligned_cols=199 Identities=33% Similarity=0.543 Sum_probs=168.7
Q ss_pred CeeecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc---hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEe
Q 007035 409 NTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYF 485 (621)
Q Consensus 409 ~~ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~---~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f 485 (621)
...+.++|++++.||+|+||.||+|++..+++.||+|++.... .....+.+|+++++.+ .||||+++++++
T Consensus 17 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~ 90 (287)
T 2wei_A 17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL------DHPNIMKLFEIL 90 (287)
T ss_dssp THHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTC------CCTTBCCEEEEE
T ss_pred HHHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhc------cCCCccEEEEEE
Confidence 4456789999999999999999999999999999999987532 2345677788887766 478999999999
Q ss_pred EecCeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccC-CCeEE
Q 007035 486 YHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQ-RCEIK 563 (621)
Q Consensus 486 ~~~~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~-~~~IK 563 (621)
......++||||+.+ +|.+.+.... .+++..++.++.||+.||.|||++||+||||||+||+++... .+.+|
T Consensus 91 ~~~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~k 164 (287)
T 2wei_A 91 EDSSSFYIVGELYTGGELFDEIIKRK------RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIK 164 (287)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred eCCCeEEEEEEccCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEE
Confidence 999999999999974 7777765433 288999999999999999999999999999999999997532 45799
Q ss_pred EEecCCccccCCC--ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 564 IIDLGSSCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 564 L~DFGls~~~~~~--~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
|+|||++...... .....+++.|+|||++.+. ++.++||||||+++|+|++|+.||
T Consensus 165 L~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~ 222 (287)
T 2wei_A 165 IIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPF 222 (287)
T ss_dssp ECSTTGGGTBCCCSSCSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred EeccCcceeecCCCccccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCC
Confidence 9999998755433 2334678899999998764 899999999999999999999998
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=5.2e-32 Score=282.29 Aligned_cols=203 Identities=22% Similarity=0.310 Sum_probs=169.6
Q ss_pred eecCceEEEEEeccCCCCceeEEEeCCCCc-----EEEEEEEecCc--hhhhhHHHHHHHHHHhcccCCCCCCceEEEee
Q 007035 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGV-----DVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYD 483 (621)
Q Consensus 411 ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~-----~VAlKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~ 483 (621)
+..++|++.+.||+|+||.||+|.+..+++ .||+|++.... .....+.+|+.+++.+. .||||+++++
T Consensus 43 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----~h~~iv~~~~ 117 (333)
T 2i1m_A 43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLG-----QHENIVNLLG 117 (333)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHC-----CCTTBCCEEE
T ss_pred CCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhc-----CCCCeeeEEE
Confidence 445789999999999999999999877665 79999997643 34466788999998884 4789999999
Q ss_pred EeEecCeEEEEEecccc-chHHHHHhhhccC--------CCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEE
Q 007035 484 YFYHLEHLFIVCELLRA-NLYEFQKFNQESG--------GEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILI 554 (621)
Q Consensus 484 ~f~~~~~l~LVmEyl~g-sLld~l~~~~~~~--------~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl 554 (621)
++...+..++||||+.+ +|.+++....... ....+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 118 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~ 197 (333)
T 2i1m_A 118 ACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLL 197 (333)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEE
T ss_pred EEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEE
Confidence 99999999999999975 8888876543210 01237889999999999999999999999999999999999
Q ss_pred eccCCCeEEEEecCCccccCCCc-----cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 555 KSYQRCEIKIIDLGSSCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 555 ~~~~~~~IKL~DFGls~~~~~~~-----~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
+. ++.+||+|||++....... ....+++.|+|||++.+..++.++|||||||++|+|++ |..||
T Consensus 198 ~~--~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 267 (333)
T 2i1m_A 198 TN--GHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY 267 (333)
T ss_dssp EG--GGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred CC--CCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCC
Confidence 84 7899999999987543221 12345778999999999899999999999999999998 99887
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=5.9e-32 Score=280.26 Aligned_cols=193 Identities=30% Similarity=0.419 Sum_probs=156.0
Q ss_pred ecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeE
Q 007035 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (621)
Q Consensus 412 i~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l 491 (621)
-.++|++.+.||+|+||+||++++ .++.||+|++.... ....+.+|+++++.++ ||||+++++++.+ ..
T Consensus 6 ~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~------hp~iv~~~~~~~~--~~ 74 (307)
T 2eva_A 6 DYKEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESES-ERKAFIVELRQLSRVN------HPNIVKLYGACLN--PV 74 (307)
T ss_dssp CGGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSSTT-HHHHHHHHHHHHHHCC------CTTBCCEEEBCTT--TT
T ss_pred CHhHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecChh-HHHHHHHHHHHHhcCC------CCCcCeEEEEEcC--Cc
Confidence 347899999999999999999986 47889999997543 3466788888888774 7899999998773 47
Q ss_pred EEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHH---CCeecccCCCccEEEeccCCC-eEEEEe
Q 007035 492 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS---LGIIHCDLKPENILIKSYQRC-EIKIID 566 (621)
Q Consensus 492 ~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs---~gIvHrDLKP~NILl~~~~~~-~IKL~D 566 (621)
++||||+.+ +|.+++..... ...++...+..++.||+.||.|||+ +||+||||||+|||++. ++ .+||+|
T Consensus 75 ~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~--~~~~~kl~D 149 (307)
T 2eva_A 75 CLVMEYAEGGSLYNVLHGAEP---LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVA--GGTVLKICD 149 (307)
T ss_dssp EEEEECCTTCBHHHHHHCSSS---EECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEET--TTTEEEECC
T ss_pred EEEEEcCCCCCHHHHHhccCC---CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeC--CCCEEEEcc
Confidence 899999975 78777764321 1236788899999999999999999 89999999999999984 44 489999
Q ss_pred cCCccccCCCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 567 LGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 567 FGls~~~~~~~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
||++...........+|+.|+|||++.+..++.++||||||+++|+|++|+.||
T Consensus 150 fg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~ 203 (307)
T 2eva_A 150 FGTACDIQTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPF 203 (307)
T ss_dssp CCC------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTT
T ss_pred cccccccccccccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCc
Confidence 999977665555567899999999999999999999999999999999999998
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=4.2e-32 Score=280.49 Aligned_cols=203 Identities=28% Similarity=0.443 Sum_probs=162.0
Q ss_pred CeeecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCch-------hhhhHHHHHHHHHHhcccCCCCCCceEEE
Q 007035 409 NTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD-------FFDQSLDEIKLLKLVNKNDPADEHHILRL 481 (621)
Q Consensus 409 ~~ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~-------~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl 481 (621)
...+.++|++.+.||+|+||.||+|++..+++.||+|++..... ......+|+.+++.+... ..|+||+++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~--~~h~~i~~~ 103 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAG--GGHPGVIRL 103 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSS--CCCSSBCCE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhccc--CCCCCeeeE
Confidence 45677899999999999999999999999999999999975432 234456788888888642 368999999
Q ss_pred eeEeEecCeEEEEEec-cc-cchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCC
Q 007035 482 YDYFYHLEHLFIVCEL-LR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQR 559 (621)
Q Consensus 482 ~~~f~~~~~l~LVmEy-l~-gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~ 559 (621)
++++...+..++|||+ +. ++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++. .+
T Consensus 104 ~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~-~~ 176 (312)
T 2iwi_A 104 LDWFETQEGFMLVLERPLPAQDLFDYITEKG------PLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDL-RR 176 (312)
T ss_dssp EEEC-----CEEEEECCSSEEEHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEET-TT
T ss_pred EEEEecCCeEEEEEEecCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeC-CC
Confidence 9999999999999998 54 68888776533 2889999999999999999999999999999999999983 37
Q ss_pred CeEEEEecCCccccCCC-ccccccCCcccCchhhcCCCCC-chhhHHHHHHHHHHHHhCCCCC
Q 007035 560 CEIKIIDLGSSCFQTDN-LCLYVQSRSYRAPEVIIGLPYD-QKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 560 ~~IKL~DFGls~~~~~~-~~~~~gt~~Y~APEvl~~~~~s-~ksDIWSLGvILyELltG~~PF 620 (621)
+.+||+|||++...... .....+++.|+|||++.+..+. .++||||||+++|+|++|+.||
T Consensus 177 ~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf 239 (312)
T 2iwi_A 177 GCAKLIDFGSGALLHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPF 239 (312)
T ss_dssp TEEEECCCSSCEECCSSCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSC
T ss_pred CeEEEEEcchhhhcccCcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCC
Confidence 78999999998765433 3445789999999999876654 5899999999999999999998
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=7.7e-32 Score=278.64 Aligned_cols=201 Identities=19% Similarity=0.283 Sum_probs=157.7
Q ss_pred ecCceEEEEEeccCCCCceeEEEeCC---CCcEEEEEEEecCc---hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEe
Q 007035 412 IAGRYYVTEYLGSAAFSKVFQAQDLH---TGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYF 485 (621)
Q Consensus 412 i~~rY~I~~~LG~G~fG~Vyka~d~~---tg~~VAlKii~~~~---~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f 485 (621)
..++|.+.+.||+|+||.||+|.+.. +++.||+|+++... ...+.+.+|+.+++.+ .||||+++++++
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l------~h~~iv~~~~~~ 105 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDF------SHPNVIRLLGVC 105 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTC------CCTTBCCCCEEE
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcC------CCCCeeeeeEEE
Confidence 35789999999999999999998765 56689999987542 2345566777777666 478999999999
Q ss_pred EecC-----eEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCC
Q 007035 486 YHLE-----HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQR 559 (621)
Q Consensus 486 ~~~~-----~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~ 559 (621)
.... ..++||||+.+ +|.+++...........+++..++.++.||+.||.|||++||+||||||+|||++. +
T Consensus 106 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~--~ 183 (313)
T 3brb_A 106 IEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRD--D 183 (313)
T ss_dssp EC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECT--T
T ss_pred eeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcC--C
Confidence 8754 45999999985 77777755443333445899999999999999999999999999999999999984 7
Q ss_pred CeEEEEecCCccccCCC-----ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 560 CEIKIIDLGSSCFQTDN-----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 560 ~~IKL~DFGls~~~~~~-----~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
+.+||+|||++...... .....+++.|+|||++.+..++.++||||||+++|+|++ |++||
T Consensus 184 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~ 250 (313)
T 3brb_A 184 MTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPY 250 (313)
T ss_dssp SCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred CcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCC
Confidence 88999999998754332 223456788999999999999999999999999999999 88887
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.1e-32 Score=286.59 Aligned_cols=200 Identities=23% Similarity=0.314 Sum_probs=165.1
Q ss_pred eeecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCch--hhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEe
Q 007035 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD--FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (621)
Q Consensus 410 ~ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~--~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~ 487 (621)
.+..++|++.+.||+|+||.||+|++ .+|+.||+|++..... ....+.+|+.+++. ..||||+++++++..
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~------l~h~~iv~~~~~~~~ 98 (326)
T 3uim_A 26 QVASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGGELQFQTEVEMISM------AVHRNLLRLRGFCMT 98 (326)
T ss_dssp HTTTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-----CCCHHHHHHHGGGT------CCCTTBCCCCEEECC
T ss_pred HHHhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCchHHHHHHHHHHHHHh------ccCCCccceEEEEec
Confidence 34567899999999999999999984 5789999999876432 12245566655544 358999999999999
Q ss_pred cCeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHC---CeecccCCCccEEEeccCCCeEE
Q 007035 488 LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSL---GIIHCDLKPENILIKSYQRCEIK 563 (621)
Q Consensus 488 ~~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~---gIvHrDLKP~NILl~~~~~~~IK 563 (621)
.+..++||||+.+ +|.+++..... ....+++..++.++.||+.||.|||++ ||+||||||+|||++ .++.+|
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~--~~~~~k 174 (326)
T 3uim_A 99 PTERLLVYPYMANGSVASCLRERPE--SQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLD--EEFEAV 174 (326)
T ss_dssp SSCCEEEEECCTTCBHHHHHHCCST--TCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEEC--TTCCEE
T ss_pred CCceEEEEEeccCCCHHHHHHhccc--cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEEC--CCCCEE
Confidence 9999999999985 77777764432 223488999999999999999999999 999999999999998 478999
Q ss_pred EEecCCccccCCC----ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 564 IIDLGSSCFQTDN----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 564 L~DFGls~~~~~~----~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
|+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||
T Consensus 175 l~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf 235 (326)
T 3uim_A 175 VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 235 (326)
T ss_dssp ECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSB
T ss_pred eccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcc
Confidence 9999998764322 22345899999999998888999999999999999999999998
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=3.2e-32 Score=278.74 Aligned_cols=206 Identities=29% Similarity=0.389 Sum_probs=151.1
Q ss_pred CeeecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEec
Q 007035 409 NTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (621)
Q Consensus 409 ~~ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~ 488 (621)
..+..++|++.+.||+|+||.||+|.+..+++.||||++...... . ....+++++.....+.||||+++++++...
T Consensus 10 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 85 (303)
T 2vwi_A 10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQ--T--SMDELLKEIQAMSQCHHPNIVSYYTSFVVK 85 (303)
T ss_dssp ---CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC--------------------CCCCCCCTTBCCEEEEEESS
T ss_pred cccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcc--h--hHHHHHHHHHHHhhcCCCCEeeEEEEEeec
Confidence 345568999999999999999999999999999999988654211 0 111233444445556799999999999999
Q ss_pred CeEEEEEeccc-cchHHHHHhhhcc--CCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEE
Q 007035 489 EHLFIVCELLR-ANLYEFQKFNQES--GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKII 565 (621)
Q Consensus 489 ~~l~LVmEyl~-gsLld~l~~~~~~--~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~ 565 (621)
+..++||||+. ++|.+++...... .....+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+
T Consensus 86 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~--~~~~kl~ 163 (303)
T 2vwi_A 86 DELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGE--DGSVQIA 163 (303)
T ss_dssp SCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECT--TCCEEEC
T ss_pred CCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcC--CCCEEEE
Confidence 99999999996 5777777643211 11234889999999999999999999999999999999999984 7889999
Q ss_pred ecCCccccCCC--------ccccccCCcccCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 566 DLGSSCFQTDN--------LCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 566 DFGls~~~~~~--------~~~~~gt~~Y~APEvl~~-~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
|||++...... .....+|+.|+|||++.+ ..++.++||||||+++|+|++|+.||
T Consensus 164 dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf 227 (303)
T 2vwi_A 164 DFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPY 227 (303)
T ss_dssp CCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred eccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 99987654321 223568999999999976 46899999999999999999999998
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=1.7e-32 Score=293.25 Aligned_cols=197 Identities=24% Similarity=0.342 Sum_probs=155.1
Q ss_pred eecCceEEEEEeccCCCCceeEEEeC---CCCcEEEEEEEecC--chhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEe
Q 007035 411 VIAGRYYVTEYLGSAAFSKVFQAQDL---HTGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYF 485 (621)
Q Consensus 411 ii~~rY~I~~~LG~G~fG~Vyka~d~---~tg~~VAlKii~~~--~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f 485 (621)
+...+|++.+.||+|+||.||+|++. .++..||||+++.. ......+.+|+.+++.+ .||||+++++++
T Consensus 42 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~~~~~~ 115 (373)
T 2qol_A 42 LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF------DHPNIIRLEGVV 115 (373)
T ss_dssp CCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTC------CCTTBCCEEEEE
T ss_pred cCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhC------CCCCCCeEEEEE
Confidence 44578999999999999999999876 56778999999754 23344566677766555 588999999999
Q ss_pred EecCeEEEEEeccc-cchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEE
Q 007035 486 YHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKI 564 (621)
Q Consensus 486 ~~~~~l~LVmEyl~-gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL 564 (621)
...+..++||||+. ++|.+++..... .+++..+..++.||+.||.|||+++|+||||||+|||++. ++.+||
T Consensus 116 ~~~~~~~lv~e~~~~~sL~~~l~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~--~~~~kl 188 (373)
T 2qol_A 116 TKSKPVMIVTEYMENGSLDSFLRKHDA-----QFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINS--NLVCKV 188 (373)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTTT-----CSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT--TCCEEE
T ss_pred eeCCceEEEEeCCCCCcHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcC--CCCEEE
Confidence 99999999999996 578777754321 2889999999999999999999999999999999999984 789999
Q ss_pred EecCCccccCCCcc------ccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 565 IDLGSSCFQTDNLC------LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 565 ~DFGls~~~~~~~~------~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
+|||++........ ...+++.|+|||++.+..++.++||||||+++|||++ |+.||
T Consensus 189 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~ 251 (373)
T 2qol_A 189 SDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY 251 (373)
T ss_dssp CCC----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTT
T ss_pred CcCccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCC
Confidence 99999876543211 1234678999999999999999999999999999998 99998
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=3.2e-32 Score=284.27 Aligned_cols=200 Identities=23% Similarity=0.333 Sum_probs=168.7
Q ss_pred cCCCcceeeCeeecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceE
Q 007035 400 ENKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHIL 479 (621)
Q Consensus 400 ~~~~~pi~l~~ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIv 479 (621)
.....|+.....+.++|++.+.||+|+||.||+|++ +|+.||||++.... .....+|.++++.+. ..||||+
T Consensus 28 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~e~~~~~~~~----l~h~ni~ 99 (342)
T 1b6c_B 28 SGSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE--ERSWFREAEIYQTVM----LRHENIL 99 (342)
T ss_dssp CCSSSCHHHHHHHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGG--HHHHHHHHHHHHHSC----CCCTTBC
T ss_pred CCCCCceeecccccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchh--HHHHHHHHHHHHHhh----cCCCcEE
Confidence 344677778888899999999999999999999987 58999999997543 355677877777653 4689999
Q ss_pred EEeeEeEecC----eEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHH--------HCCeeccc
Q 007035 480 RLYDYFYHLE----HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLH--------SLGIIHCD 546 (621)
Q Consensus 480 rl~~~f~~~~----~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLH--------s~gIvHrD 546 (621)
++++++.... .+++||||+.+ +|.+++... .+++..++.++.||+.||.||| +.+|+|||
T Consensus 100 ~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~D 172 (342)
T 1b6c_B 100 GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRD 172 (342)
T ss_dssp CEEEEEECCCSSCCCEEEEECCCTTCBHHHHHHHC-------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSC
T ss_pred EEEeeecccCCccceeEEEEeecCCCcHHHHHhcc-------CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCC
Confidence 9999998876 89999999986 888877532 1889999999999999999999 89999999
Q ss_pred CCCccEEEeccCCCeEEEEecCCccccCCCc-------cccccCCcccCchhhcCCC------CCchhhHHHHHHHHHHH
Q 007035 547 LKPENILIKSYQRCEIKIIDLGSSCFQTDNL-------CLYVQSRSYRAPEVIIGLP------YDQKIDLWSLGCILAEL 613 (621)
Q Consensus 547 LKP~NILl~~~~~~~IKL~DFGls~~~~~~~-------~~~~gt~~Y~APEvl~~~~------~s~ksDIWSLGvILyEL 613 (621)
|||+|||++. ++.+||+|||++....... ....+|+.|+|||++.+.. ++.++|||||||++|+|
T Consensus 173 lkp~NIll~~--~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el 250 (342)
T 1b6c_B 173 LKSKNILVKK--NGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 250 (342)
T ss_dssp CSGGGEEECT--TSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHH
T ss_pred CCHHHEEECC--CCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHH
Confidence 9999999984 7889999999987654332 3347899999999998763 33689999999999999
Q ss_pred HhC
Q 007035 614 WTG 616 (621)
Q Consensus 614 ltG 616 (621)
++|
T Consensus 251 ~tg 253 (342)
T 1b6c_B 251 ARR 253 (342)
T ss_dssp HTT
T ss_pred Hhc
Confidence 999
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.1e-31 Score=269.80 Aligned_cols=197 Identities=15% Similarity=0.169 Sum_probs=159.7
Q ss_pred eecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEec--
Q 007035 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL-- 488 (621)
Q Consensus 411 ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~-- 488 (621)
+..++|++.+.||+|+||.||+|++. ++.||+|+++....... ....+.+++.....+.||||+++++++...
T Consensus 7 i~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 81 (271)
T 3kmu_A 7 IDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTR---KSRDFNEECPRLRIFSHPNVLPVLGACQSPPA 81 (271)
T ss_dssp CCGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHH---HHHHHHHHGGGGCCCSCTTEECEEEEECTTTS
T ss_pred CCHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHH---HHHHHHHHHHHHHhcCCCchhheEEEEccCCC
Confidence 44578999999999999999999974 88999999986432111 112244455555556799999999999887
Q ss_pred CeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCC--eecccCCCccEEEeccCCCeEEEE
Q 007035 489 EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLG--IIHCDLKPENILIKSYQRCEIKII 565 (621)
Q Consensus 489 ~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~g--IvHrDLKP~NILl~~~~~~~IKL~ 565 (621)
.+.++||||+.+ +|.+++..... ..+++..++.++.||+.||.|||+++ |+||||||+|||++. ++.++|+
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~--~~~~~l~ 155 (271)
T 3kmu_A 82 PHPTLITHWMPYGSLYNVLHEGTN----FVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDE--DMTARIS 155 (271)
T ss_dssp SSCEEEEECCTTCBHHHHHHSCSS----CCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECT--TSCEEEE
T ss_pred CCeEeeecccCCCcHHHHHhhccc----CCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcC--CcceeEE
Confidence 789999999985 88888764322 23889999999999999999999999 999999999999984 7788888
Q ss_pred ecCCccccCCCccccccCCcccCchhhcCCCCCc---hhhHHHHHHHHHHHHhCCCCC
Q 007035 566 DLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQ---KIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 566 DFGls~~~~~~~~~~~gt~~Y~APEvl~~~~~s~---ksDIWSLGvILyELltG~~PF 620 (621)
|||++..... ....+|+.|+|||++.+..++. ++||||||+++|+|++|+.||
T Consensus 156 ~~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~ 211 (271)
T 3kmu_A 156 MADVKFSFQS--PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPF 211 (271)
T ss_dssp GGGSCCTTSC--TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTT
T ss_pred eccceeeecc--cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence 8887644332 2346799999999998765444 799999999999999999998
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=4.5e-32 Score=282.77 Aligned_cols=202 Identities=22% Similarity=0.287 Sum_probs=164.7
Q ss_pred ecCceEEEEEeccCCCCceeEEEeCCCCcEE--EEEEEecC--chhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEe
Q 007035 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDV--CLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (621)
Q Consensus 412 i~~rY~I~~~LG~G~fG~Vyka~d~~tg~~V--AlKii~~~--~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~ 487 (621)
-.++|++.+.||+|+||.||+|++..++..+ |+|.++.. ......+.+|+.+++.+. .||||+++++++..
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~-----~hp~iv~~~~~~~~ 97 (327)
T 1fvr_A 23 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG-----HHPNIINLLGACEH 97 (327)
T ss_dssp CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCC-----CCTTBCCEEEEEEE
T ss_pred cHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhcc-----CCCchhhhceeeee
Confidence 3478999999999999999999999998865 99988753 233455677777776653 58899999999999
Q ss_pred cCeEEEEEecccc-chHHHHHhhhc----------cCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEec
Q 007035 488 LEHLFIVCELLRA-NLYEFQKFNQE----------SGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS 556 (621)
Q Consensus 488 ~~~l~LVmEyl~g-sLld~l~~~~~----------~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~ 556 (621)
.+.+++||||+.+ +|.+++..... ......+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~ 177 (327)
T 1fvr_A 98 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGE 177 (327)
T ss_dssp TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECG
T ss_pred CCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcC
Confidence 9999999999975 88887765421 011223889999999999999999999999999999999999984
Q ss_pred cCCCeEEEEecCCccccCC--CccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 557 YQRCEIKIIDLGSSCFQTD--NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 557 ~~~~~IKL~DFGls~~~~~--~~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
++.+||+|||++..... ......+++.|+|||++.+..++.++|||||||++|+|++ |+.||
T Consensus 178 --~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf 242 (327)
T 1fvr_A 178 --NYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY 242 (327)
T ss_dssp --GGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred --CCeEEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCC
Confidence 77999999999864332 2223456788999999998889999999999999999998 99998
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.1e-31 Score=273.29 Aligned_cols=196 Identities=22% Similarity=0.343 Sum_probs=162.8
Q ss_pred eecCceEEEEEeccCCCCceeEEEeCC---CCcEEEEEEEecC--chhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEe
Q 007035 411 VIAGRYYVTEYLGSAAFSKVFQAQDLH---TGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYF 485 (621)
Q Consensus 411 ii~~rY~I~~~LG~G~fG~Vyka~d~~---tg~~VAlKii~~~--~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f 485 (621)
+..++|++.+.||+|+||+||+|.+.. ++..||+|++... ....+.+.+|+.+++.++ ||||+++++++
T Consensus 9 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~------h~~i~~~~~~~ 82 (281)
T 3cc6_A 9 IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD------HPHIVKLIGII 82 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHC------CTTBCCEEEEE
T ss_pred ecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCC------CCCcceEEEEE
Confidence 456789999999999999999998643 4456999998864 234567788999998884 78999999998
Q ss_pred EecCeEEEEEeccc-cchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEE
Q 007035 486 YHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKI 564 (621)
Q Consensus 486 ~~~~~l~LVmEyl~-gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL 564 (621)
.. +..++||||+. ++|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||
T Consensus 83 ~~-~~~~~v~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~--~~~~kl 154 (281)
T 3cc6_A 83 EE-EPTWIIMELYPYGELGHYLERNKN-----SLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVAS--PECVKL 154 (281)
T ss_dssp CS-SSCEEEEECCTTCBHHHHHHHHTT-----TCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEE--TTEEEE
T ss_pred cC-CCCEEEEecCCCCCHHHHHHhccc-----cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECC--CCcEEe
Confidence 65 45689999998 477777765432 2788999999999999999999999999999999999984 789999
Q ss_pred EecCCccccCCCc----cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 565 IDLGSSCFQTDNL----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 565 ~DFGls~~~~~~~----~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
+|||++....... ....+++.|+|||++.+..++.++||||||+++|+|++ |+.||
T Consensus 155 ~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~ 215 (281)
T 3cc6_A 155 GDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPF 215 (281)
T ss_dssp CCCCGGGCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred CccCCCcccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCc
Confidence 9999987654321 22355778999999998899999999999999999998 99998
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=6.7e-32 Score=278.38 Aligned_cols=203 Identities=24% Similarity=0.342 Sum_probs=168.3
Q ss_pred eecCceEEEEEeccCCCCceeEEEe-----CCCCcEEEEEEEecCc--hhhhhHHHHHHHHHHhcccCCCCCCceEEEee
Q 007035 411 VIAGRYYVTEYLGSAAFSKVFQAQD-----LHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYD 483 (621)
Q Consensus 411 ii~~rY~I~~~LG~G~fG~Vyka~d-----~~tg~~VAlKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~ 483 (621)
+..++|++.+.||+|+||+||+|++ ..+++.||+|+++... .....+.+|+.+++.+. .||||+++++
T Consensus 24 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----~hp~iv~~~~ 98 (316)
T 2xir_A 24 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG-----HHLNVVNLLG 98 (316)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHC-----CCTTBCCEEE
T ss_pred cchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcc-----cCCCeeeEEE
Confidence 4468999999999999999999984 4577999999998643 23456788999988885 3789999999
Q ss_pred EeEecC-eEEEEEecccc-chHHHHHhhhccC----------CCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCcc
Q 007035 484 YFYHLE-HLFIVCELLRA-NLYEFQKFNQESG----------GEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPEN 551 (621)
Q Consensus 484 ~f~~~~-~l~LVmEyl~g-sLld~l~~~~~~~----------~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~N 551 (621)
++...+ .+++||||+.+ +|.+++....... ....+++..++.++.||+.||.|||++||+||||||+|
T Consensus 99 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~N 178 (316)
T 2xir_A 99 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN 178 (316)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred EEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccce
Confidence 988754 59999999985 8888776543210 01227899999999999999999999999999999999
Q ss_pred EEEeccCCCeEEEEecCCccccCCCc-----cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 552 ILIKSYQRCEIKIIDLGSSCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 552 ILl~~~~~~~IKL~DFGls~~~~~~~-----~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
||++. ++.+||+|||++....... ....+|+.|+|||++.+..++.++||||||+++|+|++ |+.||
T Consensus 179 il~~~--~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~ 251 (316)
T 2xir_A 179 ILLSE--KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 251 (316)
T ss_dssp EEECG--GGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred EEECC--CCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCC
Confidence 99984 7889999999987543321 22456788999999999999999999999999999998 99998
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=5.4e-32 Score=281.65 Aligned_cols=196 Identities=27% Similarity=0.314 Sum_probs=163.7
Q ss_pred eeecCce-EEEEEeccCCCCceeEEE----eCCCCcEEEEEEEecCc--hhhhhHHHHHHHHHHhcccCCCCCCceEEEe
Q 007035 410 TVIAGRY-YVTEYLGSAAFSKVFQAQ----DLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLY 482 (621)
Q Consensus 410 ~ii~~rY-~I~~~LG~G~fG~Vyka~----d~~tg~~VAlKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~ 482 (621)
.++.++| ++++.||+|+||+||++. +..+++.||||+++... .....+.+|+++++.++ ||||++++
T Consensus 26 ~~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~ 99 (318)
T 3lxp_A 26 TVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLY------HEHIIKYK 99 (318)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCC------CTTBCCEE
T ss_pred ceecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCC------CcchhhEE
Confidence 3456666 999999999999997664 55689999999998653 33466788888888874 78999999
Q ss_pred eEeEec--CeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCC
Q 007035 483 DYFYHL--EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQR 559 (621)
Q Consensus 483 ~~f~~~--~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~ 559 (621)
+++... ..+++||||+.+ +|.+++.... +++..++.++.||+.||.|||++||+||||||+|||++. +
T Consensus 100 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-------~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~--~ 170 (318)
T 3lxp_A 100 GCCEDAGAASLQLVMEYVPLGSLRDYLPRHS-------IGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDN--D 170 (318)
T ss_dssp EEEEETTTTEEEEEECCCTTCBHHHHGGGSC-------CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT--T
T ss_pred EEEecCCCceEEEEEecccCCcHHHHHhhCC-------CCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcC--C
Confidence 999974 689999999975 7777664321 888999999999999999999999999999999999984 7
Q ss_pred CeEEEEecCCccccCCCc------cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 560 CEIKIIDLGSSCFQTDNL------CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 560 ~~IKL~DFGls~~~~~~~------~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
+.+||+|||++....... ....+++.|+|||++.+..++.++||||||+++|+|++|+.||
T Consensus 171 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~ 237 (318)
T 3lxp_A 171 RLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSS 237 (318)
T ss_dssp CCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGG
T ss_pred CCEEECCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcc
Confidence 889999999987654432 2245678899999999988999999999999999999999987
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.98 E-value=1.1e-31 Score=281.71 Aligned_cols=198 Identities=23% Similarity=0.332 Sum_probs=159.6
Q ss_pred eeecCceEEEEEeccCCCCceeEEEeCCCC----cEEEEEEEecCc--hhhhhHHHHHHHHHHhcccCCCCCCceEEEee
Q 007035 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTG----VDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYD 483 (621)
Q Consensus 410 ~ii~~rY~I~~~LG~G~fG~Vyka~d~~tg----~~VAlKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~ 483 (621)
++...+|++.+.||+|+||+||+|.+..++ ..||+|+++... .....+.+|+.+++.+ .||||+++++
T Consensus 40 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l------~h~~iv~~~~ 113 (333)
T 1mqb_A 40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF------SHHNIIRLEG 113 (333)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTC------CCTTBCCEEE
T ss_pred cCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhC------CCCCCCcEEE
Confidence 445678999999999999999999876553 459999997542 2334566777777655 4889999999
Q ss_pred EeEecCeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeE
Q 007035 484 YFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEI 562 (621)
Q Consensus 484 ~f~~~~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~I 562 (621)
++...+..++||||+.+ +|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||++ .++.+
T Consensus 114 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~--~~~~~ 186 (333)
T 1mqb_A 114 VISKYKPMMIITEYMENGALDKFLREKDG-----EFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVN--SNLVC 186 (333)
T ss_dssp EECSSSSEEEEEECCTTEEHHHHHHHTTT-----CSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC--TTCCE
T ss_pred EEecCCCcEEEEeCCCCCcHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEEC--CCCcE
Confidence 99999999999999986 77777654322 288999999999999999999999999999999999998 47899
Q ss_pred EEEecCCccccCCCc------cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 563 KIIDLGSSCFQTDNL------CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 563 KL~DFGls~~~~~~~------~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
||+|||++....... ....+++.|+|||++.+..++.++||||||+++|+|++ |+.||
T Consensus 187 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf 251 (333)
T 1mqb_A 187 KVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPY 251 (333)
T ss_dssp EECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred EECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCc
Confidence 999999987654321 12244678999999999999999999999999999999 99998
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-31 Score=273.64 Aligned_cols=195 Identities=23% Similarity=0.316 Sum_probs=163.2
Q ss_pred ecCceEEEE-EeccCCCCceeEEEeC--CCCcEEEEEEEecC--chhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeE
Q 007035 412 IAGRYYVTE-YLGSAAFSKVFQAQDL--HTGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (621)
Q Consensus 412 i~~rY~I~~-~LG~G~fG~Vyka~d~--~tg~~VAlKii~~~--~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~ 486 (621)
..++|.+.+ .||+|+||.||+|.+. .+++.||+|+++.. ....+.+.+|+.+++.++ ||||+++++++
T Consensus 7 ~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~------h~~i~~~~~~~- 79 (287)
T 1u59_A 7 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLD------NPYIVRLIGVC- 79 (287)
T ss_dssp CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCC------CTTBCCEEEEE-
T ss_pred cHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCC------CCCEeEEEEEe-
Confidence 356788887 9999999999999853 57888999999863 334566788888888773 78999999998
Q ss_pred ecCeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEE
Q 007035 487 HLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKII 565 (621)
Q Consensus 487 ~~~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~ 565 (621)
..+..++||||+.+ +|.+++.... ..+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~--~~~~kl~ 152 (287)
T 1u59_A 80 QAEALMLVMEMAGGGPLHKFLVGKR-----EEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVN--RHYAKIS 152 (287)
T ss_dssp ESSSEEEEEECCTTEEHHHHHTTCT-----TTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEE--TTEEEEC
T ss_pred cCCCcEEEEEeCCCCCHHHHHHhCC-----ccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcC--CCCEEEC
Confidence 55679999999986 6777664322 22889999999999999999999999999999999999984 7899999
Q ss_pred ecCCccccCCCc------cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 566 DLGSSCFQTDNL------CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 566 DFGls~~~~~~~------~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
|||++....... ....+|+.|+|||++.+..++.++||||||+++|+|++ |+.||
T Consensus 153 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~ 214 (287)
T 1u59_A 153 DFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPY 214 (287)
T ss_dssp CCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred cccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCc
Confidence 999987654321 22345788999999998889999999999999999998 99998
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.97 E-value=4e-32 Score=284.53 Aligned_cols=203 Identities=20% Similarity=0.381 Sum_probs=167.6
Q ss_pred eCeeecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchh------------------hhhHHHHHHHHHHhcc
Q 007035 408 LNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDF------------------FDQSLDEIKLLKLVNK 469 (621)
Q Consensus 408 l~~ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~------------------~~~~~~Ei~iL~~l~~ 469 (621)
.+....++|++.+.||+|+||.||+|.+ +|+.||+|++...... ...+.+|+.+++.+
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-- 100 (348)
T 2pml_X 25 EKDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDI-- 100 (348)
T ss_dssp SSCEEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTC--
T ss_pred hcccccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhC--
Confidence 3456678999999999999999999998 9999999998753221 15677777777666
Q ss_pred cCCCCCCceEEEeeEeEecCeEEEEEecccc-chHHHHHhhh--ccCCCccccHHHHHHHHHHHHHHHHHHHH-CCeecc
Q 007035 470 NDPADEHHILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQ--ESGGEAYFTLGRLQVITRQCLEALEYLHS-LGIIHC 545 (621)
Q Consensus 470 ~~~~~hpnIvrl~~~f~~~~~l~LVmEyl~g-sLld~l~~~~--~~~~~~~ls~~~i~~I~~qIl~aL~yLHs-~gIvHr 545 (621)
.||||+++++++...+..++||||+.+ +|.+++.... .......+++..++.++.||+.||.|||+ .||+||
T Consensus 101 ----~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~ 176 (348)
T 2pml_X 101 ----KNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHR 176 (348)
T ss_dssp ----CCTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECC
T ss_pred ----CCCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeec
Confidence 478999999999999999999999986 7766522110 01112348999999999999999999999 999999
Q ss_pred cCCCccEEEeccCCCeEEEEecCCccccCC-CccccccCCcccCchhhcCC-CCCc-hhhHHHHHHHHHHHHhCCCCC
Q 007035 546 DLKPENILIKSYQRCEIKIIDLGSSCFQTD-NLCLYVQSRSYRAPEVIIGL-PYDQ-KIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 546 DLKP~NILl~~~~~~~IKL~DFGls~~~~~-~~~~~~gt~~Y~APEvl~~~-~~s~-ksDIWSLGvILyELltG~~PF 620 (621)
||||+|||++. ++.+||+|||++..... ......+++.|+|||++.+. .++. ++||||||+++|+|++|+.||
T Consensus 177 dl~p~Nil~~~--~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf 252 (348)
T 2pml_X 177 DVKPSNILMDK--NGRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPF 252 (348)
T ss_dssp CCCGGGEEECT--TSCEEECCCTTCEECBTTEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSS
T ss_pred CCChHhEEEcC--CCcEEEeccccccccccccccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCC
Confidence 99999999984 78999999999876433 33445789999999999887 5666 999999999999999999998
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-31 Score=274.15 Aligned_cols=196 Identities=27% Similarity=0.391 Sum_probs=161.4
Q ss_pred ceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc-hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeEEE
Q 007035 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFI 493 (621)
Q Consensus 415 rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~-~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l~L 493 (621)
+|.....||+|+||.||+|.+..+++.||+|++.... ...+.+.+|+.+++.+ .||||+++++++...+..++
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l------~h~~iv~~~~~~~~~~~~~l 96 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHL------KHKNIVQYLGSFSENGFIKI 96 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTC------CCTTBCCEEEEEEETTEEEE
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhC------CCCCEeeEeeEEEeCCcEEE
Confidence 3444458999999999999999999999999987643 3345677788777766 47899999999999999999
Q ss_pred EEeccc-cchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCccc
Q 007035 494 VCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF 572 (621)
Q Consensus 494 VmEyl~-gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~~ 572 (621)
||||+. ++|.+++..... ...+++..++.++.||+.||.|||++||+||||||+|||++. .++.+||+|||++..
T Consensus 97 v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~-~~~~~kl~Dfg~~~~ 172 (295)
T 2clq_A 97 FMEQVPGGSLSALLRSKWG---PLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINT-YSGVLKISDFGTSKR 172 (295)
T ss_dssp EEECCSEEEHHHHHHHTTC---CCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET-TTCCEEECCTTTCEE
T ss_pred EEEeCCCCCHHHHHHhhcc---CCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEEC-CCCCEEEeecccccc
Confidence 999996 577776654321 223678889999999999999999999999999999999984 367899999999876
Q ss_pred cCCC---ccccccCCcccCchhhcCCC--CCchhhHHHHHHHHHHHHhCCCCC
Q 007035 573 QTDN---LCLYVQSRSYRAPEVIIGLP--YDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 573 ~~~~---~~~~~gt~~Y~APEvl~~~~--~s~ksDIWSLGvILyELltG~~PF 620 (621)
.... .....+++.|+|||++.+.. ++.++||||||+++|+|++|+.||
T Consensus 173 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf 225 (295)
T 2clq_A 173 LAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPF 225 (295)
T ss_dssp SCC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTT
T ss_pred cCCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCc
Confidence 5432 23457899999999997654 789999999999999999999998
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.2e-32 Score=285.28 Aligned_cols=196 Identities=23% Similarity=0.328 Sum_probs=156.6
Q ss_pred eecCceEEEEEeccCCCCceeEEEeCCCCcEE----EEEEEecC--chhhhhHHHHHHHHHHhcccCCCCCCceEEEeeE
Q 007035 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDV----CLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDY 484 (621)
Q Consensus 411 ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~V----AlKii~~~--~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~ 484 (621)
+..++|++++.||+|+||+||+|++..+++.+ ++|.+... ......+.+|+.+++.+ .||||++++++
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l------~hp~iv~~~~~ 85 (327)
T 3lzb_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV------DNPHVCRLLGI 85 (327)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTC------CBTTBCCCCEE
T ss_pred cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhC------CCCCeeEEEEE
Confidence 34578999999999999999999998888765 56655432 23345667777777655 47899999999
Q ss_pred eEecCeEEEEEeccc-cchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEE
Q 007035 485 FYHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 563 (621)
Q Consensus 485 f~~~~~l~LVmEyl~-gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IK 563 (621)
+.... .++|+||+. ++|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+|
T Consensus 86 ~~~~~-~~~v~~~~~~g~L~~~l~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~--~~~~k 157 (327)
T 3lzb_A 86 CLTST-VQLITQLMPFGCLLDYVREHKD-----NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKT--PQHVK 157 (327)
T ss_dssp EESSS-EEEEECCCSSCBHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEE--TTEEE
T ss_pred EecCC-ceEEEEecCCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcC--CCCEE
Confidence 98765 677888877 578877765432 2889999999999999999999999999999999999984 78999
Q ss_pred EEecCCccccCCC-----ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 564 IIDLGSSCFQTDN-----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 564 L~DFGls~~~~~~-----~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
|+|||++...... .....+|+.|+|||++.+..++.++|||||||++|+|++ |+.||
T Consensus 158 L~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~ 220 (327)
T 3lzb_A 158 ITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 220 (327)
T ss_dssp ECCTTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred EccCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCC
Confidence 9999998764332 122345778999999999999999999999999999999 99998
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-31 Score=274.52 Aligned_cols=193 Identities=24% Similarity=0.330 Sum_probs=160.7
Q ss_pred cCceEEEE-EeccCCCCceeEE--EeCCCCcEEEEEEEecCc---hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeE
Q 007035 413 AGRYYVTE-YLGSAAFSKVFQA--QDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (621)
Q Consensus 413 ~~rY~I~~-~LG~G~fG~Vyka--~d~~tg~~VAlKii~~~~---~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~ 486 (621)
..+|++.+ .||+|+||.||+| .+..+++.||+|+++... ...+.+.+|+.+++.+ .||||+++++++
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~- 87 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL------DNPYIVRMIGIC- 87 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTC------CCTTBCCEEEEE-
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhC------CCCCEEEEEEEE-
Confidence 46899998 9999999999999 446678999999997542 2345677787777766 478999999998
Q ss_pred ecCeEEEEEeccc-cchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEE
Q 007035 487 HLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKII 565 (621)
Q Consensus 487 ~~~~l~LVmEyl~-gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~ 565 (621)
..+..++||||+. ++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+
T Consensus 88 ~~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~--~~~~kl~ 159 (291)
T 1xbb_A 88 EAESWMLVMEMAELGPLNKYLQQNR------HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVT--QHYAKIS 159 (291)
T ss_dssp ESSSEEEEEECCTTEEHHHHHHHCT------TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEE--TTEEEEC
T ss_pred CCCCcEEEEEeCCCCCHHHHHHhCc------CCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeC--CCcEEEc
Confidence 6678899999998 57777776432 2889999999999999999999999999999999999984 7899999
Q ss_pred ecCCccccCCCcc------ccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 566 DLGSSCFQTDNLC------LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 566 DFGls~~~~~~~~------~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
|||++........ ...+++.|+|||++.+..++.++||||||+++|+|++ |+.||
T Consensus 160 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~ 221 (291)
T 1xbb_A 160 DFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY 221 (291)
T ss_dssp CCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred cCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCC
Confidence 9999876543321 1244678999999998889999999999999999999 99998
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=7.1e-32 Score=295.68 Aligned_cols=197 Identities=25% Similarity=0.368 Sum_probs=164.0
Q ss_pred eeecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecC
Q 007035 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (621)
Q Consensus 410 ~ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~ 489 (621)
.+..++|++.+.||+|+||.||+|.+.. +..||||+++......+.+.+|+.+++.++ ||||+++++++.. +
T Consensus 180 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~------hp~iv~~~~~~~~-~ 251 (452)
T 1fmk_A 180 EIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLR------HEKLVQLYAVVSE-E 251 (452)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSCHHHHHHHHHHHHHCC------CTTBCCEEEEECS-S
T ss_pred ccChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCCHHHHHHHHHHHHhCC------CCCEeeEEEEEcC-C
Confidence 4556789999999999999999999764 467999999876555567889999998884 7899999999876 6
Q ss_pred eEEEEEeccc-cchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecC
Q 007035 490 HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (621)
Q Consensus 490 ~l~LVmEyl~-gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFG 568 (621)
.++|||||+. ++|.+++...... .+++..+..++.||+.||.|||+++|+||||||+|||++. ++.+||+|||
T Consensus 252 ~~~iv~e~~~~gsL~~~l~~~~~~----~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~--~~~~kl~DfG 325 (452)
T 1fmk_A 252 PIYIVTEYMSKGSLLDFLKGETGK----YLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGE--NLVCKVADFG 325 (452)
T ss_dssp SCEEEECCCTTCBHHHHHSHHHHT----TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG--GGCEEECCCC
T ss_pred ceEEEehhhcCCCHHHHHHhcCCC----CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECC--CCCEEECCCc
Confidence 7899999997 4888887643322 2788999999999999999999999999999999999984 7899999999
Q ss_pred CccccCCCc----cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 569 SSCFQTDNL----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 569 ls~~~~~~~----~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
++....... ....+++.|+|||++.+..++.++||||||++||||++ |+.||
T Consensus 326 ~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~ 382 (452)
T 1fmk_A 326 LARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 382 (452)
T ss_dssp TTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred cceecCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCC
Confidence 987654321 12345678999999998899999999999999999999 99998
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-31 Score=293.17 Aligned_cols=194 Identities=23% Similarity=0.292 Sum_probs=158.2
Q ss_pred CceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeEEE
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFI 493 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l~L 493 (621)
.+|.+.+.||+|+||+||. ....+|+.||||++.... .....+|+.+++.+. .||||+++++++.+....+|
T Consensus 24 ~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~--~~~~~~E~~~l~~l~-----~HpnIv~l~~~~~~~~~~~l 95 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPEC--FSFADREVQLLRESD-----EHPNVIRYFCTEKDRQFQYI 95 (432)
T ss_dssp EEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTT--EEECHHHHHHHHHSC-----CCTTBCCEEEEEEETTEEEE
T ss_pred EEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHH--HHHHHHHHHHHHhcc-----CCCCcCeEEEEEecCCEEEE
Confidence 4799999999999999764 345789999999987543 245678898888774 58899999999999999999
Q ss_pred EEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEec---cCCCeEEEEecCCc
Q 007035 494 VCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS---YQRCEIKIIDLGSS 570 (621)
Q Consensus 494 VmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~---~~~~~IKL~DFGls 570 (621)
||||++++|.+++...... +....+..++.||+.||.|||++||+||||||+|||++. +....+||+|||++
T Consensus 96 v~E~~~g~L~~~l~~~~~~-----~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a 170 (432)
T 3p23_A 96 AIELCAATLQEYVEQKDFA-----HLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLC 170 (432)
T ss_dssp EEECCSEEHHHHHHSSSCC-----CCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEE
T ss_pred EEECCCCCHHHHHHhcCCC-----ccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccce
Confidence 9999999999988754322 444567789999999999999999999999999999953 23456889999998
Q ss_pred cccCC------CccccccCCcccCchhhc---CCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 571 CFQTD------NLCLYVQSRSYRAPEVII---GLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 571 ~~~~~------~~~~~~gt~~Y~APEvl~---~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
..... ......||+.|+|||++. ...++.++|||||||++|+|++ |..||
T Consensus 171 ~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf 230 (432)
T 3p23_A 171 KKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPF 230 (432)
T ss_dssp ECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTT
T ss_pred eeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCc
Confidence 76542 223457899999999997 4567889999999999999999 88887
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=8.3e-32 Score=280.77 Aligned_cols=194 Identities=21% Similarity=0.276 Sum_probs=154.7
Q ss_pred eecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEe---
Q 007035 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH--- 487 (621)
Q Consensus 411 ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~--- 487 (621)
+..++|++++.||+|+||.||+|++ +++.||||++..... .....|.+++ ......||||+++++.+..
T Consensus 10 ~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~e~~~~----~~~~~~h~~i~~~~~~~~~~~~ 81 (336)
T 3g2f_A 10 LDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANR--QNFINEKNIY----RVPLMEHDNIARFIVGDERVTA 81 (336)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGH--HHHHHHHHHH----TSTTCCCTTBCCEEEEEEEECT
T ss_pred cChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccch--hhHHHHHHHH----HHHhccCcchhhheeccccccc
Confidence 3457899999999999999999975 789999999975432 2333333332 2334679999999986543
Q ss_pred --cCeEEEEEeccc-cchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHC---------CeecccCCCccEEEe
Q 007035 488 --LEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSL---------GIIHCDLKPENILIK 555 (621)
Q Consensus 488 --~~~l~LVmEyl~-gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~---------gIvHrDLKP~NILl~ 555 (621)
....++||||++ ++|.+++.... +++..+..++.||+.||.|||+. +|+||||||+|||++
T Consensus 82 ~~~~~~~lv~e~~~~g~L~~~l~~~~-------~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~ 154 (336)
T 3g2f_A 82 DGRMEYLLVMEYYPNGSLXKYLSLHT-------SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVK 154 (336)
T ss_dssp TSCEEEEEEECCCTTCBHHHHHHHCC-------BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEEC
T ss_pred CCCceEEEEEecCCCCcHHHHHhhcc-------cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEc
Confidence 346899999996 48888775432 57788899999999999999999 999999999999998
Q ss_pred ccCCCeEEEEecCCccccCCC-----------ccccccCCcccCchhhcC-------CCCCchhhHHHHHHHHHHHHhCC
Q 007035 556 SYQRCEIKIIDLGSSCFQTDN-----------LCLYVQSRSYRAPEVIIG-------LPYDQKIDLWSLGCILAELWTGE 617 (621)
Q Consensus 556 ~~~~~~IKL~DFGls~~~~~~-----------~~~~~gt~~Y~APEvl~~-------~~~s~ksDIWSLGvILyELltG~ 617 (621)
. ++.+||+|||++...... .....||+.|+|||++.+ ..++.++|||||||++|||++|.
T Consensus 155 ~--~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~ 232 (336)
T 3g2f_A 155 N--DGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC 232 (336)
T ss_dssp T--TSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTB
T ss_pred C--CCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcC
Confidence 4 789999999998754321 223468999999999987 34667899999999999999998
Q ss_pred CCCC
Q 007035 618 VCLI 621 (621)
Q Consensus 618 ~PF~ 621 (621)
.||+
T Consensus 233 ~p~~ 236 (336)
T 3g2f_A 233 TDLF 236 (336)
T ss_dssp GGGS
T ss_pred CcCC
Confidence 7763
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-31 Score=272.07 Aligned_cols=193 Identities=20% Similarity=0.272 Sum_probs=159.1
Q ss_pred ceEEEEEeccCCCCceeEEEeCCCCc---EEEEEEEecCc--hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecC
Q 007035 415 RYYVTEYLGSAAFSKVFQAQDLHTGV---DVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (621)
Q Consensus 415 rY~I~~~LG~G~fG~Vyka~d~~tg~---~VAlKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~ 489 (621)
+|++.+.||+|+||+||+|.+..+++ .||+|++.... ...+.+.+|+.+++.+ .||||+++++++...+
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l------~h~~iv~~~~~~~~~~ 95 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGL------NHPNVLALIGIMLPPE 95 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTC------CCTTBCCCCEEECCSS
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhC------CCCCeeeEEEEEecCC
Confidence 57788999999999999999765544 79999987533 3345667788777766 4789999999998766
Q ss_pred eE-EEEEeccc-cchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEec
Q 007035 490 HL-FIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 567 (621)
Q Consensus 490 ~l-~LVmEyl~-gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DF 567 (621)
.. ++||||+. ++|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+||
T Consensus 96 ~~~~~v~e~~~~~~L~~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~--~~~~~kl~Df 168 (298)
T 3pls_A 96 GLPHVLLPYMCHGDLLQFIRSPQR-----NPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLD--ESFTVKVADF 168 (298)
T ss_dssp SCCEEEECCCTTCBHHHHHHCTTC-----CCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC--TTCCEEECCT
T ss_pred CCcEEEEecccCCCHHHHHhcccc-----CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEc--CCCcEEeCcC
Confidence 54 99999996 577777754322 278899999999999999999999999999999999998 4789999999
Q ss_pred CCccccCC-------CccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 568 GSSCFQTD-------NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 568 Gls~~~~~-------~~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
|++..... ......+++.|+|||.+.+..++.++||||||+++|+|++|..||
T Consensus 169 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~ 228 (298)
T 3pls_A 169 GLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228 (298)
T ss_dssp TSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCT
T ss_pred CCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCC
Confidence 99865332 222345688899999999999999999999999999999966654
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-31 Score=279.06 Aligned_cols=197 Identities=24% Similarity=0.310 Sum_probs=165.1
Q ss_pred eecCceEEEEEeccCCCCceeEEE----eCCCCcEEEEEEEecCc-hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEe
Q 007035 411 VIAGRYYVTEYLGSAAFSKVFQAQ----DLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYF 485 (621)
Q Consensus 411 ii~~rY~I~~~LG~G~fG~Vyka~----d~~tg~~VAlKii~~~~-~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f 485 (621)
+..++|++++.||+|+||.||+++ +..+++.||+|++.... .....+.+|+.+++.+ .||||+++++++
T Consensus 38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~h~~iv~~~~~~ 111 (326)
T 2w1i_A 38 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL------QHDNIVKYKGVC 111 (326)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTC------CCTTBCCEEEEE
T ss_pred cCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhC------CCCCeeeEEEEE
Confidence 345789999999999999999998 56789999999997643 3445677888888766 378999999998
Q ss_pred EecC--eEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeE
Q 007035 486 YHLE--HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEI 562 (621)
Q Consensus 486 ~~~~--~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~I 562 (621)
...+ .+++||||+.+ +|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+
T Consensus 112 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~--~~~~ 184 (326)
T 2w1i_A 112 YSAGRRNLKLIMEYLPYGSLRDYLQKHKE-----RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVEN--ENRV 184 (326)
T ss_dssp CC----CCEEEECCCTTCBHHHHHHHSTT-----SSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEE--TTEE
T ss_pred EecCCCceEEEEECCCCCCHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcC--CCcE
Confidence 7654 78999999975 88887765432 2888999999999999999999999999999999999984 7899
Q ss_pred EEEecCCccccCCCc------cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 563 KIIDLGSSCFQTDNL------CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 563 KL~DFGls~~~~~~~------~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
||+|||++....... ....++..|+|||++.+..++.++||||||+++|+|++|+.||
T Consensus 185 kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~ 248 (326)
T 2w1i_A 185 KIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKS 248 (326)
T ss_dssp EECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGG
T ss_pred EEecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCC
Confidence 999999987654332 2234567799999999888999999999999999999998876
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-31 Score=272.95 Aligned_cols=194 Identities=21% Similarity=0.262 Sum_probs=157.1
Q ss_pred CceEEEEEeccCCCCceeEEEeCCC---CcEEEEEEEecCc--hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeE-e
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQDLHT---GVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY-H 487 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d~~t---g~~VAlKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~-~ 487 (621)
.+|++.+.||+|+||+||+|.+..+ +..+|+|.+.... .....+.+|+.+++.+ .||||+++++++. .
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l------~h~~iv~~~~~~~~~ 98 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF------SHPNVLSLLGICLRS 98 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTC------CCTTBCCCCEEECCS
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhC------CCCCEeeeeeEEEcC
Confidence 5799999999999999999996544 3468999987533 3345667788777766 4789999999854 5
Q ss_pred cCeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEe
Q 007035 488 LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (621)
Q Consensus 488 ~~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~D 566 (621)
.+..++||||+.+ +|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|
T Consensus 99 ~~~~~~v~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~--~~~~~kl~D 171 (298)
T 3f66_A 99 EGSPLVVLPYMKHGDLRNFIRNETH-----NPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLD--EKFTVKVAD 171 (298)
T ss_dssp SSCCEEEEECCTTCBHHHHHHCTTC-----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC--TTCCEEECS
T ss_pred CCceEEEEeCCCCCCHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEC--CCCCEEECc
Confidence 5688999999986 77777754322 278899999999999999999999999999999999998 478999999
Q ss_pred cCCccccCCC-------ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 567 LGSSCFQTDN-------LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 567 FGls~~~~~~-------~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
||++...... .....+|+.|+|||++.+..++.++||||||+++|+|++ |.+||
T Consensus 172 fg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~ 233 (298)
T 3f66_A 172 FGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 233 (298)
T ss_dssp CGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred ccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCC
Confidence 9998754332 222455778999999999999999999999999999999 55554
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-31 Score=298.95 Aligned_cols=198 Identities=25% Similarity=0.360 Sum_probs=168.2
Q ss_pred CeeecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEec
Q 007035 409 NTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (621)
Q Consensus 409 ~~ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~ 488 (621)
..+..++|++.+.||+|+||.||+|.+.. +..||||+++......+.+.+|+++++.++ |+||+++++++..
T Consensus 262 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~------hpniv~~~~~~~~- 333 (535)
T 2h8h_A 262 WEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLR------HEKLVQLYAVVSE- 333 (535)
T ss_dssp SBCCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSCHHHHHHHHHHHHHCC------CTTBCCEEEEECS-
T ss_pred eecchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCCHHHHHHHHHHHHhCC------CCCEeeEEEEEee-
Confidence 34556889999999999999999999764 467999999876555567889999998884 7899999999876
Q ss_pred CeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEec
Q 007035 489 EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 567 (621)
Q Consensus 489 ~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DF 567 (621)
+.++|||||+.+ +|.+++...... .+++..+..++.||+.||.|||+++|+||||||+|||++. ++.+||+||
T Consensus 334 ~~~~lv~e~~~~gsL~~~l~~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~--~~~~kl~DF 407 (535)
T 2h8h_A 334 EPIYIVTEYMSKGSLLDFLKGETGK----YLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGE--NLVCKVADF 407 (535)
T ss_dssp SSCEEEECCCTTEEHHHHHSHHHHT----TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG--GGCEEECCT
T ss_pred ccceEeeehhcCCcHHHHHhhcCCC----CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcC--CCcEEEccc
Confidence 678999999974 888887643322 2788999999999999999999999999999999999984 788999999
Q ss_pred CCccccCCC----ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 568 GSSCFQTDN----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 568 Gls~~~~~~----~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
|++...... .....++..|+|||++.+..++.++|||||||+||||++ |+.||
T Consensus 408 G~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~ 465 (535)
T 2h8h_A 408 GLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 465 (535)
T ss_dssp TSTTTCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSS
T ss_pred ccceecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 998765432 122345678999999998899999999999999999999 99998
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.8e-31 Score=270.55 Aligned_cols=196 Identities=27% Similarity=0.368 Sum_probs=155.4
Q ss_pred eecCceEEEEEeccCCCCceeEEEeCC-CC--cEEEEEEEecC----chhhhhHHHHHHHHHHhcccCCCCCCceEEEee
Q 007035 411 VIAGRYYVTEYLGSAAFSKVFQAQDLH-TG--VDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYD 483 (621)
Q Consensus 411 ii~~rY~I~~~LG~G~fG~Vyka~d~~-tg--~~VAlKii~~~----~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~ 483 (621)
+..++|++.+.||+|+||+||+|++.. ++ ..||+|+++.. ....+.+.+|+++++.+ .||||+++++
T Consensus 15 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~ 88 (291)
T 1u46_A 15 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL------DHRNLIRLYG 88 (291)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHC------CCTTBCCEEE
T ss_pred cchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhC------CCCCcccEEE
Confidence 345789999999999999999998643 33 36899988753 23456677888888877 3789999999
Q ss_pred EeEecCeEEEEEeccc-cchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeE
Q 007035 484 YFYHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEI 562 (621)
Q Consensus 484 ~f~~~~~l~LVmEyl~-gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~I 562 (621)
++.... .++||||+. ++|.+.+..... .+++..++.++.||+.||.|||+++|+||||||+|||++. ++.+
T Consensus 89 ~~~~~~-~~~v~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~--~~~~ 160 (291)
T 1u46_A 89 VVLTPP-MKMVTELAPLGSLLDRLRKHQG-----HFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLAT--RDLV 160 (291)
T ss_dssp EECSSS-CEEEEECCTTCBHHHHHHHHGG-----GSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEE--TTEE
T ss_pred EEccCC-ceeeEecccCCCHHHHHHhccC-----CcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcC--CCCE
Confidence 998765 889999998 578887765432 2889999999999999999999999999999999999984 7899
Q ss_pred EEEecCCccccCCCc------cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 563 KIIDLGSSCFQTDNL------CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 563 KL~DFGls~~~~~~~------~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
||+|||++....... ....+++.|+|||++.+..++.++||||||+++|+|++ |+.||
T Consensus 161 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~ 225 (291)
T 1u46_A 161 KIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPW 225 (291)
T ss_dssp EECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred EEccccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCc
Confidence 999999987654332 12355778999999998889999999999999999999 99998
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.5e-31 Score=271.80 Aligned_cols=189 Identities=22% Similarity=0.316 Sum_probs=159.5
Q ss_pred EEEEeccCCCCceeEEEeCCCCcEEEEEEEecC-----chhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeEE
Q 007035 418 VTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND-----KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLF 492 (621)
Q Consensus 418 I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~-----~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l~ 492 (621)
..+.||+|+||.||+|.+ +++.||+|++... ....+.+.+|+.+++.++ ||||+++++++...+..+
T Consensus 35 ~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~------h~~i~~~~~~~~~~~~~~ 106 (307)
T 2nru_A 35 GGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ------HENLVELLGFSSDGDDLC 106 (307)
T ss_dssp TCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCC------CTTBCCEEEEECSSSSCE
T ss_pred cCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcC------CCCeEEEEEEEecCCceE
Confidence 346799999999999985 6889999998753 233566778888888774 789999999999999999
Q ss_pred EEEeccc-cchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCcc
Q 007035 493 IVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 571 (621)
Q Consensus 493 LVmEyl~-gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~ 571 (621)
+||||+. ++|.+++...... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++.
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~--~~~~~kl~Dfg~~~ 181 (307)
T 2nru_A 107 LVYVYMPNGSLLDRLSCLDGT---PPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLD--EAFTAKISDFGLAR 181 (307)
T ss_dssp EEEECCTTCBHHHHHHTGGGC---CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC--TTCCEEECCCTTCE
T ss_pred EEEEecCCCcHHHHHHhccCC---CCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEc--CCCcEEEeeccccc
Confidence 9999996 5787777643322 2388999999999999999999999999999999999998 47899999999987
Q ss_pred ccCCC-----ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 572 FQTDN-----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 572 ~~~~~-----~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
..... .....+++.|+|||++.+ .++.++||||||+++|+|++|+.||
T Consensus 182 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~ 234 (307)
T 2nru_A 182 ASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAV 234 (307)
T ss_dssp ECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSB
T ss_pred ccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCc
Confidence 54432 223468999999999876 4789999999999999999999998
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-32 Score=288.56 Aligned_cols=197 Identities=23% Similarity=0.259 Sum_probs=157.7
Q ss_pred ecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc---------hhhhhHHHHHHHHHHhcccCCC---CCCceE
Q 007035 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---------DFFDQSLDEIKLLKLVNKNDPA---DEHHIL 479 (621)
Q Consensus 412 i~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~---------~~~~~~~~Ei~iL~~l~~~~~~---~hpnIv 479 (621)
..++|++++.||+|+||+||+|++ +|+.||||++.... ...+.+.+|+.+++.++..... .||||+
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv 95 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI 95 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred ccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence 357899999999999999999997 78999999997542 1236788999999988743211 344555
Q ss_pred EE-----------------eeEeEe-------------cCeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHH
Q 007035 480 RL-----------------YDYFYH-------------LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITR 528 (621)
Q Consensus 480 rl-----------------~~~f~~-------------~~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~ 528 (621)
++ +++|.. ..+++|||||+.+ ++++.+.. ..+++..++.++.
T Consensus 96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-------~~~~~~~~~~i~~ 168 (336)
T 2vuw_A 96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-------KLSSLATAKSILH 168 (336)
T ss_dssp CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-------TCCCHHHHHHHHH
T ss_pred hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-------cCCCHHHHHHHHH
Confidence 44 444443 6899999999975 46655532 1278999999999
Q ss_pred HHHHHHHHHH-HCCeecccCCCccEEEeccC------------------CCeEEEEecCCccccCCCccccccCCcccCc
Q 007035 529 QCLEALEYLH-SLGIIHCDLKPENILIKSYQ------------------RCEIKIIDLGSSCFQTDNLCLYVQSRSYRAP 589 (621)
Q Consensus 529 qIl~aL~yLH-s~gIvHrDLKP~NILl~~~~------------------~~~IKL~DFGls~~~~~~~~~~~gt~~Y~AP 589 (621)
||+.||.||| +++|+||||||+|||++.+. ...+||+|||++...... ..+||+.|+||
T Consensus 169 qi~~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~--~~~gt~~y~aP 246 (336)
T 2vuw_A 169 QLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG--IVVFCDVSMDE 246 (336)
T ss_dssp HHHHHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT--EEECCCCTTCS
T ss_pred HHHHHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC--cEEEeecccCh
Confidence 9999999999 99999999999999999632 128999999999876544 34789999999
Q ss_pred hhhcCCCCCchhhHHHHHHH-HHHHHhCCCCC
Q 007035 590 EVIIGLPYDQKIDLWSLGCI-LAELWTGEVCL 620 (621)
Q Consensus 590 Evl~~~~~s~ksDIWSLGvI-LyELltG~~PF 620 (621)
|++.+.. +.++|||||+++ .+++++|..||
T Consensus 247 E~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~ 277 (336)
T 2vuw_A 247 DLFTGDG-DYQFDIYRLMKKENNNRWGEYHPY 277 (336)
T ss_dssp GGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTH
T ss_pred hhhcCCC-ccceehhhhhCCCCcccccccCCC
Confidence 9999876 899999998777 77788898886
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.2e-31 Score=304.85 Aligned_cols=196 Identities=24% Similarity=0.381 Sum_probs=162.2
Q ss_pred eeeCeeecCceEEEEEeccCCCCceeEEEeCC-CCcEEEEEEEecCc--hhhhhHHHHHHHHHHhcccCCCCCCceEEEe
Q 007035 406 IILNTVIAGRYYVTEYLGSAAFSKVFQAQDLH-TGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLY 482 (621)
Q Consensus 406 i~l~~ii~~rY~I~~~LG~G~fG~Vyka~d~~-tg~~VAlKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~ 482 (621)
+..++++.++|++.+.||+|+||+||++.+.. +|+.||||++.... .....+.+|+.+++.+ .||||++++
T Consensus 72 ~~~g~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l------~hp~iv~~~ 145 (681)
T 2pzi_A 72 LNPGDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEV------VHPSIVQIF 145 (681)
T ss_dssp SCTTCEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGC------CCTTBCCEE
T ss_pred CCCCCEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhc------CCCCcCeEe
Confidence 34567888999999999999999999999976 79999999986532 2334455566555444 589999999
Q ss_pred eEeEecCe-----EEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEec
Q 007035 483 DYFYHLEH-----LFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS 556 (621)
Q Consensus 483 ~~f~~~~~-----l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~ 556 (621)
+++...+. .||||||+++ +|.+.+.. .+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 146 ~~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~~--------~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~ 217 (681)
T 2pzi_A 146 NFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ--------KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTE 217 (681)
T ss_dssp EEEEEECTTSCEEEEEEEECCCCEECC----C--------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECS
T ss_pred eeEeecCCCCCceeEEEEEeCCCCcHHHHHhC--------CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeC
Confidence 99997765 7999999985 55544321 2889999999999999999999999999999999999984
Q ss_pred cCCCeEEEEecCCccccCCCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 557 YQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 557 ~~~~~IKL~DFGls~~~~~~~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
+.+||+|||++...... ....||+.|+|||++.+.. +.++|||||||+||+|++|.+||
T Consensus 218 ---~~~kl~DFG~a~~~~~~-~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~ 276 (681)
T 2pzi_A 218 ---EQLKLIDLGAVSRINSF-GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTR 276 (681)
T ss_dssp ---SCEEECCCTTCEETTCC-SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEE
T ss_pred ---CcEEEEecccchhcccC-CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCC
Confidence 48999999998776544 4557899999999998754 88999999999999999998876
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-30 Score=279.05 Aligned_cols=194 Identities=20% Similarity=0.254 Sum_probs=148.2
Q ss_pred CceEEEEEeccCCCCceeEEEeCCC---CcEEEEEEEecCc--hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeE-e
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQDLHT---GVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY-H 487 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d~~t---g~~VAlKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~-~ 487 (621)
.+|++.+.||+|+||+||+|.+..+ +..||+|.++... ....++.+|+.++ ..+.||||+++++++. .
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il------~~l~hpnIv~~~~~~~~~ 162 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM------KDFSHPNVLSLLGICLRS 162 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTS------TTCCCTTBCCCCEEECCC
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHH------HhCCCCCcceEEEEEEcC
Confidence 3588999999999999999987543 3468999886532 2233444444444 4456899999999865 4
Q ss_pred cCeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEe
Q 007035 488 LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (621)
Q Consensus 488 ~~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~D 566 (621)
.+..++||||+.+ +|.+++..... .+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|
T Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~--~~~~~kL~D 235 (373)
T 3c1x_A 163 EGSPLVVLPYMKHGDLRNFIRNETH-----NPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLD--EKFTVKVAD 235 (373)
T ss_dssp SSCCEEEEECCTTCBHHHHHHCTTC-----CCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC--TTCCEEECC
T ss_pred CCCeEEEEECCCCCCHHHHHhhccc-----CCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEEC--CCCCEEEee
Confidence 5688999999985 78777754322 278889999999999999999999999999999999998 478999999
Q ss_pred cCCccccCCC-------ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 567 LGSSCFQTDN-------LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 567 FGls~~~~~~-------~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
||++...... .....+++.|+|||++.+..++.++|||||||++|+|++ |.+||
T Consensus 236 FG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~ 297 (373)
T 3c1x_A 236 FGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 297 (373)
T ss_dssp C---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSC
T ss_pred ccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCC
Confidence 9998754322 122355778999999999999999999999999999999 67776
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-30 Score=295.95 Aligned_cols=194 Identities=22% Similarity=0.312 Sum_probs=157.9
Q ss_pred cCceEEEE-EeccCCCCceeEEEeC--CCCcEEEEEEEecCc--hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEe
Q 007035 413 AGRYYVTE-YLGSAAFSKVFQAQDL--HTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (621)
Q Consensus 413 ~~rY~I~~-~LG~G~fG~Vyka~d~--~tg~~VAlKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~ 487 (621)
.+++.+.+ .||+|+||.||+|.+. .++..||||+++... ...+.+.+|+++++.+ .||||+++++++..
T Consensus 334 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l------~hpniv~l~~~~~~ 407 (613)
T 2ozo_A 334 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL------DNPYIVRLIGVCQA 407 (613)
T ss_dssp TTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTC------CCTTBCCEEEEEES
T ss_pred ccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhC------CCCCEeeEEEEecc
Confidence 45666666 8999999999999865 456779999997642 3456677888877655 58899999999876
Q ss_pred cCeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEe
Q 007035 488 LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (621)
Q Consensus 488 ~~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~D 566 (621)
+.++|||||+.+ +|.+++.... ..+++..+..++.||+.||.|||+++|+||||||+|||++. ++.+||+|
T Consensus 408 -~~~~lv~E~~~~g~L~~~l~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~--~~~vkL~D 479 (613)
T 2ozo_A 408 -EALMLVMEMAGGGPLHKFLVGKR-----EEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVN--RHYAKISD 479 (613)
T ss_dssp -SSEEEEEECCTTCBHHHHHTTCT-----TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEE--TTEEEECC
T ss_pred -CCeEEEEEeCCCCcHHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcC--CCcEEEee
Confidence 569999999985 6766664332 23889999999999999999999999999999999999984 78999999
Q ss_pred cCCccccCCCc------cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 567 LGSSCFQTDNL------CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 567 FGls~~~~~~~------~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
||++....... ....+++.|+|||++.+..++.++|||||||+||||++ |+.||
T Consensus 480 FGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf 540 (613)
T 2ozo_A 480 FGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPY 540 (613)
T ss_dssp CSTTTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred ccCcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 99997653321 11234678999999998899999999999999999998 99998
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2.1e-30 Score=267.08 Aligned_cols=178 Identities=17% Similarity=0.208 Sum_probs=148.0
Q ss_pred CcceeeCe-eecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc----hhhhhHHHHHHHHHHhcccCCCCCCc
Q 007035 403 DLPIILNT-VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHH 477 (621)
Q Consensus 403 ~~pi~l~~-ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~hpn 477 (621)
..++..+. ++.++|++.+.||+|+||.||+|++..+++.||||++.... .....+.+|+.++..+ .|||
T Consensus 19 ~~~~~~g~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l------~hp~ 92 (286)
T 3uqc_A 19 DVQLVPGARIANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRI------DKPG 92 (286)
T ss_dssp -CCCCTTCEETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTC------CCTT
T ss_pred CCcCCCCCEEecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcC------CCCC
Confidence 34556677 78899999999999999999999999999999999997643 2235566676666544 5889
Q ss_pred eEEEeeEeEecCeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEec
Q 007035 478 ILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS 556 (621)
Q Consensus 478 Ivrl~~~f~~~~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~ 556 (621)
|+++++++...+..|+||||+.+ +|.+++... .....+..++.||+.||.|||++||+||||||+|||++.
T Consensus 93 iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~--------~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~ 164 (286)
T 3uqc_A 93 VARVLDVVHTRAGGLVVAEWIRGGSLQEVADTS--------PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSI 164 (286)
T ss_dssp BCCEEEEEEETTEEEEEEECCCEEEHHHHHTTC--------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEET
T ss_pred cceeeEEEEECCcEEEEEEecCCCCHHHHHhcC--------CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcC
Confidence 99999999999999999999975 777766321 234467889999999999999999999999999999994
Q ss_pred cCCCeEEEEecCCccccCCCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 557 YQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 557 ~~~~~IKL~DFGls~~~~~~~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
++.+||++++ |++ +++.++|||||||++|+|++|+.||
T Consensus 165 --~g~~kl~~~~-----------------~~~-------~~~~~~Di~slG~il~elltg~~Pf 202 (286)
T 3uqc_A 165 --DGDVVLAYPA-----------------TMP-------DANPQDDIRGIGASLYALLVNRWPL 202 (286)
T ss_dssp --TSCEEECSCC-----------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECS
T ss_pred --CCCEEEEecc-----------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCC
Confidence 7889988543 333 3788999999999999999999998
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.9e-31 Score=285.13 Aligned_cols=204 Identities=17% Similarity=0.214 Sum_probs=155.6
Q ss_pred CceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc----hhhhhHHHHHHHHHHhcccC----------CCC-----
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKND----------PAD----- 474 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~----~~~~~~~~Ei~iL~~l~~~~----------~~~----- 474 (621)
.+|.+.+.||+|+||+||+|++..+|+.||||++.... ...+.+.+|+.+++.+.+.. ...
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 35888999999999999999999999999999988322 22456777887777665411 000
Q ss_pred -CCceEEEeeEeEe-----cCeEEEEEeccccchHHHHHhhhc-cCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccC
Q 007035 475 -EHHILRLYDYFYH-----LEHLFIVCELLRANLYEFQKFNQE-SGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDL 547 (621)
Q Consensus 475 -hpnIvrl~~~f~~-----~~~l~LVmEyl~gsLld~l~~~~~-~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDL 547 (621)
.++...+..++.. ....+++|+++.++|.+++..... ......+++..+..++.||+.||.|||+++|+||||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDi 237 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYL 237 (413)
T ss_dssp ECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred ccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCc
Confidence 0111111122222 235789999999999988854321 112334788889999999999999999999999999
Q ss_pred CCccEEEeccCCCeEEEEecCCccccCCCccccccCCcccCchhh----------cCCCCCchhhHHHHHHHHHHHHhCC
Q 007035 548 KPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVI----------IGLPYDQKIDLWSLGCILAELWTGE 617 (621)
Q Consensus 548 KP~NILl~~~~~~~IKL~DFGls~~~~~~~~~~~gt~~Y~APEvl----------~~~~~s~ksDIWSLGvILyELltG~ 617 (621)
||+|||++. ++.+||+|||++..........+| +.|+|||++ .+..++.++|||||||++|+|++|+
T Consensus 238 Kp~NILl~~--~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~ 314 (413)
T 3dzo_A 238 RPVDIVLDQ--RGGVFLTGFEHLVRDGASAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314 (413)
T ss_dssp CGGGEEECT--TCCEEECCGGGCEETTEEECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSS
T ss_pred ccceEEEec--CCeEEEEeccceeecCCccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCC
Confidence 999999994 778999999998876666666677 999999999 5556888999999999999999999
Q ss_pred CCC
Q 007035 618 VCL 620 (621)
Q Consensus 618 ~PF 620 (621)
.||
T Consensus 315 ~Pf 317 (413)
T 3dzo_A 315 LPN 317 (413)
T ss_dssp CCC
T ss_pred CCC
Confidence 998
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.2e-30 Score=294.69 Aligned_cols=190 Identities=23% Similarity=0.324 Sum_probs=156.4
Q ss_pred eEEE-EEeccCCCCceeEEE--eCCCCcEEEEEEEecCc---hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecC
Q 007035 416 YYVT-EYLGSAAFSKVFQAQ--DLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (621)
Q Consensus 416 Y~I~-~~LG~G~fG~Vyka~--d~~tg~~VAlKii~~~~---~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~ 489 (621)
+.+. +.||+|+||.||+|. +..+++.||||+++... ...+.+.+|+++++.++ ||||+++++++.. +
T Consensus 370 ~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~------hpnIv~l~~~~~~-~ 442 (635)
T 4fl3_A 370 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD------NPYIVRMIGICEA-E 442 (635)
T ss_dssp EEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCC------CTTBCCEEEEEES-S
T ss_pred ccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCC------CCCEeeEEEEEec-C
Confidence 4443 479999999999995 45677899999997643 23467888999998884 7899999999864 5
Q ss_pred eEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecC
Q 007035 490 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (621)
Q Consensus 490 ~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFG 568 (621)
..+|||||+.+ +|.+++.... .+++..++.++.||+.||.|||+++|+||||||+||||+. ++.+||+|||
T Consensus 443 ~~~lv~E~~~~g~L~~~l~~~~------~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~--~~~~kL~DFG 514 (635)
T 4fl3_A 443 SWMLVMEMAELGPLNKYLQQNR------HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVT--QHYAKISDFG 514 (635)
T ss_dssp SEEEEEECCTTEEHHHHHHHCT------TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEE--TTEEEECCTT
T ss_pred CEEEEEEccCCCCHHHHHhhCC------CCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeC--CCCEEEEEcC
Confidence 68899999984 7777775432 2889999999999999999999999999999999999994 7899999999
Q ss_pred CccccCCC------ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 569 SSCFQTDN------LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 569 ls~~~~~~------~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
++...... .....+|+.|+|||++.+..++.++|||||||+||||++ |+.||
T Consensus 515 la~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf 573 (635)
T 4fl3_A 515 LSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY 573 (635)
T ss_dssp HHHHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred CccccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 98754332 122345678999999999999999999999999999998 99998
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-29 Score=261.38 Aligned_cols=177 Identities=32% Similarity=0.444 Sum_probs=149.7
Q ss_pred ecCceEEE-EEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEe---
Q 007035 412 IAGRYYVT-EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH--- 487 (621)
Q Consensus 412 i~~rY~I~-~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~--- 487 (621)
+.++|.++ +.||+|+||.||++.+..+++.||+|+++.. ....+|+.++..+. .||||+++++++..
T Consensus 15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~e~~~~~~~~-----~h~~i~~~~~~~~~~~~ 85 (299)
T 3m2w_A 15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRAS-----QCPHIVRIVDVYENLYA 85 (299)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHT-----TSTTBCCEEEEEEEEET
T ss_pred cccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc----HHHHHHHHHHHHhc-----cCCCchhHHhhhhhhcC
Confidence 45667777 7899999999999999999999999999764 34567777775543 57899999999987
Q ss_pred -cCeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccC-CCeEEE
Q 007035 488 -LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQ-RCEIKI 564 (621)
Q Consensus 488 -~~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~-~~~IKL 564 (621)
..++++||||+.+ +|.+++..... ..+++..++.++.||+.||.|||++||+||||||+|||++... ++.+||
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl 161 (299)
T 3m2w_A 86 GRKCLLIVMECLDGGELFSRIQDRGD----QAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKL 161 (299)
T ss_dssp TEEEEEEEECCCCSCBHHHHHHHCTT----CCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEE
T ss_pred CCceEEEEEeecCCCcHHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEE
Confidence 7789999999975 88888775432 2389999999999999999999999999999999999998532 678999
Q ss_pred EecCCccccCCCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 565 IDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 565 ~DFGls~~~~~~~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
+|||++.... +..++.++|||||||++|+|++|+.||
T Consensus 162 ~Dfg~a~~~~-------------------~~~~~~~~DiwslG~il~el~tg~~pf 198 (299)
T 3m2w_A 162 TDFGFAKETT-------------------GEKYDKSCDMWSLGVIMYILLCGYPPF 198 (299)
T ss_dssp CCCTTCEECT-------------------TCGGGGHHHHHHHHHHHHHHHHSSCSC
T ss_pred eccccccccc-------------------cccCCchhhHHHHHHHHHHHHHCCCCC
Confidence 9999985432 234678999999999999999999998
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.6e-31 Score=273.64 Aligned_cols=198 Identities=22% Similarity=0.367 Sum_probs=157.6
Q ss_pred eeeCeeecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc---hhhhhHHHHHHHHHHhcccCCCCCCceEEEe
Q 007035 406 IILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLY 482 (621)
Q Consensus 406 i~l~~ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~---~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~ 482 (621)
.....+..++|++.+.||+|+||.||+|.+.. .+|+|+++... .....+.+|+.+++.+ .||||++++
T Consensus 25 ~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l------~h~~iv~~~ 95 (319)
T 2y4i_B 25 LQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQT------RHENVVLFM 95 (319)
T ss_dssp GGGSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTC------CCTTBCCCC
T ss_pred cccccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcC------CCCCEeEEE
Confidence 34445567899999999999999999998753 49999987532 2223445555555444 588999999
Q ss_pred eEeEecCeEEEEEeccc-cchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCe
Q 007035 483 DYFYHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCE 561 (621)
Q Consensus 483 ~~f~~~~~l~LVmEyl~-gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~ 561 (621)
+++......++||||+. ++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.
T Consensus 96 ~~~~~~~~~~iv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~---~~~ 167 (319)
T 2y4i_B 96 GACMSPPHLAIITSLCKGRTLYSVVRDAK-----IVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD---NGK 167 (319)
T ss_dssp EEEECSSCEEEECBCCCSEEHHHHTTSSC-----CCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC-----C
T ss_pred EEEecCCceEEEeecccCCcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe---CCC
Confidence 99999999999999997 47776664322 2388899999999999999999999999999999999997 568
Q ss_pred EEEEecCCccccC--------CCccccccCCcccCchhhcC---------CCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 562 IKIIDLGSSCFQT--------DNLCLYVQSRSYRAPEVIIG---------LPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 562 IKL~DFGls~~~~--------~~~~~~~gt~~Y~APEvl~~---------~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
+||+|||++.... .......+++.|+|||++.+ ..++.++||||||+++|+|++|+.||
T Consensus 168 ~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~ 243 (319)
T 2y4i_B 168 VVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPF 243 (319)
T ss_dssp CEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSS
T ss_pred EEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 9999999875432 12233467899999999975 35788999999999999999999998
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1e-29 Score=291.53 Aligned_cols=197 Identities=24% Similarity=0.330 Sum_probs=162.3
Q ss_pred eeecCceEEEEEeccCCCCceeEEEeCCC---CcEEEEEEEecC--chhhhhHHHHHHHHHHhcccCCCCCCceEEEeeE
Q 007035 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHT---GVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDY 484 (621)
Q Consensus 410 ~ii~~rY~I~~~LG~G~fG~Vyka~d~~t---g~~VAlKii~~~--~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~ 484 (621)
.+..++|++.+.||+|+||+||+|.+..+ +..||+|.++.. ....+.+.+|+.+++.+ .||||++++++
T Consensus 386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l------~HpnIv~l~~~ 459 (656)
T 2j0j_A 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQF------DHPHIVKLIGV 459 (656)
T ss_dssp BCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHC------CCTTBCCEEEE
T ss_pred ccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhC------CCCCCCeEEEE
Confidence 34568899999999999999999998654 467999998753 23345677888888777 47899999999
Q ss_pred eEecCeEEEEEeccc-cchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEE
Q 007035 485 FYHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 563 (621)
Q Consensus 485 f~~~~~l~LVmEyl~-gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IK 563 (621)
+. .+.+++||||+. ++|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+|
T Consensus 460 ~~-~~~~~lv~E~~~~g~L~~~l~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~--~~~vk 531 (656)
T 2j0j_A 460 IT-ENPVWIIMELCTLGELRSFLQVRKF-----SLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSS--NDCVK 531 (656)
T ss_dssp EC-SSSCEEEEECCTTCBHHHHHHHTTT-----TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEE--TTEEE
T ss_pred Ee-cCceEEEEEcCCCCcHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeC--CCCEE
Confidence 85 467899999998 577777764322 2788999999999999999999999999999999999994 78999
Q ss_pred EEecCCccccCCCc----cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 564 IIDLGSSCFQTDNL----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 564 L~DFGls~~~~~~~----~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
|+|||++....... ....+++.|+|||++.+..++.++|||||||++|||++ |..||
T Consensus 532 L~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf 593 (656)
T 2j0j_A 532 LGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF 593 (656)
T ss_dssp ECCCCCCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred EEecCCCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCC
Confidence 99999987654332 12345778999999998899999999999999999997 99998
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.6e-30 Score=294.39 Aligned_cols=201 Identities=26% Similarity=0.349 Sum_probs=166.1
Q ss_pred eecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecC--chhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEe-
Q 007035 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH- 487 (621)
Q Consensus 411 ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~--~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~- 487 (621)
...++|++.+.||.|+||.||+|.+..+|+.||||+++.. ....+.+.+|+.+++.++ ||||+++++++..
T Consensus 11 ~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~------HpnIV~l~~v~~~~ 84 (676)
T 3qa8_A 11 QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLN------HPNVVSAREVPDGL 84 (676)
T ss_dssp ------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCC------BTTBCCEEECCTTT
T ss_pred CCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCC------CCCCCceeeeeccc
Confidence 3458999999999999999999999999999999998753 334566788999988884 7899999998765
Q ss_pred -----cCeEEEEEeccc-cchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccC-CC
Q 007035 488 -----LEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQ-RC 560 (621)
Q Consensus 488 -----~~~l~LVmEyl~-gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~-~~ 560 (621)
.+..++||||+. ++|.+++..... ...+++..++.++.||+.||.|||+.||+||||||+|||++.+. ..
T Consensus 85 ~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~---~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~ 161 (676)
T 3qa8_A 85 QKLAPNDLPLLAMEYCEGGDLRKYLNQFEN---CCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRL 161 (676)
T ss_dssp CCCCTTSSCCCEEECCSSCBHHHHHHSSSC---TTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSC
T ss_pred ccccCCCeEEEEEEeCCCCCHHHHHHhccc---CCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCce
Confidence 678899999996 578777764322 12388889999999999999999999999999999999998532 23
Q ss_pred eEEEEecCCccccCCC--ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 561 EIKIIDLGSSCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 561 ~IKL~DFGls~~~~~~--~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
.+||+|||++...... .....+|+.|+|||++.+..++.++|||||||++|+|++|+.||
T Consensus 162 ~vKL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf 223 (676)
T 3qa8_A 162 IHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPF 223 (676)
T ss_dssp EEEECSCCCCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSC
T ss_pred eEEEcccccccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCC
Confidence 5899999998765433 33457899999999999999999999999999999999999998
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.4e-27 Score=267.71 Aligned_cols=181 Identities=19% Similarity=0.068 Sum_probs=125.7
Q ss_pred EeccCCCCceeEEEeCCCCcEEEEEEEecCc-----------hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecC
Q 007035 421 YLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-----------DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (621)
Q Consensus 421 ~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~-----------~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~ 489 (621)
.++.|++|.+..++....|+.+++|++.++. ...+++.+|+++|+++. .|+||+++++++++.+
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~-----~~~~i~~~~~~~ed~~ 315 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPP-----AGFDAPAVLAHGENAQ 315 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCC-----TTCCCCCEEEEEECSS
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcC-----CCCCeeEEEEEEEECC
Confidence 4678888888888888899999999997642 23456778888888774 4789999999999999
Q ss_pred eEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecC
Q 007035 490 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (621)
Q Consensus 490 ~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFG 568 (621)
.+||||||++| +|.+.+..... +++ ..|+.||+.||.|||++|||||||||+||||+ .++.+||+|||
T Consensus 316 ~~yLVMEyv~G~~L~d~i~~~~~------l~~---~~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~--~dg~vKL~DFG 384 (569)
T 4azs_A 316 SGWLVMEKLPGRLLSDMLAAGEE------IDR---EKILGSLLRSLAALEKQGFWHDDVRPWNVMVD--ARQHARLIDFG 384 (569)
T ss_dssp EEEEEEECCCSEEHHHHHHTTCC------CCH---HHHHHHHHHHHHHHHHTTCEESCCCGGGEEEC--TTSCEEECCCT
T ss_pred EEEEEEecCCCCcHHHHHHhCCC------CCH---HHHHHHHHHHHHHHHHCCceeccCchHhEEEC--CCCCEEEeecc
Confidence 99999999996 77777764322 444 35889999999999999999999999999998 47899999999
Q ss_pred CccccCCC---ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCC
Q 007035 569 SSCFQTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEV 618 (621)
Q Consensus 569 ls~~~~~~---~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~ 618 (621)
+++..... ....+||+.|+|||++.+. +..++|+||+|+++++|.++..
T Consensus 385 lAr~~~~~~~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~ 436 (569)
T 4azs_A 385 SIVTTPQDCSWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWS 436 (569)
T ss_dssp TEESCC---CCSHHHHHHHHHHHHHHC------------------CCCCTTHH
T ss_pred cCeeCCCCCccccCceechhhccHHHhCCC-CCCcccccccccchhhhccccc
Confidence 98765432 3456899999999999874 5778999999999887765543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=6.8e-23 Score=229.93 Aligned_cols=178 Identities=17% Similarity=0.149 Sum_probs=137.8
Q ss_pred EEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc---------hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEe
Q 007035 417 YVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---------DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (621)
Q Consensus 417 ~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~---------~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~ 487 (621)
...+.||+|+||+||++. ..++.+++|...... ...+++.+|+++++.++ ||||+++..++..
T Consensus 339 ~~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~------h~nIv~~~~~~~~ 410 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVK------DFGIPAPYIFDVD 410 (540)
T ss_dssp ---------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGG------GGTCCCCCEEEEE
T ss_pred CCCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcC------CCCcCceEEEEEe
Confidence 345689999999999994 568889999865321 11344688889998885 6789966666667
Q ss_pred cCeEEEEEeccc-cchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEe
Q 007035 488 LEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (621)
Q Consensus 488 ~~~l~LVmEyl~-gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~D 566 (621)
.+..+|||||++ ++|.+++.. +..++.||+.||.|||+++|+||||||+|||++. .+||+|
T Consensus 411 ~~~~~lVmE~~~ggsL~~~l~~--------------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~----~~kL~D 472 (540)
T 3en9_A 411 LDNKRIMMSYINGKLAKDVIED--------------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK----DLYIID 472 (540)
T ss_dssp TTTTEEEEECCCSEEHHHHSTT--------------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS----SEEECC
T ss_pred CCccEEEEECCCCCCHHHHHHH--------------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC----eEEEEE
Confidence 778899999997 577766543 4579999999999999999999999999999983 899999
Q ss_pred cCCccccCCCc----------cccccCCcccCchhhcC--CCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 567 LGSSCFQTDNL----------CLYVQSRSYRAPEVIIG--LPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 567 FGls~~~~~~~----------~~~~gt~~Y~APEvl~~--~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
||++....... ....||+.|+|||++.. ..|+...|+|+..+-..+.+.++.+|
T Consensus 473 FGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 473 FGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp CTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred CccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 99998765531 34678999999999987 55788899999999999988888776
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=1.1e-20 Score=194.84 Aligned_cols=155 Identities=21% Similarity=0.253 Sum_probs=118.7
Q ss_pred ceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCch-------------------hhhhHHHHHHHHHHhcccCCCCC
Q 007035 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD-------------------FFDQSLDEIKLLKLVNKNDPADE 475 (621)
Q Consensus 415 rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~-------------------~~~~~~~Ei~iL~~l~~~~~~~h 475 (621)
.|.+.+.||+|+||.||+|.+ .+|+.||||+++.... ....+.+|+.+++.++ |
T Consensus 91 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~------~ 163 (282)
T 1zar_A 91 VDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ------G 163 (282)
T ss_dssp CSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT------T
T ss_pred EEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc------C
Confidence 466779999999999999998 8899999999974321 2345788999999886 1
Q ss_pred CceEEEeeEeEecCeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEE
Q 007035 476 HHILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILI 554 (621)
Q Consensus 476 pnIvrl~~~f~~~~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl 554 (621)
++++.+ +.. ++.++||||+++ +|.+ +. ......++.||+.||.|||++||+||||||+|||+
T Consensus 164 ~~v~~~---~~~-~~~~lvmE~~~g~~L~~-l~------------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl 226 (282)
T 1zar_A 164 LAVPKV---YAW-EGNAVLMELIDAKELYR-VR------------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLV 226 (282)
T ss_dssp SSSCCE---EEE-ETTEEEEECCCCEEGGG-CC------------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEE
T ss_pred CCcCeE---Eec-cceEEEEEecCCCcHHH-cc------------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEE
Confidence 234433 322 556999999976 6655 21 12345799999999999999999999999999999
Q ss_pred eccCCCeEEEEecCCccccCCCccccccCCcccCchhhcC----------CCCCchhhHHHH
Q 007035 555 KSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIG----------LPYDQKIDLWSL 606 (621)
Q Consensus 555 ~~~~~~~IKL~DFGls~~~~~~~~~~~gt~~Y~APEvl~~----------~~~s~ksDIWSL 606 (621)
+ ++.+||+|||++. .+..+.|||.+.. ..|...+|+|.+
T Consensus 227 ~---~~~vkl~DFG~a~----------~~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~~ 275 (282)
T 1zar_A 227 S---EEGIWIIDFPQSV----------EVGEEGWREILERDVRNIITYFSRTYRTEKDINSA 275 (282)
T ss_dssp E---TTEEEECCCTTCE----------ETTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHHH
T ss_pred E---CCcEEEEECCCCe----------ECCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHHH
Confidence 8 7889999999985 3455789998853 345666787763
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=2.7e-18 Score=174.17 Aligned_cols=138 Identities=17% Similarity=0.244 Sum_probs=105.6
Q ss_pred eEEEEEeccCCCCceeEEEeCCCCcE--EEEEEEecCchh-------------------------hhhHHHHHHHHHHhc
Q 007035 416 YYVTEYLGSAAFSKVFQAQDLHTGVD--VCLKIIKNDKDF-------------------------FDQSLDEIKLLKLVN 468 (621)
Q Consensus 416 Y~I~~~LG~G~fG~Vyka~d~~tg~~--VAlKii~~~~~~-------------------------~~~~~~Ei~iL~~l~ 468 (621)
|.+.+.||+|+||.||+|.+..+|+. ||||+++..... .....+|+.+++.+.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 78999999999999999998788999 999997643211 125678999999998
Q ss_pred ccCCCCCCceEEEeeEeEecCeEEEEEecccc------chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHH-HCC
Q 007035 469 KNDPADEHHILRLYDYFYHLEHLFIVCELLRA------NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLH-SLG 541 (621)
Q Consensus 469 ~~~~~~hpnIvrl~~~f~~~~~l~LVmEyl~g------sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLH-s~g 541 (621)
+.. ..+|.++ .. ...+|||||+++ .|.+.... .++..+..++.||+.||.||| +.|
T Consensus 129 ~~~-i~~p~~~---~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---------~~~~~~~~i~~qi~~~l~~lH~~~g 191 (258)
T 1zth_A 129 EAG-VSVPQPY---TY----MKNVLLMEFIGEDELPAPTLVELGRE---------LKELDVEGIFNDVVENVKRLYQEAE 191 (258)
T ss_dssp HTT-CCCCCEE---EE----ETTEEEEECCEETTEECCBHHHHGGG---------GGGSCHHHHHHHHHHHHHHHHHTSC
T ss_pred hCC-CCCCeEE---Ec----CCCEEEEEecCCCCCccccHHHHhhc---------cChHHHHHHHHHHHHHHHHHHHHCC
Confidence 653 2334333 22 356899999953 44443211 234567889999999999999 999
Q ss_pred eecccCCCccEEEeccCCCeEEEEecCCccccC
Q 007035 542 IIHCDLKPENILIKSYQRCEIKIIDLGSSCFQT 574 (621)
Q Consensus 542 IvHrDLKP~NILl~~~~~~~IKL~DFGls~~~~ 574 (621)
|+||||||.|||++. .++|+|||++....
T Consensus 192 ivHrDlkp~NILl~~----~~~liDFG~a~~~~ 220 (258)
T 1zth_A 192 LVHADLSEYNIMYID----KVYFIDMGQAVTLR 220 (258)
T ss_dssp EECSSCSTTSEEESS----SEEECCCTTCEETT
T ss_pred EEeCCCCHHHEEEcC----cEEEEECcccccCC
Confidence 999999999999983 89999999986543
|
| >2z0u_A WW domain-containing protein 1; C2 domain, alternative splicing, coiled coil, cytoplasm, phosphorylation, polymorphism, lipid binding protein; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.66 E-value=8.3e-18 Score=158.65 Aligned_cols=97 Identities=13% Similarity=0.037 Sum_probs=84.5
Q ss_pred CcceEEEEecC-CCccccCcCCCCcceEeecCCCCC-CcccceeeccccCCCceeccceeeeccccccc-cccccccccc
Q 007035 265 NDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPG-TEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKG-AEKDLMPAEI 341 (621)
Q Consensus 265 ~~~l~v~l~e~-~L~~~d~~g~sDpyVK~~Llp~~~-~~~k~kt~v~k~tlnP~fnE~f~f~~~~~~~~-~~k~L~~~V~ 341 (621)
...|.|.|.+| ||+++|.+|.+|||||++|+|... +..++||+++|+|+||+|||+|.|. ++... .++.|.++||
T Consensus 42 ~~~L~V~Vi~a~~L~~~d~~g~sDPyVkv~l~~~~~~~~~~~kT~v~~~tlnP~wnE~F~f~--v~~~~l~~~~L~~~V~ 119 (155)
T 2z0u_A 42 NKQFAILIIQLSNLSALLQQQDQKVNIRVAVLPCSESTTCLFRTRPLDASDTLVFNEVFWVS--MSYPALHQKTLRVDVC 119 (155)
T ss_dssp TTEEEEEEEEEECGGGTCCSCCSEEEEEEEEESCSCHHHHEEECCCEECCSSEEEEEEEEEE--CCHHHHHHCEEEEEEE
T ss_pred CCEEEEEEEEccCcCCcccCCCCCEEEEEEEecCCCCCccceeCCcCCCCCCCccccEEEEE--cCHHHhCcCEEEEEEE
Confidence 56789999999 999999999999999999998432 3457899999999999999999998 55444 3778999999
Q ss_pred CCCCCCCCCccccccccccccc
Q 007035 342 DNSDTRDGEVNGALHEGKADAE 363 (621)
Q Consensus 342 D~d~~~r~d~iG~v~~~~a~~~ 363 (621)
|+|++++++++|++..++.++.
T Consensus 120 d~d~~~~~d~iG~~~i~l~~l~ 141 (155)
T 2z0u_A 120 TTDRSHLEECLGGAQISLAEVC 141 (155)
T ss_dssp EECTTSCEEEEEEEEEECTTSC
T ss_pred ECCCCCCCcEEEEEEEEHHHcc
Confidence 9999999999999998887764
|
| >3fbk_A RGS3, RGP3, regulator of G-protein signaling 3; all beta-sheet fold, structural genomics, PSI-2, protein structure initiative; 2.00A {Homo sapiens} SCOP: b.7.1.0 | Back alignment and structure |
|---|
Probab=99.65 E-value=7.1e-17 Score=151.20 Aligned_cols=112 Identities=14% Similarity=0.063 Sum_probs=91.9
Q ss_pred CcceEEEEecC-CCccccCcCCCCcceEeecCCCCCCcccceeeccccCCCceeccceeeecccccccccccccccccCC
Q 007035 265 NDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDN 343 (621)
Q Consensus 265 ~~~l~v~l~e~-~L~~~d~~g~sDpyVK~~Llp~~~~~~k~kt~v~k~tlnP~fnE~f~f~~~~~~~~~~k~L~~~V~D~ 343 (621)
.+.|+|.|.+| ||+++| +|.+|||||+.+.++.....++||+++++|+||+|||+|.|. +.....++.|.++|||+
T Consensus 26 ~~~L~V~v~~a~~L~~~d-~g~~Dpyv~v~l~~~~~~~~~~kT~v~~~t~nP~wne~f~f~--v~~~~~~~~L~i~V~d~ 102 (153)
T 3fbk_A 26 DRVLLLHIIEGKGLISKQ-PGTCDPYVKISLIPEDSRLRHQKTQTVPDCRDPAFHEHFFFP--VQEEDDQKRLLVTVWNR 102 (153)
T ss_dssp SSEEEEEEEEEESCCCCS-SSCCCEEEEEEEESCSCCTTCEECCCCTTCSSCEEEEEEEEE--CCGGGTTSEEEEEEEEC
T ss_pred CCEEEEEEEEeeCCCCCC-CCCCCEEEEEEEEcCCCCccEEeccccCCCCCCccccEEEEe--cccHHhCCEEEEEEEeC
Confidence 67889999999 999999 699999999999998888889999999999999999999998 55455545699999999
Q ss_pred CCCCC-CCcccccccccccccccCCCCccchhccchhhh
Q 007035 344 SDTRD-GEVNGALHEGKADAEEHGVATPDLLMFDNLEEE 381 (621)
Q Consensus 344 d~~~r-~d~iG~v~~~~a~~~~~~~~~~~ll~~~~l~eE 381 (621)
|.+++ ++++|.+..++.++..... ....|+....++
T Consensus 103 d~~~~~d~~lG~~~i~l~~l~~~~~--~~~~W~~L~~~~ 139 (153)
T 3fbk_A 103 ASQSRQSGLIGCMSFGVKSLLTPDK--EISGWYYLLGEH 139 (153)
T ss_dssp CSSGGGCEEEEEEEEEHHHHTC--C--CEEEEEECBCTT
T ss_pred CCCCCCCcEEEEEEEEHHHhcCCCC--ccccEEECCChh
Confidence 99987 8999999998887764221 112366555443
|
| >1v27_A Regulating synaptic membrane exocytosis protein 2; RAB3-interacting molecule, riken structural genomics/proteomics initiative, RSGI; NMR {Homo sapiens} SCOP: b.7.1.2 | Back alignment and structure |
|---|
Probab=99.64 E-value=7.6e-17 Score=148.00 Aligned_cols=101 Identities=15% Similarity=0.068 Sum_probs=87.8
Q ss_pred CcceEEEEecC-CCccccCcCCCCcceEeecCCCCCCcccceeeccccCCCceeccceeeecccccccccccccccccCC
Q 007035 265 NDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDN 343 (621)
Q Consensus 265 ~~~l~v~l~e~-~L~~~d~~g~sDpyVK~~Llp~~~~~~k~kt~v~k~tlnP~fnE~f~f~~~~~~~~~~k~L~~~V~D~ 343 (621)
...|.|.|.+| ||+++|.+|.+||||+++++|++....++||+++++|+||+|||+|.|..+...+..+..|.++|||+
T Consensus 20 ~~~L~v~v~~a~~L~~~d~~g~~dpyv~v~~~~~~~~~~~~kT~~~~~t~nP~wne~f~f~~~~~~~~~~~~l~i~V~d~ 99 (141)
T 1v27_A 20 GHQLIVTILGAKDLPSREDGRPRNPYVKIYFLPDRSDKNKRRTKTVKKTLEPKWNQTFIYSPVHRREFRERMLEITLWDQ 99 (141)
T ss_dssp TTEEEEEEEEEESCCCCSSSCCCCEEEECCCSSCCSSSSCCBCCCCSSCSSCCCCCCCEECSCCTTGGGTCEEEEEEEEB
T ss_pred CCEEEEEEEEccCCCCcCCCCCCCCEEEEEEecCCCCCcceeCccccCCCCCccccEEEEccCCHHHhcCCEEEEEEEEC
Confidence 56788999999 99999999999999999999988777899999999999999999999984333444567799999999
Q ss_pred CCCCC--CCccccccccccccccc
Q 007035 344 SDTRD--GEVNGALHEGKADAEEH 365 (621)
Q Consensus 344 d~~~r--~d~iG~v~~~~a~~~~~ 365 (621)
|.+++ ++++|.+..++..+...
T Consensus 100 d~~~~~~~~~lG~~~i~l~~l~~~ 123 (141)
T 1v27_A 100 ARVREEESEFLGEILIELETALLD 123 (141)
T ss_dssp CSSSSCCBCCCEEEEEEGGGCCCS
T ss_pred CCCcCCCCceEEEEEEEccccCCC
Confidence 99997 99999998887766543
|
| >1a25_A CALB, protein kinase C (beta); calcium++/phospholipid binding protein, calcium-binding protein; HET: PSE; 2.70A {Rattus norvegicus} SCOP: b.7.1.2 | Back alignment and structure |
|---|
Probab=99.62 E-value=1.7e-16 Score=147.71 Aligned_cols=111 Identities=22% Similarity=0.298 Sum_probs=93.4
Q ss_pred CcceEEEEecC-CCccccCcCCCCcceEeecCCCCCCcccceeeccccCCCceeccceeeecccccccccccccccccCC
Q 007035 265 NDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDN 343 (621)
Q Consensus 265 ~~~l~v~l~e~-~L~~~d~~g~sDpyVK~~Llp~~~~~~k~kt~v~k~tlnP~fnE~f~f~~~~~~~~~~k~L~~~V~D~ 343 (621)
.+.|.|.|.+| ||+++|..|.+||||++++.++.+...++||+++++|+||+|||+|.|. +.....++.|.++|||+
T Consensus 30 ~~~L~v~v~~a~~L~~~d~~g~~dpyv~v~~~~~~~~~~~~kT~v~~~t~nP~wne~f~f~--v~~~~~~~~L~i~V~d~ 107 (149)
T 1a25_A 30 REVLIVVVRDAKNLVPMDPNGLSDPYVKLKLIPDPKSESKQKTKTIKCSLNPEWNETFRFQ--LKESDKDRRLSVEIWDW 107 (149)
T ss_dssp SSEEEEEEEEEESCCCCSTTSCCCEEEEEEEESCTTCSSCEECCCCSSCSSCEEEEEEEEE--CCSGGGGCEEEEEEEEC
T ss_pred CCEEEEEEEEeeCCCCCCCCCCcCeEEEEEEECCCCCcceEecceeCCCCCCcCCcEEEEE--eccccCCCEEEEEEEEC
Confidence 45788999999 9999999999999999999998877788999999999999999999998 55444456799999999
Q ss_pred CCCCCCCcccccccccccccccCCCCccchhccchhhh
Q 007035 344 SDTRDGEVNGALHEGKADAEEHGVATPDLLMFDNLEEE 381 (621)
Q Consensus 344 d~~~r~d~iG~v~~~~a~~~~~~~~~~~ll~~~~l~eE 381 (621)
|.+++++++|++..++.++...... .|+.....+
T Consensus 108 d~~~~~~~iG~~~i~l~~l~~~~~~----~W~~L~~~~ 141 (149)
T 1a25_A 108 DLTSRNDFMGSLSFGISELQKAGVD----GWFKLLSQE 141 (149)
T ss_dssp CSSSCCEEEEEEEEEHHHHTTCCEE----EEEECBCHH
T ss_pred CCCCCCCEEEEEEEEHHHhCcCccC----CeEEccCCC
Confidence 9999999999999988777655322 366655443
|
| >2bwq_A Regulating synaptic membrane exocytosis protein 2; C2 domain, neurotransmitter release, transport protein; 1.41A {Rattus norvegicus} SCOP: b.7.1.2 | Back alignment and structure |
|---|
Probab=99.61 E-value=2.2e-16 Score=142.85 Aligned_cols=102 Identities=15% Similarity=0.068 Sum_probs=84.1
Q ss_pred CcceEEEEecC-CCccccCcCCCCcceEeecCCCCCCcccceeeccccCCCceeccceeeecccccccccccccccccCC
Q 007035 265 NDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDN 343 (621)
Q Consensus 265 ~~~l~v~l~e~-~L~~~d~~g~sDpyVK~~Llp~~~~~~k~kt~v~k~tlnP~fnE~f~f~~~~~~~~~~k~L~~~V~D~ 343 (621)
.+.|.|.|.+| ||+++|.+|.+||||++.++|++....++||+++++|+||+|||+|.|......+.....|.++|||+
T Consensus 17 ~~~L~v~v~~a~~L~~~d~~~~~dpyv~v~~~~~~~~~~~~kT~v~~~t~nP~wne~f~f~~~~~~~~~~~~l~~~V~d~ 96 (129)
T 2bwq_A 17 GHQLIVTILGAKDLPSREDGRPRNPYVKIYFLPDRSDKNKRRTKTVKKTLEPKWNQTFIYSPVHRREFRERMLEITLWDQ 96 (129)
T ss_dssp TTEEEEEEEEEESCCCCTTSCCBCEEEEEEEESSCSGGGEEECCCCSSBSSCEEEEEEEECSCCGGGGGGCEEEEEEEEC
T ss_pred CCEEEEEEEEeeCCCCCCCCCCCCCEEEEEEecCCCCCcceecccccCCCCCccccEEEEccCCHHHhcCCeEEEEEEEC
Confidence 46789999999 99999999999999999999988778899999999999999999999984333444467799999999
Q ss_pred CCCCC--CCcccccccccccccccC
Q 007035 344 SDTRD--GEVNGALHEGKADAEEHG 366 (621)
Q Consensus 344 d~~~r--~d~iG~v~~~~a~~~~~~ 366 (621)
|.+++ ++++|.+..++.++...+
T Consensus 97 d~~~~~~~~~lG~~~i~l~~l~~~~ 121 (129)
T 2bwq_A 97 ARVREEESEFLGEILIELETALLDD 121 (129)
T ss_dssp -------CEEEEEEEEEGGGCCCSS
T ss_pred CcCcCcCCceeEEEEEEccccCCCc
Confidence 99997 999999998887766544
|
| >2b3r_A Phosphatidylinositol-4-phosphate 3-kinase C2 DOMA containing alpha polypeptide; C2 domain, lipid binding, PI3-kinase, transferase; 2.30A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.61 E-value=3.1e-16 Score=143.75 Aligned_cols=99 Identities=12% Similarity=0.070 Sum_probs=86.0
Q ss_pred CcceEEEEecC-CCccccCcCCCCcceEeecCCCCCCcccceeeccccCCCceeccceeeecccccccccccccccccCC
Q 007035 265 NDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDN 343 (621)
Q Consensus 265 ~~~l~v~l~e~-~L~~~d~~g~sDpyVK~~Llp~~~~~~k~kt~v~k~tlnP~fnE~f~f~~~~~~~~~~k~L~~~V~D~ 343 (621)
.+.|.|.|.+| ||++ |.+|.+|||||++++|+.+...++||+++++|+||+|||+|.|..+...+..+..|.++|||+
T Consensus 19 ~~~L~V~V~~a~~L~~-~~~g~~DPyv~v~l~~~~~~~~~~kT~v~~~t~nP~wnE~f~f~~v~~~~l~~~~L~~~V~d~ 97 (134)
T 2b3r_A 19 NGTLFIMVMHIKDLVT-EDGADPNPYVKTYLLPDTHKTSKRKTKISRKTRNPTFNEMLVYSGYSKETLRQRELQLSVLSA 97 (134)
T ss_dssp TTEEEEEEEEEECCCC-TTSCCCCEEEEEEEESCSSSCCCEECCCCCSCSSCEEEEEEEEESCCHHHHTTCEEEEEEEEC
T ss_pred CCEEEEEEEEeeCCCC-CCCCCCCeEEEEEEEcCCCCCceecCCcCcCCCCCCCccEEEECCcCHHHhCcCEEEEEEEEC
Confidence 57789999999 9997 889999999999999988777889999999999999999999973333344567799999999
Q ss_pred CCCCCCCcccccccccccccc
Q 007035 344 SDTRDGEVNGALHEGKADAEE 364 (621)
Q Consensus 344 d~~~r~d~iG~v~~~~a~~~~ 364 (621)
|++++++++|++..++.++..
T Consensus 98 d~~~~~~~lG~~~i~l~~l~~ 118 (134)
T 2b3r_A 98 ESLRENFFLGGITLPLKDFNL 118 (134)
T ss_dssp CSSSCCEEEEEEEEEGGGSCT
T ss_pred CCCCCCcEEEEEEEEhhhccC
Confidence 999999999999888777654
|
| >3fdw_A Synaptotagmin-like protein 4; structural genomics, phospholipid binding, alternative splicing, cell membrane, cytoplasmic vesicle, membrane; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.59 E-value=3.9e-16 Score=145.14 Aligned_cols=99 Identities=9% Similarity=-0.030 Sum_probs=87.7
Q ss_pred CcceEEEEecC-CCcccc-CcCCCCcceEeecCCCCCCcccceeeccccCCCceeccceeeecccccccc-ccccccccc
Q 007035 265 NDYGYLSSKEA-DLIDLQ-HNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEI 341 (621)
Q Consensus 265 ~~~l~v~l~e~-~L~~~d-~~g~sDpyVK~~Llp~~~~~~k~kt~v~k~tlnP~fnE~f~f~~~~~~~~~-~k~L~~~V~ 341 (621)
.+.|.|.|.+| ||+++| .+|.+||||++++.|+++...++||+++++|+||+|||+|.|. +..... .+.|.++||
T Consensus 22 ~~~L~V~v~~a~~L~~~d~~~~~~dpyv~v~l~~~~~~~~~~kT~v~~~t~nP~wne~f~f~--v~~~~~~~~~L~~~V~ 99 (148)
T 3fdw_A 22 TQSLVVHVKECHQLAYADEAKKRSNPYVKTYLLPDKSRQGKRKTSIKRDTVNPLYDETLRYE--IPESLLAQRTLQFSVW 99 (148)
T ss_dssp TTEEEEEEEEEESCCCSBTTTTBCCEEEEEEEETCCSGGGEEECCCCSSCSSCEEEEEEEEE--CCSTTGGGCEEEEEEE
T ss_pred CCEEEEEEEEecCCCCcccCCCCCCeEEEEEEEcCCcccCccccccCCCCCCCcEeeEEEEE--eChhHhCceEEEEEEE
Confidence 56789999999 999999 6899999999999999887889999999999999999999998 555444 677999999
Q ss_pred CCCCCCCCCccccccccccccccc
Q 007035 342 DNSDTRDGEVNGALHEGKADAEEH 365 (621)
Q Consensus 342 D~d~~~r~d~iG~v~~~~a~~~~~ 365 (621)
|+|++++++++|.+..++..+...
T Consensus 100 d~d~~~~~~~iG~~~i~l~~l~~~ 123 (148)
T 3fdw_A 100 HHGRFGRNTFLGEAEIQMDSWKLD 123 (148)
T ss_dssp EECGGGCEEEEEEEEEEHHHHHHH
T ss_pred ECCCCcCCcEEEEEEEEccccccc
Confidence 999999999999998887766544
|
| >2dmg_A KIAA1228 protein; beta-sandwich, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.58 E-value=9.8e-16 Score=141.17 Aligned_cols=97 Identities=14% Similarity=0.086 Sum_probs=83.9
Q ss_pred CcceEEEEecC-CCccccCcCCCCcceEeecCCCCCCcccceeeccccCCCceeccceeeecccccccc-cccccccccC
Q 007035 265 NDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEID 342 (621)
Q Consensus 265 ~~~l~v~l~e~-~L~~~d~~g~sDpyVK~~Llp~~~~~~k~kt~v~k~tlnP~fnE~f~f~~~~~~~~~-~k~L~~~V~D 342 (621)
...|.|.|.+| ||+++|.+| +||||++++.++.+...++||+++++|+||+|||+|.|. +..... .+.|.++|||
T Consensus 23 ~~~L~v~v~~a~~L~~~d~~g-~dpyv~v~l~~~~~~~~~~kT~v~~~t~nP~wne~f~f~--v~~~~l~~~~L~i~V~d 99 (142)
T 2dmg_A 23 RNKLIVVVHACRNLIAFSEDG-SDPYVRMYLLPDKRRSGRRKTHVSKKTLNPVFDQSFDFS--VSLPEVQRRTLDVAVKN 99 (142)
T ss_dssp TTEEEEEEEEEECCCCSSTTC-CCEEEEEEEESCCCSSSCEECCCCCSCSSCEEEEEEEEC--CCHHHHHHCEEEEEEEE
T ss_pred CCEEEEEEEEeECCCCCCCCC-CCeeEEEEEEcCCCCCCcccCCccCCCCCCCcCceEEEE--ecHHHhCcCEEEEEEEE
Confidence 56788999999 999999999 999999999998887788999999999999999999998 554443 5679999999
Q ss_pred CCCCCC--CCcccccccccccccc
Q 007035 343 NSDTRD--GEVNGALHEGKADAEE 364 (621)
Q Consensus 343 ~d~~~r--~d~iG~v~~~~a~~~~ 364 (621)
+|.+++ ++++|.+..++..+..
T Consensus 100 ~d~~~~~~~~~iG~~~i~l~~~~~ 123 (142)
T 2dmg_A 100 SGGFLSKDKGLLGKVLVALASEEL 123 (142)
T ss_dssp CCCSSCCSCCCCEEEEEECCCSTT
T ss_pred CCCccccCCcEEEEEEEecccccc
Confidence 999874 5799999887766554
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.57 E-value=2.3e-15 Score=161.83 Aligned_cols=139 Identities=19% Similarity=0.176 Sum_probs=96.5
Q ss_pred eEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchh---------------hh--------hHHHHHHHHHHhcccCC
Q 007035 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDF---------------FD--------QSLDEIKLLKLVNKNDP 472 (621)
Q Consensus 416 Y~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~---------------~~--------~~~~Ei~iL~~l~~~~~ 472 (621)
|+|.+.||.|++|.||+|.+ .+|+.||||+++..... .. ....|...+.++....
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d-~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g- 174 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVAD-EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG- 174 (397)
T ss_dssp SEEEEEEEECSSEEEEEEEC-TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred EEecCEeeeCCceEEEEEEC-CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC-
Confidence 99999999999999999997 57999999997642110 00 1134566666665432
Q ss_pred CCCCceEEEeeEeEecCeEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccE
Q 007035 473 ADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENI 552 (621)
Q Consensus 473 ~~hpnIvrl~~~f~~~~~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NI 552 (621)
. .++..++. . ..+|||||++|..+..+ ........++.||+.+|.+||+.|||||||||.||
T Consensus 175 v---~vp~p~~~---~-~~~LVME~i~G~~L~~l-----------~~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NI 236 (397)
T 4gyi_A 175 F---PVPEPIAQ---S-RHTIVMSLVDALPMRQV-----------SSVPDPASLYADLIALILRLAKHGLIHGDFNEFNI 236 (397)
T ss_dssp C---SCCCEEEE---E-TTEEEEECCSCEEGGGC-----------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSE
T ss_pred C---CCCeeeec---c-CceEEEEecCCccHhhh-----------cccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHE
Confidence 1 12222222 1 23799999987432111 11234567889999999999999999999999999
Q ss_pred EEeccCCC--------eEEEEecCCccccC
Q 007035 553 LIKSYQRC--------EIKIIDLGSSCFQT 574 (621)
Q Consensus 553 Ll~~~~~~--------~IKL~DFGls~~~~ 574 (621)
|++.++++ .+.|+||+.+....
T Consensus 237 Ll~~dgd~~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 237 LIREEKDAEDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp EEEEEECSSCTTSEEEEEEECCCTTCEETT
T ss_pred EEeCCCCcccccccccceEEEEeCCcccCC
Confidence 99864322 48999999875433
|
| >1ugk_A Synaptotagmin IV, KIAA1342; beta sandwich, structural genomics, riken structural genomics/proteomics initiative, RSGI, protein binding; NMR {Homo sapiens} SCOP: b.7.1.2 | Back alignment and structure |
|---|
Probab=99.57 E-value=1.3e-15 Score=139.72 Aligned_cols=99 Identities=12% Similarity=0.015 Sum_probs=83.4
Q ss_pred CcceEEEEecC-CCccccCc-CCCCcceEeecCCCCCCcccceeeccccCCCceeccceeeecccccccccccccccccC
Q 007035 265 NDYGYLSSKEA-DLIDLQHN-VVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEID 342 (621)
Q Consensus 265 ~~~l~v~l~e~-~L~~~d~~-g~sDpyVK~~Llp~~~~~~k~kt~v~k~tlnP~fnE~f~f~~~~~~~~~~k~L~~~V~D 342 (621)
...|.|.|.+| ||+++|.. |.+||||++++.++++ .++||+++++|+||+|||+|.|..+...+.....|.++|||
T Consensus 21 ~~~L~v~v~~a~~L~~~d~~~~~~dpyv~v~~~~~~~--~~~kT~v~~~t~nP~wne~f~f~~v~~~~~~~~~l~i~V~d 98 (138)
T 1ugk_A 21 RKAFVVNIKEARGLPAMDEQSMTSDPYIKMTILPEKK--HKVKTRVLRKTLDPAFDETFTFYGIPYTQIQELALHFTILS 98 (138)
T ss_dssp GTEEEEEEEEEESCCCCBTTTTBCEEEEEEEEETTTC--SEEECCCCSSCSSCEEEEEEEEECCCSTTGGGCEEEEEEEE
T ss_pred CCEEEEEEEEeeCCCCCCCCCCCCCCEEEEEEecCCC--ceEecCcCcCCCCCcEeeEEEEcCcCHHHhccCEEEEEEEE
Confidence 45688999999 99999995 9999999999998755 57888888999999999999995333334446779999999
Q ss_pred CCCCCCCCccccccccccccccc
Q 007035 343 NSDTRDGEVNGALHEGKADAEEH 365 (621)
Q Consensus 343 ~d~~~r~d~iG~v~~~~a~~~~~ 365 (621)
+|.+++++++|.+..++.++...
T Consensus 99 ~d~~~~~~~lG~~~i~l~~l~~~ 121 (138)
T 1ugk_A 99 FDRFSRDDIIGEVLIPLSGIELS 121 (138)
T ss_dssp ECSSCCCCCCEEEEEECTTCCCT
T ss_pred CCCCCCCcEEEEEEEehhHccCC
Confidence 99999999999998887766543
|
| >3n5a_A Synaptotagmin-7; calcium/phospholipid binding protein, protein transport; 1.44A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.57 E-value=9e-16 Score=140.14 Aligned_cols=95 Identities=13% Similarity=0.067 Sum_probs=84.4
Q ss_pred CcceEEEEecC-CCccccCcCCCCcceEeecCCCCCCcccceeeccccCCCceeccceeeecccccccc-cccccccccC
Q 007035 265 NDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEID 342 (621)
Q Consensus 265 ~~~l~v~l~e~-~L~~~d~~g~sDpyVK~~Llp~~~~~~k~kt~v~k~tlnP~fnE~f~f~~~~~~~~~-~k~L~~~V~D 342 (621)
.+.|.|.|.+| ||+++|.+|.+||||++++.++.++..++||+++++|+||+|||+|.|. +..... +..|.++|||
T Consensus 15 ~~~L~v~v~~a~~L~~~d~~g~~dpyv~v~~~~~~~~~~~~kT~~~~~t~nP~wne~f~f~--v~~~~l~~~~l~~~V~d 92 (138)
T 3n5a_A 15 ANSIIVNIIKARNLKAMDIGGTSDPYVKVWLMYKDKRVEKKKTVTKKRNLNPIFNESFAFD--IPTEKLRETTIIITVMD 92 (138)
T ss_dssp TTEEEEEEEEEESCCCCBTTTBCCEEEEEEEEETTEEEEEEECCCCSSCSSCEEEEEEEEE--CCGGGGGGEEEEEEEEE
T ss_pred CCeEEEEEEEeeCCCCcCCCCCcCeEEEEEEEeCCCccceEeCccccCCCCCcCcceEEEE--CChhhcCceEEEEEEEE
Confidence 56789999999 9999999999999999999998877788999999999999999999998 554443 6679999999
Q ss_pred CCCCCCCCccccccccccc
Q 007035 343 NSDTRDGEVNGALHEGKAD 361 (621)
Q Consensus 343 ~d~~~r~d~iG~v~~~~a~ 361 (621)
+|.+++++++|.+..++..
T Consensus 93 ~~~~~~~~~lG~~~i~l~~ 111 (138)
T 3n5a_A 93 KDKLSRNDVIGKIYLSWKS 111 (138)
T ss_dssp CCSSSCCEEEEEEEESSSS
T ss_pred CCCCCCCcEEEEEEEcccc
Confidence 9999999999999887653
|
| >1w15_A Synaptotagmin IV; metal binding protein, endocytosis/exocytosis neurotransmitter release, transmembrane; 1.93A {Rattus norvegicus} SCOP: b.7.1.2 PDB: 1w16_A | Back alignment and structure |
|---|
Probab=99.57 E-value=9.1e-16 Score=143.31 Aligned_cols=95 Identities=15% Similarity=0.040 Sum_probs=78.3
Q ss_pred CcceEEEEecC-CCccccCcCCCCcceEeecCCCCCCcccceeeccccCCCceeccceeeecccccccc-cccccccccC
Q 007035 265 NDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEID 342 (621)
Q Consensus 265 ~~~l~v~l~e~-~L~~~d~~g~sDpyVK~~Llp~~~~~~k~kt~v~k~tlnP~fnE~f~f~~~~~~~~~-~k~L~~~V~D 342 (621)
...|.|.|.+| ||+++|.+|.+||||++++.+++++..++||+++++|+||+|||+|.|. +..... +..|.++|||
T Consensus 29 ~~~L~v~v~~a~~L~~~d~~g~~dpyv~v~~~~~~~~~~~~kT~v~~~t~nP~wne~f~f~--v~~~~l~~~~l~v~V~d 106 (153)
T 1w15_A 29 TNTLTVVVLKARHLPKSDVSGLSDPYVKVNLYHAKKRISKKKTHVKKCTPNAVFNELFVFD--IPCESLEEISVEFLVLD 106 (153)
T ss_dssp TTEEEEEEEEEESCC------CCCEEEEEEEEETTEEEEEEECCCCCSCSSEEEEEEEEEE--CCSSSSTTEEEEEEEEE
T ss_pred CCEEEEEEEEeECCCCcCCCCCCCeEEEEEEEeCCeEeceEecCcccCCCCCeecceEEEE--CCHHHhCceEEEEEEEe
Confidence 56788999999 9999999999999999999998776678899999999999999999998 555444 5679999999
Q ss_pred CCCCCCCCccccccccccc
Q 007035 343 NSDTRDGEVNGALHEGKAD 361 (621)
Q Consensus 343 ~d~~~r~d~iG~v~~~~a~ 361 (621)
+|++++++++|.+..++.+
T Consensus 107 ~d~~~~~~~lG~~~i~l~~ 125 (153)
T 1w15_A 107 SERGSRNEVIGRLVLGATA 125 (153)
T ss_dssp CCTTSCCEEEEEEEESTTC
T ss_pred CCCCCCCcEEEEEEECCCC
Confidence 9999999999999887754
|
| >2chd_A Rabphilin-3A, exophilin-1; C2 domain, C2A, calcium binding, synaptic EXOC metal-binding, protein transport, synapse, transport, zinc-; 1.92A {Rattus norvegicus} PDB: 2k3h_A | Back alignment and structure |
|---|
Probab=99.57 E-value=8.1e-16 Score=141.71 Aligned_cols=102 Identities=14% Similarity=0.062 Sum_probs=87.5
Q ss_pred CcceEEEEecC-CCccccCcCCCCcceEeecCCCCCCcccceeeccccCCCceeccceeeecccccccccccccccccCC
Q 007035 265 NDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDN 343 (621)
Q Consensus 265 ~~~l~v~l~e~-~L~~~d~~g~sDpyVK~~Llp~~~~~~k~kt~v~k~tlnP~fnE~f~f~~~~~~~~~~k~L~~~V~D~ 343 (621)
...|.|.|.+| ||+++|.+|.+||||++++.++..+..++||+++++|+||+|||+|.|..+...+.....|.++|||+
T Consensus 28 ~~~L~V~v~~a~~L~~~d~~g~~dpyv~v~~~~~~~~~~~~kT~v~~~t~nP~wne~f~f~~~~~~~~~~~~l~i~V~d~ 107 (142)
T 2chd_A 28 NSNLQCTIIRAKGLKPMDSNGLADPYVKLHLLPGASKSNKLRTKTLRNTRNPVWNETLQYHGITEEDMQRKTLRISVCDE 107 (142)
T ss_dssp GTEEEEEEEEEESCCCCCTTSCCCEEEEEEEESCCSGGGEEECCCCCSCSSCEEEEEEEEESCCHHHHHHCEEEEEEEEE
T ss_pred CCEEEEEEEEecCCCCCCCCCCCCCEEEEEEEcCCCCcceeeCCcCCCCCCCcCcCEEEEcccCHHHccCCEEEEEEEEC
Confidence 56678999999 99999999999999999999988777899999999999999999999974333333356799999999
Q ss_pred CCCCCCCcccccccccccccccC
Q 007035 344 SDTRDGEVNGALHEGKADAEEHG 366 (621)
Q Consensus 344 d~~~r~d~iG~v~~~~a~~~~~~ 366 (621)
|.+++++++|.+..++.++....
T Consensus 108 d~~~~d~~iG~~~i~l~~l~~~~ 130 (142)
T 2chd_A 108 DKFGHNEFIGETRFSLKKLKANQ 130 (142)
T ss_dssp CTTSCEEEEEEEEEEGGGCCTTC
T ss_pred CCCCCCcEEEEEEEEHHHcCCCC
Confidence 99999999999988877665443
|
| >2d8k_A Synaptotagmin VII; exocytosis, calcium binding, lysosome, C2 domain, structural genomics, NPPSFA; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.56 E-value=1.7e-15 Score=139.54 Aligned_cols=99 Identities=12% Similarity=0.025 Sum_probs=83.9
Q ss_pred CcceEEEEecC-CCccccCcCCCCcceEeecCCCCCCcccceeeccccCCCceeccceeeecccccccccccccccccCC
Q 007035 265 NDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDN 343 (621)
Q Consensus 265 ~~~l~v~l~e~-~L~~~d~~g~sDpyVK~~Llp~~~~~~k~kt~v~k~tlnP~fnE~f~f~~~~~~~~~~k~L~~~V~D~ 343 (621)
...|.|.|.+| ||+++|.+|.+||||++++.++++. +.||+++++|+||+|||+|.|......+..+..|.++|||+
T Consensus 25 ~~~L~v~v~~a~~L~~~d~~g~~dpyv~v~~~~~~~~--~~kT~v~~~t~nP~wne~f~f~~~~~~~~~~~~l~i~V~d~ 102 (141)
T 2d8k_A 25 ESTLTVKIMKAQELPAKDFSGTSDPFVKIYLLPDKKH--KLETKVKRKNLNPHWNETFLFEGFPYEKVVQRILYLQVLDY 102 (141)
T ss_dssp SCCEEEEEEEEESCCCCSSSSCCCEEEEEEEESCCSS--EEECCCCTTCSSCCCCEEEEECSCCHHHHTTSEEEEEEEEC
T ss_pred CCEEEEEEEEeECCCCCCCCCCCCcEEEEEEECCCCc--cEeCceEcCCCCCccccEEEECccCHHHcccCEEEEEEEEC
Confidence 56788999999 9999999999999999999987654 67888889999999999999983333333467799999999
Q ss_pred CCCCCCCccccccccccccccc
Q 007035 344 SDTRDGEVNGALHEGKADAEEH 365 (621)
Q Consensus 344 d~~~r~d~iG~v~~~~a~~~~~ 365 (621)
|++++++++|.+..++.++...
T Consensus 103 d~~~~~~~iG~~~i~l~~l~~~ 124 (141)
T 2d8k_A 103 DRFSRNDPIGEVSIPLNKVDLT 124 (141)
T ss_dssp CSSSSCEEEEEEEEETTTSCTT
T ss_pred CCCCCCcEEEEEEEEhhhhcCC
Confidence 9999999999998887766543
|
| >1wfm_A Synaptotagmin XIII; C2 domain, exocytosis, neurotransmitter release, riken structural genomics/proteomics initiative, RSGI, structural genomics; NMR {Homo sapiens} SCOP: b.7.1.2 | Back alignment and structure |
|---|
Probab=99.55 E-value=2.1e-15 Score=138.86 Aligned_cols=94 Identities=18% Similarity=0.139 Sum_probs=80.2
Q ss_pred CcceEEEEecCCCccccCcCCCCcceEeecCCCCCCcccceeeccccCCCceeccceeeecccccccc-cccccccccCC
Q 007035 265 NDYGYLSSKEADLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEIDN 343 (621)
Q Consensus 265 ~~~l~v~l~e~~L~~~d~~g~sDpyVK~~Llp~~~~~~k~kt~v~k~tlnP~fnE~f~f~~~~~~~~~-~k~L~~~V~D~ 343 (621)
...|.|.|.+|- ++|.+|.+|||||++|+|+.+ +.++||+++++|+||+|||+|.|. ++.... .+.|.++|||+
T Consensus 25 ~~~L~V~v~~a~--~~d~~g~sDPyv~v~l~~~~~-~~~~kT~v~~~tlnP~wnE~f~f~--v~~~~l~~~~L~~~V~d~ 99 (138)
T 1wfm_A 25 KAELFVTRLEAV--TSNHDGGCDCYVQGSVANRTG-SVEAQTALKKRQLHTTWEEGLVLP--LAEEELPTATLTLTLRTC 99 (138)
T ss_dssp TTEEEEEEEEEE--CCCCSSCCCEEEEEEEEETTE-EEEEECCCCCCCSSEECSSCEEEE--CCTTSSTTCEEEEEEEEC
T ss_pred CCEEEEEEEEEE--cCCCCCCcceEEEEEEEcCCC-cccEecccCcCCCCCcCCceEEEE--ecHHHcCCCEEEEEEEEC
Confidence 567889999985 478999999999999998543 356789999999999999999998 554444 67799999999
Q ss_pred CCCCCCCccccccccccccc
Q 007035 344 SDTRDGEVNGALHEGKADAE 363 (621)
Q Consensus 344 d~~~r~d~iG~v~~~~a~~~ 363 (621)
|++++++++|++..++.++.
T Consensus 100 d~~~~dd~lG~~~i~l~~l~ 119 (138)
T 1wfm_A 100 DRFSRHSVAGELRLGLDGTS 119 (138)
T ss_dssp CSSCTTSCSEEEEEESSSSS
T ss_pred CCCCCCcEEEEEEEEccccc
Confidence 99999999999998887765
|
| >2enp_A B/K protein; C2 type 1,beta sandwich, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.55 E-value=2.5e-15 Score=139.33 Aligned_cols=97 Identities=14% Similarity=0.124 Sum_probs=81.8
Q ss_pred CcceEEEEecC-CCcc-ccCcC------CCCcceEeecCCCCCCcccceeeccccCCCceeccceeeeccccccc-cccc
Q 007035 265 NDYGYLSSKEA-DLID-LQHNV------VGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKG-AEKD 335 (621)
Q Consensus 265 ~~~l~v~l~e~-~L~~-~d~~g------~sDpyVK~~Llp~~~~~~k~kt~v~k~tlnP~fnE~f~f~~~~~~~~-~~k~ 335 (621)
...|.|.|.+| ||++ ||.+| .+||||++++.|++++ ++||+++++|+||+|||+|.|. +.... .++.
T Consensus 25 ~~~L~V~v~~a~~L~~~~d~~g~~~~~~~~dpyv~v~l~~~~~~--~~kT~v~~~t~nP~wne~f~f~--v~~~~l~~~~ 100 (147)
T 2enp_A 25 HNHLTVRVIEARDLPPPISHDGSRQDMAHSNPYVKICLLPDQKN--SKQTGVKRKTQKPVFEERYTFE--IPFLEAQRRT 100 (147)
T ss_dssp TTEEEEEEEEEECCCCSCSSCCSSCTTCCCCCEEEEEEETCCSS--CEECCCCCSCSSCCCCBCCEEC--CCHHHHHHSE
T ss_pred CCEEEEEEEEEeCCCCccccccccccCCCCCcEEEEEEEeCCCc--ceEeecccCCCCCeEeeeEEEE--eChHHhccCE
Confidence 56788999999 9999 57664 7999999999987653 6788888999999999999998 55443 3567
Q ss_pred ccccccCCCCCCCCCccccccccccccccc
Q 007035 336 LMPAEIDNSDTRDGEVNGALHEGKADAEEH 365 (621)
Q Consensus 336 L~~~V~D~d~~~r~d~iG~v~~~~a~~~~~ 365 (621)
|.++|||+|++++++++|.+..++.++...
T Consensus 101 L~~~V~d~d~~~~~~~iG~~~i~l~~l~~~ 130 (147)
T 2enp_A 101 LLLTVVDFDKFSRHCVIGKVSVPLCEVDLV 130 (147)
T ss_dssp EEEEEECCSTTCCSCCCEEEEEETTTSCTT
T ss_pred EEEEEEECCCCcCCcEEEEEEEechhcCCC
Confidence 999999999999999999998887766543
|
| >2cm5_A Rabphilin-3A; protein transport, zinc-finger, Ca2+ binding, metal-binding, synaptic exocytosis, C2A-C2B linker fragment, C2B, zinc, synapse; 1.28A {Rattus norvegicus} SCOP: b.7.1.2 PDB: 2cm6_A 3rpb_A | Back alignment and structure |
|---|
Probab=99.55 E-value=2.9e-15 Score=142.02 Aligned_cols=96 Identities=16% Similarity=0.108 Sum_probs=82.7
Q ss_pred CcceEEEEecC-CCccccCcCCCCcceEeecCCCCCCcccceeeccccCCCceeccceeeeccccccc-ccccccccccC
Q 007035 265 NDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKG-AEKDLMPAEID 342 (621)
Q Consensus 265 ~~~l~v~l~e~-~L~~~d~~g~sDpyVK~~Llp~~~~~~k~kt~v~k~tlnP~fnE~f~f~~~~~~~~-~~k~L~~~V~D 342 (621)
...|.|.|.+| ||+++|.+|.+||||++++.++..+..++||+++++|+||+|||+|.|. +.... ..+.|.++|||
T Consensus 36 ~~~L~V~v~~a~~L~~~d~~g~~DPyv~v~l~~~~~~~~~~kT~v~~~t~nP~wne~f~f~--v~~~~l~~~~L~i~V~d 113 (166)
T 2cm5_A 36 QGGLIVGIIRCVHLAAMDANGYSDPFVKLWLKPDMGKKAKHKTQIKKKTLNPEFNEEFFYD--IKHSDLAKKSLDISVWD 113 (166)
T ss_dssp TTEEEEEEEEEESCCCCSTTSCCCEEEEEEEETC---CCEEECCCCCSCSSCEEEEEEEEE--CCGGGGGGCEEEEEEEE
T ss_pred CCEEEEEEEEeECCCCccCCCCCCcEEEEEEECCCCccceEeCCcccCCCCCcccceEEEE--cchHhcCCCEEEEEEEE
Confidence 56788999999 9999999999999999999998777788999999999999999999998 55444 36779999999
Q ss_pred CCCCCCCCcccccccccccc
Q 007035 343 NSDTRDGEVNGALHEGKADA 362 (621)
Q Consensus 343 ~d~~~r~d~iG~v~~~~a~~ 362 (621)
+|.+++++++|.+..++...
T Consensus 114 ~d~~~~~~~iG~~~i~l~~~ 133 (166)
T 2cm5_A 114 YDIGKSNDYIGGCQLGISAK 133 (166)
T ss_dssp CCSSSCCEEEEEEEEETTCC
T ss_pred CCCCCCCcEEEeEEEecccC
Confidence 99999999999998876543
|
| >3f04_A Synaptotagmin-1; C2A, calcium, cell junction, cytoplasmic vesicle, glycoprotein, lipoprotein, membrane, metal- binding, palmitate, phosphoprotein; 1.35A {Homo sapiens} SCOP: b.7.1.2 PDB: 3f01_A 3f05_A 3f00_A 1byn_A 2k45_A 2k4a_A 2k8m_A 2ki6_A* | Back alignment and structure |
|---|
Probab=99.54 E-value=3.2e-15 Score=137.83 Aligned_cols=97 Identities=14% Similarity=0.095 Sum_probs=83.8
Q ss_pred CcceEEEEecC-CCccccCcCCCCcceEeecCCCCCCcccceeeccccCCCceeccceeeeccccccc-ccccccccccC
Q 007035 265 NDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKG-AEKDLMPAEID 342 (621)
Q Consensus 265 ~~~l~v~l~e~-~L~~~d~~g~sDpyVK~~Llp~~~~~~k~kt~v~k~tlnP~fnE~f~f~~~~~~~~-~~k~L~~~V~D 342 (621)
...|.|.|.+| ||+++|.+|.+||||++++.+++++ ++||+++++|+||+|||+|.|. +.... .+..|.++|||
T Consensus 33 ~~~L~v~v~~a~~L~~~d~~g~~dpyv~v~l~~~~~~--~~kT~v~~~t~nP~wne~f~f~--v~~~~l~~~~L~i~V~d 108 (143)
T 3f04_A 33 NNQLLVGIIQAAELPALDMGGTSDPYVKVFLLPDKKK--KFETKVHRKTLNPVFNEQFTFK--VPYSELGGKTLVMAVYD 108 (143)
T ss_dssp TTEEEEEEEEEECCCCBGGGBCCCEEEEEEEESCCSC--CEECCCCCSCSSCEEEEEEEEC--CCHHHHTTCEEEEEEEE
T ss_pred CCEEEEEEEEecCCCCCCCCCCcCcEEEEEEECCCCc--cEECccCcCCCCCcCcCeEEEe--ecHhhcCCCEEEEEEEe
Confidence 56788999999 9999999999999999999987764 7888889999999999999998 54433 35779999999
Q ss_pred CCCCCCCCccccccccccccccc
Q 007035 343 NSDTRDGEVNGALHEGKADAEEH 365 (621)
Q Consensus 343 ~d~~~r~d~iG~v~~~~a~~~~~ 365 (621)
+|.+++++++|++..++..+...
T Consensus 109 ~d~~~~~~~iG~~~i~l~~l~~~ 131 (143)
T 3f04_A 109 FDRFSKHDIIGEFKVPMNTVDFG 131 (143)
T ss_dssp CCSSSCCEEEEEEEEEGGGCCTT
T ss_pred CCCCCCCceEEEEEEEHHHccCC
Confidence 99999999999998887766443
|
| >1rh8_A Piccolo protein; beta-sandwich, metal binding protein; NMR {Rattus norvegicus} SCOP: b.7.1.2 | Back alignment and structure |
|---|
Probab=99.54 E-value=1.2e-15 Score=140.34 Aligned_cols=100 Identities=14% Similarity=0.062 Sum_probs=84.4
Q ss_pred CcceEEEEecC-CCccccCcCCCCcceEeecCCCCCC---------cccceeeccccCCCceeccceeeecccccccccc
Q 007035 265 NDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGT---------EKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEK 334 (621)
Q Consensus 265 ~~~l~v~l~e~-~L~~~d~~g~sDpyVK~~Llp~~~~---------~~k~kt~v~k~tlnP~fnE~f~f~~~~~~~~~~k 334 (621)
.+.|.|.|.+| ||+++|.+|.+||||++++.++.+. ..++||+++++|+||+|||+|.|..+...+....
T Consensus 17 ~~~L~V~v~~a~~L~~~d~~g~~Dpyv~v~~~~~~~~~~~~~~~~~~~~~kT~v~~~t~nP~wne~f~f~~v~~~~l~~~ 96 (142)
T 1rh8_A 17 LGNLIIHILQARNLVPRDNNGYSDPFVKVYLLPGRGQVMVVQNASAEYKRRTKYVQKSLNPEWNQTVIYKSISMEQLMKK 96 (142)
T ss_dssp TTEEEEEEEEEESCCCCSSSSCSCCEEEEEETTSSCCCEECCCCCHHHHTTTTTTHHHHSCEEEEEEEECSCCHHHHTTC
T ss_pred CCEEEEEEEEecCCCCCCCCCCCCceEEEEEecCCCcccccccccccceeeccccCCCCCCCCCCEEEECCcCHHHccCC
Confidence 56788999999 9999999999999999999987643 3578899899999999999999963333333466
Q ss_pred cccccccCCCCCCCCCcccccccccccccc
Q 007035 335 DLMPAEIDNSDTRDGEVNGALHEGKADAEE 364 (621)
Q Consensus 335 ~L~~~V~D~d~~~r~d~iG~v~~~~a~~~~ 364 (621)
.|.++|||+|.+++++++|.+..++..+..
T Consensus 97 ~l~i~V~d~d~~~~~~~lG~~~i~l~~l~~ 126 (142)
T 1rh8_A 97 TLEVTVWDYDRFSSNDFLGEVLIDLSSTSH 126 (142)
T ss_dssp EEEEEEEEECSSSCEEEEEEEEEETTSCGG
T ss_pred EEEEEEEECCCCCCCceEEEEEEecccccc
Confidence 799999999999999999999888766544
|
| >2q3x_A Regulating synaptic membrane exocytosis protein 1; C2 domain dimer, neurotransmitter release, transport protein; HET: MSE; 1.73A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.53 E-value=2.2e-15 Score=143.92 Aligned_cols=96 Identities=7% Similarity=-0.115 Sum_probs=82.9
Q ss_pred CcceEEEEecC-CCccccC-cCCCCcceEeecCCCCCCcccceeeccccCCCceeccceeeeccccccccccccccccc-
Q 007035 265 NDYGYLSSKEA-DLIDLQH-NVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEI- 341 (621)
Q Consensus 265 ~~~l~v~l~e~-~L~~~d~-~g~sDpyVK~~Llp~~~~~~k~kt~v~k~tlnP~fnE~f~f~~~~~~~~~~k~L~~~V~- 341 (621)
.+.|.|.|.+| ||+++|. +|.+|||||+++.++.+...++||+++++|+||+|||+|.|. +.. .+..|.++||
T Consensus 29 ~~~L~V~v~~a~~L~~~d~~~g~~DPyv~v~l~~~~~~~~~~kT~v~~~t~nP~wne~f~f~--v~~--~~~~L~~~V~~ 104 (171)
T 2q3x_A 29 KGQLEVEVIRARSLTQKPGSKSTPAPYVKVYLLENGACIAKKKTRIARKTLDPLYQQSLVFD--ESP--QGKVLQVIVWG 104 (171)
T ss_dssp TTEEEEEEEEEESCCCCC---CCCEEEEEEEEEETTEEEEEEECCCCCSCSSCEEEEEEECS--SCC--TTEEEEEEEEE
T ss_pred CCEEEEEEEEeeCCCCCCcCCCCCCceEEEEEECCCccccceeCccCCCCCCCCCCcEEEEE--ecC--CCCEEEEEEEE
Confidence 56788999999 9999996 799999999999998776678899999999999999999998 432 2467999999
Q ss_pred CCCCCCCCCcccccccccccccc
Q 007035 342 DNSDTRDGEVNGALHEGKADAEE 364 (621)
Q Consensus 342 D~d~~~r~d~iG~v~~~~a~~~~ 364 (621)
|+|++++++++|.+..++.++..
T Consensus 105 d~d~~~~d~~iG~~~i~l~~l~~ 127 (171)
T 2q3x_A 105 DYGRMDHKCFMGVAQILLEELDL 127 (171)
T ss_dssp ECSTTCSSEEEEEEEECGGGSCT
T ss_pred cCCCCCCCCEEEEEEEEHHHccc
Confidence 99999999999999988877653
|
| >1tjx_A Similar to synaptotagmini/P65; C2B domain, calcium binding, endocytosis-EX complex; HET: GOL; 1.04A {Rattus norvegicus} SCOP: b.7.1.2 PDB: 1tjm_A* 1uov_A 1uow_A 1k5w_A 2lha_A* | Back alignment and structure |
|---|
Probab=99.53 E-value=3.8e-15 Score=140.06 Aligned_cols=95 Identities=14% Similarity=0.111 Sum_probs=83.7
Q ss_pred CcceEEEEecC-CCccccCcCCCCcceEeecCCCCCCcccceeeccccCCCceeccceeeecccccccc-cccccccccC
Q 007035 265 NDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEID 342 (621)
Q Consensus 265 ~~~l~v~l~e~-~L~~~d~~g~sDpyVK~~Llp~~~~~~k~kt~v~k~tlnP~fnE~f~f~~~~~~~~~-~k~L~~~V~D 342 (621)
.+.|.|.|.+| ||+++|.+|.+||||++++.++.+...+.||+++++|+||+|||+|.|. +..... ...|.++|||
T Consensus 24 ~~~L~V~v~~a~~L~~~d~~g~~dpyv~v~l~~~~~~~~~~kT~v~~~t~nP~wne~f~f~--v~~~~l~~~~l~i~V~d 101 (159)
T 1tjx_A 24 AGKLTVVILEAKNLKKMDVGGLSDPYVKIHLMQNGKRLKKKKTTIKKNTLNPYYNESFSFE--VPFEQIQKVQVVVTVLD 101 (159)
T ss_dssp TTEEEEEEEEEESCCCCSTTSCCCEEEEEEEEETTEEEEEEECCCCCSCSSCEEEEEEEEE--CCGGGGGGCEEEEEEEE
T ss_pred CCEEEEEEEEeeCCCCccCCCCCCeEEEEEEEeCCceeceeeCceecCCCCCcccceEEEE--cCHHHhCCcEEEEEEEE
Confidence 56788999999 9999999999999999999988766678899999999999999999998 554443 5679999999
Q ss_pred CCCCCCCCccccccccccc
Q 007035 343 NSDTRDGEVNGALHEGKAD 361 (621)
Q Consensus 343 ~d~~~r~d~iG~v~~~~a~ 361 (621)
+|.+++++++|.+..++..
T Consensus 102 ~d~~~~~~~iG~~~i~l~~ 120 (159)
T 1tjx_A 102 YDKIGKNDAIGKVFVGYNS 120 (159)
T ss_dssp CCSSSCCEEEEEEEEETTC
T ss_pred CCCCCCCceEEEEEECCCC
Confidence 9999999999999887654
|
| >1rsy_A Synaptotagmin I; calcium/phospholipid binding protein; 1.90A {Rattus norvegicus} SCOP: b.7.1.2 | Back alignment and structure |
|---|
Probab=99.52 E-value=5e-15 Score=138.33 Aligned_cols=96 Identities=16% Similarity=0.112 Sum_probs=83.0
Q ss_pred CcceEEEEecC-CCccccCcCCCCcceEeecCCCCCCcccceeeccccCCCceeccceeeeccccccc-ccccccccccC
Q 007035 265 NDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKG-AEKDLMPAEID 342 (621)
Q Consensus 265 ~~~l~v~l~e~-~L~~~d~~g~sDpyVK~~Llp~~~~~~k~kt~v~k~tlnP~fnE~f~f~~~~~~~~-~~k~L~~~V~D 342 (621)
...|.|.|.+| ||+++|.+|.+||||++++.|+++ .+.||+++++|+||+|||+|.|. +.... .+..|.++|||
T Consensus 41 ~~~L~V~v~~a~~L~~~d~~g~~dpyv~v~~~~~~~--~~~kT~v~~~t~nP~wne~f~f~--v~~~~l~~~~L~i~V~d 116 (152)
T 1rsy_A 41 NNQLLVGIIQAAELPALDMGGTSDPYVKVFLLPDKK--KKFETKVHRKTLNPVFNEQFTFK--VPYSELGGKTLVMAVYD 116 (152)
T ss_dssp TTEEEEEEEEEESCCCCSTTSCCCEEEEEEEETTCC--SCEECCCCTTCSSCEEEEEEEEC--CCHHHHTTCEEEEEEEE
T ss_pred CCEEEEEEEEeECCCCccCCCCcCeEEEEEEEcCCC--ceEeccccCCCCCCcCcccEEEe--ecHHHcCCCEEEEEEEE
Confidence 46788999999 999999999999999999998765 46788888999999999999997 55433 36779999999
Q ss_pred CCCCCCCCcccccccccccccc
Q 007035 343 NSDTRDGEVNGALHEGKADAEE 364 (621)
Q Consensus 343 ~d~~~r~d~iG~v~~~~a~~~~ 364 (621)
+|.+++++++|.+..++..+..
T Consensus 117 ~d~~~~~~~iG~~~i~l~~l~~ 138 (152)
T 1rsy_A 117 FDRFSKHDIIGEFKVPMNTVDF 138 (152)
T ss_dssp CCSSSCCEEEEEEEEEGGGCCC
T ss_pred CCCCCCCcEEEEEEEEchhccC
Confidence 9999999999999888776643
|
| >2fk9_A Protein kinase C, ETA type; ATP-binding, metal-binding, nucleotide-binding, diacylglycerol binding, serine/threonine-protein kinase, transferase; 1.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.48 E-value=9.5e-15 Score=138.12 Aligned_cols=92 Identities=12% Similarity=0.018 Sum_probs=76.3
Q ss_pred cCcceEEEEecC-CCccccCc----------CCCCcceEeecCCCCCCcccceeeccccCCCceeccceeeecccccccc
Q 007035 264 NNDYGYLSSKEA-DLIDLQHN----------VVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA 332 (621)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~----------g~sDpyVK~~Llp~~~~~~k~kt~v~k~tlnP~fnE~f~f~~~~~~~~~ 332 (621)
..++|+|.|.+| ||+++|.+ |.+||||+++|-. +...||+++++|+||+|||+|.|. +..
T Consensus 27 ~~g~L~V~VieA~~L~~~D~~~~~~~f~~~~g~sDPYv~v~l~~----~~~~kT~v~~ktlnP~WNE~F~f~--v~~--- 97 (157)
T 2fk9_A 27 FNGYLRVRIGEAVGLQPTRWSLRHSLFKKGHQLLDPYLTVSVDQ----VRVGQTSTKQKTNKPTYNEEFCAN--VTD--- 97 (157)
T ss_dssp EEEEEEEEEEEEECCCCCHHHHHTTTSSSSCCCCCEEEEEEETT----EEEEECCCCSSCSSCEEEEEEEEE--EEE---
T ss_pred CccEEEEEEEEEECCCCccccccccccccCCCCCCeEEEEEECC----EeeEEeeecCCCCCCccCcEEEEE--cCC---
Confidence 367889999999 99999943 7899999999943 234678888999999999999998 432
Q ss_pred cccccccccCCCCCCCCCcccccccccccccc
Q 007035 333 EKDLMPAEIDNSDTRDGEVNGALHEGKADAEE 364 (621)
Q Consensus 333 ~k~L~~~V~D~d~~~r~d~iG~v~~~~a~~~~ 364 (621)
...|.++|||+|++++++++|.+..++.++..
T Consensus 98 ~~~L~~~V~D~d~~~~dd~iG~~~i~l~~l~~ 129 (157)
T 2fk9_A 98 GGHLELAVFHETPLGYDHFVANCTLQFQELLR 129 (157)
T ss_dssp ECEEEEEEEECCSSSSCEEEEEEEEEHHHHHH
T ss_pred CCEEEEEEEECCCCCCCCEEEEEEEEHHHhhc
Confidence 34699999999999999999999887765544
|
| >1dqv_A Synaptotagmin III; beta sandwich, calcium ION, C2 domain, endocytosis/exocytosis complex; 3.20A {Rattus rattus} SCOP: b.7.1.2 b.7.1.2 PDB: 3hn8_A | Back alignment and structure |
|---|
Probab=99.47 E-value=2.9e-14 Score=147.63 Aligned_cols=96 Identities=17% Similarity=0.079 Sum_probs=85.2
Q ss_pred CcceEEEEecC-CCccccCcCCCCcceEeecCCCCCCcccceeeccccCCCceeccceeeecccccccc-cccccccccC
Q 007035 265 NDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEID 342 (621)
Q Consensus 265 ~~~l~v~l~e~-~L~~~d~~g~sDpyVK~~Llp~~~~~~k~kt~v~k~tlnP~fnE~f~f~~~~~~~~~-~k~L~~~V~D 342 (621)
.+.++|.|.+| ||+++|.+|.+|||||+++.+++++..++||+++++|+||+|||+|.|. +..... +..|.++|||
T Consensus 151 ~~~l~v~v~~a~~L~~~d~~g~~Dpyv~v~l~~~~~~~~~~kT~v~~~t~nP~wne~f~f~--v~~~~l~~~~L~i~V~d 228 (296)
T 1dqv_A 151 AGLLTVTIIKASNLKAMDLTGFSDPYVKASLISEGRRLKKRKTSIKKNTLNPTYNEALVFD--VAPESVENVGLSIAVVD 228 (296)
T ss_dssp TTEEEEEEEEEESCCCCSSSSCCCEEEEECCCTTCCTTSCEECCCCCSCSSCEEEECCCCC--CCSGGGGSCCCCCEEEE
T ss_pred cceeEEEEEEeecCCccCCCCCCCcEEEEEEEeCCcCccceecceecCCCCCeECceEEEE--cCHHHccCcEEEEEEEe
Confidence 56789999999 9999999999999999999998877788999999999999999999998 555544 5679999999
Q ss_pred CCCCCCCCcccccccccccc
Q 007035 343 NSDTRDGEVNGALHEGKADA 362 (621)
Q Consensus 343 ~d~~~r~d~iG~v~~~~a~~ 362 (621)
+|.+++++++|.+..++.+.
T Consensus 229 ~d~~~~~~~iG~~~i~l~~~ 248 (296)
T 1dqv_A 229 YDCIGHNEVIGVCRVGPEAA 248 (296)
T ss_dssp CCSSSCCEEEEECCCSSCTT
T ss_pred CCCCCCCceEEEEEECCccC
Confidence 99999999999998776544
|
| >1rlw_A Phospholipase A2, CALB domain; hydrolase, C2 domain; 2.40A {Homo sapiens} SCOP: b.7.1.1 | Back alignment and structure |
|---|
Probab=99.46 E-value=3.3e-14 Score=127.90 Aligned_cols=93 Identities=13% Similarity=0.015 Sum_probs=77.8
Q ss_pred CcceEEEEecC-CCccc---cCcCCCCcceEeecCCCCCCcccceeeccccCCCceeccceeeecccccccccccccccc
Q 007035 265 NDYGYLSSKEA-DLIDL---QHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAE 340 (621)
Q Consensus 265 ~~~l~v~l~e~-~L~~~---d~~g~sDpyVK~~Llp~~~~~~k~kt~v~k~tlnP~fnE~f~f~~~~~~~~~~k~L~~~V 340 (621)
.+.|.|.|.+| ||++| |..|.+||||++++.+.++ .++||+++++|+||+|||+|.|. +... ....|.++|
T Consensus 2 ~~~L~v~v~~a~~L~~~~~~d~~g~~dpyv~v~~~~~~~--~~~kT~v~~~t~nP~wne~f~f~--v~~~-~~~~l~i~V 76 (126)
T 1rlw_A 2 SHKFTVVVLRATKVTKGAFGDMLDTPDPYVELFISTTPD--SRKRTRHFNNDINPVWNETFEFI--LDPN-QENVLEITL 76 (126)
T ss_dssp CEEEEEEEEEEESCCSCHHHHHHCCCCEEEEEECTTSTT--CCEECCCCTTCSSCEEEEEEEEE--ECTT-SCCEEEEEE
T ss_pred CcEEEEEEEeeeCCCCCCccccCCCCCCEEEEEEccCCC--ceEEccccCCCCCCcccceEEEE--ecCC-CCCEEEEEE
Confidence 46788999999 99995 7789999999999998653 57788888999999999999998 4322 245699999
Q ss_pred cCCCCCCCCCccccccccccccc
Q 007035 341 IDNSDTRDGEVNGALHEGKADAE 363 (621)
Q Consensus 341 ~D~d~~~r~d~iG~v~~~~a~~~ 363 (621)
||+|.++ ++++|.+..++.++.
T Consensus 77 ~d~d~~~-~~~iG~~~i~l~~l~ 98 (126)
T 1rlw_A 77 MDANYVM-DETLGTATFTVSSMK 98 (126)
T ss_dssp EECCSSC-CEEEEEEEEEGGGSC
T ss_pred EECCCCC-CceeEEEEEEHHHcc
Confidence 9999985 889999988776654
|
| >2dmh_A Myoferlin; beta-sandwich, FER-1-like protein 3, muscular dystrophy, cardiomyopathy, membrane fusion, dystrophin, structural genomics, NPPSFA; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.45 E-value=7.3e-14 Score=128.13 Aligned_cols=94 Identities=9% Similarity=-0.073 Sum_probs=78.4
Q ss_pred CcceEEEEecC-CCccccCcCCCCcceEeecCCCCCCcccceeeccccCCCceeccceeeecccccccccccccccccCC
Q 007035 265 NDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDN 343 (621)
Q Consensus 265 ~~~l~v~l~e~-~L~~~d~~g~sDpyVK~~Llp~~~~~~k~kt~v~k~tlnP~fnE~f~f~~~~~~~~~~k~L~~~V~D~ 343 (621)
.+.|.|.|.+| ||+++|. |.+||||++++.. .++||+++++|+||+|||+|.|............|.++|||+
T Consensus 6 ~g~L~v~v~~a~~L~~~~~-g~~dpyv~v~~~~-----~~~kT~v~~~t~nP~wne~f~f~v~~~~~~~~~~l~i~V~d~ 79 (140)
T 2dmh_A 6 SGMLRVIVESASNIPKTKF-GKPDPIVSVIFKD-----EKKKTKKVDNELNPVWNEILEFDLRGIPLDFSSSLGIIVKDF 79 (140)
T ss_dssp CCEEEEEEEEEESCCCCSS-SCCCEEEEEECSS-----CEEECCCCCSCSSCEEEEEEEEECSSCCCCTTCEEEEEEEET
T ss_pred CcEEEEEEEEeeCCCCCCC-CCCCeEEEEEECC-----EeEEeeeecCCCCCccCcEEEEEecccccCCCCEEEEEEEEC
Confidence 45778999999 9999999 9999999999984 358888899999999999999983222222356799999999
Q ss_pred CCCCCCCcccccccccccccc
Q 007035 344 SDTRDGEVNGALHEGKADAEE 364 (621)
Q Consensus 344 d~~~r~d~iG~v~~~~a~~~~ 364 (621)
|.+++++++|.+..++.++..
T Consensus 80 d~~~~~~~lG~~~i~l~~l~~ 100 (140)
T 2dmh_A 80 ETIGQNKLIGTATVALKDLTG 100 (140)
T ss_dssp TCSSSCCCCEEEEEEGGGTCS
T ss_pred CCCCCCceEEEEEEEHHHhcc
Confidence 999999999999887766543
|
| >3pyc_A E3 ubiquitin-protein ligase smurf1; phospholipid binding, membrane associate, lipid binding PROT; 1.96A {Homo sapiens} PDB: 2jqz_A | Back alignment and structure |
|---|
Probab=99.43 E-value=4.8e-14 Score=128.31 Aligned_cols=89 Identities=9% Similarity=-0.010 Sum_probs=75.3
Q ss_pred cceEEEEecC-CCccccCcCCCCcceEeecCCCCCCcccceeeccccCCCceeccceeeecccccccccccccccccCCC
Q 007035 266 DYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDNS 344 (621)
Q Consensus 266 ~~l~v~l~e~-~L~~~d~~g~sDpyVK~~Llp~~~~~~k~kt~v~k~tlnP~fnE~f~f~~~~~~~~~~k~L~~~V~D~d 344 (621)
..|.|.|.+| ||+++|..|.+||||++.+.++. .+.||+++++|+||+|||+|.|. +... ..|.++|||+|
T Consensus 5 ~~L~V~v~~a~~L~~~d~~g~sDpyv~v~~~~~~---~~~kT~v~~~t~nP~wne~f~f~--v~~~---~~l~~~v~d~d 76 (132)
T 3pyc_A 5 IKIRLTVLCAKNLAKKDFFRLPDPFAKIVVDGSG---QCHSTDTVKNTLDPKWNQHYDLY--VGKT---DSITISVWNHK 76 (132)
T ss_dssp EEEEEEEEEEESCCCCSTTCCCCEEEEEEETTTC---CEEECCCCSSCSSCEEEEEEEEE--EETT---CCEEEEEEEGG
T ss_pred EEEEEEEEEeECCCCCCCCCCcCeEEEEEECCCC---ceEECCccCCCCCCCccCEEEEE--eCCC---CEEEEEEEECC
Confidence 4678999999 99999999999999999997652 46788889999999999999997 3322 23999999999
Q ss_pred CCCC---CCcccccccccccc
Q 007035 345 DTRD---GEVNGALHEGKADA 362 (621)
Q Consensus 345 ~~~r---~d~iG~v~~~~a~~ 362 (621)
.+++ ++++|.+..++..+
T Consensus 77 ~~~~~~~d~~lG~~~i~l~~l 97 (132)
T 3pyc_A 77 KIHKKQGAGFLGCVRLLSNAI 97 (132)
T ss_dssp GTTSSTTTTEEEEEEECHHHH
T ss_pred CCCCCCCCCceEEEEEeHHHh
Confidence 9987 69999998876554
|
| >1gmi_A Protein kinase C, epsilon type; PKC, C2 domain, X-RAY, phospholipids, PKC epsilon.; 1.7A {Rattus rattus} SCOP: b.7.1.1 | Back alignment and structure |
|---|
Probab=99.43 E-value=2.9e-14 Score=130.63 Aligned_cols=92 Identities=10% Similarity=0.065 Sum_probs=75.5
Q ss_pred CcceEEEEecC-CCccccCcCC-----------CCcceEeecCCCCCCcccceeeccccCCCceeccceeeecccccccc
Q 007035 265 NDYGYLSSKEA-DLIDLQHNVV-----------GDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA 332 (621)
Q Consensus 265 ~~~l~v~l~e~-~L~~~d~~g~-----------sDpyVK~~Llp~~~~~~k~kt~v~k~tlnP~fnE~f~f~~~~~~~~~ 332 (621)
.+.|.|.|.+| ||+++|..|. +||||++++.. +...+|+++++|+||+|||+|.|. +...
T Consensus 5 ~g~L~v~v~~a~~L~~~d~~~~~~~g~~~~~~~~DPyv~v~l~~----~~~~~T~~~~~t~nP~WnE~f~f~--v~~~-- 76 (136)
T 1gmi_A 5 NGLLKIKICEAVSLKPTAWSLRDAVGPRPQTFLLDPYIALNVDD----SRIGQTATKQKTNSPAWHDEFVTD--VCNG-- 76 (136)
T ss_dssp EEEEEEEEEEEESCCCCHHHHCC-CCSSCCCCCCCEEEEEEETT----EEEEECCCCSSCSSCEEEEEEEEE--EEEE--
T ss_pred ceEEEEEEEeCcCCCCcccccccccccccCCcCcCcEEEEEECC----eEeeeeeEECCCcCCccCCEEEEE--ecCC--
Confidence 35778999999 9999997654 99999999842 234577778999999999999998 4332
Q ss_pred cccccccccCCCCCCCCCccccccccccccccc
Q 007035 333 EKDLMPAEIDNSDTRDGEVNGALHEGKADAEEH 365 (621)
Q Consensus 333 ~k~L~~~V~D~d~~~r~d~iG~v~~~~a~~~~~ 365 (621)
+.|.++|||+|.+++++++|.+..++.++...
T Consensus 77 -~~L~~~V~d~d~~~~dd~iG~~~i~l~~l~~~ 108 (136)
T 1gmi_A 77 -RKIELAVFHDAPIGYDDFVANCTIQFEELLQN 108 (136)
T ss_dssp -CEEEEEEEECCSSSSCEEEEEEEEEHHHHTST
T ss_pred -CEEEEEEEeCCCCCCCCEEEEEEEEHHHhccc
Confidence 66999999999999999999998877665543
|
| >3b7y_A E3 ubiquitin-protein ligase NEDD4; C2 domain, UBL-conjugation pathway, structural genomics consortium, SGC, cytoplasm; 1.80A {Homo sapiens} PDB: 2nsq_A | Back alignment and structure |
|---|
Probab=99.42 E-value=6.7e-14 Score=130.45 Aligned_cols=98 Identities=11% Similarity=0.029 Sum_probs=75.6
Q ss_pred CcceEEEEecC-CCccccCcCCCCcceEeecCCCCC-CcccceeeccccCCCceeccceeeecccccccccccccccccC
Q 007035 265 NDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPG-TEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEID 342 (621)
Q Consensus 265 ~~~l~v~l~e~-~L~~~d~~g~sDpyVK~~Llp~~~-~~~k~kt~v~k~tlnP~fnE~f~f~~~~~~~~~~k~L~~~V~D 342 (621)
...|.|.|.+| ||+++|..|.+||||++.+.+... ...++||+++++|+||+|||+|.|. +.. .+..|.++|||
T Consensus 19 ~~~L~V~v~~a~~L~~~d~~g~~dpyv~v~~~~~~~~~~~~~kT~v~~~t~nP~wne~f~f~--v~~--~~~~l~~~V~d 94 (153)
T 3b7y_A 19 SRIVRVRVIAGIGLAKKDILGASDPYVRVTLYDPMNGVLTSVQTKTIKKSLNPKWNEEILFR--VHP--QQHRLLFEVFD 94 (153)
T ss_dssp CEEEEEEEEEEESCC-------CCEEEEEEEEETTTEEEEEEECCCCSSCSSCCCCEEEEEE--ECT--TTCEEEEEEEE
T ss_pred ccEEEEEEEEeeCCCCCCCCCCCCcEEEEEEECCCCccceeeeCccccCCCCCCCCCEEEEE--ecC--CCCEEEEEEEE
Confidence 56778999999 999999999999999999986443 2457788889999999999999998 433 24569999999
Q ss_pred CCCCCCCCcccccccccccccccC
Q 007035 343 NSDTRDGEVNGALHEGKADAEEHG 366 (621)
Q Consensus 343 ~d~~~r~d~iG~v~~~~a~~~~~~ 366 (621)
+|.+++++++|.+..++.++....
T Consensus 95 ~d~~~~d~~iG~~~i~l~~l~~~~ 118 (153)
T 3b7y_A 95 ENRLTRDDFLGQVDVPLYPLPTEN 118 (153)
T ss_dssp CCSSSCCEEEEEEEEECCSCCBCC
T ss_pred CCCCcCCCeeEEEEEEHHHcccCC
Confidence 999999999999988877665543
|
| >2ep6_A MCTP2 protein; beta sandwich, Ca2+ binding, membrane binding, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: b.7.1.1 | Back alignment and structure |
|---|
Probab=99.41 E-value=8.9e-14 Score=126.66 Aligned_cols=91 Identities=11% Similarity=0.060 Sum_probs=78.8
Q ss_pred cCcceEEEEecC-CCccccCcCCCCcceEeecCCCCCCcccceeeccccCCCceeccceeeecccccccccccccccccC
Q 007035 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEID 342 (621)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyVK~~Llp~~~~~~k~kt~v~k~tlnP~fnE~f~f~~~~~~~~~~k~L~~~V~D 342 (621)
+.+.|.|.|.+| ||+++|..|.+||||++.+.+. +.||+++++|+||+|||+|.|. +.. .+..|.++|||
T Consensus 11 ~~~~L~v~v~~a~~L~~~d~~g~~dpyv~v~~~~~-----~~kT~~~~~t~nP~wne~f~f~--~~~--~~~~l~i~V~d 81 (133)
T 2ep6_A 11 DVGILQVKVLKAADLLAADFSGKSDPFCLLELGND-----RLQTHTVYKNLNPEWNKVFTFP--IKD--IHDVLEVTVFD 81 (133)
T ss_dssp CSEEEEEEEEEEESCCCSSSSSCCCEEEEEEETTE-----EEECCCCSSCSSCCCCEEEEEE--ESC--TTCEEEEEEEE
T ss_pred CceEEEEEEEeeECCCCCCCCCCcCeEEEEEECCE-----EEEeeeecCCCCCccccEEEEE--ecC--CCCEEEEEEEE
Confidence 467889999999 9999999999999999999752 5688888999999999999998 432 34569999999
Q ss_pred CCCCCCCCccccccccccccc
Q 007035 343 NSDTRDGEVNGALHEGKADAE 363 (621)
Q Consensus 343 ~d~~~r~d~iG~v~~~~a~~~ 363 (621)
+|.+++++++|.+..++.++.
T Consensus 82 ~d~~~~~~~lG~~~i~l~~l~ 102 (133)
T 2ep6_A 82 EDGDKPPDFLGKVAIPLLSIR 102 (133)
T ss_dssp EETTEEEEECCBCEEEGGGCC
T ss_pred CCCCCCCCeeEEEEEEHHHcc
Confidence 999999999999988776653
|
| >3m7f_B E3 ubiquitin-protein ligase NEDD4; C2 domain, GRB10, SH2 domain, phosphoprotein, conjugation pathway, signaling protein-ligase complex; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.41 E-value=8.4e-14 Score=133.27 Aligned_cols=97 Identities=9% Similarity=-0.013 Sum_probs=75.4
Q ss_pred CcceEEEEecC-CCccccCcCCCCcceEeecCCCCCC-cccceeeccccCCCceeccceeeecccccccccccccccccC
Q 007035 265 NDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGT-EKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEID 342 (621)
Q Consensus 265 ~~~l~v~l~e~-~L~~~d~~g~sDpyVK~~Llp~~~~-~~k~kt~v~k~tlnP~fnE~f~f~~~~~~~~~~k~L~~~V~D 342 (621)
.+.|.|.|.+| ||+++|..|.+||||++.+...+.+ ..+.||+++++++||+|||+|.|. +.. ....|.++|||
T Consensus 7 ~g~L~V~v~~a~~L~~~d~~g~~DPyv~v~l~~~~~~~~~~~kT~v~~~t~nP~Wne~f~f~--v~~--~~~~L~~~V~d 82 (176)
T 3m7f_B 7 TRVVRVKVIAGIGLAKKDILGASDPYVRVTLYDPMSGILTSVQTKTIKKSLNPKWNEEILFR--VLP--QRHRILFEVFD 82 (176)
T ss_dssp CEEEEEEEEEEESCC---CCCCCCEEEEEEEEETTTEEEEEEECCCCSSCSSCEEEEEEEEE--ECT--TTCEEEEEEEE
T ss_pred cEEEEEEEEEeeCCCCcCCCCCcCcEEEEEEECCCCCcccceeCceECCCCCCcccceEEEE--EcC--CCCEEEEEEEE
Confidence 56789999999 9999999999999999999964433 257889999999999999999998 432 23569999999
Q ss_pred CCCCCCCCccccccccccccccc
Q 007035 343 NSDTRDGEVNGALHEGKADAEEH 365 (621)
Q Consensus 343 ~d~~~r~d~iG~v~~~~a~~~~~ 365 (621)
+|.+++++++|.+..++..+...
T Consensus 83 ~d~~~~d~~lG~~~i~l~~l~~~ 105 (176)
T 3m7f_B 83 ENRLTRDDFLGQVDVPLYPLPTE 105 (176)
T ss_dssp CC----CEEEEEEEEESCSCCBC
T ss_pred CCCCCCCcEEEEEEEEHHHcccc
Confidence 99999999999998887666554
|
| >2r83_A Synaptotagmin-1; C2A-C2B, exocytosis, calcium, cell junction, cytoplasmic vesicle, glycoprotein, lipoprotein, membrane, metal-binding palmitate; 2.70A {Homo sapiens} SCOP: b.7.1.2 | Back alignment and structure |
|---|
Probab=99.41 E-value=8.8e-14 Score=142.48 Aligned_cols=95 Identities=14% Similarity=0.111 Sum_probs=83.8
Q ss_pred CcceEEEEecC-CCccccCcCCCCcceEeecCCCCCCcccceeeccccCCCceeccceeeecccccccc-cccccccccC
Q 007035 265 NDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEID 342 (621)
Q Consensus 265 ~~~l~v~l~e~-~L~~~d~~g~sDpyVK~~Llp~~~~~~k~kt~v~k~tlnP~fnE~f~f~~~~~~~~~-~k~L~~~V~D 342 (621)
...++|.|.+| ||+++|.+|.+|||||+++.+++++..++||+++++|+||+|||+|.|. ++.+.. +..|.++|||
T Consensus 149 ~~~l~v~v~~a~~L~~~d~~~~~dpyv~v~~~~~~~~~~~~kT~v~~~t~nP~wne~f~f~--v~~~~l~~~~l~i~V~d 226 (284)
T 2r83_A 149 AGKLTVVILEAKNLKKMDVGGLSDPYVKIHLMQNGKRLKKKKTTIKKNTLNPYYNESFSFE--VPFEQIQKVQVVVTVLD 226 (284)
T ss_dssp TTEEEEEEEEEESCCCCSTTSCCCEEEEEEEEETTEEEEEEECCCCCSCSSCEEEEEEEEE--CCTTTGGGEEEEEEEEE
T ss_pred CCceEEEEEEeECCCCcCCCCCcCeEEEEEEEeCCcEeeeeccceecCCCCCEEceeEEEe--CCHHHhCceEEEEEEEe
Confidence 46788999999 9999999999999999999998776678999999999999999999998 554444 5679999999
Q ss_pred CCCCCCCCccccccccccc
Q 007035 343 NSDTRDGEVNGALHEGKAD 361 (621)
Q Consensus 343 ~d~~~r~d~iG~v~~~~a~ 361 (621)
+|.+++++++|.+..++..
T Consensus 227 ~d~~~~~~~iG~~~i~l~~ 245 (284)
T 2r83_A 227 YDKIGKNDAIGKVFVGYNS 245 (284)
T ss_dssp CCSSSCCCEEEEEEEETTC
T ss_pred CCCCCCCcEEEEEEECCCC
Confidence 9999999999999877643
|
| >1wfj_A Putative elicitor-responsive gene; C2 domain, riken structural genomics/proteomics initiative, RSGI, structural genomics, plant protein; NMR {Arabidopsis thaliana} SCOP: b.7.1.2 | Back alignment and structure |
|---|
Probab=99.40 E-value=1.6e-13 Score=125.22 Aligned_cols=90 Identities=12% Similarity=0.065 Sum_probs=77.5
Q ss_pred cCcceEEEEecC-CCccccCcCCCCcceEeecCCCCCCcccceeeccc-cCCCceeccceeeeccccccccccccccccc
Q 007035 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSK-RGSSIDWIEGFKGSSDLHFKGAEKDLMPAEI 341 (621)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyVK~~Llp~~~~~~k~kt~v~k-~tlnP~fnE~f~f~~~~~~~~~~k~L~~~V~ 341 (621)
+.+.|.|.|.+| ||+++|..|.+||||++.+.+. +.||++++ +|+||+|||+|.|. +.. ....|.++||
T Consensus 8 ~~~~L~v~v~~a~~L~~~d~~g~~dpyv~v~~~~~-----~~kT~~~~~~~~nP~Wne~f~f~--v~~--~~~~l~~~V~ 78 (136)
T 1wfj_A 8 PHGTLEVVLVSAKGLEDADFLNNMDPYVQLTCRTQ-----DQKSNVAEGMGTTPEWNETFIFT--VSE--GTTELKAKIF 78 (136)
T ss_dssp CEEEEEEEEEEEEECSSCCSSCSSCCCEEEESSSC-----EEECCCCTTCCSSCEEEEEEEEE--EES--SCCEEEEEEC
T ss_pred CcEEEEEEEEeccCCCCcccCCCcCceEEEEECCc-----cceeEeccCCCCCCccCcEEEEE--ECC--CCCEEEEEEE
Confidence 356788999999 9999999999999999999864 46788877 99999999999998 443 4566999999
Q ss_pred CCCCCCCCCcccccccccccc
Q 007035 342 DNSDTRDGEVNGALHEGKADA 362 (621)
Q Consensus 342 D~d~~~r~d~iG~v~~~~a~~ 362 (621)
|+|.+++++++|.+..++.++
T Consensus 79 d~~~~~~d~~lG~~~i~l~~l 99 (136)
T 1wfj_A 79 DKDVGTEDDAVGEATIPLEPV 99 (136)
T ss_dssp CSSSCTTTCCSEEEEEESHHH
T ss_pred ECCCCCCCceEEEEEEEHHHh
Confidence 999999999999998876655
|
| >1dqv_A Synaptotagmin III; beta sandwich, calcium ION, C2 domain, endocytosis/exocytosis complex; 3.20A {Rattus rattus} SCOP: b.7.1.2 b.7.1.2 PDB: 3hn8_A | Back alignment and structure |
|---|
Probab=99.39 E-value=2.6e-13 Score=140.39 Aligned_cols=90 Identities=17% Similarity=0.089 Sum_probs=78.8
Q ss_pred CcceEEEEecC-CCccccCcCCCCcceEeecCCCCCCcccceeeccccCCCceeccceeeeccccccc-ccccccccccC
Q 007035 265 NDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKG-AEKDLMPAEID 342 (621)
Q Consensus 265 ~~~l~v~l~e~-~L~~~d~~g~sDpyVK~~Llp~~~~~~k~kt~v~k~tlnP~fnE~f~f~~~~~~~~-~~k~L~~~V~D 342 (621)
.+.|.|.|.+| ||+++|.+|.+||||+++++|+++. +.||+++++|+||+|||+|.|. +..+. ..+.|.++|||
T Consensus 19 ~~~L~v~v~~a~~L~~~d~~g~~dPyv~v~l~~~~~~--~~kT~v~~~t~nP~wne~f~f~--v~~~~l~~~~L~~~V~d 94 (296)
T 1dqv_A 19 SDQLVVRILQALDLPAKDSNGFSDPYVKIYLLPDRKK--KFQTKVHRKTLNPIFNETFQFS--VPLAELAQRKLHFSVYD 94 (296)
T ss_dssp SCEEEEEEEEEECCCCCSTTSCCCEEEEEECTTSTTS--CEECCCCCSCSSCEEEEEEEEE--CCGGGGSSCCCEEEEEE
T ss_pred CCEEEEEEEEeECCCCcCCCCCcCeEEEEEEEcCCCe--eEeCCccCCCCCCcEeeEEEEE--ecHHHhcCCEEEEEEEE
Confidence 56788999999 9999999999999999999987654 6688888999999999999998 55443 35679999999
Q ss_pred CCCCCCCCcccccccc
Q 007035 343 NSDTRDGEVNGALHEG 358 (621)
Q Consensus 343 ~d~~~r~d~iG~v~~~ 358 (621)
+|++++++++|++..+
T Consensus 95 ~d~~~~~~~iG~~~i~ 110 (296)
T 1dqv_A 95 FDRFSRHDLIGQVVLD 110 (296)
T ss_dssp CCSSSCCCEEEEEECC
T ss_pred cCCCCCCceEEEEEec
Confidence 9999999999999763
|
| >2r83_A Synaptotagmin-1; C2A-C2B, exocytosis, calcium, cell junction, cytoplasmic vesicle, glycoprotein, lipoprotein, membrane, metal-binding palmitate; 2.70A {Homo sapiens} SCOP: b.7.1.2 | Back alignment and structure |
|---|
Probab=99.37 E-value=4.2e-13 Score=137.42 Aligned_cols=96 Identities=16% Similarity=0.108 Sum_probs=83.4
Q ss_pred CcceEEEEecC-CCccccCcCCCCcceEeecCCCCCCcccceeeccccCCCceeccceeeeccccccc-ccccccccccC
Q 007035 265 NDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKG-AEKDLMPAEID 342 (621)
Q Consensus 265 ~~~l~v~l~e~-~L~~~d~~g~sDpyVK~~Llp~~~~~~k~kt~v~k~tlnP~fnE~f~f~~~~~~~~-~~k~L~~~V~D 342 (621)
.+.|.|.|.+| ||+++|.+|.+||||++++.+++++ +.||+++++|+||+|||+|.|. +..+. ....|.++|||
T Consensus 18 ~~~L~v~v~~a~~L~~~d~~~~~dpyv~v~~~~~~~~--~~~T~~~~~~~nP~wne~f~f~--v~~~~~~~~~l~~~V~d 93 (284)
T 2r83_A 18 NNQLLVGIIQAAELPALDMGGTSDPYVKVFLLPDKKK--KFETKVHRKTLNPVFNEQFTFK--VPYSELAGKTLVMAVYD 93 (284)
T ss_dssp TTEEEEEEEEEECCCCCSSSSSCCEEEEEEEETCTTS--CEECCCCCSCSSCEEEEEEEEC--CCGGGCTTCEEEEEEEE
T ss_pred CCEEEEEEEEeeCCCCCCCCCCCCeEEEEEEEcCCCc--eEeCCcccCCCCCeeCceEEEE--echHHhCcCEEEEEEEE
Confidence 56788999999 9999999999999999999987654 6778888999999999999998 55444 36779999999
Q ss_pred CCCCCCCCcccccccccccccc
Q 007035 343 NSDTRDGEVNGALHEGKADAEE 364 (621)
Q Consensus 343 ~d~~~r~d~iG~v~~~~a~~~~ 364 (621)
+|++++++++|++..++..+..
T Consensus 94 ~d~~~~~~~lG~~~i~l~~l~~ 115 (284)
T 2r83_A 94 FDRFSKHDIIGEFKVPMNTVDF 115 (284)
T ss_dssp CCSSSCCCEEEEEEEEGGGCCC
T ss_pred CCCCCCCceeEEEEEcchhccc
Confidence 9999999999999888776654
|
| >3nsj_A Perforin-1; pore forming protein, immune system; HET: NAG; 2.75A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.36 E-value=3.2e-13 Score=150.77 Aligned_cols=100 Identities=12% Similarity=0.087 Sum_probs=80.9
Q ss_pred Cccc-cCCCCc---c--c----CcceEEEEecC-CCccccCcCCCCcceEeecCCCCCCcccceeeccccCCCceeccce
Q 007035 253 LCKC-CAGEGK---I--N----NDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGF 321 (621)
Q Consensus 253 ~c~~-~~g~~~---~--s----~~~l~v~l~e~-~L~~~d~~g~sDpyVK~~Llp~~~~~~k~kt~v~k~tlnP~fnE~f 321 (621)
+|.| |...-. + + ..+|+|.|.+| ||++ |..|.+|||||+++.. .+.||+++++++||+|||+|
T Consensus 371 ~C~C~C~~~~~t~~~~C~~~~~~~~L~V~V~~A~~L~~-D~~g~sDPYV~v~l~~-----~~~kTkvik~tlNP~Wne~f 444 (540)
T 3nsj_A 371 SCQCECQDSKVTNQDCCPRQRGLAHLVVSNFRAEHLWG-DYTTATDAYLKVFFGG-----QEFRTGVVWNNNNPRWTDKM 444 (540)
T ss_dssp TTCEEESCTTTBCGGGCBSSTTEEEEEEEEEEEESCCC-SSCSCCCEEEEEEETT-----EEEECCCBCSCSSCBCCCCE
T ss_pred ceEeeCCCCCCcccccccccCcccEEEEEEEEccCCCc-ccCCCcCeEEEEEECC-----EeeeeeeecCCCCCCCCeEE
Confidence 5788 775422 1 1 45678999999 9999 9999999999999962 35899999999999999999
Q ss_pred eeecccccccccccccccccCCCCCCCCCcccccccccc
Q 007035 322 KGSSDLHFKGAEKDLMPAEIDNSDTRDGEVNGALHEGKA 360 (621)
Q Consensus 322 ~f~~~~~~~~~~k~L~~~V~D~d~~~r~d~iG~v~~~~a 360 (621)
.|. +......+.|.++|||+|.++++|++|.+..++.
T Consensus 445 ~f~--~~~~~~~~~L~~~V~D~D~~~~dD~LG~~~~~L~ 481 (540)
T 3nsj_A 445 DFE--NVLLSTGGPLRVQVWDADYGWDDDLLGSCDRSPH 481 (540)
T ss_dssp EEE--EEETTTCCCEEEEEEECCSSSCCEEEEEEEECCC
T ss_pred EEE--EecCCCCCEEEEEEEECCCCCCCCEEEEEEEEee
Confidence 987 2221235669999999999999999999977654
|
| >3kwu_A MUNC13-1; calcium binding protein, phospholipid binding protein, metal binding protein; HET: GOL; 1.37A {Rattus norvegicus} SCOP: b.7.1.0 PDB: 3kwt_A* | Back alignment and structure |
|---|
Probab=99.36 E-value=4.5e-13 Score=124.09 Aligned_cols=89 Identities=11% Similarity=0.063 Sum_probs=76.2
Q ss_pred CcceEEEEecC-CCccccCcCCCCcceEeecCCCCCCcccceeeccccCCCceeccceeeecccccccccccccccccCC
Q 007035 265 NDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDN 343 (621)
Q Consensus 265 ~~~l~v~l~e~-~L~~~d~~g~sDpyVK~~Llp~~~~~~k~kt~v~k~tlnP~fnE~f~f~~~~~~~~~~k~L~~~V~D~ 343 (621)
.+.|.|.|.+| ||+++|.+|.+||||++++. ..+.+|+++++|+||.|||+|.|.. ... ...|.++|||+
T Consensus 16 ~~~L~V~v~~a~~L~~~d~~g~~dpyv~v~~~-----~~~~kT~~~~~t~nP~Wne~f~f~v--~~~--~~~l~~~v~d~ 86 (148)
T 3kwu_A 16 SAKISITVVCAQGLQAKDKTGSSDPYVTVQVG-----KTKKRTKTIYGNLNPVWEENFHFEC--HNS--SDRIKVRVLDE 86 (148)
T ss_dssp CEEEEEEEEEEESCCCCSTTSCCCEEEEEEET-----TEEEECCCCCSCSSCEEEEEEEEEE--CST--TCEEEEEEEEC
T ss_pred ccEEEEEEEeeeCCCCCCCCCCcCeEEEEEEC-----CEEEECCccCCCCCCCcccEEEEEe--cCC--CCEEEEEEEEC
Confidence 56788999999 99999999999999999993 2467888899999999999999983 322 35699999999
Q ss_pred CCC-----------CCCCcccccccccccc
Q 007035 344 SDT-----------RDGEVNGALHEGKADA 362 (621)
Q Consensus 344 d~~-----------~r~d~iG~v~~~~a~~ 362 (621)
|.+ ++++++|.+..++..+
T Consensus 87 d~~~~~~~~~~~~~~~~~~lG~~~i~l~~l 116 (148)
T 3kwu_A 87 DDDIKSRVKQRFKRESDDFLGQTIIEVRTL 116 (148)
T ss_dssp CCSHHHHHHTTTSSCSSEEEEEEEEEGGGC
T ss_pred CCCccccccccccCCCCccEEEEEEEHHHC
Confidence 987 7899999998877665
|
| >2nq3_A Itchy homolog E3 ubiquitin protein ligase; C2 domain, UBL conjugation pathway, structural genomics consortium, SGC; 1.80A {Homo sapiens} SCOP: b.7.1.1 | Back alignment and structure |
|---|
Probab=99.32 E-value=6e-13 Score=127.59 Aligned_cols=89 Identities=7% Similarity=-0.039 Sum_probs=73.3
Q ss_pred CcceEEEEecC-CCc-cccCcCCCCcceEeecCCCCCCcccceeeccccCCCceeccceeeecccccccccccccccccC
Q 007035 265 NDYGYLSSKEA-DLI-DLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEID 342 (621)
Q Consensus 265 ~~~l~v~l~e~-~L~-~~d~~g~sDpyVK~~Llp~~~~~~k~kt~v~k~tlnP~fnE~f~f~~~~~~~~~~k~L~~~V~D 342 (621)
...|.|.|.+| +|+ +++..+ +||||++++.. .+.||+++++|+||+|||+|.|. +. ....|.++|||
T Consensus 35 ~~~L~V~V~~A~~L~~~~~~~~-sDPYv~v~~~~-----~~~kT~v~~~tlnP~Wne~f~f~--v~---~~~~L~~~V~D 103 (173)
T 2nq3_A 35 KSQLQITVISAKLKENKKNWFG-PSPYVEVTVDG-----QSKKTEKCNNTNSPKWKQPLTVI--VT---PVSKLHFRVWS 103 (173)
T ss_dssp CEEEEEEEEEEEECCCC--CCC-CCEEEEEEETT-----EEEECCCCSSCSSCEEEEEEEEE--EC---TTCEEEEEEEE
T ss_pred ceEEEEEEEEeECCCCcccCCC-CCeEEEEEECC-----EEeEccccCCCCCCeECCEEEEE--eC---CCCEEEEEEEE
Confidence 55678999999 999 666655 99999999964 57788899999999999999997 43 26669999999
Q ss_pred CCCCCCCCcccccccccccccc
Q 007035 343 NSDTRDGEVNGALHEGKADAEE 364 (621)
Q Consensus 343 ~d~~~r~d~iG~v~~~~a~~~~ 364 (621)
+|.+++++++|.+..++.++..
T Consensus 104 ~d~~~~dd~lG~~~i~l~~l~~ 125 (173)
T 2nq3_A 104 HQTLKSDVLLGTAALDIYETLK 125 (173)
T ss_dssp CCSSSCCEEEEEEEEEHHHHHH
T ss_pred CCCCCCCceEEEEEEEHHHhcc
Confidence 9999999999999887655443
|
| >2cjt_A UNC-13 homolog A, MUNC13-1; phorbol-ester binding, neurotransmitter release, RIM, MUNC13 domains, exocytosis, metal-binding; 1.44A {Rattus norvegicus} SCOP: b.7.1.1 | Back alignment and structure |
|---|
Probab=99.26 E-value=2.2e-12 Score=117.94 Aligned_cols=88 Identities=10% Similarity=0.006 Sum_probs=68.8
Q ss_pred cCcceEEEEecC-CCccccCcCCCCcceEeecCCCCCCcccceeec-cccCCCceeccceeeeccccccccccccccccc
Q 007035 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSS-SKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEI 341 (621)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyVK~~Llp~~~~~~k~kt~v-~k~tlnP~fnE~f~f~~~~~~~~~~k~L~~~V~ 341 (621)
+...|+|.|++| +|++ +|.+||||++. . .+.||++ +++|+||+|||+|.|. +.. .+..|.++||
T Consensus 3 ~~~~L~V~V~~A~~l~~---~g~~DPYv~v~-~------~~~kt~~~~~~t~nP~WnE~f~f~--v~~--~~~~L~~~V~ 68 (131)
T 2cjt_A 3 VMSLLCVGVKKAKFDGA---QEKFNTYVTLK-V------QNVKSTTIAVRGSQPSWEQDFMFE--INR--LDLGLTVEVW 68 (131)
T ss_dssp CCEEEEEEEEEEECSSC---GGGCEEEEEEE-E------TTEEEECCCEESSSCEEEEEEEEE--ECC--CSSEEEEEEE
T ss_pred cceEEEEEEEEeECCCC---CCCcCeEEEEE-e------cCEEEeEecCCCCCceECCEEEEE--EeC--CCCeEEEEEE
Confidence 346789999999 7753 78999999999 1 1234444 4589999999999998 442 3445999999
Q ss_pred CCCCCCCCCcccccccccccccccC
Q 007035 342 DNSDTRDGEVNGALHEGKADAEEHG 366 (621)
Q Consensus 342 D~d~~~r~d~iG~v~~~~a~~~~~~ 366 (621)
|+| +++++++|.+..++.++....
T Consensus 69 D~d-~~~dd~iG~~~i~l~~l~~~~ 92 (131)
T 2cjt_A 69 NKG-LIWDTMVGTVWIPLRTIRQSN 92 (131)
T ss_dssp ECC-SSCEEEEEEEEEEGGGSCBCS
T ss_pred ECC-CCCCCeEEEEEEEHHHhhhcC
Confidence 999 889999999999887766554
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.17 E-value=2.1e-10 Score=115.09 Aligned_cols=140 Identities=17% Similarity=0.142 Sum_probs=106.7
Q ss_pred CceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc-hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeEE
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLF 492 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~-~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l~ 492 (621)
+.|++...++.|+.+.||++.. .+..+++|+..... .....+.+|..+++.+.. +..++++++++...+..|
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~-----~~~vP~v~~~~~~~~~~~ 86 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEG-----KLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTT-----TSCCCCEEEEEEETTEEE
T ss_pred ccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhc-----CCCCCeEEEEEecCCceE
Confidence 4588899999999999999973 36889999987521 223468899999999964 235778888888888999
Q ss_pred EEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHH---------------------------------
Q 007035 493 IVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS--------------------------------- 539 (621)
Q Consensus 493 LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs--------------------------------- 539 (621)
+||||++|..+.... .+......++.+++.+|..||+
T Consensus 87 lv~e~i~G~~l~~~~----------~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (263)
T 3tm0_A 87 LLMSEADGVLCSEEY----------EDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCE 156 (263)
T ss_dssp EEEECCSSEEHHHHC----------CTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGG
T ss_pred EEEEecCCeehhhcc----------CCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccc
Confidence 999999985443221 1112235688899999999998
Q ss_pred --------------------------CCeecccCCCccEEEeccCCCeEEEEecCCccc
Q 007035 540 --------------------------LGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF 572 (621)
Q Consensus 540 --------------------------~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~~ 572 (621)
..++|+|++|.|||++. ...+.|+||+.+..
T Consensus 157 ~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~--~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 157 NWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKD--GKVSGFIDLGRSGR 213 (263)
T ss_dssp GGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEET--TEEEEECCCTTCEE
T ss_pred cccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEEC--CcEEEEEEchhccc
Confidence 45899999999999973 44456999997643
|
| >2cjs_A UNC-13 homolog A, MUNC13-1; neurotransmitter transport, zinc finger, synapto phorbol-ester binding; 1.78A {Rattus norvegicus} SCOP: b.7.1.1 | Back alignment and structure |
|---|
Probab=99.15 E-value=2.8e-11 Score=115.34 Aligned_cols=86 Identities=10% Similarity=-0.002 Sum_probs=67.3
Q ss_pred CcceEEEEecC-CCccccCcCCCCcceEeecCCCCCCcccceeecc-ccCCCceeccceeeecccccccccccccccccC
Q 007035 265 NDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSS-KRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEID 342 (621)
Q Consensus 265 ~~~l~v~l~e~-~L~~~d~~g~sDpyVK~~Llp~~~~~~k~kt~v~-k~tlnP~fnE~f~f~~~~~~~~~~k~L~~~V~D 342 (621)
..+|.|.|++| +|+ .+|.+||||++. . .+.||+++ ++|+||+|||+|.|. +.. .+..|.++|||
T Consensus 13 ~~~L~V~V~~A~~l~---~~g~~DPYV~v~-~------~~~kt~~~~~~t~nP~WnE~f~f~--v~~--~~~~L~~~V~D 78 (167)
T 2cjs_A 13 LSLLCVGVKKAKFDG---AQEKFNTYVTLK-V------QNVESTTIAVRGSQPSWEQDFMFE--INR--LDLGLTVEVWN 78 (167)
T ss_dssp CCEEEEEEEEEECSS---CGGGCEEEEEEE-E------TTEEEECCCEESSSCEEEEEEEEE--CCC--TTSEEEEEEEE
T ss_pred eEEEEEEEEEEECCC---CCCCCCeEEEEE-e------cceEEEEecCCCCCCCCCCEEEEE--eeC--CCCEEEEEEEE
Confidence 46788999999 774 378899999999 1 13455554 479999999999998 442 34469999999
Q ss_pred CCCCCCCCccccccccccccccc
Q 007035 343 NSDTRDGEVNGALHEGKADAEEH 365 (621)
Q Consensus 343 ~d~~~r~d~iG~v~~~~a~~~~~ 365 (621)
+| +++++++|.+..++..+...
T Consensus 79 ~d-~~~dd~iG~~~i~L~~l~~~ 100 (167)
T 2cjs_A 79 KG-LIWDTMVGTVWIPLRTIRQS 100 (167)
T ss_dssp CC-SSCCEEEEEEEEEGGGSCBC
T ss_pred CC-CCCCceEEEEEEEHHHhccc
Confidence 99 88999999998877665443
|
| >1cjy_A CPLA2, protein (cytosolic phospholipase A2); lipid-binding, hydrolase; HET: MES; 2.50A {Homo sapiens} SCOP: b.7.1.1 c.19.1.2 PDB: 1bci_A | Back alignment and structure |
|---|
Probab=99.08 E-value=4.8e-11 Score=137.38 Aligned_cols=94 Identities=13% Similarity=0.008 Sum_probs=80.6
Q ss_pred CcceEEEEecC-CCcc---ccCcCCCCcceEeecCCCCCCcccceeeccccCCCceeccceeeecccccccccccccccc
Q 007035 265 NDYGYLSSKEA-DLID---LQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAE 340 (621)
Q Consensus 265 ~~~l~v~l~e~-~L~~---~d~~g~sDpyVK~~Llp~~~~~~k~kt~v~k~tlnP~fnE~f~f~~~~~~~~~~k~L~~~V 340 (621)
...|+|.|.+| ||++ +|.+|.+||||++++.+++. .++||+++++|+||+|||+|.|. +... ....|.++|
T Consensus 17 ~g~L~V~Vi~A~nL~~~~~~D~~g~sDPYV~V~l~~~~~--~k~kTkvik~tlNPvWNEtF~F~--v~~~-~~~~L~~~V 91 (749)
T 1cjy_A 17 SHKFTVVVLRATKVTKGAFGDMLDTPDPYVELFISTTPD--SRKRTRHFNNDINPVWNETFEFI--LDPN-QENVLEITL 91 (749)
T ss_dssp CEEEEEEEEEEECCCSCHHHHHHCCCCEEEEEECTTSTT--CCEECCCCTTCSSCEEEEEEEEE--ECTT-SCCBCEEEE
T ss_pred ccEEEEEEEEEECCCCccccCCCCCcCeEEEEEEecCCC--CeEecceEcCCCCCeeeeEEEEE--ecCC-CCCEEEEEE
Confidence 46788999999 9999 99999999999999998654 57788888999999999999998 4432 344699999
Q ss_pred cCCCCCCCCCcccccccccccccc
Q 007035 341 IDNSDTRDGEVNGALHEGKADAEE 364 (621)
Q Consensus 341 ~D~d~~~r~d~iG~v~~~~a~~~~ 364 (621)
||+|.++ ++++|++..++..+..
T Consensus 92 ~D~D~~~-ddfIG~v~I~L~~L~~ 114 (749)
T 1cjy_A 92 MDANYVM-DETLGTATFTVSSMKV 114 (749)
T ss_dssp EECCSSS-CEEEEEECCBSTTSCT
T ss_pred EECCCCC-CceeEEEEEEHHHcCC
Confidence 9999999 9999999888776643
|
| >3jzy_A Intersectin 2; C2 domain, structural genomics consortium (SGC), endocytosis; 1.56A {Homo sapiens} PDB: 3qbv_B* 1ki1_B | Back alignment and structure |
|---|
Probab=99.08 E-value=5e-11 Score=131.93 Aligned_cols=92 Identities=11% Similarity=-0.005 Sum_probs=77.1
Q ss_pred CcceEEEEecC-CCccccCcCCCCcceEeecCCCCCCcccceeeccccCCCceeccceeeecccccccccccccccccCC
Q 007035 265 NDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDN 343 (621)
Q Consensus 265 ~~~l~v~l~e~-~L~~~d~~g~sDpyVK~~Llp~~~~~~k~kt~v~k~tlnP~fnE~f~f~~~~~~~~~~k~L~~~V~D~ 343 (621)
.+.+.|.|.+| ||+++|.+|.+||||++.+.+ .+.||+++++|+||+|||+|.|. +.. .....|.++|||+
T Consensus 386 ~~~l~v~v~~a~~L~~~d~~~~sdpyv~v~~~~-----~~~~T~~~~~t~nP~w~e~f~f~--~~~-~~~~~l~~~v~d~ 457 (510)
T 3jzy_A 386 IGRLMVHVIEATELKACKPNGKSNPYCEISMGS-----QSYTTRTIQDTLNPKWNFNCQFF--IKD-LYQDVLCLTLFDR 457 (510)
T ss_dssp CEEEEEEEEEEESCCCCSTTSCCCEEEEEEETT-----EEEECCCCSSCSSCEEEEEEEEE--ESC-TTTCEEEEEEEEC
T ss_pred CceEEEEeceeecCCCCCCCCCCCeEEEEEECC-----eeccCCccCCCCCCccCceEEEE--ecC-CCCCEEEEEEEeC
Confidence 34668999999 999999999999999999943 46789999999999999999998 332 2235699999999
Q ss_pred CCCCCCCcccccccccccccc
Q 007035 344 SDTRDGEVNGALHEGKADAEE 364 (621)
Q Consensus 344 d~~~r~d~iG~v~~~~a~~~~ 364 (621)
|.+++++++|.+..++..+..
T Consensus 458 d~~~~~d~lG~~~~~l~~l~~ 478 (510)
T 3jzy_A 458 DQFSPDDFLGRTEIPVAKIRT 478 (510)
T ss_dssp CSSSSCCEEEEEEEEHHHHHH
T ss_pred CCCCCCCceEEEEEEHHHhcc
Confidence 999999999999887655443
|
| >1djx_A PLC-D1, phosphoinositide-specific phospholipase C, isozyme delta1; phosphoric diester hydrolase, hydrolase, lipid degradation, transducer; HET: I3P; 2.30A {Rattus norvegicus} SCOP: a.39.1.7 b.7.1.1 c.1.18.1 PDB: 1djg_A 1dji_A 1djh_A* 1djw_A* 1djy_A* 1djz_A* 2isd_A 1qas_A 1qat_A | Back alignment and structure |
|---|
Probab=99.08 E-value=5.5e-11 Score=135.26 Aligned_cols=95 Identities=8% Similarity=-0.022 Sum_probs=78.4
Q ss_pred CcceEEEEecC-CCccccC--cCCCCcceEeecCCCCCCcccceeeccccC-CCceeccceeeecccccccccccccccc
Q 007035 265 NDYGYLSSKEA-DLIDLQH--NVVGDSSTDCDLAPHPGTEKSSSYSSSKRG-SSIDWIEGFKGSSDLHFKGAEKDLMPAE 340 (621)
Q Consensus 265 ~~~l~v~l~e~-~L~~~d~--~g~sDpyVK~~Llp~~~~~~k~kt~v~k~t-lnP~fnE~f~f~~~~~~~~~~k~L~~~V 340 (621)
...|.|.|.+| +|+++|. +|.+||||++.|...+....++||++++++ +||+|||+|.|. +..... ..|.++|
T Consensus 496 ~~~L~V~Vi~A~~L~~~d~~~~~~~DPYV~V~l~g~~~d~~~~kTkvi~~ng~NP~WnE~f~F~--v~~~el-~~L~~~V 572 (624)
T 1djx_A 496 PERLRVRIISGQQLPKVNKNKNSIVDPKVIVEIHGVGRDTGSRQTAVITNNGFNPRWDMEFEFE--VTVPDL-ALVRFMV 572 (624)
T ss_dssp CEEEEEEEEEEESCCCCSSCSSSCCCEEEEEEEESSGGGCEEEECCCCTTCSSSCEEEEEEEEE--ESCGGG-CEEEEEE
T ss_pred ceEEEEEEEEcCCCCcccccccCCCCcEEEEEEecCCCCcceeecccccCCCCCCccCceEEEE--EecCCC-CEEEEEE
Confidence 45778999999 9999994 789999999999765555567899988876 999999999998 332222 3599999
Q ss_pred cCCCCCCCCCcccccccccccc
Q 007035 341 IDNSDTRDGEVNGALHEGKADA 362 (621)
Q Consensus 341 ~D~d~~~r~d~iG~v~~~~a~~ 362 (621)
||+|.+++++++|.+..++..+
T Consensus 573 ~D~D~~~~dd~iG~~~ipl~~L 594 (624)
T 1djx_A 573 EDYDSSSKNDFIGQSTIPWNSL 594 (624)
T ss_dssp EECCSSSCCEEEEEEEEEGGGB
T ss_pred EEcCCCCCCceeEEEEEEHHHc
Confidence 9999999999999998876654
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.00 E-value=1.6e-09 Score=107.26 Aligned_cols=136 Identities=14% Similarity=0.087 Sum_probs=96.0
Q ss_pred ceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeEEEE
Q 007035 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIV 494 (621)
Q Consensus 415 rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l~LV 494 (621)
.|.+....+.|..+.||++. ..+|..+++|+.... .......|..+++.+.... -.+++++.+....+..++|
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~-~~~g~~~vlK~~~~~--~~~~~~~E~~~l~~l~~~~----~~vP~~~~~~~~~~~~~~v 93 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLS-AQGRPVLFVKTDLSG--ALNELQDEAARLSWLATTG----VPCAAVLDVVTEAGRDWLL 93 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEE-CTTSCCEEEEEECSC--TTSCHHHHHHHHHHHHTTT----CCBCCEEEEEECSSCEEEE
T ss_pred CCceEecccCCCCceEEEEe-cCCCCeEEEEeCCcc--cchhhhHHHHHHHHHHhCC----CCCCeEEEeccCCCCCEEE
Confidence 45554444466679999996 456788999998754 2356788999999987531 1366778887777889999
Q ss_pred EeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCC---------------------------------
Q 007035 495 CELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLG--------------------------------- 541 (621)
Q Consensus 495 mEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~g--------------------------------- 541 (621)
|||++|..+. .. . . ....++.+++..|..||+..
T Consensus 94 ~e~i~G~~l~-~~---~------~---~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (264)
T 1nd4_A 94 LGEVPGQDLL-SS---H------L---APAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDE 160 (264)
T ss_dssp EECCSSEETT-TS---C------C---CHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCG
T ss_pred EEecCCcccC-cC---c------C---CHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhh
Confidence 9999875333 10 0 1 11245666667777777543
Q ss_pred -------------------------eecccCCCccEEEeccCCCeEEEEecCCccc
Q 007035 542 -------------------------IIHCDLKPENILIKSYQRCEIKIIDLGSSCF 572 (621)
Q Consensus 542 -------------------------IvHrDLKP~NILl~~~~~~~IKL~DFGls~~ 572 (621)
++|+|++|.|||++. +..+.|+||+.+..
T Consensus 161 ~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~--~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 161 EHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVEN--GRFSGFIDCGRLGV 214 (264)
T ss_dssp GGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEET--TEEEEECCCTTCEE
T ss_pred hccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEEC--CcEEEEEcchhccc
Confidence 999999999999973 44556999998754
|
| >3l9b_A Otoferlin; C2-domain, beta-sheets, cell membrane, synaptic V hearing, membrane, synapse, transmembrane, membrane protein; 1.95A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=98.97 E-value=1.4e-10 Score=106.89 Aligned_cols=91 Identities=12% Similarity=-0.011 Sum_probs=76.0
Q ss_pred CcceEEEEecC-CCccccCcCCCCcceEeecCCCCCCcccceeeccc-cCCCceeccceeeecccccccccccccccccC
Q 007035 265 NDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSK-RGSSIDWIEGFKGSSDLHFKGAEKDLMPAEID 342 (621)
Q Consensus 265 ~~~l~v~l~e~-~L~~~d~~g~sDpyVK~~Llp~~~~~~k~kt~v~k-~tlnP~fnE~f~f~~~~~~~~~~k~L~~~V~D 342 (621)
---|+|.|+.| ||+ |.+|||+|+.. +..|+||++++ +++||+|||+|.|...- .-+.+..|.+.|.|
T Consensus 20 ~msL~V~l~~a~~Lp-----g~~Dp~akv~F-----Rg~k~kTkvi~~~~~npvfnE~F~wpl~~-~ld~~e~L~v~V~d 88 (144)
T 3l9b_A 20 HMALIVHLKTVSELR-----GRADRIAKVTF-----RGQSFYSRVLENCEDVADFDETFRWPVAS-SIDRNEVLEIQIFN 88 (144)
T ss_dssp CEEEEEEEEEEESCC-----SCEEEEEEEEE-----TTEEEECCCEEEECSCEEEEEEEEEEESS-CCCTTCEEEEEEEE
T ss_pred cEEEEEEEEEecCCC-----CCCCCeEEEEE-----eccceeeEEeccCCCCceEcceEEecCCC-CCCCCCEEEEEEEE
Confidence 45678999999 999 68999999999 46789999987 79999999999997332 33346669999999
Q ss_pred CCCCCCCCcccccccccccccccC
Q 007035 343 NSDTRDGEVNGALHEGKADAEEHG 366 (621)
Q Consensus 343 ~d~~~r~d~iG~v~~~~a~~~~~~ 366 (621)
+++++++.+||+...++..+...+
T Consensus 89 ~~~v~~nrlIG~~~i~Lq~lv~~~ 112 (144)
T 3l9b_A 89 YSKVFSNKLIGTFRMVLQKVVEEN 112 (144)
T ss_dssp ECTTSCCEEEEEEEEESHHHHHHS
T ss_pred CccccCCCEEEEEEEEhHHhccCC
Confidence 999999999999988776666554
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.92 E-value=1.4e-09 Score=111.91 Aligned_cols=184 Identities=18% Similarity=0.178 Sum_probs=115.2
Q ss_pred EEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecC---eEEEEEe
Q 007035 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE---HLFIVCE 496 (621)
Q Consensus 420 ~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~---~l~LVmE 496 (621)
+.++.|....||++. ..+++|+.... .......+|..+++.+....... +++++....... ..|+||+
T Consensus 26 ~~~~~G~~n~v~~v~-----~~~vlR~~~~~-~~~~~~~~E~~~l~~l~~~~~v~---vP~~~~~~~~~~~~~~~~~vm~ 96 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN-----RDFIFKFPKHS-RGSTNLFNEVNILKRIHNKLPLP---IPEVVFTGMPSETYQMSFAGFT 96 (304)
T ss_dssp CEEEECSSEEEEEST-----TSEEEEEESSH-HHHHHHHHHHHHHHHHTTSSSSC---CCCEEEECCCCSSCSCSCEEEE
T ss_pred EecCCCCcceEEEEC-----CEEEEEecCCc-chHHHHHHHHHHHHHHHhcCCCC---CCceEeecCCCCCCCcceEEEc
Confidence 348889999999864 46889987643 33467888999999886543333 334444333332 4588999
Q ss_pred ccccchHH-HHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHH------------------------------------
Q 007035 497 LLRANLYE-FQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS------------------------------------ 539 (621)
Q Consensus 497 yl~gsLld-~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs------------------------------------ 539 (621)
+++|..+. ... . .++..+...++.+++..|..||+
T Consensus 97 ~i~G~~l~~~~~-~-------~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (304)
T 3sg8_A 97 KIKGVPLTPLLL-N-------NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGP 168 (304)
T ss_dssp CCCCEECCHHHH-H-------TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHH
T ss_pred ccCCeECCcccc-c-------cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcc
Confidence 99974322 111 0 14555666677777777777774
Q ss_pred ----------------------CCeecccCCCccEEEeccCCCeEEEEecCCccccCCCccccccCCcc---cCchhhc-
Q 007035 540 ----------------------LGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSY---RAPEVII- 593 (621)
Q Consensus 540 ----------------------~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~~~~~~~~~~~gt~~Y---~APEvl~- 593 (621)
..++|+|++|.||+++.+....+.|+||+.+...... .-....... ..|+...
T Consensus 169 ~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~-~Dl~~~~~~~~~~~~~~~~~ 247 (304)
T 3sg8_A 169 QMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPD-NDFISLMEDDEEYGMEFVSK 247 (304)
T ss_dssp HHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTT-HHHHTTCCTTTSCCHHHHHH
T ss_pred cHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChH-HHHHHHHhhccccCHHHHHH
Confidence 2379999999999998532456789999987553221 111111111 2222221
Q ss_pred ---CCC----------CCchhhHHHHHHHHHHHHhCCCCCC
Q 007035 594 ---GLP----------YDQKIDLWSLGCILAELWTGEVCLI 621 (621)
Q Consensus 594 ---~~~----------~s~ksDIWSLGvILyELltG~~PF~ 621 (621)
... .....++|+++.++|.+.+|+.+|+
T Consensus 248 ~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 248 ILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp HHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred HHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 000 1123689999999999999998763
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.87 E-value=6.7e-09 Score=109.33 Aligned_cols=141 Identities=13% Similarity=0.192 Sum_probs=100.8
Q ss_pred EEEeccCCCCceeEEEeCCCCcEEEEEEEe--cCc--hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEec---CeE
Q 007035 419 TEYLGSAAFSKVFQAQDLHTGVDVCLKIIK--NDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL---EHL 491 (621)
Q Consensus 419 ~~~LG~G~fG~Vyka~d~~tg~~VAlKii~--~~~--~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~---~~l 491 (621)
++.|+.|.++.||+... .+..+++|+.. ... .....+.+|..+++.+... +..+++++.++.+. +..
T Consensus 43 ~~~l~~G~sn~~y~v~~--~~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~----~vpvP~~~~~~~~~~~~g~~ 116 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVT--PGQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGT----DVPVAKMYALCEDESVIGRA 116 (359)
T ss_dssp EEECCC-CCSCEEEEEC--SSCEEEEECCCC----------CHHHHHHHHHHHTTS----SSCCCCEEEEECCTTTTSSC
T ss_pred EEEcCCcccceEEEEEE--CCceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcC----CCCCCcEEEECCCCCccCCe
Confidence 56789999999999874 34678888876 332 1235678899999999763 23577777777665 458
Q ss_pred EEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHH--------------------------------
Q 007035 492 FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS-------------------------------- 539 (621)
Q Consensus 492 ~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs-------------------------------- 539 (621)
++||||++|..+.. . . -..++......++.+++.+|..||+
T Consensus 117 ~~vme~v~G~~l~~----~-~--~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (359)
T 3dxp_A 117 FYIMEFVSGRVLWD----Q-S--LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLS 189 (359)
T ss_dssp EEEEECCCCBCCCC----T-T--CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHH
T ss_pred EEEEEecCCeecCC----C-c--cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhc
Confidence 99999999743210 0 0 0115677788899999999999997
Q ss_pred --------------------------CCeecccCCCccEEEeccCCCeEEEEecCCccc
Q 007035 540 --------------------------LGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF 572 (621)
Q Consensus 540 --------------------------~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~~ 572 (621)
..++|||++|.|||++.+....+.|+||+.+..
T Consensus 190 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 190 ETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred CCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 359999999999999853333468999998754
|
| >3bxj_A RAS GTPase-activating protein syngap; GTPase activation, membrane, phosphoprotein, SH3-binding, signaling protein; 3.00A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=98.73 E-value=1.3e-09 Score=120.65 Aligned_cols=88 Identities=15% Similarity=0.027 Sum_probs=8.2
Q ss_pred CcceEEEEecC-CCccccCcCCCCcceEeecCCCCCCcccceeeccccC---CCceeccceeeecccccccccccccccc
Q 007035 265 NDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRG---SSIDWIEGFKGSSDLHFKGAEKDLMPAE 340 (621)
Q Consensus 265 ~~~l~v~l~e~-~L~~~d~~g~sDpyVK~~Llp~~~~~~k~kt~v~k~t---lnP~fnE~f~f~~~~~~~~~~k~L~~~V 340 (621)
.+.|.|.|.+| ||+++| ||||++++-. +.+.||+++++| +||+|||+|.|... .. ...|.++|
T Consensus 10 ~~~L~V~VieAk~L~~~d-----dpYv~v~l~~----~~~~kT~v~~kt~~glnP~WnE~F~f~~~--~~--~~~L~v~V 76 (483)
T 3bxj_A 10 DNVLKLWIIEARELPPKK-----RYYCELCLDD----MLYARTTSKPRSASGDTVFWGEHFEFNNL--PA--VRALRLHL 76 (483)
T ss_dssp EECC------------------------------------------------------CCEECC----------------
T ss_pred ccEEEEEEEEcCCcCCCC-----CCeEEEEECC----eEEeeeeEEeCCCCCCCCccccEEEEecC--CC--ccEEEEEE
Confidence 45788999999 999998 9999999943 224578888999 99999999999842 22 25699999
Q ss_pred cC-CC---CCCCCCccccccccccccccc
Q 007035 341 ID-NS---DTRDGEVNGALHEGKADAEEH 365 (621)
Q Consensus 341 ~D-~d---~~~r~d~iG~v~~~~a~~~~~ 365 (621)
|| +| ++++++++|.+..++..+...
T Consensus 77 ~d~~d~~~~~~~d~~lG~v~i~l~~l~~~ 105 (483)
T 3bxj_A 77 YRDSDKKRKKDKAGYVGLVTVPVATLAGR 105 (483)
T ss_dssp -----------------------------
T ss_pred EecCCccccCCCCceEEEEEEEHHHhcCC
Confidence 99 56 478899999999888776543
|
| >3qr0_A Phospholipase C-beta (PLC-beta); PH domain, EF hand, C2 domain, TIM barrel domain, hydrolase, calcium binding, phospholipid binding; 2.00A {Sepia officinalis} PDB: 3qr1_A | Back alignment and structure |
|---|
Probab=98.56 E-value=3.9e-08 Score=114.35 Aligned_cols=86 Identities=13% Similarity=-0.070 Sum_probs=64.5
Q ss_pred CcceEEEEecC-CCccccCcCCCCcceEeecCCCCC--Ccccceeeccc-cCCCceeccc-eeeeccccccccccccccc
Q 007035 265 NDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPG--TEKSSSYSSSK-RGSSIDWIEG-FKGSSDLHFKGAEKDLMPA 339 (621)
Q Consensus 265 ~~~l~v~l~e~-~L~~~d~~g~sDpyVK~~Llp~~~--~~~k~kt~v~k-~tlnP~fnE~-f~f~~~~~~~~~~k~L~~~ 339 (621)
...|.|.|..| +|+.+ .+|||||+.|...+. ...|+||++++ +++||+|||+ |.|..+...+. ..|.+.
T Consensus 649 ~~~L~V~Visaq~L~~~----~~DPYV~V~l~g~p~d~~~~k~kTkvv~~nglNPvWNE~~F~F~~v~~pel--a~Lrf~ 722 (816)
T 3qr0_A 649 AGTIEIKIISAQFLSDK----QISSYVEVEMYGLPTDTVRKKFKTKIIENNGMDPYYDEKVFVFKKVVLPDL--AVVRII 722 (816)
T ss_dssp CEEEEEEEEEEECCCSS----CCCEEEEEEEESSGGGCEEEEEECCCBCSCSSCCBCCCCCEEEEEESCGGG--CEEEEE
T ss_pred ceEEEEEEEEcccCCCC----CCCCeEEEEEeCCCcccccceeeeEEecCCCCCCeEcCceeEEccccCCCc--cEEEEE
Confidence 35688999999 99853 689999999985432 23677888866 5799999998 99973333333 258999
Q ss_pred ccCCCCCCCCCcccccccccc
Q 007035 340 EIDNSDTRDGEVNGALHEGKA 360 (621)
Q Consensus 340 V~D~d~~~r~d~iG~v~~~~a 360 (621)
|||++ ++++|....++.
T Consensus 723 V~D~d----ddfiG~~~ipL~ 739 (816)
T 3qr0_A 723 VSEEN----GKFIGHRVMPLD 739 (816)
T ss_dssp EEETT----SCEEEEEEEEST
T ss_pred EEecC----CCeeeEEEEEHH
Confidence 99985 789998866543
|
| >2zkm_X 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase beta-2; phospholipase C, phosphoinositide phospholipase, PLC-beta-2, calcium, coiled coil; 1.62A {Homo sapiens} SCOP: a.39.1.7 b.7.1.1 b.55.1.1 c.1.18.1 PDB: 2fju_B | Back alignment and structure |
|---|
Probab=98.53 E-value=7.5e-08 Score=112.27 Aligned_cols=87 Identities=15% Similarity=0.048 Sum_probs=64.4
Q ss_pred CcceEEEEecC-CCccccCcCCCCcceEeecCCCCC-Ccccceee-cc-ccCCCceecc-ceee-ecccccccccccccc
Q 007035 265 NDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPG-TEKSSSYS-SS-KRGSSIDWIE-GFKG-SSDLHFKGAEKDLMP 338 (621)
Q Consensus 265 ~~~l~v~l~e~-~L~~~d~~g~sDpyVK~~Llp~~~-~~~k~kt~-v~-k~tlnP~fnE-~f~f-~~~~~~~~~~k~L~~ 338 (621)
...|.|.|..| +|+. +.+|||||+.|...+. .+.|+||+ ++ ++++||+||| +|.| .. ...+.. .|.+
T Consensus 677 ~~~L~V~Visa~~L~~----~~~DPYV~V~l~g~p~d~~~k~kTk~vv~~n~~NPvWnEe~f~F~~v-~~~el~--~Lr~ 749 (799)
T 2zkm_X 677 ATTLSITVISGQFLSE----RSVRTYVEVELFGLPGDPKRRYRTKLSPSTNSINPVWKEEPFVFEKI-LMPELA--SLRV 749 (799)
T ss_dssp CEEEEEEEEEEESCCS----SCCCEEEEEEEECCTTSCCCCEECCCCSSSCCSSCBCCCCCEEEEEE-SSGGGC--EEEE
T ss_pred eeeEEEEEEeccccCc----cCCCcEEEEEEEecCCCcccceeecccccCCCCCCeeecceEEEEEE-ccCCcc--EEEE
Confidence 45688999999 9985 4789999999975321 12356788 65 5689999999 7999 62 223322 5899
Q ss_pred cccCCCCCCCCCcccccccccccc
Q 007035 339 AEIDNSDTRDGEVNGALHEGKADA 362 (621)
Q Consensus 339 ~V~D~d~~~r~d~iG~v~~~~a~~ 362 (621)
.|||+| ++++|....++..+
T Consensus 750 ~V~D~d----~d~iG~~~ipl~~L 769 (799)
T 2zkm_X 750 AVMEEG----NKFLGHRIIPINAL 769 (799)
T ss_dssp EEEETT----TEEEEEEEEEGGGB
T ss_pred EEEEeC----CCccceEeeehhhc
Confidence 999997 78999987766544
|
| >3ohm_B 1-phosphatidylinositol-4,5-bisphosphate phosphodi beta-3; PH domain, EF hand, TIM barrel, C2 domain, GTPase, lipase, C binding, GTP binding; HET: GDP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.51 E-value=8.1e-08 Score=112.41 Aligned_cols=84 Identities=17% Similarity=0.050 Sum_probs=62.3
Q ss_pred cceEEEEecC-CCccccCcCCCCcceEeecCCCC-CCcccceeeccc-cCCCceecc-ceeeeccccccccccccccccc
Q 007035 266 DYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHP-GTEKSSSYSSSK-RGSSIDWIE-GFKGSSDLHFKGAEKDLMPAEI 341 (621)
Q Consensus 266 ~~l~v~l~e~-~L~~~d~~g~sDpyVK~~Llp~~-~~~~k~kt~v~k-~tlnP~fnE-~f~f~~~~~~~~~~k~L~~~V~ 341 (621)
..|.|.|..| +|+.+ .+|||||+.|.... ..+.|+||++++ +++||+||| +|.|..+...+.. .|.+.||
T Consensus 725 ~~L~V~Visaq~L~~~----~~DPYV~V~l~g~p~D~~~k~kTkvi~~NglNPvWnEe~F~F~~V~~pela--~Lrf~V~ 798 (885)
T 3ohm_B 725 NALRVKVISGQFLSDR----KVGIYVEVDMFGLPVDTRRKYRTRTSQGNSFNPVWDEEPFDFPKVVLPTLA--SLRIAAF 798 (885)
T ss_dssp EEEEEEEEEEESCCSS----CCCEEEEEEEESSTTTCBCCCCCCCCSSCSSSCBCCCCCEEEEEESCGGGC--EEEEEEE
T ss_pred eEEEEEEEEeccCccc----CCCcEEEEEEeCCCcccccceeeEEeeCCCcCCeeccceeEEeeEEcCCcC--EEEEEEE
Confidence 3678999999 99853 68999999997522 123457888865 579999999 6999832223322 5899999
Q ss_pred CCCCCCCCCccccccccc
Q 007035 342 DNSDTRDGEVNGALHEGK 359 (621)
Q Consensus 342 D~d~~~r~d~iG~v~~~~ 359 (621)
|+| ++++|....++
T Consensus 799 D~d----ddfiG~~~lpL 812 (885)
T 3ohm_B 799 EEG----GKFVGHRILPV 812 (885)
T ss_dssp ETT----TEEEEEEEEET
T ss_pred cCC----ccEEeeEEEEH
Confidence 997 78999886654
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.33 E-value=6.2e-06 Score=85.12 Aligned_cols=73 Identities=18% Similarity=0.086 Sum_probs=51.5
Q ss_pred EEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeE-ecCeEEEEEecc
Q 007035 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY-HLEHLFIVCELL 498 (621)
Q Consensus 420 ~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~-~~~~l~LVmEyl 498 (621)
+.++.|....||+. |..+++|+... .........|..+++.+...... .+++++.+.. ..+..++|||++
T Consensus 25 ~~l~~G~~n~v~~v-----g~~~VlR~~~~-~~~~~~~~~E~~~L~~L~~~~~v---~VP~~~~~~~~~~g~~~~v~e~i 95 (306)
T 3tdw_A 25 ESLGEGFRNYAILV-----NGDWVFRFPKS-QQGADELNKEIQLLPLLVGCVKV---NIPQYVYIGKRSDGNPFVGYRKV 95 (306)
T ss_dssp EEEEECSSEEEEEE-----TTTEEEEEESS-HHHHHHHHHHHHHHHHHTTTCSS---BCCCEEEEEECTTSCEEEEEECC
T ss_pred eecCCCcceeEEEE-----CCEEEEEecCC-chHHHHHHHHHHHHHHHHhcCCC---CCCCeEeecccCCCceEEEEecc
Confidence 45778888899987 56788998543 33456788999999999864322 2455555543 445688999999
Q ss_pred ccc
Q 007035 499 RAN 501 (621)
Q Consensus 499 ~gs 501 (621)
+|.
T Consensus 96 ~G~ 98 (306)
T 3tdw_A 96 QGQ 98 (306)
T ss_dssp CSE
T ss_pred CCe
Confidence 974
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.23 E-value=2.4e-05 Score=78.26 Aligned_cols=132 Identities=14% Similarity=0.141 Sum_probs=88.9
Q ss_pred eccCCCC-ceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeEEEEEecccc
Q 007035 422 LGSAAFS-KVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRA 500 (621)
Q Consensus 422 LG~G~fG-~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l~LVmEyl~g 500 (621)
+..|..+ .||+......+..+++|+..... ...+.+|..+++.+... + -+++++.+..+.+..++|||+++|
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~--~~~~~~E~~~l~~l~~~--v---PVP~v~~~~~~~~~~~lvme~l~G 104 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKGSV--ANDVTDEMVRLNWLTAF--M---PLPTIKHFIRTPDDAWLLTTAIPG 104 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEETHH--HHHHHHHHHHHHHHTTT--S---CCCCEEEEEEETTEEEEEEECCCS
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCCCC--HhHHHHHHHHHHHhccC--C---CcCeEEEEEEECCeEEEEEEeeCC
Confidence 4445444 68998877778889999876543 35678899999988642 2 267778888888999999999987
Q ss_pred chH-HHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHC---------------------------------------
Q 007035 501 NLY-EFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSL--------------------------------------- 540 (621)
Q Consensus 501 sLl-d~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~--------------------------------------- 540 (621)
... +..... ......+..++...|..||..
T Consensus 105 ~~~~~~~~~~----------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (272)
T 4gkh_A 105 KTAFQVLEEY----------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGW 174 (272)
T ss_dssp EEHHHHHHHC----------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTC
T ss_pred ccccccccCC----------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccch
Confidence 432 222110 111223444444444444421
Q ss_pred -------------------CeecccCCCccEEEeccCCCeEEEEecCCccc
Q 007035 541 -------------------GIIHCDLKPENILIKSYQRCEIKIIDLGSSCF 572 (621)
Q Consensus 541 -------------------gIvHrDLKP~NILl~~~~~~~IKL~DFGls~~ 572 (621)
.++|+|+.+.|||++. .+.+-|+||+.+..
T Consensus 175 ~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~--~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 175 PVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDE--GKLIGCIDVGRVGI 223 (272)
T ss_dssp CHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEET--TEEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEEC--CeEEEEEECccccc
Confidence 2689999999999983 45567999998754
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.99 E-value=3.5e-05 Score=81.98 Aligned_cols=77 Identities=18% Similarity=0.126 Sum_probs=51.1
Q ss_pred EEEeccCCCCceeEEEeCCCCcEEEEEEEecCc--------hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCe
Q 007035 419 TEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--------DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (621)
Q Consensus 419 ~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~--------~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~ 490 (621)
.+.||.|..+.||++.....++.+++|...... ...++...|.++++.+.... ...+++++.+ +...
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~---~~~vP~~~~~--d~~~ 109 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHV---PHLVPRVFYS--DTEM 109 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTC---GGGSCCEEEE--ETTT
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhC---CCCcCeEEEE--cCCc
Confidence 467999999999999766667889999865321 12345678999999886532 1235555543 4455
Q ss_pred EEEEEecccc
Q 007035 491 LFIVCELLRA 500 (621)
Q Consensus 491 l~LVmEyl~g 500 (621)
.++|||++++
T Consensus 110 ~~lvmE~l~g 119 (397)
T 2olc_A 110 AVTVMEDLSH 119 (397)
T ss_dssp TEEEECCCTT
T ss_pred cEEEEEeCCC
Confidence 6899999976
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.69 E-value=0.00044 Score=70.94 Aligned_cols=76 Identities=21% Similarity=0.308 Sum_probs=44.2
Q ss_pred EEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEe-e--EeEecCeEEEEE
Q 007035 419 TEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLY-D--YFYHLEHLFIVC 495 (621)
Q Consensus 419 ~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~-~--~f~~~~~l~LVm 495 (621)
++.|+.|..+.||++.. .. ..+++|+..... .....|..+++.+.... ...|.++... + +....+..++||
T Consensus 37 ~~~l~gG~~n~~~~v~~-~~-~~~vlk~~~~~~---~~~~~e~~~l~~L~~~g-~~vp~~~~~~~g~~~~~~~~~~~~l~ 110 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHT-DS-GAVCLKRIHRPE---KKALFSIFAQDYLAKKG-MNVPGILPNKKGSLYSKHGSFLFVVY 110 (346)
T ss_dssp EEECC----CEEEEEEE-TT-EEEEEEEECSCH---HHHHHHHHHHHHHHHHT-CSSCCBCCCTTSCSCEEETTEEEEEE
T ss_pred eeeccccccCcEEEEEe-CC-CCEEEEecCCCH---HHHHHHHHHHHHHHHcC-CCCCceeecCCCCEEEEECCEEEEEE
Confidence 34566677889999874 33 358999987643 34445677777776542 2233333211 0 123467789999
Q ss_pred ecccc
Q 007035 496 ELLRA 500 (621)
Q Consensus 496 Eyl~g 500 (621)
+|++|
T Consensus 111 ~~i~G 115 (346)
T 2q83_A 111 DWIEG 115 (346)
T ss_dssp ECCCC
T ss_pred EeecC
Confidence 99987
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.65 E-value=8.2e-05 Score=77.63 Aligned_cols=81 Identities=9% Similarity=0.029 Sum_probs=54.8
Q ss_pred EEEEEe-ccCCCCceeEEEeCC------CCcEEEEEEEecCch----hhhhHHHHHHHHHHhcccCCCCCCceEEEeeEe
Q 007035 417 YVTEYL-GSAAFSKVFQAQDLH------TGVDVCLKIIKNDKD----FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYF 485 (621)
Q Consensus 417 ~I~~~L-G~G~fG~Vyka~d~~------tg~~VAlKii~~~~~----~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f 485 (621)
..++.| +.|....+|+..... .++.+++|+...... .......|..+++.+...... .+++++.+.
T Consensus 23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~v---pvP~v~~~~ 99 (357)
T 3ats_A 23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDV---PVPRVRWIE 99 (357)
T ss_dssp EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCS---CCCCEEEEE
T ss_pred EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCC---CCCcEEEEc
Confidence 445678 888889999886420 267789998765331 125678899999988764111 356666665
Q ss_pred Eec---CeEEEEEecccc
Q 007035 486 YHL---EHLFIVCELLRA 500 (621)
Q Consensus 486 ~~~---~~l~LVmEyl~g 500 (621)
.+. +..++|||+++|
T Consensus 100 ~~~~~~g~~~~v~e~l~G 117 (357)
T 3ats_A 100 TTGDVLGTPFFLMDYVEG 117 (357)
T ss_dssp CSSTTTSSCEEEEECCCC
T ss_pred cCCCccCCceEEEEecCC
Confidence 544 357899999986
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.36 E-value=0.00086 Score=68.42 Aligned_cols=69 Identities=16% Similarity=0.129 Sum_probs=45.0
Q ss_pred EEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeEEEEEecc
Q 007035 419 TEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELL 498 (621)
Q Consensus 419 ~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l~LVmEyl 498 (621)
++.|+.|....+|++ ..+++|+.............|..+++.+...... ++++.. ..+.-++|+||+
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~-----P~~~~~--~~~~~~~v~e~i 89 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVS-----PEVLHV--DPATGVMVTRYI 89 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC----CCCHHHHHHHHHHHHHTTSS-----CCEEEE--CTTTCCEEEECC
T ss_pred eeEcCCcccccccee------eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCC-----CceEEE--ECCCCEEEEeec
Confidence 567888989999998 5688998876433333446788888888765321 344443 333457899999
Q ss_pred -cc
Q 007035 499 -RA 500 (621)
Q Consensus 499 -~g 500 (621)
++
T Consensus 90 ~~g 92 (301)
T 3dxq_A 90 AGA 92 (301)
T ss_dssp TTC
T ss_pred CCC
Confidence 65
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.13 E-value=0.0012 Score=70.79 Aligned_cols=75 Identities=13% Similarity=0.151 Sum_probs=46.3
Q ss_pred EEEeccCCCCceeEEEeCCCCcEEEEEEEec-----Cch---hhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCe
Q 007035 419 TEYLGSAAFSKVFQAQDLHTGVDVCLKIIKN-----DKD---FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (621)
Q Consensus 419 ~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~-----~~~---~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~ 490 (621)
++.||.|..+.||++.. .++.++||.... ... ...+...|.+++..+.... ...+++++.+. ...
T Consensus 39 i~~l~~G~~n~vyrv~~--~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~---~~~vP~v~~~~--~~~ 111 (420)
T 2pyw_A 39 IKEVGDGNLNFVFIVVG--SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLS---PDHVPEVYHFD--RTM 111 (420)
T ss_dssp EEECCCSSSCEEEEEEC--SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHS---GGGSCCEEEEE--TTT
T ss_pred EEEccCCCcEEEEEEEc--CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhC---CCCCCeEEEEC--CCc
Confidence 46689999999999963 567899994321 111 1123344555555443221 12466666654 566
Q ss_pred EEEEEecc-cc
Q 007035 491 LFIVCELL-RA 500 (621)
Q Consensus 491 l~LVmEyl-~g 500 (621)
.++||||+ ++
T Consensus 112 ~~lv~e~l~~g 122 (420)
T 2pyw_A 112 ALIGMRYLEPP 122 (420)
T ss_dssp TEEEECCCCTT
T ss_pred cEEEEeecCCc
Confidence 78999999 75
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.92 E-value=0.0085 Score=61.34 Aligned_cols=74 Identities=16% Similarity=0.177 Sum_probs=48.0
Q ss_pred EeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeE-----eEecCeEEEEE
Q 007035 421 YLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDY-----FYHLEHLFIVC 495 (621)
Q Consensus 421 ~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~-----f~~~~~l~LVm 495 (621)
.|+ |....||+.. ..+|+.+++|+..........+..|..+++.+.... .. +++++.. ....+..++||
T Consensus 33 ~l~-g~~n~~y~v~-~~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g-~~---vp~~~~~~g~~~~~~~g~~~~l~ 106 (328)
T 1zyl_A 33 PLN-SYENRVYQFQ-DEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDE-VP---VAAPVAFNGQTLLNHQGFYFAVF 106 (328)
T ss_dssp EEC-CSSSEEEEEC-CTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTT-CS---BCCCCCBTTBSCEEETTEEEEEE
T ss_pred eec-CcccceEEEE-cCCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcC-Ce---ecceeecCCcEEEEECCEEEEEE
Confidence 355 7778899876 345667999998743223356677888888887542 22 2333222 22356778999
Q ss_pred ecccc
Q 007035 496 ELLRA 500 (621)
Q Consensus 496 Eyl~g 500 (621)
++++|
T Consensus 107 ~~i~G 111 (328)
T 1zyl_A 107 PSVGG 111 (328)
T ss_dssp ECCCC
T ss_pred EecCC
Confidence 99986
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=96.87 E-value=0.0059 Score=63.35 Aligned_cols=76 Identities=21% Similarity=0.212 Sum_probs=58.6
Q ss_pred EEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeEEEEEecc
Q 007035 419 TEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELL 498 (621)
Q Consensus 419 ~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l~LVmEyl 498 (621)
.+.|+.|....+|+... .+..+++|+..... ...+..|...++.+.... ...+++++.+....+..++||||+
T Consensus 41 ~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~~--~~~~~~E~~~L~~L~~~~---~v~VP~vl~~~~~~g~~~lvme~l 113 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND--EVQTVFVKINERSY--RSMFRAEADQLALLAKTN---SINVPLVYGIGNSQGHSFLLLEAL 113 (312)
T ss_dssp EEEECCSSSSEEEEEES--SSCEEEEEEEEGGG--HHHHHHHHHHHHHHHHTT---SSBCCCEEEEEECSSEEEEEEECC
T ss_pred eEEeCCccceeeeEEEE--CCCeEEEEeCCccc--HHHHHHHHHHHHHHHhhC---CCCcceEEEEeecCCceEEEEEec
Confidence 56789999999999873 56788999887542 456788999999887542 134777777777778899999999
Q ss_pred ccc
Q 007035 499 RAN 501 (621)
Q Consensus 499 ~gs 501 (621)
++.
T Consensus 114 ~G~ 116 (312)
T 3jr1_A 114 NKS 116 (312)
T ss_dssp CCC
T ss_pred cCC
Confidence 863
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=96.85 E-value=0.011 Score=59.73 Aligned_cols=80 Identities=10% Similarity=0.091 Sum_probs=56.1
Q ss_pred cCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc-hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeE
Q 007035 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (621)
Q Consensus 413 ~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~-~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l 491 (621)
.....-++.+|.|..+.||+.. ..+|+.|++|+..... .....+..|...|+.+........|. ++.+ . .-
T Consensus 14 G~~v~~v~~~g~G~~~~vyrv~-l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~---v~~~--~--~~ 85 (288)
T 3f7w_A 14 GREVAAVAERGHSHRWHLYRVE-LADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQ---VAGW--D--DR 85 (288)
T ss_dssp CCCEEEEEEEEEETTEEEEEEE-ETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCC---EEEE--E--TT
T ss_pred CCCeEEEEecCCCCCeEEEEEE-ECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcce---EEec--c--Cc
Confidence 3456667889999999999997 5789999999876432 22345678999999997654344343 3333 2 23
Q ss_pred EEEEecccc
Q 007035 492 FIVCELLRA 500 (621)
Q Consensus 492 ~LVmEyl~g 500 (621)
++||||+.+
T Consensus 86 ~lv~e~l~~ 94 (288)
T 3f7w_A 86 TLAMEWVDE 94 (288)
T ss_dssp EEEEECCCC
T ss_pred eEEEEeecc
Confidence 688999864
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.80 E-value=0.016 Score=59.09 Aligned_cols=149 Identities=11% Similarity=0.083 Sum_probs=79.0
Q ss_pred EEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEe-e--EeEecCeEEEE
Q 007035 418 VTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLY-D--YFYHLEHLFIV 494 (621)
Q Consensus 418 I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~-~--~f~~~~~l~LV 494 (621)
-++.|+.|....+|+... ..| .+++|+..... ....+..|..+++.+.... ...|.++... + +....+..+++
T Consensus 26 ~~~~i~~G~~n~~~~v~~-~~g-~~vlk~~~~~~-~~~~l~~e~~~l~~L~~~g-~~vP~~~~~~~g~~~~~~~g~~~~l 101 (322)
T 2ppq_A 26 SYKGIAEGVENSNFLLHT-TKD-PLILTLYEKRV-EKNDLPFFLGLMQHLAAKG-LSCPLPLPRKDGELLGELSGRPAAL 101 (322)
T ss_dssp EEEEECC---EEEEEEEE-SSC-CEEEEEECC----CCHHHHHHHHHHHHHHTT-CCCCCBCCBTTCCSCEEETTEEEEE
T ss_pred EeeccCCCcccceEEEEe-CCc-cEEEEEeCCCC-CHHHHHHHHHHHHHHHHCC-CCCCcccCCCCCCEEEEECCEEEEE
Confidence 456678888889999874 334 68899887631 1245667888888887653 2233333211 1 11234677899
Q ss_pred EeccccchH------------HH---HHhh-hccCCC--ccccHHHHHH---------------HHHHHHHHHHHHHH--
Q 007035 495 CELLRANLY------------EF---QKFN-QESGGE--AYFTLGRLQV---------------ITRQCLEALEYLHS-- 539 (621)
Q Consensus 495 mEyl~gsLl------------d~---l~~~-~~~~~~--~~ls~~~i~~---------------I~~qIl~aL~yLHs-- 539 (621)
|+|++|... .. +... ...... .......... +...+...+..+..
T Consensus 102 ~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~ 181 (322)
T 2ppq_A 102 ISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHW 181 (322)
T ss_dssp EECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHC
T ss_pred EEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhC
Confidence 999986310 01 1110 000000 0000000000 01123444555552
Q ss_pred -----CCeecccCCCccEEEeccCCCeEEEEecCCccc
Q 007035 540 -----LGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF 572 (621)
Q Consensus 540 -----~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~~ 572 (621)
.+++|+|+++.|||++. +..+.|+||+.+..
T Consensus 182 ~~~~~~~liHgDl~~~Nil~~~--~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 182 PKDLPAGVIHADLFQDNVFFLG--DELSGLIDFYFACN 217 (322)
T ss_dssp CCSSCEEEECSCCCGGGEEEET--TEEEEECCCTTCEE
T ss_pred cccCCcccCCCCCCccCEEEeC--CceEEEecchhccC
Confidence 36999999999999983 34457999997643
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.75 E-value=0.007 Score=64.52 Aligned_cols=144 Identities=14% Similarity=0.121 Sum_probs=79.1
Q ss_pred EEeccCCCCceeEEEeCC-------CCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeEE
Q 007035 420 EYLGSAAFSKVFQAQDLH-------TGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLF 492 (621)
Q Consensus 420 ~~LG~G~fG~Vyka~d~~-------tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l~ 492 (621)
+.|..|-...+|++.... .++.+++|+............+|.++++.+..... .+++++.+.. .
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv-----~P~ll~~~~~----g 126 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSL-----GPQLYGVFPE----G 126 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTS-----SCCEEEEETT----E
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCC-----CCeEEEEcCC----c
Confidence 356667777888887432 35789999864422234556689999999887542 2455555543 2
Q ss_pred EEEeccccchH---------------HHHHhhhccC---CCccc-cHHHHHHHHHHHHH-------------------HH
Q 007035 493 IVCELLRANLY---------------EFQKFNQESG---GEAYF-TLGRLQVITRQCLE-------------------AL 534 (621)
Q Consensus 493 LVmEyl~gsLl---------------d~l~~~~~~~---~~~~l-s~~~i~~I~~qIl~-------------------aL 534 (621)
+||||++|..+ +.+....... +.... ....+..+..++.. .+
T Consensus 127 ~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~ 206 (379)
T 3feg_A 127 RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEM 206 (379)
T ss_dssp EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHH
T ss_pred cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHH
Confidence 89999986211 1111111110 11111 23444545444321 23
Q ss_pred HHHH----H----CCeecccCCCccEEEecc--CCCeEEEEecCCccc
Q 007035 535 EYLH----S----LGIIHCDLKPENILIKSY--QRCEIKIIDLGSSCF 572 (621)
Q Consensus 535 ~yLH----s----~gIvHrDLKP~NILl~~~--~~~~IKL~DFGls~~ 572 (621)
..|. . ..++|+|+.+.|||++.+ ..+.+.|+||..+..
T Consensus 207 ~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 207 GNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 3332 2 248999999999999853 136899999998753
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.68 E-value=0.0039 Score=65.38 Aligned_cols=73 Identities=16% Similarity=0.144 Sum_probs=44.4
Q ss_pred EEEeccCCCCceeEEEeCC--------CCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCe
Q 007035 419 TEYLGSAAFSKVFQAQDLH--------TGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (621)
Q Consensus 419 ~~~LG~G~fG~Vyka~d~~--------tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~ 490 (621)
++.|+.|....+|++.... .++.+++|+.............|..+++.+..... .+++++.+ .+
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~-----~P~~~~~~--~~- 109 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKI-----APQLLNTF--NG- 109 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTS-----SCCEEEEE--TT-
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCC-----CCceEEec--CC-
Confidence 4567778888899987532 13688999886544333334688899998876531 33444433 22
Q ss_pred EEEEEecccc
Q 007035 491 LFIVCELLRA 500 (621)
Q Consensus 491 l~LVmEyl~g 500 (621)
++||||++|
T Consensus 110 -~~v~e~i~G 118 (369)
T 3c5i_A 110 -GRIEEWLYG 118 (369)
T ss_dssp -EEEEECCCS
T ss_pred -cEEEEEecC
Confidence 679999876
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.29 E-value=0.021 Score=58.74 Aligned_cols=33 Identities=18% Similarity=0.374 Sum_probs=26.6
Q ss_pred CCeecccCCCccEEEeccC--CCeEEEEecCCccc
Q 007035 540 LGIIHCDLKPENILIKSYQ--RCEIKIIDLGSSCF 572 (621)
Q Consensus 540 ~gIvHrDLKP~NILl~~~~--~~~IKL~DFGls~~ 572 (621)
..++|||+.+.|||++.+. .+.+.|+||+.+..
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 4699999999999998521 15789999998754
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.12 E-value=0.065 Score=58.44 Aligned_cols=73 Identities=10% Similarity=0.174 Sum_probs=47.1
Q ss_pred EEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeEEEEEecc
Q 007035 419 TEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELL 498 (621)
Q Consensus 419 ~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l~LVmEyl 498 (621)
++.|+.|-...+|++.....+..+++|+........-....|..+++.+.... ..+++++.+. + .+||||+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~g-----l~P~ll~~~~--~--G~v~e~I 183 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKN-----IAKKIYVFFT--N--GRIEEFM 183 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSS-----SBCCEEEEET--T--EEEEECC
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcC-----CCCCEEEEeC--C--eEEEEee
Confidence 45678888889999986444578999988543222222368899999997643 2355666653 2 2599999
Q ss_pred cc
Q 007035 499 RA 500 (621)
Q Consensus 499 ~g 500 (621)
+|
T Consensus 184 ~G 185 (458)
T 2qg7_A 184 DG 185 (458)
T ss_dssp CS
T ss_pred CC
Confidence 76
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=95.98 E-value=0.051 Score=58.56 Aligned_cols=72 Identities=14% Similarity=0.110 Sum_probs=48.3
Q ss_pred EEEeccCCCCceeEEEeCC-------CCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeE
Q 007035 419 TEYLGSAAFSKVFQAQDLH-------TGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (621)
Q Consensus 419 ~~~LG~G~fG~Vyka~d~~-------tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l 491 (621)
++.|+.|....+|++.... .++.+++|+..... ....+..|..+++.+..... .+++++.+..
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~-~~~~li~E~~~l~~L~~~g~-----~P~l~~~~~~---- 147 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-TESHLVAESVIFTLLSERHL-----GPKLYGIFSG---- 147 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-CHHHHHHHHHHHHHHHHTTS-----SSCEEEEETT----
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC-cHHHHHHHHHHHHHHHhCCC-----CCcEEEEeCC----
Confidence 4567888888999997542 35789999985421 11455679999998876532 2445555432
Q ss_pred EEEEecccc
Q 007035 492 FIVCELLRA 500 (621)
Q Consensus 492 ~LVmEyl~g 500 (621)
.+|+||++|
T Consensus 148 g~v~e~l~G 156 (429)
T 1nw1_A 148 GRLEEYIPS 156 (429)
T ss_dssp EEEECCCCE
T ss_pred CEEEEEeCC
Confidence 288999976
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.78 E-value=0.059 Score=55.97 Aligned_cols=69 Identities=12% Similarity=0.141 Sum_probs=43.6
Q ss_pred ccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeE------eEecCeEEEEEe
Q 007035 423 GSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDY------FYHLEHLFIVCE 496 (621)
Q Consensus 423 G~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~------f~~~~~l~LVmE 496 (621)
|.|....||+.. ...| .+++|+..... ...|+.+++.+.... . |++++++.. ....+..++||+
T Consensus 32 G~g~~N~vy~v~-~~~g-~~vLK~~~~~~-----~~~E~~~l~~L~~~g-~--~~vp~pi~~~~G~~~~~~~g~~~~l~~ 101 (339)
T 3i1a_A 32 GADTNAFAYQAD-SESK-SYFIKLKYGYH-----DEINLSIIRLLHDSG-I--KEIIFPIHTLEAKLFQQLKHFKIIAYP 101 (339)
T ss_dssp TSCSSCEEEEEE-CSSC-EEEEEEEECSS-----CCHHHHHHHHHHHTT-C--CSSCCCCCCTTSCSSEECSSEEEEEEE
T ss_pred cCccccceEEEE-eCCC-CEEEEEecCcc-----chHHHHHHHHHHhcC-C--cccccceecCCCCEEEEECCEEEEEEe
Confidence 344467899987 3455 89999887643 246777888876542 1 223333321 233577899999
Q ss_pred ccccc
Q 007035 497 LLRAN 501 (621)
Q Consensus 497 yl~gs 501 (621)
|++|.
T Consensus 102 ~i~G~ 106 (339)
T 3i1a_A 102 FIHAP 106 (339)
T ss_dssp CCCCC
T ss_pred ccCCC
Confidence 99863
|
| >1yrk_A NPKC-delta, protein kinase C, delta type; C2 domain, protein binding; HET: PTR; 1.70A {Homo sapiens} PDB: 1bdy_A | Back alignment and structure |
|---|
Probab=95.28 E-value=0.0056 Score=54.87 Aligned_cols=85 Identities=12% Similarity=0.128 Sum_probs=51.2
Q ss_pred ceEEEEecCCCcccc-CcCCCCcceEeecCCCCCCccccee-eccccCCCceeccceeeecccccccccccccccccCCC
Q 007035 267 YGYLSSKEADLIDLQ-HNVVGDSSTDCDLAPHPGTEKSSSY-SSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDNS 344 (621)
Q Consensus 267 ~l~v~l~e~~L~~~d-~~g~sDpyVK~~Llp~~~~~~k~kt-~v~k~tlnP~fnE~f~f~~~~~~~~~~k~L~~~V~D~d 344 (621)
.|-|.+....+.++. ..-..|||+.+++---.... +-+| .++++|..|+|||.|+-. +. ..+.|.+.|++..
T Consensus 7 flRi~~~~~~~~~~~~~~~~lDPy~aV~vdE~~~~e-~g~t~~~K~kT~~P~Wne~Fd~~--V~---~Gr~l~i~Vfh~a 80 (126)
T 1yrk_A 7 FLRIAFNSYELGSLQAEDEANQPFCAVKMKEALSTE-RGKTLVQKKPTMYPEWKSTFDAH--IY---EGRVIQIVLMRAA 80 (126)
T ss_dssp EEEEEEEEEECSSCCCSSSSCCCEEEEEEEEEEEET-TEEEEECCSCCBCCCTTCEEEEE--CC---TTCEEEEEEEEET
T ss_pred cEEeeeccccccccCCccccCCceEEEEeeeeEEcc-cceeecccCCCCCcCccceEEee--ee---CCEEEEEEEEcCC
Confidence 445566555443322 23357999998774321111 2243 557899999999999865 22 2455888888544
Q ss_pred CCCCCCccccccccccc
Q 007035 345 DTRDGEVNGALHEGKAD 361 (621)
Q Consensus 345 ~~~r~d~iG~v~~~~a~ 361 (621)
. +++.++..+...
T Consensus 81 ~----~fvAn~tV~~ed 93 (126)
T 1yrk_A 81 E----EPVSEVTVGVSV 93 (126)
T ss_dssp T----EEEEEEEEEHHH
T ss_pred C----CeeeEEEEEHHH
Confidence 3 667766554433
|
| >2enj_A NPKC-theta, protein kinase C theta type; beta-sandwich, phosphotyrosine binding, TCR, T-cell, diacylglycerol, phorbol ester, structural genomics; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=95.24 E-value=0.0066 Score=55.11 Aligned_cols=89 Identities=7% Similarity=-0.028 Sum_probs=56.2
Q ss_pred CcceEEEEecCCCccccC--cCCCCcceEeecCCCCCCccccee-eccccCCCceeccceeeeccccccccccccccccc
Q 007035 265 NDYGYLSSKEADLIDLQH--NVVGDSSTDCDLAPHPGTEKSSSY-SSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEI 341 (621)
Q Consensus 265 ~~~l~v~l~e~~L~~~d~--~g~sDpyVK~~Llp~~~~~~k~kt-~v~k~tlnP~fnE~f~f~~~~~~~~~~k~L~~~V~ 341 (621)
...|-|.+....+.+... .-..|||+.+++---.... +-+| .++++|..|+|||.|+-. +. ..+.|.+.|+
T Consensus 9 ~~flRi~l~~~~~~~~~~~~~~~lDPY~aV~VdE~~~te-~gqtl~~KkkT~~P~Wne~Fd~~--V~---~Gr~l~i~Vf 82 (138)
T 2enj_A 9 SPFLRIGLSNFDCGSCQSCQGEAVNPYCAVLVKEYVESE-NGQMYIQKKPTMYPPWDSTFDAH--IN---KGRVMQIIVK 82 (138)
T ss_dssp CCCEEEEEEEEECCCCCCSCCCCCCCEEEEEEEEEEEET-TEEEEEEEEEEECCCSSSEEEEC--CC---SSCEEEEEEE
T ss_pred CcceEEEeeccccCCCCCcccccCCceEEEEeeeeeecc-CceeecccCCCCCccccceEeee--EE---CCeEEEEEEE
Confidence 345667776665544332 3356999998874321111 2344 556899999999999865 22 2455888888
Q ss_pred CCCCCCCCCccccccccccccc
Q 007035 342 DNSDTRDGEVNGALHEGKADAE 363 (621)
Q Consensus 342 D~d~~~r~d~iG~v~~~~a~~~ 363 (621)
+... +|+.++..+...+.
T Consensus 83 h~a~----~fVAn~tV~~edL~ 100 (138)
T 2enj_A 83 GKNV----DLISETTVELYSLA 100 (138)
T ss_dssp CSSC----SCCEEEEEESHHHH
T ss_pred cCCC----CeeeEEEEEHHHHH
Confidence 5544 77777766554444
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=93.99 E-value=0.46 Score=51.19 Aligned_cols=73 Identities=12% Similarity=0.133 Sum_probs=46.7
Q ss_pred EEEeccCCCCceeEEEeCC-------CCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeE
Q 007035 419 TEYLGSAAFSKVFQAQDLH-------TGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (621)
Q Consensus 419 ~~~LG~G~fG~Vyka~d~~-------tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l 491 (621)
++.|..|-...+|+..... .++.+++|+........-...+|..+++.+..... .+++++.+ .+
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi-----~P~l~~~~--~~-- 145 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINI-----APNIIADF--PE-- 145 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTS-----SCCEEEEE--TT--
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCC-----CCCEEEEc--CC--
Confidence 3456667777888887532 15789999876543333345688999998876532 34444433 22
Q ss_pred EEEEecccc
Q 007035 492 FIVCELLRA 500 (621)
Q Consensus 492 ~LVmEyl~g 500 (621)
++||||++|
T Consensus 146 ~~I~efI~G 154 (424)
T 3mes_A 146 GRIEEFIDG 154 (424)
T ss_dssp EEEEECCCS
T ss_pred CEEEEEeCC
Confidence 688999986
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=92.28 E-value=0.52 Score=46.44 Aligned_cols=97 Identities=12% Similarity=0.042 Sum_probs=60.6
Q ss_pred chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHH-CCeecccCCCccEEEeccCCCeEEEEecCCccccCCCccc
Q 007035 501 NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS-LGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL 579 (621)
Q Consensus 501 sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs-~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~~~~~~~~~ 579 (621)
+|.+.+...... +++.++|.++.|++.+|.-+-. ..-..+=+.|..|++.. +|.|.+.+ ..+.
T Consensus 34 SL~eIL~~~~~P-----lsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~--dG~V~f~~-~~s~-------- 97 (229)
T 2yle_A 34 SLEEILRLYNQP-----INEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWR--DGAVTLAP-AADD-------- 97 (229)
T ss_dssp EHHHHHHHHTSC-----CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEET--TSCEEECC-C-----------
T ss_pred cHHHHHHHcCCC-----cCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEec--CCceeccc-cccc--------
Confidence 577777665432 9999999999999999877632 12123445568898884 77776654 1110
Q ss_pred cccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh
Q 007035 580 YVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT 615 (621)
Q Consensus 580 ~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt 615 (621)
.....+.|||... ...+.+.=|||||++||..+-
T Consensus 98 -~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 98 -AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp ----------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred -ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence 1233466887763 244678899999999998653
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=92.10 E-value=0.68 Score=49.08 Aligned_cols=31 Identities=26% Similarity=0.443 Sum_probs=25.4
Q ss_pred eecccCCCccEEEec----cCCCeEEEEecCCccc
Q 007035 542 IIHCDLKPENILIKS----YQRCEIKIIDLGSSCF 572 (621)
Q Consensus 542 IvHrDLKP~NILl~~----~~~~~IKL~DFGls~~ 572 (621)
++|+|+.+.|||+.. +....+.++||..|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 679999999999953 2456799999998753
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 621 | ||||
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-45 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-44 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-43 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-42 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-42 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-41 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-41 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-40 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 5e-40 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 5e-40 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 8e-40 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-39 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-39 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 7e-39 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 8e-39 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-37 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-37 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-37 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 4e-37 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-36 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-36 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-36 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-36 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-36 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 5e-36 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 9e-36 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-35 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-34 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-34 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-34 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-34 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-33 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 8e-33 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-32 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-32 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-32 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-32 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-32 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 4e-32 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 7e-32 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-31 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 4e-31 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 5e-31 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-30 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-30 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-28 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-28 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 7e-28 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-27 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-27 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-27 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-27 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 4e-27 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 5e-27 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 5e-27 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 6e-27 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-26 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 5e-26 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 5e-26 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-25 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-24 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-23 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-18 |
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 161 bits (409), Expect = 4e-45
Identities = 50/215 (23%), Positives = 93/215 (43%), Gaps = 15/215 (6%)
Query: 407 ILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSL-DEIKLLK 465
I + + Y + E LG+ AF V + + TG + K + + +++ EI+ +
Sbjct: 19 IKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMS 78
Query: 466 LVNKNDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQ 524
++ H ++ L+D F + ++ E + F+K E +
Sbjct: 79 VLR-------HPTLVNLHDAFEDDNEMVMIYEFMSGGEL-FEKVADEHNK---MSEDEAV 127
Query: 525 VITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN--LCLYVQ 582
RQ + L ++H +H DLKPENI+ + + E+K+ID G + + +
Sbjct: 128 EYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTG 187
Query: 583 SRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGE 617
+ + APEV G P D+WS+G + L +G
Sbjct: 188 TAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGL 222
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 2e-44
Identities = 54/208 (25%), Positives = 88/208 (42%), Gaps = 18/208 (8%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK----NDKDFFDQSLDEIKLLKLVNKN 470
+ + LG F V+ A++ + + LK++ Q E+++ +
Sbjct: 7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH- 65
Query: 471 DPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQC 530
+ILRLY YF+ ++++ E + F R +
Sbjct: 66 -----PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-----FDEQRTATYITEL 115
Query: 531 LEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF-QTDNLCLYVQSRSYRAP 589
AL Y HS +IH D+KPEN+L+ S E+KI D G S + + Y P
Sbjct: 116 ANALSYCHSKRVIHRDIKPENLLLGS--AGELKIADFGWSVHAPSSRRTTLCGTLDYLPP 173
Query: 590 EVIIGLPYDQKIDLWSLGCILAELWTGE 617
E+I G +D+K+DLWSLG + E G+
Sbjct: 174 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 201
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 3e-43
Identities = 53/208 (25%), Positives = 88/208 (42%), Gaps = 19/208 (9%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK--NDKDFFDQSLDEIKLLKLVNKNDP 472
+ LG+ VF+ +G+ + K+I +Q + E+++L N
Sbjct: 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECN---- 62
Query: 473 ADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCL 531
+I+ Y FY + I E + + L ++ +
Sbjct: 63 ---SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-----RIPEQILGKVSIAVI 114
Query: 532 EALEYLHS-LGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL-YVQSRSYRAP 589
+ L YL I+H D+KP NIL+ S R EIK+ D G S D++ +V +RSY +P
Sbjct: 115 KGLTYLREKHKIMHRDVKPSNILVNS--RGEIKLCDFGVSGQLIDSMANSFVGTRSYMSP 172
Query: 590 EVIIGLPYDQKIDLWSLGCILAELWTGE 617
E + G Y + D+WS+G L E+ G
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGR 200
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 154 bits (390), Expect = 2e-42
Identities = 48/211 (22%), Positives = 92/211 (43%), Gaps = 17/211 (8%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSL-DEIKLLKLVNKN 470
+ Y + E LGS AF V + + TG K I ++ +EI ++ ++
Sbjct: 27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLH-- 84
Query: 471 DPADEH-HILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITR 528
H ++ L+D F + ++ E L L++ + + R
Sbjct: 85 -----HPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK-----MSEAEVINYMR 134
Query: 529 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN--LCLYVQSRSY 586
Q E L+++H I+H D+KPENI+ ++ + +KIID G + + + + + +
Sbjct: 135 QACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEF 194
Query: 587 RAPEVIIGLPYDQKIDLWSLGCILAELWTGE 617
APE++ P D+W++G + L +G
Sbjct: 195 AAPEIVDREPVGFYTDMWAIGVLGYVLLSGL 225
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 2e-42
Identities = 65/212 (30%), Positives = 101/212 (47%), Gaps = 21/212 (9%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKII-KNDKDFFDQSLDEIKLLKLVNKNDPA 473
+ + LG AF KV++AQ+ T V K+I ++ + + EI +L +
Sbjct: 13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDH---- 68
Query: 474 DEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEA 533
+I++L D FY+ +L+I+ E + E T ++QV+ +Q L+A
Sbjct: 69 --PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP----LTESQIQVVCKQTLDA 122
Query: 534 LEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL---YVQSRSYRAPE 590
L YLH IIH DLK NIL +IK+ D G S T + ++ + + APE
Sbjct: 123 LNYLHDNKIIHRDLKAGNILFTL--DGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPE 180
Query: 591 VIIGL-----PYDQKIDLWSLGCILAELWTGE 617
V++ PYD K D+WSLG L E+ E
Sbjct: 181 VVMCETSKDRPYDYKADVWSLGITLIEMAEIE 212
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 1e-41
Identities = 53/209 (25%), Positives = 89/209 (42%), Gaps = 14/209 (6%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKND 471
+ +Y + E LG F V + + + K +K EI +L +
Sbjct: 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIAR--- 59
Query: 472 PADEHHILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQC 530
+IL L++ F +E L ++ E + +++E + + Q
Sbjct: 60 ---HRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFE-----LNEREIVSYVHQV 111
Query: 531 LEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF--QTDNLCLYVQSRSYRA 588
EAL++LHS I H D++PENI+ ++ + IKII+ G + DN L + Y A
Sbjct: 112 CEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYA 171
Query: 589 PEVIIGLPYDQKIDLWSLGCILAELWTGE 617
PEV D+WSLG ++ L +G
Sbjct: 172 PEVHQHDVVSTATDMWSLGTLVYVLLSGI 200
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 1e-41
Identities = 53/209 (25%), Positives = 95/209 (45%), Gaps = 20/209 (9%)
Query: 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKII-KNDKDFFDQSLDEIKLLKLVNKNDP 472
+Y E +G A V+ A D+ TG +V ++ + + + ++EI +++
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENK---- 75
Query: 473 ADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCL 531
+ +I+ D + + L++V E L G++ + R+CL
Sbjct: 76 ---NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET------CMDEGQIAAVCRECL 126
Query: 532 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF---QTDNLCLYVQSRSYRA 588
+ALE+LHS +IH D+K +NIL+ +K+ D G + V + + A
Sbjct: 127 QALEFLHSNQVIHRDIKSDNILLGM--DGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMA 184
Query: 589 PEVIIGLPYDQKIDLWSLGCILAELWTGE 617
PEV+ Y K+D+WSLG + E+ GE
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (373), Expect = 3e-40
Identities = 64/216 (29%), Positives = 97/216 (44%), Gaps = 22/216 (10%)
Query: 411 VIAGRYYVT-EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNK 469
I Y VT + LG KV Q + T LK++++ E++L ++
Sbjct: 8 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKA----RREVELHWRASQ 63
Query: 470 NDPADEHHILRLYDYFYHL----EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQ 524
HI+R+ D + +L + L IV E L L+ + G+ FT
Sbjct: 64 CP-----HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQ----DRGDQAFTEREAS 114
Query: 525 VITRQCLEALEYLHSLGIIHCDLKPENILIKSY-QRCEIKIIDLGSSCFQTDN--LCLYV 581
I + EA++YLHS+ I H D+KPEN+L S +K+ D G + T + L
Sbjct: 115 EIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPC 174
Query: 582 QSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGE 617
+ Y APEV+ YD+ D+WSLG I+ L G
Sbjct: 175 YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGY 210
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 146 bits (370), Expect = 5e-40
Identities = 46/211 (21%), Positives = 90/211 (42%), Gaps = 23/211 (10%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK----NDKDFFDQSLDEIKLLKLVNKN 470
+ +G +F V+ A+D+ V +K + + + + E++ L+ +
Sbjct: 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-- 73
Query: 471 DPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQ 529
H + ++ + ++V E + + + +++ + +T
Sbjct: 74 -----HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP-----LQEVEIAAVTHG 123
Query: 530 CLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAP 589
L+ L YLHS +IH D+K NIL+ +K+ D GS+ +V + + AP
Sbjct: 124 ALQGLAYLHSHNMIHRDVKAGNILLSE--PGLVKLGDFGSASIMAPA-NSFVGTPYWMAP 180
Query: 590 EVIIGL---PYDQKIDLWSLGCILAELWTGE 617
EVI+ + YD K+D+WSLG EL +
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIELAERK 211
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 146 bits (368), Expect = 5e-40
Identities = 44/222 (19%), Positives = 83/222 (37%), Gaps = 24/222 (10%)
Query: 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKN 470
V+ Y V +G +F +F+ +L V +K D Q DE + KL+
Sbjct: 2 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-PQLRDEYRTYKLLAGC 60
Query: 471 DPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQC 530
I +Y + H +V +LL +L + F++ + + +Q
Sbjct: 61 -----TGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGR-----KFSVKTVAMAAKQM 110
Query: 531 LEALEYLHSLGIIHCDLKPENILIKSYQRCE---IKIIDLGSSCFQTDNLC--------- 578
L ++ +H +++ D+KP+N LI I ++D G F D +
Sbjct: 111 LARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREK 170
Query: 579 -LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVC 619
+ Y + +G ++ DL +LG + G +
Sbjct: 171 KNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLP 212
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 8e-40
Identities = 58/209 (27%), Positives = 99/209 (47%), Gaps = 10/209 (4%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHT-GVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPA 473
+Y +G A+ KVF+A+DL G V LK ++ L I+ + ++ +
Sbjct: 8 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 67
Query: 474 DEHHILRLYDYFY-----HLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITR 528
+ +++RL+D L +V E + +L + E G ++ +
Sbjct: 68 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG----VPTETIKDMMF 123
Query: 529 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRA 588
Q L L++LHS ++H DLKP+NIL+ S + ++ L L V + YRA
Sbjct: 124 QLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRA 183
Query: 589 PEVIIGLPYDQKIDLWSLGCILAELWTGE 617
PEV++ Y +DLWS+GCI AE++ +
Sbjct: 184 PEVLLQSSYATPVDLWSVGCIFAEMFRRK 212
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 144 bits (364), Expect = 2e-39
Identities = 48/219 (21%), Positives = 88/219 (40%), Gaps = 22/219 (10%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKND 471
+ RY + +GS +F ++ D+ G +V +K+ Q E K+ K++
Sbjct: 5 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-PQLHIESKIYKMMQ--- 60
Query: 472 PADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCL 531
I + ++ +V ELL +L + F F+L + ++ Q +
Sbjct: 61 --GGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK-----FSLKTVLLLADQMI 113
Query: 532 EALEYLHSLGIIHCDLKPENILIKSY-QRCEIKIIDLGSSCFQTDN----------LCLY 580
+EY+HS IH D+KP+N L+ + + IID G + D
Sbjct: 114 SRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNL 173
Query: 581 VQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVC 619
+ Y + +G+ ++ DL SLG +L G +
Sbjct: 174 TGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLP 212
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (360), Expect = 3e-39
Identities = 55/215 (25%), Positives = 92/215 (42%), Gaps = 18/215 (8%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-------DFFDQSLDEIKLL 464
+ +Y V LGS F V+ + + V +K ++ D+ + E+ LL
Sbjct: 2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 61
Query: 465 KLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQ 524
K V+ ++RL D+F + ++ E F + +
Sbjct: 62 KKVSSGFS----GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA----LQEELAR 113
Query: 525 VITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL-YVQS 583
Q LEA+ + H+ G++H D+K ENILI R E+K+ID GS D + + +
Sbjct: 114 SFFWQVLEAVRHCHNCGVLHRDIKDENILI-DLNRGELKLIDFGSGALLKDTVYTDFDGT 172
Query: 584 RSYRAPEVIIGLPY-DQKIDLWSLGCILAELWTGE 617
R Y PE I Y + +WSLG +L ++ G+
Sbjct: 173 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 207
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 144 bits (364), Expect = 7e-39
Identities = 74/224 (33%), Positives = 118/224 (52%), Gaps = 11/224 (4%)
Query: 405 PIILNTVIA-GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKL 463
P RY + LG FS V+ A+D+ V +KI++ DK + + + DEIKL
Sbjct: 3 PAFKGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKL 62
Query: 464 LKLVN-----KNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYF 518
L+ VN K D +HIL+L D+F H + ++ L E +
Sbjct: 63 LQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGI 122
Query: 519 TLGRLQVITRQCLEALEYL-HSLGIIHCDLKPENILIKS----YQRCEIKIIDLGSSCFQ 573
L ++ I++Q L L+Y+ GIIH D+KPEN+L++ +IKI DLG++C+
Sbjct: 123 PLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWY 182
Query: 574 TDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGE 617
++ +Q+R YR+PEV++G P+ D+WS C++ EL TG+
Sbjct: 183 DEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 226
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 8e-39
Identities = 50/214 (23%), Positives = 90/214 (42%), Gaps = 21/214 (9%)
Query: 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKII--KNDKDFFDQSLDEIKLLKLVNKND 471
+ + + LG A+ +V A + T V +KI+ K D + EI + K++N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN--- 61
Query: 472 PADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCL 531
++++ Y + ++ E F + + G Q Q +
Sbjct: 62 ---HENVVKFYGHRREGNIQYLFLEYCSGGEL-FDRIEPDIG----MPEPDAQRFFHQLM 113
Query: 532 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF-----QTDNLCLYVQSRSY 586
+ YLH +GI H D+KPEN+L+ R +KI D G + + L + Y
Sbjct: 114 AGVVYLHGIGITHRDIKPENLLLDE--RDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 171
Query: 587 RAPEVIIGLPYD-QKIDLWSLGCILAELWTGEVC 619
APE++ + + +D+WS G +L + GE+
Sbjct: 172 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 205
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 2e-37
Identities = 55/213 (25%), Positives = 91/213 (42%), Gaps = 24/213 (11%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK----NDKDFFDQSLDEIKLLKLVNKN 470
+ + LG +FS V A++L T + +KI++ ++ E ++ ++
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-- 66
Query: 471 DPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQ 529
H ++LY F E L+ + S F + T +
Sbjct: 67 -----HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS-----FDETCTRFYTAE 116
Query: 530 CLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN-----LCLYVQSR 584
+ ALEYLH GIIH DLKPENIL+ I+I D G++ + +V +
Sbjct: 117 IVSALEYLHGKGIIHRDLKPENILLNE--DMHIQITDFGTAKVLSPESKQARANSFVGTA 174
Query: 585 SYRAPEVIIGLPYDQKIDLWSLGCILAELWTGE 617
Y +PE++ + DLW+LGCI+ +L G
Sbjct: 175 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGL 207
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 3e-37
Identities = 51/219 (23%), Positives = 97/219 (44%), Gaps = 24/219 (10%)
Query: 410 TVIAGRYY-VTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKN---DKDFFDQSLDEIKLLK 465
GR+ +G +F V++ D T V+V +++ K + +E ++LK
Sbjct: 4 MSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLK 63
Query: 466 LVNKNDPADEHHILRLYDYFYHL----EHLFIVCELLRANLYEFQKFNQESGGEAYFTLG 521
+ +I+R YD + + + +V EL+ + + + +
Sbjct: 64 GLQ------HPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV-----MKIK 112
Query: 522 RLQVITRQCLEALEYLHSLG--IIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC- 578
L+ RQ L+ L++LH+ IIH DLK +NI I +KI DLG + + +
Sbjct: 113 VLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITG-PTGSVKIGDLGLATLKRASFAK 171
Query: 579 LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGE 617
+ + + APE+ YD+ +D+++ G + E+ T E
Sbjct: 172 AVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSE 209
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 137 bits (346), Expect = 3e-37
Identities = 59/222 (26%), Positives = 95/222 (42%), Gaps = 32/222 (14%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK----------NDKDFFDQSLDEIKLL 464
Y E LG S V + T + +KII ++ + +L E+ +L
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 465 KLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRL 523
+ V+ +I++L D + F+V +L++ L+++ +
Sbjct: 64 RKVS-----GHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV------TLSEKET 112
Query: 524 QVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF--QTDNLCLYV 581
+ I R LE + LH L I+H DLKPENIL+ IK+ D G SC + L
Sbjct: 113 RKIMRALLEVICALHKLNIVHRDLKPENILLDD--DMNIKLTDFGFSCQLDPGEKLREVC 170
Query: 582 QSRSYRAPEVIIG------LPYDQKIDLWSLGCILAELWTGE 617
+ SY APE+I Y +++D+WS G I+ L G
Sbjct: 171 GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS 212
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 138 bits (348), Expect = 4e-37
Identities = 64/213 (30%), Positives = 99/213 (46%), Gaps = 20/213 (9%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQS--LDEIKLLKLVNK 469
I Y + LG+ AFS+V A+D T V +K I + +EI +L +
Sbjct: 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIK- 65
Query: 470 NDPADEH-HILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVIT 527
H +I+ L D + HL+++ +L+ L++ ++T +
Sbjct: 66 ------HPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG------FYTERDASRLI 113
Query: 528 RQCLEALEYLHSLGIIHCDLKPENILIKS-YQRCEIKIIDLGSSCFQTDN--LCLYVQSR 584
Q L+A++YLH LGI+H DLKPEN+L S + +I I D G S + L +
Sbjct: 114 FQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTP 173
Query: 585 SYRAPEVIIGLPYDQKIDLWSLGCILAELWTGE 617
Y APEV+ PY + +D WS+G I L G
Sbjct: 174 GYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGY 206
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 136 bits (343), Expect = 1e-36
Identities = 54/220 (24%), Positives = 92/220 (41%), Gaps = 23/220 (10%)
Query: 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK----NDKDFFDQSLDEIKLLK 465
+ ++ RY + E LG S+V A+DL DV +K+++ D F+ + E +
Sbjct: 3 SHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAA 62
Query: 466 LVNKNDPADEHHILRLYDYFYHLEH----LFIVCELLRANLYEFQKFNQESGGEAYFTLG 521
+N I+ +YD +IV E + + T
Sbjct: 63 ALN------HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-----MTPK 111
Query: 522 RLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN----L 577
R + +AL + H GIIH D+KP NI+I + ++ + + + N
Sbjct: 112 RAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 171
Query: 578 CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGE 617
+ + Y +PE G D + D++SLGC+L E+ TGE
Sbjct: 172 AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 211
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 1e-36
Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 19/210 (9%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK---NDKDFFDQSLDEIKLLKLVNKND 471
+ E +G + V++A++ TG V LK I+ + ++ EI LLK +N
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH-- 60
Query: 472 PADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCL 531
+I++L D + L++V E L +L +F + +G L ++ Q L
Sbjct: 61 ----PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG----IPLPLIKSYLFQLL 112
Query: 532 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF---QTDNLCLYVQSRSYRA 588
+ L + HS ++H DLKP+N+LI + IK+ D G + V + YRA
Sbjct: 113 QGLAFCHSHRVLHRDLKPQNLLINT--EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRA 170
Query: 589 PEVIIGLPY-DQKIDLWSLGCILAELWTGE 617
PE+++G Y +D+WSLGCI AE+ T
Sbjct: 171 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 2e-36
Identities = 46/216 (21%), Positives = 86/216 (39%), Gaps = 24/216 (11%)
Query: 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK---NDKDFFDQSLDEIKLLKLVNKNDP 472
Y V +G+ ++ + + + G + K + + + E+ LL+ +
Sbjct: 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK---- 61
Query: 473 ADEHHILRLYDYFYHLE--HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQ 529
+I+R YD L+IV E +L + Y + + Q
Sbjct: 62 --HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQ--YLDEEFVLRVMTQ 117
Query: 530 CLEALEYLHSLG-----IIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL---YV 581
AL+ H ++H DLKP N+ + + +K+ D G + + +V
Sbjct: 118 LTLALKECHRRSDGGHTVLHRDLKPANVFLDG--KQNVKLGDFGLARILNHDTSFAKAFV 175
Query: 582 QSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGE 617
+ Y +PE + + Y++K D+WSLGC+L EL
Sbjct: 176 GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALM 211
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 3e-36
Identities = 61/212 (28%), Positives = 107/212 (50%), Gaps = 21/212 (9%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPAD 474
Y T+ +G+ +F V+QA+ +G V +K + DK F ++ E+++++ ++
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR---ELQIMRKLD------ 71
Query: 475 EHHILRLYDYFYH------LEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITR 528
+I+RL +FY +L +V + + +Y + + + +++
Sbjct: 72 HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQT--LPVIYVKLYMY 129
Query: 529 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN--LCLYVQSRSY 586
Q +L Y+HS GI H D+KP+N+L+ +K+ D GS+ Y+ SR Y
Sbjct: 130 QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAV-LKLCDFGSAKQLVRGEPNVSYICSRYY 188
Query: 587 RAPEVIIG-LPYDQKIDLWSLGCILAELWTGE 617
RAPE+I G Y ID+WS GC+LAEL G+
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 135 bits (342), Expect = 3e-36
Identities = 55/207 (26%), Positives = 91/207 (43%), Gaps = 19/207 (9%)
Query: 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK----NDKDFFDQSLDEIKLLKLVNKND 471
+ + LG+ +F +V + H G +K++K + + DE +L +V
Sbjct: 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT--- 62
Query: 472 PADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQC 530
H I+R++ F + +F++ + + + F + +
Sbjct: 63 ----HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQ-----RFPNPVAKFYAAEV 113
Query: 531 LEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPE 590
ALEYLHS II+ DLKPENIL+ IKI D G + + D + Y APE
Sbjct: 114 CLALEYLHSKDIIYRDLKPENILLDK--NGHIKITDFGFAKYVPDVTYTLCGTPDYIAPE 171
Query: 591 VIIGLPYDQKIDLWSLGCILAELWTGE 617
V+ PY++ ID WS G ++ E+ G
Sbjct: 172 VVSTKPYNKSIDWWSFGILIYEMLAGY 198
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (342), Expect = 5e-36
Identities = 63/220 (28%), Positives = 105/220 (47%), Gaps = 29/220 (13%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK--NDKDFFDQSLDEIKLLKLVNK 469
+ RY Y+G A+ V A D V V +K I + + ++L EIK+L
Sbjct: 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR- 64
Query: 470 NDPADEHHILRLYDYFY-----HLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQ 524
+I+ + D ++ +++V L+ A+LY+ K + +
Sbjct: 65 -----HENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH-------LSNDHIC 112
Query: 525 VITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN------LC 578
Q L L+Y+HS ++H DLKP N+L+ + C++KI D G + + L
Sbjct: 113 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNT--TCDLKICDFGLARVADPDHDHTGFLT 170
Query: 579 LYVQSRSYRAPEVII-GLPYDQKIDLWSLGCILAELWTGE 617
YV +R YRAPE+++ Y + ID+WS+GCILAE+ +
Sbjct: 171 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 210
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 136 bits (342), Expect = 9e-36
Identities = 53/209 (25%), Positives = 93/209 (44%), Gaps = 16/209 (7%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK----NDKDFFDQSLDEIKLLKLVNKN 470
+ V +G F +V+ + TG +K + K +L+E +L LV+
Sbjct: 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64
Query: 471 DPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQC 530
D I+ + F+ + L + +L+ + EA ++ +
Sbjct: 65 D---CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA-----DMRFYAAEI 116
Query: 531 LEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC-FQTDNLCLYVQSRSYRAP 589
+ LE++H+ +++ DLKP NIL+ + ++I DLG +C F V + Y AP
Sbjct: 117 ILGLEHMHNRFVVYRDLKPANILLDEH--GHVRISDLGLACDFSKKKPHASVGTHGYMAP 174
Query: 590 EVII-GLPYDQKIDLWSLGCILAELWTGE 617
EV+ G+ YD D +SLGC+L +L G
Sbjct: 175 EVLQKGVAYDSSADWFSLGCMLFKLLRGH 203
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (334), Expect = 3e-35
Identities = 61/208 (29%), Positives = 98/208 (47%), Gaps = 23/208 (11%)
Query: 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIK------NDKDFFDQSLDEIKLLKLVNKNDPA 473
++LG F+ V++A+D +T V +K IK +L EIKLL+ ++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSH---- 59
Query: 474 DEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEA 533
+I+ L D F H ++ +V + + +L K N + ++ L+
Sbjct: 60 --PNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPS-----HIKAYMLMTLQG 112
Query: 534 LEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL---YVQSRSYRAPE 590
LEYLH I+H DLKP N+L+ +K+ D G + V +R YRAPE
Sbjct: 113 LEYLHQHWILHRDLKPNNLLLDE--NGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPE 170
Query: 591 VIIGL-PYDQKIDLWSLGCILAELWTGE 617
++ G Y +D+W++GCILAEL
Sbjct: 171 LLFGARMYGVGVDMWAVGCILAELLLRV 198
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 1e-34
Identities = 59/217 (27%), Positives = 98/217 (45%), Gaps = 20/217 (9%)
Query: 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD---FFDQSLDEIKLLKLVNKN 470
+Y +G F +VF+A+ TG V LK + + + F +L EIK+L+L+
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 471 DPADEHHILRLYDYFYHLE--HLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITR 528
+ + I R Y+ +++V + +L FTL ++ + +
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK-----FTLSEIKRVMQ 124
Query: 529 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS-------CFQTDNLCLYV 581
L L Y+H I+H D+K N+LI + +K+ D G + Q + V
Sbjct: 125 MLLNGLYYIHRNKILHRDMKAANVLIT--RDGVLKLADFGLARAFSLAKNSQPNRYTNRV 182
Query: 582 QSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGE 617
+ YR PE+++G Y IDLW GCI+AE+WT
Sbjct: 183 VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 219
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (325), Expect = 2e-34
Identities = 45/205 (21%), Positives = 82/205 (40%), Gaps = 19/205 (9%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPAD 474
+ + +G F V + G V +K IKND L E ++ +
Sbjct: 8 ELKLLQTIGKGEFGDVMLGD--YRGNKVAVKCIKNDATA-QAFLAEASVMTQLR------ 58
Query: 475 EH-HILRLYDYFYHLE-HLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITRQCL 531
H ++++L + L+IV E + + +L ++ + S G + L +
Sbjct: 59 -HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLR----SRGRSVLGGDCLLKFSLDVC 113
Query: 532 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEV 591
EA+EYL +H DL N+L+ K+ D G + + + APE
Sbjct: 114 EAMEYLEGNNFVHRDLAARNVLVSE--DNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEA 171
Query: 592 IIGLPYDQKIDLWSLGCILAELWTG 616
+ + K D+WS G +L E+++
Sbjct: 172 LREKKFSTKSDVWSFGILLWEIYSF 196
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 2e-34
Identities = 55/211 (26%), Positives = 94/211 (44%), Gaps = 21/211 (9%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKN 470
+ + + LG +F KVF A+ T +K +K D D + ++ E ++L L ++
Sbjct: 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62
Query: 471 DPADEHHILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQ 529
+ ++ F E+LF V E L +L + + F L R +
Sbjct: 63 P-----FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK------FDLSRATFYAAE 111
Query: 530 CLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF---QTDNLCLYVQSRSY 586
+ L++LHS GI++ DLK +NIL+ KI D G + + Y
Sbjct: 112 IILGLQFLHSKGIVYRDLKLDNILLDKDGHI--KIADFGMCKENMLGDAKTNTFCGTPDY 169
Query: 587 RAPEVIIGLPYDQKIDLWSLGCILAELWTGE 617
APE+++G Y+ +D WS G +L E+ G+
Sbjct: 170 IAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 200
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (326), Expect = 3e-34
Identities = 55/218 (25%), Positives = 95/218 (43%), Gaps = 24/218 (11%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQS-------LDEIKLL 464
+ Y E LGS F+ V + ++ TG+ K IK + + E+ +L
Sbjct: 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 67
Query: 465 KLVNKNDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRL 523
K + H +++ L++ + + + ++ EL+ +ES E
Sbjct: 68 KEIQ-------HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEE-----A 115
Query: 524 QVITRQCLEALEYLHSLGIIHCDLKPENILI--KSYQRCEIKIIDLGSSCF--QTDNLCL 579
+Q L + YLHSL I H DLKPENI++ ++ + IKIID G + +
Sbjct: 116 TEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 175
Query: 580 YVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGE 617
+ + APE++ P + D+WS+G I L +G
Sbjct: 176 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA 213
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 3e-33
Identities = 67/216 (31%), Positives = 109/216 (50%), Gaps = 25/216 (11%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK---NDKDFFDQSLDEIKLLKLVN 468
+ Y + +GS A+ V A D TG V +K + + F ++ E++LLK +
Sbjct: 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMR 75
Query: 469 KNDPADEHHILRLYDYFYHLE------HLFIVCELLRANLYEFQKFNQESGGEAYFTLGR 522
+++ L D F E ++V + +L + K + R
Sbjct: 76 ------HENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK-------LGEDR 122
Query: 523 LQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQ 582
+Q + Q L+ L Y+H+ GIIH DLKP N+ + + CE+KI+D G + + YV
Sbjct: 123 IQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVN--EDCELKILDFGLARQADSEMTGYVV 180
Query: 583 SRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGE 617
+R YRAPEVI+ + Y Q +D+WS+GCI+AE+ TG+
Sbjct: 181 TRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 216
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 8e-33
Identities = 60/210 (28%), Positives = 104/210 (49%), Gaps = 11/210 (5%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKN---DKDFFDQSLDEIKLLKLVN 468
+ RY + +GS A V A D +V +K + ++ ++ E+ L+K VN
Sbjct: 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN 74
Query: 469 KNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITR 528
+ ++ + +++V EL+ ANL + + R+ +
Sbjct: 75 HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME--------LDHERMSYLLY 126
Query: 529 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRA 588
Q L +++LHS GIIH DLKP NI++KS +I L + + + YV +R YRA
Sbjct: 127 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 186
Query: 589 PEVIIGLPYDQKIDLWSLGCILAELWTGEV 618
PEVI+G+ Y + +D+WS+GCI+ E+ ++
Sbjct: 187 PEVILGMGYKENVDIWSVGCIMGEMVRHKI 216
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 1e-32
Identities = 57/211 (27%), Positives = 93/211 (44%), Gaps = 20/211 (9%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK---NDKDFFDQSLDEIKLLKLVNKND 471
+Y E +G + VF+A++ T V LK ++ +D+ +L EI LLK +
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELK--- 59
Query: 472 PADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCL 531
+I+RL+D + + L +V E +L ++ ++ Q L
Sbjct: 60 ---HKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPE-----IVKSFLFQLL 111
Query: 532 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF---QTDNLCLYVQSRSYRA 588
+ L + HS ++H DLKP+N+LI K+ + G + V + YR
Sbjct: 112 KGLGFCHSRNVLHRDLKPQNLLINRNGEL--KLANFGLARAFGIPVRCYSAEVVTLWYRP 169
Query: 589 PEVIIGLP-YDQKIDLWSLGCILAELWTGEV 618
P+V+ G Y ID+WS GCI AEL
Sbjct: 170 PDVLFGAKLYSTSIDMWSAGCIFAELANAGR 200
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (313), Expect = 1e-32
Identities = 56/215 (26%), Positives = 90/215 (41%), Gaps = 27/215 (12%)
Query: 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDV-CLKIIKNDKDFFDQSLDEIKLLKLVNKNDP 472
G+ V + +GS +F V++ + H V V L + +E+ +L+
Sbjct: 8 GQITVGQRIGSGSFGTVYKGK-WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR---- 62
Query: 473 ADEH-HILRLYDYFYHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQC 530
H +IL Y L IV + ++LY + F + +L I RQ
Sbjct: 63 ---HVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHIIETK-----FEMIKLIDIARQT 113
Query: 531 LEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF-----QTDNLCLYVQSRS 585
+ ++YLH+ IIH DLK NI + +KI D G + + S
Sbjct: 114 AQGMDYLHAKSIIHRDLKSNNIFLHE--DLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 171
Query: 586 YRAPEVIIGL---PYDQKIDLWSLGCILAELWTGE 617
+ APEVI PY + D+++ G +L EL TG+
Sbjct: 172 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 206
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (313), Expect = 2e-32
Identities = 45/206 (21%), Positives = 77/206 (37%), Gaps = 17/206 (8%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPAD 474
+ LG F +V+ T V +K +K + L E +++K +
Sbjct: 18 SLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLR------ 70
Query: 475 EHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEAL 534
+++LY E ++IV E + + Y L +L + Q +
Sbjct: 71 HEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGK---YLRLPQLVDMAAQIASGM 126
Query: 535 EYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN----LCLYVQSRSYRAPE 590
Y+ + +H DL+ NIL+ K+ D G + DN + APE
Sbjct: 127 AYVERMNYVHRDLRAANILVGE--NLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 184
Query: 591 VIIGLPYDQKIDLWSLGCILAELWTG 616
+ + K D+WS G +L EL T
Sbjct: 185 AALYGRFTIKSDVWSFGILLTELTTK 210
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 124 bits (312), Expect = 2e-32
Identities = 59/210 (28%), Positives = 97/210 (46%), Gaps = 21/210 (10%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKII---KNDKDFFDQSLDEIKLLKLVNKND 471
+Y+ E +G + V++AQ+ + G LK I K D+ ++ EI +LK +
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELK--- 58
Query: 472 PADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCL 531
+I++LYD + + L +V E L +L + + + Q L
Sbjct: 59 ---HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG-----LESVTAKSFLLQLL 110
Query: 532 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN---LCLYVQSRSYRA 588
+ Y H ++H DLKP+N+LI E+KI D G + + + YRA
Sbjct: 111 NGIAYCHDRRVLHRDLKPQNLLINR--EGELKIADFGLARAFGIPVRKYTHEIVTLWYRA 168
Query: 589 PEVIIGL-PYDQKIDLWSLGCILAELWTGE 617
P+V++G Y ID+WS+GCI AE+ G
Sbjct: 169 PDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 3e-32
Identities = 50/207 (24%), Positives = 80/207 (38%), Gaps = 19/207 (9%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPAD 474
+ E LG+ F +V+ + V +K +K D L E L+K +
Sbjct: 14 TLKLVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQ------ 66
Query: 475 EH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEA 533
H ++RLY E ++I+ E + T+ +L + Q E
Sbjct: 67 -HQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIK---LTINKLLDMAAQIAEG 121
Query: 534 LEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS----YRAP 589
+ ++ IH DL+ NIL+ C KI D G + DN + + AP
Sbjct: 122 MAFIEERNYIHRDLRAANILVSDTLSC--KIADFGLARLIEDNEYTAREGAKFPIKWTAP 179
Query: 590 EVIIGLPYDQKIDLWSLGCILAELWTG 616
E I + K D+WS G +L E+ T
Sbjct: 180 EAINYGTFTIKSDVWSFGILLTEIVTH 206
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 124 bits (312), Expect = 4e-32
Identities = 56/206 (27%), Positives = 100/206 (48%), Gaps = 17/206 (8%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPAD 474
Y + LG +S+VF+A ++ V +KI+K K + EIK+L+ +
Sbjct: 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK--KKIKREIKILENLRGGP--- 90
Query: 475 EHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEAL 534
+I+ L D N +F++ Q T ++ + L+AL
Sbjct: 91 --NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT------LTDYDIRFYMYEILKAL 142
Query: 535 EYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN--LCLYVQSRSYRAPEVI 592
+Y HS+GI+H D+KP N++I + ++++ID G + F + V SR ++ PE++
Sbjct: 143 DYCHSMGIMHRDVKPHNVMIDH-EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL 201
Query: 593 IGLP-YDQKIDLWSLGCILAELWTGE 617
+ YD +D+WSLGC+LA + +
Sbjct: 202 VDYQMYDYSLDMWSLGCMLASMIFRK 227
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 124 bits (312), Expect = 7e-32
Identities = 55/229 (24%), Positives = 101/229 (44%), Gaps = 18/229 (7%)
Query: 393 KNRTGFEENKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK- 451
K + F + + P NT ++ + LG+ +F +V + +G +KI+ K
Sbjct: 21 KAKEDFLKKWETPS-QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV 79
Query: 452 ---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKF 508
+ +L+E ++L+ VN +++L F +L++V E +
Sbjct: 80 VKLKQIEHTLNEKRILQAVNF------PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR 133
Query: 509 NQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568
F+ + Q + EYLHSL +I+ DLKPEN+LI Q+ I++ D G
Sbjct: 134 RIG-----RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI--DQQGYIQVTDFG 186
Query: 569 SSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGE 617
+ + APE+I+ Y++ +D W+LG ++ E+ G
Sbjct: 187 FAKRVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGY 235
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (308), Expect = 2e-31
Identities = 63/210 (30%), Positives = 101/210 (48%), Gaps = 13/210 (6%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKN---DKDFFDQSLDEIKLLKLVN 468
+ RY +GS A+ V A D TG+ V +K + ++ E++LLK +
Sbjct: 16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 75
Query: 469 KNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITR 528
+ + +++V L+ A+L K + T +Q +
Sbjct: 76 HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-------LTDDHVQFLIY 128
Query: 529 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRA 588
Q L L+Y+HS IIH DLKP N+ + KI+D G + D + YV +R YRA
Sbjct: 129 QILRGLKYIHSADIIHRDLKPSNLAVNEDCEL--KILDFGLARHTDDEMTGYVATRWYRA 186
Query: 589 PEVIIG-LPYDQKIDLWSLGCILAELWTGE 617
PE+++ + Y+Q +D+WS+GCI+AEL TG
Sbjct: 187 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 120 bits (303), Expect = 4e-31
Identities = 41/207 (19%), Positives = 75/207 (36%), Gaps = 17/207 (8%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPAD 474
+ LG + +V++ + V +K +K D ++ L E ++K +
Sbjct: 18 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK------ 71
Query: 475 EH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEA 533
H ++++L +I+ E + + L + Q A
Sbjct: 72 -HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE---VSAVVLLYMATQISSA 127
Query: 534 LEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN----LCLYVQSRSYRAP 589
+EYL IH DL N L+ +K+ D G S T + + AP
Sbjct: 128 MEYLEKKNFIHRDLAARNCLVGE--NHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 185
Query: 590 EVIIGLPYDQKIDLWSLGCILAELWTG 616
E + + K D+W+ G +L E+ T
Sbjct: 186 ESLAYNKFSIKSDVWAFGVLLWEIATY 212
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 5e-31
Identities = 50/209 (23%), Positives = 85/209 (40%), Gaps = 20/209 (9%)
Query: 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKND 471
+ + LG F KV ++ TG +KI++ + KD ++ E ++L+
Sbjct: 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR--- 63
Query: 472 PADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCL 531
+ L F + L V E F + FT R + + +
Sbjct: 64 ---HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER-----VFTEERARFYGAEIV 115
Query: 532 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS---CFQTDNLCLYVQSRSYRA 588
ALEYLHS +++ D+K EN+++ IKI D G + + + Y A
Sbjct: 116 SALEYLHSRDVVYRDIKLENLMLDKD--GHIKITDFGLCKEGISDGATMKTFCGTPEYLA 173
Query: 589 PEVIIGLPYDQKIDLWSLGCILAELWTGE 617
PEV+ Y + +D W LG ++ E+ G
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (296), Expect = 2e-30
Identities = 41/208 (19%), Positives = 79/208 (37%), Gaps = 21/208 (10%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPAD 474
+ +GS F V L V +K I+ + ++E +++ ++
Sbjct: 6 ELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLS------ 58
Query: 475 EH-HILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLE 532
H +++LY + +V E + L ++ + + L + E
Sbjct: 59 -HPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAE-----TLLGMCLDVCE 112
Query: 533 ALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN----LCLYVQSRSYRA 588
+ YL +IH DL N L+ + IK+ D G + F D+ + +
Sbjct: 113 GMAYLEEACVIHRDLAARNCLVG--ENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWAS 170
Query: 589 PEVIIGLPYDQKIDLWSLGCILAELWTG 616
PEV Y K D+WS G ++ E+++
Sbjct: 171 PEVFSFSRYSSKSDVWSFGVLMWEVFSE 198
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (295), Expect = 2e-30
Identities = 45/206 (21%), Positives = 88/206 (42%), Gaps = 21/206 (10%)
Query: 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADE 475
+ LG+ F V + DV +K+IK D+ ++E K++ ++
Sbjct: 6 LTFLKELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLS------- 57
Query: 476 H-HILRLYDYFYHLEHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEA 533
H +++LY +FI+ E + L + + + F +L + + EA
Sbjct: 58 HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR-----FQTQQLLEMCKDVCEA 112
Query: 534 LEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN----LCLYVQSRSYRAP 589
+EYL S +H DL N L+ + +K+ D G S + D+ + P
Sbjct: 113 MEYLESKQFLHRDLAARNCLVND--QGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPP 170
Query: 590 EVIIGLPYDQKIDLWSLGCILAELWT 615
EV++ + K D+W+ G ++ E+++
Sbjct: 171 EVLMYSKFSSKSDIWAFGVLMWEIYS 196
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (282), Expect = 1e-28
Identities = 49/215 (22%), Positives = 79/215 (36%), Gaps = 28/215 (13%)
Query: 415 RYYVTEYLGSAAFSKVFQAQ---DLHTGVDVCLKIIK----NDKDFFDQSLDEIKLLKLV 467
+ E LG +F V + + V V +K +K + + D + E+ + +
Sbjct: 9 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 68
Query: 468 NKNDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVI 526
+ H +++RLY + +L + + +Q F LG L
Sbjct: 69 D-------HRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGH-----FLLGTLSRY 116
Query: 527 TRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS- 585
Q E + YL S IH DL N+L+ R +KI D G N YV
Sbjct: 117 AVQVAEGMGYLESKRFIHRDLAARNLLL--ATRDLVKIGDFGLMRALPQNDDHYVMQEHR 174
Query: 586 -----YRAPEVIIGLPYDQKIDLWSLGCILAELWT 615
+ APE + + D W G L E++T
Sbjct: 175 KVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 209
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (285), Expect = 2e-28
Identities = 47/232 (20%), Positives = 83/232 (35%), Gaps = 37/232 (15%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTG-----VDVCLKIIKNDKD--FFDQSLDEIKLLKLV 467
+ LGS AF KV A + V +K++K D + + E+K++ +
Sbjct: 38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL 97
Query: 468 NKNDPADEHHILRLYDYFYHLEHLFIVCELL------------------RANLYEFQKFN 509
++ +I+ L ++++ E YE QK
Sbjct: 98 GSHE-----NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRL 152
Query: 510 QESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569
+E T L Q + +E+L +H DL N+L+ +KI D G
Sbjct: 153 EEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTH--GKVVKICDFGL 210
Query: 570 SCFQTDN-----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTG 616
+ + + APE + Y K D+WS G +L E+++
Sbjct: 211 ARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSL 262
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (280), Expect = 7e-28
Identities = 45/212 (21%), Positives = 83/212 (39%), Gaps = 24/212 (11%)
Query: 416 YYVTEYLGSAAFSKVFQAQDLHTG----VDVCLKIIK--NDKDFFDQSLDEIKLLKLVNK 469
+ + LGS AF V++ + G + V +K ++ + LDE ++ V+
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 470 NDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQ 529
H+ RL I + L ++ + ++++ G Y L Q
Sbjct: 71 ------PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQY-----LLNWCVQ 119
Query: 530 CLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF-----QTDNLCLYVQSR 584
+ + YL ++H DL N+L+K+ +KI D G + + +
Sbjct: 120 IAKGMNYLEDRRLVHRDLAARNVLVKT--PQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 177
Query: 585 SYRAPEVIIGLPYDQKIDLWSLGCILAELWTG 616
+ A E I+ Y + D+WS G + EL T
Sbjct: 178 KWMALESILHRIYTHQSDVWSYGVTVWELMTF 209
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (277), Expect = 1e-27
Identities = 42/224 (18%), Positives = 83/224 (37%), Gaps = 29/224 (12%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKND 471
IA + E +G F +V++ + G +V +KI + ++ E ++ + V
Sbjct: 1 IARTIVLQESIGKGRFGEVWRGK--WRGEEVAVKIFSSREE--RSWFREAEIYQTVMLRH 56
Query: 472 PADEHHILRLYDYFYH----LEHLFIVCELLRA-NLYEF-QKFNQESGGEAYFTLGRLQV 525
+IL L++V + +L+++ ++ G L
Sbjct: 57 E----NILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASG 112
Query: 526 ITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLY----- 580
+ +E + I H DLK +NIL+K I DLG +
Sbjct: 113 LAHLHMEIVGTQGKPAIAHRDLKSKNILVKK--NGTCCIADLGLAVRHDSATDTIDIAPN 170
Query: 581 --VQSRSYRAPEVIIG------LPYDQKIDLWSLGCILAELWTG 616
V ++ Y APEV+ ++ D++++G + E+
Sbjct: 171 HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR 214
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (275), Expect = 2e-27
Identities = 44/205 (21%), Positives = 76/205 (37%), Gaps = 25/205 (12%)
Query: 422 LGSAAFSKVFQA--QDLHTGVDVCLKIIK---NDKDFFDQSLDEIKLLKLVNKNDPADEH 476
LGS F V + Q V +KI+K ND D+ L E +++ ++
Sbjct: 15 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDN------P 68
Query: 477 HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEY 536
+I+R+ E +V E+ + + + Q ++Y
Sbjct: 69 YIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNR-----HVKDKNIIELVHQVSMGMKY 122
Query: 537 LHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS------YRAPE 590
L +H DL N+L+ + + KI D G S + Y + APE
Sbjct: 123 LEESNFVHRDLAARNVLLVT--QHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 180
Query: 591 VIIGLPYDQKIDLWSLGCILAELWT 615
I + K D+WS G ++ E ++
Sbjct: 181 CINYYKFSSKSDVWSFGVLMWEAFS 205
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 110 bits (276), Expect = 2e-27
Identities = 40/214 (18%), Positives = 80/214 (37%), Gaps = 25/214 (11%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTG---VDVCLKIIKND--KDFFDQSLDEIKLLKLVNK 469
+ + +G+ F +V G + V +K +K+ + L E ++ +
Sbjct: 27 CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD- 85
Query: 470 NDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQ 529
+++ L + I+ E + + + FT+ +L + R
Sbjct: 86 -----HPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDG----QFTVIQLVGMLRG 136
Query: 530 CLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS---- 585
++YL + +H DL NIL+ S K+ D G S F D+ + +
Sbjct: 137 IAAGMKYLADMNYVHRDLAARNILVNS--NLVCKVSDFGLSRFLEDDTSDPTYTSALGGK 194
Query: 586 ----YRAPEVIIGLPYDQKIDLWSLGCILAELWT 615
+ APE I + D+WS G ++ E+ +
Sbjct: 195 IPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMS 228
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (274), Expect = 3e-27
Identities = 47/227 (20%), Positives = 82/227 (36%), Gaps = 32/227 (14%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLH-----TGVDVCLKIIKNDKDFFDQS--LDEIKLLKLV 467
R + LG+ AF KV +A + V +K++K ++ + E+K+L +
Sbjct: 24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYL 83
Query: 468 NKNDPADEHHILRLYDYFYHLEHLFIVCELL-------------RANLYEFQKFNQESGG 514
+ +I+ L ++ E + +
Sbjct: 84 -----GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 138
Query: 515 EAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQT 574
E L L + Q + + +L S IH DL NIL+ KI D G +
Sbjct: 139 ELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL--THGRITKICDFGLARDIK 196
Query: 575 DNLCLYVQSRS-----YRAPEVIIGLPYDQKIDLWSLGCILAELWTG 616
++ V+ + + APE I Y + D+WS G L EL++
Sbjct: 197 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSL 243
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 109 bits (273), Expect = 4e-27
Identities = 45/233 (19%), Positives = 77/233 (33%), Gaps = 39/233 (16%)
Query: 415 RYYVTEYLGSAAFSKVFQAQ-----DLHTGVDVCLKIIKND--KDFFDQSLDEIKLLKLV 467
+G AF +VFQA+ V +K++K + D E L+
Sbjct: 14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF 73
Query: 468 NKNDPADEHHILRLYDYFYHLEHLFIVCELL-RANLYEF------------------QKF 508
+ +I++L + + ++ E + +L EF +
Sbjct: 74 DN------PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRA 127
Query: 509 NQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568
S G + I RQ + YL +H DL N L+ +KI D G
Sbjct: 128 RVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGE--NMVVKIADFG 185
Query: 569 SSCFQTDNLCLYVQSRS-----YRAPEVIIGLPYDQKIDLWSLGCILAELWTG 616
S + PE I Y + D+W+ G +L E+++
Sbjct: 186 LSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSY 238
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (272), Expect = 5e-27
Identities = 46/205 (22%), Positives = 81/205 (39%), Gaps = 25/205 (12%)
Query: 422 LGSAAFSKVFQAQDLHT--GVDVCLKIIK--NDKDFFDQSLDEIKLLKLVNKNDPADEHH 477
LG F V Q +DV +K++K +K ++ + E +++ + D +
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL------DNPY 70
Query: 478 ILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEY 536
I+RL E L +V E+ L++F G + + + Q ++Y
Sbjct: 71 IVRLIGVCQA-EALMLVMEMAGGGPLHKFLV-----GKREEIPVSNVAELLHQVSMGMKY 124
Query: 537 LHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS------YRAPE 590
L +H DL N+L+ + R KI D G S + Y + + APE
Sbjct: 125 LEEKNFVHRDLAARNVLLVN--RHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPE 182
Query: 591 VIIGLPYDQKIDLWSLGCILAELWT 615
I + + D+WS G + E +
Sbjct: 183 CINFRKFSSRSDVWSYGVTMWEALS 207
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (273), Expect = 5e-27
Identities = 38/212 (17%), Positives = 71/212 (33%), Gaps = 20/212 (9%)
Query: 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIK----NDKDFFDQSLDEIKLLKLVNKNDPADE 475
+ +G F +V +A+ G+ + I + KD E+++L + +
Sbjct: 16 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHP---- 71
Query: 476 HHILRLYDYFYHLEHLFIVCELL-----------RANLYEFQKFNQESGGEAYFTLGRLQ 524
+I+ L H +L++ E L F + + + +L
Sbjct: 72 -NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 130
Query: 525 VITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSR 584
++YL IH DL NIL+ +I L +
Sbjct: 131 HFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPV 190
Query: 585 SYRAPEVIIGLPYDQKIDLWSLGCILAELWTG 616
+ A E + Y D+WS G +L E+ +
Sbjct: 191 RWMAIESLNYSVYTTNSDVWSYGVLLWEIVSL 222
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (273), Expect = 6e-27
Identities = 53/217 (24%), Positives = 99/217 (45%), Gaps = 26/217 (11%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLH---TGVDVCLKIIK-----NDKDFFDQSLDEIKLLKL 466
+ + + LG+ A+ KVF + + TG +K++K + + E ++L+
Sbjct: 25 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 84
Query: 467 VNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVI 526
+ ++ L+ F L ++ + + +E FT +Q+
Sbjct: 85 IR-----QSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER-----FTEHEVQIY 134
Query: 527 TRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF----QTDNLCLYVQ 582
+ + ALE+LH LGII+ D+K ENIL+ S + + D G S +T+ +
Sbjct: 135 VGEIVLALEHLHKLGIIYRDIKLENILLDS--NGHVVLTDFGLSKEFVADETERAYDFCG 192
Query: 583 SRSYRAPEVIIGLP--YDQKIDLWSLGCILAELWTGE 617
+ Y AP+++ G +D+ +D WSLG ++ EL TG
Sbjct: 193 TIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 229
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (269), Expect = 1e-26
Identities = 50/225 (22%), Positives = 88/225 (39%), Gaps = 28/225 (12%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVD-------VCLKIIKND--KDFFDQSLDEIKLLK 465
R + + LG AF +V A+ + D V +K++K+D + + E++++K
Sbjct: 14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMK 73
Query: 466 LVNKNDPADEHHILRLYDYFYHLEHLFIVCELL-RANLYEF----------QKFNQESGG 514
++ K+ +I+ L L+++ E + NL E+ +N
Sbjct: 74 MIGKH-----KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 128
Query: 515 EAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQT 574
E + L Q +EYL S IH DL N+L+ +I L
Sbjct: 129 EEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 188
Query: 575 D---NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTG 616
D + APE + Y + D+WS G +L E++T
Sbjct: 189 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTL 233
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (266), Expect = 5e-26
Identities = 45/234 (19%), Positives = 82/234 (35%), Gaps = 31/234 (13%)
Query: 401 NKDLPIILNTVIAGRYYVT----EYLGSAAFSKVFQAQDLH---TGVDVCLKIIK--NDK 451
N +L + V+ G + E +G F V+ L + +K + D
Sbjct: 10 NPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI 69
Query: 452 DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE-HLFIVCELLRA-NLYEFQKFN 509
Q L E ++K + ++L L E +V ++ +L F +
Sbjct: 70 GEVSQFLTEGIIMKDFSH------PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE 123
Query: 510 QESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569
+ T+ L Q + +++L S +H DL N ++ + +K+ D G
Sbjct: 124 THN-----PTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDE--KFTVKVADFGL 176
Query: 570 SCFQTDN-------LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTG 616
+ D + A E + + K D+WS G +L EL T
Sbjct: 177 ARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTR 230
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (264), Expect = 5e-26
Identities = 42/207 (20%), Positives = 81/207 (39%), Gaps = 24/207 (11%)
Query: 422 LGSAAFSKVFQAQDLHTG----VDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADE 475
+G+ F +V++ + V V +K +K + L E ++ +
Sbjct: 15 IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH------ 68
Query: 476 HHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALE 535
H+I+RL + + I+ E + + ++ F++ +L + R ++
Sbjct: 69 HNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDG----EFSVLQLVGMLRGIAAGMK 124
Query: 536 YLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN------LCLYVQSRSYRAP 589
YL ++ +H DL NIL+ S K+ D G S D+ + AP
Sbjct: 125 YLANMNYVHRDLAARNILVNS--NLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAP 182
Query: 590 EVIIGLPYDQKIDLWSLGCILAELWTG 616
E I + D+WS G ++ E+ T
Sbjct: 183 EAISYRKFTSASDVWSFGIVMWEVMTY 209
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (257), Expect = 3e-25
Identities = 45/212 (21%), Positives = 74/212 (34%), Gaps = 24/212 (11%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHT---GVDVCLKIIKN--DKDFFDQSLDEIKLLKLVNK 469
R + +G F V Q + + V +K KN ++ L E ++ +
Sbjct: 8 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD- 66
Query: 470 NDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITR 528
H HI++L I+ L F + + S L L +
Sbjct: 67 ------HPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYS-----LDLASLILYAY 115
Query: 529 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS--- 585
Q AL YL S +H D+ N+L+ S +K+ D G S + D+
Sbjct: 116 QLSTALAYLESKRFVHRDIAARNVLVSSN--DCVKLGDFGLSRYMEDSTYYKASKGKLPI 173
Query: 586 -YRAPEVIIGLPYDQKIDLWSLGCILAELWTG 616
+ APE I + D+W G + E+
Sbjct: 174 KWMAPESINFRRFTSASDVWMFGVCMWEILMH 205
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (253), Expect = 2e-24
Identities = 39/219 (17%), Positives = 84/219 (38%), Gaps = 25/219 (11%)
Query: 415 RYYVTEYLGSAAFSKVFQAQD-----LHTGVDVCLKIIKNDKDFFDQS--LDEIKLLKLV 467
+ ++ LG +F V++ V +K + ++ L+E ++K
Sbjct: 21 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF 80
Query: 468 NKNDPADEHHILRLYDYFYHLEHLFIVCEL-----LRANLYEFQKFNQESGGEAYFTLGR 522
N HH++RL + ++ EL L++ L + + A +L +
Sbjct: 81 N------CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 134
Query: 523 LQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQ 582
+ + + + + YL++ +H DL N ++ +KI D G + +
Sbjct: 135 MIQMAGEIADGMAYLNANKFVHRDLAARNCMVAE--DFTVKIGDFGMTRDIYETDYYRKG 192
Query: 583 SRS-----YRAPEVIIGLPYDQKIDLWSLGCILAELWTG 616
+ + +PE + + D+WS G +L E+ T
Sbjct: 193 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATL 231
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.4 bits (244), Expect = 3e-23
Identities = 49/226 (21%), Positives = 87/226 (38%), Gaps = 31/226 (13%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLH-----TGVDVCLKIIKND--KDFFDQSLDEIKLLKLV 467
R + + LG AF +V +A T V +K++K + E+K+L +
Sbjct: 14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 73
Query: 468 NKNDPADEHHILRLYDYFYHL-EHLFIVCELL-----------RANLYEFQKFNQESGGE 515
+++ L L ++ E + N + K E +
Sbjct: 74 G-----HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 128
Query: 516 AYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTD 575
+ TL L + Q + +E+L S IH DL NIL+ + +KI D G +
Sbjct: 129 DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE--KNVVKICDFGLARDIYK 186
Query: 576 NLCLYVQSRS-----YRAPEVIIGLPYDQKIDLWSLGCILAELWTG 616
+ + + + APE I Y + D+WS G +L E+++
Sbjct: 187 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSL 232
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 81.8 bits (201), Expect = 2e-18
Identities = 30/191 (15%), Positives = 53/191 (27%), Gaps = 7/191 (3%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRL 481
+G S VF + +K K F + ++ L
Sbjct: 8 MGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSV--LAIRSARNE 64
Query: 482 YDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLG 541
+ L+ L + + +V+ LE + + G
Sbjct: 65 FRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVL-DMILEEVAKFYHRG 123
Query: 542 IIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKI 601
I+H DL N+L+ I IID S + + R R Y +
Sbjct: 124 IVHGDLSQYNVLV---SEEGIWIIDFPQSVEVGEEGWREILERDVRNIITYFSRTYRTEK 180
Query: 602 DLWSLGCILAE 612
D+ S + +
Sbjct: 181 DINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 621 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.84 | |
| d1a25a_ | 132 | C2 domain from protein kinase c (beta) {Rat (Rattu | 99.7 | |
| d2bwqa1 | 125 | Regulating synaptic membrane exocytosis protein, r | 99.63 | |
| d1dqva1 | 130 | Synaptotagmin III {Rat (Rattus norvegicus) [TaxId: | 99.63 | |
| d1rh8a_ | 142 | Piccolo {Rat (Rattus norvegicus) [TaxId: 10116]} | 99.59 | |
| d1w15a_ | 138 | Synaptotagmin IV {Rat (Rattus norvegicus) [TaxId: | 99.59 | |
| d2cm5a1 | 137 | C2b-domain of rabphilin {Rat (Rattus norvegicus) [ | 99.56 | |
| d1dqva2 | 145 | Synaptotagmin III {Rat (Rattus norvegicus) [TaxId: | 99.56 | |
| d1ugka_ | 138 | Synaptotagmin IV {Human (Homo sapiens) [TaxId: 960 | 99.56 | |
| d1uowa_ | 157 | Synaptogamin I {Rat (Rattus norvegicus) [TaxId: 10 | 99.54 | |
| d1rsya_ | 143 | Synaptogamin I {Rat (Rattus norvegicus) [TaxId: 10 | 99.53 | |
| d1wfma_ | 138 | Synaptotagmin XIII {Human (Homo sapiens) [TaxId: 9 | 99.48 | |
| d2ep6a1 | 126 | Multiple C2 and transmembrane domain-containing pr | 99.46 | |
| d1qasa2 | 131 | PI-specific phospholipase C isozyme D1 (PLC-D1), C | 99.37 | |
| d1rlwa_ | 126 | Domain from cytosolic phospholipase A2 {Human (Hom | 99.34 | |
| d1wfja_ | 136 | C2 domain protein At1g63220 {Thale cress (Arabidop | 99.3 | |
| d1gmia_ | 136 | Domain from protein kinase C epsilon {Rat (Rattus | 99.23 | |
| d2nq3a1 | 133 | E3 ubiquitin-protein ligase Itchy {Human (Homo sap | 99.16 | |
| d1bdya_ | 123 | Domain from protein kinase C delta {Rat (Rattus no | 99.05 | |
| d2cjta1 | 128 | Unc-13 homolog A {Rat (Rattus norvegicus) [TaxId: | 98.97 | |
| d2zkmx2 | 122 | Phospholipase C-beta-2 {Human (Homo sapiens) [TaxI | 98.82 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.16 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.65 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.53 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.79 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.47 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.1 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-42 Score=347.25 Aligned_cols=193 Identities=28% Similarity=0.455 Sum_probs=170.4
Q ss_pred CceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc----hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecC
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~ 489 (621)
++|++.+.||+|+||+||+|+++.+|+.||+|++.+.. .....+.+|+.+++.+ .||||+++++++.+.+
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l------~hpnIv~~~~~~~~~~ 79 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL------RHPNILRLYGYFHDAT 79 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC------CCTTBCCEEEEEECSS
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhc------CCCCCCeEEEEEEECC
Confidence 57999999999999999999999999999999987532 2345667788887766 4789999999999999
Q ss_pred eEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecC
Q 007035 490 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (621)
Q Consensus 490 ~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFG 568 (621)
+++|||||+.+ +|.+++..... +++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||
T Consensus 80 ~~~ivmEy~~~g~L~~~l~~~~~------l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~--~~~~kl~DFG 151 (263)
T d2j4za1 80 RVYLILEYAPLGTVYRELQKLSK------FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGS--AGELKIADFG 151 (263)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT--TSCEEECCCC
T ss_pred EEEEEEeecCCCcHHHHHhhcCC------CCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecC--CCCEeecccc
Confidence 99999999985 77777664332 899999999999999999999999999999999999984 7889999999
Q ss_pred CccccCCC-ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 569 SSCFQTDN-LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 569 ls~~~~~~-~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
++...... .....||+.|+|||++.+..++.++|||||||+||+|++|++||
T Consensus 152 ~a~~~~~~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf 204 (263)
T d2j4za1 152 WSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 204 (263)
T ss_dssp SCSCCCCCCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTT
T ss_pred eeeecCCCcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCC
Confidence 99765443 44568999999999999999999999999999999999999998
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-42 Score=358.20 Aligned_cols=196 Identities=27% Similarity=0.406 Sum_probs=168.7
Q ss_pred eecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecC--chhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEec
Q 007035 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (621)
Q Consensus 411 ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~--~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~ 488 (621)
+..++|++++.||+|+||+||+|+++.+|+.||+|+++.. .....++.+|+.+++.+ .||||++++++|.+.
T Consensus 3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l------~HpnIv~l~~~~~~~ 76 (322)
T d1s9ja_ 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC------NSPYIVGFYGAFYSD 76 (322)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGC------CCTTBCCEEEEEECS
T ss_pred CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhC------CCCCCCcEEEEEEEC
Confidence 4467899999999999999999999999999999999754 23345566676666555 589999999999999
Q ss_pred CeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHH-CCeecccCCCccEEEeccCCCeEEEEe
Q 007035 489 EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS-LGIIHCDLKPENILIKSYQRCEIKIID 566 (621)
Q Consensus 489 ~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs-~gIvHrDLKP~NILl~~~~~~~IKL~D 566 (621)
++++|||||+.+ +|.+++.... .+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|
T Consensus 77 ~~~~iVmEy~~gg~L~~~l~~~~------~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~--~~~~vkl~D 148 (322)
T d1s9ja_ 77 GEISICMEHMDGGSLDQVLKKAG------RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVN--SRGEIKLCD 148 (322)
T ss_dssp SEEEEEEECCTTEEHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEEC--TTCCEEECC
T ss_pred CEEEEEEEcCCCCcHHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeEC--CCCCEEEee
Confidence 999999999985 6777665432 28999999999999999999997 5999999999999998 478999999
Q ss_pred cCCccccCC-CccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 567 LGSSCFQTD-NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 567 FGls~~~~~-~~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
||+|..... .....+||+.|+|||++.+.+|+.++|||||||++|||++|+.||
T Consensus 149 FGla~~~~~~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf 203 (322)
T d1s9ja_ 149 FGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203 (322)
T ss_dssp CCCCHHHHHHTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCS
T ss_pred CCCccccCCCccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 999876432 344578999999999999999999999999999999999999998
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-41 Score=351.15 Aligned_cols=193 Identities=28% Similarity=0.475 Sum_probs=169.7
Q ss_pred cCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc-hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeE
Q 007035 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (621)
Q Consensus 413 ~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~-~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l 491 (621)
.++|++++.||+|+||+||+|+++.+|+.||||+++... ...+.+.+|+.+++.++ ||||++++++|.+.+++
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~------HpnIv~~~~~~~~~~~~ 92 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENK------NPNIVNYLDSYLVGDEL 92 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCC------CTTBCCEEEEEEETTEE
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCC------CCCEeeEeEEEEECCEE
Confidence 357999999999999999999999999999999987543 23456788999988774 78999999999999999
Q ss_pred EEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCc
Q 007035 492 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (621)
Q Consensus 492 ~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls 570 (621)
||||||+.+ +|.+++.. . .+++..++.+++||+.||.|||++||+||||||+|||++. ++.+||+|||++
T Consensus 93 ~ivmEy~~gg~L~~~~~~-~------~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~--~~~vkl~DFG~a 163 (293)
T d1yhwa1 93 WVVMEYLAGGSLTDVVTE-T------CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGM--DGSVKLTDFGFC 163 (293)
T ss_dssp EEEEECCTTCBHHHHHHH-S------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT--TCCEEECCCTTC
T ss_pred EEEEEecCCCcHHHHhhc-c------CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECC--CCcEeeccchhh
Confidence 999999986 55554432 1 2899999999999999999999999999999999999984 789999999999
Q ss_pred cccCC---CccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 571 CFQTD---NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 571 ~~~~~---~~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
..... .....+||+.|+|||++.+..|+.++|||||||++|+|++|++||
T Consensus 164 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf 216 (293)
T d1yhwa1 164 AQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPY 216 (293)
T ss_dssp EECCSTTCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred eeeccccccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCC
Confidence 76533 234567999999999999999999999999999999999999998
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-42 Score=350.19 Aligned_cols=194 Identities=24% Similarity=0.386 Sum_probs=166.9
Q ss_pred cCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc--hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCe
Q 007035 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (621)
Q Consensus 413 ~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~ 490 (621)
.++|++++.||+|+||+||+|+++.+|+.||||++.... ...+++.+|+.+++.+ +||||+++++++.+.+.
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l------~HpnIv~~~~~~~~~~~ 77 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML------NHENVVKFYGHRREGNI 77 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTC------CCTTBCCEEEEEEETTE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhC------CCCCEeeEeeeeccCce
Confidence 468999999999999999999999999999999987643 2345678888888766 47899999999999999
Q ss_pred EEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCC
Q 007035 491 LFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (621)
Q Consensus 491 l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGl 569 (621)
+||||||+.+ +|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+
T Consensus 78 ~~ivmEy~~gg~L~~~l~~~~------~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~--~~~~KL~DFG~ 149 (271)
T d1nvra_ 78 QYLFLEYCSGGELFDRIEPDI------GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDE--RDNLKISDFGL 149 (271)
T ss_dssp EEEEEECCTTEEGGGGSBTTT------BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECT--TCCEEECCCTT
T ss_pred eEEEEeccCCCcHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECC--CCCEEEccchh
Confidence 9999999985 7777664322 3899999999999999999999999999999999999984 78899999999
Q ss_pred ccccCC-----CccccccCCcccCchhhcCCCC-CchhhHHHHHHHHHHHHhCCCCC
Q 007035 570 SCFQTD-----NLCLYVQSRSYRAPEVIIGLPY-DQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 570 s~~~~~-----~~~~~~gt~~Y~APEvl~~~~~-s~ksDIWSLGvILyELltG~~PF 620 (621)
+..... .....+||+.|+|||++.+..+ +.++|||||||+||+|++|++||
T Consensus 150 a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf 206 (271)
T d1nvra_ 150 ATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW 206 (271)
T ss_dssp CEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSC
T ss_pred heeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCC
Confidence 975432 2344689999999999998876 57899999999999999999998
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.3e-41 Score=351.81 Aligned_cols=194 Identities=28% Similarity=0.468 Sum_probs=171.4
Q ss_pred CceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc----hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecC
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~ 489 (621)
++|++++.||+|+||+||+|+++.+|+.||||++++.. ...+.+.+|+.+++.+ .||||+++++++.+.+
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l------~HpnIv~~~~~~~~~~ 77 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV------THPFIIRMWGTFQDAQ 77 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC------CBTTBCCEEEEEECSS
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhc------cCcChhheeeeEeeCC
Confidence 57999999999999999999999999999999997532 2345667788777765 4789999999999999
Q ss_pred eEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCC
Q 007035 490 HLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (621)
Q Consensus 490 ~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGl 569 (621)
++|+||||+.++.+..+...... +++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+
T Consensus 78 ~~~ivmE~~~gg~l~~~~~~~~~-----~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~--~g~vkL~DFG~ 150 (316)
T d1fota_ 78 QIFMIMDYIEGGELFSLLRKSQR-----FPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDK--NGHIKITDFGF 150 (316)
T ss_dssp EEEEEECCCCSCBHHHHHHHTSS-----CCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECT--TSCEEECCCSS
T ss_pred eeeeEeeecCCcccccccccccc-----ccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcC--CCCEEEecCcc
Confidence 99999999987544444333222 788889999999999999999999999999999999984 78999999999
Q ss_pred ccccCCCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 570 SCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 570 s~~~~~~~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
+..........+||+.|+|||++.+..|+.++|||||||+||+|++|+.||
T Consensus 151 a~~~~~~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf 201 (316)
T d1fota_ 151 AKYVPDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPF 201 (316)
T ss_dssp CEECSSCBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTT
T ss_pred ceEeccccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCC
Confidence 988877777789999999999999999999999999999999999999998
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-41 Score=346.46 Aligned_cols=193 Identities=28% Similarity=0.458 Sum_probs=169.4
Q ss_pred CceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc----hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecC
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~ 489 (621)
++|++++.||+|+||+||+|+++.+|+.||||++.+.. ...+.+.+|+++++.++ ||||++++++|.+.+
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~------HpnIv~l~~~~~~~~ 81 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD------HPFFVKLYFTFQDDE 81 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCC------STTBCCEEEEEECSS
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcC------CCCeeEEEEEEEECC
Confidence 67999999999999999999999999999999997532 23456788999888774 789999999999999
Q ss_pred eEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecC
Q 007035 490 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (621)
Q Consensus 490 ~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFG 568 (621)
.+||||||+.+ +|.+++..... +++..++.++.||+.||.|||+++|+||||||+|||++. ++.+||+|||
T Consensus 82 ~~~ivmEy~~gg~L~~~~~~~~~------l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~--~~~vkl~DFG 153 (288)
T d1uu3a_ 82 KLYFGLSYAKNGELLKYIRKIGS------FDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNE--DMHIQITDFG 153 (288)
T ss_dssp EEEEEECCCTTEEHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT--TSCEEECCCT
T ss_pred EEEEEEEccCCCCHHHhhhccCC------CCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCC--CceEEecccc
Confidence 99999999985 77777665432 899999999999999999999999999999999999984 7889999999
Q ss_pred CccccCC-----CccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 569 SSCFQTD-----NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 569 ls~~~~~-----~~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
++..... .....+||+.|+|||++.+..|+.++|||||||+||+|++|+.||
T Consensus 154 ~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf 210 (288)
T d1uu3a_ 154 TAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 210 (288)
T ss_dssp TCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSS
T ss_pred cceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCC
Confidence 9976432 223467999999999999999999999999999999999999998
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.2e-41 Score=349.68 Aligned_cols=197 Identities=32% Similarity=0.474 Sum_probs=158.8
Q ss_pred ecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc--hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecC
Q 007035 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (621)
Q Consensus 412 i~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~ 489 (621)
+.++|++.+.||+|+||+||+|+++.+|+.||||++.+.. .....+.+|+.+++.+ .||||+++++++.+.+
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l------~HpnIv~l~~~~~~~~ 80 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKI------KHPNIVALDDIYESGG 80 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTC------CCTTBCCEEEEEECSS
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhC------CCCCCCcEEEEEEECC
Confidence 5678999999999999999999999999999999997543 2234566788888766 4889999999999999
Q ss_pred eEEEEEeccc-cchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEec-cCCCeEEEEec
Q 007035 490 HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS-YQRCEIKIIDL 567 (621)
Q Consensus 490 ~l~LVmEyl~-gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~-~~~~~IKL~DF 567 (621)
.+||||||+. ++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||+.. +.++.+||+||
T Consensus 81 ~~~lvmE~~~gg~L~~~l~~~~------~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DF 154 (307)
T d1a06a_ 81 HLYLIMQLVSGGELFDRIVEKG------FYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDF 154 (307)
T ss_dssp EEEEEECCCCSCBHHHHHHTCS------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC
T ss_pred EEEEEEeccCCCcHHHhhhccc------CCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEecc
Confidence 9999999998 57888876432 2899999999999999999999999999999999999974 34689999999
Q ss_pred CCccccCCC--ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 568 GSSCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 568 Gls~~~~~~--~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
|++...... ....+||+.|+|||++.+..|+.++|||||||+||+|++|++||
T Consensus 155 G~a~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf 209 (307)
T d1a06a_ 155 GLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPF 209 (307)
T ss_dssp ------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred ceeEEccCCCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCC
Confidence 999765432 34568999999999999999999999999999999999999998
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-40 Score=343.72 Aligned_cols=194 Identities=33% Similarity=0.481 Sum_probs=168.6
Q ss_pred CceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecC-chhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeEE
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND-KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLF 492 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~-~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l~ 492 (621)
+.|++++.||+|+||+||+|+++.+|+.||+|++... ....+.+.+|+++++.++ ||||+++++++.+.+.++
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~------HpnIv~l~~~~~~~~~~~ 85 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCD------HPNIVKLLDAFYYENNLW 85 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCC------CTTBCCEEEEEEETTEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCC------CCCCCeEEEEEeeCCeEE
Confidence 5699999999999999999999999999999999753 344577889999998874 789999999999999999
Q ss_pred EEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCcc
Q 007035 493 IVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 571 (621)
Q Consensus 493 LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~ 571 (621)
|||||+.+ +|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++.
T Consensus 86 lvmEy~~~g~L~~~~~~~~~-----~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~--~~~~Kl~DFG~a~ 158 (288)
T d2jfla1 86 ILIEFCAGGAVDAVMLELER-----PLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTL--DGDIKLADFGVSA 158 (288)
T ss_dssp EEEECCTTEEHHHHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT--TSCEEECCCTTCE
T ss_pred EEEecCCCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECC--CCCEEEEechhhh
Confidence 99999986 55555543322 2899999999999999999999999999999999999984 7889999999986
Q ss_pred ccCCC---ccccccCCcccCchhhc-----CCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 572 FQTDN---LCLYVQSRSYRAPEVII-----GLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 572 ~~~~~---~~~~~gt~~Y~APEvl~-----~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
..... .....||+.|+|||++. +..|+.++|||||||+||+|++|++||
T Consensus 159 ~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf 215 (288)
T d2jfla1 159 KNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPH 215 (288)
T ss_dssp ECHHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTT
T ss_pred ccCCCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCC
Confidence 54322 23467899999999984 456889999999999999999999998
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.5e-40 Score=351.61 Aligned_cols=198 Identities=24% Similarity=0.380 Sum_probs=174.1
Q ss_pred ecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc-hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCe
Q 007035 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (621)
Q Consensus 412 i~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~-~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~ 490 (621)
+-++|++++.||+|+||+||+|+++.+|+.||||++.... ...+.+.+|+.+++.++ ||||++++++|.+.++
T Consensus 24 il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~------HpnIv~~~~~~~~~~~ 97 (350)
T d1koaa2 24 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLR------HPTLVNLHDAFEDDNE 97 (350)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTC------CTTBCCEEEEEEETTE
T ss_pred CccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCC------CCCCCcEEEEEEECCE
Confidence 3468999999999999999999999999999999987643 33456778888888874 7899999999999999
Q ss_pred EEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCC
Q 007035 491 LFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (621)
Q Consensus 491 l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGl 569 (621)
+||||||+.+ +|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||++.+.++.+||+|||+
T Consensus 98 ~~ivmE~~~gg~L~~~l~~~~~-----~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~ 172 (350)
T d1koaa2 98 MVMIYEFMSGGELFEKVADEHN-----KMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGL 172 (350)
T ss_dssp EEEEECCCCSCBHHHHHTCTTS-----CBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTT
T ss_pred EEEEEEcCCCCCHHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecch
Confidence 9999999985 77777643321 28999999999999999999999999999999999999866678999999999
Q ss_pred ccccCCC--ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 570 SCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 570 s~~~~~~--~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
+...... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||
T Consensus 173 a~~~~~~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf 225 (350)
T d1koaa2 173 TAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPF 225 (350)
T ss_dssp CEECCTTSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSS
T ss_pred heecccccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCC
Confidence 9875543 33468899999999999999999999999999999999999998
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.6e-40 Score=351.40 Aligned_cols=193 Identities=25% Similarity=0.437 Sum_probs=171.8
Q ss_pred CceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc----hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecC
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~ 489 (621)
++|++++.||+|+||+||+|+++.+|+.||||++.+.. ...+.+.+|+++++.+ .||||+++++++....
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l------~hpnIv~~~~~~~~~~ 114 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV------NFPFLVKLEFSFKDNS 114 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC------CCTTBCCEEEEEECSS
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHc------CCCcEeeccccccccc
Confidence 68999999999999999999999999999999997532 2334566777776655 5889999999999999
Q ss_pred eEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecC
Q 007035 490 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (621)
Q Consensus 490 ~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFG 568 (621)
.+++||||+.+ ++...+..... +++..++.++.||+.||.|||+++|+||||||+|||++. ++.+||+|||
T Consensus 115 ~~~~v~e~~~~g~l~~~l~~~~~------l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~--~g~ikL~DFG 186 (350)
T d1rdqe_ 115 NLYMVMEYVAGGEMFSHLRRIGR------FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQ--QGYIQVTDFG 186 (350)
T ss_dssp EEEEEEECCTTCBHHHHHHHHCC------CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT--TSCEEECCCT
T ss_pred ccccccccccccchhhhHhhcCC------CCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCC--CCCEEeeece
Confidence 99999999986 56666554322 899999999999999999999999999999999999984 7899999999
Q ss_pred CccccCCCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 569 SSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 569 ls~~~~~~~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
++...........||+.|+|||++.+..++.++|||||||+||+|+||++||
T Consensus 187 ~a~~~~~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf 238 (350)
T d1rdqe_ 187 FAKRVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238 (350)
T ss_dssp TCEECSSCBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred eeeecccccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCC
Confidence 9988877777789999999999999999999999999999999999999998
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-40 Score=349.03 Aligned_cols=194 Identities=25% Similarity=0.406 Sum_probs=170.4
Q ss_pred CceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc----hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecC
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~ 489 (621)
++|++++.||+|+||+||+|+++.+|+.||||++++.. .....+.+|+.+++.+ .||||++++++|++.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l------~hp~Iv~l~~~~~~~~ 78 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT------RHPFLTALKYAFQTHD 78 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC------CCTTBCCEEEEEECSS
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhC------CCCCEEEEEeeecccc
Confidence 57999999999999999999999999999999997532 2345677788887765 4789999999999999
Q ss_pred eEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecC
Q 007035 490 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (621)
Q Consensus 490 ~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFG 568 (621)
++|+||||+.+ +|.+++..... +++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||
T Consensus 79 ~~~iv~ey~~gg~L~~~~~~~~~------~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~--~g~vkl~DFG 150 (337)
T d1o6la_ 79 RLCFVMEYANGGELFFHLSRERV------FTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDK--DGHIKITDFG 150 (337)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSC------CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECT--TSCEEECCCT
T ss_pred ccccceeccCCCchhhhhhcccC------CcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecC--CCCEEEeecc
Confidence 99999999985 56666554332 889999999999999999999999999999999999984 7899999999
Q ss_pred CccccCC---CccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 007035 569 SSCFQTD---NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCLI 621 (621)
Q Consensus 569 ls~~~~~---~~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF~ 621 (621)
+|..... .....+||+.|+|||++.+..|+.++|||||||++|||++|++||.
T Consensus 151 ~a~~~~~~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~ 206 (337)
T d1o6la_ 151 LCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY 206 (337)
T ss_dssp TCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred cccccccCCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCC
Confidence 9976433 3345789999999999999999999999999999999999999984
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.9e-40 Score=342.72 Aligned_cols=194 Identities=24% Similarity=0.399 Sum_probs=167.2
Q ss_pred CceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc----hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecC
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~ 489 (621)
.+|++++.||+|+||+||+|+++.+|+.||||++.... ...+.+.+|+.+++.+ .||||+++++++.+.+
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l------~HpnIv~~~~~~~~~~ 88 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL------RHPNTIQYRGCYLREH 88 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTC------CCTTBCCEEEEEEETT
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHC------CCCCEeeEEEEEEECC
Confidence 46999999999999999999999999999999987543 2234566677776655 5899999999999999
Q ss_pred eEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCC
Q 007035 490 HLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (621)
Q Consensus 490 ~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGl 569 (621)
++||||||+.++++..+..... .+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+
T Consensus 89 ~~~iv~E~~~~g~l~~~~~~~~-----~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~--~~~~~Kl~DFG~ 161 (309)
T d1u5ra_ 89 TAWLVMEYCLGSASDLLEVHKK-----PLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLS--EPGLVKLGDFGS 161 (309)
T ss_dssp EEEEEEECCSEEHHHHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEE--TTTEEEECCCTT
T ss_pred EEEEEEEecCCCchHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEC--CCCCEEEeeccc
Confidence 9999999999877665544332 289999999999999999999999999999999999999 488999999999
Q ss_pred ccccCCCccccccCCcccCchhhcC---CCCCchhhHHHHHHHHHHHHhCCCCCC
Q 007035 570 SCFQTDNLCLYVQSRSYRAPEVIIG---LPYDQKIDLWSLGCILAELWTGEVCLI 621 (621)
Q Consensus 570 s~~~~~~~~~~~gt~~Y~APEvl~~---~~~s~ksDIWSLGvILyELltG~~PF~ 621 (621)
+...... ....||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.
T Consensus 162 a~~~~~~-~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~ 215 (309)
T d1u5ra_ 162 ASIMAPA-NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 215 (309)
T ss_dssp CBSSSSB-CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred ccccCCC-CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCC
Confidence 9765543 44689999999999964 358999999999999999999999983
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-41 Score=341.72 Aligned_cols=198 Identities=24% Similarity=0.377 Sum_probs=156.5
Q ss_pred cCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc---hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEe--
Q 007035 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH-- 487 (621)
Q Consensus 413 ~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~---~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~-- 487 (621)
.++|++++.||+|+||+||+|+++.+|+.||+|++.... ...+.+.+|+++++ .+.||||+++++++.+
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~------~l~HpnIv~~~~~~~~~~ 76 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLR------ELKHPNIVRYYDRIIDRT 76 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTT------SCCCTTBCCEEEEEEC--
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHH------HCCCCCEeeEEEEEEeCC
Confidence 467999999999999999999999999999999987643 22333445555544 4468999999999875
Q ss_pred cCeEEEEEeccc-cchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCC-----eecccCCCccEEEeccCCCe
Q 007035 488 LEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLG-----IIHCDLKPENILIKSYQRCE 561 (621)
Q Consensus 488 ~~~l~LVmEyl~-gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~g-----IvHrDLKP~NILl~~~~~~~ 561 (621)
.+.+||||||++ |+|.+++....... ..+++..++.++.||+.||.|||+++ |+||||||+|||++. ++.
T Consensus 77 ~~~~~ivmEy~~~g~L~~~i~~~~~~~--~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~--~~~ 152 (269)
T d2java1 77 NTTLYIVMEYCEGGDLASVITKGTKER--QYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDG--KQN 152 (269)
T ss_dssp --CEEEEEECCTTEEHHHHHHHHHHHT--CCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECT--TSC
T ss_pred CCEEEEEEecCCCCcHHHHHHhccccC--CCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCC--CCc
Confidence 457899999998 57888776543221 23899999999999999999999976 999999999999984 789
Q ss_pred EEEEecCCccccCCC---ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 562 IKIIDLGSSCFQTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 562 IKL~DFGls~~~~~~---~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
+||+|||++...... .....||+.|+|||++.+..|+.++|||||||++|||+||++||
T Consensus 153 vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf 214 (269)
T d2java1 153 VKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPF 214 (269)
T ss_dssp EEECCHHHHHHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSC
T ss_pred EEEeeccceeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCC
Confidence 999999998765432 33468899999999999999999999999999999999999998
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-40 Score=336.47 Aligned_cols=196 Identities=27% Similarity=0.421 Sum_probs=164.5
Q ss_pred eecCce-EEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc---hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeE
Q 007035 411 VIAGRY-YVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (621)
Q Consensus 411 ii~~rY-~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~---~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~ 486 (621)
...+|| ++.++||+|+||+||+|+++.+++.||+|.+.... ...+.+.+|+++++.+ .||||++++++|.
T Consensus 5 ~~~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l------~HpnIv~~~~~~~ 78 (270)
T d1t4ha_ 5 SNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL------QHPNIVRFYDSWE 78 (270)
T ss_dssp CTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTC------CCTTBCCEEEEEE
T ss_pred CCCCCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhC------CCCCeeeEEEEEe
Confidence 345666 57778999999999999999999999999987542 2334566677776554 5889999999987
Q ss_pred e----cCeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCC--eecccCCCccEEEeccCC
Q 007035 487 H----LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLG--IIHCDLKPENILIKSYQR 559 (621)
Q Consensus 487 ~----~~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~g--IvHrDLKP~NILl~~~~~ 559 (621)
. ...++|||||+++ +|.+++..... +++..++.++.||+.||.|||+++ |+||||||+|||++. .+
T Consensus 79 ~~~~~~~~~~ivmE~~~~g~L~~~l~~~~~------~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~-~~ 151 (270)
T d1t4ha_ 79 STVKGKKCIVLVTELMTSGTLKTYLKRFKV------MKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITG-PT 151 (270)
T ss_dssp EESSSCEEEEEEEECCCSCBHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESS-TT
T ss_pred eccccCCEEEEEEeCCCCCcHHHHHhcccc------ccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeC-CC
Confidence 5 3578999999985 77777654432 889999999999999999999998 999999999999963 46
Q ss_pred CeEEEEecCCccccCCC-ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 560 CEIKIIDLGSSCFQTDN-LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 560 ~~IKL~DFGls~~~~~~-~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
+.+||+|||++...... ....+||+.|+|||++.+ +++.++|||||||+||||++|+.||
T Consensus 152 ~~~Kl~DFGla~~~~~~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf 212 (270)
T d1t4ha_ 152 GSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPY 212 (270)
T ss_dssp SCEEECCTTGGGGCCTTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred CCEEEeecCcceeccCCccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCC
Confidence 78999999999765443 445789999999999876 5999999999999999999999998
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.1e-40 Score=350.77 Aligned_cols=198 Identities=24% Similarity=0.358 Sum_probs=171.5
Q ss_pred ecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCch-hhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCe
Q 007035 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD-FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (621)
Q Consensus 412 i~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~-~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~ 490 (621)
+.++|++++.||+|+||+||+|+++.+|+.||||+++.... ....+.+|+.+++.+ .||||++++++|.+.++
T Consensus 27 ~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l------~HpnIv~~~~~~~~~~~ 100 (352)
T d1koba_ 27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQL------HHPKLINLHDAFEDKYE 100 (352)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTC------CSTTBCCEEEEEECSSE
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhC------CCCCCCcEEEEEEECCE
Confidence 35689999999999999999999999999999999976542 234456677776655 58999999999999999
Q ss_pred EEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCC
Q 007035 491 LFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (621)
Q Consensus 491 l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGl 569 (621)
+||||||+.+ +|.+.+.... ..+++.+++.++.||+.||.|||++||+||||||+||||+...++.+||+|||+
T Consensus 101 ~~ivmE~~~gg~L~~~~~~~~-----~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGl 175 (352)
T d1koba_ 101 MVLILEFLSGGELFDRIAAED-----YKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGL 175 (352)
T ss_dssp EEEEEECCCCCBHHHHTTCTT-----CCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTT
T ss_pred EEEEEEcCCCChHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeeccc
Confidence 9999999985 6666554332 128999999999999999999999999999999999999866678999999999
Q ss_pred ccccCCC--ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 570 SCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 570 s~~~~~~--~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
+...... .....+|+.|+|||++.+..|+.++|||||||+||+|+||++||
T Consensus 176 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf 228 (352)
T d1koba_ 176 ATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPF 228 (352)
T ss_dssp CEECCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSS
T ss_pred ceecCCCCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCC
Confidence 9876543 34468899999999999999999999999999999999999998
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-40 Score=343.84 Aligned_cols=198 Identities=26% Similarity=0.386 Sum_probs=176.5
Q ss_pred ecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeE
Q 007035 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (621)
Q Consensus 412 i~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l 491 (621)
+.++|++++.||+|+||+||+|+++.+|+.||+|+++........+.+|+.+++.++ ||||++++++|.+.+++
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~------HpnIv~~~~~~~~~~~~ 76 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIAR------HRNILHLHESFESMEEL 76 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSC------CTTBCCEEEEEEETTEE
T ss_pred CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCC------CCCCCeEEEEEEECCEE
Confidence 467899999999999999999999999999999999887665567788999888774 78999999999999999
Q ss_pred EEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCc
Q 007035 492 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (621)
Q Consensus 492 ~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls 570 (621)
||||||+.+ +|.+++..... .+++.+++.++.||+.||.|||++||+||||||+|||++.+....+||+|||++
T Consensus 77 ~lvmE~~~gg~L~~~i~~~~~-----~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~ 151 (321)
T d1tkia_ 77 VMIFEFISGLDIFERINTSAF-----ELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQA 151 (321)
T ss_dssp EEEECCCCCCBHHHHHTSSSC-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTC
T ss_pred EEEEecCCCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchh
Confidence 999999985 78777754321 289999999999999999999999999999999999998766778999999998
Q ss_pred cccCCC--ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 571 CFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 571 ~~~~~~--~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
...... .....+|+.|+|||.+.+..|+.++|||||||++|+|++|+.||
T Consensus 152 ~~~~~~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf 203 (321)
T d1tkia_ 152 RQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPF 203 (321)
T ss_dssp EECCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTT
T ss_pred hccccCCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCC
Confidence 765433 34467899999999999999999999999999999999999998
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-40 Score=336.46 Aligned_cols=197 Identities=27% Similarity=0.422 Sum_probs=172.4
Q ss_pred ecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc-------hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeE
Q 007035 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-------DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDY 484 (621)
Q Consensus 412 i~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~-------~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~ 484 (621)
+.++|++++.||+|+||+||+|+++.+|+.||||++.+.. ...+.+.+|+.+++.++ ||||++++++
T Consensus 8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~------HpnIv~~~~~ 81 (293)
T d1jksa_ 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ------HPNVITLHEV 81 (293)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCC------CTTBCCEEEE
T ss_pred cccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCC------CCCCCcEEEE
Confidence 5678999999999999999999999999999999987532 12456788999998884 7899999999
Q ss_pred eEecCeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccC--CCe
Q 007035 485 FYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQ--RCE 561 (621)
Q Consensus 485 f~~~~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~--~~~ 561 (621)
|.+.+++||||||+.+ +|.+++.... .+++..++.++.||+.||.|||+++|+||||||+|||++.+. ...
T Consensus 82 ~~~~~~~~iv~E~~~gg~L~~~i~~~~------~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~ 155 (293)
T d1jksa_ 82 YENKTDVILILELVAGGELFDFLAEKE------SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPR 155 (293)
T ss_dssp EECSSEEEEEEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCC
T ss_pred EEECCEEEEEEEcCCCccccchhcccc------ccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccc
Confidence 9999999999999985 7777776543 289999999999999999999999999999999999998533 236
Q ss_pred EEEEecCCccccCC--CccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 562 IKIIDLGSSCFQTD--NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 562 IKL~DFGls~~~~~--~~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
+||+|||++..... ......+|+.|+|||++.+..++.++|||||||+||+|++|+.||
T Consensus 156 vkl~DfG~a~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf 216 (293)
T d1jksa_ 156 IKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 216 (293)
T ss_dssp EEECCCTTCEECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred eEecchhhhhhcCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCC
Confidence 99999999976543 344467899999999999999999999999999999999999998
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.4e-40 Score=339.38 Aligned_cols=199 Identities=21% Similarity=0.307 Sum_probs=173.9
Q ss_pred eeecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecC
Q 007035 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (621)
Q Consensus 410 ~ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~ 489 (621)
++..++|++.+.||+|+||+||+|+++.+|+.||||+++.+....+++.+|+.+++.++ ||||+++++++.+.+
T Consensus 13 ei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~------HpnIv~~~~~~~~~~ 86 (287)
T d1opja_ 13 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK------HPNLVQLLGVCTREP 86 (287)
T ss_dssp BCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCC------CTTBCCEEEEECSSS
T ss_pred EecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCC------CCCEecCCccEeeCC
Confidence 34457899999999999999999999999999999999877766778899999998884 789999999999999
Q ss_pred eEEEEEeccc-cchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecC
Q 007035 490 HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (621)
Q Consensus 490 ~l~LVmEyl~-gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFG 568 (621)
.++|||||+. |++.+++..... ..+++..+..++.||+.||.|||+++|+||||||+||||+. ++.+||+|||
T Consensus 87 ~~~iv~E~~~~g~l~~~l~~~~~----~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~--~~~~Kl~DFG 160 (287)
T d1opja_ 87 PFYIITEFMTYGNLLDYLRECNR----QEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGE--NHLVKVADFG 160 (287)
T ss_dssp SCEEEEECCTTCBHHHHHHHSCT----TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG--GGCEEECCCC
T ss_pred eeEEEeecccCcchHHHhhhccc----cchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECC--CCcEEEcccc
Confidence 9999999998 577777654322 23889999999999999999999999999999999999984 7899999999
Q ss_pred CccccCCCcc----ccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 569 SSCFQTDNLC----LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 569 ls~~~~~~~~----~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
++........ ...+++.|+|||++.+..|+.++|||||||++|||++|..||
T Consensus 161 ~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~ 216 (287)
T d1opja_ 161 LSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 216 (287)
T ss_dssp CTTTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCS
T ss_pred ceeecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCC
Confidence 9976544322 234688899999999999999999999999999999987776
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.1e-39 Score=344.53 Aligned_cols=196 Identities=26% Similarity=0.406 Sum_probs=168.2
Q ss_pred CceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCch----hhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecC
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD----FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~----~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~ 489 (621)
++|++++.||+|+||+||+|+++.+|+.||||++.+... ......+|..+++.++. ..||||++++++|.+.+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~---~~hpnIv~l~~~~~~~~ 80 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST---GDCPFIVCMSYAFHTPD 80 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSS---SCCTTBCCEEEEEECSS
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhc---CCCCcEEEEEEEEEECC
Confidence 579999999999999999999999999999999875321 22334556666666654 46999999999999999
Q ss_pred eEEEEEeccc-cchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecC
Q 007035 490 HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (621)
Q Consensus 490 ~l~LVmEyl~-gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFG 568 (621)
.+||||||+. ++|.+++..... +++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||
T Consensus 81 ~~~ivmE~~~gg~L~~~l~~~~~------~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~--~~g~iKl~DFG 152 (364)
T d1omwa3 81 KLSFILDLMNGGDLHYHLSQHGV------FSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLD--EHGHVRISDLG 152 (364)
T ss_dssp EEEEEECCCCSCBHHHHHHHHCS------CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC--SSSCEEECCCT
T ss_pred EEEEEEEecCCCcHHHHHHhccc------ccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEc--CCCcEEEeeec
Confidence 9999999998 577777654432 78899999999999999999999999999999999998 47899999999
Q ss_pred CccccCC-CccccccCCcccCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 569 SSCFQTD-NLCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 569 ls~~~~~-~~~~~~gt~~Y~APEvl~~-~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
++..... ......||+.|+|||++.. ..|+.++|||||||+||+|+||+.||
T Consensus 153 la~~~~~~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf 206 (364)
T d1omwa3 153 LACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF 206 (364)
T ss_dssp TCEECSSSCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred eeeecCCCcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCC
Confidence 9986543 3445689999999999974 56899999999999999999999998
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-39 Score=332.71 Aligned_cols=198 Identities=28% Similarity=0.456 Sum_probs=170.1
Q ss_pred ecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCch-------hhhhHHHHHHHHHHhcccCCCCCCceEEEeeE
Q 007035 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD-------FFDQSLDEIKLLKLVNKNDPADEHHILRLYDY 484 (621)
Q Consensus 412 i~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~-------~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~ 484 (621)
+.++|++.+.||+|+||+||+|+++.+|+.||||++.+... ...++.+|+.+++.++. .||||++++++
T Consensus 2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~----~h~nIv~~~~~ 77 (273)
T d1xwsa_ 2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS----GFSGVIRLLDW 77 (273)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCS----SSCSBCCEEEE
T ss_pred CCCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhcc----CCCCccEEEEE
Confidence 46799999999999999999999999999999999875321 12346789999999864 48899999999
Q ss_pred eEecCeEEEEEecccc--chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeE
Q 007035 485 FYHLEHLFIVCELLRA--NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEI 562 (621)
Q Consensus 485 f~~~~~l~LVmEyl~g--sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~I 562 (621)
+.+.+..++||||+.+ .+.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++. +.+.+
T Consensus 78 ~~~~~~~~lv~e~~~~~~~l~~~~~~~~------~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~-~~~~v 150 (273)
T d1xwsa_ 78 FERPDSFVLILERPEPVQDLFDFITERG------ALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDL-NRGEL 150 (273)
T ss_dssp EECSSEEEEEEECCSSEEEHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEET-TTTEE
T ss_pred EeeCCeEEEEEEeccCcchHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEec-CCCeE
Confidence 9999999999999964 5555555432 2899999999999999999999999999999999999985 35789
Q ss_pred EEEecCCccccCCC-ccccccCCcccCchhhcCCCC-CchhhHHHHHHHHHHHHhCCCCC
Q 007035 563 KIIDLGSSCFQTDN-LCLYVQSRSYRAPEVIIGLPY-DQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 563 KL~DFGls~~~~~~-~~~~~gt~~Y~APEvl~~~~~-s~ksDIWSLGvILyELltG~~PF 620 (621)
||+|||++...... .....||+.|+|||++.+..+ +.++|||||||++|+|++|+.||
T Consensus 151 kl~DFG~a~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf 210 (273)
T d1xwsa_ 151 KLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 210 (273)
T ss_dssp EECCCTTCEECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSC
T ss_pred EECccccceecccccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCC
Confidence 99999999765443 345689999999999987765 57799999999999999999998
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.7e-39 Score=329.97 Aligned_cols=197 Identities=29% Similarity=0.439 Sum_probs=161.9
Q ss_pred eeecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc----hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEe
Q 007035 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYF 485 (621)
Q Consensus 410 ~ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f 485 (621)
..+.++|++.+.||+|+||+||+|+++.+|+.||||+++... ....++.+|+++++.+ .||||+++++++
T Consensus 3 ~~l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~------~hpniv~~~~~~ 76 (277)
T d1o6ya_ 3 SHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL------NHPAIVAVYDTG 76 (277)
T ss_dssp SEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTC------CCTTBCCEEEEE
T ss_pred cCccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhc------CCCCCCccccee
Confidence 356789999999999999999999999999999999997532 3344567777777655 588999999999
Q ss_pred EecC----eEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCC
Q 007035 486 YHLE----HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRC 560 (621)
Q Consensus 486 ~~~~----~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~ 560 (621)
...+ .+||||||+.+ +|.+.+..... +++.+++.++.||+.||.|||++||+||||||+|||++. ++
T Consensus 77 ~~~~~~~~~~~lvmE~~~g~~L~~~~~~~~~------l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~--~~ 148 (277)
T d1o6ya_ 77 EAETPAGPLPYIVMEYVDGVTLRDIVHTEGP------MTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISA--TN 148 (277)
T ss_dssp EEECSSSEEEEEEEECCCEEEHHHHHHHHCS------CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET--TS
T ss_pred eeccCCCceEEEEEECCCCCEehhhhcccCC------CCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCc--cc
Confidence 8654 48999999986 56555544322 889999999999999999999999999999999999994 78
Q ss_pred eEEEEecCCccccCC------CccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 561 EIKIIDLGSSCFQTD------NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 561 ~IKL~DFGls~~~~~------~~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
.++|+|||.+..... .....+||+.|+|||++.+..++.++|||||||++|+|+||++||
T Consensus 149 ~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf 214 (277)
T d1o6ya_ 149 AVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPF 214 (277)
T ss_dssp CEEECCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSC
T ss_pred cceeehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCC
Confidence 899999998754322 233457899999999999999999999999999999999999998
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-39 Score=333.30 Aligned_cols=195 Identities=31% Similarity=0.503 Sum_probs=168.2
Q ss_pred CceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc---hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCe
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~---~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~ 490 (621)
++|++++.||+|+||+||+|+++.+|+.||||+++... ....++.+|+++++.+ +||||++++++|.+..+
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l------~Hp~Iv~~~~~~~~~~~ 75 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL------NHPNIVKLLDVIHTENK 75 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTC------CCTTBCCEEEEEEETTE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhC------CCCcEEEeccccccccc
Confidence 58999999999999999999999999999999997543 2345677788887755 48899999999999999
Q ss_pred EEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCc
Q 007035 491 LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (621)
Q Consensus 491 l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls 570 (621)
+|+||||+.++++.++...... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++
T Consensus 76 ~~iv~e~~~~~~~~~~~~~~~~----~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~--~~~~kl~DFG~a 149 (298)
T d1gz8a_ 76 LYLVFEFLHQDLKKFMDASALT----GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT--EGAIKLADFGLA 149 (298)
T ss_dssp EEEEEECCSEEHHHHHHHTTTT----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT--TSCEEECSTTHH
T ss_pred eeEEEeecCCchhhhhhhhccc----CCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecc--cCcceeccCCcc
Confidence 9999999999888877654332 2899999999999999999999999999999999999984 778999999998
Q ss_pred cccCCC---ccccccCCcccCchhhcCCC-CCchhhHHHHHHHHHHHHhCCCCC
Q 007035 571 CFQTDN---LCLYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 571 ~~~~~~---~~~~~gt~~Y~APEvl~~~~-~s~ksDIWSLGvILyELltG~~PF 620 (621)
...... .....+|+.|+|||++.... ++.++|||||||++|+|++|+.||
T Consensus 150 ~~~~~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf 203 (298)
T d1gz8a_ 150 RAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALF 203 (298)
T ss_dssp HHHCCCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred eeccCCcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCC
Confidence 765433 33457899999999987766 578999999999999999999998
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-39 Score=339.69 Aligned_cols=196 Identities=32% Similarity=0.417 Sum_probs=168.4
Q ss_pred ecCceEEEE-EeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEe---
Q 007035 412 IAGRYYVTE-YLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH--- 487 (621)
Q Consensus 412 i~~rY~I~~-~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~--- 487 (621)
+.++|+|+. .||+|+||+||+|+++.+++.||||+++.. ....+|+.++.++. +||||++++++|.+
T Consensus 9 i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~----~~~~~E~~~~~~~~-----~hpnIv~l~~~~~~~~~ 79 (335)
T d2ozaa1 9 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRAS-----QCPHIVRIVDVYENLYA 79 (335)
T ss_dssp GGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHT-----TSTTBCCEEEEEEEEET
T ss_pred cccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc----HHHHHHHHHHHHhc-----CCCCCCeEEEEEeeccc
Confidence 456899986 599999999999999999999999999764 34667888776553 48899999999976
Q ss_pred -cCeEEEEEeccc-cchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccC-CCeEEE
Q 007035 488 -LEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQ-RCEIKI 564 (621)
Q Consensus 488 -~~~l~LVmEyl~-gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~-~~~IKL 564 (621)
..++||||||++ |+|.+++..... ..+++..++.++.||+.||.|||++||+||||||+|||++... .+.+||
T Consensus 80 ~~~~~~ivmEy~~gg~L~~~i~~~~~----~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl 155 (335)
T d2ozaa1 80 GRKCLLIVMECLDGGELFSRIQDRGD----QAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKL 155 (335)
T ss_dssp TEEEEEEEEECCCSEEHHHHHHSCSC----CCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEE
T ss_pred CCCEEEEEEECCCCCcHHHHHHhcCC----CCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccc
Confidence 467999999997 588888764321 2399999999999999999999999999999999999998533 568999
Q ss_pred EecCCccccCC--CccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 565 IDLGSSCFQTD--NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 565 ~DFGls~~~~~--~~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
+|||++..... .....+||+.|+|||++.+..|+.++|||||||+||+|+||++||
T Consensus 156 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf 213 (335)
T d2ozaa1 156 TDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 213 (335)
T ss_dssp CCCTTCEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSC
T ss_pred cccceeeeccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCC
Confidence 99999976433 344568999999999999999999999999999999999999998
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-39 Score=335.46 Aligned_cols=194 Identities=29% Similarity=0.475 Sum_probs=167.2
Q ss_pred CceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc----hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecC
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~ 489 (621)
++|++++.||+|+||+||+|+++.+|+.||||+++++. ........|..++... ..||||+++++++.+.+
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~-----~~hp~Iv~~~~~~~~~~ 76 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA-----WEHPFLTHMFCTFQTKE 76 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHH-----TTCTTBCCEEEEEECSS
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHh-----CCCCcEEEEEEEEccCC
Confidence 57999999999999999999999999999999997542 2233455565554432 35899999999999999
Q ss_pred eEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecC
Q 007035 490 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (621)
Q Consensus 490 ~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFG 568 (621)
++||||||+.+ +|.+++..... +++..++.++.||+.||.|||+++|+||||||+|||++ ..+.+||+|||
T Consensus 77 ~~yivmEy~~~g~L~~~i~~~~~------~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~--~~~~~kl~DFG 148 (320)
T d1xjda_ 77 NLFFVMEYLNGGDLMYHIQSCHK------FDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLD--KDGHIKIADFG 148 (320)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC--TTSCEEECCCT
T ss_pred ceeEEEeecCCCcHHHHhhccCC------CCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeec--CCCceeccccc
Confidence 99999999985 77776654432 88999999999999999999999999999999999999 47899999999
Q ss_pred CccccCC---CccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 569 SSCFQTD---NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 569 ls~~~~~---~~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
++..... ......||+.|+|||++.+..|+.++|||||||++|+|++|+.||
T Consensus 149 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF 203 (320)
T d1xjda_ 149 MCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPF 203 (320)
T ss_dssp TCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred hhhhcccccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCC
Confidence 9875432 234468899999999999999999999999999999999999998
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.2e-38 Score=326.37 Aligned_cols=196 Identities=30% Similarity=0.471 Sum_probs=170.9
Q ss_pred ecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc----------hhhhhHHHHHHHHHHhcccCCCCCCceEEE
Q 007035 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----------DFFDQSLDEIKLLKLVNKNDPADEHHILRL 481 (621)
Q Consensus 412 i~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~----------~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl 481 (621)
+.++|++++.||+|+||+||+|+++.+|+.||||++++.. ...+.+.+|+.+++.+. .||||+++
T Consensus 1 f~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----~hpnIv~~ 75 (277)
T d1phka_ 1 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVS-----GHPNIIQL 75 (277)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHT-----TCTTBCCE
T ss_pred CcccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhc-----CCCCeEEE
Confidence 3578999999999999999999999999999999997642 12345778888888886 36899999
Q ss_pred eeEeEecCeEEEEEeccc-cchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCC
Q 007035 482 YDYFYHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRC 560 (621)
Q Consensus 482 ~~~f~~~~~l~LVmEyl~-gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~ 560 (621)
+++|.+.+++||||||++ ++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++ .++
T Consensus 76 ~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~------~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~--~~~ 147 (277)
T d1phka_ 76 KDTYETNTFFFLVFDLMKKGELFDYLTEKV------TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLD--DDM 147 (277)
T ss_dssp EEEEECSSEEEEEEECCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--TTC
T ss_pred EeecccCcceEEEEEcCCCchHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEc--CCC
Confidence 999999999999999997 48888876433 289999999999999999999999999999999999998 488
Q ss_pred eEEEEecCCccccCC--CccccccCCcccCchhhcC------CCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 561 EIKIIDLGSSCFQTD--NLCLYVQSRSYRAPEVIIG------LPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 561 ~IKL~DFGls~~~~~--~~~~~~gt~~Y~APEvl~~------~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
.+||+|||++..... ......||+.|+|||++.+ ..++.++||||+||+||+|++|++||
T Consensus 148 ~~kl~DFG~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf 215 (277)
T d1phka_ 148 NIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 215 (277)
T ss_dssp CEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred CeEEccchheeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCC
Confidence 999999999976544 3445678999999999953 34788999999999999999999998
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-39 Score=330.75 Aligned_cols=199 Identities=30% Similarity=0.496 Sum_probs=169.7
Q ss_pred cCceEEEEEeccCCCCceeEEEeCCC-CcEEEEEEEecCc---hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEe-
Q 007035 413 AGRYYVTEYLGSAAFSKVFQAQDLHT-GVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH- 487 (621)
Q Consensus 413 ~~rY~I~~~LG~G~fG~Vyka~d~~t-g~~VAlKii~~~~---~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~- 487 (621)
.++|++++.||+|+||+||+|++..+ ++.||||+++... .......+|+.+++.+... .||||++++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~---~HpnIv~~~~~~~~~ 82 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF---EHPNVVRLFDVCTVS 82 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHT---CCTTBCCEEEEEEEE
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhc---CCCCcceeeeeeccc
Confidence 47899999999999999999999766 6779999986532 2334567899999888753 58999999999863
Q ss_pred ----cCeEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEE
Q 007035 488 ----LEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 563 (621)
Q Consensus 488 ----~~~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IK 563 (621)
..+++++|||+.++++.+....... .+++..++.++.||+.||+|||+++|+||||||+|||++. .+.+|
T Consensus 83 ~~~~~~~~~~~~e~~~~~~~~~~~~~~~~----~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~--~~~~k 156 (305)
T d1blxa_ 83 RTDRETKLTLVFEHVDQDLTTYLDKVPEP----GVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTS--SGQIK 156 (305)
T ss_dssp ECSSEEEEEEEEECCSCBHHHHHHHSCTT----CSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT--TCCEE
T ss_pred ccccCceEEEEEEeccCCchhhhhhccCC----CCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcC--CCCee
Confidence 3579999999998877665543322 2889999999999999999999999999999999999984 78999
Q ss_pred EEecCCccccCC--CccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 564 IIDLGSSCFQTD--NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 564 L~DFGls~~~~~--~~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
|+|||++..... ......||+.|+|||++.+.+|+.++|||||||++|||++|++||
T Consensus 157 l~dfg~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf 215 (305)
T d1blxa_ 157 LADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLF 215 (305)
T ss_dssp ECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred ecchhhhhhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCC
Confidence 999999865432 334568899999999999999999999999999999999999998
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-39 Score=324.45 Aligned_cols=193 Identities=21% Similarity=0.339 Sum_probs=159.6
Q ss_pred CceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeEEE
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFI 493 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l~L 493 (621)
++|++++.||+|+||+||+|++. +++.||||+++......+++.+|+++++.++ ||||+++++++...+.+++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~------HpnIv~~~g~~~~~~~~~l 77 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLS------HPKLVQLYGVCLEQAPICL 77 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSCHHHHHHHHHHHHHCC------CTTBCCEEEEECSSSSCEE
T ss_pred HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCcHHHHHHHHHHHHhcC------CCCcccccceeccCCceEE
Confidence 67999999999999999999975 6778999999877666678889999998884 7899999999999999999
Q ss_pred EEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCccc
Q 007035 494 VCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF 572 (621)
Q Consensus 494 VmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~~ 572 (621)
||||+.+ +|.+++..... .+++..+..++.||+.||.|||+++|+||||||+|||++. ++.+||+|||++..
T Consensus 78 v~E~~~~g~L~~~l~~~~~-----~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~--~~~~Kl~DFGla~~ 150 (263)
T d1sm2a_ 78 VFEFMEHGCLSDYLRTQRG-----LFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGE--NQVIKVSDFGMTRF 150 (263)
T ss_dssp EEECCTTCBHHHHHHTTTT-----CCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECG--GGCEEECSCC----
T ss_pred EEEecCCCcHHHHhhcccc-----CCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecC--CCCeEecccchhee
Confidence 9999985 67776654322 2788999999999999999999999999999999999994 78999999999876
Q ss_pred cCCC----ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhC-CCCC
Q 007035 573 QTDN----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTG-EVCL 620 (621)
Q Consensus 573 ~~~~----~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG-~~PF 620 (621)
.... .....||+.|+|||++.+..|+.++|||||||+||||+|+ ++||
T Consensus 151 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~ 203 (263)
T d1sm2a_ 151 VLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPY 203 (263)
T ss_dssp --------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred ccCCCceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCC
Confidence 4432 2235678999999999999999999999999999999995 5554
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.9e-38 Score=325.34 Aligned_cols=200 Identities=22% Similarity=0.318 Sum_probs=174.9
Q ss_pred eeecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecC
Q 007035 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (621)
Q Consensus 410 ~ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~ 489 (621)
+++.++|++.+.||+|+||+||+|+++.+|+.||||++..... ...+.+|+++++.+.+ |+|++.+++++....
T Consensus 1 ~vig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~e~~~~~~l~~-----~~~i~~~~~~~~~~~ 74 (293)
T d1csna_ 1 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-APQLRDEYRTYKLLAG-----CTGIPNVYYFGQEGL 74 (293)
T ss_dssp CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-SCCHHHHHHHHHHTTT-----CTTCCCEEEEEEETT
T ss_pred CCCCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC-cHHHHHHHHHHHHhcC-----CCCCCEEEEEeecCC
Confidence 4678999999999999999999999999999999999876433 3567788888888864 468999999999999
Q ss_pred eEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEecc---CCCeEEEEe
Q 007035 490 HLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSY---QRCEIKIID 566 (621)
Q Consensus 490 ~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~---~~~~IKL~D 566 (621)
+.++||||++++|.+++..... .++...+..++.|++.||.|||++||+||||||+|||++.. ..+.+||+|
T Consensus 75 ~~~~vme~~~~~l~~~~~~~~~-----~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~D 149 (293)
T d1csna_ 75 HNVLVIDLLGPSLEDLLDLCGR-----KFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVD 149 (293)
T ss_dssp EEEEEEECCCCBHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECC
T ss_pred ccEEEEEecCCCHHHHHHhhcc-----chhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcc
Confidence 9999999999999888765433 28899999999999999999999999999999999999742 356899999
Q ss_pred cCCccccCCC----------ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 567 LGSSCFQTDN----------LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 567 FGls~~~~~~----------~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
||++...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 150 FG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf 213 (293)
T d1csna_ 150 FGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPW 213 (293)
T ss_dssp CTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred cceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcC
Confidence 9999764321 22357899999999999999999999999999999999999998
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-39 Score=334.25 Aligned_cols=190 Identities=33% Similarity=0.516 Sum_probs=162.0
Q ss_pred EEEEeccCCCCceeEEEeCCCCcEEEEEEEecCch------hhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeE
Q 007035 418 VTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD------FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (621)
Q Consensus 418 I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~------~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l 491 (621)
.+++||+|+||+||+|+++.+|+.||||+++.... ....+.+|+.+++.++ ||||+++++++...+++
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~------hpnIv~~~~~~~~~~~~ 75 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS------HPNIIGLLDAFGHKSNI 75 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCC------CTTBCCEEEEECCTTCC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCC------CCCEeEEEeeeccCCce
Confidence 57899999999999999999999999999865322 2346788999988874 78999999999999999
Q ss_pred EEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCcc
Q 007035 492 FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 571 (621)
Q Consensus 492 ~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~ 571 (621)
+|||||+.++++..+.... ..+++..++.+++||+.||.|||++||+||||||+|||++ .++.+||+|||++.
T Consensus 76 ~ivmE~~~~~~~~~~~~~~-----~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~--~~~~~KL~DFG~a~ 148 (299)
T d1ua2a_ 76 SLVFDFMETDLEVIIKDNS-----LVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLD--ENGVLKLADFGLAK 148 (299)
T ss_dssp EEEEECCSEEHHHHHTTCC-----SSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC--TTCCEEECCCGGGS
T ss_pred eehhhhhcchHHhhhhhcc-----cCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEec--CCCccccccCcccc
Confidence 9999999988776665432 2388899999999999999999999999999999999998 47899999999987
Q ss_pred ccCCC---ccccccCCcccCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 572 FQTDN---LCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 572 ~~~~~---~~~~~gt~~Y~APEvl~~~-~~s~ksDIWSLGvILyELltG~~PF 620 (621)
..... ....++|+.|+|||++.+. .|+.++|||||||++|||++|++||
T Consensus 149 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf 201 (299)
T d1ua2a_ 149 SFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFL 201 (299)
T ss_dssp TTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSS
T ss_pred ccCCCcccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCC
Confidence 65432 3345789999999999754 5799999999999999999999998
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-39 Score=326.33 Aligned_cols=196 Identities=27% Similarity=0.362 Sum_probs=166.0
Q ss_pred eecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCe
Q 007035 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (621)
Q Consensus 411 ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~ 490 (621)
+..++|++.+.||+|+||+||+|+++ +++.||||+++......+.+.+|+.+++.++ ||||+++++++.+ +.
T Consensus 10 i~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~------HpnIv~~~g~~~~-~~ 81 (272)
T d1qpca_ 10 VPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQ------HQRLVRLYAVVTQ-EP 81 (272)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCC------CTTBCCEEEEECS-SS
T ss_pred cCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCCHHHHHHHHHHHHhCC------CCCEeEEEeeecc-CC
Confidence 44578999999999999999999964 6788999999877666678899999998885 7899999998754 56
Q ss_pred EEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCC
Q 007035 491 LFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (621)
Q Consensus 491 l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGl 569 (621)
++|||||+.+ +|.+++...... .+++..+..++.||+.||.|||+++|+||||||+||||+ .++.+||+|||+
T Consensus 82 ~~iv~Ey~~~g~L~~~~~~~~~~----~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~--~~~~~Kl~DFGl 155 (272)
T d1qpca_ 82 IYIITEYMENGSLVDFLKTPSGI----KLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVS--DTLSCKIADFGL 155 (272)
T ss_dssp CEEEEECCTTCBHHHHTTSHHHH----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--TTSCEEECCCTT
T ss_pred eEEEEEeCCCCcHHHHHhhcCCC----CCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeee--cccceeeccccc
Confidence 7999999985 666655433322 288999999999999999999999999999999999998 488999999999
Q ss_pred ccccCCC----ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 570 SCFQTDN----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 570 s~~~~~~----~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
+...... .....+|+.|+|||++.+..++.++|||||||+||||+||..|+
T Consensus 156 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~ 210 (272)
T d1qpca_ 156 ARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP 210 (272)
T ss_dssp CEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCS
T ss_pred eEEccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCC
Confidence 9765433 22346788999999999889999999999999999999965554
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-38 Score=333.31 Aligned_cols=194 Identities=35% Similarity=0.616 Sum_probs=166.1
Q ss_pred ecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecC---chhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEec
Q 007035 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (621)
Q Consensus 412 i~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~---~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~ 488 (621)
+.++|++++.||+|+||+||+|.++.+|+.||||+++.. ....+++.+|+++++.++ ||||++++++|...
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~------hpniv~l~~~~~~~ 89 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMR------HENVIGLLDVFTPD 89 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCC------BTTBCCCSEEECSC
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcC------CCCeeEEEEEeccC
Confidence 678999999999999999999999999999999999753 234567788999988874 68999999999865
Q ss_pred C------eEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeE
Q 007035 489 E------HLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEI 562 (621)
Q Consensus 489 ~------~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~I 562 (621)
+ ++|+||||++..+....... .+++..++.+++||+.||.|||++||+||||||+|||++ .++.+
T Consensus 90 ~~~~~~~~~~lv~e~~~~~l~~~~~~~-------~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~--~~~~~ 160 (346)
T d1cm8a_ 90 ETLDDFTDFYLVMPFMGTDLGKLMKHE-------KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVN--EDCEL 160 (346)
T ss_dssp SSTTTCCCCEEEEECCSEEHHHHHHHC-------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC--TTCCE
T ss_pred ccccccceEEEEEecccccHHHHHHhc-------cccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcc--ccccc
Confidence 4 57999999977776665432 189999999999999999999999999999999999998 48899
Q ss_pred EEEecCCccccCCCccccccCCcccCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 563 KIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 563 KL~DFGls~~~~~~~~~~~gt~~Y~APEvl~~~-~~s~ksDIWSLGvILyELltG~~PF 620 (621)
||+|||++...........+|+.|+|||++.+. .++.++|||||||++|+|++|++||
T Consensus 161 kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf 219 (346)
T d1cm8a_ 161 KILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLF 219 (346)
T ss_dssp EECCCTTCEECCSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSS
T ss_pred ccccccceeccCCccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCC
Confidence 999999999888877788999999999999875 4689999999999999999999998
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.6e-38 Score=328.75 Aligned_cols=195 Identities=23% Similarity=0.336 Sum_probs=154.1
Q ss_pred cCceEEEEEeccCCCCceeEEEeCCCCc---EEEEEEEecC--chhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEe
Q 007035 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGV---DVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (621)
Q Consensus 413 ~~rY~I~~~LG~G~fG~Vyka~d~~tg~---~VAlKii~~~--~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~ 487 (621)
.++|++.+.||+|+||+||+|+++.+++ .||||.+... ....+.+.+|+++++.+ .||||+++++++..
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l------~HpnIv~l~g~~~~ 98 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF------DHPNVIHLEGVVTK 98 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTC------CCTTBCCEEEEECS
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhC------CCCCCccEEEEEee
Confidence 4689999999999999999999887765 5888887653 33345667777777655 58899999999999
Q ss_pred cCeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEe
Q 007035 488 LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (621)
Q Consensus 488 ~~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~D 566 (621)
.+.+++||||+.+ +|.+++..... .+++..+..++.||+.||.|||+++|+||||||+||||+ .++.+||+|
T Consensus 99 ~~~~~iv~Ey~~~g~L~~~~~~~~~-----~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~--~~~~~Kl~D 171 (299)
T d1jpaa_ 99 STPVMIITEFMENGSLDSFLRQNDG-----QFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVN--SNLVCKVSD 171 (299)
T ss_dssp SSSCEEEEECCTTEEHHHHHHTTTT-----CSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC--TTCCEEECC
T ss_pred CCEEEEEEEecCCCcceeeeccccC-----CCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEEC--CCCcEEECC
Confidence 9999999999986 56555543222 289999999999999999999999999999999999998 478999999
Q ss_pred cCCccccCCCc--------cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 567 LGSSCFQTDNL--------CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 567 FGls~~~~~~~--------~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
||++....... ....+|+.|+|||++.+..++.++|||||||+||||+| |++||
T Consensus 172 FGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf 234 (299)
T d1jpaa_ 172 FGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPY 234 (299)
T ss_dssp C-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred cccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCC
Confidence 99987543321 12356889999999999999999999999999999998 89998
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-38 Score=330.47 Aligned_cols=202 Identities=22% Similarity=0.315 Sum_probs=167.0
Q ss_pred ecCceEEEEEeccCCCCceeEEEeCCCCc-----EEEEEEEecC--chhhhhHHHHHHHHHHhcccCCCCCCceEEEeeE
Q 007035 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGV-----DVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDY 484 (621)
Q Consensus 412 i~~rY~I~~~LG~G~fG~Vyka~d~~tg~-----~VAlKii~~~--~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~ 484 (621)
-.++|++.+.||+|+||+||+|++..+++ .||+|.+... ......+.+|+.++..+. .||||++++++
T Consensus 35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----~HpnIv~l~~~ 109 (325)
T d1rjba_ 35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLG-----SHENIVNLLGA 109 (325)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHC-----CCTTBCCEEEE
T ss_pred CHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhc-----CCCcEeEEEEE
Confidence 34789999999999999999999876554 6999988653 334456788898888874 37899999999
Q ss_pred eEecCeEEEEEeccc-cchHHHHHhhhcc-----------------CCCccccHHHHHHHHHHHHHHHHHHHHCCeeccc
Q 007035 485 FYHLEHLFIVCELLR-ANLYEFQKFNQES-----------------GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCD 546 (621)
Q Consensus 485 f~~~~~l~LVmEyl~-gsLld~l~~~~~~-----------------~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrD 546 (621)
+.+.+.++|||||++ |+|.+++...... .....+++..++.++.||+.||.|||+++|+|||
T Consensus 110 ~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRD 189 (325)
T d1rjba_ 110 CTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRD 189 (325)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred EeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeecc
Confidence 999999999999998 5788877654321 1123488899999999999999999999999999
Q ss_pred CCCccEEEeccCCCeEEEEecCCccccCCCc-----cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 547 LKPENILIKSYQRCEIKIIDLGSSCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 547 LKP~NILl~~~~~~~IKL~DFGls~~~~~~~-----~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
|||+|||++. ++.+||+|||+|....... ....+|+.|+|||++.+..++.++|||||||+||||+| |++||
T Consensus 190 lKp~Nill~~--~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf 267 (325)
T d1rjba_ 190 LAARNVLVTH--GKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY 267 (325)
T ss_dssp CSGGGEEEET--TTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred Cchhcccccc--CCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCC
Confidence 9999999984 7899999999997644322 23467999999999999999999999999999999998 89998
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-38 Score=326.24 Aligned_cols=193 Identities=28% Similarity=0.430 Sum_probs=157.2
Q ss_pred eecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecC---chhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEe
Q 007035 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (621)
Q Consensus 411 ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~---~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~ 487 (621)
+..++|++.+.||+|+||+||+|+.. ..||||+++.. ....+.+.+|+.+++.+ .||||+++++++.
T Consensus 5 i~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l------~HpnIv~~~~~~~- 74 (276)
T d1uwha_ 5 IPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT------RHVNILLFMGYST- 74 (276)
T ss_dssp CCTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTC------CCTTBCCEEEEEC-
T ss_pred cccccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhC------CCCCEeeeeEEEe-
Confidence 44578999999999999999999743 35999998753 33445666777777655 4889999999865
Q ss_pred cCeEEEEEeccc-cchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEe
Q 007035 488 LEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (621)
Q Consensus 488 ~~~l~LVmEyl~-gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~D 566 (621)
...++|||||++ ++|.+++..... .+++..+..++.||+.||.|||+++|+||||||+|||++. ++.+||+|
T Consensus 75 ~~~~~lv~Ey~~~g~L~~~l~~~~~-----~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~--~~~~Kl~D 147 (276)
T d1uwha_ 75 APQLAIVTQWCEGSSLYHHLHIIET-----KFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHE--DLTVKIGD 147 (276)
T ss_dssp SSSCEEEEECCCEEEHHHHHHTSCC-----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEET--TSSEEECC
T ss_pred ccEEEEEEecCCCCCHHHHHhhccC-----CCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcC--CCCEEEcc
Confidence 456899999998 578777754322 2889999999999999999999999999999999999984 78999999
Q ss_pred cCCccccCC-----CccccccCCcccCchhhcCC---CCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 567 LGSSCFQTD-----NLCLYVQSRSYRAPEVIIGL---PYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 567 FGls~~~~~-----~~~~~~gt~~Y~APEvl~~~---~~s~ksDIWSLGvILyELltG~~PF 620 (621)
||++..... ......||+.|+|||++.+. +|+.++|||||||+||||+||+.||
T Consensus 148 FGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf 209 (276)
T d1uwha_ 148 FGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPY 209 (276)
T ss_dssp CCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred ccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCC
Confidence 999866432 22345789999999999643 5899999999999999999999998
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.2e-37 Score=320.69 Aligned_cols=199 Identities=24% Similarity=0.327 Sum_probs=172.2
Q ss_pred eecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCe
Q 007035 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (621)
Q Consensus 411 ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~ 490 (621)
.++++|++.+.||+|+||+||+|+++.+|+.||||++..... ..++..|+++++.+++ |++|+.+..++...+.
T Consensus 4 ~vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~E~~i~~~l~~-----~~~i~~~~~~~~~~~~ 77 (299)
T d1ckia_ 4 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQG-----GVGIPTIRWCGAEGDY 77 (299)
T ss_dssp EETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT-SCCHHHHHHHHHHSTT-----STTCCCEEEEEEETTE
T ss_pred eECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc-CHHHHHHHHHHHHccC-----CCcccEEEEEEecCCE
Confidence 356799999999999999999999999999999999876543 3567889999998864 3467788888889999
Q ss_pred EEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEecc-CCCeEEEEecCC
Q 007035 491 LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSY-QRCEIKIIDLGS 569 (621)
Q Consensus 491 l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~-~~~~IKL~DFGl 569 (621)
.++||||+++++...+...... +++..+..++.||+.||.|||++||+||||||+|||++.. ....++|+|||+
T Consensus 78 ~~ivme~~~~~l~~~~~~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~ 152 (299)
T d1ckia_ 78 NVMVMELLGPSLEDLFNFCSRK-----FSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGL 152 (299)
T ss_dssp EEEEEECCCCBHHHHHHHTTTC-----CCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSS
T ss_pred EEEEEEEcCCchhhhhhhccCC-----CcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCc
Confidence 9999999999988877654332 8999999999999999999999999999999999998642 356799999999
Q ss_pred ccccCCC----------ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 570 SCFQTDN----------LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 570 s~~~~~~----------~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
+...... .....||+.|+|||++.+.+++.++|||||||++|||++|+.||
T Consensus 153 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~ 213 (299)
T d1ckia_ 153 AKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPW 213 (299)
T ss_dssp CEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred ceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcc
Confidence 9765432 23357899999999999999999999999999999999999998
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-38 Score=319.32 Aligned_cols=193 Identities=23% Similarity=0.398 Sum_probs=167.8
Q ss_pred CceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeEEE
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFI 493 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l~L 493 (621)
++|+++++||+|+||+||+|++ .+++.||||+++......+.+++|+.+++.++ ||||+++++++.+.+.+++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~------HpnIv~~~g~~~~~~~~~i 76 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLS------HEKLVQLYGVCTKQRPIFI 76 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEE-TTTEEEEEEEEESSSSCHHHHHHHHHHHHTCC------CTTBCCEEEEECCSSSEEE
T ss_pred HHCEEeEEEecCCCeEEEEEEE-CCCCEEEEEEECcCcCCHHHHHHHHHHHHhcC------CCceeeEEEEEeeCCceEE
Confidence 5788999999999999999997 57889999999987766678888888888774 7899999999999999999
Q ss_pred EEeccc-cchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCccc
Q 007035 494 VCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF 572 (621)
Q Consensus 494 VmEyl~-gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~~ 572 (621)
||||+. |++.+++...... +++..++.++.||++||.|||++||+||||||+|||++. ++.+||+|||++..
T Consensus 77 v~Ey~~~g~l~~~~~~~~~~-----~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~--~~~~kl~DfG~a~~ 149 (258)
T d1k2pa_ 77 ITEYMANGCLLNYLREMRHR-----FQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVND--QGVVKVSDFGLSRY 149 (258)
T ss_dssp EEECCTTEEHHHHHHSGGGC-----CCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECT--TCCEEECCCSSCCB
T ss_pred EEEccCCCcHHHhhhccccC-----CcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcC--CCcEEECcchhhee
Confidence 999998 5666665544332 788999999999999999999999999999999999984 78999999999975
Q ss_pred cCCC----ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 573 QTDN----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 573 ~~~~----~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
.... .....+|+.|+|||++.+..++.++|||||||++|||+| |+.||
T Consensus 150 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf 202 (258)
T d1k2pa_ 150 VLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPY 202 (258)
T ss_dssp CSSSSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred ccCCCceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCC
Confidence 4332 223567889999999999999999999999999999998 89998
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=9.5e-38 Score=319.34 Aligned_cols=193 Identities=30% Similarity=0.494 Sum_probs=164.5
Q ss_pred CceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCch---hhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCe
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD---FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~---~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~ 490 (621)
+||++++.||+|+||+||+|+++ +|+.||||+++.... ...++.+|+.+++.+ .||||++++++|...++
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l------~hpnIv~~~~~~~~~~~ 74 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKEL------KHSNIVKLYDVIHTKKR 74 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGC------CCTTBCCEEEEEECSSC
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhC------CCCcEEeeeeecccCCc
Confidence 58999999999999999999985 889999999976432 245667777777665 47899999999999999
Q ss_pred EEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCc
Q 007035 491 LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (621)
Q Consensus 491 l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls 570 (621)
.+++||++.++++..+..... .+++..++.++.||+.||+|||+++|+||||||+|||++. ++.+||+|||.+
T Consensus 75 ~~i~~e~~~~~~~~~~~~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~--~~~~kl~DfG~a 147 (286)
T d1ob3a_ 75 LVLVFEHLDQDLKKLLDVCEG-----GLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINR--EGELKIADFGLA 147 (286)
T ss_dssp EEEEEECCSEEHHHHHHTSTT-----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT--TSCEEECCTTHH
T ss_pred eeEEEEeehhhhHHHHHhhcC-----CcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcC--CCCEEecccccc
Confidence 999999999988877765432 2899999999999999999999999999999999999984 789999999998
Q ss_pred cccCCC---ccccccCCcccCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 571 CFQTDN---LCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 571 ~~~~~~---~~~~~gt~~Y~APEvl~~~-~~s~ksDIWSLGvILyELltG~~PF 620 (621)
...... .....+++.|+|||.+.+. .++.++|||||||++|||++|++||
T Consensus 148 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf 201 (286)
T d1ob3a_ 148 RAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLF 201 (286)
T ss_dssp HHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred eecccCccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCC
Confidence 765433 3345689999999999765 4689999999999999999999998
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-37 Score=319.49 Aligned_cols=193 Identities=23% Similarity=0.329 Sum_probs=161.8
Q ss_pred CceEEEEE-eccCCCCceeEEEeCC--CCcEEEEEEEecC--chhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEec
Q 007035 414 GRYYVTEY-LGSAAFSKVFQAQDLH--TGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (621)
Q Consensus 414 ~rY~I~~~-LG~G~fG~Vyka~d~~--tg~~VAlKii~~~--~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~ 488 (621)
++|.+.+. ||+|+||+||+|.++. ++..||||+++.. ....+++.+|+++++.++ ||||+++++++..
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~------HpnIv~l~g~~~~- 80 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLD------NPYIVRLIGVCQA- 80 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCC------CTTBCCEEEEEES-
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCC------CCCEeeEeeeecc-
Confidence 57888885 9999999999997654 4567999999754 334567888999988774 7899999999865
Q ss_pred CeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEec
Q 007035 489 EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 567 (621)
Q Consensus 489 ~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DF 567 (621)
+.++|||||+++ +|.+++..... .+++..+..++.||+.||.|||+++|+||||||+|||++. ++.+||+||
T Consensus 81 ~~~~lvmE~~~~g~L~~~l~~~~~-----~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~--~~~~Kl~DF 153 (285)
T d1u59a_ 81 EALMLVMEMAGGGPLHKFLVGKRE-----EIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVN--RHYAKISDF 153 (285)
T ss_dssp SSEEEEEECCTTEEHHHHHTTCTT-----TSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEE--TTEEEECCC
T ss_pred CeEEEEEEeCCCCcHHHHhhcccc-----CCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeecc--CCceeeccc
Confidence 568999999985 67666543322 2899999999999999999999999999999999999984 789999999
Q ss_pred CCccccCCC------ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 568 GSSCFQTDN------LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 568 Gls~~~~~~------~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
|++...... .....+|+.|+|||++.+..++.++|||||||++|||+| |+.||
T Consensus 154 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf 213 (285)
T d1u59a_ 154 GLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPY 213 (285)
T ss_dssp TTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred hhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCC
Confidence 999765432 223467889999999999899999999999999999998 99998
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-37 Score=317.42 Aligned_cols=196 Identities=21% Similarity=0.293 Sum_probs=156.1
Q ss_pred cCceEEEEEeccCCCCceeEEEeCCCC----cEEEEEEEecCc--hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeE
Q 007035 413 AGRYYVTEYLGSAAFSKVFQAQDLHTG----VDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (621)
Q Consensus 413 ~~rY~I~~~LG~G~fG~Vyka~d~~tg----~~VAlKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~ 486 (621)
...|++.+.||+|+||+||+|.++.++ ..||||+++... ....++.+|+++++.+ .||||+++++++.
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l------~H~nIv~~~g~~~ 79 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF------SHHNIIRLEGVIS 79 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTC------CCTTBCCEEEEEC
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhc------CCCCEeeeeEEEe
Confidence 467999999999999999999977654 469999987543 2334567778777766 4789999999999
Q ss_pred ecCeEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEe
Q 007035 487 HLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (621)
Q Consensus 487 ~~~~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~D 566 (621)
+.+.+++||||+.++++........ ..+++..+..++.||+.||.|||+++|+||||||+||||+. ++.+||+|
T Consensus 80 ~~~~~~~v~e~~~~~~l~~~~~~~~----~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~--~~~~Kl~D 153 (283)
T d1mqba_ 80 KYKPMMIITEYMENGALDKFLREKD----GEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNS--NLVCKVSD 153 (283)
T ss_dssp SSSSEEEEEECCTTEEHHHHHHHTT----TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT--TCCEEECC
T ss_pred cCCceEEEEEecccCcchhhhhccc----ccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECC--CCeEEEcc
Confidence 9999999999998754443332221 12889999999999999999999999999999999999994 78999999
Q ss_pred cCCccccCCC------ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 567 LGSSCFQTDN------LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 567 FGls~~~~~~------~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
||++...... .....||+.|+|||++.+..++.++|||||||+||||++|..||
T Consensus 154 FGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~ 213 (283)
T d1mqba_ 154 FGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP 213 (283)
T ss_dssp CCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred cchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCc
Confidence 9999764332 22245788999999999999999999999999999999976665
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-37 Score=326.05 Aligned_cols=194 Identities=31% Similarity=0.571 Sum_probs=164.8
Q ss_pred ceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEec------
Q 007035 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL------ 488 (621)
Q Consensus 415 rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~------ 488 (621)
+|+++++||+|+||+||+|+++.+|+.||||++..+... ..+|+.+++.++ ||||++++++|...
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~---~~~Ei~il~~l~------h~niv~~~~~~~~~~~~~~~ 91 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF---KNRELQIMRKLD------HCNIVRLRYFFYSSGEKKDE 91 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS---CCHHHHHHHHCC------CTTBCCEEEEEEEC--CCSC
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH---HHHHHHHHHhcC------CCCCCcEEEEEEecCccCCc
Confidence 799999999999999999999999999999999876533 347889988774 78999999998643
Q ss_pred CeEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecC
Q 007035 489 EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (621)
Q Consensus 489 ~~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFG 568 (621)
.+++|||||+++++...+...... ...+++..++.+++||+.||.|||++||+||||||+|||++. +...+||+|||
T Consensus 92 ~~~~lv~Ey~~~~~~~~l~~~~~~--~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~-~~~~~kl~DFG 168 (350)
T d1q5ka_ 92 VYLNLVLDYVPETVYRVARHYSRA--KQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP-DTAVLKLCDFG 168 (350)
T ss_dssp CEEEEEEECCSEEHHHHHHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECT-TTCCEEECCCT
T ss_pred eEEEEEEeccCCccHHHHHhhhhc--cCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEec-CCCceeEeccc
Confidence 468999999998877766543222 223899999999999999999999999999999999999985 23579999999
Q ss_pred CccccCC--CccccccCCcccCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 569 SSCFQTD--NLCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 569 ls~~~~~--~~~~~~gt~~Y~APEvl~~~-~~s~ksDIWSLGvILyELltG~~PF 620 (621)
++..... ......+|+.|+|||.+.+. .++.++|||||||++|||++|++||
T Consensus 169 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf 223 (350)
T d1q5ka_ 169 SAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 223 (350)
T ss_dssp TCEECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSS
T ss_pred chhhccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCC
Confidence 9876433 34446889999999998764 6899999999999999999999998
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-37 Score=319.23 Aligned_cols=195 Identities=29% Similarity=0.500 Sum_probs=164.5
Q ss_pred cCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc---hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEe--
Q 007035 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH-- 487 (621)
Q Consensus 413 ~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~---~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~-- 487 (621)
.++|+++++||+|+||+||+|+++.+|+.||||++.... ....++.+|+.+++.++ ||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~------h~nii~~~~~~~~~~ 82 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLK------HENVVNLIEICRTKA 82 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCC------CTTBCCEEEEEEC--
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhc------CCCccceEeeeeccc
Confidence 479999999999999999999999999999999986532 34456788999998874 6789999998865
Q ss_pred ------cCeEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCe
Q 007035 488 ------LEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCE 561 (621)
Q Consensus 488 ------~~~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~ 561 (621)
..++++||||++++++........ .+++..++.+++||+.||.|||++||+||||||+|||++. ++.
T Consensus 83 ~~~~~~~~~~~iv~e~~~~~~~~~~~~~~~-----~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~--~~~ 155 (318)
T d3blha1 83 SPYNRCKGSIYLVFDFCEHDLAGLLSNVLV-----KFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITR--DGV 155 (318)
T ss_dssp --------CEEEEEECCCEEHHHHHTCTTC-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT--TSC
T ss_pred ccccccCceEEEEEeccCCCccchhhhccc-----ccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecC--CCc
Confidence 356899999999888776654332 2889999999999999999999999999999999999984 789
Q ss_pred EEEEecCCccccCC-------CccccccCCcccCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 562 IKIIDLGSSCFQTD-------NLCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 562 IKL~DFGls~~~~~-------~~~~~~gt~~Y~APEvl~~~-~~s~ksDIWSLGvILyELltG~~PF 620 (621)
+||+|||++..... .....+||+.|+|||++.+. .++.++|||||||++|||++|++||
T Consensus 156 ~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf 222 (318)
T d3blha1 156 LKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIM 222 (318)
T ss_dssp EEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred EEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCC
Confidence 99999999865432 22335789999999999865 5899999999999999999999998
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-37 Score=325.49 Aligned_cols=202 Identities=33% Similarity=0.563 Sum_probs=166.4
Q ss_pred CcceeeCee---ecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecC---chhhhhHHHHHHHHHHhcccCCCCCC
Q 007035 403 DLPIILNTV---IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEH 476 (621)
Q Consensus 403 ~~pi~l~~i---i~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~---~~~~~~~~~Ei~iL~~l~~~~~~~hp 476 (621)
.+|+.+++. +.++|+++++||+|+||+||+|+++.+|+.||||+++.. .....++.+|+.+++.++ ||
T Consensus 3 ~~~~~~~~~~f~i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~------hp 76 (355)
T d2b1pa1 3 FYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN------HK 76 (355)
T ss_dssp EEEEEETTEEEEEETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCC------CT
T ss_pred CEEEEeCCcceeecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcC------CC
Confidence 467888883 448999999999999999999999999999999999754 333456778888888773 78
Q ss_pred ceEEEeeEeEe------cCeEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCc
Q 007035 477 HILRLYDYFYH------LEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPE 550 (621)
Q Consensus 477 nIvrl~~~f~~------~~~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~ 550 (621)
||++++++|.. ..++|+||||+.+++++.+.. .+++..++.+++||+.||.|||++||+||||||+
T Consensus 77 nIv~~~~~f~~~~~~~~~~~~~iv~Ey~~~~l~~~~~~--------~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~ 148 (355)
T d2b1pa1 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM--------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPS 148 (355)
T ss_dssp TBCCCSEEECSCCSTTTCCEEEEEEECCSEEHHHHHTS--------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred CeeEEEEEEecccccccCceeEEEEeccchHHHHhhhc--------CCCHHHHHHHHHHHHHHHHHhhhcccccccCCcc
Confidence 99999999964 368999999999998876632 2889999999999999999999999999999999
Q ss_pred cEEEeccCCCeEEEEecCCccccCC--CccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 551 NILIKSYQRCEIKIIDLGSSCFQTD--NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 551 NILl~~~~~~~IKL~DFGls~~~~~--~~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
|||++. ++.++|+|||++..... ......+|+.|+|||++.+..++.++||||+||++|+|++|++||
T Consensus 149 Nil~~~--~~~~kl~df~~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF 218 (355)
T d2b1pa1 149 NIVVKS--DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILF 218 (355)
T ss_dssp GEEECT--TCCEEECCCCC---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSS
T ss_pred cccccc--ccceeeechhhhhccccccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCC
Confidence 999994 78899999998765443 334467899999999999999999999999999999999999998
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-37 Score=316.63 Aligned_cols=186 Identities=24% Similarity=0.336 Sum_probs=154.1
Q ss_pred EEeccCCCCceeEEEeC--CCCcEEEEEEEecC---chhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeEEEE
Q 007035 420 EYLGSAAFSKVFQAQDL--HTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIV 494 (621)
Q Consensus 420 ~~LG~G~fG~Vyka~d~--~tg~~VAlKii~~~---~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l~LV 494 (621)
++||+|+||+||+|.+. .+++.||||+++.. ....+++.+|+++++++ .||||+++++++.. +..+||
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l------~HpnIv~~~g~~~~-~~~~lv 85 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL------DNPYIVRMIGICEA-ESWMLV 85 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTC------CCTTBCCEEEEEES-SSEEEE
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhC------CCCCCceEEEEecc-CCEEEE
Confidence 46999999999999754 45688999998653 23345677888888766 47899999999865 457899
Q ss_pred Eecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCcccc
Q 007035 495 CELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQ 573 (621)
Q Consensus 495 mEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~~~ 573 (621)
|||+++ +|.+++.... .+++..+..++.||+.||.|||+++|+||||||+|||++. ++.+||+|||++...
T Consensus 86 mE~~~~g~L~~~l~~~~------~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~--~~~~kl~DFGla~~~ 157 (277)
T d1xbba_ 86 MEMAELGPLNKYLQQNR------HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVT--QHYAKISDFGLSKAL 157 (277)
T ss_dssp EECCTTEEHHHHHHHCT------TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEE--TTEEEECCCTTCEEC
T ss_pred EEcCCCCcHHHHHhhcc------CCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccc--cCcccccchhhhhhc
Confidence 999985 6777665432 2889999999999999999999999999999999999994 889999999999764
Q ss_pred CCC------ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 574 TDN------LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 574 ~~~------~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
... .....||+.|+|||++.+..++.++|||||||++|||+| |++||
T Consensus 158 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf 211 (277)
T d1xbba_ 158 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY 211 (277)
T ss_dssp CTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred cccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCC
Confidence 332 122467899999999999999999999999999999998 89998
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=5e-37 Score=319.98 Aligned_cols=193 Identities=28% Similarity=0.487 Sum_probs=165.9
Q ss_pred cCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEec--Ce
Q 007035 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL--EH 490 (621)
Q Consensus 413 ~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~--~~ 490 (621)
.++|+++++||+|+||+||+|+++.+|+.||||+++... .+++.+|+.+++.++ +||||++++++|... .+
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~Ei~il~~l~-----~hpnIv~~~~~~~~~~~~~ 106 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK--KKKIKREIKILENLR-----GGPNIITLADIVKDPVSRT 106 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC--HHHHHHHHHHHHHHT-----TSTTBCCEEEEEECTTTCS
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH--HHHHHHHHHHHHhcc-----CCCCCcEEEEEEEecCCCc
Confidence 368999999999999999999999999999999997654 367889999999885 478999999999844 57
Q ss_pred EEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCc
Q 007035 491 LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (621)
Q Consensus 491 l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls 570 (621)
+++||||+.++.+..+. ..+++..++.+++||+.||.|||++||+||||||+|||++. +...+||+|||++
T Consensus 107 ~~~v~e~~~~~~L~~~~--------~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~-~~~~vkl~DFG~a 177 (328)
T d3bqca1 107 PALVFEHVNNTDFKQLY--------QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDH-EHRKLRLIDWGLA 177 (328)
T ss_dssp EEEEEECCCSCBGGGTT--------TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET-TTTEEEECCGGGC
T ss_pred eeEEEeecCCCcHHHHh--------cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcC-CCCeeeecccccc
Confidence 99999999975432221 12899999999999999999999999999999999999985 3457999999999
Q ss_pred cccCC--CccccccCCcccCchhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCC
Q 007035 571 CFQTD--NLCLYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVCLI 621 (621)
Q Consensus 571 ~~~~~--~~~~~~gt~~Y~APEvl~~~~-~s~ksDIWSLGvILyELltG~~PF~ 621 (621)
..... ......+|+.|+|||.+.+.. ++.++|||||||++|+|++|+.||.
T Consensus 178 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~ 231 (328)
T d3bqca1 178 EFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF 231 (328)
T ss_dssp EECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred eeccCCCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCC
Confidence 76543 345567899999999988764 7999999999999999999999983
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-37 Score=319.69 Aligned_cols=193 Identities=23% Similarity=0.321 Sum_probs=156.7
Q ss_pred CceEEEEEeccCCCCceeEEEeCCCCc----EEEEEEEecC--chhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEe
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQDLHTGV----DVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d~~tg~----~VAlKii~~~--~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~ 487 (621)
.+|++++.||+|+||+||+|++..+|+ .||+|.++.. ....+++.+|+++++.++ ||||+++++++.+
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~------HpnIv~l~g~~~~ 82 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD------NPHVCRLLGICLT 82 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCC------CTTBCCEEEEEES
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCC------CCCEeeEEEEEec
Confidence 469999999999999999999988876 5788877643 234567888999988874 7899999999987
Q ss_pred cCeEEEEEeccc-cchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEe
Q 007035 488 LEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (621)
Q Consensus 488 ~~~l~LVmEyl~-gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~D 566 (621)
... +++||++. ++|.+.+..... .+++..++.++.||+.||.|||+++|+||||||+|||++. ++.+||+|
T Consensus 83 ~~~-~~v~e~~~~~~l~~~~~~~~~-----~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~--~~~~kl~D 154 (317)
T d1xkka_ 83 STV-QLITQLMPFGCLLDYVREHKD-----NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKT--PQHVKITD 154 (317)
T ss_dssp SSE-EEEEECCTTCBHHHHHHHTSS-----SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEE--TTEEEECC
T ss_pred CCe-eEEEEeccCCccccccccccc-----CCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCC--CCCeEeec
Confidence 655 55556555 678877665432 2889999999999999999999999999999999999984 78999999
Q ss_pred cCCccccCCC-----ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 567 LGSSCFQTDN-----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 567 FGls~~~~~~-----~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
||++...... .....||+.|+|||++.+..|+.++|||||||+||||+| |++||
T Consensus 155 FGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~ 214 (317)
T d1xkka_ 155 FGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 214 (317)
T ss_dssp CSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred cccceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCC
Confidence 9998764332 222467999999999999999999999999999999998 78887
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-37 Score=317.36 Aligned_cols=196 Identities=24% Similarity=0.353 Sum_probs=161.2
Q ss_pred eecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCe
Q 007035 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (621)
Q Consensus 411 ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~ 490 (621)
+-.++|++.+.||+|+||+||+|++..+ +.||||+++......+.+.+|+.+++.++ ||||+++++++.+ +.
T Consensus 14 i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~~~~~~~E~~~l~~l~------h~nIv~~~g~~~~-~~ 85 (285)
T d1fmka3 14 IPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLR------HEKLVQLYAVVSE-EP 85 (285)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSCHHHHHHHHHHHHHCC------CTTBCCEEEEECS-SS
T ss_pred cCHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCCHHHHHHHHHHHHhcc------cCCEeEEEEEEec-CC
Confidence 3457899999999999999999997654 57999999877666677889999988874 6799999999855 55
Q ss_pred EEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCC
Q 007035 491 LFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (621)
Q Consensus 491 l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGl 569 (621)
+++||||+.+ ++..++...... .+++..++.++.||+.||+|||+++|+||||||+||||+. ++.+||+|||+
T Consensus 86 ~~lv~Ey~~~g~l~~~~~~~~~~----~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~--~~~~kl~DfGl 159 (285)
T d1fmka3 86 IYIVTEYMSKGSLLDFLKGETGK----YLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGE--NLVCKVADFGL 159 (285)
T ss_dssp CEEEECCCTTCBHHHHHSHHHHT----TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG--GGCEEECCCCT
T ss_pred eEEEEEecCCCchhhhhhhcccc----cchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECC--CCcEEEcccch
Confidence 7899999996 555555443322 2899999999999999999999999999999999999984 78999999999
Q ss_pred ccccCCC----ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 570 SCFQTDN----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 570 s~~~~~~----~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
+...... .....+|+.|+|||++....++.++|||||||+||||++|..||
T Consensus 160 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~ 214 (285)
T d1fmka3 160 ARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 214 (285)
T ss_dssp TC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCS
T ss_pred hhhccCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCC
Confidence 8754322 22356799999999999999999999999999999999976654
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-37 Score=321.16 Aligned_cols=194 Identities=32% Similarity=0.587 Sum_probs=163.4
Q ss_pred ecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecC--chhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEec-
Q 007035 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL- 488 (621)
Q Consensus 412 i~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~--~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~- 488 (621)
+..||+++++||+|+||+||+|.++.+|+.||||++... ....+++.+|+.+++.++ ||||+++++++...
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~------hp~iv~~~~~~~~~~ 79 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR------HENIIGINDIIRAPT 79 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCC------CTTBCCCCEEECCSS
T ss_pred cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcC------CCCCCcEEEEEeecc
Confidence 357899999999999999999999999999999999753 334567788999998885 67999999998764
Q ss_pred ----CeEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEE
Q 007035 489 ----EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKI 564 (621)
Q Consensus 489 ----~~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL 564 (621)
.+.+++|++.+++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||
T Consensus 80 ~~~~~~~~l~~~~~~g~L~~~l~~~-------~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~--~~~~~kl 150 (345)
T d1pmea_ 80 IEQMKDVYLVTHLMGADLYKLLKTQ-------HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN--TTCDLKI 150 (345)
T ss_dssp TTTCCCEEEEEECCCEEHHHHHHHC-------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC--TTCCEEE
T ss_pred ccccceEEEEEeecCCchhhhhhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEEC--CCCCEEE
Confidence 357888888878999888642 189999999999999999999999999999999999998 4789999
Q ss_pred EecCCccccCC------CccccccCCcccCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 565 IDLGSSCFQTD------NLCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 565 ~DFGls~~~~~------~~~~~~gt~~Y~APEvl~~-~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
+|||++..... .....++|+.|+|||++.. ..++.++||||+||++|+|++|+.||
T Consensus 151 ~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf 213 (345)
T d1pmea_ 151 CDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 213 (345)
T ss_dssp CCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSC
T ss_pred cccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCC
Confidence 99999865332 2334578999999999854 46789999999999999999999998
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-37 Score=312.46 Aligned_cols=196 Identities=24% Similarity=0.332 Sum_probs=153.8
Q ss_pred eecCceEEEEEeccCCCCceeEEEeCCC---CcEEEEEEEecC--chhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEe
Q 007035 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHT---GVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYF 485 (621)
Q Consensus 411 ii~~rY~I~~~LG~G~fG~Vyka~d~~t---g~~VAlKii~~~--~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f 485 (621)
+..++|++.+.||+|+||+||+|++..+ +..||||.++.. ....+.+.+|+.+++.+ .||||+++++++
T Consensus 4 i~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l------~HpnIv~l~~~~ 77 (273)
T d1mp8a_ 4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF------DHPHIVKLIGVI 77 (273)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTC------CCTTBCCEEEEE
T ss_pred cCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhC------CCCCEeeEEEEE
Confidence 4457899999999999999999998654 356888888643 33345677788877766 488999999998
Q ss_pred EecCeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEE
Q 007035 486 YHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKI 564 (621)
Q Consensus 486 ~~~~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL 564 (621)
. .+.+++||||+.+ ++.+++..... .+++..++.++.||+.||.|||+++|+||||||+|||++. ++.+||
T Consensus 78 ~-~~~~~iv~E~~~~g~l~~~~~~~~~-----~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~--~~~~Kl 149 (273)
T d1mp8a_ 78 T-ENPVWIIMELCTLGELRSFLQVRKY-----SLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSS--NDCVKL 149 (273)
T ss_dssp C-SSSCEEEEECCTTEEHHHHHHHTTT-----TSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEE--TTEEEE
T ss_pred e-cCeEEEEEEeccCCcHHhhhhccCC-----CCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecC--CCcEEE
Confidence 5 4678999999985 56555543322 2889999999999999999999999999999999999995 789999
Q ss_pred EecCCccccCCC----ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 565 IDLGSSCFQTDN----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 565 ~DFGls~~~~~~----~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
+|||++...... .....+|+.|+|||++.+..++.++|||||||+||||++ |++||
T Consensus 150 ~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~ 210 (273)
T d1mp8a_ 150 GDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF 210 (273)
T ss_dssp CC-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred ccchhheeccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCC
Confidence 999998764332 233567899999999999999999999999999999998 89887
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-36 Score=309.02 Aligned_cols=195 Identities=30% Similarity=0.441 Sum_probs=166.9
Q ss_pred CceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc---hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCe
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~---~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~ 490 (621)
+||++++.||+|+||+||+|+++.+|+.||||+++... ....++.+|+.+++.+ .||||+++++++.+...
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l------~h~niv~~~~~~~~~~~ 75 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL------KHKNIVRLHDVLHSDKK 75 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTC------CCTTBCCEEEEEECSSE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhc------CcCCEEeeccccccccc
Confidence 58999999999999999999999999999999997543 3345667777777655 57899999999999999
Q ss_pred EEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCc
Q 007035 491 LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (621)
Q Consensus 491 l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls 570 (621)
.++|||++.+..+..+..... .+++..++.++.|++.||+|||++||+||||||+|||++. ++.+||+|||.+
T Consensus 76 ~~iv~~~~~~~~l~~~~~~~~-----~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~--~~~~kl~DFG~a 148 (292)
T d1unla_ 76 LTLVFEFCDQDLKKYFDSCNG-----DLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINR--NGELKLANFGLA 148 (292)
T ss_dssp EEEEEECCSEEHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT--TCCEEECCCTTC
T ss_pred eeEEeeecccccccccccccc-----ccchhHHHHHHHHHHHHHHHhhcCCEeeecccCccccccc--CCceeeeecchh
Confidence 999999999876666554332 2789999999999999999999999999999999999984 778999999999
Q ss_pred cccCCC---ccccccCCcccCchhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCC
Q 007035 571 CFQTDN---LCLYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVCLI 621 (621)
Q Consensus 571 ~~~~~~---~~~~~gt~~Y~APEvl~~~~-~s~ksDIWSLGvILyELltG~~PF~ 621 (621)
...... .....+++.|+|||++.+.. ++.++|||||||++|||++|+.||+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 203 (292)
T d1unla_ 149 RAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF 203 (292)
T ss_dssp EECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSC
T ss_pred hcccCCCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCC
Confidence 765433 22345678899999998765 6899999999999999999999974
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-36 Score=308.96 Aligned_cols=195 Identities=23% Similarity=0.353 Sum_probs=156.8
Q ss_pred eecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEe-cC
Q 007035 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH-LE 489 (621)
Q Consensus 411 ii~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~-~~ 489 (621)
+-.++|++++.||+|+||.||+|++ +|..||||+++.+.. .+.+.+|+++++++ +||||+++++++.+ .+
T Consensus 4 i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~~-~~~~~~E~~~l~~l------~HpnIv~~~g~~~~~~~ 74 (262)
T d1byga_ 4 LNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDAT-AQAFLAEASVMTQL------RHSNLVQLLGVIVEEKG 74 (262)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC---HHHHHTHHHHTTC------CCTTBCCEEEEECCC--
T ss_pred cCHHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHHH-HHHHHHHHHHHHhC------CCCCEeeEEEEEEecCC
Confidence 3456899999999999999999997 478899999976543 45677888877655 48899999998865 46
Q ss_pred eEEEEEeccc-cchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecC
Q 007035 490 HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (621)
Q Consensus 490 ~l~LVmEyl~-gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFG 568 (621)
.+++||||+. |+|.+++...... .+++..++.++.||+.||.|||+++|+||||||+|||++. ++.+||+|||
T Consensus 75 ~~~lv~ey~~~g~L~~~l~~~~~~----~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~--~~~~kl~dfg 148 (262)
T d1byga_ 75 GLYIVTEYMAKGSLVDYLRSRGRS----VLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSE--DNVAKVSDFG 148 (262)
T ss_dssp CCEEEECCCTTEEHHHHHHHHHHH----HCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECT--TSCEEECCCC
T ss_pred cEEEEEeccCCCCHHHHHHhcCCC----CCCHHHHHHHHHHHHhhccccccCceeccccchHhheecC--CCCEeecccc
Confidence 7899999997 5788777544322 2789999999999999999999999999999999999994 8899999999
Q ss_pred CccccCCCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 569 SSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 569 ls~~~~~~~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
++...........+++.|+|||++.+..++.++|||||||++|||+| |++||
T Consensus 149 ~s~~~~~~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~ 201 (262)
T d1byga_ 149 LTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY 201 (262)
T ss_dssp C------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSC
T ss_pred cceecCCCCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCC
Confidence 99877666666778999999999999999999999999999999998 78776
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-36 Score=308.91 Aligned_cols=203 Identities=24% Similarity=0.332 Sum_probs=156.6
Q ss_pred eecCceEEEEEeccCCCCceeEEEeCC-----CCcEEEEEEEecCc--hhhhhHHHHHHHHHHhcccCCCCCCceEEEee
Q 007035 411 VIAGRYYVTEYLGSAAFSKVFQAQDLH-----TGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYD 483 (621)
Q Consensus 411 ii~~rY~I~~~LG~G~fG~Vyka~d~~-----tg~~VAlKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~ 483 (621)
+..++|++.+.||+|+||+||+|.+.. +++.||||+++... .....+..|..++.++. .|+||+++++
T Consensus 10 i~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~-----~h~~iv~~~~ 84 (299)
T d1ywna1 10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG-----HHLNVVNLLG 84 (299)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHC-----CCTTBCCEEE
T ss_pred ccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhc-----CCCeEEEeee
Confidence 345789999999999999999998654 45789999987532 33455667777777765 3679999999
Q ss_pred EeEec-CeEEEEEeccc-cchHHHHHhhhccC----------CCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCcc
Q 007035 484 YFYHL-EHLFIVCELLR-ANLYEFQKFNQESG----------GEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPEN 551 (621)
Q Consensus 484 ~f~~~-~~l~LVmEyl~-gsLld~l~~~~~~~----------~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~N 551 (621)
++... ..+++||||++ |+|.+++....... ....+++..+..++.||+.||.|||+++|+||||||+|
T Consensus 85 ~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~N 164 (299)
T d1ywna1 85 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN 164 (299)
T ss_dssp EECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred eeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccc
Confidence 87754 57899999998 57777776543211 12348899999999999999999999999999999999
Q ss_pred EEEeccCCCeEEEEecCCccccCCC-----ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCC-CCC
Q 007035 552 ILIKSYQRCEIKIIDLGSSCFQTDN-----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGE-VCL 620 (621)
Q Consensus 552 ILl~~~~~~~IKL~DFGls~~~~~~-----~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~-~PF 620 (621)
|||+. ++.+||+|||+|...... .....||+.|+|||++.+..++.++|||||||++|||+||. +||
T Consensus 165 ILl~~--~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~ 237 (299)
T d1ywna1 165 ILLSE--KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 237 (299)
T ss_dssp EEECG--GGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred eeECC--CCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCC
Confidence 99984 789999999998654322 22357899999999999999999999999999999999975 565
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-36 Score=316.59 Aligned_cols=193 Identities=35% Similarity=0.620 Sum_probs=163.0
Q ss_pred cCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc---hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEec-
Q 007035 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL- 488 (621)
Q Consensus 413 ~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~---~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~- 488 (621)
.+||++++.||+|+||+||+|+++.+|+.||||++++.. ...+++.+|+.+++.++ ||||+++++++...
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~------h~~iv~~~~~~~~~~ 90 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK------HENVIGLLDVFTPAR 90 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCC------CTTBCCCSEEECSCS
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcC------CCCeeeEEEEEeecc
Confidence 579999999999999999999999999999999997542 33456778898888874 78999999998643
Q ss_pred -----CeEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEE
Q 007035 489 -----EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 563 (621)
Q Consensus 489 -----~~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IK 563 (621)
.+.++++++.+++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+|
T Consensus 91 ~~~~~~~~~i~~~~~gg~L~~~~~~~-------~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~--~~~~k 161 (348)
T d2gfsa1 91 SLEEFNDVYLVTHLMGADLNNIVKCQ-------KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE--DCELK 161 (348)
T ss_dssp STTTCCCCEEEEECCSEEHHHHHTTC-------CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT--TCCEE
T ss_pred ccccCceEEEEEeecCCchhhhcccc-------cccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccc--ccccc
Confidence 346666666667888776432 2899999999999999999999999999999999999984 78999
Q ss_pred EEecCCccccCCCccccccCCcccCchhhcCCC-CCchhhHHHHHHHHHHHHhCCCCC
Q 007035 564 IIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 564 L~DFGls~~~~~~~~~~~gt~~Y~APEvl~~~~-~s~ksDIWSLGvILyELltG~~PF 620 (621)
|+|||++...........|++.|+|||++.+.. ++.++|||||||++|+|++|++||
T Consensus 162 l~dfg~a~~~~~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF 219 (348)
T d2gfsa1 162 ILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 219 (348)
T ss_dssp ECCC----CCTGGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSC
T ss_pred ccccchhcccCcccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCC
Confidence 999999988777777778899999999987765 688999999999999999999998
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-36 Score=306.12 Aligned_cols=194 Identities=27% Similarity=0.372 Sum_probs=153.5
Q ss_pred cCceEEEEEeccCCCCceeEEEeCC-CC--cEEEEEEEecC----chhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEe
Q 007035 413 AGRYYVTEYLGSAAFSKVFQAQDLH-TG--VDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYF 485 (621)
Q Consensus 413 ~~rY~I~~~LG~G~fG~Vyka~d~~-tg--~~VAlKii~~~----~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f 485 (621)
.++|++++.||+|+||+||+|++.. ++ ..||||+++.+ ....+.+.+|+.+++.++ ||||+++++++
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~------H~nIv~~~g~~ 80 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD------HRNLIRLYGVV 80 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCC------CTTBCCEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCC------CCCEEEEEEEE
Confidence 3679999999999999999998543 33 46899988653 334466788888888774 78999999999
Q ss_pred EecCeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEE
Q 007035 486 YHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKI 564 (621)
Q Consensus 486 ~~~~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL 564 (621)
.+ ...++||||+.+ ++.+.+...... +++..+..++.||+.||.|||+++|+||||||+|||++. ++.+||
T Consensus 81 ~~-~~~~lv~e~~~~~~l~~~~~~~~~~-----l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~--~~~vkl 152 (273)
T d1u46a_ 81 LT-PPMKMVTELAPLGSLLDRLRKHQGH-----FLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLAT--RDLVKI 152 (273)
T ss_dssp CS-SSCEEEEECCTTCBHHHHHHHHGGG-----SCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEE--TTEEEE
T ss_pred ee-cchheeeeeecCcchhhhhhcccCC-----CCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhcccc--ccceee
Confidence 75 467899999984 666665544322 899999999999999999999999999999999999995 779999
Q ss_pred EecCCccccCCCc------cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 565 IDLGSSCFQTDNL------CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 565 ~DFGls~~~~~~~------~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
+|||++....... ....+++.|+|||++.+..++.++|||||||++|||+| |++||
T Consensus 153 ~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf 215 (273)
T d1u46a_ 153 GDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPW 215 (273)
T ss_dssp CCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred ccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCC
Confidence 9999987654321 22456788999999999999999999999999999998 89998
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.1e-36 Score=308.40 Aligned_cols=200 Identities=23% Similarity=0.299 Sum_probs=164.3
Q ss_pred cCceEEEEEeccCCCCceeEEEeC-----CCCcEEEEEEEecCc--hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEe
Q 007035 413 AGRYYVTEYLGSAAFSKVFQAQDL-----HTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYF 485 (621)
Q Consensus 413 ~~rY~I~~~LG~G~fG~Vyka~d~-----~tg~~VAlKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f 485 (621)
.++|++++.||+|+||+||+|+++ .+++.||||+++... ....++.+|+.+++.+ .||||+++++++
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l------~h~niv~~~~~~ 85 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF------DNPNIVKLLGVC 85 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTC------CCTTBCCEEEEE
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhc------CCCCcccceeee
Confidence 468999999999999999999864 356889999987543 3345678888887766 478999999999
Q ss_pred EecCeEEEEEeccc-cchHHHHHhhhc------------------cCCCccccHHHHHHHHHHHHHHHHHHHHCCeeccc
Q 007035 486 YHLEHLFIVCELLR-ANLYEFQKFNQE------------------SGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCD 546 (621)
Q Consensus 486 ~~~~~l~LVmEyl~-gsLld~l~~~~~------------------~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrD 546 (621)
...+.+++||||+. ++|.+++..... ......+++..+..++.||+.||.|||+++|+|||
T Consensus 86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrD 165 (301)
T d1lufa_ 86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRD 165 (301)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeE
Confidence 99999999999998 577777754321 11123378889999999999999999999999999
Q ss_pred CCCccEEEeccCCCeEEEEecCCccccCC-----CccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCC-CCC
Q 007035 547 LKPENILIKSYQRCEIKIIDLGSSCFQTD-----NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGE-VCL 620 (621)
Q Consensus 547 LKP~NILl~~~~~~~IKL~DFGls~~~~~-----~~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~-~PF 620 (621)
|||+|||++. ++.+||+|||++..... ......+++.|+|||.+.+..|+.++|||||||+||||++|. +||
T Consensus 166 lKp~NILld~--~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~ 243 (301)
T d1lufa_ 166 LATRNCLVGE--NMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 243 (301)
T ss_dssp CSGGGEEECG--GGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred EcccceEECC--CCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCC
Confidence 9999999994 78899999999865322 122356788999999999999999999999999999999996 555
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.9e-35 Score=310.63 Aligned_cols=213 Identities=36% Similarity=0.614 Sum_probs=180.4
Q ss_pred cceeeCeeec-CceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCC-----CCCc
Q 007035 404 LPIILNTVIA-GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPA-----DEHH 477 (621)
Q Consensus 404 ~pi~l~~ii~-~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~-----~hpn 477 (621)
+|+.+++.+. +||+++++||+|+||+||+|+++.+|+.||||+++++....+...+|+++++.+.+.... .|+|
T Consensus 2 ~p~~~g~~~~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~ 81 (362)
T d1q8ya_ 2 HPAFKGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANH 81 (362)
T ss_dssp CCCCTTCEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTT
T ss_pred CCCCCCCCccCCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCc
Confidence 6888899887 579999999999999999999999999999999998877777889999999999876543 5789
Q ss_pred eEEEeeEeEec--CeEEEEEeccc--cchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHH-CCeecccCCCccE
Q 007035 478 ILRLYDYFYHL--EHLFIVCELLR--ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS-LGIIHCDLKPENI 552 (621)
Q Consensus 478 Ivrl~~~f~~~--~~l~LVmEyl~--gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs-~gIvHrDLKP~NI 552 (621)
|+++++++... ...+++|+++. +........... ..+++..++.+++||+.||.|||+ .||+||||||+||
T Consensus 82 iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NI 157 (362)
T d1q8ya_ 82 ILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEH----RGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENV 157 (362)
T ss_dssp BCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTT----SCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGE
T ss_pred eEEEEEEeeeccccceeeeeeecccccccccccccccc----cCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHe
Confidence 99999998754 45566666554 343333333222 238889999999999999999998 8999999999999
Q ss_pred EEeccCC----CeEEEEecCCccccCCCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 553 LIKSYQR----CEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 553 Ll~~~~~----~~IKL~DFGls~~~~~~~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
||+.+.. ..++|+|||.+..........++|+.|+|||++.+..++.++|||||||++++|++|+.||
T Consensus 158 ll~~~~~~~~~~~~kl~dfg~s~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF 229 (362)
T d1q8ya_ 158 LMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLF 229 (362)
T ss_dssp EEEEEETTTTEEEEEECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC
T ss_pred eeeccCcccccceeeEeecccccccccccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCC
Confidence 9985332 3599999999987777777788999999999999999999999999999999999999998
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-35 Score=305.28 Aligned_cols=204 Identities=24% Similarity=0.367 Sum_probs=163.1
Q ss_pred eeecCceEEEEEeccCCCCceeEEEeCCCC-------cEEEEEEEecCc--hhhhhHHHHHHHHHHhcccCCCCCCceEE
Q 007035 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTG-------VDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILR 480 (621)
Q Consensus 410 ~ii~~rY~I~~~LG~G~fG~Vyka~d~~tg-------~~VAlKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~hpnIvr 480 (621)
++..++|++.+.||+|+||.||+|++..++ ..||||+++.+. .....+.+|..++.++. .||||++
T Consensus 9 ~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~-----~HpnIv~ 83 (299)
T d1fgka_ 9 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG-----KHKNIIN 83 (299)
T ss_dssp BCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHC-----CCTTBCC
T ss_pred cccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhc-----CCCeEEe
Confidence 345689999999999999999999876554 479999997644 33456677777777764 4889999
Q ss_pred EeeEeEecCeEEEEEecccc-chHHHHHhhhc----------cCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCC
Q 007035 481 LYDYFYHLEHLFIVCELLRA-NLYEFQKFNQE----------SGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKP 549 (621)
Q Consensus 481 l~~~f~~~~~l~LVmEyl~g-sLld~l~~~~~----------~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP 549 (621)
+++++.+...+++||||+.+ ++.+++..... ......+++..++.++.||+.||.|||+++|+||||||
T Consensus 84 ~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp 163 (299)
T d1fgka_ 84 LLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAA 163 (299)
T ss_dssp EEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred cccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecc
Confidence 99999999999999999985 67777654321 11234489999999999999999999999999999999
Q ss_pred ccEEEeccCCCeEEEEecCCccccCCC-----ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 007035 550 ENILIKSYQRCEIKIIDLGSSCFQTDN-----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVCL 620 (621)
Q Consensus 550 ~NILl~~~~~~~IKL~DFGls~~~~~~-----~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELlt-G~~PF 620 (621)
+|||++. ++.+||+|||++...... .....+++.|+|||.+.+..|+.++|||||||++|||++ |++||
T Consensus 164 ~NiLl~~--~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~ 238 (299)
T d1fgka_ 164 RNVLVTE--DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 238 (299)
T ss_dssp GGEEECT--TCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred cceeecC--CCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCC
Confidence 9999984 788999999998754332 233577899999999999999999999999999999998 68876
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-35 Score=308.60 Aligned_cols=194 Identities=27% Similarity=0.425 Sum_probs=166.4
Q ss_pred CceEEEEEeccCCCCceeEEEe---CCCCcEEEEEEEecC-----chhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEe
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQD---LHTGVDVCLKIIKND-----KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYF 485 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d---~~tg~~VAlKii~~~-----~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f 485 (621)
++|++++.||+|+||+||+|++ +.+|+.||||++++. ....+.+.+|+++++++++ ||||+++++++
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h-----~pnIv~~~~~~ 98 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQ-----SPFLVTLHYAF 98 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHT-----CTTBCCEEEEE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccC-----CCeEEEeeeee
Confidence 7799999999999999999987 447899999998643 2345678899999999975 46999999999
Q ss_pred EecCeEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEE
Q 007035 486 YHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKI 564 (621)
Q Consensus 486 ~~~~~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL 564 (621)
.+...+++||||+.+ +|.+.+..... +++..++.++.||+.||.|||+++|+||||||+|||++. ++.+||
T Consensus 99 ~~~~~~~~v~e~~~~~~L~~~i~~~~~------~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~--~~~vkL 170 (322)
T d1vzoa_ 99 QTETKLHLILDYINGGELFTHLSQRER------FTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDS--NGHVVL 170 (322)
T ss_dssp EETTEEEEEECCCCSCBHHHHHHHHSC------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT--TSCEEE
T ss_pred ccCCceeeeeecccccHHHHHHHhccc------ccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecC--CCCEEE
Confidence 999999999999985 67777665543 678889999999999999999999999999999999995 789999
Q ss_pred EecCCccccCC----CccccccCCcccCchhhcCCC--CCchhhHHHHHHHHHHHHhCCCCC
Q 007035 565 IDLGSSCFQTD----NLCLYVQSRSYRAPEVIIGLP--YDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 565 ~DFGls~~~~~----~~~~~~gt~~Y~APEvl~~~~--~s~ksDIWSLGvILyELltG~~PF 620 (621)
+|||++..... ......+++.|+|||.+.+.. ++.++|||||||+||+|++|+.||
T Consensus 171 ~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF 232 (322)
T d1vzoa_ 171 TDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPF 232 (322)
T ss_dssp SCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTT
T ss_pred eeccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCC
Confidence 99999865432 233467899999999997654 678999999999999999999998
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-35 Score=307.38 Aligned_cols=200 Identities=22% Similarity=0.275 Sum_probs=162.8
Q ss_pred CceEEEEEeccCCCCceeEEEeCCCCcE--EEEEEEecC--chhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecC
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVD--VCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d~~tg~~--VAlKii~~~--~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~ 489 (621)
++|++.+.||+|+||+||+|+++.+|.. ||||.++.. ....+.+.+|++++.++. +||||+++++++...+
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-----~HpnIv~~~~~~~~~~ 84 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG-----HHPNIINLLGACEHRG 84 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCC-----CCTTBCCEEEEEEETT
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhcc-----CCCCEeeEEEEEecCC
Confidence 6899999999999999999999888875 677776542 234456788888887663 4889999999999999
Q ss_pred eEEEEEeccc-cchHHHHHhhhc----------cCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccC
Q 007035 490 HLFIVCELLR-ANLYEFQKFNQE----------SGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQ 558 (621)
Q Consensus 490 ~l~LVmEyl~-gsLld~l~~~~~----------~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~ 558 (621)
.++|||||++ |+|.+++..... ......+++..+..++.||+.||.|||+++|+||||||+|||++.
T Consensus 85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~-- 162 (309)
T d1fvra_ 85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGE-- 162 (309)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECG--
T ss_pred eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcC--
Confidence 9999999998 578877754311 112234899999999999999999999999999999999999984
Q ss_pred CCeEEEEecCCccccCCC--ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCC-CC
Q 007035 559 RCEIKIIDLGSSCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEV-CL 620 (621)
Q Consensus 559 ~~~IKL~DFGls~~~~~~--~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~-PF 620 (621)
++.+||+|||++...... .....+|+.|+|||.+.+..++.++|||||||++|||++|.. ||
T Consensus 163 ~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~ 227 (309)
T d1fvra_ 163 NYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY 227 (309)
T ss_dssp GGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred CCceEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCC
Confidence 789999999998654432 223467899999999999999999999999999999999765 55
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-35 Score=305.65 Aligned_cols=192 Identities=22% Similarity=0.294 Sum_probs=155.2
Q ss_pred ecCceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecC--
Q 007035 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE-- 489 (621)
Q Consensus 412 i~~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~-- 489 (621)
++.+|.+.+.||+|+||+||+|++ +|+.||||+++.+.. .....|.++ .......||||+++++++...+
T Consensus 1 ~~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~--~~~~~e~ei----~~~~~~~HpnIv~~~~~~~~~~~~ 72 (303)
T d1vjya_ 1 IARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE--RSWFREAEI----YQTVMLRHENILGFIAADNKDNGT 72 (303)
T ss_dssp CGGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGH--HHHHHHHHH----HTSTTCCCTTBCCEEEEEEEECSS
T ss_pred CCcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch--hHHHHHHHH----HHHhhCCCCcCcceEEEEEeCCCc
Confidence 356899999999999999999985 689999999975543 233344333 3333457999999999998654
Q ss_pred --eEEEEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHH--------CCeecccCCCccEEEeccC
Q 007035 490 --HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS--------LGIIHCDLKPENILIKSYQ 558 (621)
Q Consensus 490 --~l~LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs--------~gIvHrDLKP~NILl~~~~ 558 (621)
++++||||+.+ +|.+++... .+++..+..++.|++.||.|||+ ++|+||||||+||||+ .
T Consensus 73 ~~~~~lv~Ey~~~g~L~~~l~~~-------~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~--~ 143 (303)
T d1vjya_ 73 WTQLWLVSDYHEHGSLFDYLNRY-------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK--K 143 (303)
T ss_dssp SEEEEEEEECCTTCBHHHHHHHC-------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEEC--T
T ss_pred ceEEEEEEecccCCCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEc--C
Confidence 68999999985 777777532 18899999999999999999996 5999999999999998 4
Q ss_pred CCeEEEEecCCccccCCC-------ccccccCCcccCchhhcCCC------CCchhhHHHHHHHHHHHHhCCCCC
Q 007035 559 RCEIKIIDLGSSCFQTDN-------LCLYVQSRSYRAPEVIIGLP------YDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 559 ~~~IKL~DFGls~~~~~~-------~~~~~gt~~Y~APEvl~~~~------~s~ksDIWSLGvILyELltG~~PF 620 (621)
++.+||+|||++...... .....||+.|+|||++.+.. ++.++|||||||+||||+||.+||
T Consensus 144 ~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~ 218 (303)
T d1vjya_ 144 NGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG 218 (303)
T ss_dssp TSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBT
T ss_pred CCCeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCC
Confidence 789999999998754332 23457899999999997653 567899999999999999998876
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-35 Score=301.28 Aligned_cols=205 Identities=24% Similarity=0.300 Sum_probs=168.6
Q ss_pred CeeecCceEEEEEeccCCCCceeEEEe-----CCCCcEEEEEEEecCc--hhhhhHHHHHHHHHHhcccCCCCCCceEEE
Q 007035 409 NTVIAGRYYVTEYLGSAAFSKVFQAQD-----LHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRL 481 (621)
Q Consensus 409 ~~ii~~rY~I~~~LG~G~fG~Vyka~d-----~~tg~~VAlKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl 481 (621)
+++..++|++.++||+|+||.||+|++ ..+++.||||+++... .....+.+|+.+++.+. +||||+++
T Consensus 18 ~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~-----~HpnIv~~ 92 (311)
T d1t46a_ 18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG-----NHMNIVNL 92 (311)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHC-----CCTTBCCE
T ss_pred ccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhcc-----CCCCEEEE
Confidence 345568999999999999999999975 3567889999997643 33456778888888874 48899999
Q ss_pred eeEeEecCeEEEEEecccc-chHHHHHhhhcc------------CCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCC
Q 007035 482 YDYFYHLEHLFIVCELLRA-NLYEFQKFNQES------------GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLK 548 (621)
Q Consensus 482 ~~~f~~~~~l~LVmEyl~g-sLld~l~~~~~~------------~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLK 548 (621)
++++.....++|||||+.+ +|.+++...... .....+++..+..++.||+.||.|||+++|+|||||
T Consensus 93 ~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLK 172 (311)
T d1t46a_ 93 LGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLA 172 (311)
T ss_dssp EEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred EEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccc
Confidence 9999999999999999985 677766543321 122348889999999999999999999999999999
Q ss_pred CccEEEeccCCCeEEEEecCCccccCCCc-----cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 549 PENILIKSYQRCEIKIIDLGSSCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 549 P~NILl~~~~~~~IKL~DFGls~~~~~~~-----~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
|+|||++. .+.+||+|||++....... ....+|+.|+|||++.+..++.++|||||||++|||+|++.||
T Consensus 173 p~NIl~~~--~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~ 247 (311)
T d1t46a_ 173 ARNILLTH--GRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247 (311)
T ss_dssp GGGEEEET--TTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCS
T ss_pred cccccccc--cCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCC
Confidence 99999984 7899999999987654321 2356799999999999999999999999999999999954443
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-35 Score=301.30 Aligned_cols=203 Identities=19% Similarity=0.275 Sum_probs=163.4
Q ss_pred eeecCceEEEEEeccCCCCceeEEEeCC-----CCcEEEEEEEecCchh--hhhHHHHHHHHHHhcccCCCCCCceEEEe
Q 007035 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLH-----TGVDVCLKIIKNDKDF--FDQSLDEIKLLKLVNKNDPADEHHILRLY 482 (621)
Q Consensus 410 ~ii~~rY~I~~~LG~G~fG~Vyka~d~~-----tg~~VAlKii~~~~~~--~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~ 482 (621)
++..++|++.+.||+|+||+||+|.+.. ++..||||+++..... ...+.+|+.+++.+ .||||++++
T Consensus 16 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l------~h~nIv~~~ 89 (308)
T d1p4oa_ 16 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF------NCHHVVRLL 89 (308)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGC------CCTTBCCEE
T ss_pred eecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHc------CCCCEeeee
Confidence 4556899999999999999999998753 4678999999754322 22345555555544 688999999
Q ss_pred eEeEecCeEEEEEeccc-cchHHHHHhhhc----cCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEecc
Q 007035 483 DYFYHLEHLFIVCELLR-ANLYEFQKFNQE----SGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSY 557 (621)
Q Consensus 483 ~~f~~~~~l~LVmEyl~-gsLld~l~~~~~----~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~ 557 (621)
+++...+..++||||+. |+|.+++..... ......+++..+..++.||+.||.|||+++|+||||||+|||++
T Consensus 90 ~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld-- 167 (308)
T d1p4oa_ 90 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA-- 167 (308)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEEC--
T ss_pred eEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeec--
Confidence 99999999999999998 567776654321 11122367888999999999999999999999999999999998
Q ss_pred CCCeEEEEecCCccccCCC-----ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCC-CCC
Q 007035 558 QRCEIKIIDLGSSCFQTDN-----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGE-VCL 620 (621)
Q Consensus 558 ~~~~IKL~DFGls~~~~~~-----~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~-~PF 620 (621)
.++.+||+|||++...... .....+|+.|+|||.+.+..++.++|||||||+||||+||. +||
T Consensus 168 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~ 236 (308)
T d1p4oa_ 168 EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY 236 (308)
T ss_dssp TTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTT
T ss_pred CCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCC
Confidence 5889999999998754332 22346789999999999999999999999999999999985 555
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-34 Score=295.83 Aligned_cols=189 Identities=21% Similarity=0.280 Sum_probs=154.9
Q ss_pred EEEeccCCCCceeEEEeCCCC---cEEEEEEEec--CchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEe-cCeEE
Q 007035 419 TEYLGSAAFSKVFQAQDLHTG---VDVCLKIIKN--DKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH-LEHLF 492 (621)
Q Consensus 419 ~~~LG~G~fG~Vyka~d~~tg---~~VAlKii~~--~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~-~~~l~ 492 (621)
.++||+|+||+||+|++..++ ..||||.++. ......++.+|+++++++ .||||+++++++.. ....+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l------~HpnIv~~~g~~~~~~~~~~ 105 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF------SHPNVLSLLGICLRSEGSPL 105 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTC------CCTTBCCCCEEEEETTTEEE
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhC------CCCCEeEEeEEEEecCCceE
Confidence 578999999999999986543 3689999874 333456678888888776 47899999999875 46899
Q ss_pred EEEecccc-chHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEeccCCCeEEEEecCCcc
Q 007035 493 IVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 571 (621)
Q Consensus 493 LVmEyl~g-sLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~~IKL~DFGls~ 571 (621)
+||||+++ +|.+++..... .+++..+..++.||+.||.|||+.+|+||||||+|||++ .++.+||+|||++.
T Consensus 106 lv~E~~~~g~l~~~~~~~~~-----~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~--~~~~~kL~DFG~~~ 178 (311)
T d1r0pa_ 106 VVLPYMKHGDLRNFIRNETH-----NPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLD--EKFTVKVADFGLAR 178 (311)
T ss_dssp EEEECCTTCBHHHHHHCTTC-----CCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC--TTCCEEECSSGGGC
T ss_pred EEEEEeecCchhhhhccccc-----cchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeEC--CCCCEEEecccchh
Confidence 99999996 55555543322 267888899999999999999999999999999999998 47899999999987
Q ss_pred ccCCC-------ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007035 572 FQTDN-------LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVCL 620 (621)
Q Consensus 572 ~~~~~-------~~~~~gt~~Y~APEvl~~~~~s~ksDIWSLGvILyELltG~~PF 620 (621)
..... .....+|+.|+|||.+....++.++||||||++||||+||+.||
T Consensus 179 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~ 234 (311)
T d1r0pa_ 179 DMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 234 (311)
T ss_dssp CTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred hccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCC
Confidence 54322 22246789999999999999999999999999999999988876
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.84 E-value=4.2e-22 Score=190.88 Aligned_cols=164 Identities=18% Similarity=0.165 Sum_probs=113.1
Q ss_pred eEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCch-------------------hhhhHHHHHHHHHHhcccCCCCCC
Q 007035 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD-------------------FFDQSLDEIKLLKLVNKNDPADEH 476 (621)
Q Consensus 416 Y~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~-------------------~~~~~~~Ei~iL~~l~~~~~~~hp 476 (621)
+.+.++||+|+||+||+|++ .+|+.||||+++.... .......|...+..+. +.
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~-~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~------~~ 74 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ------GL 74 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT------TS
T ss_pred chhCCEeeeCcceEEEEEEC-CCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHcc------CC
Confidence 45788999999999999997 4799999998764211 0112233444555443 45
Q ss_pred ceEEEeeEeEecCeEEEEEeccccchHHHHHhhhccCCCccccHHHHHHHHHHHHHHHHHHHHCCeecccCCCccEEEec
Q 007035 477 HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS 556 (621)
Q Consensus 477 nIvrl~~~f~~~~~l~LVmEyl~gsLld~l~~~~~~~~~~~ls~~~i~~I~~qIl~aL~yLHs~gIvHrDLKP~NILl~~ 556 (621)
+++..+++. ..++||||+++.... .++...+..++.||+.+|.|||++||+||||||+|||++
T Consensus 75 ~v~~~~~~~----~~~lvme~~~~~~~~------------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~- 137 (191)
T d1zara2 75 AVPKVYAWE----GNAVLMELIDAKELY------------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS- 137 (191)
T ss_dssp SSCCEEEEE----TTEEEEECCCCEEGG------------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-
T ss_pred CcceEEEec----CCEEEEEeecccccc------------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeee-
Confidence 677766542 237899999864221 145556778999999999999999999999999999998
Q ss_pred cCCCeEEEEecCCccccCCCccccccCCcccCc--hh---hcCCCCCchhhHHHHHHHH
Q 007035 557 YQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAP--EV---IIGLPYDQKIDLWSLGCIL 610 (621)
Q Consensus 557 ~~~~~IKL~DFGls~~~~~~~~~~~gt~~Y~AP--Ev---l~~~~~s~ksDIWSLGvIL 610 (621)
+..++|+|||++.....+... .|... +. .....|+.++|+||+.--+
T Consensus 138 --~~~~~liDFG~a~~~~~~~~~-----~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 138 --EEGIWIIDFPQSVEVGEEGWR-----EILERDVRNIITYFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp --TTEEEECCCTTCEETTSTTHH-----HHHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred --CCCEEEEECCCcccCCCCCcH-----HHHHHHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence 345899999998765433221 12111 11 1234678899999965443
|
| >d1a25a_ b.7.1.2 (A:) C2 domain from protein kinase c (beta) {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: C2 domain-like superfamily: C2 domain (Calcium/lipid-binding domain, CaLB) family: Synaptotagmin-like (S variant) domain: C2 domain from protein kinase c (beta) species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.70 E-value=2.1e-18 Score=155.68 Aligned_cols=111 Identities=22% Similarity=0.308 Sum_probs=94.9
Q ss_pred CcceEEEEecC-CCccccCcCCCCcceEeecCCCCCCcccceeeccccCCCceeccceeeecccccccccccccccccCC
Q 007035 265 NDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDN 343 (621)
Q Consensus 265 ~~~l~v~l~e~-~L~~~d~~g~sDpyVK~~Llp~~~~~~k~kt~v~k~tlnP~fnE~f~f~~~~~~~~~~k~L~~~V~D~ 343 (621)
.+.|.|.|.+| ||+++|.+|.+|||||++|+++.....++||+++++|+||+|||+|.|. +.....+..|.++|||+
T Consensus 14 ~~~L~V~V~~a~~L~~~d~~g~~DpYv~v~l~~~~~~~~~~kT~v~~~t~nP~wne~f~f~--v~~~~~~~~L~i~V~d~ 91 (132)
T d1a25a_ 14 REVLIVVVRDAKNLVPMDPNGLSDPYVKLKLIPDPKSESKQKTKTIKCSLNPEWNETFRFQ--LKESDKDRRLSVEIWDW 91 (132)
T ss_dssp SSEEEEEEEEEESCCCCSTTSCCCEEEEEEEESCTTCSSCEECCCCSSCSSCEEEEEEEEE--CCSGGGGCEEEEEEEEC
T ss_pred CCEEEEEEEeeeCCCCCCCCCCcCeEEEEEEccCCCCccccEEeeecCCCCCccceEEEEE--eEccccCCEEeEEEEec
Confidence 56789999999 9999999999999999999999888889999999999999999999998 54444456799999999
Q ss_pred CCCCCCCcccccccccccccccCCCCccchhccchhhh
Q 007035 344 SDTRDGEVNGALHEGKADAEEHGVATPDLLMFDNLEEE 381 (621)
Q Consensus 344 d~~~r~d~iG~v~~~~a~~~~~~~~~~~ll~~~~l~eE 381 (621)
|.+++++++|.+..++..+...+... |+..+.++
T Consensus 92 d~~~~d~~iG~~~i~l~~l~~~~~~~----W~~L~~~~ 125 (132)
T d1a25a_ 92 DLTSRNDFMGSLSFGISELQKAGVDG----WFKLLSQE 125 (132)
T ss_dssp CSSSCCEEEEEEEEEHHHHTTCCEEE----EEECBCHH
T ss_pred CCCCCCcEeEEEEEeHHHcCCCCCCe----EEECCCCC
Confidence 99999999999999888776554433 77665433
|
| >d2bwqa1 b.7.1.2 (A:729-853) Regulating synaptic membrane exocytosis protein, rim2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: C2 domain-like superfamily: C2 domain (Calcium/lipid-binding domain, CaLB) family: Synaptotagmin-like (S variant) domain: Regulating synaptic membrane exocytosis protein, rim2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.63 E-value=4.2e-17 Score=145.68 Aligned_cols=103 Identities=15% Similarity=0.061 Sum_probs=87.1
Q ss_pred CcceEEEEecC-CCccccCcCCCCcceEeecCCCCCCcccceeeccccCCCceeccceeeecccccccccccccccccCC
Q 007035 265 NDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDN 343 (621)
Q Consensus 265 ~~~l~v~l~e~-~L~~~d~~g~sDpyVK~~Llp~~~~~~k~kt~v~k~tlnP~fnE~f~f~~~~~~~~~~k~L~~~V~D~ 343 (621)
...|.|.|.+| ||++++.+|.+|||||+.|+|+.....++||+++++|+||.|||+|.|..+...+..+++|.++|||.
T Consensus 13 ~~~L~V~V~~a~~L~~~~~~~~~dpyVkv~l~~~~~~~~~~kT~~~~~t~~P~wne~f~f~~~~~~~l~~~~L~i~v~d~ 92 (125)
T d2bwqa1 13 GHQLIVTILGAKDLPSREDGRPRNPYVKIYFLPDRSDKNKRRTKTVKKTLEPKWNQTFIYSPVHRREFRERMLEITLWDQ 92 (125)
T ss_dssp TTEEEEEEEEEESCCCCTTSCCBCEEEEEEEESSCSGGGEEECCCCSSBSSCEEEEEEEECSCCGGGGGGCEEEEEEEEC
T ss_pred CCEEEEEEEEeECCCCcCCCCCCCEEEEEEEeCCCCCccccccCEEcCCCCCEEccEEEEeeeChhhcCCCEEEEEEEEC
Confidence 56788999999 99999999999999999999998888889999999999999999999986566666678899999999
Q ss_pred CCCC--CCCcccccccccccccccCC
Q 007035 344 SDTR--DGEVNGALHEGKADAEEHGV 367 (621)
Q Consensus 344 d~~~--r~d~iG~v~~~~a~~~~~~~ 367 (621)
++++ +++++|++..++.++..+..
T Consensus 93 ~~~~~~~~~~iG~~~i~l~~~~~~~~ 118 (125)
T d2bwqa1 93 ARVREEESEFLGEILIELETALLDDE 118 (125)
T ss_dssp -------CEEEEEEEEEGGGCCCSSC
T ss_pred CCCCCCCCeeEEEEEEEchhcCCCCC
Confidence 9875 36799999998877766554
|
| >d1dqva1 b.7.1.2 (A:295-424) Synaptotagmin III {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: C2 domain-like superfamily: C2 domain (Calcium/lipid-binding domain, CaLB) family: Synaptotagmin-like (S variant) domain: Synaptotagmin III species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.63 E-value=1.4e-16 Score=143.28 Aligned_cols=91 Identities=15% Similarity=0.078 Sum_probs=80.1
Q ss_pred CcceEEEEecC-CCccccCcCCCCcceEeecCCCCCCcccceeeccccCCCceeccceeeecccccccc-cccccccccC
Q 007035 265 NDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEID 342 (621)
Q Consensus 265 ~~~l~v~l~e~-~L~~~d~~g~sDpyVK~~Llp~~~~~~k~kt~v~k~tlnP~fnE~f~f~~~~~~~~~-~k~L~~~V~D 342 (621)
...|.|.|.+| ||+++|..|.+|||||+.|++++++ ++||+++++|+||+|||+|.|. ++.... +..|.++|||
T Consensus 17 ~~~L~V~V~~a~~L~~~~~~g~~dpyv~v~l~~~~~~--~~kT~v~~~t~~P~wne~f~f~--v~~~~~~~~~L~v~V~d 92 (130)
T d1dqva1 17 SDQLVVRILQALDLPAKDSNGFSDPYVKIYLLPDRKK--KFQTKVHRKTLNPIFNETFQFS--VPLAELAQRKLHFSVYD 92 (130)
T ss_dssp SCEEEEEEEEEECCCCCSTTSCCCEEEEEECTTSTTS--CEECCCCCSCSSCEEEEEEEEE--CCGGGGSSCCCEEEEEE
T ss_pred CCEEEEEEEeeeCCccccCCCCcceEEEEEEccCCCc--eEeceeEcCCCCeeeeeEEEEE--EchHHcCCCeEEEEEEE
Confidence 56789999999 9999999999999999999997664 6788888999999999999998 544443 6679999999
Q ss_pred CCCCCCCCccccccccc
Q 007035 343 NSDTRDGEVNGALHEGK 359 (621)
Q Consensus 343 ~d~~~r~d~iG~v~~~~ 359 (621)
+|.+++++++|++..+.
T Consensus 93 ~~~~~~d~~iG~~~i~~ 109 (130)
T d1dqva1 93 FDRFSRHDLIGQVVLDN 109 (130)
T ss_dssp CCSSSCCCEEEEEECCC
T ss_pred cCCCCCCceEEEEEECc
Confidence 99999999999998754
|
| >d1rh8a_ b.7.1.2 (A:) Piccolo {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: C2 domain-like superfamily: C2 domain (Calcium/lipid-binding domain, CaLB) family: Synaptotagmin-like (S variant) domain: Piccolo species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.59 E-value=6.8e-17 Score=147.03 Aligned_cols=102 Identities=13% Similarity=0.037 Sum_probs=87.3
Q ss_pred CcceEEEEecC-CCccccCcCCCCcceEeecCCCCCCc---------ccceeeccccCCCceeccceeeecccccccccc
Q 007035 265 NDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTE---------KSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEK 334 (621)
Q Consensus 265 ~~~l~v~l~e~-~L~~~d~~g~sDpyVK~~Llp~~~~~---------~k~kt~v~k~tlnP~fnE~f~f~~~~~~~~~~k 334 (621)
.+.|.|.|.+| ||+++|..|.+|||||+.|+++.... .++||+++++|+||.|||+|.|..+...+..+.
T Consensus 17 ~~~L~V~V~~A~~L~~~d~~g~~DpyV~v~l~~~~~~~~~~~~~~~~~~~kT~v~~~t~nP~wne~f~f~~~~~~~~~~~ 96 (142)
T d1rh8a_ 17 LGNLIIHILQARNLVPRDNNGYSDPFVKVYLLPGRGQVMVVQNASAEYKRRTKYVQKSLNPEWNQTVIYKSISMEQLMKK 96 (142)
T ss_dssp TTEEEEEEEEEESCCCCSSSSCSCCEEEEEETTSSCCCEECCCCCHHHHTTTTTTHHHHSCEEEEEEEECSCCHHHHTTC
T ss_pred CCEEEEEEEEeECCCCcCCCCCCCcCEEEEEecCcccccccccCCCceeeeccCCcCCCCceeEEEEEEeeecccccCCC
Confidence 56788999999 99999999999999999999876543 357888889999999999999985555555577
Q ss_pred cccccccCCCCCCCCCcccccccccccccccC
Q 007035 335 DLMPAEIDNSDTRDGEVNGALHEGKADAEEHG 366 (621)
Q Consensus 335 ~L~~~V~D~d~~~r~d~iG~v~~~~a~~~~~~ 366 (621)
.|.++|||+|.+++++++|++..++..+....
T Consensus 97 ~L~i~V~d~d~~~~~~~lG~~~i~L~~l~~~~ 128 (142)
T d1rh8a_ 97 TLEVTVWDYDRFSSNDFLGEVLIDLSSTSHLD 128 (142)
T ss_dssp EEEEEEEEECSSSCEEEEEEEEEETTSCGGGT
T ss_pred EEEEEEEEecCCCCCeeeEEEEEEhHHcCCCC
Confidence 79999999999999999999999887765543
|
| >d1w15a_ b.7.1.2 (A:) Synaptotagmin IV {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: C2 domain-like superfamily: C2 domain (Calcium/lipid-binding domain, CaLB) family: Synaptotagmin-like (S variant) domain: Synaptotagmin IV species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.59 E-value=1.7e-16 Score=144.15 Aligned_cols=94 Identities=15% Similarity=0.041 Sum_probs=78.7
Q ss_pred CcceEEEEecC-CCccccCcCCCCcceEeecCCCCCCcccceeeccccCCCceeccceeeecccccccc-cccccccccC
Q 007035 265 NDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEID 342 (621)
Q Consensus 265 ~~~l~v~l~e~-~L~~~d~~g~sDpyVK~~Llp~~~~~~k~kt~v~k~tlnP~fnE~f~f~~~~~~~~~-~k~L~~~V~D 342 (621)
++.|.|.|.+| ||+++|.+|.+|||||++|.|+.++..++||+++++|.||.|||+|.|. ++.+.. +.+|.+.|||
T Consensus 14 ~~~L~V~v~~a~~L~~~~~~~~~dpyvkv~l~~~~~~~~~~kT~~~~~t~~P~wne~f~F~--v~~~~~~~~~l~i~v~d 91 (138)
T d1w15a_ 14 TNTLTVVVLKARHLPKSDVSGLSDPYVKVNLYHAKKRISKKKTHVKKCTPNAVFNELFVFD--IPCESLEEISVEFLVLD 91 (138)
T ss_dssp TTEEEEEEEEEESCC------CCCEEEEEEEEETTEEEEEEECCCCCSCSSEEEEEEEEEE--CCSSSSTTEEEEEEEEE
T ss_pred CCEEEEEEEEeECCCCCCCCCCcCEEEEEEEeCCcccCccccceeECCCCCCeECcEEEEE--ecHHHhCccEEEEEEEe
Confidence 56789999999 9999999999999999999999888888999999999999999999998 554444 6679999999
Q ss_pred CCCCCCCCcccccccccc
Q 007035 343 NSDTRDGEVNGALHEGKA 360 (621)
Q Consensus 343 ~d~~~r~d~iG~v~~~~a 360 (621)
+|.+++++++|++..++.
T Consensus 92 ~~~~~~~~~iG~~~i~l~ 109 (138)
T d1w15a_ 92 SERGSRNEVIGRLVLGAT 109 (138)
T ss_dssp CCTTSCCEEEEEEEESTT
T ss_pred CCCCCCCCEEEEEEEcch
Confidence 999999999999988654
|
| >d2cm5a1 b.7.1.2 (A:541-677) C2b-domain of rabphilin {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: C2 domain-like superfamily: C2 domain (Calcium/lipid-binding domain, CaLB) family: Synaptotagmin-like (S variant) domain: C2b-domain of rabphilin species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.56 E-value=6e-16 Score=139.76 Aligned_cols=95 Identities=15% Similarity=0.098 Sum_probs=82.8
Q ss_pred CcceEEEEecC-CCccccCcCCCCcceEeecCCCCCCcccceeeccccCCCceeccceeeecccccccc-cccccccccC
Q 007035 265 NDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEID 342 (621)
Q Consensus 265 ~~~l~v~l~e~-~L~~~d~~g~sDpyVK~~Llp~~~~~~k~kt~v~k~tlnP~fnE~f~f~~~~~~~~~-~k~L~~~V~D 342 (621)
++.|.|.|.+| ||++++..|.+|||||+.|+|+.+...++||+++++|+||.|||+|.|. ++.... ..+|.+.|||
T Consensus 14 ~~~L~V~v~~a~nL~~~~~~~~~dpyv~v~l~~~~~~~~~~kT~v~~~t~~P~wne~f~f~--v~~~~l~~~~l~v~v~~ 91 (137)
T d2cm5a1 14 QGGLIVGIIRCVHLAAMDANGYSDPFVKLWLKPDMGKKAKHKTQIKKKTLNPEFNEEFFYD--IKHSDLAKKSLDISVWD 91 (137)
T ss_dssp TTEEEEEEEEEESCCCCSTTSCCCEEEEEEEETC---CCEEECCCCCSCSSCEEEEEEEEE--CCGGGGGGCEEEEEEEE
T ss_pred CCEEEEEEEEEECCCCCCCCCCcCeEEEEEEEcCCccceeecCEeEcCCCCCccceEEEEE--eEHHHccccEEEEEeee
Confidence 56789999999 9999999999999999999999888889999999999999999999998 554444 6779999999
Q ss_pred CCCCCCCCccccccccccc
Q 007035 343 NSDTRDGEVNGALHEGKAD 361 (621)
Q Consensus 343 ~d~~~r~d~iG~v~~~~a~ 361 (621)
++.+++++++|++..+..+
T Consensus 92 ~~~~~~~~~iG~~~i~l~~ 110 (137)
T d2cm5a1 92 YDIGKSNDYIGGCQLGISA 110 (137)
T ss_dssp CCSSSCCEEEEEEEEETTC
T ss_pred CCCCCCCCEEEEEEeCccc
Confidence 9999999999999887643
|
| >d1dqva2 b.7.1.2 (A:425-569) Synaptotagmin III {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: C2 domain-like superfamily: C2 domain (Calcium/lipid-binding domain, CaLB) family: Synaptotagmin-like (S variant) domain: Synaptotagmin III species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.56 E-value=4.4e-16 Score=142.50 Aligned_cols=97 Identities=16% Similarity=0.088 Sum_probs=86.5
Q ss_pred CcceEEEEecC-CCccccCcCCCCcceEeecCCCCCCcccceeeccccCCCceeccceeeecccccccc-cccccccccC
Q 007035 265 NDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEID 342 (621)
Q Consensus 265 ~~~l~v~l~e~-~L~~~d~~g~sDpyVK~~Llp~~~~~~k~kt~v~k~tlnP~fnE~f~f~~~~~~~~~-~k~L~~~V~D 342 (621)
++.|.|.|.+| ||++++.+|.+|||||+.|+++.++..++||+++++|+||+|||+|.|. ++.+.. ...|.++|||
T Consensus 19 ~~~L~V~V~~a~nL~~~~~~~~~dpyv~v~l~~~~~~~~~~kT~~~~~t~~P~wne~f~F~--v~~~~~~~~~l~v~v~d 96 (145)
T d1dqva2 19 AGLLTVTIIKASNLKAMDLTGFSDPYVKASLISEGRRLKKRKTSIKKNTLNPTYNEALVFD--VAPESVENVGLSIAVVD 96 (145)
T ss_dssp TTEEEEEEEEEESCCCCSSSSCCCEEEEECCCTTCCTTSCEECCCCCSCSSCEEEECCCCC--CCSGGGGSCCCCCEEEE
T ss_pred CCEEEEEEEEEeCCCCcCCCCCcCceEEEEEccCCccceeecCEEEeCCCCceecceEEEE--EehhhcCCCEEEEEEEe
Confidence 67889999999 9999999999999999999999888889999999999999999999997 554444 6679999999
Q ss_pred CCCCCCCCccccccccccccc
Q 007035 343 NSDTRDGEVNGALHEGKADAE 363 (621)
Q Consensus 343 ~d~~~r~d~iG~v~~~~a~~~ 363 (621)
++.+++++++|++..++..+.
T Consensus 97 ~~~~~~~~~iG~~~i~l~~~~ 117 (145)
T d1dqva2 97 YDCIGHNEVIGVCRVGPEAAD 117 (145)
T ss_dssp CCSSSCCEEEEECCCSSCTTC
T ss_pred cCCCCCCcEEEEEEECchHcC
Confidence 999999999999988765543
|
| >d1ugka_ b.7.1.2 (A:) Synaptotagmin IV {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: C2 domain-like superfamily: C2 domain (Calcium/lipid-binding domain, CaLB) family: Synaptotagmin-like (S variant) domain: Synaptotagmin IV species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.56 E-value=1.2e-15 Score=138.68 Aligned_cols=97 Identities=12% Similarity=0.014 Sum_probs=82.5
Q ss_pred CcceEEEEecC-CCccccCcC-CCCcceEeecCCCCCCcccceeeccccCCCceeccceeeecccccccccccccccccC
Q 007035 265 NDYGYLSSKEA-DLIDLQHNV-VGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEID 342 (621)
Q Consensus 265 ~~~l~v~l~e~-~L~~~d~~g-~sDpyVK~~Llp~~~~~~k~kt~v~k~tlnP~fnE~f~f~~~~~~~~~~k~L~~~V~D 342 (621)
...|.|.|.+| ||+++|..| .+|||||+.|+|+++. ++||+++++++||.|||+|.|..+...+..+.+|.++|||
T Consensus 21 ~~~L~V~V~~a~~L~~~d~~~~~~dpyV~v~l~~~~~~--~~kT~v~~~t~nP~wne~f~f~~~~~~~l~~~~L~~~V~d 98 (138)
T d1ugka_ 21 RKAFVVNIKEARGLPAMDEQSMTSDPYIKMTILPEKKH--KVKTRVLRKTLDPAFDETFTFYGIPYTQIQELALHFTILS 98 (138)
T ss_dssp GTEEEEEEEEEESCCCCBTTTTBCEEEEEEEEETTTCS--EEECCCCSSCSSCEEEEEEEEECCCSTTGGGCEEEEEEEE
T ss_pred CCEEEEEEEEecCCCCCCCCCCccceEEEEEEcCCCCE--eEeCeeEeCCCCCceeeEEEEeeeCHHHcccceEEEEEEE
Confidence 56789999999 999998776 5799999999997654 6678888999999999999997444444457779999999
Q ss_pred CCCCCCCCccccccccccccc
Q 007035 343 NSDTRDGEVNGALHEGKADAE 363 (621)
Q Consensus 343 ~d~~~r~d~iG~v~~~~a~~~ 363 (621)
.|++++++++|++..++.+++
T Consensus 99 ~d~~~~~~~iG~~~i~L~~~~ 119 (138)
T d1ugka_ 99 FDRFSRDDIIGEVLIPLSGIE 119 (138)
T ss_dssp ECSSCCCCCCEEEEEECTTCC
T ss_pred CCCCCCCcEEEEEEEEccccc
Confidence 999999999999988876654
|
| >d1uowa_ b.7.1.2 (A:) Synaptogamin I {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: C2 domain-like superfamily: C2 domain (Calcium/lipid-binding domain, CaLB) family: Synaptotagmin-like (S variant) domain: Synaptogamin I species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.54 E-value=9.8e-16 Score=142.23 Aligned_cols=95 Identities=14% Similarity=0.111 Sum_probs=85.2
Q ss_pred CcceEEEEecC-CCccccCcCCCCcceEeecCCCCCCcccceeeccccCCCceeccceeeecccccccc-cccccccccC
Q 007035 265 NDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEID 342 (621)
Q Consensus 265 ~~~l~v~l~e~-~L~~~d~~g~sDpyVK~~Llp~~~~~~k~kt~v~k~tlnP~fnE~f~f~~~~~~~~~-~k~L~~~V~D 342 (621)
++.|.|.|.+| ||++++.+|.+|||||++|++++++..++||+++++|+||+|||+|.|. ++.... +..|.++|||
T Consensus 24 ~~~L~V~V~~a~~L~~~~~~~~~dpyV~v~l~~~~~~~~~~kT~v~~~t~nP~wne~f~F~--v~~~~l~~~~l~i~v~d 101 (157)
T d1uowa_ 24 AGKLTVVILEAKNLKKMDVGGLSDPYVKIHLMQNGKRLKKKKTTIKKNTLNPYYNESFSFE--VPFEQIQKVQVVVTVLD 101 (157)
T ss_dssp TTEEEEEEEEEESCCCCSTTSCCCEEEEEEEEETTEEEEEEECCCCCSCSSCEEEEEEEEE--CCGGGGGGCEEEEEEEE
T ss_pred CCEEEEEEEEEEEcccccCCCCCCeeEEEEEecCCccccceecccccCCCCcccCCeEEEE--ecHHHcCccEEEEEEcc
Confidence 56889999999 9999999999999999999999888888899999999999999999998 554444 6679999999
Q ss_pred CCCCCCCCccccccccccc
Q 007035 343 NSDTRDGEVNGALHEGKAD 361 (621)
Q Consensus 343 ~d~~~r~d~iG~v~~~~a~ 361 (621)
+|++++++++|++..+...
T Consensus 102 ~~~~~~~~~iG~~~i~l~~ 120 (157)
T d1uowa_ 102 YDKIGKNDAIGKVFVGYNS 120 (157)
T ss_dssp CCSSSCCCEEEEEEEETTC
T ss_pred cCCCCCCceeEEEEEeccc
Confidence 9999999999999887643
|
| >d1rsya_ b.7.1.2 (A:) Synaptogamin I {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: C2 domain-like superfamily: C2 domain (Calcium/lipid-binding domain, CaLB) family: Synaptotagmin-like (S variant) domain: Synaptogamin I species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.53 E-value=1.8e-15 Score=138.15 Aligned_cols=96 Identities=15% Similarity=0.092 Sum_probs=83.4
Q ss_pred CcceEEEEecC-CCccccCcCCCCcceEeecCCCCCCcccceeeccccCCCceeccceeeeccccc-ccccccccccccC
Q 007035 265 NDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHF-KGAEKDLMPAEID 342 (621)
Q Consensus 265 ~~~l~v~l~e~-~L~~~d~~g~sDpyVK~~Llp~~~~~~k~kt~v~k~tlnP~fnE~f~f~~~~~~-~~~~k~L~~~V~D 342 (621)
...|.|.|.+| ||+++|.+|.+|||||+.|+|++++ +.||+++++|+||+|||+|.|. +.. +..+.+|.++|||
T Consensus 33 ~~~L~V~V~~a~~L~~~~~~g~~dpyV~v~l~~~~~~--~~kT~~~~~t~~P~wne~f~f~--i~~~~l~~~~L~i~V~d 108 (143)
T d1rsya_ 33 NNQLLVGIIQAAELPALDMGGTSDPYVKVFLLPDKKK--KFETKVHRKTLNPVFNEQFTFK--VPYSELGGKTLVMAVYD 108 (143)
T ss_dssp TTEEEEEEEEEESCCCCSTTSCCCEEEEEEEETTCCS--CEECCCCTTCSSCEEEEEEEEC--CCHHHHTTCEEEEEEEE
T ss_pred CCEEEEEEEEccCCCCCCCCCCCCeEEEEEEcCCCCe--eEEEEEeccccCcceeeeeEEE--EEeeccCCceEEEEEEE
Confidence 56788999999 9999999999999999999998664 5678888999999999999998 443 3346779999999
Q ss_pred CCCCCCCCcccccccccccccc
Q 007035 343 NSDTRDGEVNGALHEGKADAEE 364 (621)
Q Consensus 343 ~d~~~r~d~iG~v~~~~a~~~~ 364 (621)
+|++++++++|.+..++..+..
T Consensus 109 ~d~~~~~~~iG~~~i~L~~~~~ 130 (143)
T d1rsya_ 109 FDRFSKHDIIGEFKVPMNTVDF 130 (143)
T ss_dssp CCSSSCCEEEEEEEEEGGGCCC
T ss_pred cCCCCCCcEEEEEEEEchhccC
Confidence 9999999999999998777644
|
| >d1wfma_ b.7.1.2 (A:) Synaptotagmin XIII {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: C2 domain-like superfamily: C2 domain (Calcium/lipid-binding domain, CaLB) family: Synaptotagmin-like (S variant) domain: Synaptotagmin XIII species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.48 E-value=1.2e-14 Score=131.84 Aligned_cols=95 Identities=18% Similarity=0.130 Sum_probs=80.4
Q ss_pred CcceEEEEecC-CCccccCcCCCCcceEeecCCCCCCcccceeeccccCCCceeccceeeeccccccc-ccccccccccC
Q 007035 265 NDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKG-AEKDLMPAEID 342 (621)
Q Consensus 265 ~~~l~v~l~e~-~L~~~d~~g~sDpyVK~~Llp~~~~~~k~kt~v~k~tlnP~fnE~f~f~~~~~~~~-~~k~L~~~V~D 342 (621)
...|.|.|.+| ||+ ..|.+|||||++|+|+++ ..++||+++++++||+|||+|.|. +..+. ...+|.++|||
T Consensus 25 ~~~L~V~v~~a~~L~---~~g~~dpyVkv~l~~~~~-~~~~kT~v~~~~~~P~wne~f~f~--v~~~~l~~~~L~~~V~d 98 (138)
T d1wfma_ 25 KAELFVTRLEAVTSN---HDGGCDCYVQGSVANRTG-SVEAQTALKKRQLHTTWEEGLVLP--LAEEELPTATLTLTLRT 98 (138)
T ss_dssp TTEEEEEEEEEECCC---CSSCCCEEEEEEEEETTE-EEEEECCCCCCCSSEECSSCEEEE--CCTTSSTTCEEEEEEEE
T ss_pred CCEEEEEEEEcCCCC---CCCCcCcEEEEEECCCCC-ccceeeeEECCCCCceEeeeEEEE--eeehhccceEEEEEEee
Confidence 56788999999 984 578899999999999855 356788889999999999999998 44444 47779999999
Q ss_pred CCCCCCCCccccccccccccccc
Q 007035 343 NSDTRDGEVNGALHEGKADAEEH 365 (621)
Q Consensus 343 ~d~~~r~d~iG~v~~~~a~~~~~ 365 (621)
+|++++++++|++..++.+++..
T Consensus 99 ~~~~~~~~~iG~~~i~L~~l~~~ 121 (138)
T d1wfma_ 99 CDRFSRHSVAGELRLGLDGTSVP 121 (138)
T ss_dssp CCSSCTTSCSEEEEEESSSSSSC
T ss_pred ecccccceeeeEEEEEhHHccCC
Confidence 99999999999999988776543
|
| >d2ep6a1 b.7.1.1 (A:92-217) Multiple C2 and transmembrane domain-containing protein 2, MCTP2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: C2 domain-like superfamily: C2 domain (Calcium/lipid-binding domain, CaLB) family: PLC-like (P variant) domain: Multiple C2 and transmembrane domain-containing protein 2, MCTP2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.46 E-value=8.4e-15 Score=130.60 Aligned_cols=90 Identities=11% Similarity=0.053 Sum_probs=77.2
Q ss_pred CcceEEEEecC-CCccccCcCCCCcceEeecCCCCCCcccceeeccccCCCceeccceeeecccccccccccccccccCC
Q 007035 265 NDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDN 343 (621)
Q Consensus 265 ~~~l~v~l~e~-~L~~~d~~g~sDpyVK~~Llp~~~~~~k~kt~v~k~tlnP~fnE~f~f~~~~~~~~~~k~L~~~V~D~ 343 (621)
.++|.|.|.+| ||+++|..|.+||||++.+.. .+++|+++++|+||.|||+|.|. +.. ....|.++|||+
T Consensus 5 ~G~L~V~v~~A~~L~~~d~~g~~Dpyv~v~~~~-----~~~~T~~~~~t~nP~wne~f~f~--v~~--~~~~L~i~V~d~ 75 (126)
T d2ep6a1 5 VGILQVKVLKAADLLAADFSGKSDPFCLLELGN-----DRLQTHTVYKNLNPEWNKVFTFP--IKD--IHDVLEVTVFDE 75 (126)
T ss_dssp SEEEEEEEEEEESCCCSSSSSCCCEEEEEEETT-----EEEECCCCSSCSSCCCCEEEEEE--ESC--TTCEEEEEEEEE
T ss_pred cEEEEEEEEEeECCCCCCCCCCcCeEEEEEcCC-----eEEEEEeeCCceeEEEEEEEEEE--Eec--cCceeEEEEEEc
Confidence 46789999999 999999999999999999953 35788888999999999999998 432 234699999999
Q ss_pred CCCCCCCccccccccccccc
Q 007035 344 SDTRDGEVNGALHEGKADAE 363 (621)
Q Consensus 344 d~~~r~d~iG~v~~~~a~~~ 363 (621)
+.+++++++|.+..++..+.
T Consensus 76 ~~~~~d~~lG~~~i~l~~l~ 95 (126)
T d2ep6a1 76 DGDKPPDFLGKVAIPLLSIR 95 (126)
T ss_dssp ETTEEEEECCBCEEEGGGCC
T ss_pred cCCcCcceEEEEEEEHHHCC
Confidence 99999999999988776654
|
| >d1qasa2 b.7.1.1 (A:626-756) PI-specific phospholipase C isozyme D1 (PLC-D1), C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: C2 domain-like superfamily: C2 domain (Calcium/lipid-binding domain, CaLB) family: PLC-like (P variant) domain: PI-specific phospholipase C isozyme D1 (PLC-D1), C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.37 E-value=1.4e-13 Score=123.64 Aligned_cols=93 Identities=10% Similarity=-0.028 Sum_probs=71.4
Q ss_pred ceEEEEecC-CCcc--ccCcCCCCcceEeecCCCCCCcccceeecc-ccCCCceeccceeeecccccccccccccccccC
Q 007035 267 YGYLSSKEA-DLID--LQHNVVGDSSTDCDLAPHPGTEKSSSYSSS-KRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEID 342 (621)
Q Consensus 267 ~l~v~l~e~-~L~~--~d~~g~sDpyVK~~Llp~~~~~~k~kt~v~-k~tlnP~fnE~f~f~~~~~~~~~~k~L~~~V~D 342 (621)
.|.|.|.+| ||+. +|.+|.+||||++.|.+......++||+++ ++++||.|||+|.|....+ . ...|.++|||
T Consensus 5 ~l~V~Vi~a~~L~~~~~~~~~~~DPyV~v~l~g~~~~~~~~~T~~v~~~~~nP~wne~f~f~~~~~--~-~~~L~~~V~D 81 (131)
T d1qasa2 5 RLRVRIISGQQLPKVNKNKNSIVDPKVIVEIHGVGRDTGSRQTAVITNNGFNPRWDMEFEFEVTVP--D-LALVRFMVED 81 (131)
T ss_dssp EEEEEEEEEESCCCCC-----CCCEEEEEEEESSTTTCEEEECCCCSSCSSSCEEEEEEEEEESCG--G-GCEEEEEEEE
T ss_pred EEEEEEEEeeCCCCCCCCCCCCcCeEEEEEEccCCCCcEEEEEEEEecccCCceEEEEEEEEEEcc--h-hceEEEEEEE
Confidence 578999999 9965 567888999999999887666677888875 5669999999999973222 2 2348999999
Q ss_pred CCCCCCCCcccccccccccc
Q 007035 343 NSDTRDGEVNGALHEGKADA 362 (621)
Q Consensus 343 ~d~~~r~d~iG~v~~~~a~~ 362 (621)
+|.+++++++|++..++..+
T Consensus 82 ~d~~~~d~~iG~~~i~l~~l 101 (131)
T d1qasa2 82 YDSSSKNDFIGQSTIPWNSL 101 (131)
T ss_dssp CCTTTCCEEEEEEEEEGGGB
T ss_pred ecCCCCCcEEEEEEEEEecc
Confidence 99999999999998876544
|
| >d1rlwa_ b.7.1.1 (A:) Domain from cytosolic phospholipase A2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: C2 domain-like superfamily: C2 domain (Calcium/lipid-binding domain, CaLB) family: PLC-like (P variant) domain: Domain from cytosolic phospholipase A2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.34 E-value=2.9e-13 Score=120.14 Aligned_cols=94 Identities=13% Similarity=0.011 Sum_probs=75.7
Q ss_pred CcceEEEEecC-CCcc---ccCcCCCCcceEeecCCCCCCcccceeeccccCCCceeccceeeecccccccccccccccc
Q 007035 265 NDYGYLSSKEA-DLID---LQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAE 340 (621)
Q Consensus 265 ~~~l~v~l~e~-~L~~---~d~~g~sDpyVK~~Llp~~~~~~k~kt~v~k~tlnP~fnE~f~f~~~~~~~~~~k~L~~~V 340 (621)
+..|.|.|.+| ||+. .|..|.+||||++++.+++.. ++||+++++++||.|||+|.|. +.. .....|.++|
T Consensus 2 s~~l~V~v~~a~~L~~~~~~d~~~~~Dpyv~v~l~~~~~~--~~~T~~~~~t~nP~wne~f~f~--i~~-~~~~~L~v~V 76 (126)
T d1rlwa_ 2 SHKFTVVVLRATKVTKGAFGDMLDTPDPYVELFISTTPDS--RKRTRHFNNDINPVWNETFEFI--LDP-NQENVLEITL 76 (126)
T ss_dssp CEEEEEEEEEEESCCSCHHHHHHCCCCEEEEEECTTSTTC--CEECCCCTTCSSCEEEEEEEEE--ECT-TSCCEEEEEE
T ss_pred CcEEEEEEEEccCCCCccccccCCCCCcEEEEEECCcccc--eeEeeecCCCccceeceeeeec--ccC-cccCcEEEEE
Confidence 56789999999 9986 466789999999999876543 5778888999999999999998 432 2244599999
Q ss_pred cCCCCCCCCCcccccccccccccc
Q 007035 341 IDNSDTRDGEVNGALHEGKADAEE 364 (621)
Q Consensus 341 ~D~d~~~r~d~iG~v~~~~a~~~~ 364 (621)
||+|..+ ++++|++..++..+..
T Consensus 77 ~d~d~~~-d~~lG~~~i~L~~l~~ 99 (126)
T d1rlwa_ 77 MDANYVM-DETLGTATFTVSSMKV 99 (126)
T ss_dssp EECCSSC-CEEEEEEEEEGGGSCT
T ss_pred EECCCCC-CCeEEEEEEEHHHccC
Confidence 9998765 6899999888766643
|
| >d1wfja_ b.7.1.2 (A:) C2 domain protein At1g63220 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: C2 domain-like superfamily: C2 domain (Calcium/lipid-binding domain, CaLB) family: Synaptotagmin-like (S variant) domain: C2 domain protein At1g63220 species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]
Probab=99.30 E-value=6.4e-13 Score=119.61 Aligned_cols=89 Identities=12% Similarity=0.060 Sum_probs=73.2
Q ss_pred CcceEEEEecC-CCccccCcCCCCcceEeecCCCCCCcccceeecc-ccCCCceeccceeeecccccccccccccccccC
Q 007035 265 NDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSS-KRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEID 342 (621)
Q Consensus 265 ~~~l~v~l~e~-~L~~~d~~g~sDpyVK~~Llp~~~~~~k~kt~v~-k~tlnP~fnE~f~f~~~~~~~~~~k~L~~~V~D 342 (621)
.+.|.|.|.+| +|+++|..|.+||||++.+... +.+|+++ ++++||.|||+|.|. +.. ....|.++|||
T Consensus 9 ~G~L~V~v~~a~~L~~~d~~g~~Dpyv~v~~~~~-----~~~t~~~~~~~~nP~Wne~f~f~--v~~--~~~~L~v~V~d 79 (136)
T d1wfja_ 9 HGTLEVVLVSAKGLEDADFLNNMDPYVQLTCRTQ-----DQKSNVAEGMGTTPEWNETFIFT--VSE--GTTELKAKIFD 79 (136)
T ss_dssp EEEEEEEEEEEEECSSCCSSCSSCCCEEEESSSC-----EEECCCCTTCCSSCEEEEEEEEE--EES--SCCEEEEEECC
T ss_pred cEEEEEEEEEeeCCCCCCCCCCCCccEEEEEeee-----eEEEEEEecCCCcEEEeeEEEEE--EcC--ccceEEEEEEE
Confidence 46788999999 9999999999999999998642 4456665 479999999999998 442 23449999999
Q ss_pred CCCCCCCCcccccccccccc
Q 007035 343 NSDTRDGEVNGALHEGKADA 362 (621)
Q Consensus 343 ~d~~~r~d~iG~v~~~~a~~ 362 (621)
+|.+++++++|.+..++.++
T Consensus 80 ~d~~~~d~~iG~~~i~L~~l 99 (136)
T d1wfja_ 80 KDVGTEDDAVGEATIPLEPV 99 (136)
T ss_dssp SSSCTTTCCSEEEEEESHHH
T ss_pred ecCCCCCCEEEEEEEEhHHh
Confidence 99999999999997766544
|
| >d1gmia_ b.7.1.1 (A:) Domain from protein kinase C epsilon {Rat (Rattus rattus) [TaxId: 10117]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: C2 domain-like superfamily: C2 domain (Calcium/lipid-binding domain, CaLB) family: PLC-like (P variant) domain: Domain from protein kinase C epsilon species: Rat (Rattus rattus) [TaxId: 10117]
Probab=99.23 E-value=1.4e-12 Score=117.71 Aligned_cols=94 Identities=11% Similarity=0.100 Sum_probs=76.2
Q ss_pred CcceEEEEecC-CCcccc-----------CcCCCCcceEeecCCCCCCcccceeeccccCCCceeccceeeecccccccc
Q 007035 265 NDYGYLSSKEA-DLIDLQ-----------HNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA 332 (621)
Q Consensus 265 ~~~l~v~l~e~-~L~~~d-----------~~g~sDpyVK~~Llp~~~~~~k~kt~v~k~tlnP~fnE~f~f~~~~~~~~~ 332 (621)
++.|.|.|.+| +|++++ .+|..||||++.+- .+...+|++++++.||+|||+|.|. ++.
T Consensus 5 ~G~L~v~I~~A~~L~~~~~~~~~~~~~~~~~~~~DPYv~v~l~----~~~~~~T~~~~~t~~P~Wne~f~f~--v~~--- 75 (136)
T d1gmia_ 5 NGLLKIKICEAVSLKPTAWSLRDAVGPRPQTFLLDPYIALNVD----DSRIGQTATKQKTNSPAWHDEFVTD--VCN--- 75 (136)
T ss_dssp EEEEEEEEEEEESCCCCHHHHCC-CCSSCCCCCCCEEEEEEET----TEEEEECCCCSSCSSCEEEEEEEEE--EEE---
T ss_pred EEEEEEEEEEeECCCcccccccccccccCCCCCcCcEEEEEeC----CCcCcEeeEEcCCCCccCccEEEEE--Eec---
Confidence 45678999999 999976 56778999999993 2334567778999999999999998 432
Q ss_pred cccccccccCCCCCCCCCcccccccccccccccCC
Q 007035 333 EKDLMPAEIDNSDTRDGEVNGALHEGKADAEEHGV 367 (621)
Q Consensus 333 ~k~L~~~V~D~d~~~r~d~iG~v~~~~a~~~~~~~ 367 (621)
.+.|.++|||.+.+++++++|.+..++.++-+...
T Consensus 76 ~~~l~i~V~d~~~~~~d~~iG~~~i~l~~l~~~~~ 110 (136)
T d1gmia_ 76 GRKIELAVFHDAPIGYDDFVANCTIQFEELLQNGS 110 (136)
T ss_dssp ECEEEEEEEECCSSSSCEEEEEEEEEHHHHTSTTC
T ss_pred CCceEEEEEEecCCCCceeEEEEEEEHHHhhhcCC
Confidence 34699999999999999999999988877655543
|
| >d2nq3a1 b.7.1.1 (A:13-145) E3 ubiquitin-protein ligase Itchy {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: C2 domain-like superfamily: C2 domain (Calcium/lipid-binding domain, CaLB) family: PLC-like (P variant) domain: E3 ubiquitin-protein ligase Itchy species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.16 E-value=5.6e-12 Score=113.39 Aligned_cols=88 Identities=7% Similarity=-0.047 Sum_probs=71.6
Q ss_pred cceEEEEecC-CCccccCcCCCCcceEeecCCCCCCcccceeeccccCCCceeccceeeecccccccccccccccccCCC
Q 007035 266 DYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDNS 344 (621)
Q Consensus 266 ~~l~v~l~e~-~L~~~d~~g~sDpyVK~~Llp~~~~~~k~kt~v~k~tlnP~fnE~f~f~~~~~~~~~~k~L~~~V~D~d 344 (621)
..|.|.|.+| +++..+..+..||||++.+-. .+.+|+++++|+||.|||.|.|. +.. ...|.++|||+|
T Consensus 6 ~~L~v~v~~A~~~~~~~~~~~~dpyv~v~~~~-----~~~kT~v~~~t~nP~wne~f~f~--~~~---~~~l~~~V~d~d 75 (133)
T d2nq3a1 6 SQLQITVISAKLKENKKNWFGPSPYVEVTVDG-----QSKKTEKCNNTNSPKWKQPLTVI--VTP---VSKLHFRVWSHQ 75 (133)
T ss_dssp EEEEEEEEEEEECCCC--CCCCCEEEEEEETT-----EEEECCCCSSCSSCEEEEEEEEE--ECT---TCEEEEEEEECC
T ss_pred eEEEEEEEEeECCCcCCCCCCcCeEEEEEECC-----eEEeeEEEEecccEEEcceEEEE--EEe---cceeEEEEEEcc
Confidence 4578999999 888888888899999999864 25678888999999999999998 332 235999999999
Q ss_pred CCCCCCccccccccccccc
Q 007035 345 DTRDGEVNGALHEGKADAE 363 (621)
Q Consensus 345 ~~~r~d~iG~v~~~~a~~~ 363 (621)
.+++++++|.+..++.++.
T Consensus 76 ~~~~d~~iG~~~i~L~~l~ 94 (133)
T d2nq3a1 76 TLKSDVLLGTAALDIYETL 94 (133)
T ss_dssp SSSCCEEEEEEEEEHHHHH
T ss_pred CCCCCceEEEEEEEHHHhh
Confidence 9999999999988765543
|
| >d1bdya_ b.7.1.1 (A:) Domain from protein kinase C delta {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: C2 domain-like superfamily: C2 domain (Calcium/lipid-binding domain, CaLB) family: PLC-like (P variant) domain: Domain from protein kinase C delta species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.05 E-value=2.8e-11 Score=107.44 Aligned_cols=83 Identities=10% Similarity=0.095 Sum_probs=63.2
Q ss_pred EEEEecC-CCccccCcCCCCcceEeecCCCCCCcccceeeccccCCCceeccceeeecccccccccccccccccCCCCCC
Q 007035 269 YLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDNSDTR 347 (621)
Q Consensus 269 ~v~l~e~-~L~~~d~~g~sDpyVK~~Llp~~~~~~k~kt~v~k~tlnP~fnE~f~f~~~~~~~~~~k~L~~~V~D~d~~~ 347 (621)
.|.+.++ .+++ .+|.+||||+++|.+..+.+.+++|+++|+|+||+|||+|.|. +.. ...|.+.|||+|
T Consensus 8 ~~~~~~~~~~~~--~~~~~dPY~~v~l~~~~~~~~~~~t~~~kkT~nP~WnE~F~~~--v~~---~~~l~i~V~d~d--- 77 (123)
T d1bdya_ 8 SFNSYELGSLQA--EDDASQPFCAVKMKEALTTDRGKTLVQKKPTMYPEWKSTFDAH--IYE---GRVIQIVLMRAA--- 77 (123)
T ss_dssp EEEEEECCTTCC--CCCSCCCEEEEEEEEECCGGGTTBEEECSCCBCCCTTCEEEEE--CCT---TCEEEEEEEEET---
T ss_pred EEEEeecccCCC--CCCCCCCEEEEEEcCccccccceEEEEeCCCCCcccceEEEEE--Ecc---ccEEEEEEEEcc---
Confidence 3455555 5444 4789999999999887776677788889999999999999998 442 245899999976
Q ss_pred CCCcccccccccccc
Q 007035 348 DGEVNGALHEGKADA 362 (621)
Q Consensus 348 r~d~iG~v~~~~a~~ 362 (621)
++++|....+.+.+
T Consensus 78 -d~~~g~~~i~l~~l 91 (123)
T d1bdya_ 78 -EDPMSEVTVGVSVL 91 (123)
T ss_dssp -TEEEEEEEEEHHHH
T ss_pred -ccccCccEEehhhe
Confidence 56788776655444
|
| >d2cjta1 b.7.1.1 (A:1-128) Unc-13 homolog A {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: C2 domain-like superfamily: C2 domain (Calcium/lipid-binding domain, CaLB) family: PLC-like (P variant) domain: Unc-13 homolog A species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=98.97 E-value=1.5e-10 Score=103.44 Aligned_cols=87 Identities=10% Similarity=0.027 Sum_probs=69.3
Q ss_pred cceEEEEecC-CCccccCcCCCCcceEeecCCCCCCcccceeeccccCCCceeccceeeecccccccccccccccccCCC
Q 007035 266 DYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDNS 344 (621)
Q Consensus 266 ~~l~v~l~e~-~L~~~d~~g~sDpyVK~~Llp~~~~~~k~kt~v~k~tlnP~fnE~f~f~~~~~~~~~~k~L~~~V~D~d 344 (621)
..|.|.|.+| +|++.| ..||||++.+- ..+++|++.| +.||+|||+|.|. +.. .+..|.++|||.+
T Consensus 2 ~~L~V~v~~a~~l~~~~---~~dpYv~l~~~-----~~k~~T~~~k-~~nP~Wne~f~f~--v~~--~~~~L~v~V~d~~ 68 (128)
T d2cjta1 2 SLLCVGVKKAKFDGAQE---KFNTYVTLKVQ-----NVKSTTIAVR-GSQPSWEQDFMFE--INR--LDLGLTVEVWNKG 68 (128)
T ss_dssp EEEEEEEEEEECSSCGG---GCEEEEEEEET-----TEEEECCCEE-SSSCEEEEEEEEE--ECC--CSSEEEEEEEECC
T ss_pred eEEEEEEEEEECCCCCC---CcCeEEEEEeC-----CEEEEEEEec-CCCCeEEEEEEEe--ecc--ccceEEEEEEeCC
Confidence 3578999999 999977 57999999993 3467777665 6699999999998 432 2445999999998
Q ss_pred CCCCCCcccccccccccccccC
Q 007035 345 DTRDGEVNGALHEGKADAEEHG 366 (621)
Q Consensus 345 ~~~r~d~iG~v~~~~a~~~~~~ 366 (621)
..+ ++++|.+..++..+...+
T Consensus 69 ~~~-d~~lG~~~I~L~~l~~~~ 89 (128)
T d2cjta1 69 LIW-DTMVGTVWIPLRTIRQSN 89 (128)
T ss_dssp SSC-EEEEEEEEEEGGGSCBCS
T ss_pred CcC-CcceEEEEEEehhhccCC
Confidence 874 789999999988775443
|
| >d2zkmx2 b.7.1.1 (X:678-799) Phospholipase C-beta-2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: C2 domain-like superfamily: C2 domain (Calcium/lipid-binding domain, CaLB) family: PLC-like (P variant) domain: Phospholipase C-beta-2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.82 E-value=1.2e-09 Score=96.55 Aligned_cols=85 Identities=14% Similarity=0.026 Sum_probs=59.4
Q ss_pred ceEEEEecC-CCccccCcCCCCcceEeecCC---CCCCcccceeeccccCCCceeccc-eeeeccccccccccccccccc
Q 007035 267 YGYLSSKEA-DLIDLQHNVVGDSSTDCDLAP---HPGTEKSSSYSSSKRGSSIDWIEG-FKGSSDLHFKGAEKDLMPAEI 341 (621)
Q Consensus 267 ~l~v~l~e~-~L~~~d~~g~sDpyVK~~Llp---~~~~~~k~kt~v~k~tlnP~fnE~-f~f~~~~~~~~~~k~L~~~V~ 341 (621)
.++|.|..| +|+.. ..|||||+.|.. |..++.++++.+.++++||+|||+ |.|......+. ..|.+.||
T Consensus 2 tl~V~Visaq~L~~~----~~dPyV~V~l~g~~~D~~~~~~t~~~~~~n~~nP~wne~~~~~~~~~~~~l--~~L~f~V~ 75 (122)
T d2zkmx2 2 TLSITVISGQFLSER----SVRTYVEVELFGLPGDPKRRYRTKLSPSTNSINPVWKEEPFVFEKILMPEL--ASLRVAVM 75 (122)
T ss_dssp EEEEEEEEEESCCSS----CCCEEEEEEEECCTTSCCCCEECCCCSSSCCSSCBCCCCCEEEEEESSGGG--CEEEEEEE
T ss_pred EEEEEEEEeeCCCCC----CCCcEEEEEEECcCCCCCccEEEEEEEeCCeecceEcccEeEEEecCCCcc--cEEEEEEE
Confidence 467888888 99754 479999999963 344444555555689999999987 44432222222 35899999
Q ss_pred CCCCCCCCCccccccccccc
Q 007035 342 DNSDTRDGEVNGALHEGKAD 361 (621)
Q Consensus 342 D~d~~~r~d~iG~v~~~~a~ 361 (621)
|+| ++++|....++..
T Consensus 76 D~d----~~~lG~~~ipl~~ 91 (122)
T d2zkmx2 76 EEG----NKFLGHRIIPINA 91 (122)
T ss_dssp ETT----TEEEEEEEEEGGG
T ss_pred CCC----CCEEEEEEEEccc
Confidence 986 7899998776643
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.16 E-value=9.5e-06 Score=78.33 Aligned_cols=82 Identities=10% Similarity=0.065 Sum_probs=57.8
Q ss_pred CceEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCc-hhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeEE
Q 007035 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLF 492 (621)
Q Consensus 414 ~rY~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~-~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l~ 492 (621)
..|++.+..+-++.+.||+.. ..+..+++|+..... .......+|..+++.+...- -+++++.+....+..+
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~v-----pvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKL-----PVPKVLHFERHDGWSN 86 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTS-----CCCCEEEEEEETTEEE
T ss_pred hceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccC-----CCCcEEEEEecCCceE
Confidence 456666665555567899885 466677888876433 23445778888988886421 2567777778889999
Q ss_pred EEEeccccch
Q 007035 493 IVCELLRANL 502 (621)
Q Consensus 493 LVmEyl~gsL 502 (621)
+||++++|..
T Consensus 87 lv~~~l~G~~ 96 (263)
T d1j7la_ 87 LLMSEADGVL 96 (263)
T ss_dssp EEEECCSSEE
T ss_pred EEEEeccccc
Confidence 9999998743
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.65 E-value=0.00014 Score=69.53 Aligned_cols=73 Identities=10% Similarity=0.025 Sum_probs=52.6
Q ss_pred EeccCC-CCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeEEEEEeccc
Q 007035 421 YLGSAA-FSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLR 499 (621)
Q Consensus 421 ~LG~G~-fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l~LVmEyl~ 499 (621)
.+..|. .+.||+.. ...+..+++|+..... ...+..|..+++.+.... -.+++++.+..+.+..++||++++
T Consensus 17 ~~~~G~s~~~v~r~~-~~~~~~~vlK~~~~~~--~~~l~~E~~~l~~L~~~g----vpvP~v~~~~~~~~~~~~v~~~i~ 89 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLS-AQGRPVLFVKTDLSGA--LNELQDEAARLSWLATTG----VPCAAVLDVVTEAGRDWLLLGEVP 89 (255)
T ss_dssp ECSCTTSSCEEEEEE-CTTSCCEEEEEECSCT--TSCHHHHHHHHHHHHTTT----CCBCCEEEEEECSSCEEEEEECCS
T ss_pred EcCCcccCCeEEEEE-eCCCCEEEEEeCCccC--HhHHHHHHHHHHHHHhcC----CCCCceeeecccccceEEEEEeee
Confidence 344444 36789887 4567778999876543 346788999998887542 136777777788889999999997
Q ss_pred c
Q 007035 500 A 500 (621)
Q Consensus 500 g 500 (621)
|
T Consensus 90 G 90 (255)
T d1nd4a_ 90 G 90 (255)
T ss_dssp S
T ss_pred c
Confidence 5
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.53 E-value=0.00019 Score=74.25 Aligned_cols=77 Identities=18% Similarity=0.125 Sum_probs=50.8
Q ss_pred EEEeccCCCCceeEEEeCCCCcEEEEEEEecC--------chhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCe
Q 007035 419 TEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND--------KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (621)
Q Consensus 419 ~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~--------~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~ 490 (621)
.+.||-|....||++.+...++.+++|.-... ....++...|.++++.+.... ...+++++.+ +...
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~---p~~vP~v~~~--d~~~ 105 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHV---PHLVPRVFYS--DTEM 105 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTC---GGGSCCEEEE--ETTT
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhC---CCCcceEEEE--cCCC
Confidence 44589999999999998777889999975321 112345677888888886542 2246666654 4555
Q ss_pred EEEEEecccc
Q 007035 491 LFIVCELLRA 500 (621)
Q Consensus 491 l~LVmEyl~g 500 (621)
.++|||++++
T Consensus 106 ~~lvmE~L~~ 115 (392)
T d2pula1 106 AVTVMEDLSH 115 (392)
T ss_dssp TEEEECCCTT
T ss_pred CEEEEeccCC
Confidence 6789999975
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.79 E-value=0.0043 Score=61.76 Aligned_cols=72 Identities=15% Similarity=0.138 Sum_probs=48.3
Q ss_pred CCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEE--eeEeEecCeEEEEEecccc
Q 007035 427 FSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRL--YDYFYHLEHLFIVCELLRA 500 (621)
Q Consensus 427 fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl--~~~f~~~~~l~LVmEyl~g 500 (621)
--.||++. ..+|+.+++|+.+.......++..|..++..|..... ..+..+.. -..+......+.+++++.|
T Consensus 35 EN~vy~v~-~~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gi-pv~~p~~~~g~~~~~~~~~~~~l~~~~~G 108 (325)
T d1zyla1 35 ENRVYQFQ-DEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEV-PVAAPVAFNGQTLLNHQGFYFAVFPSVGG 108 (325)
T ss_dssp SSEEEEEC-CTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTC-SBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred cceeEEEE-cCCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCC-CCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence 35799997 4688999999998765455778889999998886531 11111111 1123355678889999875
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.47 E-value=0.0035 Score=64.15 Aligned_cols=72 Identities=14% Similarity=0.126 Sum_probs=48.5
Q ss_pred EEEeccCCCCceeEEEeC-------CCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccCCCCCCceEEEeeEeEecCeE
Q 007035 419 TEYLGSAAFSKVFQAQDL-------HTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (621)
Q Consensus 419 ~~~LG~G~fG~Vyka~d~-------~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~hpnIvrl~~~f~~~~~l 491 (621)
++.|+-|-.-.+|++... ...+.|.+++.-..... ....+|..+++.+.... -.+++++++..
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~-idr~~E~~i~~~ls~~g-----l~Pkll~~~~~---- 116 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETE-SHLVAESVIFTLLSERH-----LGPKLYGIFSG---- 116 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCH-HHHHHHHHHHHHHHHTT-----SSSCEEEEETT----
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchh-hHHHHHHHHHHHHHhCC-----CCCeEEEEcCC----
Confidence 356777888889988754 23466888887643333 35568899999887653 23466666643
Q ss_pred EEEEecccc
Q 007035 492 FIVCELLRA 500 (621)
Q Consensus 492 ~LVmEyl~g 500 (621)
.+||||+.|
T Consensus 117 g~I~efi~g 125 (395)
T d1nw1a_ 117 GRLEEYIPS 125 (395)
T ss_dssp EEEECCCCE
T ss_pred ceEEEEecc
Confidence 578999876
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.10 E-value=0.083 Score=51.27 Aligned_cols=53 Identities=6% Similarity=-0.022 Sum_probs=32.7
Q ss_pred eEEEEEeccCCCCceeEEEeCCCCcEEEEEEEecCchhhhhHHHHHHHHHHhcccC
Q 007035 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKND 471 (621)
Q Consensus 416 Y~I~~~LG~G~fG~Vyka~d~~tg~~VAlKii~~~~~~~~~~~~Ei~iL~~l~~~~ 471 (621)
..-.+.|..|---+.|+... ..| .+++|++.... ..+.+..|++++..+....
T Consensus 20 ~~~~~~i~~G~~N~ny~v~t-~~g-~yVLri~~~~~-~~~~l~~~~~~l~~L~~~g 72 (316)
T d2ppqa1 20 LTSYKGIAEGVENSNFLLHT-TKD-PLILTLYEKRV-EKNDLPFFLGLMQHLAAKG 72 (316)
T ss_dssp EEEEEEECC---EEEEEEEE-SSC-CEEEEEECC----CCHHHHHHHHHHHHHHTT
T ss_pred ceEeecCCCCcccCeEEEEE-CCC-cEEEEEcCCCC-CHHHHHHHHHHHHhhhhcc
Confidence 44456677787788899873 345 48999986532 2355667788888887653
|